<SEC-DOCUMENT>0001213900-24-023073.txt : 20240315
<SEC-HEADER>0001213900-24-023073.hdr.sgml : 20240315
<ACCEPTANCE-DATETIME>20240315162103
ACCESSION NUMBER:		0001213900-24-023073
CONFORMED SUBMISSION TYPE:	20-F
PUBLIC DOCUMENT COUNT:		77
CONFORMED PERIOD OF REPORT:	20231231
FILED AS OF DATE:		20240315
DATE AS OF CHANGE:		20240315

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Wearable Devices Ltd.
		CENTRAL INDEX KEY:			0001887673
		STANDARD INDUSTRIAL CLASSIFICATION:	COMPUTER COMMUNICATIONS EQUIPMENT [3576]
		ORGANIZATION NAME:           	06 Technology
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		20-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41502
		FILM NUMBER:		24755093

	BUSINESS ADDRESS:	
		STREET 1:		5 HA-TNUFA ST.
		CITY:			YOKNE'AM ILLIT
		STATE:			L3
		ZIP:			2066736
		BUSINESS PHONE:		97246185670

	MAIL ADDRESS:	
		STREET 1:		5 HA-TNUFA ST.
		CITY:			YOKNE'AM ILLIT
		STATE:			L3
		ZIP:			2066736
</SEC-HEADER>
<DOCUMENT>
<TYPE>20-F
<SEQUENCE>1
<FILENAME>ea0200952-20f_wearable.htm
<DESCRIPTION>ANNUAL REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:dtr="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:compsci="http://compsciresources.com" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:wlds="http://www.wearabledevices.co.il/20231231" xmlns:srt="http://fasb.org/srt/2023" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml">
<head>
     <title> </title>

<meta content="text/html" http-equiv="Content-Type"/>
</head>
<body><div style="font: 10pt Times New Roman, Times, Serif"><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0in; margin-bottom: 0in; width: 100%"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <ix:nonNumeric contextRef="c0" name="dei:DocumentType" id="ixv-18799">20-F</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:DocumentRegistrationStatement" id="ixv-18800">&#9744;</ix:nonNumeric> REGISTRATION STATEMENT PURSUANT TO SECTION
12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>OR</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:DocumentAnnualReport" id="ixv-18801">&#9746;</ix:nonNumeric> ANNUAL REPORT PURSUANT TO SECTION 13 OR
15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">For the fiscal year ended <ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="ixv-18802"><ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-en" name="dei:CurrentFiscalYearEndDate" id="ixv-18803">December 31</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalYearFocus" id="ixv-18804">2023</ix:nonNumeric></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>OR</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:DocumentTransitionReport" id="ixv-18805">&#9744;</ix:nonNumeric> TRANSITION REPORT PURSUANT TO SECTION 13
OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>OR</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:DocumentShellCompanyReport" id="ixv-18806">&#9744;</ix:nonNumeric> SHELL COMPANY REPORT PURSUANT TO SECTION
13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Commission File No.: <ix:nonNumeric contextRef="c0" name="dei:EntityFileNumber" id="ixv-18807">001-41502</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName" id="ixv-62"><b>Wearable Devices Ltd.</b></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>(Exact name of registrant as specified in its
charter)</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>Translation of registrant&#8217;s name into
English: Not applicable</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt-sec:edgarprovcountryen" name="dei:EntityIncorporationStateCountryCode" id="ixv-78"><b>Israel</b></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>(Jurisdiction of incorporation or organization)</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><ix:nonNumeric contextRef="c0" name="dei:EntityAddressAddressLine1" id="ixv-18808">5 Ha-Tnufa Street</ix:nonNumeric> </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><ix:nonNumeric contextRef="c0" name="dei:EntityAddressAddressLine2" id="ixv-18809">Yokne&#8217;am Illit</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:EntityAddressPostalZipCode" id="ixv-18810">2066736</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><ix:nonNumeric contextRef="c0" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry" id="ixv-18811"><ix:nonNumeric contextRef="c0" name="dei:EntityAddressCityOrTown" id="ixv-18812">Israel</ix:nonNumeric></ix:nonNumeric> </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>(Address of principal executive offices)</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c1" name="dei:ContactPersonnelName" id="ixv-103"><b>Asher Dahan</b></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Chief Executive Officer</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Tel: <ix:nonNumeric contextRef="c1" name="dei:CityAreaCode" id="ixv-18813">+972.</ix:nonNumeric><ix:nonNumeric contextRef="c1" name="dei:LocalPhoneNumber" id="ixv-18814">4.6185670</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>asher.dahan@wearabledevices.co.il</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><ix:nonNumeric contextRef="c1" name="dei:EntityAddressAddressLine1" id="ixv-18815">5 Ha-Tnufa Street</ix:nonNumeric> </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><ix:nonNumeric contextRef="c1" name="dei:EntityAddressAddressLine2" id="ixv-18816">Yokne&#8217;am Illit</ix:nonNumeric>, <ix:nonNumeric contextRef="c1" name="dei:EntityAddressPostalZipCode" id="ixv-18817">2066736</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><ix:nonNumeric contextRef="c1" name="dei:EntityAddressCityOrTown" id="ixv-18818"><ix:nonNumeric contextRef="c1" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry" id="ixv-18819">Israel</ix:nonNumeric></ix:nonNumeric> </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>(Name, Telephone, E-mail and/or Facsimile number
and Address of Company Contact Person)</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Securities registered or to
be registered pursuant to Section 12(b) of the Act:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 32%"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Title of each class</b></p></td> <td style="white-space: nowrap; width: 2%; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading Symbol(s)</b></span></td> <td style="white-space: nowrap; width: 2%; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of each exchange on which <br/>
registered</b></span></td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="text-align: center"><ix:nonNumeric contextRef="c2" name="dei:Security12bTitle" id="ixv-152"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary Shares, NIS 0.01 par value per share</span></ix:nonNumeric></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><ix:nonNumeric contextRef="c2" name="dei:TradingSymbol" id="ixv-156"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">WLDS</span></ix:nonNumeric></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c2" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-18820">Nasdaq</ix:nonNumeric> Capital Market</span></td></tr> <tr style="vertical-align: top; background-color: white"> <td style="text-align: center"><ix:nonNumeric contextRef="c3" name="dei:Security12bTitle" id="ixv-163"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants to Purchase Ordinary Shares</span></ix:nonNumeric></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><ix:nonNumeric contextRef="c3" name="dei:TradingSymbol" id="ixv-167"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">WLDSW</span></ix:nonNumeric></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c3" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-18821">Nasdaq</ix:nonNumeric> Capital Market</span></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Securities registered or to
be registered pursuant to Section 12(g) of the Act: None</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Securities for which there
is a reporting obligation pursuant to Section 15(d) of the Act: None</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Indicate the number of outstanding shares of each
of the issuer&#8217;s classes of capital or common stock as of the close of the period covered by the annual report: <ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-18822">20,387,428</ix:nonFraction> ordinary
shares as of December 31, 2023.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Indicate by check mark if the registrant is a well-known
seasoned issuer, as defined in Rule 405 of the Securities Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Yes &#9744;&#160;&#160;&#160;<ix:nonNumeric contextRef="c0" name="dei:EntityWellKnownSeasonedIssuer" id="ixv-18823">No</ix:nonNumeric> &#9746;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If this report is an annual or transition report,
indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Exchange Act of 1934.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">Yes &#9744;&#160;&#160;&#160;<ix:nonNumeric contextRef="c0" name="dei:EntityVoluntaryFilers" id="ixv-18824">No</ix:nonNumeric>
&#9746;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Indicate by check mark whether the registrant (1)
has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter
period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><ix:nonNumeric contextRef="c0" name="dei:EntityCurrentReportingStatus" id="ixv-18825">Yes</ix:nonNumeric> &#9746;&#160;&#160;&#160;No
&#9744;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Indicate by check mark whether the registrant has
submitted every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><ix:nonNumeric contextRef="c0" name="dei:EntityInteractiveDataCurrent" id="ixv-18826">Yes</ix:nonNumeric> &#9746;&#160;&#160;&#160;No
&#9744;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Indicate by check mark whether the registrant is
a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See definition of &#8220;large
accelerated filer, &#8220;accelerated filer,&#8221; and emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="white-space: nowrap; width: 25%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large accelerated filer &#9744;</span></td> <td style="white-space: nowrap; width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated filer &#9744;</span></td> <td style="white-space: nowrap; width: 25%"><ix:nonNumeric contextRef="c0" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="ixv-242"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accelerated filer</span></ix:nonNumeric></td> <td style="white-space: nowrap; width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td></tr> <tr style="vertical-align: top"> <td style="white-space: nowrap">&#160;</td> <td style="white-space: nowrap">&#160;</td> <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging growth company</span></td> <td style="white-space: nowrap"><ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:EntityEmergingGrowthCompany" id="ixv-252"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></ix:nonNumeric></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If an emerging growth company that prepares its
financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition
period for complying with any new or revised financial accounting standards &#8224; provided pursuant to Section 13(a) of the Exchange
Act. <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:EntityExTransitionPeriod" id="ixv-18827">&#9746;</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#8224;The term &#8220;new or revised financial
accounting standard&#8221; refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification
after April 5, 2012.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Indicate by check mark whether the registrant has
filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting
under Section 404(b) of the Sarbanes Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its
audit report. <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:IcfrAuditorAttestationFlag" id="ixv-18828">&#9744;</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If securities are registered pursuant to Section
12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction
of an error to previously issued financial statements. <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:DocumentFinStmtErrorCorrectionFlag" id="ixv-18829">&#9744;</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Indicate by check mark whether any of those error
corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s
executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). &#9744;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Indicate by check mark which basis of accounting
the registrant has used to prepare the financial statements included in this filing.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><ix:nonNumeric contextRef="c0" name="dei:DocumentAccountingStandard" id="ixv-18830">U.S. GAAP</ix:nonNumeric> &#9746;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">International Financial Reporting Standards as
issued by the International Accounting Standards Board &#9744;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Other &#9744;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If &#8220;Other&#8221; has been checked in response
to the previous question, indicate by check mark which financial statement item the registrant has elected to follow.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&#9744; Item 17&#160;&#160;&#160;&#9744;
Item 18</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If this is an annual report, indicate by check
mark whether the registrant is a shell company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">Yes &#9744;&#160;&#160;&#160;No
<ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:EntityShellCompany" id="ixv-18831">&#9746;</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0in; margin-bottom: 0in; width: 100%"><div style="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TABLE OF CONTENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 10%">&#160;</td>
    <td style="width: 82%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b>&#160;</span><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2"><a href="#a_001"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">INTRODUCTION</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td colspan="2"><a href="#a_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td colspan="3" style="text-align: center"><a href="#a_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART I</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 1.</span></td>
    <td><a href="#a_004"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 2.</span></td>
    <td><a href="#a_005"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OFFER STATISTICS AND EXPECTED TIMETABLE.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 3.</span></td>
    <td><a href="#a_006"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KEY INFORMATION.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="text-align: justify"><a href="#a_007"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Reserved]</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td><a href="#a_008"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalization and Indebtedness.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td><a href="#a_009"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reasons for the Offer and Use of Proceeds.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td><a href="#a_010"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk Factors.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td><a href="#a_011"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Summary Risk Factors</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 4.</span></td>
    <td><a href="#a_012"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">INFORMATION ON THE COMPANY.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td><a href="#a_013"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">History and Development of the Company.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td><a href="#a_014"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business Overview.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td><a href="#a_015"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Organizational Structure.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td><a href="#a_016"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property, Plants and Equipment.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 4A.</span></td>
    <td><a href="#a_017"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">UNRESOLVED STAFF COMMENTS.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 5.</span></td>
    <td><a href="#a_018"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OPERATING AND FINANCIAL REVIEW AND PROSPECTS.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td><a href="#a_019"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating Results.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td><a href="#a_020"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liquidity and Capital Resources.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td><a href="#a_021"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research and development, patents and licenses, etc.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td><a href="#a_022"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trend information.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</span></td>
    <td><a href="#a_023"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Critical Accounting Estimates.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 6.</span></td>
    <td><a href="#a_024"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td><a href="#a_025"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors and Senior Management.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td><a href="#a_026"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td><a href="#a_027"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board Practices.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td><a href="#a_028"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employees.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">82</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</span></td>
    <td><a href="#a_029"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share Ownership.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">82</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.</span></td>
    <td><a href="#a_030"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Action to Recover Erroneously Awarded Compensation</span></a></td>
    <td style="text-align: center">82</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 7.</span></td>
    <td><a href="#a_031"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td><a href="#a_032"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Major Shareholders.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td><a href="#a_033"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Related Party Transactions.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">85</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td><a href="#a_041"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interests of Experts and Counsel.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">86</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 8.</span></td>
    <td><a href="#a_034"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FINANCIAL INFORMATION.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">86</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td><a href="#a_035"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Statements and Other Financial Information.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">86</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td><a href="#a_036"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant Changes.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">86</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 9.</span></td>
    <td><a href="#a_037"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE OFFER AND LISTING.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">87</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td><a href="#a_038"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offer and Listing Details.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">87</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td><a href="#a_039"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plan of Distribution.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">87</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td><a href="#a_040"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Markets.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">87</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td><a href="#a_042"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling Shareholders.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">87</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</span></td>
    <td><a href="#a_043"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dilution.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">87</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.</span></td>
    <td><a href="#a_044"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenses of the Issue.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">87</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 10.</span></td>
    <td><a href="#a_045"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ADDITIONAL INFORMATION.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">87</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td><a href="#a_046"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share Capital.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">87</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td><a href="#a_047"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Memorandum and Articles of Association.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">87</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td><a href="#a_048"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Material Contracts.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">88</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td><a href="#a_049"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange Controls.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">88</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</span></td>
    <td><a href="#a_050"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxation.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">88</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.</span></td>
    <td><a href="#a_051"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends and Paying Agents.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">G.</span></td>
    <td><a href="#a_052"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statement by Experts.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.</span></td>
    <td><a href="#a_053"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Documents on Display.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">I.</span></td>
    <td><a href="#a_054"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsidiary Information.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">J.</span></td>
    <td><a href="#a_055"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual Report to Security Holders.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 11.</span></td>
    <td><a href="#a_056"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">98</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 12.</span></td>
    <td><a href="#a_057"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">98</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td><a href="#a_058"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debt Securities.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">98</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td><a href="#a_059"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants and rights.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">98</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td><a href="#a_060"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Securities.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">98</span></td></tr>
</table><div>

</div><p style="margin: 0">&#160;</p><div>

</div><p style="margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence -->&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="3" style="text-align: center"><a href="#a_062"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART II</span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td colspan="3">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 13.</span></td>
    <td style="width: 82%"><a href="#a_063"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES.</span></a></td>
    <td style="text-align: center; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 14.</span></td>
    <td><a href="#a_064"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 15.</span></td>
    <td><a href="#a_065"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONTROLS AND PROCEDURES.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM&#160;16. </span></td>
    <td><a href="#a_066"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[RESERVED]</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 16A.</span></td>
    <td><a href="#a_067"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUDIT COMMITTEE FINANCIAL EXPERT.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 16B.</span></td>
    <td><a href="#a_068"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CODE OF ETHICS.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 16C.</span></td>
    <td><a href="#a_069"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRINCIPAL ACCOUNTANT FEES AND SERVICES.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 16D.</span></td>
    <td><a href="#a_070"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">102</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 16E.</span></td>
    <td><a href="#a_071"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">102</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 16F.</span></td>
    <td><a href="#a_072"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CHANGE IN REGISTRANT&#8217;S CERTIFYING ACCOUNTANT.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">102</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 16G.</span></td>
    <td><a href="#a_073"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CORPORATE GOVERNANCE.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">102</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 16H.</span></td>
    <td><a href="#a_074"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MINE SAFETY DISCLOSURE.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 16I.</span></td>
    <td><a href="#a_075"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 16J.</span></td>
    <td><a href="#a_076"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">INSIDER TRADING POLICIES</span></a></td>
    <td style="text-align: center">104</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 16K.</span></td>
    <td><a href="#a_077"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CYBERSECURITY</span></a></td>
    <td style="text-align: center">104</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="3" style="text-align: center"><a href="#a_078"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART III</span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td colspan="3">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 17.</span></td>
    <td><a href="#a_079"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FINANCIAL STATEMENTS.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">106</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 18.</span></td>
    <td><a href="#a_080"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FINANCIAL STATEMENTS.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">106</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 19.</span></td>
    <td><a href="#a_081"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBITS.</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">106</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td colspan="2"><a href="#a_082"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNATURES</span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">108</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 4; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence -->&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><img alt="" src="image_001.jpg"/></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Wearable Devices Ltd.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><div><a id="a_001"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTRODUCTION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In this annual report, &#8220;we,&#8221; &#8220;us,&#8221;
&#8220;our,&#8221; the &#8220;Company&#8221; and &#8220;WLDS&#8221; refer to Wearable Devices Ltd.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Wearable Devices Ltd. was incorporated in Israel
in 2014 under the name &#8220;Wearable Devices Ltd.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We are a growth company
developing a non-invasive neural input interface in the form of a wrist wearable band for controlling digital devices using subtle touchless
finger movements. Since our technology was introduced to the market in 2014, we have been working with both Business-to-Business, or B2B,
and Business to Consumer, or B2C, customers as part of our push-pull strategy. We have completed the transition phase from research and
development to commercialization of our technology into B2B and B2C products. At the same time, we are manufacturing our first B2C consumer
product, the &#8220;Mudra Band&#8221;, an aftermarket accessory band for the Apple Watch which allows touchless operation and control
of Apple ecosystem devices such as iPhone, Mac computer, Apple TV, and iPad, inter alia.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On September 15, 2022, we completed our initial
public offering, or IPO, having listed our ordinary shares and warrants on the Nasdaq Capital Market on September 13, 2022 under the symbols
&#8220;WLDS&#8221; and &#8220;WLDSW,&#8221; respectively.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our reporting currency and functional currency
is the U.S. dollar. Unless otherwise expressly stated or the context otherwise requires, references in this annual report to &#8220;NIS&#8221;
are to New Israeli Shekels, and references to &#8220;dollars&#8221; or &#8220;$&#8221; mean U.S. dollars.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">This annual report includes
statistical, market and industry data and forecasts which we obtained from publicly available information and independent industry publications
and reports that we believe to be reliable sources. These publicly available industry publications and reports generally state that they
obtain their information from sources that they believe to be reliable, but they do not guarantee the accuracy or completeness of the
information. Although we believe that these sources are reliable, we have not independently verified the information contained in such
publications.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We report our financial statements in accordance
with generally accepted accounting principles in the United States, or U.S. GAAP.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 5; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence -->&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="a_002"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Certain information included or incorporated by
reference in this annual report on Form 20-F may be deemed to be &#8220;forward-looking statements&#8221;. Forward-looking statements
are often characterized by the use of forward-looking terminology such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221;
&#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;believe,&#8221; &#8220;should,&#8221; &#8220;intend,&#8221;
&#8220;project&#8221; or other similar words, but are not the only way these statements are identified.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">These forward-looking statements may include, but
are not limited to, statements relating to our objectives, plans and strategies, statements that contain projections of results of operations
or of financial condition, expected capital needs, and expenses, statements relating to the research, development, completion and use
of our products, and all statements (other than statements of historical facts) that address activities, events or developments that we
intend, expect, project, believe or anticipate will or may occur in the future.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Forward-looking statements are not guarantees of
future performance and are subject to risks and uncertainties. We have based these forward-looking statements on assumptions and assessments
made by our management in light of their experience and their perception of historical trends, current conditions, expected future developments,
and other factors they believe to be appropriate.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Important factors that could cause actual results,
developments, and business decisions to differ materially from those anticipated in these forward-looking statements include, among other
things:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 0.5in">&#160;</td>
    <td style="vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our financial statements for the year ended December 31, 2023, contained an explanatory paragraph regarding substantial doubt about our ability to continue as a going concern, which could prevent us from obtaining new financing on reasonable terms or at all;</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Surface Nerve Conductance, or SNC, becoming the industry standard input method for wearable computing and consumer electronics;</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to maintain and expand our existing customer base; &#160;</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to maintain and expand compatibility of our devices with a broad range of mobile devices and operating systems; &#160;</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to maintain our business models; &#160;</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to correctly predict the market growth;</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to remediate material weaknesses in our internal control over financial reporting; &#160;</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to retain our founders; &#160;</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to maintain, protect, and enhance our intellectual property; &#160;</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to raise capital through the issuance of additional securities; &#160;</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the impact of competition and new technologies; &#160;</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">general market, political and economic conditions in the countries in which we operate;</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">projected capital expenditures and liquidity; &#160;</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes in our strategy;&#160;&#160;&#160;</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to comply with the Nasdaq listing requirements;</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the overall global political and economic environment in the countries in which we operate including those related to recent unrest and actual or potential armed conflict in Israel and other parts of the Middle East, such as the recent attack by Hamas and other terrorist organizations from the Gaza Strip and Israel&#8217;s war against them;</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">litigation; and</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other risks and uncertainties, including those factors referred to in &#8220;Item 3. Key Information &#8211; D. Risk Factors,&#8221; &#8220;Item 4. Information on the Company,&#8221; and &#8220;Item 5. Operating and Financial Review and Prospects&#8221;, as well as in this annual report on Form 20-F generally. &#160;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Readers are urged to carefully review and consider
the various disclosures made throughout this annual report on Form 20-F which are designed to advise interested parties of the risks and
factors that may affect our business, financial condition, results of operations and prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">You should not put undue reliance on any forward-looking
statements. Any forward-looking statements in this annual report on Form 20-F are made as of the date hereof, and we undertake no obligation
to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except
as required by law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 6; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence -->&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><div><a id="a_003"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PART I</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><div><a id="a_004"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="a_005"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="a_006"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 3. KEY INFORMATION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="a_007"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>A. [Reserved]</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="a_008"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>B. Capitalization and Indebtedness</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="a_009"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>C. Reasons for the Offer and Use of Proceeds.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="a_010"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>D. Risk Factors.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our business faces significant risks. You should
carefully consider the risks described below, together with all of the other information in this annual report on Form 20-F. The risks
described below are not the only risks facing us. Additional risks and uncertainties not currently known to us or that we currently deem
to be immaterial may also materially and adversely affect our business operations. If any of these risks actually occurs, our business
and financial condition could suffer and the price of our securities could decline. This annual report also contains forward-looking statements
that involve risks and uncertainties. Our results could materially differ from those anticipated in these forward-looking statements,
as a result of certain factors including the risks described below and elsewhere in this report and our other Securities and Exchange
Commission, or SEC, filings. See &#8220;Cautionary Note Regarding Forward-Looking Statements&#8221; above.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="a_011"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Summary Risk Factors</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Risks Related to Our Business</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There is no assurance that wrist SNC will be the dominant input method in the wearable computing and consumer electronics industry;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If we are unable to successfully develop and timely introduce new products and services or enhance existing products and services, our business may be affected;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If we are unable to develop and introduce new gesture input functions and improve existing functions in a cost-effective and timely manner, our business, results of operations and financial condition would be adversely affected;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our current and future products and services may experience quality problems from time to time that can result in adverse publicity, product recalls, litigation, regulatory proceedings, and warranty claims resulting in significant direct or indirect costs, decreased revenue and operating margin, and harm to our brand;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The period of time from a license agreement to implementation of our technology is long and we are subject to the risks of cancellation or postponement of the contract or unsuccessful implementation;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We rely on a limited number of suppliers, contract manufacturers, and logistics providers, and each of our products is manufactured by a single contract manufacturer;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We are a growth company with limited operating history. We may never be able to effectuate our business plan or achieve sufficient revenue or reach profitability;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We invest effort and money into seeking validation of our technology and products with B2B companies. There can be no assurance that we will enter into license agreements, which could adversely affect our future business, results of operations and financial condition.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our actual or perceived failure to comply with legal obligations with respect to personal information and customer data could harm our business.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Risks Related to the Industry in Which We Operate</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The forecasts of market growth included in this annual report on Form 20-F may prove to be inaccurate, and even if the markets in which we compete achieve the forecasted growth, we cannot assure you our business will grow at similar rates, if at all;</span></td></tr>
</table><div>

</div><p style="margin: 0">&#160;</p><div>

</div><p style="margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 7; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The market for wearable computing devices is still in the early stages of growth and if it does not continue to grow, grows more slowly than we expect, or fails to grow as large as we expect, our business and operating results would be harmed;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If we do not compete effectively, our prospects, operating results, and financial condition could be adversely affected.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b><i>Risks Related to Our Financial Condition
and Operations</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may need to raise additional capital required to grow our business. We may not be able to raise capital on terms acceptable to us or at all, and the sale of additional shares, equity or debt securities could result in additional dilution to our shareholders;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have a going concern opinion which could prevent us from obtaining new financing on reasonable terms or at all; </span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our operating results could be materially harmed if we are unable to accurately forecast consumer demand for our products and services and adequately manage our inventory.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b><i>Risks Related to Ownership of our Ordinary
Shares and Warrants</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our current officers and directors and holders of more than 5% of our Ordinary Shares currently beneficially own an aggregate of approximately 32.2% of our Ordinary Shares and are able to exert significant control over matters submitted to our shareholders for approval; </span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Warrants, which are speculative in nature, are listed on Nasdaq separately and may provide investors with an arbitrage opportunity that could adversely affect the trading price of our Ordinary Shares;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain warrant holders may be entitled to receive additional Ordinary Shares, to the extent we engage in future dilutive issuances;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We do not know whether a market for the Ordinary Shares or Warrants will be sustained or what the trading price of the Ordinary Shares or Warrants will be. As a result, it may be difficult for you to sell your securities;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If we are unable to regain compliance with all applicable continued listing requirements and standards of Nasdaq, our Ordinary Shares could be delisted from Nasdaq.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Risks Related to Our Intellectual Property</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may not be able to adequately protect or enforce our intellectual property rights. Our efforts to do so may be costly;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If we are unable to protect our domain names, our brand, business, and operating results could be adversely affected;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may become subject to litigation brought by third parties claiming infringement by us of their intellectual property rights;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our use of &#8220;open source&#8221; software could negatively affect our ability to sell our products and subject us to possible litigation.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b><i>Risks Related to Operations in Israel</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conditions in Israel, including <span style="background-color: white">implications of political, economic and military instability arising from the Israel-Hamas war</span>, affect our operations and may limit our ability to produce or sell our products and our ability to raise additional funds;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may be subject to the limitations resulting from our receipt of Israeli government grants for certain of our research and development activities, the terms of which may require us to pay royalties and to satisfy specified conditions;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provisions of Israeli law and our amended and restated articles of association may delay, prevent or otherwise impede a merger with, or an acquisition of, us, which could prevent a change of control, even when the terms of such a transaction are favorable to us and our shareholders.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>General Risk Factors</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We incur significant costs as a result of our being a public company. Our management is required to devote substantial time to compliance with ongoing SEC and Nasdaq requirements; </span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There can be no assurance that we will be able to comply with the continued listing standards of Nasdaq, which could result in a de-listing of our Ordinary Shares or Warrants.</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 8; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Risks Related to Our Business</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>There is no assurance
that wrist SNC will be the dominant input method in the wearable computing and consumer electronics industry.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Although we believe that
SNC, the technology behind our Mudra gesture recognition system that tracks neural signals in the user&#8217;s wrist, will become the
industry standard input method for wearable computing and consumer electronics, it is possible that other input methods, such as electroencephalography,
electromyography voice or camera gestures&#8212;or a new, disruptive sensor based on new or existing technology&#8212;will achieve acceptance
or dominance in the market. If wearable computing and consumer electronics based on other input methods gain acceptance by the market,
consumer electronics companies, consumer electronics brands and consumers in place of or as a substitute to SNC, and we do not sign license
and integration agreements to the same extent as we expect, our business, results of operations and financial condition would be adversely
affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>If we are unable
to successfully develop and timely introduce new products and services or enhance existing products and services, our business may be
adversely affected.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We must continually develop
and introduce new products and services and improve and enhance our existing products and services to maintain or increase our sales.
The success of new or enhanced products and services may depend on a number of factors, including anticipating and effectively addressing
consumer preferences and demand, the success of our sales and marketing efforts, timely and successful research and development, effective
forecasting and management of product demand, purchase commitments and inventory levels, effective management of manufacturing and supply
costs, and the quality of or defects in our products.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The development of our
products and services is a complex and costly process, and we typically have several products and services in development at the same
time. Given the complexity, we occasionally have experienced, and could experience in the future, delays in completing the development
and introduction of new and enhanced products, product features, and services. Problems in the design or quality of our products or services
may also have an adverse effect on our business, financial condition, brand, and operating results. Unanticipated problems in developing
products and services could also divert substantial research and development resources, which may impair our ability to develop new products
and services and enhancements of existing products and services, and could substantially increase our costs. If new or enhanced product
and service introductions are delayed or not successful, we may not be able to achieve an acceptable return, if any, on our research and
development efforts, and our business may be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>If we are unable
to develop and introduce new gesture input functions and improve existing functions in a cost-effective and timely manner, our business,
results of operations and financial condition would be adversely affected. </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our business and future operating results will
depend on our ability to complete development of existing finger and hand gestures and to develop and introduce new and enhanced gesture
functions that incorporate the latest technological advancements in user experience and user interaction, software, algorithms and electrode
technologies and to satisfy our customers and consumers. This will require us to invest resources in research and development and also
require that we:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">design new innovative, intuitive natural and accurate gestures to suit a large variety of wearable computing devices, operating system platforms and form factors, that differentiate our products from those of our competitors;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">integrate successfully the hardware and the software into consumer electronics companies&#8217; products;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">respond effectively to technological changes or product announcements by our competitors; and</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">adjust to changing market conditions and consumer preferences quickly and cost-effectively.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 9; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">If there are delays in
or we fail to complete our existing and new development programs, we may not be able to meet the requirements, needs and preferences of
our customers and consumers and our results of operations and financial condition would be adversely affected. In addition, we cannot
assure you that our investment in research and development will lead to any corresponding revenue, in which case our business, results
of operations and financial condition would also be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>The failure to effectively
manage the introduction of new or enhanced products may adversely affect our operating results.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We make efforts to release
new consumer products or enhanced product features successfully. The release of new consumer products could adversely impact the sales
of our existing products to consumers. For instance, consumers may decide to purchase new products instead of existing products. Moreover,
future consumer electronics customers may decide to integrate enhanced features which do not yet exist in our own consumer products. This
could lead to excess inventory and discounting of our existing products. In addition, we anticipate incurring higher levels of sales and
marketing expenses accompanying each product introduction. Accordingly, if we fail to effectively manage introductions of new consumer
products or enhanced product features, our operating results would be harmed.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>Our current and
future products and services may experience quality problems from time to time that can result in adverse publicity, product recalls,
litigation, regulatory proceedings, and warranty claims resulting in significant direct or indirect costs, decreased revenue and operating
margin, and harm to our brand. </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We sell complex products
and services that could contain design and manufacturing defects in their materials, hardware, software, and firmware. These defects could
include defective materials or components, or &#8220;bugs&#8221; that can unexpectedly interfere with the products&#8217; intended operations
or cause injuries to users. Although we significantly and thoroughly test new and enhanced products and services before their release,
there can be no assurance we will be able to detect, prevent, or fix all defects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Failure to detect, prevent,
or fix defects could result in a variety of consequences, including a greater number of returns of products than expected from our customers
and consumers, or future retail customers, regulatory proceedings, product recalls, and litigation, which could harm our revenue and operating
results. The occurrence of real or perceived quality problems or material defects in our current and future products could expose us to
warranty claims. If we experience relatively large returns from our retail customers or our other customers and consumers, our business
and operating results could be harmed. In addition, any negative publicity or lawsuits filed against us related to the perceived quality
and safety of our products could also affect our brand and decrease demand for our products and services, and adversely affect our operating
results and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Furthermore, our products
are used to monitor our users&#8217; hand bio-potentials activity and to operate control functions on a large variety of digital devices
which operate on different users&#8217; wrist physiology and device operating system and model. It may happen that our products do not
provide accurate measurements or correctly classify gestures to users, which may result in negative publicity, and, in some cases, may
require us to expend time and resources to defend litigation. If our products fail to provide accurate measurements and control functions
to users, or if there are reports or claims of inaccurate measurements or claims regarding the overall benefits of our products and services
in the future, we may become the subject of negative publicity, litigation, including class action litigation, regulatory proceedings,
and warranty claims, and our brand, operating results, and business could be harmed.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>The period of time
from a license agreement to implementation of our technology is long and we are subject to the risks of cancellation or postponement of
the contract or unsuccessful implementation.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Our products are technologically
complex, incorporate many technological innovations and are typically intended for use in interface input applications. Prospective consumer
electronics customers generally must make significant commitments of resources to test and validate our technology before including it
in any particular product device. The development cycles of our products with new consumer electronics customers may take approximately
one to three years after an initial agreement is reached, depending on the customer and the complexity of the input solution. These development
cycles result in our investment of our resources prior to realization of any revenues. Further, we are subject to the risk that a consumer
electronics company cancels or postpones implementation of our technology, as well as that we may not be able to implement our technology
successfully. Further, our sales could be less than forecast if the product device is unsuccessful, due to reasons related or unrelated
to our technology. Long development cycles and product cancellations or postponements may adversely affect our business, results of operations
and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 10; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>We are a growth
company with limited operating history. We may never be able to effectuate our business plan or achieve sufficient revenue or reach profitability.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">For some aspects of our
technology, we are still a growth company, and are subject to all of the risks inherent in the establishment of a new business enterprise.
We have a limited operating history and only a preliminary and unproven business plan upon which investors may evaluate our prospects.
Although we have produced a working development kit, the Mudra Inspire, we have not mass produced any product planned for global consumers.
Even if we are able to do so, we may not be able to manufacture the product at the low costs needed to support our business models. We
have not yet entered into any commercial arrangement for the licensing of our technology under a licensing model.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Furthermore, even if our
technology becomes commercially viable, our business models may not generate sufficient revenue necessary to support our business. The
consumer electronics industry is highly competitive, and our technology, products, services or business models may not achieve widespread
market acceptance. If we are unable to address any of the aforementioned issues, or encounter other problems, expenses, difficulties,
complications, and delays in connection with the starting and expansion of our business, our entire business may fail.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Our ability to generate
revenue from our operations and, ultimately, achieve profitability will depend on, among other things, whether we can complete the development
and commercialization of our technology, our ability to integrate and license our technology into consumer electronic devices, our future
products and our services, whether we can manufacture products on a commercial scale in such amounts and at such costs as we anticipate,
and whether we can achieve market acceptance of our products, services and business models. We may never generate any revenue or operate
on a profitable basis. Even if we achieve profitability, we may not be able to sustain it.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>We invest effort
and money into seeking validation of our technology and products with B2B companies, such as consumer electronics companies and consumer
electronics brands, and there can be no assurance that we will enter into license agreements, which could adversely affect our future
business, results of operations and financial condition.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We invest effort and money
from the time of our initial contact with a B2B company, be it a consumer electronics company or a consumer electronics brand, to the
date on which the B2B company chooses to integrate our technology into one or more of its products. The B2B company integrates our products
and our proprietary software and hardware into a complete consumer electronics product that it manufactures. Successful validation of
our technology will result in a signed commercial license agreement with the B2B company. However, we estimate there will be a three-to-five-year
period from the time we are first introduced to such a customer to signing a licensing agreement and as of March 13, 2024, we have not
entered into any licensing agreements. This is a significant amount of time and negotiations may break down during the course of such
negotiations. Accordingly, there is a possibility that we could expend our resources without success.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">In addition, a B2B company&#8217;s
current solution, internally developed or integrated with a third-party solution, may have an advantage with the company going forward
because of the established trust and relationship between the parties, which could make it more difficult for competitors, like us, to
integrate new solutions for other products or product lines. If we fail to sign a significant number of B2B license agreements in the
future, our business, results of operations and financial condition would be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>If we are unable
to anticipate and satisfy consumer preferences in a timely manner, our business may be adversely affected. </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Our success depends on
our ability to anticipate and satisfy consumer preferences in a timely manner. All of our products are subject to changing consumer preferences
that cannot be predicted with certainty. Consumers may decide not to choose our solutions or purchase our products and services as their
preferences could shift rapidly to different types of input methods or away from these types of products and services altogether, and
our future success depends in part on our ability to anticipate and respond to shifts in consumer preferences. In addition, future products
may have higher prices than our current products and the products of some of our competitors, which may not appeal to consumers or only
appeal to a smaller subset of consumers. It is also possible that competitors could introduce new products and services that negatively
impact consumer preferences for our input method and technology, which could result in decreased sales of our products and services and
a loss in market share. Accordingly, if we fail to anticipate and satisfy consumer preferences in a timely manner, our business may be
adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 11; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>If we are unable
to successfully comply with Apple&#8217;s &#8220;Accessory Design Guidelines for Apple Devices&#8221;, our business, results of operation
and financial condition may be adversely affected.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Our consumer product,
the &#8220;Mudra Band&#8221;, is an aftermarket accessory band for the Apple Watch which allows touchless operation and control of the
watch and iPhone. Apple enforces strict guidelines which address the physical design of cases, covers, screen overlays, and camera attachments
for Apple devices and specifications for hardware accessories that use Bluetooth to communicate with Apple products including Mac, iPhone,
iPad and iPod touch models. All accessories must meet requirements which include, and may not be limited to, compliance testing, integrated
USB receptacles, user supplied cables and AC power adapters, attachments, magnetic interference, radio frequency performance, thermal
management and tripod connections. In particular, watch bands,&#160;such as the Mudra Band,&#160;have to meet certain requirements with
respect to lugs, magnetic chargers, band sizes and dimensions, band material, and environmental regulations. Accessories have to also
comply with Bluetooth accessory identification, accessory power (lighting), app discovery, device power, power and communications protocols,
Bluetooth, Bluetooth low energy and connectors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Apple reserves the right
to change specifications and the terms and conditions at its sole consideration, and, therefore, we may be required&#160;to change the
Mudra Band specifications to comply with future Apple change&#160;requirements. Our company is investing significant resources to ensure
that&#160;the Mudra Band is&#160;compatible with all the relevant guidelines. Therefore, a significant change in the Apple guidelines
may cause our business, results of operations and financial condition to be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>We rely on a limited
number of suppliers, contract manufacturers, and logistics providers, and each of our products is manufactured by a single contract manufacturer.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We rely on a limited number
of suppliers, contract manufacturers, and logistics providers.&#160;In particular, we use contract manufacturers located in Asia and Israel,
and each of our products&#8217; sub-components are manufactured by a different single contract manufacturer.&#160; Our reliance on single
contract manufacturers for each of our products&#8217; components increases our risks since we do not currently have any alternative or
replacement manufacturers.&#160;In the event of an interruption from a contract manufacturer, we may not be able to develop alternate
or secondary sources without incurring material additional costs and substantial delays.&#160;While component shortages have historically
been immaterial, they could be material in the future. Furthermore, these risks could materially and adversely affect our business if
one of our contract manufacturers is impacted by a natural disaster or other interruption at a particular location because each of our
contract manufacturers produces our product&#8217;s components in a single location. In addition, some of our suppliers, contract manufacturers,
and logistics providers may have more established relationships with our competitors and potential competitors, and as a result of such
relationships, such suppliers, contract manufacturers, and logistics providers may choose to limit or terminate their relationship with
us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">If we experience significantly
increased demand, or if we need to replace an existing supplier, contract manufacturer, or logistics provider, we may be unable to supplement
or replace such supply, contract manufacturing, or logistics capacity on terms that are acceptable to us, which may undermine our ability
to deliver our products to customers in a timely manner.&#160;For example, for certain of our products, it may take a significant amount
of time to identify a contract manufacturer that has the capability and resources to build the product to our specifications in sufficient
volume. Identifying suitable suppliers, contract manufacturers, and logistics providers is an extensive process that requires us to become
satisfied with their quality control, technical capabilities, responsiveness and service, financial stability, regulatory compliance,
and labor and other ethical practices.&#160;Accordingly, a loss of any key supplier, contract manufacturer, or logistics provider could
adversely impact our revenue and operating results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 12; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>Because many of
the key components in our products come from limited or sole sources of supply, we are susceptible to supply shortages, long lead times
for components, and supply changes, any of which could disrupt our supply chain.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Many of the key components
used to manufacture our products come from limited or sole sources of supply. Our contract manufacturers generally purchase these components
on our behalf, subject to certain approved supplier lists, and we do not have any long-term arrangements with our suppliers. We are therefore
subject to the risk of shortages and long lead times in the supply of these components and the risk that our suppliers discontinue or
modify components used in our products. In addition, the lead times associated with certain components are lengthy and preclude rapid
changes in quantities and delivery schedules. We have in the past experienced and may in the future experience component shortages, and
the predictability of the availability of these components may be limited. While component shortages have historically been immaterial,
they could be material in the future. In the event of a component shortage or supply interruption from suppliers of these components,
we may not be able to develop alternate sources in a timely manner. Developing alternate sources of supply for these components may be
time-consuming, difficult, and costly and we may not be able to source these components on terms that are acceptable to us, or at all,
which may undermine our ability to meet our requirements or to fill our orders in a timely manner. Any interruption or delay in the supply
of any of these parts or components, or the inability to obtain these parts or components from alternate sources at acceptable prices
and within a reasonable amount of time, would harm our ability to meet our scheduled product deliveries to our customers and users. This
could harm our relationships with our channel partners and users and could cause delays in shipment of our products and adversely affect
our operating results. In addition, increased component costs could result in lower gross margins. If we are unable to buy these components
in quantities sufficient to meet our requirements on a timely basis, we will not be able to deliver products and services to our customers
and users.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>We have limited
control over our suppliers, contract manufacturers, and logistics providers, which subjects us to significant risks, including the potential
inability to obtain or produce quality products on a timely basis or in sufficient quantity.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We have limited control
over our suppliers, contract manufacturers, and logistics providers, including aspects of their specific manufacturing processes and their
labor, environmental, or other practices, which subjects us to significant risks, including the following:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inability to satisfy demand for our products;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reduced control over delivery timing and product reliability;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reduced ability to oversee the manufacturing process and components used in our products;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reduced ability to monitor compliance with our product manufacturing specifications;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reduced ability to develop comprehensive manufacturing specifications that take into account materials shortages, materials substitutions, and variance in the manufacturing capabilities of our third-party contract manufacturers;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">price increases;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the failure of a key supplier, contract manufacturer, or logistics provider to perform its obligations to us for technical, market, or other reasons;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulties in establishing additional contract manufacturing relationships if we experience difficulties with our existing contract manufacturers;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shortages of materials or components;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">misappropriation of our intellectual property;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">exposure to natural catastrophes, political unrest, terrorism, labor disputes, and economic instability resulting in the disruption of trade from foreign countries in which our products are manufactured;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes in local economic conditions in countries where our suppliers, contract manufacturers, or logistics providers are located;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the imposition of new laws and regulations, including those relating to labor conditions, quality and safety standards, imports, duties, taxes, and other charges on imports, as well as trade restrictions and restrictions on currency exchange or the transfer of funds; and</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">insufficient warranties and indemnities on components supplied to our contract manufacturers.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 13; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>Our future success
depends on the continuing efforts of our key employees, including our founders, Asher Dahan, Guy Wagner and Leeor Langer, and on our ability
to attract and retain highly skilled personnel and senior management. </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Our future success depends,
in part, on our ability to continue to attract and retain highly skilled personnel. In particular, we are highly dependent on the contributions
of our co-founders, Asher Dahan, Guy Wagner and Leeor Langer, as well as other members of our management team. The loss of any key personnel
could make it difficult to manage our operations and research and development activities, reduce our employee retention and revenue, and
impair our ability to compete. Although we have entered into employment agreements with our key personnel, these agreements have no specific
duration and provide for at-will employment, which means they may terminate their employment relationship with us at any time.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Competition for highly
skilled personnel is often intense, especially in Israel where we are located, and we may incur significant costs to attract them. We
may not be successful in attracting, integrating, or retaining qualified personnel to fulfill our current or future needs. We have, from
time to time, experienced, and we expect to continue to experience, difficulty in hiring and retaining highly skilled employees with appropriate
qualifications. In addition, job candidates and existing employees often consider the value of the equity awards they receive in connection
with their employment. If the perceived value of our equity or equity awards declines, it may adversely affect our ability to retain highly
skilled employees. If we fail to attract new personnel or fail to retain and motivate our current personnel, our business and future growth
prospects could be severely harmed.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>We collect, store,
process, and use personal information and other customer data, which subjects us to governmental regulation and other legal obligations
related to privacy, information security, and data protection, and our actual or perceived failure to comply with such obligations could
harm our business. </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We collect, store, process,
and use personal information and other user data, and we rely on third parties that are not directly under our control to do so as well.
Our users&#8217; neural finger and hand signals and movement-related data and other personal information may include, but is not limited
to, names, addresses, phone numbers, email addresses, payment account information, wrist size and circumference, and biometric information
such as neural signals, hand movement rotation and acceleration, GPS-based location, and hand activity patterns. Due to the volume and
sensitivity of the personal information and data we manage and the nature of our products, the security features of our platform and information
systems are critical. If our security measures, some of which are managed by third parties, are breached or fail, unauthorized persons
may be able to obtain access to sensitive user data. If we or our third-party service providers, business partners, or third-party apps
with which our users choose to share their data were to experience a breach of systems compromising our users&#8217; sensitive data, use
of our products and services could decrease, our brand and reputation could be adversely affected, and we could be exposed to a risk of
loss, litigation, and regulatory proceedings. Depending on the nature of the information compromised, in the event of a data breach or
other unauthorized access to our user data, we may also have obligations to notify users about the incident and we may need to provide
some form of remedy for the individuals affected by the incident. A growing number of legislative and regulatory bodies have adopted consumer
notification requirements in the event of unauthorized access to or acquisition of certain types of personal data. Such breach notification
laws continue to evolve and may be inconsistent from one jurisdiction to another. Complying with these obligations could cause us to incur
substantial costs and could increase negative publicity surrounding any incident that compromises user data. Our users may also accidentally
disclose or lose control of their passwords, creating the perception that our systems are not secure against third-party access. Additionally,
if third parties we work with, such as vendors, developers, or consumer electronics customers who licensed our technology, violate applicable
laws, agreements, or our policies, such violations may also put our users&#8217; information at risk and could in turn have an adverse
effect on our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 14; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><b><i>We
rely on third-party application stores to distribute our mobile application. </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We are dependent on third-party
application stores that may prevent us from timely updating our applications, building new features, integrations, capabilities and enhancements
or charging for access.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We distribute the mobile
Mudra Inspire, Mudra Band application, and other future applications, through smartphone and tablet application stores managed by Apple
and Google, among others. We cannot assure you that the third-party application stores through which we distribute our mobile applications
will maintain their current structures or that such application stores will not charge us fees to list our application for download. We
are also depending on these third-party application stores to enable us and our users to timely update our mobile applications and to
incorporate new features, integrations, capabilities and enhancements. In addition, certain of these companies are now, and others may
in the future become, competitors of ours and could stop allowing or supporting access to our platform through their products, could allow
access for us only at an unsustainable cost, or could make changes to the terms of access in order to make our platform less desirable
or harder to access, in each case for competitive reasons.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><b><i>Our
management team has limited experience managing a public company. </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Most members of our management
team have limited experience managing a publicly-traded company, interacting with public company investors, and complying with the increasingly
complex laws pertaining to public companies. Our management team may not successfully or efficiently manage our obligations as a public
company subject to significant regulatory oversight and reporting obligations under the federal securities laws and the continuous scrutiny
of securities analysts and investors. These obligations and constituents require significant attention from our senior management and
could divert their attention away from the day-to-day management of our business, which could adversely affect our business, financial
condition, and operating results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>If we experience
a period of significant growth or expansion, it could place a substantial strain on our resources, and we may be unable to execute our
business plan or maintain high levels of service and customer satisfaction.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We may experience rapid
growth, which will place significant demands on our management and our operational and financial resources. We may also experience significant
growth in the number of customers and organizations using our products, and in the amount of data that we collect and process. Additionally,
our organizational structure and our operations may become more complex, requiring us to scale our operational, financial and management
controls as well as our reporting systems and procedures.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">As we continue to grow
our business, we will face challenges in integrating, developing, training and motivating a growing employee base and maintaining our
company culture. Moreover, our potential continued growth will require significant capital expenditures and the allocation of valuable
management resources. Our growth could place a significant strain on our management, customer experience, research and development, sales
and marketing, and other resources. In addition, as we expand our business and our customer base continues to grow, it is important that
we continue to maintain a high level of customer service and satisfaction. As such, we will need to expand our account management, our
customer service and other personnel so we can continue providing personalized account management and customer service as well as personalized
features, integrations, capabilities and enhancements. If we fail to manage our growth in a manner that preserves high levels of customer
service and the key aspects of our corporate culture, the quality of our products and services may suffer, which could negatively affect
our reputation and harm our ability to attract employees, users and organizations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>We spend significant
amounts on advertising and other marketing campaigns to acquire new users, and we expect to increase these advertising and marketing efforts,
which may not be successful or cost effective.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We spend significant amounts
on advertising and other marketing campaigns, such as online advertising and social media, to acquire new users and we expect our marketing
expenses to increase in the future as we continue to spend significant amounts to acquire new users and increase awareness of our products
and services. We expect to increase advertising and marketing efforts. While we seek to structure our advertising campaigns in the manner
that we believe is most likely to encourage people to use our products and services, we may fail to identify advertising opportunities
that satisfy our anticipated return on advertising spend as we scale our investments in marketing, accurately predict user acquisition,
or fully understand or estimate the conditions and behaviors that drive user behavior. If for any reason any of our advertising campaigns
prove less successful and/or cost effective than anticipated in attracting new users, we may not be able to recover our advertising spend,
and our rate of user acquisition may fail to meet market expectations, either of which could have an adverse effect on our business. There
can be no assurance that our advertising and other marketing efforts will result in increased sales of our products and services.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 15; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><b><i>We
depend on third-party data center service providers. Any disruption in the operation of the data center facilities or failure to renew
the services could adversely affect our business. </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Our services are hosted
using data centers operated by third parties. We control neither the operation of the data centers nor our third-party data center service
providers. The third-party data center service providers may have no obligation to renew their services with us on commercially reasonable
terms, or at all. If we are unable to renew these services on commercially reasonable terms, we may be required to transfer our servers
or data to new data center facilities or engage new service providers, and we may incur significant costs and a possible interruption
in our platform in connection with doing so.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Problems with our third-party
data center service providers, the telecommunications network providers with whom they contract, or with the systems by which telecommunications
providers allocate capacity among their users could adversely affect the experience of our users. Our third-party data center service
providers could decide to close their facilities or cease to provide us services without adequate notice. In addition, any financial difficulties,
such as bankruptcy, faced by our third-party data center service providers or parties they contract with may have negative effects on
our business, the nature and extent of which are difficult to predict. Additionally, any failure of our data centers to meet our needs
for capacity could have an adverse effect on our business. Any changes in third-party service levels at our data centers or any errors,
defects, disruptions, or other performance problems with our platform could harm our brand and may damage the data of our users. Outages
at our data centers, and future interruptions to our platform, might reduce our revenue, cause us to issue refunds, subject us to potential
liability, or harm our ability to retain users and attract new customers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>Disruptions to our
Information Technology, or IT, system may disrupt our operations and materially adversely affect our business and results of operations.
</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We depend on our IT systems,
as well as those of third parties, to develop new products and services, operate our websites, host and manage our services, store data,
process transactions, respond to user inquiries, and manage inventory and our supply chain. Our servers and equipment may be subject to
cyber-security crimes, ransom hijacking, computer viruses, break-ins and similar disruptions from unauthorized tampering with computer
systems. We can provide no assurance that our current IT system is fully protected against third-party intrusions, viruses, hacker attacks,
information or data theft or other similar threats. A cyber-attack that bypasses our IT security systems causing an IT security breach
may lead to a material disruption of our IT business systems and/or the loss of business information. Any such event could have a material
adverse effect on our business until we recover using our back-up information. To the extent that such disruptions or uncertainties result
in delays or cancellations of customer programs or misappropriation or release of our confidential data or our intellectual property,
our business and results of operations could be materially and adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>Our business is
subject to data security risks, and our data security measures may be inadequate to address these risks, making our systems susceptible
to compromise, which could materially adversely affect our business, financial condition, results of operations, and prospects.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">During the ordinary course
of our business, we may collect, process, store and transmit substantial amounts of data and information, including users&#8217; data.
We have implemented measures to separate the data stored in our internet data centers and those stored with the third-party vendors. Security
incidents may occur in the future, causing unauthorized access to, loss of, or unauthorized disclosure of such information, resulting
in regulatory enforcement actions, litigation, indemnification obligations, and other potential liabilities, as well as negative publicity,
which could materially adversely affect our business, reputation, financial condition, results of operations, and prospects. Cyberattacks,
computer malware, and other compromises of information security measures or malicious internet-based activity continue to increase, and
cloud-native platform providers of products and services have been targeted, resulting in breaches of their information security, and
are expected to continue to be targeted. We and our third-party vendors are at risk of suffering from similar attacks and breaches.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 16; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Our products may also
be subject to fraudulent usage and schemes, including third parties accessing customer accounts or viewing data from our platform without
our authorization. While we undertake significant efforts to protect the security and integrity of the information we collect, process,
store, and transmit, we cannot entirely mitigate these risks, and there is no guarantee that inadvertent or unauthorized use or disclosure
of such information will not occur or that third parties will not gain unauthorized access to such information despite our efforts. In
addition, we rely on our third-party vendors to take appropriate measures to protect the security and integrity of the information on
their information systems. We may not be able to anticipate or prevent all techniques that could be used to obtain unauthorized access
or to compromise our systems because such techniques change frequently and are generally not detected until after an incident has occurred.
Additionally, we cannot be certain that we will be able to address any vulnerabilities in our software that we may become aware of in
the future. We expect similar issues to arise in the future as we continue to expand the features and functionality of our products and
platform and introduce new products, and we expect to expend significant resources in an effort to protect against security incidents.
In addition, any actual or suspected cybersecurity incident or other compromise of our security measures, or those of our third-party
vendors, whether as a result of hacking efforts,&#160;denial-of-service&#160;attacks, viruses, malicious software,&#160;break-ins,&#160;phishing
attacks, social engineering, or otherwise, could result in governmental investigations or enforcement actions, litigation, harm to our
business, damage to our brand and reputation, significant costs for remediating the effects of such an incident and preventing future
incidents, lost revenue due to network downtime, and a decrease in customer and user trust. Concerns regarding privacy, data protection,
and information security may also cause some of our customers to stop using our products and platform and make it harder to acquire new
customers. To the extent we do not effectively address these risks, our business, financial condition, results of operations, and prospects
could be materially adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Many governments have
enacted laws requiring companies to provide notice of data security incidents involving certain types of personal data. We are also contractually
required to notify certain customers of certain data security breaches. To protect customers&#8217; information, we have adopted multiple
security measures that address security risks associated with data transmission, usage, storage, export and presentation. We have adopted
an access control policy that requires user authentication every time there is a request to access&#160;non-public&#160;data. In addition,
we have implemented an encryption program that encrypts the sensitive and confidential information stored by us. Despite our efforts,
security incidents experienced by us, or by others, such as our competitors or customers, may lead to public disclosures and widespread
negative publicity for us, our customers, or the construction software industry generally.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Regulatory requirements
regarding the protection of personal information are constantly evolving and can be subject to differing interpretations, making the extent
of our responsibilities in that regard uncertain. We currently adopt a data privacy policy with respect to how we collect, store, process
and use user data and information, and we may only use such data and information to provide and improve our services, content and advertising
in strict compliance with such policy. Despite the absence of any material data breach or similar incidents and our continuous efforts
to comply with our privacy policy as well as all applicable laws and regulations, any failure or perceived failure to comply with these
laws, regulations or policy may result in inquiries and other proceedings or actions against us by governmental authorities or others,
which could cause us to lose users and business partners.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">There can be no assurance
that any limitations of liability provisions with customers would be enforceable or adequate or would otherwise protect us from any such
liabilities or damages with respect to any particular claim. The successful assertion of one or more large claims against us could materially
adversely affect our business, financial condition, results of operations, and prospects.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 17; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Risks Related to the Industry in Which We Operate</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>The forecasts of
market growth included in this annual report on Form 20-F may prove to be inaccurate, and even if the markets in which we compete achieve
the forecasted growth, we cannot assure you our business will grow at similar rates, if at all.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Growth forecasts are subject
to significant uncertainty and are based on assumptions and estimates that may not prove to be accurate. The forecasts in this annual
report on Form 20-F relating to the expected growth in the market for wearable computing devices, wearable devices, and consumer electronics
industry may prove to be inaccurate. Even if these markets experience the forecasted growth described herein, we may not grow our business
at similar rates, or at all. Our growth is subject to many factors, including our success in implementing our business strategy, which
is subject to many risks and uncertainties. Accordingly, the forecasts of market growth included in this annual report on Form 20-F should
not be taken as indicative of our future growth.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>The market for wearable
computing devices is still in the early stages of growth and if it does not continue to grow, grows more slowly than we expect, or fails
to grow as large as we expect, our business and operating results would be harmed.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The market for wearable
computing devices is relatively new and unproven, and it is uncertain whether wearable devices and wearable computers will sustain high
levels of demand and wide market acceptance. Our success will depend to a substantial extent on the willingness of people to widely adopt
these products and services. In part, adoption of our products and services will depend on the increasing prevalence of connected wearable
computing devices as well as new entrants to the wearable computing device market to raise the profile of both the market as a whole and
our own platform. Our input technology devices have largely been used to control the Apple Watch and explore input methods for wearable
computers and consumer electronics. However, they have not been widely adopted for other consumer electronics devices such as AR glasses,
VR headsets, and large displays for which other products are more often used. Furthermore, some individuals may be reluctant or unwilling
to use wearable input devices because they have concerns regarding the risks associated with data privacy, security, accuracy and comfortability.
If the wider public does not perceive the benefits of our neural input devices or chooses not to adopt them as a result of concerns regarding
privacy, data security, accuracy, comfortability, or for other reasons, then the market for these products and services may not further
develop, it may develop more slowly than we expect, or it may not achieve the growth potential we expect it to, any of which would adversely
affect our operating results. The development and growth of this relatively new market may also prove to be a short-term trend.&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>We operate in a
highly competitive market. If we do not compete effectively, our prospects, operating results, and financial condition could be adversely
affected.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The market of input methods
and peripheral devices for digital computers is highly competitive, with companies offering a variety of competitive products and services.
We plan to develop and offer additional consumer electronics products for controlling and interacting with computers and digital devices.
Additional consumer offerings will include applications for a variety of devices which will add value to the consumer beyond hardware
functions. However, if we are unable to successfully develop additional consumer products, our results of operation may suffer. We expect
competition in our market to intensify in the future as new and existing competitors introduce new or enhanced products and services that
are potentially more competitive than our products and services. The digital devices input methods market has a multitude of participants,
including specialized consumer electronics companies, such as Apple Inc., or Apple, Facebook, Inc., or Facebook, and Google LLC, and traditional
peripheral and input solutions companies, such as Microsoft Corporation, Logitech International S.A. and Razer. In addition, many large,
broad-based consumer electronics companies either compete in our market or adjacent markets or have announced plans to do so, including
Apple and Facebook. For example, in October 2023, Apple released the Apple Watch Ultra2 Double Tap capability, which allows users to tap
the index finger and thumb together twice to answer a call, reply to a message, see and scroll through the Smart Stack and more based
on the watch&#8217;s Inertial Measurement Unit<span style="background-color: white">&#160;</span>(IMU) and Photoplethysmography (PPG)
sensors. We also compete with a wide range of after-market periphery-related input devices that can be purchased in retail and online
stores from a multitude of manufacturers. We believe that many of our competitors and potential competitors have significant competitive
advantages, including longer operating histories, ability to leverage their sales efforts and marketing expenditures across a broader
portfolio of products and services, larger and broader customer bases, more established relationships with a larger number of suppliers,
contract manufacturers, and channel partners, greater brand recognition, ability to leverage app stores which they may operate, and greater
financial, research and development, marketing, distribution, and other resources than we do. Our competitors and potential competitors
may also be able to develop products or services that are equal or superior to ours, achieve greater market acceptance of their products
and services, and increase sales by utilizing different distribution channels than we do. Some of our competitors may aggressively discount
their products and services in order to gain market share, which could result in pricing pressures, reduced profit margins, lost market
share, or a failure to grow market share for us. If we are not able to compete effectively against our current or potential competitors,
our prospects, operating results, and financial condition could be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 18; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>An economic downturn
or economic uncertainty may adversely affect consumer discretionary spending and demand for our products and services.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Our products and services
may be considered discretionary items for consumers. Factors affecting the level of consumer spending for such discretionary items include
general economic conditions, and other factors, such as consumer confidence in future economic conditions, fears of recession, the availability
and cost of consumer credit, levels of unemployment, and tax rates. As global economic conditions continue to be volatile or economic
uncertainty remains, trends in consumer discretionary spending also remain unpredictable and subject to reductions. Unfavorable economic
conditions may lead consumers to delay or reduce purchases of our products and services and consumer demand for our products and services
may not grow as we expect. Our sensitivity to economic cycles and any related fluctuation in consumer demand for our products and services
may have an adverse effect on our operating results and financial condition.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>Changes in laws
and regulations related to the internet or changes in the internet infrastructure itself may diminish the demand for our services and
have a negative impact on our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The future success of
our business depends upon the continued use of the internet as a primary medium for commerce, communication and business solutions. We
may be required to comply with laws or regulations regarding the use of the internet in foreign jurisdictions, such as the General Data
Protection Regulation in the European Union, or the GDPR, and the California Consumer Privacy Act in the United States. Changes in these
laws or regulations could require us to modify our products in order to comply with these changes. While we have implemented measures
to promote compliance with applicable laws and regulations and track their developments, we cannot assure you that we will always be in
compliance. In addition, the modification of our products to ensure compliance can be time-consuming, if not technically impossible. If
we are unable to comply with these laws and regulations, or if we cannot modify our products in a timely fashion, our reputation, business,
results of operations and financial condition could be materially adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">In addition, government
agencies may begin to impose taxes, fees or other charges for accessing the internet. These laws and changes could limit the growth of
internet-related commerce or communications generally and reduce the demand for internet-based services such as ours. As our suppliers
also carry out their services on the internet, such measures could increase our operating costs and we may not be able to maintain our
competitive pricing as compared to the legacy software. These effects combined could adversely affect our business, results of operations
and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">In addition, use of the
internet as a business tool could be adversely affected. The performance of the internet and its acceptance as a business tool has been
adversely affected by &#8220;viruses,&#8221; &#8220;worms&#8221; and similar malicious programs and the internet has experienced a variety
of outages and other delays as a result of damage to portions of its infrastructure. If the use of the internet is adversely affected
by these issues, demand for our services could suffer.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 19; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>Our business is
subject to a variety of U.S. and international laws and regulations, including those regarding privacy, cybersecurity and data protection.
Any failure of our platform to comply with applicable laws and regulations could harm our business, operating results and financial condition.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Our operations may from
time to time involve cross-border transfer of data, which may subject us and our customers that use our products to privacy, cybersecurity
and data protection-related laws and regulations that impose obligations in connection with the collection, processing and use of personal
data, financial data, health or other similar data and general cybersecurity. Multiple jurisdictions have adopted or proposed limitations
on, or requirements regarding, the collection, distribution, use, security and storage of information, including personally identifiable
information of individuals.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">In the United States,
the U.S. Federal Trade Commission and numerous state attorneys general are applying federal and state consumer protection laws to impose
standards on the online collection, use and dissemination of data, and to the security measures applied to such data. We continue to see
increased regulation of privacy cybersecurity and data protection, including the adoption of more stringent subject matter specific state
laws in the United States. For example, in 2018, California enacted the CCPA, which took effect on January&#160;1, 2020. The CCPA gives
California residents expanded rights to access and delete their personal information, opt out of certain personal information sharing,
and receive detailed information about how their personal information is used. The CCPA provides for civil penalties for violations, as
well as a private right of action for data breaches that is expected to increase data breach litigation. The CCPA may increase our compliance
costs and potential liability, and we may be required to modify our practices and take additional steps in an effort to comply with the
CCPA. Some observers have noted that the CCPA could mark the beginning of a trend toward more stringent state privacy legislation in the
United States, which could increase our potential liability and adversely affect our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Similarly, many other
countries and governmental bodies, including the EU member states, have laws and regulations concerning the collection and use of personal
data obtained from individuals located in the EU or by businesses operating within their jurisdiction, which are often more restrictive
than those in the United States. Laws and regulations in these jurisdictions apply broadly to the collection, use, storage, disclosure
and security of personal data that identifies or may be used to identify an individual, such as names, telephone numbers, email addresses
and, in certain circumstances, IP addresses and other online identifiers. For example, the EU has adopted the GDPR, which enhances data
protection obligations for businesses and requires service providers (data processors) processing personal data on behalf of customers
to cooperate with European data protection authorities, implement security measures and keep records of personal data processing activities.
Noncompliance with the GDPR can trigger fines equal to or greater of &#8364;20&#160;million or 4% of global annual revenues. Given the
breadth and depth of its obligations, working to meet the requirements of the GDPR has required significant time and resources, including
a review of our technology and systems currently in use against the requirements of the GDPR. There are also additional EU laws and regulations
(and member states implementations thereof) which govern the protection of consumers and of electronic communications. We have taken measures
to address certain obligations under the GDPR and to make us GDPR compliant, but we may be required to take additional steps in order
to comply with the GDPR. If our efforts to comply with GDPR or other applicable EU laws and regulations are not successful, we may be
subject to penalties and fines that would adversely impact our business and operating results, and our ability to conduct business in
the EU could be significantly impaired.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We also continue to see
jurisdictions imposing data localization laws, which require personal information, or certain subcategories of personal information to
be stored in the jurisdiction of origin. These regulations may inhibit our ability to expand into those markets or prohibit us from continuing
to offer services in those markets without significant additional costs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 20; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Additionally, although
we endeavor to have our products and platform comply with applicable laws and regulations, these and other obligations may be modified,
they may be interpreted and applied in an inconsistent manner from one jurisdiction to another, and they may conflict with one another,
other regulatory requirements, contractual commitments or our practices. We expect that there will continue to be new proposed laws, rules
of self- regulatory bodies, regulations and industry standards concerning privacy, data protection and information security in the United
States, the EU and other jurisdictions, and we cannot yet determine the impact such future laws, rules, regulations and standards may
have on our business. The uncertainty and changes in the requirements of multiple jurisdictions may increase the cost of compliance, delay
or reduce demand for our services, restrict our ability to offer services in certain locations, impact our customers&#8217; ability to
deploy our products and solutions in certain jurisdictions, or subject us to claims and litigation from private actors and investigations,
proceedings, and sanctions by data protection regulators, all of which could harm our business, financial condition and operating results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We also may be bound by
contractual obligations relating to our collection, use and disclosure of personal, financial and other data or may find it necessary
or desirable to join industry or other self-regulatory bodies or other privacy, cybersecurity or data protection-related organizations
that require compliance with their rules pertaining to privacy and data protection.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Any failure or perceived
failure by us, our products or our platform to comply with new or existing U.S., EU or other foreign privacy, cybersecurity or data protection
laws, regulations, policies, industry standards or legal obligations, any failure to bind our suppliers and contractors to appropriate
agreements or to manage their practices or any systems failure or security incident that results in the unauthorized access to, or acquisition,
release or transfer of, personally identifiable information or other data relating to customers or individuals may result in governmental
investigations, inquiries, enforcement actions and prosecutions, private claims and litigation, fines and penalties, adverse publicity
or potential loss of business.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>Our business is
subject to the risk of earthquakes, fire, power outages, floods, and other catastrophic events, and to interruption by manmade problems
such as terrorism. </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Our business is vulnerable to damage or interruption
from earthquakes, fires, floods, pandemics, power losses, telecommunications failures, terrorist attacks, acts of war, human errors, break-ins,
and similar events. The third-party systems and operations and contract manufacturers we rely on, such as the data centers we lease, are
subject to similar risks. For example, a significant natural disaster, such as an earthquake, fire, or flood, could have an adverse effect
on our business, operating results, and financial condition, and our insurance coverage may be insufficient to compensate us for losses
that may occur.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Our corporate offices
are located in Israel, a state that frequently experiences terrorist attacks and acts of war. In addition, the facilities at which our
contract manufacturers manufacture our products are located in parts of Asia that frequently endure typhoons and earthquakes. Acts of
terrorism, which may be targeted at metropolitan areas that have higher population density than rural areas, could also cause disruptions
in our or our suppliers&#8217;, contract manufacturers&#8217;, and logistics providers&#8217; businesses or the economy as a whole. Our
servers may also be vulnerable to computer viruses, break-ins, denial-of-service attacks, and similar disruptions from unauthorized tampering
with our computer systems, which could lead to interruptions, delays, and loss of critical data. We may not have sufficient protection
or recovery plans in some circumstances, such as natural disasters affecting Israel or other locations where we have data centers or store
significant inventory of our products. As we rely heavily on our data center facilities, computer and communications systems, and the
Internet to conduct our business and provide high-quality customer service, these disruptions could negatively impact our ability to run
our business and either directly or indirectly disrupt suppliers&#8217; businesses, which could have an adverse effect on our business,
operating results, and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>Regulations related
to conflict minerals may cause us to incur additional expenses and could limit the supply and increase the costs of certain metals used
in the manufacturing of our products.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">As a public company, we
are subject to requirements under the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, which requires us to conduct
due diligence on and disclose whether or not our products contain conflict minerals. The compliance with these requirements could adversely
affect the sourcing, availability, and pricing of the materials used in the manufacture of components used in our products. In addition,
we additional costs to comply with the disclosure requirements, including costs related to conducting diligence procedures to determine
the sources of minerals that may be used or necessary to the production of our products and, if applicable, potential changes to products,
processes, or sources of supply as a consequence of such due diligence activities. It is also possible that we may face reputational harm
if we determine that certain of our products contain minerals not determined to be conflict free or if we are unable to alter our products,
processes, or sources of supply to avoid such materials.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 22.5pt"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 21; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 22.5pt"><b>Risks Related to Our Financial
Condition and Operations</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>Our financial statements
for the year ended December 31, 2023, contained an explanatory paragraph regarding substantial doubt about our ability to continue as
a going concern. This going concern opinion could prevent us from obtaining new financing on reasonable terms or at all and risk our ability
to continue operating as a going concern.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In part because we have incurred losses in each
year since our inception, our audited consolidated financial statements for the period ended December 31, 2023 contained an explanatory
paragraph regarding substantial doubt about our ability to continue as a going concern. These events and conditions, along with other
matters, indicated that a material uncertainty existed as of December 31, 2023, that could cast significant doubt on our ability to continue
as a going concern. The financial statements for the year ended December 31, 2023 have been prepared assuming that we will continue as
a going concern. <span style="background-color: white">To date, the Company has not generated significant revenues from its activities
and has incurred substantial operating losses. Management expects the Company to continue to generate substantial operating losses and
to continue to fund its operations primarily through the utilization of its current financial resources, sales of its products, and through
additional raises of capital. </span>As of December 31, 2023, we incurred accumulated losses of approximately $21.2&#160;million. A going
concern opinion could materially limit our ability to raise additional funds through the issuance of equity or debt securities or otherwise
in the future. Further financial statements may also include an explanatory paragraph with respect to our ability to continue as a going
concern. Until we can generate significant recurring revenues, we expect to satisfy our future cash needs through existing cash, debt
or equity financing. We have completed our IPO and follow on fund raising, but we require additional financing in the near future. We
cannot be certain that additional funding will be available to us on acceptable terms, if at all. If funds are not available, we may be
required to delay, reduce the scope of, or eliminate research or development plans for, or commercialization efforts with respect to our
products and it risks our ability to continue operating as a going concern.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>We may need to raise
additional capital required to grow our business, and we may not be able to raise capital on terms acceptable to us or at all, and the
sale of additional shares or equity or debt securities could result in additional dilution to our shareholders.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Growing and operating
our business will require significant cash outlays and capital expenditures and commitments. If cash on hand and cash from operating activities
are not sufficient to meet our cash requirements, we will need to seek additional capital, potentially through debt or equity financing,
to fund our growth. We may not be able to raise needed cash on terms acceptable to us or at all. Financing may be on terms that are dilutive
or potentially dilutive to our shareholders, as described below, and the prices at which new investors would be willing to purchase our
securities may be lower than the current price per share. The holders of new securities may also have rights, preferences, or privileges
which are senior to those of existing holders of Ordinary Shares. If new sources of financing are required, but are insufficient or unavailable,
we will be required to modify our growth and operating plans based on available funding, if any, which would harm our ability to grow
our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We may need to raise additional
capital through a combination of private and public equity offerings, debt financings and collaborations, and strategic and licensing
arrangements. To the extent that we raise additional capital through the issuance of equity or convertible debt securities, your ownership
interest will be diluted, and the terms may include liquidation or other preferences that adversely affect your rights as a holder of
our Ordinary Shares. Debt financing, if available, may involve agreements that include covenants limiting or restricting our ability to
take certain actions, such as incurring debt, making capital expenditures or declaring dividends. If we raise additional funds through
strategic partnerships and alliances and licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies
or product candidates or grant licenses on terms that are not favorable to us. If we are unable to raise additional funds through equity
or debt financing when needed, we may be required to delay, limit, reduce or terminate our product development or commercialization efforts
or grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 22; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>Our operating
results or other operating metrics may fluctuate significantly, which could cause the trading price of our securities to decline. </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Our operating results
and other operating metrics have fluctuated in the past and may continue to fluctuate in each reported period. We expect that this trend
will continue as a result of a number of factors, many of which are outside of our control and may be difficult to predict, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the level of demand for our neural input devices and our ability to maintain or increase the size and engagement of our users;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the demand and volume of our licensing agreements with third-party companies such as computer electronics manufacturers;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the continued market acceptance of, and the growth of the market for, neural input technology for wearable computing devices;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the timing and success of new product and service introductions by us or our competitors or any other change in the competitive landscape of our market;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">pricing pressure as a result of competition or otherwise;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays or disruptions in our supply, manufacturing, or distribution chain;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">errors in our forecasting of the demand for our products, which could lead to lower revenue or increased costs, or both;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the mix of products sold in a reported period;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">seasonal buying patterns of consumers;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">increases in and timing of sales and marketing and other operating expenses that we may incur to grow and expand our operations and to remain competitive;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">insolvency, credit, or other difficulties confronting our suppliers, contract manufacturers, or logistics providers leading to disruptions in our supply or distribution chain;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">levels of product returns, stock rotation, and price protection rights;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">adverse litigation judgments, settlements, or other litigation-related costs;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes in the legislative or regulatory environment, such as with respect to privacy, information security, consumer product safety, and advertising;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">product recalls, regulatory proceedings, or other adverse publicity about our products;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fluctuations in foreign exchange rates;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">costs related to the acquisition of businesses, talent, technologies, or intellectual property, including potentially significant amortization costs and possible write-downs; </span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the overall global political and economic environment in the countries in which we operate including those related to recent unrest and actual or potential armed conflict in Israel and other parts of the Middle East, such as the recent attack by Hamas and other terrorist organizations from the Gaza Strip and Israel&#8217;s war against them; and</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">general economic conditions in either domestic or international markets.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 23; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Any one of the factors
above or the cumulative effect of some of the factors above may result in significant fluctuations in our operating results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The variability and unpredictability
of our operating results or other operating metrics could result in our failure to meet our expectations or those of any analysts that
cover us or investors with respect to revenue or other operating results for a particular period. If we fail to meet or exceed such expectations
for these or any other reasons, the market price of our securities could fall substantially, and we could face costly lawsuits, including
securities class action suits.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>Our operating results
could be materially harmed if we are unable to accurately forecast consumer demand for our products and services and adequately manage
our inventory. </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">To ensure adequate inventory
supply, we must forecast inventory needs and expenses and place orders with our suppliers and contract manufacturers sufficiently in advance
based on our estimates of future demand for our products. Our ability to accurately forecast demand for our products could be affected
by many factors, including an increase or decrease in customer demand for our products and services or for products and services of our
competitors, product and service introductions by competitors, unanticipated changes in general market conditions, and the weakening of
economic conditions or consumer confidence in future economic conditions. We may face challenges acquiring adequate and timely supplies
of our products to satisfy the levels of demand, which we believe negatively affects our revenue. This risk may be exacerbated by the
fact that we may not carry a significant amount of inventory, either directly or with our contract manufacturers or logistics providers,
to satisfy short-term demand increases. If we fail to accurately forecast customer demand, we may experience excess inventory levels or
a shortage of products available for sale.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Inventory levels in excess
of customer demand may result in inventory write-downs or write-offs and the sale of excess inventory at discounted prices, which would
cause our gross margin to suffer and could impair the strength of our brand. Conversely, if we underestimate customer demand for our products
and services, our contract manufacturers may not be able to deliver products to meet our requirements, and this could result in damage
to our brand and customer relationships and adversely affect our revenue and operating results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>Our
financial performance is subject to risks associated with changes in the value of the U.S. dollar, Israeli shekel, versus local currencies.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Our primary exposure to
movements in foreign currency exchange rates relates to non-U.S. dollar denominated sales and operating expenses worldwide. Weakening
of foreign currencies relative to the U.S. dollar adversely affects the U.S. dollar value of our foreign currency-denominated sales and
earnings, and generally leads us to raise international pricing, potentially reducing demand for our products. In some circumstances,
for competitive or other reasons, we may decide not to raise local prices to fully offset the dollar&#8217;s strengthening, or at all,
which would adversely affect the U.S. dollar value of our foreign currency denominated sales and earnings. Conversely, a strengthening
of the Israeli shekel or foreign currencies relative to the U.S. dollar will increase our Israeli operations costs and could cause us
to increase our international pricing and become less competitive.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>We may not be able
to sustain our revenue growth rate or profitability in the future.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Our recent revenue growth
should not be considered indicative of our future performance. As we grow our business, we expect our revenue growth rates to slow in
future periods due to a number of reasons, which may include increasing competition, slowing demand for our products and services, a decrease
in the growth of our overall market, our failure, for any reason, to continue to capitalize on growth opportunities, or the maturation
of our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We have not achieved profitability
on a quarterly or annual basis. We expect our expenses to increase substantially in the near term, particularly as we make significant
investments in our research and development and sales and marketing organizations, expand our operations and infrastructure internationally,
develop new products and services, and enhance our existing products and services. In addition, in connection with operating as a public
company, we will incur additional significant legal, accounting, and other expenses that we did not incur as a private company. If our
revenue does not increase to offset these increases in our operating expenses, we may not be profitable in future periods.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 24; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>Risks Related to the
Ownership of the Ordinary Shares and Warrants</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>Our current officers
and directors and holders of more than 5% of our Ordinary Shares currently beneficially own an aggregate of approximately 32.2% of our
Ordinary Shares and they will be able to exert significant control over matters submitted to our shareholders for approval. </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">As of March 13, 2024,
our current officers and directors and holders of more than 5% of our Ordinary Shares beneficially own an aggregate of approximately 32.2%
of our Ordinary Shares. Consequently, they are able to exert significant control over matters submitted to our shareholders for approval.
This significant concentration of share ownership may adversely affect the trading price for our Ordinary Shares because investors often
perceive disadvantages in owning shares in companies with controlling shareholders. As a result, these shareholders, if they acted together,
could significantly influence or even unilaterally approve matters requiring approval by our shareholders, including the election of directors
and the approval of mergers or other business combination transactions. The interests of these shareholders may not always coincide with
our interests or the interests of other shareholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>We do not know whether
a market for the Ordinary Shares or Warrants will be sustained or what the trading price of the Ordinary Shares or Warrants will be and
as a result it may be difficult for you to sell your securities.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Although our Ordinary
Shares and Warrants are listed on Nasdaq, an active trading market for the Ordinary Shares or Warrants may not be sustained. It may be
difficult for you to sell your Ordinary Shares or Warrants without depressing the market price for the Ordinary Shares or Warrants at
all. As a result of these and other factors, you may not be able to sell your securities at or above the offering price or at all. Further,
an inactive market may also impair our ability to raise capital through the sale of additional equity securities and may impair our ability
to enter into strategic partnerships or acquire companies,&#160;products, or services by using our equity securities as consideration.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b>&#160;<i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>We have never paid
cash dividends on our share capital, and we do not anticipate paying any cash dividends in the foreseeable future.&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have never declared or paid cash dividends,
and we do not anticipate paying cash dividends in the foreseeable future. Therefore, you should not rely on an investment in Ordinary
Shares as a source for any future dividend income.&#160;Our board of directors has complete discretion as to whether to distribute dividends.
Even if our board of directors decides to declare and pay dividends, the timing, amount and form of future dividends, if any, will depend
on our future results of operations and cash flow, our capital requirements and surplus, the amount of distributions, if any, received
by us from our subsidiaries, our financial condition, contractual restrictions and other factors deemed relevant by our board of directors.
For more information, see &#8220;Item 8.A. - Consolidated Statements and Other Financial Information &#8211; Dividends.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>Management will
have broad discretion as to the use of the proceeds from the potential exercise of the Warrants and from our recently completed public
offering.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Our management will have
broad discretion in the allocation of the net proceeds, if any, from the exercise of the Warrants and from our recently completed public
offering, which closed on November 13, 2023. Our shareholders may not agree with the manner in which our management chooses to allocate
and spend the net proceeds.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 25; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>The Warrants are
listed on Nasdaq separately from our Ordinary Shares and this may provide investors with an arbitrage opportunity that could adversely
affect the trading price of our Ordinary Shares.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Because the Warrants are
traded on Nasdaq, investors may be provided with an arbitrage opportunity that could depress the price of our Ordinary Shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>We have been notified by The Nasdaq Stock
Market LLC of our failure to comply with certain continued listing requirements and, if we are unable to regain compliance with all applicable
continued listing requirements and standards of Nasdaq, our Ordinary Shares could be delisted from Nasdaq.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On October 24, 2023, we received a written notification
from the Listing Qualifications Department of the Nasdaq Stock Market LLC notifying us that we were not in compliance with the Minimum
Bid Price Requirement because the closing bid price of our Ordinary Shares was below $1.00 per Ordinary Share for the previous 30 consecutive
business days. We were granted 180 calendar days, or until April&#160;22, 2024, to regain compliance with the Minimum Bid Price Requirement.
In the event we do not regain compliance with the Minimum Bid Price Requirement by April 22, 2024, we may be eligible for an additional
180-calendar day grace period. To qualify, we will be required to meet the continued listing requirement for market value of publicly
held shares and all other listing standards for Nasdaq, with the exception of the Minimum Bid Price Requirement, and will need to provide
written notice to The Nasdaq Stock Market LLC of our intent to regain compliance with such requirement during such second compliance period.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We intend to monitor the closing bid price of our
Ordinary Shares and may, if appropriate, consider implementing available options to regain compliance with the minimum bid price requirement,
including initiating a reverse stock split. If we do not regain compliance within the allotted compliance period(s), including any extensions
that may be granted, The Nasdaq Stock Market LLC will provide notice that our Ordinary Shares will be subject to delisting from Nasdaq.
At that time, we may appeal The Nasdaq Stock Market LLC&#8217;s determination to a hearings panel.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">There can be no assurances that we will be able
to regain compliance with the Minimum Bid Price Requirement or if we do later regain compliance with the Minimum Bid Price Requirement,
that we will be able to continue to comply with all applicable Nasdaq listing requirements now or in the future. If we are unable to maintain
compliance with these Nasdaq requirements, our Ordinary Shares will be delisted from Nasdaq.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In the event that our Ordinary Shares or Warrants
are delisted from Nasdaq, as a result of our failure to comply with the Minimum Bid Price Requirement, or due to our failure to continue
to comply with any other requirement for continued listing on Nasdaq, and are not eligible for listing on another exchange, trading in
our Ordinary Shares and Warrants could be conducted in the over-the-counter market or on an electronic bulletin board established for
unlisted securities such as the Pink Sheets or the OTC Bulletin Board. In such event, it could become more difficult to dispose of, or
obtain accurate price quotations for, our Ordinary Shares or Warrants, and it would likely be more difficult to obtain coverage by securities
analysts and the news media, which could cause the price of our Ordinary Shares or Warrants to decline further. Also, it may be difficult
for us to raise additional capital if we are not listed on a national exchange.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>The Warrants are
speculative in nature.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Except as otherwise set
forth therein, our Warrants do not confer any rights of Ordinary Share ownership on their holders, such as voting rights, but rather merely
represent the right to acquire Ordinary Shares at a fixed price for a limited period of time. Specifically, holders of the Warrants may
exercise their right to acquire Ordinary Shares and pay an exercise price of $4.00 per Ordinary Share, prior to five years from the date
of issuance, after which date any unexercised Warrants will expire and have no further value. There can be no assurance that the market
price of our Ordinary Shares will ever equal or exceed the exercise price of the Warrants. In the event that our Ordinary Shares price
does not exceed the exercise price of such Warrants during the period when such Warrants are exercisable, the Warrants may not have any
value.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 26; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>The JOBS Act will
allow us to postpone the date by which we must comply with some of the laws and regulations intended to protect investors and to reduce
the amount of information we provide in our reports filed with the SEC, which could undermine investor confidence in our company and adversely
affect the market price of our securities.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">For so long as
we remain an &#8220;emerging growth company&#8221; as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act, we
intend to take advantage of certain exemptions from various requirements that are applicable to public companies that are not &#8220;emerging
growth companies&#8221; including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the provisions of the Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley Act, requiring that our independent registered public accounting firm provide an attestation report on the effectiveness of our internal control over financial reporting;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 107 of the JOBS Act, which provides that an &#8220;emerging growth company&#8221; can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. This means that an &#8220;emerging growth company&#8221; can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. However, we are electing not to delay such adoption of new or revised accounting standards. Our election not to use this extended transition period for complying with new or revised accounting standards is irrevocable;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">exemption from compliance with any requirement that may be adopted by the Public Company Accounting Oversight Board with respect to mandatory audit firm rotation or a supplement to the auditor&#8217;s report providing additional information about the audit and the financial statements (i.e., critical audit matters); and</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to present only two&#160;years of audited financial statements and only two&#160;years of related disclosure in certain SEC filings.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We intend to take advantage
of some of these exemptions until we are no longer an &#8220;emerging growth company.&#8221; We will remain an emerging growth company
until the earlier of (1) the last day of the fiscal year (a) following the fifth anniversary of the date of our first sale of ordinary
equity securities pursuant to an effective registration statement under the Securities Act, (b) in which we have total annual gross revenue
of at least $1.235 billion), or (c) in which we are deemed to be a large accelerated filer, which means the market value of our Ordinary
Shares that is held by non-affiliates exceeds $700 million as of the prior June 30, and (2) the date on which we have issued more than
$1.0 billion in non-convertible debt during the prior three-year period.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We cannot predict if investors
will find our securities less attractive because we may rely on these exemptions. If some investors find our securities less attractive
as a result, there may be a less active trading market for our securities, and our market prices may be more volatile and may decline.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>As a &#8220;foreign
private issuer&#8221; we are subject to less stringent disclosure requirements than domestic registrants and are permitted, and may in
the future elect to follow certain home country corporate governance practices instead of otherwise applicable SEC and Nasdaq requirements,
which may result in less protection than is accorded to investors under rules applicable to domestic U.S. registrants.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">As a foreign private issuer
and emerging growth company, we may be subject to different disclosure and other requirements than domestic U.S. registrants and&#160;non-emerging&#160;growth
companies. For example, as a foreign private issuer, in the United States, we are not subject to the same disclosure requirements as a
domestic U.S. registrant under the Exchange Act, including the requirements to prepare and issue quarterly reports on Form&#160;10-Q&#160;or
to file current reports on Form&#160;8-K&#160;upon the occurrence of specified significant events, the proxy rules applicable to domestic
U.S. registrants under Section&#160;14 of the Exchange Act or the insider reporting and short-swing profit rules applicable to domestic
U.S. registrants under Section&#160;16 of the Exchange Act. In addition, we intend to rely on exemptions from certain U.S. rules which
will permit us to follow Israeli legal requirements rather than certain of the requirements that are applicable to U.S. domestic registrants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We will follow Israeli
laws and regulations that are applicable to Israeli companies. However, Israeli laws and regulations applicable to Israeli companies do
not contain any provisions comparable to the U.S. proxy rules, the U.S. rules relating to the filing of reports on Form&#160;10-Q&#160;or&#160;8-K&#160;or
the U.S. rules relating to liability for insiders who profit from trades made in a short period of time, as referred to above.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 27; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Furthermore, foreign private
issuers are required to file their annual report on Form&#160;20-F&#160;within 120 days after the end of each fiscal year, while U.S.
domestic registrants that are non-accelerated filers are required to file their annual report on Form&#160;10-K&#160;within 90 days after
the end of each fiscal year. Foreign private issuers are also exempt from Regulation Fair Disclosure, aimed at preventing issuers from
making selective disclosures of material information, although we will be subject to Israeli laws and regulations having substantially
the same effect as Regulation Fair Disclosure. As a result of the above, even though we are required to file reports on Form&#160;6-K&#160;disclosing
the limited information which we have made or are required to make public pursuant to Israeli law, or are required to distribute to shareholders
generally, and that is material to us, you may not receive information of the same type or amount that is required to be disclosed to
shareholders of a U.S. registrant.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">These exemptions and leniencies
will reduce the frequency and scope of information and protections to which you are entitled as an investor.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The determination of foreign
private issuer status is made annually on the last business day of an issuer&#8217;s most recently completed second fiscal quarter and,
accordingly, the next determination will be made with respect to us on June 30, 2024. In the future, we would lose our foreign private
issuer status if a majority of our shareholders, directors or management are U.S. citizens or residents and we fail to meet additional
requirements necessary to avoid loss of foreign private issuer status. The regulatory and compliance costs to us under U.S. securities
laws as a U.S. domestic registrant may be significantly higher.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>We may be a &#8220;passive
foreign investment company,&#8221; or PFIC, for U.S. federal income tax purposes in the current taxable year or may become one in any
subsequent taxable year. There generally would be negative tax consequences for U.S. taxpayers that are holders of the Ordinary Shares
if we are or were to become a PFIC.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We may be considered a
PFIC or become a PFIC in the future. The determination of whether we are a PFIC is made on an annual basis and will depend on the composition
of our income and assets from time to time. We will be treated as a PFIC for U.S. federal income tax purposes in any taxable year in which
either (1) at least 75% of our gross income is &#8220;passive income&#8221; or (2) on average at least 50% of our assets by value produce
passive income or are held for the production of passive income. Passive income for this purpose generally includes, among other things,
certain dividends, interest, royalties, rents and gains from commodities and securities transactions and from the sale or exchange of
property that gives rise to passive income. Passive income also includes amounts derived by reason of the temporary investment of funds,
including those raised in a public offering. In determining whether a non-U.S. corporation is a PFIC, a proportionate share of the income
and assets of each corporation in which it owns, directly or indirectly, at least a 25% interest (by value) is taken into account. The
tests for determining PFIC status are applied annually, and it is difficult to make accurate projections of future income and assets which
are relevant to this determination. In addition, our PFIC status may depend in part on the market value of the Ordinary Shares. Accordingly,
there can be no assurance that we currently are not or will not become a PFIC in the future. If we are a PFIC in any taxable year during
which a U.S. taxpayer holds the Ordinary Shares, such U.S. taxpayer would be subject to certain adverse U.S. federal income tax rules.
A U.S. taxpayer that holds our warrants is taxed in a manner similar to a U.S. taxpayer owning Ordinary Shares if such taxpayer realizes
gain on the sale of the warrants. If the U.S. taxpayer holding the warrants exercises the warrants to purchase common shares, the holding
period over which any income realized is allocated includes the holding period of the warrants. The U.S. warrant holder is treated as
a holder of PFIC stock taxable under the ordinary income allocation and interest charge regime described above. If the U.S. taxpayer did
not make an election to treat us as a &#8220;qualified electing fund&#8221;, or QEF, or make a &#8220;mark-to-market&#8221; election,
then &#8220;excess distributions&#8221; to the U.S. taxpayer, and any gain realized on the sale or other disposition of the Ordinary Shares
and Warrants by the U.S. taxpayer: (1) would be allocated ratably over the U.S. taxpayer&#8217;s holding period for the Ordinary Shares
and Warrants; (2) the amount allocated to the current taxable year and any period prior to the first day of the first taxable year in
which we were a PFIC would be taxed as ordinary income; and (3) the amount allocated to each of the other taxable years would be subject
to tax at the highest rate of tax in effect for the applicable class of taxpayer for that year, and an interest charge for the deemed
deferral benefit would be imposed with respect to the resulting tax attributable to each such other taxable year. In addition, if the
U.S. Internal Revenue Service, or the IRS, determines that we are a PFIC for a year with respect to which we have determined that we were
not a PFIC, it may be too late for a U.S. taxpayer to make a timely QEF or mark-to-market election. U.S. taxpayers that have held the
Ordinary Shares and Warrants during a period when we were a PFIC will be subject to the foregoing rules, even if we cease to be a PFIC
in subsequent years, subject to exceptions for U.S. taxpayer who made a timely QEF or mark-to-market election. A U.S. taxpayer can make
a QEF election by completing the relevant portions of and filing IRS Form 8621 in accordance with the instructions thereto. We do not
intend to notify U.S. taxpayers that hold the Ordinary Shares and Warrants if we believe we will be treated as a PFIC for any taxable
year in order to enable U.S. taxpayers to consider whether to make a QEF election. In addition, we do not intend to furnish such U.S.
taxpayers annually with information needed in order to complete IRS Form 8621 and to make and maintain a valid QEF election for any year
in which we or any of our subsidiaries are a PFIC. U.S. taxpayers that hold the Ordinary Shares and Warrants are strongly urged to consult
their tax advisors about the PFIC rules, including tax return filing requirements and the eligibility, manner, and consequences to them
of making a QEF or mark-to-market election with respect to the Ordinary Shares and Warrants in the event that we are a PFIC. See &#8220;<span style="background-color: white">Item
10.E. Taxation &#8212; U.S. Federal Income Tax Considerations &#8212; Passive Foreign Investment Companies</span>&#8221; for additional
information.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 28; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>Risks Related to Our
Intellectual Property</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>We may not be able
to adequately protect or enforce our intellectual property rights throughout the world, and our efforts to do so may be costly.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">If we are not able to
adequately protect or enforce the proprietary aspects of our technology, competitors may be able to access our proprietary technology
and our business, results of operations and financial condition could be adversely affected. We currently attempt to protect our technology
through a combination of patent, copyright, trademark and trade secret laws, unfair competition laws, employee and third party nondisclosure
agreements and similar means. Despite our efforts, other parties may attempt to disclose, obtain or use our technologies or systems. Our
competitors may also be able to independently develop similar products or design around our patents. In addition, the laws of some countries
do not protect our proprietary rights as fully as do the laws of other countries. As a result, we may not be able to protect our proprietary
rights adequately in the United States, China or abroad.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Filing, prosecuting, and
defending patents on products and services, as well as monitoring their infringement in all countries throughout the world would be prohibitively
expensive, and our intellectual property rights in some countries can be less extensive than those according to federal and state laws
in the United States or laws in China. Competitors may use our technologies to develop their own products or services in jurisdictions
where we have not obtained patent protection and may export infringing products or services to territories where we have patent protection,
but where patents are not enforced as strictly as they are in the United States. These products or services may compete with our products
or services. Future patents or other intellectual property rights may not be effective or sufficient to prevent them from competing.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Many companies have encountered
significant problems in protecting and defending intellectual property rights in some jurisdictions. The legal systems of certain countries,
particularly certain developing countries, do not favor the enforcement of patents, trade secrets, and other intellectual property protection,
which could make it difficult for us to stop the marketing of competing products or services in violation of our proprietary rights generally.
Proceedings to enforce our patent rights in foreign jurisdictions, whether or not successful, could result in substantial costs and divert
our efforts and attention from other aspects of our business, could put our future patents at risk of being invalidated or interpreted
narrowly, put the issuance of our patent applications at risk, and could provoke third parties to assert claims against us. We may not
prevail in any lawsuits that we initiate, and any damages or other remedies that we may be awarded, may not be commercially meaningful.
Accordingly, our efforts to monitor and enforce our intellectual property rights around the world may be inadequate to obtain a significant
commercial advantage from the intellectual property that we develop or license.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">In addition, any litigation
initiated by us concerning the violation by third parties of our intellectual property rights is likely to be expensive and time-consuming
and could lead to the invalidation of, or render unenforceable, our intellectual property, or could otherwise have negative consequences
for us. In the future, we may be a party to claims and litigation as a result of alleged infringement by third parties of our intellectual
property. Even when we sue other parties for such infringement, that suit may have adverse consequences for our business. Any such suit
may be time-consuming and expensive to resolve and may divert our management&#8217;s time and attention from our business. Furthermore,
such a lawsuit could result in a court or governmental agency invalidating or rendering unenforceable our patents or other intellectual
property rights upon which the suit is based, which would seriously harm our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 29; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>If we are unable
to protect our domain names, our brand, business, and operating results could be adversely affected.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We have registered domain
names for websites, or URLs, that we use in our business, such as wearabledevices.co.il and mudra-band.com. We have registered digital
names for social media handlers, that we use in our business, such as Facebook and LinkedIn. If we are unable to maintain our rights in
these domain and digital names, our competitors or other third parties could capitalize on our brand recognition by using these domain
names for their own benefit. In addition, we might not be able to, or may choose not to, acquire or maintain other country-specific versions
of the &#8220;Wearable Devices&#8221; or &#8220;Mudra&#8221; domain and digital names or other potentially similar URLs. The regulation
of domain and digital names in the United States and elsewhere is generally conducted by Internet regulatory bodies and is subject to
change. If we lose the ability to use a domain or digital name in a particular country, we may be forced to either incur significant additional
expenses to market our solutions within that country, including the development of a new brand and the creation of new promotional materials,
or elect not to sell our solutions in that country. Either result could substantially harm our business and operating results. Regulatory
bodies could establish additional top-level domains, appoint additional domain or digital name registrars, or modify the requirements
for holding domain or digital names. As a result, we may not be able to acquire or maintain the domain or digital names that utilize the
name &#8220;Wearable Devices&#8221; or &#8220;Mudra&#8221; in all of the countries in which we currently conduct or intend to conduct
business. Further, the relationship between regulations governing domain and digital names and laws protecting trademarks and similar
proprietary rights varies among jurisdictions and is unclear in some jurisdictions. Domain and digital names similar to ours have already
been registered in the United States and elsewhere, and we may be unable to prevent third parties from acquiring and using domain or digital
names that infringe, are similar to, or otherwise decrease the value of, our brand or our trademarks. Protecting and enforcing our rights
in our domain and digital names and determining the rights of others may require litigation, which could result in substantial costs,
divert management attention, and not be decided favorably to us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>We may become subject
to litigation brought by third parties claiming infringement by us of their intellectual property rights. </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The industry in which
our business operates is characterized by a large number of patents, some of which may be of questionable scope, validity or enforceability,
and some of which may appear to overlap with other issued patents. As a result, there is a significant amount of uncertainty in the industry
regarding patent protection, enforcement and infringement. In recent years, there has been significant litigation globally involving patents
and other intellectual property rights. We could become subject to claims and litigation alleging infringement by us of third-party patents
and other intellectual property generally. These claims and any resulting lawsuits, if resolved adversely to us, could subject us to significant
liability for damages, impose temporary or permanent injunctions against our products or business operations, or invalidate or render
unenforceable our intellectual property. In addition, because patent applications can take many years until the patents are issued, there
currently may be pending applications of which we are unaware, which may later result in issued patents that our products may infringe.
If any of our products infringes a valid and enforceable patent, or if we wish to avoid potential intellectual property litigation on
any alleged infringement of such products, we may be prevented from selling, or elect not to sell, such products unless we obtain a license,
which may be unavailable. Alternatively, we may be forced to pay substantial royalties or to redesign one or more of our products to avoid
any infringement or allegations thereof. Additionally, we may face liability to our customers, business partners or third parties for
indemnification or other remedies in the event that they are sued for infringement in connection with their use of our products.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We also may not be successful
in any attempt to redesign our products to avoid any alleged infringement. A successful claim of infringement against us, or our failure
or inability to develop and implement non-infringing technology, or license the infringed technology, on acceptable terms and on a timely
basis, could materially adversely affect our business and results of operations. Furthermore, such lawsuits, regardless of their success,
would likely be time-consuming and expensive to resolve and would divert management&#8217;s time and attention from our business, which
could seriously harm our business. Also, such lawsuits, regardless of their success, could seriously harm our reputation with our consumer
electronics customers and in the industry at large.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 30; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>Our use of &#8220;open
source&#8221; software could negatively affect our ability to sell our products and subject us to possible litigation.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">A portion of the technologies
we use incorporates &#8220;open source&#8221; software, and we may incorporate open source software in the future. Such open source software
is generally licensed by its authors or other third parties under open source licenses. These licenses may subject us to certain unfavorable
conditions, including requirements that we offer our products and services that incorporate the open source software for no cost, that
we make publicly available source code for modifications or derivative works we create based upon, incorporating, or using the open source
software, or that we license such modifications or derivative works under the terms of the particular open source license, or limitations
on intellectual property protection and enforcement. Additionally, if a third-party software provider has incorporated open source software
into software that we license from such provider, we could be required to disclose or provide at no cost any of our source code that incorporates
or is a modification of such licensed software. If an author or other third party that distributes open source software that we use or
license were to allege that we had not complied with the conditions of the applicable license, we could be required to incur significant
legal expenses defending against such allegations and could be subject to significant damages and enjoined from the sale of our products
and services that contained the open source software. Any of the foregoing could disrupt the distribution and sale of our products and
services and harm our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>Patent policy and
rule changes could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or
defense of any issued patents.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Changes in either the
patent laws or interpretation of the patent laws in the United States and other countries may diminish the value of any patents that may
issue from our patent applications or narrow the scope of our patent protection. The laws of foreign countries may not protect our rights
to the same extent as the laws of the United States. Publications of discoveries in the scientific literature often lag behind the actual
discoveries, and patent applications in the United States and other jurisdictions are typically not published until 18 months after filing,
or in some cases not at all. We therefore cannot be certain that we were the first to file the invention claimed in our owned and licensed
patent or pending applications, or that we or our licensor were the first to file for patent protection of such inventions. Assuming all
other requirements for patentability are met, in the United States prior to March 15, 2013, the first to make the claimed invention without
undue delay in filing, is entitled to the patent, while generally outside the United States, the first to file a patent application is
entitled to the patent. After March 15, 2013, under the Leahy-Smith America Invents Act, or the Leahy-Smith Act, enacted on September
16, 2011, the United States has moved to a first to file system. The Leahy-Smith Act also includes a number of significant changes that
affect the way patent applications will be prosecuted and may also affect patent litigation. In general, the Leahy-Smith Act and its implementation
could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of any
issued patents, all of which could have a material adverse effect on our business and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>We may be subject
to claims challenging the inventorship of our intellectual property.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We may be subject to claims
that former employees, collaborators or other third parties have an interest in, or right to compensation, with respect to our current
patent and patent applications, future patents or other intellectual property as an inventor or co-inventor. For example, we may have
inventorship disputes arise from conflicting obligations of consultants or others who are involved in developing our products or services.
Litigation may be necessary to defend against these and other claims challenging inventorship or claiming the right to compensation. If
we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights, such
as exclusive ownership of, or right to use, valuable intellectual property. Such an outcome could have a material adverse effect on our
business. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction
to management and other employees.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Risks Related to Operations in Israel</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="background-color: white"><b><i>We
conduct our operations in Israel.</i></b></span>&#160;<b><i>Conditions in Israel, including conditions affected by the recent attack by&#160;Hamas&#160;and
other terrorist organizations and Israel&#8217;s war against them, may affect our operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Our offices are located in
Yokne&#8217;am Illit, Israel, thus, political, economic, and military conditions in Israel may directly affect our business. On October
7, 2023, Hamas terrorists infiltrated Israel&#8217;s southern border from the Gaza Strip and conducted a series of attacks on civilian
and military targets. Hamas also launched extensive rocket attacks on the Israeli population and industrial centers located along Israel&#8217;s
border with the Gaza Strip and in other areas within the State of Israel. Following the attack, Israel&#8217;s security cabinet declared
war against Hamas and the Israeli military began to call-up reservists for active duty. At the same time, and because of the declaration
of war against Hamas, the clash between Israel and Hezbollah in Lebanon has escalated and there is a possibility that it will turn into
a greater regional conflict in the future.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 31; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">As of today, these events
have had no material impact on the Company&#8217;s operations. According to the recent guidelines of the Israeli government, the Company&#8217;s
offices are open and functioning as usual. However, if the war escalates and expands to the Northern border with Lebanon, the Israeli
government potentially will impose additional restrictions on movement and travel, and our management and employees&#8217; ability to
effectively perform their daily tasks might be temporarily disrupted, which may result in delays in some of our projects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The Company currently has
the supply of materials needed for its regular operations. While there may be some possible delays in supply, those are currently not
anticipated to be material to the Company&#8217;s operations. However, if the war continues for a significant amount of time, this situation
may change.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Any hostilities involving
Israel, terrorist activities, political instability or violence in the region, or the interruption or curtailment of trade or transport
among Israel and its trading partners could make it more difficult for us to raise capital, if needed in the future, and adversely affect
our operations and results of operations and the market price of our Ordinary Shares. Moreover, we cannot predict how this war will ultimately
affect Israel&#8217;s economy in general, which may involve a downgrade in Israel&#8217;s credit rating by rating agencies (such as the
recent downgrade by Moody&#8217;s of its credit rating of Israel from A1 to A2, as well as the downgrade of its outlook rating from &#8220;stable&#8221;
to &#8220;negative&#8221;).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Our commercial insurance does
not cover losses that may occur as a result of an event associated with the security situation in the Middle East. Although the Israeli
government is currently committed to covering the reinstatement value of direct damages that are caused by terrorist attacks or acts of
war, we cannot assure you that this government coverage will be maintained or, if maintained, will be sufficient to compensate us fully
for damages incurred. Any losses or damages incurred by us could have a material adverse effect on our business, financial condition,
and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Further, many Israeli citizens
are obligated to perform several days, and in some cases, more, of annual military reserve duty each year until they reach the age of
40 (or older for certain reservists) and, in the event of a military conflict, may be called to active duty. In response to the series
of attacks on civilian and military targets in October 2023, there have been significant call-ups of military reservists. Currently, none
of the Company&#8217;s employees are in military reserve service. However, if the number of reservists in our Company increases and becomes
significant, our operations could be disrupted by such call-ups.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Any armed conflicts, terrorist
activities or political instability in the region could adversely affect business conditions, could harm our results of operations and
the market price of our Ordinary Shares, and could make it more difficult for us to raise capital. Parties with whom we do business may
sometimes decline to travel to Israel during periods of heightened unrest or tension, forcing us to make alternative arrangements when
necessary, in order to meet our business partners face to face.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The intensity and duration
of Israel&#8217;s current war against Hamas is difficult to predict at this stage, as are such war&#8217;s economic implications on the
Company&#8217;s business and operations and on Israel&#8217;s economy in general. However, if the war extends for a long period of time
or expands to other fronts, such as Lebanon, Syria and the West Bank, our operations may be harmed.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">It is currently not possible
to predict the duration or severity of the ongoing conflict or its effects on our business, operations and financial condition. The ongoing
conflict is rapidly evolving and developing, and could disrupt our business and operations, and adversely affect our ability to raise
additional funds or sell our securities, among other impacts.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 32; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>We may be required
to pay monetary remuneration to our Israeli employees for their inventions, even if the rights to such inventions have been duly assigned
to us.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We enter into agreements
with our Israeli employees pursuant to which such individuals agree that any inventions created in the scope of their employment are either
owned exclusively by us or are assigned to us, depending on the jurisdiction, without the employee retaining any rights. A portion of
our intellectual property has been developed by our Israeli employees during their employment for us. Under the Israeli Patent Law, 5727-1967,
or the Patent Law, inventions conceived by an employee during the course of his or her employment and within the scope of said employment
are considered &#8220;service inventions&#8221;. Service inventions belong to the employer by default, absent a specific agreement between
the employee and employer otherwise. The Patent Law also provides that if there is no agreement regarding the remuneration for the service
inventions, even if the ownership rights were assigned to the employer, the Israeli Compensation and Royalties Committee, or the Committee,
a body constituted under the Patent Law, shall determine whether the employee is entitled to remuneration for these inventions. The Committee
has not yet determined the method for calculating this Committee-enforced remuneration. While it has previously been held that an employee
may waive his or her rights to remuneration in writing, orally or by conduct, litigation is pending in the Israeli labor court is questioning
whether such waiver under an employment agreement is enforceable. Although our Israeli employees have agreed that we exclusively own any
rights related to their inventions, we may face claims demanding remuneration in consideration for employees&#8217; service inventions.
As a result, we could be required to pay additional remuneration or royalties to our current and/or former employees, or be forced to
litigate such claims, which could negatively affect our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>We received Israeli
government grants for certain of our research and development activities, the terms of which may require us to pay royalties and to satisfy
specified conditions in order to manufacture products and transfer technologies outside of Israel. If we fail to satisfy these conditions,
we may be required to pay penalties and refund grants previously received.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our research and development efforts have been
financed in part through royalty-bearing and non-royalty-bearing grants in an aggregate principal amount of approximately $2.2&#160;million
that we accrued or received from the IIA as of December 31, 2023. With respect to the royalty-bearing grants we are committed to pay royalties
at a rate of 3.0%-3.5% on sales proceeds from our products that were developed under the Israeli Innovation Authority, or the IIA, programs
up to the total amount of grants received, linked to the U.S. dollar and bearing interest at an annual rate of SOFR applicable to U.S.
dollar deposits. Until October 25, 2023, the interest was calculated at a rate based on 12-month LIBOR applicable to US Dollar deposits.
However, on October 25, 2023, the IIA published a directive concerning changes in royalties to address the expiration of the LIBOR. Under
such directive, regarding IIA grants approved by the IIA prior to January 1, 2024 but which are outstanding thereafter, as of January
1, 2024 the annual interest is calculated at a rate based on 12-month Secured Overnight Financing Rate, or SOFR, or at an alternative
rate published by the Bank of Israel plus 0.71513%; and, for grants approved on or following January 1, 2024 the annual interest shall
be the higher of (i) the 12 months SOFR interest rate, plus 1%, or (ii) a fixed annual interest rate of 4%. As of December 31, 2023, our
contingent liabilities regarding IIA grants accrued or received by us were in an aggregate principal amount of approximately $2.2 million
plus SOFR interest. The terms of the grants under the of the Israeli Encouragement of Industrial Research, Development and Technological
Innovation Law, 5744-1984, as amended, and related regulations, or the Research Law, and the related IIA rules and regulations, require
that the manufacturing of products resulting from IIA-funded programs be carried out in Israel, unless a prior written approval of the
IIA is obtained. In December 2022, we received an approval from the IIA to transfer some of our manufacturing activities abroad.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As a condition for obtaining approval to manufacture
outside of Israel (or following a declaration that up to 10% of the production is transferred abroad), we would be required to pay increased
royalties, which usually amount to 1% in addition to the standard royalties rate 3%-3.5%, and also the total amount of our liability to
IIA may be increased to between 100% and 150% of the grants we received from IIA, depending on the manufacturing volume that is performed
outside of Israel (less royalties already paid to IIA).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We are further required
to comply with the requirements of the Research Law with respect to those past grants. When a company develops know-how, technology or
products using IIA grants, the terms of these grants and the Research Law restrict the transfer or license of such know-how, and the transfer
of manufacturing or manufacturing rights of such products, technologies or know-how outside of Israel, without the prior approval of the
IIA. Our obligations in regard to know-how, technology or products that may be subject to these restrictions are not to transfer to anyone
the information, rights thereon and production rights to be derived from the research and development, in whole or part, of our Mudra
Inspire product and our Mudra Band product, without the IIA Research Committee approval. Therefore, the discretionary approval of an IIA
committee would be required for any transfer or license to third parties inside or outside of Israel of know how or for the transfer outside
of Israel of manufacturing or manufacturing rights related to those aspects of such technologies. We may not receive those approvals.
Furthermore, the IIA may impose certain conditions on any arrangement under which it permits us to transfer technology or development.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 33; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The transfer or license
of IIA-supported technology or know-how outside of Israel and the transfer of manufacturing of IIA-supported products, technology or know-how
outside of Israel may involve the payment of significant amounts, depending upon the value of the transferred or licensed technology or
know-how, our research and development expenses, the amount of IIA support, the time of completion of the IIA-supported research project
and other factors. These restrictions and requirements for payment may impair our ability to sell, license or otherwise transfer our technology
assets outside of Israel or to outsource or transfer development or manufacturing activities with respect to any product or technology
outside of Israel. Furthermore, the consideration available to our shareholders in a transaction involving the transfer outside of Israel
of technology or know-how developed with IIA funding (such as a merger or similar transaction) may be reduced by any amounts that we are
required to pay to the IIA.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b>&#160;</b>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>We may not be able
to enforce covenants not-to-compete under current Israeli law that might result in added competition for our products.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We have non-competition
agreements with all of our employees, all of which are governed by Israeli law. These agreements prohibit our employees from competing
with or working for our competitors, generally during their employment and for up to 12 months after termination of their employment.
However, Israeli courts are reluctant to enforce non-compete undertakings of former employees and tend to enforce those provisions for
relatively brief periods of time in restricted geographical areas, if at all, and only when the employee has provided unique value to
the employer specific to that employer&#8217;s business and not just regarding the professional development of the employee. If we are
not able to enforce non-compete covenants, we may be faced with added competition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>Provisions of Israeli
law may delay, prevent or otherwise impede a merger with, or an acquisition of, us, which could prevent a change of control, even when
the terms of such a transaction are favorable to us and our shareholders.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Israeli corporate law
regulates mergers, requires tender offers for acquisitions of shares above specified thresholds, requires special approvals for transactions
involving directors, officers or significant shareholders and regulates other matters that may be relevant to such types of transactions.
For example, a merger may not be consummated unless at least 50&#160;days have passed from the date on which a merger proposal is filed
by each merging company with the Israel Registrar of Companies and at least 30&#160;days have passed from the date on which the shareholders
of both merging companies have approved the merger. In addition, a majority of each class of securities of the target company must approve
a merger. Moreover, a tender offer for all of a company&#8217;s issued and outstanding shares can only be completed if the acquirer receives
positive responses from the holders of at least 95% of the issued share capital. Completion of the tender offer also requires approval
of a majority of the offerees that do not have a personal interest in the tender offer, unless, following consummation of the tender offer,
the acquirer would hold at least 98% of the Company&#8217;s outstanding shares. Furthermore, the shareholders, including those who indicated
their acceptance of the tender offer, may, at any time within six months following the completion of the tender offer, claim that the
consideration for the acquisition of the shares does not reflect their fair market value, and petition an Israeli court to alter the consideration
for the acquisition accordingly, unless the acquirer stipulated in its tender offer that a shareholder that accepts the offer may not
seek such appraisal rights, and the acquirer or the company published all required information with respect to the tender offer prior
to the tender offer&#8217;s response date.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Furthermore, Israeli tax
considerations may make potential transactions unappealing to us or to our shareholders whose country of residence does not have a tax
treaty with Israel exempting such shareholders from Israeli tax. For example, Israeli tax law does not recognize tax-free share exchanges
to the same extent as U.S. tax law. With respect to mergers, Israeli tax law allows for tax deferral in certain circumstances but makes
the deferral contingent on the fulfillment of a number of conditions, including, in some cases, a holding period of two years from the
date of the transaction during which sales and dispositions of shares of the participating companies are subject to certain restrictions.
Moreover, with respect to certain share swap transactions, the tax deferral is limited in time, and when such time expires, the tax becomes
payable even if no disposition of the shares has occurred. These provisions could delay, prevent or impede an acquisition of us or our
merger with another company, even if such an acquisition or merger would be beneficial to us or to our shareholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 34; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>It may be difficult
to enforce a judgment of a U.S. court against us and our executive officers and directors in Israel or the United States, to assert U.S.
securities laws claims in Israel or to serve process on our executive officers and directors and these experts.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We were incorporated in
Israel. Most of our executive officers and directors reside outside of the United States, and all of our assets and most of the assets
of these persons are located outside of the United States. Therefore, a judgment obtained against us, or any of these persons, including
a judgment based on the civil liability provisions of the U.S. federal securities laws, may not be collectible in the United States and
may not be enforced by an Israeli court. It also may be difficult for you to effect service of process on these persons in the United
States or to assert U.S. securities law claims in original actions instituted in Israel. Additionally, it may be difficult for an investor,
or any other person or entity, to initiate an action with respect to U.S. securities laws in Israel. Israeli courts may refuse to hear
a claim based on an alleged violation of U.S. securities laws reasoning that Israel is not the most appropriate forum in which to bring
such a claim. In addition, even if an Israeli court agrees to hear a claim, it may determine that Israeli law and not U.S. law is applicable
to the claim. If U.S. law is found to be applicable, the content of applicable U.S. law must be proven as a fact by expert witnesses,
which can be a time consuming and costly process. Certain matters of procedure will also be governed by Israeli law. There is little binding
case law in Israel that addresses the matters described above. As a result of the difficulty associated with enforcing a judgment against
us in Israel, you may not be able to collect any damages awarded by either a U.S. or foreign court.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white"><b>&#160;<i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>Our amended and
restated articles of association may be deemed to have an anti-takeover effect.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Certain provisions of
our amended and restated articles of association may make a change in control of us more difficult to effect. Our amended and restated
articles of association will provide for a staggered board of directors consisting of three classes of directors. Directors of each class
are chosen for three-year terms upon the expiration of their current terms and each year one class of our directors will be elected by
our shareholders. This classified board provision could have the effect of making the replacement of incumbent directors more time consuming
and difficult. At least two annual meetings of shareholders, instead of one, will generally be required to effect a change in a majority
of our board of directors. Thus, the classified board provision could increase the likelihood that incumbent directors will retain their
positions. The staggered terms of directors may delay, defer or prevent an attempt to change control of us, even though a change in control
might be considered by our shareholders to be in their best interest.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>Your rights and
responsibilities as a shareholder will be governed in key respects by Israeli laws, which differs in some material respects from the rights
and responsibilities of shareholders of U.S. companies.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The rights and responsibilities
of the holders of our Ordinary Shares are governed by our amended and restated articles of association and by Israeli law. These rights
and responsibilities differ in some material respects from the rights and responsibilities of shareholders in U.S. companies. In particular,
a shareholder of an Israeli company has a duty to act in good faith and in a customary manner in exercising its rights and performing
its obligations towards the company and other shareholders, and to refrain from abusing its power in such company, including, among other
things, in voting at a general meeting of shareholders on matters such as amendments to a company&#8217;s amended and restated articles
of association, increases in a company&#8217;s authorized share capital, mergers and acquisitions and related party transactions requiring
shareholder approval, as well as a general duty to refrain from discriminating against other shareholders. In addition, a shareholder
who is aware that it possesses the power to determine the outcome of a vote at a meeting of the shareholders or to appoint or prevent
the appointment of a director or executive officer in the company has a duty of fairness toward the company. However, Israeli law does
not define the substance of this duty of fairness. There is limited case law available to assist us in understanding the nature of these
duties or the implications of these provisions. These provisions may be interpreted to impose additional obligations and liabilities on
holders of our Ordinary Shares that are not typically imposed on shareholders of U.S. companies (see &#8220;Description of Share Capital
&#8211; Provisions Restricting Change in Control of Our Company&#8221; for additional information).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 35; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>General Risk Factors</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>We incur significant
costs as a result of our being a public company. Our management is required to devote substantial time to compliance with ongoing SEC
and Nasdaq requirements.&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">As a public company in
the United States, we incur significant accounting, legal and other expenses. We also incur costs associated with corporate governance
requirements of the SEC, and incur costs in connection with the requirements under Section 404 and other provisions of the Sarbanes-Oxley
Act. These rules and regulations have increased our legal and financial compliance costs, introduce new costs such as investor relations,
stock exchange listing fees and shareholder reporting, and make some activities more time consuming and costly. The maintenance and testing
of such processes and systems may require us to hire outside consultants and incur other significant costs. Any future changes in the
laws and regulations affecting public companies in the United States, including Section 404 and other provisions of the Sarbanes-Oxley
Act, and the rules and regulations adopted by the SEC, for so long as they apply to us, will result in increased costs to us as we respond
to such changes. These laws, rules and regulations could make it more difficult or more costly for us to obtain certain types of insurance,
including director and officer liability insurance, and we may be forced to accept reduced policy limits and coverage or incur substantially
higher costs to obtain the same or similar coverage. The impact of these requirements could also make it more difficult for us to attract
and retain qualified persons to serve on our board of directors, our board committees, or as executive officers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>If we engage in
future merger and acquisition activities or strategic partnerships, this could require significant management attention, may increase
our capital requirements, dilute our shareholders, cause us to incur debt or assume contingent liabilities, and subject us to other risks.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">As part of our business
strategy, we may make investments in other companies, products, or technologies. We may not be able to find suitable acquisition candidates
and we may not be able to complete acquisitions on favorable terms, if at all. If we do complete acquisitions, we may not ultimately strengthen
our competitive position or achieve our goals, and any acquisitions we complete could be viewed negatively by users or investors. In addition,
if we fail to successfully integrate such acquisitions, or the technologies associated with such acquisitions, into our company, the revenue
and operating results of the combined company could be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Additionally, we may evaluate
various strategic partnerships, including licensing or acquiring complementary products, intellectual property rights, technologies or
businesses. Any potential acquisition or strategic partnership may entail numerous risks, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">increased operating expenses and cash requirements;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the assumption of additional indebtedness or contingent liabilities;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the issuance of our equity securities;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>
    <p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">assimilation of operations, intellectual property and products
of an acquired company, including difficulties associated with integrating new personnel;</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the diversion of our management&#8217;s attention from our existing product programs and initiatives in pursuing such a strategic merger or acquisition;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">retention of key employees, the loss of key personnel and uncertainties
    in our ability to maintain key business relationships;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">risks and uncertainties associated with the other party to such a transaction,
    including the prospects of that party and their existing products or product candidates and marketing approvals; and</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our inability to generate revenue from acquired technology and/or products sufficient to meet our objectives in undertaking the acquisition or even to offset the associated acquisition and maintenance costs.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 36; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>We are subject to
risks associated with doing business globally. </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Our operations are subject
to risks inherent in conducting business globally and under the laws, regulations and customs of various jurisdictions and geographies.
In addition to risks related to currency exchange rates, these risks include changes in exchange controls, changes in taxation, importation
limitations, export control restrictions, changes in or violations of applicable laws, including the U.S. Foreign Corrupt Practices Act
and the U.K. Bribery Act of 2010, economic and political instability, disputes between countries, diminished or insufficient protection
of intellectual property, and disruption or destruction of operations in a significant geographic region regardless of cause, including
war, terrorism, riot, civil insurrection or social unrest. Failure to comply with, or material changes to, the laws and regulations that
affect our global operations could have an adverse effect on our business, results of operations and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>Our operating margins
may decline as a result of increasing product costs. </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Our business is subject
to significant pressure on pricing and costs caused by many factors, including intense competition, the cost of components used in our
products, labor costs, constrained sourcing capacity, inflationary pressure, pressure from users to reduce the prices we charge for our
products and services, and changes in consumer demand. Costs for the raw materials used in the manufacture of our products are affected
by, among other things, energy prices, consumer demand, fluctuations in commodity prices and currency, global pandemic slowing down manufacturing
capacity, and other factors that are generally unpredictable and beyond our control. Increases in the cost of raw materials used to manufacture
our products or in the cost of labor and other costs of doing business in the United States and internationally could have an adverse
effect on, among other things, the cost of our products, gross margins, operating results, financial condition, and cash flows.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>Sales of a significant
number of shares of our Ordinary Shares in the public markets or significant short sales of our Ordinary Shares, or the perception that
such sales could occur, could depress the market price of our Ordinary Shares and impair our ability to raise capital.&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Sales of a substantial
number of shares of our Ordinary Shares or other equity-related securities in the public markets, could depress the market price of our
Ordinary Shares. For example, in November 2023, we issued 4,444,444 Ordinary Shares in a public offering. If there are significant short
sales of our Ordinary Shares, the price decline that could result from this activity may cause the share price to decline more so, which,
in turn, may cause long holders of the Ordinary Shares to sell their shares, thereby contributing to sales of Ordinary Shares in the market.
Such sales also may impair our ability to raise capital through the sale of additional equity securities in the future at a time and price
that our management deems acceptable, if at all.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>The market price
of our Ordinary Shares and Warrants may be highly volatile, and you could lose all or part of your investment.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The market price of our
Ordinary Shares and Warrants is likely to be volatile. This volatility may prevent you from being able to sell your securities at or above
the price you paid for your securities. The market price of our Ordinary Shares and Warrants may fluctuate significantly in response to
numerous factors, some of which are beyond our control, which include:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in">&#9679;</td>
    <td>whether we achieve our anticipated corporate objectives;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#9679;</td>
    <td>actual or anticipated fluctuations in our quarterly or annual operating results; &#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#9679;</td>
    <td>changes in our financial or operational estimates or projections; &#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#9679;</td>
    <td>our ability to implement our operational plans; &#160;</td></tr>
</table><div>

</div><p style="margin: 0">&#160;</p><div>

</div><p style="margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 37; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in">&#9679;</td>
    <td>termination of the lock-up agreement or other restrictions on the ability of our shareholders to sell shares; &#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#9679;</td>
    <td>changes in the economic performance or market valuations of companies similar to ours; and &#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#9679;</td>
    <td>general economic or political conditions in the United States or elsewhere, including those related to recent unrest and actual or potential armed conflict in Israel and other parts of the Middle East, such as the recent attack by Hamas and other terrorist organizations from the Gaza Strip and Israel&#8217;s war against them.</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">In addition, the stock
market in general has experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating
performance of these companies. Broad market and industry factors may negatively affect the market price of our securities, regardless
of our actual operating performance, and we have little or no control over these factors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>We may be
subject to securities litigation, which is expensive and could divert management attention.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">In the past, companies
that have experienced volatility in the market price of their stock have been subject to securities class action litigation. We may be
the target of this type of litigation in the future. Litigation of this type could result in substantial costs and diversion of management&#8217;s
attention and resources, which could seriously hurt our business. Any adverse determination in litigation could also subject us to significant
liabilities.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>If securities or
industry analysts do not publish or cease publishing research or reports about us, our business or our market, or if they adversely change
their recommendations or publish negative reports regarding our business or the Ordinary Shares, our share price and trading volume could
decline.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The trading market for
the Ordinary Shares and/or Warrants will be influenced by the research and reports that industry or securities analysts may publish about
us, our business, our market or our competitors. We do not have any control over these analysts and we cannot provide any assurance that
analysts will cover us or provide favorable coverage. If any of the analysts who may cover us adversely change their recommendation regarding
the Ordinary Shares, or provide more favorable relative recommendations about our competitors, the price of our Ordinary Shares and/or
Warrants would likely decline. If any analyst who may cover us were to cease coverage of our company or fail to regularly publish reports
on us, we could lose visibility in the financial markets, which in turn could cause the price of our Ordinary Shares or trading volume
to decline.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>Our internal control
over financial reporting currently meets all of the standards contemplated by Section 404 of the Sarbanes-Oxley Act, but failure to maintain
effective internal control over financial reporting in accordance with Section 404 of the Sarbanes-Oxley Act could have a material adverse
effect on our business, our operating results, investor confidence in our reported financial information, and the market price of our
ordinary shares. </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We have established formal
policies, processes and practices related to our internal control over financial reporting and to identify key financial reporting risks,
including an assessment of the potential impact and linkage of those risks to specific areas and activities within our organization, in
order to satisfy the requirements of Section 404 (a) of the Sarbanes-Oxley Act, which requires an annual management assessment of the
effectiveness of our internal control over financial reporting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We are required to comply
with the requirements of Sections&#160;302 and 404 of the Sarbanes-Oxley Act, which require our management to certify financial and other
information in our annual reports and require that we provide an annual management report on the effectiveness of control over financial
reporting. Additionally, while we remain an emerging growth company, we will not be required to include an attestation report on internal
control over financial reporting issued by our independent registered public accounting firm. To achieve compliance with Section&#160;404
within the prescribed period, we engaged in a process to document and evaluate our internal control over financial reporting. In this
regard, we will need to continue to dedicate internal resources, potentially engage outside consultants and adopt a detailed work plan
to assess and document the adequacy of internal control over financial reporting, continue steps to improve control processes as appropriate,
validate through testing that controls are functioning as documented and implement a continuous reporting and improvement process for
internal control over financial reporting. We believe we are in compliance with Section&#160;404 of the Sarbanes-Oxley Act as of the date
of this annual report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 38; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If we are not able to continue to implement and
document the necessary policies, processes and controls to mitigate financial reporting risks, we may not be able to comply with the requirements
of Sections 404(a) in a timely manner or with adequate compliance. Matters impacting our internal controls may cause us to be unable to
report our financial information on a timely basis and thereby subject us to adverse regulatory consequences, including sanctions by the
SEC or violations of applicable stock exchange listing rules. There could also be a negative reaction in the financial markets due to
a loss of investor confidence in our company and the reliability of our financial statements. Confidence in the reliability of our financial
statements could also suffer if we were to report a material weakness in our internal control over financial reporting. This could materially
adversely affect us and lead to a decline in the price of our securities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Our efforts to comply
with the requirements of Section 404 of the Sarbanes-Oxley Act of 2002, governing internal control and procedures for financial reporting
have resulted in increased general and administrative expenses and a diversion of management time and attention, and we expect these efforts
to require the continued commitment of significant resources.&#160;We may identify material weaknesses or significant deficiencies in
our assessments of our internal control over financial reporting.&#160; Failure to maintain effective internal control over financial
reporting could result in investigations or sanctions by regulatory authorities, and could have a material adverse effect on our operating
results, investor confidence in our reported financial information, and the market price of our ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>Our amended and restated articles of association
provide that, unless we consent to an alternative forum, the federal district courts of the United States shall be the&#160;exclusive&#160;forum&#160;for
resolution of any complaint asserting a cause of action arising under the&#160;Securities Act, which could limit our shareholders&#8217;
ability to choose the judicial forum for disputes with us, our directors, shareholders, or other employees.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our amended and restated articles of association
provide that, unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States
shall be the&#160;exclusive&#160;forum&#160;for the resolution of any complaint asserting a cause of action arising under the&#160;Securities
Act. Section 22 of the Securities Act creates concurrent jurisdiction for U.S. federal and state courts over all such&#160;Securities
Act&#160;actions. Accordingly, both U.S. state and federal courts have jurisdiction to entertain such claims. To prevent having to litigate
claims in multiple jurisdictions and the threat of inconsistent or contrary rulings by different courts, among other considerations, our
amended and restated articles of association provide that, unless we consent in writing to the selection of an alternative forum, the
federal district courts of the United States shall be the&#160;exclusive&#160;forum&#160;for the resolution of any complaint asserting
a cause of action arising under the&#160;Securities Act. This&#160;exclusive&#160;forum&#160;provision will not apply to suits brought
to enforce any liability or duty created by the&#160;Exchange Act, and our shareholders cannot and will not be deemed to have waived our
compliance with the U.S. federal securities laws and the rules and regulations promulgated under the Securities Act or the Exchange Act
as a result of our&#160;exclusive&#160;forum&#160;provision.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Any person or entity purchasing or otherwise acquiring
any interest in any of our securities shall be deemed to have notice of and consented to the foregoing provision of our amended and restated
articles of association. However, the enforceability of similar forum provisions (including exclusive federal forum provisions for actions,
suits, or proceedings asserting a cause of action arising under the&#160;Securities Act) in other companies&#8217; organizational documents
has been challenged in legal proceedings, and there is uncertainty as to whether courts would enforce the&#160;exclusive&#160;forum&#160;provision
in our amended and restated articles of association. If a court were to find the&#160;exclusive&#160;forum&#160;provision contained in
our amended and restated articles of association to be inapplicable or unenforceable in an action, we may incur additional costs associated
with resolving such action in other jurisdictions, which could materially adversely affect our business, financial condition, and results
of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Although we believe the&#160;exclusive&#160;forum&#160;provision
benefit us by providing increased consistency in the application of U.S. federal securities laws <span style="background-color: white">the
Israeli Companies Law 5759-1999, </span>or the Companies Law, <span style="background-color: white">or New York law</span>, as applicable,
in the types of lawsuits to which they apply, such&#160;exclusive&#160;forum&#160;provision may limit a shareholder&#8217;s ability to
bring a claim in the judicial forum that they find favorable and may increase certain litigation costs for disputes with us or any of
our directors, shareholders, officers, or other employees, which may discourage lawsuits with respect to such claims against us and our
current and former directors, shareholders, officers, or other employees.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 39; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><b><i>We may be subject
to liability claims if we breach our contracts, and our insurance may be inadequate to cover our losses.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We are subject to numerous
obligations in our contracts with organizations and our partners. Despite the procedures, systems and internal controls we have implemented
to comply with our contracts, we may breach these commitments, whether through a weakness in these procedures, systems and internal controls,
negligence or the willful act of an employee or contractor. Our insurance policies may be inadequate to compensate us for the potentially
significant losses that may result from claims arising from breaches of our contracts, disruptions in our services, failures or disruptions
to our infrastructure, catastrophic events, and disasters or otherwise. Further, our insurance may not cover all claims made against us
and defending a suit, regardless of its merit, could be costly and divert management&#8217;s attention. In addition, such insurance may
not be available to us in the future on economically reasonable terms, or at all.<b>&#160;</b>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="a_012"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM 4. INFORMATION ON THE COMPANY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="a_013"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>A. History and Development of the Company</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We were incorporated in 2014 in Israel. <span style="background-color: white">Our
Ordinary Shares and Warrants are currently listed for trading on the Capital Market under the symbols &#8220;WLDS&#8221; and &#8220;WLDSW&#8221;,
respectively.</span> We are a growth company developing a non-invasive neural input interface in the form of a wearable wristband band
for controlling digital devices using subtle touchless finger movements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our principal executive offices are located at
5 Ha-Tnufa St., Yokne&#8217;am Illit, 2066736 Israel. Our telephone number in Israel is 972.4.6185670. Our website address is <i>www.wearabledevices.co.il</i>.
The information contained on our website or available through our website is not incorporated by reference into and should not be considered
a part of this annual report on Form 20-F, and the reference to our website in this annual report on Form 20-F is an inactive textual
reference only. Mudra Wearable, Inc. is our agent in the United States and its address is 24A Trolley Square #2203, Wilmington, DE 19806.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are an &#8220;emerging growth company,&#8221;
as defined in Section&#160;2(a) of the Securities Act of 1933, as amended, or the Securities Act, as modified by the JOBS Act. As such,
we are eligible to, and intend to, take advantage of certain exemptions from various reporting requirements applicable to other public
companies that are not &#8220;emerging growth companies&#8221; such as not being required to comply with the auditor attestation requirements
of Section&#160;404 of the Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley Act. We could remain an &#8220;emerging growth company&#8221;
for up to five years, or until the earliest of (a)&#160;the last day of the first fiscal year in which our annual gross revenues exceeds
$1.235&#160;billion, (b)&#160;the date that we become a &#8220;large accelerated filer&#8221; as defined in Rule&#160;12b-2 under the
U.S. Securities Exchange Act of 1934, as amended, or the Exchange Act, which would occur if the market value of our Ordinary Shares that
is held by non-affiliates exceeds $700&#160;million as of the last business day of our most recently completed second fiscal quarter,
or (c)&#160;the date on which we have issued more than $1&#160;billion in nonconvertible debt during the preceding three-year period.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are a foreign private issuer as defined by the
rules under the Securities Act and the Exchange Act. Our status as a foreign private issuer also exempts us from compliance with certain
laws and regulations of the SEC and certain regulations of the Nasdaq Stock Market, including the proxy rules, the short-swing profits
recapture rules, and certain governance requirements such as independent director oversight of the nomination of directors and executive
compensation. In addition, we are not required to file annual, quarterly and current reports and financial statements with the SEC as
frequently or as promptly as U.S. domestic companies registered under the Exchange Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 40; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_014"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>B. Business Overview</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are a growth company developing a non-invasive
neural input interface in the form of a wearable wristband for controlling digital devices using subtle touchless finger movements. Since
our technology was introduced to the market in 2014, we have been working with both B2B and B2C customers as part of our push-pull strategy.
We are now in the transition phase from research and development to commercialization of our technology into B2B products. At the same
time, we have commenced shipment of the &#8220;Mudra Band&#8221;, our first B2C consumer product, and aftermarket accessory band for Apple
Watch that enables gesture control across Apple ecosystem devices such as iPhone, Mac computer, Apple TV, and iPad, inter alia.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our company&#8217;s vision is to create a world
in which the user&#8217;s hand becomes a universal input device for touchlessly interacting with technology. We believe that our technology
is setting the standard input interface for the Metaverse. At CES 2024, the Mudra Band won global recognition and was featured by the
tech magazines Mashable and VentureBeat. The Mudra Band received recognition as one of the coolest tech CES 2024 products by a leading
global technology and lifestyle influencer, and was included in the &#8220;Best of CES 2024&#8221; products list by SlashGear. On February
12, 2024, we signed an agreement with Qualcomm to collaborate in elevating XR experiences with Mudra Neural Technology. This collaboration
will help Qualcomm&#8217;s customers looking to use the innovative Mudra technology when developing products using the Qualcomm Snapdragon
Spaces&#8482; XR Developer Platform, redefining interaction in augmented reality, or AR, and virtual reality, or VR, environments.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We intend to transform interaction and control
of digital devices to be as natural and intuitive as real-life experiences. We imagine a future in which humans can share skills, thoughts,
emotions, and movements with each other and with computers, using wearable interfaces and devices. We believe that neural-based interfaces
will become as ubiquitous to interact with wearable computing and digital devices in the near future as the touchscreen is a universal
input method for smartphones.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Combining our own proprietary sensors and AI algorithms
into a stylish wristband, our Mudra platform enables users to control digital devices through subtle finger movements and hand gestures,
without physical touch or contact. These digital devices include consumer electronics, smart watches, smartphones, AR glasses, VR headsets,
televisions, personal computers and laptop computers, drones, robots, etc.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Mudra Development Kit, originally named Mudra Inspire,
our B2B development kit product, started selling to B2B customers in 2018 as the first point of business engagement and contributed to
our early-stage revenues. At CES 2024, the Mudra Band for Apple Watch, our flagship B2C product was included in the &#8220;Best of CES
2024&#8221; products list by SlashGear.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our early-stage revenues are composed of sales
of our Mudra Inspire and from pilot transactions with several B2B customers. Towards the end of 2023, we commenced the shipments of the
&#8220;Mudra Band&#8221;, our first B2C consumer product. In 2023 and 2022, we had revenues of $82 thousand and $45 thousand, respectively,
and comprehensive and net loss of $7.8 million and $6.5 million, respectively.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Over 100 companies have purchased our Mudra Inspire
development kit, 30 of which are multinational technology companies. These companies are exploring various input and control use-cases
for their products, ranging over multiple countries and industry sectors, including consumer electronics manufacturers, consumer electronics
brands, electronic components manufacturers, IT services and software development companies, industrial companies, and utility providers.
Our objective with these companies is to commercialize the Mudra technology by licensing it for integration in the hardware and software
of these companies&#8217; products and services. We estimate that there will be a three-to-five-year period from the time we are first
introduced to a customer to signing a licensing agreement. As of March 13, 2024, we have not signed a license agreement with any of these
companies.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition to consumer electronics, we have recently
expanded our brand to include neurotech and brain-computer interface sensors, with additional verticals that include Industry 4.0 &#8211;
a new phase in the Industrial Revolution that focuses on interconnectivity, automation, machine learning, and real-time data, digital
health, sport analytics, and more.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 41; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The core of our platform is Mudra, which means
&#8220;gesture&#8221; in Sanskrit. Mudra&#8211; our SNC technology and wristband tracks neural signals on the user&#8217;s wrist skin
surface, which our algorithms decipher to predict as gestures made by finger and hand movements. The interface binds each gesture with
a specific digital function, allowing users to input commands without physical touch or contact. Mudra gestures are natural to perform,
and gestures can be tailored per a user&#8217;s intent, desired function, and the controlled digital device. Mudra can detect multiple
gesture types, including hand movements, finger movements, and fingertip pressure gradations. In addition to the control use-case, our
Mudra technology and SNC sensor can be utilized in multiple monitoring use-cases where we can monitor neural and hand movements for digital
health purposes, sport analytics performance, and Industry 4.0 solutions.</p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><img alt="" src="image_002.jpg"/></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>Figure 1: Our Mudra Platform</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Figure 1 above displays the appearance and major
features of our current products&#8212;the Mudra Band for Apple Watch and the Mudra Development Kit . Our gestures are discrete or continuous
hand and finger movements, deciphered from neural signals at the wrist. Our interface can control multiple digital devices using a single
interface. In addition to consumer electronics, we have recently expanded our brand to include neurotech and brain/computer interface
monitoring, with additional verticals including Industry 4.0, digital health, sport analytics, and more.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 42; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Our Strengths</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We believe that our strengths include:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left"><b>Direct relationships with the world&#8217;s leading multinational
technology consumer electronics companies</b>. Our B2B customers are seeking new, intuitive and natural methods for input and control
of wearable computers, including smartwatches, AR glasses, VR headsets, smartphones, and other consumer entertainment devices (such as
smart televisions, large displays, voice assistants, etc.).</td>
</tr></table><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left"><b>Vertically integrated platform that is difficult to replicate.
</b>We believe that we are setting the standard of using gestures to interact with wearable computers. Our technology is based on six
layers which form three pillars &#8211; hardware, software and humanware, which is the method of adding a human facet into the development
of hardware and software with the main goal of making it as functional as possible. Our hardware and software emphasize natural, intuitive,
easy to use user-experience and user interface humanware. Our technologies are interdependent and are optimized to sense wrist area bio-potentials,
which are electrical potentials generated in the tissues of the wrist. There is a very high interdependency between each layer, and we
believe that we possess the expertise for all technology layers.</td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left"><b>Expanding our products to multiple market verticals. </b>In
addition to working with businesses and individual customers in the consumer electronics market, we have developed several use-cases
for digital health, Industry 4.0, and sport analytics markets. These use-cases involve utilizing the Mudra SNC sensor as a platform to
be used in additional verticals, such as frontline workers, patients, and athletes and sport enthusiasts.</td>
</tr></table><div>
</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left"><b>A Push-Pull strategy to win both B2B and B2C sales</b>.
Using a &#8220;Push-Pull&#8221; strategy and working directly with manufacturers of digital devices and with consumers using wearable
computing devices, we have successfully created customer demand for consumer products and proved to manufacturers the validity of our
solution to consumers. Working with both manufacturers and consumers allows us to develop products that are based on needs, inputs, demands,
requests and behaviors of all stakeholders along the value chain.</td>
</tr></table><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left"><b>World-class research, engineering and product teams. </b>Our
employees have a diverse set of skills and industry experience, including expertise in highly scalable distributed software systems,
machine learning algorithms, artificial intelligence architecture, and user-centric product design. Our engineering, product, and design
teams work together to bring our products to life, from conception to implementation. We are committed to leveraging data to continuously
improve our customer experience by studying and understanding points of interaction and how our customers use our platform features.</td>
</tr></table><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left"><b>Strong, advantageous platform that contains</b>:</td>
</tr></table><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.75in"/><td style="width: 0.25in; text-align: left"><b>-</b></td><td style="text-align: left"><b>A proprietary sensor to capture neural signals. </b>Our
proprietary Mudra SNC sensor can be utilized to decipher signal patterns for gesture control as input for digital devices, and it can
also be utilized to monitor and track the neural activity of the hand motor neurons for short and long-term diagnosis.</td>
</tr></table><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left"><b>-</b></td><td style="text-align: left"><b>Natural, intuitive operation using subtle finger movements.
</b>By making communication with computers much easier, we intend to empower users to interact with computers and work, enjoy entertainment,
and live better. Our stylish, elegant devices have a small size and shape, and support natural, intuitive, and subtle finger movements
and gestures. Our gestures are familiar to users and are comfortable to perform in relaxed spatial body postures.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left"><b>-</b></td><td style="text-align: left"><b>Human-centered design that optimizes user experience.
</b>Our products are designed around our customers&#8217; user experience. Our large global network of consumers and business customers
provides highly useful feedback and insights, which we use to constantly improve our products and the value we offer to our users.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left"><b>-</b></td><td style="text-align: left"><b>A large hand and finger gesture database. </b>Through
anonymized data from cloud-based calibrations and mobile apps, we are building a large database of finger and hand gestures. This will
allow us to gain unparalleled insights on trends, behaviors, and usage.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 43; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left">-</td><td style="text-align: left"><b>Flexible gestures and user-interaction choices.</b> Our
platform supports the development and implementation of a large variety of new gestures. We can tailor gestures for each use-case per
user requests or our own internal insights. Defining the right gesture and binding it with the correct function is important for high
adoption of our input solution for wearable computing, and for our platform solution to become ubiquitous in multiple digital devices.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Industry Overview and Market Opportunity</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Total Addressable Market</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Every digital device - whether worn on the body,
placed on a desk, held in the hands, or hung on a wall - requires an interface. The Total Addressable Market, or TAM, of digital devices
that we are targeting can be categorized into three segments&#8212;wearable computers, face computers and home digital devices. We view
Mudra as an all-encompassing input, operation, and control interface for all digital devices, connecting the physical world with digital
devices using subtle finger movements and gestures.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The basic pillars of Human-Computer Interface,
or HCI, input are text, navigation, and digital element interaction. The most common interface solutions include the keyboards and mice
for PCs. Additional common interfaces are the touchscreens for mobile phones and tablet computers, handheld controllers for televisions,
game consoles, VR headsets, and temple area touchpads and/or gesture cameras for AR glasses. Voice assistants are now commonly used with
smart home devices.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The pace of technology advancements has always
been dictated by user interfaces. With the future of computers tilting increasingly toward wearable devices, especially as smartwatches
and smart glasses enter the market, HCI methods for wearable computing will need to be reinvented as well. We believe that the industry&#8217;s
foreseeable future is based on wearable computers for different body parts, instead of computers that are restricted to lying on a desk.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The industry of digital computers peripherals and
input devices has evolved dramatically in the past 70 years. It started in the 1950s with punch-cards as the major input method. Punch-cards
were replaced by the QWERTY keyboard to input text and for two-dimensional navigation starting in the 1960s. The computer mouse, which
allowed users to navigate and interact with digital elements on a Graphical User-Interface, was introduced in the 1980s. Touchpads became
popular as a mouse replacement for laptop computers in the 1990s. Gesture recognition cameras to detect body, hand and finger movement
were introduced in the early 2000s. Touchscreens as inputs for mobile smartphones became ubiquitous at the end of 2010.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Technologies which are used in all devices for
input, interaction, control and operation, include:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Handheld devices </b>such as computer mice, presentation clickers,
    gaming controllers, and styluses.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Touch based devices</b> such as the touchpad or touchscreen.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Keyboard technology devices</b> or digital displays which contain
    alphanumeric symbols to input text and for navigation.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Voice assistant devices and services </b>which interpret human speech
    to digital commands and speech-to-text input.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Gesture detection sensors</b> such as gesture detection cameras,
    LiDar, Radar and additional optional technologies that sense the finger and hand movements.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Wearable input devices</b> such as smart gloves, wearable keyboards,
    wearable computer mice, smart rings, and smart wearable clickers.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Neural interface devices</b> that are based on capturing bio-potential signals and transforming signal patterns to input commands, in invasive implant and in non-invasive wearable methods.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 44; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">According to an article &#8220;Worldwide Wearables
Market Is Forecast to Rebound in 2023 ,&#8221; by International Data Corporation, or IDC, published in June 2023 by IDC, in 2023, a total
of 504.1 million units of wearable devices will be shipped to consumers, of which approximately 157.3 million are smartwatches and approximately
32.1 million smart wristbands. IDC forecasts the market for wearable devices will reach 629.4 million units shipped to consumers in 2027,
of which 206.2 million will be smartwatches. This industry is expected to show a healthy 6.8% five-year compound annual growth rate.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">According to an article &#8220;Another Slow Year
Expected for AR/VR Headsets Before 2024 Rebound ,&#8221; published in September 2023 by IDC, 2023 shipments of face computers will reach
a total of 8.5 million units shipped. IDC forecasts that the face computers market will reach 30.3 million shipped units in 2027,. The
category is expected to show a 37.3% year-over-year growth. Face computers are considered devices that have a potential to replace smartphones
by the end of the decade. This product category includes AR glasses, such as the Apple Vision Pro, and VR head-mounted devices, such as
the Meta Quest3.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Smart computing consumer
devices include smartphones, tablets, desktop computers, and gaming consoles. According to the IDC articles published in June 2023, 2023
shipments of category products will reach approximately a total of 1.84 billion units shipped in 2023. IDC forecasts this market will
reach 2.08 billion units shipped in 2027.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Taking the aforementioned figures into consideration,
the TAM that we are targeting is approximately 12.7 billion devices shipped between 2023 to 2027. The smart-computing and smart-home device
categories present several challenges that need to be addressed before we will be able to take advantage of this opportunity. One of our
major challenges is to determine whether consumers will be reluctant to adopt our products and services as an alternative to established,
traditional devices, such as remote controls, touchscreens, camera gesture control solutions, keyboards and mice.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As a result, we plan to focus on delivering the
greatest value to users by first focusing on the wearables and face computer device categories. We believe that as we continue to expand
our platform and as consumers increasingly view a connected world of ambient computing and smart-home products and services as an alternative
or complement to wearable devices, there will be an opportunity to extend our addressable market to the broader consumer electronics categories
and markets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Neural control interface market </i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The global neural control interface market is expanding
due to several significant trends, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>The pace of technology advancements is always dictated by user interfaces:
    </b>Input methods have evolved in the past 70 years from paper printed punch-cards to touchscreens and gesture sensing technologies. The
    purpose of input is to lower the cognitive load of the user and provide a natural and intuitive method to communicate intentions and commands
    into a computer. The computer mouse helped place a personal computer in every home, and the touchscreen revolution put a smartphone in
    every pocket. Input technology is the enabler and herald of the next computing platform. We believe that the input method for wearable
    computing will have to be re-invented as well, with interactions beyond the touchscreen.&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Spatial computing is reshaping business processes and consumer entertainment
    patterns:</b> The use of wearable technology makes it easier for frontline and assembly line workers to operate more efficiently and provide
    better service. It boosts labor efficiency, reduces quality defects and revisions, and improves safety. Wearable consumer products are
    already an integral part of consumers&#8217; lives. The Apple Vision Pro and the Meta Quest 3 are two examples of spatial computing products.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p></td></tr>
</table><div>

</div><p style="margin: 0">&#160;</p><div>

</div><p style="margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 45; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>The &#8220;Metaverse&#8221; is widely considered to become
the future of the internet</b>. Instead of just viewing content - users will be in it, experiencing it all around. Users will remotely
create and explore with other users as if they are present with them - socialize, work, play, learn, shop, and more. Accessible across
multiple computing platforms such as VR, AR, mobile devices and computers, the Metaverse will offer rich immersive experiences and reach
content. Already termed as &#8220;the next computing platform,&#8221; it is becoming the major catalyst to adopting wearable computing.
We believe that our technology is setting the standard input interface for the Metaverse, by providing a wearable-based gesture control
input which goes beyond the boundaries of vision-based solutions.</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The human wrist is a highly valuable tool for sensing the human body:</b> Nerve bundles and arteries pass directly beneath the skin making it possible to sense the electrical conductance of nerves and other bodily functions and to collect valuable data. Today, physical tools are being replaced with digital accessories such as wristbands and smartwatches. These devices measure wrist movement, heartbeat, electroencephalography, rhythm, skin temperature, hydration, and blood oxygen. Recent advancements in sensors and signal processing combined with artificial intelligence algorithms have enabled the emergence of wrist-based wearable neural input technology, thus opening a wide range of applications in HCI and bio-potential signals monitoring.&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Neurotech market and brain-computer interfaces are gaining traction:</b> The neurotech industry is based on connecting human brains to computers, so that brain-computer interfaces open up a new area of economic enterprise. Brain-computer interfaces and neural inputs are starting to move beyond the confines of academia and toward industry and the consumer market. In January 2024, Neuralink announced the first human patient has received a Neuralink brain implant. In February 2024, Synchron announced it is one step closer to brain chip commercialization. We believe a wearable interface which can supply pointing functionality of tap, pinch, pinch and drag and slide and glide, using gestures is the key to mass consumer market adoption, whereas brain implants may be common only years ahead. </span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Our Technology</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our technology is based on six layers which form
three pillars-- hardware, software and humanware. We develop the hardware and the software from the bottom up and define the user-experience.
Using the domain expertise and the insights we have gathered and continue to gather as users provide feedback, we define the standard
for interaction with wearables and digital devices. Our technology layers are interdependent and are optimized to the wrist area thus
creating a significant protection moat - there is a very high interdependency between each layer to adjacent layers, and developing similar
solutions requires expertise in each individual layer.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The first pillar is <b>hardware</b>, which includes
electrodes, band design, including form factor and materials, the SNC sensor and the miniaturized flex-rigid electronics. We research
and develop electrode materials and geometry to achieve a durable electrode that sustains its physical properties on wrist skin contact
and endures thousands of wear/off cycles. Band design includes the modeling of the curvature of the band to snuggly fit the wrist area,
and feel pleasant and comfortable to be worn on daily basis. The SNC sensors were developed specifically for the inner wrist area; therefore,
they are able to sense low energy biopotentials and to maintain optimal bandwidth and minimize external interference sources. The miniaturized
flex-rigid electronics design and manufacturing offer a flexible shell with dynamic semi flex-rigid printed circuit board, to meet strict
bill of materials and design for assembly requirements, and consumer laws.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 46; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><img alt="" src="image_003.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>Figure 2: The Three Pillars of the Mudra Technology</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Figure 2 above displays the three pillars of our
technology.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The first pillar is <b>hardware</b>, which includes
electrodes, band design, including form factor and materials, the SNC sensor and the miniaturized flex-rigid electronics.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The second pillar is <b>software</b>, which includes
cross platform software engine, artificial intelligence learning algorithms and software applications. We developed a unique cross-platform
software engine, which supports real-time signal processing and is capable of cross-platform algorithms mitigation on multiple operating
systems. This allows us to run our software on low compute power wearables and digital devices, and to mitigate algorithms across platforms
without the need to re-write the algorithms for each operating system. Our machine learning algorithms and deep learning neural networks
artificial intelligence architecture leverages the most advanced approaches of few-shot learning algorithms, making classification based
on a very small number of samples, on a unique bio-signal for which we create the unique, and non-available, training and validation sets.
We achieved over 96% accuracy with a very short calibration procedure for multiple users. We develop software applications for mobile
and desktop operating systems which integrate the algorithms and supply the users with the desired gestures and functions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The third pillar is the <b>humanware and user experience</b>
which is the hand and finger gestures that the user performs and the functions that bind with these gestures to input commands and control
devices. We developed a set of gestures that create a natural interaction and are optimized for humans rather than for computers. As a
result, we immerse users naturally to control their devices and increase the fidelity of intention. Furthermore, we developed functionality
that allows users to toggle and switch between connected devices and provides a seamless transition of control across devices such as
an iPhone, iPad, Mac computer, and Apple TV devices, as well as other connected devices including smart glasses, using handsfree and touchless
subtle finger and wrist movements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our Mudra platform supports discrete gestures,
continuous gestures, and air-touch gestures:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Discrete gestures.</b> Moving a single finger or softly tapping
    the finger or thumb.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Continuous gestures.</b> Applying various gradations of fingertip
    pressure to manipulate digital objects.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Air-touch gestures.</b> Combining the above with hand and forearm movements, such as &#8220;slide-to-unlock&#8221;.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 47; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="text-align: center; margin-top: 0; margin-bottom: 0"><img alt="" src="image_004.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>Figure 3: The Mudra Platform Gestures Types</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Figure 3 above displays the three types of Mudra
gestures &#8211; discrete gestures, continuous gestures, and air-touch gestures.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We specifically tailor the set of gestures to each
controlled device and scenario, as we deeply believe each device&#8217;s form factor and user input should be tailored specifically to
the user&#8217;s intent, rather than having a set of pre-defined gestures for all devices and functions. Each electronics company or electronic
brand may require different bundles of hardware, software, and humanware solutions, with integration interfaces for its device, system
and design.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Our Core Products and Solutions</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>The Mudra Platform</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Mudra, our neural interface platform, is designed
to enable our customers and users to improve interaction and control of digital devices by:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; font-size: 10pt">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Creating a natural and intuitive collaboration with computers.</b>
    We empower users to interact, entertain, work, and live more natural, relaxed, and productive lifestyles by lowering the burden of communicating
    with computers and enabling an intuitive mode of interacting with computers. Our technology includes both a non-invasive neural input
    interface for the wrist that allows building innovative user experiences and applications for digital devices and a smart watch band that
    lets the user control the Apple ecosystem using gestures, subtle hand and finger movements. These devices span over multiple styles, form
    factors, capabilities, and functions, addressing the needs of everyone &#8211; from consumers using their favorite wearable for infotainment
    and relaxation to business and enterprise customers serving their customers and helping their employees to maximize their performance.</p></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Designing products with a human-centered design, focusing on optimizing
    the customer experience. </b>Our products are designed bottom up from the user experience, through the gestures used and the device design
    and form factor. We have a global network of businesses customers and consumers who share their thoughts, insights, and activities with
    us, which allows us to aggregate the best solutions to interact with any wearable device. We are conducting extensive user-tests and observations
    to custom-tailor each gesture with the right control function. We use familiar gestures such as tap and pinch and glide, which can be
    performed in relaxed and comfortable body postures.</p></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Learning through cloud-based calibrations and mobile apps. </b>We are building a large hand and fingers gesture database. The information is stored anonymized on cloud-based servers, which allows us to gain meaningful insights on user trends, behaviors, and usage of our products. We then use transfer learning, a machine learning method for storing knowledge gained while solving one problem and applying it to a different but related problem, to implement new insights and wisdom into our next generation algorithms, devices, and user experiences.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 48; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Our Products</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are offering both B2B and B2C products.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><b><i>B2B products.</i></b> We offer two ways for our business
customers to access our technology: (i) paid pilot projects which include the purchase of a Mudra Development Kit to evaluate the experience
and to validate the technology, and (ii) an SNC sensor module to integrate into a customer device (including AR/VR headsets, smartphones,
smartwatches, televisions, and laptops) under a license agreement. Typically, we work with the B2B customer on validating our technology
with the goal of integrating our technology into the customer&#8217;s device. We also offer licensing of a SNC sensor module, with the
option to license our operating system, or OS, software package and algorithm software package.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our B2B product offerings include:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>SNC sensor module</b>. We provide the SNC sensor, OS software package
    and an algorithm package to customers. The customer can then integrate the SNC sensor in its own wrist-worn device, and use our OS software
    package and algorithm package to offer Mudra capabilities integrated in its own product. After the validation phase, we create a reference
    design for the SNC sensor and electronics that are built around our SNC sensor. The customer, based on our reference design, builds a
    module for the complete sensor system that includes the motherboard board, our proprietary SNC sensor, and our software and algorithm
    package. This complete sensor system with the required gesture functionalities is then integrated into the customer device. We also give
    the customer the option to develop its own OS software and algorithm software.</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Mudra Development Kit</b>. We provide access to our platform via the Mudra Development Kit (formerly named Mudra Inspire), which contains the Mudra wristband, to allow the customer to evaluate the device form factor and user experience, and through the API, which grants access to development of new applications and user experiences, based on the Mudra gesture set, with no commercial rights. This was used as the first point of engagement with B2B clients to validate our technology. It was launched in June 2018 under the name Mudra Inspire, and over 200 kits have been sold since. This product is now sold only to B2B customers as part of a pilot transaction.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We believe that offering our own consumer products
presents vast monetization opportunities because we can utilize meta-data mining for the purpose of building a large hand and finger gestures
database.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our B2C product offerings include:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>



</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Mudra
Band. </b>A neural input wristband which allows users to control Apple ecosystem devices such as iPhone, Mac computer, Apple TV, and
iPad using subtle touchless finger movements and gestures. The product was launched in June 2020 and was delivered to consumers for the
first time in September 2023. The retail price of the Mudra Band is $349.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Mudra
XR wristband</b>. A wearable controller for smart glasses and spatial computing which supports hands-free interaction. We initially introduced
the concept in November 2019, and recently at SPIE, a leading global conference, in early 2024. We are now defining the product specification
as we receive feedback from AR and VR experts. The product is planned to launch in the fourth quarter of 2024.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;What our platform devices track </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our products track the following signals which
our algorithms decipher to classify the user intent hand and finger gestures:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Fingertip Pressure</b>. Our SNC sensors are placed in proximity
    to the ulnar, median and radial nerves close to the inner wrist skin surface area. These signals are directly correlated with the hand
    and finger movements and with fingertip pressure between fingers or on external objects.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Acceleration and Movement</b>. We use an inertia measurement unit to measure the wrist acceleration in three-axes and to measure the wrist rotation on four quaternions. These measurements are used to estimate the direction the hand is moving and the palm orientation in relationship to the forearm and body.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 49; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Compatibility and Wireless Syncing</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In order to reach the widest set of corporate customers
and customer users, we focus on ensuring that our devices are compatible with a broad range of mobile devices and OSs. Currently, our
platform can sync with mobile devices operating with iOS8 and above, Android 8.0 and above, and Windows 10 and above.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Our Customers</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our customers include businesses and private consumers,
as we operate in both the B2B and B2C sectors. We define &#8220;customer&#8221; as an individual or entity that has purchased our products.
We consider individuals that are or could be interested in our products as &#8220;consumers.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>B2B Market </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our B2B customer market includes consumer electronics
companies, consumer electronics brands, industrial manufacturing companies, IT and software solutions providers, software development
studios, and academic institutions. As the rate of adoption for neural input solution among companies and users increases, the likelihood
of our platform becoming universally compatible with any wearable device or computer also increases, creating positive network effects
that enhance our growth. In addition, the data we accept from our large user and customer base enables us to enhance our product features,
provide improved insights, and offer more valuable experiences for our users.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We explore a large variety of use-cases with our
customers. A use-case is a well-defined scenario, which involves a user, a user objective or task, a controlled device, and the user&#8217;s
environment. An example for a use-case is a bike-rider that controls the display of data layers on AR smart glasses designed for cycling,
and uses touchless subtle finger movements to scroll, swipe and select data layers and digital items. While cycling, the rider wears gloves
and has the fingers clenched on the bike steering wheel.</p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><img alt="" src="image_005.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>Figure 4: Number of Our B2B Customers and Use-Cases</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In Figure 4 above, the chart on the left illustrates
the number of total business customers buying the Mudra Inspire, which was 27 in the second half of 2018 (all of which were new customers),
82 in 2019 (55 of which were new customers), 103 in 2020 (21 of which were new customers), 121 in 2021 (18 of which were new customers),
and 126 in 2022 (5 of which are new customers). If a separate team from a company bought the Mudra Inspire, we consider such team as a
new customer. If the same team bought the Mudra Inspire, we do not consider it as a new customer.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 50; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The chart on the right above illustrates the number
of total business customer use-cases for integrating or implementing our Mudra technology into their devices, products or services: 21
in the second half of 2018 (all of which were new use-cases), 59 in 2019 (38 of which were new use-cases), 74 in 2020 (15 of which were
new use-cases), 89 in 2021 (15 of which were new use-cases), and 92 in 2022 (3 of which were new use-cases).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">At the beginning of 2024, we launched the B2B Mudra
Development Kit, in order to replace the Mudra Inspire which was at the &#8220;end of life&#8221; during 2023. The new Mudra Development
Kit provides our customers with enhanced capabilities and additional features.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>Consumer Electronics Companies </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We define consumer electronics companies as a B2B
market, where these customers have all the resources needed to develop, manufacture and market a wide variety of consumer electronic devices.
Our customers in this market are exploring our Mudra technology as an input-method for current and future products, which include AR glasses,
smartwatches, VR headsets, gaming consoles, mobile phones, smart televisions, voice assistants, smart homes, and large displays.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We estimate there will be a three-to-five-year
period from the time we are first introduced to a customer to signing a licensing agreement. Some of the following seven phases may be
introduced earlier to qualify the customer.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The first phase of engagement usually occurs when
the customer receives the Mudra Inspire dev-kit after a paid pilot was signed. In this phase, we educate the customer about our technology,
including our cutting-edge algorithms, the product form factor, the gestures and binding functions, and the user experience. During this
period, the customer usually evaluates these factors and validates the technology as a whole.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In the second phase the customer defines a use-case
for evaluating our Mudra technology for its business goals. This includes defining user functions, and defining the gestures that will
be used to control the device. The second phase is mostly focused on the end-user experience, or what we term as the &#8220;humanware&#8221;
layer.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The third phase focuses on the customer&#8217;s
needs, desires and &#8220;nice-to-have&#8221; features that it lists in a technical document. This phase has a prolonged direct interaction
with the customer which includes support, conversations, and further explorations of our technology scope.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The fourth phase includes a detailed written software
requirement specification document which is part of the pilot transaction. The outcome is, generally, a software or a mobile application
which includes customer specific requests for which gestures perform certain functions on a specific device and operating system. This
phase may also include defining new gestures, collecting new gesture data from users, developing algorithms, and writing the program.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In the fifth phase, upon successful completion
of the customer&#8217;s pilot transaction, a full technical specification of the solution and the integration method are discussed, including:
definition of the wrist device form factor, material, and design; definition of the software, and compute unit requirements; the full
set of gestures and interactions; and finally, the complete product specification and integration methods.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In the sixth phase, we define the business model
and revenue model, the licensing scope, the site license rights, and the license period. We offer a business model which includes a mix
of fixed annual license fee and variable royalties per each device sold. The business model and pricing are dependent on the integration
level required, the development period, the exclusivity rights, the scope of the reference engineering design, and the expected volume
of units that the customer is expected to sell.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In the seventh and final phase, the commercial
contract with the customer is signed. All necessary integration design information to start serial manufacturing and integration into
the consumer electronics customer device are delivered.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 51; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>Consumer Electronics Brands</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We define consumer electronics brands as a B2B
market, where these customers have all the necessary resources to develop, manufacture and market a single product or product line of
a consumer electronic device. Customers in this market are exploring our Mudra technology as an input method for current and future products.
We are working with leading consumer electronics brands on integrating the Mudra technology into their products.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">With this type of customer, we seek to get enter
into a bulk purchase order or to create a co-branded device or a white label. We are in charge of the development and manufacturing of
the wrist device, based on the customer&#8217;s specifications.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The business model with this customer segment is
to charge for research and development costs to adjust our Mudra technology per customer specification. We sell a bulk order of the devices
at an agreed price to the customer. The minimum order quantity for this customer segment is 10,000 units per year.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>Industrial Companies</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We define industrial companies as a B2B market
segment, where the customer operates in various Industry 4.0 areas such as automotive, aircraft, energy, medical, infrastructure, and
utilities, among others.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As explained briefly above, Industry 4.0 refers
to a new phase in the Industrial Revolution that focuses heavily on interconnectivity, automation, machine learning, and real-time data.
Industry 4.0, which encompasses the Industrial Internet of Things, or IoT, and smart manufacturing, unites physical production and operations
with smart digital technology, machine learning, and big data to create a more holistic and better-connected ecosystem for companies that
focus on manufacturing and supply chain management.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Customers in this market are seeking ways to increase
profitability and reduce costs in production and assembly lines, optimize manufacturing processes, and make their employees more efficient
and less vulnerable to mistakes or physical harm.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We conducted several evaluations of the Mudra technology
with industrial companies, which included developing new gestures for monitoring manual activity of assembly line employees. The motivations
of the customers are:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">inadvertent error prevention for an equipment operator to avoid mistakes
    and defects by monitoring, correcting, drawing attention, or preventing human errors as they occur; and</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">process engineering and business activities to continuously improve all functions and involve all employees from senior management to the assembly line workers</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Manufacturing and assembly lines contain multiple
manual tasks that employees perform repeatedly without being monitored with regard to accuracy or the employees&#8217; physical conditions.
Using our Mudra technology to monitor employee actions and the way they perform tasks can reduce mistakes on assembly lines, and continuously
improve employee productivity and engineering processes. Principally, a manual hand operation on a production line or an assembly line
can be defined as a gesture with our Mudra technology. We offer these customers wristbands that their employees can wear and monitor hand
and finger movements. A local computer unit such as smartphone, tablet or PC, is connected to a cloud-based server to collect, analyze
and identify if a certain manual task is performed accurately, thus preventing incurring losses on later stages of production. It can
also monitor the movement frequency and infer stress of the employee to alert when performance is degrading during a work day, or over
time.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Based on customer feedback and pilot transactions,
the business model for this customer segment may be SaaS. In such model, we will supply the wrist devices, specific software, and the
cloud and integration solution. The customer will pay per site where the solution is implemented and on the number of users, on monthly
or annual automatic renewable subscription.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 52; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>Information Technology, Software Solutions
Providers</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We define information technology, or software solutions
providers, as a B2B market, where the customers offer third-party clients with project management needs, from conception to installation.
Customers in this market are traditionally hired as vendors for consumer electronics companies, consumer electronics brands, or industrial
company segments, to integrate the Mudra technology as part of a solution to their clients. The common use-cases include defining new
input methods for industrial robots, drones, and other machines or devices. The business model is similar to the business model we will
use when directly facing the customer&#8217;s client, which can be a license agreement, a bulk order, or a SaaS model.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>Software Development Studios</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We define software development studios as a B2B
market, where the customers seek new opportunities in computer games and mobile applications. The customers can leverage their existing
users and install-base with new innovative digital health, entertainment, and gaming applications. The business model is revenue sharing
from the install base, based on monthly or annual revenues. The software segment includes developers, designers and artists, all working
together towards delivering engaging, high visual and technical quality games.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>Academia</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have a few customers from academia and research
universities which explored the use of our Mudra technology to aid individuals with physical disabilities, and new alternative methods
of input and interaction for individuals with limited hand movements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>B2C Market </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have started offering our products directly
to consumers, in the form of pre-orders, or early bookings. The Mudra Band for Apple Watch is our first consumer product, launched in
June 2020. The band connects to the Apple Watch and allows a user touchless operation and control Apple ecosystem products. So far we
have delivered over one thousand units of the Mudra Bands for Apple Watches since the first batch was delivered to customers in September
2023.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Establishing a direct connection with customers
and users enables us to learn, improve and enhance our product offerings. This also enables us to mine meta-data to build hand and finger
movements and gestures database, which we believe has huge monetization opportunities. The Mudra Band for Apple Watch is aimed at four
major consumer markets: (i) users who are Apple afficionados and like buying Apple related products; (ii) users who are technology early
adopters and like purchasing innovative consumer gadgets; (iii) users who are active sport and fitness users, and (iv) crowd-funding backers
who ordered the device in our Indiegogo crowdfunding campaign.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We plan to develop and offer additional consumer
electronics products for controlling and interacting with computers and digital devices. We expect additional consumer offerings will
include applications for a variety of devices which will add value to the consumer beyond hardware functions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;<b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>The value of Mudra Input Technology to Our
Customers</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>Smartwatch </b>operation methods include touchscreen,
buttons, digital crown, bezel, and wrist gestures. By integrating our Mudra technology into a smartwatch, our business customers can:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Offer a touchless input operation method feature for the smartwatch;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Diversify their product line offering by introducing new hardware products,
    software applications, and user service;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Integrate touchless interaction into existing applications;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
</table><div>

</div><p style="margin: 0">&#160;</p><div>

</div><p style="margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 53; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Enable developers to introduce exciting new applications in entertainment,
    gaming, fitness, digital health, using a gesture-based watch OS; and</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase eco-system products connectivity by controlling multiple connected devices from the watch, using gestures.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our Mudra technology enables the smartwatch end-user
to enjoy a touchless watch operation experience. The user can operate applications and watch OS functions without physical touch using
same-hands subtle finger movements, while multi-tasking or on-the-go, keeping a visible display.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>Mobile phone</b> usage has been limited by the
touchscreen, an interface which requires constant physical touch. By linking a Mudra wristband with a mobile phone, our business customers
can:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Turn the phone to a content-hub by streaming video, music, games and
    applications to larger screens, and input provided using a mudra wristband;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Establish a strong products eco-system integration, where connected
    devices work together and are controlled using a common interface;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Create an additional input method for mobile phones, with interactions
    beyond the touchscreen; and</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase their market differentiation and add revenue streams by providing additional value to their phone users by providing ambient computing features.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our Mudra technology allows the mobile phone end-user
to benefit from turning the phone into a stationary hub for work, video streaming, and gaming. The user can access a world of new experiences
by integrating touchless interactions with connected eco-system devices to achieve more of the phone.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>AR glasses</b> use semi-transparent display
lenses to overlay digital data and digital holograms into the user&#8217;s real-world view. AR glasses input solutions include gesture
recognition cameras, temple area touchpads, wired remote, handheld clicker, handheld remote, and voice commands.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">By integrating our Mudra technology with AR glasses,
our business customers can:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Manufacture a stylish, light weight, and smaller form factor pair of
    glasses, by removing the gesture recognition hardware from the device;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Reduce research and development costs related to the development of
    hardware and software for the gesture camera;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Increase device battery life by eliminating central processing units
    and sensor gesture recognition related power consumption;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Offer a natural and intuitive interaction experience which does not
    block real-world view and is discrete and socially acceptable; and</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provide an input solution that works well indoors and outdoors, is not dependent on a line of sight or limited by field of view, not affected by ambient light conditions, and is robust to environmental conditions.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">When using our Mudra technology, the AR glasses
end-user enjoys a natural, hands-free, and safer input method to interact with digital overlays. The user can operate the device using
natural and intuitive hand postures and gestures along the waist, with less fatigue caused by waving the hands in mid-air. The user&#8217;s
real-world environment is clear and not blocked by the hands.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 54; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>VR headsets</b> use digital displays which cover
eyes to immerse the user in a fully computer-generated alternative environment, displaying computer-generated video capture which entirely
occludes the user&#8217;s natural surroundings. VR headset input solutions include handheld controllers, a gesture camera, a keyboard,
a mouse, input gloves, and voice commands.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">By integrating our Mudra technology with VR glasses,
our business customers can:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Diversify after-market input solutions, alongside existing controllers
    and input methods;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Support multiple additional natural and exciting interactions with
    video games, where the user can use the hands to grab, hold and manipulate digital objects;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Enrich digital content by turning daily simple physical objects to
    smart digital peripherals, for example, turn any pencil into a stylus to capture and input digital data such as handwriting;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Reduce the user&#8217;s loss of proprioception (kinesthesia) by using
    natural hand and finger movements where the finger is not clenched around handheld controllers; and</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reduce costs by integrating hand and finger tracking without developing expensive sensor hardware and the accompanying software and algorithms.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">When using our Mudra technology, the VR headset
end-user is immersed in a real-life VR experience. Interaction with digital holograms such as grabbing, throwing, holding, and dragging
is done using hand and finger movements instead of by pressing buttons. Using our Mudra technology allows the user to be fully immersed
into an entertaining digital experience that feels like a real-life interaction.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>Recent Developments (2023-2024)</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In February 2023, we released new Mudra Air-Touch
functionality that allows users to toggle and switch between connected devices. This functionality provides a seamless transition of control
across devices such as an iPhone, iPad, Mac computer, and Apple TV devices, as well as other connected devices including smart glasses,
using handsfree and touchless subtle finger and wrist movements. As spatial computing is becoming more and more prevalent, and with multiple
connected devices, a smooth hand-off and transition from controlling one device to another is crucial for a seamless immersive user experience.
We believe that our new Mudra Air-Touch switch and toggle feature is an important step forward in the functionality of our products and
further fulfills our mission of setting the input standard for the Metaverse. In June 2023, we released Mudra Air-Touch functionality
for Android devices.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In May 2023, we announced that our Mudra technology
is compatible with two leading augmented reality glasses manufacturers- RealWear and Nreal. In the same month, the Mudra Band was made
available for preorder. In August 2023, we completed the first commercial manufacturing batch of the Mudra Band for Apple Watch. In September
2023, the first batch of Mudra Bands for Apple Watches was delivered to customers. In November 2023, we completed shipment of the second
manufacturing batch of Mudra Bands for Apple Watches.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In October 2023, we signed a non-binding memorandum
of understanding with a leading Chinese original equipment manufacturer of extended reality smart glasses with the original equipment
manufacturer exploring the potential deployment of our touchless technology into its own product suite.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In November 2023, we received a purchase order
for our evaluation kit samples and dedicated evaluation software from a prominent Japanese industrial automation company and we successfully
completed the first phase of a deployment project with a leading extended reality smart glasses original equipment manufacturer, having
satisfied certain criteria outlined in a memorandum of understanding.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In December 2023, we signed an agreement with a
leading defense company, with a view to designing a prototype that employs our neural gesture technology for defense scenarios where silent
activation is necessary.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 55; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In January 2024, we announced the launch of the
Mudra Developer Kit, which comes with surface nerve conductance sensors optimized for capturing nerve signals from major wrist nerve bundles.
&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In January 2024, we announced a new revolutionary
&#8220;Spatial Depth&#8221; control functionality which allows users to use the Mudra Band for depth navigation, adding an extra dimension
to user interactions. Adding depth to navigation enhances user interactions by allowing more intuitive control. This is particularly useful
in spatial computing applications, where perception is important in rich 3-dimensional environments. It provides a more immersive experience,
enabling users to interact with 3-dimensional elements in digital space, making tasks more natural and efficient.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Competition</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The basic input pillars of HCI are through text,
navigation, and digital element interaction. The most common interface solutions include keyboard and mouse for PC, touchscreen for mobile
phones and tablet computers, handheld controllers for television, game consoles, and VR headsets, temple area touchpads and/or gesture
cameras for AR glasses, and voice recognition for smart home devices.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The market of input methods and peripheral for
digital devices is both evolving and competitive, with companies offering a variety of competitive products in multiple price points.
The established industry-standard technologies include physical or digital keyboards, PC-mice, handheld controllers, touch surfaces, voice
assistants, and gesture cameras. These categories have a multitude of participants including specialized consumer electronics companies
such as Logitech International S.A., Razer, and Microsoft. There is also a wide range of after-market products that can be purchased on
retail and online stores from a multitude of manufacturers. Voice assistants are now available through multiple technology consumer companies
such as Apple, Google, Amazon, Microsoft, and Samsung.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">There are also many large, broad-based consumer
electronics companies that either compete in our market or adjacent markets, or have announced plans to do so. For example, in October
2023, Apple released the Apple Watch Ultra2 Double Tap capability, which allows users to tap the index finger and thumb together twice
to answer a call, reply to a message, see and scroll through the Smart Stack, and more, based on the watch&#8217;s IMU and PPG sensors.
In December 2023, Doublepoint Technologies unveiled a wristband controller with continuous touch-based gesture tracking. In February 2023,
Pison launched Ready, a new sports performance wearable tool designed to measure, track and enhance athletes&#8217; readiness, mental agility,
and focus. Meta (Facebook) acquired our former direct competitor CTRL-Labs in September 2019. In February 2024, Mark Zuckerberg declared
on his Apple Vision Pro review that &#8220;for typing or complex tasks you are going to want things like hands, or a keyboard, or controllers,
or eventually a neural interface for those kind of inputs&#8221;.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">There are also multiple participants which
utilize emerging wearable, sensor, and bio-potential signals to offer neural and wearable interfaces such as Coolso and Wispr.ai, whereas
Electroencephalogram-based companies include Neuralink Corporation and NextMind (acquired by Snap in March 2022).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We believe that our competitive advantages include:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 72px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Push-Pull strategy all along the value chain and creating a blue ocean business environment. </b>We have strong relationships with consumer electronics companies, and we also communicate directly with consumers. Thus, we gain meaningful insights on the market and consumer needs, and constantly improve our products along the value chain. We aim towards a &#8220;blue ocean&#8221; strategy, where we do not compete with established market solutions, but rather we create a whole new arena where multiple input methods can co-exist together to provide the best user experience for the consumer.</span></td></tr>
</table><div>

</div><p style="margin: 0">&#160;</p><div>

</div><p style="margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 56; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 72px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We seek to work with multiple consumer electronics companies and consumer electronics brands. </b>We seek to integrate elements of our Mudra technology &#8211; sensors, electronics, software, and user experience - with multiple consumer electronics manufacturers and companies. We believe in our Push-Pull strategy approach of working directly with consumers to validate demand and we are working with companies to customize our technology integrated into their specific needs. Because we provide the hardware specification and the actual software and user-experience, each company can tailor our technology to fit its own wrist-worn device or watch band, form factor, appearance and style, material, user experience and gesture set. We have a very strong track record of connecting with global leading companies and our positioning leverages us to familiarize ourselves with their needs, requirements, limitations, and use-cases; thus, we can tailor the right product specification and user-experience.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Advanced, purpose-built hardware and software technologies</b>. Our devices leverage industry-standard technologies, such as Bluetooth low energy, as well as proprietary technologies, such as our SNC sensors, and our algorithms that more accurately track and decipher user intent and action. Our technology layers are interdependent and are optimized to the wrist area from the start, focusing first on device style, form factor, gestures, and user experience. Thus, we&#8217;ve created a significant moat &#8211; a key advantage that sets us apart from our competitors. There is a very high interdependency between each layer to adjacent layers, and developing similar solutions requires expertise in each individual layer. New entrants that move from the forearm or the wrist back to the inner wrist area will need to develop all these layers, reduce the number of sensors to fit the wrist area size, re-design device form factor and electronics, collect and train algorithms using new biopotential signals patterns, re-design their data communication protocol, and define the gestures and user interaction, as if they are developing a new device altogether.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 72px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Broad mobile, API, and algorithms compatibility.</b> Our broad mobile compatibility means our users will be able to sync their Mudra devices with multiple mobile phone models, including iOS, Android, and Windows products. Our API allows access and exploration of our Mudra technology to various industry sectors in consumer electronics, industry, IT and software solutions, academia, and software development. Our cross-platform software engine supports real-time signal processing and supports cross-platform algorithms mitigation on multiple operating systems. This allows us to activate our software on low compute power wearables and digital devices, and to mitigate algorithms across platforms without the need to re-write the algorithms for each operating system.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Agile go-to-market strategy for consumer products</b>. We are launching our products after communicating product benefits, receiving meaningful and valuable feedback from our users and then implementing the feedback into the design phase, while generating demand to the product before it has been manufactured. This strategy ensures that we only produce and market products that are suitable to the market and to customers&#8217; demand.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>First mover advantage</b>. We are in the final phases of serial production of the world&#8217;s first consumer wrist neural controller. This enables us to gain a competitive advantage by being the first to market with a neural input device. This supports us to establish strong brand recognition and customer loyalty before other competitors enter the market. This advantage also allows us additional time to perfect the product, define our interactions and gestures as industry standard, and set pricing points. We plan to establish sufficient market share and a solid customer base to maintain a majority of market share.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Based on these variables, we believe that we compete
favorably when compared with the global competition in this market, which will enable us to maintain and extend our leadership position.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Our Growth Strategy</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We intend to achieve a leading position for neural
input technology, and to expand our operations to digital and wearable computers. Key elements of our growth strategy include:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Offer a broad range of platform devices.</b> We believe everyone&#8217;s needs are unique, so we will offer our users a wide range of connected devices to interact and control in multiple styles, form factors, and price points, to allow people to find the devices that fit their lifestyles and goals. We believe that we can leverage the growing public acceptance and awareness of wearable neural technologies and the rising adoption of wearable device to market multiple Mudra-based consumer products.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 136.5pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 136.5pt"></p><div>

</div><!-- Field: Page; Sequence: 57; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 136.5pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Introduce new features, use-cases, software applications, and services.</b> We plan to continue introducing new features and services to increase user engagement and revenue. For example, we are investing in building a diverse user-gesture data bank, which will enable us to develop additional new gestures. It is our belief that the gestures should be natural for the user and tailored based on the use-case and controlled device, instead of a &#8220;one size fits all&#8221; approach which forces the user to learn new interactions. In addition to the control use-case, our Mudra technology and SNC sensor can be utilized in multiple monitoring use-cases where we can monitor neural and hand movements for digital health purposes, sport analytics performance, and Industry solutions. The platform serves multiple corporations, businesses and individuals in the form of customized mobile and computer applications with a broad range of business models that include hardware sales, licensing, and SaaS model.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Integrate our Mudra technology into existing devices</b>. We intend to leverage our strong relationships with multiple consumer electronics companies and brands to sign software and hardware licenses and royalty contracts to make ourselves a fundamental input component for all digital devices and platforms. We also believe our superior software and hardware integration ability to work with companies will enable us to sign agreements with leading global and smaller companies for consumer devices and industry use-cases.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Further penetrate the additional markets.</b> We intend to increase our focus on building relationships with corporations in Industry 4.0, wellness and digital health, and sports analytics. Our main advantage is the ability to continuously and securely track the user&#8217;s engagement over lengthened periods of times and supply meaningful insights for employee performance and safety and the user&#8217;s physiology.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expand brand awareness, global distribution and drive sales of our products and services.</b> We intend to increase our marketing efforts to further expand global awareness of our brand and drive greater sales of our products and services. The international markets represent a significant growth opportunity for us, and we intend to expand sales of our products and services globally through select retailers and strategic partnerships.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Data monetization</b>. Once we have a sufficiently large database, we intend to monetize data derived from a combination of gestures that authenticates a user, identification of patterns of daily behavior, and monitoring of metrics and identification. This will expand our offerings related to data and user behavior, which can open multiple new markets and opportunities.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Intellectual Property</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our ability to compete effectively depends in part
on our ability to develop and maintain the proprietary aspects of our technology in hardware, software, sensors, and user experience.
Our policy is to obtain appropriate proprietary rights protection for any potentially significant new technology acquired or developed
by us. We currently hold two U.S. patents: the first patent concerns a wrist wearable gesture control system that uses bio-potential signals
to control digital devices and provides user feedback, and the second patent is a continuation in part of the first patent and adds the
ability to detect user applied fingertip pressure for analog control of digital devices. In addition, we have one China patent application,
and one U.S. patent application.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In November 2023 and December 2023, we filed patent
applications with the U.S. Patent and Trademark Office for our continued parameter adjustment that uses hand and wrist gestures of augmented
reality wearables and virtual reality headsets and for our touchless pinch-to-zoom technology for augmented and virtual reality wearables,
respectively.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition to patent laws, we rely upon a combination
of designs, copyrights, trade secrets, domain names and trademark rights, and contractual restrictions such as confidentiality agreements,
licenses, and intellectual property assignment agreements. We attempt to protect our trade secrets and other proprietary information through
agreements with all our B2B customer segments, other customers and suppliers, distributors, proprietary information agreements with our
employees and consultants, and other similar measures. Our primary U.S. registered trademark is for our product line name (&#8220;Mudra&#8221;).
We cannot be certain that we will be successful in protecting our proprietary rights. While we believe our patents, patent applications,
hardware, software and other proprietary know-how have value, changing technology makes our future success dependent principally upon
our ability to successfully achieve continuing innovation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 58; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Litigation may be necessary in the future to enforce
our proprietary rights, to determine the validity and scope of the proprietary rights of others, or to defend us against claims of infringement
or invalidity by others. An adverse outcome in such litigation or similar proceedings could subject us to significant liabilities to third
parties, require disputed rights to be licensed from others or require us to cease marketing or using certain products, any of which could
have a material adverse effect on our business, financial condition and results of operations. In addition, the cost of addressing any
intellectual property litigation claim, both in legal fees and expenses, as well as from the diversion of management&#8217;s resources,
regardless of whether the claim is valid, could be significant and could have a material adverse effect on our business, financial condition
and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">At this time, we are not a party to any pending
litigation for infringement of intellectual property rights.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Research and Development</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are passionate about developing innovative products
and services that allow interaction and control of computers to become natural and intuitive as real-life experiences. We believe our
future success depends on our ability to develop new products and features that expand the versatility and performance of our existing
platform, and we plan to continue to invest significant resources to enhance performance, functionality, and convenience and style for
our users. Our research and development team supports the design and development of our wrist-worn devices, proprietary sensors, firmware,
algorithms, and mobile apps. The team is composed of dedicated research employees, electrical engineers, mechanical engineers, firmware
engineers, site operations engineers, and mobile app developers. Our research and development team is primarily based at our headquarters
in Yokne&#8217;am Illit, Israel. Our subsidiary, Mudra Wearable, Inc., or Mudra Wearable, established an office in Redwood City, California
to enhance the Company&#8217;s market presence and partner relations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our research and development expenses, net were
approximately $3.3 million and approximately $2.3 million for the years ended December 31, 2023 and 2022, respectively.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The increase in research and development expenses,
net is primarily attributable to an increase of approximately $497 thousand in labor costs, mainly due to the increase in the number of
employees in research and development, as well as an increase in material expenses of <span style="background-color: white">approximately</span>
$427 thousand, an increase in subcontractor expenses of <span style="background-color: white">approximately</span> $263 thousand and an
increase in travel expenses of <span style="background-color: white">approximately</span> $129 thousand, due to the beginning of Mudra
Band&#8217;s transition phase from development into production. This increase in research and development expenses, net was partially
offset by an increase in IIA participation of approximately $432 thousand.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We believe that the receipt of these IIA grants
in the years 2015 to 2023 is a positive signal that our technology is innovative and feasible. We received these grants for the purpose
of developing the Mudra SNC core technology, for developing the Mudra Band for Apple Watch hardware architecture, and for developing a
manufacturing process for the Mudra Band.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We continue to pursue non-dilutive grants from
the IIA as well as other organizations in Israel.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Manufacturing, Logistics and Fulfillment</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We outsource the manufacturing of our products
to several contract manufacturers. These contract manufacturers produce components of our products in their facilities located in Asia
and Israel. The components used in our products are sourced either directly by us or on behalf of us by our contract manufacturers from
a variety of component suppliers selected by us and located worldwide.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 59; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our operations employees coordinate our relationships
with our contract manufacturers and component suppliers. We believe that using outsourced manufacturing enables greater scale and flexibility
at lower costs than establishing our own manufacturing facilities. We evaluate on an ongoing basis our current contract manufacturers
and component suppliers, including, whether or not to utilize new or alternative contract manufacturers or component suppliers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We work with third-party fulfillment partners to
deliver our products from final manufacturing facilities worldwide, which allows us to reduce order fulfillment time, reduce shipping
costs, and improve inventory flexibility.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Sales Channels</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>Direct to consumer channel.</b> We market and
offer our products directly to consumers in the United States and other countries through our online stores at Mudra-band.com. We drive
consumers to our website through online and offline advertising as well as marketing promotions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We plan to offer additional channels as we increase
our production capability.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>Retail channel.</b> We plan to offer our products
in retail stores and are currently focused on building close relationships with our retailers, working with them to merchandise our products
in a compelling manner both in-store and on their e-commerce sites, promote our products through their marketing efforts, and educate
their sales forces about our products. Retail channel stores may also include consumer electronics and specialty retailers, e-commerce
retailers, mass merchant, department store, and club retailers, as well as wireless carriers&#8217; stores.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Marketing and Advertising</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our marketing and advertising programs are focused
on building global brand awareness, increasing product adoption, and driving sales. Our B2C marketing and advertising efforts target consumers
primarily by digital marketing, channel marketing, newsletters, and public relations. We are also exploring opportunities of endorsements
by micro-influencers and brand ambassadors. Our B2B marketing and advertising efforts target business customers by thought leadership
content creation, inbound marketing, conferences, and tradeshows.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="a_015"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>C. Organizational Structure</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have one wholly-owned subsidiary, Mudra Wearable,
which was incorporated in Delaware. Mudra Wearable has two full-time employees. One employee acts as general manager and chief marketing
officer and the other is an Executive Vice President of U.S. operations. Mudra Wearable is responsible for the marketing and distribution
of our products in the United States.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="a_016"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>D. Property, Plant and Equipment</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have headquarters which are located at 5 Ha-Tnufa
St., Yokne&#8217;am Illit, Israel. This facility comprises approximately 732 square meters, or 7,880 square feet of space. This lease
will expire on January 31, 2025, with an option to extend the lease period by two additional lease periods, each for an additional 12
months. Our monthly rent payment for this facility is NIS 57,794 (approximately $16,000) during the first lease year and will be increased
to NIS 72,722 (approximately $20,000) during the second lease year During the option lease periods, the lease payment may be increased
up to 10% as compared to the second lease year.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our subsidiary, Mudra Wearable, established an
office located at 303 Twin Dolphin Drive, Redwood City, California. The lease is on month-to-month basis and this facility comprises approximately
80 square feet of space. Our monthly rent payment for this facility is $1,289.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We consider that our current office space is sufficient
to meet our anticipated needs for the foreseeable future and is suitable for the conduct of our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_017"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM 4A. UNRESOLVED STAFF COMMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">None.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 60; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="a_018"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM 5. OPERATING AND FINANCIAL REVIEW AND
PROSPECTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b>&#160;</p><div>

</div><div><a id="a_019"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>A.&#160;Operating Results</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>The following discussion and analysis of our
financial condition and results of operations should be read in conjunction with our financial statements and the related notes included
elsewhere in this annual report on Form 20-F. The discussion below contains forward-looking statements that are based upon our current
expectations and are subject to uncertainty and changes in circumstances. Actual results </i>may <i>differ materially from these expectations
due to inaccurate assumptions and known or unknown risks and uncertainties, including those identified in &#8220;Cautionary Note Regarding
Forward-Looking Statements&#8221; and under &#8220;Risk Factors&#8221; elsewhere in this annual report on Form 20-F. Our discussion and
analysis for the year ended December 31, 2021 and December 31, 2022 can be found in our Annual Report on Form 20-F for the fiscal year
ended December 31, 2022, filed with the SEC on March 22, 2023. </i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Overview</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Our company develops&#160;a&#160;non-invasive
neural input interface for controlling digital devices. <span style="background-color: white">Since our founding in 2014,</span> we have
developed the Mudra technology, that allows digital devices to be controlled through a neural input interface.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We are&#160;in a&#160;growth
stage and at an early stage of revenues. We are currently in the transition phase from research and development to commercialization of&#160;our&#160;technology
into&#160;B2B&#160;and&#160;B2C&#160;products.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We are continuing to ship
out our first B2C&#160;consumer product, the Mudra Band,&#160;and expect to launch the Mudra XR wristband, which supports hands-free interaction,
in the fourth quarter of 2024.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"><b>Components
of Results of Operations</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b><i>Revenues</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Revenue is recognized
when (or as) control of the promised goods or services is transferred to the customer, and in an amount that reflects the consideration
we are contractually due in exchange for those services or goods. We follow five steps to record revenue: (i) identify the contract with
a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction
price to the performance obligations in the contract, and (v) recognize revenue when (or as) we satisfy our performance obligations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">In 2023, we started production
of our B2C consumer product, the &#8220;Mudra Band&#8221;, and started to generate revenues, all of which were pre-paid. The Mudra Band
allows touchless operation and control of the watch and iPhone by using an app which is considered combined with the band as one performance
obligation. Revenue derived from the sale of Mudra Band is recognized at a point of time when control transfers to the customer. We believe
that the delivery date is the most appropriate point in time indicating control has transferred to the customer.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A pilot transaction has multiple performance obligations
and it generally takes a few months but less than one year.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each Mudra Inspire development kit sale also has
multiple performance obligations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In those transactions, each obligation: hardware
and API (for Mudra Inspire development kit) and tailor-made software application and technical support (for a pilot transaction) is distinct
and separately identifiable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The amount allocated to the delivered items is
recognized upon delivery, the amount allocated to API is recognized over the API period and the amount allocated to the technical support
is recognized over the service period (a pilot period).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The payment terms of the
Mudra Inspire development kits are upon delivery of the hardware, while the payment terms of the pilot transactions are within the pilot
period.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 61; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>Operating Expenses</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Our current operating
expenses consist of four components&#8212;cost of revenues, research and development expenses, sales and marketing expenses and general
and administrative expenses.&#160;<span style="background-color: white">Labor costs are the most significant component of operating expenses
and consist of salaries (including benefits) and share-based compensation.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Cost of revenues</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Cost of revenues consists
primarily of cost of component parts of our products sold and outbound freight charges.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Research and Development Expenses, net</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="background-color: white">Research
and development expenses consist primarily of labor cost</span>, subcontractors and materials. Costs are expensed as incurred, net of
governmental grants from the IIA. We expect that our research and development expenses will materially increase as we continue to develop
products and recruit additional research and development employees.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Sales and Marketing Expenses, net</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">Sales and
marketing expenses consist primarily of labor cost,&#160;</span>consultants, and digital advertising.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>General and Administrative Expenses</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="background-color: white">General
and administrative expenses consist primarily of labor cost</span>, professional service fees and facilities<span style="background-color: white">.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Public Offering Expenses</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Public offering expenses&#160;<span style="background-color: white">consist
of&#160;</span>professional service fees relating to a firm commitment underwritten initial public offering we closed on September 15,
2022<span style="background-color: white">.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"><i>Financial
Income and Expense</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">Financial
income mainly consists of interest on deposits while financial expenses consist of interest on senior secured credit facility, bank charges
and net currency exchange rates differences</span>.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Comparison of the Years Ended December 31, 2023 and 2022</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Results of Operations</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table summarizes our results of operations for the periods
presented.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year Ended<br/> December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">U.S. dollars in thousands</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; padding-bottom: 1.5pt">Revenues</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">82</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">45</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Cost of revenues</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(62</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(10</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Research and development expenses, net</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(3,316</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(2,271</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Sales and marketing expenses, net</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(2,008</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(1,370</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">General and administrative expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(2,882</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(1,948</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Public offering expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(904</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Operating loss</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(8,186</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(6,458</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Finance (expense) income, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">372</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(38</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Net loss and the total comprehensive loss</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(7,814</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(6,496</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 62; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Revenues</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">Revenues
increased by approximately $37 thousand, or 82%, to approximately $82 thousand for the year ended December 31, 2023 from approximately
$45 thousand for the year ended December 31, 2022. The increase was mainly due to revenues from the sale of our B2C Mudra Bands.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Cost of revenues</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">The cost
of revenues increased by approximately $52 thousand, or 520%, to approximately $62 thousand for the year ended December 31, 2023 from
approximately $10 thousand for the year ended December 31, 2022. The increase was mainly due to manufacturing costs associated with the
sales of our B2C Mudra Bands.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Research and development expenses, net</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Research and development
expenses, net increased by&#160;<span style="background-color: white">approximately</span>&#160;$1.0&#160;<span style="background-color: white">million</span>,
or 46%, to approximately $3,316 <span style="background-color: white">thousand</span> for the year ended December 31, 2023&#160;<span style="background-color: white">from
approximately</span>&#160;$2,271 <span style="background-color: white">thousand</span> for the year ended December 31, 2022. The increase
was primarily due to an increase of approximately $497 thousand in labor costs, mainly due to the increase in the number of employees
in the research and development, an increase in materials expenses of <span style="background-color: white">approximately</span> $427
thousand, an increase in subcontractors expenses of <span style="background-color: white">approximately</span> $263 thousand and an increase
in travel expenses of <span style="background-color: white">approximately</span> $129 thousand, due to the beginning of Mudra Band&#8217;s
production abroad, offset by an increase in IIA participation of approximately $432 thousand.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Sales and marketing expenses, net</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Sales and marketing expenses,
net increased by&#160;<span style="background-color: white">approximately</span>&#160;$638&#160;<span style="background-color: white">thousand</span>,
or 47%, to&#160;<span style="background-color: white">approximately</span>&#160;$2,008&#160;<span style="background-color: white">thousand</span>&#160;for
the year ended December 31, 2023 from&#160;<span style="background-color: white">approximately</span>&#160;$1,370&#160;<span style="background-color: white">thousand&#160;</span>for
the year ended December 31, 2022. The increase was primarily due to an increase of approximately $285 thousand in labor costs, mainly
due to the increase in the number of employees, an increase of approximately $192 thousand in exhibitions, conventions, and travel expenses.
an increase of approximately $219 thousand in consultant expenses and an increase of approximately $170 thousand in advertising expenses,
offset by a decrease of approximately $339 thousand in share-based compensation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>General and administrative expenses</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">General and administrative
expenses increased by&#160;<span style="background-color: white">approximately</span>&#160;$934&#160;<span style="background-color: white">thousand,&#160;</span>or
48%, to&#160;<span style="background-color: white">approximately</span>&#160;$2,882&#160;<span style="background-color: white">thousand</span>&#160;for
the year ended December 31, 2023, from&#160;<span style="background-color: white">approximately</span>&#160;$1,948&#160;<span style="background-color: white">thousand
for the&#160;</span>year ended December 31, 2022. The increase was primarily due to an increase of approximately $306 <span style="background-color: white">thousand</span>
in labor costs, mainly due to the increase in the number of employees, an increase of approximately $420 <span style="background-color: white">thousand
in insurance and public company expenses and </span>an increase of approximately $314 <span style="background-color: white">thousand in
professional services.</span> This increase was partially offset by a decrease of approximately $113 thousand in share-based compensation
expenses.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Finance income (expense), net</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Finance income, net was approximately $372&#160;<span style="background-color: white">thousand</span>&#160;for
the year ended December 31, 2023, compared to finance expense, net of approximately $38&#160;<span style="background-color: white">thousand</span>&#160;for
the year ended December 31, 2022. Finance income, net in 2023 was primarily due to interest on bank deposits, partially offset by bank
charges. Finance expenses, net in 2022 was primarily due to interest on senior secured credit facility, bank charges and net currency
exchange rates differences, offset by interest on deposits.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 63; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Net loss and the total comprehensive loss</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 58.5pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As a result of the foregoing, our total comprehensive
and net loss for the year ended December 31, 2023 was approximately $7.8 million, compared to approximately $6.5 million for the same
period ended December 31, 2022, an increase of approximately $1.3 million, or 20%.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="a_020"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>B.&#160;Liquidity and Capital Resources</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Overview</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We are still in a transition
phase from development stage to an early stage of generating revenues. Therefore, we have suffered recurring losses from operations and
negative cash flows from operations since inception. Our operations have been funded substantially through issuance of convertible securities
to certain investors which were converted to equity, issuance of shares and warrants, through Israeli governmental grants, and an underwritten
public offering in November 2023 and our IPO. Considering the above, our dependency on external funding for our operations raises a substantial
doubt about our ability to continue as a going concern.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">As of December 31, 2023,
our principal source of liquidity was cash and proceeds from our IPO from September 2022 and the public offering from November 2023, totaling
approximately $15 million net.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">As of December 31, 2023,
the Company had incurred accumulated losses of $21.2 million and expects to continue to fund its operations through issuances of Ordinary
Shares and warrants, convertible securities, and through Israeli governmental grants. <span style="background-color: white">There is no
assurance that such financing will be obtained</span>. We&#160;<span style="background-color: white">believe that our existing cash, including
the proceeds from the underwritten public offering in November 2023</span>,&#160;<span style="background-color: white">will be sufficient
to support working capital and capital expenditure requirements through&#160;</span>June 2024.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Our future capital requirements
will depend on many factors, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the progress and costs of our research and development activities;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the costs of manufacturing our products;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the time that we will be able to generate significant revenues;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the costs of filing, prosecuting, enforcing and defending patent claims and other intellectual property rights;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the potential costs of contracting with third parties to provide marketing and distribution services for us or for building such capacities internally; and</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the magnitude of our general and administrative expenses.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Until we can generate
significant recurring revenues, profit and cash flow provided by operating activity we expect to satisfy future cash needs through existing
cash, debt or equity financings as well as governmental grants and proceeds from exercises of options and warrants.&#160;<span style="background-color: white">In
the event that&#160;</span>we&#160;<span style="background-color: white">require additional financing, we may not be able to raise such
financing on terms acceptable to us or at all. If&#160;</span>we are&#160;<span style="background-color: white">unable to raise additional
capital or generate cash flows necessary to expand our operations and invest in continued innovation,&#160;</span>we&#160;<span style="background-color: white">may
not be able to compete successfully, which would harm our business, results of operations, and financial condition.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The table below summarizes our cash flows for the
periods indicated.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Year Ended<br/> December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">U.S. dollars</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Net cash used in operating activities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(8,434</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(5,714</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net cash used in investing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,248</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(66</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Net cash provided by financing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,119</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">14,879</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt">Net increase (decrease) in cash and cash equivalents</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(9,563</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">9,099</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 64; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Operating Activities</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have generated negative cash flow. Our primary
uses of cash from operating activities are for labor costs, research and development expenses for materials and subcontractors and professional
services.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="background-color: white">Cash
used in operating activities mainly consists of&#160;</span>our&#160;<span style="background-color: white">net loss adjusted for certain&#160;</span>non-cash&#160;<span style="background-color: white">items,
including share-based compensation</span>,&#160;<span style="background-color: white">depreciation expenses and changes in operating assets
and liabilities during each period.</span>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">During the
years ended December 31, 2023 and 2022, net cash used in operating activities was approximately $8.4 million and approximately $5.7 million,
respectively. The primary factors affecting operating cash flows were a net loss of approximately $7.8 million and an increase of inventory
of approximately $1.0 million during the year ended December 31, 2023, as compared to net loss of approximately $6.5 million during the
years ended December 31, 2022. These factors were partially offset by&#160;non-cash adjustments of approximately $196 thousand and approximately
$813 thousand during the years ended December 31, 2023 and 2022, respectively.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Net cash used in investing activities</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Cash used in investing
activities&#160;<span style="background-color: white">for the years ended December 31, 2023 and 2022&#160;</span>was approximately $4.2
<span style="background-color: white">million&#160;</span>and $66&#160;<span style="background-color: white">thousand, respectively. The
primary factors affecting investing cash flows during 2023 was an increase of $4.1 million in</span> short term deposits.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Net cash provided by financing activities</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Cash provided by financing
activities during the year ended December 31, 2023 totaled approximately $3.1 million, mainly as a result of approximately $1.7 million
from issuance of shares issued in the public offering, net of issuance cost, and of approximately $1.4 million of proceeds from the issuance
of ordinary shares as a result of the exercise of warrants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Cash provided by financing
activities during the year ended December 31, 2022 totaled approximately $14.9 million, mainly as a result of consideration of our IPO
in which we issued 3,750,000 Ordinary Shares and warrants to purchase 8,625,000 Ordinary Shares, the conversion of SAFEs into 118,204
Ordinary shares and the exercise of 40,000 warrants into shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In January 2022, our board of directors authorized
us to enter into a series of SAFEs for aggregate proceeds of up to $3 million, of which we received $500 thousand under the SAFEs we had
entered into. Pursuant to the terms of the SAFEs, any amounts received under the SAFEs entered into by us were to be automatically converted
into our Ordinary Shares in the event we closed an Equity Financing (as defined hereinafter) at a discount of 20% from the per share purchase
price in such Equity Financing, unless if such investors chose to receive cash payments equal to the amount of their investment. An Equity
Financing is a transaction or series of transactions with the principal purpose of raising capital in an aggregate amount of at least
$5,000,000, excluding all outstanding (i) SAFEs, and (ii) other convertible securities (if any), pursuant to which we issue and sell Ordinary
Shares at a fixed pre-money valuation. In case of an initial public offering or a Change of Control transaction (as defined hereinafter),
the SAFE amount shall, at the election of the investor thereunder, either (i) convert into our Ordinary Shares at a discount of 20% from
the per share price at such event, or (ii) be repaid to the investor (subject to adjustments in case there are insufficient funds for
such repayment to all SAFE investors) at the closing thereof. The conversion of the SAFE amounts into the Ordinary Shares in case of an
initial public offering, is also subject to certain lock-up periods and other restrictions on transfer. In the event of a dissolution
event (e.g., a voluntary or involuntary termination of operations, dissolution or our winding-up), the SAFE amount shall be repaid to
the investors prior to or concurrently with the consummation of such an event. In addition, we <span style="background-color: white">issued
to each SAFE investor a warrant to purchase Ordinary Shares with an exercise price of $6.345 per share for an aggregate amount of up to
$25 thousand (exercisable for a total of 15,760 Ordinary Shares </span>until the earlier of: (i) eighteen (18) months from January 2022;
or (ii) in a Change of Control event, which generally covers (a) transaction in which any person or group becomes the beneficial owner,
directly or indirectly, of more than 50% of our outstanding voting securities with the right to vote for the election of members of our
board of directors, or (b) any reorganization, merger or our consolidation, or (c) a sale, lease or other disposition of all or substantially
all of our assets. Following the consummation of our IPO, $100 thousand received under the SAFEs&#160;were repaid in cash and $400 thousand
was converted into 118,204 Ordinary Shares, based on the public offering price of $4.23 per Ordinary Share.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 65; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On July 4, 2022, we entered into a senior secured
credit facility agreement, or the Credit Facility Agreement, with Pure Capital to borrow from time to time amounts from Pure Capital for
the purposes of financing our ongoing activities and the payment of certain expenses in connection with our IPO, or the Credit Facility.
During July, August and September 2022, we received $800,000 from Pure Capital pursuant to the Credit Facility Agreement, which were fully
repaid on September 19, 2022 from the proceeds of the IPO.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Credit Facility bore interest at the rate of
4% per annum equal to $40,000 (4% of $1,000,000), which interest shall be accrued whether or not there was outstanding credit). Pursuant
to the Credit Facility Agreement, the outstanding credit, together with interest accrued and unpaid was due and payable on the earlier
of (i) June 30, 2024, (ii) certain customary events of default or a change of control, or (ii) upon the closing of either (a) a single
financing transaction in an amount not less than $3,000,000 or (b) several financing transactions in an aggregate amount of at least $6,000,000
by us, following the date of the Credit Facility Agreement. The outstanding credit had priority in relation and senior to any other debts
owed by us to any third party, and was subject to a registered floating charge, for the benefit of Pure Capital, against all of our assets
on the date on which the floating charge is perfected, equal to the total amount of the outstanding credit and the unpaid and accrued
interest thereon at such time.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">On September 15,
2022, we closed the IPO with gross proceeds to the Company of approximately $16.0 million, before deducting underwriting discounts and
other expenses paid by the Company.<b><i>&#160;</i></b>The offering consisted of 3,750,000 units each consisting of one ordinary share
and two warrants to purchase one ordinary share each priced to the public at $4.25 per unit. Upon the consummation of our IPO, we repaid
the outstanding credit, in a total amount of $800,000 to Pure Capital from the proceeds of the IPO.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Additionally, the Credit Facility Agreement provides
that we will enter into a three-year consulting agreement with Pure Capital, which shall not include a provision of termination by us
for convenience after the Consulting Commencement Date (as defined below), whereby Pure Capital shall render press release related services
and other related strategic services to us in exchange for a monthly base fee of $20,000 plus VAT, or the Base Monthly Fee, which Base
Monthly Fee shall automatically increase to $35,000 upon the closing of our IPO, or the Increased Fee. For the avoidance of any doubt,
such Increased Fee shall apply retroactively to the commencement of the consulting agreement, such that we will owe Pure Capital the difference
between the Base Monthly Fee and Increased Fee for such number of months that transpired between the commencement of the initial consulting
agreement and the closing date of our IPO, and which consulting agreement shall be executed and enter into effect upon the earlier of:
(i) our IPO, (ii) a single financing transaction in an amount not less than $3,000,000 or (iii) several financing transactions in an aggregate
amount of not less than $6,000,000, or the Consulting Commencement Date. We and Pure Capital shall make reasonable efforts to enter into
the consulting agreement on the first practicable date following the signing date of the Credit Facility Agreement. If 70% or more of
the warrants (or other convertible securities) issued in connection with our IPO are exercised during the term of such instrument, then
the Base Monthly Fee will immediately increase to $70,000, which increase shall apply retroactively to the Consulting Commencement Date;
and, for the avoidance of any doubt, the base increase shall remain effective and in full force notwithstanding the lapse of three years.
Pure Capital started providing consulting services to us on September 15, 2022.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Finally, the Credit Facility Agreement provides
that from July 4, 2022 and for a term of the Credit Facility Agreement, Pure Capital shall serve as our strategic consultant in connection
with any offering or financing transaction of our company, each in excess of $5,000,000, in exchange for a per offering and/or transaction
fee of $100,000 for the closing(s) of any such offering, which does not include our IPO.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In June 2022, we&#160;received from one of our
shareholders, Alpha Capital Anstalt, or Alpha,, the contractually required written consent, or the June 2022 Consent, to proceed with
an initial public offering of our Ordinary Shares in the United States in exchange for a cash payment of $300,000 from the proceeds of
that offering and certain price protection terms, which amount was paid on September 28, 2022, following the completion of the IPO.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 66; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On September 20, 2022, the volume weighted average
of our share price was less than the exercise price of $2.00 for the Warrants. Accordingly, effective after the closing of trading on
December 14, 2022 (the 90th calendar day immediately following the issuance date of the warrants), the Warrants&#8217; exercise price
was adjusted pursuant to their terms to $2.00, or the Exercise Price Adjustment.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Following the Exercise Price Adjustment, on February
16, 2023, we issued an aggregate of 169,125 Ordinary Shares to Alpha and the other investors in the April 2021 financing. We do not have
any remaining obligation to issue additional securities as a result of our IPO.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In June 2023, we issued an additional 724,139 Ordinary
Shares upon the exercise of Warrants at an exercise price of $2.00 per share for aggregate proceeds of $1.4 million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">On November 13, 2023,
we closed a public offering with gross proceeds to the Company of $2.0 million, before deducting underwriting discounts and other expenses
paid by the Company, and net proceeds of approximately $1.7 million after such discounts and expenses.<b><i>&#160;</i></b>The offering
consisted of 4,444,444 ordinary shares priced to the public at $0.45 per share.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Off-Balance Sheet Arrangements</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our headquarters are located at 5 Ha-Tnufa St.,
Yokne&#8217;am Illit, Israel. This facility comprises approximately 732 square meters, or 7,880 square feet of space. We have leased this
office since February 1, 2023 and this lease will expire on January 31, 2025, with an option to extend the lease period by two additional
lease periods, each for an additional 12 months. Our monthly rent payment for this facility is NIS 57,794 (approximately $16,000) during
the first lease year and will be increased to NIS 72,722 (approximately $20,000) during the second lease year During the option lease
periods, the lease payment may be increased up to 10% as compared to the second lease year.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have off-balance sheet arrangements in connection
with our research and development agreements with the IIA. Under the applicable laws, we are required to pay royalties at the rate of
3%-3.5% of sales of products developed with the funds provided by the IIA, up to an amount equal to 100% of the IIA research and development
grants received, linked to the dollar including accrued interest. Until October 25, 2023, the interest was calculated at a rate based
on 12-month LIBOR applicable to US Dollar deposits. However, on October 25, 2023, the IIA published a directive concerning changes in
royalties to address the expiration of the LIBOR. Under such directive, regarding IIA grants approved by the IIA prior to January 1, 2024
but which are outstanding thereafter, as of January 1, 2024 the annual interest is calculated at a rate based on 12-month Secured Overnight
Financing Rate, or SOFR, or at an alternative rate published by the Bank of Israel plus 0.71513%; and, for grants approved on or following
January 1, 2024 the annual interest shall be the higher of (i) the 12 months SOFR interest rate, plus 1%, or (ii) a fixed annual interest
rate of 4%. We obligated to repay the Israeli government for the grants received only to the extent that there are revenues of the funded
products (currently all the Company&#8217;s products). The royalty payments to the IIA are on a semi-annual basis. As December 31, 2023,
we had a contingent obligation to pay royalties to the IIA in the principal amounted of $2.2 million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition, the terms of the grants under the
Research Law require that the manufacturing of products resulting from IIA-funded programs be carried out in Israel, unless a prior written
approval of the IIA is obtained. In December 2022, we received an approval from the IIA to transfer some of our manufacturing activities
abroad. As a condition for obtaining approval to manufacture outside of Israel (or following a declaration that up to 10% of the production
is transferred abroad), we would be required to pay increased royalties, which usually amount to 1% in addition to the standard royalties
rate 3%-3.5%, and also the total amount of our liability to IIA may be increased to between 100% and 150% of the grants we received from
IIA, depending on the manufacturing volume that is performed outside of Israel (less royalties already paid to IIA). For more information,
see also &#8220;Item 10.E &#8211; Taxation - Israeli Tax Considerations and Government Programs - Tax Benefits and Grants for Research
and Development.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 67; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In January 2023, the IIA approved a program
to finance further development of our manufacturing process of our wearable neural interface in Israel, for a period of 12 months starting
February 1, 2023. The approved program is in amount of approximately $900 thousand, of which the IIA will finance 60%.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We also have off-balance sheet arrangements in
connection with our sales and marketing agreement with the IMEI. Under the applicable laws, if the export revenues in the defined target
market increase by $311 thousand compared to the base year, the Company would be required to pay royalties at the rate of 3% of the increase.
The royalty payments to the IMEI are calculated as 3% annually of the excess of Company&#8217;s annual revenues from the Mudra Band in
the U.S. market in each year commencing 2022 over the Company&#8217;s 2020 actual revenues from the U.S. market plus NIS 1 million (i.e.,
3% on revenues in the U.S. market in each year exceeding approximately $311 thousand). The royalty payments to the IMEI are on an annual
basis.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As of December 31, 2023, the maximum obligation
with respect to the grant received from the IMEI, contingent upon entitled future sales, was $95 thousand linked to the consumer price
index.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We do not believe that off-balance sheet arrangements
and commitments (with the exception of our lease contract, which may have some impact on our expenses and results of operations) are reasonably
likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of
operations, liquidity, capital expenditures or capital resources that is material to investors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="a_021"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>C.&#160;Research and development, patents and licenses, etc.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For a description of our research and development
programs and the amounts that we have incurred over the last two years pursuant to those programs, please see &#8220;Item 5.A. Operating
Results&#8212; Operating Expenses&#8212; Research and Development Expenses, net&#8221; and &#8220;Item 5.A. Results of Operations&#8212;
Comparison of the years ended December 31, 2023 and December 31, 2022&#8212; Research and Development Expenses, net.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="a_022"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>D.&#160;Trend information</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 58.5pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As of the date of this annual report, we employ
29 full-time employees (including one employee located in Lithuania and two employees located in the United States), and ten part-time
employees. In addition, we have one consultant located in Japan. We have two sub-contractors located in India, performing front end software
application development. We intend to maintain this number of employees and expenses during 2024, mainly to support our business development
activities, the continuous research and development activity of our Mudra technology, and to manufacture the Mudra Band, which includes
the purchase of components, manufacturing of components, and assembly of the product.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 58.5pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Following the delivery of our first B2C&#160;consumer
product, the &#8220;Mudra Band&#8221;, we are developing the Mudra XR wristband with the aim of it being shipped to customers by the fourth
quarter of 2024.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="a_023"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>E. Critical Accounting Estimates</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The preparation of the consolidated financial statements
in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities
and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues
and expenses during the reporting period. Critical accounting policies are those that are the most important to the portrayal of the Company&#8217;s
financial condition and results of operations, and that require the most difficult, subjective and complex judgments. The most critical
accounting policies, discussed below, pertain to areas where judgment of management, historical factors and estimates require a high degree
of involvement when determining the final reported balance in the Company&#8217;s consolidated financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Revenue recognition</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Revenue is recognized when (or as) control of the
promised goods or services is transferred to the customer, and in an amount that reflects the consideration we are contractually due in
exchange for those services or goods. We follow five steps to record revenue: (i) identify the contract with a customer, (ii) identify
the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance
obligations in the contract, and (v) recognize revenue when (or as) we satisfy our performance obligations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 68; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">In 2023, we started production
of our B2C consumer product, the &#8220;Mudra Band&#8221; and started to generate revenues, all of which were pre-paid. The Mudra Band
allows touchless operation and control of the watch and iPhone by using an app which is considered combined with the band as one performance
obligation. Revenue derived from the sale of Mudra Band is recognized at a point of time when control transfers to the customer. We believe
that the delivery date is the most appropriate point in time indicating control has transferred to the customer.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A pilot transaction has multiple performance obligations
and it generally takes a few months but less than one year.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each Mudra Inspire development kit sale has multiple
performance obligations.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In those transactions, each obligation: hardware
and API (for Mudra Inspire development kit) and tailor-made software application and technical support (for a pilot transaction) is distinct
and separately identifiable:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the amount allocated to the delivered items is recognized upon delivery, </span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the amount allocated to API is recognized over the API period, and </span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the amount allocated to the technical support is recognized over the service period (pilot period).</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The payment terms of Mudra Inspire development
kit sales are upon delivery of the hardware and of pilot transactions within the pilot period.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Governmental grants</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company receives royalty-bearing grants from
the Israeli government for approved research and development projects and marketing efforts. These grants are recognized at the time the
Company is entitled to such grants based on the costs incurred or milestones achieved as provided by the relevant agreement and included
as a deduction from research and development or sales and marketing expenses, respectively.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Share based compensation</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Share-based compensation expenses
related to employees&#8217; and consultants&#8217; options are measured at the grant date based on the fair value of the award and are
generally expensed over the requisite service period (generally the vesting period). We recognize compensation expense on a straight-line
basis from the beginning of the service period. For awards with graded-vesting features, each vesting tranche is separately expensed over
the related vesting period. We estimate the fair value of each stock option grant using the Black-Scholes option pricing model, which
requires management to make certain assumptions of future expectations based on historical and current data include the expected term
of the stock option, expected volatility, dividend yield, and risk-free interest rate.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 69; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_024"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="a_025"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>A.&#160;Directors and Senior Management</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table sets forth information regarding
our executive officers, key employees and directors as of March 13, 2024:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 18%; border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 9%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 47%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position </b>&#160;</span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 23%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class</b></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asher Dahan </span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46 </span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer, Chairman of the Board of Directors &#160;&#160;</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class III<sup>(6)</sup></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alon Mualem </span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56 </span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer &#160;&#160;</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tamar Fleisher </span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Operating Officer</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Guy Wagner </span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46 </span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Scientific Officer, President and Director &#160;&#160;</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class III<sup>(6)</sup></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leeor Langer </span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42 </span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Technology Officer &#160;&#160;</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shmuel Barel</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Marketing Officer</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offir Remez</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Vice President of Business Development</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eli Bachar<sup>(1)(2)(3)</sup></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41 </span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director &#160;&#160;</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class II<sup>(5)</sup></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Barry Kaplan </span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53 </span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Vice President of the U.S. Operations &#160;</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yaacov Goldman<sup>(1)(2)(3)</sup></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68 </span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent Director &#160;</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class II<sup>(5)</sup></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ilana Lurie<sup>(1)(2)(3)</sup></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49 </span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent Director &#160;</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class I<sup>(4)</sup></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="background-color: white">
    <td style="vertical-align: top; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member of the Compensation Committee </span></td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member of the Audit Committee and Financial Statement Examination Committee </span></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent Director (as defined under Nasdaq Stock Market rules) </span></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class I directors shall hold office until the annual general meeting to be held in 2026 and until their successors shall have been elected and qualified.</span></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class II directors shall hold office until the annual general meeting to be held in 2024 and until their successors shall have been elected and qualified.</span></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class III directors shall hold office until the annual general meeting to be held in 2025 and until their successors shall have been elected and qualified.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white"><b>&#160;</b></span>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white"><b>Asher Dahan, Chief Executive
Officer, Chairman of the Board of Directors</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">Mr. Asher
Dahan has served as our director since March 2014 and as our Chief Executive Officer and as acting Chief Financial Officer since March
2016 and as the chairman of our board of directors since March 6, 2022. Mr. Dahan founded our company together with Mr. Guy Wagner and
Mr. Leeor Langer in March 2014. From 2013 to 2015, Mr. Dahan worked as Electrical Validation Manager at Intel Haifa, Israel. He worked
for Intel Haifa, Israel from 2006 to 2012 as Technical Leader and Engineer for High Speed Interfaces. Mr. Dahan has a BSc. in Electrical
Engineering from Ort Braude College. Mr. Dahan serves both as our Chief Executive Officer and as the Chairman of our board of directors,
in accordance with the provisions of the Companies Law and the Companies Regulations (Validity Period of a Decision According to Section
121 of the Companies Law), 5776-2016, which allows such dual office for a period of five years following the completion of the IPO.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 70; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white"><b>Alon Mualem, Chief Financial
Officer</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">Mr. Alon
Mualem has served as our Chief Financial Officer since January 7, 2022. Mr. Mualem previously served as the Chief Financial Officer of
Eltek Ltd. (Nasdaq: ELTK), an Israeli public company, from January 2019 to January 2022. Mr. Mualem served as the Chief Financial Officer
of SharpLink Gaming Ltd. (Nasdaq: SBET), formerly known as Mer Telemanagement Solutions Ltd., an Israeli public company, from 2007 to
September 2018. Prior thereto, between 2005 and 2007, Mr. Mualem served as the Chief Financial Officer of Xfone, Inc. (AMEX and TASE:
XFN), an international communications services company. Previously, Mr. Mualem served as a controller and Chief Financial Officer of hi-tech
companies, and as an audit manager at Somekh Chaikin,</span> a member firm of KPMG International<span style="background-color: white">.
Mr. Mualem holds a B.A. degree in Accounting and Economics from Tel Aviv University and is a licensed CPA (Israel).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white"><b>Tamar Fleisher, Chief Operating
Officer</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">Ms. Tamar
Fleisher has served as our Chief Operating Officer since January 2023. As our Chief Operating Officer, Ms. Fleisher leads and scales our
global business operations with the primary responsibility of accelerating operational performance and managing our manufacturing and
production processes for the Mudra Band. Ms. Fleisher previously served as the Chief Operating Officer and Director of Product Management
at Serenno Medical Ltd. from August 2021 to December 2022, a healthcare company with a pioneering technology to improve acute kidney injury
and fluid management. Before then, she served as a director of product management at StemRad Ltd. from January 2018 to August 2021, a
world leader in the provision of personal radiation protection solutions and technology. Prior to that, Ms. Fleisher served as a general
manager and head of design and engineering at Librus Design Ltd. from October 2015 to December 2017, a company specializing in the design
and engineering of plastic products. Ms. Fleisher has a B.A. degree in industrial design from the Holon Institute of Technology.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white"><b>Guy Wagner, Chief Scientific
Officer, President and Director</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">Mr. Guy Wagner
has served as our director since March 2014 and as our Chief Scientific Officer and as Company President since March 2016. Mr. Wagner
founded our company together with Mr. Asher Dahan and Mr. Leeor Langer in March 2014. From 2005 to 2014, Mr. Wagner worked as Hardware
Engineer at Intel Haifa, Israel. Mr. Wagner has a BSc. in Electrical Engineering from Ort Braude College. </span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white"><b>Leeor Langer, Chief Technology
Officer</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Mr. Leeor Langer has served as our Chief Technology
Officer since March 2016. Mr. Langer founded our company together with Mr. Asher Dahan and Mr. Guy Wagner in March 2014. From 2014 to
2015, Mr. Langer worked as an algorithms developer at CMT Medical Technologies Ltd., developing image processing techniques for medical
x-ray applications. Prior to that, he worked for BrandShield Ltd. from 2012 to 2014 as an algorithms engineer, developing ranking algorithms
for digital brand protection. From 2009 to 2012, Mr. Langer worked as a tools developer and algorithms engineer at Intel in Israel, developing
signal processing methods for electrical validation labs. Mr. Langer has a BSc. in Electrical Engineering from the Technion - Israel Institute
of Technology and an MSc. in Applied Mathematics from the Tel Aviv University. Mr. Langer graduated cum laude and published his thesis
and papers on digital pathology in peer reviewed journals.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white"><b>Shmuel Barel, Chief Marketing
Officer</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Mr. Shmuel Barel has served as our Chief Marketing
Officer since March 2018 and has served as General Manager of Mudra Wearable since January 2024. Mr. Barel previously served as owner
at SamsProjects, a consultancy business, from January 2014 to March 2018. Mr. Barel served as a Senior Marketing Analyst at Media World
Ltd., a global investment and sales company, from February 2010 to December 2013. Prior thereto, between 2006 and 2010, Mr. Barel served
as Application and Training Engineer at Applied Materials, Inc. (Nasdaq: AMAT), an international semiconductor equipment and software
supplier. Previously, Mr. Barel served as Computer Aided Design Engineer at the Israeli Aircraft Industries, a major aerospace and aviation
manufacturer in Israel, from February 2006 to January 2010. Mr. Barel holds an MBA degree from the Bar Ilan University, a Master of Systems
Engineering degree from the Technion &#8211; Israel Institute of Technology, and a BSc in Mechanical Engineering from the Tel-Aviv University.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;<span style="background-color: white">Offir Remez, Executive
Vice President of Business Development </span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Mr. Offir Remez has served as our Executive Vice
President of Business Development since November 2021. Before then, Mr. Remez served as an advisor to our Chief Executive Officer from
June 2017 to October 2021. Mr. Remez served as a member on the board of directors of Adshir Ltd. from January 2014 to October 2021. Mr.
Remez holds a M.Sc with excellence (magna cum laud) in Mathematics and Computer Science from the Tel Aviv University.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 71; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white"><b>Eli Bachar, Director</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">Mr. Eli Bachar
has served as </span>our <span style="background-color: white">director since 2016. From 2013 to 2021, Mr. Bachar is a serial investor.
He was a director of Xjet3D from 2014 to 2021. From 2015 to 2019, Mr. Bachar was a director of 6 Over 6 Vision Ltd. He was a director
of GetSat Ltd. from 2014 to 2021. From 2013 to 2021, Mr. Bachar was a director of Silentium Ltd. He was a director of Cupixel Ltd. from
2017 to 2021. Mr. Bachar holds a BA in Business Administration and Management from the Reichman University (previously known as IDC Herzliya).
</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white"><b>Barry Kaplan, Executive Vice
President of the U.S. Operations</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Mr. Barry Kaplan has served as Executive Vice President
of the U.S. operations since July 2021. Prior to our IPO, Mr. Kaplan also served as director from April 2018 to September 2022. From 2012
to 2021, Mr. Kaplan worked as Chief of Operations at Stuhrling Original LLC . From 2003 to 2012, Mr. Kaplan founded and worked as Chief
Executive Officer at Gem Nation Corporation, a luxury jewelry and watch etailer. He was Chief Executive Officer and Chief Designer of
Alexander Watch LLC from 2014 to 2017. Mr. Kaplan has a Bachelor of Commerce (B.Com) and a Bachelor of Accounting (B.Acc. Hons.) from
University of the Witwatersrand (South Africa). Mr. Kaplan did his accounting traineeship with Grant Thornton and is an expert and published
author concerning the luxury watch industry.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Yaacov Goldman, Independent Director</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Mr. Yaacov Goldman has served as one of our directors
since September 2022. He provides consulting services to companies in strategic-financial areas, through his wholly owned company, Maanit-Goldman
Management &amp; Investments (2002) Ltd. Mr. Goldman has served as external director for Can-Fite BioPharma Ltd. (NYSE:CANF) since August
2017. Mr. Goldman also serves as a director of Avgol Industries 1953 Ltd., Mivne Real Estate (K.D) Ltd., and Prashkovsky Investments and
Construction Ltd. Mr. Goldman served as the Professional Secretary of the Peer Review Institute of the Certified Public Accountants Institute
in Israel from October 2004 until September 2008. Commencing in 1981, Mr. Goldman worked for Kesselman &amp; Kesselman (Israeli member
firm of PricewaterhouseCoopers) for 19 years, and from 1991 until 2000, as a partner and then senior partner of such firm. From September
2000 until November 2001, Mr. Goldman served as managing director of Argoquest Holdings, LLC. Mr. Goldman holds a B.A. degree in Economics
and Accounting from Tel Aviv University and is a Certified Public Accountant (Israel).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Ilana Lurie, Independent Director</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Ms. Ilana Lurie has served as one of our directors
since September 2022. Ms. Lurie is a Chief Financial Officer, Chief Operations Officer, and Director with vast experience in international
finance and operations, within both large technology companies as well as Start-Ups. In a course of last 10 years, Ilana led significant
financing rounds, as well as debt restructuring processes. She has served as an external director for Eltek Ltd. (NASDAQ:ELTK) since September
2018. Ms. Lurie played a critical role in transition from R&amp;D to production in NovelSat and she is currently leading this activity
in IO Tech, in her capacity as Chief Financial Officer and Chief Operations Officer. During 2012 until 2020, Ms. Lurie has been Chief
Financial Officer of NovelSat, Landa Ventures portfolio company. Prior to her tenure at NovelSat, Ms. Lurie served as Finance Manager
for the Enterprise Services business unit (formerly EDS) of Hewlett Packard (NYSE:HPQ).&#160; From 2006 to 2011, Ms. Lurie held several
financial management positions at Ness Technologies (NASDAQ/TASE:NSTC), which, at the time, was a public company. Ms. Lurie earned her
B.A. degree and an MBA degree with a specialization in Finance and Marketing from Hebrew University of Jerusalem.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b><i>&#160;&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="background-color: white"><b><i>Family
Relationships</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">There are no family relationships between any members
of our executive management and our directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="background-color: white"><b><i>Arrangements
for Election of Directors and Members of Management</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">There are
no arrangements or understandings with major shareholders, customers, suppliers or others pursuant to which any of our executive management
or our directors were selected.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 72; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_026"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>B.&#160;Compensation</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table presents in the aggregate all
compensation we paid to all of our directors and senior management as a group for the year ended December 31, 2023. The table does not
include any amounts we paid to reimburse any of such persons for costs incurred in providing us with services during this period.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">All amounts reported in the tables below reflect
the cost to the Company, in thousands of U.S. Dollars, for the year ended December 31, 2023. Amounts paid in NIS are translated into U.S.
dollars at the rate of NIS 3.69 = U.S. $1.00, based on the average representative rate of exchange between the NIS and the U.S. dollar
as reported by the Bank of Israel during such period of time.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Salary, <br/> bonuses and <br/> Related <br/> Benefits</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Pension, <br/> Retirement <br/> and Other <br/> Similar <br/> Benefits</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share <br/> Based <br/> Compensation<sup>(1)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -9pt; padding-left: 9pt">All directors and senior management as a group, consisting of&#160;11 persons as of December 31, 2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,687,179</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">409,577</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">123,303</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 58.5pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes: (i) options granted to Alon Mualem to purchase 120,000 Ordinary Shares under the Wearable Devices Ltd. 2015 Share Option Plan, as amended, or the 2015 Plan. The options have expiration dates ranging from January 2032 to August 2033, with an exercise price ranging from $0.003 to $1.32; (ii) options granted to Barry Kaplan (a former director) to purchase 254,426 Ordinary Shares under the 2015 Plan. The options have expiration dates ranging from April 2028 to August 2033, and an exercise price ranging from $1.32 to $2.25 per share; (iii) options granted to Offir Remez to purchase 157,000 Ordinary Shares under the 2015 Plan. The options have expiration dates ranging from January 2032 to August 2033, with an exercise price ranging from $0.003 to $1.32, (v) options granted to Shmuel Barel to purchase 167,213 Ordinary Shares under the 2015 Plan. The options have expiration dates ranging from December 2027 to August 2033; (vi) options granted to Asher Dahan to purchase 30,000 Ordinary Shares under the 2015 Plan. The options expire in August 2033 and have an exercise price of $1.32; (vii) options granted to Guy Wagner to purchase 30,000 Ordinary Shares under the 2015 Plan. The options expire in August 2033 and have an exercise price of $1.32; (vii) options granted to Leeor Langer to purchase 30,000 Ordinary Shares under the 2015 Plan. The options expire in August 2033 and have an exercise price of $1.32; (vii) options granted to Yaacov Goldman to purchase 20,000 Ordinary Shares under the 2015 Plan. The options expire in August 2033 and have an exercise price of $1.32; (vii) options granted to Ilana Lurie to purchase 20,000 Ordinary Shares under the 2015 Plan. The options expire in August 2033 and have an exercise price of $1.32; and (vii) options granted to Eli Bachar to purchase 20,000 Ordinary Shares under the 2015 Plan. The options expire in August 2033 and have an exercise price of $1.32.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For so long as we qualify as a foreign private
issuer, we will not be required to comply with the proxy rules applicable to U.S. domestic companies regarding disclosure of the compensation
of certain executive officers on an individual basis. In accordance with the Companies Law, we are required to disclose the compensation
granted to our five most highly compensated officers. The table below reflects the compensation granted during or with respect to the
year ended December 31, 2023.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Executive Officer</b></p></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Salary, Bonuses <br/> and&#160;Related<br/> Benefits<sup>(1)(3)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Social<br/> Benefits <br/> and<br/> Perquisites<sup>(3)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share-Based<br/> Compensation&#160;<sup>(2)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total<sup>(3)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Asher Dahan</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">228,886</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">62,482</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">915</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">292,283</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Guy Wagner</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">228,886</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">61,381</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">915</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">291,182</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Leeor Langer</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">229,428</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">61,851</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,322</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">296,601</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Alon Mualem</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">197,314</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">55,690</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">74,153</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">327,157</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Barry Kaplan</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">250,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">51,520</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,661</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">304,181</td><td style="text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Represents the directors&#8217; and senior management&#8217;s gross salary plus payment of mandatory social benefits made by the company on behalf of such persons. Such benefits may include, to the extent applicable to the executive, payments, contributions and/or allocations for savings funds, education funds (referred to in Hebrew as &#8220;Keren Hishtalmut&#8221;), pension, severance, risk insurances (e.g., life or work disability insurance) and payments for social security</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Computed based on the Black-Scholes option pricing model</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Cash compensation amounts denominated in NIS were converted into U.S. dollars at the rate of NIS 3.69 per $1.00 (the average exchange rate in 2023).</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 73; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Employment Agreements with Executive Officers</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have entered into written employment agreements
with each of our executive officers. All of these agreements contain customary provisions regarding noncompetition, confidentiality of
information and assignment of inventions. However, the enforceability of the noncompetition provisions may be limited under applicable
law. In addition, we have entered into agreements with each executive officer and director pursuant to which we will indemnify each of
them up to a certain amount and to the extent that these liabilities are not covered by directors and officers insurance.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On March 6, 2022, our board of directors determined
that it is in the best interest of our company to amend the employment agreements and approve new terms of compensation for each of our
officers, subject to the approval of our shareholders. The amendments to the agreements were approved at the shareholders meeting, which
took place on March 14, 2022.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For a description of the terms of our options and
option plans, see &#8220;Item 6.C. Board Practices &#8212; Share Option Plan<span style="font-variant: small-caps">&#8221; </span>below.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Directors&#8217; Service Contracts</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Other than with respect to our directors who are
also executive officers, we do not have written agreements with any director providing for benefits upon the termination of his employment
with our company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="a_027"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>C. Board Practices</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our board of directors presently consists of five
members. Our amended and restated articles of association provide that the number of board of directors&#8217; members (including external
directors, if applicable) shall be set by our board of directors provided that it will consist of not less than three and not more than
twelve. Pursuant to the Companies Law, the management of our business is vested in our board of directors. Our board of directors may
exercise all powers and may take all actions that are not specifically granted to our shareholders or to management. Our executive officers
are responsible for our day-to-day management and have individual responsibilities established by our board of directors. Our Chief Executive
Officer is appointed by, and serves at the discretion of, our board of directors, subject to the employment agreement that we have entered
into with him. All other executive officers are appointed by our Chief Executive Officer. Their terms of employment are subject to the
terms of our compensation policy and any applicable law, and are subject to the approval of the board of directors&#8217; compensation
committee, the board of directors, and in some cases of our general meeting of our shareholders, and are subject to the terms of any applicable
employment agreements that we may enter into with them. Our board of directors has established an audit committee, compensation committee,
and a financial statement examination committee.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our articles of association provide for a split
of the board of directors into three classes with staggered three-year terms (excluding external directors, if applicable). At each annual
general meeting of our shareholders, the election or re-election of directors following the expiration of the term of office of the directors
of that class of directors will be for a term of office that expires on the third annual general meeting following such election or re-election,
such that each year the term of office of only one class of directors will expire. The director whom is to be retired and re-elected shall
be the director that served the longest period since its appointment or last re-election or, if more than one director served the longest
time, or if a director who is not to be re-elected agrees to be re-elected, the meeting of the board of directors which sets the date
and agenda for the annual general meeting (acting by a simple majority) will decide which of such directors will be brought for re-election
at the relevant general meeting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 74; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each director, except external directors (if applicable),
will hold office until the next annual general meeting of our shareholders following his or her appointment, or until he or she resigns
or unless he or she is removed by a majority vote of our shareholders at a general meeting of our shareholders or upon the occurrence
of certain events, in accordance with the Companies Law and our amended and restated articles of association.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition, under certain circumstances, our amended
and restated articles of association allow our board of directors to appoint directors to fill vacancies on our board of directors or
in addition to the acting directors (subject to the limitation on the number of directors), until the next annual general meeting or special
general meeting in which directors may be appointed or terminated. External directors, if applicable, may be elected for up to two additional
three-year terms after their initial three-year term under certain circumstances. External directors may be removed from office only under
the limited circumstances set forth in the Companies Law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under the Companies Law, any shareholder holding
at least one percent of our outstanding voting power may nominate a director at a general meeting of the shareholders. However, any such
shareholder may make such a nomination only if a written notice of such shareholder&#8217;s intent to make such nomination has been given
to our board of directors, in accordance with the provisions of our articles of association and the Companies Law. Any such notice must
include certain information, including the consent of the proposed director nominee to serve as our director if elected, and a declaration
that the nominee signed declaring that he or she possesses the requisite skills and has the availability to carry out his or her duties.
Additionally, the nominee must provide details of such skills, and demonstrate an absence of any limitation under the Companies Law that
may prevent his or her election, and affirm that all of the required election-information is provided to us, pursuant to the Companies
Law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">However, under a new exemption applicable as of March 12, 2024, one
or more shareholders of an Israeli company whose shares are listed outside of Israel, may request the company&#8217;s board of directors
to include an appointment of a candidate for a position on the board of directors or the termination of a board member, as an item on
the agenda of a future general meeting (if the company sees fit), provided that the shareholder hold at least five percent (5%) of the
voting rights of the company, instead of one percent (1%) required in the past.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under the Companies Law, our board of directors
must determine the minimum number of directors who are required to have accounting and financial expertise. In determining the number
of directors required to have such expertise, our board of directors must consider, among other things, the type and size of the company
and the scope and complexity of its operations. Our board of directors has determined that the minimum number of directors of our company
who are required to have accounting and financial expertise is one.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The board of directors must elect one director
to serve as the chairman of the board of directors to preside at the meetings of the board of directors, and may also remove that director
as chairman. Pursuant to the Companies Law, neither the chief executive officer nor any of his or her relatives is permitted to serve
as the chairman of the board of directors, and a company may not vest the chairman or any of his or her relatives with the chief executive
officer&#8217;s authorities. In addition, a person who reports, directly or indirectly, to the chief executive officer may not serve as
the chairman of the board of directors; the chairman may not be vested with authorities of a person who reports, directly or indirectly,
to the chief executive officer; and the chairman may not serve in any other position in the company or a controlled company, but he or
she may serve as a director or chairman of a controlled company. However, the Companies Law permits a company&#8217;s shareholders to
determine, for a period not exceeding three years from each such determination, that the chairman or his or her relative may serve as
chief executive officer or be vested with the chief executive officer&#8217;s authorities, and that the chief executive officer or his
or her relative may serve as chairman or be vested with the chairman&#8217;s authorities. Such determination of a company&#8217;s shareholders
requires either: (1) the approval of at least a majority of the shares of those shareholders present and voting on the matter (other than
controlling shareholders and those having a personal interest in the determination) (shares held by abstaining shareholders shall not
be considered); or (2) that the total number of shares opposing such determination does not exceed 2% of the total voting power in the
company. Since March 6, 2022,&#160;our Chief Executive Officer, Mr. Asher Dahan,&#160;has also served as the chairman of our board of
directors. Mr. Dahan serves both as our Chief Executive Officer and as the Chairman of our board of directors, in accordance with the
provisions of the Companies Law and the Companies Regulations (Validity Period of a Decision According to Section 121 of the Companies
Law), 5776-2016, which allows such dual office for a period of five years following the completion of the IPO.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 75; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The board of directors may, subject to the provisions
of the Companies Law, delegate any or all of its powers to committees of the board, and it may, from time to time, revoke such delegation
or alter the composition of any such committees, subject to certain limitations. Unless otherwise expressly provided by the board of directors,
the committees shall not be empowered to further delegate such powers. The composition and duties of our audit committee, financial statement
examination committee and compensation committee are described below.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The board of directors oversees how management
monitors compliance with our risk management policies and procedures, and reviews the adequacy of the risk management framework in relation
to the risks faced by us. The board of directors is assisted in its oversight role by an internal auditor. The internal auditor undertakes
both regular and ad hoc reviews of risk management controls and procedures, the results of which are reported to our audit committee.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;<b>External Directors</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Under the Companies Law,
a public company incorporated in Israel is required to appoint two external directors to serve on its board of directors. One of the external
directors must have &#8220;financial and accounting expertise&#8221;, as defined under the Companies Law. In addition, external directors
must meet stringent standards of independence as set forth in the Companies Law, including regulations regarding: limitations on the duration
of the term of office of the external directors, limitations on compensation terms, etc.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under regulations promulgated pursuant to the Companies
Law, a company with no controlling shareholder whose shares are listed for trading on specified exchanges outside of Israel, including
the Nasdaq Capital Market, may adopt exemptions from various corporate governance requirements of the Companies Law, so long as such company
satisfies the requirements of applicable foreign country laws and regulations, including applicable stock exchange rules, that apply to
companies organized in that country and relating to the appointment of independent directors and the composition of audit and compensation
committees. Such exemptions include an exemption from the requirement to appoint external directors and the requirement that an external
director be a member of certain committees, as well as exemption from limitations on directors&#8217; compensation. We do not currently
have a controlling shareholder and we use this exemption from the requirement described herein.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Independent Directors Under the Companies
Law</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">An &#8220;independent director&#8221; under the
Companies Law is either an external director or a director who meets the same non-affiliation criteria as an external director (except
for (i) the requirement that the director be an Israeli resident (which does not apply to companies such as ours whose securities have
been offered outside of Israel or are listed outside of Israel) and (ii) the requirement for accounting and financial expertise or professional
qualifications), as determined by the audit committee, and who has not served as a director of the company for more than nine consecutive
years. For these purposes, ceasing to serve as a director for a period of two years or less would not be deemed to sever the consecutive
nature of such director&#8217;s service.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Regulations promulgated pursuant to the Companies
Law provide that a director in a public company whose shares are listed for trading on specified exchanges outside of Israel, including
the Nasdaq Capital Market, who qualifies as an independent director under the relevant non-Israeli rules and who meets certain non-affiliation
criteria, which are less stringent than those applicable to independent directors as set forth above, would be deemed an &#8220;independent&#8221;
director pursuant to the Companies Law provided: (i) he or she has not served as a director for more than nine consecutive years; (ii)
he or she has been approved as such by the audit committee; and (iii) his or her remuneration shall be in accordance with the Companies
Law and the regulations promulgated thereunder. For these purposes, ceasing to serve as a director for a period of two years or less would
not be deemed to sever the consecutive nature of such director&#8217;s service.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Furthermore, pursuant to these regulations, such
company may reappoint a person as an independent director for additional terms, beyond nine years, which do not exceed three years each,
if each of the audit committee and the board of directors determine, in that order, that in light of the independent director&#8217;s
expertise and special contribution to the board of directors and its committees, the reappointment for an additional term is in the company&#8217;s
best interest.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 76; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Alternate Directors</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Our amended and restated
articles of association provide, as allowed by the Companies Law, that any director may, subject to the conditions set thereto including
approval of the nominee by our board of directors, appoint a person as an alternate to act in his place, to remove the alternate and appoint
another in his place and to appoint an alternate in place of an alternate whose office is vacated for any reason whatsoever. Under the
Companies Law, a person who is not qualified to be appointed as a director, a person who is already serving as a director or a person
who is already serving as an alternate director for another director, may not be appointed as an alternate director. Nevertheless, a director
who is already serving as a director may be appointed as an alternate director for a member of a committee of the board of directors so
long as he or she is not already serving as a member of such committee, and if the alternate director is to replace an external director,
he or she is required to be an external director and to have either &#8220;financial and accounting expertise&#8221; or &#8220;professional
expertise,&#8221; depending on the qualifications of the external director he or she is replacing. A person who does not have the requisite
&#8220;financial and accounting experience&#8221; or the &#8220;professional expertise,&#8221; depending on the qualifications of the
external director he or she is replacing, may not be appointed as an alternate director for an external director. A person who is not
qualified to be appointed as an independent director, pursuant to the Companies Law, may not be appointed as an alternate director of
an independent director qualified as such under the Companies Law. Unless the appointing director limits the time or scope of the appointment,
the appointment is effective for all purposes until the appointing director ceases to be a director or terminates the appointment.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;<b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Committees of the Board of Directors</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our board of directors has three standing committees,
the audit committee, the compensation committee and the Financial Statement Examination Committee.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Audit Committee</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under the Companies Law, we are required to appoint
an audit committee. The audit committee must be composed of at least three directors, including all of the external directors, if applicable
(one of whom must serve as chairman of the committee). The audit committee may not include the chairman of the board; a controlling shareholder
of the company or a relative of a controlling shareholder; a director employed by or providing services on a regular basis to the company,
to a controlling shareholder or to an entity controlled by a controlling shareholder; or a director who derives most of his or her income
from a controlling shareholder. Pursuant to the Companies Law, chairman of the audit committee is elected by the members of the audit
committee.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition, a majority of the members of the audit
committee of a publicly traded company must be independent directors under the Companies Law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under the Companies Law, our audit committee is
responsible for:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determining whether there are deficiencies in the business management practices of our company, and making recommendations to the board of directors to improve such practices;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determining whether to approve certain related party transactions (including transactions in which an office holder has a personal interest and whether such transaction is extraordinary or material under Companies Law) and establishing the approval process for certain transactions with a controlling shareholder or in which a controlling shareholder has a personal interest (see &#8220;Item 6.C. Board Practices&#8212;Approval of Related Party Transactions under Israeli law&#8221;);</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determining the approval process for transactions that are &#8220;non-negligible&#8221; (i.e., transactions with a controlling shareholder that are classified by the audit committee as non-negligible, even though they are not deemed extraordinary transactions), as well as determining which types of transactions would require the approval of the audit committee, optionally based on criteria which may be determined annually in advance by the audit committee;</span></td></tr>
</table><div>

</div><p style="margin: 0">&#160;</p><div>

</div><p style="margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 77; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">examining our internal controls and internal auditor&#8217;s performance, including whether the internal auditor has sufficient resources and tools to dispose of its responsibilities;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">examining the scope of our auditor&#8217;s work and compensation and submitting a recommendation with respect thereto to our board of directors or shareholders, depending on which of them is considering the appointment of our auditor;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">establishing procedures for the handling of employees&#8217; complaints as to deficiencies in the management of our business and the protection to be provided to such employees; and</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">where the board of directors approves the working plan of the internal auditor, examining such working plan before its submission to the board of directors and proposing amendments thereto.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our audit committee may not conduct any discussions
or approve any actions requiring its approval (see &#8220;Management&#8212;Approval of Related Party Transactions under Israeli law&#8221;),
unless at the time of the approval a majority of the committee&#8217;s members are present, which majority consists of independent directors
under the Companies Law, including at least one external director, if applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our board of directors has adopted an audit committee
charter setting forth, among others, the responsibilities of the audit committee consistent with the rules of the SEC and Nasdaq rules
(in addition to the requirements for such committee under the Companies Law), including, among others, the following:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">oversight of our independent registered public accounting firm and recommending the engagement, compensation or termination of engagement of our independent registered public accounting firm to the board of directors in accordance with Israeli law;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recommending the engagement or termination of the person filling the office of our internal auditor, reviewing the services provided by our internal auditor and reviewing effectiveness of our system of internal control over financial reporting;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recommending the terms of audit and non-audit services provided by the independent registered public accounting firm for pre-approval by our board of directors; and</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing and monitoring, if applicable, legal matters with significant impact, finding of regulatory authorities&#8217; findings, receive reports regarding irregularities and legal compliance, acting according to &#8220;whistleblower policy&#8221; and recommend to our board of directors if so required.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Nasdaq Stock Market Listing Rules for Audit
Committee</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under the Nasdaq rules, we are required to maintain
an audit committee consisting of at least three members, all of whom are independent and are financially literate and one of whom has
accounting or related financial management expertise.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As noted above, the members of our audit committee
are each &#8220;independent,&#8221; as such term is defined in under Nasdaq rules. All members of our audit committee meet the requirements
for financial literacy under the Nasdaq rules. Our board of directors has determined that Mr. Goldman is an audit committee financial
expert as defined by the SEC rules and has the requisite financial experience as defined by the Nasdaq rules.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Financial Statement Examination Committee</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under the Companies Law, the board of directors
of a public company in Israel must appoint a financial statement examination committee, which consists of members with accounting and
financial expertise or the ability to read and understand financial statements. The function of a financial statements examination committee
is to discuss and provide recommendations to its board of directors (including the report of any deficiency found) with respect to the
following issues: (1) estimations and assessments made in connection with the preparation of financial statements; (2) internal controls
related to the financial statements; (3) completeness and propriety of the disclosure in the financial statements; (4) the accounting
policies adopted and the accounting treatments implemented in material matters of the company; and (5) value evaluations, including the
assumptions and assessments on which evaluations are based and the supporting data in the financial statements. Our independent registered
public accounting firm and our internal auditor are invited to attend all meetings of our financial statements examination committee.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;<b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 78; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Compensation Committee</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under the Companies Law, the board of directors
of any public company must establish a compensation committee. The compensation committee must be composed of at least three directors,
including all of the external directors, if applicable, who if applicable must constitute a majority of the members of the compensation
committee. Each compensation committee member that is not an external director must be a director whose compensation does not exceed an
amount that may be paid to an external director. The compensation committee is subject to the same Companies Law restrictions as the audit
committee as to: (a) who may not be a member of the committee; and (b)&#160;who may not be present during committee deliberations as described
above.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our compensation committee acts pursuant to a written
charter, and complies with the provisions of the Companies Law, the regulations promulgated thereunder, and our amended and restated articles
of association, on all aspects referring to its independence, authorities and practice. Our compensation committee follows home country
practice as opposed to complying with the compensation committee membership and charter requirements prescribed under the Nasdaq rules.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our compensation committee reviews and recommends
to our board of directors (and in accordance with the provisions of our compensation policy): with respect to our executive officers&#8217;
and directors&#8217;: (1) annual base compensation (2) annual incentive bonus, including the specific goals and amounts; (3) equity compensation;
(4) employment agreements, severance arrangements, and change in control agreements and provisions; (5) retirement grants and/or retirement
bonuses; and (6) any other benefits, compensation, compensation policies or arrangements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The duties of the compensation committee will include
the recommendation to the company&#8217;s board of directors of a policy regarding the terms of engagement of office holders, to which
we refer as a compensation policy. Such policy was adopted by our board of directors and was approved by the shareholders (see &#8220;Management&#8212;Board
Practices&#8212;Approval of Related Party Transactions under Israeli law&#8221;). Under the Companies Law, the board of directors may
adopt the compensation policy if it is not approved by the shareholders, provided that after the shareholders oppose the approval of such
policy, the compensation committee and the board of directors revisit the matter and determine that adopting the compensation policy would
be in the best interests of the company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The compensation policy must serve as the basis
for decisions concerning the financial terms of employment or engagement of executive officers and directors, including exculpation, insurance,
indemnification or any monetary payment or obligation of payment in respect of employment or engagement. The compensation policy must
relate to certain factors, including advancement of the company&#8217;s objectives, the company&#8217;s business and its long-term strategy,
and creation of appropriate incentives for executives. It must also consider, among other things, the company&#8217;s risk management,
size and the nature of its operations. The compensation policy must furthermore consider the following additional factors:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the education, skills, expertise and accomplishments of the relevant director or executive;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the director&#8217;s or executive&#8217;s roles and responsibilities and prior compensation agreements with him or her;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the relationship between the cost of the terms of service of an office holder and the average median compensation of the other employees of the company (including those employed through manpower companies), including the impact of disparities in salary upon work relationships in the company;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the possibility of reducing variable compensation at the discretion of the board of directors; and the possibility of setting a limit on the exercise value of non-cash variable compensation; and</span></td></tr>
</table><div>

</div><p style="margin: 0">&#160;</p><div>

</div><p style="margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 79; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as to severance compensation, the period of service of the director or executive, the terms of his or her compensation during such service period, the company&#8217;s performance during that period of service, the person&#8217;s contribution towards the company&#8217;s achievement of its goals and the maximization of its profits, and the circumstances under which the person is leaving the company.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The compensation policy must also include the following
principles:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">with the exception of office holders who report directly to the chief executive officer, the link between variable compensation and long-term performance and measurable criteria;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the relationship between variable and fixed compensation, and the ceiling for the value of variable compensation at the time of its grant;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the conditions under which a director or executive would be required to repay compensation paid to him or her if it was later shown that the data upon which such compensation was based was inaccurate and was required to be restated in the company&#8217;s financial statements;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the minimum holding or vesting period for variable, equity-based compensation; and</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">maximum limits for severance compensation.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The compensation policy must
also consider appropriate incentives from a long-term perspective.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The compensation committee is responsible for:
(1) recommending the compensation policy to a company&#8217;s board of directors for its approval (and subsequent approval by the shareholders);
and (2) duties related to the compensation policy and to the compensation of a company&#8217;s office holders, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recommending whether a compensation policy should continue in effect, if the then-current policy has a term of greater than three years (approval of either a new compensation policy or the continuation of an existing compensation policy must in any case occur every three years);</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recommending to the board of directors periodic updates to the compensation policy;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">assessing implementation of the compensation policy;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">administering the Company&#8217;s clawback policy;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determining whether the terms of compensation of certain office holders of the company need not be brought to approval of the shareholders; and</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determining whether to approve the terms of compensation of office holders that require the committee&#8217;s approval.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our compensation policy is designed to promote
our long-term goals, work plan and policy, retain, motivate and incentivize our directors and executive officers, while considering the
risks that our activities involve, our size, the nature and scope of our activities and the contribution of an officer to the achievement
of our goals and maximization of profits, and align the interests of our directors and executive officers with our long-term performance.
To that end, a portion of an executive officer compensation package is targeted to reflect our short and long-term goals, as well as the
executive officer&#8217;s individual performance. On the other hand, our compensation policy includes measures designed to reduce the
executive officer&#8217;s incentives to take excessive risks that may harm us in the long-term, such as limits on the value of cash bonuses
and equity-based compensation, limitations on the ratio between the variable and the total compensation of an executive officer and minimum
vesting periods for equity-based compensation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 80; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our compensation policy also addresses our executive
officer&#8217;s individual characteristics (such as his or her respective position, education, scope of responsibilities and contribution
to the attainment of our goals) as the basis for compensation variation among our executive officers, and considers the internal ratios
between compensation of our executive officers and directors and other employees. For example, the compensation that may be granted to
an executive officer may include: base salary, annual bonuses, equity-based compensation, benefits and retirement and termination of service
arrangements. All cash bonuses are limited to a maximum amount linked to the executive officer&#8217;s base salary. In addition, our compensation
policy provides for maximum permitted ratios between the total variable (cash bonuses and equity-based compensation) and non-variable
(base salary) compensation components, in accordance with an officer&#8217;s respective position with the company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">An annual cash bonus may be awarded to executive
officers upon the attainment of pre-set periodic objectives and individual targets. The annual cash bonus that may be granted to executive
officers other than our chairman or Chief Executive Officer may be based entirely on a discretionary evaluation. Our Chief Executive Officer
will be entitled to recommend performance objectives to such executive officers, and such performance objectives will be approved by our
compensation committee (and, if required by law, by our board of directors).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The performance measurable objectives of our chairman
and Chief Executive Officer will be determined annually by our compensation committee and board of directors. A less significant portion
of the chairman&#8217;s and/or the Chief Executive Officer&#8217;s annual cash bonus may be based on a discretionary evaluation of the
chairman&#8217;s or the Chief Executive Officer&#8217;s respective overall performance by the compensation committee and the board of
directors based on quantitative and qualitative criteria.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The equity-based compensation under our compensation
policy for our executive officers (including members of our board of directors) is designed in a manner consistent with the underlying
objectives in determining the base salary and the annual cash bonus, with its main objectives being to enhance the alignment between the
executive officers&#8217; interests with our long-term interests and those of our shareholders and to strengthen the retention and the
motivation of executive officers in the long term. Our compensation policy provides for executive officer compensation in the form of
share options or other equity-based awards, such as restricted shares, options, in accordance with our stock option plan then in place.
Share options granted to executive officers shall be subject to vesting periods in order to promote long-term retention of the awarded
executive officers. The equity-based compensation shall be granted from time to time and be individually determined and awarded according
to the performance, educational background, prior business experience, qualifications, role and the personal responsibilities of the executive
officer.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition, our compensation policy contains compensation
recovery provisions which allows us under certain conditions to recover bonuses paid in excess, will enable our Chief Executive Officer
to approve an immaterial change in the terms of employment of an executive officer (provided that the changes of the terms of employment
are in accordance our compensation policy) and allows us to exculpate, indemnify and insure our executive officers and directors subject
to certain limitations set forth thereto.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our compensation policy also provides for compensation
to the members of our board of directors either: (i) in accordance with the amounts provided in the Companies Regulations (Rules Regarding
the Compensation and Expenses of an External Director) of 2000, as amended by the Companies Regulations (Relief for Public Companies Traded
in Stock Exchange Outside of Israel) of 2000, as such regulations may be amended from time to time; or (ii) in accordance with the amounts
determined in our compensation policy.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Nasdaq Requirements for Compensation Committee</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under the Nasdaq rules, we are required to maintain
a compensation committee consisting of at least two members, each of whom are independent.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As noted above, the members of our compensation
committee include Mr. Eli Bachar, Mr. Yaacov Goldman, and Ms. Ilana Lurie, each of whom is &#8220;independent,&#8221; as such term is
defined in under Nasdaq rules.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 81; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Joint Committee</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In accordance with the provisions of the Companies
Law and the regulations promulgated pursuant to it and under certain conditions, an Israeli company may unite its audit committee, the
compensation committee and the financial statement examination committee into one committee, or the Joint Committee. As of March 13, 2024,
the Company meets such conditions and therefore formed a Joint Committee. The members of our Joint Committee consist of Mr. Eli Bachar,
Mr. Yaacov Goldman and Ms. Ilana Lurie, with Mr. Yaacov Goldman serving as chairman.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;Internal Auditor </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under the Companies Law, the board of directors
of an Israeli public company must appoint an internal auditor nominated by the audit committee. The role of the internal auditor is to
examine, among other things, whether a company&#8217;s actions comply with the law and proper business procedure. The audit committee
is required to oversee the activities, and to assess the performance of the internal auditor as well as to review the internal auditor&#8217;s
work plan. An internal auditor may not be an interested party or office holder, or a relative of any interested party or office holder,
and may not be a member of the company&#8217;s independent accounting firm or its representative. The Companies Law defines an interested
party as a holder of 5% or more of the outstanding shares or voting rights of a company, any person or entity that has the right to appoint
at least one director or the general manager of the company or any person who serves as a director or as the general manager of a company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On December 15, 2022, our board of directors re-appointed
Doron Cohen, of Fahn Kanne &amp; Co., the Israeli member firm of Grant Thornton International Ltd., as our internal auditor. Our internal
auditor is a partner of a firm which specializes in internal auditing.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Remuneration of Directors</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under the Companies Law, remuneration of directors
is subject to the approval of the compensation committee, thereafter by the board of directors and thereafter, unless exempted under the
regulations promulgated under the Companies Law, by the general meeting of the shareholders. In case the remuneration of the directors
is in accordance with regulations applicable to remuneration of the external directors, if applicable, then such remuneration shall be
exempt from the approval of the general meeting. Where the director is also a controlling shareholder, the requirements for approval of
transactions with controlling shareholders apply.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Fiduciary Duties of Office Holders</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Companies Law imposes a duty of care and a
duty of loyalty on all office holders of a company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The duty of care requires an office holder to act
with the level of care with which a reasonable office holder in the same position would have acted under the same circumstances. The duty
of care of an office holder includes a duty to use reasonable means to obtain:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">information on the advisability of a given action brought for his approval or performed by him by virtue of his position; and</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">all other important information pertaining to these actions.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The duty of loyalty of an office holder requires
an office holder to act in good faith and for the benefit of the company, and includes a duty to:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">refrain from any conflict of interest between the performance of his duties in the company and his performance of his other duties or personal affairs;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">refrain from any action that is competitive with the company&#8217;s business;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">refrain from exploiting any business opportunity of the company to receive a personal gain for himself or others; and</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">disclose to the company any information or documents relating to the company&#8217;s affairs which the office holder has received due to his position as an office holder.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 82; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Insurance</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under the Companies Law, a company may obtain insurance
for any of its office holders against the following liabilities incurred due to acts he or she performed as an office holder, if and to
the extent provided for in the company&#8217;s articles of association:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">breach of his or her duty of care to the company or to another person, to the extent such a breach arises out of the negligent conduct of the office holder;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a breach of his or her duty of loyalty to the company, provided that the office holder acted in good faith and had reasonable cause to assume that his or her act would not prejudice the company&#8217;s interests; and</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a financial liability imposed upon him or her in favor of another person.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We maintain directors&#8217; and officers&#8217;
liability insurance with coverage of up to $10,000,000 for the benefit of all of our directors and officers, with an annual premium that
shall not exceed $1,000,000. The terms for the directors&#8217; and officers&#8217; liability insurance were approved by our shareholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Indemnification</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Companies Law, and the Israeli Securities Law,
5728-1968, or the Securities Law, provide that a company may indemnify an office holder against the following liabilities and expenses
incurred for acts performed by him or her as an office holder, either pursuant to an undertaking made in advance of an event or following
an event, provided its articles of association include a provision authorizing such indemnification:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a financial liability imposed on him or her in favor of another person by any judgment concerning an act performed in his or her capacity as an office holder, including a settlement or arbitrator&#8217;s award approved by a court;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reasonable litigation expenses, including attorneys&#8217; fees, expended by the office holder (a) as a result of an investigation or proceeding instituted against him or her by an authority authorized to conduct such investigation or proceeding, provided that (1) no indictment (as defined in the Companies Law) was filed against such office holder as a result of such investigation or proceeding; and (2) no financial liability as a substitute for the criminal proceeding (as defined in the Companies Law) was imposed upon him or her as a result of such investigation or proceeding, or, if such financial liability was imposed, it was imposed with respect to an offense that does not require proof of criminal intent; or (b) in connection with a monetary sanction; </span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reasonable litigation expenses, including attorneys&#8217; fees, expended by the office holder or imposed on him or her by a court; (1) in proceedings that the company institutes, or that another person institutes on the company&#8217;s behalf, against him or her; (2) in a criminal proceeding of which he or she was acquitted; or (3) as a result of a conviction for a crime that does not require proof of criminal intent; and</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">expenses incurred by an office holder in connection with an Administrative Procedure under the Securities Law, including reasonable litigation expenses and reasonable attorneys&#8217; fees. An &#8220;Administrative Procedure&#8221; is defined as a procedure pursuant to chapters H3 (Monetary Sanction by the Israeli Securities Authority), H4 (Administrative Enforcement Procedures of the Administrative Enforcement Committee) or I1 (Arrangement to prevent Procedures or Interruption of procedures subject to conditions) to the Securities Law.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 83; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Companies Law also permits a company to undertake
in advance to indemnify an office holder, provided that if such indemnification relates to financial liability imposed on him or her,
as described above, then the undertaking should be limited and shall detail the following foreseen events and amount or criterion:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to events that in the opinion of the board of directors can be foreseen based on the company&#8217;s activities at the time that the undertaking to indemnify is made; and</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in amount or criterion determined by the board of directors, at the time of the giving of such undertaking to indemnify, to be reasonable under the circumstances.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The board of directors has approved indemnification
agreements with all of our directors and with all members of our senior management, which were also approved by our shareholders at a
general meeting. Such indemnification agreements provide the office holder with indemnification permitted under applicable law and up
to a certain amount, and to the extent that these liabilities are not covered by directors and officers insurance.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;<b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Exculpation</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under the Companies Law, an Israeli company may
not exculpate an office holder from liability for a breach of his or her duty of loyalty, but may exculpate in advance an office holder
from his or her liability to the company, in whole or in part, for damages caused to the company as a result of a breach of his or her
duty of care (other than in relation to distributions), but only if a provision authorizing such exculpation is included in its articles
of association. Our amended and restated articles of association provide that we may exculpate, in whole or in part, any office holder
from liability to us for damages caused to the company as a result of a breach of his or her duty of care, but prohibit an exculpation
from liability arising from a company&#8217;s transaction in which our controlling shareholder or officer has a personal interest. Subject
to the aforesaid limitations, under the indemnification agreements, we will exculpate and release our office holders from any and all
liability to us related to any breach by them of their duty of care to us to the fullest extent permitted by law.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Limitations</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Companies Law provides that we may not exculpate
or indemnify an office holder nor enter into an insurance contract that would provide coverage for any liability incurred as a result
of any of the following: (1) a breach by the office holder of his or her duty of loyalty unless (in the case of indemnity or insurance
only, but not exculpation) the office holder acted in good faith and had a reasonable basis to believe that the act would not prejudice
us; (2) a breach by the office holder of his or her duty of care if the breach was carried out intentionally or recklessly (as opposed
to merely negligently); (3) any act or omission committed with the intent to derive an illegal personal benefit; or (4) any fine, monetary
sanction, penalty or forfeit levied against the office holder.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under the Companies Law, exculpation, indemnification
and insurance of office holders in a public company must be approved by the compensation committee and the board of directors and, with
respect to certain office holders or under certain circumstances, also by the shareholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our amended and restated articles of association
permit us to exculpate (subject to the aforesaid limitation), indemnify and insure our office holders to the fullest extent permitted
or to be permitted by the Companies Law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The foregoing descriptions summarize the material
aspects and practices of our board of directors. For additional details, we also refer you to the full text of the Companies Law, as well
as of our amended and restated articles of association, which are exhibits to this annual report on Form 20-F, and are incorporated herein
by reference.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">There are no service contracts between us or our
Subsidiary, on the one hand, and our directors in their capacity as directors, on the other hand, providing for benefits upon termination
of service.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 84; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Approval of Related Party Transactions under
Israeli Law</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>General</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Under the Companies Law,
we may approve an action by an office holder from which the office holder would otherwise have to refrain, as described above, if:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the office holder acts in good faith and the act or its approval does not cause harm to the company; and</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the office holder disclosed the nature of his or her interest in the transaction (including any significant fact or document) to the company at a reasonable time before the company&#8217;s approval of such matter.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Disclosure of Personal Interests of an Office
Holder</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The Companies Law requires
that an office holder disclose to the company, promptly, and, in any event, not later than the board meeting at which the transaction
is first discussed, any direct or indirect personal interest that he or she may have and all related material information known to him
or her relating to any existing or proposed transaction by the company. If the transaction is an extraordinary transaction, the office
holder must also disclose any personal interest held by:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the office holder&#8217;s relatives; or</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any corporation in which the office holder or his or her relatives holds 5% or more of the shares or voting rights, serves as a director or general manager or has the right to appoint at least one director or the general manager.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">An office holder is not,
however, obliged to disclose a personal interest if it derives solely from the personal interest of his or her relative in a transaction
that is not considered an extraordinary transaction. Under the Companies Law, an extraordinary transaction is a transaction:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">not in the ordinary course of business;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">not on market terms; or</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">that is likely to have a material effect on the company&#8217;s profitability, assets or liabilities.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The Companies Law does
not specify to whom within us nor the manner in which required disclosures are to be made. We require our office holders to make such
disclosures to our board of directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Under the Companies Law,
once an office holder complies with the above disclosure requirement, the board of directors may approve a transaction between the company
and an office holder, or a third party in which an office holder has a personal interest, unless the articles of association provide otherwise
and provided that the transaction is in the company&#8217;s interest. If the transaction is an extraordinary transaction in which an office
holder has a personal interest, first the audit committee and then the board of directors, in that order, must approve the transaction.
Under specific circumstances, shareholder approval may also be required. Generally, a person who has a personal interest in a matter which
is considered at a meeting of the board of directors or the audit committee may not be present at such a meeting unless the chairman of
the audit committee or board of directors (as applicable) determines that he or she should be present in order to present the transaction
that is subject to approval. A director who has a personal interest in a transaction, which is considered at a meeting of the board of
directors or the audit committee, may not be present at this meeting or vote on this matter, unless a majority of members of the board
of directors or the audit committee, as the case may be, has a personal interest. If a majority of the board of directors has a personal
interest, then shareholder approval is generally also required.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 85; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Disclosure of Personal Interests of a Controlling
Shareholder</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Under the Companies Law,
the disclosure requirements that apply to an office holder also apply to a controlling shareholder of a public company. Extraordinary
transactions with a controlling shareholder or in which a controlling shareholder has a personal interest, including a private placement
in which a controlling shareholder has a personal interest, as well as transactions for the provision of services whether directly or
indirectly by a controlling shareholder or his or her relative, or a company such controlling shareholder controls, and transactions concerning
the terms of engagement and compensation of a controlling shareholder or a controlling shareholder&#8217;s relative, whether as an office
holder or an employee, require the approval of the audit committee or the compensation committee, as the case may be, the board of directors
and a majority of the shares voted by the shareholders of the company participating and voting on the matter in a shareholders&#8217;
meeting. In addition, the shareholder approval must fulfill one of the following requirements:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at least a majority of the shares held by shareholders who have no personal interest in the transaction and are voting at the meeting must be voted in favor of approving the transaction, excluding abstentions; or</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the shares voted by shareholders who have no personal interest in the transaction who vote against the transaction represent no more than 2% of the voting rights in the company.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">In addition, any extraordinary
transaction with a controlling shareholder or in which a controlling shareholder has a personal interest with a term of more than three
years requires the abovementioned approval every three years; however, such transactions not involving the receipt of services or compensation
can be approved for a longer term, provided that the audit committee determines that such longer term is reasonable under the circumstances.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The Companies Law requires
that every shareholder that participates, in person, by proxy or by voting instrument, in a vote regarding a transaction with a controlling
shareholder, must indicate in advance or in the ballot whether or not that shareholder has a personal interest in the vote in question.
Failure to so indicate will result in the invalidation of that shareholder&#8217;s vote.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The term &#8220;controlling
shareholder&#8221; is defined in the Companies Law as a shareholder with the ability to direct the activities of the company, other than
by virtue of being an office holder. A shareholder is presumed to be a controlling shareholder if the shareholder holds 50% or more of
the voting rights in a company or has the right to appoint 50% or more of the directors of the company or its general manager. In the
context of a transaction involving a shareholder of the company, a controlling shareholder also includes a shareholder who holds 25% or
more of the voting rights in the company if no other shareholder holds more than 50% of the voting rights in the company. For this purpose,
the holdings of all shareholders who have a personal interest in the same transaction will be aggregated.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Approval of the Compensation of Directors and
Executive Officers</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The compensation of, or an undertaking to indemnify,
insure or exculpate, an office holder who is not a director requires the approval of the company&#8217;s compensation committee, followed
by the approval of the company&#8217;s board of directors, and, if such compensation arrangement or an undertaking to indemnify, insure
or exculpate is inconsistent with the company&#8217;s stated compensation policy, or if the said office holder is the chief executive
officer of the company (subject to a number of specific exceptions), then such arrangement is subject to the approval of our shareholders,
by a special majority requirement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Directors</i>. Under the Companies Law, the
compensation of our directors requires the approval of our compensation committee, the subsequent approval of the board of directors and,
unless exempted under the regulations promulgated under the Companies Law, the approval of the general meeting of our shareholders. If
the compensation of our directors is inconsistent with our stated compensation policy, then, provided that those provisions that must
be included in the compensation policy according to the Companies Law have been considered by the compensation committee and board of
directors, shareholder approval by a special majority will be required.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Executive officers other than the chief executive
officer.</i>&#160;The Companies Law requires the approval of the compensation of a public company&#8217;s executive officers (other than
the chief executive officer) in the following order: (i) the compensation committee, (ii) the company&#8217;s board of directors, and
(iii) only if such compensation arrangement is inconsistent with the company&#8217;s stated compensation policy, the company&#8217;s shareholders
by a special majority. However, if the shareholders of the company do not approve a compensation arrangement with an executive officer
that is inconsistent with the company&#8217;s stated compensation policy, the compensation committee and board of directors may override
the shareholders&#8217; decision if each of the compensation committee and the board of directors provide detailed reasons for their decision,
after rediscussing the terms of the compensation and the shareholders&#8217; non-approval.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;<i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 86; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Chief executive officer.</i>&#160;Under the
Companies Law, the compensation of a public company&#8217;s chief executive officer is required to be approved by: (i) the company&#8217;s
compensation committee; (ii) the company&#8217;s board of directors, and (iii) the company&#8217;s shareholders by a special majority.
However, if the shareholders of the company do not approve the compensation arrangement with the chief executive officer, the compensation
committee and board of directors may override the shareholders&#8217; decision if each of the compensation committee and the board of
directors provides detailed reasons for their decision, after rediscussing the terms of the compensation and the shareholders&#8217; non-approval.
In addition, the compensation committee may exempt the engagement terms of a candidate to serve as the chief executive officer from shareholders&#8217;
approval, if the compensation committee determines that the compensation arrangement is consistent with the company&#8217;s stated compensation
policy, that the chief executive officer did not have a prior business relationship with the company or a controlling shareholder of the
company, and that subjecting the approval to a shareholder vote would impede the company&#8217;s ability to attain the candidate to serve
as the company&#8217;s chief executive officer (and provide detailed reasons for the latter).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The approval of each of the compensation committee
and the board of directors, with regard to the office holders and directors above, must be in accordance with the company&#8217;s stated
compensation policy; however, under special circumstances, the compensation committee and the board of directors may approve compensation
terms of a chief executive officer that are inconsistent with the company&#8217;s compensation policy provided that they have considered
those provisions that must be included in the compensation policy according to the Companies Law and that shareholder approval was obtained
by a special majority requirement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Duties of Shareholders</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Under the Companies Law,
a shareholder has a duty to refrain from abusing his power in the company and to act in good faith and in an acceptable manner in exercising
his rights and performing his obligations toward the company and other shareholders, including, among other things, in voting at general
meetings of shareholders (and at shareholder class meetings) on the following matters:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">amendment of the articles of association;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">increase in the company&#8217;s authorized share capital;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">merger; and</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the approval of related party transactions and acts of office holders that require shareholder approval.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">A shareholder also has
a general duty to refrain from oppressing other shareholders. The remedies generally available upon a breach of contract will also apply
to a breach of the above mentioned duties, and in the event of oppression of other shareholders, additional remedies are available to
the injured shareholder.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">In addition, any controlling
shareholder, any shareholder that knows that its vote can determine the outcome of a shareholder vote and any shareholder that, under
a company&#8217;s articles of association, has the power to appoint or prevent the appointment of an office holder, or has another power
with respect to a company, is under a duty to act with fairness towards the company. The Companies Law does not describe the substance
of this duty except to state that the remedies generally available upon a breach of contract will also apply in the event of a breach
of the duty to act with fairness, taking the shareholder&#8217;s position in the company into account.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Share Option Plan</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In September 2015, our board of directors adopted
the 2015 Plan, pursuant to the provisions of the Israeli Income Tax Ordinance, or the Tax Ordinance. Following several amendments, our
board of directors currently has the discretion to grant options, or Options, to purchase Ordinary Shares of our company from a pool of
up to 3,188,597 Ordinary Shares. The number of Ordinary Shares in the Pool is also subject to adjustment under certain circumstances (e.g.,
reorganization of our equity capital). As of March 13, 2024, 372,771 Ordinary Shares had been issued upon the exercise of Options, 1,749,189
Options had been allocated and/or granted but had not been exercised, and 1,066,637 Ordinary Shares remained available for future grants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 87; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the 2015 Plan, the Options may be granted
to employees, consultants and service providers, directors and non-employees of our company and/or our affiliates, or the Optionees; provided
however, that the Optionees who are Israeli employees or directors (who are not controlling shareholders of our company) may only receive
Options pursuant to Section 102 of the Tax Ordinance, or Section 102, and non-employees (and/or employees who are also controlling shareholders),
may receive Options pursuant to Section 3(i) of the Tax Ordinance. Section 102 Options may be either approved Options or unapproved Options.
Approved Section 102 Options are: (1) required to be held by a trustee appointed by our board of directors pursuant to the 2015 Plan,
or Trustee; (2) require a holding period as set forth in Section 102; and (3) are subject to an irrevocable proxy provided to the Trustee.
Section 102 Options may either be subject to a capital gains track or ordinary income track, as elected and designated by us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our board of directors has the discretion to determine
the terms of the Options for each option grant, including the exercise price and vesting dates of the Options. If not earlier exercised,
the Options expire upon the earlier of (i) 10 years from the date of grant; (ii) depending on the circumstances, following a pre-determined
time period after the termination of the Optionees employment or engagement with us, as applicable; or (iii) as provided in the Optionee&#8217;s
option agreement. Any Ordinary Shares underlying Options which are forfeited, expired or canceled before expiration of the 2015 Plan,
become available for future grants thereunder. Our board of directors has discretion to change the terms of existing Options, including
the acceleration of vesting periods in connection with a change of control transaction.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In December 2022, our board of directors approved
the amendment to our 2015 Plan to include restricted stock units under the 2015 Plan.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="a_028"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>D. Employees</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As of the date of this annual report, we employ
29 full-time employees (including one employee located in Lithuania and two employees located in the United States), and 10 part-time
employees. In addition, we have one consultant located in Japan. We have two sub-contractors located in India, performing front end software
application development. The majority of our employees are located in Israel.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">None of our employees are members of a union or
subject to the terms of a collective bargaining agreement. However, in Israel, we are subject to certain Israeli Labor laws, regulations
and national labor court precedent rulings, as well as certain provisions of collective bargaining agreements applicable to us by virtue
of extension orders issued in accordance with relevant labor laws by the Israeli Industry and Economy Office, and which apply such agreement
provisions to our employees even though they are not part of a union that has signed a collective bargaining agreement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="a_029"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>E. Share Ownership</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">See &#8220;Item 7.A. Major
Shareholders&#8221; below.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_030"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>F. Action to Recover Erroneously Awarded Compensation</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 88; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_031"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY
TRANSACTIONS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="a_032"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>A. Major Shareholders</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table sets forth information regarding
beneficial ownership of our Ordinary Shares as of March 13, 2024 by:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each person, or group of affiliated persons, known to us to be the beneficial owner of more than 5% of our outstanding Ordinary Shares;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each of our directors, and executive officers; and</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">all of our directors, and executive officers as a group.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Beneficial ownership is determined in accordance
with the rules of the SEC and includes voting or investment power with respect to Ordinary Shares. Ordinary Shares issuable pursuant to
outstanding options or warrants to purchase Ordinary Shares that are exercisable, or securities that are convertible into Ordinary Shares,
within 60 days after March 13, 2024, are deemed outstanding for the purpose of computing the percentage ownership of the person holding
the options, warrants or convertible securities, but are not deemed outstanding for the purpose of computing the percentage ownership
of any other person. Percentage of shares beneficially owned is based on 20,387,428 Ordinary Shares outstanding on March 13, 2024.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are not controlled by another corporation, by
any foreign government or by any natural or legal persons except as set forth herein, and there are no arrangements known to us which
would result in a change in control of our company at a subsequent date. Except as indicated in footnotes to this table, we believe that
the shareholders named in this table have sole voting and investment power with respect to all shares shown to be beneficially owned by
them, based on information provided to us by such shareholders. Unless otherwise noted below, each beneficial owner&#8217;s address is
c/o Wearable Devices Ltd., 2 Ha-Ta&#8217;asiya St., Yokne&#8217;am Illit, 2069803 Israel.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">No.&#160;of&#160;Shares<br/> Beneficially<br/> Owned</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Percentage<br/> Owned</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Holders of more than 5% of our voting securities:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Asher Dahan * (1)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,350,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">6.6</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Guy Wagner * (2)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,800,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8.8</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Leeor Langer (3)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,350,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6.6</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Alumot (4)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,198,774</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.9</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Directors and senior management who are not 5% holders:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Eli Bachar * (5)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">276,640</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.3</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Barry Kaplan (6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">234,426</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.1</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Alon Mualem (7)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">77,778</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.4</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Offir Remez (8)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">137,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.7</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Shmuel Barel (9)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">135,546</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.7</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Tamar Fleisher (10)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,167</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.1</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Yaacov Goldman * (11)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Ilana Lurie * (11)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">All directors and senior management as a group (11 persons)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,375,557</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25.4</td><td style="text-align: left">%</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicates director of the Company.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The beneficial ownership is based on a Schedule 13G filed by Mr. Dahan with the SEC on February 13, 2023.&#160;In addition, Mr. Dahan hold options to purchase 30,000 Ordinary Shares that are not exercisable within 60 days, with expiration dates of November 2033, with an exercise price of $1.32.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The beneficial ownership is based on a Schedule 13G filed by Mr. Wagner
    with the SEC on February 13, 2023.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, Mr. Wagner hold options to purchase 30,000 Ordinary Shares
    that are not exercisable within 60 days, with expiration dates of November 2033, with an exercise price of $1.32.&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The beneficial ownership is based on a Schedule 13G filed by Mr. Langer
    with the SEC on February 13, 2023.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, Mr. Langer hold options to purchase 30,000 Ordinary Shares
    that are not exercisable within 60 days, with expiration dates of August 2033, with an exercise price of $1.32.&#160;</p></td></tr>
</table><div>

</div><p style="margin: 0">&#160;</p><div>

</div><p style="margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 89; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="text-align: left">The beneficial ownership is based on transfer agent report dated March
    13, 2024. Alumot is a private Cayman Islands company. Alexandr Khamidullin has the sole voting and investment control over the shares.</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: left">(5)</td>
    <td style="text-align: left">The beneficial ownership consists
    of 92,213 Ordinary Shares based on transfer agent report dated March 13, 2024 and 184,427 Ordinary Shares issuable upon exercise of outstanding
    options that are exercisable within 60 days. Mr. Bachar&#8217;s options have an expiration date of November 2027, and a weighted average
    exercise price of $0.003. In addition, Mr. Bahar holds options to purchase 20,000 Ordinary Shares that are not exercisable within 60 days,
    at an exercise price of $1.32 and with an expiration date of November 2033.</td></tr>
</table><div>

</div><p style="text-align: left; margin: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="text-align: left; width: 24px">(6)</td>
    <td style="text-align: left"> Consists of 234,426 Ordinary Shares issuable upon exercise of outstanding options that are exercisable within 60 days. Mr. Kaplan&#8217;s options have expiration dates ranging from April 26, 2028 to July 1, 2031, and a weighted average exercise price of $2.251. In addition, Mr. Kaplan holds options to purchase 15,000 Ordinary Shares that are not exercisable within 60 days, at an exercise price of $1.32 and with an expiration date of August 2033. &#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: left">(7)</td>
    <td style="text-align: left"> Consists of 77,778 Ordinary Shares issuable upon exercise of outstanding options that are exercisable within 60 days. In addition, Mr. Mualem holds options to purchase 42,222 Ordinary Shares that are not exercisable within 60 days. Mr. Mualem&#8217;s options have expiration dates ranging from January 2032 to August 2033, with an exercise price ranging from $0.003 to $1.32. &#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: left">(8)</td>
    <td style="text-align: left"> Consists of 137,000 Ordinary Shares issuable upon exercise of outstanding options that are exercisable within 60 days. Mr. Remez&#8217;s options have an expiration date of November 1, 2031, and a weighted average exercise price of $0.003. In addition, Mr. Remez holds options to purchase 20,000 Ordinary Shares that are not exercisable within 60 days, at an exercise price of $1.32 and with an expiration date of August 2033.</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: left">(9)</td>
    <td style="text-align: left"> Consists of 135,546 Ordinary Shares issuable upon exercise of outstanding options that are exercisable within 60 days. In addition, Mr. Barel holds options to purchase 31,667 Ordinary Shares that are not exercisable within 60 days. Mr. Barel options have expiration dates ranging from December 2027 to August 2033, and an exercise price ranging from $0.003 to $1.32.</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>(10)</td>
    <td style="text-align: justify">Consists of 14,167 Ordinary Shares issuable upon exercise of outstanding options that are exercisable within 60 days. In addition, Ms. Fleisher holds options to purchase 35,833 Ordinary Shares that are not exercisable within 60 days. Ms. Fleisher options have expiration dates ranging from January 2033 to August 2033, with an exercise price ranging from $0.66 to $1.32.</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
Lurie and Mr. Goldman have no Ordinary Shares issuable upon exercise of outstanding options that are exercisable within 60 days. In addition,
Ms. Lurie and Mr. Goldman each hold options to purchase 20,000 Ordinary Shares that are not exercisable within 60 days, with expiration
dates ranging of November 2033, with an exercise price of $1.32.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Changes in Percentage Ownership by Major
Shareholders</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Over the course of 2023, there was a decrease in
the percentage ownership of OurCrowd General Partner, L.P. (from 8.1% to 0%) and a decrease in the percentage ownership of Mudra CEO LLC
(from 6.0% to 0%). In addition, there were decreases in the percentage ownership of: (i) Alumot (from 7.9% to 5.9%), (ii) Asher Dahan
(from 9.0% to 6.6%), (iii) Leeor Langer (from 9.0% to 6.6%), (iv) Guy Wagner (from 12.0% to 8.8%), which were due to the dilution as a
result of warrant exercises in June 2023 and a public offering in November 2023.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Over the course of 2022, there was an increase
in the percentage ownership of OurCrowd General Partner, L.P. (from 0% to 8.1%) as a result of their purchase of our shares from Hubble
Ventures Co., Ltd. On the other hand, there were decreases in the percentage ownership of: (i) Alumot (from 10.8% to 7.9%), (ii) Asher
Dahan (from 12.1% to 9.0%), (iii) Leeor Langer (from 12.1% to 9.0%), (iv) Mudra CEO LLC (from 7.6% to 6%), and (v) Guy Wagner (from 16.2%
to 12.0%), which was due to the dilution as a result of our IPO in September 2022. Additionally, Hubble Ventures Co., Ltd.&#8217;s ownership
decreased from 11.0% to 0% as a result of the sale of their shares to OurCrowd General Partner, L.P.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 90; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Over the course of 2021, there were decreases in
the percentage ownership of our major shareholders of: (ii) Asher Dahan (from 29.2% to 12.1%), (iii) Leeor Langer (from 29.2% to 12.1%),
and (vi) Guy Wagner (from 38.9% to 16.2%). On the other hand, there were increases in the percentage ownership of (i) Alumot (from 0%
to 10.8%), (ii) Hubble Ventures Co., Ltd. (from 0% to 11.0%) and (iii) Mudra CEO LLC (from 0% to 7.6%), which were due to the investment
in our Ordinary Shares and warrants and a conversion of convertible notes into Ordinary Shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;<b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Record Holders</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As of March 13, 2024, there were 25 shareholders
of record of our Ordinary Shares. This number is not representative of the number of beneficial holders of our shares nor is it representative
of where such beneficial holders reside, since many of these shares were held of record by brokers or other nominees.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are not controlled by another corporation, by
any foreign government or by any natural or legal persons except as set forth herein, and there are no arrangements known to us which
would result in a change in our control at a subsequent date.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="a_033"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>B. Related Party Transactions</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Employment Agreements</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We have entered into written
employment agreements with each of our executive officers. All of these agreements contain customary provisions regarding noncompetition,
confidentiality of information and assignment of inventions. However, the enforceability of the noncompetition provisions may be limited
under applicable law. In addition, we have entered into agreements with each executive officer and director pursuant to which we have
agreed to indemnify each of them up to a certain amount and to the extent that these liabilities are not covered by directors and officers
insurance. Members of our senior management are eligible for bonuses each year. The bonuses are payable upon meeting objectives and targets
that are set by our Chief Executive Officer and approved annually by our board of directors that also set the bonus targets for our Chief
Executive Officer.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">On March 6, 2022, our
board of directors approved new terms of compensation for each of our officers, subject to the approval of our shareholders. The new terms
of compensation were approved by our shareholders in a meeting that took place on March 14, 2022.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Options</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Since our inception, we
have granted options to purchase our Ordinary Shares to our officers and certain of our directors. Such option agreements may contain
acceleration provisions upon certain merger, acquisition, or change of control transactions. We describe our option plans under &#8220;Item
6.C Board Practices &#8212; Share Option Plan.&#8221; If the relationship between us and an executive officer or a director is terminated,
except for cause (as defined in the various option plan agreements), options that are vested will generally remain exercisable for three
months after such termination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><i>Employment Agreement
with Barry Kaplan</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">In July 2021, effective
as of July 1, 2021, our subsidiary, Mudra Wearable, entered into an employment agreement with Barry Kaplan. Pursuant to the terms of his
employment agreement, Mudra Wearable pays Mr. Kaplan a gross annual salary of $200,000 for his services as the Executive Vice President
of the U.S. Operations. In addition to options received for service as one of our directors, on July 1, 2021, we also issued Mr. Kaplan
options to purchase 50,000 Ordinary Shares under our 2015 Plan, at an exercise price of $2.25 per share. Pursuant to the employment agreement,
we or Mr. Kaplan may terminate the employment agreement by providing 30 days&#8217; prior written notice.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 91; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">On March 6, 2022, our
board of directors approved and ratified the employment agreement by and between the Company and Mr. Kaplan. This amendment was subsequently
approved by our shareholders on March 14, 2022. As of the effective date of the agreement, our board and shareholders approved a grant
payment to Mr. Kaplan for the completion of the IPO, in a total amount equal to three months&#8217; salary.&#160;In September 2022, our
board of directors approved the increase of Mr. Kaplan&#8217;s gross annual salary to $250,000 per year and the amount of the grant payment
was increased to an amount equal to five months&#8217; salary pursuant to the approval of our compensation committee and our board of
directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><div>

</div><div><a id="a_041"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>C. Interests of Experts and Counsel</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">None.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="a_034"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 8. FINANCIAL INFORMATION.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="a_035"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>A. Consolidated Statements and Other Financial
Information</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">See &#8220;Item 18. Financial
Statements.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Legal Proceedings</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">From time to time, we may become involved in legal
proceedings that arise in the ordinary course of business. During the period covered by the financial statements contained herein, we
were not subject to any material legal proceedings that have had a material adverse effect on our financial position. No assurance can
be given that future litigation will not have a material adverse effect on our financial position. When appropriate in management&#8217;s
estimation, we may record reserves in our financial statements for pending litigation and other claims.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Dividends</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have never declared or paid any cash dividends
on our Ordinary Shares and do not anticipate paying any cash dividends in the foreseeable future. Payment of cash dividends, if any, in
the future will be at the discretion of our board of directors and will depend on then-existing conditions, including our financial condition,
operating results, contractual restrictions, capital requirements, business prospects and other factors our board of directors may deem
relevant.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under the Companies Law, we may declare and pay
dividends only if, upon the determination of our board of directors, there is no reasonable concern that the distribution will prevent
us from being able to meet the terms of our existing and foreseeable obligations as they become due. Under the Companies Law, the distribution
amount is further limited to the greater of retained earnings or earnings generated over the two most recent years legally available for
distribution according to our then last reviewed or audited financial statements, provided that the end of the period to which the financial
statements relate is not more than six months prior to the date of distribution. In the event that we do not meet such earnings criteria,
we may seek the approval of the court in order to distribute a dividend. The court may approve our request if it is convinced that there
is no reasonable concern that the payment of a dividend will prevent us from satisfying our existing and foreseeable obligations as they
become due.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Payment of dividends may be subject to Israeli
withholding taxes. See &#8220;Item 10. E. Taxation&#8221; for additional information.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="a_036"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>B. Significant Changes</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">No significant change, other than as otherwise
described in this annual report on Form 20-F, has occurred in our operations since the date of our consolidated financial statements included
in this annual report on Form 20-F.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 92; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="a_037"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 9. THE OFFER AND LISTING.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_038"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>A. Offer and Listing Details</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Ordinary Shares and Warrants were approved
for listing on the Nasdaq Capital Market and commenced trading under the symbol &#8220;WLDS&#8221; and &#8220;WLDSW&#8221;, respectively,
on September 13, 2022.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_039"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>B. Plan of Distribution</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_040"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>C. Markets</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">See &#8220;Item 9A. Offer and Listing Details.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On October 24, 2023, we received a written notification
from the Listing Qualifications Department of the Nasdaq Stock Market LLC notifying us that we were not in compliance with the Minimum
Bid Price Requirement because the closing bid price of our Ordinary Shares was below $1.00 per Ordinary Share for the previous 30 consecutive
business days. We were granted 180 calendar days, or until April&#160;22, 2024, to regain compliance with the Minimum Bid Price Requirement.
In the event we do not regain compliance with the Minimum Bid Price Requirement by April 22, 2024, we may be eligible for an additional
180-calendar day grace period. To qualify, we will be required to meet the continued listing requirement for market value of publicly
held shares and all other listing standards for Nasdaq, with the exception of the Minimum Bid Price Requirement, and will need to provide
written notice to The Nasdaq Stock Market LLC of our intent to regain compliance with such requirement during such second compliance period.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We intend to monitor the closing bid price of our
Ordinary Shares and may, if appropriate, consider implementing available options to regain compliance with the minimum bid price requirement,
including initiating a reverse stock split. If we do not regain compliance within the allotted compliance period(s), including any extensions
that may be granted, The Nasdaq Stock Market LLC will provide notice that our Ordinary Shares will be subject to delisting from Nasdaq.
At that time, we may appeal The Nasdaq Stock Market LLC&#8217;s determination to a hearings panel.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_042"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>D. Selling Shareholders</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_043"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>E. Dilution</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_044"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>F. Expenses of the Issue</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_045"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 10. ADDITIONAL INFORMATION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_046"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>A. Share Capital</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_047"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>B. Memorandum and Articles of Association</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A copy of our current articles of association is
attached as Exhibit 1.1 to this annual report.&#160;The information called for by this Item is set forth in Exhibit 1.1 to this annual
report and is incorporated by reference into this annual report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 93; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_048"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>C. Material Contracts</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following is a summary of each material contract,
other than material contracts entered into in the ordinary course of business, to which we are or have been a party, for the two years
immediately preceding the date of this annual report:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senior Credit Facility Agreement, dated July 4, 2022, by and between Wearable Devices Ltd. and L.I.A. Pure Capital Ltd., <span style="background-color: white">filed as&#160;Exhibit 10.6&#160;to a registration statement on Form F-1 (File No. 333-262838) filed on September 8, 2022. </span>See Item &#8220;5.B Liquidity and Capital Resources &#8211; Net Cash Provided by Financing Activities&#8221;.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">First Addendum to Senior Credit Facility Agreement, dated July 19, 2022, by and between Wearable Devices Ltd. and L.I.A. Pure Capital Ltd., <span style="background-color: white">filed as&#160;Exhibit 10.8&#160;to a registration statement on Form F-1 (File No. 333-262838) filed on September 8, 2022.</span> See Item &#8220;5.B Liquidity and Capital Resources &#8211; Net Cash Provided by Financing Activities.&#8221;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Compensation Policy, filed as&#160;</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit <span style="background-color: white">10.5&#160;to a registration statement on Form F-1 (File No. 333-262838) filed on September 8, 2022, and incorporated herein by reference.&#160;See &#8220;Item 6. C. Board Practices &#8212; Committees of the Board of Directors &#8212; Compensation Committee&#8221; for more information about this document</span>.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#9679;</p></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Indemnification Agreement, <span style="background-color: white">filed as&#160;Exhibit 10.1&#160;to a registration statement on Form F-1 (File No. 333-262838) filed on September 8, 2022, and incorporated herein by reference.&#160;See &#8220;Item 6. C. Board Practices &#8212; Indemnification.&#8221;</span></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_049"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>D. Exchange Controls</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">There are currently no Israeli currency control
restrictions on payments of dividends or other distributions with respect to our Ordinary Shares or the proceeds from the sale of the
shares, except for the obligation of Israeli residents to file reports with the Bank of Israel regarding certain transactions. However,
legislation remains in effect pursuant to which currency controls can be imposed by administrative action at any time.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The ownership or voting of our Ordinary Shares
by non-residents of Israel, except with respect to citizens of countries that are in a state of war with Israel, is not restricted in
any way by our memorandum of association or amended and restated articles of association or by the laws of the State of Israel.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p><div>

</div><div><a id="a_050"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>E. Taxation</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>The following description is not intended to
constitute a complete analysis of all tax consequences relating to the ownership or disposition of our Ordinary Shares. You should consult
your own tax advisor </i>concerning <i>the tax consequences of your particular situation, as well as any tax consequences that may arise
under the laws of any state, local, foreign, including Israeli, or other taxing jurisdiction.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Israeli Tax Considerations and Government Programs</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="background-color: white">The
following is a description of the material Israeli income tax consequences of the ownership of our Ordinary Shares. The following also
contains a description of material relevant provisions of the current Israeli income tax structure applicable to companies in Israel,
with reference to its effect on us. To the extent that the discussion is based on new tax legislation which has not been subject to judicial
or administrative interpretation, there can be no assurance that the tax authorities will accept the views expressed in the discussion
in question. The discussion is not intended, and should not be taken, as legal or professional tax advice and is not exhaustive of all
possible tax considerations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="background-color: white">The
following description is not intended to constitute a complete analysis of all tax consequences relating to the ownership or disposition
of our Ordinary Shares. Shareholders should consult their own tax advisors concerning the tax consequences of their particular situation,
as well as any tax consequences that may arise under the laws of any state, local, foreign or other taxing jurisdiction.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 94; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>General Corporate Tax Structure in Israel</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Israeli companies are generally subject to corporate
tax, currently at the rate of 23%. However, the effective tax rate payable by a company that derives income from a Preferred Enterprise
or Preferred Technological Enterprise (as discussed below)&#160;may be considerably less.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Capital gains derived by an Israeli resident company
are subject to tax at the regular corporate tax rate. Under Israeli tax legislation, a corporation will be considered as an &#8220;Israeli
resident company&#8221; if it meets one of the following criteria: (i)&#160;it was incorporated in Israel; or (ii)&#160;the control and
management of its business are exercised in Israel.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Law for the Encouragement of Industry (Taxes), 5729-1969</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="background-color: white">The
Law for the Encouragement of Industry (Taxes), 5729-1969, generally referred to as the Industry Encouragement Law, provides several tax
benefits for &#8220;Industrial Companies.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="background-color: white">The
Industry Encouragement Law defines an &#8220;Industrial Company&#8221; as an Israeli resident-company, which has 90% or more of its income
in any tax year, other than income from defense loans, derived from an &#8220;Industrial Enterprise&#8221; owned by it. An &#8220;Industrial
Enterprise&#8221; is defined as an enterprise whose principal activity in a given tax year is industrial production.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="background-color: white">The
following corporate tax benefits, among others, are available to Industrial Companies:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">amortization of the cost to purchase a patent, rights to use a patent, and know-how, which are used for the development or advancement of the company, over an eight-year period, commencing on the year in which such rights were first exercised;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">under limited conditions, an election to file consolidated tax returns with related Israeli Industrial Companies; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">expenses related to a public offering are deductible in equal amounts over three years.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="background-color: white">Eligibility
for benefits under the Industry Encouragement Law is not contingent upon approval of any governmental authority, but it quite common to
maintain preapproval from the Israeli Tax Authority, or the ITA.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Tax Benefits and Grants for Research and Development</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Under the Research Law, programs
which meet specified criteria and are approved by the IIA are eligible for grants of up to 85% of the project&#8217;s expenditure, as
determined by the research committee, in exchange for the payment of royalties from the revenues generated from the sale of products and
related services developed, in whole or in part pursuant to, or as a result of, a research and development program funded by the IIA.
The royalties are generally at a range of 3.0% to 3.5% of revenues until the entire IIA grant is repaid, together with an annual interest.
Until October 25, 2023, the interest was calculated at a rate based on 12-month LIBOR applicable to US Dollar deposits. However, on October
25, 2023, the IIA published a directive concerning changes in royalties to address the expiration of the LIBOR. Under such directive,
regarding IIA grants approved by the IIA prior to January 1, 2024 but which are outstanding thereafter, as of January 1, 2024 the annual
interest is calculated at a rate based on 12-month Secured Overnight Financing Rate, or SOFR, or at an alternative rate published by the
Bank of Israel plus 0.71513%; and, for grants approved on or following January 1, 2024 the annual interest shall be the higher of (i)
the 12 months SOFR interest rate, plus 1%, or (ii) a fixed annual interest rate of 4%.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 95; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The terms of the Research
Law also require that the manufacture of products developed with government grants be performed in Israel. The transfer of manufacturing
activity outside Israel may be subject to the prior approval of the IIA. Under the regulations of the Research Law, assuming we receive
approval from the IIA to manufacture our IIA funded products outside Israel, we may be required to pay increased royalties. The increase
in royalties depends upon the manufacturing volume that is performed outside of Israel as follows:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Manufacturing Volume Outside of Israel</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Royalties<br/> to the IIA as<br/> a&#160;Percentage<br/> of Grant</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Up to 50%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">120</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">between 50% and 90%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">150</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">90% &#160;and more</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">300</td><td style="text-align: left">%</td></tr>
  </table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">If the manufacturing is
performed outside of Israel by us, the rate of royalties payable by us on revenues from the sale of products manufactured outside of Israel
will increase by 1% over the regular rates. If the manufacturing is performed outside of Israel by a third party, the rate of royalties
payable by us on those revenues will be equal to the ratio obtained by dividing the amount of the grants received from the IIA and our
total investment in the project that was funded by these grants. The transfer of no more than 10% of the manufacturing capacity in the
aggregate outside of Israel is exempt under the Research Law from obtaining the prior approval of the IIA. A company requesting funds
from the IIA also has the option of declaring in its IIA grant application an intention to perform part of its manufacturing outside Israel,
thus avoiding the need to obtain additional approval. On January 6, 2011, the Research Law was amended to clarify that the potential increased
royalties specified in the table above will apply even in those cases where the IIA approval for transfer of manufacturing outside of
Israel is not required, namely when the volume of the transferred manufacturing capacity is less than 10% of total capacity or when the
company received an advance approval to manufacture abroad in the framework of its IIA grant application. For applications to manufacture
abroad, submitted to the IIA after October 25, 2023, the maximum increased liability is up to 150% of the IIA grants, plus interest accrued
thereon, instead of 300%.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The know-how developed
within the framework of the IIA plan may not be transferred to third parties outside Israel without the prior approval of a governmental
committee charted under the Research Law. The approval, however, is not required for the export of any products developed using grants
received from the IIA. The IIA approval to transfer know-how created, in whole or in part, in connection with an IIA-funded project to
third party outside Israel where the transferring company remains an operating Israeli entity is subject to payment of a redemption fee
to the IIA calculated according to a formula provided under the Research Law that is based, in general, on the ratio between the aggregate
IIA grants to the company&#8217;s aggregate investments in the project that was funded by these IIA grants, multiplied by the transaction
consideration. The transfer of such know-how to a party outside Israel where the transferring company ceases to exist as an Israeli entity
is subject to a redemption fee formula that is based, in general, on the ratio between the aggregate IIA grants to the total financial
investments in the company, multiplied by the transaction consideration. According to the January 2011 amendment, the redemption fee in
case of transfer of know-how to a party outside Israel will be based on the ratio between the aggregate IIA grants received by the company
and the company&#8217;s aggregate R&amp;D expenses, multiplied by the transaction consideration. According to regulations promulgated
following the 2011 amendment, the maximum amount payable to the IIA in case of transfer of know how outside Israel shall not exceed 6
times the value of the grants received plus interest, and in the event that the receiver of the grants ceases to be an Israeli corporation
such payment shall not exceed 6 times the value of the grants received plus interest, with a possibility to reduce such payment to up
to 3 times the value of the grants received plus interest if the R&amp;D activity remains in Israel for a period of three years after
payment to the IIA and maintain at least 75% of the research and development employees the Company had for the six months before the know-how
was transferred, subject to additional conditions specified in the regulations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Transfer of know-how within
Israel is subject to an undertaking of the recipient Israeli entity to comply with the provisions of the Research Law and related regulations,
including the restrictions on the transfer of know-how and the obligation to pay royalties, as further described in the Research Law and
related regulations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">These restrictions may impair our ability to outsource manufacturing,
engage in change of control transactions or otherwise transfer our know-how outside Israel and may require us to obtain the approval
or the IIA for certain actions and transactions and pay additional royalties to the IIA. In particular, any change of control and any
change of ownership of our Ordinary Shares that would make a non-Israeli citizen or resident an &#8220;interested party,&#8221; as defined
in the Research Law, requires a prior written notice to the IIA in addition to any payment that may be required of us for transfer of
manufacturing or know-how outside Israel. If we fail to comply with the Research Law, we may be subject to criminal charges or to mandatory
repayment of grants received by us (together with interest and penalties).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 96; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Tax Benefits for Research and Development</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="background-color: white">Israeli tax law allows, under
certain conditions, a tax deduction for expenditures, including capital expenditures, for the year in which they are incurred. Expenditures
are deemed related to scientific research and development projects, if:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The expenditures are approved by the relevant Israeli government ministry, determined by the field of research;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The research and development must be for the promotion of the company; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The research and development is carried out by or on behalf of the company seeking such tax deduction.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="background-color: white">The
amount of such deductible expenses is reduced by the sum of any funds received through government grants for the finance of such scientific
research and development projects. No deduction under these research and development deduction rules is allowed if such deduction is related
to an expense invested in an asset depreciable under the general depreciation rules of the Tax Ordinance. Expenditures not so approved
are deductible in equal amounts over three years.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="background-color: white">From
time to time we may apply the Office of the Chief Scientist for approval to allow a tax deduction for all research and development expenses
during the year incurred. There can be no assurance that such application will be accepted.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Law for the Encouragement of Capital Investments, 5719-1959</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="background-color: white">The
Law for the Encouragement of Capital Investments, 5719-1959, generally referred to as the Investment Law, provides certain incentives
for capital investments in production facilities (or other eligible assets).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="background-color: white">The
Investment Law was significantly amended effective as of as of January&#160;1, 2011, or the 2011 Amendment, and as of January&#160;1,
2017, or the 2017 Amendment. The 2011 Amendment introduced new benefits to replace those granted in accordance with the provisions of
the Investment Law in effect prior to the 2011 Amendment. The 2017 Amendment introduces new benefits for Technological Enterprises, alongside
the existing tax benefits.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><i>Tax benefits under
the 2011 Amendment</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The 2011 Amendment canceled
the availability of the benefits granted under the Investment Law prior to 2011 and, instead, introduced new benefits for income generated
by a &#8220;Preferred Company&#8221; through its &#8220;Preferred Enterprise&#8221; (as such terms are defined in the Investment Law)
as of January&#160;1, 2011. The definition of a Preferred Company includes a company incorporated in Israel that is not fully owned by
a governmental entity, and that has, among other things, Preferred Enterprise status and is controlled and managed from Israel. Pursuant
<span style="background-color: white">to the 2011 Amendment, a Preferred Company is entitled to a reduced corporate tax rate of 16% with
respect to its income derived from its Preferred Enterprise, unless the Preferred Enterprise is located in a specified development zone,
in which case the rate will be 7.5%. Income derived by a Preferred Company from a &#8220;Special Preferred Enterprise&#8221; (as such
term is defined in the Investment Law) would be entitled, during a benefits period of 10 years, to further reduced tax rates of 8%, or
5% if the Special Preferred Enterprise is located in a certain development zone.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Dividends distributed
from income which is attributed to a &#8220;Preferred Enterprise&#8221; should generally be subject to withholding tax at source at the
following rates: (i)&#160;Israeli resident&#160;corporations - 0%,&#160;(although, if such dividends are subsequently distributed to individuals
or a&#160;non-Israeli&#160;company the below rates detailed in sub sections (ii)&#160;and (iii)&#160;shall apply), (ii)&#160;Israeli resident&#160;individuals
- 20%&#160;and&#160;(iii)&#160;non-Israeli&#160;residents (individuals and corporations) - subject to the receipt in advance of a valid
certificate from the ITA allowing for a reduced tax rate, 20% or such lower rate as may be provided under the provisions of any applicable
double tax treaty.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We currently do not intend
to implement the 2011 Amendment.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 97; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><i>Tax benefits under
the 2017 Amendment that became effective on January&#160;1, 2017</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The 2017 Amendment was
enacted as part of the Economic Efficiency Law that was published on December&#160;29, 2016, and is effective as of January&#160;1, 2017.
The 2017 Amendment provided new tax benefits for two types of &#8220;Technological Enterprises,&#8221; as described below, and is in addition
to the other existing tax beneficial programs under the Investment Law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The 2017 Amendment provides
that a technology company satisfying certain conditions should qualify as a Preferred Technological Enterprise, or PTE, and thereby enjoy
a reduced corporate tax rate of 12% on income that qualifies as &#8220;Preferred Technological Income&#8221;, as defined in the Investment
Law. The tax rate is further reduced to 7.5% for a PTE located in development zone &#8220;A&#8221;. In addition, a PTE will enjoy a reduced
corporate tax rate of 12% on capital gain derived from the sale of certain &#8220;Benefited Intangible Assets&#8221; (as defined in the
Investment Law) to a related foreign company if the Benefited Intangible Assets were acquired from a foreign company on or after January&#160;1,
2017 for at least NIS 200&#160;million, and the sale received prior approval from the National Authority for Technological Innovation
previously known as the Israeli Office of the Chief Scientist), to which we refer as IIA.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The 2017 Amendment further
provides that a technology company satisfying certain conditions (group turnover of at least NIS 10 billion) should qualify as a &#8220;Special
Preferred Technological Enterprise&#8221; and will thereby enjoy a reduced corporate tax rate of 6% on &#8220;Preferred Technological
Income&#8221; regardless of the company&#8217;s geographic location within Israel. In addition, a Special Preferred Technological Enterprise
should enjoy a reduced corporate tax rate of 6% on capital gain derived from the sale of certain &#8220;Benefited Intangible Assets&#8221;
to a related foreign company if the Benefited Intangible Assets were either developed by the Special Preferred Enterprise or acquired
from a foreign company on or after January&#160;1, 2017, and the sale received prior approval from IIA. A Special Preferred Technological
Enterprise that acquires Benefited Intangible Assets from a foreign company for more than NIS 500&#160;million should be eligible for
these benefits for at least ten years, subject to certain approvals as specified in the Investment Law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="background-color: white">Dividends
distributed out of Preferred Technological Income to Israeli shareholders by a PTE or a Special Preferred Technology Enterprise, paid
out of Preferred Technological Income, should generally subject to withholding tax at source at the rate of 20% (in the case of&#160;non-Israeli&#160;shareholders,
a lower rate may be provided in an applicable tax treaty) but in either case, subject to the receipt in advance of a valid certificate
from the ITA allowing for a reduced tax rate. However, if such dividends are paid to an Israeli company, no tax is generally required
to be withheld (although, if such dividends are subsequently distributed to individuals or a&#160;non-Israeli&#160;company, withholding
tax at a rate of 20% or such lower rate as may be provided in an applicable tax treaty, should apply). If such dividends are distributed
to a foreign company that holds solely or together with other foreign companies 90% or more in the Israeli company and other conditions
are met, the withholding tax rate should be 4% (or such lower rate as may be provided in an applicable tax treaty, in either case, subject
to the receipt in advance of a valid certificate from the ITA allowing for such reduced tax rate).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="background-color: white">We
are examining the potential impact of the 2017 Amendment and the degree to which we may qualify as a PTE, the amount of Preferred Technological
Income that we may have and other benefits that we may receive from the 2017 Amendment in the future.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Taxation of our Shareholders</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="background-color: white"><i>Capital
Gains Taxes Applicable to Non-Israeli Resident Shareholders</i>. A non-Israeli resident who derives capital gains from the sale of shares
in an Israeli resident company will be exempt from Israeli tax so long as the shares were not held through a permanent establishment that
the non-resident maintains in Israel. However, non-Israeli corporations will not be entitled to the foregoing exemption if Israeli residents:
(i) have a controlling interest of 25% or more in such non-Israeli corporation or (ii) are the beneficiaries of, or are entitled to, 25%
or more of the revenues or profits of such non-Israeli corporation, whether directly or indirectly.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 98; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="background-color: white">Additionally,
a sale of securities by a non-Israeli resident may be exempt from Israeli capital gains tax under the provisions of an applicable tax
treaty. For example, under Convention Between the Government of the United States of America and the Government of the State of Israel
with respect to Taxes on Income, as amended, or the United States-Israel Tax Treaty, the sale, exchange or other disposition of shares
by a shareholder who is a United States resident (for purposes of the treaty) holding the shares as a capital asset and is entitled to
claim the benefits afforded to such a resident by the U.S.- Israel Tax Treaty, or a Treaty U.S. Resident, is generally exempt from Israeli
capital gains tax unless: (i) the capital gain arising from such sale, exchange or disposition is attributed to real estate located in
Israel; (ii) the capital gain arising from such sale, exchange or disposition is attributed to royalties; (iii) the capital gain arising
from the such sale, exchange or disposition is attributed to a permanent establishment in Israel, under certain terms; (iv) such Treaty
U.S. Resident holds, directly or indirectly, shares representing 10% or more of the voting capital during any part of the 12-month period
preceding the disposition, subject to certain conditions; or (v) such Treaty U.S. Resident is an individual and was present in Israel
for 183 days or more during the relevant taxable year.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="background-color: white">In
some instances where our shareholders may be liable for Israeli tax on the sale of their Ordinary Shares, the payment of the consideration
may be subject to the withholding of Israeli tax at source. Shareholders may be required to demonstrate that they are exempt from tax
on their capital gains in order to avoid withholding at source at the time of sale.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="background-color: white"><i>Taxation
of Non-Israeli Shareholders on Receipt of Dividends</i>. Non-Israeli residents are generally subject to Israeli income tax on the receipt
of dividends paid on our Ordinary Shares at the rate of 25%, which tax will be withheld at source, unless relief is provided in a treaty
between Israel and the shareholder&#8217;s country of residence. With respect to a person who is a &#8220;substantial shareholder&#8221;
at the time of receiving the dividend or at any time during the preceding twelve months, the applicable tax rate is 30%. A &#8220;substantial
shareholder&#8221; is generally a person who alone or together with such person&#8217;s relative or another person who collaborates with
such person on a permanent basis, holds, directly or indirectly, at least 10% of any of the &#8220;means of control&#8221; of the corporation
at the time of receiving the dividend or at any time during the preceding twelve months. &#8220;Means of control&#8221; generally include
the right to vote, receive profits, nominate a director or an executive officer, receive assets upon liquidation, or order someone who
holds any of the aforesaid rights how to act, regardless of the source of such right. However, a distribution of dividends to non-Israeli
residents is subject to withholding tax at source at a rate of 20% if the dividend is distributed from income attributed to a Preferred
Enterprise or PTE, unless a reduced tax rate is provided under an applicable tax treaty. For example, under the United States-Israel Tax
Treaty, the maximum rate of tax withheld at source in Israel on dividends paid to a holder of our Ordinary Shares who is a Treaty U.S.
Resident is 25%. However, generally, the maximum rate of withholding tax on dividends, not generated by a Preferred Enterprise or PTE,
that are paid to a United States corporation holding 10% or more of the outstanding voting capital throughout the tax year in which the
dividend is distributed as well as during the previous tax year, is 12.5%, provided that not more than 25% of the gross income for such
preceding year consists of certain types of dividends and interest. Notwithstanding the foregoing, dividends distributed from income attributed
to an Preferred Enterprise or PTE are not entitled to such reduction under the tax treaty but are subject to a withholding tax rate of
15% for a shareholder that is a U.S. corporation, provided that the condition related to our gross income for the previous year (as set
forth in the previous sentence) is met. If the dividend is attributable partly to income derived from a Preferred Enterprise or PTE, and
partly to other sources of income, the withholding rate will be a blended rate reflecting the relative portions of the two types of income.
We cannot assure you that we will designate the profits that we may distribute in a way that will reduce shareholders&#8217; tax liability.</span>
&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>U.S. Federal Income Tax Considerations</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">THE FOLLOWING SUMMARY IS INCLUDED HEREIN FOR GENERAL
INFORMATION AND IS NOT INTENDED TO BE, AND SHOULD NOT BE CONSIDERED TO BE, LEGAL OR TAX ADVICE. EACH U.S. HOLDER SHOULD CONSULT WITH HIS
OR HER OWN TAX ADVISOR AS TO THE PARTICULAR U.S. FEDERAL INCOME TAX CONSEQUENCES OF THE PURCHASE, OWNERSHIP AND SALE OF ORDINARY SHARES,
<span style="text-transform: uppercase">the Warrants, and the Ordinary Shares issued or issuable upon exercise of the Warrants</span>,
INCLUDING THE EFFECTS OF APPLICABLE STATE, LOCAL, FOREIGN OR OTHER TAX LAWS AND POSSIBLE CHANGES IN THE TAX LAWS.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 99; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Subject to the limitations described in the next
paragraph, the following discussion summarizes the material U.S. federal income tax consequences to a &#8220;U.S. Holder&#8221; arising
from the purchase, ownership and sale of the Ordinary Shares, the Warrants, and the Ordinary Shares issued or issuable upon exercise of
the Warrants, collectively, the &#8220;securities&#8221;. For this purpose, a &#8220;U.S. Holder&#8221; is a holder of Ordinary Shares
that is: (1) an individual citizen or resident of the United States, including an alien individual who is a lawful permanent resident
of the United States or meets the substantial presence residency test under U.S. federal income tax laws; (2) a corporation (or entity
treated as a corporation for U.S. federal income tax purposes) or a partnership (other than a partnership that is not treated as a U.S.
person under any applicable U.S. Treasury regulations) created or organized under the laws of the United States or the District of Columbia
or any political subdivision thereof; (3) an estate, the income of which is includable in gross income for U.S. federal income tax purposes
regardless of source; (4) a trust if a court within the United States is able to exercise primary supervision over the administration
of the trust and one or more U.S. persons have authority to control all substantial decisions of the trust; or (5) a trust that has a
valid election in effect to be treated as a U.S. person to the extent provided in U.S. Treasury regulations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This summary is for general information purposes
only and does not purport to be a comprehensive description of all of the U.S. federal income tax considerations that may be relevant
to a decision to purchase our securities. This summary generally considers only U.S. Holders that will own our securities as capital assets.
Except to the limited extent discussed below, this summary does not consider the U.S. federal tax consequences to a person that is not
a U.S. Holder, nor does it describe the rules applicable to determine a taxpayer&#8217;s status as a U.S. Holder. This summary is based
on the provisions of the Internal Revenue Code of 1986, as amended, or the Code, final, temporary and proposed U.S. Treasury regulations
promulgated thereunder, administrative and judicial interpretations thereof, (including with respect to the Tax Cuts and Jobs Act of 2017),
and the U.S.-Israel Income Tax Treaty, all as in effect as of the date hereof and all of which are subject to change, possibly on a retroactive
basis, and all of which are open to differing interpretations. We will not seek a ruling from the IRS with regard to the U.S. federal
income tax treatment of an investment in our securities by U.S. Holders and, therefore, can provide no assurances that the IRS will agree
with the conclusions set forth below.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This discussion does not address all of the aspects
of U.S. federal income taxation that may be relevant to a particular U.S. holder based on such holder&#8217;s particular circumstances
and in particular does not discuss any estate, gift, generation-skipping, transfer, state, local, excise or foreign tax considerations.
In addition, this discussion does not address the U.S. federal income tax treatment of a U.S. Holder who is: (1) a bank, life insurance
company, regulated investment company, or other financial institution or &#8220;financial services entity;&#8221; (2) a broker or dealer
in securities or foreign currency; (3) a person who acquired our securities in connection with employment or other performance of services;
(4) a U.S. Holder that is subject to the U.S. alternative minimum tax; (5) a U.S. Holder that holds our securities as a hedge or as part
of a hedging, straddle, conversion or constructive sale transaction or other risk-reduction transaction for U.S. federal income tax purposes;
(6) a tax-exempt entity; (7) real estate investment trusts or grantor trusts; (8) a U.S. Holder that expatriates out of the United States
or a former long-term resident of the United States; or (9) a person having a functional currency other than the U.S. dollar. This discussion
does not address the U.S. federal income tax treatment of a U.S. Holder that owns, directly or constructively, at any time, securities
representing 10% or more of our voting power. Additionally, the U.S. federal income tax treatment of partnerships (or other pass-through
entities) or persons who hold securities through a partnership or other pass-through entity are not addressed.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each prospective investor is advised to consult
his or her own tax adviser for the specific tax consequences to that investor of purchasing, holding or disposing of our securities, including
the effects of applicable state, local, foreign or other tax laws and possible changes in the tax laws.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="background-color: white"><b><i>Exercise
or Expiry of Warrants</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">No gain or loss will be realized on the exercise
of a Warrant. When a Warrant is exercised, the U.S. Holder&#8217;s cost of the common share acquired thereby will be equal to the U.S.
Holder&#8217;s adjusted cost basis of the Warrant plus the exercise price paid for the common share. The expiry of an unexercised Warrant
will generally give rise to a capital loss equal to the adjusted cost basis to the U.S. Holder of the expired Warrant. The holding period
of the common share acquired thru the exercise of a Warrant includes the holding period of the Warrant.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 100; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="background-color: white"><b><i>Taxation
of Dividends Paid on Securities</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We do not intend to pay dividends in the foreseeable
future and U.S. Holders of Warrants are not entitled to dividends. In the event that we do pay dividends, and subject to the discussion
under the heading &#8220;Passive Foreign Investment Companies&#8221; below and the discussion of &#8220;qualified dividend income&#8221;
below, a U.S. Holder, other than certain U.S. Holder&#8217;s that are U.S. corporations, will be required to include in gross income as
ordinary income the amount of any distribution paid on securities (including distributions paid on Warrants if such warrants were to become
entitled to dividends and the amount of any Israeli tax withheld on the date of the distribution), to the extent that such distribution
does not exceed our current and accumulated earnings and profits, as determined for U.S. federal income tax purposes. The amount of a
distribution which exceeds our earnings and profits will be treated first as a non-taxable return of capital, reducing the U.S. Holder&#8217;s
tax basis for the securities to the extent thereof, and then capital gain. We do not expect to maintain calculations of our earnings and
profits under U.S. federal income tax principles and, therefore, U.S. Holders should expect that the entire amount of any distribution
generally will be reported as dividend income.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In general, preferential tax rates for &#8220;qualified
dividend income&#8221; and long-term capital gains are applicable for U.S. Holders that are individuals, estates or trusts. For this purpose,
&#8220;qualified dividend income&#8221; means, inter alia, dividends received from a &#8220;qualified foreign corporation.&#8221; A &#8220;qualified
foreign corporation&#8221; is a corporation that is entitled to the benefits of a comprehensive tax treaty with the United States which
includes an exchange of information program. The IRS has stated that the U.S.-Israel Tax Treaty satisfies this requirement and we believe
we are eligible for the benefits of that treaty.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition, our dividends will be qualified dividend
income if our securities are readily tradable on the Nasdaq Capital Market or another established securities market in the United States.
Dividends will not qualify for the preferential rate if we are treated, in the year the dividend is paid or in the prior year, as a PFIC,
as described below under &#8220;Passive Foreign Investment Companies.&#8221; A U.S. Holder will not be entitled to the preferential rate:
(1) if the U.S. Holder has not held our securities for at least 61 days of the 121 day period beginning on the date which is 60 days before
the ex-dividend date, or (2) to the extent the U.S. Holder is under an obligation to make related payments on substantially similar property.
Any days during which the U.S. Holder has diminished its risk of loss on our securities are not counted towards meeting the 61-day holding
period. Finally, U.S. Holders who elect to treat the dividend income as &#8220;investment income&#8221; pursuant to Code section 163(d)(4)
will not be eligible for the preferential rate of taxation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The amount of a distribution with respect to our
securities will be measured by the amount of the fair market value of any property distributed, and for U.S. federal income tax purposes,
the amount of any Israeli taxes withheld therefrom. Cash distributions paid by us in NIS will be included in the income of U.S. Holders
at a U.S. dollar amount based upon the spot rate of exchange in effect on the date the dividend is includible in the income of the U.S.
Holder, and U.S. Holders will have a tax basis in such NIS for U.S. federal income tax purposes equal to such U.S. dollar value. If the
U.S. Holder subsequently converts the NIS into U.S. dollars or otherwise disposes of it, any subsequent gain or loss in respect of such
NIS arising from exchange rate fluctuations will be U.S. source ordinary exchange gain or loss.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="background-color: white"><b><i>Taxation
of the Disposition of Securities</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Except as provided under the PFIC rules described
below under &#8220;Passive Foreign Investment Companies,&#8221; upon the sale, exchange or other disposition of our securities, a U.S.
Holder will recognize capital gain or loss in an amount equal to the difference between such U.S. Holder&#8217;s tax basis for the securities
in U.S. dollars and the amount realized on the disposition in U.S. dollar (or its U.S. dollar equivalent determined by reference to the
spot rate of exchange on the date of disposition, if the amount realized is denominated in a foreign currency). The gain or loss realized
on the sale, exchange or other disposition of securities will be long-term capital gain or loss if the U.S. Holder has a holding period
of more than one year at the time of the disposition. Individuals who recognize long-term capital gains may be taxed on such gains at
reduced rates of tax. The deduction of capital losses is subject to various limitations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="background-color: white"><b><i>Passive
Foreign Investment Companies</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Special U.S. federal income tax laws apply to U.S.
taxpayers who own shares of a corporation that is a PFIC. We will be treated as a PFIC for U.S. federal income tax purposes for any taxable
year that either:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">75% or more of our gross income (including our pro rata share of gross income for any company, in which we are considered to own 25% or more of the shares by value), in a taxable year is passive; or</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 101; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At least 50% of our assets, averaged over the year and generally determined based upon fair market value (including our pro rata share of the assets of any company in which we are considered to own 25% or more of the shares by value) are held for the production of, or produce, passive income.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For this purpose, passive income generally consists
of dividends, interest, rents, royalties, annuities and income from certain commodities transactions and from notional principal contracts.
Cash is treated as generating passive income.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Based on the projected composition of our income
and valuation of our assets, we cannot determine if we will become a PFIC for 2023 or in the future. The tests for determining PFIC status
are applied annually, and it is difficult to make accurate projections of future income and assets which are relevant to this determination.
In addition, our PFIC status may depend in part on the market value of our securities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If we currently are or become a PFIC, each U.S.
Holder who has not elected to mark the shares to market (as discussed below), would, upon receipt of certain distributions by us and upon
disposition of our securities at a gain:&#160;(1) have such distribution or gain allocated ratably over the U.S. Holder&#8217;s holding
period for the securities, as the case may be; (2) the amount allocated to the current taxable year and any period prior to the first
day of the first taxable year in which we were a PFIC would be taxed as ordinary income; and (3) the amount allocated to each of the other
taxable years would be subject to tax at the highest rate of tax in effect for the applicable class of taxpayer for that year, and an
interest charge for the deemed deferral benefit would be imposed with respect to the resulting tax attributable to each such other taxable
year. In addition, when shares of a PFIC are acquired by reason of death from a decedent that was a U.S. Holder, the tax basis of such
shares would not receive a step-up to fair market value as of the date of the decedent&#8217;s death, but instead would be equal to the
decedent&#8217;s basis if lower, unless all gain were recognized by the decedent. Indirect investments in a PFIC may also be subject to
these special U.S. federal income tax rules.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The PFIC rules described above would not apply
to a U.S. Holder who makes a QEF election for all taxable years that such U.S. Holder has held the securities while we are a PFIC, provided
that we comply with specified reporting requirements. Instead, each U.S. Holder who has made such a QEF election is required for each
taxable year that we are a PFIC to include in income such U.S. Holder&#8217;s pro rata share of our ordinary earnings as ordinary income
and such U.S. Holder&#8217;s pro rata share of our net capital gains as long-term capital gain, regardless of whether we make any distributions
of such earnings or gain. In general, a QEF election is effective only if we make available certain required information. The QEF election
is made on a shareholder-by-shareholder basis and generally may be revoked only with the consent of the IRS. We do not intend to notify
U.S. Holders if we believe we will be treated as a PFIC for any tax year. In addition, we do not intend to furnish U.S. Holders annually
with information needed in order to complete IRS Form 8621 and to make and maintain a valid QEF election for any year in which we or any
of our subsidiaries are a PFIC. Therefore, the QEF election will not be available with respect to our securities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition, the PFIC rules described above would
not apply if we were a PFIC and a U.S. Holder made a mark-to-market election. A U.S. Holder of our securities which are regularly traded
on a qualifying exchange, including the Nasdaq Capital Market, can elect to mark the securities to market annually, recognizing as ordinary
income or loss each year an amount equal to the difference as of the close of the taxable year between the fair market value of the securities
and the U.S. Holder&#8217;s adjusted tax basis in the securities. Losses are allowed only to the extent of net mark-to-market gain previously
included income by the U.S. Holder under the election for prior taxable years.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">U.S. Holders who hold our securities during a period
when we are a PFIC will be subject to the foregoing rules, even if we cease to be a PFIC. U.S. Holders are strongly urged to consult their
tax advisors about the PFIC rules.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="background-color: white"><b>Tax
on Net Investment Income</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">U.S. Holders who are individuals, estates or trusts
will generally be required to pay a 3.8% Medicare tax on their net investment income (including dividends on and gains from the sale or
other disposition of our securities), or in the case of estates and trusts on their net investment income that is not distributed. In
each case, the 3.8% Medicare tax applies only to the extent the U.S. Holder&#8217;s total adjusted income exceeds applicable thresholds.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 102; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="background-color: white"><b><i>Information
Reporting and Withholding</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A U.S. Holder may be subject to backup withholding
at a rate of 24% with respect to cash dividends and proceeds from a disposition of securities. In general, backup withholding will apply
only if a U.S. Holder fails to comply with specified identification procedures. Backup withholding will not apply with respect to payments
made to designated exempt recipients, such as corporations and tax-exempt organizations. Backup withholding is not an additional tax and
may be claimed as a credit against the U.S. federal income tax liability of a U.S. Holder, provided that the required information is timely
furnished to the IRS.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to recently enacted legislation,
a U.S. Holder with interests in &#8220;specified foreign financial assets&#8221; (including, among other assets, our securities, unless
such securities are held on such U.S. Holder&#8217;s behalf through a financial institution) may be required to file an information report
with the IRS if the aggregate value of all such assets exceeds $50,000 on the last day of the taxable year or $75,000 at any time during
the taxable year (or such higher dollar amount as may be prescribed by applicable IRS guidance); and may be required to file a Report
of Foreign Bank and Financial Accounts if the aggregate value of the foreign financial accounts exceeds $10,000 at any time during the
calendar year. You should consult your own tax advisor as to the possible obligation to file such information report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_051"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>F. Dividends and Paying Agents</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_052"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>G. Statement by Experts</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_053"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>H. Documents on Display</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are subject to certain information reporting
requirements of the Exchange Act, applicable to foreign private issuers and under those requirements will file reports with the SEC. The
SEC maintains an Internet website that contains reports and other information regarding issuers that file electronically with the SEC.
Our filings with the SEC will also available to the public through the SEC&#8217;s website at www.sec.gov.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As a foreign private issuer, we are exempt from
the rules under the Exchange Act related to the furnishing and content of proxy statements, and our officers, directors and principal
shareholders will be exempt from the reporting and short-swing profit recovery provisions contained in Section 16 of the Exchange Act.
In addition, we are not required under the Exchange Act to file annual, quarterly and current reports and financial statements with the
SEC as frequently or as promptly as U.S. domestic companies whose securities are registered under the Exchange Act. However, we will file
with the SEC, within 120 days after the end of each fiscal year, or such applicable time as required by the SEC, an annual report containing
financial statements audited by an independent registered public accounting firm, and may submit to the SEC, on a Form 6-K, unaudited
half-yearly financial information.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We maintain a corporate website <i>www.mudra-band.com</i>.
Information contained on, or that can be accessed through, our website and the other websites referenced above do not constitute a part
of this annual report. We have included these website addresses in this annual report solely as inactive textual references.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_054"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>I. Subsidiary Information</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_055"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>J. Annual Report to Security Holders</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 103; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_056"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are exposed to market risks in the ordinary
course of our business. <span style="background-color: white">Market risk represents the risk of loss that may impact </span>our <span style="background-color: white">financial
position due to adverse changes in financial market prices and rates.</span> Our market risk exposure is primarily the result of <span style="background-color: white">foreign
currency exchange rates</span>.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white"><b><i>Foreign Currency Exchange
Risk</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Currency Fluctuations</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our reporting currency and the functional currency
is the U.S. dollar. Our funding was in U.S. dollars and our sales are currently denominated in U.S. dollars. Our operating expenses are
denominated mainly in NIS, and therefore, our NIS denominated operating expenses are currently subject to foreign currency risk. To date,
we have been affected by changes in the rate of inflation and NIS currency compared to the U.S. dollar, as shown below.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The NIS devaluated against the U.S. dollar by approximately
3.1% in 2023 and devaluated against the U.S. dollar by approximately 13.2% in 2022.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A decrease of 10% in the U.S. dollar/NIS exchange
rate would have increased our cost of revenues and operating expenses by approximately $580 thousand and $366 thousand, for the years
ended December 31, 2023 and 2022, respectively. If the NIS fluctuates significantly against the U.S. dollar, it may have a negative impact
on our results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">During the&#160;year ended December&#160;31, 2022
we did not hedge our foreign currency exchange risk. During the year ended December 31, 2023, we partially hedged our foreign currency
exchange risk. If we were to determine that it is in our best interests to continue hedging transactions in the future in order to protect
ourselves in part from currency fluctuations, we may not be able to do so, or such transactions, if entered into, may not materially reduce
the effect of fluctuations in foreign currency exchange rates on our results of operations and may result in additional expenses.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We cannot assure you that we will not be adversely
affected by currency fluctuations in the future.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_057"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_058"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>A. Debt Securities.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_059"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>B. Warrants and rights.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_060"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>C. Other Securities</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_061"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>D. American Depositary Shares</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 104; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->98<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="a_062"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PART II</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><div><a id="a_063"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">None.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_064"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS
AND USE OF PROCEEDS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with the IPO (including a partial
exercise of over-allotment option), the Company issued and sold 3,750,000 Ordinary Shares and 8,625,000 Warrants and received aggregate
gross proceeds of approximately $16 million, before deducting underwriting discounts, commissions and offering expenses.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The net proceeds from
IPO have been used, and are expected to continue to be used, as described in the final prospectus for the IPO filed with the SEC on September
15, 2022.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_065"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 15. CONTROLS AND PROCEDURES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>(a) Disclosure Controls and Procedures</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We maintain disclosure controls and procedures
designed to provide reasonable assurance that information required to be disclosed in reports filed under the Exchange Act is recorded,
processed, summarized and reported within the specified time periods and accumulated and communicated to our management, including our
Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our management, with the participation of our Chief
Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as such term
is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of December 31, 2023, or the Evaluation Date. Based on such evaluation,
those officers have concluded that, as of the Evaluation Date, our disclosure controls and procedures were effective.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>(b) Management&#8217;s Annual Report on Internal Control over Financial
Reporting</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Our management is responsible
for establishing and maintaining adequate internal control over our financial reporting.&#160; Internal control over financial reporting
is defined in Rule 13a-15(f) or 15d-15(f) promulgated under the Exchange Act as a process designed by, or under the supervision of, the
Company&#8217;s principal executive and principal financial officers and effected by the Company&#8217;s board of directors, management
and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures
that:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td><span style="font-family: Times New Roman, Times, Serif">pertain to the maintenance of records that in reasonable detail accurately
and fairly reflect the transactions and dispositions of the assets of the Company;</span></td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td><span style="font-family: Times New Roman, Times, Serif">provide reasonable assurance that transactions are recorded as necessary
to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures
of the Company are being made only in accordance with authorizations of management and directors of the Company; and</span></td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td><span style="font-family: Times New Roman, Times, Serif">provide reasonable assurance regarding prevention or timely detection of
unauthorized acquisition, use or disposition of the Company&#8217;s assets that could have a material effect on our financial statements.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Because of its inherent
limitations, internal control over financial reporting may not prevent or detect misstatements.&#160; Projections of any evaluation of
effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that
the degree of compliance with the policies or procedures may deteriorate.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 105; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Our management assessed
the effectiveness of our internal control over financial reporting as of December 31, 2023.&#160; In making this assessment, our management
used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control-Integrated
Framework.&#160; Based on that assessment, our management concluded that as of December 31, 2023, our internal control over financial
reporting is effective.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>(c) Attestation Report of the Registered Public Accounting Firm</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This annual report does not include a report of
management&#8217;s assessment regarding internal control over financial reporting or an attestation report of the company&#8217;s registered
public accounting firm due to a transition period established by rules of the SEC for newly public companies and due to an exemption for
emerging growth companies under the JOBS Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>(d) Changes in Internal Control over Financial Reporting</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">During the year ended December 31, 2023, we completed
the process of documenting our internal control procedures to satisfy the requirements of Section 404(a) of the Sarbanes-Oxley Act, which
requires an annual management assessment of the effectiveness of our internal control over financial reporting. We have established formal
policies, processes and practices related to our internal control over financial reporting and to identify key financial reporting risks,
including an assessment of the potential impact and linkage of those risks to specific areas and activities within our organization.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 106; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->100<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_066"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 16. [RESERVED]</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_067"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 16. A. AUDIT COMMITTEE FINANCIAL EXPERT</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our board of directors has determined that Mr.
Goldman is an audit committee financial expert as such term is defined by the SEC rules and has the requisite financial experience as
defined by the Nasdaq Rules. Each of the members of our audit committee is &#8220;independent&#8221; as such term is defined in Rule 10A-3(b)(1)
under the Exchange Act and satisfies the independent director requirements under the Nasdaq Rules.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_068"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM&#160;16 B. CODE OF ETHICS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Code of Business Conduct and Ethics</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have adopted a written Code of Business Ethics
that applies to our officers and employees, including the Chief Executive Officer, President, Chief Financial Officer, Principal Executive
Officer, Principal Financial Officer, Principal Accounting Officer, Controller and persons performing similar functions, as well as our
directors. Our Code of Business Ethics is posted on our website at <span style="background-color: white">www.wearabledevices.co.il</span>.
Information contained on, or that can be accessed through, our website does not constitute a part of this annual report on Form 20-F and
is not incorporated by reference herein. If we make any amendment to the Code of Business Ethics or grant any waivers, including any implicit
waiver, from a provision of the code, we will disclose the nature of such amendment or waiver on our website to the extent required by
the rules and regulations of the SEC including the instructions to Item 16B of Form 20-F. Any waiver of this Code for any Covered Person
may be made only by the Board or the Audit Committee and will be promptly disclosed to stockholders and others, as required by applicable
law. The Company must disclose changes to and waivers of the Code in accordance with applicable law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_069"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM&#160;16 C. PRINCIPAL ACCOUNTANT FEES AND SERVICES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Pre-Approval of Auditors&#8217; Compensation</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Ziv Haft, Certified Public Accountants, Isr., BDO
Member Firm, an independent registered public accounting firm, has served as our principal independent registered public accounting firm
for each of the two years ended December 31, 2023 and 2022.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table provides information regarding
fees paid by us to Ziv Haft, Certified Public Accountants, Isr., BDO Member Firm, an independent registered public accounting firm, including
audit services, for the years ended December 31, 2023 and 2022.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year Ended<br/> December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit fees&#160;<sup>(1)</sup></span></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">136,000</td><td style="padding-bottom: 2pt; width: 1%; text-align: left"><sup>(3)</sup></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">100,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Audit-related fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,000</td><td style="padding-bottom: 2pt; text-align: left"><sup>(2)</sup></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Tax fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,500</td><td style="padding-bottom: 2pt; text-align: left"><sup>(4)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">All other fees</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">138,500</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">112,000</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
professional services rendered in connection with the audit of our annual financial statements, review of our interim financial statements
and tax returns.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
professional services rendered in connection with the fees which were required for the purpose of the IPO process.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
$36,000 for professional services rendered in connection with the fees which were required for the purpose of registration statements
related to the follow-on public offering completed by the Company in November 2023.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">(4)</td><td style="text-align: left">Includes professional services rendered in connection with
a VAT audit.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 107; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->101<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Pre-Approval of Auditors&#8217; Compensation</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Our audit committee charter
provides that one of the audit committee&#8217;s duties is to pre-approve audit and non-audit services provided to us by the independent
registered public accounting firm. The audit committee shall also review and approve disclosures relating to fees and non-audit services
required to be included in our SEC reports. Subject to our board of directors and shareholders approval (if and to the extent required
by applicable law), the audit committee shall have the authority to approve all audit engagement fees and terms and all non-audit engagements,
as may be permissible, with the independent registered public accounting firm.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">All services provided
by our auditors are approved in advance by our audit committee.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_070"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 16 D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_071"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 16 E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED
PURCHASERS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_072"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 16 F. CHANGE IN REGISTRANT&#8217;S CERTIFYING ACCOUNTANT</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_073"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 16 G. CORPORATE GOVERNANCE</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Sarbanes-Oxley Act, as well as related rules
subsequently implemented by the SEC, require foreign private issuers, such as us, to comply with various corporate governance practices.
In addition, following the listing of the Ordinary Shares on Nasdaq, we will be required to comply with the Nasdaq Stock Market Listing
Rules. Under those rules, we may elect to follow certain corporate governance practices permitted under the Companies Law in lieu of compliance
with corresponding corporate governance requirements otherwise imposed by the Nasdaq Stock Market Listing Rules for U.S. domestic issuers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In accordance with Israeli law and practice and
subject to the exemption set forth in Rule 5615 of the Nasdaq Stock Market Listing Rules, we have elected to follow the provisions of
the Companies Law, rather than the Nasdaq Stock Market Listing Rules, with respect to the following requirements:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Quorum</i>. While the Nasdaq Stock Market Listing Rules require that the quorum for purposes of any meeting of the holders of a listed company&#8217;s common voting stock, as specified in the company&#8217;s bylaws, be no less than 33 1/3% of the company&#8217;s outstanding common voting stock, under Israeli law, a company is entitled to determine in its articles of association the number of shareholders and percentage of holdings required for a quorum at a shareholders meeting. The Companies Law provides that a quorum of two or more shareholders holding at least 25% of the voting rights in person or by proxy is required for commencement of business at a general meeting. However, the quorum set forth in our articles of association with respect to an adjourned meeting consists of at least any shareholders present in person or by proxy.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#9679;</i></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Nomination of our directors.</i> With the exception of directors elected by our board of directors and external directors, our directors are elected by an annual meeting of our shareholders (i) to hold office until the next annual meeting following his or her election or (ii) for a three-year term. The nominations for directors, which are presented to our shareholders by our board of directors, are generally made by the board of directors itself, in accordance with the provisions of our amended and restated articles of association and the Companies Law. Nominations need not be made by a nominating committee of our board of directors consisting solely of independent directors, as required under the Nasdaq rules.</span></td></tr>
</table><div>

</div><p style="margin: 0">&#160;</p><div>

</div><p style="margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 108; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->102<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Compensation of officers.</i> Israeli law and our articles of association do not require that the independent members of our board of directors (or a compensation committee composed solely of independent members of our board of directors) determine an executive officer&#8217;s compensation, as is generally required under the Nasdaq Stock Market Listing Rules with respect to the chief executive officer and all other executive officers. Instead, compensation of executive officers is determined and approved by our compensation committee and our board of directors, and in certain circumstances by our shareholders, either in consistency with our office holder compensation policy or, in special circumstances in deviation therefrom, taking into account certain considerations stated in the Companies Law (see &#8220;Item 6.C.Board Practices &#8212; Approval of Related Party Transactions under Israeli Law&#8221; for additional information).</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#9679;</i></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Independent directors.</i>&#160;Israeli law does not require that a majority of the directors serving on our board of directors be &#8220;independent,&#8221; as defined under Nasdaq Listing Rule&#160;5605(a)(2), and rather requires we have at least two external directors, if applicable, who meet the requirements of the Companies Law, as described above under &#8220;Management&#8212;Board Practices&#8212;External Directors.&#8221; We are required, however, to ensure that all members of our Audit Committee are &#8220;independent&#8221; under the applicable Nasdaq and SEC criteria for independence (as we cannot exempt ourselves from compliance with that SEC independence requirement, despite our status as a foreign private issuer), and we must also ensure that a majority of the members of our Audit Committee are &#8220;independent directors&#8221; as defined in the Companies Law. We have established an Audit Committee and appointed independent directors compliant with applicable rules. Furthermore, Israeli law does not require, nor do our independent directors conduct, regularly scheduled meetings at which only they are present, which the Nasdaq rules otherwise require.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholder approval.</i> We will seek shareholder approval for all corporate actions requiring such approval under the requirements of the Companies Law, rather than seeking approval for corporation actions in accordance with Nasdaq Listing Rule 5635. In particular, under this Nasdaq listing rule, shareholder approval is generally required for: (i) an acquisition of shares/assets of another company that involves the issuance of 20% or more of the acquirer&#8217;s shares or voting rights or if a director, officer or 5% shareholder has greater than a 5% interest in the target company or the consideration to be received; (ii) the issuance of shares leading to a change of control; (iii) adoption/amendment of equity compensation arrangements (although under the provisions of the Companies Law there is no requirement for shareholder approval for the adoption/amendment of the equity compensation plan); and (iv) issuances of 20% or more of the shares or voting rights (including securities convertible into, or exercisable for, equity) of a listed company via a private placement (and/or via sales by directors/officers/5% shareholders) if such equity is issued (or sold) at below the greater of the book or market value of shares. By contrast, under the Companies Law, shareholder approval is required for, among other things: (i) transactions with directors concerning the terms of their service or indemnification, exemption and insurance for their service (or for any other position that they may hold at a company), for which approvals of the compensation committee, board of directors and shareholders are all required, (ii) extraordinary transactions with controlling shareholders of publicly held companies, which require the special approval, and (iii) terms of employment or other engagement of the controlling shareholder of us or such controlling shareholder&#8217;s relative, which require special approval. In addition, under the Companies Law, a merger requires approval of the shareholders of each of the merging companies.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Approval of Related Party Transactions</i>. All related party transactions are approved in accordance with the requirements and procedures for approval of interested party acts and transaction as set forth in the Companies Law, which requires the approval of the audit committee, or the compensation committee, as the case may be, the board of directors and shareholders, as may be applicable, for specified transactions, rather than approval by the audit committee or other independent body of our board of directors as required under the Nasdaq Stock Market Listing Rules (see &#8220;Management &#8212; Board Practices &#8212; Approval of Related Party Transactions under Israeli Law&#8221; for additional information).</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Annual Shareholders Meeting. </i>As opposed to the Nasdaq listing Rule 5620(a), which mandates that a listed company hold its annual shareholders meeting within one year of the company&#8217;s fiscal year-end, we are required, under the Companies Law, to hold an annual shareholder meeting each calendar year and within 15 months of the last annual shareholders meeting.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Distribution of periodic reports to shareholders; proxy solicitation. </i>As opposed to the Nasdaq Stock Market Listing Rules, which require listed issuers to make such reports available to shareholders in one of a number of specific manners, Israeli law does not require us to distribute periodic reports directly to shareholders, and the generally accepted business practice in Israel is not to distribute such reports to shareholders but to make such reports available through a public website. In addition to making such reports available on a public website, we currently make our audited financial statements available to our shareholders at our offices and will only mail such reports to shareholders upon request. As a foreign private issuer, we are generally exempt from the SEC&#8217;s proxy solicitation rules.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 109; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->103<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_074"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 16 H. MINE SAFETY DISCLOSURE</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_075"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 16 I. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT
INSPECTIONS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_076"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM 16 J. INSIDER TRADING POLICIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="a_077"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM 16 K. CYBERSECURITY.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our Board recognizes the
critical importance of maintaining the trust and confidence of our customers, clients, business partners and employees. The audit committee
is involved in oversight of our IT general controls and cybersecurity. Our IT general controls cybersecurity policies, standards, processes
and practices are fully integrated into our risk management program. In general, we seek to address IT general controls cybersecurity
risks through a comprehensive, cross-functional approach that is focused on preserving the confidentiality, security and availability
of the information that we collect and store by identifying, preventing and mitigating cybersecurity threats and effectively responding
to cybersecurity incidents when they occur.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risk Management and Strategy</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As part of the critical elements
of our overall risk management approach, our cybersecurity program is focused on the following key areas:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Governance: As discussed in more detail under
the heading &#8220;Governance,&#8221; the audit committee oversees our cybersecurity risk management and interacts with the Company&#8217;s
Sarbanes-Oxley Act, or SOX, advisor and the Company&#8217;s Information Security advisor and other relevant members of management.</span></td></tr></table><div>

</div><p style="text-align: left; margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="text-align: left; width: 0.5in"/><td style="text-align: left; width: 0.25in">&#9679;</td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Collaborative Approach: The Company has implemented
a comprehensive, cross-functional approach to identifying, preventing and mitigating cybersecurity threats and incidents, while also implementing
controls and procedures that provide for the prompt escalation of certain cybersecurity incidents so that decisions regarding the public
disclosure and reporting of such incidents can be made by management in a timely manner.</span></td></tr></table><div>

</div><p style="text-align: left; margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="text-align: left; width: 0.5in"/><td style="text-align: left; width: 0.25in">&#9679;</td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Technical Safeguards: The Company deploys technical
safeguards that are designed to protect the Company&#8217;s information systems from cybersecurity threats, including firewalls, intrusion
prevention and detection systems, anti-malware functionality and access controls, which are evaluated and improved through vulnerability
assessments and cybersecurity threat intelligence.</span></td></tr></table><div>

</div><p style="text-align: left; margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="text-align: left; width: 0.5in"/><td style="text-align: left; width: 0.25in">&#9679;</td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Recovery Planning: The Company has established
and maintains comprehensive recovery plans that fully address the Company&#8217;s response to a cybersecurity incident, and such plans
are tested and evaluated on a regular basis.</span></td></tr></table><div>

</div><p style="text-align: left; margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="text-align: left; width: 0.5in"/><td style="text-align: left; width: 0.25in">&#9679;</td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Education and Awareness: The Company provides
regular, mandatory training for personnel regarding cybersecurity threats as a means to equip the Company&#8217;s personnel with effective
tools to address cybersecurity threats, and to communicate the Company&#8217;s evolving information security policies, standards, processes
and practices.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 110; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->104<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We engage in the periodic
assessment and testing of our policies, standards, processes and practices that are designed to address cybersecurity threats and incidents.
These efforts include a wide range of activities, including audits, assessments, tabletop exercises, threat modeling, vulnerability testing,
and other exercises focused on evaluating the effectiveness of our cybersecurity measures and planning. We are engaged with a subcontractor
that monitors the IT system and cybersecurity, as part of their routine job functions. We regularly engage third parties to perform assessments
on our cybersecurity measures, including information security maturity assessments, audits and independent reviews of our information
security control environment and operating effectiveness. The results of such assessments, audits and reviews are reported to the Board,
and we adjust our cybersecurity policies, standards, processes and practices as necessary based on the information provided by these assessments,
audits and reviews. .</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Governance</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The audit committee interacts
with the Company&#8217;s SOX advisor and the Company&#8217;s Information Security advisor and other relevant members of management. <span style="background-color: white">The
Company&#8217;s Information</span> Security advisor <span style="background-color: white">is responsible for assessing and managing cyber
risk management, informs senior management regarding the prevention, detection, mitigation, and remediation of cybersecurity incidents
and supervises such efforts. The Company&#8217;s Information</span> Security advisor <span style="background-color: white">has experience
selecting, deploying, and operating cybersecurity technologies, initiatives, and processes, and relies on threat intelligence as well
as other information obtained from governmental, public or private sources.</span> The audit committee receives updates on IT general
controls, and&#160;a set of policies and procedures that govern how the Company&#8217;s IT systems operate and ensure the confidentiality, integrity,
and availability of data as well as on cybersecurity risks, including prevention of data theft, unauthorized access, operational disruption,
and data breaches. The audit committee also receives prompt and timely information regarding any cybersecurity incident that meets established
reporting thresholds, as well as ongoing updates regarding any such incident until it has been addressed. On an annual basis, the audit
committee discusses our approach to IT general controls and cybersecurity risk management with the Company&#8217;s SOX advisor.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As of the date of this annual
report, we do not believe that we have experienced any cybersecurity attack. Cybersecurity threats and cybersecurity incidents, if they
occur, can materially affect or are reasonably likely to affect the Company, including its business strategy, results of operations or
financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 111; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->105<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><div><a id="a_078"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PART III</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><div><a id="a_079"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 17. FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have elected to provide financial statements
and related information pursuant to Item 18.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="a_080"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 18. FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The financial statements and the related notes
required by this Item are included in this annual report beginning on page F-1.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="a_081"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 19. EXHIBITS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following documents are filed as part of this
annual report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; width: 9%; border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number</b></span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top; width: 90%; border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit Description</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1887673/000121390022012239/ea156798ex3-2_wearable.htm">Amended and Restated Articles of Association of Wearable Devices Ltd. (filed as Exhibit 3.2 to Form F-1 (File No. 333-262838) filed on September 8, 2022 and incorporated herein by reference).</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1887673/000121390022054088/ea164883ex4-4_wearabledev.htm">Form of Warrant (filed as Exhibit 4.4 to F-1 (File No. 333-262838) filed on September 8, 2022 and incorporated herein by reference).</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1887673/000121390022018390/ea157448ex4-1_wearable.htm">Form of Underwriter&#8217;s Warrant (filed as Exhibit 4.1 to Form F-1 (File No. 333-262838) filed on September 8, 2022 and incorporated herein by reference).</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3*</span></td>
    <td>&#160;</td>
    <td><a href="ea020095201ex2-3_wearable.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description of Securities.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1887673/000121390022012239/ea156798ex10-1_wearable.htm">Form of Indemnification Agreement (filed as Exhibit 10.1 to Form F-1 (File No. 333-262838) filed on September 8, 2022 and incorporated herein by reference).</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1887673/000121390022019279/ea158314ex4-3_wearable.htm">Form of Warrant Agent Agreement (filed as Exhibit 4.3 to Form F-1 (File No. 333-262838) filed on September 8, 2022 and incorporated herein by reference ).</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1887673/000121390022008340/ea155863ex10-2_wearable.htm">Wearable Devices Ltd. 2015 Share Option Plan (filed as Exhibit 10.2 to Form F-1 (File No. 333-262838) filed on September 8, 2022 and incorporated herein by reference ).</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1887673/000121390023072128/ea184450ex10-1_wearable.htm">First Amendment to Wearable Devices Ltd. 2015 Share Option Plan (filed as Exhibit 10.1 to Form 6-K (File No. 001-41502) filed on August 31, 2023 and incorporated herein by reference).</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5#</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1887673/000121390022018390/ea157448ex10-4_wearable.htm">Agreement, dated July 16, 2020, by and between Wearable Devices Ltd. and the Israeli Innovation Authority (filed as Exhibit 10.4 to Form F-1 (File No. 333-262838) filed on September 8, 2022 and incorporated herein by reference).</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1887673/000121390022012239/ea156798ex10-5_wearable.htm">Compensation Policy (filed as Exhibit 10.5 to Form F-1 (File No. 333-262838) filed on September 8, 2022 and incorporated herein by reference).</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1887673/000121390022040341/ea163052ex10-6_wearabledev.htm">Senior Credit Facility Agreement, dated July 4, 2022, by and between Wearable Devices Ltd. and L.I.A. Pure Capital Ltd (filed as Exhibit 10.6 to Form F-1 (File No. 333-262838) filed on September 8, 2022 and incorporated herein by reference).</a></span></td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 112; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->106<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1887673/000121390022040341/ea163052ex10-8_wearabledev.htm">First Addendum to Senior Agreement, dated July 19, 2022, by and between Wearable Devices Ltd. and L.I.A. Pure Capital Ltd (filed as Exhibit 10.8 to Form F-1 (File No. 333-262838) filed on September 8, 2022 and incorporated herein by reference).</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1887673/000121390022008340/ea155863ex21-1_wearable.htm">List of Subsidiaries (filed as Exhibit 21.1 to Form F-1 (File No. 333-262838) filed on September 8, 2022 and incorporated herein by reference).</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.1*</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea020095201ex12-1_wearable.htm">Certification of the Principal Executive Officer pursuant to rule 13a-14(a) of the Securities Exchange Act of 1934.</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.2*</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea020095201ex12-2_wearable.htm">Certification of the Principal Financial and Accounting Officer pursuant to rule 13a-14(a) of the Securities Exchange Act of 1934.</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.1%</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea020095201ex13-1_wearable.htm">Certification of the Principal Executive Officer pursuant to 18 U.S.C. 1350.</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2%</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea020095201ex13-2_wearable.htm">Certification of the Principal Financial and Accounting Officer pursuant to 18 U.S.C. 1350.</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.1*</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea020095201ex15-1_wearable.htm">Consent of Ziv Haft, Certified Public Accountants, Isr. BDO member firm, an independent registered public accounting firm.</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97.1*</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea020095201ex97-1_wearable.htm">Clawback Policy</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following financial information from the Registrant&#8217;s Annual Report on Form 20-F for the year ended December 31, 2023, formatted in Inline XBRL (eXtensible Business Reporting Language): (i) Consolidated Balance Sheets; (ii) Consolidated Statements of Comprehensive Loss; (iii) Statements of Changes in Shareholders&#8217; Equity (Deficit); (iv) Consolidated Statements of Cash Flows; and (v) Notes to Consolidated Financial Statements.</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed herewith.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furnished herewith</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"># </span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain identified information in the exhibit has been excluded from the exhibit because it is both (i) not material and (ii) is the type that Wearable Devices Ltd. treats as private or confidential.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 113; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->107<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_082"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The registrant hereby certifies that it meets all
of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this annual report on Form
20-F filed on its behalf.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Wearable Devices Ltd.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%">&#160;</td>
    <td style="width: 5%">&#160;</td>
    <td style="width: 35%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: March 15, 2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="white-space: nowrap; border-bottom: black 1.5pt solid">/s/ <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asher Dahan</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asher Dahan</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><!-- Field: Page; Sequence: 114; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->108<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>INDEX
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: top; width: 88%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 12%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif"><a href="#fin_001">Report of Independent Registered Public Accounting Firm (BDO Ziv Haft: Tel Aviv, Israel: PCAOB ID#<ix:nonNumeric contextRef="c0" name="dei:AuditorFirmId" id="ixv-18832">1185</ix:nonNumeric>)</a></span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2</span></td></tr> <tr style="background-color: White"> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif"><a href="#fin_002">Consolidated Balance Sheets</a></span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-3</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif"><a href="#fin_003">Consolidated Statements of Comprehensive Loss</a></span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-4</span></td></tr> <tr style="background-color: White"> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif"><a href="#fin_004">Statements of Changes in Shareholders&#8217; Equity (Deficit)</a></span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif"><a href="#fin_005">Consolidated Statements of Cash Flows</a></span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-7</span></td></tr> <tr style="background-color: White"> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif"><a href="#fin_006">Notes to Consolidated Financial Statements</a></span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-8 to F-24</span></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


    </div><!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><img alt="" src="image_006.jpg"/></span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="fin_001"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><b><span style="text-decoration:underline">REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Shareholders
and Board of Directors<br/>
of WEARABLE DEVICES LTD.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Opinion
on the Consolidated Financial Statements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We
have audited the accompanying consolidated balance sheets of Wearable Devices Ltd. and its subsidiary (&#8220;the Company&#8221;) as
of December&#160;31, 2023 and 2022, and the related consolidated statements of comprehensive loss, changes in shareholders&#8217; equity
(deficit) and cash flows for each of the three&#160;years in the period ended December 31, 2023, and the related notes (collectively,
the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material
respects, the financial position of the Company as of December&#160;31, 2023 and 2022, and the results of its operations and its cash
flows for each of the three&#160;years in the period ended December&#160;31, 2023, in conformity with accounting principles generally
accepted in the United States of America.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>Going
Concern</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying consolidated financial statements
have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1d to the consolidated financial statements,
the Company is still in a transition phase from its development stage to an early stage of generating revenues, and therefore, it has
suffered recurring losses and negative cash flows from operations since inception. As of December 31, 2023, the Company had incurred accumulated
losses of $21.2 million. The Company&#8217;s operations have been funded substantially through issuance of shares and warrants and Israeli
governmental grants. Considering the above, the Company&#8217;s dependency on external funding for its operations raises a substantial
doubt about the Company&#8217;s ability to continue as a going concern. Management&#8217;s evaluation of the events and conditions and
management&#8217;s plans regarding these matters are described in Note 1d. The consolidated financial statements do not include any adjustments
that might result from the outcome of these uncertainties.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Basis
for Opinion</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">These
consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion
on the Company&#8217;s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public
Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;), and we are required to be independent with respect to the Company
in accordance with the United States federal securities laws and the applicable rules and regulations of the Securities and Exchange
Commission and the PCAOB.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud.
The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part
of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing
an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Our
audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether
due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence
regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles
used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements.
We believe that our audits provide a reasonable basis for our opinion.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="border-bottom: black 1.5pt solid; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ <ix:nonNumeric contextRef="c0" name="dei:AuditorName" id="ixv-18833">Ziv Haft</ix:nonNumeric></span></td> <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ziv Haft</span></td> <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certified Public Accountants (Isr.)</span></td> <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BDO Member Firm</span></td> <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">We have served
as the Company&#8217;s auditor since 2021.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">March 13, 2024<br/>
<ix:nonNumeric contextRef="c0" name="dei:AuditorLocation" id="ixv-18834">Tel Aviv, Israel</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><img alt="" src="image_007.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 3; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="fin_002"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>WEARABLE
DEVICES LTD. AND ITS SUBSIDIARY</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 78.7pt 0pt 64.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">CONSOLIDATED
BALANCE SHEETS</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">December
    31</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2023</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2022</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">U.S.
    dollars<br/> in thousands</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Assets</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">CURRENT
    ASSETS:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cash
    and cash equivalents</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" unitRef="usd" id="ixv-18835">810</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" unitRef="usd" id="ixv-18836">10,373</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Short
    term bank deposits</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepositsAssetsCurrent" scale="3" unitRef="usd" id="ixv-18837">4,045</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-0; font-family: Times New Roman, Times, Serif">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Governmental
    grant receivable</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrantsReceivable" scale="3" unitRef="usd" id="ixv-18838">108</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrantsReceivable" scale="3" unitRef="usd" id="ixv-18839">54</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other
    receivables and prepaid expenses</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" unitRef="usd" id="ixv-18840">757</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" unitRef="usd" id="ixv-18841">543</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Inventories
    (Note 3)</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FIFOInventoryAmount" scale="3" unitRef="usd" id="ixv-18842">1,032</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FIFOInventoryAmount" scale="3" unitRef="usd" id="ixv-18843">6</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">TOTAL
    CURRENT ASSETS</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" unitRef="usd" id="ixv-18844">6,752</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" unitRef="usd" id="ixv-18845">10,976</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">NON-CURRENT
    ASSETS:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Long-term
    bank deposits</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepositsAssetsNoncurrent" scale="3" unitRef="usd" id="ixv-18846">54</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-1; font-family: Times New Roman, Times, Serif">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Right-of-use
    assets (Note 5)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" unitRef="usd" id="ixv-18847">592</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" unitRef="usd" id="ixv-18848">180</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Property
    and equipment, net (Note 4)</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd" id="ixv-18849">194</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd" id="ixv-18850">68</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">TOTAL
    NON-CURRENT ASSETS</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsNoncurrent" scale="3" unitRef="usd" id="ixv-18851">840</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsNoncurrent" scale="3" unitRef="usd" id="ixv-18852">248</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">TOTAL
    ASSETS</span></td>
    <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" unitRef="usd" id="ixv-18853">7,592</ix:nonFraction></span></td>
    <td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" unitRef="usd" id="ixv-18854">11,224</ix:nonFraction></span></td>
    <td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Liabilities
    and Shareholders&#8217; Equity</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">CURRENT
    LIABILITIES:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accounts
    payable</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="3" unitRef="usd" id="ixv-18855">410</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="3" unitRef="usd" id="ixv-18856">156</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Advance
    payments</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="wlds:AdvanceFromCustomers" scale="3" unitRef="usd" id="ixv-18857">312</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="wlds:AdvanceFromCustomers" scale="3" unitRef="usd" id="ixv-18858">353</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred
    revenues</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-2; font-family: Times New Roman, Times, Serif">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredRevenueCurrent" scale="3" unitRef="usd" id="ixv-18859">12</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accrued
    payroll and other employment related accruals</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-18860">579</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-18861">416</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accrued
    expenses</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-18862">190</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-18863">145</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Lease
    liabilities</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" unitRef="usd" id="ixv-18864">297</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" unitRef="usd" id="ixv-18865">68</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">TOTAL
    CURRENT LIABILITIES</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-18866">1,788</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-18867">1,150</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Lease
    liabilities</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" unitRef="usd" id="ixv-18868">278</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" unitRef="usd" id="ixv-18869">94</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">TOTAL
    LIABILITIES</span></td>
    <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="3" unitRef="usd" id="ixv-18870">2,066</ix:nonFraction></span></td>
    <td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="3" unitRef="usd" id="ixv-18871">1,244</ix:nonFraction></span></td>
    <td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>COMMITMENTS
    AND CONTINGENCIES</b> <span style="font-size: 10pt; font-variant: normal">(Note 6)</span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-3"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-4"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>SHAREHOLDERS&#8217;
    EQUITY</b> (Note 9):</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Ordinary shares, NIS <ix:nonFraction contextRef="c4" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="ilsPershares" id="ixv-18872"><ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="ilsPershares" id="ixv-18873">0.01</ix:nonFraction></ix:nonFraction> par value: Authorized <ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-18874"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-18875">50,000,000</ix:nonFraction></ix:nonFraction> as of December 31, 2023 and December 31, 2022; Issued and outstanding <ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-18876"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-18877">20,387,428</ix:nonFraction></ix:nonFraction> shares as of December 31, 2023 and <ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-18878"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-18879">15,049,720</ix:nonFraction></ix:nonFraction> shares as of December 31, 2022</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockValue" scale="3" unitRef="usd" id="ixv-18880">57</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockValue" scale="3" unitRef="usd" id="ixv-18881">43</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Additional
    paid-in capital</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="3" unitRef="usd" id="ixv-18882">26,692</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="3" unitRef="usd" id="ixv-18883">23,346</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Accumulated
    losses</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" sign="-" unitRef="usd" id="ixv-18884">21,223</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" sign="-" unitRef="usd" id="ixv-18885">13,409</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">TOTAL
    SHAREHOLDERS&#8217; EQUITY</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-18886">5,526</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-18887">9,980</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">TOTAL
    LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</span></td>
    <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" unitRef="usd" id="ixv-18888">7,592</ix:nonFraction></span></td>
    <td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" unitRef="usd" id="ixv-18889">11,224</ix:nonFraction></span></td>
    <td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">The
accompanying notes are an integral part of the consolidated financial statements.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 78.85pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>


</div><!-- Field: Page; Sequence: 4; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="fin_003"></a></div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>WEARABLE
DEVICES LTD. AND ITS SUBSIDIARY</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">CONSOLIDATED
STATEMENTS OF COMPREHENSIVE LOSS</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Year
    ended December 31</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2023</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2022</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2021</span></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif"><b>U.S.
    dollars<br/>  in thousands <br/>
    (except per share amounts)</b></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Revenues</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-18890">82</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-18891">45</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-18892">142</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Expenses:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Cost of revenues</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostDirectMaterial" scale="3" unitRef="usd" id="ixv-18893">62</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostDirectMaterial" scale="3" unitRef="usd" id="ixv-18894">10</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostDirectMaterial" scale="3" unitRef="usd" id="ixv-18895">10</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Research and development,
    net (Note 6a)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" unitRef="usd" id="ixv-18896">3,316</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" unitRef="usd" id="ixv-18897">2,271</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" unitRef="usd" id="ixv-18898">1,411</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Sales and marketing expenses,
    net (Note 6b)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingAndMarketingExpense" scale="3" unitRef="usd" id="ixv-18899">2,008</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingAndMarketingExpense" scale="3" unitRef="usd" id="ixv-18900">1,370</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingAndMarketingExpense" scale="3" unitRef="usd" id="ixv-18901">665</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">General and administrative
    expenses</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" unitRef="usd" id="ixv-18902">2,882</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" unitRef="usd" id="ixv-18903">1,948</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" unitRef="usd" id="ixv-18904">628</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Initial
    public offering expenses</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-5; font-family: Times New Roman, Times, Serif">-</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wlds:ProspectiveInitialPublicOfferingExpenses" scale="3" unitRef="usd" id="ixv-18905">904</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="wlds:ProspectiveInitialPublicOfferingExpenses" scale="3" unitRef="usd" id="ixv-18906">97</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">OPERATING LOSS</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-18907">8,186</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-18908">6,458</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-18909">2,669</ix:nonFraction></span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>FINANCING
    INCOME (EXPENSES),</b> net</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wlds:InterestExpenseAndExchangeRate" scale="3" unitRef="usd" id="ixv-18910">372</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wlds:InterestExpenseAndExchangeRate" scale="3" sign="-" unitRef="usd" id="ixv-18911">38</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="wlds:InterestExpenseAndExchangeRate" scale="3" unitRef="usd" id="ixv-18912">55</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">NET
    LOSS <span style="font-size: 10pt">AND TOTAL COMPREHENSIVE LOSS</span></span></td>
    <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-18913">7,814</ix:nonFraction></span></td>
    <td style="padding-bottom: 2pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-18914">6,496</ix:nonFraction></span></td>
    <td style="padding-bottom: 2pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-18915">2,614</ix:nonFraction></span></td>
    <td style="padding-bottom: 2pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt"><span style="-sec-ix-hidden: hidden-fact-8; -sec-ix-hidden: hidden-fact-7; -sec-ix-hidden: hidden-fact-6; font-family: Times New Roman, Times, Serif">Net loss per ordinary shares, basic and diluted</span></td>
    <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-18916">0.48</ix:nonFraction></span></td>
    <td style="padding-bottom: 2pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c6" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-18917">0.53</ix:nonFraction></span></td>
    <td style="padding-bottom: 2pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
    <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-18918">0.27</ix:nonFraction></span></td>
    <td style="padding-bottom: 2pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt"><span style="-sec-ix-hidden: hidden-fact-11; -sec-ix-hidden: hidden-fact-10; -sec-ix-hidden: hidden-fact-9; font-family: Times New Roman, Times, Serif">Weighted average number of ordinary shares outstanding basic and diluted *</span></td>
    <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" id="ix_0_fact" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares">16,201,238</ix:nonFraction></span></td>
    <td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" id="ix_1_fact" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares">12,277,224</ix:nonFraction></span></td>
    <td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" id="ix_2_fact" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares">9,709,590</ix:nonFraction></span></td>
    <td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify"><ix:footnote id="ix_0_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In April 2021, the Company completed a 1:1 conversion of all of its issued and outstanding ordinary A shares into ordinary shares, NIS 0.01 par value, which was applied retroactively for the calculation of the basic and diluted loss per share.</span></ix:footnote></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">The
accompanying notes are an integral part of the consolidated financial statements.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 78.85pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>


</div><!-- Field: Page; Sequence: 5; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="fin_004"></a></div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>WEARABLE
DEVICES LTD. AND ITS SUBSIDIARY</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">CONSOLIDATED
STATEMENTS OF CHANGES IN SHAREHOLDERS&#8217; EQUITY (DEFICIT)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Ordinary
    shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Ordinary
    A shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Subscription<br/>
    receivables</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Additional</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number<br/>
    of shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number<br/>
    of shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(ordinary<br/>
    shares)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">paid-in<br/>
    capital</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Accumulated<br/>
    losses</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">U.S.&#160;dollars<br/>
    in&#160;thousands</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
                                                                                                                              <td colspan="18" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>U.S.
                                            dollars in thousands</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 32%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">BALANCE
    AS OF DECEMBER 31, 2020</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-18922">4,626,572</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-18923">12</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c9" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-18924">1,844,268</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;<ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-18925">5</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;(<ix:nonFraction contextRef="c10" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-18926">12</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-18927">1,406</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-18928">4,299</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-18929">2,888</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">CHANGES
    DURING THE YEAR 2021:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Issuance
    of ordinary shares and warrants, net of issuance cost</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c14" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" scale="0" unitRef="shares" id="ixv-18930">1,343,375</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="wlds:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost" scale="3" unitRef="usd" id="ixv-18931">4</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-12; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-13; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c17" decimals="-3" format="ixt:num-dot-decimal" name="wlds:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost" scale="3" unitRef="usd" id="ixv-18932">2,921</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-14; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="wlds:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost" scale="3" unitRef="usd" id="ixv-18933">2,925</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Conversion
    of convertible securities (including accrued interest) to ordinary shares</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c14" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" unitRef="shares" id="ixv-18934">3,081,102</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" unitRef="usd" id="ixv-18935">9</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-15; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-16; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c17" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" unitRef="usd" id="ixv-18936">3,063</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-17; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" unitRef="usd" id="ixv-18937">3,072</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Conversion
    of ordinary A shares to ordinary shares</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c14" decimals="INF" format="ixt:num-dot-decimal" name="wlds:ConversionOfOrdinaryASharesToOrdinaryShares" scale="0" unitRef="shares" id="ixv-18938">1,844,268</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="wlds:ConversionOfOrdinaryASharesToOrdinarySharesValue" scale="3" unitRef="usd" id="ixv-18939">5</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c15" decimals="INF" format="ixt:num-dot-decimal" name="wlds:ConversionOfOrdinaryASharesToOrdinaryShares" scale="0" sign="-" unitRef="shares" id="ixv-18940">1,844,268</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="wlds:ConversionOfOrdinaryASharesToOrdinarySharesValue" scale="3" sign="-" unitRef="usd" id="ixv-18941">5</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-18; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-19; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-20; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-21; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Share-based
    compensation</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-22; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-23; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-24; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c17" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-18942">299</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-25; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-18943">299</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Exercise of options</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c14" decimals="INF" format="ixt:num-dot-decimal" name="wlds:StockIssuedDuringPeriodShareOfExerciseOfOptionsinShares" scale="0" unitRef="shares" id="ixv-18944">241,533</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" unitRef="usd" id="ixv-18945">1</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-26; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-27; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-28; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-29; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" unitRef="usd" id="ixv-18946">1</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Payment
    on behalf of issued shares</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-30; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-31; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c16" decimals="-3" format="ixt:num-dot-decimal" name="wlds:StockIssuedDuringPeriodValueOfPaymentOnBehalfOfSharesIssued" scale="3" unitRef="usd" id="ixv-18947">12</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-32; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-33; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="wlds:StockIssuedDuringPeriodValueOfPaymentOnBehalfOfSharesIssued" scale="3" unitRef="usd" id="ixv-18948">12</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Comprehensive
    loss</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-34; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-35; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-36; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-37; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c18" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" sign="-" unitRef="usd" id="ixv-18949">2,614</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" sign="-" unitRef="usd" id="ixv-18950">2,614</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">BALANCE
    AS OF DECEMBER 31, 2021</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c19" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-18951">11,136,850</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-18952">31</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-38; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-39; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-18953">7,689</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-18954">6,913</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c24" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-18955">807</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify"><ix:footnote id="ix_1_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represent an amount less than $500</span></ix:footnote></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">The
accompanying notes are an integral part of the consolidated financial statements.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 6; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>WEARABLE
DEVICES LTD. AND ITS SUBSIDIARY</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">CONSOLIDATED
STATEMENTS OF CHANGES IN SHAREHOLDERS&#8217; EQUITY (DEFICIT)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Ordinary
    shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 1.5pt; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Number
    <br/>
    of shares</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Additional<br/>
    paid-in<br/>
    capital</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Accumulated
    losses</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">U.S.
    dollars <br/>
    in thousands</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 40%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">BALANCE
    AS OF DECEMBER 31, 2021</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c19" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-18956">11,136,850</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-18957">31</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-18958">7,689</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-18959">6,913</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c24" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-18960">807</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">CHANGES
    DURING THE YEAR 2022:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Issuance of units of ordinary shares and warrants in connection with the initial public offering, net of issuance expenses of $<ix:nonFraction contextRef="c6" decimals="-2" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" unitRef="usd" id="ixv-18961">1.6</ix:nonFraction> million</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c25" decimals="INF" format="ixt:num-dot-decimal" name="wlds:IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares" scale="0" unitRef="shares" id="ixv-18962">3,750,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c25" decimals="-3" format="ixt:num-dot-decimal" name="wlds:IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet" scale="3" unitRef="usd" id="ixv-18963">11</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="wlds:IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet" scale="3" unitRef="usd" id="ixv-18964">14,308</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-40; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wlds:IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet" scale="3" unitRef="usd" id="ixv-18965">14,319</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Conversion
    of SAFEs into ordinary shares upon completion of initial public offering</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c25" decimals="INF" format="ixt:num-dot-decimal" name="wlds:ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering" scale="0" unitRef="shares" id="ixv-18966">118,204</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c25" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" unitRef="usd" id="ixv-18967">1</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" unitRef="usd" id="ixv-18968">399</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-41; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" unitRef="usd" id="ixv-18969">400</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Issuance of ordinary
    shares as a result of exercise of warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c25" decimals="INF" format="ixt:num-dot-decimal" name="wlds:IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrantsinShares" scale="0" unitRef="shares" id="ixv-18970">40,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-42; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">*</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="wlds:IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" scale="3" unitRef="usd" id="ixv-18971">160</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-43; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wlds:IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" scale="3" unitRef="usd" id="ixv-18972">160</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Exercise of options</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c25" decimals="INF" format="ixt:num-dot-decimal" name="wlds:StockIssuedDuringPeriodShareOfExerciseOfOptionsinShares" scale="0" unitRef="shares" id="ixv-18973">4,666</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-44; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">*</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-45; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-46; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-47; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Share-based
    compensation</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-48; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-18974">790</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-49; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-18975">790</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Comprehensive
    loss</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-50; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-51; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c27" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" sign="-" unitRef="usd" id="ixv-18976">6,496</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" sign="-" unitRef="usd" id="ixv-18977">6,496</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">BALANCE
    AS OF DECEMBER 31, 2022</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c28" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-18978">15,049,720</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c28" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-18979">43</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c29" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-18980">23,346</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c30" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-18981">13,409</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-18982">9,980</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>

<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">CHANGES
    DURING THE YEAR 2023:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Shares
    issued in the public offering, net of issuance cost</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c31" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-18983">4,444,444</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c31" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" unitRef="usd" id="ixv-18984">11</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c32" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" unitRef="usd" id="ixv-18985">1,659</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" unitRef="usd" id="ixv-18986">1,670</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Issuance
    of shares <span style="font-size: 10pt">to April 2021 investors (Note 7)</span></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c31" decimals="INF" format="ixt:num-dot-decimal" name="wlds:StockIssuedDuringPeriodSharesInvestors" scale="0" unitRef="shares" id="ixv-18987">169,125</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c31" decimals="-3" format="ixt:num-dot-decimal" name="wlds:StockIssuedDuringPeriodValueInvestors" scale="3" unitRef="usd" id="ixv-18988">1</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><p style="margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c32" decimals="-3" format="ixt:num-dot-decimal" name="wlds:StockIssuedDuringPeriodValueInvestors" scale="3" sign="-" unitRef="usd" id="ixv-18989">1</ix:nonFraction>)</span></p></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Exercise of warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c31" decimals="INF" format="ixt:num-dot-decimal" name="wlds:StockIssuedDuringPeriodSharesExerciseOfWarrants" scale="0" unitRef="shares" id="ixv-18990">724,139</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c31" decimals="-3" format="ixt:num-dot-decimal" name="wlds:StockIssuedDuringPeriodValueExerciseOfWarrants" scale="3" unitRef="usd" id="ixv-18991">2</ix:nonFraction> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c32" decimals="-3" format="ixt:num-dot-decimal" name="wlds:StockIssuedDuringPeriodValueExerciseOfWarrants" scale="3" unitRef="usd" id="ixv-18992">1,447</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wlds:StockIssuedDuringPeriodValueExerciseOfWarrants" scale="3" unitRef="usd" id="ixv-18993">1,449</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Share-based
    compensation</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c32" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-18994">241</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-18995">241</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Comprehensive
    loss</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c33" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" sign="-" unitRef="usd" id="ixv-18996">7,814</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" sign="-" unitRef="usd" id="ixv-18997">7,814</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 4pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">BALANCE
    AS OF DECEMBER 31, 2023</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c34" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-18998">20,387,428</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c34" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-18999">57</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c35" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-19000">26,692</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c36" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-19001">21,223</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-19002">5,526</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represent an amount less than $500</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">The
accompanying notes are an integral part of the consolidated financial statements.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 7; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="fin_005"></a></div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>WEARABLE
DEVICES LTD. AND ITS SUBSIDIARY</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">CONSOLIDATED
STATEMENTS OF CASH FLOWS</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Year
    ended December 31</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>U.S.
                                            dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>in
                                            thousands</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">CASH
    FLOWS FROM OPERATING ACTIVITIES:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; width: 64%; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Net
    loss</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-19003">7,814</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-19004">6,496</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-19005">2,614</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Adjustments
    required to reconcile net loss to net cash used in operating activities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.375in"><span style="font-family: Times New Roman, Times, Serif">Depreciation</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="3" unitRef="usd" id="ixv-19006">68</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="3" unitRef="usd" id="ixv-19007">23</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="3" unitRef="usd" id="ixv-19008">11</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.375in"><span style="font-family: Times New Roman, Times, Serif">Accrued
    interest on convertible securities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-52; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-53; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="wlds:AccruedInterestOnConvertibleSecurities" scale="3" unitRef="usd" id="ixv-19009">20</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.375in"><span style="font-family: Times New Roman, Times, Serif">Accrued
    interest on deposits</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wlds:AccruedInterestOnDeposits" scale="3" sign="-" unitRef="usd" id="ixv-19010">45</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-54; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-55; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.375in"><span style="font-family: Times New Roman, Times, Serif">Share
    based compensation expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-19011">241</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-19012">790</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-19013">299</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.375in"><span style="font-family: Times New Roman, Times, Serif">Unrealized
    gain <span style="font-size: 10pt">from foreign currency derivative activities</span></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" scale="3" unitRef="usd" id="ixv-19014">68</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-56; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-57; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Changes
    in operating assets and liabilities items:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.375in"><span style="font-family: Times New Roman, Times, Serif">Decrease
    (increase) in accounts receivable</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-58; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" sign="-" unitRef="usd" id="ixv-19015">8</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" unitRef="usd" id="ixv-19016">8</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.375in"><span style="font-family: Times New Roman, Times, Serif">Decrease
    (increase) in inventories</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" unitRef="usd" id="ixv-19017">1,026</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" sign="-" unitRef="usd" id="ixv-19018">5</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" sign="-" unitRef="usd" id="ixv-19019">9</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.375in"><span style="font-family: Times New Roman, Times, Serif">Decrease
    (increase) in governmental grants receivables</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wlds:DecreaseincreaseInGovernmentalGrantsReceivables" scale="3" unitRef="usd" id="ixv-19020">54</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wlds:DecreaseincreaseInGovernmentalGrantsReceivables" scale="3" sign="-" unitRef="usd" id="ixv-19021">8</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="wlds:DecreaseincreaseInGovernmentalGrantsReceivables" scale="3" unitRef="usd" id="ixv-19022">11</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.375in"><span style="font-family: Times New Roman, Times, Serif">Increase
    in other receivables and prepaid expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wlds:IncreaseInOtherReceivablesAndPrepaidExpenses" scale="3" unitRef="usd" id="ixv-19023">136</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wlds:IncreaseInOtherReceivablesAndPrepaidExpenses" scale="3" unitRef="usd" id="ixv-19024">496</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="wlds:IncreaseInOtherReceivablesAndPrepaidExpenses" scale="3" unitRef="usd" id="ixv-19025">30</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.375in"><span style="font-family: Times New Roman, Times, Serif">Increase
    (decrease) in advance payments</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wlds:IncreaseDecreaseInAdvancePayments" scale="3" sign="-" unitRef="usd" id="ixv-19026">41</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wlds:IncreaseDecreaseInAdvancePayments" scale="3" unitRef="usd" id="ixv-19027">79</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="wlds:IncreaseDecreaseInAdvancePayments" scale="3" unitRef="usd" id="ixv-19028">63</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.375in"><span style="font-family: Times New Roman, Times, Serif">Increase
    (decrease) in deferred revenues</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" sign="-" unitRef="usd" id="ixv-19029">12</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" sign="-" unitRef="usd" id="ixv-19030">12</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" unitRef="usd" id="ixv-19031">9</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.375in"><span style="font-family: Times New Roman, Times, Serif">Increase
    in accounts payable</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" unitRef="usd" id="ixv-19032">254</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" unitRef="usd" id="ixv-19033">84</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" unitRef="usd" id="ixv-19034">40</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.375in"><span style="font-family: Times New Roman, Times, Serif">Increase
    in accrued payroll and other employment related accruals</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="3" unitRef="usd" id="ixv-19035">163</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="3" unitRef="usd" id="ixv-19036">194</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="3" unitRef="usd" id="ixv-19037">119</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.375in"><span style="font-family: Times New Roman, Times, Serif">Decrease
    in advance payments on governmental grant</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-59; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-60; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="wlds:IncreaseDecreaseInAdvancePaymentsOnGovernmentalGrant" scale="3" unitRef="usd" id="ixv-19038">42</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.375in"><span style="font-family: Times New Roman, Times, Serif">Increase
    in accrued expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" unitRef="usd" id="ixv-19039">36</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" unitRef="usd" id="ixv-19040">99</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" unitRef="usd" id="ixv-19041">32</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.375in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Net
    cash used in operating activities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" sign="-" unitRef="usd" id="ixv-19042">8,434</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" sign="-" unitRef="usd" id="ixv-19043">5,714</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" sign="-" unitRef="usd" id="ixv-19044">2,103</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">CASH
    FLOWS FROM INVESTING ACTIVITIES:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Purchase
    of property and equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" unitRef="usd" id="ixv-19045">194</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" unitRef="usd" id="ixv-19046">48</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" unitRef="usd" id="ixv-19047">36</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Investment
    in deposits, net</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireRestrictedCertificatesOfDeposit" scale="3" unitRef="usd" id="ixv-19048">4,054</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-61; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-62; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-bottom: 1.5pt; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Prepayments
    of leasing</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-63; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wlds:PrepaymentsOfLeasing" scale="3" unitRef="usd" id="ixv-19049">18</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-64; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Net
    cash used in investing activities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" sign="-" unitRef="usd" id="ixv-19050">4,248</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" sign="-" unitRef="usd" id="ixv-19051">66</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" sign="-" unitRef="usd" id="ixv-19052">36</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">CASH
    FLOWS FROM FINANCING ACTIVITIES:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Proceeds
    from issuance of shares issued in the public offering, net of issuance cost</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wlds:ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost" scale="3" unitRef="usd" id="ixv-19053">1,670</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-65; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-66; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Proceeds
    from issuance of units of ordinary shares and warrants in connection with the initial public offering, net of issuance expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-67; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wlds:ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPubli" scale="3" unitRef="usd" id="ixv-19054">14,319</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-68; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Proceeds
    from issuance of ordinary shares and warrants, net of issuance cost</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-69; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-70; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="wlds:ProceedsFromIssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost" scale="3" unitRef="usd" id="ixv-19055">2,925</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Proceeds
    from issuance of SAFEs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-71; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wlds:ProceedsFromIssuanceOfSAFEs" scale="3" unitRef="usd" id="ixv-19056">500</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-72; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Refund
    to SAFE investors</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-73; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wlds:RefundToSAFEInvestors" scale="3" unitRef="usd" id="ixv-19057">100</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-74; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Proceeds
    from credit line</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-75; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromLinesOfCredit" scale="3" unitRef="usd" id="ixv-19058">800</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-76; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Repayment
    of credit line</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-77; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfLinesOfCredit" scale="3" unitRef="usd" id="ixv-19059">800</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-78; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Proceeds from issuance
    of ordinary shares as a result of exercise of warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-79; font-family: Times New Roman, Times, Serif">1,44<span style="font-size: 10pt">9</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wlds:ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" scale="3" unitRef="usd" id="ixv-19060">160</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-80; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Exercise of options</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-81; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-82; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" unitRef="usd" id="ixv-19061">1</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Payment
    on behalf of issued shares</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-83; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-84; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="wlds:PaymentOnBehalfOfIssuedShares" scale="3" unitRef="usd" id="ixv-19062">12</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Net
    cash provided by financing activities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" unitRef="usd" id="ixv-19063">3,119</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" unitRef="usd" id="ixv-19064">14,879</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" unitRef="usd" id="ixv-19065">2,938</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net
    increase (decrease) in cash and cash equivalents</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="3" sign="-" unitRef="usd" id="ixv-19066">9,563</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="3" unitRef="usd" id="ixv-19067">9,099</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="3" unitRef="usd" id="ixv-19068">799</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Cash
    and Cash Equivalents at the beginning of year</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-19069">10,373</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c24" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-19070">1,274</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-19071">475</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Cash
    and cash equivalents at the end of year</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-19072">810</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-19073">10,373</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c24" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-19074">1,274</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-decoration: underline; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Supplemental
    Disclosure:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Interest
    on credit line</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-85; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestPaidNet" scale="3" unitRef="usd" id="ixv-19075">40</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-86; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Interest
    received from deposits</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wlds:InterestReceivedFromDeposits" scale="3" sign="-" unitRef="usd" id="ixv-19076">305</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-87; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-88; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Conversion
    of SAFE<span style="font-size: 10pt">s</span> to equity</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-89; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wlds:ConversionOfSAFEToEquity" scale="3" unitRef="usd" id="ixv-19077">400</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-90; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Right-of<span style="font-size: 10pt">-use
    asset recognized against lease liability</span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wlds:RightofUseAssetRecognizedAgainstLeaseLiability" scale="3" unitRef="usd" id="ixv-19078">644</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wlds:RightofUseAssetRecognizedAgainstLeaseLiability" scale="3" unitRef="usd" id="ixv-19079">229</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-91; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">The
accompanying notes are an integral part of these financial statements.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 8; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><div><a id="fin_006"></a></div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>WEARABLE
DEVICES LTD. AND ITS SUBSIDIARY</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="ixv-15617"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 1
- GENERAL:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wearable Devices Ltd. (the
    &#8220;Company&#8221;) was incorporated in Israel in March 2014. The Company develops&#160;and sells human-machine interface solutions
    for the smart wearables industry. In 2023, the Company started production of its B2C consumer product, the &#8220;Mudra Band&#8221;
    and started to generate revenues. The Company&#8217;s products are designated directly to end users and also designated to businesses
    in integration of its technology in their smart wearable devices. The Company&#8217;s Ordinary Shares and warrants began trading
    on the Nasdaq Capital Market (&#8220;Nasdaq&#8221;) on September 13, 2022, under the symbols &#8220;WLDS&#8221; and &#8220;WLDSW,&#8221;
    respectively (see Note 1e below). </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">We qualify as an &#8220;emerging growth
company,&#8221; as defined in Section 2(a) of the Securities Act of 1933, as amended, or the Securities Act, as modified by the U.S. Jumpstart
Our Business Startups Act of 2012 and we may take advantage of certain exemptions, including exemptions from various reporting requirements
that are otherwise applicable to public traded entities that do not qualify as emerging growth companies. These exemptions include:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.75in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002; and</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">not
                                            being required to comply with any requirement that may be adopted by the Public Company Accounting
                                            Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor&#8217;s
                                            report providing additional information about the audit and the financial statements (i.e.,
                                            an auditor discussion and analysis).</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We
will remain an emerging growth company until the earliest of: (i) the last day of the first fiscal year in which our annual gross revenues
exceed $<ix:nonFraction contextRef="c0" decimals="-6" format="ixt:num-dot-decimal" name="wlds:AnnualGrossRevenuesExceed" scale="9" unitRef="usd" id="ixv-19080">1.235</ix:nonFraction> billion; (ii) the last day of the fiscal year following the fifth anniversary of the date of our initial public offering
(i.e., December 31, 2027); (iii) the date that we become a &#8220;large accelerated filer&#8221; as defined in Rule&#160;12b-2&#160;under
the&#160;Exchange Act, which would occur if the aggregate worldwide market value of our ordinary shares, including ordinary shares represented
by warrants, held by non-affiliates is at least $<ix:nonFraction contextRef="c0" decimals="-6" format="ixt:num-dot-decimal" name="wlds:OrdinarySharesWarrantsHeldByNonaffiliates" scale="6" unitRef="usd" id="ixv-19081">700</ix:nonFraction> million as of the last business day of our most recently completed second fiscal
quarter; or (iv) the date on which we have issued more than $<ix:nonFraction contextRef="c0" decimals="-8" format="ixt:num-dot-decimal" name="wlds:NonconvertibleDebtSecurities" scale="9" unitRef="usd" id="ixv-19082">1.0</ix:nonFraction> billion in non-convertible debt securities during any three-year period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s revenues were derived from:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 72px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</span></td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
        sales of B2C consumer product, the &#8220;Mudra Band&#8221;.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The sales of B2B Mudra
    development kits composed of multiple performance obligations including tangible parts (&#8220;Hardware&#8221;) and a limited period
    (generally one year) application programming interface (&#8220;API&#8221;) with no commercial rights, to enable the customer to evaluate
    the Company&#8217;s solution with its own products.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 72px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The sales of pilot transactions
    to evaluate the integration of the Company&#8217;s solution with the customer&#8217;s products composed of multiple performance obligations
    including Hardware, tailor-made software applications and technical support during the pilot period.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
2023, most of the Company&#8217;s revenues were derived from the sales of Mudra Band to B2C customers. In 2022, all of the Company&#8217;s
revenues were derived from the sales of Mudra development kits. In 2021, most of the Company&#8217;s revenues were derived from a pilot
transaction in the amount of $<ix:nonFraction contextRef="c37" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-19083">84</ix:nonFraction> thousand, which was fully completed in 2021 and from the sales of Mudra development kits to multinational
technology companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</span></td>
    <td style="padding-right: 3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    2018, the Company established a wholly owned subsidiary in the United States of America for the purpose of marketing and distribution
    of its solutions &#8211; Mudra Wearable, Inc. (the &#8220;Subsidiary&#8221;) &#8211; which commenced its operations in 2020. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; font-size: 10pt">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</span></td>
    <td style="padding-right: 3pt; text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company&#8217;s headquarters is located in Israel. On October 7, 2023, Hamas terrorists infiltrated Israel&#8217;s southern border from the Gaza Strip and conducted a series of attacks on civilian and military targets. Following the attack, Israel declared war against Hamas and the Israeli military began to call-up reservists for active duty. At the same time, and because of the declaration of war against Hamas, the clash between Israel and Hezbollah in Lebanon has escalated and there is a possibility that it will turn into a greater regional conflict in the future. Further, many Israeli citizens are obligated to perform several days, and in some cases, more, of annual military reserve duty each year until they reach the age of 40 (or older for certain reservists) and, in the event of a military conflict, may be called to active duty. As of today, these events have had no material impact on the Company&#8217;s operations.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 36pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">d.</span></td><td><span style="font-family: Times New Roman, Times, Serif"><b>Going
                                            Concern:</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The accompanying consolidated financial
statements have been prepared assuming that the Company will continue as a going concern. To date, the Company is still in a transition
phase from its development stage to an early stage of generating revenues. Therefore, the Company has suffered recurring losses from operations
and negative cash flows from operations since inception. As detailed in Note 1e below, in September 2022, the Company completed an initial
public offering (&#8220;IPO&#8221;) and listed its ordinary shares, NIS <ix:nonFraction contextRef="c38" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="ilsPershares" id="ixv-19084">0.01</ix:nonFraction> par value, (the &#8220;Ordinary Shares&#8221;) and warrants
for trading on Nasdaq and raised net proceeds of $<ix:nonFraction contextRef="c39" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="6" unitRef="usd" id="ixv-19085">13.3</ix:nonFraction> million. In November 2023, the Company completed a secondary offering and raised
net proceeds of $<ix:nonFraction contextRef="c40" decimals="-5" format="ixt:num-dot-decimal" name="wlds:NetProceedsFromIssuanceSecondaryPublicOffering" scale="6" unitRef="usd" id="ixv-19086">1.7</ix:nonFraction> million.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric><div>
</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 9; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>WEARABLE
DEVICES LTD. AND ITS SUBSIDIARY</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS (cont.)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE
1 - GENERAL </b>(cont.)<b>:</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As
of December 31, 2023, the Company had incurred accumulated losses of $<ix:nonFraction contextRef="c4" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" unitRef="usd" id="ixv-19087">21.2</ix:nonFraction> million and expects to continue to fund its operations through
fundings such as issuance of convertible securities, Ordinary Shares and warrants and through Israeli governmental grants. There is no
assurance that such financing will be obtained. Considering the above, the Company&#8217;s dependency on external funding for its operations
raises a substantial doubt about its ability to continue as a going concern. The consolidated financial statements do not include any
adjustments that might result from the outcome of these uncertainties.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 36pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">e.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In September 2022, <span style="background-color: white">the Company completed its IPO whereby the Company issued and sold in connection with the closing of the IPO <ix:nonFraction contextRef="c41" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-19088">3,750,000</ix:nonFraction> units, each consisting of one Ordinary Share and two warrants to purchase one Ordinary Share each. In addition, the underwriter exercised its over-allotment option with respect to <ix:nonFraction contextRef="c42" decimals="0" format="ixt:num-dot-decimal" name="wlds:Warrants" scale="0" unitRef="shares" id="ixv-19089">1,125,000</ix:nonFraction> warrants to purchase <ix:nonFraction contextRef="c43" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-19090">1,125,000</ix:nonFraction> Ordinary Shares.</span></span></td></tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; background-color: white">The
warrants were exercisable immediately upon issuance, at an exercise price of $<ix:nonFraction contextRef="c44" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares" id="ixv-19091">4.00</ix:nonFraction> per Ordinary Share and are exercisable until September
12, 2027. On September 16, 2022, <ix:nonFraction contextRef="c45" decimals="0" format="ixt:num-dot-decimal" name="wlds:WarrantsExerciseIntoOrdinaryShares" scale="0" unitRef="shares" id="ixv-19092">40,000</ix:nonFraction> warrants were exercised into <ix:nonFraction contextRef="c45" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-19093">40,000</ix:nonFraction> Ordinary Shares. On December 14, 2022, the exercise price
of the warrants was adjusted to $<ix:nonFraction contextRef="c46" decimals="2" format="ixt:num-dot-decimal" name="wlds:ExercisePriceOfWarrant" scale="0" unitRef="usdPershares" id="ixv-19094">2.00</ix:nonFraction> per Ordinary Share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="background-color: white">In connection with the IPO, the
Company received gross proceeds of approximately $<ix:nonFraction contextRef="c0" decimals="-5" format="ixt:num-dot-decimal" name="wlds:GrossProceeds" scale="6" unitRef="usd" id="ixv-19095">16.0</ix:nonFraction> million, before deducting underwriting discounts and commissions and before offering
expenses ($<ix:nonFraction contextRef="c0" decimals="-5" format="ixt:num-dot-decimal" name="wlds:UnderwritingNetProceed" scale="6" unitRef="usd" id="ixv-19096">14.9</ix:nonFraction> million net proceeds after deducting approximately $<ix:nonFraction contextRef="c0" decimals="-5" format="ixt:num-dot-decimal" name="wlds:UnderwritingDiscountsAndCommissions" scale="6" unitRef="usd" id="ixv-19097">1.1</ix:nonFraction> million of underwriting discounts and commissions and approximately
$<ix:nonFraction contextRef="c47" decimals="-5" format="ixt:num-dot-decimal" name="wlds:GrossAfterOtherIPOExpenses" scale="6" unitRef="usd" id="ixv-19098">13.3</ix:nonFraction> million after other IPO expenses).&#160;The Ordinary Shares and warrants were approved for listing on the Nasdaq and commenced trading
under the symbol &#8220;WLDS&#8221; and &#8220;WLDSW,&#8221; respectively, on September 13, 2022. The Company&#8217;s Ordinary Share and
warrant prices on Nasdaq were $<ix:nonFraction contextRef="c48" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:SharePrice" scale="0" unitRef="usdPershares" id="ixv-19099">0.4450</ix:nonFraction> and $<ix:nonFraction contextRef="c48" decimals="4" format="ixt:num-dot-decimal" name="wlds:WarrantsExercisePricePerShare" scale="0" unitRef="usd" id="ixv-19100">0.0682</ix:nonFraction>, respectively, as of March 12, 2024.</span><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 36pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">f.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On November&#160;25, 2022, the Company received a written notification from the Listing Qualifications Department of the Nasdaq Stock Market LLC regarding its noncompliance with Nasdaq&#8217;s minimum bid price requirement because the closing bid price of the Ordinary Shares was below $<ix:nonFraction contextRef="c49" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares" id="ixv-19101">1.00</ix:nonFraction> per Ordinary Share for the previous 30 consecutive business days. On May 23, 2023, the Company received a notification letter from Nasdaq that the Company had been granted an additional 180-day compliance period, or until November 20, 2023, to regain compliance with Nasdaq&#8217;s minimum bid price rule. On June 9, 2023, the Company received a written notice from Nasdaq Stock Market LLC, indicating that it has regained compliance with the minimum bid price requirement. On October 24, 2023, the Company received a written notification from the Listing Qualifications Department of the Nasdaq Stock Market LLC regarding its noncompliance with Nasdaq&#8217;s minimum bid price requirement because the closing bid price of the Ordinary Shares was below $<ix:nonFraction contextRef="c50" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares" id="ixv-19102">1.00</ix:nonFraction> per Ordinary Share for the previous 30 consecutive business days. The Company was granted 180 calendar days, or until April&#160;22, 2024, to regain compliance with the minimum bid price requirement. In the event the Company does not regain compliance with the minimum bid price requirement by April 22, 2024, it may be eligible for an additional 180-calendar day grace period.&#160;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 36pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">g.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On November 13, 2023, <span style="background-color: white">the Company completed a public offering of its securities whereby the Company issued and sold <ix:nonFraction contextRef="c51" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-19103">4,444,444</ix:nonFraction> Ordinary Shares. The Company received gross proceeds of approximately $<ix:nonFraction contextRef="c51" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" unitRef="usd" id="ixv-19104">2</ix:nonFraction> million, before deducting underwriting discounts and commissions and before offering expenses ($<ix:nonFraction contextRef="c51" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" unitRef="usd" id="ixv-19105">1.7</ix:nonFraction> million net proceeds after deducting underwriting discounts and commissions and other expenses).</span></span></td></tr></table></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 10; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>WEARABLE
DEVICES LTD. AND ITS SUBSIDIARY</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS (cont.)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_1" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="ixv-15832"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 2
- SIGNIFICANT ACCOUNTING POLICIES:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the
United States of America (&#8220;U.S. GAAP&#8221;). The significant accounting policies followed in the preparation of the financial
statements are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_ConsolidationPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:ConsolidationPolicyTextBlock" id="ixv-15842"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>a.</b></span></td> <td style="padding-right: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principles of consolidation</b></span></td></tr> </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_ConsolidationPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
accompanying consolidated financial statements include the accounts of the Company and the Subsidiary. All intercompany transactions
have been eliminated in consolidation.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_UseOfEstimates-c0_cont_1" escape="true" name="us-gaap:UseOfEstimates" id="ixv-15860"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>b.</b></span></td> <td style="padding-right: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of estimates</b></span></td></tr> </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<ix:continuation id="_UseOfEstimates-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities, as well as to disclose contingent liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the reporting years. On an ongoing basis, management evaluates its
estimates, judgments and assumptions. Management bases its estimates, judgments and assumptions on historical experience and on various
other factors that are believed to be reasonable under the circumstances. Actual results could differ from those estimates.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="ixv-15879"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>c.</b></span></td> <td style="padding-right: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Foreign currency</b></span></td></tr> </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<ix:continuation continuedAt="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_2" id="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
currency of the primary economic environment in which the operations of the Company are conducted is the U.S. dollar (&#8220;USD&#8221;).
The Company&#8217;s funding and revenues are mostly in USD. Thus, the functional currency of the Company is the USD.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt 0pt 80.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Transactions
and balances originally denominated in USD are presented at their original amounts. Balances in non-USD currencies are translated into
USD using historical and current exchange rates for non-monetary and monetary balances, respectively. For non-USD transactions and other
items (stated below) reflected in the statements of operations, the following exchange rates are used: (i) for transactions &#8211; exchange
rates at transaction dates or average rates; and (ii) for other items (derived from non-monetary balance sheet items such as depreciation
etc.) &#8211; historical exchange rates. Currency transaction gains or losses are recorded to finance income or expenses, as appropriate.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_InventoryPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:InventoryPolicyTextBlock" id="ixv-15903"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>d.</b></span></td> <td style="padding-right: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inventories:</b></span></td></tr> </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<ix:continuation id="_InventoryPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Inventories
are composed of parts of the Company&#8217;s products as well as completed products and are stated at the lower of cost or net realizable
value. Inventory cost is determined on FIFO basis. Net realizable value is the estimated selling prices in the ordinary course of business,
less reasonably predictable costs of completion, disposal, and transportation. The cost of inventories comprises all costs of purchase,
and other costs incurred in bringing the inventories to their present location and condition.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="ixv-15922"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>e.</b></span></td> <td style="padding-right: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Property and equipment</b></span></td></tr> </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<ix:continuation continuedAt="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_2" id="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Property
and equipment are stated at cost. Depreciation is computed based on the straight-line method, over the estimated useful life of the assets.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_3" id="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><ix:nonNumeric contextRef="c0" continuedAt="wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock-c0_cont_1" escape="true" name="wlds:ScheduleOfAnnualRatesOfDepreciationTableTextBlock" id="ixv-15943"><span style="font-family: Times New Roman, Times, Serif">Annual
rates of depreciation are as follows:</span></ix:nonNumeric></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock-c0_cont_1"><ix:continuation id="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_3"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>%
    </b>&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Office furniture, machines, leasehold improvements,
    and electronic equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c53" decimals="2" format="ixt:num-dot-decimal" name="wlds:AnnualRateOfDepreciation" scale="-2" unitRef="pure" id="ixv-19106">7</ix:nonFraction>-<ix:nonFraction contextRef="c54" decimals="2" format="ixt:num-dot-decimal" name="wlds:AnnualRateOfDepreciation" scale="-2" unitRef="pure" id="ixv-19107">15</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 88%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Computers and software</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c55" decimals="2" format="ixt:num-dot-decimal" name="wlds:AnnualRateOfDepreciation" scale="-2" unitRef="pure" id="ixv-19108">33</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Mold</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c56" decimals="2" format="ixt:num-dot-decimal" name="wlds:AnnualRateOfDepreciation" scale="-2" unitRef="pure" id="ixv-19109">50</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p></ix:continuation></ix:continuation></ix:nonNumeric><div>


</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 11; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>WEARABLE
DEVICES LTD. AND ITS SUBSIDIARY</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS (cont.)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 2
- SIGNIFICANT ACCOUNTING POLICIES</b> (cont.)<b>:</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_2" id="_SignificantAccountingPoliciesTextBlock-c0_cont_1"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:LesseeLeasesPolicyTextBlock" id="ixv-16032"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>f.</b></span></td> <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>Leases</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On January 1, 2022, the Company began to implement ASU 2016-02, Leases (Topic 842) (&#8220;ASU 2016-02&#8221;) using the modified retrospective approach for all lease arrangements as of such date. The Company leases office space and vehicles under operating leases.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Arrangements meeting the definition of a lease are classified as operating or financing leases and are recorded on the balance sheet as both a right-of-use asset and lease liability, calculated by discounting fixed lease payments over the lease term at the rate implicit in the lease or the Company&#8217;s incremental borrowing rate. Lease liabilities are increased by interest and reduced by payments each period, and the right-of-use asset is amortized over the lease term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The lease liability was measured at the present value of the remaining lease payments, discounted using the Company&#8217;s incremental borrowing rate. The weighted-average&#160;rate applied was <ix:nonFraction contextRef="c52" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtWeightedAverageInterestRate" scale="-2" unitRef="pure" id="ixv-19110">8</ix:nonFraction>%. Right-of-use&#160;assets were measured at an amount equal to the lease liability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">For operating leases, interest on the lease liability and the amortization of the right-of-use asset result in straight-line&#160;rent expense over the lease term. Variable lease expenses are recorded when incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Leases with a lease term of <ix:nonNumeric contextRef="c4" format="ixt-sec:durmonth" name="us-gaap:LesseeFinanceLeaseRenewalTerm1" id="ixv-19111">12</ix:nonNumeric> months or less at inception are not recorded within the Consolidated Balance Sheets and are expensed on a straight-line basis over the lease term in the Consolidated Statements of Operations and Comprehensive Loss.<span style="font-size: 10pt; background-color: white">&#160;</span></span></p></td></tr> </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="ixv-16068"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>g.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenue recognition </b></span></td></tr> </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_2" id="_RevenueRecognitionPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Revenue
is recognized when (or as) control of the promised goods or services is transferred to the customer, and in an amount that reflects the
consideration the Company is contractually due in exchange for those services or goods. The Company follows five steps to record revenue:
(i) identify the contract with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction
price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the
Company satisfies its performance obligations.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_3" id="_RevenueRecognitionPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Company generate revenues from
the sales of B2C &#8220;Mudra Band&#8221;, sales of B2B &#8220;Mudra development kits&#8221; and sales of pilot transactions.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_4" id="_RevenueRecognitionPolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The &#8220;Mudra Band&#8221; is an
aftermarket accessory band for the Apple Watch which allows touchless operation and control of the watch and iPhone by using an app which
is considered combined with the band as one performance obligation. Revenue derived from the sale of &#8220;Mudra Band&#8221; is recognized
at a point of time when control transfers to the customer. The Company believes that the delivery date is the most appropriate point in
time indicating control has transferred to the customer.&#160;&#160;</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_5" id="_RevenueRecognitionPolicyTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Company allows return and refund
of Mudra Band within 30 days of having the Mudra Band delivered. The Company records an appropriate provision for such refunds.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_6" id="_RevenueRecognitionPolicyTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Revenue derived from freight charges
is considered as a separate performance obligation recognized when the related product revenue is recognized.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_7" id="_RevenueRecognitionPolicyTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">A
pilot transaction has multiple performance obligations, and it generally takes a few months but less than one year. Each Mudra development
kit sale also has multiple performance obligations.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_8" id="_RevenueRecognitionPolicyTextBlock-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
payment terms of the Mudra development kit sales are upon delivery of the Hardware, while the payment terms of the pilot transactions
are within the pilot period.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_9" id="_RevenueRecognitionPolicyTextBlock-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
those transactions, each obligation- Hardware and API (for Mudra development kit) and tailor-made software application and technical
support (for a pilot transaction) - is distinct and separately identifiable.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_RevenueRecognitionPolicyTextBlock-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
amount allocated to the delivered items is recognized upon delivery, the amount allocated to API is recognized over the API period and
the amount allocated to the technical support is recognized over the service period (a pilot period).&#160;</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="wlds_CostOfRevenuesPolicyTextBlock-c0_cont_1" escape="true" name="wlds:CostOfRevenuesPolicyTextBlock" id="ixv-16119"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>h.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cost of revenues</b></span></td></tr> </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="wlds_CostOfRevenuesPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.4pt"><span style="font-family: Times New Roman, Times, Serif">Costs
are expensed as incurred. The primary components of cost of revenues include the cost of the product and outbound freight charges.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 80.3pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_ResearchAndDevelopmentExpensePolicy-c0_cont_1" escape="true" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="ixv-16137"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>i.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Research and development</b></span></td></tr> </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_ResearchAndDevelopmentExpensePolicy-c0_cont_1"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.4pt"><span style="font-family: Times New Roman, Times, Serif">Research
and development expenses consist primarily of payroll, payroll related expenses, subcontractors, and materials. Costs are expensed as
incurred.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 12; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>WEARABLE
DEVICES LTD. AND ITS SUBSIDIARY</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS (cont.)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 2
- SIGNIFICANT ACCOUNTING POLICIES</b> (cont.)<b>:</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_3" id="_SignificantAccountingPoliciesTextBlock-c0_cont_2"><ix:nonNumeric contextRef="c0" continuedAt="wlds_GovernmentalGrantsPolicyTextBlock-c0_cont_1" escape="true" name="wlds:GovernmentalGrantsPolicyTextBlock" id="ixv-16189"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>j.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Governmental grants</b></span></td></tr> </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="wlds_GovernmentalGrantsPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company receives royalty-bearing grants from the Israeli government for approved research and development projects and marketing efforts.
These grants are recognized at the time the Company is entitled to such grants based on the costs incurred or milestones achieved as
provided by the relevant agreement and included as a deduction from research and development or sales and marketing expenses, respectively.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock-c0_cont_1" escape="true" name="wlds:FinanceIncomeAndExpensesPolicyPolicyTextBlock" id="ixv-16207"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>k.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Finance income and expenses</b></span></td></tr> </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 80.55pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Finance
income is composed of interest on deposits and unrealized gain from foreign currency derivative activities, while finance expenses are
composed of interest on senior secured credit facility, bank charges and net currency exchange rates differences.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_IncomeTaxPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock" id="ixv-16225"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>l.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Income taxes</b></span></td></tr> </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 80.3pt; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_IncomeTaxPolicyTextBlock-c0_cont_2" id="_IncomeTaxPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company accounts for income taxes in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 740, &#8220;Income Taxes&#8221;
(&#8220;ASC 740&#8221;). Deferred taxes are determined utilizing the assets and liabilities method, which is based on the estimated future
tax effects of the differences between the financial accounting and tax bases of assets and liabilities under the applicable tax laws.
Deferred tax balances are computed using the tax rates expected to be in effect when those differences reverse. A valuation allowance
in respect of deferred tax assets is provided if, based upon the weight of available evidence, it is more likely than not that some or
all the deferred tax assets will not be realized. The measurement of deferred tax assets is reduced, if necessary, by the amount of any
tax benefits that, based on available evidence, are not expected to be realized.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 80.3pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_IncomeTaxPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company applies ASC 740, which clarifies the accounting and reporting for uncertainties with respect to income taxes. ASC 740 prescribes
a comprehensive model for the financial statement recognition, measurement, presentation, and disclosure of uncertain tax positions taken
or expected to be taken in income tax returns.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_1" escape="true" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="ixv-16248"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>m.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share based compensation</b></span></td></tr> </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<ix:continuation id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Share-based
compensation expenses related to employees&#8217; and consultants&#8217; options are measured at the grant date based on the fair value
of the award and are generally expensed over the requisite service period (generally the vesting period). The Company recognizes compensation
expense on a straight-line basis from the beginning of the service period. For awards with graded-vesting features, each vesting tranche
is separately expensed over the related vesting period. The Company estimates the fair value of each stock option grant using the Black-Scholes
option pricing model, which requires management to make certain assumptions of future expectations based on historical and current data
include the expected term of the stock option, expected volatility, dividend yield, and risk-free interest rate.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="wlds_WarrantsPolicyPolicyTextBlock-c0_cont_1" escape="true" name="wlds:WarrantsPolicyPolicyTextBlock" id="ixv-16267"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>m.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants</b></span></td></tr> </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="wlds_WarrantsPolicyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
warrants&#8217; mechanism does not create any obligation to transfer cash to the investors. Warrants are exercised for a fixed amount
of Ordinary Shares upon exercise. Therefore, the Company accounts for the warrants as equity-classified instruments (as part of additional
paid in capital), based on an assessment of the applicable U.S. GAAP authoritative guidance. The assessment considers whether the warrants
are freestanding financial instruments, meet the definition of a liability or whether the warrants meet all of the requirements for equity
classification, including whether the warrants are indexed to the Company&#8217;s own shares, among other conditions for equity classification.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 13; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>WEARABLE
DEVICES LTD. AND ITS SUBSIDIARY</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS (cont.)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 80.3pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 2
- SIGNIFICANT ACCOUNTING POLICIES</b> (cont.)<b>:</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_4" id="_SignificantAccountingPoliciesTextBlock-c0_cont_3"><ix:nonNumeric contextRef="c0" continuedAt="wlds_SeverancePolicyTextBlock-c0_cont_1" escape="true" name="wlds:SeverancePolicyTextBlock" id="ixv-16319"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>o.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Severance</b></span></td></tr> </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 15pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="wlds_SeverancePolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Israeli
labor law generally requires payment of severance pay upon dismissal of an employee or upon termination of employment in certain other
circumstances. The Company&#8217;s pension and severance pay liabilities are covered mainly by insurance policies. Pursuant to section
14 of the Israeli Severance Compensation Act, 1963 (&#8220;section 14&#8221;), the Company&#8217;s employees are entitled to monthly
deposits, at a rate of <ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="wlds:RateOfMonthlySeverancePercentage" scale="-2" unitRef="pure" id="ixv-19112">8.33</ix:nonFraction>% of their monthly salary, made in their name with insurance companies. Payments in accordance with section
14 relieve the Company from any future severance payments in respect of those employees and, as such, the Company may only utilize the
insurance policies for the purpose of paying severance pay.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 15pt 0pt 80.3pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_EarningsPerSharePolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock" id="ixv-16337"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>p.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basic and diluted loss per share</b></span></td></tr> </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 80.55pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_EarningsPerSharePolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Basic
and diluted loss per share is calculated by dividing the loss attributable to equity holders of the Company by the weighted average number
of Ordinary Shares outstanding during the financial year, adjusted for Ordinary Shares issued during the year, if applicable.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="ixv-16356"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>q.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair Value Measurements</b></span></td></tr> </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_2" id="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company measures and discloses fair value in accordance with the Financial Accounting Standards Board (&#8220;FASB&#8221;), ASC 820,
Fair Value Measurements and Disclosures (&#8220;ASC 820&#8221;). ASC 820 defines fair value, establishes a framework and gives guidance
regarding the methods used for measuring fair value, and expands disclosures about fair value measurements. Fair value is an exit price,
representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market
participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions
that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, there exists a three-tier
fair-value hierarchy, which prioritizes the inputs used in measuring fair value as follows:</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 79.1pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_3" id="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Level
1 &#8211; unadjusted quoted prices are available in active markets for identical assets or liabilities that the Company has the ability
to access as of the measurement date.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 79.1pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<ix:continuation continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_4" id="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Level
2 &#8211; pricing inputs are other than quoted prices in active markets that are directly observable for the asset or liability or indirectly
observable through corroboration with observable market data.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 79.1pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<ix:continuation continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_5" id="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Level
3 &#8211; pricing inputs are unobservable for the non-financial asset or liability and only used when there is little, if any, market
activity for the non-financial asset or liability at the measurement date. The inputs into the determination of fair value require significant
management judgment or estimation. Level 3 inputs are considered as the lowest priority within the fair value hierarchy.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 79.1pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<ix:continuation continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_6" id="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">This
hierarchy requires the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining
fair value.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 79.1pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
fair value of cash is based on its demand value, which is equal to its carrying value. Additionally, the carrying value of all other
short-term monetary assets and liabilities are estimated to be equal to their fair value due to the short-term nature of these instruments.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 14; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>WEARABLE
DEVICES LTD. AND ITS SUBSIDIARY</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS (cont.)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 80.3pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 2
- SIGNIFICANT ACCOUNTING POLICIES</b> (cont.)<b>:</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation id="_SignificantAccountingPoliciesTextBlock-c0_cont_4"><ix:nonNumeric contextRef="c0" continuedAt="_ConcentrationRiskCreditRisk-c0_cont_1" escape="true" name="us-gaap:ConcentrationRiskCreditRisk" id="ixv-16436"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>r.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Concentration of Credit Risk</b></span></td></tr> </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_ConcentrationRiskCreditRisk-c0_cont_2" id="_ConcentrationRiskCreditRisk-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Company maintains certain cash
balances in a well-known Israeli banks and a U.S.-based bank.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_ConcentrationRiskCreditRisk-c0_cont_3" id="_ConcentrationRiskCreditRisk-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Company&#8217;s labor expenses
are denominated mainly in NIS, and therefore, subject to foreign currency risk. During the year ended December 31, 2023, the Company partially
hedged its foreign currency exchange risk.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<ix:continuation id="_ConcentrationRiskCreditRisk-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Company&#8217;s derivative instruments
primarily include foreign currency forward agreements related to the NIS and associated with certain payroll payments. The Company&#8217;s
foreign currency forward agreements related to foreign currency&#160;balance sheet exposure provide economic hedges but are not designated
as hedges for accounting purposes. Changes in the value of the derivative,&#160;along with the transaction gain or loss on the hedged
item, are recorded within the Company&#8217;s consolidated statements of loss.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_CashAndCashEquivalentsPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="ixv-16459"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>s.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cash and cash equivalents:</b></span></td></tr> </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_CashAndCashEquivalentsPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Cash
equivalents are highly liquid investments that are readily convertible into cash, typically with an original maturity of three months
or less.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="ixv-16477"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 49px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>t.</b></span></td> <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>Segment Information </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company has a single operating and reportable segment. The Company&#8217;s chief operating decision maker, who is the Chief Executive Officer, evaluates the performance of its business based on financial data consistent with the presentation in the accompanying consolidated financial statements for the purposes of making operating decisions, assessing financial performance, and allocating resources. &#160;&#160;</span></p></td></tr> </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_SubsequentEventsPolicyPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:SubsequentEventsPolicyPolicyTextBlock" id="ixv-16495"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top; text-align: justify">
<td style="width: 49px"/><td style="width: 24px; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>u.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Subsequent Events</b></span></td>
</tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<ix:continuation id="_SubsequentEventsPolicyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">In connection with the preparation of these consolidated financial
statements, the Company and management evaluated subsequent events through March 13, 2024, the date these consolidated financial statements
were available to be issued.<span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 15; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>WEARABLE
DEVICES LTD. AND ITS SUBSIDIARY</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS (cont.)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:InventoryDisclosureTextBlock" id="ixv-16535"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 3
- INVENTORIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="ixv-16541"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">December
    31</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">U.S.
    dollars <br/>
    in thousands</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Cost:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Raw materials</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="3" unitRef="usd" id="ixv-19113">514</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="3" unitRef="usd" id="ixv-19114">6</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Work-in-progress</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" unitRef="usd" id="ixv-19115">206</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-92; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Finished
    goods</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" unitRef="usd" id="ixv-19116">312</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-93; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FIFOInventoryAmount" scale="3" unitRef="usd" id="ixv-19117">1,032</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FIFOInventoryAmount" scale="3" unitRef="usd" id="ixv-19118">6</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="ixv-16673"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE</b>&#160;
<b>4 - PROPERTY AND EQUIPMENT, net</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="ixv-16680"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">December
    31</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">U.S.
    dollars <br/>
    in thousands</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Cost:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Computers and
    software</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c57" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-19119">204</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c58" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-19120">124</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Furniture and leasehold
    improvements</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c59" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-19121">38</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c60" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-19122">7</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Electronic equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c61" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-19123">20</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c62" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-19124">9</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Machines
    and molds</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c63" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-19125">72</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-94; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-19126">334</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-19127">140</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less
    - <span style="font-style: normal; font-weight: normal">accumulated depreciation</span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" unitRef="usd" id="ixv-19128">140</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" unitRef="usd" id="ixv-19129">72</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd" id="ixv-19130">194</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd" id="ixv-19131">68</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:LesseeOperatingLeasesTextBlock" id="ixv-16869"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 5-
LEASES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company has operating leases for
its offices and vehicles. The Company&#8217;s leases have remaining terms of less than one year to approximately <ix:nonNumeric contextRef="c4" format="ixt-sec:duryear" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" id="ixv-19132">2</ix:nonNumeric> years, some of which
may include options to extend the leases for up to <ix:nonNumeric contextRef="c0" name="us-gaap:LesseeOperatingLeaseOptionToExtend" id="ixv-19133">2 years</ix:nonNumeric>.</p>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 0.5in"><ix:nonNumeric contextRef="c0" continuedAt="_OperatingLeasesOfLesseeDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock" id="ixv-16880"><span style="font-family: Times New Roman, Times, Serif">The
following table summarizes the classification of operating lease right-of-use assets and liabilities in the Company&#8217;s Consolidated
Balance Sheets as of December&#160;31, 2023 and 2022:</span></ix:nonNumeric></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<ix:continuation id="_OperatingLeasesOfLesseeDisclosureTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">December
    31</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">U.S.
    dollars in thousands</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Right of
    use assets</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" unitRef="usd" id="ixv-19134">592</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" unitRef="usd" id="ixv-19135">180</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Short term</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" unitRef="usd" id="ixv-19136">297</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" unitRef="usd" id="ixv-19137">68</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Long term</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" unitRef="usd" id="ixv-19138">278</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" unitRef="usd" id="ixv-19139">94</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Total lease liabilities</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiability" scale="3" unitRef="usd" id="ixv-19140">575</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiability" scale="3" unitRef="usd" id="ixv-19141">162</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><ix:nonNumeric contextRef="c0" continuedAt="_LesseeOperatingLeaseLiabilityMaturityTableTextBlock-c0_cont_1" escape="true" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="ixv-19142">At December&#160;31, 2023, the future minimum lease payments
under the Company&#8217;s operating lease liabilities are as follows:</ix:nonNumeric></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<ix:continuation id="_LesseeOperatingLeaseLiabilityMaturityTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left; font-weight: bold; border-bottom: Black 1.5pt solid">Year ended December 31,</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">U.S.&#160;dollars<br/> in&#160;thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" unitRef="usd" id="ixv-19143">308</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2025</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" unitRef="usd" id="ixv-19144">289</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">2026</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="3" unitRef="usd" id="ixv-19145">22</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total future minimum lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="3" unitRef="usd" id="ixv-19146">619</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">Less imputed interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" unitRef="usd" id="ixv-19147">44</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total operating lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiability" scale="3" unitRef="usd" id="ixv-19148">575</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">Less operating lease liabilities, current</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" unitRef="usd" id="ixv-19149">297</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 4pt; text-align: left">Operating lease liabilities, non-current</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" unitRef="usd" id="ixv-19150">278</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table></ix:continuation>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Total expenses under all operating leases were $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseExpense" scale="3" unitRef="usd" id="ixv-19151">232</ix:nonFraction> thousand,
$<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseExpense" scale="3" unitRef="usd" id="ixv-19152">74</ix:nonFraction> thousand, and $<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseExpense" scale="3" unitRef="usd" id="ixv-19153">42</ix:nonFraction> thousand for the years ended December 31, 2023, 2022 and 2021, respectively.</p></ix:nonNumeric><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 16; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>WEARABLE
DEVICES LTD. AND ITS SUBSIDIARY</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS (cont.)</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="ixv-17124"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 6
- COMMITMENTS AND CONTINGENCIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>a.</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Royalties to the Israel Innovation Authority (&#8220;IIA&#8221;):</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.4pt; text-indent: -0.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company receives royalty-bearing grants from the IIA, for approved research and development projects. The programs include grants for:
wages, materials, subcontractors and miscellaneous. The Company was required to pay royalties at the rate of <ix:nonFraction contextRef="c65" decimals="2" format="ixt:num-dot-decimal" name="wlds:RoyaltiesRate" scale="-2" unitRef="pure" id="ixv-19154">3</ix:nonFraction>%-<ix:nonFraction contextRef="c66" decimals="3" format="ixt:num-dot-decimal" name="wlds:RoyaltiesRate" scale="-2" unitRef="pure" id="ixv-19155">3.5</ix:nonFraction>% on sales of products
developed with the funds provided by the IIA, up to an amount equal to <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="wlds:GrantsReceivedEqualPercentageRate" scale="-2" unitRef="pure" id="ixv-19156">100</ix:nonFraction>% of the IIA research and development grants received, linked
to the dollar including accrued interest. Until October 25, 2023, the interest was calculated at a rate based on 12-month LIBOR applicable
to US Dollar deposits. However, on October 25, 2023, the IIA published a directive concerning changes in royalties to address the expiration
of the LIBOR. Under such directive, regarding IIA grants approved by the IIA prior to January 1, 2024 but which are outstanding thereafter,
as of January 1, 2024 the annual interest is calculated at a rate based on 12-month SOFR, or at an alternative rate published by the
Bank of Israel plus <ix:nonFraction contextRef="c0" decimals="7" format="ixt:num-dot-decimal" name="wlds:AnnualAlternativeInterestPercentage" scale="-2" unitRef="pure" id="ixv-19157">0.71513</ix:nonFraction>%; and, for grants approved on or following January 1, 2024 the annual interest shall be the higher of (i)
the 12 months SOFR interest rate, plus <ix:nonFraction contextRef="c67" decimals="2" format="ixt:num-dot-decimal" name="wlds:AnnualInterestRate" scale="-2" unitRef="pure" id="ixv-19158">1</ix:nonFraction>%, or (ii) a fixed annual interest rate of <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="wlds:FixedAnnualInterestRate" scale="-2" unitRef="pure" id="ixv-19159">4</ix:nonFraction>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As
of December 31, 2018, two IIA programs were completed, while the amounts received for them aggregated to $<ix:nonFraction contextRef="c68" decimals="-3" format="ixt:num-dot-decimal" name="wlds:AmountsReceivedAggregateAmount" scale="6" unitRef="usd" id="ixv-19160">1.224</ix:nonFraction> million. In addition,
another IIA approved plan commenced on May 1, 2020, and was completed on July 31, 2021, pursuant to which a total of $<ix:nonFraction contextRef="c69" decimals="-3" format="ixt:num-dot-decimal" name="wlds:AmountsReceivedAggregateAmount" scale="3" unitRef="usd" id="ixv-19161">627</ix:nonFraction> thousand was
received. During January 2023, the IIA approved an additional program to finance further development of the Company&#8217;s manufacturing
process of its wearable neural interface in Israel. The approved program is in amount of approximately $<ix:nonFraction contextRef="c70" decimals="-3" format="ixt:num-dot-decimal" name="wlds:AmountOfDevelopmentProgram" scale="3" unitRef="usd" id="ixv-19162">900</ix:nonFraction> thousand (NIS <ix:nonFraction contextRef="c70" decimals="-5" format="ixt:num-dot-decimal" name="wlds:AmountOfDevelopmentProgram" scale="6" unitRef="ils" id="ixv-19163">3.1</ix:nonFraction> million),
of which the IIA will finance <ix:nonFraction contextRef="c4" decimals="2" format="ixt:num-dot-decimal" name="wlds:PercentageOfFinancing" scale="-2" unitRef="pure" id="ixv-19164">60</ix:nonFraction>%; as of December 31, 2023, $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wlds:TotalCashReceivedFromTheIIA" scale="3" unitRef="usd" id="ixv-19165">288</ix:nonFraction> thousand was received.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
terms of the grants under the Encouragement of Research, Development and Technological Innovation in the Industry 1984 require that the
manufacturing of products resulting from IIA-funded programs be carried out in Israel, unless a prior written approval of the IIA is
obtained (except for a transfer of up to <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="wlds:ExceptTransferProductionRight" scale="-2" unitRef="pure" id="ixv-19166">10</ix:nonFraction>% of the production rights, for which a notification to the IIA is sufficient). During December
2022, the Company received an approval from the IIA to transfer some of its manufacturing activities abroad.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As
a condition for obtaining approval to manufacture outside Israel (or following a declaration that up to <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="wlds:ProductionTransferred" scale="-2" unitRef="pure" id="ixv-19167">10</ix:nonFraction>% of the production is transferred
abroad), <ix:nonNumeric contextRef="c0" name="wlds:PayIncreasedRoyaltiesDescription" id="ixv-19168">the Company would be required to pay increased royalties, which usually amount to 1% in addition to the standard royalties rate
3%-3.5%, and also the total amount of its liability to the IIA may be increased to between 120% and 300% of the grants received from
the IIA, depending on the manufacturing volume that is performed outside Israel (less royalties already paid to IIA).</ix:nonNumeric></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 17; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>WEARABLE
DEVICES LTD. AND ITS SUBSIDIARY</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS (cont.)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 6
- COMMITMENTS AND CONTINGENCIES</b> (cont.)<b>:</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Research
and development grants deducted from research and development expenses amounted to $<ix:nonFraction contextRef="c71" decimals="-3" format="ixt:num-dot-decimal" name="wlds:ResearchAndDevelopmentGrantsDetection" scale="3" unitRef="usd" id="ixv-19169">415</ix:nonFraction>, <span style="-sec-ix-hidden: hidden-fact-95">nil</span> and $<ix:nonFraction contextRef="c73" decimals="-3" format="ixt:num-dot-decimal" name="wlds:ResearchAndDevelopmentGrantsDetection" scale="3" unitRef="usd" id="ixv-19170">289</ix:nonFraction> thousand for the years ended December
31, 2023, 2022 and 2021, respectively. As of December 31, 2023, the maximum obligation with respect to the grants received from the IIA,
contingent upon entitled future sales, is $<ix:nonFraction contextRef="c74" decimals="-5" format="ixt:num-dot-decimal" name="wlds:MaximumObligatinAmount" scale="6" unitRef="usd" id="ixv-19171">2.2</ix:nonFraction> million plus interest which may be increased, depending on the manufacturing volume that
is performed outside Israel. The Company has obligations regarding know-how, technology, or products, not to transfer the information,
rights thereon and production rights which derive from the research and development, in whole or part, of its Mudra product and its Mudra
Band product, without the IIA Research Committee approval.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>b.</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Royalties to the Israeli Ministry of Economy and
    Industry (&#8220;IMEI&#8221;):</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 35.5pt 0pt 77.3pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During
2020, the Company received a grant from the IMEI, for approved marketing expenses amounting to $<ix:nonFraction contextRef="c75" decimals="-3" format="ixt:num-dot-decimal" name="wlds:GrantsReceivedFromTheIMEI" scale="3" unitRef="usd" id="ixv-19172">95</ix:nonFraction> thousand. The program includes participation
in expenses for: consulting for marketing, advertising and online marketing, flights to exhibitions and miscellaneous. &#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Sales
and marketing grants deducted from sales and marketing expenses amounted to $<ix:nonFraction contextRef="c76" decimals="-3" format="ixt:num-dot-decimal" name="wlds:SalesAndMarketingExpensesDeductions" scale="3" unitRef="usd" id="ixv-19173">42</ix:nonFraction> thousand for the year ended December 31, 2021.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.6pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Under the agreement with the IMEI,
if the export revenues in the defined target market increase by $<ix:nonFraction contextRef="c77" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenuesNetOfInterestExpense" scale="3" unitRef="usd" id="ixv-19174">311</ix:nonFraction> thousand compared to the base year, the Company would be required
to pay royalties at the rate of <ix:nonFraction contextRef="c77" decimals="2" format="ixt:num-dot-decimal" name="wlds:RoyaltiesRatePercentage" scale="-2" unitRef="pure" id="ixv-19175">3</ix:nonFraction>% of the increase, with the funds provided by the IMEI up to an amount equal to <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="wlds:MarketingGrantReceived" scale="-2" unitRef="pure" id="ixv-19176">100</ix:nonFraction>% of the IMEI marketing
grant received, linked to the consumer price index (&#8220;CPI&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">As of December 31, 2023, the maximum
obligation with respect to the grant received from the IMEI, contingent upon entitled future sales, is $<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrantsReceivableCurrent" scale="3" unitRef="usd" id="ixv-19177">95</ix:nonFraction> thousand linked to the CPI.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>c.</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lease Commitments &#8211; Operating Leases:</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
July 1, 2018, the Company entered into a lease agreement for a period which expired on September 30, 2022. The monthly lease payment
totaled approximately $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LeaseCost" scale="3" unitRef="usd" id="ixv-19178">5</ix:nonFraction> thousand.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">After
September 30, 2022, the Company stayed on the lease on a month-to-month basis. At the end of January 2023, the Company terminated this
lease with 60 days&#8217; termination notice that ended on March 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
January 2023, the Company entered into a new lease agreement in Yokne&#8217;am Illit, Israel for a period which started on February 1,
2023, and expires on January 31, 2025, with an option to extend the lease period by two additional lease periods, each for an additional
12 months. The Company&#8217;s monthly rent payment for this facility is approximately $<ix:nonFraction contextRef="c78" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRent" scale="3" unitRef="usd" id="ixv-19179">16</ix:nonFraction> thousand during the first lease year and will
be increased to approximately $<ix:nonFraction contextRef="c79" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRent" scale="3" unitRef="usd" id="ixv-19180">20</ix:nonFraction> thousand during the second lease year. During the option lease periods, the lease payment may be increased
up to <ix:nonFraction contextRef="c80" decimals="2" format="ixt:num-dot-decimal" name="wlds:LeasePaymentIncreased" scale="-2" unitRef="pure" id="ixv-19181">10</ix:nonFraction>% as compared to the second lease year. The Company expects to exercise the option and extend the lease for another year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Company&#8217;s subsidiary, Mudra
Wearable, established an office located in California. The lease is on a month-to-month basis with de-minimis consideration. Additionally,
during 2022, the Company entered into lease agreements to lease <ix:nonNumeric contextRef="c81" name="wlds:LeaseAgreements" id="ixv-19182">5</ix:nonNumeric> vehicles for a period of <ix:nonNumeric contextRef="c81" format="ixt-sec:duryear" name="wlds:LeaseAgreementsPeriod" id="ixv-19183">3</ix:nonNumeric> years.</p></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 18; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>WEARABLE
DEVICES LTD. AND ITS SUBSIDIARY</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS (cont.)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:DebtDisclosureTextBlock" id="ixv-17276"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 7
- CONVERTIBLE SECURITIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">A.
During 2017, 2018, January 2019, April 2019 and November 2019, the Company entered into convertible security agreements with certain
investors, according to which the Company received an aggregate amount of $<ix:nonFraction contextRef="c82" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="3" unitRef="usd" id="ixv-19184">400</ix:nonFraction> thousand, $<ix:nonFraction contextRef="c83" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="3" unitRef="usd" id="ixv-19185">600</ix:nonFraction> thousand, $<ix:nonFraction contextRef="c84" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="3" unitRef="usd" id="ixv-19186">100</ix:nonFraction> thousand, $<ix:nonFraction contextRef="c85" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="3" unitRef="usd" id="ixv-19187">200</ix:nonFraction> thousand
and $<ix:nonFraction contextRef="c86" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="3" unitRef="usd" id="ixv-19188">100</ix:nonFraction> thousand, respectively, bearing interest at the rate of <ix:nonFraction contextRef="c87" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" unitRef="pure" id="ixv-19189">4</ix:nonFraction>% per annum. Such amounts including the accrued interest were converted
into Ordinary Shares, based on a share price agreed upon in the respective agreement of $<ix:nonFraction contextRef="c88" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharePrice" scale="0" unitRef="usdPershares" id="ixv-19190">0.79</ix:nonFraction>, $<ix:nonFraction contextRef="c89" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharePrice" scale="0" unitRef="usdPershares" id="ixv-19191">0.79</ix:nonFraction> $<ix:nonFraction contextRef="c90" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharePrice" scale="0" unitRef="usdPershares" id="ixv-19192">0.92</ix:nonFraction>, $<ix:nonFraction contextRef="c91" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharePrice" scale="0" unitRef="usdPershares" id="ixv-19193">0.92</ix:nonFraction> and $<ix:nonFraction contextRef="c92" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharePrice" scale="0" unitRef="usdPershares" id="ixv-19194">1.69</ix:nonFraction>, respectively,
in April 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.6pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
December 2019, the Company entered into additional convertible security agreements with an aggregate principal amount of $<ix:nonFraction contextRef="c93" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" unitRef="usd" id="ixv-19195">1.5</ix:nonFraction> million,
which was converted into Ordinary Shares based on a share price agreed upon in the agreement of $<ix:nonFraction contextRef="c94" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharePrice" scale="0" unitRef="usdPershares" id="ixv-19196">1.22</ix:nonFraction> in April 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Those&#160;convertible
security agreements, including accrued interest, were not mandatorily redeemable, nor redeemable at the option of the holder after a
specified date, but a change of control event as described in the agreements would constitute a redemption event outside of the Company&#8217;s
control. Therefore, all the convertible securities were presented as current liabilities. <ix:nonNumeric contextRef="c0" name="wlds:ConvertibleSecurityDescription" id="ixv-19197">The beneficial conversion feature of each one
of convertible security was valued at zero.</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">B.
April 2021 investors - In June 2022, the Company&#160;received from Alpha Capital Anstalt (&#8220;Alpha&#8221;) the contractually required
written consent to proceed with the IPO (the &#8220;June 2022 Consent&#8221;) in exchange for a cash payment of $<ix:nonFraction contextRef="c95" decimals="0" format="ixt:num-dot-decimal" name="wlds:CashPayment" scale="0" unitRef="usd" id="ixv-19198">300,000</ix:nonFraction> from the proceeds
of the IPO, which was paid on September 28, 2022, following the completion of the IPO. Pursuant to the share purchase agreements the
Company entered into with certain investors in April 2021 (the &#8220;April 2021 SPAs&#8221;), in the event of an initial public offering
event or in a Dilutive Issuance event (as defined below), reflecting a pre-money valuation of $<ix:nonFraction contextRef="c96" decimals="0" format="ixt:num-dot-decimal" name="wlds:PremoneyValuationAmount" scale="0" unitRef="usd" id="ixv-19199">26,400,000</ix:nonFraction>, or a lower one, then such
investors shall receive additional Ordinary Shares and additional shares underlying each warrant, based on <ix:nonFraction contextRef="c97" decimals="2" format="ixt:num-dot-decimal" name="wlds:WarrantPricePerSharePercentage" scale="-2" unitRef="pure" id="ixv-19200">80</ix:nonFraction>% of the price per share
at the IPO (the &#8220;Discounted PPS&#8221;), less the number of Ordinary Shares issued to them in the April 2021 financing, and the
number of shares underlying each warrant shall be increased assuming the exercise amount is divided by the Discounted PPS. Additionally,
beginning on April 22, 2021 and until the earlier of (i) the 90th calendar day after the expiration of the applicable lock-ups, following
the IPO date (i.e. June 2023) or (ii) three years from April 22, 2021, if the Company or its subsidiary shall issue any Ordinary Shares
or equivalents of Ordinary Shares, in an equity transaction other than an exempt issuance, entitling any person or entity to acquire
Ordinary Shares at an effective price per share less than the per share purchase price of $<ix:nonFraction contextRef="c98" decimals="2" format="ixt:num-dot-decimal" name="wlds:PurchasePricePerShare" scale="0" unitRef="usdPershares" id="ixv-19201">2.25</ix:nonFraction> (subject to prior adjustment for reverse
and forward stock splits and the like) (a &#8220;Dilutive Issuance&#8221;), then, for no additional consideration, the Company shall
immediately issue to the investors in the April 2021 financing that number of additional Ordinary Shares equal to (a) the per share purchase
price of $<ix:nonFraction contextRef="c99" decimals="2" format="ixt:num-dot-decimal" name="wlds:PurchasePricePerShare" scale="0" unitRef="usdPershares" id="ixv-19202">2.25</ix:nonFraction> divided by amount actually paid in new cash consideration by third parties for each Ordinary Share in the Dilutive Issuance
less (b) the number of Ordinary Shares issued to Alpha and other investors at the closing of the April 2021 financing pursuant to April
2021 SPAs. Pursuant to the June 2022 Consent, the investor in the April 2021 financing waived their rights for such adjustments as of
the date of the IPO and deferred such adjustments (if any) to be effected on the 90th calendar day following the closing of the IPO.&#160;&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
September 20, 2022, the Company&#8217;s volume weighted average stock price was less than the exercise price of $<ix:nonFraction contextRef="c100" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares" id="ixv-19203">2.00</ix:nonFraction> for the warrants.
Accordingly, effective after the closing of trading on December 14, 2022 (the 90th calendar day immediately following the issuance date
of the warrants), the warrants&#8217; exercise price was adjusted pursuant to their terms to $<ix:nonFraction contextRef="c101" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares" id="ixv-19204">2.00</ix:nonFraction> (the &#8220;Exercise Price Adjustment&#8221;).
Following the Exercise Price Adjustment, on February 16, 2023, the Company issued an aggregate of <ix:nonFraction contextRef="c102" decimals="0" format="ixt:num-dot-decimal" name="wlds:AggregateOrdinaryShares" scale="0" unitRef="shares" id="ixv-19205">169,125</ix:nonFraction> Ordinary Shares to the April
2021&#160;investors&#160;as a result of the IPO.&#160;&#160;</span></p></ix:nonNumeric><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 19; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>WEARABLE
DEVICES LTD. AND ITS SUBSIDIARY</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS (cont.)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="wlds:CreditFacilityDisclosureTextBlock" id="ixv-17328"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE
8 &#8211; CREDIT FACILITY </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
July 4, 2022, the Company entered into a senior secured credit facility agreement with L.I.A. Pure Capital Ltd. (&#8220;Pure Capital&#8221;)
to borrow from time to time amounts until the closing of the IPO in an amount of up to $<ix:nonFraction contextRef="c103" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherBorrowings" scale="3" unitRef="usd" id="ixv-19206">800</ix:nonFraction> thousand (the &#8220;Initial Credit&#8221;),
which Initial Credit could be increased, upon the request of the Company, to an amount not exceeding $<ix:nonFraction contextRef="c4" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" unitRef="usd" id="ixv-19207">1</ix:nonFraction> million (together with the Initial
Credit, the &#8220;Credit Facility&#8221;) in aggregate. The underlying outstanding amounts had priority in relation and senior to any
other debts owed by the Company to any third party, and were subject to a registered floating charge, for the benefit of Pure Capital,
against all of the Company&#8217;s assets. During July, August and September 2022, the Company received an aggregate of $<ix:nonFraction contextRef="c104" decimals="-3" format="ixt:num-dot-decimal" name="wlds:AggregateAmount" scale="3" unitRef="usd" id="ixv-19208">800</ix:nonFraction> thousand
under the Credit Facility. The Credit Facility bore interest at the rate of <ix:nonFraction contextRef="c104" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" unitRef="pure" id="ixv-19209">4</ix:nonFraction>% per annum. The outstanding amounts, together with interest
accrued and unpaid were due and payable on the earlier of (i) June 30, 2024, or (ii) upon receipt of a certain financing transaction
or in the event of certain customary events of default or a change of control. The Credit Facility was fully repaid on September 19,
2022. The agreement indicates that the Company shall not assume any debt senior to the Credit Facility during the term of the Credit
Facility, unless Pure Capital has provided its advance written consent; and subject to applicable law, any debt assumed by the Company
during such term shall be deemed subordinated to any debt accrued under the agreement, if Pure Capital had not provided its prior written
consent; and without Pure Capital&#8217;s prior written consent, the Company shall not pledge in favor of a third-party creditor or lender
any of its assets or rights, including by a floating charge, until such time that the Credit Facility, and any interest accrued thereon,
has been repaid in full to Pure Capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Additionally, the Credit Facility agreement
requires the Company to retain Pure Capital for investor relations services and other related strategic services in exchange for a monthly
base fee of $<ix:nonFraction contextRef="c47" decimals="-3" format="ixt:num-dot-decimal" name="wlds:ServicesInExchangeForMonthlyBaseFee" scale="3" unitRef="usd" id="ixv-19210">35</ix:nonFraction> thousand, upon the closing of the IPO, under a <ix:nonNumeric contextRef="c47" format="ixt-sec:duryear" name="wlds:AggrementTerm" id="ixv-19211">3</ix:nonNumeric> year consulting agreement. If <ix:nonFraction contextRef="c47" decimals="2" format="ixt:num-dot-decimal" name="wlds:WarrantsIssuedPercentage" scale="-2" unitRef="pure" id="ixv-19212">70</ix:nonFraction>% or more of the warrants (or other convertible
securities) issued in connection with the IPO are exercised during the term of such instrument, then the base monthly fee will immediately
increase to $<ix:nonFraction contextRef="c47" decimals="-3" format="ixt:num-dot-decimal" name="wlds:BaseMonthlyFeeImmediatelyIncreaseAmount" scale="3" unitRef="usd" id="ixv-19213">70</ix:nonFraction> thousand, which increase shall apply retroactively to the closing of the IPO date. In addition, Pure Capital shall serve
as the Company&#8217;s strategic consultant in connection with any offering or financing transaction of the Company, each, in excess of
$<ix:nonFraction contextRef="c47" decimals="-6" format="ixt:num-dot-decimal" name="wlds:OfferingOrFinancingTransactionAmount" scale="6" unitRef="usd" id="ixv-19214">5</ix:nonFraction> million (which does not include the IPO) in exchange for a per offering and/or transaction fee of $<ix:nonFraction contextRef="c47" decimals="-3" format="ixt:num-dot-decimal" name="wlds:TransactionFeeClosingValue" scale="3" unitRef="usd" id="ixv-19215">100</ix:nonFraction> thousand for the closing. Total
expenses for services rendered under the Pure Capital agreement were $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wlds:ExpenseOnServiceRendering" scale="3" unitRef="usd" id="ixv-19216">420</ix:nonFraction> thousand and $<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wlds:ExpenseOnServiceRendering" scale="3" unitRef="usd" id="ixv-19217">122</ix:nonFraction> thousand for the years ended December 31,
2023 and 2022, respectively.</p></ix:nonNumeric><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 20; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>WEARABLE
DEVICES LTD. AND ITS SUBSIDIARY</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS (cont.)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="ixv-17368"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE
9 &#8211; SHAREHOLDERS&#8217; EQUITY (DEFICIT):</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>a.</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share capital</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfStockholdersEquityTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfStockholdersEquityTableTextBlock" id="ixv-17389"><span style="font-family: Times New Roman, Times, Serif">The
share capital as of December 31, 2023 and 2022, is composed of as follows:</span></ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_ScheduleOfStockholdersEquityTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Number
    of shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Authorized</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Issued
    and outstanding</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">December
    31,<br/> 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">December
    31, <br/> 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">December
    31,<br/> 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">December
    31, <br/> 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Ordinary shares, NIS <ix:nonFraction contextRef="c135" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="ilsPershares" id="ixv-19218"><ix:nonFraction contextRef="c115" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="ilsPershares" id="ixv-19219">0.01</ix:nonFraction></ix:nonFraction> par value</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-19220">50,000,000</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c115" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-19221">50,000,000</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c135" decimals="INF" format="ixt:num-dot-decimal" name="wlds:NumberOfSharesIssuedAndOutstanding" scale="0" unitRef="shares" id="ixv-19222">20,387,428</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c115" decimals="INF" format="ixt:num-dot-decimal" name="wlds:NumberOfSharesIssuedAndOutstanding" scale="0" unitRef="shares" id="ixv-19223">15,049,720</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Ordinary Shares entitle their holders: to receive notices of, and to attend, general meetings where each Ordinary Share shall have one
vote for all purposes; to share distributions as may be declared by the Board of Directors of the Company and approved by the shareholders,
if required; and, upon liquidation or dissolution - to participate in the distribution of the assets of the Company after payment of
all debts and other liabilities of the Company, in accordance with the terms of the Company&#8217;s Articles of Association.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
inception, the Company issued <ix:nonFraction contextRef="c105" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-19224">4,500,000</ix:nonFraction> Ordinary Shares to its three co-founders for a total consideration equal to their par value (approximately
$<ix:nonFraction contextRef="c106" decimals="-3" format="ixt:num-dot-decimal" name="wlds:TotalValueOfTheShares" scale="3" unitRef="usd" id="ixv-19225">12</ix:nonFraction> thousand). In October 2021, the total consideration was paid off by the co-founders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
March 10, 2016, the Company issued to certain investors <ix:nonFraction contextRef="c107" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-19226">1,844,268</ix:nonFraction> ordinary A shares, NIS <ix:nonFraction contextRef="c108" decimals="2" format="ixt:num-dot-decimal" name="wlds:OrdinaryShareParValue" scale="0" unitRef="ilsPershares" id="ixv-19227">0.01</ix:nonFraction> par value of the Company (&#8220;Ordinary
A Shares&#8221;) for a total consideration of $<ix:nonFraction contextRef="c108" decimals="-3" format="ixt:num-dot-decimal" name="wlds:ValueOfOrdinaryAShare" scale="3" unitRef="usd" id="ixv-19228">500</ix:nonFraction> thousand.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Ordinary A Shares conferred on the holders all rights to holders of Ordinary Shares in the Company and, in addition, bore preferred rights
primarily advanced in return of their investments plus <ix:nonFraction contextRef="c109" decimals="2" format="ixt:num-dot-decimal" name="wlds:InterestPercentage" scale="-2" unitRef="pure" id="ixv-19229">2</ix:nonFraction>% per year, in a liquidation event as described in the Company&#8217;s Articles
of Association.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
2021, those Ordinary A Shares were converted into Ordinary Shares, and the Company reclassified the Company&#8217;s authorized share
capital of <ix:nonFraction contextRef="c110" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="0" unitRef="shares" id="ixv-19230">2,000,000</ix:nonFraction> Ordinary A Shares into <ix:nonFraction contextRef="c111" decimals="0" format="ixt:num-dot-decimal" name="wlds:AShareReclassifiedToOrdinaryShares" scale="0" unitRef="shares" id="ixv-19231">2,000,000</ix:nonFraction> Ordinary Shares and increased the Company&#8217;s authorized share capital by <ix:nonFraction contextRef="c110" decimals="0" format="ixt:num-dot-decimal" name="wlds:OrdinarySharesAuthorizedIncreased" scale="0" unitRef="shares" id="ixv-19232">10,000,000</ix:nonFraction>
Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During
2018, 2020, 2021 and 2022, the Company issued <ix:nonFraction contextRef="c112" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-19233">111,142</ix:nonFraction>, <ix:nonFraction contextRef="c113" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-19234">15,430</ix:nonFraction>, <ix:nonFraction contextRef="c114" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-19235">241,533</ix:nonFraction> and <ix:nonFraction contextRef="c115" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-19236">4,666</ix:nonFraction> Ordinary Shares, respectively, upon exercise of employees&#8217;
options.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
April 2021, the Company issued to new investors <ix:nonFraction contextRef="c116" decimals="0" format="ixt:num-dot-decimal" name="wlds:OrdinarySharesIssued" scale="0" unitRef="shares" id="ixv-19237">1,343,374</ix:nonFraction> Ordinary Shares, and <ix:nonFraction contextRef="c99" decimals="0" format="ixt:num-dot-decimal" name="wlds:OrdinarySharesWarrantExercisable" scale="0" unitRef="shares" id="ixv-19238">671,687</ix:nonFraction> warrants exercisable into Ordinary Shares in consideration
of <ix:nonFraction contextRef="c117" decimals="2" format="ixt:num-dot-decimal" name="wlds:OrdinarySharesInConsiderationPercentage" scale="-2" unitRef="pure" id="ixv-19239">125</ix:nonFraction>% of the per share purchase price in an initial public offering of the Company, if and when it shall occur, for total consideration
of $<ix:nonFraction contextRef="c117" decimals="-3" format="ixt:num-dot-decimal" name="wlds:TotalConsiderationAmount" scale="6" unitRef="usd" id="ixv-19240">3.025</ix:nonFraction> million, before $<ix:nonFraction contextRef="c117" decimals="-3" format="ixt:num-dot-decimal" name="wlds:IssuanceExpenses" scale="3" unitRef="usd" id="ixv-19241">100</ix:nonFraction> thousand of issuance expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During
September 2022, the Company completed the IPO, in which were issued <ix:nonFraction contextRef="c41" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-19242">3,750,000</ix:nonFraction> Ordinary Shares and warrants to purchase <ix:nonFraction contextRef="c41" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" unitRef="shares" id="ixv-19243">8,625,000</ix:nonFraction> Ordinary
Shares.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 21; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>WEARABLE
DEVICES LTD. AND ITS SUBSIDIARY</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS (cont.)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 9
&#8211; SHAREHOLDERS&#8217; EQUITY (DEFICIT) </b>(cont.)<b>:</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_2" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During
2022, the Company entered into SAFEs for $<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wlds:SAFEsAmount" scale="3" unitRef="usd" id="ixv-19244">500</ix:nonFraction> thousand with <ix:nonNumeric contextRef="c6" name="wlds:Investor" id="ixv-19245">5</ix:nonNumeric> investors, $<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wlds:InvestorAmount" scale="3" unitRef="usd" id="ixv-19246">100</ix:nonFraction> thousand each, of which $<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wlds:ConvertedAmount" scale="3" unitRef="usd" id="ixv-19247">400</ix:nonFraction> thousand were converted to
<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="wlds:ConvertedToOrdinaryShares" scale="0" unitRef="shares" id="ixv-19248">118,204</ix:nonFraction>&#160;Ordinary Shares and $<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Cash" scale="3" unitRef="usd" id="ixv-19249">100</ix:nonFraction> thousand of <ix:nonNumeric contextRef="c118" name="wlds:Investor" id="ixv-19250">one</ix:nonNumeric> investor were paid back in cash upon the closing of the IPO. Those&#160;SAFEs were
not mandatorily redeemable, nor redeemable at the option of the holder after a specified date, but in an Equity Financing (as defined
in the SAFEs) which under current liquidity circumstances constitutes a redemption event outside of the Company&#8217;s control. The
Company issued to each SAFE investor a warrant to purchase Ordinary Shares of the Company with an exercise price of $<ix:nonFraction contextRef="c28" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares" id="ixv-19251">6.345</ix:nonFraction> per share
in such offering for an aggregate amount of up to $<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement" scale="3" unitRef="usd" id="ixv-19252">25</ix:nonFraction> thousand (exercisable for a total of <ix:nonFraction contextRef="c25" decimals="0" format="ixt:num-dot-decimal" name="wlds:ExercisableWarrantsToShares" scale="0" unitRef="shares" id="ixv-19253">15,760</ix:nonFraction> Ordinary Shares, until the earlier
of: (i) eighteen (18) months from January 2022; or (ii) in a change of control event, which generally covers (a) a transaction in which
any person or group becomes the beneficial owner, directly or indirectly, of more than <ix:nonFraction contextRef="c119" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" unitRef="pure" id="ixv-19254">50</ix:nonFraction>% of the Company&#8217;s outstanding voting
securities with the right to vote for the election of members of the Company&#8217;s Board of Directors, or (b) any reorganization, merger
or consolidation of the Company, or (c) a sale, lease or other disposition of all or substantially all of the Company&#8217;s assets).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During
September 2022, investors exercised <ix:nonFraction contextRef="c39" decimals="0" format="ixt:num-dot-decimal" name="wlds:InvestorsExercisedWarrants" scale="0" unitRef="shares" id="ixv-19255">40,000</ix:nonFraction> warrants into Ordinary Shares. During October 2022, a former employee of the Company exercised
<ix:nonFraction contextRef="c120" decimals="0" format="ixt:num-dot-decimal" name="wlds:EmployeeExercisedWarrants" scale="0" unitRef="shares" id="ixv-19256">4,666</ix:nonFraction> options into Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
June 2023, <ix:nonFraction contextRef="c121" decimals="0" format="ixt:num-dot-decimal" name="wlds:ExercisableWarrantsToShares" scale="0" unitRef="shares" id="ixv-19257">724,139</ix:nonFraction> warrants were exercised into <ix:nonFraction contextRef="c121" decimals="0" format="ixt:num-dot-decimal" name="wlds:StockIssuedDuringPeriodSharesExerciseOfWarrants" scale="0" unitRef="shares" id="ixv-19258">724,139</ix:nonFraction> Ordinary Shares at an exercise price of $<ix:nonFraction contextRef="c121" decimals="2" format="ixt:num-dot-decimal" name="wlds:ExercisePricePerShare" scale="0" unitRef="usdPershares" id="ixv-19259">2.00</ix:nonFraction> per Ordinary Share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; background-color: white">During November 2023, the Company
completed a follow-on public offering for gross proceeds of $<ix:nonFraction contextRef="c122" decimals="-6" format="ixt:num-dot-decimal" name="wlds:ProceedsFromIssuanceFollowOnPublicOffering" scale="6" unitRef="usd" id="ixv-19260">2</ix:nonFraction> million, in which the Company issued <ix:nonFraction contextRef="c122" decimals="0" format="ixt:num-dot-decimal" name="wlds:OrdinarySharesIssued" scale="0" unitRef="shares" id="ixv-19261">4,444,444</ix:nonFraction> Ordinary Shares priced to
the public at $<ix:nonFraction contextRef="c122" decimals="2" format="ixt:num-dot-decimal" name="wlds:OrdinarySharePerValue" scale="0" unitRef="usdPershares" id="ixv-19262">0.45</ix:nonFraction> per share.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>b.</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share-based compensation</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 77.3pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
2015, the Company&#8217;s Board of Directors adopted the 2015 Share Option Plan (the &#8220;2015 Plan&#8221;), with&#160;<ix:nonFraction contextRef="c123" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" unitRef="shares" id="ixv-19263">1,032,805</ix:nonFraction> options
available for grant, and through December 31, 2021, the Company&#8217;s Board of Directors approved, in the aggregate, an increase of&#160;<ix:nonFraction contextRef="c124" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" scale="0" unitRef="shares" id="ixv-19264">800,000</ix:nonFraction>
options available for grant, for allocation to existing and future employees, consultants and directors of the Company and/or its Subsidiary,
such that, there are <ix:nonFraction contextRef="c24" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" unitRef="shares" id="ixv-19265">1,832,805</ix:nonFraction> Ordinary Shares reserved under the 2015 Plan (including those that were exercised into Ordinary Shares).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
December 15, 2022, the Company&#8217;s Board of Directors approved an increase of&#160;a total of <ix:nonFraction contextRef="c125" decimals="0" format="ixt:num-dot-decimal" name="wlds:OptionsAvailableForGrant" scale="0" unitRef="shares" id="ixv-19266">424,653</ix:nonFraction> Ordinary Shares underlying
options available for grant, for allocation to existing and future employees, consultants and directors of the Company and/or its Subsidiary,
such that there are <ix:nonFraction contextRef="c126" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" unitRef="shares" id="ixv-19267">2,257,458</ix:nonFraction> Ordinary Shares underlying options granted (including options that were exercised into Ordinary Shares)
or reserved for future issuance under the 2015 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">On August 23, 2023, the Company&#8217;s
Board of Directors approved an increase of&#160;a total of <ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="wlds:OptionsAvailableForGrant" scale="0" unitRef="shares" id="ixv-19268">931,139</ix:nonFraction> Ordinary Shares underlying options available for grant, for allocation
to existing and future employees, consultants and directors of the Company and/or its Subsidiary, such that there are <ix:nonFraction contextRef="c128" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" unitRef="shares" id="ixv-19269">3,188,597</ix:nonFraction> Ordinary
Shares underlying options granted (including options that were exercised into Ordinary Shares) or reserved for future issuance under the
2015 Plan.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">As of March 13, 2024, the Company had <ix:nonFraction contextRef="c129" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" unitRef="shares" id="ixv-19270">1,066,637</ix:nonFraction> Ordinary Shares reserved
for future issuance under the 2015 Plan.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"></p><div>

</div><!-- Field: Page; Sequence: 22; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>WEARABLE
DEVICES LTD. AND ITS SUBSIDIARY</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS (cont.)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 9
&#8211; SHAREHOLDERS&#8217; EQUITY (DEFICIT) </b>(cont.)<b>:</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_3" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>Options
to employees </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="ixv-17636"><span style="font-family: Times New Roman, Times, Serif">Below
is a summary of the Company&#8217;s options activity and related information with respect to options granted to employees during the
years ended December 31, 2023 and 2022.</span></ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3cm"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock-c0_cont_2" id="_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year ended
    <br/> December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year ended
    <br/> December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Amount<br/>
    of <br/> options</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Weighted<br/>
    average <br/> exercise <br/> price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Amount<br/>
    of <br/> options</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Weighted
    <br/> average <br/> exercise<br/> price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; text-indent: -11.35pt; padding-left: 11.35pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding
    - beginning of the year</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares" id="ixv-19271">988,264</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-19272">0.563</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c24" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares" id="ixv-19273">863,264</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c24" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-19274">0.614</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -11.35pt; padding-left: 11.35pt"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">*<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" id="ix_3_fact" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" unitRef="shares">471,500</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-19276">1.224</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" unitRef="shares" id="ixv-19277">145,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-19278">0.184</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -11.35pt; padding-left: 11.35pt"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-96; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-97; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" unitRef="shares" id="ixv-19279">4,666</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-19280">0.003</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -11.35pt; padding-left: 11.35pt"><span style="font-family: Times New Roman, Times, Serif">Expired
    or forfeited</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="0" unitRef="shares" id="ixv-19281">5,000</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-19282">0.664</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="0" unitRef="shares" id="ixv-19283">15,334</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-19284">0.003</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -11.35pt; padding-left: 11.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -11.35pt; padding-left: 11.35pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding
    - end of the year</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares" id="ixv-19285">1,454,764</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-19286">0.777</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares" id="ixv-19287">988,264</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-19288">0.563</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -11.35pt; padding-left: 11.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -11.35pt; padding-left: 11.35pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable
    at end of year</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" unitRef="shares" id="ixv-19289">889,125</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-19290">0.612</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" unitRef="shares" id="ixv-19291">753,236</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-19292">0.703</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The weighted-average grant date fair
value of stock-based awards granted&#160;was $<ix:nonFraction contextRef="c0" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares" id="ixv-19293">1.224</ix:nonFraction>, $<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="3" unitRef="usdPershares" id="ixv-19294">0.184</ix:nonFraction> and $<ix:nonFraction contextRef="c7" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares" id="ixv-19295">0.323</ix:nonFraction> per share during the years ended December 31, 2023, December 31,&#160;2022
and December 31, 2021, respectively. The options will expire at the earlier of (i) <ix:nonNumeric contextRef="c130" format="ixt-sec:durwordsen" name="wlds:TerminationPeriod" id="ixv-19296">ten years</ix:nonNumeric> from the date of grant or (ii) <ix:nonNumeric contextRef="c130" format="ixt-sec:durday" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" id="ixv-19297">90</ix:nonNumeric> days
following the termination of employment.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="ixv-18024"><span style="font-family: Times New Roman, Times, Serif">The
following weighted-average assumptions were used in determining the most recent fair values of stock options using the Black-Scholes
valuation model:</span></ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left; text-indent: -11.35pt; padding-left: 11.35pt"><span style="font-family: Times New Roman, Times, Serif">Expected
    dividend yield</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" unitRef="pure" id="ixv-19298">0</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -11.35pt; padding-left: 11.35pt"><span style="font-family: Times New Roman, Times, Serif">Expected
    stock price volatility</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" unitRef="pure" id="ixv-19299">55.0</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -11.35pt; padding-left: 11.35pt"><span style="font-family: Times New Roman, Times, Serif">Risk
    free interest rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" unitRef="pure" id="ixv-19300">4.10</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -11.35pt; padding-left: 11.35pt"><span style="font-family: Times New Roman, Times, Serif">Expected
    life of options</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="wlds:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions" id="ixv-18089"><span style="font-family: Times New Roman, Times, Serif">6.25</span></ix:nonNumeric></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock-c0_cont_2"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">*</span></td><td style="text-align: justify"><ix:footnote id="ix_2_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif">Including the grant of <ix:nonFraction contextRef="c131" decimals="0" format="ixt:num-dot-decimal" name="wlds:IssuanceOfSharesOptions" scale="0" unitRef="shares" id="ixv-19301">120,000</ix:nonFraction> options to purchase up to <ix:nonFraction contextRef="c132" decimals="0" format="ixt:num-dot-decimal" name="wlds:IssuanceOfSharesOptions" scale="0" unitRef="shares" id="ixv-19302">120,000</ix:nonFraction> Ordinary Shares to directors, as approved by the Company&#8217;s shareholders on November 30, 2023, with an exercise price of $<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="wlds:ExercisePricePerShare" scale="0" unitRef="usdPershares" id="ixv-19303">1.32</ix:nonFraction> per share. The options will expire at the earlier of (i) <ix:nonNumeric contextRef="c0" format="ixt-sec:durwordsen" name="wlds:TerminationPeriod" id="ixv-19304">ten years</ix:nonNumeric> from the date of grant or (ii) <ix:nonNumeric contextRef="c0" format="ixt-sec:durday" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" id="ixv-19305">90</ix:nonNumeric> days following a termination of employment or service. The fair value of each option as of the grant date was $<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="wlds:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate" scale="0" unitRef="usdPershares" id="ixv-19306">0.12</ix:nonFraction>, determined using the Black-Scholes option pricing model and the total expenses of $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wlds:OptionsExpenses" scale="3" unitRef="usd" id="ixv-19307">15</ix:nonFraction> thousand will be expensed over the option vesting periods of <ix:nonNumeric contextRef="c0" format="ixt-sec:durwordsen" name="wlds:VestingPeriods" id="ixv-19308">three years</ix:nonNumeric>.</span></ix:footnote></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 23; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>WEARABLE
DEVICES LTD. AND ITS SUBSIDIARY</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS (cont.)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 9
&#8211; SHAREHOLDERS&#8217; EQUITY (DEFICIT) </b>(cont.)<b>:</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_4" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>Options
to consultants </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><ix:nonNumeric contextRef="c0" continuedAt="wlds_ScheduleOfOptionsToConsultantsTableTextBlock-c0_cont_1" escape="true" name="wlds:ScheduleOfOptionsToConsultantsTableTextBlock" id="ixv-18148"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s outstanding options to consultants as of December 31, 2023 were as follows:</span></ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 77.3pt; text-indent: -1cm"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="wlds_ScheduleOfOptionsToConsultantsTableTextBlock-c0_cont_2" id="wlds_ScheduleOfOptionsToConsultantsTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left; font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Issuance
    date</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">In
    connection with</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>No.
of options<br/>
issued</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">&#160;<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Exercise<br/>
price</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>No.
of options<br/>
exercisable</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 32%"><span style="font-family: Times New Roman, Times, Serif">2015</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 31%; text-align: center"><ix:nonNumeric contextRef="c136" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" id="ixv-18194"><span style="font-family: Times New Roman, Times, Serif">Rendered services</span></ix:nonNumeric></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c136" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" scale="0" unitRef="shares" id="ixv-19309">110,655</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c137" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-19310">0.003</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c137" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="0" unitRef="shares" id="ixv-19311">110,655</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">2017</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c138" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" id="ixv-18226"><span style="font-family: Times New Roman, Times, Serif">Rendered services</span></ix:nonNumeric></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c138" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" scale="0" unitRef="shares" id="ixv-19312">36,885</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c139" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-19313">0.003</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="0" unitRef="shares" id="ixv-19314">36,885</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c140" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" id="ixv-18258"><span style="font-family: Times New Roman, Times, Serif">Rendered services</span></ix:nonNumeric></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c140" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" scale="0" unitRef="shares" id="ixv-19315">69,090</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c141" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-19316">0.003</ix:nonFraction>-$<ix:nonFraction contextRef="c142" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-19317">2.25</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c143" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="0" unitRef="shares" id="ixv-19318">69,090</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">2023*</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c144" id="ix_4_fact" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms"><span style="font-family: Times New Roman, Times, Serif">Rendered services</span></ix:nonNumeric></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c144" decimals="INF" format="ixt:num-dot-decimal" id="ix_5_fact" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" scale="0" unitRef="shares">100,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c145" decimals="3" format="ixt:num-dot-decimal" id="ix_6_fact" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">0.546</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c145" decimals="0" format="ixt:num-dot-decimal" id="ix_7_fact" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="0" unitRef="shares">37,778</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 77.3pt; text-indent: -1cm"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="wlds_ScheduleOfOptionsToConsultantsTableTextBlock-c0_cont_2"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">*</span></td><td style="text-align: justify"><ix:footnote id="ix_3_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif">On April 27, 2023, the Company&#8217;s Board of Directors approved the additional grant of options to purchase up to <ix:nonFraction contextRef="c133" decimals="0" format="ixt:num-dot-decimal" name="wlds:IssuanceOfSharesOptions" scale="0" unitRef="shares" id="ixv-19322">100,000</ix:nonFraction> Ordinary Shares to a consultant, with an exercise price of $<ix:nonFraction contextRef="c134" decimals="2" format="ixt:num-dot-decimal" name="wlds:ExercisePricePerShare" scale="0" unitRef="usdPershares" id="ixv-19323">0.55</ix:nonFraction> per share. The options will expire at the earlier of (i) <ix:nonNumeric contextRef="c134" continuedAt="wlds_TerminationPeriod-c134_cont_1" format="ixt-sec:durwordsen" name="wlds:TerminationPeriod" id="ixv-19324">ten</ix:nonNumeric><ix:continuation id="wlds_TerminationPeriod-c134_cont_1"> years</ix:continuation> from the date of grant or (ii) <ix:nonNumeric contextRef="c134" format="ixt-sec:durday" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" id="ixv-19326">90</ix:nonNumeric> days following a termination of services. The fair value of each option as of the grant date was $<ix:nonFraction contextRef="c134" decimals="2" format="ixt:num-dot-decimal" name="wlds:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate" scale="0" unitRef="usdPershares" id="ixv-19327">0.26</ix:nonFraction>, determined using the Black-Scholes option pricing model and the total expenses of $<ix:nonFraction contextRef="c134" decimals="-3" format="ixt:num-dot-decimal" name="wlds:OptionsExpenses" scale="3" unitRef="usd" id="ixv-19328">26</ix:nonFraction> thousand will be expensed over the option vesting periods of <ix:nonNumeric contextRef="c134" format="ixt-sec:durwordsen" name="wlds:VestingPeriods" id="ixv-19329">three years</ix:nonNumeric>.</span></ix:footnote></td>
</tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="ixv-18329"><span style="font-family: Times New Roman, Times, Serif">The
share-based compensation expenses are recognized in the following line items in the consolidated statements of comprehensive loss in
the years ended:</span></ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">U.S.
    dollars in thousands</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Research and development expenses</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c146" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-19330">83</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c147" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-19331">180</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c148" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-19332">105</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Sales and marketing expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c149" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-19333">61</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c150" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-19334">401</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c151" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-19335">111</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">General and administrative
    expenses</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c152" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-19336">97</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c153" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-19337">209</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c154" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-19338">83</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-19339">241</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-19340">790</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-19341">299</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table></ix:continuation>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 0.25in"><ix:nonNumeric contextRef="c0" continuedAt="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock-c0_cont_1" escape="true" name="wlds:ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock" id="ixv-18485"><span style="font-family: Times New Roman, Times, Serif"><b>Equity
Warrants to investors and associated with the IPO, as of December 31, 2023:</b></span></ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock-c0_cont_2" id="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Number&#160;of
    warrants/ options</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Issuance
    date</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Exercise
    price</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Exercise
    ratio</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Expiration
    date</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Notes</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c155" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" unitRef="shares" id="ixv-19342">7,860,861</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 14%; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">September
    13, 2022</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c156" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" unitRef="usdPershares" id="ixv-19343">2.00</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 25%; text-align: left; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c156" name="wlds:ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio" id="ixv-18554"><span style="font-family: Times New Roman, Times, Serif">Each warrant is exercisable into 1 Ordinary Share</span></ix:nonNumeric></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 16%; text-align: left; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c156" name="wlds:ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate" id="ixv-18559"><span style="font-family: Times New Roman, Times, Serif">5 years following the issuance date</span></ix:nonNumeric></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 18%; text-align: left; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c156" id="ix_8_fact" name="wlds:ShareBasedCompensationArrangementNotes"><span style="font-family: Times New Roman, Times, Serif">Registered for trading (*)</span></ix:nonNumeric></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c157" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" unitRef="shares" id="ixv-19344">671,687</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">September 15, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c158" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" unitRef="usdPershares" id="ixv-19345">5.29</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c158" name="wlds:ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio" id="ixv-18588"><span style="font-family: Times New Roman, Times, Serif">Each warrant is exercisable into 1 Ordinary Share, See note 7(B) above</span></ix:nonNumeric></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: justify; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c158" name="wlds:ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate" id="ixv-18593"><span style="font-family: Times New Roman, Times, Serif">18 months following the issuance date</span></ix:nonNumeric></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c158" name="wlds:ShareBasedCompensationArrangementNotes" id="ixv-18598"><span style="font-family: Times New Roman, Times, Serif">Owned by April 2021 investors</span></ix:nonNumeric></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c159" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" unitRef="shares" id="ixv-19346">187,500</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">September 15, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c160" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" unitRef="usdPershares" id="ixv-19347">5.31</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c160" name="wlds:ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio" id="ixv-18622"><span style="font-family: Times New Roman, Times, Serif">Each warrant is exercisable into 1 Ordinary Share</span></ix:nonNumeric></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c160" name="wlds:ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate" id="ixv-18627"><span style="font-family: Times New Roman, Times, Serif">5 years following the issuance date</span></ix:nonNumeric></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c160" name="wlds:ShareBasedCompensationArrangementNotes" id="ixv-18632"><span style="font-family: Times New Roman, Times, Serif">Owned by underwriter</span></ix:nonNumeric></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c161" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" unitRef="shares" id="ixv-19348">23,640</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">September 15, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c162" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" unitRef="usdPershares" id="ixv-19349">4.23</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c162" name="wlds:ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio" id="ixv-18656"><span style="font-family: Times New Roman, Times, Serif">Each warrant is exercisable into 1 Ordinary Share</span></ix:nonNumeric></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c162" name="wlds:ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate" id="ixv-18661"><span style="font-family: Times New Roman, Times, Serif">10 years following the issuance date</span></ix:nonNumeric></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: justify; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c162" name="wlds:ShareBasedCompensationArrangementNotes" id="ixv-18666"><span style="font-family: Times New Roman, Times, Serif">Owned by the legal advisor</span></ix:nonNumeric></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>


</div><div>

</div><!-- Field: Page; Sequence: 24; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>WEARABLE
DEVICES LTD. AND ITS SUBSIDIARY</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS (cont.)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 9
&#8211; SHAREHOLDERS&#8217; EQUITY (DEFICIT) </b>(cont.)<b>:</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_4"><ix:continuation id="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">(*) <ix:footnote id="ix_4_footnote" xml:lang="en-US">The warrants are exercisable at
any time after their original issuance and at any time up to the date that is five&#160;years after their original issuance. The warrants
will be exercisable, at the option of each holder, in whole or in part by delivering to us a duly executed exercise notice and, at any
time a registration statement registering the issuance of the Ordinary Shares underlying the warrants under the Securities Act is effective
and available for the issuance of such shares, by payment in full in immediately available funds for the number of Ordinary Shares purchased
upon such exercise.</ix:footnote></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The exercise price per whole Ordinary
Share purchasable upon exercise of the warrants $<ix:nonFraction contextRef="c4" decimals="2" format="ixt:num-dot-decimal" name="wlds:ExercisePriceOfWarrants" scale="0" unitRef="usdPershares" id="ixv-19351">4.00</ix:nonFraction> per share (the &#8220;Initial Exercise Price&#8221;). The exercise price is subject
to appropriate adjustment in the event of certain stock dividends and distributions, stock splits, stock combinations, reclassifications
or similar events affecting the Company&#8217;s Ordinary Shares and also upon any distributions of assets, including cash, stock or other
property to the Company&#8217;s shareholders. Subject to certain exemptions outlined in the warrant, for a period until <span style="-sec-ix-hidden: hidden-fact-98">two</span> years from
the date of issuance of the warrant, if the Company shall sell, enter into an agreement to sell and subsequently sells, or grant any option
to purchase, or sell, enter into an agreement to sell and subsequently sells, or grant any right to reprice, or otherwise dispose of or
issue (or announce any offer, sale, grant or any option to purchase or other disposition the subsequently closes) any Ordinary Shares
or convertible security, at an effective price per share less than the exercise price of the warrant then in effect, the exercise price
of the warrant shall be reduced to equal the effective price per share in such Dilutive Issuance;&#160;provided, however, that in no event
shall the exercise price of the warrant be reduced to an exercise price lower than <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="wlds:WarrantBeReducedToAnExercisePricePercentage" scale="-2" unitRef="pure" id="ixv-19352">50</ix:nonFraction>% of the Initial Exercise Price. On the date that
is 90 calendar days immediately following the initial issuance date of the warrants, the exercise price of the warrants will adjust (the
&#8220;Reset Price&#8221;), provided that such value is less than the exercise price in effect on that date. The Reset Price is equal
to the greater of (a) <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="wlds:InitialExercisePricePercentage" scale="-2" unitRef="pure" id="ixv-19353">50</ix:nonFraction>% of the Initial Exercise Price of the warrants on the issuance date or (b) <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="wlds:WeightedAveragePricePercentage" scale="-2" unitRef="pure" id="ixv-19354">100</ix:nonFraction>% of the lowest volume weighted
average price per Ordinary Share occurring on any day between the initial exercise date of the warrants and 90 calendar days following
the issuance date of the warrants. The lowest Reset Price is $<ix:nonFraction contextRef="c4" decimals="2" format="ixt:num-dot-decimal" name="wlds:LowestResetPrice" scale="0" unitRef="usdPershares" id="ixv-19355">2.00</ix:nonFraction>, which is <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="wlds:InitialExercisePricesPercentage" scale="-2" unitRef="pure" id="ixv-19356">50</ix:nonFraction>% of the Initial Exercise Price.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock" id="ixv-18713"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 10
- TAXES ON INCOME:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 54pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td>
    <td style="text-indent: 0in; padding-left: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company
    is taxed under the Israeli law.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.15pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 54pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income of an Israeli company is subject to corporate tax. The corporate tax rate in Israel is&#160;<ix:nonFraction contextRef="c163" decimals="2" format="ixt:num-dot-decimal" name="wlds:CorporateTaxRatePercentage" scale="-2" unitRef="pure" id="ixv-19357">23</ix:nonFraction>%.</span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.15pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 54pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax assessments - In accordance
    with the Israeli Income Tax Ordinance, tax assessments of the Company through tax year 2016 are considered final.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.25pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 54pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carryforward tax losses of the Company as of December 31, 2023, amounted to approximately $<ix:nonFraction contextRef="c4" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingLossCarryforwards" scale="6" unitRef="usd" id="ixv-19358">13.8</ix:nonFraction> million; however, a full valuation allowance of $<ix:nonFraction contextRef="c4" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" unitRef="usd" id="ixv-19359">3.2</ix:nonFraction> million was recorded against the potential future tax benefits.</span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.25pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 54pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Subsidiary is taxed under the U.S. tax law. The federal tax rate is <ix:nonFraction contextRef="c7" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" unitRef="pure" id="ixv-19360"><ix:nonFraction contextRef="c6" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" unitRef="pure" id="ixv-19361"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" unitRef="pure" id="ixv-19362">21</ix:nonFraction></ix:nonFraction></ix:nonFraction>%.</span></td></tr> </table></ix:nonNumeric><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="ixv-18771"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE
11 &#8211; RELATED PARTIES</b>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
employment expenses of the co-founders who each owns more than <ix:nonFraction contextRef="c164" decimals="2" format="ixt:num-dot-decimal" name="wlds:PercentageOfOwnership" scale="-2" unitRef="pure" id="ixv-19363">5</ix:nonFraction>% of the Company&#8217;s Ordinary Shares: Asher Dahan (the Chairman of
the Board of Directors and the Chief Executive Officer), Guy Wanger (President and Director) and Leeor Langer (the Chief Technology Officer),
for the years ended December 31, 2023, 2022 and 2021 amounted to approximately $<ix:nonFraction contextRef="c164" decimals="-3" format="ixt:num-dot-decimal" name="wlds:EmploymentExpenses" scale="3" unitRef="usd" id="ixv-19364">293</ix:nonFraction> thousand, $<ix:nonFraction contextRef="c165" decimals="-3" format="ixt:num-dot-decimal" name="wlds:EmploymentExpenses" scale="3" unitRef="usd" id="ixv-19365">331</ix:nonFraction> thousand, and $<ix:nonFraction contextRef="c166" decimals="-3" format="ixt:num-dot-decimal" name="wlds:EmploymentExpenses" scale="3" unitRef="usd" id="ixv-19366">145</ix:nonFraction> thousand, respectively.
On March 14, 2022, the Company&#8217;s shareholders meeting approved the increase of the monthly salary of each of the Company&#8217;s
co-founders to NIS&#160;<ix:nonFraction contextRef="c167" decimals="-3" format="ixt:num-dot-decimal" name="wlds:OfficerEmployeeMonthlySalary" scale="3" unitRef="ils" id="ixv-19367">70</ix:nonFraction>&#160;thousand (approximately $<ix:nonFraction contextRef="c167" decimals="-3" format="ixt:num-dot-decimal" name="wlds:RelatedPartyMonthlySalary" scale="3" unitRef="usd" id="ixv-19368">19</ix:nonFraction>&#160;thousand), plus social benefits and leased car, and approved a one-time
bonus equal to 6 monthly salaries, upon the closing of the IPO which was accomplished in September 2022 (see note 1e).</span></p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">F-24</span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>




























































</div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonFraction contextRef="c5" id="hidden-fact-0" name="us-gaap:DepositsAssetsCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-1" name="us-gaap:DepositsAssetsNoncurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-2" name="us-gaap:DeferredRevenueCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-3" name="us-gaap:CommitmentsAndContingencies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-4" name="us-gaap:CommitmentsAndContingencies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-5" name="wlds:ProspectiveInitialPublicOfferingExpenses" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" decimals="2" id="hidden-fact-6" name="us-gaap:EarningsPerShareDiluted" sign="-" unitRef="usdPershares">0.27</ix:nonFraction>
<ix:nonFraction contextRef="c0" decimals="2" id="hidden-fact-7" name="us-gaap:EarningsPerShareDiluted" sign="-" unitRef="usdPershares">0.48</ix:nonFraction>
<ix:nonFraction contextRef="c6" decimals="2" id="hidden-fact-8" name="us-gaap:EarningsPerShareDiluted" sign="-" unitRef="usdPershares">0.53</ix:nonFraction>
<ix:nonFraction contextRef="c6" decimals="0" id="hidden-fact-9" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="shares">12277224</ix:nonFraction>
<ix:nonFraction contextRef="c0" decimals="0" id="hidden-fact-10" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="shares">16201238</ix:nonFraction>
<ix:nonFraction contextRef="c7" decimals="0" id="hidden-fact-11" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="shares">9709590</ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-12" name="wlds:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-13" name="wlds:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c18" id="hidden-fact-14" name="wlds:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-15" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-16" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c18" id="hidden-fact-17" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-18" name="wlds:ConversionOfOrdinaryASharesToOrdinarySharesValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c17" id="hidden-fact-19" name="wlds:ConversionOfOrdinaryASharesToOrdinarySharesValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c18" id="hidden-fact-20" name="wlds:ConversionOfOrdinaryASharesToOrdinarySharesValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-21" name="wlds:ConversionOfOrdinaryASharesToOrdinarySharesValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c14" id="hidden-fact-22" name="us-gaap:ShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-23" name="us-gaap:ShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-24" name="us-gaap:ShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c18" id="hidden-fact-25" name="us-gaap:ShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-26" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-27" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c17" id="hidden-fact-28" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c18" id="hidden-fact-29" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c14" id="hidden-fact-30" name="wlds:StockIssuedDuringPeriodValueOfPaymentOnBehalfOfSharesIssued" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-31" name="wlds:StockIssuedDuringPeriodValueOfPaymentOnBehalfOfSharesIssued" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c17" id="hidden-fact-32" name="wlds:StockIssuedDuringPeriodValueOfPaymentOnBehalfOfSharesIssued" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c18" id="hidden-fact-33" name="wlds:StockIssuedDuringPeriodValueOfPaymentOnBehalfOfSharesIssued" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c14" id="hidden-fact-34" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-35" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-36" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c17" id="hidden-fact-37" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-38" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c21" id="hidden-fact-39" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-40" name="wlds:IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-41" name="us-gaap:StockIssuedDuringPeriodValueOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-42" name="wlds:IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-43" name="wlds:IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-44" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-45" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-46" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-47" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-48" name="us-gaap:ShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-49" name="us-gaap:ShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-50" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-51" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-52" name="wlds:AccruedInterestOnConvertibleSecurities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-53" name="wlds:AccruedInterestOnConvertibleSecurities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-54" name="wlds:AccruedInterestOnDeposits" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-55" name="wlds:AccruedInterestOnDeposits" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-56" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-57" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-58" name="us-gaap:IncreaseDecreaseInAccountsReceivable" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-59" name="wlds:IncreaseDecreaseInAdvancePaymentsOnGovernmentalGrant" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-60" name="wlds:IncreaseDecreaseInAdvancePaymentsOnGovernmentalGrant" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-61" name="us-gaap:PaymentsToAcquireRestrictedCertificatesOfDeposit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-62" name="us-gaap:PaymentsToAcquireRestrictedCertificatesOfDeposit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-63" name="wlds:PrepaymentsOfLeasing" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-64" name="wlds:PrepaymentsOfLeasing" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-65" name="wlds:ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-66" name="wlds:ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-67" name="wlds:ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPubli" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-68" name="wlds:ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPubli" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-69" name="wlds:ProceedsFromIssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-70" name="wlds:ProceedsFromIssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-71" name="wlds:ProceedsFromIssuanceOfSAFEs" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-72" name="wlds:ProceedsFromIssuanceOfSAFEs" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-73" name="wlds:RefundToSAFEInvestors" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-74" name="wlds:RefundToSAFEInvestors" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-75" name="us-gaap:ProceedsFromLinesOfCredit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-76" name="us-gaap:ProceedsFromLinesOfCredit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-77" name="us-gaap:RepaymentsOfLinesOfCredit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-78" name="us-gaap:RepaymentsOfLinesOfCredit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" decimals="-3" id="hidden-fact-79" name="wlds:ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" unitRef="usd">1449000</ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-80" name="wlds:ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-81" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-82" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-83" name="wlds:PaymentOnBehalfOfIssuedShares" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-84" name="wlds:PaymentOnBehalfOfIssuedShares" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-85" name="us-gaap:InterestPaidNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-86" name="us-gaap:InterestPaidNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-87" name="wlds:InterestReceivedFromDeposits" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-88" name="wlds:InterestReceivedFromDeposits" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-89" name="wlds:ConversionOfSAFEToEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-90" name="wlds:ConversionOfSAFEToEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-91" name="wlds:RightofUseAssetRecognizedAgainstLeaseLiability" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-92" name="us-gaap:InventoryWorkInProcessNetOfReserves" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-93" name="us-gaap:InventoryFinishedGoodsNetOfReserves" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c64" id="hidden-fact-94" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c72" id="hidden-fact-95" name="wlds:ResearchAndDevelopmentGrantsDetection" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-96" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-97" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c4" id="hidden-fact-98" name="us-gaap:WarrantsAndRightsOutstandingTerm">P2Y</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:AmendmentFlag" id="ixv-19470">false</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalPeriodFocus" id="ixv-19471">FY</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey" id="ixv-19472">0001887673</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="wlds-20231231.xsd" xlink:type="simple"/></ix:references>
<ix:resources><ix:relationship fromRefs="ix_0_fact ix_1_fact ix_2_fact hidden-fact-9 hidden-fact-10 hidden-fact-11" toRefs="ix_0_footnote"></ix:relationship>
<ix:relationship fromRefs="hidden-fact-42 hidden-fact-44" toRefs="ix_1_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_3_fact" toRefs="ix_2_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_4_fact ix_5_fact ix_6_fact ix_7_fact" toRefs="ix_3_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_8_fact" toRefs="ix_4_footnote"></ix:relationship>
<xbrli:context id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c1">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c2">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wlds:OrdinarySharesNIS001ParValuePerShareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c3">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wlds:WarrantsToPurchaseOrdinarySharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c4">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c5">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c6">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c7">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c8">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c9">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c10">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">wlds:SubscriptionReceivablesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c11">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c12">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c13">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c14">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c15">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c16">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">wlds:SubscriptionReceivablesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c17">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c18">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c19">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c20">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c21">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">wlds:SubscriptionReceivablesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c22">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c23">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c24">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c25">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c26">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c27">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c28">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c29">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c30">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c31">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c32">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c33">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c34">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c35">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c36">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c37">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">wlds:MudraInspireDevelopmentKitsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c38">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c39">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-09-01</xbrli:startDate>
    <xbrli:endDate>2022-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c40">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c41">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c42">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c43">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c44">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c45">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-16</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c46">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-12-01</xbrli:startDate>
    <xbrli:endDate>2022-12-14</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c47">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c48">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-03-12</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c49">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-11-25</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c50">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-10-24</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c51">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-11-01</xbrli:startDate>
    <xbrli:endDate>2023-11-13</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c52">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wlds:LeaseLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c53">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c54">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c55">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:ComputersAndSoftwareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c56">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:MoldMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c57">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:ComputersAndSoftwareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c58">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:ComputersAndSoftwareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c59">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c60">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c61">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:ElectronicEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c62">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:ElectronicEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c63">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:MachinesAndMoldsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c64">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:MachinesAndMoldsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c65">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c66">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c67">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c68">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2018-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c69">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-07-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c70">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-01-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c71">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">wlds:IIAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c72">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">wlds:IIAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c73">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">wlds:IIAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c74">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">wlds:IMEIMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c75">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">wlds:IMEIMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c76">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">wlds:IMEIMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c77">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">wlds:IMEIMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c78">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c79">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrYE9rliDcrbWhjsc3i7BCl/DvlJVwr+JR0O2nYady5Se133BDWCF8ON/Jzif84CehHV5r9vMQwYxP2psHDnPZsunu1t2oh0qhdKXAlJyzN93OrPInDu+qpjJa2tGyv2XwvSkfjcWfQLzhpm2ZADneXuFkrcNjL16FM7h6sOb4n/vSj6ATmkI0Ua4rjBBddfCaAl+Fxnk9xc2lAOSp4aGVOy] CSR-->
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c80">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c81">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LeaseAgreementsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c82">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2017-01-01</xbrli:startDate>
    <xbrli:endDate>2017-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c83">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2018-01-01</xbrli:startDate>
    <xbrli:endDate>2018-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c84">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2019-01-01</xbrli:startDate>
    <xbrli:endDate>2019-01-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c85">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2019-04-01</xbrli:startDate>
    <xbrli:endDate>2019-04-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c86">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2019-11-01</xbrli:startDate>
    <xbrli:endDate>2019-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c87">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wlds:ConvertibleSecuritiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c88">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wlds:ConvertibleSecuritiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2017-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c89">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wlds:ConvertibleSecuritiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2018-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c90">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wlds:ConvertibleSecuritiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-01-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c91">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wlds:ConvertibleSecuritiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-04-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c92">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wlds:ConvertibleSecuritiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-11-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c93">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wlds:ConvertibleSecuritiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c94">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wlds:ConvertibleSecuritiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-04-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c95">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c96">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-06-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c97">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-04-01</xbrli:startDate>
    <xbrli:endDate>2021-04-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c98">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-04-22</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c99">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-04-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c100">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-20</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c101">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-20</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c102">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wlds:ConvertibleSecuritiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-02-01</xbrli:startDate>
    <xbrli:endDate>2023-02-16</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c103">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-07-04</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c104">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c105">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">wlds:CofoundersMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c106">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">wlds:CofoundersMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c107">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2016-03-10</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c108">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2016-03-10</xbrli:startDate>
    <xbrli:endDate>2016-03-10</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c109">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c110">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c111">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c112">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2018-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c113">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c114">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c115">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c116">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-04-01</xbrli:startDate>
    <xbrli:endDate>2021-04-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c117">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-04-01</xbrli:startDate>
    <xbrli:endDate>2021-04-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c118">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c119">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c120">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-10-01</xbrli:startDate>
    <xbrli:endDate>2022-10-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c121">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-06-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c122">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-11-01</xbrli:startDate>
    <xbrli:endDate>2023-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c123">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:TwoZeroOneFiveMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2015-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c124">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:TwoZeroOneFiveMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c125">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-15</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c126">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:TwoZeroOneFiveMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-15</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c127">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-08-23</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c128">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:TwoZeroOneFiveMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-08-23</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c129">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:TwoZeroOneFiveMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c130">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-01-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c131">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c132">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c133">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-04-27</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c134">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-04-01</xbrli:startDate>
    <xbrli:endDate>2023-04-27</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c135">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c136">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandFifteenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c137">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandFifteenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c138">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandSeventeenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c139">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandSeventeenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c140">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandTwentyoneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c141">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandTwentyoneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c142">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandTwentyoneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c143">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandTwentyoneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c144">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandTwentyThreeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c145">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandTwentyThreeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c146">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c147">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c148">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c149">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c150">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c151">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c152">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c153">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c154">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c155">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:September132022Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c156">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:September132022Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c157">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:September152022OneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c158">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:September152022OneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c159">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:September152022TwoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c160">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:September152022TwoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c161">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:September152022ThreeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c162">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:September152022ThreeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c163">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c164">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wlds:CofoundersMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">wlds:AsherDahanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c165">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wlds:CofoundersMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">wlds:AsherDahanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c166">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wlds:CofoundersMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">wlds:AsherDahanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c167">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-03-01</xbrli:startDate>
    <xbrli:endDate>2022-03-14</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:unit id="shares">
  <xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unit><xbrli:unit id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit><xbrli:unit id="ilsPershares">
  <xbrli:divide>
    <xbrli:unitNumerator>
      <xbrli:measure>iso4217:ILS</xbrli:measure>
    </xbrli:unitNumerator>
    <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unitDenominator>
  </xbrli:divide>
</xbrli:unit><xbrli:unit id="usdPershares">
  <xbrli:divide>
    <xbrli:unitNumerator>
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unitNumerator>
    <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unitDenominator>
  </xbrli:divide>
</xbrli:unit><xbrli:unit id="pure">
  <xbrli:measure>xbrli:pure</xbrli:measure>
</xbrli:unit><xbrli:unit id="ils">
  <xbrli:measure>iso4217:ILS</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>

</div></div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.3
<SEQUENCE>2
<FILENAME>ea020095201ex2-3_wearable.htm
<DESCRIPTION>DESCRIPTION OF SECURITIES
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 2.3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DESCRIPTION OF SHARE CAPITAL</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following description of the share capital
of Wearable Devices Ltd., or the Company, and the provisions of our articles of association&nbsp;<FONT STYLE="background-color: white">and
Israeli law</FONT>&nbsp;are summaries, do not purport to be complete and is qualified in its entirety by reference to our articles of
association, Israeli law and any other documents referenced.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Type and class of securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Ordinary Shares</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As of March 21, 2022, our authorized share capital
consists of 50,000,000 Ordinary Shares, NIS 0.01 par value each, or the Ordinary Shares, of which 15,218,845 Ordinary Shares were issued
and outstanding as of such date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">All of our outstanding Ordinary Shares have been
validly issued, fully paid and non-assessable. Our Ordinary Shares are not redeemable and are not subject to any preemptive right.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our Ordinary Shares and warrants have been listed
on the Nasdaq Capital Market under the symbol &ldquo;WLDS&rdquo; and &ldquo;WLDSW,&rdquo; respectively, since September 13, 2022.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Warrants and Options</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As of March 21, 2023, we have issued and outstanding
warrants, or the Warrants, to purchase an aggregate of 8,585,000 Ordinary Shares, with exercise price of $2.00 per Ordinary Share. The
Warrants were issued as part of our initial public offering and have been listed on the Nasdaq Capital Market under the symbol &ldquo;WLDSW&rdquo;
since September 13, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As of March 21, 2023, we issued options to purchase
an aggregate of 372,771 Ordinary Shares to certain employees, directors and consultants, under our 2015 Share Option Plan. Additional
636,998 Ordinary Shares are reserved for future issuance under our 2015 Share Option Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Articles of Association</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Directors</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our Board of directors shall direct our policy
and shall supervise the performance of our Chief Executive Officer and his actions. Our Board of directors may exercise all powers that
are not required under the Israeli Companies Law 5759-1999, or the Companies Law, or under our articles of association to be exercised
or taken by our shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Rights Attached to Shares</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our Ordinary Shares shall confer upon the holders
thereof:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: .5in; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: .25in; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">equal right to attend and to vote at all of our general meetings, whether regular or special, with each Ordinary Share entitling the holder thereof, which attend the meeting and participate at the voting, either in person or by a proxy or by a written ballot, to one vote;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: .5in">&nbsp;</TD>
    <TD STYLE="width: .25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">equal right to participate in distribution of dividends, if any, whether payable in cash or in bonus shares, in distribution of assets or in any other distribution, on a per share pro rata basis; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: .5in">&nbsp;</TD>
    <TD STYLE="width: .25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">equal right to participate, upon our dissolution, in the distribution of our assets legally available for distribution, on a per share pro rata basis.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Election of Directors</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to our articles of association, our directors
are elected by the general meeting and, unless appointed for a shorter term, serve in office until the third annual general meeting after
the general meeting in which such director was appointed, in which such later annual general meeting the directors will be brought for
re-election or replacement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In each annual general meeting, only one director
whose service term lapsed will be deemed retired and brought for re-election, and all other directors whose service term lapsed shall
be deemed to have been re-elected for a term until the next annual general meeting. The director to be deemed and to be re-elected is
the director that served the longest period since its appointment or last re-election. If more than one director served the longest time,
the board of directors will decide which of such directors will be brought for re-election at the relevant general meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Annual and Special Meetings</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under the Israeli law, we are required to hold
an annual general meeting of our shareholders once every calendar year, at such time and place which shall be determined by our Board
of directors, that must be no later than 15 months after the date of the previous annual general meeting. All meetings other than the
annual general meeting of shareholders are referred to as special general meetings. Our Board of directors may call special meetings whenever
it sees fit and upon the request of: (a) any two of our directors or such number of directors equal to one quarter of the directors then
at office; and/or (b) one or more shareholders holding, in the aggregate, (i) 5% or more of our outstanding issued shares and 1% of our
outstanding voting power or (ii) 5% or more of our outstanding voting power, or the Non Exempted Holding. However, under a new exemption
applicable as of March 12, 2024, the board of directors of an Israeli company whose shares are listed outside of Israel, shall convene
a special meeting at the request of one or more shareholders holding at least ten percent (10%) of the issued and outstanding share capital
instead of five (5%) in the past, and at least one percent (1%) of the voting rights in the company, or one or more shareholders holding
at least ten percent (10%) of the voting rights in the company, provided that if the applicable law as applicable to companies incorporated
in the country which the Company is listed for trade, establishes a right to demand convening of such a meeting for those holding a percentage
of holdings lower than ten percent (10%), then the Non Exempted Holding shall apply.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Subject to the provisions of the Companies Law
and the regulations promulgated thereunder, shareholders entitled to participate and vote at general meetings are the shareholders of
record on a date to be decided by the board of directors, which may be between four and sixty days prior to the date of the meeting. Resolutions
regarding the following matters must be passed at a general meeting of our shareholders:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: .5in">&nbsp;</TD>
    <TD STYLE="width: .25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">amendments to our articles of association;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: .5in">&nbsp;</TD>
    <TD STYLE="width: .25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">the exercise of our Board of Director&rsquo;s powers by a general meeting if our Board of directors is unable to exercise its powers and the exercise of any of its powers is required for our proper management;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: .5in">&nbsp;</TD>
    <TD STYLE="width: .25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">appointment or termination of our auditors;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: .5in">&nbsp;</TD>
    <TD STYLE="width: .25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">appointment of directors, including external directors (other than with respect to circumstances specified in our articles of association);</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: .5in">&nbsp;</TD>
    <TD STYLE="width: .25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">approval of acts and transactions requiring general meeting approval pursuant to the provisions of the Companies Law (mainly certain related party transactions) and any other applicable law;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: .5in">&nbsp;</TD>
    <TD STYLE="width: .25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">increases or reductions of our authorized share capital; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: .5in">&nbsp;</TD>
    <TD STYLE="width: .25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">a merger (as such term is defined in the Companies Law).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Notices</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Companies Law require that a notice of any
annual or special shareholders meeting be provided at least 21 days prior to the meeting, and if the agenda of the meeting includes the
appointment or removal of directors, the approval of transactions with office holders or interested or related parties, approval of the
company&rsquo;s general manager to serve as the chairman of the board of directors or an approval of a merger, notice must be provided
at least 35 days prior to the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Quorum</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As permitted under the Companies Law, the quorum
required for our general meetings consists of at least two shareholders present in person, by proxy, written ballot or voting by means
of electronic voting system, who hold or represent between them at least 25% of the total outstanding voting rights. If within half an
hour of the time set forth for the general meeting a quorum is not present, the general meeting shall stand adjourned the same day of
the following week, at the same hour and in the same place, or to such other date, time and place as prescribed in the notice to the shareholders
and in such adjourned meeting, if no quorum is present within half an hour of the time arranged, any number of shareholders participating
in the meeting, shall constitute a quorum.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If a special general meeting was summoned following
the request of a shareholder, and within half an hour a legal quorum shall not have been formed, the meeting shall be canceled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Adoption of Resolutions</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our articles of association provide that resolutions
amending provisions of the articles of association related to the staggered board of directors and the composition of the board of directors,
as well as a resolution to dismiss a director, will require an affirmative vote of 70% of the voting power represented at a general meeting
and voting thereon. Other than that, and unless otherwise required under the Companies Law and our articles, all resolutions of the Company&rsquo;s
shareholders require a simple majority vote. A shareholder may vote in a general meeting in person, by proxy, by a written ballot.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Changing Rights Attached to Shares</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Unless otherwise provided by the terms of the shares
and subject to any applicable law, any modification of rights attached to any class of shares must be adopted by the holders of a majority
of the shares of that class present a general meeting of the affected class or by a written consent of all the shareholders of the affected
class.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The enlargement of an existing class of shares
or the issuance of additional shares thereof, shall not be deemed to modify the rights attached to the previously issued shares of such
class or of any other class, unless otherwise provided by the terms of the shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Limitations on the Right to Own Securities
in Our Company</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">There are no limitations on the right to own our
securities in our articles of association. In certain circumstances the Warrants have restrictions upon the exercise of such warrants
if such exercise would result in the holders thereof owning more than 4.99% or 9.99% of our Ordinary Shares upon such exercise, as further
described below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Provisions Restricting Change in Control
of Our Company</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our articles of association provide for a staggered
board of directors, which mechanism may delay, defer or prevent a change of control of the Company&rsquo;s board of directors. Other than
that, there are no specific provisions of our articles of association that would have an effect of delaying, deferring or preventing a
change in control of the Company or that would operate only with respect to a merger, acquisition or corporate restructuring involving
us. However, as described below, certain provisions of the Companies Law may have such effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Companies Law includes provisions that allow
a merger transaction and requires that each company that is a party to the merger have the transaction approved by its board of directors
and, unless certain requirements described under the Companies Law are met, a vote of the majority of shareholders, and, in the case of
the target company, also a majority vote of each class of its shares. For purposes of the shareholder vote of each party, unless a court
rules otherwise, the merger will not be deemed approved if shares representing a majority of the voting power present at the shareholders
meeting and which are not held by the other party to the merger (or by any person or group of persons acting in concert who holds 25%
or more of the voting power or the right to appoint 25% or more of the directors of the other party) vote against the merger. If, however,
the merger involves a merger with a company&rsquo;s own controlling shareholder or if the controlling shareholder has a personal interest
in the merger, then the merger is instead subject to the same special majority approval that governs all extraordinary transactions with
controlling shareholders. Upon the request of a creditor of either party to the proposed merger, the court may delay or prevent the merger
if it concludes that there exists a reasonable concern that as a result of the merger the surviving company will be unable to satisfy
the obligations of any of the parties to the merger, and may further give instructions to secure the rights of creditors. If the transaction
would have been approved by the shareholders of a merging company but for the separate approval of each class or the exclusion of the
votes of certain shareholders as provided above, a court may still approve the merger upon the petition of holders of at least 25% of
the voting rights of a company. For such petition to be granted, the court must find that the merger is fair and reasonable, taking into
account the value of the parties to the merger and the consideration offered to the shareholders. In addition, a merger may not be completed
unless at least (1) 50 days have passed from the time that the requisite proposals for approval of the merger were filed with the Israeli
Registrar of Companies by each merging company and (2) 30 days have passed since the merger was approved by the shareholders of each merging
company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The term &ldquo;Special Majority&rdquo; hereof
will be defined as described in section 275(a)(3) of the Companies Law as:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: .5in">&nbsp;</TD>
    <TD STYLE="width: .25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">at least a majority of the shares held by shareholders who are not controlling shareholders and do not have personal interest in the merger (excluding a personal interest that did not result from the shareholder&rsquo;s relationship with the controlling shareholder) have voted in favor of the proposal (shares held by abstaining shareholders shall not be considered); or</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: .5in">&nbsp;</TD>
    <TD STYLE="width: .25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">the total number of shares voted against the merger, does not exceed 2% of the aggregate voting rights of the company.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Companies Law also provides that, subject to
certain exceptions, an acquisition of shares in an Israeli public company must be made by means of a &ldquo;special&rdquo; tender offer
if as a result of the acquisition (1) the purchaser would become a holder of 25% or more of the voting rights in the company, unless there
is already another holder of at least 25% or more of the voting rights in the company or (2) the purchaser would become a holder of 45%
or more of the voting rights in the company, unless there is already a holder of more than 45% of the voting rights in the company. These
requirements do not apply if, in general, the acquisition (1) was made in a private placement that received shareholders&rsquo; approval,
subject to certain conditions, (2) was from a holder of 25% or more of the voting rights in the company which resulted in the acquirer
becoming a holder of 25% or more of the voting rights in the company, or (3) was from a holder of more than 45% of the voting rights in
the company which resulted in the acquirer becoming a holder of more than 45% of the voting rights in the company. A &ldquo;special&rdquo;
tender offer must be extended to all shareholders. In general, a &ldquo;special&rdquo; tender offer may be consummated only if (1) at
least 5% of the voting power attached to the company&rsquo;s outstanding shares will be acquired by the offeror and (2) the offer is accepted
by a majority of the offerees who notified the company of their position in connection with such offer (excluding the offeror, controlling
shareholders, holders of 25% or more of the voting rights in the company or anyone on their behalf, or any person having a personal interest
in the acceptance of the tender offer). If a special tender offer is accepted, then the purchaser or any person or entity controlling
it or under common control with the purchaser or such controlling person or entity may not make a subsequent tender offer for the purchase
of shares of the target company and may not enter into a merger with the target company for a period of one year from the date of the
offer, unless the purchaser or such person or entity undertook to effect such an offer or merger in the initial special tender offer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If, as a result of an acquisition of shares, the
acquirer will hold more than 90% of an Israeli company&rsquo;s outstanding shares or of certain class of shares, the acquisition must
be made by means of a tender offer for all of the outstanding shares, or for all of the outstanding shares of such class, as applicable.
In general, if less than 5% of the outstanding shares, or of applicable class, are not tendered in the tender offer and more than half
of the offerees who have no personal interest in the offer tendered their shares, all the shares that the acquirer offered to purchase
will be transferred to it by operation of law. However, a tender offer will also be accepted if the shareholders who do not accept the
offer hold less than 2% of the issued and outstanding share capital of the company or of the applicable class of shares. Any shareholders
that was an offeree in such tender offer, whether such shareholder accepted the tender offer or not, may request, by petition to an Israeli
court, (i) appraisal rights in connection with a full tender offer, and (ii) that the fair value should be paid as determined by the court,
for a period of six months following the acceptance thereof. However, the acquirer is entitled to stipulate, under certain conditions,
that tendering shareholders will forfeit such appraisal rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Lastly, Israeli tax law treats some acquisitions,
such as stock-for-stock exchanges between an Israeli company and a foreign company, less favorably than U.S. tax laws. For example, Israeli
tax law may, under certain circumstances, subject a shareholder who exchanges his Ordinary Shares for shares in another corporation to
taxation prior to the sale of the shares received in such stock-for-stock swap.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Changes in Our Capital</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The general meeting may, by a simple majority vote
of the shareholders attending the general meeting:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: .5in">&nbsp;</TD>
    <TD STYLE="width: .25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">increase our registered share capital by the creation of new shares from the existing class or a new class, as determined by the general meeting;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: .5in">&nbsp;</TD>
    <TD STYLE="width: .25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">cancel any registered share capital which have not been taken or agreed to be taken by any person;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: .5in">&nbsp;</TD>
    <TD STYLE="width: .25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">consolidate and divide all or any of our share capital into shares of larger nominal value than our existing shares;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: .5in">&nbsp;</TD>
    <TD STYLE="width: .25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">subdivide our existing shares or any of them, our share capital or any of it, into shares of smaller nominal value than is fixed; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: .5in">&nbsp;</TD>
    <TD STYLE="width: .25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">reduce our share capital and any fund reserved for capital redemption in any manner, and with and subject to any incident authorized, and consent required, by the Companies Law.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Exclusive Forum</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our articles of association provide that unless
the Company consents in writing to the selection of an alternative forum, the federal district courts of the United States of America
shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act&nbsp;of
1933, as amended, or the Securities Act and that any person or entity purchasing or otherwise acquiring any interest in any security of
the Company, shall be deemed to have notice of and consented to this exclusive forum provision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Staggered Board</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our articles of association provide for a split
of the board of directors into three classes with staggered three-year terms. At each annual general meeting of our shareholders, the
election or re-election of directors following the expiration of the term of office of the directors of that class of directors will be
for a term of office that expires on the third annual general meeting following such election or re-election, such that each year the
term of office of only one class of directors will expire. The director whom is to be retired and re-elected shall be the director that
served the longest period since its appointment or last re-election or, if more than one director served the longest time, or if a director
who is not to be re-elected agrees to be re-elected, the meeting of the board of directors which sets the date and agenda for the annual
general meeting (acting by a simple majority) will decide which of such directors will be brought for re-election at the relevant general
meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following summary of certain terms and provisions
of the Warrants and is subject to, and qualified in its entirety by, the provisions of the warrant agent agreement between us and VStock
Transfer, LLC, as warrant agent, and the form of Warrant, both of which are filed as exhibits to the Annual Report on Form 20-F for the
year ended December 31, 2022, or the Annual Report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Exercisability</I></B><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Warrants are exercisable at any time after
their original issuance and at any time up to the date that is five&nbsp;years after their original issuance. The Warrants will be exercisable,
at the option of each holder, in whole or in part by delivering to the Company a duly executed exercise notice and, at any time a registration
statement registering the issuance of the Ordinary Shares underlying the Warrants under the Securities Act is effective and available
for the issuance of such shares, by payment in full in immediately available funds for the number of Ordinary Shares purchased upon such
exercise. If a registration statement registering the issuance of the Ordinary Shares underlying the Warrants under the Securities Act
is not effective or available the holder may, in its sole discretion, elect to exercise the Warrant through a cashless exercise, in which
case the holder would receive upon such exercise the net number of Ordinary Shares determined according to the formula set forth in the
Warrant. No fractional shares will be issued in connection with the exercise of a Warrant. In lieu of fractional shares, the Company will
pay the holder an amount in cash equal to the fractional amount multiplied by the exercise price.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Exercise Limitation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A holder will not have the right to exercise any
portion of the warrant if the holder (together with its affiliates) would beneficially own in excess of 4.99% of the number of Ordinary
Shares outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the
terms of the Warrants. However, any holder may increase or decrease such percentage to any other percentage not in excess of 9.99%, provided
that any increase in such percentage shall not be effective until 61&nbsp;days following notice from the holder to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Exercise Price</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The exercise price per
whole Ordinary Share purchasable upon exercise of the Warrants $4.00 per share. The exercise price is subject to appropriate adjustment
in the event of certain stock dividends and distributions, stock splits, stock combinations, reclassifications or similar events affecting
our Ordinary Shares and also upon any distributions of assets, including cash, stock or other property to our shareholders. Subject to
certain exemptions outlined in the Warrant, for a period until two years from the date of issuance of the Warrant, if the Company shall
sell, enter into an agreement to sell and subsequently sells, or grant any option to purchase, or sell, enter into an agreement to sell
and subsequently sells, or grant any right to reprice, or otherwise dispose of or issue (or announce any offer, sale, grant or any option
to purchase or other disposition the subsequently closes) any Ordinary Shares or convertible security, at an effective price per share
less than the exercise price of the Warrant then in effect, the exercise price of the Warrant shall be reduced to equal the effective
price per share in such Dilutive Issuance;&nbsp;provided, however, that in no event shall the exercise price of the Warrant be reduced
to an exercise price lower than 50% of the Initial Exercise Price. On the date that is 90 calendar days immediately following the initial
issuance date of the Warrants, the exercise price of the Warrants will adjust to be equal to the Reset Price, provided that such value
is less than the exercise price in effect on that date. The Reset Price is equal to the greater of (a) 50% of the Initial Exercise Price
of the Warrants on the issuance date or (b) 100% of the lowest volume weighted average price per Ordinary Share occurring on any day between
the initial exercise date of the Warrants and 90 calendar days following the issuance date of the Warrants. The lowest Reset Price is
$2.00, which is 50% of the Initial Exercise Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On September 20, 2022, the Company&rsquo;s volume
weighted average stock price was less than the exercise floor of $2.00 for the Warrants. Accordingly, effective after the closing of trading
on December 14, 2022 (the 90th calendar day immediately following the issuance date of the Warrants), the Warrants were adjusted pursuant
to their terms, including, but not limited to, to adjust the exercise price of the Warrants to $2.00.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Transferability</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Subject to applicable laws, the Warrants may be
offered for sale, sold, transferred or assigned without the Company&rsquo;s consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Warrant Agent</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Warrants were issued in registered form under
a warrant agent agreement between VStock Transfer, LLC, as warrant agent, and the Company. The Warrants were initially represented only
by one or more global warrants deposited with the warrant agent, as custodian on behalf of The Depository Trust Company, or DTC, and registered
in the name of Cede&nbsp;&amp; Co., a nominee of DTC, or as otherwise directed by DTC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Fundamental Transactions</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In the event of a fundamental transaction, as described
in the Warrants and generally including any reorganization, recapitalization or reclassification of the Ordinary Shares, the sale, transfer
or other disposition of all or substantially all of our properties or assets, our consolidation or merger with or into another person,
the acquisition of more than 50% of the Company&rsquo;s outstanding Ordinary Shares, or any person or group becoming the beneficial owner
of 50% of the voting power represented by the Company&rsquo;s outstanding Ordinary Shares, the holders of the Warrants will be entitled
to receive upon exercise of the Warrants the kind and amount of securities, cash or other property that the holders would have received
had they exercised the Warrants immediately prior to such fundamental transaction without regard to any limitations on exercised contained
in the Warrants.&nbsp;The holders of the Warrants may also require the Company or any successor entity to purchase the Warrants from the
holders by paying to the holder an amount in cash (or other types or form of consideration in special circumstances listed in the Warrant)
equal to the Black Scholes value of the remaining unexercised portion of the Warrant on the date of the fundamental transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Home Country Practice</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For so long as any of the Warrants remains outstanding,
the Company will elect to follow home country practice in lieu of any rules and regulations of the trading market that would limit the
Company&rsquo;s ability to effect the provisions of the Warrants, including but not limited to shareholder approval rules related to the
issuance of securities or adjustment of terms of this Warrant for the benefit of warrant holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Rights as a Stockholder</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Except as otherwise provided in the Warrants or
by virtue of such holder&rsquo;s ownership of the Company&rsquo;s Ordinary Shares, the holder of a Warrant does not have the rights or
privileges of a holder of the Company&rsquo;s Ordinary Shares, including any voting rights, until the holder exercises the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Governing Law</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Warrants and the warrant agent agreement are
governed by New&nbsp;York law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Underwriter&rsquo;s Warrants</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following summary of certain terms and provisions
of the underwriter&rsquo;s warrants, or the Underwriter&rsquo;s Warrant, is subject to, and qualified in its entirety by, the provisions
of the form of Underwriter&rsquo;s Warrant which was filed as an exhibit to the Annual Report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As part of the Company&rsquo;s initial public offering
on the Nasdaq Capital Market, the Company issued the Underwriter&rsquo;s warrant to the underwriter. The Underwriter&rsquo;s Warrants
are exercisable at $5.31 per Ordinary Share&nbsp;are exercisable beginning on beginning March 12, 2023 and will expire on September 12,
2027. The Underwriter&rsquo;s Warrants have been deemed compensation by FINRA and are therefore subject to a six-month lock-up&nbsp;pursuant
to Rule&nbsp;5110 of FINRA.&nbsp;Furthermore, such Underwriter&rsquo;s Warrants shall be exercisable on a cash basis, provided that if
a registration statement registering the ordinary shares underlying the Underwriter&rsquo;s Warrants is not effective, the Underwriter&rsquo;s
Warrants may be exercised on a cashless basis and have anti-dilution terms that are consistent with FINRA Rule 5110(g)(8)(E) and (F).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">7</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.1
<SEQUENCE>3
<FILENAME>ea020095201ex12-1_wearable.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 12.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CERTIFICATION PURSUANT TO EXCHANGE ACT RULE
13a-14(a) or 15d-14(a)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asher
Dahan, certify that:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
have reviewed this annual report on Form 20&ndash;F of Wearable Devices Ltd. (the &ldquo;company&rdquo;);</FONT></TD>
</TR></TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered
by this report;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects
the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
company&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15(d)-15(f)) for the company and have:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure
that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being prepared;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision,
to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluated
the effectiveness of the company&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosed
in this report any change in the company&rsquo;s internal control over financial reporting that occurred during the period covered by
the annual report that has materially affected, or is reasonably likely to materially affect, the company&rsquo;s internal control over
financial reporting.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
company&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the company&rsquo;s auditors and the audit committee of the company&rsquo;s board of directors (or persons performing the
equivalent function):</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably
likely to adversely affect the company&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
fraud, whether or not material, that involves management or other employees who have a significant role in the company&rsquo;s internal
control over financial reporting.</FONT></TD>
</TR></TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 60%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: March 15, 2024</FONT></TD>
    <TD STYLE="text-align: left; width: 40%; border-bottom: black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Asher Dahan</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asher Dahan</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.2
<SEQUENCE>4
<FILENAME>ea020095201ex12-2_wearable.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 12.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CERTIFICATION PURSUANT TO EXCHANGE ACT RULE
13a-14(a) or 15d-14(a)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alon
Mualem, certify that:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
have reviewed this annual report on Form 20&ndash;F of Wearable Devices Ltd. (the &ldquo;company&rdquo;);</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered
by this report;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects
the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
company&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15d-15(f)) for the company and have:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure
that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being prepared;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision,
to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluated
the effectiveness of the company&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosed
in this report any change in the company&rsquo;s internal control over financial reporting that occurred during the period covered by
the annual report that has materially affected, or is reasonably likely to materially affect, the company&rsquo;s internal control over
financial reporting; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
company&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the Company&rsquo;s auditors and the audit committee of the company&rsquo;s board of directors (or persons performing the
equivalent function):</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably
likely to adversely affect the company&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
fraud, whether or not material, that involves management or other employees who have a significant role in the company&rsquo;s internal
control over financial reporting.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 21pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; white-space: nowrap; width: 60%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: March 15, 2024</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: left; white-space: nowrap; width: 40%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Alon Mualem</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; white-space: nowrap; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; white-space: nowrap; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alon Mualem</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; white-space: nowrap; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; white-space: nowrap; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 21pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.1
<SEQUENCE>5
<FILENAME>ea020095201ex13-1_wearable.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 13.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>18 U.S.C.&nbsp;Section 1350</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">In connection with the filing
of the Annual Report on Form 20-F for the period ended December 31, 2023 (the &ldquo;Report&rdquo;) by Wearable Devices Ltd. (the &ldquo;Company&rdquo;),
the undersigned, as the Chief Executive Officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350, that, to my knowledge:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the
Company.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: March 15, 2024</FONT></TD>
    <TD STYLE="width: 40%; border-bottom: black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Asher Dahan</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asher Dahan</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.2
<SEQUENCE>6
<FILENAME>ea020095201ex13-2_wearable.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 13.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>18 U.S.C.&nbsp;Section 1350</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">In connection with the filing
of the Annual Report on Form 20-F for the period ended December 31, 2023 (the &ldquo;Report&rdquo;) by Wearable Devices Ltd. (the &ldquo;Company&rdquo;),
the undersigned, as the Chief Financial Officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350, that, to my knowledge:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the
Company.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: March 15, 2024</FONT></TD>
    <TD STYLE="width: 40%; border-bottom: black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Alon Mualem</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alon Mualem</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-15.1
<SEQUENCE>7
<FILENAME>ea020095201ex15-1_wearable.htm
<DESCRIPTION>CONSENT OF ZIV HAFT, CERTIFIED PUBLIC ACCOUNTANTS, ISR. BDO MEMBER FIRM, AN INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 15.1</B></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: left; margin-top: 0; margin-bottom: 0"><IMG SRC="ex15-1_001.jpg" ALT=""></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><U>Consent of Independent Registered
Public Accounting Firm</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Wearable Devices Ltd.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (333-269869 and 333-274343) and on Form F-3
(333-274841) of Wearable Devices Ltd. of our report dated March 13, 2024, relating to the consolidated financial statements as of December
31, 2023 and 2022 and for each of the years in the three-year period ended December 31, 2023 which appears in this Form 20-F for the year
ended December 31,2023.</FONT> Our report contains an explanatory paragraph regarding the Company&rsquo;s ability to continue as a going
concern.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Ziv Haft</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 60%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ziv Haft</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certified Public Accountants (Isr.)</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BDO Member Firm</FONT></TD>
    <TD STYLE="padding-bottom: 8pt">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">March 15, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Tel Aviv, Israel</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex15-1_002.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-97.1
<SEQUENCE>8
<FILENAME>ea020095201ex97-1_wearable.htm
<DESCRIPTION>CLAWBACK POLICY
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 97.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.35pt; text-align: center"><B>Wearable Devices Ltd. (the &ldquo;Company&rdquo;)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.35pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.35pt; text-align: center"><B>CLAWBACK POLICY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.35pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Effective as of December 1, 2023</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Background</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Board of Directors of the Company (the &ldquo;<B>Board</B>&rdquo;)
believes that it is in the best interests of the Company and its shareholders to create and maintain a culture that emphasizes integrity
and accountability and that reinforces the Company&rsquo;s pay-for-performance compensation philosophy. The Compensation Committee of
the Board (the &ldquo;<B>Compensation Committee</B>&rdquo;) and the Board have therefore adopted this policy, which provides for the recoupment
(or clawback) of certain executive compensation in the event of an accounting restatement resulting from material noncompliance with financial
reporting requirements under the federal securities laws of the United States (the &ldquo;<B>Policy</B>&rdquo;). This Policy is designed
to comply with Section 10D of the Securities Exchange Act of 1934, as amended (the &ldquo;<B>Exchange Act</B>&rdquo;), Rule 10D-1 promulgated
under the Exchange Act (&ldquo;<B>Rule 10D-1</B>&rdquo;) and the listing standards of the Nasdaq Stock Market (&ldquo;<B>Nasdaq</B>&rdquo;)
under Nasdaq Listing Rule 5608. In addition, this Policy is designed to comply with the requirements under the Israeli Companies Law 5759-1999
(the &ldquo;<B>Companies Law</B>&rdquo;) with respect to clawback provisions to be included in the Company&rsquo;s Compensation Policy,
as may be amended from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B><U>Administration</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">This Policy shall be administered by the Compensation
Committee. Any determinations made by the Compensation Committee shall be final and binding on all affected individuals. Subject to any
limitation under applicable law, the Compensation Committee may authorize and empower any officer or employee of the Company to take any
and all actions necessary or appropriate to carry out the purpose and intent of this Policy (the &ldquo;<B>Authorized Officers</B>&rdquo;)
(other than with respect to any recovery under this Policy involving such officer or employee).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B><U>Covered Executives</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">This Policy applies to the Company&rsquo;s current
and former executive officers, as determined by the Board in accordance with Section 10D of the Exchange Act and the listing standards
of the Nasdaq (&ldquo;<B>Covered Executives</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B><U>Recoupment; Accounting Restatement</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">In the event the Company is required to prepare
an accounting restatement of its financial statements due to the Company&rsquo;s material noncompliance with any financial reporting requirement
under the securities laws, the Compensation Committee will require prompt reimbursement or forfeiture of any excess Incentive Compensation
(as defined below) received by any Covered Executive during the three completed fiscal years immediately preceding the date on which the
Company is required to prepare an accounting restatement. For the sake of clarity, recoupment is required in the event of any restatement
that either: (a) corrects an error in previously issued financial statements that is material to the previously issued financial statements;
or (b) corrects an error not material to previously issued financial statements, but that would result in a material misstatement if (i)
the error was left uncorrected in the then current period; or (ii) the error correction was recognized in the then current period. The
Company&rsquo;s obligation to recover erroneously awarded compensation is not dependent on if or when the restated financial statements
are filed. For purposes of determining the relevant recovery period, the date that the Company is required to prepare an accounting restatement
as described above is the earlier to occur of: (A) the date the Board, a committee of the Board, the Authorized Officers, or officers
of the Company authorized to take such action if Board action is not required, concludes, or reasonably should have concluded, that the
Company is required to prepare an accounting restatement as described above; or (B) the date a court, regulator, or other legally authorized
body directs the Company to prepare an accounting restatement as described above. In accordance with Nasdaq Rule 5608(e), this Policy
is applicable to Incentive Compensation (as described below) received on or after October 2, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Incentive Compensation</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">For purposes of this Policy, &ldquo;Incentive
Compensation&rdquo; means any of the following, provided that such compensation is granted, earned or vested based wholly or in part on
the attainment of a financial reporting measure affected by the restated financial statements:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="text-align: left; width: 0.25in">&#9679;</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual bonuses and other short-
and long-term cash incentives.</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="text-align: left; width: 0.25in">&#9679;</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share options.</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="text-align: left; width: 0.25in">&#9679;</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share appreciation rights.</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="text-align: left; width: 0.25in">&#9679;</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted shares.</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="text-align: left; width: 0.25in">&#9679;</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted share units.</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="text-align: left; width: 0.25in">&#9679;</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Performance shares.</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="text-align: left; width: 0.25in">&#9679;</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Performance units.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Financial reporting measures are measures that
are determined and presented in accordance with the accounting principles used in preparing the Company&rsquo;s financial statements,
and any measures that are derived wholly or in part from such measures. A financial reporting measure need not be presented within the
financial statements or included in a filing with the Securities and Exchange Commission. The Company&rsquo;s financial reporting measures
may include, but are not limited to, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="text-align: left; width: 0.25in">&#9679;</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues.</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="text-align: left; width: 0.25in">&#9679;</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net income.</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="text-align: left; width: 0.25in">&#9679;</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnings before interest, taxes,
depreciation and amortization (EBITDA).</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="text-align: left; width: 0.25in">&#9679;</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Funds from operations.</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="text-align: left; width: 0.25in">&#9679;</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liquidity measures such as working
capital, operating cash flow or Free Cash Flow.</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="text-align: left; width: 0.25in">&#9679;</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Return measures such as return
on invested capital or return on assets.</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="text-align: left; width: 0.25in">&#9679;</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnings measures such as earnings
per share.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This Policy applies to all Incentive Compensation received by a Covered
Executive:</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="text-align: left; width: 0.25in">&#9679;</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After beginning service as an
executive officer; </FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="text-align: left; width: 0.25in">&#9679;</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Who served as an executive officer
at any time during the performance period for that Incentive Compensation; </FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="text-align: left; width: 0.25in">&#9679;</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While the Company has a class
of securities listed on a national securities exchange or a national securities association; and </FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="text-align: left; width: 0.25in">&#9679;</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three completed fiscal
years immediately preceding the date that the Company is required to prepare an accounting restatement as described in this Policy. In
addition to these last three completed fiscal years, this Policy applies to any transition period (that results from a change in the Company&rsquo;s
fiscal year) within or immediately following those three completed fiscal years. However, a transition period between the last day of
the Company&rsquo;s previous fiscal year end and the first day of its new fiscal year that comprises a period of nine to 12 months would
be deemed a completed fiscal year.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Incentive Compensation is deemed received in the
Company&rsquo;s fiscal period during which the financial reporting measure specified in the Incentive Compensation award is attained,
even if the payment or grant of the Incentive Compensation occurs after the end of that period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B><U>Excess Incentive Compensation: Amount Subject
to Recovery</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The amount to be recovered will be the excess
of the Incentive Compensation paid to the Covered Executive based on the erroneous data over the Incentive Compensation that would have
been paid to the Covered Executive had it been based on the restated results, as determined by the Compensation Committee, and without
regard to any taxes paid by or withheld from the Covered Executive. If the Compensation Committee cannot determine the amount of excess
Incentive Compensation received by the Covered Executive directly from the information in the accounting restatement, then it will make
its determination based on a reasonable estimate of the effect of the accounting restatement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B><U>Method of Recoupment</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Compensation Committee will determine, in
its sole discretion, the method for recouping Incentive Compensation hereunder which may include, without limitation:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="text-align: left; width: 0.25in">&#9679;</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Requiring reimbursement of cash
Incentive Compensation previously paid;</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="text-align: left; width: 0.25in">&#9679;</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seeking recovery of any gain
realized on the vesting, exercise, settlement, sale, transfer, or other disposition of any equity-based awards;</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="text-align: left; width: 0.25in">&#9679;</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offsetting the recouped amount
from any compensation otherwise owed by the Company to the Covered Executive in accordance with applicable law;</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="text-align: left; width: 0.25in">&#9679;</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cancelling outstanding vested
or unvested equity awards; and/or</FONT></TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="text-align: left; width: 0.25in">&#9679;</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taking any other remedial and
recovery action permitted by law, as determined by the Compensation Committee.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&zwnj;<B><U>No Indemnification</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company shall not indemnify any Covered Executives
against the loss of any Incentive Compensation recovered under this Policy or from any consequence arising therefrom.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Interpretation</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Compensation Committee is authorized to interpret
and construe this Policy and to make all determinations necessary, appropriate or advisable for the administration of this Policy. It
is intended that this Policy be interpreted in a manner that is consistent with the requirements of Section 10D of the Exchange Act, Rule
10D-1 and any applicable rules or standards adopted by the Securities and Exchange Commission or Nasdaq and the Companies Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B><U>Effective Date</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">This Policy shall be effective as of the date
it is adopted by the Board and by the Compensation Committee (the &ldquo;<B>Effective Date</B>&rdquo;) and, in accordance with Nasdaq
Rule 5608(e), shall apply to Incentive Compensation that is received by Covered Executives on or after October 2, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B><U>Amendment; Termination</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Board and the Compensation Committee may amend
this Policy from time to time at their discretion and shall amend this Policy as it deems necessary to reflect regulations adopted by
the Securities and Exchange Commission under Section 10D of the Exchange Act and to comply with any rules or standards adopted by Nasdaq.
The Board and the Compensation Committee may terminate this Policy at any time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B><U>Other Recoupment Rights</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Board intends that this Policy will be applied
to the fullest extent of applicable law. The Compensation Committee may require that any employment agreement, equity award agreement,
or similar agreement entered into or amended on or after the Effective Date shall, as a condition to the grant of any benefit thereunder,
require a Covered Executive to agree to abide by the terms of this Policy. Any right of recoupment under this Policy is in addition to,
and not in lieu of: (a) any other remedies or rights of recoupment that may be available to the Company pursuant to the terms of any similar
policy in any employment agreement, equity award agreement or similar agreement and any other legal remedies available to the Company,
including termination of employment or institution of legal proceedings; and (b) any statutory recoupment requirement, including Section
304 of the Sarbanes-Oxley Act of 2022. For the avoidance of doubt, any amounts paid to the Company pursuant to Section 304 of the Sarbanes-Oxley
Act of 2022 shall be considered (and may be credited) in determining any amounts recovered under this Policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B><U>Impracticability</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Compensation Committee shall recover any excess
Incentive Compensation in accordance with this Policy unless such recovery would be impracticable, as determined in accordance with Rule
10D-1(b)(1)(iv) under the Exchange Act and the listing standards of Nasdaq. In order for the Company to determine that recovery would
be impracticable, the Compensation Committee must conclude the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="text-align: left; width: 0.25in">a)</TD><TD STYLE="text-align: left">The direct expense paid to a third party to assist in enforcing this Policy would exceed the amount to
be recovered after making a reasonable attempt to recover such Incentive Compensation. Note that the attempt(s) to recover must be documented
by the Company and such documentation provided to Nasdaq;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">b)</TD><TD STYLE="text-align: left">Recovery would violate home country law where that law was adopted prior to November 28, 2022. Note that
the Company must obtain a legal opinion of home country counsel that such recovery would result in a violation of local law and provide
such opinion to Nasdaq; or</TD></TR></TABLE>

<P STYLE="text-align: left; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="text-align: left; width: 0.25in">c)</TD><TD STYLE="text-align: left">Recovery would likely cause an otherwise tax-qualified retirement plan under which benefits are broadly
available to Company employees to fail to meet the requirements for qualified pension, profit-sharing and stock bonus plans under Section
401(a)(13) of the U.S. Internal Revenue Code or the minimum vesting standards under Section 411(a) of the U.S. Internal Revenue Code.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B><U>Successors</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">This Policy shall be binding and enforceable against
all Covered Executives and their beneficiaries, heirs, executors, administrators or other legal representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Exhibit Filing</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A copy of this Policy shall be filed as an exhibit
to the Company&rsquo;s annual report on Form 20-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ATTESTATION AND ACKNOWLEDGEMENT OF CLAWBACK
POLICY FOR WEARABLE DEVICES LTD. (the &ldquo;Company&rdquo;)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By my signature below, I acknowledge and agree that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I have received and read the attached Clawback Policy (this
&ldquo;Policy&rdquo;) of the Company. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I hereby agree to abide by all of the terms of the Policy
both during and after my employment with the Company, including, without limitation, by promptly repaying or returning any incorrectly
awarded Incentive Compensation to the Company as determined in accordance with the Policy. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I hereby waive any claim against the Company, its Authorized
Officers and the Board in connection with the implementation of the Policy. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 11%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 29%; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Printed Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">6</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !' '8# 2(  A$! Q$!_\0
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MZ$NIRQ0+86^N"."*(3?:A$DL;@']>'C_ .-/AGX1? WQ-\>OBZ&^'?A#P/\
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MZ_BBIQZQ:34EV:>GG\C]!OB;_P %/_'GA_\ :W^,_P"R/\#/V(?C7^T=XF^
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M%V[76ZRS=26=C]F8*'O?WZV\WH_Q?_:5T?P1XOT3X4:-\,O&/QC^*.N^&?\
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M2-"U>)'\FUCCTZYM)Q<W^GFVBABBU"PMC9RI:Q[[R)V2WF]J?PYHDS[CI&E
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<D$$:1Q'<A*I L,(,DA,;,4*:%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" &Y G # 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#_ #_Z***
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P ,YYI&021>.-.TV'7?"RDET\1Z9JFFQK--XBM$@ /Y2_\ @HI_P3^^.?\
MP30_:C\;?LM_'FVL;G7O#D5CK?A7QIH*7G_")?$GP+K2/+H'C;PI/>PP7+:?
M?"*YL;^RN8UO-%UW3]5T6]'VG3Y'?Z=_8K_X(1_\%+OV_?@;K7[1?[.7P-M-
M8^%.GS:M::#KWBWQCX<\$3?$*^T(W4.K6?P\L/$%Y:W'B8V-]9SZ3+>QBVTD
MZPCZ7'J#WL%S##_H9?\ !RK_ ,$E(O\ @I!^QQ=?$KX5^'5OOVKOV7].UKQE
M\,?L,"-JOC_P1Y0OO'GPG;;&9[RXU6TM%U[PC;*_F+XJTR"QMQMUR\$GA?\
MP:[?\%*_A+\6O^"8<GP'\3)#X0^*'_!/;PGXBT_XC>&K6!I-0UOX36UUX@\7
M:'\2-+T:,"^N)WC?5_#?B*SCA>=/$VD"X<J?$%G"H!_ET>./!'B_X:>,O%/P
M\^('AS5O"'CCP1K^K>%?%WA;7K.73]9\/>(M"O9M.U?2-3LI@LEO>6%[;S6\
M\;# ="5+*58_U;_\$Y/^#3#]HC]N+]D/1/VH_B!\?/#W[.5Y\4M ?Q)\#_AW
MKW@#5_$^I:YH$Y;^PO$_CV\AUG1IO"FA^*(@NH:+%ING:_JDFBR6NJ2VJ1W]
MM#7)?\$_/V2;S_@X=_X+:_'K]J'Q?X"N?"7[)5I\7+OXZ_&6SB@,5O=^%+:\
MAL/AG\(YKZ/RX)?%7Q&M]#T\>,9;5VGATF+QAJ\++<&P>;_1>_;]_;/^#G_!
M,_\ 8R^)O[2OCZ#3=.\*_"GPI!HWP_\  NFK:Z7_ ,)=XTN+4Z3\.?AGX8LH
M!##;G5M1BM;(1VD0@T30+34=6>./3])N&C /\5C]H[X!?$3]ECX\?%G]G3XM
M:?;:9\2/@SXYU[P!XPM+&Z2^L!J^@WCVLMSIUX@5;O3KZ(17VGW&U#-9W,$C
M1QLQ1?%:_<3X<Z)\-?\ @H#XK^(7[<O[6#ZI>ZE?_''XLR_M1W>AZW/I'VK7
M_CM#X=TK]E^[TI4RFCZ)I?Q)\0ZIHE_;P(K3>%_!;/=RN3=7,6#I'_!./X6Z
MEX\\:_#?Q?XMUWP?K7[.W@WX*>%?C'9^%C#KOBOQ-\9_C'XDUYKJ\TG2M16Y
M@M?#'@/2VTC0-4M[&W:XU?6%TRVT[9<ZTL] 'XLT5^OG@[_@G#\-]3TDVFK?
M$;XJ^(]?US1/VK/%'AGQC\-OAM:ZE\*M#TC]F6S\9+_9WQ(OM=U'3/$7AC7_
M !AJ'A*.ZFM)K&!_#&B:_H-S>VUY/J2)%P^F?L4_!5UU"\F\:?&GQ0GP]_9=
M^!?QZ^)WA;P/X+\+WWCC5O$?QZT/X?:OI/ASX8:3/K<JZEX5\#Q>./M7C3Q5
MK0@GBL[6W6UTE9;K?& ?EW17[KZE_P $Y/@7X:LO'7P\UB']H'Q%KVB?M;?"
M+X,Z#X_\#_#>&_\ &.EZ5\7O@!X>\?VD'Q)\%7/B0Z+X<TCPSXDU>8WT5G]I
M\1:@]I=64-[:B"1(_,/#'[!/PK\76OANTUCQ-+HL/@'X3>-_$/C_ %;P#<G5
M=7^*&O:1^TEK/P:TS6?#:^()KO2M.T."R2RU">Z@LHXIK1=.MEMCJ&JK=* ?
MCO17KWQ]^&>G?!KXS_$CX6Z1XG7QEI?@?Q3J.A6'B8:5J.AOJ]I;,K0W%QH^
MK6]KJ&G7D:2"WOK6X@0Q7D,XCWP^6[>0T %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110!<T_3[O5+VWT^QA:XN[J18H8DZLQZDGHJJ 6=SA54%B0
M :]SLO@E&8$;4===;DJ#)'96BO#&3U42S2JTF. 6\I 2"1D$8YGX-PQR>*IY
M'4,T&DW<D1/\#M+;Q%A[F.1U^C&OI^NO#T83BY25]6DKM)6MVMKJ<]6I*,N6
M+MHFWUU/$O\ A26E_P#0=O\ _P !+?\ ^.4?\*2TO_H.W_\ X"6__P <KVVB
MNCV%+^1??+_,R]K4_F?X?Y'B7_"DM+_Z#M__ . EO_\ '*/^%):7_P!!V_\
M_ 2W_P#CE>VT4>PI?R+[Y?YA[6I_,_P_R/$O^%):7_T';_\ \!+?_P".4?\
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M#M__ . EO_\ '*]MHH]A2_D7WR_S#VM3^9_A_D>)?\*2TO\ Z#M__P" EO\
M_'*/^%):7_T';_\ \!+?_P".5[;11["E_(OOE_F'M:G\S_#_ "/$O^%):7_T
M';__ ,!+?_XY1_PI+2_^@[?_ /@);_\ QRO;:*/84OY%]\O\P]K4_F?X?Y'B
M7_"DM+_Z#M__ . EO_\ '*/^%):7_P!!V_\ _ 2W_P#CE>VT4>PI?R+[Y?YA
M[6I_,_P_R/$O^%):7_T';_\ \!+?_P".4?\ "DM,_P"@[?\ _@);_P#QVO;:
M*/84OY%]\O\ ,/:U/YG^'^1XE_PI+3/^@[?_ /@);_\ QVC_ (4EIG_0=O\
M_P !+?\ ^.U[;11["E_(OOE_F/VM3^9_<O\ (\2_X4EI?_0=O_\ P$M__CE'
M_"DM+_Z#M_\ ^ EO_P#'*]MHH]A2_D7WR_S%[6I_,_P_R/$O^%):7_T';_\
M\!+?_P".4?\ "DM+_P"@[?\ _@);_P#QRO;:*/84OY%]\O\ ,/:U/YG^'^1X
ME_PI+2_^@[?_ /@);_\ QRC_ (4EI?\ T';_ /\  2W_ /CE>VT4>PI?R+[Y
M?YA[6I_,_P /\CQ+_A26E_\ 0=O_ /P$M_\ XY1_PI+3/^@[?_\ @);_ /QV
MO;:*/84OY%]\O\Q^UJ?S/[E_D>)?\*2TS_H.W_\ X"6__P =H_X4EI?_ $';
M_P#\!+?_ ..5[;11["E_(OOE_F+VM3^9_A_D>)?\*2TS_H.W_P#X"6__ ,=H
M_P"%):9_T';_ /\  2W_ /CM>VT4>PI?R+[Y?YC]K4_F?W+_ "/$O^%):7_T
M';__ ,!+?_XY1_PI+3/^@[?_ /@);_\ QVO;:*/84OY%]\O\Q>UJ?S/\/\CP
MZ7X)6!1O)U^[63!V&6RA9-V.-P2=6 SU()('(!Z'QGQ+X9U'PMJ+:?J"JVY?
M,MKF+)@NH<D"6(D C# JZ, R,"&'0G[7KQ/XV0QG2]$G*CS4OKF)7[^7) CL
MOT+(I ['/J:QK481@Y17*XVZMIW:75OON:4ZDG)1D[I_AH?.=%%%<1TA1110
M 4444 %=%X1\6^)? /BKPUXX\&:WJ'AKQ?X.U[2?$_A?Q#I,[6NIZ'X@T*_@
MU/1]6T^X7YH;S3[^VM[JWD .V6)201D'G:* /]G3_@B'_P %0O"W_!5#]B+P
M9\7Y;K3K'XY^ 5L_AS^T;X.M7BCET3XCZ98QE?$MG9"1Y8?#'Q"TY$\4>'I2
MODPR3ZKH2R2W>@7I7^,3_@J/\3/"/_!![_@XBTO]H[]EIK-_ _Q3\*^'OBM^
MT/\  ;2#:0Z0_A_XOZQK>F_%WP''I\:+8Z?#XJBT9/B9X1M+A470O$]_8W$,
M$6A16-M+_*[^S%^V3^U-^Q?XOU+QY^RO\=OB)\#?%.M::='UO4? FNRZ=#KF
MFY=H[36]*F6YT?6$M7DEDL6U*PNI-/FEEFL7MY9'=O)/B=\4?B/\:?'GB;XH
M_%OQQXH^)'Q%\9:E+J_BGQIXSUJ^\0>(]<U"4*AGO]4U&:>YE$4*16UK '6W
MLK.&"SLXH+6"&% #_<0_8ZT7]D4_!#PS\6?V,O /PA\#_!OX]Z9IOQAL=0^$
M7@KPKX'T;Q<_BC3H;Q=?UVS\+V&GP2Z_#"W]GZHFHJ]_I5Y:7.E7(@FM)8$_
MS//^#H3_ (*W-^WW^UN_[.GP@\2?;OV6_P!E#7-;\-Z-<Z7<^9I'Q-^+R.^E
M^-OB$SQ,8]1TS1V@D\(^#)B7@73[;6-7L2(_$<K/^)GPK_X*/?MW_ _X&^(_
MV:OA%^U=\:_A[\"_%::A'K'PW\,^--1T_0O)U8.-6M])=&.H^';753+*^IVO
MAV^TJWU"6:::[BFEFE=_BF@#[+^%G@[P)=_#/X>Z5KUU\2K?4?CE\5-7\&SW
M/@WQ''!INES>$1X5'A34;[P7-;?9/%)M-7\7W4UQ-=7MO=:;9-</I#1WDN9/
M0HOV?_BMX+L=3^*4_P"T-K7A'QKJ-B=9\5:]9ZOKL$UWX!U+Q*GA^\UJY\;V
M'B:/6_$%_<62)X@?PS_9<K7VG1K$FH2:@BVP^3?"_P =OBOX+\(2^!?"_BZ?
M1_#3WVIZG#;6^E:%)J.FZCK-I:V&J7VB>(;G2YO$6@75]:6-I!<3:)JNGR.D
M"'<&W,:1^,OQ+/@0?#3_ (2FX_X0T0?8_P"SA8Z2+TZ:+TZB-';Q -/'B-M"
M%\3=#0FU8Z.)OG%D#B@#ZV\+?!'XV^&M/\9_#B'XA>(M,UC6H/%M_;> ;7QG
MXL\,6%[=6GQ \.?"C3?&.H6=A<G0]7A\::EJWB#1+5M4VI]AT757O[DQ&VCD
MQ? 7P>\0:Q\2F'P@_:.\17>M>#/"/BB3Q_XLTK3O%OA'Q3X*\+>!+32]!O+/
M0C=Z_8GQ-H4T-YINA:'86OB+2)GM(Q#>:/I>GVZ$_,>H_&?XJ:O>7.H:EXYU
MZ\OKOP9H7P\N+R:Y0W+^#/#*:<NAZ$LPC#QVU@VE6%PLT3)>37L+7]S<37MQ
M<SS=%?\ [2'QJU/6M"U^\\;S2:EX=34ET[R]$\,VVGRG685M]9FUG1K718=&
M\276KPI''JMWXBL-5NM26.,7LT_EIM /J*?X2?%WPI-\6[RS_:=\81ZKI>BV
MWB&&P\,ZMXOU'Q3X[TF^\#2ZJVI^+=*T3Q//J6B:?9Z'81^&-9OY!XJCT26.
M*VU;['X=%MJLWPYH/Q!\>^%K_3-5\,^-O%WAW4]$L[G3]&U'0_$>L:5?:387
MLLD]Y8Z9=6-Y!/86=W/+)-<VUK)%#/-(\LJ,[,Q[Q?VBOC.LOBV8>.+OS/&\
M'V;7V.EZ 1Y T>7P^J:&ITHIX3VZ%*^CHWA1=%=-,VV2,MO''&OBE %BZN[J
M^N;B]OKFXO+R[FDN;J[NII+BYN;B9S)-/<3S,\LTTLC,\DLCL\CL69BQ)JO1
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'KOP8_Y&>\_[ US
M_P"E-I7TW7S)\&/^1GO/^P-<_P#I3:5]-UZ&&_A?]O2_0Y*WQOTC^3/9_@M^
MS[\6OVA;SX@Z9\(/"LWC'5OAC\,?%/Q@\5Z19W-O%J<?@3P7'!/XEU+2K.9U
MEUB\TVUG%XVEV(DOIK6&YF@B<0.*YE?AAXP?X/M\=ELK8_#9/B7!\(SJYO81
M=_\ "<7'A2?QI%I_]FG%S]E/A^VEN3?D"!9E%L<2D"OJO]A[X@Z_\++']KOQ
M[X.\4-X/\<^&/V6-;UOP/KD%Y#:7]MXHTOXD?#Z_TX:<LSJ+ZX)MW\[30DZ7
MUC]JMKBWFM))XV_47X;>(?V7+_X.?LW?&Z'6_A=X2\%_&7_@HI>^.O&/PI\7
MRV-]X<^ _P >[']E;QOH=K)XR\-7?RM\!)/CA?\ @OQ[H.H7T4VC1>"-0U+P
MYJIG_P"$<O?M6DIN+>EU>*Z]5)M/UMH_56V(44UO;?\ -*_^?_#G\\5[H/B#
M3?L_]I>'O$.G?:X%NK07^A:M9&[MG=(TN;47-G%]HMWDDCC6:'?$TDD<8??(
M@;MOBG\'_B5\%?&>J> /B;X0UCPOXJT:ST?4-0L+JUFEABLM>T/2?$>FW,=_
M DEC/#)I6MZ9+/)#.Z6=Q<BRNFBNT>$?LW;7?[>?@K]F3_@HN?VQOB9XC9M7
M^"OA;4_AE:_%/XEZ?XK\::_XIL?V@?ACJ4WBO]G*=M:U?5].\ 0Z>B7>HW_@
M.YTOP9J-NFAKIT-Q<Z7_ *)Z5\9M:^+_ ,7_ -IG]J31?%/Q(U_QYH_[5/[!
M.E^%OV.+_P :_%!_$?@_Q_XGM="_9P\9^)?"/P\U77O$-]HV@^(M=U3P#XQL
M9=&:72+K6/'4 TFYCDUF_C$B]H[_ &6DM6FVG\+T=NBDVUY/;H^7O=?)>?GW
M5OG]_P#.M';74H0PVEY.)&=8S!:7,XE>)0\J1&*)Q*\*$/,D>YH497D"JRDZ
ML/AGQ/<W\FE6WACQ+<ZK#:)?SZ5;>']8N-3M[&6-9HKVXT^&R>\@M)8726*Y
MFA2&2-T='974G^B?]BOP;XU_9=TW]AVQ^)MQX>^'7Q,TGXE_\%&?&D_@[7]:
M\,S^*_ $D_[+G@RT\+?\)_X;N;F[7PQJVL7U@+S1-$\10+<7UNUM*+1C,(C\
M<_![XA?M9_&?]D*34?V8_BG\4/$/[5NJ_'K7_$/[5%]X0^(VJ:3^TEXU^&L?
M@?P1:?!#55\1'6=-\9:W\'_!6JVGCZTUC1M!U4Z#X5U2ZTJX\0:9!IIT1[9\
M[;=DK)I7;=M;ZO3;3YMK7J'+MJ[M7LEKTTWWU7RZ'YL>"?@UXU\>^"/C/\0-
M%BTVVT'X#>$_#'C/QU'K5S<Z9JDNB^+O&=EX#TD^';)[&4:O=KK]_"+V&2:R
MCMK..XG$\LL1MSM?!']GWQ]\?+OQH/"%SX1T'P]\-_#=KXM^(GCSXA>*++P9
MX$\$:%J.KVWA_1[GQ!X@O4G$$^N:[=V^D:-96MK=WE_>-(L<(B@GEC_;K]K/
MQ/?7_P (_CY%XY\<_#OQ5\1YO^"5?[$^C>,]4\$:WX:O=+UGXAZ9^U-JLWBR
MSAN?#T_]CZWXHM)Q+<>*KO0UEMK[41>ZM%OM9UG?Y"_8#L-5L?@!\==7^$?P
M,T;]J_XK?$#QKX<^#/QK_9^U36YSJC_LFZMH[^(M6\5^#/!=I?Z==WOBBX^(
M.GZ98:;\4+5=8N/A/?V=EJ,6GP)J-Q+.E4;C)VLTXI=M5K=NRMH[-V6RZARJ
MZ5^]_P#AOGK;7?L?F9\3/ASXJ^$?CWQ3\-?&]K86GBKPAJ7]FZM'I6KZ9X@T
MF9I+:WOK*_TC7-'N;S2M8TG5-.N[/4M+U*PN9K:\L;NWG1AO*K)XF\"'0=.^
M'M[IGB;0?&MUX]\)0^*+C1/"-OXAO=8\$74^LWFCQ>%/%T%YHEE;CQ%*UM#?
M0KH%SKFF26FH648U%;Z1[1/N7]O#]E;X*?LR^&/A-'\&?$U[\53XRUCQCJ/C
M?XC-XQ\,:Y;_  WU:.WTB?2OV7?$6B>$=6U?2H_B;\+K&ZGF\?>,UD@TWQ1J
M,\2>&HQ86EY!:_;5K\7=3^&7[-_PF\5_#WQKIWA[QSHW_!%-_#NF:MIVH:8=
M>T#7M6_;;\+P7,6DN9&N]'\9V>CW-SJ6DW=H+?Q#HK1QZWIKVTMK%=1OGTBU
MK=M:JUVDMUJUKK;?UTNN7=/I9Z:_Y)GXL?#KX(?%?XJ_$6R^$W@GP-K^H?$.
M_LM5U&#PO>Z?<Z-J26.BZ/=Z]J%U<Q:K%:&TACTRRN)XI+@1I<N([>W:2>:)
M'\PEMKRW -W8W]B2Q0I?V-W8RI*$21X)(KN&&2*XB22-YK>15GA62,RQH'3/
M[X?L:_M(?$37=<_8'^(?C;XX>(S\6KCXB?MD? 6Y^)VN?$?5+#XAZWX$OOAC
MX2UWX9>!/'GCN\UR'6]:\/6WQ%\2WS^#6\7:C-::??SP6ME<QQ:=:):_,GB7
MX+_M*_M ?L@^'/AO_8_BWXF?M+_ W]J7XZZM^T=X5\3^++36?BSX<M_B7X ^
M#=CH/CWQE/XCUV;6=7\-2WW@OQ!9:_XVEO;_ $W0IK&,ZW?VL-S;2R'.[V=D
MM%N]'>2;N^ETM]KZARJVEW\O)/[]7]Q\ ^!/@WKGQ&TNW'AK6] E\>:O\3?
M7PM\)_"2[77+;Q_XRU7XA//!IFM:#$=';0$\/:9>I:6NM7>KZWID]NNHVUW;
M6]U:)<2Q,U'X/:_H.D_$J3Q3J>E^%O&?PT\5:+X3NOA=K%GXB3QWXHNM3O\
M5=.U+4O"MK;:+<:1>Z/X9GTJ4ZO=W>JV;SQSP2:3#J$8E>/]X_CSXXTOX5_'
MV_UC3?BAH&ER>!/VZ_\ @EA/?>._!OC2VBLK;0?#7[,(T?QQKFF>)-$ODDD\
M-V-K_:6G:[J5I<&P^R27-M>R&&=XW\4\:_%7]H7X"_\ #<WQ4^)OC#Q+J_QC
M\&_M6?L@?$SX9W_CSQR_C_4_$7P[T7XJ?$_6O#!\.:K>:YK3ZW\/+_0WGMK:
MSTR]DT7^Q=2F@$4-M=E72FWM;6UEU;;6BTVLU?JKW[#Y5;SNU\DF[V[W7X6[
MGX7A)&2618Y6B@4/<2K%(T5NC-L5KB55,<"N_P B&5D#OE%RPQ6A?Z+K>E0V
M5SJVAZWI-MJ49ETVYU71]2TVVU&( ,9+">^MH(KQ I#%K9Y!M(;[I!/[QEOV
M7?V6_B=\#O#-SX@\'Z]\#OVT/VK_ (>_M1>/A!?:7K-KX*_9+\.7$&K?"/X9
M>.0&U2VLCI?Q&\7>+;CQ;I6JVKI/%X):34]/DM8XHZN?M4Z[XAT?]FG]J*U^
M.6F_M5Z_'XVU+PBGP?U#]K/]IGX+?$;P?/X\3Q[INHI\0?V3?#/P[\ K>ZGI
M,'@RWU[2-3N_ ^K>%?AA;>#-72TOY+B_M?#^E%^TU6FC>GGJD[>:=[^2^8<N
M^NJ_RO\ CT/Y_J***T("BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ KQ?XU_\@;1O^PE-_P"DU>T5XO\ &O\ Y VC?]A*;_TFK*O_
M  I^B_\ 2D72_B1]?T9\WT445YAVA1110 4444 %%%>Q?#'X$_$;XO6NHWG@
MC3=/OH-*NX;*]:]UC3M,*3W$7G1JJWL\32*8QDN@*J>"<\5Z&695F>=8RGEV
M48#%YGCZL:LZ6#P-">(Q-2%&'M*TH4H-2E&G37/-K2,=7H<^*Q>%P5&6(QF(
MHX7#P<5.M7FJ=.+G+E@I3EHG*7NQ[O0\=HK?\4^&-<\%^(=7\*^)+"33=<T.
M]EL-1LI2K&*>/!!21"T<T,T;)/;SQLT4\$D<T;,CJ3]%_LY_L8_'G]JFQ\1Z
MA\&] T36;7PKJ&F:7K+:MXJT+PZT-YJ]O=W-BD2:Q>6K7"2165P7DA#)$557
M(+J"8;*<TQF/EE6%R[&8C,X3Q%.>7TL/4EC(5,)SK%0GA[1J1GAW3J*M&23I
M\DN9:&6*S++\%@_[0QF-PN&P/+2E]<KUH4\-RUW%49>V=X6JN<53:;4N96>I
M\JT5N^*?#FJ^#O$WB+PCKL44&M^%==U?PYK,$$\5U##JNAZA<:9J$4-U SP7
M,4=W:S)'/"[Q3(HDC9D92<*N&<)4YSISBX3A*4)PDK2A.$I0G&2>JE&<)QDG
MJI1DNAUPE&<(SA)3A.,9PE%WC*$XQG"46M'&4)QE%]8R3ZA1114E!1110 44
M44 %%%% !117])'Q\_X-YM:^!W_!*;PS_P %/I?VI='\1V'B/X,_!/XO#X.Q
M?"R_TV^M8OC'_P (QY6A'QB_C2[MI9- _P"$D427PT!$OS9MLMK83*4QJXBC
M0=)59\KK5%2IJTGS3=K1T3MNM79>9K2H5:RJ.G'F5*#J5-4N6"O=ZM7V>BNS
M^;>BBBMC(**** "BBB@ HHHH **** "BBB@ HHHH ]=^#'_(SWG_ &!KG_TI
MM*^FZ^9/@Q_R,]Y_V!KG_P!*;2OINO0PW\+_ +>E^AR5OC?I'\F>R_"GX?Z3
MXW\-?'?5=2\/>+M;O/AI\(+WX@Z+>^&==\,:/I?AB]L/$FA:5<:]XWM/$%I<
M7_B'PS':ZJ]G_8_A*>R\0_VE<VEVLLMC!=0GV_X@?\$\?VIOAA;>/V\8^$O
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MX(4_\$;/V0_^"BW[,'Q,^+W[05]\6K7Q7X2^/&J_#C2D\ ^+]+\/Z4WAZS\
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MI]DFI:[?!9M3M=7N/#'AVZN7E;7$1;B\6XF_X+!?\%7_ -@G]K/_ ()&^./
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MQ?XU_P#(&T;_ +"4W_I-65?^%/T7_I2+I?Q(^OZ,^;Z***\P[0HHHH ****
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MN:Q=RWVI:E>S8WW%U<SLTCD*J11("(K>WCBMX$C@BCC7'JDK;MO3Y?Y_-ZL
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M_P#2:O:*\7^-?_(&T;_L)3?^DU17_A3]%_Z4BZ7\2/K^C/F^BBBO,.T****
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MG_E*[^T/_P!B=^S-_P"LM?!FC_@EY\/?AE\*?@O^U[_P4Q^,/PU\/?&2W_9
ML?AMX$_9T^$_C?2)/$'P[\9_M8_&W5M3M/A]K'Q$\/+&\7B/PE\+O#?ASQ/\
M0KCPS?XTGQ!JVF:-IVJ.+:3RK@ ^!O!G[#/[:WQ'\'+\1/A]^R#^T]XY\ R6
MSWD7C;PA\!?BGXD\)RVD:&22ZA\0Z/X5O-)FMDC!=YXKMXE4%BP )KYNUNVU
MNQU2\T[Q';ZK9ZUIDK:;?V&MQ7=OJFGSV)^SM87EK?*EW:2V9C\AK6:.-[<I
MY1C3;M'W)\1O^"D/_!2'XI_$&Y^)_BW]KO\ :C_X2^:]DOK*?PU\4?B!X*T?
MP\7P%L_"7ACP=JFA^&_"6EP1JL%OI7AS2M,L(856-;?&<_H7\5?&NM?\%0_^
M"97Q_P#VHOCSHEA<?MM_\$Z/%WP-M_&?[046@Z=X=\1?M'_LT?'WQ3<_#'P]
MHOQ9;3K6P@\8_$SX5?$"WTD:#XWGM1K-YX)U2XTK6;C4);2WNXP#\!]/T[4-
M7OK32]*L;S4]3U"XBM+#3M/M9[V^O;N=Q'!:VEI;)+<7-Q-(RI%##&\DCD*B
MEB!7U#XJ_80_;>\#>#I/B'XU_8Z_:D\(^ H;1;^;QKXF^ /Q5T+PI!8NAD6]
MG\0:GX4M=*@M&C!<7,MTD)0%@^!FOU:^%OCT_P#!*?\ X)I? W]J#X-Z9H5O
M^WK_ ,%"_%/Q:B\"?&[5M#TW7?$/[+_[,/P<UBU\%:D_PE&K0ZAIOAWXF?&3
MQE>WAN_'-M;'7-%\'Z+-I%D=.N;K[5+^;/@;_@IC_P %"_AQ\0;?XI>$_P!M
M;]IRU\<07R:A+JVJ_&?QYXGMM4F0DB'Q!H?B?6]8\/\ B73VR0^E:_I>I:8Z
MA5>T*H@4 ^'J_>;_ (+2_ W7O%O[<WP(^&G[/WP>U;Q'XD\0_L(_L9:I9^ /
M@]X O-7UK6]8U'X.Z3<ZKJ5OX7\&Z5<WVHZC?7,AN=1O8[&6XN)G,US(S-NK
MY+_X*._&/]EK]IE_V=OVFO@OH^@?#G]H7XO?#76C^W!\%O W@Z^\(_#3PI\>
MO"7B6;1(OB7X!M/LL'AZQTSX[>'&M?'6J>%/"DUQI/A77DU*(BVN-1>!?VA_
MX+I?MU>//V=_$7[./P$_94UO6/@EXR^(W[!W['_B[]J+XU^ M4O/#OQ8^),G
M_"KM.LO 'PI@\<Z<++Q+X8^&?@OP_8+JUWX9\,ZM9Z;XLUWQ+<7?B/\ M#^S
M;2"( _FT^+_[(?[5_P"SYHUAXB^//[,O[0'P6\/:K>'3],U[XK?!WXA?#[1=
M0OU!8V-EJOBOP]I-A=7@4%C:PW#S[03Y> 2/#M \/Z]XKUO2?#/A?1-7\2>(
M]>U"UTG0_#^@:;>:QK>LZK?3);V6FZ5I6GPW%]J.H7EQ(D%K9V<$UQ<3.D44
M;NP4_K__ ,$SO^"E?[0'PX_:0^'7P>^./Q!\<?M%_LB_M$^-?#/P9_:1_9U^
M,7BC6OB3X"\:_#KXD:[9^&-<U/2M$\77^J6_ASQWX<&K+XF\+>*M ;2M9MM>
MTG3O-OWM@\=>B?LI_L^VW[*?_!Q?\ /V;])O7O=(^#7_  4]^'G@'P[?27'V
MVYE\-:-\;],M_#4][</# +C45T!M..HOY"1M?K<;5,>"0#\G/A5^RW^TS\==
M2\0Z-\$_V>/CA\7M6\)326_BK3/AE\*?'7CJ^\,W$4S6\EOX@M?#&A:G-HUP
MEPK0/!J*6TJS*T93>K*.8^+'P0^-'P%\2)X.^.7PC^)OP;\6R6L=_'X8^*G@
M3Q1\/_$$MC+_ *J]BT?Q7I>DZA):2=$N8[=H7/"N37ZG_P#!3/\ X*)_&/Q!
M^TO\:_@?^S9X[\>?L[?LF_"'XR?%/PU\-/@]\+O%6L^!+#5;VW\;ZN/%'Q(^
M)=SX7U*QN_B+\1O''B2*_P!?U+Q-XKN]6N[&WNK31](.GZ991VY^@_V /V@O
MB?\ \%%O@+^UC_P3K_:U\6^(/CSIOAG]E[XT_M/?LC_$'XEZA<>,OB1\ /C3
M\ /#9^(.IV?A/Q[KMQ<>*H_ /Q$\"Z1KWASQ1X+N=8FT.22VT6XT^VLI;9UN
M #^=VOJ#X??L1?MG?%KPE_PGOPK_ &2/VF/B3X&\N28>,O 7P)^*'B[PL\4*
MN\LL>OZ!X7U#2I(XEC=I'2Z94".6(VG'WE_P2P^%?P=\&?#W]KS_ (*._M"_
M#W1OBY\/_P!AKPAX#C^%7PC\60?;/ ?Q1_:I^,OB&Z\._!71/B#IX23^V/ W
MA;^R/$/C[Q%X?F1;/Q!#X=MM)OY/L=U/#-\U?%O_ (*G_P#!1/XU>/I?B-XP
M_;(_:$T[6TG$FB:9X!^*/B[X9^#_  =:PQ_9[+2_!'@OP!JWAWPQX2TS3K(1
M:?96VAZ79E+*"&*628IO(!\+:WH>M>&M6O\ 0?$>CZIH&N:5<RV6J:+K>GW>
ME:MIMY"Q6:TO].OH8+RSN8F!66"XACEC8$,@/%?L7\(/#'AJY_X(.?MF^+;G
MP[H5QXKTS_@H)^RQH^F>*)])L9?$.G:1J'PN^*$]_I5CK+P-J-IIM]/;P3WE
MC!<);7,L$4DT;O&I'O.B_%?5/^"O_P"PO^U7!^TFNF>*_P!O/]@/X46'[1?P
MF_:4_LK3M.^(OQM_9M\.:]IOAKXM_![XV:MIMI:+XWO/AUI>MZ9XQ^'?C+68
M[KQ+!#8W/AFYOI+:[GN+CR+X,_\ *OY^VW_VD5_9-_\ 54_%:@#\2K>VN+RX
M@M+2":ZNKF6."VMK>)Y[BXGE8)%#!#$K22RR.RI''&K.[$*H)(%?5&J?L'_M
MP:'X)?XE:U^QQ^U-I'P[CLAJ<GCK4_V?_BO8^$(]-*&0:A)XCNO"<6D1V)C5
MG^UO=K;[ 7\S:":_4C]G;Q'IW_!,'_@FSX"_;T\%Z!X9UC]N7]MWXJ_%'X9?
MLN?$#Q/H.D^*8OV7O@E\"CI.D?%/XL>#-"\06-YI=K\9_&GC?Q!8^&/"'B:]
ML=0C\/>&["_U317MM3-TD_YX>'_^"G7_  46\,?$>'XM:-^W#^U-#X_AU./5
MO[<N_C?\0=5AN+F&Y-W%;W^B:MKM]X?U/2(YSE-!U'2KK0UC"VZZ<+=5B !\
M,LK*S*RE64E65@0RL#@JP."""""",@\&MSPUX7\3>--<T[PQX.\.Z[XL\2ZO
M<+:Z3X>\-:1J&NZYJET^=EMIVDZ7;W5_>W#8.V&VMY9&P<*:_;+]OVT\!?MK
M_L,?!#_@JEX4\ >%OAO\>S\9_$'[)_[=7ASX<Z#:>'_ WC7XI6/A2U\>_##]
MHVP\+:-;6^C>"M1^*7A.74='\<6EG#:Z=K7CO0[S4M/M+=Y[E[OU3XI?&+Q'
M_P $??V,?V4OA%^RW<VOP^_;0_;A_9\\/_M8_M*_M.Z38VK?%;P9\%/BW=:F
MOP/^ WP@\7S6\UY\/]&U#PCI<OBKXD:CX<N+#Q+J>O7T%E+?06%M:Q( ?CE\
M4/V+_P!L'X(>&X_&7QG_ &5/VC_A+X1E\OR_%/Q*^"/Q*\#>'6,P0Q#^V_$W
MAK3--!E\R/RP;D%]Z[0=PSXFW@7QLFF>%]:?P?XI31O&]]=Z7X+U9_#^K+IG
MB[4M/NX+"_T_PQ?M:"UUZ^LKZZMK.[M-*ENI[:ZN(+>:-)98T;[5^#W_  5,
M_P""@GP5\;'QKX?_ &KOC1XO%_).GB[P3\7?'OB7XP?#'XC:5?A8=;\/_$;X
M=?$;4_$7A3Q?H^OV ETO54U/37OS8W-PMC?V5PZW"?K%_P %@?%/P1US_@FU
M_P $??B?^R]X;G^%G@/QYKO[7_Q1C^'%AJ5Q=V7P<^*&N>._A]=_$;P%X/U.
M6.&_/A+PUXYLM0O?!#74D]]8>'M0TNRFNYI;+< #^;GQ)X:\1^#=>U7PMXO\
M/ZWX5\3Z#>S:;KGASQ)I5]H>O:-J-NVV>PU72-3@M=0TZ]@;Y9K6[MX9XSPZ
M*:@T/0];\3:QIGA[PWH^J^(=?UJ]M]-T?0]#T^[U;6-6U&[D6&UL-,TRPAN+
MV_O;F5EBM[6U@EGFD94CC9B ?VZ_X*ZVUE^U#\*?V+O^"JWA>T@:?]JCX:+\
M%OVH7LDC4:5^V/\ LXZ;IOA'QKJ6KQ0*SVES\5_ :>$OB%IUSJ<[:AXBNCXF
MU0*T<,CCG?\ @C=IVG? _5?VI?\ @IAXNM(W\/\ [ 'P2O\ 7?A9]LA<V>M?
MM:_&P7WPP_9ST:"X*R0+?Z'JU_XB^)*I-!<H8O I$D2"19D /Q@U+3=1T;4;
M[2-7L+S2M5TN\N=/U+3-1M9K+4-/O[.9[>[LKZSN4CN+6[M9XY(;BWGCCFAE
M1XY$5U(%*M#5]6U+7M5U/7-9O)]1U?6=0O=5U74+IS)<WVHZC<R7=]>7$AY>
M>ZN9I9Y7/+2.S=ZSZ "BBB@#UWX,?\C/>?\ 8&N?_2FTKZ;KYD^#'_(SWG_8
M&N?_ $IM*^FZ]##?PO\ MZ7Z')6^-^D?R85];_!KXU_!KPKH7A#0/BU\,+KQ
MKI_AJ/XGI<-X<T/P!9:YJ,_C^+0=*TN\O?$6M:+<:AJ8\)Z%%XK&C6^J7%XN
MCZWK&FZUHRVU[I4,@^2**W:3T=_D[&2=NWS/=_V@/BIX/^*GB?0;KP'\.="^
M'7ACPOX6T;PU86^FZ?I=CK.OR6.D:5;7^L>*'T:PTRPO+^74K.]GLY3:S7ZP
M7LQU'5-3GEWP^$444TK*W_!#<**** /NOX5_&GX/V?@/P;\/+KX2-XK^)3>$
M]2\(^'/$=A\.O!6OZGX.^(>J^-/$VL67Q#M--O-+NKOXOZGJ'A[6-'\&6_@[
MQ@NH:1I=K9R7VFVHU*VTTQ_3?PU^(/P=TCQ-XFO+C]A[XE>+;CQ#8^*+)O##
M?!W0-0&B2^!=>M8/$CZ7$- U.&WO)+?6M+T_Q0EM!:1^#M3U&UL)KNUBNM-F
MC_(73K^YTK4=/U2R94O-,OK/4;1W4LBW5C<1W5NSH&4N@EB0NFY=RY7(SFOJ
M32_VUOC[H7@G_A M!UCPOH>CQZ-KVB66HZ7X1TVW\4:5#XGUDZ]KNH:7XC9I
M+^TUR^U+RIO[8S)>VAM;*2R>VN;&TN(<Y0;VN[[WDUU\OR5MBE+OI;LD_P S
M)^,'Q&^$?B;X8> _!_P_\*)HGB70/&_Q&\2>*-9D\,Z3H]WJFE^+9]'G\.>'
MGO[2U?4+J'P8EEJ&G1)<:FUD?M32V.G0(SN?F6E)+,S,2S,S,S,2S,S$LS,Q
M)+,S$LS$DLQ))))-)5I65E^)+=PHHHI@?0/P-^+'A#X;67CG2_&7@O3?&&G^
M,KKX=0$W/AGPAK6J:5HFB>,8+[Q[#H6J^)M)U*[\/:KXB\%R:EHNFWVD2VIB
MU*2TNKLLENC+]<77[6O[*%Y<WT5E^S5IWA/1[VRU"&&/2_!_P]UC6](6?3K3
MP_;VFE:OKFEZA$MVNA^&_#E['KNH:;?RQ^+M6\8:H]G#%K$EU#^8U%2X)N[O
M?R;7;MZ#4FNWW(]?^./Q#T'XG^.X_$_AGPSIWA+1HO!_@'0(]&TSP_X;\-0?
MVGX<\&Z+HWB/59=/\*Z=IFERW.O>([35=;FO6MVO+HWX:ZE9P OD%%%4E9)=
MA!2'D$>H-+10!^EO@KXE?#W4?ASINJZ9^SGXFUV/PUI?PN\-:A\6M#^"?@OQ
M)HW@R[\+:!H47Q#\#W-I=:'<:%XMU;XPR:?JNJ3^+_%\TWBCPPMY:3Z%<6J/
MJDS>O^#_ !-\-?#7A/Q_I=_^P9\6-4N]:@NKJ:XU+X,Z?<R>"=23/A&Z\-VF
MK7WAR[N+>PT;Q/I%]/)J#W6DW3ZE'<Z.[C4[:\AG_-SX2_'_ .(_P3N-+NO
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MU1"EKLQD'(!\<4444 %%%% 'KOP8_P"1GO/^P-<_^E-I7TW7S)\&/^1GO/\
ML#7/_I3:5]-UZ&&_A?\ ;TOT.2M\;](_DSJO#G@_4/$\5U-9:MX/TU;.2.*1
M/$_C/PWX5FE:5696M(=>U&QDO(E"D2RVRR1Q,521E9@#TG_"I]=_Z&GX3_\
MAWOA[_\ +ZO," >H!^M&!Z#\A71KW_#_ ()EIV_'_@'I_P#PJ?7?^AI^$_\
MX=[X>_\ R^H_X5/KO_0T_"?_ ,.]\/?_ )?5YA@>@_(48'H/R%&O?\/^"&G;
M\?\ @'I__"I]=_Z&GX3_ /AWOA[_ /+ZC_A4^N_]#3\)_P#P[WP]_P#E]7F&
M!Z#\A1@>@_(4:]_P_P""&G;\?^ >G_\ "I]=_P"AI^$__AWOA[_\OJ/^%3Z[
M_P!#3\)__#O?#W_Y?5YA@>@_(48'H/R%&O?\/^"&G;\?^ =)XC\+WOAB:UAO
M=2\+ZDUY%)-&_A?Q5H/BJ&)8G$;)>3:#>WT5E,Q.Z*&Y:.26/,D:L@)'VM\!
MOV'8OCMX#F\6V?Q6F\':AIW@;Q!\0]6M?$'PYO9/"LFB:)'XA\O1O"OC&#Q0
MC^+?'-S+H+3W'A*R\/6UU9:0U_JD=S>G3&M;GX&P!T&*VU\3>)TTRST1/$_B
M5-$TZ:[N-.T5/$&L)HVG7&H1-!J%Q8:4EZ-/LI]0@>2"_FM;>*2]ADDBNFEC
M=E*:DUH[/O;_ (<:MU5_F?HKXX_X)Y6?@FZGB;XJ>+O$-KJFO6OAKP9>>&?@
MR/$/GW;>&=(\377B/XBVNA_$?4+KX8^")X-;L[31-3U6+4/$=Y/::XFK^%-!
MNM(:SNNG^(/_  3.TCX<VFDZEJ?[15CK&G:I\4/@/\-'F\,> M#\0-IY^.E]
MXIM=/\13W.E?%B[T2_LM%@\.07TFGZ'K6JWSIJ\=AKR^%=7TW4=/A_,^7QOX
MXGDU>6?QQXUGE\06MC8>()9O%WB*67Q!8:85.F6.NR2:DSZS9:840Z;::DUU
M;V&Q/LD<.Q<5X_%GBV&QFTN+Q9XJBTNYDMYKG2XO$FMQZ9<S6EY+J-G-<:>E
M\+.>:SU&>?4+266%Y+6_GFO8&CNI9)6GEG_.O_ ?ZL.\?Y?Q/I;]H[]F71_@
M1X8\ ^)](^(]]X]M?'NM_$;3+1+CP39^$UL+3X??$+QE\/9+JX,?C?Q/=M>Z
MM>^#;C5(K!["WM;73[^W5-5O9XI5/SYX?\#ZGXDLGO[/6? ^G1)</;&#Q)X\
M\*^&;]GC5&:1-/UO4[.[>W8.!'<K$8)&#JCED8#$N_$7B*_TRUT74/$7B#4-
M%L;NYU"QT6_UO5+W1['4+TLU[J%EI=U=RV%G?WK/(U[>VUO%<W;22-<2R,[D
MX^ >H!_"J2=M7=]["=K[:'I__"I]=_Z&GX3_ /AWOA[_ /+ZC_A4^N_]#3\)
M_P#P[WP]_P#E]7F&!Z#\A1@>@_(4]>_X?\$6G;\?^ >G_P#"I]=_Z&GX3_\
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MC]<:?\0-'LY;RTN/%_PQ\.ZCX5^(%]>I<6^L:5X<O?'NOQZ)IU]:P2&2SO\
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MT?5JO9?^!(/;4^[^YGS=17TC_P *4T3_ *#&I_\ ?JU_^)H_X4IHG_08U/\
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MC^5=#;?\&S_[,TP4M^T3\:1GN-#\&'Z];<?ID#]*SEX:\6P^+!X1?]U'"O\
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MH;FY50)'M+E1#(PZNL<J;H]W79O<+T#$5_9>O_!J5^RF3_R<[\>/_">\"?\
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MO_@3!_\ $U_;</\ @T4_9&[_ +5'[0/U_P"$<\ ?R^RU.O\ P:'_ +(I&?\
MAJG]H'_PG/ !Y]Q]E_K6;PF8K>,/_ J?^1M'B[AR6U?$:_\ 4+B/\S^(K_A=
MFG?] .]_\"8/_B:/^%V:=_T [W_P)@_^)K^WE?\ @T,_9$)_Y.J_:"_\)SP!
MG_TDJ<?\&@_[(9&?^&J_V@^?^I;^'_\ \BUFZ..5[J&F^M/_ "-X\39#/X:U
M?YX>LOU/X?\ _A=FG?\ 0#O?_ F#_P")H_X79IW_ $ [W_P)@_\ B:_N$7_@
MT$_9"."?VJ_V@R/0>'/A_P#S^R\>G2OQ%_X*Z_\ !NS\2_\ @GE\-KG]I#X*
M_$B\^/W[/&CWME9>/'U70(?#_P 1OA<=4N4L],U?7M/T^[O=*U_PE=7\T&F2
M>(-*>TN--O9K8:II%M:W*W:93>*@FY6LM[*#LN]DCLPV;Y3BJL*-*M)3F[05
M2%2FI2>T5*7N\SZ)M7>B=VD_PU_X79IW_0#O?_ F#_XFC_A=FG?] .]_\"8/
M_B:3]E+]EOXP?MG?'SX>_LX? O0$\0?$;XC:LVGZ9%=3BSTG2;"U@DOM:\1Z
M_J#(Z:;X?\/Z5;W6J:O?,DAAM+9Q#%-</%#)_:Y\.?\ @SP^ ]KX0T>/XM_M
MA_%'5O'S6T,GB&?X=^!?#.D>#[>^:)//M-#C\1W&IZU>V<$WF"+4-0-A/=)M
M=M.M#\AR5>L]FO\ P&)V8C$8+"RC"M/EG)74(\TY<M[<S4=HMJR;:NT[)V9_
M%)_PNS3O^@'>_P#@3!_\31_PNS3O^@'>_P#@3!_\37]RX_X,]OV/N_[5_P"T
M-CV\-_#W_P"1*F7_ (,\?V/F/_)V'[0_3/\ R+?P]Y_\E*AXJJMY?^2HS6.R
M^6TYN_\ <J'\,7_"[-._Z =[_P"!,'_Q-'_"[-._Z =[_P"!,'_Q-?W1+_P9
MW?L>DX/[6/[1'_A-_#S_ .1/ZT__ (@Z_P!CW_H[']HC_P )KX>?_(E1]>E_
M/_Y(O\C>-7"R^%R=_*2_,_A:_P"%V:=_T [W_P "8/\ XFC_ (79IW_0#O?_
M  )@_P#B:_NJ'_!G1^QV<'_AK+]HGGG_ )%KX>=/_ 3^OY5,/^#.7]CKO^UE
M^T3_ .$W\/>/_)0UF\R4=ZC_ /!9LH4I6LF[^;_S/X3_ /A=FG?] .]_\"8/
M_B:/^%V:=_T [W_P)@_^)K^[3_B#B_8Y_P"CLOVB?_";^'G_ ,B4\?\ !G!^
MQPW_ #=E^T4#_P!BW\/#Q_X!_A6;S>"WJ2TW_=;&L<,I;1_\FL?PD?\ "[-.
M_P"@'>_^!,'_ ,31_P +LT[_ * =[_X$P?\ Q-?W=+_P9N_L<$@']K3]HK_P
MFOAYS_Y*?C4@_P"#-G]CACC_ (:U_:+'T\,_#OG\[0XJ'G=%.SJR_P#!+-EE
M\Y;07_@Q'\(/_"[-._Z =[_X$P?_ !-'_"[-._Z =[_X$P?_ !-?W@_\0:W[
M&_\ T=M^T9_X37PZ_P#D.I/^(-/]C?\ Z.W_ &C/_"9^'7_R'4//L.M'6GI_
MTXD:QRFM+X:<7_W%2/X.O^%V:=_T [W_ ,"8/_B:/^%V:=_T [W_ ,"8/_B:
M_O%'_!FG^QOW_:W_ &C!_P!RS\.O_D.I?^(,_P#8W[_M<?M&_P#A,_#H?^V9
MJ?\ 6'"_\_Y_^$\C59'BI6M2AK_T_@?P:_\ "[-._P"@'>_^!,'_ ,31_P +
MLT[_ * =[_X$P?\ Q-?WG+_P9G?L:D?\G;_M&YZ9_P"$9^'7_P A\_D*7_B#
M-_8V_P"CMOVC.O\ T+?P[Z8Z?\>7KS^E2^),(O\ E]/_ ,)Y%+(,:]J,?_!\
M3^##_A=FG?\ 0#O?_ F#_P")H_X79IW_ $ [W_P)@_\ B:_O2_X@ROV-\<?M
M;_M%].O_  CGP[_/_CQH_P"(,K]C?_H[?]HO_P )OX=__(-1_K/@O^?]3_PG
MD5_J]CO^?$?_  ?$_@M_X79IW_0#O?\ P)@_^)H_X79IW_0#O?\ P)@_^)K^
M]+_B#*_8W_Z.V_:+_P#"<^'?_P @T?\ $&5^QO\ ]';_ +1?_A.?#O\ ^0:/
M]9\%_P _ZG_A/(/]7L=_SXC_ .#XG\%;_&VQ",8]!NF?:=@DNXD0MCC<RQNP
M&>I"DXZ"O&O$WB;4?%.HF_U HH1?*MK:+(@M8,EA'&&)8DD[I)&):1N3@!5'
M^A3JW_!F)^R7<:9?0Z)^V+\?M,UB2VD73;_4O!?@'5]/M+PJ?)FO=,MWTBXO
MK97QYUO#JEC*Z9$=S&V#7\:__!4#_@F'\>O^"6/[09^"/QFETKQ/H?B+26\5
M_"OXI^&([I/"WQ'\'F[ELFU"S@O%6[TC6]*O(GT_Q%X=O2]UI-Z$*37EC=65
M]<[X?.<-CY.E2KN4TN;DE!TW)+=Q3TER[M)W2UM;585\KQ."BJE6CRQ;Y>=3
M4TF^C:^&_2ZUVN?FY11178<@4444 %%%% !7U)\'XT3PF[JH#3:G=/(>[,B0
MQKS[(H&/;CJ:^6Z^I_A#_P BBO\ V$;W^<==&&_B_P#;LOT,JWP?]O+]3U#(
MR!W/3@X..N#TR.N,YQSC%+^?X@C/TSU'N.,Y':OU^_9JT[X-^*?^">5U\)OB
MWIWA7P\OQT_;7E\!^#?CIJ6GP)KGP8^(^G?!*\UCX=:Q=ZX%6YC^&GB'Q$4\
M*?$K3YY&L[;0=:_X2)5ADT61W]2T_P#8?L_$]GX!A^-7@_3M)U#]E#_@GIX=
M\4?$3X3ZO\5?!7[.\_C[XG:Y^VE^TE\,-&TKQ+\6?&4MAIF@:'936GVO7_$,
M,D_B#4-(L- T_12ZWD.SM=1)NZ>C:];6M;U;MY>AS<K=K=5?TWW^2OYGX7T5
M^Q'B#]C+]GO6(=/\6:7;:5X(U"]_9Z_:R\:^*/@C\/?VFO!7[1MAX+\=_ GP
M3_PE?@;QGI?Q3\'7.KSW/@?Q5'.!K?@OQ3#::SIM]IEW!%>-IEQ%.GD_[%W[
M*/P;^.WA#]GWQ'\2E\:A?B-_P4*\)_LT>-)_"NOIIC+\)=4^$FE>.]9308)K
M"ZM[7QFFH7=S+8:Q/)-$MNUO:361B#3$YXVOK9.VWDW\_A?EM8.5IVT_JW^9
M^9]*%9@2J.P4%G*(SA%'5W*@[$&0"[84$@$C(K]&M'\)_LDVOP1\>?M<7OP)
M\<>)/A\/B_X4_9R^#_P,NOCMK&A7-QKMMX#G\;^,?B_\6OB)I7ANZU^&\UW2
M?[,'AWP'X7TRWT&VUV[UR"/4;C3/#\8G^N?"7PG^!?@?X2_%;X@_ OP_X]\-
MZ#^T)_P1T_:!^+?B/PY\1O$,/BV]\.^++/\ :0UWX>/I7AK61I>EO>^%M.TC
MP;IEMHVLS6XO]=5)M:O##<7TD$8YI='VUM:ZM=:-[)]K7TN3IW3ZZ=M;/;9V
M_P" ?AM%87\]I>:A!8WL]AIQMEU&_AM9Y;+3VO93!9"^NHXV@LS>3@P6@N)(
MS<S Q0[W&VJF#Z5]\?LQ_#?2_'/[-7[4MWJOB'QOI]EIWQ4_8J\-77AO0/$]
MQI/A3Q+I_P 0OC8_AG5)_%N@I!-;:_J.B6$TMUX0O+AXV\/:K(]]$LY=HCZW
M\3_A)^Q_KNM?MP?"#X/_  E^)?@'Q'^R5X0\??$;P#\7_$OQ>O?&>H_$[2OA
MC\4?!?@#Q+X;^(GP]N- T[PWX<77[+QI%J?AW4O"NHR76BS:3]GOUO1?SO$^
M=)M6>CUMT^'5ZKK);7[BNVDTEKM=_P"+LG_*][=MVC\K@K'M^?\ GG\*78WM
M7[4>-/V=?V&?#O[:WAO]@K3OA%\;9M2^(FH_!/P1%\?[SXPW[>)O 'Q&^-'P
M\\$>(--O/#_PFB\*?\([XU\!Z%KWBV![V'7;^UU[6=+>^6QF@^Q:?)-\4_$O
M]G?PO\//$'['?A:XDOKC5?B_=3:1\4[BSUK[;IU_J>F_M"ZA\)=1NO!<XM(_
M[/TV?2-/D-C+&MX'NV2^'+>0!33MHU=75^JLW?=]OZN)J>MK:::7WNM-;=_3
M?JCXLV'.,C.,X[XYP?H<4NP^H_7_  K];_V@O#G[/OPL_8W\=_#[2_@2^H^,
M?"/_  4G_;(^#/@SXM7OQ4UNV\2:;HGP\T+X86WAF_UG1;;PV+3Q7;V?AN6Q
MT>3PS>ZE::-_;$.I>,(O(U/Q!?6D?Y,;#[=O\_A_^JG%\UW9K6VO7;7\1/G5
MMGI?;;?O;L5]C>U&QO:I]C>GZBC8WI^H_P :8KS[?@O\RMM;T/'^?Q_"DP1Q
MW_R:LX/H?RI* YVMXE<*K_(P!5_D8'H5;Y6!]B"17NG_  1EL+"?_@H7X+-S
M:03C3/#/Q5OK#S8TD^R7MKX6U1+:[@W@^7/;K(YAE7$D;'<A# &O%$4%XP1Q
MO7IQU(KW#_@C2WE_\%!O#I!QCPA\6P.__,M:@/Y9KV^%4I<7<+)I-/.\#HTF
MM*K:W3V:3]4GNDU\_P 82;X-XK:;BUD.8:IM-7HI.S33U3:?=-K5-I_VNZ?<
M#(&>",]?Y<XXX./0=>U=UIDY=MJAF."=J@L3CDG"YP,<].G?%>4Z?<Y*^WN,
MY[CN/7'3K7AWC"";XJ_M :9\&_$&O>(=(^'7AOX1/\4]4\.^%_$6K^$M1^(6
MO7_C"+POI\&K^(?#E]I?B./PMX5MUDNYM,T;4[!=0U>]MAJT\U@@M)?ZWQ\_
M80BU3=6=6M2P]&'/&FI5:SGR\U249*$(QI5)3ERSE:*C"$IRBC^':.$6)J5%
M*HJ-*CAZV)KU.2564:-%4W+DI1E!U*DI5:4(0YZ<;S<IU(4X3D?H!83,N%8,
MIX90P(R#W ..#U'8\8XY/:Z=<?*O)Z_U]3U].3_@/R)^)GC_ ,2_LA:K\2M-
M^%NH:CXI\.77[./B[XS>&? ?Q!\3>(?%]MX&\;^"O$^G:$DMEKVO7^J^)X?!
M/CB'5A;3Z5J.L7<5CK>DW$FBM;V[/9)]#:K\;?B_\"_$_AP_&/4/!'COPEXU
M^'/Q2\6Q0>!_#E[X9U?P7XL^&'ABU\9S^&K:ZN]0OT\4>&M?TB6_T^UUG48;
M/6+#4--BGFMY8+[9%\U6S&BI5:=:E6I5,/-0Q,HI5J%!RJ.E3DZ\7#GA4ERM
M.%!S@I?O:=-IFT\AQ,X4JN&K4*U/%PE4P4)RE0Q6*Y**K581PTHU%"I2AS*2
MGB8TZDH/V%6JFC]);&X!"]>WX^H_R.N,\\5V-G<H&C4NH9LE4+H'<+]XHA.]
MPG!=E4[<@MCY<_DK\+?VL/BQJ^L_!#5=9;3?&>A_&+7/#.D>)? GA3X&_&'P
MS=_"2U\=6'V_0/$%E\1O$&AQZ)XJT7PQ/-8V/C2]UM=-MKJWGNM6T&9(HK>&
M3Z#_ &C?B2WPW^(WPT\1Z?X6\-ZOXCT?X+_M:^+=#\0:Q#>3:EH-Q\/_ (17
M'C2+3M--O=0VXT[Q#?Z18V>OI/#--+81!+66"0LY\>MCL/4H5,1#GY*<Z,9\
M\'%J-=*<)147-2O3?,HJ5XR_=U52DF0\CQE'&4L%5=)U:U+%3I.E4C.+GA92
MI5*<W45)PY:\>1S<+3IM5<.Z\&F?HI:3 XY_SQD?Y/ 'UK;C)4XP0>H!&#R/
M0\\CGZ<CUK\T_ GQH_:7TBW_ &5?&'Q0O_A3JV@?M/7/AKPEJGA#PGX<U/2[
MSX1^,/''@:\\6>$]5T?Q)=ZC<OX]T."[LI-.\3Z?JMEI=P%G2XT>X1(VC;R/
MX5?M$_'_ .$_[,/@#6/'?CKPQ\1_''QF_:*\<_";X?>(KOP%XWU2'P#967Q
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M;)/K^S)\9O\ U!]7K@K1TEY*2?FK2/>P-3]_A];?OJ-O+]]2M]S_ $/XA_\
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MUH^Y-VU49)_^ R_KT/>P%3]_A]?^7]#_ -/4?S_-,_B<_P"#0;C]N/\ :/\
M^S5]1_7XH?#X5_H7J<@'O_6O\\[_ (-"#C]N+]H__LUC4?\ U9_P^/\ 2O\
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M>/\ XY_#OPI^UG\3?'NL?L^V?[(GPU\3_LH7?[0OB_QE\']+^)>JWM_J]O\
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M\0:9/%=:;KF@^)]<TG5]/N8F5X[BRU"ROH;JVFC=59)(I%8, 0>*RE@.9/\
M>6OJO<V?_@1TPR]TVK5D]?\ GVUTO_,]#_8+'N"""00>H(Z@CL1[TK30P &X
MGM[=7Y0W%Q#;A\'!V><Z;QQ@E<@$8ZU^$G_!&#_@H3\1_P!I/_@G7\0/BS\=
MY[CQI\0OV8IO'6@>)?$K/%;ZK\1="\%>"T\:Z%J6K2+&(%\27>G>;HFI7XCV
MWEQ9Q:G.GGW,X/\ "[^U-^V+\??VROBWXG^,7QI^(7B37=4UO5K^XT'0(]7U
M"U\+>"-!EG?^S/#/A+0H+E-/T?2]-LA#;8MX1<7LL;WE_/<W<TLS\M+ 3K5*
MM.4U!4G:4K.5Y/6/+&ZT:U;;5D[:LZ*7,G)7U@[/\U_79V/]7]-0T_&/[2TW
MC_J(V73_ +_^O\ZL)J&G8Q_:6F\?]1&R_P#C]?X^46HZGC_D*ZMP%/\ R%=0
M_P#DFKZ7^I9/_$UU;I_T%=1]1_T\UH\B4K_[5:__ $Y]/^GGS.I8GV;^&^J^
MUUMZ=G8_V A?Z>""-1TW_P &-E_\?J?[?I__ $$M-_\ !C9?_'Z_R 8]1U,#
M_D*ZMP<?\A74.G'_ $\U=CU#4S@'5=6^[G_D*ZAUX_Z>?>LWPSS?\QEO^Y>_
M_N4Z(9FX+^#?3_GY;S_D>W0_U_H)X+@$V]Q;7!3EQ;W$%P4QW<0R.5'NP JX
MIW8P,D\8 [^@_I7^3M^SM^U)\=OV4_B=X>^+OP3^(_BCPEXH\/:A:7L\$&LZ
MA+HGB73[:=);KP[XIT::XDL-<T'5(%DM+VRO8)0(IFFMVANHX9H_[P/^"HG_
M  42\>?!G_@EAX$_:8^"OF>#OB-^TYHGPITWP?JAC22\^']M\4/"R^)?$&LZ
M>)#+$NMZ1IGF6>CR2F1;>XNEO%+S6L>?(QV05\-7PE&G5A6CC:CHTYN+I\E1
M:R4XWG[JA>:E%NZBU92M?T\+FE.K3KU)PE!X>//.*:ES1M:\7:.KE:-G:S:=
M[7M^Y+75I"3'->V,,BG#1S7MK%(OLR23*ZD=,$ C'2C[=8?]!'3O_!A9_P#Q
M^O\ (NUKQ?XP\4ZQJ7B+Q/XO\5^(O$&L7<M]J^N:WXDUG4]6U2]G;?/=W]_=
MWLMS=7$SG=)+-([L>IJNFH:EG']JZMTS_P A74?7_KYKTO\ 4KF6N8V>C=L*
MVKZ7M>NFUKU2=NG0RAQ-R:+!MI;7KV?SM2:VM<_UWDO[ C']H:=D?]1"RZ?]
M_P"I5OK '/\ :.G>A_XF%GT_[_U_D31ZCJ8!_P")KJW7OJNH'T];FK2ZCJ>!
M_P 375N@_P"8IJ'_ ,DTO]1;IK^T_+_<[_\ NP;KBYQT^H7N[?[S;;_N ?ZZ
MOVVP_P"@AIW_ (,+/_X_5Z-E=%=&22-L[)(W66-P,9VR1LR,1D9 ;C(K_(D&
MHZE@?\335>@_YBE__P#)%?O%_P $'_VZ_C)\%_VQ/A;^SSJ/C/Q#XB^!/QXU
M>Z\%:OX'UO4[W5],\,^)KK3+^_\ #WB[PM!>S3MHM\-2LTT_5H;#R;;5+*^:
M2\B>6TAD'!F'!%7#8/$8FCCXUY8>E.LZ,\.Z3G"E%SFHU%6J+G4(R<5**4G'
MEYDVF=>"XNIU\11P]7!RHPK58TE4C653DG-J,'*#IP;BY.*;3NN9.S5S^_RO
MXUO^#SO_ )-$_8\_[.%\8_\ JO&K^RHC!(/4$C\J_C5_X/._^31/V//^SA?&
M/_JO&KY/)O\ D9X3_'+_ --U#Z+-_P#D78G_  1_]+@?YV%%%%?HA\"%%%%
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MOH?0X7+*M1)K$X>,7&,DYQQ,(RC*W*X.=*',I74HV@KP:DFXOF7[HH><>O\
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M3Q(_C6RO-3\(+MM?$,\A_P"$FTS3]0U'1F6,K>6%C=WB'[-!)(OR#\0?A?\
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M5=.T>?4=7N;N Z:^H2SZE;1:?.\$\DHO TD<D4A^BT/ YY'^?Y5\Z?LVZ_\
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MBDX)0K)J+I-0C&\[SBGR6DM4IQ4N>FY244<#\2M<OOV8?A1X7^ '@2>7P_\
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M *;+G$KG_;?/_?1K^-__ (/-^?V0_P!CS_LX;QC_ .J\:O['Y/\ 62?[[?\
MH1K^-W_@\T_Y-"_8\]OVA_&7_JO"?ZU^.98O^%'"/_IX[^GLZA^I9F[Y?B7_
M '%_Z<@C_.VHHHK[L^'"BBB@ HHHH *^_?V<(]WPX!'?7-1!/''^H_SWZ]*^
M J_0O]F>+?\ #9#V_M[4AW["$]C[ ?KZUZ.5J^*M_P!.Y_\ MIQX]VH?]Q(?
M^W?TO.Q[NEOTSGH>V!P>,<$=O7VJVEMSDCD_IT[Y^@Y/)QCIQ>CA'7'7 4>O
MTYZ]>G0#I5V. '@#))/MSZ8SQCN/RZ\?50AMV[?U_P /T[G@N=OZ_K7O_P ,
M94EC!<0S6\Z"2"XBDBFC9<K)%*K)(A'&5*,1@C')XR#7PIXIT*X\/ZK>:3<@
MF;2+AK#>Q)-Q9$&72+O<P^99;%HXB5!020-'DL"*_0U;8*,D D#'//&.@_IW
M_KX=\:_!'VW3E\5VD+--IEO]EUJ.*,O)-HY<O'>J@&YY-(F/G#C)M)+A 1@&
MIQ>'<J:J05YTKRLNL/M+SLES+T:1T8+$*%5TY.T*MHK564T_=;\FVXM^:1X*
MH^(GQ87PM::_KNIZSI'@GP]I_@;PF^KW$UU9>&O#&F33W&G>&= L^&DL[*:\
MNI8;2)1'%-<3/)(7=E/<BX\$?"Z"6VC+:YXJEC\J2PMIT\^*7&"=>U.,/%I$
M$+X<Z+8A]1E"%9C9XCDE\=B\5^*_#FGWNAZ9K5U8:=>N\LJ6AC5S]JACBEEL
MKS:;BT6^@BA$DMG+$SJBM&Z.69OZ&_\ @E?_ ,&T_P"U7_P49^#UG^TCXG^)
M/A/]F7X'^+M.NK[X2:[XA\.W/Q \7?% Q7<]E_;EEX2TS7O#JZ!X.^UV]U%'
MKFLZR-3U.2$OINA7%BZZB/%E.G3?/5FN6_N0:M3B^LII-NK)MMI>[3BM91G*
MZ/;U>D59]97O)^2NK15MWK)]&E8_'?X"?#G]H;XP>+O$>O\ P?\ AEXQ^)LO
MANQ.I^.(?!OAZ]O-#T/1I'W16^H742M8Z9),6']EVEQ=?;KNY9?(BF:0Y^A-
M+U"+44E"Q7%K=6D\MIJ.G7D,EIJ.E7]NYCN=/U"SF5)[6[MY04DCE16R,X((
M)_IG^"WQF\2_\$I_AI-_P20_;V^$/@_X":OH^I^,?%/P!_:V\(6/V7X/?M.Z
M-KNKWNJ->^-/%LEM!+'XSL'O3I6GZIK<BW&GZ?%I_A?6[/1KJR@DO/YY/VQ_
MB=\)->^*]SK/PDU33O$/BA]0<>)O$WAB1)_"NI6$1D5;;4[J)19ZUJ^X*D-Q
M:%Y[6)3]KF*O$H^UPN&PE/(\'F4<?"MBL1B\52Q. <Z+EAZ<)0^K5*?++VTW
M7I/VTG*#I--1IRC*E-'DUZ<L17K0=)4O91A[&J^9JM%_$I:65I7BOM1L^:ZD
MCR_Q/I4>M^'-;TATC8ZAIMU#$)!E%G$?F6LA4$$F*YBCE7W0 @CBOS U.%X+
MNWDE#I)9RW.GR@Y4I#<R &-^I_<S*"N1E64\9K]+-.\1OJVCW&LR:7JUIIMC
M)]FU#6UTG4Y_#%G=* 6M[KQ'':/H]A<#<I-K?7L$X!&%8L#7PO\ %70UT[Q1
MK$<0 MM3SJ5JZ$,I6Z_TC,;@[6 F+8*\$$ <8KQ<VA&2HUZ;B^5NG*UM[JI3
M4M;IJ491L[/WK7U-, JD/:4:D7&]II/;^63B]FOA=UVZ'EY^4D' /W3R3R".
MN?F/.< 8/7.#U4').,''!!]<\;L?FJ <X&3QBHU=9$CE.,R1*6X ^9<I)DC)
M4"16)Q\S9SQS4RH2BR@-Y;95)-A"/M.&"'!!(YZ$DYQVKR+IVML]4K]'KY]&
MNE]+Z'?K;SMK_7JMOZ?>^&]&G\16\FF6B(]Y&'O(8S.EO(QB3:XA=MT?FLI&
M$F\M)"-HDC;+KM:3XG\:^!M3A.F:E?Z9J-F[-;KYLVGZG;DHT3-"P>.=5:)V
M1I;25X'CD9%FD5F!B^%4K'Q19Q#< Y<. 6PP\N0DMM4CCC[S =.,DY^D=3TO
M3]1A-MJ-E:W]N>D=W!',H&?X?-!*$^J$'CJ<&N_#X:56FZU&M.C6A+DNKN,D
MDI1NHM2BU=J\6[K=71G.HHR4914HM7MLUJT^Z:?FO1G(G]JSXSKI$FCG6)3;
M2HR-(VGV$=P%=0C+'?VMC!?A9$RDJF\9)4:1)1(DDBO\V^*O%6K:[>FZU>]G
MU/4Y%\N& OODC3.X1QQ)\EM "22=L: DD@L>?H:Z^&W@RXD_>Z==0KD-Y5IJ
MVIVUNJY^Z+=+CRP.3P%X^G3T;P7X$^&NFM$8/#5DEXK!DN+PO=F24$8=S,65
MV[#S Z[<@@XISPF8XIJG6Q5-TT]+SFT[;-04()R[<\G;6W6\NO1IQ<HTYM]D
MHKUN[Z+T7R/#?A#\)]4UN2/5=8M'L--D:$0W-P&6:Y+NKW+V4!V/+G_5+<R;
M+=4W>6)<C9ZO_P $M8E@_;GTV%,[(?#_ ,5(DW'+;8]$U!%R>I. ,GN>:^CX
M85$L0 4?O(\%> H# !5 ^4* .-I  P!P,5\Z_P#!+S_D^ZS_ .P)\6/_ $SZ
MC7N\.8.E@^,."(PO*4N(L'SSE\4FIKILE>]DNFK;;/FN**\Z_"G%3EI%9'C>
M6*V5Z3OYNZ2U\K))']2=>*?'K5&L_!NDZ5;Z??ZI?^)_'7@C2;"QL+C2[-[@
MZ?XAL?%.H1SW>L:GI%C#;R:1X>U",K+> 7,KQ6C1M'<.5]KKSCXN>'K/Q-\.
M/%UA=6NGW%Q;Z'J6IZ/-J-C;:A%IVMZ;9S7>EZE'!<Q2J)+:ZB0LT861X&F@
MW[)G5O[+S*%2IE^-A2:C4EAJO*VKW48JI**3TYITZ52G%M.*G4A*2<5)/^1\
M!.%/&X2=1-PCB*5[.UN:7)&3MKRPG5A.25FXPE&+4G%KQWQQ\6/B%K>K7_AC
MPHU_\*FF\.IJ6@:UJ5AX,\5ZCK>HW&MZ?H%VLRZ7XHUNV\/Z?H,VJV5R@^SS
M7NL-YL:7%M #&WL=[\(/$FO:+?:#K?QO^(NH:=JMC)IVJP/I_A&)+RWG0+<
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MDW?![P2#_P ^FK=<=?\ A(M8_P#U=.#@5[G$QX]2?U[?GZ>N,5YL(_N:2?\
MSZIV_P# (V-\5*^*Q37_ $$U_P#T[,XKPP?^+D?% ?\ 3'P,?_*!@_RKU%&S
M]1BOG#2OBA\-M'^)_P 5+?5?B#X*TVX@/@^UGAO?$ND020WEGHK0WEI,CW8:
M.ZM9,175LX$UNY"3(C\5V[?'7X*0G,OQ<^',8XSN\6Z-T/\ NW1^M<//32=Z
ME--3J)WJ4T_XDN\UV]3OE0Q#G!QP^(DG0PVL:%>2_@4VFG&BUY[[/[_9$;D'
ML?\ /Z?XUHVQS-#ZB6//_?8_S^=>"G]HKX!19$OQI^&:<]&\6Z7P?PF/!_\
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M5;K#]U4:Y75H_N9N5/W3Y=B& 1DG '+$LQ/.2S')9B>68DDDDDDFKJ?P_P#
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MP'^&7B7Q)KOAKQY'*/B)"+NR\-MH6I6DOAO1M/A@UBVBL[*.W-Q9>'X]+O\
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MVSXPG_RRM5&*Y<3']U5[JE5^[V=3_@'?ED_]MP2Z/&83_P!2\-I\G^I_%_\
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M#V3Y5&<GS=+4^:;CJXOENY1;9^BVE_M!?!O5KK4[/3_BYX,N+O1GGBU:U?Q
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M^TU.#['_ #FINE<%2.Z[ZK^O4]C#UYQ2BIR2WLGHG?>VMFGUT=F?*UG^Q?\
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M<CX;VA_[CUP/3_IT..E?G?17I1SO,X[8I_\ @JC_ /*SA>5X%Z.AI_U\J?\
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M_P#P1AO_ )2:+PMX%6V1Q7_<]F/_ ,V']CX_X.U=;  _X8J\/G'_ %5G6/\
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M=UK_ .9S-2I_P>$:XG3]AOPY[?\ %W]:X]O^1;_&OXIZ*AYEC7O6O??W*?\
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MI_\ R1_<(/\ @\QU\=/V#_#7_AY-;_\ F9J5?^#S7Q !C_A@[PR?^ZR:Y_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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=?G^'_! XBBNW/3\5_F*#U7Z_T-/V?GWZ=OF!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #? 5 # 2(  A$! Q$!_\0
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MK6NE?\([XDLM2_L5]<_XG*J[>&]<XT0X=%C.=I_>!2M>^I]T?C_,UYC\1/\
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MPP?$_P#PF"^, Q#E1@5ZAX$_X*,W_B3]J[PM^SU)X5^"?B7PA\1?$?Q.\+^
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M$)%T+P=XU1-_B:-/"\>M2%'\*S^#G42^6XW'8?<OAG^R-\(_A-\5A\6O!_\
MPDP\8#X#^ /V<S_:WB.2_P!,/PQ^%4@_X1X#1\H#XBWJ1)XDY+!@KKM<*X!\
M'_ 3_@JX_P =_C/X!\(6'PDT^'X8_&/Q?X[\&?#?7O#GC#6/$?Q-\*?\($/$
M!_X3#XV>!F^'<7A7PYX>\7MH1_X0=O"_C3QBOS .VP<?MK7Y\?!K]B[P[\ _
MB:OB+X:?%;X^:)\/;76?%6MZ3^SV/B+_ &E^SWH6J>.)==;6&T/P2_AYO$RJ
M/$>MMXD_X1?_ (2T^#O"$A\V'RU0U^@] !1110 4444 %%%% !1110 4444
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M]M/[W\%.-<5Q#PY' 9S?^V<EC&-I-N4X\JBGNW)VT=N:SNMSH@, #T&**!R
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MFTE%-RU6B2;=]=-$]['S[\>/BI8_";X?:OXB_P!&N=8N?]"\.61_YB'B9@P
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M%#5_@M??$WPG_P +7T'1]5\3^)/!!N_[2U30=+T+1CKO_$[Z>&/#_P#Q3O\
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M<[_WK_MU_DR2BBB@Z0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?[;'_"R3M/()')QC((P:WQXO\4@_\DD\?\GOK'PS'7IT^(P]\9KD/@=\0/\
MA*M'-C?S ZOIF+.]SUW#N.<=@.QXXZU] ]2>.F,9'\C_ )Q_+^<LSPTLIQE3
M!8J-FI24>9.SLVTTUTM:WG==#^[>&L[PG%63Y7F^$>JC%5+.S344FI*ZMJGO
MT\CPVTF%IK%QXCL?@!XEMM?U,9O-6M!\'3J9X((;6?\ A9 +?[O\1[9Q74?\
M)?XI_P"B0>/_ /P<?#+_ .>17J=%>?\ 6/Z_IGT/L%>^G]?(\T_X37Q1_P!$
M?^(/_@X^&/\ \\>C_A-?%'_1'_B#_P"#CX8__/'KTNB@Z#S3_A-?%'_1'_B#
M_P"#CX8__/'JQ-KNK6>A'7+CP]XF\_;@^'+0:+J/B3)_B4_\)&/#8/MYF%&#
M@'FO0Z* /-/#7C#0_%D-^=*FN/M.F79LM8TK5+7^SM3T+42.FM:-\I!)VG/3
MKC/##T.O--,_Y*QXJ_[)QX#_ /3YX_KTN@"Q1110 4444 %%%% !1110 444
M4 %%%% /8JD'L>Y]>_/J"/P]>_.3A1D\ 9[G'KW/6E/8>O?TQ_CTKQ/XM?$&
MP^&'@[7_ !1>*MQ/:VK6MG:# -]JAW-HFDJ,<LSOACWRS$G(K;"X;$XS%PPF
M%5W*48VM=WFTDEZW?W-]#Q\SQ>%RG!SQV+:7LTY:NR3BG)7;:MJEO;\CY!_:
M_P#BG]MFM_A;H5QQ9_V9K/B/[(?ER2#HFC?>()!'_"398!E(\-X.'(/Q%!W_
M !_I4^H:OJFN:E?:UK4PU#5]3NQ>:M<J HO=3'R@ 8P !P!P!C P!4$'?\?Z
M5_5'".1_V!D_U1I<TTG-\N\FDW>ZN^VM^FB/X(XWXEQ/%/$>:XK%-.G&3C35
MU:,5)J-K2:6B3T\]=C0@[_C_ $K0@[_C_2L^#O\ C_2M"#O^/]*^BMY?A_P#
MX6Z[K[U_F:$'?\?Z5?A_UP^I_G5"#O\ C_2K$'?\?Z5N\(FFN5*Z:O9:735_
MAZ7*6+LT^>UFG\6UFG_-TL?C1^R-X4\$7?Q;_:'\8:[H7[&%QXHM?VL_VV]&
MT?Q!JWB0_P##:/\ :A\9^/="T#1M"T/MX=((\,>O_"%D5\P>'/VK?VJ="^#G
M['_PL_9VU;PEING^&?V!?@1\3?")U7QC^S1X,\-_$OXH?VUKW@/Q!X,\<:W^
MT!XG\(-XA^'?A/\ X0C_ (1CQMX7^%!'C/P;XUUX_P#">-QX.Q_0?#\,?AE#
MXC_X3$_#+X;CQC]L_MO_ (2S_A _!O\ PD_]J<_\3K^W?^$;_P"$G_X2+Z_X
M9UM3^'OPYUZUT^QUSX<^ -;T[0;O5-:TBT\0^!/!NI:9H.J:Z<Z[K6ACQ!X;
M_P"*?\1>O0=B2*^0EPWC6W]4S3=O2ST5V^J>U_/Y]/OEQKD\8\N+RE9UHK*Z
MBDU%13?*HIVU[::7[_F%XR^+_P 3?BG)_P %!M#USX[6OPO\0?!3PU\>?A+X
M#_8Y\/6GPST[Q/X[TP?LROXZT+XFG6]>9OCKKWB+Q;XCUO7#X)'PJ"^#?^)
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MQZ.?T&?\Y/>K/_"F/'W_ $ ]._\ "DT:N?\ .N/^?FY_\#*G^VW/_/>X_P#
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M?^6/S9IC&!CICCZ44@Z#'3 Q2UX!^@K97WLK^ME?\;A1110)[/T?Y,\KTO\
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M;QAXN\2>%]?^%?ACXZW?C?P1\*_B7XV\#>!/@YXYUK7]"T+XF_%/7= \-_\
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M?U_P-\3?V6/BHOQ)\('X/_$,^(_'&,AO%_@W_B0>&#G./!E6?'?[&GC#Q?\
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MKW]O3PS>?M%>/_V<],^$GQ1\37/PF_X1;6?B]\3+9="TWX:_#CX9^-OAB?B
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M $-5O_70\9AAGZ]O_K_X^V/7J,:'D>_Z_P#UJ]?_ .$D\*_]"/X2_P#!,?\
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M_B!X<T/XT_&.Z\&^*/VCO^"8=CH^K?#[XI_'WXD>.?AIX7^.GQF\?:#^T?\
M#+_A>'Q?^"OPB^)WA[Q$/AWH>A-XW'/@KP40/^1/'BXH?;KWXM?&/P3XVMOA
MG\=_CM^TA\/_ -CCX8?M]_M9?"3QY^TS9ZSXPT[XO?\ "!:'\&/A'XZ_93T7
MQS\5/#_AT^*1\//%?Q&\;_%/PR?BB5&5\!>&/ _COQN!@'G?$DDVO[*EY/5J
M^JOI';9][>@+@K%891?]KP=]6N:.BO'SMK?3=Z;(_<#X;_$?P#\6O!NG>/\
MX9>*=-\:^!]4O/$]EH_B'21_Q++_ %/0]:U[P+KG/7_BE/$6AZWX7!Z8T'WK
MN*_!_P""FI_$[P)_P0NTZ^^&6N_%#PW\0+2\\>#P?XLTH:UIWQ@.E>.OVZ=?
M'_"9C_BG!XG_ .$B\5_#K7!XH_X2G!XUX^.,#.1M>(M+^/WPM^,OQ E\&_'[
M]KOQKI'PD_X*4_L3? SPAH'Q#\?:S\1O OB#]G/XXZ'\)'^*^BZYHC>',?$#
MP_X4\1^./'"K\4 ?^$U\&G0/"ZKXW9O"63A_;;B_A?G\6]_2W6VR\]%<(\-*
M3S.*S97;CRKW;N]DU>Z2LN9WT];[_M]>7ECIMK<7VJWUOIVGVMG]MO=6U:\.
MF:98#WUSZ_CTZ <V*_F!\9_%_P#:,_:;LOVYO!.AV?Q/M/#WQ9_8>_;:O+S]
MEOQSX]^,GQ;^)GPS^*/@;QKX"T+P)H^NZ#X_^&WA+PW\(/B%XK\-ZWXX/@GP
MO\)O%WC/P5XT\%X!&?":^,Z]?_:#^./BK3=*^ &F? C]J?XGZ)^S/XG^!/QC
MO-'_ &@_B=\;OC[\-R?VLSK.@Z#H.B^-_BF/V<?BWXI\0CX4>'-:_P"$G\$_
M 7Q5X0\'>"_&8/B7<?&#>$PM='^L36G(]=/AE;3_ +=T[)-Z].YW+A1<BPO]
MKQO:][QM913YK\UVM[Z=+*[T/W_\7^+_  M\/_"?B?QAXV\1:+X4\$^#])U3
MQ-XO\5^(+K^S?#?A3PQH?_$]US6=;UP')\/$X  Y["MBSG@U&UM[ZQGMKFWU
M2S^VV=W:9_T_2QQ_^K_]0K\3_B->?M-'X=_M_?$;7/BY\6;KXG_!']AWX7WG
MPLTGX3ZUXQTOX&Z]\9/'/[)7B#7?'?C/P/\ "T^',>/B/B,#XG\$E@1X)/\
MPC!XP:Y>]_:6^..H_M__ +/W@CP[JGQ'\ Z/I?QK^#GP8^(WP^\5^/?C%J9^
M-'PNUS]GXZYKOQGT3X'CX;GX%^'O@T?$>MG'Q1/Q?_X37_A,_#X;A67P8>=9
MXTV^5VNNCUW;:LG?MKLUOU'AN$EB=?[67NMWUBM%:VCL]]+W>ZLNK_:CX<?$
M;P3\6? GACXF?#/Q3IWC7P!XZTC^V?"'BO2LC3M=TP==9T3.#D'/!&<@YP17
M<5^>W_!*F"^TW_@GE^R_X5U6QU+1/%'@+P?XH^'WC#P]XAT?6?#FI^$O%&A>
M--?T'7=%US0_$'/'7GZCDG'Z$U]!A<0\5A?K35FTM+-7Z/1I=;;=[^;^7S'#
M+"8S-,(M8WT>CT5K.ZT>BOI;796"BBK%=)S+9>B_(KU[]\%?%XTZY_X1V]FS
M!<Y-CR1CZ$$8R0/\@UX35B&>>SNK>>"X^S7%KGO[]_Z?SKQ<]RW^UL$\'U2;
M3=FTTFT_6]NOYGM9'G6*R#.,KQ>$^%M*:NM5=)\UM'HW\1^DF%*!A_=R"#[9
M_G00H&1GG@=.^>O'^?UKS'P'XJB\2:1;SY_?D8NAWW9.<GT./R_*O23C@YQS
MWX]1WQVS7X!C,//!XN6#Q/Q*3LI:7Y6_P=DT^Q_7^69GA<UP2QV#E>Z5[;7:
M3>NJWOZ:'FFE_P#)6/%7_9.? G_I]^(%>J5Y7I?_ "5CQ5_V3GP)_P"GWX@5
MZI7/B-G;^OB/0H;?+](A1113.@**** "BBB@ HHHH ^,_P!H+X@+I^AV_A#2
M;@-?Z[:.=7((/V#PT&*MDA>OBC!C&3D#<'&5!KXKKZU\2_LX>(O%'BC5O$6K
M>.-$N;C5[IG0'PYJX^R:.A']C:4F?$O*1\F1APN#GJ,G_#*VM_\ 0Y:)_P"$
M[JO_ ,T]?J_#><<.Y3E7U5YDU.5I2:A)MM):.:@VTDK+5:=%?7^;^-N'N+.*
MLV6+661M'2*YU9+?1<Z2O>^EM3Y2JQ7U7_PS#KG_ $.6B?\ A/:M_P#-/1_P
MS#KG_0Y:)_X3VK?_ #3U]!_KMP]M_:;_ / '_P#(GQW_ !#GBS_H61_\&+_Y
M,^7*L5]1_P##-6M_]#7H7_A/:I_\T]'_  S5K?\ T->A?^$]JG_S3T_]=>'_
M /H9_P#DK_R'_P 0[XB_Z%:O_CC_ /)GS)6A#>WT,7D07UR+?'_'I]L]/7'M
MSQ^7K]*?\,X:Q_T,^@_^$]JO_P T_P#G/UP#]FS7"<?\)3HO_@GUG_YI?\Y^
MN.=\9\/2O?,;^L$_S3.B/ ?%N\<LBGW4TO3533_$^:X;R<1>1Y]S]G_Y].N1
MZ?U]N_O8\Z?'^ON<77X?R_S],U]&_P##,NM?]#9IG_@IU?\ ^::C_AG/6/\
MH9M*_P#!3K'_ ,T])<4\./\ YF7_ )(U^<4<[X$XX_Z%T/\ P./_ ,F?/4UY
M/-_KY[FY]#_7'/Z=^>*/MD_E?9_/N?LV/^/3)Z8^G_UZ^CO^&==<_P"AET/_
M ,%&L_\ S24__AG75O\ H8M$_P#!1K'_ ,T=/_6GAS_H9/\ \ ?_ ,B'^HG'
M%[_V=&_?G5_OY[_B?/WVV]_Y[W7YFL?Q)H]CXPT'Q!X4\1_:=2\/^*-'U31-
M8M/[8UG31?Z7KO\ U'/#W_%3^'_IQ['%?3O_  SWJ/\ T,FF?^"C5O\ YIJL
M?\,_ZG_T'-$_\$^K_P#S3USOBCAS7_A2_P#)?^ =*X.XX5FLMU6WOK=;?;\C
MX:^$'P&^$GP'_P"$H/PK\*W/AO4/&5YI=[XP\0ZMXP\9>-O'/BW^PM&_L'0O
M[<\<?$#Q'XO\3^(/^$3\.<>"?"Y\8<=1[^P>?[?I_P#7KZ%'P U,C/\ ;NB#
MZZ/K']/$YI&^ &IK_P QW1#GTT?6/Z^)Q2PW%7#J;_X4WZ*/6[7;Y=-MA8C@
MSCG%6Q>+RWLDE45M-%M4Z?>>!RWE]+Q/?7-SGG_C\_7\OP(S2>=<?\]Y_P#/
MXU]$_P#"AM9/_,P:+_X3+_\ S04?\*&UG_H8-%_\)E__ )H:Z/\ 6GAW98^?
M_@J7Z0,?]3..7_S+'_X'_G,^?_.G\[S_ +1=>?\ \_??I^?7]:3SKC_GN/\
M/XU]!?\ "A=8_P"AAT;_ ,)AO_FBH_X4+K'_ $,.C?\ A,-_\T5<_P#K3PY_
MT,7_ ."_^ 3_ *A\<_\ 0LCK_>7X^^?/QO+Z:/R//N/L]KQS>?E]/3]>]'VR
M^\WS_MUS]H_Z_.^>O7'ZY]J^@?\ A0NL?]#!HO\ X3#?_-#]?\GC+_X4U=_]
M![1O_!?J7_QRC_6GAS_H8V_[<[_]NG1_J)QQ_P!"Z'KSQO\ ?SGB7G3C[/\
MZ1<_Z+_];\NG\OQ/MD_E?9_/N?LV/^/3)Z8^G_UZ]]_X4)J7_0=TS_P5+_\
M%5+_ ,* U?\ Z#^C?^$PW_S1_7_)X?\ K3PYTS%NW:FW_P"V@N ^..F6Q\[3
M7Z3/G6>:>;_7^G^?I^%%?1'_  H'5_\ H8=%_P#!/J__ ,TM'_"@M7_Z&'1?
M_!/J_P#\TM="XUX>2LLRLMK*-OP2-_\ B'/%CU>61;>[=1-OYN;9\[U8KW__
M (4%JO\ T'-$_P#!3J__ ,TE6/\ A06J_P#0QZ;_ .$T/_FC^O\ D\+_ %KX
M>Z9C4?I";_0:\.N(G_S*D_\ MY?_ "1\\45]#_\ "@M5_P"ACTW_ ,)H?_-'
M]?\ )X9_PH74O^@YIO\ X*T_^+]_\X%-<5\/7US&:UZPFKZ]/=_JX?\ $.N(
MMGE27_;R7E_,<%\,?& \.:]!!/./L&IG//J/\\'K^'%?9WGV\\(GZP?+D*>5
M)_F!VSCIVZU\WGX%:K_T,>F'_N$+_4BO3])T_P :Z;HC6]G/X:U76K0$VZS_
M -K6.G>P=8R[\#ICC&>W%?GW%>)RG-,6L9@KM]?=<;VV>J6NW].Q^K< Y?Q'
MD-\HS?+4LI:O%J46TW=I?$W_ ,$MZ9Q\6O$__8B>!/\ T]>/Z]/?[I_#^8KR
M+P?X9U/1M4UO5-=OK34?$>M6&F6M_<:3;#3K'3=*\/ACHVDZ5"1OCBC_ +=U
MAC*S9+2#?LX+^NO]T_A_,5\BS]2H=;*RULNRTLODK#J***1T!1110 4444 %
&%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "" G # 2(  A$! Q$!_\0
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MO&'Q"\'^!/!M_P"/?%.MPZ7X/TFQ%]>^(K2UU75-+T_3> -6<Z 9'_L #!W
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M?P]X@\#KXV7PL\,GC;RW\$>.L1^#_!<E 'Z@W?QK^%ME\0[?X97'Q&\)6_Q
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M[>-2^B^(#X?*>)A#YFT*&V2"2+8P!] 445\G^-9/$5W<?%'Q%I?B?4O#UO\
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M+"3VR?7KM]S_ )QZ5YYX\\:Z5\//#.K>,=4ENO[(T*T:]O?L=H-2U&]!!/\
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MW  <"C.%@UBK8+966MVM--WKNGOU%DU?-GA.;&I<U]';777MY_@:%%%%<)]
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M@^)UYIEP=1^&.LZJGQ(MM)LP19:7K.C-H&O^,?[&'7P^C:'I!*NQ<>#M?E.
M <>OD=#"8G.,KPN,265)KF5]Y;J+;LO>=HZ][7TL?,\5XG&83A_-,7@K\Z6E
MDVX]')))OW5=Z+I=GD6F>+OVF?'\E_8ZY\3?&_VC4QJ=C>>']*\(>#F\-87C
M7-%;16\-Y)ZY)\8DG.<G)K]'/V??C+JWQ'T?7]!\8Z9:Z;\2/ >H:5HWBZRT
MM6;2[\:X VB>,]$.\'_A'?%>)-C'Y5;0O$0P0@#_  +X/^+7A7Q)?^%_$=]8
MZW;:?X7T?[%H]W::SHVI:9J&EZ%_R =:US_J8_\ H=SVSX8KZ9_9/MIM?\2_
M%#XLKY[>&/$A\+>&?"-[=[6/BG3? W]NKKGC%064C0IM?\0,B8(PNA9.0RJ_
MV_%F%P7U3W,I63.*]WE:O);7NG9J2Y6KK1N_F?F'"69X["YMEF%EFLL[6=7E
M*_-:FE=OF;TBXNZZ7M9)O?\ 1>B@'(!]1FBOS$_=0HHHH **** "DP/0?E2T
M4 >!>'&MO!7C*_\ "$VW_A'_ !2^I^(_ I)"_8-3W9\<>"\YR<L1XHB7YMWF
M>)Q]WPH6'7P^#[#3/%VH>*M-N9]-.N6;6WB'3+;:NGZWJ6X_V-K."J@:\BE4
M\Q>2CC<=P#R9/Q:BFM_"UOXJLHOM%_X#UG2O&=I:VS &^T[1G4:VF<]6\.R:
MVJ <_<7DE:])L[VWO;6WO;&<7=M=6OVNUNK4@"^!&1P0<Y&, ^O7C  /+/B;
M"ND3:5\1;"&:YU'P?DZQ:VF-^H>!]8(3Q!I!!^]Y>(_$^['!\/@' VUZG!>P
M7MM#?6,]O=6UU:_;+2ZM< 7WR@Y'L00>I^]@XP0-NOGA=,O/AQJV@0Z-?"Z\
M$:WXA71O^$5O#@Z%J.O'<C^#-9R OA]61MOAAEVJ0S1E-SHH!]#T444 %%%%
M 'AFDS_\(K\3]>TK40OV?XC?\5-X=U3( _M70]%T#0-;T3YMH)/A[0]#\3+D
M<M_PDI&,5E:I'JGP^\1ZGXLTNSU/6?"&MW_VKQ=X=TH27E_H>JRQQ[?&.AZ0
M=PEWNZCQIX=@&5<_\)FH\Q)4?O?''A6'QCH'V#SAI]];7@UKP]KY (T+Q-HF
M1H>L\D XZMG=E 5"DD&L/P%XIF\26\UMJ]BNC>,/#]X=)\7:$Q'^@:GEU!3+
MN_\ PC_BB-E\2>#9&51(LH^8@O&#I;IVZ?=M^ K+>R^Y?Y&?X)FN/$/B?Q=X
MW-G?Z79:E:>%_#&@+JEF;34KS3M"_MR635_['8+L!U[7V12Z(QCT564)PE>[
M]:**!O8\Y\4^,=#\'VMO+JDMS]IU*Z6QTG3-+M6U'5=:U+ .S1=(R[229RV
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M6UA;K=+2WKI_7J=D I.1R<YZGC\.WT^M./\ G&?Z<U\7Z1XY^)_PETV'P_\
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MR?<_Y[C\Q1Q_</YG_/<?G7RW_P -.P?]$0_:0_\ #0:U[^_O^GTP?\-.P?\
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M#T'Y"C ]!^0I:*+ON_O?^8679?<O\@HHHI!9=E]R_P @HHHH&%%%% !1110
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M&VA#QIX5\)_\5DY)#(=J"O0/ ?P4^(WQM^)_P9U7XS^ OC7IOPVM/C;_ ,%
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M7PQHND:KX5^"6K_$?Q/\-/VA_P#A9OCP>-O&?]A_![XC>$/#/PA^,7_"._\
M"E63Q22?!F_0O%(!"CQDOB_TWXO_  .^(/C;X@_M@^"M*^&GQ3^+^F?%CX&?
M'5M9\5>-/!_C#P1J7A;QQHO@?P(OPK^&7PS^*<OB!?AG\6OAYXK\3:/YO@SP
MIX1\(K+X,>+Q)_PGKL&>%_WVHH _GI^)%A\4_"WA?QI!\"?@'^U&W@?XK_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
IHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>image_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "@ D # 2(  A$! Q$!_\0
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M.G>.8K_XA6=UJOC+PIXZT1WTK1_[-TOP_J'CC3]%%SJFA*KED9=8TB76WC8
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M_0-T_P#\ X_\:/[#TK_H&Z?_ . <?^-:V1ZC_)Q_,@?6B@#)_L/2O^@;I_\
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M^_\ '/\ &M;(/0@T4 9/VZ?_ *!U]_XY_C1]NG_Z!U]_XY_C6M10!D_;I_\
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M"6D4'G_"GQC^&GC/5[#1?#?B6"]UW5-)US6H=)BMYH;W[!X:U>+0M::XM)%
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MC_VQH_\ S^Q_G-_A1_;&C_\ /['^<W^%;%% &/\ VQH__/['^<W^%']L:/\
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M_;B,6A=\J0#[(>V\RVCC\^XB\N-$WA\.0JA=S8ZEL98YZY]ZK?V2?^@A?_\
M?X?_ !%3-<D6Z7(2Z8/&D@019D4.H8!EP!D9 8=,YXIO]I+_ ,^][_X#M_\
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M>S^Y_P"0KKNOO7^9&-+4Y(U*](! .)UX) (!^7@D,I /)!'J*=_96>FH7_\
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M7CDG^K?_ '&_D:]C_:!_Y+U\:/\ LJ'CP=?^HOK/X_Q+_P!]+ZC/CDG^K?\
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M(_:*^+WQ;TK]H'XW:5H_Q4^(NEZ3IWQ2\4VUI;:?XJO;?3-.TM=5Y@M[19%
MVY.41?D[ =OL^!N",;Q_F,LKR^K3IU(TU4E*JI\L8\_(W)QE"SOLFUW/A^..
M-L%P3E\<PQM.<U)\L5"S;>FBTE?SM>VEC^B'X"_#OXB^!=2\0GQW=F\CETKP
MKX>TR\A\3ZGK]MKY\,::;>[\;ZQ:Z@V='U[Q),RM>Z=8YM?W>XY))'U,6+$8
MV$'& I&1G/;.><$CKFOXR9/C9\:]CX^,?Q,^XVT_\)IJGH<$?O/7T[]J_J9_
M9/FUK5/V;O@KJFJ:U?WVIWOP[\,7&I:I?2G4-2U&^ETJ)IIY[F8DN\CYD+D9
M;CDY)/J\=^&&-\/\)1Q68YM3Q'MZDJ<53IUM'&$IN5YRFI?"HI15VVM4DSQN
M"?$S#<:XRIA,#E$Z,:<>><YRA9+1-M*,>]W?;7N?4U%97V.Z_P"@C=_]^XO\
M*/L=U_T$;O\ []Q?X5^;;J_=7^]'ZB7:_*7_ (*ZD#]GCPGD@?\ %T] ZG'_
M ##->]:_4D6MT/\ F(770?P1<X'3[O7G&/U-?EC_ ,%:X)%_9X\)J\\LY'Q7
MT(Y:*(DJ=*UX!<'C"D?*>^>0,5]AX;_\EYP>[[XV@[:Z.UK/N^MUIJ?%>(/_
M "16>^="6G_<1:]O+N?SO5^EW_!*+)_:CU-@"?\ BU_B3) /7^V]%[^O]>*_
M-(\$_6OTD_X)5)*_[3^I[9VMQ_PJ_P 3!E0=SK.BX)'.,<' ] <\U_:OBFK^
M'^?K1?NIZVV\]-3^1/#RZX\R1K^9_F?TQT5E?8[K_H(W?_?N+_"C['=?]!&[
M_P"_<7^%?Y]G]WK9>B_)&K37^XW^ZW\C69]CNO\ H(W?_?N+_"D-I<@$G4+L
M@ D@QQ8( Z'CH>E-;KU7YH4_@G_@G_Z1(_CM_:"_Y+Y\:/\ LJ7C_P#].QKQ
MU_N-_NM_(U[%^T%_R7SXS_\ 94O'_P"?]K<G\>M>.O\ <?\ W6_D:_T>R;_D
MELA_[ Z?_J) _P ZLV_Y&^=?]A4O_4EG]=G[(8/_  S!\#>#_P DR\)?^FF*
MOIP?>;_@/\J^6OV1+:X_X9D^!G^GW&1\-/"66\N/+9T>/&[ XVYP!G&!S7TB
M+2ZR1_:-WQCGRXN>/]WM7^>>?K_A>SW7_F-Q???ZUB-/5=]NQ_??#W_(@R.^
MG^RTO.W[F&O:WIJ:J]!]!_*EK*%G=$ _VC=\C/\ JXO\*/L=U_T$;O\ []Q?
MX5Y;V?H_R9[A^3?_  5Z('P.\ Y(&?B?;8SQG_B3:W7\^%?T$?\ !7.&6#X(
M?#[=<3W/_%T+<_-%$3SH^M':=W  / /N?>OY]Z_MCP"_Y(B6M_\ :*S^?M5^
M1_%_C=_R7$/^O4?_ $D_37_@DV#_ ,-.ZT<''_"L?$//;_D/:%WK^DQ.K_0_
MR6OYJ_\ @E&DK_M,:T%F> 'X8>)1A>>NN:* V!W!^;ID$<<FOZ0EM;H[O^)C
M='@GB./G'L1QG^6/P_ _'-?\9_B'?>EAU;72WM-7T=_+;J?N_@OKP/2UM:I5
M^=TMNUO/0V:RM1_U^F?]?J_^@FC['=?]!&[_ ._<7^%&H_Z_3/\ K]7_ -!-
M?DA^LAIW^OU/_K]?_P!!%?-'BK]J/X<>$O$_BKPTRZKJNJ^$[@6VM6MC';+
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M 'XG_P#B:TLCU'YBC(]1^8H S?[6L?\ GL?^_$__ ,31_:UC_P ]C_WXG_\
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M_ME_X#G_  H\O5?^?VR_\!S_ (5:_M/3_P#H(6W_ '\3_&C^T]/_ .@A;?\
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M3/ZF-"ORF_X*YY_X9Y\)X_Z*EH)X]/[+U[)^F#UZ8-?J*+LY_P"/'4?N@?\
M'O!_\?\ 4=C^7?\ +7_@K9<F7]G?PJWD72%OB=HJ[1Y:$8TK7/O!VYW?P@>A
MS7V'ANO^,\X0??&T7;T5N_\ D^R9\5X@_P#)$YZ^]"2_\J7_ "[_ 'G\[M?I
M;_P2BY_:CU,]0/A?XDR>V?[:T0]?QK\TJ_27_@E/(\?[4.J*H8_\6O\ $_ 7
M)XUC12.W4G'Z>U?VKXIJ_A_GZ[TIK\#^1/#S3CS)'_>?W7U/Z8Z*Q_M9_P"@
M?J7_ (#0?_'Z/M9_Z!^I?^ T'_Q^O\^S^[ULO1?DC8IK_<;_ '6_D:R?M9_Z
M!^I?^ T'_P ?I&NR0?\ 0-1'!Y-O  ..I(GSCUIK=>J_-"G\$_\ !/\ ](D?
MQX?M!?\ )?/C1_V5+Q__ .G8UXZ_W&_W6_D:]B_:"_Y+Y\9_^RI>/_\ T[?Y
MZ<>E>.O]Q_\ =;^1]>/SK_1[)O\ DE<A_P"P.G_ZB0/\ZLV_Y&^=?]A4O_4D
M_KL_9#!_X9@^!HP<CX9>$LC!R/\ B4Q5].#[S?\  ?Y5\K?LC7FS]F3X&XLK
MXC_A6?A0Y2V@&,:/&>0+C Y'&."""2":^DA=MD_Z!J7;_EW@S^(\_C\*_P \
M\^7_  NY[_V&8M]-GBL1Y_\ !\D?WYP]_P B#(_^P6BO_*,#87H/H/Y4M8XN
MS@?Z!J7_ (#0?_'S1]K/_0/U+_P&@_\ C]>6]GZ/\F>V?D]_P5ZX^!W@'/&?
MB?;8]_\ B3:YTK^?"OZ"/^"NER'^"'P^+VUV!_PL^ #B(<KH^M#)). I/W<=
M@>37\^]?VQX!)K@B7_816?WU=/ZW\C^+_&[_ )+B'E3BONC_ %MH?II_P2;_
M .3G=:/;_A6/B'GM_P A[0N]?TFIU?Z'^2U_-9_P2A=D_:9UP*"3_P *O\2L
M%49R1KFBE<8'7ICGV[U_1\MV?FQ8ZB?^W>#T!R?](SW^OO7X'XYK_C/\0^]+
M#K[E49^[^"^O ]+RJ57]Z7]=3<K*U'_7Z9_U^K_Z":9]K/\ T#]2_P# :#_X
M_3]1_P!?IG_7ZO\ Z":_)#]9#3O]?J?_ %^M_P"@BO(]<^!7PJ\1ZO=:MJ?@
M;19=6U!HY;S4X+>2SFOXHIA))::S+;2QM>C5OMLZWD<H:.ZC $H9HP:]<T[_
M %^I_P#7ZW_H(KXT\?R_M,+XZUH^";'7?^$/%D+/3TF@\(X_X2N:;59-&O8?
M-V&?P7?M+IH\8I@:E9"%@B7P9L 'VPL4;Q"$P1BW"A%C(&T*@"JH7&  !@#C
M  IGDP_\^H_[\P5$YO?LR"%+5KD(@D\PR+$)-HW[3MSM#YV=<@=.U1YUC^[8
M_P#?4M %GR8?^?4?]^8*;LM\X^SIG.W'EV^=VW?MQUSL^;'7;\W3FH,ZQ_=L
M?SEKR_QCX_B\"2Z*FLZ?J-XOB#55T>TNM TF[O+&PO<""(:W;F\;4+E'MKI+
MDC38;B5;:PN[ME%O SJ >L&* =;91DX&8K<9)Z#ZGTJGJ-WI.E6=UJ.HSV-A
MI]C!+=7M_>-:6UE96T"-)/<W=U<-'!;6\**SRS3.D:(K,6P":\PTWXJ^&[WX
M<VOQ6DO+;PWX*FT236[W5_%WF^'QI6CPN4DN=1MIB[V5Q&XV^5/LF5B(PGF'
M;7S/;:-X\_:UU)-<\4Z?>>$?V;+9S-X?\"W2W6G>)OC7+&=UOK'CJ.18YM&\
M %PLVD:#Y<6HW^[=K$8BPAZ*&'C77-5?LX)VDYZ:]DI)-R:O9?.7*DV<F)Q3
MH:4[5)-67(U.S>B^%M63:U]4KLB>\\3_ +8-[-:^%=6U7P=^S)IM^\&M>*+
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ML2"!>VA)!  N(<D^GWZ:W7JOS0I_!/\ P3_])D?QU_M!?\E\^-'_ &5+Q_\
M^G8UXZ_W&_W6_D:]B_:"_P"2^?&C_LJ7C_\ ].U>.O\ <;_=;^1K_1[)O^26
MR'_L#I_^HD#_ #JS;_D;YU_V%2_]26?UV?LA _\ #,'P-&#G_A67A+CO_P @
MF*OIL$;FY';O[5\N?LC7MFG[,?P+W7=LN?AIX2(W3Q+D#2(\D9<9Q@Y],&OI
M/[?8_P#/[:?^!,/_ ,77^>>?K_A=S[_L-QC^7UK$-/T??;LS^_.'=<AR/SPU
M%?\ E&!H@C Y'0=Q2Y'J/S%9OV^Q_P"?VT_\"8?_ (NC[?8_\_MI_P"!,/\
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M?_/M#_W[7_"C[#9_\^T/_?M?\*XCTAWVNT_Y^;?_ +_1_P#Q5'VNT_Y^;?\
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M^T/_ '[7_"C[#9_\^T/_ '[7_"@!WVNT_P"?FW_[_1__ !5'VNT_Y^;?_O\
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MQ:>9?M4D:QJSF1(RH168G +4 ;1B#C##/_718Y/YY/ZTWR(_^>(_[]V_^%6
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M U?_  *7_"M:C(]1UQ^.<8^N>/KQ0!D^?J/_ $#5_P# I?\ "CS]0_Z!J_\
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M.T /GTZUNP!<PJ_IL,T.#SG[K#U/IG/?BF?V+IO_ #[G_O\ 3?UDH_MW1/\
MH+Z9_P"!UK_\=H_MW1/^@OIG_@=:_P#QVA[ <'XY\%_#WQ!H-P/'OAGP]K6B
MZ6KZC<)X@T>WUBUC,"EI+Z.S83 7*]Y(T$RDC;UY^;WTS]B:.R>^N_"/PAM[
M)+6PO));GP5H\'E1ZA/8VHM)=^F;H]6L)]3TR*_L.;VQ?4K%+F&%KN('ZGUJ
MXT+6=(U72#KR62ZI97EE/=6-[9QW\<<X\LO:SS&2!6*.P7<K8W#!X8CP*X^
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M"6=[NXD2>UMDDM0@^QZ?;*MBH)9%2-54L<BO1UU[1]H)U;3-Q/3[=;<<>GF
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MTW_QRC^Q=-_Y]S_W^F_^.4?V[HG_ $%],_\  ZU_^.T?V[HG_07TS_P.M?\
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MER"*Z7^W=$_Z"^F?^!]K_P#': #^Q=-_Y]S_ -_IO_CE']BZ;_S[G_O]-_\
M'*/[=T3_ *"^F?\ @=:__':/[=T3_H+Z9_X'6O\ \=H /[%TW_GW/_?Z;_XY
M7C!^,OP7CN[C3)_%&G07EG?R:7=V<L-TEQ:WUM<BV@>YB \V(:U<2Q6^D2.H
M&K3RQQ6C3ROMKV?^W=$_Z"^F?^!UK_\ ':^;+[X)?#:\O;O4)_$_B&YO]3U*
MZOKVX?Q'8*\LJ:HNJ:8TC(B*(_#TUG$?"0WEM.+1_:3)NH ](\,>/OAAXIU.
MSTK0-6L[S4]1L-0OK2VCM=0M6\C2;I;+5;8QW 0)JVE71-OJ5KQ>6<P,=Q%&
MW!]+_L73?^?<_P#?Z?\ ^.5XMX+^&_P^\!:O!KFD^(KV^OX/#)\)VSZOX@2Z
M\FTDU(:O)(1'%@7NI7;>9JFJ8:21XU+L22![2-=T7'_(7TS_ ,#[8_KYO/UH
M /[%TT?\NY_[_3?_ !RH-;!_L?4P/^@?J6 .>QX_*I_[=T3_ *"^F?\ @=:_
D_':R-6UK1VTO40-5TXDV&H8 O;<D[P=F )"3O_@Q][M0!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>image_006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  S ' # 2(  A$! Q$!_\0
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M)))M=/)/))B?G]*<D7PR1@RVNFY'K"Q_F*?_ ,*LL_\ H)W/_?"T?\*LL_\
MH)W/_?*UK[?$]_Q9S?5<H_GE]R-:U\5^$[&$0VEW;01CHD414?D!4.I^(/!V
MLVPMM1NH+B -N\MU;:3[C'-9_P#PJRS_ .@G<?\ ?*T?\*LL_P#H)W'_ 'RM
M1SUKWM^)7L,JM;VDON(?(^&'_/KI_P#WZ?\ PJY8W?P^TV02V<>GPR#HX@.X
M?0D5#_PJRS_Z"=S_ -\+1_PJRS_Z"=S_ -\+5NMB'H_S8EA<H6TY?^ HWO\
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E;EV:LCH****U/-"BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>image_007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !C Q\# 2(  A$! Q$!_\0
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M^V_\-_V<;4K\4O!GB/\ :F\??M ^$_'?[36KZ+X@O?AM:_%;X,?#WP[!\'/
M_P -/!/Q2L?"/B?7?A+K-E\*O"?P]\1ZIXJ\,^$SJ;>)QXZT72+[3X_$*:TG
MUE)^WY\/[3]G+QA^T)/X9U'Q##X1UGQIX=@\,?#/6]'^(5K\0-5\":4==\2:
ME\+O%L!T6P\4>"-,T=;[4]3\9ZCI_AZTT>T\/>)VU"RCET^RAU'M-?\ VM'T
M#QQ\3?AU<_"CQ%'XI\(:E\$]!\!6MWXH\*0VOQ7UKXY:MX]T?P[)IEY:7FH+
MX4\/:=)\/-=U74=1\31V^N-H4$EU;^%GU(V6D:@ <M_P3P_9V^(?[+G[+^B_
M!SXHR:%-XJTCXE_'?Q4TOAKQ3JWC+2GT+XB?&7QYX\\,0#Q'XAT70=;U2ZM?
M#_B33+?4Y=0TV"Z^WVA=Y)WW22?<AY91W\UC^&<'],U\,:C^W/H-@(C)\-O$
M1B\*V4E_\=I6US1(Q\'[.W^+7B'X'7MQ$I+OXXBM_'_A/Q-<JU@NC";P5HE[
MX@&S55C\,/\ <B%C,P8 !&;!&>6W#<#D#C#KM(SDA@0N!D<K)>:J_>J$VE]^
MY$U=1;OHJO\ Z31;^:6I\7_L$Y_X4/?#G'_"[OVA]HSP,?&WQUCCV9E(QQE@
M>Q(^WH_ZO_,5\0?L%$CX"WC=S\;/VAVYZ#/QM\9'J!G SUQG%?46O?$7P]X5
M\1^ _"NLS30ZQ\2M8UO0O",-O8ZG>QW^IZ#X4U;QMJ<5S<65C<VVFPQ>']!U
M2X@N;^>&&[NHH=-MGEU"[M;:?S,I?/E^";T:PM%JWE&2ZGU_'S_XSCBYKIG5
M1/\ \!PR^\X7]J'X?>)_BS^SG^T%\+/!ATU/%OQ,^!WQ3^'_ (6EUFZ:STB/
MQ%XQ\#>(/#VBG5;E+2_>UTY=3U"U>\O(["\DMX%9UM+C;Y=?C%IO_!*/XZ>&
MO@)\0_V=_!7B?PCI'A_QQX9_8O\ C'IWB[6?'?B[Q!XNT']H_P#9HU/P!<>-
M_@_J/BWQ3I/C7Q;K/P&\6_\ "$1:[\,-;O[_ %N/X/>)-6U^/3/AOJVA7$6E
MR_H#I'[?MAXO\!>+/&_@_P"'^A7$GACX>>&?C8VD^)OBSHFCA_@QXK_X2FWT
MS5-7OO#?AWQQ)X;^*-OJ_AB71]4^%&IZ?YEI?:E8V\/BR\NX[^TL_:]"_:#\
M6MX]^$W@+QS\)X_"&I_%7P='XA6STWXAZ1XP\0^"M3M?!<GBWQ GC+P_8Z)8
M?V;X&T?4+:Y\ 1?$2+4KBQU+Q\^EZ1%H\&GZQ8ZM)Z9\F?GK\*_^"??Q4T+X
MM?LF?%37M L[.3P'^T_^T3^T1\;].\>?'4?';5Y-=^)OP#L?A7X;\2>%-:3X
M+_"C21K^H:]I5AKFMZ58>&-.@TJ]?6/$:>(=6U75&@BX3X/?\$_/VIO@-X<^
M!?C'PUH7P*^(_P 1O!/P+_:P_9K\6?"[Q[XNU73?AYI?AK]HC]H>Z^,NC?$7
MPYXA@\#^)QJMQI>G66D>&_&_@&Z\+:5;^(?#]Y>:5I6O:5()I[C]3O'/[2NE
M> OCI\,_@EJ&CZ1J&H_%*X%AH*Z9XYT1_'*W']EZ]J\^NO\ #2>"+59O .EV
M?AS4?[:\6PZN9[*40"WT*^BE\U:WQ _:G\(>"?C1X'^ Z2^%)?'7BW3?#WB2
M[M_%'Q"T'P1'9>&?%/B+6/"OA]_#MIJ<-YK'CGQ1KFL^'?$4>C^&M'TRV@NH
M-$N7O=<TRYO=%M-5 /SH\)_\$N/B#\/?%7[#F@Z1\2-,\4?"#X7?#?X0>$_V
MP+'5H)K34OB]X@_9&U74?B1^R=J'A.QN5U0VNA>%?BCXI\1V>HZ+?ZC"8/ &
MF>&-)GGU+^R;>"MSX6_L"_'7PMXW^ ?@+Q%<_#2'X/\ [,_[7OQP_:\\/?'/
M1=9UBZ^-?Q7G^+=Y\5M0T_X7^(O"MQH>GVGA/R[GXMWMG\2?%+^,?%EIXTT;
MP3X7M-.T;3[F^DDT7ZJUS]O/P?X:OOCUI>K>'M'NKSX%'X>2:Y>>&/B;X2\3
M>'M)M?B;X]U3X=Z*WQ/UNS2#_A5MWX:U/2IO$7Q&M+JR\2)X/\$2)KWVG5;P
M-HH?X5_;X^'7C36_@[X4T:V\-V/B?XK65MK4<?BCXF>%] \.MX>N/'7B?X>6
M&I_#O73%>W?Q;F\::WX,\2ZI\+[+PSH5HOC+PKI\.KZA=^%KO4M/TF< D_X)
M[?!+XR?LV? "W^ _Q<TSP0J_#OQK\27\&^+?!7C#5?$2>._#?C?XH>.?B/'K
M^L:-JOA;P_/X.U"WC\6VVDR:.=1\33W$]E=7T^K'S8DK[W!R,CH>17YZ>+?V
MV?$'P\@^(DWQ$^%'A#PKI?@CQ_X-^& \=S_''31\)K/QCXLT;4O%-W9?$3QY
MJG@+1I?A[8>&/#,?ALZQJ:^'O%$#^+?&WAGP;8K<W\]Y=6EWPS^WYX0\3?$[
MX2_#6+P!XAT'4?BSX<^'^N:-I'BS6_#VC_$01?$CPEK'C/2=9TKX?P7.HGQ-
M\/O#6F:!JVG>/_'ND>(FM?#OB&W32]/TG7T^U7=F ?=C_<DSV+@^Q\M>_P!*
M^*/^";F/^&%?V:".O_"N=-&1P?\ C_OPPR.>N<U]KL<QS'U8G_R$M?%/_!-L
M9_85_9H'K\-]/;\5U"_P/H<<UQUO^1G0_P"P:O\ ^XSZS *W &?^7%O"'XY!
MQ6?<<XW1L..< [MVW!(!W;65BO\ >&<$9!!!(K^=[_@H-^PU^T%\<OVL_C9X
M\\"?L]^*/B-!\0OV:_@=X#^ ?QDT?]H_2?A%X+^!WQR^'?C'XL^(I?'7Q=^'
M*^,-.O/B[X5\/:AXD^'_ (CT_P .:U\//B?IDTGA_4["QT"&?5[JY'[Z^*/&
MN@>$-);6_$NHV^D:1_:WAS1$U"Z\UK9M5\5^(-+\+^'K1Y+1+MH6U37]8TO3
M+=IXXHTGO(WN'@@625/ 9OVL/"4GC?7/A_H?@CX@^*-?TWQ-XI\ Z%+HT/@R
MSTKQY\3? WA*U\<>,/AKX2OO$_C7P[]E\2:+X;N'U(:CX[A\#^#]5M[#56T3
MQ-J<NG202]A\F?EM?_L!?M#ZC^W-!\5_B1/XS\>^&=0_:*^!/[0OASXP?#R?
M]G'0(_"LGPT^'_AOPIKG@/QZ?&_AA?CM8>$FOM*\4VUMX-^&GB'7/!^O>&_&
MH9[/0]?M]3N9?'?"?_!+_P"/.F^$OV9$\+_"[P7\(_C%!XI_X*O:=\;/B_I>
ML^#+?Q#X?\/?M,>%_P!HK1?V=-;U_7/"\[^(O&VE_P!I>*_A??0:/H<\^H>%
MQ:+J-_;:?K5A=3M^QUE^V+H5Q\/-"^*6J?!SXS^'O!.K_$2X^'EUJNHP?";4
MQHDT7C73? .G^+IE\)?%SQ+'XH\&:_XGU%+7P_??#B7QOK.I6-M?:U_8=OHE
MLFHW'H?QL^/4_P %E\-W4WP@^)_Q$M/%'B#0?"EI<_#ZX^%Y:V\0^)=>T[0-
M!T>32?'/Q*\$>)M3O[Z349-5G3PWH&NPZ3X?TG6]<UJ?3=,TU[F0 _/?_@F/
M^R!\4?V==6\9>)_B;X8\<> =9U3X3?!?X5ZCX3N9/V8X_AEKNI?"\ZZ(_%/@
MNT^ 'A_PWK.H/!%J=Q9?\);\584\;>(=)U+3[+6;9;CP\D]S\B?LZ?L"?M0^
M$OVIM/\ 'MO\'?%'P/US0?VK?VQ?B5XL_:6UO]H'1_B)X(\;_ /X[:K\4I?#
M'@?X8_L\1>.O&&D^"O&U]>^(/AKXCUGQ3#X%^&-VL'@F[M=7O]7EU:?3Y/W/
M\+_'?0/$WQ;\8_!=?#GBG2/%OA'0G\4^?J!\+:EHNL^&EUD: NJV5UX1\5>)
MM1T*234'0V.A>/M)\&^)-8LA=ZCH&C:O8Z7J-Q!RNM?M,MHGQ.\0?"R;X&_&
MF_U/0O!VL>.8M>T&/X3>)-'UC0].UFP\/Z4;/2-#^+-YX[TRZ\::S<ZEIW@V
M/Q1X/\/VVI7'A?Q;]OO-+A\/7\R 'X ^%O\ @EO^U+HO[*_[2_PUU3P'XLU?
MXX:I^Q/XD_9GT"[A\2_LM>&?@S\;-<U/QUHOBBT\00W/P\T3P1\2-8\3WMQI
MD^NWGC/XY+INMZ9+K/B;1&U?7AK,NH'Z*_X*(_L/?M.?$;PWJOPN_9B^ 'PR
MLOAS8_ +P.OPDN/ASIG[-/@+Q'X0^.WASXIMXW\5Q^/?%?Q'\'ZMXTT_0[R*
M/1_$'@F7X+:EX<N+OQC#XFO/&>M)_:<4T_ZQ:;^V'\*=5T[]FB^M[7QHEY^U
M9HVF>(OASX?&A6=UK6AZ%JGPYUOXF)JWQ";3]8N]%\*V,.D:#=Z09UU?41?^
M)773M(_M"&#4+NPRO"/[97AWQC\#-/\ V@K#X3?$S3O VM6FC:QX?M]8\3_L
M[6>KZSX7UO0(O$<'B<3I\>9_"FB6MG831QZCX>\4>*="\<6U[-;V0\*O<RM'
M$ ?GA^S?^QM^TC\%/V[/B7^TEXN^&]C\1/A]\7/VC_VH[+1-*UKQ=X0O=0_9
MJ\$^/=:TOQ+X0_:&^%=M<ZJ4-M\9;6SN?!GQD\)11P_$;3DTWPE>:0X\/-XB
MT*;]U8,J K9!(P >>A?\.!C\,>U?(K_MH?"./7="T^2S\:1>']7T_P #W.J>
M/K[P]%H_@[P9JGQ+\'S>/O ?A;QFNLZCIWC'3?$WB#PG%#J$EE8>#]5L]%GO
M;#3?$=_HM_>6UO)WOPD_:&\,?%S4;K2=/\-^,_"&K1^%/#7Q"T;3?'&G:3I]
MWXJ^''C*35K?POX[T./1==\0"'1]5FT:_CFTS7I-&\6:!/\ 8K/Q1X=T2_U&
MSM9@"/\ :S7/[-'[0?&<_!?XAD9Q_#X6U@MUZ8!'USQG!QT_P6'_ !9WX3<<
M'X:> 54=,E?#&FG Y&#AUPQ^4%@Q#A64\W^U:-_[-/[0 /&?@I\2CQSR/"6J
MM_3%=3\%/^2/_"'_ +)QX#_]1;1JX8-O-:Z_ZEM!?^7$O\D?63@EX?X1IN[X
M_P 9!IZJU7@_#UF_52I12Z<K:=W9K\K?#_["W[1?PB_:V_:,_;?^$L_@&X^)
M_P 1?VAXY&\ ZOXGNH/#?QL_9'UOX<_![PYJW@KQ'J\_AV\D^%WQ1\!^/O!_
MB'XC> ->T2TU2PU6]M8O#'BV2[T3Q'+-HMCX)?L$_&SP#^TW\+/BSXH3X?W'
M@_P-^U3_ ,%*?C+>/8ZZU]K$/A7]J.?PK)\'KBQL+OPY!;#6K9-(U ^*;1+N
MW;0)(M.%MJ.L1R7C/^MGQ+\?>&_A5X$\6_$CQ?/<VGA;P/X>U3Q/X@NK.SFO
M[F#2=(MS=WKV]E;J9KNX$$;F"WA!EED 55.3CYB\?_M?V'A7XJ:U\(-*\'V.
MK:_IWBSPA\+[>XUOX@Z3X.;4_B9\1/ 3_$'P9:6>E1Z=K_B-? -_IFS1=0^(
M%KIUW=:9XI6^TZS\*ZK9Z/JNJV?<?)GYK?#/X/:G\5O^"A'[1%Y^SS\5/".K
M? SX.:+X]_:)^&7BK1H+7QSX0^'/[?\ ^U=X!U#X8^,+6:?S;_1/$UOX*\/^
M'-1^+NI^&+.^!T'Q%\:->T[4899]4ABTGD'_ .":'[9WQ.TG]I-OB]XM\'VO
MC+X\?\$[HOV5K_Q?JOQL\9_%>37/C/HWCJ\U^'QK>:/+\.O .B?#?X;ZS'/?
MWVB>#/ NE7^G^%;?7;F.\TS5+^?5(9_TE\._M(77@+X&Z5\7+/\ 9ST#PKX)
MUGQ_?::N@?#SQMX?:+Q)I&J^+M.\(^'?&OPSTQ/ OA"Y^(NM?%'4KA]6\$:)
M)IFB77B;PU:V6LC68)-9TJRO/H']H3XO^,O@WX+3QCX1^'FB_$@QZG9:1/H5
M[X_E\$ZKJ6KZW?6FB^%O#WA%4\%>+4\1>)_$WB+4+'1]/TVZ.A:= 9FO;_6[
M:"*58P#ROQWX/^-WC[]DZ'P=XJ_9U_9X^(7Q"UG0-&\.^./V?_B-\5=<U'X.
MZYX>L)6@N])/Q,'P?U:^OM3^Q1VM_I5WJ'PN:QL-84W";)K6&]E^&?@5_P $
M_/VAO!'Q)_8A\7>/;WP+?>"?V?/C7^U?\2$^&,GQ \4_%"#X _#KXP_"K2?"
M/PH^#WPW\?\ Q$\.)XP^),/@CQ3:ZAK\GB76_P#A'IM'^WG2?#]O'HNFZ5;0
M?I5X"^-'Q \2_&'QO\+/$_PO\.:!8^!O"FD>(]6\7>&?BDOC:+3]0\2W\B>&
M/!^N:)<^!O"-QI?BG5M#M;[Q+)9VM]J]M8Z5'I\LEW,-;TEKKR>?]MK3-.\7
M?M"Z)J_A3PW!I/P!\2Z?X+GM['XF6=W\4/&7BGQ GPYL_!UOI?PNO/"VE#3=
M"\8^*?B5H_@_1?$MYXPFTXZXJPR@&=8XP#\_?A'_ ,$T_CGX+\1ZCJNOV?PK
M%D?V</\ @IO\*-$^R:Y)>3Z5XE_:X_:GN/BK\*EMXI?"T<5OH?\ PKV867BJ
MX@:.30+LC0;:SUG3B]PO/^(?^"4WQI\:?#3X5?#E=1^%?@D>$/\ @F3\*_V6
MM5O+2[U#4O#TGQN^&?QQ^%WQB;0]:T.RT.SN/$WP<\:'P-JOACQIJ"7%EJNI
M>'_%'B#.BS76HN@_0CQ%^W%J'AWQIX7^%>I_#3P;X:^)VH^)O&7@WQ-IOQ#^
M.&E>"O ^C^*?#6A?"#Q3H>A^&_';>"=9/C34O'WACXT^'-8\'Z<OAW0=3OET
M/QI:/81W?A>]C/=_%3]M3X??"WQCXD\&7/ASQ)K]QX/^&?BSXA>)M<T=]*B\
M,:5J'A;Q%\-/#<W@:75]0O;5?^$ACD^*_A37?$EZ\,6A^!?"D[:UXPU#22\%
MG* ? GQ'_8,_:.^-_BKX@_&CQGH?PA\$>-OBW^TU_P $X_'?B+X/:#X[U3QG
MX.T7X:?L8?%2P\3>-O$NI^-+_P"'_A<>+_B'XY\.7.HZ=I^@MX/L=&M] \*^
M#]"N=3DNOMMY'J7/[%_[9?A?Q]\9M6^'?B/P;;?"_P",7[<7QB^-_C/X<Z%\
M5-:^#_B/QG\-/B)\#?A'\//!>K/\6_#'PS\5^*_ VJ^#/&_A'Q5XB\5>#_"5
MI:2^-]'N-+M+[Q+<O+J%G<_747[=6C:A8:K:^'?AQ<^*O&O@F3XG7WQ/\/>'
M?'7A>^T7PQX4^#FD>!=>\=>(_#OC63R-+\9//IWQ,\#Q^$=+-GX??6-3U6[L
M=?N_"2Z9<7)]!^$?[7GP^^-_Q,\3^!OA]JO@;5-)\+Q:M:SZD_Q'T/\ X3G5
MM9T*[CL=8.C_  HL;74-?7PMI5\T^DZAXCUW4]"O(M8L+R*'P]/IGV35KL Y
M_P#X)]? GX@?LR?L7? 'X!_%*YT2]\?_  Q\&WOAWQ'<^&M0N=4\/R3+XB\0
M7]I-I5_?6]G>7=J^G7EC&LES:VTZEAOMX9(BBY/[+^T?M(_M]8P,?&GX9$X'
M0G]G[X< G'J0 #WP #T%?<C$-&TG'^J9,*P<<9'WEX)XYQD Y )QFOAO]F Y
M_:/_ &_#_P!5K^&B?]\?L^?#1L_CYF,=L>_'!BDI8K*T^F*K3^:PLU]Q]CPZ
MO^,;\1GU7#&5?=_KMP\?=T8#1X(!5C("".""[9!'N#S7Y/\ BO\ X)Q>$OCO
M\=_VPO$_[2?AG3O$OPL^,/C#]F?QK\)'\,^,_$'ASQAHVI?"7X::[X'\<VNJ
MWN@KIE_I>F^+K/7=7\+:_H46I:IH_C/P1KNK:#KL?V2<)'^EWC7QSHGPX\&>
M*/'GBB6>V\+^"_#^M^*/$5Y:65]J5U:Z/H-J^HZC-;:=IUM=7M_<)9Q3R16=
MK"]Q</&L4$<CL=OS#\0OVQO#O@/XF3?#O_A&+:^CL]7^%/A&ZU?6O&FB>$[V
MX\9?'2^M]%^%5KX=\):C!<>(_%OA34/$%]INB>*O&&@6EV?#^H7=[9:+H7BZ
M_P##7BVST+OO?7OJ?';Z^2_*)\(:9^P3^T'\/OBY??M!>!]+^%7BC7OAW^W9
M\?\ ]H3X8?!S6_%EYX5\'^,/A)\:OV??AY\#M,M[CQ'IW@S7+?X=_$KX;6OA
MN^E\%*?"OBG1[+1)-8T9;RUCUU9K+'\+?\$\_P!I7X#Q_"3XI_#>/X)_&/XH
M>&_"O[7GA7Q=\(_&/B/7OAU\-O!C?M>_&F;XTW^M? OQK%X'\>W_ (=G^'-W
M/'X%GMM1\&VQ\;^"[-((YO#DL:6\GW0?VN_'6G_!WXG?&/7O@IX<L]"^%OBO
MQ!X?U!])^-VEZEHWBRR\'PQ6?B:Z\":WJ?@?P_+KNNGQH;_X;>%?#=UH^E#Q
M=XUT>]L;/5[2PN=%U'5_5_CY^TGH'P%^&_A[XB>(M,M;"S\3>(]$\+V\OCOQ
M+IOPY\+>%+[7- U?Q!#>_$WQAJ-OJUOX(TBU31Y=#O+PZ9J\T'B:]TW36M3:
MW4FHVX!^-OAC_@EC^TUX3^#]U\.5U?X8:CJMO\&?^"1OP_LM4M?%6L6]C=:_
M^Q#\=;;XC?&2^07WA=KNQM)= BEM_ \UPE[)K-W(6N+70I!%Y7OOP^_X)^_&
M?PGKGP"UN:T^&MK/\.O^"I'[57[7_BR>QU61;^7X-_&73OCI8^$+32[F/P^D
MMYXM$'CKP9:Z[X?GFM[&W@L+E(M:NH=)L(I_T4US]I71M(^ 7ACX]_\ "*ZQ
M;:7XRL_AL^B^'/$-YI^A:AI]_P#%3Q#X?\+^&T\8:L)-1T3PQH-GJ7B33KKQ
M+XHDO+[3]%T,SZLD-^R065UY-X;_ &R]=\7>(_A_I/A[X6>&;_3O$OC[QG\.
M?&5Q%\9=-FUGP+JGPKN[J/XM>*(M.LO!=WX?\3?#GP=8+HNH6WBN+QAH]SJL
MWBWPMH5_H?A[Q%JG]DP@'S?^WE^PG\9?VH?B/\<M<\":AX'T?0OB3_P3<^*7
M[*N@WOBC4[^*>V^*WBGXO^&_'^@S:KIEEIFH+%X3;2M"FCNM;A>[OM/U*XM)
M(](NXXIEKRKXA?L$?M3?$+2_VRO%(LOA5X>\=?'3XH_\$XOC5X!\+/\ $#6-
M6T./6_V2/"/P>N/B-X%UWQ8O@>TFL['4?%7@#6M"\+>)D\+WD=Y97MKXDU#P
MY;;IM%K[CU3]OKP!IOPA_:&^,*>!/'=]I?P/\:^*O!'AKPU;6^GCQ=\;;CPU
M\)O#'Q=@\0?#[1WN?-M_"^O^&_$-SJVF:OK[:>D7A'0M1\<7\5MH,D$A[K6_
MVH=9TKQ3\4O"EG\#_&NMWWP]^"GACXU: UEXJ^'5K_PLO2O$&HZ_I5[9^&$U
M;Q+IR:3:^&KO0I#K&I>+Y] O9[=Y)]"T+6?^);%JP!])^'+GQ#>:'HMYXLTC
M3] \376E6<^OZ+I.KR^(-*TO6)(('OM/T_79M.T:;6;6SE=K2'4YM%TN6^2W
M%P]G;ADA7Q_]JDD?LV?'T@D'_A3WQ$Y'!_Y%[4JY3X4?M/?\+5\=>#O!X^&7
MB3PI8^-_V<?"/[0_AWQ7JVO>%=0TO5M/\47.AP7GAO3[+1-3O]5\_P /GQ!I
MT5UJFK6NC+?7)G^PZ;)8I#?W'3_M4L6_9L^/>T<M\'OB+D$\K_Q3FJ'G&1D%
M<$9X.1G-98I_['B?*G/_ --5GK^'R/7X<3_UHX9OUX@X9:]/[?PG_P B_N.H
M^!//P5^#I[GX6_#P^Y_XI30"3^/4]_7FO8X?]6OT'\A7C/P+<)\%?@]G[J_"
MKX>$D\  >$M#)+'HH 3))(';.2*Q_BC^T7X&^$MA\0SK$6KZIJ_PU^'OAOXD
MZUI&FV$BQMX<\6^)-;\(:%.=>O?L^@V:_P!M^'=4.N37M]#!X:T:W;Q!K;V>
MD_Z14X3_ '3"O^;!8-OM_!C:WXG-FR_X6<X\LWS1?^9;/CZ#KS;XN>&]5\9?
M#/XD^$-$$"ZSXK^'?C+PUI$US*(+6+5-=\/ZEI5A]JE*3%+4W5W$]Q*L+M#%
M&SJDQ.P?)\_[9WB74-,TBY\&_"GPGXLU/_A=MA^SWXIT2U^-=C'<6?Q*U&+P
M]KL,/@C4M.\!ZWHGCCP_;^ -?;Q[J6K76H^$KO2]*T/7]/O])@U?37M&]N\!
M?&[5O%?Q2\=_"S7? T7A_5/!6BZ1XDGU;2O&&G^,=)BTG7K_ %&RTG1O%$UA
MINGS>$OB%=6^EW.OIX+D@U:.7PU-9ZI!KTK32VMON<)^-_P"_P""<GQQ\!_L
MP_!_X)Q_LO?LP? 7QK\,/CU^PC\2O''C_P"%WQIUKQ9/^T%'^SKXJTO4OB'X
MW\:+/\%_!=WH7BY;+2Y[GPU837/C)=5DUB>VFU72?L<._P!*\/?L8?MR>#?@
MYI?P;T#6?AZO@[3?VH/VOO%WBO0/#?QD\5?#:_\ BO\ "K]H#Q+XT\;?##Q-
M=?$K3/A?XD\:_#74?AYK7CB^L/&OPP\'Q+'XUM;8*?'9TF:YT6]_03X8?MA>
M&?B=\=/&OP-L?#HTS6_!J>/9-06X\4:+=>*- C^'7B#P[X:U";XE^!H-NI_#
MFS\:W7B.WUWX2:A<WVN6OC_P9;OXE9M!6XMK!MZW_:F\+ZO\=/%'P'\-P>&]
M1\4>"K2ZBUZTU7XA^&_#OB>_\2)X/TCQS#H7@WP-=1W/B#Q-:V?A_7]%F\2Z
M_*ND:;HMQJD=M8G7O[-\0RZ( ?!O[)W[%O[3?[-?C?\ 8F\5W]K\+_&,/PX_
M8<\.?L@?'B-?'.L:)=^%=0\,>.;;QW_PG7@00^"=0MOB%9:EMNM"M= O!X!>
MWF%MJ%W>_9)9+&U_9R(Y+CMD,/8%0-N.VTJ1Q_.OSSN/V_O"]O\ ";Q]\53H
MWP_ETKX:^-'\'>(-3A^.?A+_ (0'7KN/PE9^,C9?#?X@3Z/!;^./%3Z?>-I"
M>%4T/2)!XHT_5-(?4UM[0:E+H^+/^"@'@/P3J^MG6?!NOP^&-#N?^$>N9'U3
M1[?XEW/C23X07?QKL=+TSX17$L>O:KX9U+PS:7'A^Q\8:5J=^EUXUCGM;;1I
M_"5CJ?C.Q /T HKX M/V[+&X@>)?AJVL:QHOQ/\ @7X"\<+X)^*'@'QCX9\)
MZ%^T-XB\/^'_ (=^-UU^SN[34-?L[F;7)EU+1=)\.2:C876A:U-+)_PC45EX
MHOOHSX1?&>Z^*.O?&'P[?^ ==\ :I\(?B)!X"OK'Q!JOAW5KK5H[_P "^"_B
M#I&O))X6U+6M)L(=4T+QOIDL>E-JUWJED$8:I#8SR+;  Y;XJ_LK_!'XR>/O
MAS\2_B'X \/^)O%WPUUR76=$U'4] TF_FOT3P]XOT?3]'UJZU*UN9YM'TBX\
M6ZCK6FVUO/8QPZTMK<(G#*W(3_L>^ =3\0:[XL\3ZWXB\5>)?$/C'POXBN]6
MET/P)X;#:7X.^(=I\3M(\)7=CX+\)>&;#6-*N_%VD:%>>*_$&KPW'C+QAI_A
M_3-)U?Q5=Z:EO9O]6?VJ RB2 QB0,8W=R%#(@:2.X/E_Z.R,3'SO#-MY7>HJ
M5M14%<)\I<J6?S(U"A0Q<$Q$-U^0!MKKAMZG*AN+23:T:BT][J;:C:U]6TU;
M=-:I73>;JPC&4I7BHJ4FVDK0C5K4.?6HOW;JX>M&%2_)4]FW"<DX\WS?'^S=
M"WQK\??%^Y^(/B[4-.^*>DZ+X:\;?"_6/#7PYU?P?J7A30_"C^'+3PO!K=_X
M(?Q]I?AN;4+S6?%]_H6G>++;2KSQ9KVJWLEJ;*^O4GM^*/V9O!_B2R\%^$3?
MZKHOP=\&7'A?4[/X&^'](\'Z=X&O-;\%>([7Q;X8U"ZO6\/R>+K6/3-9L+26
M;3-(\5:?I6JA$M=22XL6FB?Z*&J0KP48(%BV2-E4<R#"J"RJ =WRG)^4D;L%
M@"Q]1+>7M@);>4929E."VW,8-MO=MP"C<D<>3_K-N6%JE4:ORNW*I7=EH[ZZ
MM=FFMT[)I-H4:T)W]FW5<?9W5)*JTJR3HNU.HW^]BW.GI[T(5)I*-*IR_*_C
M+]C_ .%?B/2M*T3PQ:ZA\*-*LO!/C?X6:KIWPTM/#NBZ=XC^%/Q*N].U#QW\
M/[VPU#P_K-GIVEZ_?Z=%J UG1K;2O$^B7QU"?P]JEE)JS324O%7[)?A_Q]J.
ML:IXT\=?$C6+F+0I/#/PW*R^%M&7X/:&GC_P+\3+&S\)IX<\,Z3_ ,)$^E>,
MOA5\-=7BN/B%)XWFNX/"T&BM]NTW5=;2_P#J^+5X9TWVXCN%W%5,,\<HRDGE
M2*QA\U0ZOD 1F5"RLLDD6-P4ZH!AC"$B<ND4SSJL<DL<A0QA@K*2XVM&RLX8
M^8K^7Y>YI46TVK6BTG>45JU%I6<DWI)/1-;W:L[/VM.\$I<WM'4C#DC.IS2H
MJFZD5[.G4M**J0O%I-W=K\LFOCG6/V(_ FN:1JFG:CXU^([:OXTL_BGI'Q4\
M707/A"SUOXI>&OC7!X9MOB;X4\1V=EX2A\+:)I?B&T\&>&[>VNO!FB^%=5\.
M_P!F-<Z%J%OJ^KZI>33WW[$?PLU:^\31:QJWC?5O#.J6?Q7@\->$KC4]-MM,
M\!WWQO\ %&F^-/B5K7A[6K/1(/$VIZO?>*M,T?Q%X9F\7:[XIL?!-YI%C#X9
ML-.CTZ""W^OO[48D[;5W595A9UD7",S[0\A95"Q,IC:-@S/)YB!(SG-3?;F:
M/S$M9<<-^\(153*AG9U#JP 8,ODF7< 0Q1@5 XM.S<;VO;G@^E^DGTW6K777
M0;G%*I>]Z3DJD4DYQY&DVX<_/RMM<DN3EGJX.7++E^+=;_8G\*:]%J5]JWQ#
M^)-WXU\52>/(/'_CUX_ DVM^/]"^)?A;P)X$\<:%J>@2>#'\ Z):ZWX)^&/@
MGPU;ZGX/\*>'/$&D66B75QINIV^H^)]5:[^P=&\/6/AW2-(\/Z1#/::7H>G6
M&CZ7%+<7-VT&FZ98V>G644EQ<SW=S=36]K86L+W%W<M<7#B:Y>25I'-:<5TT
MS1L(MI0_,K2#*B0D\E4920=P 4D, '!PW$\=YYSJGE*H+2 [I5W?N\8(500P
M8$G.X;<<@Y%4H36K2]U7:;C=*SZ-W]-.GH1.=.<9P;<DY*F_9^]S>\E)PE"4
ME.%-I>VJ4Y3ITHO][.*DK^!67P<O[/\ :0UWXZ?\)!'/8ZM\'?#7PM7PX+&5
M+N"?P_XS\3>*I-7;5&O#";*YB\06]HNG1V'G)+8//]J=)XXH_8/$_@_P]XU\
M/:CX8\7:%I/BGP[K5M%::OX?URQM]1TC4[99X;@6U_97D4D%Q;K/#%*4EB<
MQ*XC9U53OM(8V((3YMIR01U=4(X#DMN9=J@#=NQQMR71W0+B-T*$!<D[P0'C
M#H2KQHV&*RH3C"M'M)W-A>>E1C1C.,7S.=2524NKE)*[;MJ]-VV>AB\;B<;*
MA+%U%5GAL)0P5&:ORQPF'514*"5]%156HHI))*<E%)-I_#VD_L$_!31OA=\/
M?@IHEK>:5\*/!BVK^(/!MKX8^']N/B7=VVGZ19-J/B[Q!-X+/B;3=1U33='L
M-)\27/@O5_"\_B#1Y+S1-7GO+:6Y@3J?&_[)>@>,_!6J>#(/'/Q \-'7/CG<
M?'GQ!K5I!X*\0-XB\3/J5UK=CH?B?0/&GA3Q%X7\1>"] NH]%M]!\.ZGI%_!
M87'A;PE?P2-)H]O)']@>8G]X4I;"EAC &><@8ZY) )Q[X-:'*?('CW]D;PE\
M0?!FN:%JNOZM9>.?&,O@"3XC?&/2O"GPWM?'/Q6A^'FM6.MZ9HOQ!TP^"9O
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M**<E='R1X@_9%TR_\+? ;POX/^)/CWX;Q_L\)<2^#+W1],^'OBY]9U>ZT$Z
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M/$/@3XK#4O@]XT\.:-=OX?$%O9Q?>/\ P5$N?BQK_P ,OV-=&^ 7Q?N/A?\
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M"X\4>*H= ?2];T#2?$-W<:']8+^P;;:AX/\ "O@?Q_\ M(?M$_%?0? 7Q:^
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M!XNC^(GQ7M_BM_PG7A+Q3X5^(5KX^^(\,/CW68=4\.0_8?%$:ZCX8;P^%$)
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MMM_!5U?VVL:K9_#GQGX5TGQ>UG<Z193VFG^,K/Q#I-M+'-]FLHC>W?VB$?\
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MU_Q7?Q^*DT&*XTJ?21XB&A^%DTQ+:/1-%T/0(K<B73E:2UX2_8:^'/ASXT?
M3X_ZEXD\;>,/BK\ /V?8/V>=%\2>(]2LO)\9Z1:VL-A9^._'6EZ5I.FV&I?$
M.PL+SQK:66M:<FF6$4'Q#\40II4<<ML(P#XU_9O_ &U)_ =CX)A\?Z/%X?\
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ME> -3TJZ\)W=C/X#OM$G_LS3'2%/%NDJC7%EXD22:<2>E?'_ /95\%?';5?
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MQ>^&/BWXI>(OAU\;M$\0>%I/'OAC0/B]JD%[XM^%KV>L^"=6\">(/A>;+3]
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M@K\O_BMIW[1D5Y^T#J?PZM?BY9>%[KPC^QO;^%;S1;?3+KXGS^ [7Q-XG?\
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MEJ&NWF\W]Y([=2:W@_N?K_P/7\9=.*UE425[?$^]M[OUO;;S/U5Z#V'X\?\
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M3>)-%\-WWAGPWHOBKQ;8W'AG3]4UW6M/M8]=C-F_EW#[1F_\-6?!2?Q5\0/
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MK7/C7P?<>'M8EN/$NIR!B(-.2V^MOAQ\-].^':^+TTZZU*\7QE\0?&7Q%O\
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M6MWI6H6<UG<0H8B*^2W_ ."?'PSF^'OB7X>W7B+QK=V'B+X0?LN_"6._O/\
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M5;C2-3FL?LVK68AN[>6:UDB8^?\ Q?\ CYX2^#OC_P"!G@;Q#HWBW5-6^/\
MXSUSP'X5O?#?AW5-<LM)U'0_!^K^,;RY\0W6G6-W_9FGR6VC>6 A2=EENM9F
MC&BZ!K&H:7[1X1\/1^%O#V@>&X)+FXM?#N@:1X>MKF\>)[BXM=#L8--M)[@P
MK'&;FYAA^T7!";5FE=$.Q5 \K^,?P2@^*OB;X->*X/%WB7P5K_P5^(<GC_P_
MJ7ARW\.WRZH-2\*Z_P""O$7AK6K'Q+I.K63Z-KWASQ%?V4]W916^LV+MY^FW
M=O+AZVDKJQ,.7F7/\-G?[M/Q/#_@G^VC\.OB3XY\??#'Q Z^#OB#X1^+?[17
M@33-/DTWQ@-!\1:!\ ?%\&B:EJL?CS6/#FG^#M0\5S>%IM(\6:UX5T[7]3U3
M2]+FNKAM]IIVH3Q>S?!/]H3X/_'_ $_6K[X5>*IM<@\/KH$VIQ7GA_Q%X:U"
M'3O$^D_VOX4UZVT[Q9H^CWMYX<\4Z9!=:MX5\16EM-I6M6BO?:7=S6QDW^::
M)^QGX"TSQ#IOB&?5_%>J&R^(G[3GQ'GT:_GT:+2]3OOVJWNY?'NA7IL=.@NX
MM"TDW]S%X<2*>2^B18Y]6NM5NEC=>L_9B_9CT+]F+PIJ'A+P_K=SXDLI+;PY
MI-C?:EX0^''AK6XO#_A'2)-$\-Z=K.K> /"OA:;QMJ&G:>4MV\2^,4U'Q!=H
MHENKTRRS;H]GYK\1R<4THZZ*^O7K_7R]-CXV>-?#W[,7P"^*7Q5T;PCI%QI/
MPR\)^)O'*^%K.XTKPAHUY<Q7$VM7[W6J+8R6>C076IW%UJFJZU-:WDMNUSJ.
MINMS<N_F?,NB_MR7OBGX1Z'X]\'?#[PAXJ\1:W^U):?LMZ3#HOQ8BU?X4>(?
M$MSK$NFIXY\,_%;3?!MU)KW@Y4!C&IS>"K#59=<L;O2(M-N9+>POM2^S/C9\
M*]/^-GPF^(/PGU;5=7T"P\?>&]0\/3Z]H46F3:QHYN@'M]3TV#6K34=(GN[*
MXCAN(H-3L;NQF:/R[J"6%G0_,=]^PY8WGA'5[ ?&/XG0_$_6_COX,_:0UGXS
M)I'PM&NZA\3/ 6BZ'X5\.2Q>";?P38_"^WT>T\(^'M*T*:QB\%VTVIS6QUS4
M[J[UEFNW3A97;_3K]P1DGI/XNDNB6NEMW=66_GY'#/\ M*>";:?5/B+J'[.6
MF6W[86D_&'1/V,(O!X?PI=^)Y_&7B31;/XD^'-&MOCA!IDUU!\%]0\"W[_%G
M5-3>R2^LM M[VWF\'2^+-/3P_J'TI\'?CAK_ (Z\<_$+X1_$OP+8?#[XL?#3
M2_!GBN^TS0_%#>-/"'BGP#\07U^P\*^-?"?B.XT/PMJQMI];\'>+?#^K:)KO
MAK2=4TK4=$#NEY97]I<-P_\ PQ;X+/P_U+PTWB[XAR_$34/BY9?M!/\ 'NZU
M3P_-\5%^..E6D&EZ+\0%QX>3P2;?1="MK?P=9_#Z7P=+\.Y/A_#)X+O?#UYH
MNHZA;S^D_!SX$GX8Z_XU\=>(?&GBSXJ?$_XC0>&+#Q=\0_&4/AG2[Q_#_@J/
M4D\'^#?#?ACP7I&@>%/#'A/PZVO>(+Z*RL-,.I:CKNN:QJ^MZOK=Q=P36B4>
M9/6UO^#_ %]XIVNK.^_Z6ZOS_6YZ5X]\7^%/AIX2\7_$/QOK*Z%X-\">&]5\
M6>*M:N(WFM])\/Z#IM]J&J:E<);6\M[*+*RCGG,5LDLS%$D2-Y9)!)X'%^V)
M\ =0\%>(_'%KXKUR32/#?CW2_A?=:=/\.OB+9>--1\>:]I>E:[H/ASP[\/+W
MPM:^-O%D_B+0]7LM?T";0-$O;35M'DN[Y+A+#3]0N[;VCXT?"[2_C1\*OB9\
M)=;O=4TS1?BAX$\3^ ]7U;1Y+9-7TS3/%.BWFAWEUI+W<4UM'>P07DLT FAE
MB:0L9!C"GYW^*?[$W@CXGZ'XKT_4/$'B.TU?7OB5\._BWHNN2:?X.\2P^$_&
MWPX^'FE?"[3+E/"OBKP_J/A3Q5H^K>#[*^T[Q)H?BO2]3TV]AUB]-A;65W#I
M]U:W*Z@^K2]+[#C)72E\.SVVMZ=_Z9NV7[7OPHU_XF_!SX;^$_\ A)?%@^.?
MP@\6?&KP7XVT'PUK^J^$CX3\*:AX;TUHM4O+?3Q?:;J5[-KL<DD=W86S:1=6
M4&C:Z=/U77-'@O;^E?M>?LZ^(7TRVT+XF:7J%_K'ASX-^)=-TJUTKQ!]ONM&
M_: UZY\+_"";^SDT>29;CQ/XBL+^T.GO:K?Z)&3>:];Z19*T]%A^S!9:+X]^
M OQ!\/\ C7Q)X?U+X(^ _''PVN=+T/PY\-M-\-_$;PIX^U+P/KVLVGB3P[9^
M$[?3O"\Z^)O!.G>(+2Z^&R>#IK>Y^TVFY]*N#IZ^9>!O^">OP9^'GQ-\/?%'
M0+KQH^L>'_C!\7_C+!I=WJUE)HEQK/Q5L["UM?#MS;K;1W)\'_#5K0W/PPT)
M;H6WAJXO=7=Q<_;[C[1BISC\,5K:_,E+MJM-]_P^6O+AW?F<KZM<LK:ZVO?I
M\.VVJ]?2]'_:Z_9^UK7/&'AZU\>!;GP-HWCO7=5O[WPIXPT?PKK.C?">>"Q^
M*MSX&\5:EH-MX8^(Z_#R_G%GXRB\$ZGK;^&]2N(DOX4,H\[P7QM^U%^S=K'Q
M>_9DU+Q)X0\)Z]H'CCPC\5_''PB^*7C;X;ZM;?$+1_&7A_QM\'O ?AW3?A%X
M6\2^##XREN?B&WQ&DU6W\0:);62S:-X<768WN-#6_OM/[/1_V#?!NE7^K"Z^
M('Q$U?PO:>$?CUX0^%7@N[D\)6NG?!FQ_:2OFU7XJ3>&-6T_PY8Z]XHOKZ^)
MA\,S?$'4?$UIX2TLOI^GV3))OCWOBC^Q7X)^*/B/X#>,;GQ/X\\,^-/V;/"6
MJ^&?A#XM\-7WAZWU;PKJNJS?#XS^-;=;S2+NUO=5N=%\!3^"=6T.\M1X2U_P
MAXX\7V&MZ!>&739;$YI-J\=6U=JR2O9/3RZ=[=+Z9OD3:BWRZJ-]7:VEWIKK
MJ]O5*[^KM<\*>&/'&A:CX9\8^']'\4^&M4CABU/P[XETJQUK1]2@BFBGBBU+
M2M3BN;6\6"ZM(9(TO+4M!>VBW$9:XABN%\,@\8_ 7X$^,/!?P#T30;'X87/C
M_4;FV\$:%X;^&>J^&?AUKGB:ZT[6M=GTN+Q%HGANP^'(\6ZMI'AO7=6339=7
M77M132;F2:VEGL[1+GZ,LH+B)'$ZLS-Y?SGR1)(5C"[Y5MXHHT? "E$,B*5(
MB*P^6@^+_%?[#W@SQ1^U+H_[55WXS\;MXGT+Q-X,\7:=X1>S\#7OAZSUGP=X
M \5?#:&/2M;U/PQ=>.= T+5_#GC#4;CQ!X;T;Q-9:'JGB""SUZ>PEU*VBF%R
MYJ=G'E=VE9J]ENWKU[=R8*FW)5.:W*^7E=O>Z7\N_P"#.B\(_MH_LT>,W\6G
M0?B5:1V/@WP=KOQ%\1:YKOACQCX0\+#P+X1\1WW@_P 5^*--\1^*]!T;1_$6
MG^#_ !%I0T+Q1/X?OM4C\.7<L,%Z\*WUC&UK]G7]I#3?VB-:^-\.B:#JFD^%
M?A?XZ\&^#O#&J>(?#_BWP?XD\56/BKX.?#[XF3ZYJ'A'QOH'A_Q!X=,LOCB[
MM-+CDT\?VSX=@TSQ#;W/V74XFKSNU_X)_P#PEC\*V/@S5]5\=>(?#MM\"?BW
M^S[=6-_J>E6$U[X.^,GQ"TKXC^(-2:_TG3[6XLO$6D:IIEO8:)<V 73[>QC*
M3:?.S!C[/\!_@+=?!J3XE:KK7Q&\8_%CQI\6?&&@^,_&WC;QI8>$='O=2O\
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M?PSX?\%:AIVB:3HOAFQL$5?#6FW-Y<W]_<ZEJ%_]B31;D4(JY61& Q@85@7
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M<T?3]5TG4KZ]\.N+1;RRL=/U&:[N;GG/B9^PWX#^)-IXIDN_$?B/3/$.N_M
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M[VE_IUJZB6*15;S21\GZ)^Q)X<\-^$I/#/ASQ_XNTVY7]GO1?V<;?5=9\/\
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M[O[V%(W0_0_RHHH-8ZQ^3_4AR?;\A_A1D^WY#_"BBM[+LON1Q7?=_>PR?I]
M!_*C)]3^9HHHLM=%]WD=V&2=-MI-\SU:3>R[DPZ#Z"EHHK%[OU?YL;W?J_S$
M/0_0U#D^WY#_  HHJX)-.Z3U_0YJ[:DK-KW?U)5^Z/Q_F:=114/=^K_,J#?N
'ZOIU\C__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>ex15-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex15-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  W ( # 2(  A$! Q$!_\0
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MJ&-R9JG"'MH5:E&IRTG.A7PZ5"=*M-JG7IRY)5.:,I)?T(?MO_\ !4/X ?L
M^*?!'AOX[:)\6'7XAZ-J>L^%]:\%^#=,U_0;O^Q;U++6-*>_N_$.DR1ZOIPN
MM.N[FT\AMMGJ=C,LC^:ZQ_#W_$29_P $]]N?L7[0/3!(^&FA'GUQ_P )J!^6
M>E?(O_!TF@'P[_9!<@;V\9_%O+8' _L3P22%XX!*J6/WCM )QQ7YX_\ !%__
M ()7_LZ?\%"?A[\;?%'QNU_XK:/J/PY\:>&?#V@I\/O$/AS1K.2RUC0KO4KI
MM1CUKPAXDDN+A9X4$#PRVXCB+1E'!!'H\'^'?A8O"S"^(O&O^L]-O&XG XY9
M-CYUZ<JE/,Y9?A9T,%.E'DC)\JK>SJ[MU=8:'#Q1X@>)J\3<9P)PA/(:C>'H
M8K!4\SR^A"4(?V?#'8B%?&3JN,O=DY0<J5[\M)^]>1^\_AW_ (.,_P#@G1K6
MH06.IZY\9/"-K,RJVM>(?A5=7.FVX);<T\?A74_$NIX3 W"+3IF.1L5CQ7ZT
M_ 3]I_X$?M.>$_\ A-/@1\6O!WQ1\/QND5]<>&=3MY]0T:YF5I8K/Q%H<ZVV
MM>';YH0LB66LZ?97;QL)!!Y6)&_G7^.O_!L+\';WP]?7/[.?QZ^)'AGQ;#;R
M-IVD_%FVT'QAX7U.Z0YAM+C4_"V@>%-7T""7E)]12V\0&VR)8M(N2!"_\TPN
M?VNO^"6'[5EY8PW6L?"7XU?##4+9+Z"UNFOO#/C/P]=*+M$NH4>+2O&7@'Q5
M9,DR).L@?='(K:9K>F*^D[9=X4>%/B)@L;1\+>+,XPO$>%IU<1').)(N?UF*
MYYM?[33AC(4F[4WB,+4K4</*4%[)TW&1GC/$[Q0X$Q6#J>)'#668C(L57A3>
M9Y$U25&4K74:M&I.C4K15YK"8BG2C6C&7)44DHG^H#$2T:,6W$C.[ &[/0_*
M2.1Z'%9VH:C!IUO=7EY>6]C9V44]S=75U+!!;6UM;0O-/<7$\[I%!!#&IDDE
ME=$C16=V5%)KX^_81_;&\+_MM?LS?#SX^>%[2#2KC7K:?1O&OAD2M<2>$/'V
MB.MIXET!Y]P-Q:QW6W4=(N659KWP_J.E:E-'#+<M;+_)+_P72_X*C^-_C=\9
M/&_[)'P>\37WA_X$?"S69_"WQ#N=#O9K*7XK_$#1[EH/$ECJUU 0]UX,\):O
M'+HUEI._[!J6L:??ZW>#4K4:*MC^0\%^&7$'&/%M?A2$7E=;*)XAY]C<32K5
M*.4T<+6GAJTIP]U8BK5JTY4\'2JR@JSE"MS1C>2_4^,?$C(^%>%L)Q,Y2S&&
M;0I?V+@Z%2G2J9G6KTU4@G.+FZ-&BI*IB94E*4%&5-)MI']#7Q\_X+M_\$\_
M@'JU]X=?XIZO\9/$FF2R07VD? _P\GC2WCEB9XWBC\67M]H'@*[EWQNKQV7B
MRX:!U*3B+*%OF'P__P ',W[#&J:E'9:S\.?VF/"]G--MCU>]\$_#[4[&*$G
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MY/A\2?\ 9._A[_Z:9Z_I*_X)^?\ )EO[-?\ V2/PM_Z2&OX^X3_Y+WC/R?\
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MVFOIR#_@HS^P[;1I%!^T/\.XHXU5(TC_ +;1$1%VHBHFBJBJB_*BJH50  ,
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M-7\*75_8$G!!L[F!E*J4*XY^?]!T#_@@QX;U.#5],\#?L@M?6[F2!]5^'_\
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M_P#Z+[\-O_"8\4?_ !ZC_APG\7_^B^_#;_PF/%'_ ,>HHI?\0TX/_P"A;/\
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']FD]+W__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>ex15-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex15-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" != OX# 2(  A$! Q$!_\0
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M.R[&V9818#,LQP*G[18',,=@U.UN;ZIB\1AK^O[EIOJTWU(WN$CVY#'>S(N
MHRRH[D LR@D["@7.[>0" H9EF#*1G(YYYX/X@\CZ'FOP8_::_:L^*7[,O[0/
M[:>L^";F\U:?5-4_X)U?"WPHOB.#5?&7A#X;7GQ>O?C;HVM>*M/\$/XN\):5
M+J>I)I5EI.F:<VO>&]+UWQM?>$8M=U>TTQ+Z>NK\-?M6_MP>,_B-^RE\"9[?
MP%\&_&_Q*T;]J#6/B'XC\<_".]UFZ\0>&OV=_B5X&T7P[X@\(_#W2?BW;KX'
MO/B;X+U^7[38:QXN\6P^"->N+];^VO!I$%E<Z'$?MYD>H_,4A91W'4#J.22
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MXQR6_A/5/$EM\2=6\.^(_#-_XT\2#3=5T6ZOXMUO EI* ?NL7 ]_I@_UI2P
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M\4_#K]IK]H/P=XQ_;FT*\\9V?A/X[^+/V\H/!G@KX<:39ZO^TSHNF:?X>_9
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M"\T_4M,U""&YL]1TZ\MI[:^L+NUGCGAN[6[M998I[:6"6&:$R1SKL<!ODO\
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MQ]JL[33M2MI['4IS#-'8W,3PR,Q4L$))15EW;^]W9[WM3V_/_P"O3/*B]?\
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M/#;:?\/]1\<>&+#QK>7-U!]IM;>W\,7>K1:U<S7-OBXMTM;*=YX-KHF985<
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M.E07D_@_1O$<VR18-1^(TGA[QM8^%(WGM_M^H>%+JUMUGDN8E0 ^M_*B]?\
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M$<8(PQ&#VYSV(!K\\;C]O"R\7^,?'GA/]GGX/^-_CU_PJ76=0T7XH>(=&O\
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M/$.KZ/JFI^(?V@M7_;%_85^*GQE^#$?P>^(/P&L_AA\-OA!\1O#FF7'C;2?
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M_&#X5^+]'UKQAX)7Q'J,,>LS^ ;72X]'L[FY\,:J.M^+/[)O[6_QO?\ :O\
MC?%XOT7P3XGO_BKX*\7? +X8Z_\ #:76O&TNF_L=:E=:U\#FTKX@VGQ3T>U\
M$VOQ8\8_\)=JU[:7_@C7;_2=%^(%P+Z*\N)X[!/W,$"*'VD .S,V%7#$]=P
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M[.?[1-Q^SCX/_:+\._!F'2?VV_B7\8/B#\0_B;X//B#23J?@[1OVE?"5_P#
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MF#;;NV].OJ*K*$E'D23UO]RW_$^5OB;^U#XK^%OB/]JJZT?PAXA^(Z_!:T^
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M#<2Z<D5G',W-6Y%%[WNGY6M9KS-5*FOCBK=$O^"W\MO\OC?Q_P#MI?%;X?\
MP3T#XO:E\ ]&N[K6/@Y\4/C]=^%[#XTV7E:)\,_AII'@[Q'/<W.O7'@0QW_B
M;6= \9Q-;:!IFG:A8V.IZ8B3:Q)93W-Y%?\ %W[=T6C?M)?#7]G[0_ D/B$_
M$VT2RTKQ)%XB\16J^'?'FJ?"'Q+\8?#_ (4\<)_PKB\\&:%;ZKX>\,W%P&L_
MB3JWBZWL;NWUJV\#ZGHJ3NGT7\3#^SYX:\ >/)/B+I_@QO!'PJ^$_B"S\:Z5
M<:;'K,?ACX3:OH2#7=%N=#MDN-2M_#VKZ)X?BB;1A:'[=I^GP6UC%)%"@6Q;
M_ 7X#:AXZT/XU6_PI^'\WQ(T^STN/0_'[>%M-A\66>GV&@7'AW2%L-5DL$U.
MUAMO#^LZCI%HL%U&BZ;<M8"Y&G%K96W+DT2Y[;=+_?M\PYZ72&O3U^6^GZGR
M;\&OVM/B5XV^'/[*7Q*^*VA:1X1O_B_X0^)OC/Q'X>^&6O#Q!X=DT?PG\+IO
M&]K+<VOB?PO!XHM]1S;/(FA6&L62:1J$D&G:GXBUR":*.YH1?\%!/%5M\+M<
M^(FM?!.TMM7DMOV7_%?@?P?H?Q:TOQ+'XD\"_M8?$M/AE\/KC6O$D?A33]*\
M)>*-+U*"^O?$?A^,^)-)CM/L=[H_BW4;74-NC_<O@WX'?"7P#9Z1:^#OAYX2
M\.VWA[5?%&NZ%%I.AV6F+HVL>,$*>)[_ $R#38K:"RN-;CW1ZBUI&@N8Y)(D
M86[!#YOX:^#'[,GAC6/%7P:\)_##X>Z3<2IX%^+OBOPG8^%+>RTRYE7Q=K\_
MP\\07*VFG_V9,^F>*? ^L7.AVR3B30;S1X)[?3X4U2:6;.]?^6'W2_S#VE)/
M]Y1Y^W+?1=;[ZZI_@?-'C_\ X*%:A\./A3I/C+7?A?IUU\0QXX^+O@[Q7\*=
M'\:>+O$%]90_!'5=2TOQ]KW@_5O"_P 'M8U#Q-I>G16FFZE/JOB3PU\.?"VD
M6^K(WB#Q-I"B!)/H'X'^/O%OB/X]_MB^%/$/B"XU70?A[\0?A7I/@[29H[0)
MX;T_Q!\$?!.NZG9V\MG%'(4U#Q'?7NKW'VN>X,%S?7$,$D-K;A!W/C7]FWX
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MV%%*-_=OJM7NO2S1X'^RQ\?_ ![\6?V6/"'QY^+WAOPMX/UO6/"=]XLU+1_
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MPGX?:\N?!WB_5-"\:VFD^*-/T_Q7XC\(ZI87]UX@\$>&?#=IXHLKSP]'JO\
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M)XCU1E^*$B> _'?AVR\'Z[XDA@@\1OHOC:SU'PQ\.=?OM'O- F\+>!;C5(M
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M_#&N>&]>UN>UU".VN8?C@FJ?&)M)\06NNZ'XGUVW6[UQDO+B&Y@_53#?WO\
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M2DV^:2OT3=OP:1I[:7:/W+_(_'CXE_L2_$._^'_@'P7H/PX^'GC?2O ?C?\
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M(&W JZG:0<HVY6R>D@!B++D@2$] 35O#?WO_ !T4K#(Q[YH,I2;;DMWKVU_
M_*/]JS]EWXY_$SP=\6=*\":5H'B36?%/[26@?%CX>Z5XF\>II/@BVTG0O@C\
M.?"-I'\2_#MUX2UV#Q1X9;Q[X;UZ_P!3\%Z8^E7R+=6?BC1/$-OKT9!_432X
M;R*QL8KT1->PV5I'=M:EQ:FYC@1+C[*L\[S+;>=YA@$KM.(?+6661WEQJF-3
M]0<@D9QQ_DYJ2@N=1SC!-).-[V26]NV]K?F?EA\=OV2?B)XT\9_MVS^$? W@
M#[%^TY^RC9_#7PCXYNO%4VF>(+?X@0:'XWT/4/#VOZ.F@3/;>'=6EU[0]6_M
M^#7+O[)+ICHNE&5@U<W\8OV)?B;??"#Q!\,OA%<0Z!X3NOCSX5^(M]\/K#QS
M<:-:^.?!4WP7\*^#O&&C7>N:_H?C2PTK5;7XJ6VI?%6T35="U_2M=\0Z/::A
M?P6VHW=M>V?ZY%03DC]332@[<?F?ZUG[-<W-S/>]KNWW7M^%O(%4:25HV2M>
MRO\ ?8XCX=Z%J7AGX?\ @KPYJ^I:KK6JZ!X4T#1-2UC7;Z'4]:U6_P!+TJUL
M+K4=7U*WMK.#4=2O)K=[B^OX;.TCO+F22X2UMUD$*? /[2_[+WQ*^*/[0OA[
MQ_X'\.^&K'9H7P'TO2?C')XQO]!\7?" ?##XO^,?'/C]O#OA_3;/[3X@N?B#
MX*\06_@JTM)-4M]'EB:[M?$*?V3/<0S_ *;;<@ G./PHV+Z?J?\ &G.'/;5J
MW9M?DT3"<H2F[7YGI?7_ #_0_*SXG?LH?%R]^$'QITCPEH'@/Q/\0_B[^T3K
M/B+Q"_BOQ#-/#J7P&OOB;J_B/3/#>E:AXDT#Q7H6@ZKHNBZDMUI>@WWA77/"
M]C>S:H9K+5;NY0GS&Z_8<^/NO_#+X<:;XIUJUU;XC?#/]FWX(>"/"NLZA\4?
M$U^FC_&3P!\7YO%GB+Q6U]!HVEP:I>-X0AM-.L_%]]HTFH7BS7>G0Z1I%M=7
ML,_[0X(Z' [#&?U-&&_O?^.BH]BOYI?^!2_^2-/;/LN^R_R\C\R?#G[,WQ/M
M/VSK?XW>(?"?@_5]-L/&_P 1/%&F_&&Y\8ZOJ'CR'P#XM^%T/A'P[\&X/"6I
MV=W!X?TGPYXCCDU&<>']:BT"]06^L-;2ZY>ZI*OZ4W:M):21+@N\4J ,>"S1
ML%#'D%6;"OUS&6'>KN&_O?\ CHI2 >M7"')?5N_=M_FV1.;G:Z2LK=/T2/R%
M\$_LD?M!_#/X)>,-/\,6_@K5?C)XT_9X\+>"O%DWBCQAXCU[P_XT^)>G^,_$
M4WB#4=>O]2$KR-)X \0R:'X>U6;3[NSMYK/3K#4-*DT/3H--EXO7_P!B3]H_
M5OV8_!7PITZ^T_0O%_@/P9^UNOA7['\4+_3K;P_X\\>>(=4UW]FC4K36/"'A
M+PGI;)\-&N=*>S^P>"]%T'P;>:79IH/AJX31]-O9_P!K=IZ X'IC/UYZT;0/
MN\'UZ\?C4NDFV^:6KON__DBE5<4DHQTMK97T5KWL?C_\4?V(OBQJGPP\1_#S
MP+)I\'A&^_:/\&?%C4OAS%XP-K8?$3P:WP$\)>#_ ![HFLZIXJ\/>*]/BU2^
M^-UOK7Q7,6N:9J]EX@UK3K77+V[T[6+\26WZ??"KPSJO@_X:> /">M7FJ:EJ
MWAGP3X5\/ZCJ.N:S%X@UJ^OM(T/3["[N-6UV"QTJ'6=2DN+:5[W5H]*T]=1G
M9KD6L6_!]"PW][]!3JJ$.1-7;N[ZMO\ -LF<W-IOHK??_P ,? GQY_9B\:?$
M3XL?$+XD> -3TGP#XSUO]DOQS\'/ 7Q7MKBX3Q=X%^)/B#5II]"\0:<ENC36
MD.E6DQF&L6,HOH7_ -'@MFD6.YB\;^'_ .R'\0I/ =[X.\1^#/#7P^\ :_\
M&KX4^*-6^!_A_P >ZEKGA6R\'>%M$2R^*.H6^N6EAHES=7OQ8UYKG4]=\+!;
M72M3T^."[UR:ZUSQ%XMBF_5XJ"<]_7W[<4FW/WCG\,?RJ522GSW=[MVN[:WZ
M7MU[#]HW'ELK62O97T^11TZRM=/TVTL+*!+:ULK6.UM;>(;8[>"W010P0J&/
MEPPHJQP(&_=Q*B C:,?E3\>/V,_B%X]\1?MZR^%/"/@:+_AJ#X*_#_POX/\
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MK7@S2/#WCC0-)^'/Q1\+6'A;Q1XUU;P3;_#[XM^*+SPG<_#KX_Z-<Z797_\
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M?B+]MTG0]$DN!?>(=)B\4:C::I!<'0=4LM*OD@OKO3[9X_V%ZTW;C[IQ^O\
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M2'A']C#XG^%?"WQ#ANUO=0UOQI\)OVK?AAJ$WAWXQ>(]&\4:AH'BKXLZ3?\
M[,F@Z7XRUFPUN'PW#\-OA*-6T'PQ=1Z-<6?P\N/+TBUTS6].O]3ENOL7]B[X
M;?$#X2?L^>"?AY\2]"\$>'O$GAB+4].32O 3J^B6VBQZWJA\.BY-OI^EZ7/X
MAE\/G3+GQ7?Z+I>CZ)?^)Y]8FT;0]&T<:?91_56P=N#V/)_K2@$=3G\,4HTE
6&2DFW:^[?7YL4JTIQ<7;6WX?\,?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>18
<FILENAME>wlds-20231231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Mar 15 10:22:33 UTC 2024 -->
<xs:schema xmlns:wlds="http://www.wearabledevices.co.il/20231231" elementFormDefault="qualified" xmlns:srt-types="http://fasb.org/srt-types/2023" targetNamespace="http://www.wearabledevices.co.il/20231231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="wlds-20231231_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="wlds-20231231_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="wlds-20231231_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="wlds-20231231_cal.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef"/>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet" id="wlds_r_ConsolidatedBalanceSheet">
        <link:definition>001 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet_Parentheticals" id="wlds_r_ConsolidatedBalanceSheet_Parentheticals">
        <link:definition>002 - Statement - Consolidated Balance Sheets (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement" id="wlds_r_ConsolidatedIncomeStatement">
        <link:definition>003 - Statement - Consolidated Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement_Parentheticals" id="wlds_r_ConsolidatedIncomeStatement_Parentheticals">
        <link:definition>004 - Statement - Consolidated Statements of Comprehensive Loss (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3" id="wlds_r_ShareholdersEquityType2or3">
        <link:definition>005 - Statement - Consolidated Statements of Changes in Shareholders&#8217; Equity (Deficit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3_Parentheticals" id="wlds_r_ShareholdersEquityType2or3_Parentheticals">
        <link:definition>006 - Statement - Consolidated Statements of Changes in Shareholders&#8217; Equity (Deficit) (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ConsolidatedCashFlow" id="wlds_r_ConsolidatedCashFlow">
        <link:definition>007 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/General" id="wlds_r_General">
        <link:definition>008 - Disclosure - General</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/SignificantAccountingPolicies" id="wlds_r_SignificantAccountingPolicies">
        <link:definition>009 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/Inventories" id="wlds_r_Inventories">
        <link:definition>010 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/PropertyandEquipmentNet" id="wlds_r_PropertyandEquipmentNet">
        <link:definition>011 - Disclosure - Property and Equipment, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/Lease" id="wlds_r_Lease">
        <link:definition>012 - Disclosure - Lease</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/CommitmentsandContingencies" id="wlds_r_CommitmentsandContingencies">
        <link:definition>013 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ConvertibleSecurities" id="wlds_r_ConvertibleSecurities">
        <link:definition>014 - Disclosure - Convertible Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/CreditFacility" id="wlds_r_CreditFacility">
        <link:definition>015 - Disclosure - Credit Facility</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ShareholdersEquityDeficit" id="wlds_r_ShareholdersEquityDeficit">
        <link:definition>016 - Disclosure - Shareholders&#8217; Equity (Deficit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/TaxesonIncome" id="wlds_r_TaxesonIncome">
        <link:definition>017 - Disclosure - Taxes on Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/RelatedParties" id="wlds_r_RelatedParties">
        <link:definition>018 - Disclosure - Related Parties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy" id="wlds_r_AccountingPoliciesByPolicy">
        <link:definition>996000 - Disclosure - Accounting Policies, by Policy (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesTables" id="wlds_r_SignificantAccountingPoliciesTables">
        <link:definition>996001 - Disclosure - Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/InventoriesTables" id="wlds_r_InventoriesTables">
        <link:definition>996002 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/PropertyandEquipmentNetTables" id="wlds_r_PropertyandEquipmentNetTables">
        <link:definition>996003 - Disclosure - Property and Equipment, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/LeaseTables" id="wlds_r_LeaseTables">
        <link:definition>996004 - Disclosure - Lease (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitTables" id="wlds_r_ShareholdersEquityDeficitTables">
        <link:definition>996005 - Disclosure - Shareholders&#8217; Equity (Deficit) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/GeneralDetails" id="wlds_r_GeneralDetails">
        <link:definition>996006 - Disclosure - General (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesDetails" id="wlds_r_SignificantAccountingPoliciesDetails">
        <link:definition>996007 - Disclosure - Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ScheduleofAnnualRatesofDepreciationTable" id="wlds_r_ScheduleofAnnualRatesofDepreciationTable">
        <link:definition>996008 - Disclosure - Significant Accounting Policies (Details) - Schedule of Annual Rates of Depreciation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ScheduleofInventoriesTable" id="wlds_r_ScheduleofInventoriesTable">
        <link:definition>996009 - Disclosure - Inventories (Details) - Schedule of Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable" id="wlds_r_ScheduleofPropertyandEquipmentNetTable">
        <link:definition>996010 - Disclosure - Property and Equipment, Net (Details) - Schedule of Property and Equipment Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/LeaseDetails" id="wlds_r_LeaseDetails">
        <link:definition>996011 - Disclosure - Lease (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable" id="wlds_r_ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable">
        <link:definition>996012 - Disclosure - Lease (Details) - Schedule of Classification of Operating Lease Right-of-Use Assets and Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesTable" id="wlds_r_ScheduleofFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesTable">
        <link:definition>996013 - Disclosure - Lease (Details) - Schedule of Future Minimum Lease Payments Under Our Operating Lease Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails" id="wlds_r_CommitmentsandContingenciesDetails">
        <link:definition>996014 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails" id="wlds_r_ConvertibleSecuritiesDetails">
        <link:definition>996015 - Disclosure - Convertible Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/CreditFacilityDetails" id="wlds_r_CreditFacilityDetails">
        <link:definition>996016 - Disclosure - Credit Facility (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails" id="wlds_r_ShareholdersEquityDeficitDetails">
        <link:definition>996017 - Disclosure - Shareholders&#8217; Equity (Deficit) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable" id="wlds_r_ScheduleofShareCapitalTable">
        <link:definition>996018 - Disclosure - Shareholders&#8217; Equity (Deficit) (Details) - Schedule of Share Capital</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable_Parentheticals" id="wlds_r_ScheduleofShareCapitalTable_Parentheticals">
        <link:definition>996019 - Disclosure - Shareholders&#8217; Equity (Deficit) (Details) - Schedule of Share Capital (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable" id="wlds_r_ScheduleofOptionsActivityTable">
        <link:definition>996020 - Disclosure - Shareholders&#8217; Equity (Deficit) (Details) - Schedule of Options Activity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageAssumptionsTable" id="wlds_r_ScheduleofWeightedAverageAssumptionsTable">
        <link:definition>996021 - Disclosure - Shareholders&#8217; Equity (Deficit) (Details) - Schedule of Weighted-Average Assumptions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrYE9rliDcrbWhjsc3i7BCl/DvlJVwr+JR0O2nYady5Se133BDWCF8ON/Jzif84CehHV5r9vMQwYxP2psHDnPZsunu1t2oh0qhdKXAlJyzN93OrPInDu+qpjJa2tGyv2XwvSkfjcWfQLzhpm2ZADneXuFkrcNjL16FM7h6sOb4n/vSj6ATmkI0Ua4rjBBddfCaBFeds1g5hk00wqHWt7SFMc] CSR-->
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable" id="wlds_r_ScheduleofOptionstoConsultantsTable">
        <link:definition>996022 - Disclosure - Shareholders&#8217; Equity (Deficit) (Details) - Schedule of Options to Consultants</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ScheduleofShareBasedCompensationExpensesTable" id="wlds_r_ScheduleofShareBasedCompensationExpensesTable">
        <link:definition>996023 - Disclosure - Shareholders&#8217; Equity (Deficit) (Details) - Schedule of Share-Based Compensation Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable" id="wlds_r_ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable">
        <link:definition>996024 - Disclosure - Shareholders&#8217; Equity (Deficit) (Details) - Schedule of Issuance of Equity Warrants to Investors and Associate</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/TaxesonIncomeDetails" id="wlds_r_TaxesonIncomeDetails">
        <link:definition>996025 - Disclosure - Taxes on Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/RelatedPartiesDetails" id="wlds_r_RelatedPartiesDetails">
        <link:definition>996026 - Disclosure - Related Parties (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd"/>
  <xs:element name="ScheduleOfAnnualRatesOfDepreciationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ScheduleOfAnnualRatesOfDepreciationAbstract"/>
  <xs:element name="ScheduleOfPropertyAndEquipmentNetAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ScheduleOfPropertyAndEquipmentNetAbstract"/>
  <xs:element name="ScheduleOfClassificationOfOperatingLeaseRightOfUseAssetsAndLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ScheduleOfClassificationOfOperatingLeaseRightOfUseAssetsAndLiabilitiesAbstract"/>
  <xs:element name="ScheduleOfFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ScheduleOfFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesAbstract"/>
  <xs:element name="ScheduleOfShareCapitalAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ScheduleOfShareCapitalAbstract"/>
  <xs:element name="ScheduleOfOptionsToConsultantsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ScheduleOfOptionsToConsultantsAbstract"/>
  <xs:element name="ScheduleOfShareBasedCompensationExpensesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ScheduleOfShareBasedCompensationExpensesAbstract"/>
  <xs:element name="ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateAbstract"/>
  <xs:element name="UnlabeledAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_UnlabeledAbstract"/>
  <xs:element name="UnlabeledAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_UnlabeledAbstract0"/>
  <xs:element name="UnlabeledAbstract1" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_UnlabeledAbstract1"/>
  <xs:element name="UnlabeledAbstract2" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_UnlabeledAbstract2"/>
  <xs:element name="UnlabeledAbstract3" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_UnlabeledAbstract3"/>
  <xs:element name="ChangesDuringTheYear2021Abstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ChangesDuringTheYear2021Abstract"/>
  <xs:element name="UnlabeledAbstract4" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_UnlabeledAbstract4"/>
  <xs:element name="ChangesDuringTheYear2022Abstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ChangesDuringTheYear2022Abstract"/>
  <xs:element name="ChangesDuringTheYear2023Abstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ChangesDuringTheYear2023Abstract"/>
  <xs:element name="UnlabeledAbstract5" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_UnlabeledAbstract5"/>
  <xs:element name="UnlabeledAbstract6" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_UnlabeledAbstract6"/>
  <xs:element name="UnlabeledAbstract7" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_UnlabeledAbstract7"/>
  <xs:element name="CostAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_CostAbstract"/>
  <xs:element name="CostAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_CostAbstract0"/>
  <xs:element name="UnlabeledAbstract8" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_UnlabeledAbstract8"/>
  <xs:element name="UnlabeledAbstract9" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_UnlabeledAbstract9"/>
  <xs:element name="UnlabeledAbstract10" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_UnlabeledAbstract10"/>
  <xs:element name="AdvanceFromCustomers" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_AdvanceFromCustomers"/>
  <xs:element name="ProspectiveInitialPublicOfferingExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_ProspectiveInitialPublicOfferingExpenses"/>
  <xs:element name="InterestExpenseAndExchangeRate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_InterestExpenseAndExchangeRate"/>
  <xs:element name="IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost"/>
  <xs:element name="ConversionOfOrdinaryASharesToOrdinarySharesValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_ConversionOfOrdinaryASharesToOrdinarySharesValue"/>
  <xs:element name="ConversionOfOrdinaryASharesToOrdinaryShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ConversionOfOrdinaryASharesToOrdinaryShares"/>
  <xs:element name="StockIssuedDuringPeriodShareOfExerciseOfOptionsinShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_StockIssuedDuringPeriodShareOfExerciseOfOptionsinShares"/>
  <xs:element name="StockIssuedDuringPeriodValueOfPaymentOnBehalfOfSharesIssued" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_StockIssuedDuringPeriodValueOfPaymentOnBehalfOfSharesIssued"/>
  <xs:element name="IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet"/>
  <xs:element name="IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares"/>
  <xs:element name="ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering"/>
  <xs:element name="IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants"/>
  <xs:element name="IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrantsinShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrantsinShares"/>
  <xs:element name="StockIssuedDuringPeriodValueInvestors" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_StockIssuedDuringPeriodValueInvestors"/>
  <xs:element name="StockIssuedDuringPeriodSharesInvestors" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_StockIssuedDuringPeriodSharesInvestors"/>
  <xs:element name="StockIssuedDuringPeriodValueExerciseOfWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_StockIssuedDuringPeriodValueExerciseOfWarrants"/>
  <xs:element name="StockIssuedDuringPeriodSharesExerciseOfWarrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants"/>
  <xs:element name="AccruedInterestOnConvertibleSecurities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_AccruedInterestOnConvertibleSecurities"/>
  <xs:element name="AccruedInterestOnDeposits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_AccruedInterestOnDeposits"/>
  <xs:element name="DecreaseincreaseInGovernmentalGrantsReceivables" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_DecreaseincreaseInGovernmentalGrantsReceivables"/>
  <xs:element name="IncreaseInOtherReceivablesAndPrepaidExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_IncreaseInOtherReceivablesAndPrepaidExpenses"/>
  <xs:element name="IncreaseDecreaseInAdvancePayments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_IncreaseDecreaseInAdvancePayments"/>
  <xs:element name="IncreaseDecreaseInAdvancePaymentsOnGovernmentalGrant" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_IncreaseDecreaseInAdvancePaymentsOnGovernmentalGrant"/>
  <xs:element name="PrepaymentsOfLeasing" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_PrepaymentsOfLeasing"/>
  <xs:element name="ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost"/>
  <xs:element name="ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPubli" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPubli"/>
  <xs:element name="ProceedsFromIssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_ProceedsFromIssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost"/>
  <xs:element name="ProceedsFromIssuanceOfSAFEs" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_ProceedsFromIssuanceOfSAFEs"/>
  <xs:element name="RefundToSAFEInvestors" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_RefundToSAFEInvestors"/>
  <xs:element name="ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants"/>
  <xs:element name="PaymentOnBehalfOfIssuedShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_PaymentOnBehalfOfIssuedShares"/>
  <xs:element name="InterestReceivedFromDeposits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_InterestReceivedFromDeposits"/>
  <xs:element name="ConversionOfSAFEToEquity" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_ConversionOfSAFEToEquity"/>
  <xs:element name="RightofUseAssetRecognizedAgainstLeaseLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_RightofUseAssetRecognizedAgainstLeaseLiability"/>
  <xs:element name="CreditFacilityDisclosureTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_CreditFacilityDisclosureTextBlock"/>
  <xs:element name="CostOfRevenuesPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_CostOfRevenuesPolicyTextBlock"/>
  <xs:element name="GovernmentalGrantsPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_GovernmentalGrantsPolicyTextBlock"/>
  <xs:element name="FinanceIncomeAndExpensesPolicyPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock"/>
  <xs:element name="WarrantsPolicyPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_WarrantsPolicyPolicyTextBlock"/>
  <xs:element name="SeverancePolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_SeverancePolicyTextBlock"/>
  <xs:element name="ScheduleOfAnnualRatesOfDepreciationTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock"/>
  <xs:element name="ScheduleOfOptionsToConsultantsTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ScheduleOfOptionsToConsultantsTableTextBlock"/>
  <xs:element name="ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock"/>
  <xs:element name="SignificantAccountingPoliciesDetailsScheduleofAnnualRatesofDepreciationTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wlds_SignificantAccountingPoliciesDetailsScheduleofAnnualRatesofDepreciationTable"/>
  <xs:element name="AnnualRateOfDepreciation" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_AnnualRateOfDepreciation"/>
  <xs:element name="ShareholdersEquityDeficitDetailsScheduleofShareCapitalTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wlds_ShareholdersEquityDeficitDetailsScheduleofShareCapitalTable"/>
  <xs:element name="NumberOfSharesIssuedAndOutstanding" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="wlds_NumberOfSharesIssuedAndOutstanding"/>
  <xs:element name="ShareholdersEquityDeficitDetailsScheduleofShareCapitalParentheticalsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wlds_ShareholdersEquityDeficitDetailsScheduleofShareCapitalParentheticalsTable"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions"/>
  <xs:element name="ShareholdersEquityDeficitDetailsScheduleofOptionstoConsultantsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wlds_ShareholdersEquityDeficitDetailsScheduleofOptionstoConsultantsTable"/>
  <xs:element name="ShareholdersEquityDeficitDetailsScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wlds_ShareholdersEquityDeficitDetailsScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate"/>
  <xs:element name="ShareBasedCompensationArrangementNotes" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ShareBasedCompensationArrangementNotes"/>
  <xs:element name="GeneralDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wlds_GeneralDetailsTable"/>
  <xs:element name="AnnualGrossRevenuesExceed" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_AnnualGrossRevenuesExceed"/>
  <xs:element name="OrdinarySharesWarrantsHeldByNonaffiliates" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_OrdinarySharesWarrantsHeldByNonaffiliates"/>
  <xs:element name="NonconvertibleDebtSecurities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_NonconvertibleDebtSecurities"/>
  <xs:element name="NetProceedsFromIssuanceSecondaryPublicOffering" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_NetProceedsFromIssuanceSecondaryPublicOffering"/>
  <xs:element name="Warrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="wlds_Warrants"/>
  <xs:element name="WarrantsExerciseIntoOrdinaryShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="wlds_WarrantsExerciseIntoOrdinaryShares"/>
  <xs:element name="ExercisePriceOfWarrant" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ExercisePriceOfWarrant"/>
  <xs:element name="GrossProceeds" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_GrossProceeds"/>
  <xs:element name="UnderwritingNetProceed" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_UnderwritingNetProceed"/>
  <xs:element name="UnderwritingDiscountsAndCommissions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_UnderwritingDiscountsAndCommissions"/>
  <xs:element name="GrossAfterOtherIPOExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_GrossAfterOtherIPOExpenses"/>
  <xs:element name="WarrantsExercisePricePerShare" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="wlds_WarrantsExercisePricePerShare"/>
  <xs:element name="SignificantAccountingPoliciesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wlds_SignificantAccountingPoliciesDetailsTable"/>
  <xs:element name="SignificantAccountingPoliciesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_SignificantAccountingPoliciesDetailsLineItems"/>
  <xs:element name="RateOfMonthlySeverancePercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_RateOfMonthlySeverancePercentage"/>
  <xs:element name="CommitmentsandContingenciesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wlds_CommitmentsandContingenciesDetailsTable"/>
  <xs:element name="CommitmentsandContingenciesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_CommitmentsandContingenciesDetailsLineItems"/>
  <xs:element name="RoyaltiesRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_RoyaltiesRate"/>
  <xs:element name="GrantsReceivedEqualPercentageRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_GrantsReceivedEqualPercentageRate"/>
  <xs:element name="AnnualAlternativeInterestPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_AnnualAlternativeInterestPercentage"/>
  <xs:element name="AnnualInterestRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_AnnualInterestRate"/>
  <xs:element name="FixedAnnualInterestRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_FixedAnnualInterestRate"/>
  <xs:element name="AmountsReceivedAggregateAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_AmountsReceivedAggregateAmount"/>
  <xs:element name="AmountOfDevelopmentProgram" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_AmountOfDevelopmentProgram"/>
  <xs:element name="PercentageOfFinancing" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="wlds_PercentageOfFinancing"/>
  <xs:element name="TotalCashReceivedFromTheIIA" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_TotalCashReceivedFromTheIIA"/>
  <xs:element name="ExceptTransferProductionRight" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ExceptTransferProductionRight"/>
  <xs:element name="ProductionTransferred" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ProductionTransferred"/>
  <xs:element name="PayIncreasedRoyaltiesDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_PayIncreasedRoyaltiesDescription"/>
  <xs:element name="ResearchAndDevelopmentGrantsDetection" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_ResearchAndDevelopmentGrantsDetection"/>
  <xs:element name="MaximumObligatinAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_MaximumObligatinAmount"/>
  <xs:element name="GrantsReceivedFromTheIMEI" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_GrantsReceivedFromTheIMEI"/>
  <xs:element name="SalesAndMarketingExpensesDeductions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_SalesAndMarketingExpensesDeductions"/>
  <xs:element name="RoyaltiesRatePercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_RoyaltiesRatePercentage"/>
  <xs:element name="MarketingGrantReceived" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_MarketingGrantReceived"/>
  <xs:element name="LeasePaymentIncreased" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_LeasePaymentIncreased"/>
  <xs:element name="LeaseAgreements" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_LeaseAgreements"/>
  <xs:element name="LeaseAgreementsPeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_LeaseAgreementsPeriod"/>
  <xs:element name="ConvertibleSecuritiesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wlds_ConvertibleSecuritiesDetailsTable"/>
  <xs:element name="ConvertibleSecurityDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ConvertibleSecurityDescription"/>
  <xs:element name="CashPayment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_CashPayment"/>
  <xs:element name="PremoneyValuationAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_PremoneyValuationAmount"/>
  <xs:element name="WarrantPricePerSharePercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_WarrantPricePerSharePercentage"/>
  <xs:element name="PurchasePricePerShare" type="dtr:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="wlds_PurchasePricePerShare"/>
  <xs:element name="AggregateOrdinaryShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_AggregateOrdinaryShares"/>
  <xs:element name="CreditFacilityDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wlds_CreditFacilityDetailsTable"/>
  <xs:element name="AggregateAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_AggregateAmount"/>
  <xs:element name="ServicesInExchangeForMonthlyBaseFee" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_ServicesInExchangeForMonthlyBaseFee"/>
  <xs:element name="AggrementTerm" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_AggrementTerm"/>
  <xs:element name="WarrantsIssuedPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_WarrantsIssuedPercentage"/>
  <xs:element name="BaseMonthlyFeeImmediatelyIncreaseAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_BaseMonthlyFeeImmediatelyIncreaseAmount"/>
  <xs:element name="OfferingOrFinancingTransactionAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_OfferingOrFinancingTransactionAmount"/>
  <xs:element name="TransactionFeeClosingValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_TransactionFeeClosingValue"/>
  <xs:element name="ExpenseOnServiceRendering" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_ExpenseOnServiceRendering"/>
  <xs:element name="ShareholdersEquityDeficitDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wlds_ShareholdersEquityDeficitDetailsTable"/>
  <xs:element name="TotalValueOfTheShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_TotalValueOfTheShares"/>
  <xs:element name="OrdinaryShareParValue" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_OrdinaryShareParValue"/>
  <xs:element name="ValueOfOrdinaryAShare" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_ValueOfOrdinaryAShare"/>
  <xs:element name="InterestPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_InterestPercentage"/>
  <xs:element name="AShareReclassifiedToOrdinaryShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_AShareReclassifiedToOrdinaryShares"/>
  <xs:element name="OrdinarySharesAuthorizedIncreased" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="wlds_OrdinarySharesAuthorizedIncreased"/>
  <xs:element name="OrdinarySharesIssued" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_OrdinarySharesIssued"/>
  <xs:element name="OrdinarySharesWarrantExercisable" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="wlds_OrdinarySharesWarrantExercisable"/>
  <xs:element name="OrdinarySharesInConsiderationPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_OrdinarySharesInConsiderationPercentage"/>
  <xs:element name="TotalConsiderationAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_TotalConsiderationAmount"/>
  <xs:element name="IssuanceExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_IssuanceExpenses"/>
  <xs:element name="SAFEsAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_SAFEsAmount"/>
  <xs:element name="Investor" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_Investor"/>
  <xs:element name="InvestorAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_InvestorAmount"/>
  <xs:element name="ConvertedAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_ConvertedAmount"/>
  <xs:element name="ConvertedToOrdinaryShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="wlds_ConvertedToOrdinaryShares"/>
  <xs:element name="ExercisableWarrantsToShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ExercisableWarrantsToShares"/>
  <xs:element name="InvestorsExercisedWarrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_InvestorsExercisedWarrants"/>
  <xs:element name="EmployeeExercisedWarrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_EmployeeExercisedWarrants"/>
  <xs:element name="ExercisePricePerShare" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ExercisePricePerShare"/>
  <xs:element name="ProceedsFromIssuanceFollowOnPublicOffering" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_ProceedsFromIssuanceFollowOnPublicOffering"/>
  <xs:element name="OrdinarySharePerValue" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_OrdinarySharePerValue"/>
  <xs:element name="OptionsAvailableForGrant" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="wlds_OptionsAvailableForGrant"/>
  <xs:element name="TerminationPeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_TerminationPeriod"/>
  <xs:element name="IssuanceOfSharesOptions" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="wlds_IssuanceOfSharesOptions"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate"/>
  <xs:element name="OptionsExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_OptionsExpenses"/>
  <xs:element name="VestingPeriods" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_VestingPeriods"/>
  <xs:element name="ExercisePriceOfWarrants" type="dtr:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="wlds_ExercisePriceOfWarrants"/>
  <xs:element name="WarrantBeReducedToAnExercisePricePercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_WarrantBeReducedToAnExercisePricePercentage"/>
  <xs:element name="InitialExercisePricePercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_InitialExercisePricePercentage"/>
  <xs:element name="WeightedAveragePricePercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_WeightedAveragePricePercentage"/>
  <xs:element name="LowestResetPrice" type="dtr:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="wlds_LowestResetPrice"/>
  <xs:element name="InitialExercisePricesPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_InitialExercisePricesPercentage"/>
  <xs:element name="TaxesonIncomeDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wlds_TaxesonIncomeDetailsTable"/>
  <xs:element name="CorporateTaxRatePercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_CorporateTaxRatePercentage"/>
  <xs:element name="RelatedPartiesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wlds_RelatedPartiesDetailsTable"/>
  <xs:element name="PercentageOfOwnership" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_PercentageOfOwnership"/>
  <xs:element name="EmploymentExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_EmploymentExpenses"/>
  <xs:element name="OfficerEmployeeMonthlySalary" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_OfficerEmployeeMonthlySalary"/>
  <xs:element name="RelatedPartyMonthlySalary" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_RelatedPartyMonthlySalary"/>
  <xs:element name="AsherDahanMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_AsherDahanMember"/>
  <xs:element name="CofoundersMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_CofoundersMember"/>
  <xs:element name="ComputersAndSoftwareMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ComputersAndSoftwareMember"/>
  <xs:element name="ConvertibleSecuritiesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ConvertibleSecuritiesMember"/>
  <xs:element name="ElectronicEquipmentMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ElectronicEquipmentMember"/>
  <xs:element name="IIAMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_IIAMember"/>
  <xs:element name="IMEIMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_IMEIMember"/>
  <xs:element name="LeaseLiabilityMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_LeaseLiabilityMember"/>
  <xs:element name="MachinesAndMoldsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_MachinesAndMoldsMember"/>
  <xs:element name="MoldMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_MoldMember"/>
  <xs:element name="MudraInspireDevelopmentKitsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_MudraInspireDevelopmentKitsMember"/>
  <xs:element name="OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember"/>
  <xs:element name="OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember"/>
  <xs:element name="OrdinarySharesNIS001ParValuePerShareMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_OrdinarySharesNIS001ParValuePerShareMember"/>
  <xs:element name="September132022Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_September132022Member"/>
  <xs:element name="September152022OneMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_September152022OneMember"/>
  <xs:element name="September152022ThreeMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_September152022ThreeMember"/>
  <xs:element name="September152022TwoMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_September152022TwoMember"/>
  <xs:element name="SubscriptionReceivablesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_SubscriptionReceivablesMember"/>
  <xs:element name="TwoThousandFifteenMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_TwoThousandFifteenMember"/>
  <xs:element name="TwoThousandSeventeenMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_TwoThousandSeventeenMember"/>
  <xs:element name="TwoThousandTwentyThreeMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_TwoThousandTwentyThreeMember"/>
  <xs:element name="TwoThousandTwentyoneMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_TwoThousandTwentyoneMember"/>
  <xs:element name="TwoZeroOneFiveMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_TwoZeroOneFiveMember"/>
  <xs:element name="WarrantsToPurchaseOrdinarySharesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_WarrantsToPurchaseOrdinarySharesMember"/>
  <xs:element name="AnnualRatesOfDepreciationLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_AnnualRatesOfDepreciationLineItems"/>
  <xs:element name="ConvertibleSecuritiesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ConvertibleSecuritiesLineItems"/>
  <xs:element name="CreditFacilityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_CreditFacilityAbstract"/>
  <xs:element name="GeneralLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_GeneralLineItems"/>
  <xs:element name="ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateLineItems"/>
  <xs:element name="ScheduleOfOptionsActivityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ScheduleOfOptionsActivityAbstract"/>
  <xs:element name="ScheduleOfOptionsToConsultantsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ScheduleOfOptionsToConsultantsLineItems"/>
  <xs:element name="ScheduleOfShareBasedCompensationExpensesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ScheduleOfShareBasedCompensationExpensesLineItems"/>
  <xs:element name="ShareholdersEquityLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ShareholdersEquityLineItems"/>
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>19
<FILENAME>wlds-20231231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Mar 15 10:22:33 UTC 2024 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ConsolidatedBalanceSheet" roleURI="http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ConsolidatedIncomeStatement" roleURI="http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ConsolidatedCashFlow" roleURI="http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ScheduleofInventoriesTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofInventoriesTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ScheduleofFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesTable"/>
  <calculationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositsAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssetsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_DepositsAssetsCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrantsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrantsReceivable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_GrantsReceivable" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FIFOInventoryAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FIFOInventoryAmount"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_FIFOInventoryAmount" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositsAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssetsNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_DepositsAssetsNoncurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsNoncurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="wlds_AdvanceFromCustomers" xlink:href="wlds-20231231.xsd#wlds_AdvanceFromCustomers"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="wlds_AdvanceFromCustomers" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_DeferredRevenueCurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapital" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_Revenues" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostDirectMaterial" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostDirectMaterial"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_CostDirectMaterial" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_SellingAndMarketingExpense" order="4" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="5" weight="-1"/>
    <loc xlink:type="locator" xlink:label="wlds_ProspectiveInitialPublicOfferingExpenses" xlink:href="wlds-20231231.xsd#wlds_ProspectiveInitialPublicOfferingExpenses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="wlds_ProspectiveInitialPublicOfferingExpenses" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="wlds_InterestExpenseAndExchangeRate" xlink:href="wlds-20231231.xsd#wlds_InterestExpenseAndExchangeRate"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="wlds_InterestExpenseAndExchangeRate" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_Depreciation" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="wlds_AccruedInterestOnConvertibleSecurities" xlink:href="wlds-20231231.xsd#wlds_AccruedInterestOnConvertibleSecurities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="wlds_AccruedInterestOnConvertibleSecurities" order="3" weight="1"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrYE9rliDcrbWhjsc3i7BCl/DvlJVwr+JR0O2nYady5Se133BDWCF8ON/Jzif84CehHV5r9vMQwYxP2psHDnPZsunu1t2oh0qhdKXAlJyzN93OrPInDu+qpjJa2tGyv2XwvSkfjcWfQLzhpm2ZADneXuFkrcNjL16FM7h6sOb4n/vSj6ATmkI0Ua4rjBBddfCaBN4ZdcWjVWhhoFBuho7Mpl] CSR-->
    <loc xlink:type="locator" xlink:label="wlds_AccruedInterestOnDeposits" xlink:href="wlds-20231231.xsd#wlds_AccruedInterestOnDeposits"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="wlds_AccruedInterestOnDeposits" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="wlds_IncreaseDecreaseInAdvancePayments" xlink:href="wlds-20231231.xsd#wlds_IncreaseDecreaseInAdvancePayments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="wlds_IncreaseDecreaseInAdvancePayments" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" order="9" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="10" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" order="11" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="12" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="13" weight="-1"/>
    <loc xlink:type="locator" xlink:label="wlds_DecreaseincreaseInGovernmentalGrantsReceivables" xlink:href="wlds-20231231.xsd#wlds_DecreaseincreaseInGovernmentalGrantsReceivables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="wlds_DecreaseincreaseInGovernmentalGrantsReceivables" order="14" weight="-1"/>
    <loc xlink:type="locator" xlink:label="wlds_IncreaseInOtherReceivablesAndPrepaidExpenses" xlink:href="wlds-20231231.xsd#wlds_IncreaseInOtherReceivablesAndPrepaidExpenses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="wlds_IncreaseInOtherReceivablesAndPrepaidExpenses" order="15" weight="-1"/>
    <loc xlink:type="locator" xlink:label="wlds_IncreaseDecreaseInAdvancePaymentsOnGovernmentalGrant" xlink:href="wlds-20231231.xsd#wlds_IncreaseDecreaseInAdvancePaymentsOnGovernmentalGrant"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="wlds_IncreaseDecreaseInAdvancePaymentsOnGovernmentalGrant" order="16" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="1" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireRestrictedCertificatesOfDeposit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireRestrictedCertificatesOfDeposit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireRestrictedCertificatesOfDeposit" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="wlds_PrepaymentsOfLeasing" xlink:href="wlds-20231231.xsd#wlds_PrepaymentsOfLeasing"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="wlds_PrepaymentsOfLeasing" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost" xlink:href="wlds-20231231.xsd#wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPubli" xlink:href="wlds-20231231.xsd#wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPubli"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPubli" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="wlds_ProceedsFromIssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost" xlink:href="wlds-20231231.xsd#wlds_ProceedsFromIssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="wlds_ProceedsFromIssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="wlds_ProceedsFromIssuanceOfSAFEs" xlink:href="wlds-20231231.xsd#wlds_ProceedsFromIssuanceOfSAFEs"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="wlds_ProceedsFromIssuanceOfSAFEs" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromLinesOfCredit" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" xlink:href="wlds-20231231.xsd#wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="wlds_PaymentOnBehalfOfIssuedShares" xlink:href="wlds-20231231.xsd#wlds_PaymentOnBehalfOfIssuedShares"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="wlds_PaymentOnBehalfOfIssuedShares" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="wlds_RefundToSAFEInvestors" xlink:href="wlds-20231231.xsd#wlds_RefundToSAFEInvestors"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="wlds_RefundToSAFEInvestors" order="9" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfLinesOfCredit" order="10" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ScheduleofInventoriesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_FIFOInventoryAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FIFOInventoryAmount"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FIFOInventoryAmount" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FIFOInventoryAmount" xlink:to="us-gaap_InventoryWorkInProcessNetOfReserves" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FIFOInventoryAmount" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="2" weight="1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>20
<FILENAME>wlds-20231231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Mar 15 10:22:33 UTC 2024 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ConsolidatedBalanceSheet" roleURI="http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ConsolidatedIncomeStatement" roleURI="http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ConsolidatedIncomeStatement_Parentheticals" roleURI="http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ShareholdersEquityType2or3" roleURI="http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ShareholdersEquityType2or3_Parentheticals" roleURI="http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ConsolidatedCashFlow" roleURI="http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_General" roleURI="http://www.wearabledevices.co.il/role/General"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_SignificantAccountingPolicies" roleURI="http://www.wearabledevices.co.il/role/SignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_Inventories" roleURI="http://www.wearabledevices.co.il/role/Inventories"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_PropertyandEquipmentNet" roleURI="http://www.wearabledevices.co.il/role/PropertyandEquipmentNet"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_Lease" roleURI="http://www.wearabledevices.co.il/role/Lease"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_CommitmentsandContingencies" roleURI="http://www.wearabledevices.co.il/role/CommitmentsandContingencies"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ConvertibleSecurities" roleURI="http://www.wearabledevices.co.il/role/ConvertibleSecurities"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_CreditFacility" roleURI="http://www.wearabledevices.co.il/role/CreditFacility"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ShareholdersEquityDeficit" roleURI="http://www.wearabledevices.co.il/role/ShareholdersEquityDeficit"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_TaxesonIncome" roleURI="http://www.wearabledevices.co.il/role/TaxesonIncome"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_RelatedParties" roleURI="http://www.wearabledevices.co.il/role/RelatedParties"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_AccountingPoliciesByPolicy" roleURI="http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_SignificantAccountingPoliciesTables" roleURI="http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_InventoriesTables" roleURI="http://www.wearabledevices.co.il/role/InventoriesTables"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_PropertyandEquipmentNetTables" roleURI="http://www.wearabledevices.co.il/role/PropertyandEquipmentNetTables"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_LeaseTables" roleURI="http://www.wearabledevices.co.il/role/LeaseTables"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ShareholdersEquityDeficitTables" roleURI="http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitTables"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ScheduleofAnnualRatesofDepreciationTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofAnnualRatesofDepreciationTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ScheduleofInventoriesTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofInventoriesTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ScheduleofPropertyandEquipmentNetTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ScheduleofFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ScheduleofShareCapitalTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ScheduleofShareCapitalTable_Parentheticals" roleURI="http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ScheduleofOptionsActivityTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ScheduleofWeightedAverageAssumptionsTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageAssumptionsTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ScheduleofOptionstoConsultantsTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ScheduleofShareBasedCompensationExpensesTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofShareBasedCompensationExpensesTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_GeneralDetails" roleURI="http://www.wearabledevices.co.il/role/GeneralDetails"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_SignificantAccountingPoliciesDetails" roleURI="http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_LeaseDetails" roleURI="http://www.wearabledevices.co.il/role/LeaseDetails"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_CommitmentsandContingenciesDetails" roleURI="http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ConvertibleSecuritiesDetails" roleURI="http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_CreditFacilityDetails" roleURI="http://www.wearabledevices.co.il/role/CreditFacilityDetails"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ShareholdersEquityDeficitDetails" roleURI="http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_TaxesonIncomeDetails" roleURI="http://www.wearabledevices.co.il/role/TaxesonIncomeDetails"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_RelatedPartiesDetails" roleURI="http://www.wearabledevices.co.il/role/RelatedPartiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#DocumentAndEntityInformation" roleURI="http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositsAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_DepositsAssetsCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrantsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrantsReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_GrantsReceivable" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FIFOInventoryAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FIFOInventoryAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_FIFOInventoryAmount" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositsAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssetsNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_DepositsAssetsNoncurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_Assets" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_AdvanceFromCustomers" xlink:href="wlds-20231231.xsd#wlds_AdvanceFromCustomers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="wlds_AdvanceFromCustomers" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRevenueCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_Liabilities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesIssued" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_Revenues" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingCostsAndExpensesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostDirectMaterial" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostDirectMaterial"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_CostDirectMaterial" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_SellingAndMarketingExpense" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ProspectiveInitialPublicOfferingExpenses" xlink:href="wlds-20231231.xsd#wlds_ProspectiveInitialPublicOfferingExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="wlds_ProspectiveInitialPublicOfferingExpenses" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_InterestExpenseAndExchangeRate" xlink:href="wlds-20231231.xsd#wlds_InterestExpenseAndExchangeRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="wlds_InterestExpenseAndExchangeRate" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_SubscriptionReceivablesMember" xlink:href="wlds-20231231.xsd#wlds_SubscriptionReceivablesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="wlds_SubscriptionReceivablesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ChangesDuringTheYear2022Abstract" xlink:href="wlds-20231231.xsd#wlds_ChangesDuringTheYear2022Abstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="wlds_ChangesDuringTheYear2022Abstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet" xlink:href="wlds-20231231.xsd#wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ChangesDuringTheYear2022Abstract" xlink:to="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares" xlink:href="wlds-20231231.xsd#wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ChangesDuringTheYear2022Abstract" xlink:to="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ChangesDuringTheYear2022Abstract" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering" xlink:href="wlds-20231231.xsd#wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ChangesDuringTheYear2022Abstract" xlink:to="wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" xlink:href="wlds-20231231.xsd#wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ChangesDuringTheYear2022Abstract" xlink:to="wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrantsinShares" xlink:href="wlds-20231231.xsd#wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrantsinShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ChangesDuringTheYear2022Abstract" xlink:to="wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrantsinShares" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ChangesDuringTheYear2023Abstract" xlink:href="wlds-20231231.xsd#wlds_ChangesDuringTheYear2023Abstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="wlds_ChangesDuringTheYear2023Abstract" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ChangesDuringTheYear2023Abstract" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ChangesDuringTheYear2023Abstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_StockIssuedDuringPeriodValueInvestors" xlink:href="wlds-20231231.xsd#wlds_StockIssuedDuringPeriodValueInvestors"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ChangesDuringTheYear2023Abstract" xlink:to="wlds_StockIssuedDuringPeriodValueInvestors" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_StockIssuedDuringPeriodSharesInvestors" xlink:href="wlds-20231231.xsd#wlds_StockIssuedDuringPeriodSharesInvestors"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ChangesDuringTheYear2023Abstract" xlink:to="wlds_StockIssuedDuringPeriodSharesInvestors" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_StockIssuedDuringPeriodValueExerciseOfWarrants" xlink:href="wlds-20231231.xsd#wlds_StockIssuedDuringPeriodValueExerciseOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ChangesDuringTheYear2023Abstract" xlink:to="wlds_StockIssuedDuringPeriodValueExerciseOfWarrants" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:href="wlds-20231231.xsd#wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ChangesDuringTheYear2023Abstract" xlink:to="wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ChangesDuringTheYear2021Abstract" xlink:href="wlds-20231231.xsd#wlds_ChangesDuringTheYear2021Abstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="wlds_ChangesDuringTheYear2021Abstract" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost" xlink:href="wlds-20231231.xsd#wlds_IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ChangesDuringTheYear2021Abstract" xlink:to="wlds_IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ChangesDuringTheYear2021Abstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ChangesDuringTheYear2021Abstract" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ChangesDuringTheYear2021Abstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ConversionOfOrdinaryASharesToOrdinarySharesValue" xlink:href="wlds-20231231.xsd#wlds_ConversionOfOrdinaryASharesToOrdinarySharesValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ChangesDuringTheYear2021Abstract" xlink:to="wlds_ConversionOfOrdinaryASharesToOrdinarySharesValue" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ConversionOfOrdinaryASharesToOrdinaryShares" xlink:href="wlds-20231231.xsd#wlds_ConversionOfOrdinaryASharesToOrdinaryShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ChangesDuringTheYear2021Abstract" xlink:to="wlds_ConversionOfOrdinaryASharesToOrdinaryShares" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ChangesDuringTheYear2021Abstract" xlink:to="us-gaap_ShareBasedCompensation" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ChangesDuringTheYear2021Abstract" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_StockIssuedDuringPeriodShareOfExerciseOfOptionsinShares" xlink:href="wlds-20231231.xsd#wlds_StockIssuedDuringPeriodShareOfExerciseOfOptionsinShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ChangesDuringTheYear2021Abstract" xlink:to="wlds_StockIssuedDuringPeriodShareOfExerciseOfOptionsinShares" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_StockIssuedDuringPeriodValueOfPaymentOnBehalfOfSharesIssued" xlink:href="wlds-20231231.xsd#wlds_StockIssuedDuringPeriodValueOfPaymentOnBehalfOfSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ChangesDuringTheYear2021Abstract" xlink:to="wlds_StockIssuedDuringPeriodValueOfPaymentOnBehalfOfSharesIssued" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ChangesDuringTheYear2021Abstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="10" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_Depreciation" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_AccruedInterestOnConvertibleSecurities" xlink:href="wlds-20231231.xsd#wlds_AccruedInterestOnConvertibleSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="wlds_AccruedInterestOnConvertibleSecurities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_AccruedInterestOnDeposits" xlink:href="wlds-20231231.xsd#wlds_AccruedInterestOnDeposits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="wlds_AccruedInterestOnDeposits" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_DecreaseincreaseInGovernmentalGrantsReceivables" xlink:href="wlds-20231231.xsd#wlds_DecreaseincreaseInGovernmentalGrantsReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="wlds_DecreaseincreaseInGovernmentalGrantsReceivables" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_IncreaseInOtherReceivablesAndPrepaidExpenses" xlink:href="wlds-20231231.xsd#wlds_IncreaseInOtherReceivablesAndPrepaidExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="wlds_IncreaseInOtherReceivablesAndPrepaidExpenses" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_IncreaseDecreaseInAdvancePayments" xlink:href="wlds-20231231.xsd#wlds_IncreaseDecreaseInAdvancePayments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="wlds_IncreaseDecreaseInAdvancePayments" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_IncreaseDecreaseInAdvancePaymentsOnGovernmentalGrant" xlink:href="wlds-20231231.xsd#wlds_IncreaseDecreaseInAdvancePaymentsOnGovernmentalGrant"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="wlds_IncreaseDecreaseInAdvancePaymentsOnGovernmentalGrant" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireRestrictedCertificatesOfDeposit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireRestrictedCertificatesOfDeposit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireRestrictedCertificatesOfDeposit" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_PrepaymentsOfLeasing" xlink:href="wlds-20231231.xsd#wlds_PrepaymentsOfLeasing"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="wlds_PrepaymentsOfLeasing" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost" xlink:href="wlds-20231231.xsd#wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPubli" xlink:href="wlds-20231231.xsd#wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPubli"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPubli" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ProceedsFromIssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost" xlink:href="wlds-20231231.xsd#wlds_ProceedsFromIssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="wlds_ProceedsFromIssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ProceedsFromIssuanceOfSAFEs" xlink:href="wlds-20231231.xsd#wlds_ProceedsFromIssuanceOfSAFEs"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="wlds_ProceedsFromIssuanceOfSAFEs" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_RefundToSAFEInvestors" xlink:href="wlds-20231231.xsd#wlds_RefundToSAFEInvestors"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="wlds_RefundToSAFEInvestors" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromLinesOfCredit" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfLinesOfCredit" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" xlink:href="wlds-20231231.xsd#wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_PaymentOnBehalfOfIssuedShares" xlink:href="wlds-20231231.xsd#wlds_PaymentOnBehalfOfIssuedShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="wlds_PaymentOnBehalfOfIssuedShares" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowElementsAbstract" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_InterestPaidNet" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_InterestReceivedFromDeposits" xlink:href="wlds-20231231.xsd#wlds_InterestReceivedFromDeposits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="wlds_InterestReceivedFromDeposits" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ConversionOfSAFEToEquity" xlink:href="wlds-20231231.xsd#wlds_ConversionOfSAFEToEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="wlds_ConversionOfSAFEToEquity" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_RightofUseAssetRecognizedAgainstLeaseLiability" xlink:href="wlds-20231231.xsd#wlds_RightofUseAssetRecognizedAgainstLeaseLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="wlds_RightofUseAssetRecognizedAgainstLeaseLiability" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/General">
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/SignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/Inventories">
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNetAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InventoryNetAbstract" xlink:to="us-gaap_InventoryDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/PropertyandEquipmentNet">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/Lease">
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/CommitmentsandContingencies">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ConvertibleSecurities">
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsAbstract" xlink:to="us-gaap_DebtDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/CreditFacility">
    <loc xlink:type="locator" xlink:label="wlds_CreditFacilityAbstract" xlink:href="wlds-20231231.xsd#wlds_CreditFacilityAbstract"/>
    <loc xlink:type="locator" xlink:label="wlds_CreditFacilityDisclosureTextBlock" xlink:href="wlds-20231231.xsd#wlds_CreditFacilityDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_CreditFacilityAbstract" xlink:to="wlds_CreditFacilityDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ShareholdersEquityDeficit">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/TaxesonIncome">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/RelatedParties">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InventoryPolicyTextBlock" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_CostOfRevenuesPolicyTextBlock" xlink:href="wlds-20231231.xsd#wlds_CostOfRevenuesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="wlds_CostOfRevenuesPolicyTextBlock" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_GovernmentalGrantsPolicyTextBlock" xlink:href="wlds-20231231.xsd#wlds_GovernmentalGrantsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="wlds_GovernmentalGrantsPolicyTextBlock" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock" xlink:href="wlds-20231231.xsd#wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_WarrantsPolicyPolicyTextBlock" xlink:href="wlds-20231231.xsd#wlds_WarrantsPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="wlds_WarrantsPolicyPolicyTextBlock" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_SeverancePolicyTextBlock" xlink:href="wlds-20231231.xsd#wlds_SeverancePolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="wlds_SeverancePolicyTextBlock" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SubsequentEventsPolicyPolicyTextBlock" order="20" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/InventoriesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNetAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InventoryNetAbstract" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/PropertyandEquipmentNetTables">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/LeaseTables">
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitTables">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfStockholdersEquityTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfOptionsToConsultantsTableTextBlock" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfOptionsToConsultantsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="wlds_ScheduleOfOptionsToConsultantsTableTextBlock" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ScheduleofAnnualRatesofDepreciationTable">
    <loc xlink:type="locator" xlink:label="wlds_AnnualRatesOfDepreciationLineItems" xlink:href="wlds-20231231.xsd#wlds_AnnualRatesOfDepreciationLineItems"/>
    <loc xlink:type="locator" xlink:label="wlds_SignificantAccountingPoliciesDetailsScheduleofAnnualRatesofDepreciationTable" xlink:href="wlds-20231231.xsd#wlds_SignificantAccountingPoliciesDetailsScheduleofAnnualRatesofDepreciationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="wlds_AnnualRatesOfDepreciationLineItems" xlink:to="wlds_SignificantAccountingPoliciesDetailsScheduleofAnnualRatesofDepreciationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_SignificantAccountingPoliciesDetailsScheduleofAnnualRatesofDepreciationTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_SignificantAccountingPoliciesDetailsScheduleofAnnualRatesofDepreciationTable" xlink:to="srt_RangeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember" xlink:href="wlds-20231231.xsd#wlds_OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="wlds_OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ComputersAndSoftwareMember" xlink:href="wlds-20231231.xsd#wlds_ComputersAndSoftwareMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="wlds_ComputersAndSoftwareMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_MoldMember" xlink:href="wlds-20231231.xsd#wlds_MoldMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="wlds_MoldMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_AnnualRateOfDepreciation" xlink:href="wlds-20231231.xsd#wlds_AnnualRateOfDepreciation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_AnnualRatesOfDepreciationLineItems" xlink:to="wlds_AnnualRateOfDepreciation" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ScheduleofInventoriesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="wlds_CostAbstract" xlink:href="wlds-20231231.xsd#wlds_CostAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="wlds_CostAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_CostAbstract" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_CostAbstract" xlink:to="us-gaap_InventoryWorkInProcessNetOfReserves" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_CostAbstract" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FIFOInventoryAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FIFOInventoryAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_CostAbstract" xlink:to="us-gaap_FIFOInventoryAmount" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ComputersAndSoftwareMember" xlink:href="wlds-20231231.xsd#wlds_ComputersAndSoftwareMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="wlds_ComputersAndSoftwareMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember" xlink:href="wlds-20231231.xsd#wlds_OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="wlds_OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ElectronicEquipmentMember" xlink:href="wlds-20231231.xsd#wlds_ElectronicEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="wlds_ElectronicEquipmentMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_MachinesAndMoldsMember" xlink:href="wlds-20231231.xsd#wlds_MachinesAndMoldsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="wlds_MachinesAndMoldsMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_CostAbstract0" xlink:href="wlds-20231231.xsd#wlds_CostAbstract0"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="wlds_CostAbstract0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_CostAbstract0" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable">
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfClassificationOfOperatingLeaseRightOfUseAssetsAndLiabilitiesAbstract" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfClassificationOfOperatingLeaseRightOfUseAssetsAndLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ScheduleOfClassificationOfOperatingLeaseRightOfUseAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_AssetsAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ScheduleOfClassificationOfOperatingLeaseRightOfUseAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesTable">
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesAbstract" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ScheduleOfFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ScheduleOfFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ScheduleOfFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_OperatingLeaseLiability" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable">
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCapitalizationEquityLineItems"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareholdersEquityDeficitDetailsScheduleofShareCapitalTable" xlink:href="wlds-20231231.xsd#wlds_ShareholdersEquityDeficitDetailsScheduleofShareCapitalTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:to="wlds_ShareholdersEquityDeficitDetailsScheduleofShareCapitalTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_ShareholdersEquityDeficitDetailsScheduleofShareCapitalTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_NumberOfSharesIssuedAndOutstanding" xlink:href="wlds-20231231.xsd#wlds_NumberOfSharesIssuedAndOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:to="wlds_NumberOfSharesIssuedAndOutstanding" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCapitalizationEquityLineItems"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareholdersEquityDeficitDetailsScheduleofShareCapitalParentheticalsTable" xlink:href="wlds-20231231.xsd#wlds_ShareholdersEquityDeficitDetailsScheduleofShareCapitalParentheticalsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:to="wlds_ShareholdersEquityDeficitDetailsScheduleofShareCapitalParentheticalsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_ShareholdersEquityDeficitDetailsScheduleofShareCapitalParentheticalsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable">
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfOptionsActivityAbstract" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfOptionsActivityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ScheduleOfOptionsActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ScheduleOfOptionsActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ScheduleOfOptionsActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ScheduleOfOptionsActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ScheduleOfOptionsActivityAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ScheduleOfOptionsActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ScheduleOfOptionsActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ScheduleOfOptionsActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ScheduleOfOptionsActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ScheduleOfOptionsActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ScheduleOfOptionsActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="10" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageAssumptionsTable">
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions" xlink:href="wlds-20231231.xsd#wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable">
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfOptionsToConsultantsLineItems" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfOptionsToConsultantsLineItems"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareholdersEquityDeficitDetailsScheduleofOptionstoConsultantsTable" xlink:href="wlds-20231231.xsd#wlds_ShareholdersEquityDeficitDetailsScheduleofOptionstoConsultantsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="wlds_ScheduleOfOptionsToConsultantsLineItems" xlink:to="wlds_ShareholdersEquityDeficitDetailsScheduleofOptionstoConsultantsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_ShareholdersEquityDeficitDetailsScheduleofOptionstoConsultantsTable" xlink:to="srt_RangeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardDateAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_ShareholdersEquityDeficitDetailsScheduleofOptionstoConsultantsTable" xlink:to="us-gaap_AwardDateAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardDateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardDateDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardDateAxis" xlink:to="us-gaap_AwardDateDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardDateDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardDateDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardDateAxis" xlink:to="us-gaap_AwardDateDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_TwoThousandFifteenMember" xlink:href="wlds-20231231.xsd#wlds_TwoThousandFifteenMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AwardDateDomain" xlink:to="wlds_TwoThousandFifteenMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_TwoThousandSeventeenMember" xlink:href="wlds-20231231.xsd#wlds_TwoThousandSeventeenMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AwardDateDomain" xlink:to="wlds_TwoThousandSeventeenMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_TwoThousandTwentyoneMember" xlink:href="wlds-20231231.xsd#wlds_TwoThousandTwentyoneMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AwardDateDomain" xlink:to="wlds_TwoThousandTwentyoneMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_TwoThousandTwentyThreeMember" xlink:href="wlds-20231231.xsd#wlds_TwoThousandTwentyThreeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AwardDateDomain" xlink:to="wlds_TwoThousandTwentyThreeMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ScheduleOfOptionsToConsultantsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ScheduleOfOptionsToConsultantsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ScheduleOfOptionsToConsultantsLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ScheduleOfOptionsToConsultantsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ScheduleofShareBasedCompensationExpensesTable">
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfShareBasedCompensationExpensesLineItems" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfShareBasedCompensationExpensesLineItems"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrYE9rliDcrbWhjsc3i7BCl/DvlJVwr+JR0O2nYady5Se133BDWCF8ON/Jzif84CehHV5r9vMQwYxP2psHDnPZsunu1t2oh0qhdKXAlJyzN93OrPInDu+qpjJa2tGyv2XwvSkfjcWfQLzhpm2ZADneXuFkrcNjL16FM7h6sOb4n/vSj6ATmkI0Ua4rjBBddfCaAcAnzXKLH8rmIL1/T7b9tI] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="wlds_ScheduleOfShareBasedCompensationExpensesLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_SellingAndMarketingExpenseMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ScheduleOfShareBasedCompensationExpensesLineItems" xlink:to="us-gaap_ShareBasedCompensation" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable">
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateLineItems" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateLineItems"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareholdersEquityDeficitDetailsScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable" xlink:href="wlds-20231231.xsd#wlds_ShareholdersEquityDeficitDetailsScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateLineItems" xlink:to="wlds_ShareholdersEquityDeficitDetailsScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_ShareholdersEquityDeficitDetailsScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable" xlink:to="us-gaap_AwardTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_September132022Member" xlink:href="wlds-20231231.xsd#wlds_September132022Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="wlds_September132022Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_September152022OneMember" xlink:href="wlds-20231231.xsd#wlds_September152022OneMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="wlds_September152022OneMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_September152022TwoMember" xlink:href="wlds-20231231.xsd#wlds_September152022TwoMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="wlds_September152022TwoMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_September152022ThreeMember" xlink:href="wlds-20231231.xsd#wlds_September152022ThreeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="wlds_September152022ThreeMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio" xlink:href="wlds-20231231.xsd#wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateLineItems" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate" xlink:href="wlds-20231231.xsd#wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateLineItems" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareBasedCompensationArrangementNotes" xlink:href="wlds-20231231.xsd#wlds_ShareBasedCompensationArrangementNotes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateLineItems" xlink:to="wlds_ShareBasedCompensationArrangementNotes" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/GeneralDetails">
    <loc xlink:type="locator" xlink:label="wlds_GeneralLineItems" xlink:href="wlds-20231231.xsd#wlds_GeneralLineItems"/>
    <loc xlink:type="locator" xlink:label="wlds_GeneralDetailsTable" xlink:href="wlds-20231231.xsd#wlds_GeneralDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="wlds_GeneralLineItems" xlink:to="wlds_GeneralDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_GeneralDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_GeneralDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_GeneralDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_GeneralDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_GeneralDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_WarrantMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OverAllotmentOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_MudraInspireDevelopmentKitsMember" xlink:href="wlds-20231231.xsd#wlds_MudraInspireDevelopmentKitsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="wlds_MudraInspireDevelopmentKitsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_AnnualGrossRevenuesExceed" xlink:href="wlds-20231231.xsd#wlds_AnnualGrossRevenuesExceed"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_GeneralLineItems" xlink:to="wlds_AnnualGrossRevenuesExceed" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_OrdinarySharesWarrantsHeldByNonaffiliates" xlink:href="wlds-20231231.xsd#wlds_OrdinarySharesWarrantsHeldByNonaffiliates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_GeneralLineItems" xlink:to="wlds_OrdinarySharesWarrantsHeldByNonaffiliates" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_NonconvertibleDebtSecurities" xlink:href="wlds-20231231.xsd#wlds_NonconvertibleDebtSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_GeneralLineItems" xlink:to="wlds_NonconvertibleDebtSecurities" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_GeneralLineItems" xlink:to="us-gaap_Revenues" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_GeneralLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_GeneralLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_NetProceedsFromIssuanceSecondaryPublicOffering" xlink:href="wlds-20231231.xsd#wlds_NetProceedsFromIssuanceSecondaryPublicOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_GeneralLineItems" xlink:to="wlds_NetProceedsFromIssuanceSecondaryPublicOffering" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_GeneralLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_GeneralLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_Warrants" xlink:href="wlds-20231231.xsd#wlds_Warrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_GeneralLineItems" xlink:to="wlds_Warrants" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_GeneralLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_WarrantsExerciseIntoOrdinaryShares" xlink:href="wlds-20231231.xsd#wlds_WarrantsExerciseIntoOrdinaryShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_GeneralLineItems" xlink:to="wlds_WarrantsExerciseIntoOrdinaryShares" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ExercisePriceOfWarrant" xlink:href="wlds-20231231.xsd#wlds_ExercisePriceOfWarrant"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_GeneralLineItems" xlink:to="wlds_ExercisePriceOfWarrant" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_GrossProceeds" xlink:href="wlds-20231231.xsd#wlds_GrossProceeds"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_GeneralLineItems" xlink:to="wlds_GrossProceeds" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_UnderwritingNetProceed" xlink:href="wlds-20231231.xsd#wlds_UnderwritingNetProceed"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_GeneralLineItems" xlink:to="wlds_UnderwritingNetProceed" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_UnderwritingDiscountsAndCommissions" xlink:href="wlds-20231231.xsd#wlds_UnderwritingDiscountsAndCommissions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_GeneralLineItems" xlink:to="wlds_UnderwritingDiscountsAndCommissions" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_GrossAfterOtherIPOExpenses" xlink:href="wlds-20231231.xsd#wlds_GrossAfterOtherIPOExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_GeneralLineItems" xlink:to="wlds_GrossAfterOtherIPOExpenses" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_GeneralLineItems" xlink:to="us-gaap_SharePrice" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_WarrantsExercisePricePerShare" xlink:href="wlds-20231231.xsd#wlds_WarrantsExercisePricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_GeneralLineItems" xlink:to="wlds_WarrantsExercisePricePerShare" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_GeneralLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_GeneralLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_GeneralLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_GeneralLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" order="23" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesDetails">
    <loc xlink:type="locator" xlink:label="wlds_SignificantAccountingPoliciesDetailsLineItems" xlink:href="wlds-20231231.xsd#wlds_SignificantAccountingPoliciesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="wlds_SignificantAccountingPoliciesDetailsTable" xlink:href="wlds-20231231.xsd#wlds_SignificantAccountingPoliciesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="wlds_SignificantAccountingPoliciesDetailsLineItems" xlink:to="wlds_SignificantAccountingPoliciesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_SignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_LeaseLiabilityMember" xlink:href="wlds-20231231.xsd#wlds_LeaseLiabilityMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="wlds_LeaseLiabilityMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_DebtWeightedAverageInterestRate" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeFinanceLeaseRenewalTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_LesseeFinanceLeaseRenewalTerm1" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_RateOfMonthlySeverancePercentage" xlink:href="wlds-20231231.xsd#wlds_RateOfMonthlySeverancePercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_SignificantAccountingPoliciesDetailsLineItems" xlink:to="wlds_RateOfMonthlySeverancePercentage" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/LeaseDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseOptionToExtend" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseExpense" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails">
    <loc xlink:type="locator" xlink:label="wlds_CommitmentsandContingenciesDetailsLineItems" xlink:href="wlds-20231231.xsd#wlds_CommitmentsandContingenciesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="wlds_CommitmentsandContingenciesDetailsTable" xlink:href="wlds-20231231.xsd#wlds_CommitmentsandContingenciesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="wlds_CommitmentsandContingenciesDetailsLineItems" xlink:to="wlds_CommitmentsandContingenciesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_CommitmentsandContingenciesDetailsTable" xlink:to="srt_StatementScenarioAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCommitmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_OtherCommitmentsAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCommitmentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_OtherCommitmentsAxis" xlink:to="us-gaap_OtherCommitmentsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCommitmentsDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_OtherCommitmentsAxis" xlink:to="us-gaap_OtherCommitmentsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_CommitmentsandContingenciesDetailsTable" xlink:to="srt_RangeAxis" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_VariableRateAxis" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VariableRateDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseAgreementsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_LeaseAgreementsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_IIAMember" xlink:href="wlds-20231231.xsd#wlds_IIAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsDomain" xlink:to="wlds_IIAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_IMEIMember" xlink:href="wlds-20231231.xsd#wlds_IMEIMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsDomain" xlink:to="wlds_IMEIMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VehiclesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VehiclesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_VehiclesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_RoyaltiesRate" xlink:href="wlds-20231231.xsd#wlds_RoyaltiesRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_CommitmentsandContingenciesDetailsLineItems" xlink:to="wlds_RoyaltiesRate" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_GrantsReceivedEqualPercentageRate" xlink:href="wlds-20231231.xsd#wlds_GrantsReceivedEqualPercentageRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_CommitmentsandContingenciesDetailsLineItems" xlink:to="wlds_GrantsReceivedEqualPercentageRate" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_AnnualAlternativeInterestPercentage" xlink:href="wlds-20231231.xsd#wlds_AnnualAlternativeInterestPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_CommitmentsandContingenciesDetailsLineItems" xlink:to="wlds_AnnualAlternativeInterestPercentage" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_AnnualInterestRate" xlink:href="wlds-20231231.xsd#wlds_AnnualInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_CommitmentsandContingenciesDetailsLineItems" xlink:to="wlds_AnnualInterestRate" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_FixedAnnualInterestRate" xlink:href="wlds-20231231.xsd#wlds_FixedAnnualInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_CommitmentsandContingenciesDetailsLineItems" xlink:to="wlds_FixedAnnualInterestRate" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_AmountsReceivedAggregateAmount" xlink:href="wlds-20231231.xsd#wlds_AmountsReceivedAggregateAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_CommitmentsandContingenciesDetailsLineItems" xlink:to="wlds_AmountsReceivedAggregateAmount" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_AmountOfDevelopmentProgram" xlink:href="wlds-20231231.xsd#wlds_AmountOfDevelopmentProgram"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_CommitmentsandContingenciesDetailsLineItems" xlink:to="wlds_AmountOfDevelopmentProgram" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_PercentageOfFinancing" xlink:href="wlds-20231231.xsd#wlds_PercentageOfFinancing"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_CommitmentsandContingenciesDetailsLineItems" xlink:to="wlds_PercentageOfFinancing" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_TotalCashReceivedFromTheIIA" xlink:href="wlds-20231231.xsd#wlds_TotalCashReceivedFromTheIIA"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_CommitmentsandContingenciesDetailsLineItems" xlink:to="wlds_TotalCashReceivedFromTheIIA" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ExceptTransferProductionRight" xlink:href="wlds-20231231.xsd#wlds_ExceptTransferProductionRight"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_CommitmentsandContingenciesDetailsLineItems" xlink:to="wlds_ExceptTransferProductionRight" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ProductionTransferred" xlink:href="wlds-20231231.xsd#wlds_ProductionTransferred"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_CommitmentsandContingenciesDetailsLineItems" xlink:to="wlds_ProductionTransferred" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_PayIncreasedRoyaltiesDescription" xlink:href="wlds-20231231.xsd#wlds_PayIncreasedRoyaltiesDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_CommitmentsandContingenciesDetailsLineItems" xlink:to="wlds_PayIncreasedRoyaltiesDescription" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ResearchAndDevelopmentGrantsDetection" xlink:href="wlds-20231231.xsd#wlds_ResearchAndDevelopmentGrantsDetection"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_CommitmentsandContingenciesDetailsLineItems" xlink:to="wlds_ResearchAndDevelopmentGrantsDetection" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_MaximumObligatinAmount" xlink:href="wlds-20231231.xsd#wlds_MaximumObligatinAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_CommitmentsandContingenciesDetailsLineItems" xlink:to="wlds_MaximumObligatinAmount" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_GrantsReceivedFromTheIMEI" xlink:href="wlds-20231231.xsd#wlds_GrantsReceivedFromTheIMEI"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_CommitmentsandContingenciesDetailsLineItems" xlink:to="wlds_GrantsReceivedFromTheIMEI" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_SalesAndMarketingExpensesDeductions" xlink:href="wlds-20231231.xsd#wlds_SalesAndMarketingExpensesDeductions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_CommitmentsandContingenciesDetailsLineItems" xlink:to="wlds_SalesAndMarketingExpensesDeductions" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenuesNetOfInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesNetOfInterestExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_CommitmentsandContingenciesDetailsLineItems" xlink:to="us-gaap_RevenuesNetOfInterestExpense" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_RoyaltiesRatePercentage" xlink:href="wlds-20231231.xsd#wlds_RoyaltiesRatePercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_CommitmentsandContingenciesDetailsLineItems" xlink:to="wlds_RoyaltiesRatePercentage" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_MarketingGrantReceived" xlink:href="wlds-20231231.xsd#wlds_MarketingGrantReceived"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_CommitmentsandContingenciesDetailsLineItems" xlink:to="wlds_MarketingGrantReceived" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrantsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrantsReceivableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_CommitmentsandContingenciesDetailsLineItems" xlink:to="us-gaap_GrantsReceivableCurrent" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_CommitmentsandContingenciesDetailsLineItems" xlink:to="us-gaap_LeaseCost" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_CommitmentsandContingenciesDetailsLineItems" xlink:to="us-gaap_PaymentsForRent" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_LeasePaymentIncreased" xlink:href="wlds-20231231.xsd#wlds_LeasePaymentIncreased"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_CommitmentsandContingenciesDetailsLineItems" xlink:to="wlds_LeasePaymentIncreased" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_LeaseAgreements" xlink:href="wlds-20231231.xsd#wlds_LeaseAgreements"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_CommitmentsandContingenciesDetailsLineItems" xlink:to="wlds_LeaseAgreements" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_LeaseAgreementsPeriod" xlink:href="wlds-20231231.xsd#wlds_LeaseAgreementsPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_CommitmentsandContingenciesDetailsLineItems" xlink:to="wlds_LeaseAgreementsPeriod" order="25" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails">
    <loc xlink:type="locator" xlink:label="wlds_ConvertibleSecuritiesLineItems" xlink:href="wlds-20231231.xsd#wlds_ConvertibleSecuritiesLineItems"/>
    <loc xlink:type="locator" xlink:label="wlds_ConvertibleSecuritiesDetailsTable" xlink:href="wlds-20231231.xsd#wlds_ConvertibleSecuritiesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="wlds_ConvertibleSecuritiesLineItems" xlink:to="wlds_ConvertibleSecuritiesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_ConvertibleSecuritiesDetailsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_ConvertibleSecuritiesDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ConvertibleSecuritiesMember" xlink:href="wlds-20231231.xsd#wlds_ConvertibleSecuritiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="wlds_ConvertibleSecuritiesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ConvertibleSecuritiesLineItems" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ConvertibleSecuritiesLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ConvertibleSecuritiesLineItems" xlink:to="us-gaap_SharePrice" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ConvertibleSecuritiesLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ConvertibleSecurityDescription" xlink:href="wlds-20231231.xsd#wlds_ConvertibleSecurityDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ConvertibleSecuritiesLineItems" xlink:to="wlds_ConvertibleSecurityDescription" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_CashPayment" xlink:href="wlds-20231231.xsd#wlds_CashPayment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ConvertibleSecuritiesLineItems" xlink:to="wlds_CashPayment" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_PremoneyValuationAmount" xlink:href="wlds-20231231.xsd#wlds_PremoneyValuationAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ConvertibleSecuritiesLineItems" xlink:to="wlds_PremoneyValuationAmount" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_WarrantPricePerSharePercentage" xlink:href="wlds-20231231.xsd#wlds_WarrantPricePerSharePercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ConvertibleSecuritiesLineItems" xlink:to="wlds_WarrantPricePerSharePercentage" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_PurchasePricePerShare" xlink:href="wlds-20231231.xsd#wlds_PurchasePricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ConvertibleSecuritiesLineItems" xlink:to="wlds_PurchasePricePerShare" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ConvertibleSecuritiesLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_AggregateOrdinaryShares" xlink:href="wlds-20231231.xsd#wlds_AggregateOrdinaryShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ConvertibleSecuritiesLineItems" xlink:to="wlds_AggregateOrdinaryShares" order="11" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/CreditFacilityDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <loc xlink:type="locator" xlink:label="wlds_CreditFacilityDetailsTable" xlink:href="wlds-20231231.xsd#wlds_CreditFacilityDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="wlds_CreditFacilityDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_CreditFacilityDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherBorrowings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_OtherBorrowings" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_AggregateAmount" xlink:href="wlds-20231231.xsd#wlds_AggregateAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="wlds_AggregateAmount" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ServicesInExchangeForMonthlyBaseFee" xlink:href="wlds-20231231.xsd#wlds_ServicesInExchangeForMonthlyBaseFee"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="wlds_ServicesInExchangeForMonthlyBaseFee" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_AggrementTerm" xlink:href="wlds-20231231.xsd#wlds_AggrementTerm"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="wlds_AggrementTerm" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_WarrantsIssuedPercentage" xlink:href="wlds-20231231.xsd#wlds_WarrantsIssuedPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="wlds_WarrantsIssuedPercentage" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_BaseMonthlyFeeImmediatelyIncreaseAmount" xlink:href="wlds-20231231.xsd#wlds_BaseMonthlyFeeImmediatelyIncreaseAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="wlds_BaseMonthlyFeeImmediatelyIncreaseAmount" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_OfferingOrFinancingTransactionAmount" xlink:href="wlds-20231231.xsd#wlds_OfferingOrFinancingTransactionAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="wlds_OfferingOrFinancingTransactionAmount" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_TransactionFeeClosingValue" xlink:href="wlds-20231231.xsd#wlds_TransactionFeeClosingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="wlds_TransactionFeeClosingValue" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ExpenseOnServiceRendering" xlink:href="wlds-20231231.xsd#wlds_ExpenseOnServiceRendering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="wlds_ExpenseOnServiceRendering" order="11" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails">
    <loc xlink:type="locator" xlink:label="wlds_ShareholdersEquityLineItems" xlink:href="wlds-20231231.xsd#wlds_ShareholdersEquityLineItems"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareholdersEquityDeficitDetailsTable" xlink:href="wlds-20231231.xsd#wlds_ShareholdersEquityDeficitDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="wlds_ShareholdersEquityDeficitDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_ShareholdersEquityDeficitDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_ShareholdersEquityDeficitDetailsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_ShareholdersEquityDeficitDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_ShareholdersEquityDeficitDetailsTable" xlink:to="srt_StatementScenarioAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_ShareholdersEquityDeficitDetailsTable" xlink:to="us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" xlink:to="us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" xlink:to="us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_ShareholdersEquityDeficitDetailsTable" xlink:to="srt_TitleOfIndividualAxis" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_ShareholdersEquityDeficitDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_ShareholdersEquityDeficitDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_ShareholdersEquityDeficitDetailsTable" xlink:to="srt_RangeAxis" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_ShareholdersEquityDeficitDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" xbrldt:closed="true"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestorMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestorMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" xlink:to="us-gaap_InvestorMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_CofoundersMember" xlink:href="wlds-20231231.xsd#wlds_CofoundersMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="wlds_CofoundersMember" order="0" xbrldt:closed="true"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_InvestorMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_BoardOfDirectorsChairmanMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_BoardOfDirectorsChairmanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_BoardOfDirectorsChairmanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_DirectorMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_DirectorMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_TwoZeroOneFiveMember" xlink:href="wlds-20231231.xsd#wlds_TwoZeroOneFiveMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="wlds_TwoZeroOneFiveMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_TotalValueOfTheShares" xlink:href="wlds-20231231.xsd#wlds_TotalValueOfTheShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="wlds_TotalValueOfTheShares" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_OrdinaryShareParValue" xlink:href="wlds-20231231.xsd#wlds_OrdinaryShareParValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="wlds_OrdinaryShareParValue" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ValueOfOrdinaryAShare" xlink:href="wlds-20231231.xsd#wlds_ValueOfOrdinaryAShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="wlds_ValueOfOrdinaryAShare" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_InterestPercentage" xlink:href="wlds-20231231.xsd#wlds_InterestPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="wlds_InterestPercentage" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="us-gaap_SharesIssued" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_AShareReclassifiedToOrdinaryShares" xlink:href="wlds-20231231.xsd#wlds_AShareReclassifiedToOrdinaryShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="wlds_AShareReclassifiedToOrdinaryShares" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_OrdinarySharesAuthorizedIncreased" xlink:href="wlds-20231231.xsd#wlds_OrdinarySharesAuthorizedIncreased"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="wlds_OrdinarySharesAuthorizedIncreased" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_OrdinarySharesIssued" xlink:href="wlds-20231231.xsd#wlds_OrdinarySharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="wlds_OrdinarySharesIssued" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_OrdinarySharesWarrantExercisable" xlink:href="wlds-20231231.xsd#wlds_OrdinarySharesWarrantExercisable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="wlds_OrdinarySharesWarrantExercisable" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_OrdinarySharesInConsiderationPercentage" xlink:href="wlds-20231231.xsd#wlds_OrdinarySharesInConsiderationPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="wlds_OrdinarySharesInConsiderationPercentage" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_TotalConsiderationAmount" xlink:href="wlds-20231231.xsd#wlds_TotalConsiderationAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="wlds_TotalConsiderationAmount" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_IssuanceExpenses" xlink:href="wlds-20231231.xsd#wlds_IssuanceExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="wlds_IssuanceExpenses" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_SAFEsAmount" xlink:href="wlds-20231231.xsd#wlds_SAFEsAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="wlds_SAFEsAmount" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_Investor" xlink:href="wlds-20231231.xsd#wlds_Investor"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="wlds_Investor" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_InvestorAmount" xlink:href="wlds-20231231.xsd#wlds_InvestorAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="wlds_InvestorAmount" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ConvertedAmount" xlink:href="wlds-20231231.xsd#wlds_ConvertedAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="wlds_ConvertedAmount" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ConvertedToOrdinaryShares" xlink:href="wlds-20231231.xsd#wlds_ConvertedToOrdinaryShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="wlds_ConvertedToOrdinaryShares" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="us-gaap_Cash" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ExercisableWarrantsToShares" xlink:href="wlds-20231231.xsd#wlds_ExercisableWarrantsToShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="wlds_ExercisableWarrantsToShares" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_InvestorsExercisedWarrants" xlink:href="wlds-20231231.xsd#wlds_InvestorsExercisedWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="wlds_InvestorsExercisedWarrants" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_EmployeeExercisedWarrants" xlink:href="wlds-20231231.xsd#wlds_EmployeeExercisedWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="wlds_EmployeeExercisedWarrants" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:href="wlds-20231231.xsd#wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ExercisePricePerShare" xlink:href="wlds-20231231.xsd#wlds_ExercisePricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="wlds_ExercisePricePerShare" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ProceedsFromIssuanceFollowOnPublicOffering" xlink:href="wlds-20231231.xsd#wlds_ProceedsFromIssuanceFollowOnPublicOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="wlds_ProceedsFromIssuanceFollowOnPublicOffering" order="29" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_OrdinarySharePerValue" xlink:href="wlds-20231231.xsd#wlds_OrdinarySharePerValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="wlds_OrdinarySharePerValue" order="30" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="31" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" order="32" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_OptionsAvailableForGrant" xlink:href="wlds-20231231.xsd#wlds_OptionsAvailableForGrant"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="wlds_OptionsAvailableForGrant" order="33" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="34" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="35" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_TerminationPeriod" xlink:href="wlds-20231231.xsd#wlds_TerminationPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="wlds_TerminationPeriod" order="36" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" order="37" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_IssuanceOfSharesOptions" xlink:href="wlds-20231231.xsd#wlds_IssuanceOfSharesOptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="wlds_IssuanceOfSharesOptions" order="38" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate" xlink:href="wlds-20231231.xsd#wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate" order="39" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_OptionsExpenses" xlink:href="wlds-20231231.xsd#wlds_OptionsExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="wlds_OptionsExpenses" order="40" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_VestingPeriods" xlink:href="wlds-20231231.xsd#wlds_VestingPeriods"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="wlds_VestingPeriods" order="41" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ExercisePriceOfWarrants" xlink:href="wlds-20231231.xsd#wlds_ExercisePriceOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="wlds_ExercisePriceOfWarrants" order="42" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm" order="43" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_WarrantBeReducedToAnExercisePricePercentage" xlink:href="wlds-20231231.xsd#wlds_WarrantBeReducedToAnExercisePricePercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="wlds_WarrantBeReducedToAnExercisePricePercentage" order="44" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_InitialExercisePricePercentage" xlink:href="wlds-20231231.xsd#wlds_InitialExercisePricePercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="wlds_InitialExercisePricePercentage" order="45" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_WeightedAveragePricePercentage" xlink:href="wlds-20231231.xsd#wlds_WeightedAveragePricePercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="wlds_WeightedAveragePricePercentage" order="46" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_LowestResetPrice" xlink:href="wlds-20231231.xsd#wlds_LowestResetPrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="wlds_LowestResetPrice" order="47" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_InitialExercisePricesPercentage" xlink:href="wlds-20231231.xsd#wlds_InitialExercisePricesPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="wlds_InitialExercisePricesPercentage" order="48" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/TaxesonIncomeDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <loc xlink:type="locator" xlink:label="wlds_TaxesonIncomeDetailsTable" xlink:href="wlds-20231231.xsd#wlds_TaxesonIncomeDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="wlds_TaxesonIncomeDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_TaxesonIncomeDetailsTable" xlink:to="srt_StatementGeographicalAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_IL" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_IL" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_CorporateTaxRatePercentage" xlink:href="wlds-20231231.xsd#wlds_CorporateTaxRatePercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="wlds_CorporateTaxRatePercentage" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/RelatedPartiesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <loc xlink:type="locator" xlink:label="wlds_RelatedPartiesDetailsTable" xlink:href="wlds-20231231.xsd#wlds_RelatedPartiesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="wlds_RelatedPartiesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_RelatedPartiesDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_RelatedPartiesDetailsTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_EquityMethodInvesteeNameDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_AsherDahanMember" xlink:href="wlds-20231231.xsd#wlds_AsherDahanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="wlds_AsherDahanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_CofoundersMember" xlink:href="wlds-20231231.xsd#wlds_CofoundersMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="wlds_CofoundersMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_PercentageOfOwnership" xlink:href="wlds-20231231.xsd#wlds_PercentageOfOwnership"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="wlds_PercentageOfOwnership" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_EmploymentExpenses" xlink:href="wlds-20231231.xsd#wlds_EmploymentExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="wlds_EmploymentExpenses" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_OfficerEmployeeMonthlySalary" xlink:href="wlds-20231231.xsd#wlds_OfficerEmployeeMonthlySalary"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="wlds_OfficerEmployeeMonthlySalary" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_RelatedPartyMonthlySalary" xlink:href="wlds-20231231.xsd#wlds_RelatedPartyMonthlySalary"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="wlds_RelatedPartyMonthlySalary" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_EntityAddressesAddressTypeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain_0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_OrdinarySharesNIS001ParValuePerShareMember" xlink:href="wlds-20231231.xsd#wlds_OrdinarySharesNIS001ParValuePerShareMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="wlds_OrdinarySharesNIS001ParValuePerShareMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_WarrantsToPurchaseOrdinarySharesMember" xlink:href="wlds-20231231.xsd#wlds_WarrantsToPurchaseOrdinarySharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="wlds_WarrantsToPurchaseOrdinarySharesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_BusinessContactMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_AddressTypeDomain" xlink:to="dei_BusinessContactMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentRegistrationStatement" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentRegistrationStatement" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentShellCompanyReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentShellCompanyReport" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCountry" order="29" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_ContactPersonnelName" order="30" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="31" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="32" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="33" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="34" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="35" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag" order="36" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAccountingStandard" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAccountingStandard" order="37" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorFirmId" order="38" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorName" order="39" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorLocation" order="40" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>21
<FILENAME>wlds-20231231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Mar 15 10:22:33 UTC 2024 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:label="dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesAddressTypeAxis_lbl" xml:lang="en-US">Entity Addresses, Address Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_EntityAddressesAddressTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">TOTAL CURRENT ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsNoncurrent_lbl" xml:lang="en-US">TOTAL NON-CURRENT ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">TOTAL ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">TOTAL CURRENT LIABILITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">TOTAL LIABILITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">TOTAL SHAREHOLDERS&#8217; EQUITY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_lbl0" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_lbl1" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">TOTAL LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">OPERATING LOSS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">NET LOSS AND TOTAL COMPREHENSIVE LOSS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl0" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_lbl0" xml:lang="en-US">Balance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash and Cash Equivalents at the beginning of year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0" xml:lang="en-US">Cash and cash equivalents at the end of year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">General [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Significant Accounting Policies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNetAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNetAbstract_lbl" xml:lang="en-US">Inventories [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNetAbstract" xlink:to="us-gaap_InventoryNetAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Schedule of Inventories [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FIFOInventoryAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FIFOInventoryAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_FIFOInventoryAmount_lbl" xml:lang="en-US">Inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FIFOInventoryAmount" xlink:to="us-gaap_FIFOInventoryAmount_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FIFOInventoryAmount_lbl0" xml:lang="en-US">Inventories (Note 3)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FIFOInventoryAmount" xlink:to="us-gaap_FIFOInventoryAmount_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property and Equipment, Net [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeasesAbstract_lbl" xml:lang="en-US">Lease [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeasesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfClassificationOfOperatingLeaseRightOfUseAssetsAndLiabilitiesAbstract" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfClassificationOfOperatingLeaseRightOfUseAssetsAndLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ScheduleOfClassificationOfOperatingLeaseRightOfUseAssetsAndLiabilitiesAbstract_lbl" xml:lang="en-US">Schedule of Classification of Operating Lease Right-of-Use Assets and Liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ScheduleOfClassificationOfOperatingLeaseRightOfUseAssetsAndLiabilitiesAbstract" xlink:to="wlds_ScheduleOfClassificationOfOperatingLeaseRightOfUseAssetsAndLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Total lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseLiability_lbl0" xml:lang="en-US">Total operating lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl0"/>
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesAbstract" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ScheduleOfFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesAbstract_lbl" xml:lang="en-US">Schedule of Future Minimum Lease Payments Under Our Operating Lease Liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ScheduleOfFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesAbstract" xlink:to="wlds_ScheduleOfFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US">Total future minimum lease payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsAbstract_lbl" xml:lang="en-US">Convertible Securities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_CreditFacilityAbstract" xlink:href="wlds-20231231.xsd#wlds_CreditFacilityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_CreditFacilityAbstract_lbl" xml:lang="en-US">Credit Facility [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CreditFacilityAbstract" xlink:to="wlds_CreditFacilityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl" xml:lang="en-US">Shareholders&apos; Equity (Deficit) [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfOptionsActivityAbstract" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfOptionsActivityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ScheduleOfOptionsActivityAbstract_lbl" xml:lang="en-US">Schedule of Options Activity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ScheduleOfOptionsActivityAbstract" xlink:to="wlds_ScheduleOfOptionsActivityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Outstanding - beginning, Amount of options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl0" xml:lang="en-US">Outstanding - end, Amount of options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Outstanding - beginning, Weighted average exercise price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Outstanding - end, Weighted average exercise price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl" xml:lang="en-US">Schedule of Weighted Average Assumptions [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardDateAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardDateAxis_lbl" xml:lang="en-US">Award Date [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardDateAxis" xlink:to="us-gaap_AwardDateAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Income Statement Location [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Taxes on Income [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Parties [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentRegistrationStatement" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentShellCompanyReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_ContactPersonnelName_lbl" xml:lang="en-US">Contact Personnel Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelName" xlink:to="dei_ContactPersonnelName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Entity Ex Transition Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xml:lang="en-US">ICFR Auditor Attestation Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAccountingStandard" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US">Auditor Firm ID</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AuditorName_lbl" xml:lang="en-US">Auditor Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US">Auditor Location</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">CURRENT ASSETS:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositsAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DepositsAssetsCurrent_lbl" xml:lang="en-US">Short term bank deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositsAssetsCurrent" xlink:to="us-gaap_DepositsAssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrantsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrantsReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GrantsReceivable_lbl" xml:lang="en-US">Governmental grant receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrantsReceivable" xlink:to="us-gaap_GrantsReceivable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Other receivables and prepaid expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_UnlabeledAbstract" xlink:href="wlds-20231231.xsd#wlds_UnlabeledAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_UnlabeledAbstract_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_UnlabeledAbstract" xlink:to="wlds_UnlabeledAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsNoncurrentAbstract_lbl" xml:lang="en-US">NON-CURRENT ASSETS:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositsAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssetsNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DepositsAssetsNoncurrent_lbl" xml:lang="en-US">Long term bank deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositsAssetsNoncurrent" xlink:to="us-gaap_DepositsAssetsNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Right-of-use assets (Note 5)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl0" xml:lang="en-US">Right of use assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net (Note 4)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl0" xml:lang="en-US">Total property and equipment, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl0"/>
    <loc xlink:type="locator" xlink:label="wlds_UnlabeledAbstract0" xlink:href="wlds-20231231.xsd#wlds_UnlabeledAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_UnlabeledAbstract0_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_UnlabeledAbstract0" xlink:to="wlds_UnlabeledAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">Liabilities and Shareholders&#8217; Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">CURRENT LIABILITIES:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_AdvanceFromCustomers" xlink:href="wlds-20231231.xsd#wlds_AdvanceFromCustomers"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_AdvanceFromCustomers_lbl" xml:lang="en-US">Advance payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AdvanceFromCustomers" xlink:to="wlds_AdvanceFromCustomers_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xml:lang="en-US">Deferred revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued payroll and other employment related accruals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl0" xml:lang="en-US">Short term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl1" xml:lang="en-US">Less operating lease liabilities, current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl0" xml:lang="en-US">Long term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl1" xml:lang="en-US">Operating lease liabilities, non-current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl1"/>
    <loc xlink:type="locator" xlink:label="wlds_UnlabeledAbstract1" xlink:href="wlds-20231231.xsd#wlds_UnlabeledAbstract1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_UnlabeledAbstract1_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_UnlabeledAbstract1" xlink:to="wlds_UnlabeledAbstract1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES (Note 6)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">SHAREHOLDERS&#8217; EQUITY (Note 9):</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Ordinary shares, NIS 0.01 par value: Authorized 50,000,000 as of December 31, 2023 and December 31, 2022; Issued and outstanding 20,387,428 shares as of December 31, 2023 and 15,049,720 shares as of December 31, 2022</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Ordinary shares, par value (in New Shekels per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl0" xml:lang="en-US">Ordinary shares, par value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl1" xml:lang="en-US">Ordinary share par value (in New Shekels per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Ordinary shares, authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl0" xml:lang="en-US">Ordinary shares, Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Ordinary shares, share issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl0" xml:lang="en-US">Ordinary shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl1" xml:lang="en-US">Ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Ordinary shares, share outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Accumulated losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingCostsAndExpensesAbstract_lbl" xml:lang="en-US">Expenses:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_OperatingCostsAndExpensesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_InterestExpenseAndExchangeRate" xlink:href="wlds-20231231.xsd#wlds_InterestExpenseAndExchangeRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_InterestExpenseAndExchangeRate_lbl" xml:lang="en-US">FINANCING INCOME (EXPENSES), net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_InterestExpenseAndExchangeRate" xlink:to="wlds_InterestExpenseAndExchangeRate_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_UnlabeledAbstract2" xlink:href="wlds-20231231.xsd#wlds_UnlabeledAbstract2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_UnlabeledAbstract2_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_UnlabeledAbstract2" xlink:to="wlds_UnlabeledAbstract2_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Net loss per ordinary shares, basic (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Net loss per ordinary shares, diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted average number of ordinary shares outstanding basic (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted average number of ordinary shares outstanding diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_UnlabeledAbstract3" xlink:href="wlds-20231231.xsd#wlds_UnlabeledAbstract3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_UnlabeledAbstract3_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_UnlabeledAbstract3" xlink:to="wlds_UnlabeledAbstract3_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ChangesDuringTheYear2021Abstract" xlink:href="wlds-20231231.xsd#wlds_ChangesDuringTheYear2021Abstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ChangesDuringTheYear2021Abstract_lbl" xml:lang="en-US">CHANGES DURING THE YEAR 2021:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ChangesDuringTheYear2021Abstract" xlink:to="wlds_ChangesDuringTheYear2021Abstract_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost" xlink:href="wlds-20231231.xsd#wlds_IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost_lbl" xml:lang="en-US">Issuance of ordinary shares and warrants, net of issuance cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost" xlink:to="wlds_IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl" xml:lang="en-US">Issuance of ordinary shares and warrants, net of issuance cost (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Conversion of convertible securities (including accrued interest) to ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Conversion of convertible securities (including accrued interest) to ordinary shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ConversionOfOrdinaryASharesToOrdinarySharesValue" xlink:href="wlds-20231231.xsd#wlds_ConversionOfOrdinaryASharesToOrdinarySharesValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ConversionOfOrdinaryASharesToOrdinarySharesValue_lbl" xml:lang="en-US">Conversion of ordinary A shares to ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConversionOfOrdinaryASharesToOrdinarySharesValue" xlink:to="wlds_ConversionOfOrdinaryASharesToOrdinarySharesValue_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ConversionOfOrdinaryASharesToOrdinaryShares" xlink:href="wlds-20231231.xsd#wlds_ConversionOfOrdinaryASharesToOrdinaryShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ConversionOfOrdinaryASharesToOrdinaryShares_lbl" xml:lang="en-US">Conversion of ordinary A shares to ordinary shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConversionOfOrdinaryASharesToOrdinaryShares" xlink:to="wlds_ConversionOfOrdinaryASharesToOrdinaryShares_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Share-based compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl0" xml:lang="en-US">Share based compensation expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Exercise of options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_StockIssuedDuringPeriodShareOfExerciseOfOptionsinShares" xlink:href="wlds-20231231.xsd#wlds_StockIssuedDuringPeriodShareOfExerciseOfOptionsinShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_StockIssuedDuringPeriodShareOfExerciseOfOptionsinShares_lbl" xml:lang="en-US">Exercise of options (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodShareOfExerciseOfOptionsinShares" xlink:to="wlds_StockIssuedDuringPeriodShareOfExerciseOfOptionsinShares_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_StockIssuedDuringPeriodValueOfPaymentOnBehalfOfSharesIssued" xlink:href="wlds-20231231.xsd#wlds_StockIssuedDuringPeriodValueOfPaymentOnBehalfOfSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_StockIssuedDuringPeriodValueOfPaymentOnBehalfOfSharesIssued_lbl" xml:lang="en-US">Payment on behalf of issued shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodValueOfPaymentOnBehalfOfSharesIssued" xlink:to="wlds_StockIssuedDuringPeriodValueOfPaymentOnBehalfOfSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US">Comprehensive loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_UnlabeledAbstract4" xlink:href="wlds-20231231.xsd#wlds_UnlabeledAbstract4"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_UnlabeledAbstract4_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_UnlabeledAbstract4" xlink:to="wlds_UnlabeledAbstract4_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ChangesDuringTheYear2022Abstract" xlink:href="wlds-20231231.xsd#wlds_ChangesDuringTheYear2022Abstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ChangesDuringTheYear2022Abstract_lbl" xml:lang="en-US">CHANGES DURING THE YEAR 2022:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ChangesDuringTheYear2022Abstract" xlink:to="wlds_ChangesDuringTheYear2022Abstract_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet" xlink:href="wlds-20231231.xsd#wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet_lbl" xml:lang="en-US">Issuance of units of ordinary shares and warrants in connection with the initial public offering, net of issuance expenses of 1.6 million</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet" xlink:to="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares" xlink:href="wlds-20231231.xsd#wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares_lbl" xml:lang="en-US">Issuance of units of ordinary shares and warrants in connection with the initial public offering, net of issuance expenses of 1.6 million (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares" xlink:to="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US">Net of issuance expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xml:lang="en-US">Conversion of SAFEs into ordinary shares upon completion of initial public offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering" xlink:href="wlds-20231231.xsd#wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering_lbl" xml:lang="en-US">Conversion of SAFEs into ordinary shares upon completion of initial public offering (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering" xlink:to="wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" xlink:href="wlds-20231231.xsd#wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants_lbl" xml:lang="en-US">Issuance of ordinary shares as a result of exercise of warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" xlink:to="wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrantsinShares" xlink:href="wlds-20231231.xsd#wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrantsinShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrantsinShares_lbl" xml:lang="en-US">Issuance of ordinary shares as a result of exercise of warrants (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrantsinShares" xlink:to="wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrantsinShares_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ChangesDuringTheYear2023Abstract" xlink:href="wlds-20231231.xsd#wlds_ChangesDuringTheYear2023Abstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ChangesDuringTheYear2023Abstract_lbl" xml:lang="en-US">CHANGES DURING THE YEAR 2023:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ChangesDuringTheYear2023Abstract" xlink:to="wlds_ChangesDuringTheYear2023Abstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Shares issued in the public offering, net of issuance cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Shares issued in the public offering, net of issuance cost (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl0" xml:lang="en-US">Secondary ordinary share (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl0"/>
    <loc xlink:type="locator" xlink:label="wlds_StockIssuedDuringPeriodValueInvestors" xlink:href="wlds-20231231.xsd#wlds_StockIssuedDuringPeriodValueInvestors"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_StockIssuedDuringPeriodValueInvestors_lbl" xml:lang="en-US">Issuance of shares to April 2021 investors (Note 7)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodValueInvestors" xlink:to="wlds_StockIssuedDuringPeriodValueInvestors_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_StockIssuedDuringPeriodSharesInvestors" xlink:href="wlds-20231231.xsd#wlds_StockIssuedDuringPeriodSharesInvestors"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_StockIssuedDuringPeriodSharesInvestors_lbl" xml:lang="en-US">Issuance of shares to April 2021 investors (Note 7) (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodSharesInvestors" xlink:to="wlds_StockIssuedDuringPeriodSharesInvestors_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_StockIssuedDuringPeriodValueExerciseOfWarrants" xlink:href="wlds-20231231.xsd#wlds_StockIssuedDuringPeriodValueExerciseOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_StockIssuedDuringPeriodValueExerciseOfWarrants_lbl" xml:lang="en-US">Exercise of warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodValueExerciseOfWarrants" xlink:to="wlds_StockIssuedDuringPeriodValueExerciseOfWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:href="wlds-20231231.xsd#wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants_lbl" xml:lang="en-US">Exercise of warrants (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants_lbl0" xml:lang="en-US">Exercised ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments required to reconcile net loss to net cash used in operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_AccruedInterestOnConvertibleSecurities" xlink:href="wlds-20231231.xsd#wlds_AccruedInterestOnConvertibleSecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_AccruedInterestOnConvertibleSecurities_lbl" xml:lang="en-US">Accrued interest on convertible securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AccruedInterestOnConvertibleSecurities" xlink:to="wlds_AccruedInterestOnConvertibleSecurities_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_AccruedInterestOnDeposits" xlink:href="wlds-20231231.xsd#wlds_AccruedInterestOnDeposits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_AccruedInterestOnDeposits_lbl" xml:lang="en-US">Accrued interest on deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AccruedInterestOnDeposits" xlink:to="wlds_AccruedInterestOnDeposits_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_UnlabeledAbstract5" xlink:href="wlds-20231231.xsd#wlds_UnlabeledAbstract5"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_UnlabeledAbstract5_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_UnlabeledAbstract5" xlink:to="wlds_UnlabeledAbstract5_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities items:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_IncreaseDecreaseInAdvancePayments" xlink:href="wlds-20231231.xsd#wlds_IncreaseDecreaseInAdvancePayments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_IncreaseDecreaseInAdvancePayments_lbl" xml:lang="en-US">Increase (decrease) in advance payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IncreaseDecreaseInAdvancePayments" xlink:to="wlds_IncreaseDecreaseInAdvancePayments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xml:lang="en-US">Increase (decrease) in deferred revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Increase in accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl" xml:lang="en-US">Increase in accrued payroll and other employment related accruals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xml:lang="en-US">Increase in accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_UnlabeledAbstract6" xlink:href="wlds-20231231.xsd#wlds_UnlabeledAbstract6"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_UnlabeledAbstract6_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_UnlabeledAbstract6" xlink:to="wlds_UnlabeledAbstract6_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost" xlink:href="wlds-20231231.xsd#wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost_lbl" xml:lang="en-US">Proceeds from issuance of shares issued in the public offering, net of issuance cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost" xlink:to="wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPubli" xlink:href="wlds-20231231.xsd#wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPubli"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPubli_lbl" xml:lang="en-US">Proceeds from issuance of units of ordinary shares and warrants in connection with the initial public offering, net of issuance expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPubli" xlink:to="wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPubli_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ProceedsFromIssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost" xlink:href="wlds-20231231.xsd#wlds_ProceedsFromIssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ProceedsFromIssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost_lbl" xml:lang="en-US">Proceeds from issuance of ordinary shares and warrants, net of issuance cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProceedsFromIssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost" xlink:to="wlds_ProceedsFromIssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ProceedsFromIssuanceOfSAFEs" xlink:href="wlds-20231231.xsd#wlds_ProceedsFromIssuanceOfSAFEs"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ProceedsFromIssuanceOfSAFEs_lbl" xml:lang="en-US">Proceeds from issuance of SAFEs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProceedsFromIssuanceOfSAFEs" xlink:to="wlds_ProceedsFromIssuanceOfSAFEs_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl" xml:lang="en-US">Proceeds from credit line</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromLinesOfCredit" xlink:to="us-gaap_ProceedsFromLinesOfCredit_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" xlink:href="wlds-20231231.xsd#wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants_lbl" xml:lang="en-US">Proceeds from issuance of ordinary shares as a result of exercise of warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" xlink:to="wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US">Exercise of options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_PaymentOnBehalfOfIssuedShares" xlink:href="wlds-20231231.xsd#wlds_PaymentOnBehalfOfIssuedShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_PaymentOnBehalfOfIssuedShares_lbl" xml:lang="en-US">Payment on behalf of issued shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PaymentOnBehalfOfIssuedShares" xlink:to="wlds_PaymentOnBehalfOfIssuedShares_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_UnlabeledAbstract7" xlink:href="wlds-20231231.xsd#wlds_UnlabeledAbstract7"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_UnlabeledAbstract7_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_UnlabeledAbstract7" xlink:to="wlds_UnlabeledAbstract7_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract_lbl" xml:lang="en-US">Supplemental Disclosure:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_SupplementalCashFlowElementsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Interest on credit line</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_InterestReceivedFromDeposits" xlink:href="wlds-20231231.xsd#wlds_InterestReceivedFromDeposits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_InterestReceivedFromDeposits_lbl" xml:lang="en-US">Interest received from deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_InterestReceivedFromDeposits" xlink:to="wlds_InterestReceivedFromDeposits_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ConversionOfSAFEToEquity" xlink:href="wlds-20231231.xsd#wlds_ConversionOfSAFEToEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ConversionOfSAFEToEquity_lbl" xml:lang="en-US">Conversion of SAFEs to equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConversionOfSAFEToEquity" xlink:to="wlds_ConversionOfSAFEToEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_RightofUseAssetRecognizedAgainstLeaseLiability" xlink:href="wlds-20231231.xsd#wlds_RightofUseAssetRecognizedAgainstLeaseLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_RightofUseAssetRecognizedAgainstLeaseLiability_lbl" xml:lang="en-US">Right-of-use asset recognized against lease liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_RightofUseAssetRecognizedAgainstLeaseLiability" xlink:to="wlds_RightofUseAssetRecognizedAgainstLeaseLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostDirectMaterial" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostDirectMaterial"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_CostDirectMaterial_lbl" xml:lang="en-US">Cost of revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostDirectMaterial" xlink:to="us-gaap_CostDirectMaterial_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development, net (Note 6a)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_SellingAndMarketingExpense_lbl" xml:lang="en-US">Sales and marketing expenses, net (Note 6b)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ProspectiveInitialPublicOfferingExpenses" xlink:href="wlds-20231231.xsd#wlds_ProspectiveInitialPublicOfferingExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="wlds_ProspectiveInitialPublicOfferingExpenses_lbl" xml:lang="en-US">Initial public offering expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProspectiveInitialPublicOfferingExpenses" xlink:to="wlds_ProspectiveInitialPublicOfferingExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized_lbl" xml:lang="en-US">Unrealized gain loss from foreign currency derivative activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossUnrealized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Decrease (increase) in accounts receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Decrease (increase) in inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_DecreaseincreaseInGovernmentalGrantsReceivables" xlink:href="wlds-20231231.xsd#wlds_DecreaseincreaseInGovernmentalGrantsReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="wlds_DecreaseincreaseInGovernmentalGrantsReceivables_lbl" xml:lang="en-US">Decrease (increase) in governmental grants receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_DecreaseincreaseInGovernmentalGrantsReceivables" xlink:to="wlds_DecreaseincreaseInGovernmentalGrantsReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_IncreaseInOtherReceivablesAndPrepaidExpenses" xlink:href="wlds-20231231.xsd#wlds_IncreaseInOtherReceivablesAndPrepaidExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="wlds_IncreaseInOtherReceivablesAndPrepaidExpenses_lbl" xml:lang="en-US">Increase in other receivables and prepaid expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IncreaseInOtherReceivablesAndPrepaidExpenses" xlink:to="wlds_IncreaseInOtherReceivablesAndPrepaidExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_IncreaseDecreaseInAdvancePaymentsOnGovernmentalGrant" xlink:href="wlds-20231231.xsd#wlds_IncreaseDecreaseInAdvancePaymentsOnGovernmentalGrant"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="wlds_IncreaseDecreaseInAdvancePaymentsOnGovernmentalGrant_lbl" xml:lang="en-US">Decrease in advance payments on governmental grant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IncreaseDecreaseInAdvancePaymentsOnGovernmentalGrant" xlink:to="wlds_IncreaseDecreaseInAdvancePaymentsOnGovernmentalGrant_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchase of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireRestrictedCertificatesOfDeposit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireRestrictedCertificatesOfDeposit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireRestrictedCertificatesOfDeposit_lbl" xml:lang="en-US">Investment in deposits, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireRestrictedCertificatesOfDeposit" xlink:to="us-gaap_PaymentsToAcquireRestrictedCertificatesOfDeposit_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_PrepaymentsOfLeasing" xlink:href="wlds-20231231.xsd#wlds_PrepaymentsOfLeasing"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="wlds_PrepaymentsOfLeasing_lbl" xml:lang="en-US">Prepayments of leasing</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PrepaymentsOfLeasing" xlink:to="wlds_PrepaymentsOfLeasing_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_RefundToSAFEInvestors" xlink:href="wlds-20231231.xsd#wlds_RefundToSAFEInvestors"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="wlds_RefundToSAFEInvestors_lbl" xml:lang="en-US">Refund to SAFE investors</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_RefundToSAFEInvestors" xlink:to="wlds_RefundToSAFEInvestors_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfLinesOfCredit_lbl" xml:lang="en-US">Repayment of credit line</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLinesOfCredit" xlink:to="us-gaap_RepaymentsOfLinesOfCredit_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_BusinessContactMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_BusinessContactMember_lbl" xml:lang="en-US">Business Contact</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_BusinessContactMember" xlink:to="dei_BusinessContactMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_OrdinarySharesNIS001ParValuePerShareMember" xlink:href="wlds-20231231.xsd#wlds_OrdinarySharesNIS001ParValuePerShareMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_OrdinarySharesNIS001ParValuePerShareMember_lbl" xml:lang="en-US">Ordinary Shares, NIS 0.01 par value per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OrdinarySharesNIS001ParValuePerShareMember" xlink:to="wlds_OrdinarySharesNIS001ParValuePerShareMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_WarrantsToPurchaseOrdinarySharesMember" xlink:href="wlds-20231231.xsd#wlds_WarrantsToPurchaseOrdinarySharesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_WarrantsToPurchaseOrdinarySharesMember_lbl" xml:lang="en-US">Warrants to Purchase Ordinary Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WarrantsToPurchaseOrdinarySharesMember" xlink:to="wlds_WarrantsToPurchaseOrdinarySharesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockMember_lbl0" xml:lang="en-US">Ordinary shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_CommonStockMember_lbl1" xml:lang="en-US">Ordinary Share [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl2" xml:lang="en-US">Ordinary Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonClassAMember_lbl" xml:lang="en-US">A</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonClassAMember_lbl0" xml:lang="en-US">Ordinary A Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="wlds_SubscriptionReceivablesMember" xlink:href="wlds-20231231.xsd#wlds_SubscriptionReceivablesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_SubscriptionReceivablesMember_lbl" xml:lang="en-US">Subscription receivables (ordinary shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_SubscriptionReceivablesMember" xlink:to="wlds_SubscriptionReceivablesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional paid-in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US">Accumulated losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US">GENERAL</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock_lbl" xml:lang="en-US">Schedule of Annual Rates of Depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock" xlink:to="wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_AnnualRateOfDepreciation" xlink:href="wlds-20231231.xsd#wlds_AnnualRateOfDepreciation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_AnnualRateOfDepreciation_lbl" xml:lang="en-US">Annual rate of depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AnnualRateOfDepreciation" xlink:to="wlds_AnnualRateOfDepreciation_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">INVENTORIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Schedule of Inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_CostAbstract" xlink:href="wlds-20231231.xsd#wlds_CostAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_CostAbstract_lbl" xml:lang="en-US">Cost:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CostAbstract" xlink:to="wlds_CostAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves_lbl" xml:lang="en-US">Raw materials</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves_lbl" xml:lang="en-US">Work-in-progress</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="us-gaap_InventoryWorkInProcessNetOfReserves_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves_lbl" xml:lang="en-US">Finished goods</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">PROPERTY AND EQUIPMENT, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of Property and Equipment Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_CostAbstract0" xlink:href="wlds-20231231.xsd#wlds_CostAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_CostAbstract0_lbl" xml:lang="en-US">Cost:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CostAbstract0" xlink:to="wlds_CostAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Less - accumulated depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US">LEASES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_lbl" xml:lang="en-US">Schedule of Classification of Operating Lease Right-of-Use Assets and Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:to="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesAbstract_lbl" xml:lang="en-US">Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">Schedule of Future Minimum Lease Payments Under Our Operating Lease Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">2024</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">2025</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">2026</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">CONVERTIBLE SECURITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_CreditFacilityDisclosureTextBlock" xlink:href="wlds-20231231.xsd#wlds_CreditFacilityDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_CreditFacilityDisclosureTextBlock_lbl" xml:lang="en-US">CREDIT FACILITY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CreditFacilityDisclosureTextBlock" xlink:to="wlds_CreditFacilityDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">SHAREHOLDERS&#8217; EQUITY (DEFICIT)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfStockholdersEquityTableTextBlock_lbl" xml:lang="en-US">Schedule of Share Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_NumberOfSharesIssuedAndOutstanding" xlink:href="wlds-20231231.xsd#wlds_NumberOfSharesIssuedAndOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_NumberOfSharesIssuedAndOutstanding_lbl" xml:lang="en-US">Ordinary shares, Issued and outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_NumberOfSharesIssuedAndOutstanding" xlink:to="wlds_NumberOfSharesIssuedAndOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Options Activity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Granted amount of options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Granted weighted average exercise price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Exercised weighted average exercise price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Expired or forfeited weighted average exercise price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_UnlabeledAbstract8" xlink:href="wlds-20231231.xsd#wlds_UnlabeledAbstract8"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_UnlabeledAbstract8_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_UnlabeledAbstract8" xlink:to="wlds_UnlabeledAbstract8_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_UnlabeledAbstract9" xlink:href="wlds-20231231.xsd#wlds_UnlabeledAbstract9"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_UnlabeledAbstract9_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_UnlabeledAbstract9" xlink:to="wlds_UnlabeledAbstract9_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Exercisable at end, Amount of options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Exercisable at end, Weighted average exercise price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Schedule of weighted-Average Assumptions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_UnlabeledAbstract10" xlink:href="wlds-20231231.xsd#wlds_UnlabeledAbstract10"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_UnlabeledAbstract10_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_UnlabeledAbstract10" xlink:to="wlds_UnlabeledAbstract10_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Expected dividend yield</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl" xml:lang="en-US">Expected stock price volatility</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk free interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions" xlink:href="wlds-20231231.xsd#wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions_lbl" xml:lang="en-US">Expected life of options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfOptionsToConsultantsTableTextBlock" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfOptionsToConsultantsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ScheduleOfOptionsToConsultantsTableTextBlock_lbl" xml:lang="en-US">Schedule of Options to Consultants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ScheduleOfOptionsToConsultantsTableTextBlock" xlink:to="wlds_ScheduleOfOptionsToConsultantsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms_lbl" xml:lang="en-US">In connection with</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xml:lang="en-US">No. of options issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl" xml:lang="en-US">No. of options exercisable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Exercise price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xml:lang="en-US">Schedule of Share-Based Compensation Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock_lbl" xml:lang="en-US">Schedule of Issuance of Equity Warrants to Investors and Associate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock" xlink:to="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xml:lang="en-US">Number of warrants/options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl0" xml:lang="en-US">Options available for grant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_lbl" xml:lang="en-US">Exercise price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio" xlink:href="wlds-20231231.xsd#wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio_lbl" xml:lang="en-US">Exercise ratio</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate" xlink:href="wlds-20231231.xsd#wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate_lbl" xml:lang="en-US">Expiration date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareBasedCompensationArrangementNotes" xlink:href="wlds-20231231.xsd#wlds_ShareBasedCompensationArrangementNotes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ShareBasedCompensationArrangementNotes_lbl" xml:lang="en-US">Notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareBasedCompensationArrangementNotes" xlink:to="wlds_ShareBasedCompensationArrangementNotes_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">TAXES ON INCOME</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">RELATED PARTIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US">Less imputed interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Exercised amount of options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Expired or forfeited amount of options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember" xlink:href="wlds-20231231.xsd#wlds_OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember_lbl" xml:lang="en-US">Office furniture and electronic equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember" xlink:to="wlds_OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ComputersAndSoftwareMember" xlink:href="wlds-20231231.xsd#wlds_ComputersAndSoftwareMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ComputersAndSoftwareMember_lbl" xml:lang="en-US">Computers and software	[Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ComputersAndSoftwareMember" xlink:to="wlds_ComputersAndSoftwareMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_MoldMember" xlink:href="wlds-20231231.xsd#wlds_MoldMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_MoldMember_lbl" xml:lang="en-US">Mold [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_MoldMember" xlink:to="wlds_MoldMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember" xlink:href="wlds-20231231.xsd#wlds_OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember_lbl" xml:lang="en-US">Office furniture and equipment and leasehold improvements [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember" xlink:to="wlds_OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ElectronicEquipmentMember" xlink:href="wlds-20231231.xsd#wlds_ElectronicEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ElectronicEquipmentMember_lbl" xml:lang="en-US">Electronic equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ElectronicEquipmentMember" xlink:to="wlds_ElectronicEquipmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_MachinesAndMoldsMember" xlink:href="wlds-20231231.xsd#wlds_MachinesAndMoldsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_MachinesAndMoldsMember_lbl" xml:lang="en-US">Machines and molds [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_MachinesAndMoldsMember" xlink:to="wlds_MachinesAndMoldsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_TwoThousandFifteenMember" xlink:href="wlds-20231231.xsd#wlds_TwoThousandFifteenMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_TwoThousandFifteenMember_lbl" xml:lang="en-US">2015 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TwoThousandFifteenMember" xlink:to="wlds_TwoThousandFifteenMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_TwoThousandSeventeenMember" xlink:href="wlds-20231231.xsd#wlds_TwoThousandSeventeenMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_TwoThousandSeventeenMember_lbl" xml:lang="en-US">2017 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TwoThousandSeventeenMember" xlink:to="wlds_TwoThousandSeventeenMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_TwoThousandTwentyoneMember" xlink:href="wlds-20231231.xsd#wlds_TwoThousandTwentyoneMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_TwoThousandTwentyoneMember_lbl" xml:lang="en-US">2021 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TwoThousandTwentyoneMember" xlink:to="wlds_TwoThousandTwentyoneMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_TwoThousandTwentyThreeMember" xlink:href="wlds-20231231.xsd#wlds_TwoThousandTwentyThreeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_TwoThousandTwentyThreeMember_lbl" xml:lang="en-US">2023 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TwoThousandTwentyThreeMember" xlink:to="wlds_TwoThousandTwentyThreeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xml:lang="en-US">Research and Development Expense [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SellingAndMarketingExpenseMember_lbl" xml:lang="en-US">Selling and Marketing Expense [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpenseMember" xlink:to="us-gaap_SellingAndMarketingExpenseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US">General and Administrative Expense [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_September132022Member" xlink:href="wlds-20231231.xsd#wlds_September132022Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_September132022Member_lbl" xml:lang="en-US">September 13, 2022 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_September132022Member" xlink:to="wlds_September132022Member_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_September152022OneMember" xlink:href="wlds-20231231.xsd#wlds_September152022OneMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_September152022OneMember_lbl" xml:lang="en-US">September 15, 2022 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_September152022OneMember" xlink:to="wlds_September152022OneMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_September152022TwoMember" xlink:href="wlds-20231231.xsd#wlds_September152022TwoMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_September152022TwoMember_lbl" xml:lang="en-US">September 15, 2022 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_September152022TwoMember" xlink:to="wlds_September152022TwoMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_September152022ThreeMember" xlink:href="wlds-20231231.xsd#wlds_September152022ThreeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_September152022ThreeMember_lbl" xml:lang="en-US">September 15, 2022 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_September152022ThreeMember" xlink:to="wlds_September152022ThreeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xml:lang="en-US">Related Party Transaction [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xml:lang="en-US">Class of Warrant or Right [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VariableRateAxis_lbl" xml:lang="en-US">Variable Rate [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCommitmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCommitmentsAxis_lbl" xml:lang="en-US">Other Commitments [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentsAxis" xlink:to="us-gaap_OtherCommitmentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party, Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_lbl" xml:lang="en-US">Partner Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" xlink:to="us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Acquisition [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xml:lang="en-US">Investment, Name [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_AnnualGrossRevenuesExceed" xlink:href="wlds-20231231.xsd#wlds_AnnualGrossRevenuesExceed"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_AnnualGrossRevenuesExceed_lbl" xml:lang="en-US">Annual gross revenues exceed</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AnnualGrossRevenuesExceed" xlink:to="wlds_AnnualGrossRevenuesExceed_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_OrdinarySharesWarrantsHeldByNonaffiliates" xlink:href="wlds-20231231.xsd#wlds_OrdinarySharesWarrantsHeldByNonaffiliates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_OrdinarySharesWarrantsHeldByNonaffiliates_lbl" xml:lang="en-US">Ordinary shares warrants held by non-affiliates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OrdinarySharesWarrantsHeldByNonaffiliates" xlink:to="wlds_OrdinarySharesWarrantsHeldByNonaffiliates_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_NonconvertibleDebtSecurities" xlink:href="wlds-20231231.xsd#wlds_NonconvertibleDebtSecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_NonconvertibleDebtSecurities_lbl" xml:lang="en-US">Non-convertible debt securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_NonconvertibleDebtSecurities" xlink:to="wlds_NonconvertibleDebtSecurities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xml:lang="en-US">Raised net proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_NetProceedsFromIssuanceSecondaryPublicOffering" xlink:href="wlds-20231231.xsd#wlds_NetProceedsFromIssuanceSecondaryPublicOffering"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_NetProceedsFromIssuanceSecondaryPublicOffering_lbl" xml:lang="en-US">Net proceeds from secondary</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_NetProceedsFromIssuanceSecondaryPublicOffering" xlink:to="wlds_NetProceedsFromIssuanceSecondaryPublicOffering_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_Warrants" xlink:href="wlds-20231231.xsd#wlds_Warrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_Warrants_lbl" xml:lang="en-US">Warrants (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_Warrants" xlink:to="wlds_Warrants_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Exercise price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl0" xml:lang="en-US">Exercise price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl1" xml:lang="en-US">Exercise price range (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl1"/>
    <loc xlink:type="locator" xlink:label="wlds_WarrantsExerciseIntoOrdinaryShares" xlink:href="wlds-20231231.xsd#wlds_WarrantsExerciseIntoOrdinaryShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_WarrantsExerciseIntoOrdinaryShares_lbl" xml:lang="en-US">Warrant exercised (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WarrantsExerciseIntoOrdinaryShares" xlink:to="wlds_WarrantsExerciseIntoOrdinaryShares_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ExercisePriceOfWarrant" xlink:href="wlds-20231231.xsd#wlds_ExercisePriceOfWarrant"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ExercisePriceOfWarrant_lbl" xml:lang="en-US">Exercise price of warrants (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ExercisePriceOfWarrant" xlink:to="wlds_ExercisePriceOfWarrant_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_GrossProceeds" xlink:href="wlds-20231231.xsd#wlds_GrossProceeds"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_GrossProceeds_lbl" xml:lang="en-US">Gross proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_GrossProceeds" xlink:to="wlds_GrossProceeds_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_UnderwritingNetProceed" xlink:href="wlds-20231231.xsd#wlds_UnderwritingNetProceed"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_UnderwritingNetProceed_lbl" xml:lang="en-US">Underwriting net proceed</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_UnderwritingNetProceed" xlink:to="wlds_UnderwritingNetProceed_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_UnderwritingDiscountsAndCommissions" xlink:href="wlds-20231231.xsd#wlds_UnderwritingDiscountsAndCommissions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_UnderwritingDiscountsAndCommissions_lbl" xml:lang="en-US">Underwriting discounts and commissions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_UnderwritingDiscountsAndCommissions" xlink:to="wlds_UnderwritingDiscountsAndCommissions_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_GrossAfterOtherIPOExpenses" xlink:href="wlds-20231231.xsd#wlds_GrossAfterOtherIPOExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_GrossAfterOtherIPOExpenses_lbl" xml:lang="en-US">Gross after other IPO expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_GrossAfterOtherIPOExpenses" xlink:to="wlds_GrossAfterOtherIPOExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Share price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharePrice_lbl0" xml:lang="en-US">Share price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl0"/>
    <loc xlink:type="locator" xlink:label="wlds_WarrantsExercisePricePerShare" xlink:href="wlds-20231231.xsd#wlds_WarrantsExercisePricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_WarrantsExercisePricePerShare_lbl" xml:lang="en-US">Warrant price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WarrantsExercisePricePerShare" xlink:to="wlds_WarrantsExercisePricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Ordinary share price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xml:lang="en-US">Net proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtWeightedAverageInterestRate_lbl" xml:lang="en-US">Weighted average interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtWeightedAverageInterestRate" xlink:to="us-gaap_DebtWeightedAverageInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeFinanceLeaseRenewalTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeFinanceLeaseRenewalTerm1_lbl" xml:lang="en-US">Lease term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:to="us-gaap_LesseeFinanceLeaseRenewalTerm1_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_RateOfMonthlySeverancePercentage" xlink:href="wlds-20231231.xsd#wlds_RateOfMonthlySeverancePercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_RateOfMonthlySeverancePercentage_lbl" xml:lang="en-US">Rate of monthly severance, percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_RateOfMonthlySeverancePercentage" xlink:to="wlds_RateOfMonthlySeverancePercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl" xml:lang="en-US">Leases remaining terms</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend_lbl" xml:lang="en-US">Leases extend term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:to="us-gaap_LesseeOperatingLeaseOptionToExtend_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xml:lang="en-US">Total operating leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_RoyaltiesRate" xlink:href="wlds-20231231.xsd#wlds_RoyaltiesRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_RoyaltiesRate_lbl" xml:lang="en-US">Royalties rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_RoyaltiesRate" xlink:to="wlds_RoyaltiesRate_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_GrantsReceivedEqualPercentageRate" xlink:href="wlds-20231231.xsd#wlds_GrantsReceivedEqualPercentageRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_GrantsReceivedEqualPercentageRate_lbl" xml:lang="en-US">Grants received equal percentage rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_GrantsReceivedEqualPercentageRate" xlink:to="wlds_GrantsReceivedEqualPercentageRate_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_AnnualAlternativeInterestPercentage" xlink:href="wlds-20231231.xsd#wlds_AnnualAlternativeInterestPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_AnnualAlternativeInterestPercentage_lbl" xml:lang="en-US">Annual alternative interest percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AnnualAlternativeInterestPercentage" xlink:to="wlds_AnnualAlternativeInterestPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_AnnualInterestRate" xlink:href="wlds-20231231.xsd#wlds_AnnualInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_AnnualInterestRate_lbl" xml:lang="en-US">Annual interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AnnualInterestRate" xlink:to="wlds_AnnualInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_FixedAnnualInterestRate" xlink:href="wlds-20231231.xsd#wlds_FixedAnnualInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_FixedAnnualInterestRate_lbl" xml:lang="en-US">Fixed annual interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_FixedAnnualInterestRate" xlink:to="wlds_FixedAnnualInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_AmountsReceivedAggregateAmount" xlink:href="wlds-20231231.xsd#wlds_AmountsReceivedAggregateAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_AmountsReceivedAggregateAmount_lbl" xml:lang="en-US">Amounts received aggregate amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AmountsReceivedAggregateAmount" xlink:to="wlds_AmountsReceivedAggregateAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_AmountOfDevelopmentProgram" xlink:href="wlds-20231231.xsd#wlds_AmountOfDevelopmentProgram"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_AmountOfDevelopmentProgram_lbl" xml:lang="en-US">Approved development program</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AmountOfDevelopmentProgram" xlink:to="wlds_AmountOfDevelopmentProgram_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_PercentageOfFinancing" xlink:href="wlds-20231231.xsd#wlds_PercentageOfFinancing"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_PercentageOfFinancing_lbl" xml:lang="en-US">Financing rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PercentageOfFinancing" xlink:to="wlds_PercentageOfFinancing_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_TotalCashReceivedFromTheIIA" xlink:href="wlds-20231231.xsd#wlds_TotalCashReceivedFromTheIIA"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_TotalCashReceivedFromTheIIA_lbl" xml:lang="en-US">Total cash received from the IIA</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TotalCashReceivedFromTheIIA" xlink:to="wlds_TotalCashReceivedFromTheIIA_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ExceptTransferProductionRight" xlink:href="wlds-20231231.xsd#wlds_ExceptTransferProductionRight"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ExceptTransferProductionRight_lbl" xml:lang="en-US">Except transfer production right</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ExceptTransferProductionRight" xlink:to="wlds_ExceptTransferProductionRight_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ProductionTransferred" xlink:href="wlds-20231231.xsd#wlds_ProductionTransferred"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ProductionTransferred_lbl" xml:lang="en-US">Production transferred</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProductionTransferred" xlink:to="wlds_ProductionTransferred_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_PayIncreasedRoyaltiesDescription" xlink:href="wlds-20231231.xsd#wlds_PayIncreasedRoyaltiesDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_PayIncreasedRoyaltiesDescription_lbl" xml:lang="en-US">Pay increased royalties, description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PayIncreasedRoyaltiesDescription" xlink:to="wlds_PayIncreasedRoyaltiesDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ResearchAndDevelopmentGrantsDetection" xlink:href="wlds-20231231.xsd#wlds_ResearchAndDevelopmentGrantsDetection"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ResearchAndDevelopmentGrantsDetection_lbl" xml:lang="en-US">Research and development grants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ResearchAndDevelopmentGrantsDetection" xlink:to="wlds_ResearchAndDevelopmentGrantsDetection_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_MaximumObligatinAmount" xlink:href="wlds-20231231.xsd#wlds_MaximumObligatinAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_MaximumObligatinAmount_lbl" xml:lang="en-US">Maximum obligatin amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_MaximumObligatinAmount" xlink:to="wlds_MaximumObligatinAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_GrantsReceivedFromTheIMEI" xlink:href="wlds-20231231.xsd#wlds_GrantsReceivedFromTheIMEI"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_GrantsReceivedFromTheIMEI_lbl" xml:lang="en-US">Grants received from the IMEI</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_GrantsReceivedFromTheIMEI" xlink:to="wlds_GrantsReceivedFromTheIMEI_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_SalesAndMarketingExpensesDeductions" xlink:href="wlds-20231231.xsd#wlds_SalesAndMarketingExpensesDeductions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_SalesAndMarketingExpensesDeductions_lbl" xml:lang="en-US">Sales and marketing deductions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_SalesAndMarketingExpensesDeductions" xlink:to="wlds_SalesAndMarketingExpensesDeductions_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenuesNetOfInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesNetOfInterestExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenuesNetOfInterestExpense_lbl" xml:lang="en-US">Revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesNetOfInterestExpense" xlink:to="us-gaap_RevenuesNetOfInterestExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_RoyaltiesRatePercentage" xlink:href="wlds-20231231.xsd#wlds_RoyaltiesRatePercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_RoyaltiesRatePercentage_lbl" xml:lang="en-US">Royalties rate percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_RoyaltiesRatePercentage" xlink:to="wlds_RoyaltiesRatePercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_MarketingGrantReceived" xlink:href="wlds-20231231.xsd#wlds_MarketingGrantReceived"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_MarketingGrantReceived_lbl" xml:lang="en-US">Marketing grant received</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_MarketingGrantReceived" xlink:to="wlds_MarketingGrantReceived_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrantsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrantsReceivableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GrantsReceivableCurrent_lbl" xml:lang="en-US">Maximum obligation amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrantsReceivableCurrent" xlink:to="us-gaap_GrantsReceivableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LeaseCost_lbl" xml:lang="en-US">Monthly lease payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_LeaseCost_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsForRent_lbl" xml:lang="en-US">Rent payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRent" xlink:to="us-gaap_PaymentsForRent_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_LeasePaymentIncreased" xlink:href="wlds-20231231.xsd#wlds_LeasePaymentIncreased"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_LeasePaymentIncreased_lbl" xml:lang="en-US">Lease payment increased</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_LeasePaymentIncreased" xlink:to="wlds_LeasePaymentIncreased_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_LeaseAgreements" xlink:href="wlds-20231231.xsd#wlds_LeaseAgreements"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_LeaseAgreements_lbl" xml:lang="en-US">Lease agreements vehicles</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_LeaseAgreements" xlink:to="wlds_LeaseAgreements_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_LeaseAgreementsPeriod" xlink:href="wlds-20231231.xsd#wlds_LeaseAgreementsPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_LeaseAgreementsPeriod_lbl" xml:lang="en-US">Lease agreements period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_LeaseAgreementsPeriod" xlink:to="wlds_LeaseAgreementsPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xml:lang="en-US">Aggregate amount (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Bearing interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Aggregate principal amount (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ConvertibleSecurityDescription" xlink:href="wlds-20231231.xsd#wlds_ConvertibleSecurityDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ConvertibleSecurityDescription_lbl" xml:lang="en-US">Convertible security, description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConvertibleSecurityDescription" xlink:to="wlds_ConvertibleSecurityDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_CashPayment" xlink:href="wlds-20231231.xsd#wlds_CashPayment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_CashPayment_lbl" xml:lang="en-US">Cash payment (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CashPayment" xlink:to="wlds_CashPayment_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_PremoneyValuationAmount" xlink:href="wlds-20231231.xsd#wlds_PremoneyValuationAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_PremoneyValuationAmount_lbl" xml:lang="en-US">Pre-money valuation amount (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PremoneyValuationAmount" xlink:to="wlds_PremoneyValuationAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_WarrantPricePerSharePercentage" xlink:href="wlds-20231231.xsd#wlds_WarrantPricePerSharePercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_WarrantPricePerSharePercentage_lbl" xml:lang="en-US">Warrant price per share percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WarrantPricePerSharePercentage" xlink:to="wlds_WarrantPricePerSharePercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_PurchasePricePerShare" xlink:href="wlds-20231231.xsd#wlds_PurchasePricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_PurchasePricePerShare_lbl" xml:lang="en-US">Purchase price per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PurchasePricePerShare" xlink:to="wlds_PurchasePricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_AggregateOrdinaryShares" xlink:href="wlds-20231231.xsd#wlds_AggregateOrdinaryShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_AggregateOrdinaryShares_lbl" xml:lang="en-US">Aggregate ordinary shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AggregateOrdinaryShares" xlink:to="wlds_AggregateOrdinaryShares_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherBorrowings"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherBorrowings_lbl" xml:lang="en-US">Initial credit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherBorrowings" xlink:to="us-gaap_OtherBorrowings_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xml:lang="en-US">Credit facility</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_AggregateAmount" xlink:href="wlds-20231231.xsd#wlds_AggregateAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_AggregateAmount_lbl" xml:lang="en-US">Aggregate amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AggregateAmount" xlink:to="wlds_AggregateAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_lbl" xml:lang="en-US">Credit facility bore interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:to="us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ServicesInExchangeForMonthlyBaseFee" xlink:href="wlds-20231231.xsd#wlds_ServicesInExchangeForMonthlyBaseFee"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ServicesInExchangeForMonthlyBaseFee_lbl" xml:lang="en-US">Services in exchange for monthly base fee</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ServicesInExchangeForMonthlyBaseFee" xlink:to="wlds_ServicesInExchangeForMonthlyBaseFee_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_AggrementTerm" xlink:href="wlds-20231231.xsd#wlds_AggrementTerm"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_AggrementTerm_lbl" xml:lang="en-US">Aggrement term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AggrementTerm" xlink:to="wlds_AggrementTerm_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_WarrantsIssuedPercentage" xlink:href="wlds-20231231.xsd#wlds_WarrantsIssuedPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_WarrantsIssuedPercentage_lbl" xml:lang="en-US">Warrants issued percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WarrantsIssuedPercentage" xlink:to="wlds_WarrantsIssuedPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_BaseMonthlyFeeImmediatelyIncreaseAmount" xlink:href="wlds-20231231.xsd#wlds_BaseMonthlyFeeImmediatelyIncreaseAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_BaseMonthlyFeeImmediatelyIncreaseAmount_lbl" xml:lang="en-US">Base monthly fee immediately increase amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_BaseMonthlyFeeImmediatelyIncreaseAmount" xlink:to="wlds_BaseMonthlyFeeImmediatelyIncreaseAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_OfferingOrFinancingTransactionAmount" xlink:href="wlds-20231231.xsd#wlds_OfferingOrFinancingTransactionAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_OfferingOrFinancingTransactionAmount_lbl" xml:lang="en-US">Offering or financing transaction amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OfferingOrFinancingTransactionAmount" xlink:to="wlds_OfferingOrFinancingTransactionAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_TransactionFeeClosingValue" xlink:href="wlds-20231231.xsd#wlds_TransactionFeeClosingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_TransactionFeeClosingValue_lbl" xml:lang="en-US">Transaction fee closing value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TransactionFeeClosingValue" xlink:to="wlds_TransactionFeeClosingValue_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ExpenseOnServiceRendering" xlink:href="wlds-20231231.xsd#wlds_ExpenseOnServiceRendering"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ExpenseOnServiceRendering_lbl" xml:lang="en-US">Total expense on service</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ExpenseOnServiceRendering" xlink:to="wlds_ExpenseOnServiceRendering_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_TotalValueOfTheShares" xlink:href="wlds-20231231.xsd#wlds_TotalValueOfTheShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_TotalValueOfTheShares_lbl" xml:lang="en-US">Total value of the shares (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TotalValueOfTheShares" xlink:to="wlds_TotalValueOfTheShares_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_OrdinaryShareParValue" xlink:href="wlds-20231231.xsd#wlds_OrdinaryShareParValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_OrdinaryShareParValue_lbl" xml:lang="en-US">Ordinary share par value (in New Shekels per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OrdinaryShareParValue" xlink:to="wlds_OrdinaryShareParValue_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ValueOfOrdinaryAShare" xlink:href="wlds-20231231.xsd#wlds_ValueOfOrdinaryAShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ValueOfOrdinaryAShare_lbl" xml:lang="en-US">Value of Ordinary A share (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ValueOfOrdinaryAShare" xlink:to="wlds_ValueOfOrdinaryAShare_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_InterestPercentage" xlink:href="wlds-20231231.xsd#wlds_InterestPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_InterestPercentage_lbl" xml:lang="en-US">Interest percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_InterestPercentage" xlink:to="wlds_InterestPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharesIssued_lbl" xml:lang="en-US">Ordinary A shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_AShareReclassifiedToOrdinaryShares" xlink:href="wlds-20231231.xsd#wlds_AShareReclassifiedToOrdinaryShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_AShareReclassifiedToOrdinaryShares_lbl" xml:lang="en-US">A share reclassified to ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AShareReclassifiedToOrdinaryShares" xlink:to="wlds_AShareReclassifiedToOrdinaryShares_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_OrdinarySharesAuthorizedIncreased" xlink:href="wlds-20231231.xsd#wlds_OrdinarySharesAuthorizedIncreased"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_OrdinarySharesAuthorizedIncreased_lbl" xml:lang="en-US">Ordinary shares authorized increased</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OrdinarySharesAuthorizedIncreased" xlink:to="wlds_OrdinarySharesAuthorizedIncreased_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_OrdinarySharesIssued" xlink:href="wlds-20231231.xsd#wlds_OrdinarySharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_OrdinarySharesIssued_lbl" xml:lang="en-US">Ordinary shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OrdinarySharesIssued" xlink:to="wlds_OrdinarySharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_OrdinarySharesWarrantExercisable" xlink:href="wlds-20231231.xsd#wlds_OrdinarySharesWarrantExercisable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_OrdinarySharesWarrantExercisable_lbl" xml:lang="en-US">Ordinary shares warrants exercisable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OrdinarySharesWarrantExercisable" xlink:to="wlds_OrdinarySharesWarrantExercisable_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_OrdinarySharesInConsiderationPercentage" xlink:href="wlds-20231231.xsd#wlds_OrdinarySharesInConsiderationPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_OrdinarySharesInConsiderationPercentage_lbl" xml:lang="en-US">Ordinary shares in consideration percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OrdinarySharesInConsiderationPercentage" xlink:to="wlds_OrdinarySharesInConsiderationPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_TotalConsiderationAmount" xlink:href="wlds-20231231.xsd#wlds_TotalConsiderationAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_TotalConsiderationAmount_lbl" xml:lang="en-US">Total consideration amount (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TotalConsiderationAmount" xlink:to="wlds_TotalConsiderationAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_IssuanceExpenses" xlink:href="wlds-20231231.xsd#wlds_IssuanceExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_IssuanceExpenses_lbl" xml:lang="en-US">Issuance expenses (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceExpenses" xlink:to="wlds_IssuanceExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US">Warrants to purchase</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_SAFEsAmount" xlink:href="wlds-20231231.xsd#wlds_SAFEsAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_SAFEsAmount_lbl" xml:lang="en-US">SAFEs amount (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_SAFEsAmount" xlink:to="wlds_SAFEsAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_Investor" xlink:href="wlds-20231231.xsd#wlds_Investor"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_Investor_lbl" xml:lang="en-US">Number of investor</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_Investor" xlink:to="wlds_Investor_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_InvestorAmount" xlink:href="wlds-20231231.xsd#wlds_InvestorAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_InvestorAmount_lbl" xml:lang="en-US">Investor amount (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_InvestorAmount" xlink:to="wlds_InvestorAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ConvertedAmount" xlink:href="wlds-20231231.xsd#wlds_ConvertedAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ConvertedAmount_lbl" xml:lang="en-US">Converted amount (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConvertedAmount" xlink:to="wlds_ConvertedAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ConvertedToOrdinaryShares" xlink:href="wlds-20231231.xsd#wlds_ConvertedToOrdinaryShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ConvertedToOrdinaryShares_lbl" xml:lang="en-US">Converted to ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConvertedToOrdinaryShares" xlink:to="wlds_ConvertedToOrdinaryShares_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US">Cash (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement_lbl" xml:lang="en-US">Aggregate amount (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:to="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ExercisableWarrantsToShares" xlink:href="wlds-20231231.xsd#wlds_ExercisableWarrantsToShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ExercisableWarrantsToShares_lbl" xml:lang="en-US">Exercised warrants to shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ExercisableWarrantsToShares" xlink:to="wlds_ExercisableWarrantsToShares_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xml:lang="en-US">Outstanding voting securities percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_InvestorsExercisedWarrants" xlink:href="wlds-20231231.xsd#wlds_InvestorsExercisedWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_InvestorsExercisedWarrants_lbl" xml:lang="en-US">Investors exercised warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_InvestorsExercisedWarrants" xlink:to="wlds_InvestorsExercisedWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_EmployeeExercisedWarrants" xlink:href="wlds-20231231.xsd#wlds_EmployeeExercisedWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_EmployeeExercisedWarrants_lbl" xml:lang="en-US">Employee exercised warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_EmployeeExercisedWarrants" xlink:to="wlds_EmployeeExercisedWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ExercisePricePerShare" xlink:href="wlds-20231231.xsd#wlds_ExercisePricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ExercisePricePerShare_lbl" xml:lang="en-US">Exercise price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ExercisePricePerShare" xlink:to="wlds_ExercisePricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ProceedsFromIssuanceFollowOnPublicOffering" xlink:href="wlds-20231231.xsd#wlds_ProceedsFromIssuanceFollowOnPublicOffering"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ProceedsFromIssuanceFollowOnPublicOffering_lbl" xml:lang="en-US">Gross proceeds (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProceedsFromIssuanceFollowOnPublicOffering" xlink:to="wlds_ProceedsFromIssuanceFollowOnPublicOffering_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_OrdinarySharePerValue" xlink:href="wlds-20231231.xsd#wlds_OrdinarySharePerValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_OrdinarySharePerValue_lbl" xml:lang="en-US">Ordinary share per value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OrdinarySharePerValue" xlink:to="wlds_OrdinarySharePerValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xml:lang="en-US">Options to ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_OptionsAvailableForGrant" xlink:href="wlds-20231231.xsd#wlds_OptionsAvailableForGrant"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_OptionsAvailableForGrant_lbl" xml:lang="en-US">Options available for grant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OptionsAvailableForGrant" xlink:to="wlds_OptionsAvailableForGrant_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xml:lang="en-US">Ordinary shares reserved for future issuance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Granted weighted average exercise price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_TerminationPeriod" xlink:href="wlds-20231231.xsd#wlds_TerminationPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_TerminationPeriod_lbl" xml:lang="en-US">Termination period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TerminationPeriod" xlink:to="wlds_TerminationPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Termination period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_IssuanceOfSharesOptions" xlink:href="wlds-20231231.xsd#wlds_IssuanceOfSharesOptions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_IssuanceOfSharesOptions_lbl" xml:lang="en-US">Ordinary Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfSharesOptions" xlink:to="wlds_IssuanceOfSharesOptions_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate" xlink:href="wlds-20231231.xsd#wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate_lbl" xml:lang="en-US">Fair value option grant date (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_OptionsExpenses" xlink:href="wlds-20231231.xsd#wlds_OptionsExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_OptionsExpenses_lbl" xml:lang="en-US">Option expenses (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OptionsExpenses" xlink:to="wlds_OptionsExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_VestingPeriods" xlink:href="wlds-20231231.xsd#wlds_VestingPeriods"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_VestingPeriods_lbl" xml:lang="en-US">Vesting periods</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_VestingPeriods" xlink:to="wlds_VestingPeriods_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ExercisePriceOfWarrants" xlink:href="wlds-20231231.xsd#wlds_ExercisePriceOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ExercisePriceOfWarrants_lbl" xml:lang="en-US">Exercise of warrants (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ExercisePriceOfWarrants" xlink:to="wlds_ExercisePriceOfWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xml:lang="en-US">Warrant period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_WarrantBeReducedToAnExercisePricePercentage" xlink:href="wlds-20231231.xsd#wlds_WarrantBeReducedToAnExercisePricePercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_WarrantBeReducedToAnExercisePricePercentage_lbl" xml:lang="en-US">Warrant be reduced to an exercise price percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WarrantBeReducedToAnExercisePricePercentage" xlink:to="wlds_WarrantBeReducedToAnExercisePricePercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_InitialExercisePricePercentage" xlink:href="wlds-20231231.xsd#wlds_InitialExercisePricePercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_InitialExercisePricePercentage_lbl" xml:lang="en-US">Initial exercise price percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_InitialExercisePricePercentage" xlink:to="wlds_InitialExercisePricePercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_WeightedAveragePricePercentage" xlink:href="wlds-20231231.xsd#wlds_WeightedAveragePricePercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_WeightedAveragePricePercentage_lbl" xml:lang="en-US">Weighted average price percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WeightedAveragePricePercentage" xlink:to="wlds_WeightedAveragePricePercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_LowestResetPrice" xlink:href="wlds-20231231.xsd#wlds_LowestResetPrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_LowestResetPrice_lbl" xml:lang="en-US">Lowest reset price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_LowestResetPrice" xlink:to="wlds_LowestResetPrice_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_InitialExercisePricesPercentage" xlink:href="wlds-20231231.xsd#wlds_InitialExercisePricesPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_InitialExercisePricesPercentage_lbl" xml:lang="en-US">Initial exercise price percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_InitialExercisePricesPercentage" xlink:to="wlds_InitialExercisePricesPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_CorporateTaxRatePercentage" xlink:href="wlds-20231231.xsd#wlds_CorporateTaxRatePercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_CorporateTaxRatePercentage_lbl" xml:lang="en-US">Corporate tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CorporateTaxRatePercentage" xlink:to="wlds_CorporateTaxRatePercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Carryforward tax losses (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Federal tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_PercentageOfOwnership" xlink:href="wlds-20231231.xsd#wlds_PercentageOfOwnership"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_PercentageOfOwnership_lbl" xml:lang="en-US">Percentage of ownership</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PercentageOfOwnership" xlink:to="wlds_PercentageOfOwnership_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_EmploymentExpenses" xlink:href="wlds-20231231.xsd#wlds_EmploymentExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_EmploymentExpenses_lbl" xml:lang="en-US">Employment expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_EmploymentExpenses" xlink:to="wlds_EmploymentExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_OfficerEmployeeMonthlySalary" xlink:href="wlds-20231231.xsd#wlds_OfficerEmployeeMonthlySalary"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_OfficerEmployeeMonthlySalary_lbl" xml:lang="en-US">Officer employee monthly salary (in New Shekels)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OfficerEmployeeMonthlySalary" xlink:to="wlds_OfficerEmployeeMonthlySalary_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_RelatedPartyMonthlySalary" xlink:href="wlds-20231231.xsd#wlds_RelatedPartyMonthlySalary"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_RelatedPartyMonthlySalary_lbl" xml:lang="en-US">Monthly salary</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_RelatedPartyMonthlySalary" xlink:to="wlds_RelatedPartyMonthlySalary_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of consolidation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of estimates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">Foreign currency</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US">Inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xml:lang="en-US">Leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue recognition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_CostOfRevenuesPolicyTextBlock" xlink:href="wlds-20231231.xsd#wlds_CostOfRevenuesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_CostOfRevenuesPolicyTextBlock_lbl" xml:lang="en-US">Cost of revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CostOfRevenuesPolicyTextBlock" xlink:to="wlds_CostOfRevenuesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and development</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_GovernmentalGrantsPolicyTextBlock" xlink:href="wlds-20231231.xsd#wlds_GovernmentalGrantsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_GovernmentalGrantsPolicyTextBlock_lbl" xml:lang="en-US">Governmental grants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_GovernmentalGrantsPolicyTextBlock" xlink:to="wlds_GovernmentalGrantsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock" xlink:href="wlds-20231231.xsd#wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock_lbl" xml:lang="en-US">Finance income and expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock" xlink:to="wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Share based compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_WarrantsPolicyPolicyTextBlock" xlink:href="wlds-20231231.xsd#wlds_WarrantsPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_WarrantsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WarrantsPolicyPolicyTextBlock" xlink:to="wlds_WarrantsPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_SeverancePolicyTextBlock" xlink:href="wlds-20231231.xsd#wlds_SeverancePolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_SeverancePolicyTextBlock_lbl" xml:lang="en-US">Severance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_SeverancePolicyTextBlock" xlink:to="wlds_SeverancePolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Basic and diluted loss per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xml:lang="en-US">Fair Value Measurements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration of Credit Risk</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and cash equivalents</label>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrYE9rliDcrbWhjsc3i7BCl/DvlJVwr+JR0O2nYady5Se133BDWCF8ON/Jzif84CehHV5r9vMQwYxP2psHDnPZsunu1t2oh0qhdKXAlJyzN93OrPInDu+qpjJa2tGyv2XwvSkfjcWfQLzhpm2ZADneXuFkrcNjL16FM7h6sOb4n/vSj6ATmkI0Ua4rjBBddfCaAuhU1/2xOpLmCakF9R+SCp] CSR-->
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Segment Information</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Subsequent Events</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:to="us-gaap_SubsequentEventsPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_MudraInspireDevelopmentKitsMember" xlink:href="wlds-20231231.xsd#wlds_MudraInspireDevelopmentKitsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_MudraInspireDevelopmentKitsMember_lbl" xml:lang="en-US">Mudra Inspire Development Kits Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_MudraInspireDevelopmentKitsMember" xlink:to="wlds_MudraInspireDevelopmentKitsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IPOMember_lbl" xml:lang="en-US">IPO [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OverAllotmentOptionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OverAllotmentOptionMember_lbl" xml:lang="en-US">Over-Allotment Option [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OverAllotmentOptionMember" xlink:to="us-gaap_OverAllotmentOptionMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_LeaseLiabilityMember" xlink:href="wlds-20231231.xsd#wlds_LeaseLiabilityMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_LeaseLiabilityMember_lbl" xml:lang="en-US">Lease Liability [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_LeaseLiabilityMember" xlink:to="wlds_LeaseLiabilityMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_lbl" xml:lang="en-US">SOFR Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:to="us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_IIAMember" xlink:href="wlds-20231231.xsd#wlds_IIAMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_IIAMember_lbl" xml:lang="en-US">IIA [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IIAMember" xlink:to="wlds_IIAMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_IMEIMember" xlink:href="wlds-20231231.xsd#wlds_IMEIMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_IMEIMember_lbl" xml:lang="en-US">IMEI [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IMEIMember" xlink:to="wlds_IMEIMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ScenarioForecastMember_lbl" xml:lang="en-US">Forecast [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseAgreementsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LeaseAgreementsMember_lbl" xml:lang="en-US">Lease Agreements [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseAgreementsMember" xlink:to="us-gaap_LeaseAgreementsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VehiclesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VehiclesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_VehiclesMember_lbl" xml:lang="en-US">Vehicles [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VehiclesMember" xlink:to="us-gaap_VehiclesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ConvertibleSecuritiesMember" xlink:href="wlds-20231231.xsd#wlds_ConvertibleSecuritiesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ConvertibleSecuritiesMember_lbl" xml:lang="en-US">Convertible Security Agreements [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConvertibleSecuritiesMember" xlink:to="wlds_ConvertibleSecuritiesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_CofoundersMember" xlink:href="wlds-20231231.xsd#wlds_CofoundersMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_CofoundersMember_lbl" xml:lang="en-US">Co-founders [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CofoundersMember" xlink:to="wlds_CofoundersMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestorMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestorMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestorMember_lbl" xml:lang="en-US">Investor [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestorMember" xlink:to="us-gaap_InvestorMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl" xml:lang="en-US">Series of Individually Immaterial Business Acquisitions [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_TwoZeroOneFiveMember" xlink:href="wlds-20231231.xsd#wlds_TwoZeroOneFiveMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_TwoZeroOneFiveMember_lbl" xml:lang="en-US">2015 Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TwoZeroOneFiveMember" xlink:to="wlds_TwoZeroOneFiveMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_BoardOfDirectorsChairmanMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_BoardOfDirectorsChairmanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_BoardOfDirectorsChairmanMember_lbl" xml:lang="en-US">Board of Directors [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_BoardOfDirectorsChairmanMember" xlink:to="srt_BoardOfDirectorsChairmanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_DirectorMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_DirectorMember_lbl" xml:lang="en-US">Director [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_DirectorMember" xlink:to="srt_DirectorMember_lbl"/>
    <loc xlink:type="locator" xlink:label="country_IL" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_IL_lbl" xml:lang="en-US">Israeli [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_IL" xlink:to="country_IL_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_AsherDahanMember" xlink:href="wlds-20231231.xsd#wlds_AsherDahanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_AsherDahanMember_lbl" xml:lang="en-US">Asher Dahan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AsherDahanMember" xlink:to="wlds_AsherDahanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US">Class of Stock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US">Equity Component [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeMember_lbl" xml:lang="en-US">Statistical Measurement [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_SignificantAccountingPoliciesDetailsScheduleofAnnualRatesofDepreciationTable" xlink:href="wlds-20231231.xsd#wlds_SignificantAccountingPoliciesDetailsScheduleofAnnualRatesofDepreciationTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_SignificantAccountingPoliciesDetailsScheduleofAnnualRatesofDepreciationTable_lbl" xml:lang="en-US">Significant Accounting Policies (Details) - Schedule of Annual Rates of Depreciation [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_SignificantAccountingPoliciesDetailsScheduleofAnnualRatesofDepreciationTable" xlink:to="wlds_SignificantAccountingPoliciesDetailsScheduleofAnnualRatesofDepreciationTable_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_AnnualRatesOfDepreciationLineItems" xlink:href="wlds-20231231.xsd#wlds_AnnualRatesOfDepreciationLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_AnnualRatesOfDepreciationLineItems_lbl" xml:lang="en-US">Schedule of Annual Rates of Depreciation [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AnnualRatesOfDepreciationLineItems" xlink:to="wlds_AnnualRatesOfDepreciationLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property Plant and Equipment [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareholdersEquityDeficitDetailsScheduleofShareCapitalTable" xlink:href="wlds-20231231.xsd#wlds_ShareholdersEquityDeficitDetailsScheduleofShareCapitalTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ShareholdersEquityDeficitDetailsScheduleofShareCapitalTable_lbl" xml:lang="en-US">Shareholders&#8217; Equity (Deficit) (Details) - Schedule of Share Capital [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareholdersEquityDeficitDetailsScheduleofShareCapitalTable" xlink:to="wlds_ShareholdersEquityDeficitDetailsScheduleofShareCapitalTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCapitalizationEquityLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCapitalizationEquityLineItems_lbl" xml:lang="en-US">Schedule of share capital [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:to="us-gaap_ScheduleOfCapitalizationEquityLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareholdersEquityDeficitDetailsScheduleofShareCapitalParentheticalsTable" xlink:href="wlds-20231231.xsd#wlds_ShareholdersEquityDeficitDetailsScheduleofShareCapitalParentheticalsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ShareholdersEquityDeficitDetailsScheduleofShareCapitalParentheticalsTable_lbl" xml:lang="en-US">Shareholders&#8217; Equity (Deficit) (Details) - Schedule of Share Capital (Parentheticals) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareholdersEquityDeficitDetailsScheduleofShareCapitalParentheticalsTable" xlink:to="wlds_ShareholdersEquityDeficitDetailsScheduleofShareCapitalParentheticalsTable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfCapitalizationEquityLineItems_lbl0" xml:lang="en-US">Schedule of share capital [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:to="us-gaap_ScheduleOfCapitalizationEquityLineItems_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardDateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardDateDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardDateDomain_lbl" xml:lang="en-US">Award Date [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardDateDomain" xlink:to="us-gaap_AwardDateDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareholdersEquityDeficitDetailsScheduleofOptionstoConsultantsTable" xlink:href="wlds-20231231.xsd#wlds_ShareholdersEquityDeficitDetailsScheduleofOptionstoConsultantsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ShareholdersEquityDeficitDetailsScheduleofOptionstoConsultantsTable_lbl" xml:lang="en-US">Shareholders&#8217; Equity (Deficit) (Details) - Schedule of Options to Consultants [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareholdersEquityDeficitDetailsScheduleofOptionstoConsultantsTable" xlink:to="wlds_ShareholdersEquityDeficitDetailsScheduleofOptionstoConsultantsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfOptionsToConsultantsLineItems" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfOptionsToConsultantsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ScheduleOfOptionsToConsultantsLineItems_lbl" xml:lang="en-US">Schedule of Options to Consultants [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ScheduleOfOptionsToConsultantsLineItems" xlink:to="wlds_ScheduleOfOptionsToConsultantsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xml:lang="en-US">Income Statement Location [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfShareBasedCompensationExpensesLineItems" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfShareBasedCompensationExpensesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ScheduleOfShareBasedCompensationExpensesLineItems_lbl" xml:lang="en-US">Schedule of Share-Based Compensation Expenses [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ScheduleOfShareBasedCompensationExpensesLineItems" xlink:to="wlds_ScheduleOfShareBasedCompensationExpensesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xml:lang="en-US">Award Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareholdersEquityDeficitDetailsScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable" xlink:href="wlds-20231231.xsd#wlds_ShareholdersEquityDeficitDetailsScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ShareholdersEquityDeficitDetailsScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable_lbl" xml:lang="en-US">Shareholders&#8217; Equity (Deficit) (Details) - Schedule of Issuance of Equity Warrants to Investors and Associate [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareholdersEquityDeficitDetailsScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable" xlink:to="wlds_ShareholdersEquityDeficitDetailsScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateLineItems" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateLineItems_lbl" xml:lang="en-US">Schedule of Issuance of Equity Warrants to Investors and Associate [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateLineItems" xlink:to="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionDomain_lbl" xml:lang="en-US">Related Party Transaction [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="us-gaap_RelatedPartyTransactionDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xml:lang="en-US">Subsequent Event Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xml:lang="en-US">Sale of Stock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xml:lang="en-US">Class of Warrant or Right [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_GeneralDetailsTable" xlink:href="wlds-20231231.xsd#wlds_GeneralDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_GeneralDetailsTable_lbl" xml:lang="en-US">General (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_GeneralDetailsTable" xlink:to="wlds_GeneralDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_GeneralLineItems" xlink:href="wlds-20231231.xsd#wlds_GeneralLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_GeneralLineItems_lbl" xml:lang="en-US">General [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_GeneralLineItems" xlink:to="wlds_GeneralLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xml:lang="en-US">Debt Instrument, Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_SignificantAccountingPoliciesDetailsTable" xlink:href="wlds-20231231.xsd#wlds_SignificantAccountingPoliciesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_SignificantAccountingPoliciesDetailsTable_lbl" xml:lang="en-US">Significant Accounting Policies (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_SignificantAccountingPoliciesDetailsTable" xlink:to="wlds_SignificantAccountingPoliciesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_SignificantAccountingPoliciesDetailsLineItems" xlink:href="wlds-20231231.xsd#wlds_SignificantAccountingPoliciesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_SignificantAccountingPoliciesDetailsLineItems_lbl" xml:lang="en-US">Significant Accounting Policies [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_SignificantAccountingPoliciesDetailsLineItems" xlink:to="wlds_SignificantAccountingPoliciesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xml:lang="en-US">Scenario [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioUnspecifiedDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCommitmentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCommitmentsDomain_lbl" xml:lang="en-US">Other Commitments [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentsDomain" xlink:to="us-gaap_OtherCommitmentsDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VariableRateDomain_lbl" xml:lang="en-US">Variable Rate [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_VariableRateDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_CommitmentsandContingenciesDetailsTable" xlink:href="wlds-20231231.xsd#wlds_CommitmentsandContingenciesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_CommitmentsandContingenciesDetailsTable_lbl" xml:lang="en-US">Commitments and Contingencies (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CommitmentsandContingenciesDetailsTable" xlink:to="wlds_CommitmentsandContingenciesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_CommitmentsandContingenciesDetailsLineItems" xlink:href="wlds-20231231.xsd#wlds_CommitmentsandContingenciesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_CommitmentsandContingenciesDetailsLineItems_lbl" xml:lang="en-US">Commitments and Contingencies [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CommitmentsandContingenciesDetailsLineItems" xlink:to="wlds_CommitmentsandContingenciesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ConvertibleSecuritiesDetailsTable" xlink:href="wlds-20231231.xsd#wlds_ConvertibleSecuritiesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ConvertibleSecuritiesDetailsTable_lbl" xml:lang="en-US">Convertible Securities (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConvertibleSecuritiesDetailsTable" xlink:to="wlds_ConvertibleSecuritiesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ConvertibleSecuritiesLineItems" xlink:href="wlds-20231231.xsd#wlds_ConvertibleSecuritiesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ConvertibleSecuritiesLineItems_lbl" xml:lang="en-US">Convertible Securities [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConvertibleSecuritiesLineItems" xlink:to="wlds_ConvertibleSecuritiesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_CreditFacilityDetailsTable" xlink:href="wlds-20231231.xsd#wlds_CreditFacilityDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_CreditFacilityDetailsTable_lbl" xml:lang="en-US">Credit Facility (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CreditFacilityDetailsTable" xlink:to="wlds_CreditFacilityDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityLineItems_lbl" xml:lang="en-US">Credit Facility [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_LineOfCreditFacilityLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyDomain_lbl" xml:lang="en-US">Related Party, Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_lbl" xml:lang="en-US">Partner Type of Partners&apos; Capital Account, Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" xlink:to="us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xml:lang="en-US">Title of Individual [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareholdersEquityDeficitDetailsTable" xlink:href="wlds-20231231.xsd#wlds_ShareholdersEquityDeficitDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ShareholdersEquityDeficitDetailsTable_lbl" xml:lang="en-US">Shareholders&#8217; Equity (Deficit) (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareholdersEquityDeficitDetailsTable" xlink:to="wlds_ShareholdersEquityDeficitDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareholdersEquityLineItems" xlink:href="wlds-20231231.xsd#wlds_ShareholdersEquityLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ShareholdersEquityLineItems_lbl" xml:lang="en-US">Shareholder&apos;s Equity [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareholdersEquityLineItems" xlink:to="wlds_ShareholdersEquityLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_SegmentGeographicalDomain_lbl" xml:lang="en-US">Geographical [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_SegmentGeographicalDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_TaxesonIncomeDetailsTable" xlink:href="wlds-20231231.xsd#wlds_TaxesonIncomeDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_TaxesonIncomeDetailsTable_lbl" xml:lang="en-US">Taxes on Income (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TaxesonIncomeDetailsTable" xlink:to="wlds_TaxesonIncomeDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxContingencyLineItems_lbl" xml:lang="en-US">Income Taxes [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_IncomeTaxContingencyLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_EquityMethodInvesteeNameDomain_lbl" xml:lang="en-US">Investment, Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="srt_EquityMethodInvesteeNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_RelatedPartiesDetailsTable" xlink:href="wlds-20231231.xsd#wlds_RelatedPartiesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_RelatedPartiesDetailsTable_lbl" xml:lang="en-US">Related Parties (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_RelatedPartiesDetailsTable" xlink:to="wlds_RelatedPartiesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xml:lang="en-US">Related Parties [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_AShareReclassifiedToOrdinaryShares_lbl0" xml:lang="en-US">Shares of a share reclassified to ordinary shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AShareReclassifiedToOrdinaryShares" xlink:to="wlds_AShareReclassifiedToOrdinaryShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_AccruedInterestOnConvertibleSecurities_lbl0" xml:lang="en-US">Amount of accrued interest on convertible securities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AccruedInterestOnConvertibleSecurities" xlink:to="wlds_AccruedInterestOnConvertibleSecurities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_AccruedInterestOnDeposits_lbl0" xml:lang="en-US">Represent the amount of accrued interest on deposit.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AccruedInterestOnDeposits" xlink:to="wlds_AccruedInterestOnDeposits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_AdvanceFromCustomers_lbl0" xml:lang="en-US">It represent advances from customers.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AdvanceFromCustomers" xlink:to="wlds_AdvanceFromCustomers_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_AggregateAmount_lbl0" xml:lang="en-US">An aggregate amount or score is made up of several smaller amounts or scores added together.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AggregateAmount" xlink:to="wlds_AggregateAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_AggregateOrdinaryShares_lbl0" xml:lang="en-US">Number of shares of aggregate ordinary shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AggregateOrdinaryShares" xlink:to="wlds_AggregateOrdinaryShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_AggrementTerm_lbl0" xml:lang="en-US">Aggrement term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AggrementTerm" xlink:to="wlds_AggrementTerm_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_AmountOfDevelopmentProgram_lbl0" xml:lang="en-US">The amount of development program.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AmountOfDevelopmentProgram" xlink:to="wlds_AmountOfDevelopmentProgram_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_AmountsReceivedAggregateAmount_lbl0" xml:lang="en-US">The amounts received aggregate amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AmountsReceivedAggregateAmount" xlink:to="wlds_AmountsReceivedAggregateAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_AnnualAlternativeInterestPercentage_lbl0" xml:lang="en-US">The percentage as an alternative annual interest rate published by bank of israel.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AnnualAlternativeInterestPercentage" xlink:to="wlds_AnnualAlternativeInterestPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_AnnualGrossRevenuesExceed_lbl0" xml:lang="en-US">Amount of annual gross revenues exceed.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AnnualGrossRevenuesExceed" xlink:to="wlds_AnnualGrossRevenuesExceed_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_AnnualInterestRate_lbl0" xml:lang="en-US">Annual interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AnnualInterestRate" xlink:to="wlds_AnnualInterestRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_AnnualRateOfDepreciation_lbl0" xml:lang="en-US">The percentage of annual rate of depreciation.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AnnualRateOfDepreciation" xlink:to="wlds_AnnualRateOfDepreciation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_BaseMonthlyFeeImmediatelyIncreaseAmount_lbl0" xml:lang="en-US">The amount of base monthly fee immediately increase amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_BaseMonthlyFeeImmediatelyIncreaseAmount" xlink:to="wlds_BaseMonthlyFeeImmediatelyIncreaseAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_CashPayment_lbl0" xml:lang="en-US">Cash payment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CashPayment" xlink:to="wlds_CashPayment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ConversionOfOrdinaryASharesToOrdinaryShares_lbl0" xml:lang="en-US">It represent number of ordinary A shares converted to ordinary shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConversionOfOrdinaryASharesToOrdinaryShares" xlink:to="wlds_ConversionOfOrdinaryASharesToOrdinaryShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ConversionOfOrdinaryASharesToOrdinarySharesValue_lbl0" xml:lang="en-US">Aggregate value of stock related to A share converted to ordinary shares during the period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConversionOfOrdinaryASharesToOrdinarySharesValue" xlink:to="wlds_ConversionOfOrdinaryASharesToOrdinarySharesValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ConversionOfSAFEToEquity_lbl0" xml:lang="en-US">The amount of conversion of SAFE to equity.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConversionOfSAFEToEquity" xlink:to="wlds_ConversionOfSAFEToEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering_lbl0" xml:lang="en-US">Conversion of SAFEs into ordinary shares upon completion of initial public offering.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering" xlink:to="wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ConvertedAmount_lbl0" xml:lang="en-US">The amount of Converted.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConvertedAmount" xlink:to="wlds_ConvertedAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ConvertedToOrdinaryShares_lbl0" xml:lang="en-US">Number of converted to ordinary shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConvertedToOrdinaryShares" xlink:to="wlds_ConvertedToOrdinaryShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ConvertibleSecurityDescription_lbl0" xml:lang="en-US">Convertible security is a security usually a bond or a preferred stock that can be converted into a different security typically shares of the company&apos;s common stock.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConvertibleSecurityDescription" xlink:to="wlds_ConvertibleSecurityDescription_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_CorporateTaxRatePercentage_lbl0" xml:lang="en-US">Percentage of the corporate tax rate.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CorporateTaxRatePercentage" xlink:to="wlds_CorporateTaxRatePercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_CostOfRevenuesPolicyTextBlock_lbl0" xml:lang="en-US">Policy of cost of revenue.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CostOfRevenuesPolicyTextBlock" xlink:to="wlds_CostOfRevenuesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_CreditFacilityDisclosureTextBlock_lbl0" xml:lang="en-US">The entire disclosure for credit facility.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CreditFacilityDisclosureTextBlock" xlink:to="wlds_CreditFacilityDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_DecreaseincreaseInGovernmentalGrantsReceivables_lbl0" xml:lang="en-US">Amount of decrease increase in governmental grants receivables.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_DecreaseincreaseInGovernmentalGrantsReceivables" xlink:to="wlds_DecreaseincreaseInGovernmentalGrantsReceivables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_EmployeeExercisedWarrants_lbl0" xml:lang="en-US">Employee exercised warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_EmployeeExercisedWarrants" xlink:to="wlds_EmployeeExercisedWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_EmploymentExpenses_lbl0" xml:lang="en-US">Represent the amount of expense on employment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_EmploymentExpenses" xlink:to="wlds_EmploymentExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ExceptTransferProductionRight_lbl0" xml:lang="en-US">Except transfer production right.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ExceptTransferProductionRight" xlink:to="wlds_ExceptTransferProductionRight_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ExercisableWarrantsToShares_lbl0" xml:lang="en-US">Exercisable warrants to shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ExercisableWarrantsToShares" xlink:to="wlds_ExercisableWarrantsToShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ExercisePriceOfWarrant_lbl0" xml:lang="en-US">Exercise price of warrant.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ExercisePriceOfWarrant" xlink:to="wlds_ExercisePriceOfWarrant_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ExercisePriceOfWarrants_lbl0" xml:lang="en-US">Per share or per unit amount of exercise price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ExercisePriceOfWarrants" xlink:to="wlds_ExercisePriceOfWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ExercisePricePerShare_lbl0" xml:lang="en-US">Exercise price per share.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ExercisePricePerShare" xlink:to="wlds_ExercisePricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ExpenseOnServiceRendering_lbl0" xml:lang="en-US">Represent the amount of expense on service rendering.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ExpenseOnServiceRendering" xlink:to="wlds_ExpenseOnServiceRendering_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy for finance income and expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock" xlink:to="wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_FixedAnnualInterestRate_lbl0" xml:lang="en-US">Fixed annual interest rate.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_FixedAnnualInterestRate" xlink:to="wlds_FixedAnnualInterestRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_GovernmentalGrantsPolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy for governmental grants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_GovernmentalGrantsPolicyTextBlock" xlink:to="wlds_GovernmentalGrantsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_GrantsReceivedFromTheIMEI_lbl0" xml:lang="en-US">Grants received from the IMEI.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_GrantsReceivedFromTheIMEI" xlink:to="wlds_GrantsReceivedFromTheIMEI_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_GrossAfterOtherIPOExpenses_lbl0" xml:lang="en-US">The amunt of gross after other IPO expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_GrossAfterOtherIPOExpenses" xlink:to="wlds_GrossAfterOtherIPOExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_GrossProceeds_lbl0" xml:lang="en-US">The amount of the IPO gross proceeds.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_GrossProceeds" xlink:to="wlds_GrossProceeds_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_IncreaseDecreaseInAdvancePayments_lbl0" xml:lang="en-US">Amount of advances from customers.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IncreaseDecreaseInAdvancePayments" xlink:to="wlds_IncreaseDecreaseInAdvancePayments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_IncreaseDecreaseInAdvancePaymentsOnGovernmentalGrant_lbl0" xml:lang="en-US">Amount of increase decrease in advance payments on governmental grant.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IncreaseDecreaseInAdvancePaymentsOnGovernmentalGrant" xlink:to="wlds_IncreaseDecreaseInAdvancePaymentsOnGovernmentalGrant_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_IncreaseInOtherReceivablesAndPrepaidExpenses_lbl0" xml:lang="en-US">Increase in other receivables and prepaid expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IncreaseInOtherReceivablesAndPrepaidExpenses" xlink:to="wlds_IncreaseInOtherReceivablesAndPrepaidExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_InitialExercisePricePercentage_lbl0" xml:lang="en-US">Initial exercise price percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_InitialExercisePricePercentage" xlink:to="wlds_InitialExercisePricePercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_InitialExercisePricesPercentage_lbl0" xml:lang="en-US">Initial exercise price percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_InitialExercisePricesPercentage" xlink:to="wlds_InitialExercisePricesPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_InterestExpenseAndExchangeRate_lbl0" xml:lang="en-US">Represents the amount of financing income (expenses), net.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_InterestExpenseAndExchangeRate" xlink:to="wlds_InterestExpenseAndExchangeRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_InterestPercentage_lbl0" xml:lang="en-US">Interest percentage of return on investments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_InterestPercentage" xlink:to="wlds_InterestPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_InterestReceivedFromDeposits_lbl0" xml:lang="en-US">The amount of interest received from deposits.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_InterestReceivedFromDeposits" xlink:to="wlds_InterestReceivedFromDeposits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_Investor_lbl0" xml:lang="en-US">Number of investors.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_Investor" xlink:to="wlds_Investor_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_InvestorAmount_lbl0" xml:lang="en-US">The amount of Investor.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_InvestorAmount" xlink:to="wlds_InvestorAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_InvestorsExercisedWarrants_lbl0" xml:lang="en-US">Shares of investors exercised warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_InvestorsExercisedWarrants" xlink:to="wlds_InvestorsExercisedWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_IssuanceExpenses_lbl0" xml:lang="en-US">Amount of issuance expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceExpenses" xlink:to="wlds_IssuanceExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost_lbl0" xml:lang="en-US">It represent issuance of ordinary shares and warrants, net of issuance cost.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost" xlink:to="wlds_IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants_lbl0" xml:lang="en-US">Value of stock issued during the period upon the conversion of warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" xlink:to="wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrantsinShares_lbl0" xml:lang="en-US">Issuance of ordinary shares as a result of exercise of warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrantsinShares" xlink:to="wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrantsinShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_IssuanceOfSharesOptions_lbl0" xml:lang="en-US">Issuance of share options provides financial incentives for investors; or performance incentives for shareholders who are active in the operations of the company&apos;s business.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfSharesOptions" xlink:to="wlds_IssuanceOfSharesOptions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet_lbl0" xml:lang="en-US">Amount of issuance of units of ordinary shares and warrants in connection with the initial public offering.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet" xlink:to="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares_lbl0" xml:lang="en-US">Issuance of units of ordinary shares and warrants in connection with the initial public offering shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares" xlink:to="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_LeaseAgreements_lbl0" xml:lang="en-US">Lease agreements.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_LeaseAgreements" xlink:to="wlds_LeaseAgreements_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_LeaseAgreementsPeriod_lbl0" xml:lang="en-US">Lease agreements period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_LeaseAgreementsPeriod" xlink:to="wlds_LeaseAgreementsPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_LeasePaymentIncreased_lbl0" xml:lang="en-US">Lease payment increased.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_LeasePaymentIncreased" xlink:to="wlds_LeasePaymentIncreased_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_LowestResetPrice_lbl0" xml:lang="en-US">Lowest reset price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_LowestResetPrice" xlink:to="wlds_LowestResetPrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_MarketingGrantReceived_lbl0" xml:lang="en-US">Marketing grant received percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_MarketingGrantReceived" xlink:to="wlds_MarketingGrantReceived_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_MaximumObligatinAmount_lbl0" xml:lang="en-US">Maximum obligatin amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_MaximumObligatinAmount" xlink:to="wlds_MaximumObligatinAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_NetProceedsFromIssuanceSecondaryPublicOffering_lbl0" xml:lang="en-US">The cash inflow associated with the amount received from entity&apos;s secondary offering of stock to the public.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_NetProceedsFromIssuanceSecondaryPublicOffering" xlink:to="wlds_NetProceedsFromIssuanceSecondaryPublicOffering_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_NonconvertibleDebtSecurities_lbl0" xml:lang="en-US">Amount of non-convertible debt securities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_NonconvertibleDebtSecurities" xlink:to="wlds_NonconvertibleDebtSecurities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_NumberOfSharesIssuedAndOutstanding_lbl0" xml:lang="en-US">Number of shares Issued and outstanding.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_NumberOfSharesIssuedAndOutstanding" xlink:to="wlds_NumberOfSharesIssuedAndOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_OfferingOrFinancingTransactionAmount_lbl0" xml:lang="en-US">The amount of offering or financing transaction amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OfferingOrFinancingTransactionAmount" xlink:to="wlds_OfferingOrFinancingTransactionAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_OfficerEmployeeMonthlySalary_lbl0" xml:lang="en-US">The amount of officer employee monthly salary.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OfficerEmployeeMonthlySalary" xlink:to="wlds_OfficerEmployeeMonthlySalary_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_OptionsAvailableForGrant_lbl0" xml:lang="en-US">Total available options for grant,</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OptionsAvailableForGrant" xlink:to="wlds_OptionsAvailableForGrant_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_OptionsExpenses_lbl0" xml:lang="en-US">The amount options expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OptionsExpenses" xlink:to="wlds_OptionsExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_OrdinaryShareParValue_lbl0" xml:lang="en-US">Ordinary share par value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OrdinaryShareParValue" xlink:to="wlds_OrdinaryShareParValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_OrdinarySharePerValue_lbl0" xml:lang="en-US">The ordinary share per value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OrdinarySharePerValue" xlink:to="wlds_OrdinarySharePerValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_OrdinarySharesAuthorizedIncreased_lbl0" xml:lang="en-US">Ordinary shares authorized increased.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OrdinarySharesAuthorizedIncreased" xlink:to="wlds_OrdinarySharesAuthorizedIncreased_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_OrdinarySharesInConsiderationPercentage_lbl0" xml:lang="en-US">Ordinary shares in consideration percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OrdinarySharesInConsiderationPercentage" xlink:to="wlds_OrdinarySharesInConsiderationPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_OrdinarySharesIssued_lbl0" xml:lang="en-US">Ordinary Shares Issued.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OrdinarySharesIssued" xlink:to="wlds_OrdinarySharesIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_OrdinarySharesWarrantExercisable_lbl0" xml:lang="en-US">Ordinary shares warrants exercisable.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OrdinarySharesWarrantExercisable" xlink:to="wlds_OrdinarySharesWarrantExercisable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_OrdinarySharesWarrantsHeldByNonaffiliates_lbl0" xml:lang="en-US">Amount of ordinary shares warrants held by non-affiliates.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OrdinarySharesWarrantsHeldByNonaffiliates" xlink:to="wlds_OrdinarySharesWarrantsHeldByNonaffiliates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_PayIncreasedRoyaltiesDescription_lbl0" xml:lang="en-US">Pay increased royalties, description.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PayIncreasedRoyaltiesDescription" xlink:to="wlds_PayIncreasedRoyaltiesDescription_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_PaymentOnBehalfOfIssuedShares_lbl0" xml:lang="en-US">Amount of payment on behalf of issued shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PaymentOnBehalfOfIssuedShares" xlink:to="wlds_PaymentOnBehalfOfIssuedShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_PercentageOfFinancing_lbl0" xml:lang="en-US">The percentage of financing.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PercentageOfFinancing" xlink:to="wlds_PercentageOfFinancing_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_PercentageOfOwnership_lbl0" xml:lang="en-US">Percentage of ownership.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PercentageOfOwnership" xlink:to="wlds_PercentageOfOwnership_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_PremoneyValuationAmount_lbl0" xml:lang="en-US">The amount of pre money valuation amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PremoneyValuationAmount" xlink:to="wlds_PremoneyValuationAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_PrepaymentsOfLeasing_lbl0" xml:lang="en-US">The amount of prepayments of leasing.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PrepaymentsOfLeasing" xlink:to="wlds_PrepaymentsOfLeasing_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ProceedsFromIssuanceFollowOnPublicOffering_lbl0" xml:lang="en-US">The cash inflow associated with the amount received from entity&apos;s additional offering of stock to the public.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProceedsFromIssuanceFollowOnPublicOffering" xlink:to="wlds_ProceedsFromIssuanceFollowOnPublicOffering_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ProceedsFromIssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost_lbl0" xml:lang="en-US">Amount of proceeds from issuance of ordinary shares and warrants, net of issuance cost.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProceedsFromIssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost" xlink:to="wlds_ProceedsFromIssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants_lbl0" xml:lang="en-US">Amount of proceeds from issuance of ordinary shares as a result of exercise of warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" xlink:to="wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ProceedsFromIssuanceOfSAFEs_lbl0" xml:lang="en-US">The cash inflow from the SAFE investor.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProceedsFromIssuanceOfSAFEs" xlink:to="wlds_ProceedsFromIssuanceOfSAFEs_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost_lbl0" xml:lang="en-US">Represent the amount of proceeds from issuance of shares issued in the public offering, net of issuance cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost" xlink:to="wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPubli_lbl0" xml:lang="en-US">Amount of proceeds from issuance of units of ordinary shares and warrants in connection with the initial public offering, net of issuance expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPubli" xlink:to="wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPubli_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ProductionTransferred_lbl0" xml:lang="en-US">Production transferred.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProductionTransferred" xlink:to="wlds_ProductionTransferred_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ProspectiveInitialPublicOfferingExpenses_lbl0" xml:lang="en-US">Amount of initial public offering (IPO) refers to the process of offering shares of a private corporation to the public in a new stock issuance for the first time.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProspectiveInitialPublicOfferingExpenses" xlink:to="wlds_ProspectiveInitialPublicOfferingExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_PurchasePricePerShare_lbl0" xml:lang="en-US">Purchase price per share.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PurchasePricePerShare" xlink:to="wlds_PurchasePricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_RateOfMonthlySeverancePercentage_lbl0" xml:lang="en-US">The percentage of severance  monthly deposits rate can take their monthly salary.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_RateOfMonthlySeverancePercentage" xlink:to="wlds_RateOfMonthlySeverancePercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_RefundToSAFEInvestors_lbl0" xml:lang="en-US">Amount of refund to SAFE investors.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_RefundToSAFEInvestors" xlink:to="wlds_RefundToSAFEInvestors_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_RelatedPartyMonthlySalary_lbl0" xml:lang="en-US">The amount of related party monthly salary.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_RelatedPartyMonthlySalary" xlink:to="wlds_RelatedPartyMonthlySalary_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ResearchAndDevelopmentGrantsDetection_lbl0" xml:lang="en-US">The amount of grants detection from the value of research and development expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ResearchAndDevelopmentGrantsDetection" xlink:to="wlds_ResearchAndDevelopmentGrantsDetection_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_RightofUseAssetRecognizedAgainstLeaseLiability_lbl0" xml:lang="en-US">The amount is right-of use asset recognized against lease liability.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_RightofUseAssetRecognizedAgainstLeaseLiability" xlink:to="wlds_RightofUseAssetRecognizedAgainstLeaseLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_RoyaltiesRate_lbl0" xml:lang="en-US">Percentage of royalties rate.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_RoyaltiesRate" xlink:to="wlds_RoyaltiesRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_RoyaltiesRatePercentage_lbl0" xml:lang="en-US">Royalties rate percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_RoyaltiesRatePercentage" xlink:to="wlds_RoyaltiesRatePercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_SAFEsAmount_lbl0" xml:lang="en-US">The amount of SAFEs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_SAFEsAmount" xlink:to="wlds_SAFEsAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_SalesAndMarketingExpensesDeductions_lbl0" xml:lang="en-US">Amount of sales and marketing expenses deductions.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_SalesAndMarketingExpensesDeductions" xlink:to="wlds_SalesAndMarketingExpensesDeductions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock_lbl0" xml:lang="en-US">Tabular disclosure of annual rates of depreciation.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock" xlink:to="wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock_lbl0" xml:lang="en-US">Tabular disclosure of the change in Issuance of equity warrants to investors and associat.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock" xlink:to="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ScheduleOfOptionsToConsultantsTableTextBlock_lbl0" xml:lang="en-US">Tabular disclosure of stock options issued to consultants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ScheduleOfOptionsToConsultantsTableTextBlock" xlink:to="wlds_ScheduleOfOptionsToConsultantsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ServicesInExchangeForMonthlyBaseFee_lbl0" xml:lang="en-US">The amount of services in exchange for monthly base fee.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ServicesInExchangeForMonthlyBaseFee" xlink:to="wlds_ServicesInExchangeForMonthlyBaseFee_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_SeverancePolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy for severance.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_SeverancePolicyTextBlock" xlink:to="wlds_SeverancePolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions_lbl0" xml:lang="en-US">Expected life of options in &apos;PnYnMnDTnHnMnS&apos; format, for example, &apos;P1Y5M13D&apos; represents reported fact of one year, five months, and thirteen days.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate_lbl0" xml:lang="en-US">The fair value option granted date during the reporting period as calculated by applying the disclosed option pricing methodology.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio_lbl0" xml:lang="en-US">Description of exercise ratio.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate_lbl0" xml:lang="en-US">Description of Expiration date&#xd;    &#xd;
..</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ShareBasedCompensationArrangementNotes_lbl0" xml:lang="en-US">Description of Notes.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareBasedCompensationArrangementNotes" xlink:to="wlds_ShareBasedCompensationArrangementNotes_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_StockIssuedDuringPeriodShareOfExerciseOfOptionsinShares_lbl0" xml:lang="en-US">Shares of exercise of options.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodShareOfExerciseOfOptionsinShares" xlink:to="wlds_StockIssuedDuringPeriodShareOfExerciseOfOptionsinShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants_lbl1" xml:lang="en-US">Shares issued from the exercise of warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_StockIssuedDuringPeriodSharesInvestors_lbl0" xml:lang="en-US">Shares issued to investors</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodSharesInvestors" xlink:to="wlds_StockIssuedDuringPeriodSharesInvestors_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_StockIssuedDuringPeriodValueExerciseOfWarrants_lbl0" xml:lang="en-US">Represent the value of stock issued during the period from the exercise of warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodValueExerciseOfWarrants" xlink:to="wlds_StockIssuedDuringPeriodValueExerciseOfWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_StockIssuedDuringPeriodValueInvestors_lbl0" xml:lang="en-US">Represent the value of stock issued during the period to investors.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodValueInvestors" xlink:to="wlds_StockIssuedDuringPeriodValueInvestors_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_StockIssuedDuringPeriodValueOfPaymentOnBehalfOfSharesIssued_lbl0" xml:lang="en-US">Value of stock issued for payment on behalf of issued shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodValueOfPaymentOnBehalfOfSharesIssued" xlink:to="wlds_StockIssuedDuringPeriodValueOfPaymentOnBehalfOfSharesIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_TerminationPeriod_lbl0" xml:lang="en-US">Termination period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TerminationPeriod" xlink:to="wlds_TerminationPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_TotalCashReceivedFromTheIIA_lbl0" xml:lang="en-US">Total cash received from the IIA.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TotalCashReceivedFromTheIIA" xlink:to="wlds_TotalCashReceivedFromTheIIA_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_TotalConsiderationAmount_lbl0" xml:lang="en-US">The amount of Total consideration.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TotalConsiderationAmount" xlink:to="wlds_TotalConsiderationAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_TotalValueOfTheShares_lbl0" xml:lang="en-US">Total value of the shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TotalValueOfTheShares" xlink:to="wlds_TotalValueOfTheShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_TransactionFeeClosingValue_lbl0" xml:lang="en-US">The amount of transaction fee closing value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TransactionFeeClosingValue" xlink:to="wlds_TransactionFeeClosingValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_UnderwritingDiscountsAndCommissions_lbl0" xml:lang="en-US">It represent underwriting discounts and commissions.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_UnderwritingDiscountsAndCommissions" xlink:to="wlds_UnderwritingDiscountsAndCommissions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_UnderwritingNetProceed_lbl0" xml:lang="en-US">Amount of net proceeds after deducting.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_UnderwritingNetProceed" xlink:to="wlds_UnderwritingNetProceed_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ValueOfOrdinaryAShare_lbl0" xml:lang="en-US">Value of ordinary A shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ValueOfOrdinaryAShare" xlink:to="wlds_ValueOfOrdinaryAShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_VestingPeriods_lbl0" xml:lang="en-US">Expensed over vesting periods.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_VestingPeriods" xlink:to="wlds_VestingPeriods_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_WarrantBeReducedToAnExercisePricePercentage_lbl0" xml:lang="en-US">Warrant be reduced to an exercise price percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WarrantBeReducedToAnExercisePricePercentage" xlink:to="wlds_WarrantBeReducedToAnExercisePricePercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_WarrantPricePerSharePercentage_lbl0" xml:lang="en-US">Percentage of warrant price per share.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WarrantPricePerSharePercentage" xlink:to="wlds_WarrantPricePerSharePercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_Warrants_lbl0" xml:lang="en-US">Number of warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_Warrants" xlink:to="wlds_Warrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_WarrantsExerciseIntoOrdinaryShares_lbl0" xml:lang="en-US">It represent the warrants were exercised into ordinary shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WarrantsExerciseIntoOrdinaryShares" xlink:to="wlds_WarrantsExerciseIntoOrdinaryShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_WarrantsExercisePricePerShare_lbl0" xml:lang="en-US">Warrants exercise price per share.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WarrantsExercisePricePerShare" xlink:to="wlds_WarrantsExercisePricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_WarrantsIssuedPercentage_lbl0" xml:lang="en-US">The warrants issued percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WarrantsIssuedPercentage" xlink:to="wlds_WarrantsIssuedPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_WarrantsPolicyPolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy for warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WarrantsPolicyPolicyTextBlock" xlink:to="wlds_WarrantsPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_WeightedAveragePricePercentage_lbl0" xml:lang="en-US">Weighted average price percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WeightedAveragePricePercentage" xlink:to="wlds_WeightedAveragePricePercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ComputersAndSoftwareMember_lbl0" xml:lang="en-US">Collection of computer and software.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ComputersAndSoftwareMember" xlink:to="wlds_ComputersAndSoftwareMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ElectronicEquipmentMember_lbl0" xml:lang="en-US">Collection of Electronic equipment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ElectronicEquipmentMember" xlink:to="wlds_ElectronicEquipmentMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AddressTypeDomain_lbl" xml:lang="en-US">Address Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AddressTypeDomain" xlink:to="dei_AddressTypeDomain_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember_lbl0" xml:lang="en-US">Office Furniture And Equipment And Leasehold Improvements Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember" xlink:to="wlds_OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_UnderwritingDiscountsAndCommissions_lbl1" xml:lang="en-US">Underwriting Discounts And Commissions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_UnderwritingDiscountsAndCommissions" xlink:to="wlds_UnderwritingDiscountsAndCommissions_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_PayIncreasedRoyaltiesDescription_lbl1" xml:lang="en-US">Pay Increased Royalties Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PayIncreasedRoyaltiesDescription" xlink:to="wlds_PayIncreasedRoyaltiesDescription_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering_lbl1" xml:lang="en-US">Conversion Of SAFEs Into Ordinary Shares Upon Completion Of Initial Public Offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering" xlink:to="wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ConvertedAmount_lbl1" xml:lang="en-US">Converted Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConvertedAmount" xlink:to="wlds_ConvertedAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ServicesInExchangeForMonthlyBaseFee_lbl1" xml:lang="en-US">Services In Exchange For Monthly Base Fee</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ServicesInExchangeForMonthlyBaseFee" xlink:to="wlds_ServicesInExchangeForMonthlyBaseFee_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioForecastMember_lbl0" xml:lang="en-US">Forecast [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl0" xml:lang="en-US">Document Accounting Standard</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl0" xml:lang="en-US">Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl2" xml:lang="en-US">Operating Lease, Liability, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl0" xml:lang="en-US">Auditor Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl0" xml:lang="en-US">Entity Well-known Seasoned Issuer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl0" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_GrantsReceivedEqualPercentageRate_lbl0" xml:lang="en-US">Grants Received Equal Percentage Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_GrantsReceivedEqualPercentageRate" xlink:to="wlds_GrantsReceivedEqualPercentageRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_RoyaltiesRatePercentage_lbl1" xml:lang="en-US">Royalties Rate Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_RoyaltiesRatePercentage" xlink:to="wlds_RoyaltiesRatePercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ProceedsFromIssuanceOfSAFEs_lbl1" xml:lang="en-US">Proceeds From Issuance Of SAFEs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProceedsFromIssuanceOfSAFEs" xlink:to="wlds_ProceedsFromIssuanceOfSAFEs_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl0" xml:lang="en-US">Operating Loss Carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl0" xml:lang="en-US">Shares Issued, Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_TotalValueOfTheShares_lbl1" xml:lang="en-US">Total Value Of The Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TotalValueOfTheShares" xlink:to="wlds_TotalValueOfTheShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_StockIssuedDuringPeriodShareOfExerciseOfOptionsinShares_lbl1" xml:lang="en-US">Stock Issued During Period Share Of Exercise Of Optionsin Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodShareOfExerciseOfOptionsinShares" xlink:to="wlds_StockIssuedDuringPeriodShareOfExerciseOfOptionsinShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl0" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl0" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl0" xml:lang="en-US">Equity [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ProceedsFromIssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost_lbl1" xml:lang="en-US">Proceeds From Issuance Of Ordinary Shares And Warrants Net Of Issuance Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProceedsFromIssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost" xlink:to="wlds_ProceedsFromIssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl0" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_InterestReceivedFromDeposits_lbl1" xml:lang="en-US">Interest Received From Deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_InterestReceivedFromDeposits" xlink:to="wlds_InterestReceivedFromDeposits_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireRestrictedCertificatesOfDeposit_lbl0" xml:lang="en-US">Payments to Acquire Restricted Certificates of Deposit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireRestrictedCertificatesOfDeposit" xlink:to="us-gaap_PaymentsToAcquireRestrictedCertificatesOfDeposit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl0" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl0" xml:lang="en-US">Increase (Decrease) in Accounts Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingCostsAndExpensesAbstract_lbl0" xml:lang="en-US">Operating Costs and Expenses [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_OperatingCostsAndExpensesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ProceedsFromIssuanceFollowOnPublicOffering_lbl1" xml:lang="en-US">Proceeds From Issuance Follow On Public Offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProceedsFromIssuanceFollowOnPublicOffering" xlink:to="wlds_ProceedsFromIssuanceFollowOnPublicOffering_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl0" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_EmploymentExpenses_lbl1" xml:lang="en-US">Employment Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_EmploymentExpenses" xlink:to="wlds_EmploymentExpenses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl0" xml:lang="en-US">Document Registration Statement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl0" xml:lang="en-US">Earnings Per Share, Diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl1" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized_lbl0" xml:lang="en-US">Unrealized Gain (Loss), Foreign Currency Transaction, before Tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossUnrealized_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl0" xml:lang="en-US">Lessee, Operating Lease, Remaining Lease Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_DecreaseincreaseInGovernmentalGrantsReceivables_lbl1" xml:lang="en-US">Decreaseincrease In Governmental Grants Receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_DecreaseincreaseInGovernmentalGrantsReceivables" xlink:to="wlds_DecreaseincreaseInGovernmentalGrantsReceivables_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_BoardOfDirectorsChairmanMember_lbl0" xml:lang="en-US">Board of Directors Chairman [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_BoardOfDirectorsChairmanMember" xlink:to="srt_BoardOfDirectorsChairmanMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfShareBasedCompensationExpensesAbstract" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfShareBasedCompensationExpensesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ScheduleOfShareBasedCompensationExpensesAbstract_lbl" xml:lang="en-US">Schedule Of Share Based Compensation Expenses Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ScheduleOfShareBasedCompensationExpensesAbstract" xlink:to="wlds_ScheduleOfShareBasedCompensationExpensesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_StockIssuedDuringPeriodValueExerciseOfWarrants_lbl1" xml:lang="en-US">Stock Issued During Period Value Exercise Of Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodValueExerciseOfWarrants" xlink:to="wlds_StockIssuedDuringPeriodValueExerciseOfWarrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_WarrantsExerciseIntoOrdinaryShares_lbl1" xml:lang="en-US">Warrants Exercise Into Ordinary Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WarrantsExerciseIntoOrdinaryShares" xlink:to="wlds_WarrantsExerciseIntoOrdinaryShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_Warrants_lbl1" xml:lang="en-US">Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_Warrants" xlink:to="wlds_Warrants_lbl1"/>
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfShareCapitalAbstract" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfShareCapitalAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ScheduleOfShareCapitalAbstract_lbl" xml:lang="en-US">Schedule Of Share Capital Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ScheduleOfShareCapitalAbstract" xlink:to="wlds_ScheduleOfShareCapitalAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_lbl0" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:to="us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_AdvanceFromCustomers_lbl1" xml:lang="en-US">Advance From Customers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AdvanceFromCustomers" xlink:to="wlds_AdvanceFromCustomers_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ExpenseOnServiceRendering_lbl1" xml:lang="en-US">Expense On Service Rendering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ExpenseOnServiceRendering" xlink:to="wlds_ExpenseOnServiceRendering_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl0" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl0" xml:lang="en-US">Maximum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl0" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl0" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl0" xml:lang="en-US">Entity Address, Address Line Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl0" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl0" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl2" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl0" xml:lang="en-US">Common Stock, Shares, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl0" xml:lang="en-US">Minimum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl0" xml:lang="en-US">Depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ExercisePricePerShare_lbl1" xml:lang="en-US">Exercise Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ExercisePricePerShare" xlink:to="wlds_ExercisePricePerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl0" xml:lang="en-US">Prepaid Expense and Other Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_NetProceedsFromIssuanceSecondaryPublicOffering_lbl1" xml:lang="en-US">Net Proceeds From Issuance Secondary Public Offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_NetProceedsFromIssuanceSecondaryPublicOffering" xlink:to="wlds_NetProceedsFromIssuanceSecondaryPublicOffering_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl0" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl0" xml:lang="en-US">Title of 12(b) Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl0" xml:lang="en-US">Additional Paid-in Capital [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_WarrantPricePerSharePercentage_lbl1" xml:lang="en-US">Warrant Price Per Share Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WarrantPricePerSharePercentage" xlink:to="wlds_WarrantPricePerSharePercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants_lbl1" xml:lang="en-US">Issuance Of Ordinary Shares As AResult Of Exercise Of Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" xlink:to="wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_CostAbstract0_lbl0" xml:lang="en-US">Cost Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CostAbstract0" xlink:to="wlds_CostAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_TwoThousandSeventeenMember_lbl0" xml:lang="en-US">Two Thousand Seventeen Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TwoThousandSeventeenMember" xlink:to="wlds_TwoThousandSeventeenMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_ContactPersonnelName_lbl0" xml:lang="en-US">Contact Personnel Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelName" xlink:to="dei_ContactPersonnelName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl1" xml:lang="en-US">Property, Plant and Equipment, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl0" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl0" xml:lang="en-US">Debt Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_TwoZeroOneFiveMember_lbl0" xml:lang="en-US">Two Zero One Five Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TwoZeroOneFiveMember" xlink:to="wlds_TwoZeroOneFiveMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_IncreaseInOtherReceivablesAndPrepaidExpenses_lbl1" xml:lang="en-US">Increase In Other Receivables And Prepaid Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IncreaseInOtherReceivablesAndPrepaidExpenses" xlink:to="wlds_IncreaseInOtherReceivablesAndPrepaidExpenses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ComputersAndSoftwareMember_lbl1" xml:lang="en-US">Computers And Software Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ComputersAndSoftwareMember" xlink:to="wlds_ComputersAndSoftwareMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtWeightedAverageInterestRate_lbl0" xml:lang="en-US">Debt, Weighted Average Interest Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtWeightedAverageInterestRate" xlink:to="us-gaap_DebtWeightedAverageInterestRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl0" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssued_lbl0" xml:lang="en-US">Shares, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl0" xml:lang="en-US">Document Shell Company Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_MaximumObligatinAmount_lbl1" xml:lang="en-US">Maximum Obligatin Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_MaximumObligatinAmount" xlink:to="wlds_MaximumObligatinAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCost_lbl0" xml:lang="en-US">Lease, Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_LeaseCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_UnlabeledAbstract10_lbl0" xml:lang="en-US">Unlabeled Abstract10</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_UnlabeledAbstract10" xlink:to="wlds_UnlabeledAbstract10_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_TotalConsiderationAmount_lbl1" xml:lang="en-US">Total Consideration Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TotalConsiderationAmount" xlink:to="wlds_TotalConsiderationAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPubli_lbl1" xml:lang="en-US">Proceeds From Issuance Of Units Of Ordinary Shares And Warrants In Connection With The Initial Publi</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPubli" xlink:to="wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPubli_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_TwoThousandTwentyThreeMember_lbl0" xml:lang="en-US">Two Thousand Twenty Three Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TwoThousandTwentyThreeMember" xlink:to="wlds_TwoThousandTwentyThreeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_OrdinarySharesAuthorizedIncreased_lbl1" xml:lang="en-US">Ordinary Shares Authorized Increased</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OrdinarySharesAuthorizedIncreased" xlink:to="wlds_OrdinarySharesAuthorizedIncreased_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseAgreementsMember_lbl0" xml:lang="en-US">Lease Agreements [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseAgreementsMember" xlink:to="us-gaap_LeaseAgreementsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAbstract_lbl0" xml:lang="en-US">Liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_AsherDahanMember_lbl0" xml:lang="en-US">Asher Dahan Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AsherDahanMember" xlink:to="wlds_AsherDahanMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ConversionOfSAFEToEquity_lbl1" xml:lang="en-US">Conversion Of SAFETo Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConversionOfSAFEToEquity" xlink:to="wlds_ConversionOfSAFEToEquity_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ConvertibleSecuritiesMember_lbl0" xml:lang="en-US">Convertible Securities Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConvertibleSecuritiesMember" xlink:to="wlds_ConvertibleSecuritiesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestorMember_lbl0" xml:lang="en-US">Investor [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestorMember" xlink:to="us-gaap_InvestorMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfAnnualRatesOfDepreciationAbstract" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfAnnualRatesOfDepreciationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ScheduleOfAnnualRatesOfDepreciationAbstract_lbl" xml:lang="en-US">Schedule Of Annual Rates Of Depreciation Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ScheduleOfAnnualRatesOfDepreciationAbstract" xlink:to="wlds_ScheduleOfAnnualRatesOfDepreciationAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_PercentageOfOwnership_lbl1" xml:lang="en-US">Percentage Of Ownership</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PercentageOfOwnership" xlink:to="wlds_PercentageOfOwnership_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl0" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_WarrantsIssuedPercentage_lbl1" xml:lang="en-US">Warrants Issued Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WarrantsIssuedPercentage" xlink:to="wlds_WarrantsIssuedPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ProspectiveInitialPublicOfferingExpenses_lbl1" xml:lang="en-US">Prospective Initial Public Offering Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProspectiveInitialPublicOfferingExpenses" xlink:to="wlds_ProspectiveInitialPublicOfferingExpenses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_UnlabeledAbstract2_lbl0" xml:lang="en-US">Unlabeled Abstract2</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_UnlabeledAbstract2" xlink:to="wlds_UnlabeledAbstract2_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_UnlabeledAbstract1_lbl0" xml:lang="en-US">Unlabeled Abstract1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_UnlabeledAbstract1" xlink:to="wlds_UnlabeledAbstract1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_UnlabeledAbstract4_lbl0" xml:lang="en-US">Unlabeled Abstract4</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_UnlabeledAbstract4" xlink:to="wlds_UnlabeledAbstract4_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl0" xml:lang="en-US">Payments of Stock Issuance Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl0" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_UnlabeledAbstract3_lbl0" xml:lang="en-US">Unlabeled Abstract3</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_UnlabeledAbstract3" xlink:to="wlds_UnlabeledAbstract3_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl0" xml:lang="en-US">AOCI Attributable to Parent [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_SAFEsAmount_lbl1" xml:lang="en-US">SAFEs Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_SAFEsAmount" xlink:to="wlds_SAFEsAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_AccruedInterestOnConvertibleSecurities_lbl1" xml:lang="en-US">Accrued Interest On Convertible Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AccruedInterestOnConvertibleSecurities" xlink:to="wlds_AccruedInterestOnConvertibleSecurities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_UnlabeledAbstract0_lbl0" xml:lang="en-US">Unlabeled Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_UnlabeledAbstract0" xlink:to="wlds_UnlabeledAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VehiclesMember_lbl0" xml:lang="en-US">Vehicles [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VehiclesMember" xlink:to="us-gaap_VehiclesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_UnlabeledAbstract9_lbl0" xml:lang="en-US">Unlabeled Abstract9</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_UnlabeledAbstract9" xlink:to="wlds_UnlabeledAbstract9_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl0" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_UnlabeledAbstract6_lbl0" xml:lang="en-US">Unlabeled Abstract6</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_UnlabeledAbstract6" xlink:to="wlds_UnlabeledAbstract6_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ResearchAndDevelopmentGrantsDetection_lbl1" xml:lang="en-US">Research And Development Grants Detection</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ResearchAndDevelopmentGrantsDetection" xlink:to="wlds_ResearchAndDevelopmentGrantsDetection_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_SeverancePolicyTextBlock_lbl1" xml:lang="en-US">Severance Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_SeverancePolicyTextBlock" xlink:to="wlds_SeverancePolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_UnlabeledAbstract5_lbl0" xml:lang="en-US">Unlabeled Abstract5</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_UnlabeledAbstract5" xlink:to="wlds_UnlabeledAbstract5_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_GrossAfterOtherIPOExpenses_lbl1" xml:lang="en-US">Gross After Other IPOExpenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_GrossAfterOtherIPOExpenses" xlink:to="wlds_GrossAfterOtherIPOExpenses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_UnlabeledAbstract8_lbl0" xml:lang="en-US">Unlabeled Abstract8</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_UnlabeledAbstract8" xlink:to="wlds_UnlabeledAbstract8_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_UnlabeledAbstract7_lbl0" xml:lang="en-US">Unlabeled Abstract7</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_UnlabeledAbstract7" xlink:to="wlds_UnlabeledAbstract7_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ScheduleOfOptionsToConsultantsTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Options To Consultants Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ScheduleOfOptionsToConsultantsTableTextBlock" xlink:to="wlds_ScheduleOfOptionsToConsultantsTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_NonconvertibleDebtSecurities_lbl1" xml:lang="en-US">Nonconvertible Debt Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_NonconvertibleDebtSecurities" xlink:to="wlds_NonconvertibleDebtSecurities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_OrdinarySharesInConsiderationPercentage_lbl1" xml:lang="en-US">Ordinary Shares In Consideration Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OrdinarySharesInConsiderationPercentage" xlink:to="wlds_OrdinarySharesInConsiderationPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Issuance Of Equity Warrants To Investors And Associat Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock" xlink:to="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_CostOfRevenuesPolicyTextBlock_lbl1" xml:lang="en-US">Cost Of Revenues Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CostOfRevenuesPolicyTextBlock" xlink:to="wlds_CostOfRevenuesPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl0" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OverAllotmentOptionMember_lbl0" xml:lang="en-US">Over-Allotment Option [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OverAllotmentOptionMember" xlink:to="us-gaap_OverAllotmentOptionMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl0" xml:lang="en-US">Inventory Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_PremoneyValuationAmount_lbl1" xml:lang="en-US">Premoney Valuation Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PremoneyValuationAmount" xlink:to="wlds_PremoneyValuationAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_RateOfMonthlySeverancePercentage_lbl1" xml:lang="en-US">Rate Of Monthly Severance Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_RateOfMonthlySeverancePercentage" xlink:to="wlds_RateOfMonthlySeverancePercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl0" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_BusinessContactMember_lbl0" xml:lang="en-US">Business Contact [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_BusinessContactMember" xlink:to="dei_BusinessContactMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement_lbl0" xml:lang="en-US">Temporary Equity, Aggregate Amount of Redemption Requirement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:to="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl0" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares_lbl1" xml:lang="en-US">Issuance Of Units Of Ordinary Shares And Warrants In Connection With The Initial Public Offering Net Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares" xlink:to="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_UnlabeledAbstract_lbl0" xml:lang="en-US">Unlabeled Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_UnlabeledAbstract" xlink:to="wlds_UnlabeledAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_September152022TwoMember_lbl0" xml:lang="en-US">September152022 Two Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_September152022TwoMember" xlink:to="wlds_September152022TwoMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl0" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl1" xml:lang="en-US">Common Stock, Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_InterestExpenseAndExchangeRate_lbl1" xml:lang="en-US">Interest Expense And Exchange Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_InterestExpenseAndExchangeRate" xlink:to="wlds_InterestExpenseAndExchangeRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ExceptTransferProductionRight_lbl1" xml:lang="en-US">Except Transfer Production Right</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ExceptTransferProductionRight" xlink:to="wlds_ExceptTransferProductionRight_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_CashPayment_lbl1" xml:lang="en-US">Cash Payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CashPayment" xlink:to="wlds_CashPayment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves_lbl0" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="us-gaap_InventoryWorkInProcessNetOfReserves_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_PaymentOnBehalfOfIssuedShares_lbl1" xml:lang="en-US">Payment On Behalf Of Issued Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PaymentOnBehalfOfIssuedShares" xlink:to="wlds_PaymentOnBehalfOfIssuedShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_WarrantsToPurchaseOrdinarySharesMember_lbl0" xml:lang="en-US">Warrants To Purchase Ordinary Shares Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WarrantsToPurchaseOrdinarySharesMember" xlink:to="wlds_WarrantsToPurchaseOrdinarySharesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl2" xml:lang="en-US">Equity, Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_WarrantsPolicyPolicyTextBlock_lbl1" xml:lang="en-US">Warrants Policy Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WarrantsPolicyPolicyTextBlock" xlink:to="wlds_WarrantsPolicyPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsPolicyPolicyTextBlock_lbl0" xml:lang="en-US">Subsequent Events, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:to="us-gaap_SubsequentEventsPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl0" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_RoyaltiesRate_lbl1" xml:lang="en-US">Royalties Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_RoyaltiesRate" xlink:to="wlds_RoyaltiesRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl0" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Units</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl0" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_StockIssuedDuringPeriodValueInvestors_lbl1" xml:lang="en-US">Stock Issued During Period Value Investors</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodValueInvestors" xlink:to="wlds_StockIssuedDuringPeriodValueInvestors_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate_lbl1" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Expiration Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_Investor_lbl1" xml:lang="en-US">Investor</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_Investor" xlink:to="wlds_Investor_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl0" xml:lang="en-US">Stock Issued During Period, Value, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_GrossProceeds_lbl1" xml:lang="en-US">Gross Proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_GrossProceeds" xlink:to="wlds_GrossProceeds_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl0" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl0" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl0" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ExercisePriceOfWarrants_lbl1" xml:lang="en-US">Exercise Price Of Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ExercisePriceOfWarrants" xlink:to="wlds_ExercisePriceOfWarrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_IMEIMember_lbl0" xml:lang="en-US">IMEIMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IMEIMember" xlink:to="wlds_IMEIMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl0" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl0" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl0" xml:lang="en-US">Entity Interactive Data Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl0" xml:lang="en-US">Proceeds from Issuance of Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ConvertibleSecurityDescription_lbl1" xml:lang="en-US">Convertible Security Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConvertibleSecurityDescription" xlink:to="wlds_ConvertibleSecurityDescription_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingAndMarketingExpenseMember_lbl0" xml:lang="en-US">Selling and Marketing Expense [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpenseMember" xlink:to="us-gaap_SellingAndMarketingExpenseMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_DirectorMember_lbl0" xml:lang="en-US">Director [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_DirectorMember" xlink:to="srt_DirectorMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_AmountsReceivedAggregateAmount_lbl1" xml:lang="en-US">Amounts Received Aggregate Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AmountsReceivedAggregateAmount" xlink:to="wlds_AmountsReceivedAggregateAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_AnnualRateOfDepreciation_lbl1" xml:lang="en-US">Annual Rate Of Depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AnnualRateOfDepreciation" xlink:to="wlds_AnnualRateOfDepreciation_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl1" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_September132022Member_lbl0" xml:lang="en-US">September132022 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_September132022Member" xlink:to="wlds_September132022Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl0" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl0" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_MachinesAndMoldsMember_lbl0" xml:lang="en-US">Machines And Molds Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_MachinesAndMoldsMember" xlink:to="wlds_MachinesAndMoldsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_BaseMonthlyFeeImmediatelyIncreaseAmount_lbl1" xml:lang="en-US">Base Monthly Fee Immediately Increase Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_BaseMonthlyFeeImmediatelyIncreaseAmount" xlink:to="wlds_BaseMonthlyFeeImmediatelyIncreaseAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_IncreaseDecreaseInAdvancePaymentsOnGovernmentalGrant_lbl1" xml:lang="en-US">Increase Decrease In Advance Payments On Governmental Grant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IncreaseDecreaseInAdvancePaymentsOnGovernmentalGrant" xlink:to="wlds_IncreaseDecreaseInAdvancePaymentsOnGovernmentalGrant_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl0" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember_lbl0" xml:lang="en-US">Office Furniture Machines Leasehold Improvements And Electronic Equipment Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember" xlink:to="wlds_OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_InitialExercisePricesPercentage_lbl1" xml:lang="en-US">Initial Exercise Prices Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_InitialExercisePricesPercentage" xlink:to="wlds_InitialExercisePricesPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_NumberOfSharesIssuedAndOutstanding_lbl1" xml:lang="en-US">Number Of Shares Issued And Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_NumberOfSharesIssuedAndOutstanding" xlink:to="wlds_NumberOfSharesIssuedAndOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl0" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl0" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_IssuanceExpenses_lbl1" xml:lang="en-US">Issuance Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceExpenses" xlink:to="wlds_IssuanceExpenses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_lbl0" xml:lang="en-US">Lessee, Operating Lease, Disclosure [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:to="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl0" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl0" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl0" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl0" xml:lang="en-US">Earnings Per Share, Basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_TotalCashReceivedFromTheIIA_lbl1" xml:lang="en-US">Total Cash Received From The IIA</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TotalCashReceivedFromTheIIA" xlink:to="wlds_TotalCashReceivedFromTheIIA_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeFinanceLeaseRenewalTerm1_lbl0" xml:lang="en-US">Lessee, Finance Lease, Renewal Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:to="us-gaap_LesseeFinanceLeaseRenewalTerm1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl0" xml:lang="en-US">Research and Development Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_lbl0" xml:lang="en-US">Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_OrdinaryShareParValue_lbl1" xml:lang="en-US">Ordinary Share Par Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OrdinaryShareParValue" xlink:to="wlds_OrdinaryShareParValue_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US">Statement of Stockholders&apos; Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateAbstract" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateAbstract_lbl" xml:lang="en-US">Schedule Of Issuance Of Equity Warrants To Investors And Associate Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateAbstract" xlink:to="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate_lbl1" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Option Grant Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl0" xml:lang="en-US">Stock Issued During Period, Value, New Issues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl0" xml:lang="en-US">Commitments and Contingencies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl0" xml:lang="en-US">Document Annual Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl0" xml:lang="en-US">Research and Development Expense [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl0" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_InitialExercisePricePercentage_lbl1" xml:lang="en-US">Initial Exercise Price Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_InitialExercisePricePercentage" xlink:to="wlds_InitialExercisePricePercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_RelatedPartyMonthlySalary_lbl1" xml:lang="en-US">Related Party Monthly Salary</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_RelatedPartyMonthlySalary" xlink:to="wlds_RelatedPartyMonthlySalary_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl0" xml:lang="en-US">Common Stock, Value, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_GrantsReceivedFromTheIMEI_lbl1" xml:lang="en-US">Grants Received From The IMEI</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_GrantsReceivedFromTheIMEI" xlink:to="wlds_GrantsReceivedFromTheIMEI_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_SubscriptionReceivablesMember_lbl0" xml:lang="en-US">Subscription Receivables Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_SubscriptionReceivablesMember" xlink:to="wlds_SubscriptionReceivablesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl0" xml:lang="en-US">Entity Voluntary Filers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl0" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_WarrantBeReducedToAnExercisePricePercentage_lbl1" xml:lang="en-US">Warrant Be Reduced To An Exercise Price Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WarrantBeReducedToAnExercisePricePercentage" xlink:to="wlds_WarrantBeReducedToAnExercisePricePercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_GovernmentalGrantsPolicyTextBlock_lbl1" xml:lang="en-US">Governmental Grants Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_GovernmentalGrantsPolicyTextBlock" xlink:to="wlds_GovernmentalGrantsPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_IssuanceOfSharesOptions_lbl1" xml:lang="en-US">Issuance Of Shares Options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfSharesOptions" xlink:to="wlds_IssuanceOfSharesOptions_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl0" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ShareBasedCompensationArrangementNotes_lbl1" xml:lang="en-US">Share Based Compensation Arrangement Notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareBasedCompensationArrangementNotes" xlink:to="wlds_ShareBasedCompensationArrangementNotes_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IPOMember_lbl0" xml:lang="en-US">IPO [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueCurrent_lbl0" xml:lang="en-US">Deferred Revenue, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl0" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_InvestorsExercisedWarrants_lbl1" xml:lang="en-US">Investors Exercised Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_InvestorsExercisedWarrants" xlink:to="wlds_InvestorsExercisedWarrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl0" xml:lang="en-US">Lessee, Operating Leases [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_MarketingGrantReceived_lbl1" xml:lang="en-US">Marketing Grant Received</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_MarketingGrantReceived" xlink:to="wlds_MarketingGrantReceived_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost_lbl1" xml:lang="en-US">Proceeds From Issuance Of Shares Issued In The Public Offering Net Of Issuance Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost" xlink:to="wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_PercentageOfFinancing_lbl1" xml:lang="en-US">Percentage Of Financing</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PercentageOfFinancing" xlink:to="wlds_PercentageOfFinancing_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_PrepaymentsOfLeasing_lbl1" xml:lang="en-US">Prepayments Of Leasing</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PrepaymentsOfLeasing" xlink:to="wlds_PrepaymentsOfLeasing_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl0" xml:lang="en-US">Document Transition Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_UnderwritingNetProceed_lbl1" xml:lang="en-US">Underwriting Net Proceed</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_UnderwritingNetProceed" xlink:to="wlds_UnderwritingNetProceed_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_AggregateAmount_lbl1" xml:lang="en-US">Aggregate Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AggregateAmount" xlink:to="wlds_AggregateAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_CostAbstract_lbl0" xml:lang="en-US">Cost Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CostAbstract" xlink:to="wlds_CostAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl0" xml:lang="en-US">Warrants and Rights Outstanding, Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_WarrantsExercisePricePerShare_lbl1" xml:lang="en-US">Warrants Exercise Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WarrantsExercisePricePerShare" xlink:to="wlds_WarrantsExercisePricePerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl0" xml:lang="en-US">Accounts Payable, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_TransactionFeeClosingValue_lbl1" xml:lang="en-US">Transaction Fee Closing Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TransactionFeeClosingValue" xlink:to="wlds_TransactionFeeClosingValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_LeaseLiabilityMember_lbl0" xml:lang="en-US">Lease Liability Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_LeaseLiabilityMember" xlink:to="wlds_LeaseLiabilityMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_AnnualInterestRate_lbl1" xml:lang="en-US">Annual Interest Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AnnualInterestRate" xlink:to="wlds_AnnualInterestRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl0" xml:lang="en-US">Entity Shell Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_TwoThousandTwentyoneMember_lbl0" xml:lang="en-US">Two Thousand Twentyone Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TwoThousandTwentyoneMember" xlink:to="wlds_TwoThousandTwentyoneMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_VestingPeriods_lbl1" xml:lang="en-US">Vesting Periods</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_VestingPeriods" xlink:to="wlds_VestingPeriods_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl0" xml:lang="en-US">Property, Plant and Equipment, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FIFOInventoryAmount_lbl1" xml:lang="en-US">FIFO Inventory Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FIFOInventoryAmount" xlink:to="us-gaap_FIFOInventoryAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_LeasePaymentIncreased_lbl1" xml:lang="en-US">Lease Payment Increased</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_LeasePaymentIncreased" xlink:to="wlds_LeasePaymentIncreased_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl0" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ExercisePriceOfWarrant_lbl1" xml:lang="en-US">Exercise Price Of Warrant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ExercisePriceOfWarrant" xlink:to="wlds_ExercisePriceOfWarrant_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_InterestPercentage_lbl1" xml:lang="en-US">Interest Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_InterestPercentage" xlink:to="wlds_InterestPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityTableTextBlock_lbl0" xml:lang="en-US">Schedule of Stockholders Equity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl0" xml:lang="en-US">General and Administrative Expense [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl0" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves_lbl0" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend_lbl0" xml:lang="en-US">Lessee, Operating Lease, Option to Extend</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:to="us-gaap_LesseeOperatingLeaseOptionToExtend_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ProductionTransferred_lbl1" xml:lang="en-US">Production Transferred</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProductionTransferred" xlink:to="wlds_ProductionTransferred_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl0" xml:lang="en-US">Inventory, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl0" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_September152022ThreeMember_lbl0" xml:lang="en-US">September152022 Three Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_September152022ThreeMember" xlink:to="wlds_September152022ThreeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_AggrementTerm_lbl1" xml:lang="en-US">Aggrement Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AggrementTerm" xlink:to="wlds_AggrementTerm_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl0" xml:lang="en-US">Proceeds from Lines of Credit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromLinesOfCredit" xlink:to="us-gaap_ProceedsFromLinesOfCredit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_TerminationPeriod_lbl1" xml:lang="en-US">Termination Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TerminationPeriod" xlink:to="wlds_TerminationPeriod_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl0" xml:lang="en-US">Auditor Location</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingAndMarketingExpense_lbl0" xml:lang="en-US">Selling and Marketing Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock_lbl1" xml:lang="en-US">Finance Income And Expenses Policy Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock" xlink:to="wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ChangesDuringTheYear2023Abstract_lbl0" xml:lang="en-US">Changes During The Year2023 Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ChangesDuringTheYear2023Abstract" xlink:to="wlds_ChangesDuringTheYear2023Abstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_OfferingOrFinancingTransactionAmount_lbl1" xml:lang="en-US">Offering Or Financing Transaction Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OfferingOrFinancingTransactionAmount" xlink:to="wlds_OfferingOrFinancingTransactionAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_AccruedInterestOnDeposits_lbl1" xml:lang="en-US">Accrued Interest On Deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AccruedInterestOnDeposits" xlink:to="wlds_AccruedInterestOnDeposits_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassAMember_lbl1" xml:lang="en-US">Common Class A [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl0" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_FixedAnnualInterestRate_lbl1" xml:lang="en-US">Fixed Annual Interest Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_FixedAnnualInterestRate" xlink:to="wlds_FixedAnnualInterestRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants_lbl2" xml:lang="en-US">Stock Issued During Period Shares Exercise Of Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl0" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl0" xml:lang="en-US">Subsequent Event [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl0" xml:lang="en-US">Warrant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_RightofUseAssetRecognizedAgainstLeaseLiability_lbl1" xml:lang="en-US">Rightof Use Asset Recognized Against Lease Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_RightofUseAssetRecognizedAgainstLeaseLiability" xlink:to="wlds_RightofUseAssetRecognizedAgainstLeaseLiability_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRent_lbl0" xml:lang="en-US">Payments for Rent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRent" xlink:to="us-gaap_PaymentsForRent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_TwoThousandFifteenMember_lbl0" xml:lang="en-US">Two Thousand Fifteen Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TwoThousandFifteenMember" xlink:to="wlds_TwoThousandFifteenMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_SalesAndMarketingExpensesDeductions_lbl1" xml:lang="en-US">Sales And Marketing Expenses Deductions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_SalesAndMarketingExpensesDeductions" xlink:to="wlds_SalesAndMarketingExpensesDeductions_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl0" xml:lang="en-US">Employee-related Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl0" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl0" xml:lang="en-US">Increase (Decrease) in Inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio_lbl1" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Exercise Ratio</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_StockIssuedDuringPeriodValueOfPaymentOnBehalfOfSharesIssued_lbl1" xml:lang="en-US">Stock Issued During Period Value Of Payment On Behalf Of Shares Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodValueOfPaymentOnBehalfOfSharesIssued" xlink:to="wlds_StockIssuedDuringPeriodValueOfPaymentOnBehalfOfSharesIssued_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ConversionOfOrdinaryASharesToOrdinaryShares_lbl1" xml:lang="en-US">Conversion Of Ordinary AShares To Ordinary Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConversionOfOrdinaryASharesToOrdinaryShares" xlink:to="wlds_ConversionOfOrdinaryASharesToOrdinaryShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_CorporateTaxRatePercentage_lbl1" xml:lang="en-US">Corporate Tax Rate Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CorporateTaxRatePercentage" xlink:to="wlds_CorporateTaxRatePercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl0" xml:lang="en-US">Operating Income (Loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants_lbl1" xml:lang="en-US">Proceeds From Issuance Of Ordinary Shares As AResult Of Exercise Of Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" xlink:to="wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl0" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl0" xml:lang="en-US">Entity Address, Country</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl1" xml:lang="en-US">Operating Lease, Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl0" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl0" xml:lang="en-US">Liabilities, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_EmployeeExercisedWarrants_lbl1" xml:lang="en-US">Employee Exercised Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_EmployeeExercisedWarrants" xlink:to="wlds_EmployeeExercisedWarrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ChangesDuringTheYear2022Abstract_lbl0" xml:lang="en-US">Changes During The Year2022 Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ChangesDuringTheYear2022Abstract" xlink:to="wlds_ChangesDuringTheYear2022Abstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_CreditFacilityDisclosureTextBlock_lbl1" xml:lang="en-US">Credit Facility Disclosure Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CreditFacilityDisclosureTextBlock" xlink:to="wlds_CreditFacilityDisclosureTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_lbl0" xml:lang="en-US">Line of Credit Facility, Interest Rate at Period End</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:to="us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherBorrowings_lbl0" xml:lang="en-US">Other Borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherBorrowings" xlink:to="us-gaap_OtherBorrowings_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl0" xml:lang="en-US">Proceeds from Issuance Initial Public Offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_RefundToSAFEInvestors_lbl1" xml:lang="en-US">Refund To SAFEInvestors</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_RefundToSAFEInvestors" xlink:to="wlds_RefundToSAFEInvestors_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_September152022OneMember_lbl0" xml:lang="en-US">September152022 One Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_September152022OneMember" xlink:to="wlds_September152022OneMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl0" xml:lang="en-US">Income Tax Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ValueOfOrdinaryAShare_lbl1" xml:lang="en-US">Value Of Ordinary AShare</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ValueOfOrdinaryAShare" xlink:to="wlds_ValueOfOrdinaryAShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_OptionsExpenses_lbl1" xml:lang="en-US">Options Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OptionsExpenses" xlink:to="wlds_OptionsExpenses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostDirectMaterial_lbl0" xml:lang="en-US">Cost, Direct Material</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostDirectMaterial" xlink:to="us-gaap_CostDirectMaterial_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl1" xml:lang="en-US">Share Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl0" xml:lang="en-US">Liabilities and Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions_lbl1" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Expected Life Of Options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl0" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl0" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_OrdinarySharesWarrantExercisable_lbl1" xml:lang="en-US">Ordinary Shares Warrant Exercisable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OrdinarySharesWarrantExercisable" xlink:to="wlds_OrdinarySharesWarrantExercisable_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_OfficerEmployeeMonthlySalary_lbl1" xml:lang="en-US">Officer Employee Monthly Salary</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OfficerEmployeeMonthlySalary" xlink:to="wlds_OfficerEmployeeMonthlySalary_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrantsReceivableCurrent_lbl0" xml:lang="en-US">Grants Receivable, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrantsReceivableCurrent" xlink:to="us-gaap_GrantsReceivableCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost_lbl1" xml:lang="en-US">Issuance Of Ordinary Shares And Warrants Net Of Issuance Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost" xlink:to="wlds_IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl0" xml:lang="en-US">Assets, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl0" xml:lang="en-US">Revenue [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl0" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_IcfrAuditorAttestationFlag_lbl0" xml:lang="en-US">ICFR Auditor Attestation Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_AmountOfDevelopmentProgram_lbl1" xml:lang="en-US">Amount Of Development Program</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AmountOfDevelopmentProgram" xlink:to="wlds_AmountOfDevelopmentProgram_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrantsinShares_lbl1" xml:lang="en-US">Issuance Of Ordinary Shares As AResult Of Exercise Of Warrantsin Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrantsinShares" xlink:to="wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrantsinShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_AnnualGrossRevenuesExceed_lbl1" xml:lang="en-US">Annual Gross Revenues Exceed</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AnnualGrossRevenuesExceed" xlink:to="wlds_AnnualGrossRevenuesExceed_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract_lbl0" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_SupplementalCashFlowElementsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl0" xml:lang="en-US">Class of Warrant or Right, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_IIAMember_lbl0" xml:lang="en-US">IIAMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IIAMember" xlink:to="wlds_IIAMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_LowestResetPrice_lbl1" xml:lang="en-US">Lowest Reset Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_LowestResetPrice" xlink:to="wlds_LowestResetPrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl0" xml:lang="en-US">Proceeds from Stock Options Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl0" xml:lang="en-US">Entity Ex Transition Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_CofoundersMember_lbl0" xml:lang="en-US">Cofounders Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CofoundersMember" xlink:to="wlds_CofoundersMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl0" xml:lang="en-US">Revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl0"/>
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfOptionsToConsultantsAbstract" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfOptionsToConsultantsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ScheduleOfOptionsToConsultantsAbstract_lbl" xml:lang="en-US">Schedule Of Options To Consultants Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ScheduleOfOptionsToConsultantsAbstract" xlink:to="wlds_ScheduleOfOptionsToConsultantsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl0" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl0" xml:lang="en-US">Liabilities and Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl0"/>
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfPropertyAndEquipmentNetAbstract" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfPropertyAndEquipmentNetAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ScheduleOfPropertyAndEquipmentNetAbstract_lbl" xml:lang="en-US">Schedule Of Property And Equipment Net Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ScheduleOfPropertyAndEquipmentNetAbstract" xlink:to="wlds_ScheduleOfPropertyAndEquipmentNetAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_LeaseAgreements_lbl1" xml:lang="en-US">Lease Agreements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_LeaseAgreements" xlink:to="wlds_LeaseAgreements_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl0" xml:lang="en-US">General and Administrative Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_PurchasePricePerShare_lbl1" xml:lang="en-US">Purchase Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PurchasePricePerShare" xlink:to="wlds_PurchasePricePerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_OrdinarySharePerValue_lbl1" xml:lang="en-US">Ordinary Share Per Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OrdinarySharePerValue" xlink:to="wlds_OrdinarySharePerValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl0" xml:lang="en-US">Debt Instrument, Face Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl0" xml:lang="en-US">Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrentAbstract_lbl0" xml:lang="en-US">Assets, Noncurrent [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepositsAssetsCurrent_lbl0" xml:lang="en-US">Deposits Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositsAssetsCurrent" xlink:to="us-gaap_DepositsAssetsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl0" xml:lang="en-US">Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_AggregateOrdinaryShares_lbl1" xml:lang="en-US">Aggregate Ordinary Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AggregateOrdinaryShares" xlink:to="wlds_AggregateOrdinaryShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl0" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl0" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ConversionOfOrdinaryASharesToOrdinarySharesValue_lbl1" xml:lang="en-US">Conversion Of Ordinary AShares To Ordinary Shares Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConversionOfOrdinaryASharesToOrdinarySharesValue" xlink:to="wlds_ConversionOfOrdinaryASharesToOrdinarySharesValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl2" xml:lang="en-US">Common Stock, Shares, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl0" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl2" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_OrdinarySharesIssued_lbl1" xml:lang="en-US">Ordinary Shares Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OrdinarySharesIssued" xlink:to="wlds_OrdinarySharesIssued_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl0" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepositsAssetsNoncurrent_lbl0" xml:lang="en-US">Deposits Assets, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositsAssetsNoncurrent" xlink:to="us-gaap_DepositsAssetsNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Annual Rates Of Depreciation Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock" xlink:to="wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl0" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ChangesDuringTheYear2021Abstract_lbl0" xml:lang="en-US">Changes During The Year2021 Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ChangesDuringTheYear2021Abstract" xlink:to="wlds_ChangesDuringTheYear2021Abstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrent_lbl0" xml:lang="en-US">Assets, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl0" xml:lang="en-US">Auditor Firm ID</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl0" xml:lang="en-US">Additional Paid in Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_MudraInspireDevelopmentKitsMember_lbl0" xml:lang="en-US">Mudra Inspire Development Kits Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_MudraInspireDevelopmentKitsMember" xlink:to="wlds_MudraInspireDevelopmentKitsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl0" xml:lang="en-US">Proceeds from Convertible Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl0" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl0" xml:lang="en-US">Series of Individually Immaterial Business Acquisitions [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_InvestorAmount_lbl1" xml:lang="en-US">Investor Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_InvestorAmount" xlink:to="wlds_InvestorAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl1" xml:lang="en-US">Net Income (Loss) Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_MoldMember_lbl0" xml:lang="en-US">Mold Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_MoldMember" xlink:to="wlds_MoldMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet_lbl1" xml:lang="en-US">Issuance Of Units Of Ordinary Shares And Warrants In Connection With The Initial Public Offering Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet" xlink:to="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Plan Modification, Description and Terms</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesNetOfInterestExpense_lbl0" xml:lang="en-US">Revenues, Net of Interest Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesNetOfInterestExpense" xlink:to="us-gaap_RevenuesNetOfInterestExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl0" xml:lang="en-US">Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl1" xml:lang="en-US">Operating Lease, Right-of-Use Asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_OrdinarySharesWarrantsHeldByNonaffiliates_lbl1" xml:lang="en-US">Ordinary Shares Warrants Held By Nonaffiliates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OrdinarySharesWarrantsHeldByNonaffiliates" xlink:to="wlds_OrdinarySharesWarrantsHeldByNonaffiliates_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_AnnualAlternativeInterestPercentage_lbl1" xml:lang="en-US">Annual Alternative Interest Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AnnualAlternativeInterestPercentage" xlink:to="wlds_AnnualAlternativeInterestPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_IncreaseDecreaseInAdvancePayments_lbl1" xml:lang="en-US">Increase Decrease In Advance Payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IncreaseDecreaseInAdvancePayments" xlink:to="wlds_IncreaseDecreaseInAdvancePayments_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl0" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_lbl1" xml:lang="en-US">Shares, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_OrdinarySharesNIS001ParValuePerShareMember_lbl0" xml:lang="en-US">Ordinary Shares NIS001 Par Value Per Share Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OrdinarySharesNIS001ParValuePerShareMember" xlink:to="wlds_OrdinarySharesNIS001ParValuePerShareMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl0" xml:lang="en-US">Accrued Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfLinesOfCredit_lbl0" xml:lang="en-US">Repayments of Lines of Credit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLinesOfCredit" xlink:to="us-gaap_RepaymentsOfLinesOfCredit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ConvertedToOrdinaryShares_lbl1" xml:lang="en-US">Converted To Ordinary Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConvertedToOrdinaryShares" xlink:to="wlds_ConvertedToOrdinaryShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_IL_lbl0" xml:lang="en-US">ISRAEL</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_IL" xlink:to="country_IL_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl2" xml:lang="en-US">Operating Lease, Liability, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_OptionsAvailableForGrant_lbl1" xml:lang="en-US">Options Available For Grant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OptionsAvailableForGrant" xlink:to="wlds_OptionsAvailableForGrant_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrantsReceivable_lbl0" xml:lang="en-US">Grants Receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrantsReceivable" xlink:to="us-gaap_GrantsReceivable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_WeightedAveragePricePercentage_lbl1" xml:lang="en-US">Weighted Average Price Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WeightedAveragePricePercentage" xlink:to="wlds_WeightedAveragePricePercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_StockIssuedDuringPeriodSharesInvestors_lbl1" xml:lang="en-US">Stock Issued During Period Shares Investors</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodSharesInvestors" xlink:to="wlds_StockIssuedDuringPeriodSharesInvestors_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl0" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_AShareReclassifiedToOrdinaryShares_lbl1" xml:lang="en-US">AShare Reclassified To Ordinary Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AShareReclassifiedToOrdinaryShares" xlink:to="wlds_AShareReclassifiedToOrdinaryShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseExpense_lbl0" xml:lang="en-US">Operating Lease, Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl0" xml:lang="en-US">Lessee, Leases [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ExercisableWarrantsToShares_lbl1" xml:lang="en-US">Exercisable Warrants To Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ExercisableWarrantsToShares" xlink:to="wlds_ExercisableWarrantsToShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_LeaseAgreementsPeriod_lbl1" xml:lang="en-US">Lease Agreements Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_LeaseAgreementsPeriod" xlink:to="wlds_LeaseAgreementsPeriod_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ElectronicEquipmentMember_lbl1" xml:lang="en-US">Electronic Equipment Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ElectronicEquipmentMember" xlink:to="wlds_ElectronicEquipmentMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves_lbl0" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves_lbl0"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>22
<FILENAME>wlds-20231231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Mar 15 10:22:33 UTC 2024 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ConsolidatedBalanceSheet" roleURI="http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ConsolidatedIncomeStatement" roleURI="http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ConsolidatedIncomeStatement_Parentheticals" roleURI="http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ShareholdersEquityType2or3" roleURI="http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ShareholdersEquityType2or3_Parentheticals" roleURI="http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ConsolidatedCashFlow" roleURI="http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_General" roleURI="http://www.wearabledevices.co.il/role/General"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_SignificantAccountingPolicies" roleURI="http://www.wearabledevices.co.il/role/SignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_Inventories" roleURI="http://www.wearabledevices.co.il/role/Inventories"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_PropertyandEquipmentNet" roleURI="http://www.wearabledevices.co.il/role/PropertyandEquipmentNet"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_Lease" roleURI="http://www.wearabledevices.co.il/role/Lease"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_CommitmentsandContingencies" roleURI="http://www.wearabledevices.co.il/role/CommitmentsandContingencies"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ConvertibleSecurities" roleURI="http://www.wearabledevices.co.il/role/ConvertibleSecurities"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_CreditFacility" roleURI="http://www.wearabledevices.co.il/role/CreditFacility"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ShareholdersEquityDeficit" roleURI="http://www.wearabledevices.co.il/role/ShareholdersEquityDeficit"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_TaxesonIncome" roleURI="http://www.wearabledevices.co.il/role/TaxesonIncome"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_RelatedParties" roleURI="http://www.wearabledevices.co.il/role/RelatedParties"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_AccountingPoliciesByPolicy" roleURI="http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_SignificantAccountingPoliciesTables" roleURI="http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_InventoriesTables" roleURI="http://www.wearabledevices.co.il/role/InventoriesTables"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_PropertyandEquipmentNetTables" roleURI="http://www.wearabledevices.co.il/role/PropertyandEquipmentNetTables"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_LeaseTables" roleURI="http://www.wearabledevices.co.il/role/LeaseTables"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ShareholdersEquityDeficitTables" roleURI="http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitTables"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ScheduleofAnnualRatesofDepreciationTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofAnnualRatesofDepreciationTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ScheduleofInventoriesTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofInventoriesTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ScheduleofPropertyandEquipmentNetTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ScheduleofFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ScheduleofShareCapitalTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ScheduleofShareCapitalTable_Parentheticals" roleURI="http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ScheduleofOptionsActivityTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ScheduleofWeightedAverageAssumptionsTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageAssumptionsTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ScheduleofOptionstoConsultantsTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ScheduleofShareBasedCompensationExpensesTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofShareBasedCompensationExpensesTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_GeneralDetails" roleURI="http://www.wearabledevices.co.il/role/GeneralDetails"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_SignificantAccountingPoliciesDetails" roleURI="http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_LeaseDetails" roleURI="http://www.wearabledevices.co.il/role/LeaseDetails"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_CommitmentsandContingenciesDetails" roleURI="http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ConvertibleSecuritiesDetails" roleURI="http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_CreditFacilityDetails" roleURI="http://www.wearabledevices.co.il/role/CreditFacilityDetails"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_ShareholdersEquityDeficitDetails" roleURI="http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_TaxesonIncomeDetails" roleURI="http://www.wearabledevices.co.il/role/TaxesonIncomeDetails"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#wlds_r_RelatedPartiesDetails" roleURI="http://www.wearabledevices.co.il/role/RelatedPartiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20231231.xsd#DocumentAndEntityInformation" roleURI="http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"/>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositsAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_DepositsAssetsCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrantsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrantsReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_GrantsReceivable" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FIFOInventoryAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FIFOInventoryAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_FIFOInventoryAmount" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositsAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssetsNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_DepositsAssetsNoncurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_Assets" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AdvanceFromCustomers" xlink:href="wlds-20231231.xsd#wlds_AdvanceFromCustomers"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="AdvanceFromCustomers" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRevenueCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_Liabilities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesIssued" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_Revenues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingCostsAndExpensesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostDirectMaterial" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostDirectMaterial"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_CostDirectMaterial" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_SellingAndMarketingExpense" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ProspectiveInitialPublicOfferingExpenses" xlink:href="wlds-20231231.xsd#wlds_ProspectiveInitialPublicOfferingExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="ProspectiveInitialPublicOfferingExpenses" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="InterestExpenseAndExchangeRate" xlink:href="wlds-20231231.xsd#wlds_InterestExpenseAndExchangeRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="InterestExpenseAndExchangeRate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassAMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SubscriptionReceivablesMember" xlink:href="wlds-20231231.xsd#wlds_SubscriptionReceivablesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="SubscriptionReceivablesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="4.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ChangesDuringTheYear2022Abstract" xlink:href="wlds-20231231.xsd#wlds_ChangesDuringTheYear2022Abstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ChangesDuringTheYear2022Abstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet" xlink:href="wlds-20231231.xsd#wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2022Abstract" xlink:to="IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares" xlink:href="wlds-20231231.xsd#wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2022Abstract" xlink:to="IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2022Abstract" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering" xlink:href="wlds-20231231.xsd#wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2022Abstract" xlink:to="ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" xlink:href="wlds-20231231.xsd#wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2022Abstract" xlink:to="IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrantsinShares" xlink:href="wlds-20231231.xsd#wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrantsinShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2022Abstract" xlink:to="IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrantsinShares" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ChangesDuringTheYear2023Abstract" xlink:href="wlds-20231231.xsd#wlds_ChangesDuringTheYear2023Abstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ChangesDuringTheYear2023Abstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2023Abstract" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2023Abstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodValueInvestors" xlink:href="wlds-20231231.xsd#wlds_StockIssuedDuringPeriodValueInvestors"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2023Abstract" xlink:to="StockIssuedDuringPeriodValueInvestors" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodSharesInvestors" xlink:href="wlds-20231231.xsd#wlds_StockIssuedDuringPeriodSharesInvestors"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2023Abstract" xlink:to="StockIssuedDuringPeriodSharesInvestors" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodValueExerciseOfWarrants" xlink:href="wlds-20231231.xsd#wlds_StockIssuedDuringPeriodValueExerciseOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2023Abstract" xlink:to="StockIssuedDuringPeriodValueExerciseOfWarrants" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:href="wlds-20231231.xsd#wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2023Abstract" xlink:to="StockIssuedDuringPeriodSharesExerciseOfWarrants" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ChangesDuringTheYear2021Abstract" xlink:href="wlds-20231231.xsd#wlds_ChangesDuringTheYear2021Abstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ChangesDuringTheYear2021Abstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost" xlink:href="wlds-20231231.xsd#wlds_IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2021Abstract" xlink:to="IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2021Abstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2021Abstract" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2021Abstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConversionOfOrdinaryASharesToOrdinarySharesValue" xlink:href="wlds-20231231.xsd#wlds_ConversionOfOrdinaryASharesToOrdinarySharesValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2021Abstract" xlink:to="ConversionOfOrdinaryASharesToOrdinarySharesValue" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConversionOfOrdinaryASharesToOrdinaryShares" xlink:href="wlds-20231231.xsd#wlds_ConversionOfOrdinaryASharesToOrdinaryShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2021Abstract" xlink:to="ConversionOfOrdinaryASharesToOrdinaryShares" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2021Abstract" xlink:to="us-gaap_ShareBasedCompensation" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2021Abstract" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodShareOfExerciseOfOptionsinShares" xlink:href="wlds-20231231.xsd#wlds_StockIssuedDuringPeriodShareOfExerciseOfOptionsinShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2021Abstract" xlink:to="StockIssuedDuringPeriodShareOfExerciseOfOptionsinShares" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodValueOfPaymentOnBehalfOfSharesIssued" xlink:href="wlds-20231231.xsd#wlds_StockIssuedDuringPeriodValueOfPaymentOnBehalfOfSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2021Abstract" xlink:to="StockIssuedDuringPeriodValueOfPaymentOnBehalfOfSharesIssued" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2021Abstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_0" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding_0" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_Depreciation" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AccruedInterestOnConvertibleSecurities" xlink:href="wlds-20231231.xsd#wlds_AccruedInterestOnConvertibleSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="AccruedInterestOnConvertibleSecurities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AccruedInterestOnDeposits" xlink:href="wlds-20231231.xsd#wlds_AccruedInterestOnDeposits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="AccruedInterestOnDeposits" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="DecreaseincreaseInGovernmentalGrantsReceivables" xlink:href="wlds-20231231.xsd#wlds_DecreaseincreaseInGovernmentalGrantsReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="DecreaseincreaseInGovernmentalGrantsReceivables" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="IncreaseInOtherReceivablesAndPrepaidExpenses" xlink:href="wlds-20231231.xsd#wlds_IncreaseInOtherReceivablesAndPrepaidExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseInOtherReceivablesAndPrepaidExpenses" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="IncreaseDecreaseInAdvancePayments" xlink:href="wlds-20231231.xsd#wlds_IncreaseDecreaseInAdvancePayments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInAdvancePayments" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IncreaseDecreaseInAdvancePaymentsOnGovernmentalGrant" xlink:href="wlds-20231231.xsd#wlds_IncreaseDecreaseInAdvancePaymentsOnGovernmentalGrant"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInAdvancePaymentsOnGovernmentalGrant" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireRestrictedCertificatesOfDeposit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireRestrictedCertificatesOfDeposit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireRestrictedCertificatesOfDeposit" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="PrepaymentsOfLeasing" xlink:href="wlds-20231231.xsd#wlds_PrepaymentsOfLeasing"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="PrepaymentsOfLeasing" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost" xlink:href="wlds-20231231.xsd#wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPubli" xlink:href="wlds-20231231.xsd#wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPubli"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPubli" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProceedsFromIssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost" xlink:href="wlds-20231231.xsd#wlds_ProceedsFromIssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromIssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProceedsFromIssuanceOfSAFEs" xlink:href="wlds-20231231.xsd#wlds_ProceedsFromIssuanceOfSAFEs"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromIssuanceOfSAFEs" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RefundToSAFEInvestors" xlink:href="wlds-20231231.xsd#wlds_RefundToSAFEInvestors"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="RefundToSAFEInvestors" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromLinesOfCredit" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfLinesOfCredit" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" xlink:href="wlds-20231231.xsd#wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PaymentOnBehalfOfIssuedShares" xlink:href="wlds-20231231.xsd#wlds_PaymentOnBehalfOfIssuedShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="PaymentOnBehalfOfIssuedShares" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowElementsAbstract" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_InterestPaidNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InterestReceivedFromDeposits" xlink:href="wlds-20231231.xsd#wlds_InterestReceivedFromDeposits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="InterestReceivedFromDeposits" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConversionOfSAFEToEquity" xlink:href="wlds-20231231.xsd#wlds_ConversionOfSAFEToEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="ConversionOfSAFEToEquity" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RightofUseAssetRecognizedAgainstLeaseLiability" xlink:href="wlds-20231231.xsd#wlds_RightofUseAssetRecognizedAgainstLeaseLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="RightofUseAssetRecognizedAgainstLeaseLiability" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/General">
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/SignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/Inventories">
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNetAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryNetAbstract" xlink:to="us-gaap_InventoryDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/PropertyandEquipmentNet">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/Lease">
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/CommitmentsandContingencies">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ConvertibleSecurities">
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsAbstract" xlink:to="us-gaap_DebtDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/CreditFacility">
    <loc xlink:type="locator" xlink:label="CreditFacilityAbstract" xlink:href="wlds-20231231.xsd#wlds_CreditFacilityAbstract"/>
    <loc xlink:type="locator" xlink:label="CreditFacilityDisclosureTextBlock" xlink:href="wlds-20231231.xsd#wlds_CreditFacilityDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreditFacilityAbstract" xlink:to="CreditFacilityDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ShareholdersEquityDeficit">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/TaxesonIncome">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/RelatedParties">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InventoryPolicyTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CostOfRevenuesPolicyTextBlock" xlink:href="wlds-20231231.xsd#wlds_CostOfRevenuesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="CostOfRevenuesPolicyTextBlock" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GovernmentalGrantsPolicyTextBlock" xlink:href="wlds-20231231.xsd#wlds_GovernmentalGrantsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="GovernmentalGrantsPolicyTextBlock" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FinanceIncomeAndExpensesPolicyPolicyTextBlock" xlink:href="wlds-20231231.xsd#wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="FinanceIncomeAndExpensesPolicyPolicyTextBlock" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsPolicyPolicyTextBlock" xlink:href="wlds-20231231.xsd#wlds_WarrantsPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="WarrantsPolicyPolicyTextBlock" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SeverancePolicyTextBlock" xlink:href="wlds-20231231.xsd#wlds_SeverancePolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="SeverancePolicyTextBlock" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SubsequentEventsPolicyPolicyTextBlock" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfAnnualRatesOfDepreciationTableTextBlock" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ScheduleOfAnnualRatesOfDepreciationTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/InventoriesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNetAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryNetAbstract" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/PropertyandEquipmentNetTables">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/LeaseTables">
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitTables">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfStockholdersEquityTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfOptionsToConsultantsTableTextBlock" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfOptionsToConsultantsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="ScheduleOfOptionsToConsultantsTableTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ScheduleofAnnualRatesofDepreciationTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfAnnualRatesOfDepreciationAbstract" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfAnnualRatesOfDepreciationAbstract"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesDetailsScheduleofAnnualRatesofDepreciationTable" xlink:href="wlds-20231231.xsd#wlds_SignificantAccountingPoliciesDetailsScheduleofAnnualRatesofDepreciationTable"/>
    <loc xlink:type="locator" xlink:label="AnnualRatesOfDepreciationLineItems" xlink:href="wlds-20231231.xsd#wlds_AnnualRatesOfDepreciationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAnnualRatesOfDepreciationAbstract" xlink:to="SignificantAccountingPoliciesDetailsScheduleofAnnualRatesofDepreciationTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsScheduleofAnnualRatesofDepreciationTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember" xlink:href="wlds-20231231.xsd#wlds_OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ComputersAndSoftwareMember" xlink:href="wlds-20231231.xsd#wlds_ComputersAndSoftwareMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="ComputersAndSoftwareMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MoldMember" xlink:href="wlds-20231231.xsd#wlds_MoldMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="MoldMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsScheduleofAnnualRatesofDepreciationTable" xlink:to="srt_RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsScheduleofAnnualRatesofDepreciationTable" xlink:to="AnnualRatesOfDepreciationLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="AnnualRateOfDepreciation" xlink:href="wlds-20231231.xsd#wlds_AnnualRateOfDepreciation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AnnualRatesOfDepreciationLineItems" xlink:to="AnnualRateOfDepreciation" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ScheduleofInventoriesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="CostAbstract" xlink:href="wlds-20231231.xsd#wlds_CostAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="CostAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CostAbstract" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CostAbstract" xlink:to="us-gaap_InventoryWorkInProcessNetOfReserves" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CostAbstract" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FIFOInventoryAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FIFOInventoryAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CostAbstract" xlink:to="us-gaap_FIFOInventoryAmount" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfPropertyAndEquipmentNetAbstract" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfPropertyAndEquipmentNetAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPropertyAndEquipmentNetAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ComputersAndSoftwareMember" xlink:href="wlds-20231231.xsd#wlds_ComputersAndSoftwareMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="ComputersAndSoftwareMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember" xlink:href="wlds-20231231.xsd#wlds_OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ElectronicEquipmentMember" xlink:href="wlds-20231231.xsd#wlds_ElectronicEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="ElectronicEquipmentMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MachinesAndMoldsMember" xlink:href="wlds-20231231.xsd#wlds_MachinesAndMoldsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="MachinesAndMoldsMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="CostAbstract0" xlink:href="wlds-20231231.xsd#wlds_CostAbstract0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="CostAbstract0" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CostAbstract0" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfClassificationOfOperatingLeaseRightOfUseAssetsAndLiabilitiesAbstract" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfClassificationOfOperatingLeaseRightOfUseAssetsAndLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfClassificationOfOperatingLeaseRightOfUseAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_AssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfClassificationOfOperatingLeaseRightOfUseAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesAbstract" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_OperatingLeaseLiability" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfShareCapitalAbstract" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfShareCapitalAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityDeficitDetailsScheduleofShareCapitalTable" xlink:href="wlds-20231231.xsd#wlds_ShareholdersEquityDeficitDetailsScheduleofShareCapitalTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCapitalizationEquityLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareCapitalAbstract" xlink:to="ShareholdersEquityDeficitDetailsScheduleofShareCapitalTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDeficitDetailsScheduleofShareCapitalTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDeficitDetailsScheduleofShareCapitalTable" xlink:to="us-gaap_ScheduleOfCapitalizationEquityLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfSharesIssuedAndOutstanding" xlink:href="wlds-20231231.xsd#wlds_NumberOfSharesIssuedAndOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:to="NumberOfSharesIssuedAndOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable_Parentheticals">
    <loc xlink:type="locator" xlink:label="ScheduleOfShareCapitalAbstract" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfShareCapitalAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityDeficitDetailsScheduleofShareCapitalParentheticalsTable" xlink:href="wlds-20231231.xsd#wlds_ShareholdersEquityDeficitDetailsScheduleofShareCapitalParentheticalsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCapitalizationEquityLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareCapitalAbstract" xlink:to="ShareholdersEquityDeficitDetailsScheduleofShareCapitalParentheticalsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDeficitDetailsScheduleofShareCapitalParentheticalsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDeficitDetailsScheduleofShareCapitalParentheticalsTable" xlink:to="us-gaap_ScheduleOfCapitalizationEquityLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfOptionsActivityAbstract" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfOptionsActivityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOptionsActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOptionsActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOptionsActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOptionsActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOptionsActivityAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOptionsActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOptionsActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOptionsActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOptionsActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOptionsActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOptionsActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOptionsActivityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageAssumptionsTable">
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions" xlink:href="wlds-20231231.xsd#wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfOptionsToConsultantsAbstract" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfOptionsToConsultantsAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityDeficitDetailsScheduleofOptionstoConsultantsTable" xlink:href="wlds-20231231.xsd#wlds_ShareholdersEquityDeficitDetailsScheduleofOptionstoConsultantsTable"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfOptionsToConsultantsLineItems" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfOptionsToConsultantsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOptionsToConsultantsAbstract" xlink:to="ShareholdersEquityDeficitDetailsScheduleofOptionstoConsultantsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDeficitDetailsScheduleofOptionstoConsultantsTable" xlink:to="srt_RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardDateAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDeficitDetailsScheduleofOptionstoConsultantsTable" xlink:to="us-gaap_AwardDateAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="TwoThousandFifteenMember" xlink:href="wlds-20231231.xsd#wlds_TwoThousandFifteenMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardDateAxis" xlink:to="TwoThousandFifteenMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoThousandSeventeenMember" xlink:href="wlds-20231231.xsd#wlds_TwoThousandSeventeenMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardDateAxis" xlink:to="TwoThousandSeventeenMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrYE9rliDcrbWhjsc3i7BCl/DvlJVwr+JR0O2nYady5Se133BDWCF8ON/Jzif84CehHV5r9vMQwYxP2psHDnPZsunu1t2oh0qhdKXAlJyzN93OrPInDu+qpjJa2tGyv2XwvSkfjcWfQLzhpm2ZADneXuFkrcNjL16FM7h6sOb4n/vSj6ATmkI0Ua4rjBBddfCaAg7hLwyTRrpfV59RrfBcqe] CSR-->
    <loc xlink:type="locator" xlink:label="TwoThousandTwentyoneMember" xlink:href="wlds-20231231.xsd#wlds_TwoThousandTwentyoneMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardDateAxis" xlink:to="TwoThousandTwentyoneMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoThousandTwentyThreeMember" xlink:href="wlds-20231231.xsd#wlds_TwoThousandTwentyThreeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardDateAxis" xlink:to="TwoThousandTwentyThreeMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDeficitDetailsScheduleofOptionstoConsultantsTable" xlink:to="ScheduleOfOptionsToConsultantsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOptionsToConsultantsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOptionsToConsultantsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOptionsToConsultantsLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOptionsToConsultantsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ScheduleofShareBasedCompensationExpensesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfShareBasedCompensationExpensesAbstract" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfShareBasedCompensationExpensesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfShareBasedCompensationExpensesLineItems" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfShareBasedCompensationExpensesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationExpensesAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_SellingAndMarketingExpenseMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="ScheduleOfShareBasedCompensationExpensesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationExpensesLineItems" xlink:to="us-gaap_ShareBasedCompensation" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateAbstract" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityDeficitDetailsScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable" xlink:href="wlds-20231231.xsd#wlds_ShareholdersEquityDeficitDetailsScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateLineItems" xlink:href="wlds-20231231.xsd#wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateAbstract" xlink:to="ShareholdersEquityDeficitDetailsScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDeficitDetailsScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable" xlink:to="us-gaap_AwardTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="September132022Member" xlink:href="wlds-20231231.xsd#wlds_September132022Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="September132022Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="September152022OneMember" xlink:href="wlds-20231231.xsd#wlds_September152022OneMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="September152022OneMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="September152022TwoMember" xlink:href="wlds-20231231.xsd#wlds_September152022TwoMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="September152022TwoMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="September152022ThreeMember" xlink:href="wlds-20231231.xsd#wlds_September152022ThreeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="September152022ThreeMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDeficitDetailsScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable" xlink:to="ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio" xlink:href="wlds-20231231.xsd#wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate" xlink:href="wlds-20231231.xsd#wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementNotes" xlink:href="wlds-20231231.xsd#wlds_ShareBasedCompensationArrangementNotes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateLineItems" xlink:to="ShareBasedCompensationArrangementNotes" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/GeneralDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <loc xlink:type="locator" xlink:label="GeneralDetailsTable" xlink:href="wlds-20231231.xsd#wlds_GeneralDetailsTable"/>
    <loc xlink:type="locator" xlink:label="GeneralLineItems" xlink:href="wlds-20231231.xsd#wlds_GeneralLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="GeneralDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="MudraInspireDevelopmentKitsMember" xlink:href="wlds-20231231.xsd#wlds_MudraInspireDevelopmentKitsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="MudraInspireDevelopmentKitsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_WarrantMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_IPOMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OverAllotmentOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_OverAllotmentOptionMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsTable" xlink:to="GeneralLineItems" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="AnnualGrossRevenuesExceed" xlink:href="wlds-20231231.xsd#wlds_AnnualGrossRevenuesExceed"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralLineItems" xlink:to="AnnualGrossRevenuesExceed" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OrdinarySharesWarrantsHeldByNonaffiliates" xlink:href="wlds-20231231.xsd#wlds_OrdinarySharesWarrantsHeldByNonaffiliates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralLineItems" xlink:to="OrdinarySharesWarrantsHeldByNonaffiliates" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NonconvertibleDebtSecurities" xlink:href="wlds-20231231.xsd#wlds_NonconvertibleDebtSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralLineItems" xlink:to="NonconvertibleDebtSecurities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralLineItems" xlink:to="us-gaap_Revenues" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NetProceedsFromIssuanceSecondaryPublicOffering" xlink:href="wlds-20231231.xsd#wlds_NetProceedsFromIssuanceSecondaryPublicOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralLineItems" xlink:to="NetProceedsFromIssuanceSecondaryPublicOffering" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="Warrants" xlink:href="wlds-20231231.xsd#wlds_Warrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralLineItems" xlink:to="Warrants" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsExerciseIntoOrdinaryShares" xlink:href="wlds-20231231.xsd#wlds_WarrantsExerciseIntoOrdinaryShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralLineItems" xlink:to="WarrantsExerciseIntoOrdinaryShares" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExercisePriceOfWarrant" xlink:href="wlds-20231231.xsd#wlds_ExercisePriceOfWarrant"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralLineItems" xlink:to="ExercisePriceOfWarrant" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GrossProceeds" xlink:href="wlds-20231231.xsd#wlds_GrossProceeds"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralLineItems" xlink:to="GrossProceeds" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UnderwritingNetProceed" xlink:href="wlds-20231231.xsd#wlds_UnderwritingNetProceed"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralLineItems" xlink:to="UnderwritingNetProceed" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UnderwritingDiscountsAndCommissions" xlink:href="wlds-20231231.xsd#wlds_UnderwritingDiscountsAndCommissions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralLineItems" xlink:to="UnderwritingDiscountsAndCommissions" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GrossAfterOtherIPOExpenses" xlink:href="wlds-20231231.xsd#wlds_GrossAfterOtherIPOExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralLineItems" xlink:to="GrossAfterOtherIPOExpenses" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralLineItems" xlink:to="us-gaap_SharePrice" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsExercisePricePerShare" xlink:href="wlds-20231231.xsd#wlds_WarrantsExercisePricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralLineItems" xlink:to="WarrantsExercisePricePerShare" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesDetailsTable" xlink:href="wlds-20231231.xsd#wlds_SignificantAccountingPoliciesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesDetailsLineItems" xlink:href="wlds-20231231.xsd#wlds_SignificantAccountingPoliciesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="SignificantAccountingPoliciesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="LeaseLiabilityMember" xlink:href="wlds-20231231.xsd#wlds_LeaseLiabilityMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="LeaseLiabilityMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsTable" xlink:to="SignificantAccountingPoliciesDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_DebtWeightedAverageInterestRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeFinanceLeaseRenewalTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_LesseeFinanceLeaseRenewalTerm1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RateOfMonthlySeverancePercentage" xlink:href="wlds-20231231.xsd#wlds_RateOfMonthlySeverancePercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="RateOfMonthlySeverancePercentage" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/LeaseDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseOptionToExtend" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseExpense" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="CommitmentsandContingenciesDetailsTable" xlink:href="wlds-20231231.xsd#wlds_CommitmentsandContingenciesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="CommitmentsandContingenciesDetailsLineItems" xlink:href="wlds-20231231.xsd#wlds_CommitmentsandContingenciesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="CommitmentsandContingenciesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VehiclesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VehiclesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_VehiclesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsTable" xlink:to="srt_StatementScenarioAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioForecastMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseAgreementsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_LeaseAgreementsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCommitmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_OtherCommitmentsAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCommitmentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsAxis" xlink:to="us-gaap_OtherCommitmentsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="IIAMember" xlink:href="wlds-20231231.xsd#wlds_IIAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsAxis" xlink:to="IIAMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IMEIMember" xlink:href="wlds-20231231.xsd#wlds_IMEIMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsAxis" xlink:to="IMEIMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsTable" xlink:to="srt_RangeAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_VariableRateAxis" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsTable" xlink:to="CommitmentsandContingenciesDetailsLineItems" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="RoyaltiesRate" xlink:href="wlds-20231231.xsd#wlds_RoyaltiesRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsLineItems" xlink:to="RoyaltiesRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GrantsReceivedEqualPercentageRate" xlink:href="wlds-20231231.xsd#wlds_GrantsReceivedEqualPercentageRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsLineItems" xlink:to="GrantsReceivedEqualPercentageRate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AnnualAlternativeInterestPercentage" xlink:href="wlds-20231231.xsd#wlds_AnnualAlternativeInterestPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsLineItems" xlink:to="AnnualAlternativeInterestPercentage" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AnnualInterestRate" xlink:href="wlds-20231231.xsd#wlds_AnnualInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsLineItems" xlink:to="AnnualInterestRate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FixedAnnualInterestRate" xlink:href="wlds-20231231.xsd#wlds_FixedAnnualInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsLineItems" xlink:to="FixedAnnualInterestRate" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AmountsReceivedAggregateAmount" xlink:href="wlds-20231231.xsd#wlds_AmountsReceivedAggregateAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsLineItems" xlink:to="AmountsReceivedAggregateAmount" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AmountOfDevelopmentProgram" xlink:href="wlds-20231231.xsd#wlds_AmountOfDevelopmentProgram"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsLineItems" xlink:to="AmountOfDevelopmentProgram" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfFinancing" xlink:href="wlds-20231231.xsd#wlds_PercentageOfFinancing"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsLineItems" xlink:to="PercentageOfFinancing" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TotalCashReceivedFromTheIIA" xlink:href="wlds-20231231.xsd#wlds_TotalCashReceivedFromTheIIA"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsLineItems" xlink:to="TotalCashReceivedFromTheIIA" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExceptTransferProductionRight" xlink:href="wlds-20231231.xsd#wlds_ExceptTransferProductionRight"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsLineItems" xlink:to="ExceptTransferProductionRight" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProductionTransferred" xlink:href="wlds-20231231.xsd#wlds_ProductionTransferred"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsLineItems" xlink:to="ProductionTransferred" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PayIncreasedRoyaltiesDescription" xlink:href="wlds-20231231.xsd#wlds_PayIncreasedRoyaltiesDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsLineItems" xlink:to="PayIncreasedRoyaltiesDescription" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ResearchAndDevelopmentGrantsDetection" xlink:href="wlds-20231231.xsd#wlds_ResearchAndDevelopmentGrantsDetection"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsLineItems" xlink:to="ResearchAndDevelopmentGrantsDetection" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MaximumObligatinAmount" xlink:href="wlds-20231231.xsd#wlds_MaximumObligatinAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsLineItems" xlink:to="MaximumObligatinAmount" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GrantsReceivedFromTheIMEI" xlink:href="wlds-20231231.xsd#wlds_GrantsReceivedFromTheIMEI"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsLineItems" xlink:to="GrantsReceivedFromTheIMEI" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SalesAndMarketingExpensesDeductions" xlink:href="wlds-20231231.xsd#wlds_SalesAndMarketingExpensesDeductions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsLineItems" xlink:to="SalesAndMarketingExpensesDeductions" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenuesNetOfInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesNetOfInterestExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsLineItems" xlink:to="us-gaap_RevenuesNetOfInterestExpense" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RoyaltiesRatePercentage" xlink:href="wlds-20231231.xsd#wlds_RoyaltiesRatePercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsLineItems" xlink:to="RoyaltiesRatePercentage" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MarketingGrantReceived" xlink:href="wlds-20231231.xsd#wlds_MarketingGrantReceived"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsLineItems" xlink:to="MarketingGrantReceived" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrantsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrantsReceivableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsLineItems" xlink:to="us-gaap_GrantsReceivableCurrent" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsLineItems" xlink:to="us-gaap_LeaseCost" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsLineItems" xlink:to="us-gaap_PaymentsForRent" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LeasePaymentIncreased" xlink:href="wlds-20231231.xsd#wlds_LeasePaymentIncreased"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsLineItems" xlink:to="LeasePaymentIncreased" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LeaseAgreements" xlink:href="wlds-20231231.xsd#wlds_LeaseAgreements"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsLineItems" xlink:to="LeaseAgreements" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LeaseAgreementsPeriod" xlink:href="wlds-20231231.xsd#wlds_LeaseAgreementsPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsLineItems" xlink:to="LeaseAgreementsPeriod" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="ConvertibleSecuritiesDetailsTable" xlink:href="wlds-20231231.xsd#wlds_ConvertibleSecuritiesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ConvertibleSecuritiesLineItems" xlink:href="wlds-20231231.xsd#wlds_ConvertibleSecuritiesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsAbstract" xlink:to="ConvertibleSecuritiesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleSecuritiesDetailsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ConvertibleSecuritiesMember" xlink:href="wlds-20231231.xsd#wlds_ConvertibleSecuritiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="ConvertibleSecuritiesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleSecuritiesDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_WarrantMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleSecuritiesDetailsTable" xlink:to="ConvertibleSecuritiesLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleSecuritiesLineItems" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleSecuritiesLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleSecuritiesLineItems" xlink:to="us-gaap_SharePrice" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleSecuritiesLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertibleSecurityDescription" xlink:href="wlds-20231231.xsd#wlds_ConvertibleSecurityDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleSecuritiesLineItems" xlink:to="ConvertibleSecurityDescription" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CashPayment" xlink:href="wlds-20231231.xsd#wlds_CashPayment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleSecuritiesLineItems" xlink:to="CashPayment" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PremoneyValuationAmount" xlink:href="wlds-20231231.xsd#wlds_PremoneyValuationAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleSecuritiesLineItems" xlink:to="PremoneyValuationAmount" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantPricePerSharePercentage" xlink:href="wlds-20231231.xsd#wlds_WarrantPricePerSharePercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleSecuritiesLineItems" xlink:to="WarrantPricePerSharePercentage" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PurchasePricePerShare" xlink:href="wlds-20231231.xsd#wlds_PurchasePricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleSecuritiesLineItems" xlink:to="PurchasePricePerShare" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleSecuritiesLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="AggregateOrdinaryShares" xlink:href="wlds-20231231.xsd#wlds_AggregateOrdinaryShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleSecuritiesLineItems" xlink:to="AggregateOrdinaryShares" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/CreditFacilityDetails">
    <loc xlink:type="locator" xlink:label="CreditFacilityAbstract" xlink:href="wlds-20231231.xsd#wlds_CreditFacilityAbstract"/>
    <loc xlink:type="locator" xlink:label="CreditFacilityDetailsTable" xlink:href="wlds-20231231.xsd#wlds_CreditFacilityDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreditFacilityAbstract" xlink:to="CreditFacilityDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreditFacilityDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_IPOMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreditFacilityDetailsTable" xlink:to="us-gaap_LineOfCreditFacilityLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherBorrowings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_OtherBorrowings" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AggregateAmount" xlink:href="wlds-20231231.xsd#wlds_AggregateAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="AggregateAmount" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ServicesInExchangeForMonthlyBaseFee" xlink:href="wlds-20231231.xsd#wlds_ServicesInExchangeForMonthlyBaseFee"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="ServicesInExchangeForMonthlyBaseFee" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AggrementTerm" xlink:href="wlds-20231231.xsd#wlds_AggrementTerm"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="AggrementTerm" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsIssuedPercentage" xlink:href="wlds-20231231.xsd#wlds_WarrantsIssuedPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="WarrantsIssuedPercentage" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BaseMonthlyFeeImmediatelyIncreaseAmount" xlink:href="wlds-20231231.xsd#wlds_BaseMonthlyFeeImmediatelyIncreaseAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="BaseMonthlyFeeImmediatelyIncreaseAmount" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OfferingOrFinancingTransactionAmount" xlink:href="wlds-20231231.xsd#wlds_OfferingOrFinancingTransactionAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="OfferingOrFinancingTransactionAmount" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TransactionFeeClosingValue" xlink:href="wlds-20231231.xsd#wlds_TransactionFeeClosingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="TransactionFeeClosingValue" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExpenseOnServiceRendering" xlink:href="wlds-20231231.xsd#wlds_ExpenseOnServiceRendering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="ExpenseOnServiceRendering" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityDeficitDetailsTable" xlink:href="wlds-20231231.xsd#wlds_ShareholdersEquityDeficitDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityLineItems" xlink:href="wlds-20231231.xsd#wlds_ShareholdersEquityLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="ShareholdersEquityDeficitDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDeficitDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="CofoundersMember" xlink:href="wlds-20231231.xsd#wlds_CofoundersMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="CofoundersMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestorMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestorMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_InvestorMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDeficitDetailsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDeficitDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="TwoZeroOneFiveMember" xlink:href="wlds-20231231.xsd#wlds_TwoZeroOneFiveMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="TwoZeroOneFiveMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDeficitDetailsTable" xlink:to="srt_StatementScenarioAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioForecastMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDeficitDetailsTable" xlink:to="us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" xlink:to="us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestorMember_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestorMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" xlink:to="us-gaap_InvestorMember_0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDeficitDetailsTable" xlink:to="srt_TitleOfIndividualAxis" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_BoardOfDirectorsChairmanMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_BoardOfDirectorsChairmanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_BoardOfDirectorsChairmanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_DirectorMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_DirectorMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDeficitDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonClassAMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonStockMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDeficitDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_IPOMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDeficitDetailsTable" xlink:to="srt_RangeAxis" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDeficitDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember_0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDeficitDetailsTable" xlink:to="ShareholdersEquityLineItems" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="TotalValueOfTheShares" xlink:href="wlds-20231231.xsd#wlds_TotalValueOfTheShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="TotalValueOfTheShares" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OrdinaryShareParValue" xlink:href="wlds-20231231.xsd#wlds_OrdinaryShareParValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="OrdinaryShareParValue" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ValueOfOrdinaryAShare" xlink:href="wlds-20231231.xsd#wlds_ValueOfOrdinaryAShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="ValueOfOrdinaryAShare" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InterestPercentage" xlink:href="wlds-20231231.xsd#wlds_InterestPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="InterestPercentage" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="us-gaap_SharesIssued" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AShareReclassifiedToOrdinaryShares" xlink:href="wlds-20231231.xsd#wlds_AShareReclassifiedToOrdinaryShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="AShareReclassifiedToOrdinaryShares" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OrdinarySharesAuthorizedIncreased" xlink:href="wlds-20231231.xsd#wlds_OrdinarySharesAuthorizedIncreased"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="OrdinarySharesAuthorizedIncreased" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OrdinarySharesIssued" xlink:href="wlds-20231231.xsd#wlds_OrdinarySharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="OrdinarySharesIssued" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OrdinarySharesWarrantExercisable" xlink:href="wlds-20231231.xsd#wlds_OrdinarySharesWarrantExercisable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="OrdinarySharesWarrantExercisable" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OrdinarySharesInConsiderationPercentage" xlink:href="wlds-20231231.xsd#wlds_OrdinarySharesInConsiderationPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="OrdinarySharesInConsiderationPercentage" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TotalConsiderationAmount" xlink:href="wlds-20231231.xsd#wlds_TotalConsiderationAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="TotalConsiderationAmount" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuanceExpenses" xlink:href="wlds-20231231.xsd#wlds_IssuanceExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="IssuanceExpenses" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SAFEsAmount" xlink:href="wlds-20231231.xsd#wlds_SAFEsAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="SAFEsAmount" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Investor" xlink:href="wlds-20231231.xsd#wlds_Investor"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="Investor" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InvestorAmount" xlink:href="wlds-20231231.xsd#wlds_InvestorAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="InvestorAmount" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertedAmount" xlink:href="wlds-20231231.xsd#wlds_ConvertedAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="ConvertedAmount" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertedToOrdinaryShares" xlink:href="wlds-20231231.xsd#wlds_ConvertedToOrdinaryShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="ConvertedToOrdinaryShares" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="us-gaap_Cash" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="20.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExercisableWarrantsToShares" xlink:href="wlds-20231231.xsd#wlds_ExercisableWarrantsToShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="ExercisableWarrantsToShares" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InvestorsExercisedWarrants" xlink:href="wlds-20231231.xsd#wlds_InvestorsExercisedWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="InvestorsExercisedWarrants" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="EmployeeExercisedWarrants" xlink:href="wlds-20231231.xsd#wlds_EmployeeExercisedWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="EmployeeExercisedWarrants" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:href="wlds-20231231.xsd#wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="StockIssuedDuringPeriodSharesExerciseOfWarrants" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ExercisePricePerShare" xlink:href="wlds-20231231.xsd#wlds_ExercisePricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="ExercisePricePerShare" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProceedsFromIssuanceFollowOnPublicOffering" xlink:href="wlds-20231231.xsd#wlds_ProceedsFromIssuanceFollowOnPublicOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="ProceedsFromIssuanceFollowOnPublicOffering" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OrdinarySharePerValue" xlink:href="wlds-20231231.xsd#wlds_OrdinarySharePerValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="OrdinarySharePerValue" order="29.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" order="31.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OptionsAvailableForGrant" xlink:href="wlds-20231231.xsd#wlds_OptionsAvailableForGrant"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="OptionsAvailableForGrant" order="32.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="33.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="34.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TerminationPeriod" xlink:href="wlds-20231231.xsd#wlds_TerminationPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="TerminationPeriod" order="35.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" order="36.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuanceOfSharesOptions" xlink:href="wlds-20231231.xsd#wlds_IssuanceOfSharesOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="IssuanceOfSharesOptions" order="37.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate" xlink:href="wlds-20231231.xsd#wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate" order="38.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OptionsExpenses" xlink:href="wlds-20231231.xsd#wlds_OptionsExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="OptionsExpenses" order="39.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="VestingPeriods" xlink:href="wlds-20231231.xsd#wlds_VestingPeriods"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="VestingPeriods" order="40.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExercisePriceOfWarrants" xlink:href="wlds-20231231.xsd#wlds_ExercisePriceOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="ExercisePriceOfWarrants" order="41.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm" order="42.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantBeReducedToAnExercisePricePercentage" xlink:href="wlds-20231231.xsd#wlds_WarrantBeReducedToAnExercisePricePercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="WarrantBeReducedToAnExercisePricePercentage" order="43.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InitialExercisePricePercentage" xlink:href="wlds-20231231.xsd#wlds_InitialExercisePricePercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="InitialExercisePricePercentage" order="44.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WeightedAveragePricePercentage" xlink:href="wlds-20231231.xsd#wlds_WeightedAveragePricePercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="WeightedAveragePricePercentage" order="45.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LowestResetPrice" xlink:href="wlds-20231231.xsd#wlds_LowestResetPrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="LowestResetPrice" order="46.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InitialExercisePricesPercentage" xlink:href="wlds-20231231.xsd#wlds_InitialExercisePricesPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityLineItems" xlink:to="InitialExercisePricesPercentage" order="47.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/TaxesonIncomeDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="TaxesonIncomeDetailsTable" xlink:href="wlds-20231231.xsd#wlds_TaxesonIncomeDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="TaxesonIncomeDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TaxesonIncomeDetailsTable" xlink:to="srt_StatementGeographicalAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="country_IL" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_IL" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TaxesonIncomeDetailsTable" xlink:to="us-gaap_IncomeTaxContingencyLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="CorporateTaxRatePercentage" xlink:href="wlds-20231231.xsd#wlds_CorporateTaxRatePercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="CorporateTaxRatePercentage" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/RelatedPartiesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="RelatedPartiesDetailsTable" xlink:href="wlds-20231231.xsd#wlds_RelatedPartiesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="RelatedPartiesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="AsherDahanMember" xlink:href="wlds-20231231.xsd#wlds_AsherDahanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="AsherDahanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="CofoundersMember" xlink:href="wlds-20231231.xsd#wlds_CofoundersMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="CofoundersMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="PercentageOfOwnership" xlink:href="wlds-20231231.xsd#wlds_PercentageOfOwnership"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="PercentageOfOwnership" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="EmploymentExpenses" xlink:href="wlds-20231231.xsd#wlds_EmploymentExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="EmploymentExpenses" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OfficerEmployeeMonthlySalary" xlink:href="wlds-20231231.xsd#wlds_OfficerEmployeeMonthlySalary"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="OfficerEmployeeMonthlySalary" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RelatedPartyMonthlySalary" xlink:href="wlds-20231231.xsd#wlds_RelatedPartyMonthlySalary"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="RelatedPartyMonthlySalary" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wearabledevices.co.il/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="DocumentAndEntityInformationAbstract" xlink:href="wlds-20231231.xsd#wlds_DocumentAndEntityInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentInformationTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="OrdinarySharesNIS001ParValuePerShareMember" xlink:href="wlds-20231231.xsd#wlds_OrdinarySharesNIS001ParValuePerShareMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="OrdinarySharesNIS001ParValuePerShareMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsToPurchaseOrdinarySharesMember" xlink:href="wlds-20231231.xsd#wlds_WarrantsToPurchaseOrdinarySharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="WarrantsToPurchaseOrdinarySharesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_EntityAddressesAddressTypeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_BusinessContactMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_BusinessContactMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" order="3.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentRegistrationStatement" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentRegistrationStatement" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentShellCompanyReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentShellCompanyReport" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCountry" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_ContactPersonnelName" order="29.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="31.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="32.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="33.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="34.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag" order="35.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAccountingStandard" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAccountingStandard" order="36.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorFirmId" order="37.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorName" order="38.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorLocation" order="39.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619173969632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Wearable Devices Ltd.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">20-F<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">20,387,428<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001887673<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentShellCompanyReport', window );">Document Shell Company Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41502<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">L3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5 Ha-Tnufa Street<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Yokne&#8217;am Illit<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">2066736<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Israel<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAccountingStandard', window );">Document Accounting Standard</a></td>
<td class="text">U.S. GAAP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">1185<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Ziv Haft<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Tel Aviv, Israel<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5 Ha-Tnufa Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Yokne&#8217;am Illit<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">2066736<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Israel<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Asher Dahan<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">+972.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">4.6185670<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=wlds_OrdinarySharesNIS001ParValuePerShareMember', window );">Ordinary Shares, NIS 0.01 par value per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">WLDS<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary Shares, NIS 0.01 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=wlds_WarrantsToPurchaseOrdinarySharesMember', window );">Warrants to Purchase Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">WLDSW<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants to Purchase Ordinary Shares<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAccountingStandard">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAccountingStandard</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:accountingStandardItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentShellCompanyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentShellCompanyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=wlds_OrdinarySharesNIS001ParValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=wlds_OrdinarySharesNIS001ParValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=wlds_WarrantsToPurchaseOrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=wlds_WarrantsToPurchaseOrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619173658176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 810<span></span>
</td>
<td class="nump">$ 10,373<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositsAssetsCurrent', window );">Short term bank deposits</a></td>
<td class="nump">4,045<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrantsReceivable', window );">Governmental grant receivable</a></td>
<td class="nump">108<span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Other receivables and prepaid expenses</a></td>
<td class="nump">757<span></span>
</td>
<td class="nump">543<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FIFOInventoryAmount', window );">Inventories (Note 3)</a></td>
<td class="nump">1,032<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">TOTAL CURRENT ASSETS</a></td>
<td class="nump">6,752<span></span>
</td>
<td class="nump">10,976<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>NON-CURRENT ASSETS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositsAssetsNoncurrent', window );">Long term bank deposits</a></td>
<td class="nump">54<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets (Note 5)</a></td>
<td class="nump">592<span></span>
</td>
<td class="nump">180<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net (Note 4)</a></td>
<td class="nump">194<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">TOTAL NON-CURRENT ASSETS</a></td>
<td class="nump">840<span></span>
</td>
<td class="nump">248<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">7,592<span></span>
</td>
<td class="nump">11,224<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">410<span></span>
</td>
<td class="nump">156<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_AdvanceFromCustomers', window );">Advance payments</a></td>
<td class="nump">312<span></span>
</td>
<td class="nump">353<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenues</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued payroll and other employment related accruals</a></td>
<td class="nump">579<span></span>
</td>
<td class="nump">416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">190<span></span>
</td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease liabilities</a></td>
<td class="nump">297<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">TOTAL CURRENT LIABILITIES</a></td>
<td class="nump">1,788<span></span>
</td>
<td class="nump">1,150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liabilities</a></td>
<td class="nump">278<span></span>
</td>
<td class="nump">94<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">TOTAL LIABILITIES</a></td>
<td class="nump">2,066<span></span>
</td>
<td class="nump">1,244<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">COMMITMENTS AND CONTINGENCIES (Note 6)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>SHAREHOLDERS&#8217; EQUITY (Note 9):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary shares, NIS 0.01 par value: Authorized 50,000,000 as of December 31, 2023 and December 31, 2022; Issued and outstanding 20,387,428 shares as of December 31, 2023 and 15,049,720 shares as of December 31, 2022</a></td>
<td class="nump">57<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">26,692<span></span>
</td>
<td class="nump">23,346<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated losses</a></td>
<td class="num">(21,223)<span></span>
</td>
<td class="num">(13,409)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">TOTAL SHAREHOLDERS&#8217; EQUITY</a></td>
<td class="nump">5,526<span></span>
</td>
<td class="nump">9,980<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</a></td>
<td class="nump">$ 7,592<span></span>
</td>
<td class="nump">$ 11,224<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FIFOInventoryAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of FIFO (first in first out) inventory present at the reporting date when inventory is also valued using different valuation methods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FIFOInventoryAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrantsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrantsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_AdvanceFromCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represent advances from customers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_AdvanceFromCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619177831776">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parentheticals) - &#8362; / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value (in New Shekels per share)</a></td>
<td class="nump">&#8362; 0.01<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, authorized</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, share issued</a></td>
<td class="nump">20,387,428<span></span>
</td>
<td class="nump">15,049,720<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary shares, share outstanding</a></td>
<td class="nump">20,387,428<span></span>
</td>
<td class="nump">15,049,720<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619169729040">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 82<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">$ 142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpensesAbstract', window );"><strong>Expenses:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostDirectMaterial', window );">Cost of revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(62)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development, net (Note 6a)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3,316)<span></span>
</td>
<td class="num">(2,271)<span></span>
</td>
<td class="num">(1,411)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing expenses, net (Note 6b)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,008)<span></span>
</td>
<td class="num">(1,370)<span></span>
</td>
<td class="num">(665)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,882)<span></span>
</td>
<td class="num">(1,948)<span></span>
</td>
<td class="num">(628)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ProspectiveInitialPublicOfferingExpenses', window );">Initial public offering expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="num">(904)<span></span>
</td>
<td class="num">(97)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">OPERATING LOSS</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(8,186)<span></span>
</td>
<td class="num">(6,458)<span></span>
</td>
<td class="num">(2,669)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_InterestExpenseAndExchangeRate', window );">FINANCING INCOME (EXPENSES), net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">372<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">NET LOSS AND TOTAL COMPREHENSIVE LOSS</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (7,814)<span></span>
</td>
<td class="num">$ (6,496)<span></span>
</td>
<td class="num">$ (2,614)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per ordinary shares, basic (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (0.48)<span></span>
</td>
<td class="num">$ (0.53)<span></span>
</td>
<td class="num">$ (0.27)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of ordinary shares outstanding basic (in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">16,201,238<span></span>
</td>
<td class="nump">12,277,224<span></span>
</td>
<td class="nump">9,709,590<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In April 2021, the Company completed a 1:1 conversion of all of its issued and outstanding ordinary A shares into ordinary shares, NIS 0.01 par value, which was applied retroactively for the calculation of the basic and diluted loss per share.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostDirectMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of material used for good produced and service rendered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostDirectMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_InterestExpenseAndExchangeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of financing income (expenses), net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_InterestExpenseAndExchangeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ProspectiveInitialPublicOfferingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of initial public offering (IPO) refers to the process of offering shares of a private corporation to the public in a new stock issuance for the first time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ProspectiveInitialPublicOfferingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619169717440">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss (Parentheticals) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per ordinary shares, diluted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (0.48)<span></span>
</td>
<td class="num">$ (0.53)<span></span>
</td>
<td class="num">$ (0.27)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of ordinary shares outstanding diluted</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">16,201,238<span></span>
</td>
<td class="nump">12,277,224<span></span>
</td>
<td class="nump">9,709,590<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In April 2021, the Company completed a 1:1 conversion of all of its issued and outstanding ordinary A shares into ordinary shares, NIS 0.01 par value, which was applied retroactively for the calculation of the basic and diluted loss per share.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619172914384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Shareholders&#8217; Equity (Deficit) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>A </div>
<div>Ordinary shares</div>
</th>
<th class="th" colspan="2"><div>Ordinary shares</div></th>
<th class="th"><div>Subscription receivables (ordinary shares)</div></th>
<th class="th"><div>Additional paid-in capital</div></th>
<th class="th"><div>Accumulated losses</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (12)<span></span>
</td>
<td class="nump">$ 1,406<span></span>
</td>
<td class="num">$ (4,299)<span></span>
</td>
<td class="num">$ (2,888)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2020</a></td>
<td class="nump">1,844,268<span></span>
</td>
<td class="nump">4,626,572<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ChangesDuringTheYear2021Abstract', window );"><strong>CHANGES DURING THE YEAR 2021:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost', window );">Issuance of ordinary shares and warrants, net of issuance cost</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,921<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,925<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Issuance of ordinary shares and warrants, net of issuance cost (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,343,375<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of convertible securities (including accrued interest) to ordinary shares</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,063<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,072<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible securities (including accrued interest) to ordinary shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,081,102<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ConversionOfOrdinaryASharesToOrdinarySharesValue', window );">Conversion of ordinary A shares to ordinary shares</a></td>
<td class="num">$ (5)<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ConversionOfOrdinaryASharesToOrdinaryShares', window );">Conversion of ordinary A shares to ordinary shares (in Shares)</a></td>
<td class="num">(1,844,268)<span></span>
</td>
<td class="nump">1,844,268<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">299<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">299<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_StockIssuedDuringPeriodShareOfExerciseOfOptionsinShares', window );">Exercise of options (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">241,533<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_StockIssuedDuringPeriodValueOfPaymentOnBehalfOfSharesIssued', window );">Payment on behalf of issued shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">12<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,614)<span></span>
</td>
<td class="num">(2,614)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 31<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">7,689<span></span>
</td>
<td class="num">(6,913)<span></span>
</td>
<td class="nump">807<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,136,850<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ChangesDuringTheYear2022Abstract', window );"><strong>CHANGES DURING THE YEAR 2022:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet', window );">Issuance of units of ordinary shares and warrants in connection with the initial public offering, net of issuance expenses of 1.6 million</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,308<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">14,319<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares', window );">Issuance of units of ordinary shares and warrants in connection with the initial public offering, net of issuance expenses of 1.6 million (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Conversion of SAFEs into ordinary shares upon completion of initial public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">399<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering', window );">Conversion of SAFEs into ordinary shares upon completion of initial public offering (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">118,204<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants', window );">Issuance of ordinary shares as a result of exercise of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">160<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrantsinShares', window );">Issuance of ordinary shares as a result of exercise of warrants (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ChangesDuringTheYear2021Abstract', window );"><strong>CHANGES DURING THE YEAR 2021:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">790<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">790<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_StockIssuedDuringPeriodShareOfExerciseOfOptionsinShares', window );">Exercise of options (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,666<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(6,496)<span></span>
</td>
<td class="num">(6,496)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,346<span></span>
</td>
<td class="num">(13,409)<span></span>
</td>
<td class="nump">9,980<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,049,720<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ChangesDuringTheYear2023Abstract', window );"><strong>CHANGES DURING THE YEAR 2023:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Shares issued in the public offering, net of issuance cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,659<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,670<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued in the public offering, net of issuance cost (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,444,444<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_StockIssuedDuringPeriodValueInvestors', window );">Issuance of shares to April 2021 investors (Note 7)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_StockIssuedDuringPeriodSharesInvestors', window );">Issuance of shares to April 2021 investors (Note 7) (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">169,125<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_StockIssuedDuringPeriodValueExerciseOfWarrants', window );">Exercise of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,449<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants', window );">Exercise of warrants (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">724,139<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ChangesDuringTheYear2021Abstract', window );"><strong>CHANGES DURING THE YEAR 2021:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">241<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,814)<span></span>
</td>
<td class="num">(7,814)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,692<span></span>
</td>
<td class="num">$ (21,223)<span></span>
</td>
<td class="nump">$ 5,526<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,387,428<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="8"></td></tr>
<tr><td colspan="8"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represent an amount less than $500</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ChangesDuringTheYear2021Abstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ChangesDuringTheYear2021Abstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ChangesDuringTheYear2022Abstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ChangesDuringTheYear2022Abstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ChangesDuringTheYear2023Abstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ChangesDuringTheYear2023Abstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ConversionOfOrdinaryASharesToOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represent number of ordinary A shares converted to ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ConversionOfOrdinaryASharesToOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ConversionOfOrdinaryASharesToOrdinarySharesValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock related to A share converted to ordinary shares during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ConversionOfOrdinaryASharesToOrdinarySharesValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conversion of SAFEs into ordinary shares upon completion of initial public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represent issuance of ordinary shares and warrants, net of issuance cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued during the period upon the conversion of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrantsinShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of ordinary shares as a result of exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrantsinShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of issuance of units of ordinary shares and warrants in connection with the initial public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of units of ordinary shares and warrants in connection with the initial public offering shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_StockIssuedDuringPeriodShareOfExerciseOfOptionsinShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares of exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_StockIssuedDuringPeriodShareOfExerciseOfOptionsinShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares issued from the exercise of warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_StockIssuedDuringPeriodSharesInvestors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares issued to investors</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_StockIssuedDuringPeriodSharesInvestors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_StockIssuedDuringPeriodValueExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the value of stock issued during the period from the exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_StockIssuedDuringPeriodValueExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_StockIssuedDuringPeriodValueInvestors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the value of stock issued during the period to investors.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_StockIssuedDuringPeriodValueInvestors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_StockIssuedDuringPeriodValueOfPaymentOnBehalfOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued for payment on behalf of issued shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_StockIssuedDuringPeriodValueOfPaymentOnBehalfOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619175438608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Shareholders&#8217; Equity (Deficit) (Parentheticals)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Net of issuance expenses</a></td>
<td class="nump">$ 1,600<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619169501024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (7,814)<span></span>
</td>
<td class="num">$ (6,496)<span></span>
</td>
<td class="num">$ (2,614)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments required to reconcile net loss to net cash used in operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_AccruedInterestOnConvertibleSecurities', window );">Accrued interest on convertible securities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_AccruedInterestOnDeposits', window );">Accrued interest on deposits</a></td>
<td class="num">(45)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation expenses</a></td>
<td class="nump">241<span></span>
</td>
<td class="nump">790<span></span>
</td>
<td class="nump">299<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized', window );">Unrealized gain loss from foreign currency derivative activities</a></td>
<td class="num">(68)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities items:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Decrease (increase) in accounts receivable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Decrease (increase) in inventories</a></td>
<td class="num">(1,026)<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_DecreaseincreaseInGovernmentalGrantsReceivables', window );">Decrease (increase) in governmental grants receivables</a></td>
<td class="num">(54)<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_IncreaseInOtherReceivablesAndPrepaidExpenses', window );">Increase in other receivables and prepaid expenses</a></td>
<td class="num">(136)<span></span>
</td>
<td class="num">(496)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_IncreaseDecreaseInAdvancePayments', window );">Increase (decrease) in advance payments</a></td>
<td class="num">(41)<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Increase (decrease) in deferred revenues</a></td>
<td class="num">(12)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Increase in accounts payable</a></td>
<td class="nump">254<span></span>
</td>
<td class="nump">84<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Increase in accrued payroll and other employment related accruals</a></td>
<td class="nump">163<span></span>
</td>
<td class="nump">194<span></span>
</td>
<td class="nump">119<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_IncreaseDecreaseInAdvancePaymentsOnGovernmentalGrant', window );">Decrease in advance payments on governmental grant</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(42)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Increase in accrued expenses</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(8,434)<span></span>
</td>
<td class="num">(5,714)<span></span>
</td>
<td class="num">(2,103)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(194)<span></span>
</td>
<td class="num">(48)<span></span>
</td>
<td class="num">(36)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireRestrictedCertificatesOfDeposit', window );">Investment in deposits, net</a></td>
<td class="num">(4,054)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_PrepaymentsOfLeasing', window );">Prepayments of leasing</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(4,248)<span></span>
</td>
<td class="num">(66)<span></span>
</td>
<td class="num">(36)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost', window );">Proceeds from issuance of shares issued in the public offering, net of issuance cost</a></td>
<td class="nump">1,670<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPubli', window );">Proceeds from issuance of units of ordinary shares and warrants in connection with the initial public offering, net of issuance expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">14,319<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ProceedsFromIssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost', window );">Proceeds from issuance of ordinary shares and warrants, net of issuance cost</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,925<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ProceedsFromIssuanceOfSAFEs', window );">Proceeds from issuance of SAFEs</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_RefundToSAFEInvestors', window );">Refund to SAFE investors</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(100)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from credit line</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayment of credit line</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(800)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants', window );">Proceeds from issuance of ordinary shares as a result of exercise of warrants</a></td>
<td class="nump">1,449<span></span>
</td>
<td class="nump">160<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Exercise of options</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_PaymentOnBehalfOfIssuedShares', window );">Payment on behalf of issued shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">3,119<span></span>
</td>
<td class="nump">14,879<span></span>
</td>
<td class="nump">2,938<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net increase (decrease) in cash and cash equivalents</a></td>
<td class="num">(9,563)<span></span>
</td>
<td class="nump">9,099<span></span>
</td>
<td class="nump">799<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and Cash Equivalents at the beginning of year</a></td>
<td class="nump">10,373<span></span>
</td>
<td class="nump">1,274<span></span>
</td>
<td class="nump">475<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at the end of year</a></td>
<td class="nump">810<span></span>
</td>
<td class="nump">10,373<span></span>
</td>
<td class="nump">1,274<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Disclosure:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest on credit line</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_InterestReceivedFromDeposits', window );">Interest received from deposits</a></td>
<td class="num">(305)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ConversionOfSAFEToEquity', window );">Conversion of SAFEs to equity</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_RightofUseAssetRecognizedAgainstLeaseLiability', window );">Right-of-use asset recognized against lease liability</a></td>
<td class="nump">$ 644<span></span>
</td>
<td class="nump">$ 229<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain (loss) from foreign currency transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-6<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481956/830-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481926/830-20-50-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossUnrealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireRestrictedCertificatesOfDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from temporary investment with specific maturity and interest rate that are prohibited for current use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireRestrictedCertificatesOfDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_AccruedInterestOnConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accrued interest on convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_AccruedInterestOnConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_AccruedInterestOnDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of accrued interest on deposit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_AccruedInterestOnDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ConversionOfSAFEToEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of conversion of SAFE to equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ConversionOfSAFEToEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_DecreaseincreaseInGovernmentalGrantsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease increase in governmental grants receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_DecreaseincreaseInGovernmentalGrantsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_IncreaseDecreaseInAdvancePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of advances from customers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_IncreaseDecreaseInAdvancePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_IncreaseDecreaseInAdvancePaymentsOnGovernmentalGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase decrease in advance payments on governmental grant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_IncreaseDecreaseInAdvancePaymentsOnGovernmentalGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_IncreaseInOtherReceivablesAndPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase in other receivables and prepaid expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_IncreaseInOtherReceivablesAndPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_InterestReceivedFromDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest received from deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_InterestReceivedFromDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_PaymentOnBehalfOfIssuedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment on behalf of issued shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_PaymentOnBehalfOfIssuedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_PrepaymentsOfLeasing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of prepayments of leasing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_PrepaymentsOfLeasing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ProceedsFromIssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of proceeds from issuance of ordinary shares and warrants, net of issuance cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ProceedsFromIssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of proceeds from issuance of ordinary shares as a result of exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ProceedsFromIssuanceOfSAFEs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the SAFE investor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ProceedsFromIssuanceOfSAFEs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of proceeds from issuance of shares issued in the public offering, net of issuance cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPubli">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of proceeds from issuance of units of ordinary shares and warrants in connection with the initial public offering, net of issuance expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPubli</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_RefundToSAFEInvestors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of refund to SAFE investors.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_RefundToSAFEInvestors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_RightofUseAssetRecognizedAgainstLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount is right-of use asset recognized against lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_RightofUseAssetRecognizedAgainstLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619173966592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>General [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">GENERAL</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 1
- GENERAL:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wearable Devices Ltd. (the
    &#8220;Company&#8221;) was incorporated in Israel in March 2014. The Company develops&#160;and sells human-machine interface solutions
    for the smart wearables industry. In 2023, the Company started production of its B2C consumer product, the &#8220;Mudra Band&#8221;
    and started to generate revenues. The Company&#8217;s products are designated directly to end users and also designated to businesses
    in integration of its technology in their smart wearable devices. The Company&#8217;s Ordinary Shares and warrants began trading
    on the Nasdaq Capital Market (&#8220;Nasdaq&#8221;) on September 13, 2022, under the symbols &#8220;WLDS&#8221; and &#8220;WLDSW,&#8221;
    respectively (see Note 1e below). </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">We qualify as an &#8220;emerging growth
company,&#8221; as defined in Section 2(a) of the Securities Act of 1933, as amended, or the Securities Act, as modified by the U.S. Jumpstart
Our Business Startups Act of 2012 and we may take advantage of certain exemptions, including exemptions from various reporting requirements
that are otherwise applicable to public traded entities that do not qualify as emerging growth companies. These exemptions include:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.75in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002; and</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">not
                                            being required to comply with any requirement that may be adopted by the Public Company Accounting
                                            Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor&#8217;s
                                            report providing additional information about the audit and the financial statements (i.e.,
                                            an auditor discussion and analysis).</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We
will remain an emerging growth company until the earliest of: (i) the last day of the first fiscal year in which our annual gross revenues
exceed $1.235 billion; (ii) the last day of the fiscal year following the fifth anniversary of the date of our initial public offering
(i.e., December 31, 2027); (iii) the date that we become a &#8220;large accelerated filer&#8221; as defined in Rule&#160;12b-2&#160;under
the&#160;Exchange Act, which would occur if the aggregate worldwide market value of our ordinary shares, including ordinary shares represented
by warrants, held by non-affiliates is at least $700 million as of the last business day of our most recently completed second fiscal
quarter; or (iv) the date on which we have issued more than $1.0 billion in non-convertible debt securities during any three-year period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s revenues were derived from:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 72px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</span></td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
        sales of B2C consumer product, the &#8220;Mudra Band&#8221;.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The sales of B2B Mudra
    development kits composed of multiple performance obligations including tangible parts (&#8220;Hardware&#8221;) and a limited period
    (generally one year) application programming interface (&#8220;API&#8221;) with no commercial rights, to enable the customer to evaluate
    the Company&#8217;s solution with its own products.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 72px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The sales of pilot transactions
    to evaluate the integration of the Company&#8217;s solution with the customer&#8217;s products composed of multiple performance obligations
    including Hardware, tailor-made software applications and technical support during the pilot period.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
2023, most of the Company&#8217;s revenues were derived from the sales of Mudra Band to B2C customers. In 2022, all of the Company&#8217;s
revenues were derived from the sales of Mudra development kits. In 2021, most of the Company&#8217;s revenues were derived from a pilot
transaction in the amount of $84 thousand, which was fully completed in 2021 and from the sales of Mudra development kits to multinational
technology companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</span></td>
    <td style="padding-right: 3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    2018, the Company established a wholly owned subsidiary in the United States of America for the purpose of marketing and distribution
    of its solutions &#8211; Mudra Wearable, Inc. (the &#8220;Subsidiary&#8221;) &#8211; which commenced its operations in 2020. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; font-size: 10pt">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</span></td>
    <td style="padding-right: 3pt; text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company&#8217;s headquarters is located in Israel. On October 7, 2023, Hamas terrorists infiltrated Israel&#8217;s southern border from the Gaza Strip and conducted a series of attacks on civilian and military targets. Following the attack, Israel declared war against Hamas and the Israeli military began to call-up reservists for active duty. At the same time, and because of the declaration of war against Hamas, the clash between Israel and Hezbollah in Lebanon has escalated and there is a possibility that it will turn into a greater regional conflict in the future. Further, many Israeli citizens are obligated to perform several days, and in some cases, more, of annual military reserve duty each year until they reach the age of 40 (or older for certain reservists) and, in the event of a military conflict, may be called to active duty. As of today, these events have had no material impact on the Company&#8217;s operations.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 36pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">d.</span></td><td><span style="font-family: Times New Roman, Times, Serif"><b>Going
                                            Concern:</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The accompanying consolidated financial
statements have been prepared assuming that the Company will continue as a going concern. To date, the Company is still in a transition
phase from its development stage to an early stage of generating revenues. Therefore, the Company has suffered recurring losses from operations
and negative cash flows from operations since inception. As detailed in Note 1e below, in September 2022, the Company completed an initial
public offering (&#8220;IPO&#8221;) and listed its ordinary shares, NIS 0.01 par value, (the &#8220;Ordinary Shares&#8221;) and warrants
for trading on Nasdaq and raised net proceeds of $13.3 million. In November 2023, the Company completed a secondary offering and raised
net proceeds of $1.7 million.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As
of December 31, 2023, the Company had incurred accumulated losses of $21.2 million and expects to continue to fund its operations through
fundings such as issuance of convertible securities, Ordinary Shares and warrants and through Israeli governmental grants. There is no
assurance that such financing will be obtained. Considering the above, the Company&#8217;s dependency on external funding for its operations
raises a substantial doubt about its ability to continue as a going concern. The consolidated financial statements do not include any
adjustments that might result from the outcome of these uncertainties.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 36pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">e.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In September 2022, <span style="background-color: white">the Company completed its IPO whereby the Company issued and sold in connection with the closing of the IPO 3,750,000 units, each consisting of one Ordinary Share and two warrants to purchase one Ordinary Share each. In addition, the underwriter exercised its over-allotment option with respect to 1,125,000 warrants to purchase 1,125,000 Ordinary Shares.</span></span></td></tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; background-color: white">The
warrants were exercisable immediately upon issuance, at an exercise price of $4.00 per Ordinary Share and are exercisable until September
12, 2027. On September 16, 2022, 40,000 warrants were exercised into 40,000 Ordinary Shares. On December 14, 2022, the exercise price
of the warrants was adjusted to $2.00 per Ordinary Share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="background-color: white">In connection with the IPO, the
Company received gross proceeds of approximately $16.0 million, before deducting underwriting discounts and commissions and before offering
expenses ($14.9 million net proceeds after deducting approximately $1.1 million of underwriting discounts and commissions and approximately
$13.3 million after other IPO expenses).&#160;The Ordinary Shares and warrants were approved for listing on the Nasdaq and commenced trading
under the symbol &#8220;WLDS&#8221; and &#8220;WLDSW,&#8221; respectively, on September 13, 2022. The Company&#8217;s Ordinary Share and
warrant prices on Nasdaq were $0.4450 and $0.0682, respectively, as of March 12, 2024.</span><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 36pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">f.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On November&#160;25, 2022, the Company received a written notification from the Listing Qualifications Department of the Nasdaq Stock Market LLC regarding its noncompliance with Nasdaq&#8217;s minimum bid price requirement because the closing bid price of the Ordinary Shares was below $1.00 per Ordinary Share for the previous 30 consecutive business days. On May 23, 2023, the Company received a notification letter from Nasdaq that the Company had been granted an additional 180-day compliance period, or until November 20, 2023, to regain compliance with Nasdaq&#8217;s minimum bid price rule. On June 9, 2023, the Company received a written notice from Nasdaq Stock Market LLC, indicating that it has regained compliance with the minimum bid price requirement. On October 24, 2023, the Company received a written notification from the Listing Qualifications Department of the Nasdaq Stock Market LLC regarding its noncompliance with Nasdaq&#8217;s minimum bid price requirement because the closing bid price of the Ordinary Shares was below $1.00 per Ordinary Share for the previous 30 consecutive business days. The Company was granted 180 calendar days, or until April&#160;22, 2024, to regain compliance with the minimum bid price requirement. In the event the Company does not regain compliance with the minimum bid price requirement by April 22, 2024, it may be eligible for an additional 180-calendar day grace period.&#160;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 36pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">g.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On November 13, 2023, <span style="background-color: white">the Company completed a public offering of its securities whereby the Company issued and sold 4,444,444 Ordinary Shares. The Company received gross proceeds of approximately $2 million, before deducting underwriting discounts and commissions and before offering expenses ($1.7 million net proceeds after deducting underwriting discounts and commissions and other expenses).</span></span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619175986960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 2
- SIGNIFICANT ACCOUNTING POLICIES:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the
United States of America (&#8220;U.S. GAAP&#8221;). The significant accounting policies followed in the preparation of the financial
statements are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>a.</b></span></td> <td style="padding-right: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principles of consolidation</b></span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
accompanying consolidated financial statements include the accounts of the Company and the Subsidiary. All intercompany transactions
have been eliminated in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>b.</b></span></td> <td style="padding-right: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of estimates</b></span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities, as well as to disclose contingent liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the reporting years. On an ongoing basis, management evaluates its
estimates, judgments and assumptions. Management bases its estimates, judgments and assumptions on historical experience and on various
other factors that are believed to be reasonable under the circumstances. Actual results could differ from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>c.</b></span></td> <td style="padding-right: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Foreign currency</b></span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
currency of the primary economic environment in which the operations of the Company are conducted is the U.S. dollar (&#8220;USD&#8221;).
The Company&#8217;s funding and revenues are mostly in USD. Thus, the functional currency of the Company is the USD.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt 0pt 80.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Transactions
and balances originally denominated in USD are presented at their original amounts. Balances in non-USD currencies are translated into
USD using historical and current exchange rates for non-monetary and monetary balances, respectively. For non-USD transactions and other
items (stated below) reflected in the statements of operations, the following exchange rates are used: (i) for transactions &#8211; exchange
rates at transaction dates or average rates; and (ii) for other items (derived from non-monetary balance sheet items such as depreciation
etc.) &#8211; historical exchange rates. Currency transaction gains or losses are recorded to finance income or expenses, as appropriate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>d.</b></span></td> <td style="padding-right: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inventories:</b></span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Inventories
are composed of parts of the Company&#8217;s products as well as completed products and are stated at the lower of cost or net realizable
value. Inventory cost is determined on FIFO basis. Net realizable value is the estimated selling prices in the ordinary course of business,
less reasonably predictable costs of completion, disposal, and transportation. The cost of inventories comprises all costs of purchase,
and other costs incurred in bringing the inventories to their present location and condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>e.</b></span></td> <td style="padding-right: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Property and equipment</b></span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Property
and equipment are stated at cost. Depreciation is computed based on the straight-line method, over the estimated useful life of the assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Annual
rates of depreciation are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>%
    </b>&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Office furniture, machines, leasehold improvements,
    and electronic equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7-15</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 88%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Computers and software</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">33</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Mold</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">50</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>f.</b></span></td> <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>Leases</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On January 1, 2022, the Company began to implement ASU 2016-02, Leases (Topic 842) (&#8220;ASU 2016-02&#8221;) using the modified retrospective approach for all lease arrangements as of such date. The Company leases office space and vehicles under operating leases.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Arrangements meeting the definition of a lease are classified as operating or financing leases and are recorded on the balance sheet as both a right-of-use asset and lease liability, calculated by discounting fixed lease payments over the lease term at the rate implicit in the lease or the Company&#8217;s incremental borrowing rate. Lease liabilities are increased by interest and reduced by payments each period, and the right-of-use asset is amortized over the lease term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The lease liability was measured at the present value of the remaining lease payments, discounted using the Company&#8217;s incremental borrowing rate. The weighted-average&#160;rate applied was 8%. Right-of-use&#160;assets were measured at an amount equal to the lease liability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">For operating leases, interest on the lease liability and the amortization of the right-of-use asset result in straight-line&#160;rent expense over the lease term. Variable lease expenses are recorded when incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Leases with a lease term of 12 months or less at inception are not recorded within the Consolidated Balance Sheets and are expensed on a straight-line basis over the lease term in the Consolidated Statements of Operations and Comprehensive Loss.<span style="font-size: 10pt; background-color: white">&#160;</span></span></p></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>g.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenue recognition </b></span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Revenue
is recognized when (or as) control of the promised goods or services is transferred to the customer, and in an amount that reflects the
consideration the Company is contractually due in exchange for those services or goods. The Company follows five steps to record revenue:
(i) identify the contract with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction
price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the
Company satisfies its performance obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Company generate revenues from
the sales of B2C &#8220;Mudra Band&#8221;, sales of B2B &#8220;Mudra development kits&#8221; and sales of pilot transactions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The &#8220;Mudra Band&#8221; is an
aftermarket accessory band for the Apple Watch which allows touchless operation and control of the watch and iPhone by using an app which
is considered combined with the band as one performance obligation. Revenue derived from the sale of &#8220;Mudra Band&#8221; is recognized
at a point of time when control transfers to the customer. The Company believes that the delivery date is the most appropriate point in
time indicating control has transferred to the customer.&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Company allows return and refund
of Mudra Band within 30 days of having the Mudra Band delivered. The Company records an appropriate provision for such refunds.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Revenue derived from freight charges
is considered as a separate performance obligation recognized when the related product revenue is recognized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">A
pilot transaction has multiple performance obligations, and it generally takes a few months but less than one year. Each Mudra development
kit sale also has multiple performance obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
payment terms of the Mudra development kit sales are upon delivery of the Hardware, while the payment terms of the pilot transactions
are within the pilot period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
those transactions, each obligation- Hardware and API (for Mudra development kit) and tailor-made software application and technical
support (for a pilot transaction) - is distinct and separately identifiable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
amount allocated to the delivered items is recognized upon delivery, the amount allocated to API is recognized over the API period and
the amount allocated to the technical support is recognized over the service period (a pilot period).&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>h.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cost of revenues</b></span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.4pt"><span style="font-family: Times New Roman, Times, Serif">Costs
are expensed as incurred. The primary components of cost of revenues include the cost of the product and outbound freight charges.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 80.3pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>i.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Research and development</b></span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.4pt"><span style="font-family: Times New Roman, Times, Serif">Research
and development expenses consist primarily of payroll, payroll related expenses, subcontractors, and materials. Costs are expensed as
incurred.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>j.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Governmental grants</b></span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company receives royalty-bearing grants from the Israeli government for approved research and development projects and marketing efforts.
These grants are recognized at the time the Company is entitled to such grants based on the costs incurred or milestones achieved as
provided by the relevant agreement and included as a deduction from research and development or sales and marketing expenses, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>k.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Finance income and expenses</b></span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 80.55pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Finance
income is composed of interest on deposits and unrealized gain from foreign currency derivative activities, while finance expenses are
composed of interest on senior secured credit facility, bank charges and net currency exchange rates differences.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>l.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Income taxes</b></span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 80.3pt; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company accounts for income taxes in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 740, &#8220;Income Taxes&#8221;
(&#8220;ASC 740&#8221;). Deferred taxes are determined utilizing the assets and liabilities method, which is based on the estimated future
tax effects of the differences between the financial accounting and tax bases of assets and liabilities under the applicable tax laws.
Deferred tax balances are computed using the tax rates expected to be in effect when those differences reverse. A valuation allowance
in respect of deferred tax assets is provided if, based upon the weight of available evidence, it is more likely than not that some or
all the deferred tax assets will not be realized. The measurement of deferred tax assets is reduced, if necessary, by the amount of any
tax benefits that, based on available evidence, are not expected to be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 80.3pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company applies ASC 740, which clarifies the accounting and reporting for uncertainties with respect to income taxes. ASC 740 prescribes
a comprehensive model for the financial statement recognition, measurement, presentation, and disclosure of uncertain tax positions taken
or expected to be taken in income tax returns.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>m.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share based compensation</b></span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Share-based
compensation expenses related to employees&#8217; and consultants&#8217; options are measured at the grant date based on the fair value
of the award and are generally expensed over the requisite service period (generally the vesting period). The Company recognizes compensation
expense on a straight-line basis from the beginning of the service period. For awards with graded-vesting features, each vesting tranche
is separately expensed over the related vesting period. The Company estimates the fair value of each stock option grant using the Black-Scholes
option pricing model, which requires management to make certain assumptions of future expectations based on historical and current data
include the expected term of the stock option, expected volatility, dividend yield, and risk-free interest rate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>m.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants</b></span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
warrants&#8217; mechanism does not create any obligation to transfer cash to the investors. Warrants are exercised for a fixed amount
of Ordinary Shares upon exercise. Therefore, the Company accounts for the warrants as equity-classified instruments (as part of additional
paid in capital), based on an assessment of the applicable U.S. GAAP authoritative guidance. The assessment considers whether the warrants
are freestanding financial instruments, meet the definition of a liability or whether the warrants meet all of the requirements for equity
classification, including whether the warrants are indexed to the Company&#8217;s own shares, among other conditions for equity classification.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>o.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Severance</b></span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 15pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Israeli
labor law generally requires payment of severance pay upon dismissal of an employee or upon termination of employment in certain other
circumstances. The Company&#8217;s pension and severance pay liabilities are covered mainly by insurance policies. Pursuant to section
14 of the Israeli Severance Compensation Act, 1963 (&#8220;section 14&#8221;), the Company&#8217;s employees are entitled to monthly
deposits, at a rate of 8.33% of their monthly salary, made in their name with insurance companies. Payments in accordance with section
14 relieve the Company from any future severance payments in respect of those employees and, as such, the Company may only utilize the
insurance policies for the purpose of paying severance pay.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 15pt 0pt 80.3pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>p.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basic and diluted loss per share</b></span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 80.55pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Basic
and diluted loss per share is calculated by dividing the loss attributable to equity holders of the Company by the weighted average number
of Ordinary Shares outstanding during the financial year, adjusted for Ordinary Shares issued during the year, if applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>q.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair Value Measurements</b></span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company measures and discloses fair value in accordance with the Financial Accounting Standards Board (&#8220;FASB&#8221;), ASC 820,
Fair Value Measurements and Disclosures (&#8220;ASC 820&#8221;). ASC 820 defines fair value, establishes a framework and gives guidance
regarding the methods used for measuring fair value, and expands disclosures about fair value measurements. Fair value is an exit price,
representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market
participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions
that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, there exists a three-tier
fair-value hierarchy, which prioritizes the inputs used in measuring fair value as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 79.1pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Level
1 &#8211; unadjusted quoted prices are available in active markets for identical assets or liabilities that the Company has the ability
to access as of the measurement date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 79.1pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Level
2 &#8211; pricing inputs are other than quoted prices in active markets that are directly observable for the asset or liability or indirectly
observable through corroboration with observable market data.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 79.1pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Level
3 &#8211; pricing inputs are unobservable for the non-financial asset or liability and only used when there is little, if any, market
activity for the non-financial asset or liability at the measurement date. The inputs into the determination of fair value require significant
management judgment or estimation. Level 3 inputs are considered as the lowest priority within the fair value hierarchy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 79.1pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">This
hierarchy requires the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining
fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 79.1pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
fair value of cash is based on its demand value, which is equal to its carrying value. Additionally, the carrying value of all other
short-term monetary assets and liabilities are estimated to be equal to their fair value due to the short-term nature of these instruments.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>r.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Concentration of Credit Risk</b></span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Company maintains certain cash
balances in a well-known Israeli banks and a U.S.-based bank.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Company&#8217;s labor expenses
are denominated mainly in NIS, and therefore, subject to foreign currency risk. During the year ended December 31, 2023, the Company partially
hedged its foreign currency exchange risk.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Company&#8217;s derivative instruments
primarily include foreign currency forward agreements related to the NIS and associated with certain payroll payments. The Company&#8217;s
foreign currency forward agreements related to foreign currency&#160;balance sheet exposure provide economic hedges but are not designated
as hedges for accounting purposes. Changes in the value of the derivative,&#160;along with the transaction gain or loss on the hedged
item, are recorded within the Company&#8217;s consolidated statements of loss.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>s.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cash and cash equivalents:</b></span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Cash
equivalents are highly liquid investments that are readily convertible into cash, typically with an original maturity of three months
or less.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 49px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>t.</b></span></td> <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>Segment Information </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company has a single operating and reportable segment. The Company&#8217;s chief operating decision maker, who is the Chief Executive Officer, evaluates the performance of its business based on financial data consistent with the presentation in the accompanying consolidated financial statements for the purposes of making operating decisions, assessing financial performance, and allocating resources. &#160;&#160;</span></p></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top; text-align: justify">
<td style="width: 49px"></td><td style="width: 24px; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>u.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Subsequent Events</b></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">In connection with the preparation of these consolidated financial
statements, the Company and management evaluated subsequent events through March 13, 2024, the date these consolidated financial statements
were available to be issued.<span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619177300768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventories [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORIES</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 3
- INVENTORIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">December
    31</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">U.S.
    dollars <br/>
    in thousands</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Cost:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Raw materials</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">514</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Work-in-progress</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">206</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-92; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Finished
    goods</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">312</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-93; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,032</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//330/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619175214848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property and Equipment, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT, net</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE</b>&#160;
<b>4 - PROPERTY AND EQUIPMENT, net</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">December
    31</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">U.S.
    dollars <br/>
    in thousands</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Cost:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Computers and
    software</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">204</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">124</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Furniture and leasehold
    improvements</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">38</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">7</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Electronic equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">20</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">9</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Machines
    and molds</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">72</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-94; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">334</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">140</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less
    - <span style="font-style: normal; font-weight: normal">accumulated depreciation</span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">140</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">72</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">194</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">68</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619179261072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Lease<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Lease [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 5-
LEASES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company has operating leases for
its offices and vehicles. The Company&#8217;s leases have remaining terms of less than one year to approximately 2 years, some of which
may include options to extend the leases for up to 2 years.</p>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif">The
following table summarizes the classification of operating lease right-of-use assets and liabilities in the Company&#8217;s Consolidated
Balance Sheets as of December&#160;31, 2023 and 2022:</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">December
    31</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">U.S.
    dollars in thousands</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Right of
    use assets</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">592</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">180</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Short term</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">297</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">68</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Long term</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">278</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">94</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Total lease liabilities</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">575</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">162</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">At December&#160;31, 2023, the future minimum lease payments
under the Company&#8217;s operating lease liabilities are as follows:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left; font-weight: bold; border-bottom: Black 1.5pt solid">Year ended December 31,</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">U.S.&#160;dollars<br/> in&#160;thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">308</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2025</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">289</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">2026</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">22</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total future minimum lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">619</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">Less imputed interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(44</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total operating lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">575</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">Less operating lease liabilities, current</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(297</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 4pt; text-align: left">Operating lease liabilities, non-current</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">278</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Total expenses under all operating leases were $232 thousand,
$74 thousand, and $42 thousand for the years ended December 31, 2023, 2022 and 2021, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619175376992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 6
- COMMITMENTS AND CONTINGENCIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>a.</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Royalties to the Israel Innovation Authority (&#8220;IIA&#8221;):</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.4pt; text-indent: -0.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company receives royalty-bearing grants from the IIA, for approved research and development projects. The programs include grants for:
wages, materials, subcontractors and miscellaneous. The Company was required to pay royalties at the rate of 3%-3.5% on sales of products
developed with the funds provided by the IIA, up to an amount equal to 100% of the IIA research and development grants received, linked
to the dollar including accrued interest. Until October 25, 2023, the interest was calculated at a rate based on 12-month LIBOR applicable
to US Dollar deposits. However, on October 25, 2023, the IIA published a directive concerning changes in royalties to address the expiration
of the LIBOR. Under such directive, regarding IIA grants approved by the IIA prior to January 1, 2024 but which are outstanding thereafter,
as of January 1, 2024 the annual interest is calculated at a rate based on 12-month SOFR, or at an alternative rate published by the
Bank of Israel plus 0.71513%; and, for grants approved on or following January 1, 2024 the annual interest shall be the higher of (i)
the 12 months SOFR interest rate, plus 1%, or (ii) a fixed annual interest rate of 4%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As
of December 31, 2018, two IIA programs were completed, while the amounts received for them aggregated to $1.224 million. In addition,
another IIA approved plan commenced on May 1, 2020, and was completed on July 31, 2021, pursuant to which a total of $627 thousand was
received. During January 2023, the IIA approved an additional program to finance further development of the Company&#8217;s manufacturing
process of its wearable neural interface in Israel. The approved program is in amount of approximately $900 thousand (NIS 3.1 million),
of which the IIA will finance 60%; as of December 31, 2023, $288 thousand was received.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
terms of the grants under the Encouragement of Research, Development and Technological Innovation in the Industry 1984 require that the
manufacturing of products resulting from IIA-funded programs be carried out in Israel, unless a prior written approval of the IIA is
obtained (except for a transfer of up to 10% of the production rights, for which a notification to the IIA is sufficient). During December
2022, the Company received an approval from the IIA to transfer some of its manufacturing activities abroad.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As
a condition for obtaining approval to manufacture outside Israel (or following a declaration that up to 10% of the production is transferred
abroad), the Company would be required to pay increased royalties, which usually amount to 1% in addition to the standard royalties rate
3%-3.5%, and also the total amount of its liability to the IIA may be increased to between 120% and 300% of the grants received from
the IIA, depending on the manufacturing volume that is performed outside Israel (less royalties already paid to IIA).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Research
and development grants deducted from research and development expenses amounted to $415, <span style="-sec-ix-hidden: hidden-fact-95">nil</span> and $289 thousand for the years ended December
31, 2023, 2022 and 2021, respectively. As of December 31, 2023, the maximum obligation with respect to the grants received from the IIA,
contingent upon entitled future sales, is $2.2 million plus interest which may be increased, depending on the manufacturing volume that
is performed outside Israel. The Company has obligations regarding know-how, technology, or products, not to transfer the information,
rights thereon and production rights which derive from the research and development, in whole or part, of its Mudra product and its Mudra
Band product, without the IIA Research Committee approval.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>b.</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Royalties to the Israeli Ministry of Economy and
    Industry (&#8220;IMEI&#8221;):</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 35.5pt 0pt 77.3pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During
2020, the Company received a grant from the IMEI, for approved marketing expenses amounting to $95 thousand. The program includes participation
in expenses for: consulting for marketing, advertising and online marketing, flights to exhibitions and miscellaneous. &#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Sales
and marketing grants deducted from sales and marketing expenses amounted to $42 thousand for the year ended December 31, 2021.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.6pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Under the agreement with the IMEI,
if the export revenues in the defined target market increase by $311 thousand compared to the base year, the Company would be required
to pay royalties at the rate of 3% of the increase, with the funds provided by the IMEI up to an amount equal to 100% of the IMEI marketing
grant received, linked to the consumer price index (&#8220;CPI&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">As of December 31, 2023, the maximum
obligation with respect to the grant received from the IMEI, contingent upon entitled future sales, is $95 thousand linked to the CPI.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>c.</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lease Commitments &#8211; Operating Leases:</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
July 1, 2018, the Company entered into a lease agreement for a period which expired on September 30, 2022. The monthly lease payment
totaled approximately $5 thousand.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">After
September 30, 2022, the Company stayed on the lease on a month-to-month basis. At the end of January 2023, the Company terminated this
lease with 60 days&#8217; termination notice that ended on March 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
January 2023, the Company entered into a new lease agreement in Yokne&#8217;am Illit, Israel for a period which started on February 1,
2023, and expires on January 31, 2025, with an option to extend the lease period by two additional lease periods, each for an additional
12 months. The Company&#8217;s monthly rent payment for this facility is approximately $16 thousand during the first lease year and will
be increased to approximately $20 thousand during the second lease year. During the option lease periods, the lease payment may be increased
up to 10% as compared to the second lease year. The Company expects to exercise the option and extend the lease for another year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Company&#8217;s subsidiary, Mudra
Wearable, established an office located in California. The lease is on a month-to-month basis with de-minimis consideration. Additionally,
during 2022, the Company entered into lease agreements to lease 5 vehicles for a period of 3 years.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619175416176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Securities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsAbstract', window );"><strong>Convertible Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">CONVERTIBLE SECURITIES</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 7
- CONVERTIBLE SECURITIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">A.
During 2017, 2018, January 2019, April 2019 and November 2019, the Company entered into convertible security agreements with certain
investors, according to which the Company received an aggregate amount of $400 thousand, $600 thousand, $100 thousand, $200 thousand
and $100 thousand, respectively, bearing interest at the rate of 4% per annum. Such amounts including the accrued interest were converted
into Ordinary Shares, based on a share price agreed upon in the respective agreement of $0.79, $0.79 $0.92, $0.92 and $1.69, respectively,
in April 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.6pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
December 2019, the Company entered into additional convertible security agreements with an aggregate principal amount of $1.5 million,
which was converted into Ordinary Shares based on a share price agreed upon in the agreement of $1.22 in April 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Those&#160;convertible
security agreements, including accrued interest, were not mandatorily redeemable, nor redeemable at the option of the holder after a
specified date, but a change of control event as described in the agreements would constitute a redemption event outside of the Company&#8217;s
control. Therefore, all the convertible securities were presented as current liabilities. The beneficial conversion feature of each one
of convertible security was valued at zero.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">B.
April 2021 investors - In June 2022, the Company&#160;received from Alpha Capital Anstalt (&#8220;Alpha&#8221;) the contractually required
written consent to proceed with the IPO (the &#8220;June 2022 Consent&#8221;) in exchange for a cash payment of $300,000 from the proceeds
of the IPO, which was paid on September 28, 2022, following the completion of the IPO. Pursuant to the share purchase agreements the
Company entered into with certain investors in April 2021 (the &#8220;April 2021 SPAs&#8221;), in the event of an initial public offering
event or in a Dilutive Issuance event (as defined below), reflecting a pre-money valuation of $26,400,000, or a lower one, then such
investors shall receive additional Ordinary Shares and additional shares underlying each warrant, based on 80% of the price per share
at the IPO (the &#8220;Discounted PPS&#8221;), less the number of Ordinary Shares issued to them in the April 2021 financing, and the
number of shares underlying each warrant shall be increased assuming the exercise amount is divided by the Discounted PPS. Additionally,
beginning on April 22, 2021 and until the earlier of (i) the 90th calendar day after the expiration of the applicable lock-ups, following
the IPO date (i.e. June 2023) or (ii) three years from April 22, 2021, if the Company or its subsidiary shall issue any Ordinary Shares
or equivalents of Ordinary Shares, in an equity transaction other than an exempt issuance, entitling any person or entity to acquire
Ordinary Shares at an effective price per share less than the per share purchase price of $2.25 (subject to prior adjustment for reverse
and forward stock splits and the like) (a &#8220;Dilutive Issuance&#8221;), then, for no additional consideration, the Company shall
immediately issue to the investors in the April 2021 financing that number of additional Ordinary Shares equal to (a) the per share purchase
price of $2.25 divided by amount actually paid in new cash consideration by third parties for each Ordinary Share in the Dilutive Issuance
less (b) the number of Ordinary Shares issued to Alpha and other investors at the closing of the April 2021 financing pursuant to April
2021 SPAs. Pursuant to the June 2022 Consent, the investor in the April 2021 financing waived their rights for such adjustments as of
the date of the IPO and deferred such adjustments (if any) to be effected on the 90th calendar day following the closing of the IPO.&#160;&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
September 20, 2022, the Company&#8217;s volume weighted average stock price was less than the exercise price of $2.00 for the warrants.
Accordingly, effective after the closing of trading on December 14, 2022 (the 90th calendar day immediately following the issuance date
of the warrants), the warrants&#8217; exercise price was adjusted pursuant to their terms to $2.00 (the &#8220;Exercise Price Adjustment&#8221;).
Following the Exercise Price Adjustment, on February 16, 2023, the Company issued an aggregate of 169,125 Ordinary Shares to the April
2021&#160;investors&#160;as a result of the IPO.&#160;&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//470/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619178384656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Credit Facility<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_CreditFacilityAbstract', window );"><strong>Credit Facility [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_CreditFacilityDisclosureTextBlock', window );">CREDIT FACILITY</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE
8 &#8211; CREDIT FACILITY </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
July 4, 2022, the Company entered into a senior secured credit facility agreement with L.I.A. Pure Capital Ltd. (&#8220;Pure Capital&#8221;)
to borrow from time to time amounts until the closing of the IPO in an amount of up to $800 thousand (the &#8220;Initial Credit&#8221;),
which Initial Credit could be increased, upon the request of the Company, to an amount not exceeding $1 million (together with the Initial
Credit, the &#8220;Credit Facility&#8221;) in aggregate. The underlying outstanding amounts had priority in relation and senior to any
other debts owed by the Company to any third party, and were subject to a registered floating charge, for the benefit of Pure Capital,
against all of the Company&#8217;s assets. During July, August and September 2022, the Company received an aggregate of $800 thousand
under the Credit Facility. The Credit Facility bore interest at the rate of 4% per annum. The outstanding amounts, together with interest
accrued and unpaid were due and payable on the earlier of (i) June 30, 2024, or (ii) upon receipt of a certain financing transaction
or in the event of certain customary events of default or a change of control. The Credit Facility was fully repaid on September 19,
2022. The agreement indicates that the Company shall not assume any debt senior to the Credit Facility during the term of the Credit
Facility, unless Pure Capital has provided its advance written consent; and subject to applicable law, any debt assumed by the Company
during such term shall be deemed subordinated to any debt accrued under the agreement, if Pure Capital had not provided its prior written
consent; and without Pure Capital&#8217;s prior written consent, the Company shall not pledge in favor of a third-party creditor or lender
any of its assets or rights, including by a floating charge, until such time that the Credit Facility, and any interest accrued thereon,
has been repaid in full to Pure Capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Additionally, the Credit Facility agreement
requires the Company to retain Pure Capital for investor relations services and other related strategic services in exchange for a monthly
base fee of $35 thousand, upon the closing of the IPO, under a 3 year consulting agreement. If 70% or more of the warrants (or other convertible
securities) issued in connection with the IPO are exercised during the term of such instrument, then the base monthly fee will immediately
increase to $70 thousand, which increase shall apply retroactively to the closing of the IPO date. In addition, Pure Capital shall serve
as the Company&#8217;s strategic consultant in connection with any offering or financing transaction of the Company, each, in excess of
$5 million (which does not include the IPO) in exchange for a per offering and/or transaction fee of $100 thousand for the closing. Total
expenses for services rendered under the Pure Capital agreement were $420 thousand and $122 thousand for the years ended December 31,
2023 and 2022, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_CreditFacilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_CreditFacilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_CreditFacilityDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_CreditFacilityDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619169463488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; Equity (Deficit)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Shareholders' Equity (Deficit) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">SHAREHOLDERS&#8217; EQUITY (DEFICIT)</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE
9 &#8211; SHAREHOLDERS&#8217; EQUITY (DEFICIT):</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>a.</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share capital</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"><span style="font-family: Times New Roman, Times, Serif">The
share capital as of December 31, 2023 and 2022, is composed of as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Number
    of shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Authorized</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Issued
    and outstanding</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">December
    31,<br/> 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">December
    31, <br/> 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">December
    31,<br/> 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">December
    31, <br/> 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Ordinary shares, NIS 0.01 par value</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">50,000,000</span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">50,000,000</span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">20,387,428</span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">15,049,720</span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Ordinary Shares entitle their holders: to receive notices of, and to attend, general meetings where each Ordinary Share shall have one
vote for all purposes; to share distributions as may be declared by the Board of Directors of the Company and approved by the shareholders,
if required; and, upon liquidation or dissolution - to participate in the distribution of the assets of the Company after payment of
all debts and other liabilities of the Company, in accordance with the terms of the Company&#8217;s Articles of Association.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
inception, the Company issued 4,500,000 Ordinary Shares to its three co-founders for a total consideration equal to their par value (approximately
$12 thousand). In October 2021, the total consideration was paid off by the co-founders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
March 10, 2016, the Company issued to certain investors 1,844,268 ordinary A shares, NIS 0.01 par value of the Company (&#8220;Ordinary
A Shares&#8221;) for a total consideration of $500 thousand.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Ordinary A Shares conferred on the holders all rights to holders of Ordinary Shares in the Company and, in addition, bore preferred rights
primarily advanced in return of their investments plus 2% per year, in a liquidation event as described in the Company&#8217;s Articles
of Association.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
2021, those Ordinary A Shares were converted into Ordinary Shares, and the Company reclassified the Company&#8217;s authorized share
capital of 2,000,000 Ordinary A Shares into 2,000,000 Ordinary Shares and increased the Company&#8217;s authorized share capital by 10,000,000
Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During
2018, 2020, 2021 and 2022, the Company issued 111,142, 15,430, 241,533 and 4,666 Ordinary Shares, respectively, upon exercise of employees&#8217;
options.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
April 2021, the Company issued to new investors 1,343,374 Ordinary Shares, and 671,687 warrants exercisable into Ordinary Shares in consideration
of 125% of the per share purchase price in an initial public offering of the Company, if and when it shall occur, for total consideration
of $3.025 million, before $100 thousand of issuance expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During
September 2022, the Company completed the IPO, in which were issued 3,750,000 Ordinary Shares and warrants to purchase 8,625,000 Ordinary
Shares.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During
2022, the Company entered into SAFEs for $500 thousand with 5 investors, $100 thousand each, of which $400 thousand were converted to
118,204&#160;Ordinary Shares and $100 thousand of one investor were paid back in cash upon the closing of the IPO. Those&#160;SAFEs were
not mandatorily redeemable, nor redeemable at the option of the holder after a specified date, but in an Equity Financing (as defined
in the SAFEs) which under current liquidity circumstances constitutes a redemption event outside of the Company&#8217;s control. The
Company issued to each SAFE investor a warrant to purchase Ordinary Shares of the Company with an exercise price of $6.345 per share
in such offering for an aggregate amount of up to $25 thousand (exercisable for a total of 15,760 Ordinary Shares, until the earlier
of: (i) eighteen (18) months from January 2022; or (ii) in a change of control event, which generally covers (a) a transaction in which
any person or group becomes the beneficial owner, directly or indirectly, of more than 50% of the Company&#8217;s outstanding voting
securities with the right to vote for the election of members of the Company&#8217;s Board of Directors, or (b) any reorganization, merger
or consolidation of the Company, or (c) a sale, lease or other disposition of all or substantially all of the Company&#8217;s assets).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During
September 2022, investors exercised 40,000 warrants into Ordinary Shares. During October 2022, a former employee of the Company exercised
4,666 options into Ordinary Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
June 2023, 724,139 warrants were exercised into 724,139 Ordinary Shares at an exercise price of $2.00 per Ordinary Share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; background-color: white">During November 2023, the Company
completed a follow-on public offering for gross proceeds of $2 million, in which the Company issued 4,444,444 Ordinary Shares priced to
the public at $0.45 per share.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>b.</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share-based compensation</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 77.3pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
2015, the Company&#8217;s Board of Directors adopted the 2015 Share Option Plan (the &#8220;2015 Plan&#8221;), with&#160;1,032,805 options
available for grant, and through December 31, 2021, the Company&#8217;s Board of Directors approved, in the aggregate, an increase of&#160;800,000
options available for grant, for allocation to existing and future employees, consultants and directors of the Company and/or its Subsidiary,
such that, there are 1,832,805 Ordinary Shares reserved under the 2015 Plan (including those that were exercised into Ordinary Shares).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
December 15, 2022, the Company&#8217;s Board of Directors approved an increase of&#160;a total of 424,653 Ordinary Shares underlying
options available for grant, for allocation to existing and future employees, consultants and directors of the Company and/or its Subsidiary,
such that there are 2,257,458 Ordinary Shares underlying options granted (including options that were exercised into Ordinary Shares)
or reserved for future issuance under the 2015 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">On August 23, 2023, the Company&#8217;s
Board of Directors approved an increase of&#160;a total of 931,139 Ordinary Shares underlying options available for grant, for allocation
to existing and future employees, consultants and directors of the Company and/or its Subsidiary, such that there are 3,188,597 Ordinary
Shares underlying options granted (including options that were exercised into Ordinary Shares) or reserved for future issuance under the
2015 Plan.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">As of March 13, 2024, the Company had 1,066,637 Ordinary Shares reserved
for future issuance under the 2015 Plan.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>Options
to employees </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Below
is a summary of the Company&#8217;s options activity and related information with respect to options granted to employees during the
years ended December 31, 2023 and 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3cm"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year ended
    <br/> December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year ended
    <br/> December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Amount<br/>
    of <br/> options</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Weighted<br/>
    average <br/> exercise <br/> price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Amount<br/>
    of <br/> options</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Weighted
    <br/> average <br/> exercise<br/> price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; text-indent: -11.35pt; padding-left: 11.35pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding
    - beginning of the year</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">988,264</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.563</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">863,264</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.614</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -11.35pt; padding-left: 11.35pt"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">*471,500</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.224</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">145,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.184</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -11.35pt; padding-left: 11.35pt"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-96; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-97; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,666</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.003</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -11.35pt; padding-left: 11.35pt"><span style="font-family: Times New Roman, Times, Serif">Expired
    or forfeited</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.664</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(15,334</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.003</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -11.35pt; padding-left: 11.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -11.35pt; padding-left: 11.35pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding
    - end of the year</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,454,764</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.777</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">988,264</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.563</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -11.35pt; padding-left: 11.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -11.35pt; padding-left: 11.35pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable
    at end of year</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">889,125</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.612</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">753,236</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.703</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The weighted-average grant date fair
value of stock-based awards granted&#160;was $1.224, $0.184 and $0.323 per share during the years ended December 31, 2023, December 31,&#160;2022
and December 31, 2021, respectively. The options will expire at the earlier of (i) ten years from the date of grant or (ii) 90 days
following the termination of employment.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
following weighted-average assumptions were used in determining the most recent fair values of stock options using the Black-Scholes
valuation model:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left; text-indent: -11.35pt; padding-left: 11.35pt"><span style="font-family: Times New Roman, Times, Serif">Expected
    dividend yield</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -11.35pt; padding-left: 11.35pt"><span style="font-family: Times New Roman, Times, Serif">Expected
    stock price volatility</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">55.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -11.35pt; padding-left: 11.35pt"><span style="font-family: Times New Roman, Times, Serif">Risk
    free interest rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.10</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -11.35pt; padding-left: 11.35pt"><span style="font-family: Times New Roman, Times, Serif">Expected
    life of options</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">6.25</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">*</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Including the grant of 120,000 options to purchase up to 120,000 Ordinary Shares to directors, as approved by the Company&#8217;s shareholders on November 30, 2023, with an exercise price of $1.32 per share. The options will expire at the earlier of (i) ten years from the date of grant or (ii) 90 days following a termination of employment or service. The fair value of each option as of the grant date was $0.12, determined using the Black-Scholes option pricing model and the total expenses of $15 thousand will be expensed over the option vesting periods of three years.</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>Options
to consultants </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s outstanding options to consultants as of December 31, 2023 were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 77.3pt; text-indent: -1cm"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left; font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Issuance
    date</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">In
    connection with</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>No.
of options<br/>
issued</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">&#160;<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Exercise<br/>
price</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>No.
of options<br/>
exercisable</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 32%"><span style="font-family: Times New Roman, Times, Serif">2015</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 31%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Rendered services</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">110,655</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.003</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">110,655</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">2017</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Rendered services</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">36,885</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.003</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">36,885</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Rendered services</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">69,090</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.003-$2.25</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">69,090</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">2023*</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Rendered services</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">100,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.546</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">37,778</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 77.3pt; text-indent: -1cm"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">*</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On April 27, 2023, the Company&#8217;s Board of Directors approved the additional grant of options to purchase up to 100,000 Ordinary Shares to a consultant, with an exercise price of $0.55 per share. The options will expire at the earlier of (i) ten years from the date of grant or (ii) 90 days following a termination of services. The fair value of each option as of the grant date was $0.26, determined using the Black-Scholes option pricing model and the total expenses of $26 thousand will be expensed over the option vesting periods of three years.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
share-based compensation expenses are recognized in the following line items in the consolidated statements of comprehensive loss in
the years ended:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">U.S.
    dollars in thousands</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Research and development expenses</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">83</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">180</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">105</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Sales and marketing expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">61</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">401</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">111</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">General and administrative
    expenses</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">97</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">209</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">83</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">241</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">790</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">299</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>Equity
Warrants to investors and associated with the IPO, as of December 31, 2023:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Number&#160;of
    warrants/ options</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Issuance
    date</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Exercise
    price</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Exercise
    ratio</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Expiration
    date</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Notes</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,860,861</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 14%; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">September
    13, 2022</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.00</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 25%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Each warrant is exercisable into 1 Ordinary Share</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 16%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">5 years following the issuance date</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 18%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Registered for trading (*)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">671,687</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">September 15, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.29</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Each warrant is exercisable into 1 Ordinary Share, See note 7(B) above</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">18 months following the issuance date</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Owned by April 2021 investors</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">187,500</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">September 15, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.31</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Each warrant is exercisable into 1 Ordinary Share</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">5 years following the issuance date</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Owned by underwriter</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23,640</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">September 15, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.23</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Each warrant is exercisable into 1 Ordinary Share</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">10 years following the issuance date</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Owned by the legal advisor</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">(*) The warrants are exercisable at
any time after their original issuance and at any time up to the date that is five&#160;years after their original issuance. The warrants
will be exercisable, at the option of each holder, in whole or in part by delivering to us a duly executed exercise notice and, at any
time a registration statement registering the issuance of the Ordinary Shares underlying the warrants under the Securities Act is effective
and available for the issuance of such shares, by payment in full in immediately available funds for the number of Ordinary Shares purchased
upon such exercise.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The exercise price per whole Ordinary
Share purchasable upon exercise of the warrants $4.00 per share (the &#8220;Initial Exercise Price&#8221;). The exercise price is subject
to appropriate adjustment in the event of certain stock dividends and distributions, stock splits, stock combinations, reclassifications
or similar events affecting the Company&#8217;s Ordinary Shares and also upon any distributions of assets, including cash, stock or other
property to the Company&#8217;s shareholders. Subject to certain exemptions outlined in the warrant, for a period until <span style="-sec-ix-hidden: hidden-fact-98">two</span> years from
the date of issuance of the warrant, if the Company shall sell, enter into an agreement to sell and subsequently sells, or grant any option
to purchase, or sell, enter into an agreement to sell and subsequently sells, or grant any right to reprice, or otherwise dispose of or
issue (or announce any offer, sale, grant or any option to purchase or other disposition the subsequently closes) any Ordinary Shares
or convertible security, at an effective price per share less than the exercise price of the warrant then in effect, the exercise price
of the warrant shall be reduced to equal the effective price per share in such Dilutive Issuance;&#160;provided, however, that in no event
shall the exercise price of the warrant be reduced to an exercise price lower than 50% of the Initial Exercise Price. On the date that
is 90 calendar days immediately following the initial issuance date of the warrants, the exercise price of the warrants will adjust (the
&#8220;Reset Price&#8221;), provided that such value is less than the exercise price in effect on that date. The Reset Price is equal
to the greater of (a) 50% of the Initial Exercise Price of the warrants on the issuance date or (b) 100% of the lowest volume weighted
average price per Ordinary Share occurring on any day between the initial exercise date of the warrants and 90 calendar days following
the issuance date of the warrants. The lowest Reset Price is $2.00, which is 50% of the Initial Exercise Price.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619175214848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Taxes on Income<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Taxes on Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">TAXES ON INCOME</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 10
- TAXES ON INCOME:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 54pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td>
    <td style="text-indent: 0in; padding-left: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company
    is taxed under the Israeli law.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.15pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 54pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income of an Israeli company is subject to corporate tax. The corporate tax rate in Israel is&#160;23%.</span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.15pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 54pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax assessments - In accordance
    with the Israeli Income Tax Ordinance, tax assessments of the Company through tax year 2016 are considered final.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.25pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 54pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carryforward tax losses of the Company as of December 31, 2023, amounted to approximately $13.8 million; however, a full valuation allowance of $3.2 million was recorded against the potential future tax benefits.</span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.25pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 54pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Subsidiary is taxed under the U.S. tax law. The federal tax rate is 21%.</span></td></tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619169463488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Parties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTIES</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE
11 &#8211; RELATED PARTIES</b>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
employment expenses of the co-founders who each owns more than 5% of the Company&#8217;s Ordinary Shares: Asher Dahan (the Chairman of
the Board of Directors and the Chief Executive Officer), Guy Wanger (President and Director) and Leeor Langer (the Chief Technology Officer),
for the years ended December 31, 2023, 2022 and 2021 amounted to approximately $293 thousand, $331 thousand, and $145 thousand, respectively.
On March 14, 2022, the Company&#8217;s shareholders meeting approved the increase of the monthly salary of each of the Company&#8217;s
co-founders to NIS&#160;70&#160;thousand (approximately $19&#160;thousand), plus social benefits and leased car, and approved a one-time
bonus equal to 6 monthly salaries, upon the closing of the IPO which was accomplished in September 2022 (see note 1e).</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619172931008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Policies, by Policy (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of consolidation</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>a.</b></span></td> <td style="padding-right: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principles of consolidation</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
accompanying consolidated financial statements include the accounts of the Company and the Subsidiary. All intercompany transactions
have been eliminated in consolidation.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of estimates</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>b.</b></span></td> <td style="padding-right: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of estimates</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities, as well as to disclose contingent liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the reporting years. On an ongoing basis, management evaluates its
estimates, judgments and assumptions. Management bases its estimates, judgments and assumptions on historical experience and on various
other factors that are believed to be reasonable under the circumstances. Actual results could differ from those estimates.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign currency</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>c.</b></span></td> <td style="padding-right: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Foreign currency</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
currency of the primary economic environment in which the operations of the Company are conducted is the U.S. dollar (&#8220;USD&#8221;).
The Company&#8217;s funding and revenues are mostly in USD. Thus, the functional currency of the Company is the USD.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Transactions
and balances originally denominated in USD are presented at their original amounts. Balances in non-USD currencies are translated into
USD using historical and current exchange rates for non-monetary and monetary balances, respectively. For non-USD transactions and other
items (stated below) reflected in the statements of operations, the following exchange rates are used: (i) for transactions &#8211; exchange
rates at transaction dates or average rates; and (ii) for other items (derived from non-monetary balance sheet items such as depreciation
etc.) &#8211; historical exchange rates. Currency transaction gains or losses are recorded to finance income or expenses, as appropriate.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>d.</b></span></td> <td style="padding-right: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inventories:</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Inventories
are composed of parts of the Company&#8217;s products as well as completed products and are stated at the lower of cost or net realizable
value. Inventory cost is determined on FIFO basis. Net realizable value is the estimated selling prices in the ordinary course of business,
less reasonably predictable costs of completion, disposal, and transportation. The cost of inventories comprises all costs of purchase,
and other costs incurred in bringing the inventories to their present location and condition.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and equipment</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>e.</b></span></td> <td style="padding-right: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Property and equipment</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Property
and equipment are stated at cost. Depreciation is computed based on the straight-line method, over the estimated useful life of the assets.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Annual
rates of depreciation are as follows:</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>%
    </b>&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Office furniture, machines, leasehold improvements,
    and electronic equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7-15</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 88%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Computers and software</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">33</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Mold</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">50</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>f.</b></span></td> <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>Leases</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On January 1, 2022, the Company began to implement ASU 2016-02, Leases (Topic 842) (&#8220;ASU 2016-02&#8221;) using the modified retrospective approach for all lease arrangements as of such date. The Company leases office space and vehicles under operating leases.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Arrangements meeting the definition of a lease are classified as operating or financing leases and are recorded on the balance sheet as both a right-of-use asset and lease liability, calculated by discounting fixed lease payments over the lease term at the rate implicit in the lease or the Company&#8217;s incremental borrowing rate. Lease liabilities are increased by interest and reduced by payments each period, and the right-of-use asset is amortized over the lease term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The lease liability was measured at the present value of the remaining lease payments, discounted using the Company&#8217;s incremental borrowing rate. The weighted-average&#160;rate applied was 8%. Right-of-use&#160;assets were measured at an amount equal to the lease liability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">For operating leases, interest on the lease liability and the amortization of the right-of-use asset result in straight-line&#160;rent expense over the lease term. Variable lease expenses are recorded when incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Leases with a lease term of 12 months or less at inception are not recorded within the Consolidated Balance Sheets and are expensed on a straight-line basis over the lease term in the Consolidated Statements of Operations and Comprehensive Loss.<span style="font-size: 10pt; background-color: white">&#160;</span></span></p></td></tr> </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue recognition</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>g.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenue recognition </b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Revenue
is recognized when (or as) control of the promised goods or services is transferred to the customer, and in an amount that reflects the
consideration the Company is contractually due in exchange for those services or goods. The Company follows five steps to record revenue:
(i) identify the contract with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction
price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the
Company satisfies its performance obligations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Company generate revenues from
the sales of B2C &#8220;Mudra Band&#8221;, sales of B2B &#8220;Mudra development kits&#8221; and sales of pilot transactions.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The &#8220;Mudra Band&#8221; is an
aftermarket accessory band for the Apple Watch which allows touchless operation and control of the watch and iPhone by using an app which
is considered combined with the band as one performance obligation. Revenue derived from the sale of &#8220;Mudra Band&#8221; is recognized
at a point of time when control transfers to the customer. The Company believes that the delivery date is the most appropriate point in
time indicating control has transferred to the customer.&#160;&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Company allows return and refund
of Mudra Band within 30 days of having the Mudra Band delivered. The Company records an appropriate provision for such refunds.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Revenue derived from freight charges
is considered as a separate performance obligation recognized when the related product revenue is recognized.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">A
pilot transaction has multiple performance obligations, and it generally takes a few months but less than one year. Each Mudra development
kit sale also has multiple performance obligations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
payment terms of the Mudra development kit sales are upon delivery of the Hardware, while the payment terms of the pilot transactions
are within the pilot period.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
those transactions, each obligation- Hardware and API (for Mudra development kit) and tailor-made software application and technical
support (for a pilot transaction) - is distinct and separately identifiable.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
amount allocated to the delivered items is recognized upon delivery, the amount allocated to API is recognized over the API period and
the amount allocated to the technical support is recognized over the service period (a pilot period).&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_CostOfRevenuesPolicyTextBlock', window );">Cost of revenues</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>h.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cost of revenues</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.4pt"><span style="font-family: Times New Roman, Times, Serif">Costs
are expensed as incurred. The primary components of cost of revenues include the cost of the product and outbound freight charges.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and development</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>i.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Research and development</b></span></td></tr> </table><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.4pt"><span style="font-family: Times New Roman, Times, Serif">Research
and development expenses consist primarily of payroll, payroll related expenses, subcontractors, and materials. Costs are expensed as
incurred.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_GovernmentalGrantsPolicyTextBlock', window );">Governmental grants</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>j.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Governmental grants</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company receives royalty-bearing grants from the Israeli government for approved research and development projects and marketing efforts.
These grants are recognized at the time the Company is entitled to such grants based on the costs incurred or milestones achieved as
provided by the relevant agreement and included as a deduction from research and development or sales and marketing expenses, respectively.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock', window );">Finance income and expenses</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>k.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Finance income and expenses</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Finance
income is composed of interest on deposits and unrealized gain from foreign currency derivative activities, while finance expenses are
composed of interest on senior secured credit facility, bank charges and net currency exchange rates differences.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income taxes</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>l.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Income taxes</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company accounts for income taxes in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 740, &#8220;Income Taxes&#8221;
(&#8220;ASC 740&#8221;). Deferred taxes are determined utilizing the assets and liabilities method, which is based on the estimated future
tax effects of the differences between the financial accounting and tax bases of assets and liabilities under the applicable tax laws.
Deferred tax balances are computed using the tax rates expected to be in effect when those differences reverse. A valuation allowance
in respect of deferred tax assets is provided if, based upon the weight of available evidence, it is more likely than not that some or
all the deferred tax assets will not be realized. The measurement of deferred tax assets is reduced, if necessary, by the amount of any
tax benefits that, based on available evidence, are not expected to be realized.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company applies ASC 740, which clarifies the accounting and reporting for uncertainties with respect to income taxes. ASC 740 prescribes
a comprehensive model for the financial statement recognition, measurement, presentation, and disclosure of uncertain tax positions taken
or expected to be taken in income tax returns.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share based compensation</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>m.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share based compensation</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Share-based
compensation expenses related to employees&#8217; and consultants&#8217; options are measured at the grant date based on the fair value
of the award and are generally expensed over the requisite service period (generally the vesting period). The Company recognizes compensation
expense on a straight-line basis from the beginning of the service period. For awards with graded-vesting features, each vesting tranche
is separately expensed over the related vesting period. The Company estimates the fair value of each stock option grant using the Black-Scholes
option pricing model, which requires management to make certain assumptions of future expectations based on historical and current data
include the expected term of the stock option, expected volatility, dividend yield, and risk-free interest rate.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_WarrantsPolicyPolicyTextBlock', window );">Warrants</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>m.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
warrants&#8217; mechanism does not create any obligation to transfer cash to the investors. Warrants are exercised for a fixed amount
of Ordinary Shares upon exercise. Therefore, the Company accounts for the warrants as equity-classified instruments (as part of additional
paid in capital), based on an assessment of the applicable U.S. GAAP authoritative guidance. The assessment considers whether the warrants
are freestanding financial instruments, meet the definition of a liability or whether the warrants meet all of the requirements for equity
classification, including whether the warrants are indexed to the Company&#8217;s own shares, among other conditions for equity classification.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_SeverancePolicyTextBlock', window );">Severance</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>o.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Severance</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Israeli
labor law generally requires payment of severance pay upon dismissal of an employee or upon termination of employment in certain other
circumstances. The Company&#8217;s pension and severance pay liabilities are covered mainly by insurance policies. Pursuant to section
14 of the Israeli Severance Compensation Act, 1963 (&#8220;section 14&#8221;), the Company&#8217;s employees are entitled to monthly
deposits, at a rate of 8.33% of their monthly salary, made in their name with insurance companies. Payments in accordance with section
14 relieve the Company from any future severance payments in respect of those employees and, as such, the Company may only utilize the
insurance policies for the purpose of paying severance pay.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Basic and diluted loss per share</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>p.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basic and diluted loss per share</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Basic
and diluted loss per share is calculated by dividing the loss attributable to equity holders of the Company by the weighted average number
of Ordinary Shares outstanding during the financial year, adjusted for Ordinary Shares issued during the year, if applicable.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>q.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair Value Measurements</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company measures and discloses fair value in accordance with the Financial Accounting Standards Board (&#8220;FASB&#8221;), ASC 820,
Fair Value Measurements and Disclosures (&#8220;ASC 820&#8221;). ASC 820 defines fair value, establishes a framework and gives guidance
regarding the methods used for measuring fair value, and expands disclosures about fair value measurements. Fair value is an exit price,
representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market
participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions
that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, there exists a three-tier
fair-value hierarchy, which prioritizes the inputs used in measuring fair value as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Level
1 &#8211; unadjusted quoted prices are available in active markets for identical assets or liabilities that the Company has the ability
to access as of the measurement date.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Level
2 &#8211; pricing inputs are other than quoted prices in active markets that are directly observable for the asset or liability or indirectly
observable through corroboration with observable market data.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Level
3 &#8211; pricing inputs are unobservable for the non-financial asset or liability and only used when there is little, if any, market
activity for the non-financial asset or liability at the measurement date. The inputs into the determination of fair value require significant
management judgment or estimation. Level 3 inputs are considered as the lowest priority within the fair value hierarchy.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">This
hierarchy requires the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining
fair value.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
fair value of cash is based on its demand value, which is equal to its carrying value. Additionally, the carrying value of all other
short-term monetary assets and liabilities are estimated to be equal to their fair value due to the short-term nature of these instruments.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>r.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Concentration of Credit Risk</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Company maintains certain cash
balances in a well-known Israeli banks and a U.S.-based bank.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Company&#8217;s labor expenses
are denominated mainly in NIS, and therefore, subject to foreign currency risk. During the year ended December 31, 2023, the Company partially
hedged its foreign currency exchange risk.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Company&#8217;s derivative instruments
primarily include foreign currency forward agreements related to the NIS and associated with certain payroll payments. The Company&#8217;s
foreign currency forward agreements related to foreign currency&#160;balance sheet exposure provide economic hedges but are not designated
as hedges for accounting purposes. Changes in the value of the derivative,&#160;along with the transaction gain or loss on the hedged
item, are recorded within the Company&#8217;s consolidated statements of loss.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and cash equivalents</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>s.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cash and cash equivalents:</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Cash
equivalents are highly liquid investments that are readily convertible into cash, typically with an original maturity of three months
or less.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Information</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 49px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>t.</b></span></td> <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>Segment Information </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company has a single operating and reportable segment. The Company&#8217;s chief operating decision maker, who is the Chief Executive Officer, evaluates the performance of its business based on financial data consistent with the presentation in the accompanying consolidated financial statements for the purposes of making operating decisions, assessing financial performance, and allocating resources. &#160;&#160;</span></p></td></tr> </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsPolicyPolicyTextBlock', window );">Subsequent Events</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top; text-align: justify">
<td style="width: 49px"></td><td style="width: 24px; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>u.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Subsequent Events</b></span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">In connection with the preparation of these consolidated financial
statements, the Company and management evaluated subsequent events through March 13, 2024, the date these consolidated financial statements
were available to be issued.<span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480981/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//830/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-19<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 330<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482105/912-330-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//330/tableOfContent<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 270<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482989/270-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reporting subsequent events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_CostOfRevenuesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Policy of cost of revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_CostOfRevenuesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finance income and expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_GovernmentalGrantsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for governmental grants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_GovernmentalGrantsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_SeverancePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for severance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_SeverancePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_WarrantsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_WarrantsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619175214848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock', window );">Schedule of Annual Rates of Depreciation</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif">Annual
rates of depreciation are as follows:</span><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>%
    </b>&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Office furniture, machines, leasehold improvements,
    and electronic equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7-15</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 88%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Computers and software</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">33</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Mold</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">50</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of annual rates of depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619175486720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventories [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventories</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">December
    31</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">U.S.
    dollars <br/>
    in thousands</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Cost:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Raw materials</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">514</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Work-in-progress</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">206</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-92; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Finished
    goods</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">312</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-93; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,032</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619175404304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property and Equipment, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment Net</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">December
    31</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">U.S.
    dollars <br/>
    in thousands</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Cost:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Computers and
    software</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">204</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">124</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Furniture and leasehold
    improvements</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">38</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">7</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Electronic equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">20</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">9</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Machines
    and molds</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">72</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-94; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">334</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">140</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less
    - <span style="font-style: normal; font-weight: normal">accumulated depreciation</span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">140</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">72</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">194</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">68</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619175203840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Lease (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Lease [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock', window );">Schedule of Classification of Operating Lease Right-of-Use Assets and Liabilities</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif">The
following table summarizes the classification of operating lease right-of-use assets and liabilities in the Company&#8217;s Consolidated
Balance Sheets as of December&#160;31, 2023 and 2022:</span><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">December
    31</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">U.S.
    dollars in thousands</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Right of
    use assets</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">592</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">180</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Short term</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">297</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">68</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Long term</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">278</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">94</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Total lease liabilities</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">575</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">162</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Minimum Lease Payments Under Our Operating Lease Liabilities</a></td>
<td class="text">At December&#160;31, 2023, the future minimum lease payments
under the Company&#8217;s operating lease liabilities are as follows:<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left; font-weight: bold; border-bottom: Black 1.5pt solid">Year ended December 31,</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">U.S.&#160;dollars<br/> in&#160;thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">308</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2025</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">289</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">2026</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">22</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total future minimum lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">619</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">Less imputed interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(44</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total operating lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">575</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">Less operating lease liabilities, current</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(297</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 4pt; text-align: left">Operating lease liabilities, non-current</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">278</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for lessee's operating leases. Includes, but is not limited to, description of lessee's operating lease, existence and terms of renewal or purchase options and escalation clauses, restrictions imposed by lease, such as those concerning dividends, additional debt, and further leasing, rent holidays, rent concessions, or leasehold improvement incentives and unusual provisions or conditions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481440/840-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481418/840-10-55-40<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481501/840-20-50-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481501/840-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619173625040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; Equity (Deficit) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Shareholders' Equity (Deficit) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock', window );">Schedule of Share Capital</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif">The
share capital as of December 31, 2023 and 2022, is composed of as follows:</span><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Number
    of shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Authorized</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Issued
    and outstanding</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">December
    31,<br/> 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">December
    31, <br/> 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">December
    31,<br/> 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">December
    31, <br/> 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Ordinary shares, NIS 0.01 par value</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">50,000,000</span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">50,000,000</span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">20,387,428</span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">15,049,720</span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Options Activity</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif">Below
is a summary of the Company&#8217;s options activity and related information with respect to options granted to employees during the
years ended December 31, 2023 and 2022.</span><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year ended
    <br/> December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year ended
    <br/> December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Amount<br/>
    of <br/> options</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Weighted<br/>
    average <br/> exercise <br/> price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Amount<br/>
    of <br/> options</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Weighted
    <br/> average <br/> exercise<br/> price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; text-indent: -11.35pt; padding-left: 11.35pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding
    - beginning of the year</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">988,264</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.563</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">863,264</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.614</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -11.35pt; padding-left: 11.35pt"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">*471,500</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.224</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">145,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.184</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -11.35pt; padding-left: 11.35pt"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-96; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-97; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,666</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.003</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -11.35pt; padding-left: 11.35pt"><span style="font-family: Times New Roman, Times, Serif">Expired
    or forfeited</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.664</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(15,334</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.003</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -11.35pt; padding-left: 11.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -11.35pt; padding-left: 11.35pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding
    - end of the year</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,454,764</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.777</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">988,264</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.563</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -11.35pt; padding-left: 11.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -11.35pt; padding-left: 11.35pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable
    at end of year</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">889,125</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.612</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">753,236</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.703</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">*</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Including the grant of 120,000 options to purchase up to 120,000 Ordinary Shares to directors, as approved by the Company&#8217;s shareholders on November 30, 2023, with an exercise price of $1.32 per share. The options will expire at the earlier of (i) ten years from the date of grant or (ii) 90 days following a termination of employment or service. The fair value of each option as of the grant date was $0.12, determined using the Black-Scholes option pricing model and the total expenses of $15 thousand will be expensed over the option vesting periods of three years.</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of weighted-Average Assumptions</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif">The
following weighted-average assumptions were used in determining the most recent fair values of stock options using the Black-Scholes
valuation model:</span><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left; text-indent: -11.35pt; padding-left: 11.35pt"><span style="font-family: Times New Roman, Times, Serif">Expected
    dividend yield</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -11.35pt; padding-left: 11.35pt"><span style="font-family: Times New Roman, Times, Serif">Expected
    stock price volatility</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">55.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -11.35pt; padding-left: 11.35pt"><span style="font-family: Times New Roman, Times, Serif">Risk
    free interest rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.10</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -11.35pt; padding-left: 11.35pt"><span style="font-family: Times New Roman, Times, Serif">Expected
    life of options</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">6.25</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ScheduleOfOptionsToConsultantsTableTextBlock', window );">Schedule of Options to Consultants</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s outstanding options to consultants as of December 31, 2023 were as follows:</span><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left; font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Issuance
    date</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">In
    connection with</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>No.
of options<br/>
issued</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">&#160;<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Exercise<br/>
price</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>No.
of options<br/>
exercisable</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 32%"><span style="font-family: Times New Roman, Times, Serif">2015</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 31%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Rendered services</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">110,655</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.003</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">110,655</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">2017</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Rendered services</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">36,885</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.003</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">36,885</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Rendered services</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">69,090</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.003-$2.25</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">69,090</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">2023*</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Rendered services</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">100,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.546</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">37,778</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">*</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On April 27, 2023, the Company&#8217;s Board of Directors approved the additional grant of options to purchase up to 100,000 Ordinary Shares to a consultant, with an exercise price of $0.55 per share. The options will expire at the earlier of (i) ten years from the date of grant or (ii) 90 days following a termination of services. The fair value of each option as of the grant date was $0.26, determined using the Black-Scholes option pricing model and the total expenses of $26 thousand will be expensed over the option vesting periods of three years.</span></td>
</tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Share-Based Compensation Expenses</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif">The
share-based compensation expenses are recognized in the following line items in the consolidated statements of comprehensive loss in
the years ended:</span><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">U.S.
    dollars in thousands</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Research and development expenses</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">83</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">180</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">105</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Sales and marketing expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">61</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">401</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">111</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">General and administrative
    expenses</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">97</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">209</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">83</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">241</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">790</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">299</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock', window );">Schedule of Issuance of Equity Warrants to Investors and Associate</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif"><b>Equity
Warrants to investors and associated with the IPO, as of December 31, 2023:</b></span><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Number&#160;of
    warrants/ options</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Issuance
    date</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Exercise
    price</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Exercise
    ratio</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Expiration
    date</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Notes</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,860,861</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 14%; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">September
    13, 2022</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.00</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 25%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Each warrant is exercisable into 1 Ordinary Share</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 16%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">5 years following the issuance date</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 18%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Registered for trading (*)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">671,687</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">September 15, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.29</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Each warrant is exercisable into 1 Ordinary Share, See note 7(B) above</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">18 months following the issuance date</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Owned by April 2021 investors</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">187,500</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">September 15, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.31</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Each warrant is exercisable into 1 Ordinary Share</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">5 years following the issuance date</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Owned by underwriter</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23,640</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">September 15, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.23</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Each warrant is exercisable into 1 Ordinary Share</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">10 years following the issuance date</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Owned by the legal advisor</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">(*) The warrants are exercisable at
any time after their original issuance and at any time up to the date that is five&#160;years after their original issuance. The warrants
will be exercisable, at the option of each holder, in whole or in part by delivering to us a duly executed exercise notice and, at any
time a registration statement registering the issuance of the Ordinary Shares underlying the warrants under the Securities Act is effective
and available for the issuance of such shares, by payment in full in immediately available funds for the number of Ordinary Shares purchased
upon such exercise.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in Issuance of equity warrants to investors and associat.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ScheduleOfOptionsToConsultantsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of stock options issued to consultants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ScheduleOfOptionsToConsultantsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619167609664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 13, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 14, 2022 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 12, 2024 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>&#8362; / shares</div>
</th>
<th class="th">
<div>Oct. 24, 2023 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 25, 2022 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 20, 2022 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 16, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_GeneralLineItems', window );"><strong>General [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_AnnualGrossRevenuesExceed', window );">Annual gross revenues exceed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,235,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_OrdinarySharesWarrantsHeldByNonaffiliates', window );">Ordinary shares warrants held by non-affiliates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_NonconvertibleDebtSecurities', window );">Non-convertible debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82,000<span></span>
</td>
<td class="nump">$ 45,000<span></span>
</td>
<td class="nump">$ 142,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary share par value (in New Shekels per share) | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Raised net proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_NetProceedsFromIssuanceSecondaryPublicOffering', window );">Net proceeds from secondary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,387,428<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,049,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_WarrantsExerciseIntoOrdinaryShares', window );">Warrant exercised (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_GrossProceeds', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_UnderwritingNetProceed', window );">Underwriting net proceed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_UnderwritingDiscountsAndCommissions', window );">Underwriting discounts and commissions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Secondary ordinary share (in Shares) | shares</a></td>
<td class="nump">4,444,444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from ordinary shares</a></td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceeds</a></td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_GeneralLineItems', window );"><strong>General [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary share par value (in New Shekels per share) | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_GrossAfterOtherIPOExpenses', window );">Gross after other IPO expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_GeneralLineItems', window );"><strong>General [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Ordinary Share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_GeneralLineItems', window );"><strong>General [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary share par value (in New Shekels per share) | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">241,533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,430<span></span>
</td>
<td class="nump">111,142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Ordinary share price (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_GeneralLineItems', window );"><strong>General [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_WarrantsExercisePricePerShare', window );">Warrant price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_GeneralLineItems', window );"><strong>General [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ExercisePriceOfWarrant', window );">Exercise price of warrants (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember', window );">Warrant [Member] | Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_GeneralLineItems', window );"><strong>General [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_Warrants', window );">Warrants (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=wlds_MudraInspireDevelopmentKitsMember', window );">Mudra Inspire Development Kits Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_GeneralLineItems', window );"><strong>General [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_AnnualGrossRevenuesExceed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of annual gross revenues exceed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_AnnualGrossRevenuesExceed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ExercisePriceOfWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price of warrant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ExercisePriceOfWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_GeneralLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_GeneralLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_GrossAfterOtherIPOExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amunt of gross after other IPO expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_GrossAfterOtherIPOExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_GrossProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the IPO gross proceeds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_GrossProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_NetProceedsFromIssuanceSecondaryPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's secondary offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_NetProceedsFromIssuanceSecondaryPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_NonconvertibleDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of non-convertible debt securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_NonconvertibleDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_OrdinarySharesWarrantsHeldByNonaffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of ordinary shares warrants held by non-affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_OrdinarySharesWarrantsHeldByNonaffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_UnderwritingDiscountsAndCommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represent underwriting discounts and commissions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_UnderwritingDiscountsAndCommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_UnderwritingNetProceed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net proceeds after deducting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_UnderwritingNetProceed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_Warrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_Warrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_WarrantsExerciseIntoOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represent the warrants were exercised into ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_WarrantsExerciseIntoOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_WarrantsExercisePricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants exercise price per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_WarrantsExercisePricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=wlds_MudraInspireDevelopmentKitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=wlds_MudraInspireDevelopmentKitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619175871424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_SignificantAccountingPoliciesDetailsLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseRenewalTerm1', window );">Lease term</a></td>
<td class="text">12 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_RateOfMonthlySeverancePercentage', window );">Rate of monthly severance, percentage</a></td>
<td class="nump">8.33%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=wlds_LeaseLiabilityMember', window );">Lease Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_SignificantAccountingPoliciesDetailsLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtWeightedAverageInterestRate', window );">Weighted average interest rate</a></td>
<td class="nump">8.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of debt outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeaseRenewalTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's finance lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeaseRenewalTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_RateOfMonthlySeverancePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of severance  monthly deposits rate can take their monthly salary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_RateOfMonthlySeverancePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_SignificantAccountingPoliciesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_SignificantAccountingPoliciesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=wlds_LeaseLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=wlds_LeaseLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619173723552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Details) - Schedule of Annual Rates of Depreciation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember', window );">Office furniture and electronic equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_AnnualRatesOfDepreciationLineItems', window );"><strong>Schedule of Annual Rates of Depreciation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_AnnualRateOfDepreciation', window );">Annual rate of depreciation</a></td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember', window );">Office furniture and electronic equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_AnnualRatesOfDepreciationLineItems', window );"><strong>Schedule of Annual Rates of Depreciation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_AnnualRateOfDepreciation', window );">Annual rate of depreciation</a></td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_ComputersAndSoftwareMember', window );">Computers and software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_AnnualRatesOfDepreciationLineItems', window );"><strong>Schedule of Annual Rates of Depreciation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_AnnualRateOfDepreciation', window );">Annual rate of depreciation</a></td>
<td class="nump">33.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_MoldMember', window );">Mold [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_AnnualRatesOfDepreciationLineItems', window );"><strong>Schedule of Annual Rates of Depreciation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_AnnualRateOfDepreciation', window );">Annual rate of depreciation</a></td>
<td class="nump">50.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_AnnualRateOfDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of annual rate of depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_AnnualRateOfDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_AnnualRatesOfDepreciationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_AnnualRatesOfDepreciationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_ComputersAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_ComputersAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_MoldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_MoldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619173070768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories (Details) - Schedule of Inventories - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_CostAbstract', window );"><strong>Cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 514<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-progress</a></td>
<td class="nump">206<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">312<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FIFOInventoryAmount', window );">Inventories</a></td>
<td class="nump">$ 1,032<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FIFOInventoryAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of FIFO (first in first out) inventory present at the reporting date when inventory is also valued using different valuation methods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FIFOInventoryAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480581/330-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480581/330-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480581/330-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_CostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_CostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619173634176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment, Net (Details) - Schedule of Property and Equipment Net - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_CostAbstract0', window );"><strong>Cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Cost</a></td>
<td class="nump">$ 334<span></span>
</td>
<td class="nump">$ 140<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less - accumulated depreciation</a></td>
<td class="nump">140<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property and equipment, net</a></td>
<td class="nump">194<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_ComputersAndSoftwareMember', window );">Computers and software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_CostAbstract0', window );"><strong>Cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Cost</a></td>
<td class="nump">204<span></span>
</td>
<td class="nump">124<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember', window );">Office furniture and equipment and leasehold improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_CostAbstract0', window );"><strong>Cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Cost</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_ElectronicEquipmentMember', window );">Electronic equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_CostAbstract0', window );"><strong>Cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Cost</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_MachinesAndMoldsMember', window );">Machines and molds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_CostAbstract0', window );"><strong>Cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Cost</a></td>
<td class="nump">$ 72<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_CostAbstract0">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_CostAbstract0</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_ComputersAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_ComputersAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_ElectronicEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_ElectronicEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_MachinesAndMoldsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_MachinesAndMoldsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619175871552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Lease (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Lease [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Leases remaining terms</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseOptionToExtend', window );">Leases extend term</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Total operating leases</a></td>
<td class="nump">$ 232<span></span>
</td>
<td class="nump">$ 74<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseOptionToExtend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseOptionToExtend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619173800512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Lease (Details) - Schedule of Classification of Operating Lease Right-of-Use Assets and Liabilities - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right of use assets</a></td>
<td class="nump">$ 592<span></span>
</td>
<td class="nump">$ 180<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Short term</a></td>
<td class="nump">297<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long term</a></td>
<td class="nump">278<span></span>
</td>
<td class="nump">94<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 575<span></span>
</td>
<td class="nump">$ 162<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619173566064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Lease (Details) - Schedule of Future Minimum Lease Payments Under Our Operating Lease Liabilities - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ScheduleOfFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesAbstract', window );"><strong>Schedule of Future Minimum Lease Payments Under Our Operating Lease Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future minimum lease payments</a></td>
<td class="nump">619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(44)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">575<span></span>
</td>
<td class="nump">$ 162<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less operating lease liabilities, current</a></td>
<td class="num">(297)<span></span>
</td>
<td class="num">(68)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, non-current</a></td>
<td class="nump">$ 278<span></span>
</td>
<td class="nump">$ 94<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ScheduleOfFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ScheduleOfFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619166306192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br> $ in Thousands, &#8362; in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="6">12 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2023 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Jul. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_CommitmentsandContingenciesDetailsLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_GrantsReceivedEqualPercentageRate', window );">Grants received equal percentage rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_AnnualAlternativeInterestPercentage', window );">Annual alternative interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.71513%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_FixedAnnualInterestRate', window );">Fixed annual interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_AmountsReceivedAggregateAmount', window );">Amounts received aggregate amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 627<span></span>
</td>
<td class="nump">$ 1,224<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_AmountOfDevelopmentProgram', window );">Approved development program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
<td class="nump">&#8362; 3.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_PercentageOfFinancing', window );">Financing rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_TotalCashReceivedFromTheIIA', window );">Total cash received from the IIA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ExceptTransferProductionRight', window );">Except transfer production right</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ProductionTransferred', window );">Production transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_PayIncreasedRoyaltiesDescription', window );">Pay increased royalties, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">the Company would be required to pay increased royalties, which usually amount to 1% in addition to the standard royalties rate
3%-3.5%, and also the total amount of its liability to the IIA may be increased to between 120% and 300% of the grants received from
the IIA, depending on the manufacturing volume that is performed outside Israel (less royalties already paid to IIA).<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_MarketingGrantReceived', window );">Marketing grant received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrantsReceivableCurrent', window );">Maximum obligation amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Monthly lease payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_LeasePaymentIncreased', window );">Lease payment increased</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember', window );">SOFR Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_CommitmentsandContingenciesDetailsLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_AnnualInterestRate', window );">Annual interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_CommitmentsandContingenciesDetailsLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_RoyaltiesRate', window );">Royalties rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_CommitmentsandContingenciesDetailsLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_RoyaltiesRate', window );">Royalties rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=wlds_IIAMember', window );">IIA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_CommitmentsandContingenciesDetailsLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ResearchAndDevelopmentGrantsDetection', window );">Research and development grants</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 415<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=wlds_IMEIMember', window );">IMEI [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_CommitmentsandContingenciesDetailsLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_MaximumObligatinAmount', window );">Maximum obligatin amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_GrantsReceivedFromTheIMEI', window );">Grants received from the IMEI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_SalesAndMarketingExpensesDeductions', window );">Sales and marketing deductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesNetOfInterestExpense', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 311<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_RoyaltiesRatePercentage', window );">Royalties rate percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_CommitmentsandContingenciesDetailsLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Rent payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Vehicles [Member] | Lease Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_CommitmentsandContingenciesDetailsLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_LeaseAgreements', window );">Lease agreements vehicles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_LeaseAgreementsPeriod', window );">Lease agreements period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrantsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrantsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash payments to lessor's for use of assets under operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesNetOfInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income after deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesNetOfInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_AmountOfDevelopmentProgram">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of development program.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_AmountOfDevelopmentProgram</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_AmountsReceivedAggregateAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts received aggregate amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_AmountsReceivedAggregateAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_AnnualAlternativeInterestPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage as an alternative annual interest rate published by bank of israel.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_AnnualAlternativeInterestPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_AnnualInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Annual interest rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_AnnualInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_CommitmentsandContingenciesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_CommitmentsandContingenciesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ExceptTransferProductionRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Except transfer production right.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ExceptTransferProductionRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_FixedAnnualInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fixed annual interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_FixedAnnualInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_GrantsReceivedEqualPercentageRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_GrantsReceivedEqualPercentageRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_GrantsReceivedFromTheIMEI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Grants received from the IMEI.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_GrantsReceivedFromTheIMEI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_LeaseAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_LeaseAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_LeaseAgreementsPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease agreements period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_LeaseAgreementsPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_LeasePaymentIncreased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease payment increased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_LeasePaymentIncreased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_MarketingGrantReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Marketing grant received percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_MarketingGrantReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_MaximumObligatinAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum obligatin amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_MaximumObligatinAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_PayIncreasedRoyaltiesDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pay increased royalties, description.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_PayIncreasedRoyaltiesDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_PercentageOfFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of financing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_PercentageOfFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ProductionTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Production transferred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ProductionTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ResearchAndDevelopmentGrantsDetection">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of grants detection from the value of research and development expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ResearchAndDevelopmentGrantsDetection</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_RoyaltiesRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of royalties rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_RoyaltiesRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_RoyaltiesRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalties rate percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_RoyaltiesRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_SalesAndMarketingExpensesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sales and marketing expenses deductions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_SalesAndMarketingExpensesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_TotalCashReceivedFromTheIIA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total cash received from the IIA.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_TotalCashReceivedFromTheIIA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=wlds_IIAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=wlds_IIAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=wlds_IMEIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=wlds_IMEIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LeaseAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LeaseAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619168077536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Securities (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="6">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 16, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Apr. 30, 2021</div></th>
<th class="th"><div>Nov. 30, 2019</div></th>
<th class="th"><div>Apr. 30, 2019</div></th>
<th class="th"><div>Jan. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Sep. 20, 2022</div></th>
<th class="th"><div>Apr. 22, 2021</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ConvertibleSecuritiesLineItems', window );"><strong>Convertible Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Aggregate amount (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ConvertibleSecurityDescription', window );">Convertible security, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The beneficial conversion feature of each one
of convertible security was valued at zero.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_CashPayment', window );">Cash payment (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_PremoneyValuationAmount', window );">Pre-money valuation amount (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_WarrantPricePerSharePercentage', window );">Warrant price per share percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_PurchasePricePerShare', window );">Purchase price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ConvertibleSecuritiesLineItems', window );"><strong>Convertible Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=wlds_ConvertibleSecuritiesMember', window );">Convertible Security Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ConvertibleSecuritiesLineItems', window );"><strong>Convertible Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Bearing interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.22<span></span>
</td>
<td class="nump">$ 1.69<span></span>
</td>
<td class="nump">$ 0.92<span></span>
</td>
<td class="nump">$ 0.92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.79<span></span>
</td>
<td class="nump">$ 0.79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_AggregateOrdinaryShares', window );">Aggregate ordinary shares (in Shares)</a></td>
<td class="nump">169,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_AggregateOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of aggregate ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_AggregateOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_CashPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_CashPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ConvertibleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ConvertibleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ConvertibleSecurityDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible security is a security usually a bond or a preferred stock that can be converted into a different security typically shares of the company's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ConvertibleSecurityDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_PremoneyValuationAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of pre money valuation amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_PremoneyValuationAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_PurchasePricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase price per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_PurchasePricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_WarrantPricePerSharePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of warrant price per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_WarrantPricePerSharePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=wlds_ConvertibleSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=wlds_ConvertibleSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619173019616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Credit Facility (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jul. 04, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherBorrowings', window );">Initial credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_AggregateAmount', window );">Aggregate amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Credit facility bore interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ExpenseOnServiceRendering', window );">Total expense on service</a></td>
<td class="nump">420<span></span>
</td>
<td class="nump">$ 122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ServicesInExchangeForMonthlyBaseFee', window );">Services in exchange for monthly base fee</a></td>
<td class="nump">$ 35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_AggrementTerm', window );">Aggrement term</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_WarrantsIssuedPercentage', window );">Warrants issued percentage</a></td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_BaseMonthlyFeeImmediatelyIncreaseAmount', window );">Base monthly fee immediately increase amount</a></td>
<td class="nump">$ 70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_OfferingOrFinancingTransactionAmount', window );">Offering or financing transaction amount</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_TransactionFeeClosingValue', window );">Transaction fee closing value</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount as of the balance sheet date for the aggregate of other miscellaneous borrowings owed by the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_AggregateAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>An aggregate amount or score is made up of several smaller amounts or scores added together.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_AggregateAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_AggrementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggrement term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_AggrementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_BaseMonthlyFeeImmediatelyIncreaseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of base monthly fee immediately increase amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_BaseMonthlyFeeImmediatelyIncreaseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ExpenseOnServiceRendering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of expense on service rendering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ExpenseOnServiceRendering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_OfferingOrFinancingTransactionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of offering or financing transaction amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_OfferingOrFinancingTransactionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ServicesInExchangeForMonthlyBaseFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of services in exchange for monthly base fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ServicesInExchangeForMonthlyBaseFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_TransactionFeeClosingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of transaction fee closing value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_TransactionFeeClosingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_WarrantsIssuedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The warrants issued percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_WarrantsIssuedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619161979808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; Equity (Deficit) (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="7">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 10, 2016 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 10, 2016 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 30, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 27, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 31, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>shares</div>
</th>
<th class="th"><div>Jan. 30, 2022</div></th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 23, 2023 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 15, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 20, 2022 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 16, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareholdersEquityLineItems', window );"><strong>Shareholder's Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,387,428<span></span>
</td>
<td class="nump">15,049,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_OrdinarySharesIssued', window );">Ordinary shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,444,444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_OrdinarySharesWarrantExercisable', window );">Ordinary shares warrants exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">671,687<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_SAFEsAmount', window );">SAFEs amount (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_Investor', window );">Number of investor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_InvestorAmount', window );">Investor amount (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ConvertedAmount', window );">Converted amount (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ConvertedToOrdinaryShares', window );">Converted to ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">118,204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price range (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement', window );">Aggregate amount (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ExercisableWarrantsToShares', window );">Exercised warrants to shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">724,139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_InvestorsExercisedWarrants', window );">Investors exercised warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_EmployeeExercisedWarrants', window );">Employee exercised warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants', window );">Exercised ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">724,139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ExercisePricePerShare', window );">Exercise price per share (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 0.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ProceedsFromIssuanceFollowOnPublicOffering', window );">Gross proceeds (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_OrdinarySharePerValue', window );">Ordinary share per value (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Options available for grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,832,805<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted weighted average exercise price (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.224<span></span>
</td>
<td class="nump">$ 184<span></span>
</td>
<td class="nump">$ 0.323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_TerminationPeriod', window );">Termination period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Termination period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_IssuanceOfSharesOptions', window );">Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate', window );">Fair value option grant date (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_OptionsExpenses', window );">Option expenses (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_VestingPeriods', window );">Vesting periods</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ExercisePriceOfWarrants', window );">Exercise of warrants (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrant period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_WarrantBeReducedToAnExercisePricePercentage', window );">Warrant be reduced to an exercise price percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_InitialExercisePricePercentage', window );">Initial exercise price percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_WeightedAveragePricePercentage', window );">Weighted average price percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_LowestResetPrice', window );">Lowest reset price (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_InitialExercisePricesPercentage', window );">Initial exercise price percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareholdersEquityLineItems', window );"><strong>Shareholder's Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price range (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ExercisableWarrantsToShares', window );">Exercised warrants to shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants', window );">Exercised ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">724,139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareholdersEquityLineItems', window );"><strong>Shareholder's Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_IssuanceOfSharesOptions', window );">Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareholdersEquityLineItems', window );"><strong>Shareholder's Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_OrdinarySharesInConsiderationPercentage', window );">Ordinary shares in consideration percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_TotalConsiderationAmount', window );">Total consideration amount (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_IssuanceExpenses', window );">Issuance expenses (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants to purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,625,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Ordinary A Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareholdersEquityLineItems', window );"><strong>Shareholder's Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares</a></td>
<td class="nump">1,844,268<span></span>
</td>
<td class="nump">1,844,268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_OrdinaryShareParValue', window );">Ordinary share par value (in New Shekels per share) | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ValueOfOrdinaryAShare', window );">Value of Ordinary A share (in Dollars) | $</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_InterestPercentage', window );">Interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ordinary A shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_AShareReclassifiedToOrdinaryShares', window );">A share reclassified to ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_OrdinarySharesAuthorizedIncreased', window );">Ordinary shares authorized increased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareholdersEquityLineItems', window );"><strong>Shareholder's Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,666<span></span>
</td>
<td class="nump">241,533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,430<span></span>
</td>
<td class="nump">111,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember', window );">Board of Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareholdersEquityLineItems', window );"><strong>Shareholder's Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_OptionsAvailableForGrant', window );">Options available for grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">931,139<span></span>
</td>
<td class="nump">424,653<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_DirectorMember', window );">Director [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareholdersEquityLineItems', window );"><strong>Shareholder's Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_IssuanceOfSharesOptions', window );">Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis=us-gaap_InvestorMember', window );">Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareholdersEquityLineItems', window );"><strong>Shareholder's Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_Investor', window );">Number of investor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">one<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wlds_TwoZeroOneFiveMember', window );">2015 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareholdersEquityLineItems', window );"><strong>Shareholder's Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Options available for grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,188,597<span></span>
</td>
<td class="nump">2,257,458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,032,805<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Options to ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wlds_TwoZeroOneFiveMember', window );">2015 Plan [Member] | Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareholdersEquityLineItems', window );"><strong>Shareholder's Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Ordinary shares reserved for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,066,637<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember', window );">Series of Individually Immaterial Business Acquisitions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareholdersEquityLineItems', window );"><strong>Shareholder's Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Outstanding voting securities percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=wlds_CofoundersMember', window );">Co-founders [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareholdersEquityLineItems', window );"><strong>Shareholder's Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_TotalValueOfTheShares', window );">Total value of the shares (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember', window );">Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareholdersEquityLineItems', window );"><strong>Shareholder's Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_OrdinarySharesIssued', window );">Ordinary shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,343,374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-21<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of redemption requirements for each class or type of redeemable stock classified as temporary equity for each of the five years following the latest balance sheet date. The redemption requirement does not constitute an unconditional obligation that will be settled in a variable number of shares constituting a monetary value predominantly indexed to (a) a fixed monetary amount known at inception, (b) an amount inversely correlated with the residual value of the entity, or (c) an amount determined by reference to something other than the fair value of issuer's stock. Does not include mandatorily redeemable stock. The exception is if redemption is required upon liquidation or termination of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_AShareReclassifiedToOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares of a share reclassified to ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_AShareReclassifiedToOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ConvertedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of Converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ConvertedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ConvertedToOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of converted to ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ConvertedToOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_EmployeeExercisedWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee exercised warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_EmployeeExercisedWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ExercisableWarrantsToShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercisable warrants to shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ExercisableWarrantsToShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ExercisePriceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of exercise price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ExercisePriceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ExercisePricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ExercisePricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_InitialExercisePricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Initial exercise price percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_InitialExercisePricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_InitialExercisePricesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Initial exercise price percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_InitialExercisePricesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_InterestPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest percentage of return on investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_InterestPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_Investor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of investors.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_Investor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_InvestorAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of Investor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_InvestorAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_InvestorsExercisedWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares of investors exercised warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_InvestorsExercisedWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_IssuanceExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of issuance expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_IssuanceExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_IssuanceOfSharesOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of share options provides financial incentives for investors; or performance incentives for shareholders who are active in the operations of the company's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_IssuanceOfSharesOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_LowestResetPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lowest reset price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_LowestResetPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_OptionsAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total available options for grant,</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_OptionsAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_OptionsExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount options expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_OptionsExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_OrdinaryShareParValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ordinary share par value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_OrdinaryShareParValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_OrdinarySharePerValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The ordinary share per value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_OrdinarySharePerValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_OrdinarySharesAuthorizedIncreased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ordinary shares authorized increased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_OrdinarySharesAuthorizedIncreased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_OrdinarySharesInConsiderationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ordinary shares in consideration percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_OrdinarySharesInConsiderationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_OrdinarySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ordinary Shares Issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_OrdinarySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_OrdinarySharesWarrantExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ordinary shares warrants exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_OrdinarySharesWarrantExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ProceedsFromIssuanceFollowOnPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's additional offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ProceedsFromIssuanceFollowOnPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_SAFEsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of SAFEs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_SAFEsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value option granted date during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ShareholdersEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ShareholdersEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares issued from the exercise of warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_TerminationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Termination period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_TerminationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_TotalConsiderationAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of Total consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_TotalConsiderationAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_TotalValueOfTheShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total value of the shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_TotalValueOfTheShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ValueOfOrdinaryAShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of ordinary A shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ValueOfOrdinaryAShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_VestingPeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expensed over vesting periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_VestingPeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_WarrantBeReducedToAnExercisePricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant be reduced to an exercise price percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_WarrantBeReducedToAnExercisePricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_WeightedAveragePricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_WeightedAveragePricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis=us-gaap_InvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PartnerTypeOfPartnersCapitalAccountAxis=us-gaap_InvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wlds_TwoZeroOneFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wlds_TwoZeroOneFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=wlds_CofoundersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=wlds_CofoundersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619169558224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Shareholders&#8217; Equity (Deficit) (Details) - Schedule of Share Capital - Ordinary shares [Member] - shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationEquityLineItems', window );"><strong>Schedule of share capital [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, Authorized</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_NumberOfSharesIssuedAndOutstanding', window );">Ordinary shares, Issued and outstanding</a></td>
<td class="nump">20,387,428<span></span>
</td>
<td class="nump">15,049,720<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCapitalizationEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCapitalizationEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_NumberOfSharesIssuedAndOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares Issued and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_NumberOfSharesIssuedAndOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619173581680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Shareholders&#8217; Equity (Deficit) (Details) - Schedule of Share Capital (Parentheticals) - &#8362; / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Ordinary shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationEquityLineItems', window );"><strong>Schedule of share capital [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value</a></td>
<td class="nump">&#8362; 0.01<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCapitalizationEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCapitalizationEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619173618608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; Equity (Deficit) (Details) - Schedule of Options Activity - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ScheduleOfOptionsActivityAbstract', window );"><strong>Schedule of Options Activity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding - beginning, Amount of options</a></td>
<td class="nump">988,264<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">863,264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Outstanding - beginning, Weighted average exercise price</a></td>
<td class="nump">$ 0.563<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0.614<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted amount of options</a></td>
<td class="nump">471,500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">145,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted weighted average exercise price</a></td>
<td class="nump">$ 1.224<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0.184<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised amount of options</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4,666)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised weighted average exercise price</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0.003<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Expired or forfeited amount of options</a></td>
<td class="num">(5,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(15,334)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Expired or forfeited weighted average exercise price</a></td>
<td class="nump">$ 0.664<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0.003<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding - end, Amount of options</a></td>
<td class="nump">1,454,764<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">988,264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Outstanding - end, Weighted average exercise price</a></td>
<td class="nump">$ 0.777<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0.563<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at end, Amount of options</a></td>
<td class="nump">889,125<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">753,236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Exercisable at end, Weighted average exercise price</a></td>
<td class="nump">$ 0.612<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0.703<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif">Including the grant of 120,000 options to purchase up to 120,000 Ordinary Shares to directors, as approved by the Company&#8217;s shareholders on November 30, 2023, with an exercise price of $1.32 per share. The options will expire at the earlier of (i) ten years from the date of grant or (ii) 90 days following a termination of employment or service. The fair value of each option as of the grant date was $0.12, determined using the Black-Scholes option pricing model and the total expenses of $15 thousand will be expensed over the option vesting periods of three years.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ScheduleOfOptionsActivityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ScheduleOfOptionsActivityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619172981568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; Equity (Deficit) (Details) - Schedule of Weighted-Average Assumptions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Schedule of Weighted Average Assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Expected stock price volatility</a></td>
<td class="nump">55.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="nump">4.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions', window );">Expected life of options</a></td>
<td class="text">6 years 3 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected life of options in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619173436896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; Equity (Deficit) (Details) - Schedule of Options to Consultants<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr><th class="th" colspan="2">
<div>Dec. 31, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=wlds_TwoThousandFifteenMember', window );">2015 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ScheduleOfOptionsToConsultantsLineItems', window );"><strong>Schedule of Options to Consultants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms', window );">In connection with</a></td>
<td class="text">Rendered services<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">No. of options issued</a></td>
<td class="nump">110,655<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">No. of options exercisable</a></td>
<td class="nump">110,655<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise price (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.003<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=wlds_TwoThousandSeventeenMember', window );">2017 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ScheduleOfOptionsToConsultantsLineItems', window );"><strong>Schedule of Options to Consultants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms', window );">In connection with</a></td>
<td class="text">Rendered services<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">No. of options issued</a></td>
<td class="nump">36,885<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">No. of options exercisable</a></td>
<td class="nump">36,885<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise price (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.003<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=wlds_TwoThousandTwentyoneMember', window );">2021 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ScheduleOfOptionsToConsultantsLineItems', window );"><strong>Schedule of Options to Consultants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms', window );">In connection with</a></td>
<td class="text">Rendered services<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">No. of options issued</a></td>
<td class="nump">69,090<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">No. of options exercisable</a></td>
<td class="nump">69,090<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=wlds_TwoThousandTwentyThreeMember', window );">2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ScheduleOfOptionsToConsultantsLineItems', window );"><strong>Schedule of Options to Consultants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms', window );">In connection with</a></td>
<td class="text">Rendered services<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">No. of options issued</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">No. of options exercisable</a></td>
<td class="nump">37,778<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise price (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.546<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | 2021 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ScheduleOfOptionsToConsultantsLineItems', window );"><strong>Schedule of Options to Consultants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise price (in Dollars per share) | $ / shares</a></td>
<td class="nump">0.003<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | 2021 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ScheduleOfOptionsToConsultantsLineItems', window );"><strong>Schedule of Options to Consultants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise price (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 2.25<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif">On April 27, 2023, the Company&#8217;s Board of Directors approved the additional grant of options to purchase up to 100,000 Ordinary Shares to a consultant, with an exercise price of $0.55 per share. The options will expire at the earlier of (i) ten years from the date of grant or (ii) 90 days following a termination of services. The fair value of each option as of the grant date was $0.26, determined using the Black-Scholes option pricing model and the total expenses of $26 thousand will be expensed over the option vesting periods of three years.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of modification of award under share-based payment arrangement. Includes, but is not limited to, terms for expiration date, vesting rights and exercise price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ScheduleOfOptionsToConsultantsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ScheduleOfOptionsToConsultantsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=wlds_TwoThousandFifteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=wlds_TwoThousandFifteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=wlds_TwoThousandSeventeenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=wlds_TwoThousandSeventeenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=wlds_TwoThousandTwentyoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=wlds_TwoThousandTwentyoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=wlds_TwoThousandTwentyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=wlds_TwoThousandTwentyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619177659936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; Equity (Deficit) (Details) - Schedule of Share-Based Compensation Expenses - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ScheduleOfShareBasedCompensationExpensesLineItems', window );"><strong>Schedule of Share-Based Compensation Expenses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation expenses</a></td>
<td class="nump">$ 241<span></span>
</td>
<td class="nump">$ 790<span></span>
</td>
<td class="nump">$ 299<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ScheduleOfShareBasedCompensationExpensesLineItems', window );"><strong>Schedule of Share-Based Compensation Expenses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation expenses</a></td>
<td class="nump">83<span></span>
</td>
<td class="nump">180<span></span>
</td>
<td class="nump">105<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Selling and Marketing Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ScheduleOfShareBasedCompensationExpensesLineItems', window );"><strong>Schedule of Share-Based Compensation Expenses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation expenses</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">401<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ScheduleOfShareBasedCompensationExpensesLineItems', window );"><strong>Schedule of Share-Based Compensation Expenses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation expenses</a></td>
<td class="nump">$ 97<span></span>
</td>
<td class="nump">$ 209<span></span>
</td>
<td class="nump">$ 83<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ScheduleOfShareBasedCompensationExpensesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ScheduleOfShareBasedCompensationExpensesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619167533856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; Equity (Deficit) (Details) - Schedule of Issuance of Equity Warrants to Investors and Associate<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr><th class="th" colspan="2">
<div>Dec. 31, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wlds_September132022Member', window );">September 13, 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateLineItems', window );"><strong>Schedule of Issuance of Equity Warrants to Investors and Associate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of warrants/options | shares</a></td>
<td class="nump">7,860,861<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price | $ / shares</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio', window );">Exercise ratio</a></td>
<td class="text">Each warrant is exercisable into 1 Ordinary Share<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate', window );">Expiration date</a></td>
<td class="text">5 years following the issuance date<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareBasedCompensationArrangementNotes', window );">Notes</a></td>
<td class="text">Registered for trading (*)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wlds_September152022OneMember', window );">September 15, 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateLineItems', window );"><strong>Schedule of Issuance of Equity Warrants to Investors and Associate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of warrants/options | shares</a></td>
<td class="nump">671,687<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price | $ / shares</a></td>
<td class="nump">$ 5.29<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio', window );">Exercise ratio</a></td>
<td class="text">Each warrant is exercisable into 1 Ordinary Share, See note 7(B) above<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate', window );">Expiration date</a></td>
<td class="text">18 months following the issuance date<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareBasedCompensationArrangementNotes', window );">Notes</a></td>
<td class="text">Owned by April 2021 investors<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wlds_September152022TwoMember', window );">September 15, 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateLineItems', window );"><strong>Schedule of Issuance of Equity Warrants to Investors and Associate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of warrants/options | shares</a></td>
<td class="nump">187,500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price | $ / shares</a></td>
<td class="nump">$ 5.31<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio', window );">Exercise ratio</a></td>
<td class="text">Each warrant is exercisable into 1 Ordinary Share<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate', window );">Expiration date</a></td>
<td class="text">5 years following the issuance date<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareBasedCompensationArrangementNotes', window );">Notes</a></td>
<td class="text">Owned by underwriter<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wlds_September152022ThreeMember', window );">September 15, 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateLineItems', window );"><strong>Schedule of Issuance of Equity Warrants to Investors and Associate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of warrants/options | shares</a></td>
<td class="nump">23,640<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price | $ / shares</a></td>
<td class="nump">$ 4.23<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio', window );">Exercise ratio</a></td>
<td class="text">Each warrant is exercisable into 1 Ordinary Share<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate', window );">Expiration date</a></td>
<td class="text">10 years following the issuance date<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareBasedCompensationArrangementNotes', window );">Notes</a></td>
<td class="text">Owned by the legal advisor<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The warrants are exercisable at
any time after their original issuance and at any time up to the date that is five&#160;years after their original issuance. The warrants
will be exercisable, at the option of each holder, in whole or in part by delivering to us a duly executed exercise notice and, at any
time a registration statement registering the issuance of the Ordinary Shares underlying the warrants under the Securities Act is effective
and available for the issuance of such shares, by payment in full in immediately available funds for the number of Ordinary Shares purchased
upon such exercise.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of exercise ratio.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of Expiration date


..</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ShareBasedCompensationArrangementNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of Notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ShareBasedCompensationArrangementNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wlds_September132022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wlds_September132022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wlds_September152022OneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wlds_September152022OneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wlds_September152022TwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wlds_September152022TwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wlds_September152022ThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wlds_September152022ThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619173624448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Taxes on Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Carryforward tax losses (in Dollars)</a></td>
<td class="nump">$ 13.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance (in Dollars)</a></td>
<td class="nump">$ 3.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IL', window );">Israeli [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_CorporateTaxRatePercentage', window );">Corporate tax rate</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_CorporateTaxRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the corporate tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_CorporateTaxRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140619173820976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties (Details)<br> &#8362; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 14, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 14, 2022 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_OfficerEmployeeMonthlySalary', window );">Officer employee monthly salary (in New Shekels) | &#8362;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_RelatedPartyMonthlySalary', window );">Monthly salary</a></td>
<td class="nump">$ 19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=wlds_AsherDahanMember', window );">Asher Dahan [Member] | Co-founders [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_PercentageOfOwnership', window );">Percentage of ownership</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_EmploymentExpenses', window );">Employment expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 293<span></span>
</td>
<td class="nump">$ 331<span></span>
</td>
<td class="nump">$ 145<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_EmploymentExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of expense on employment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_EmploymentExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_OfficerEmployeeMonthlySalary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of officer employee monthly salary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_OfficerEmployeeMonthlySalary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_PercentageOfOwnership">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_PercentageOfOwnership</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_RelatedPartyMonthlySalary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of related party monthly salary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_RelatedPartyMonthlySalary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=wlds_AsherDahanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=wlds_AsherDahanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wlds_CofoundersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wlds_CofoundersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>70
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M<6?HOCT-^_J <H\O"5O)K<]$7\H]YX_ZRR0^[CB:B*4L4EJ"PK\E&[$TU4K
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MR4=U68#,9<$H#*/\=!?'(#^).(M2L,+;2.!8*U/%.O(\I>S5F=FVTP;/N@!
M?RP LB0K^1Y3WH9/%=QG2%;==E.EQ@[:CA7H9=HUXVTSX\ODVKZ&M>> FAVQ
MBYJY5F,5!&V[2+NFOFVFOD*#(N.^,0"HG%)J-D0:*]V&J'=PO)[_MG&+V5.4
M<A"3M6QGG?NR!UCY<T%Y(^BV.'%_I$+0I+C<$!P2EAO([]=49LWJ)C_$W_]H
M,_P?4$L#!!0    ( )R";U@X$V85H (  $X'   8    >&PO=V]R:W-H965T
M<R]S:&5E=#,N>&ULK55=;]HP%/TK5BI5K;21D)# 6HC44E7;PS94M.UAVH-)
M+L2J8V>V@7:_?M=.&D$;-CJ-!_QUS[GG./;U>"O5O2X #'DHN= 3KS"FNO!]
MG1504MV3%0A<64I54H-#M?)UI8#F#E1R/PR"Q"\I$UXZ=G,SE8[EVG F8*:(
M7I<E58_7P.5VXO6]IXD[MBJ,G?#3<457, ?SI9HI'/DM2\Y*$)I)010L)]Y5
M_V*:V'@7\)7!5N_TB76RD/+>#C[D$R^P@H!#9BP#Q68#4^#<$J&,GPVGUZ:T
MP-W^$_NM\XY>%E3#5/)O+#?%Q!MY)(<E77-S)[?OH?$36[Y,<NW^R;:.C3$X
M6VLCRP:,"DHFZI8^-/NP ^@/#@#"!A >"X@:0.2,ULJ<K1MJ:#I6<DN4C48V
MVW%[X]#HA@G[%>=&X2I#G$FG4FC)64X-Y.2:<BHR('-+I\G9C"H0I@##,LKU
M.7E+3D]&41)>$I_H A?UV#<HPE+Y69/PNDX8'DAX UF/1/TW) S"J ,^/1X>
M[L-]M-[Z#UO_H>.+#O#-#3K'4VF(7));)M _HYS,I&;NF'V_6FBC\+#]Z+):
M<P^ZN>T%O- 5S6#BX0W3H#;@I:<G_22X[#+^G\CVMB%JMR'Z$WOZ6>7H73TV
MG_4-J:@B&\K70,Z8()_P.N*AN >N206JCCKOVI$ZS="EL15DDP:]H#_V-[M.
M_Q*TYV#0.AB\S@%=FT(J]@OR+ITU6;PC(0[JWS.M1P3NZ8U;O?'K]+J6,*W7
MW8KC%T+"(!H-!^'HF>*7@?TX&+P;A@<4)ZWBY%\4X].@#16XMNJ2G1PK^V7@
M =G^3K6S+\U'JE9,:,)AB="@-T0.55?O>F!DY0K@0AHLIZY;X(,'R@;@^E)*
M\S2P-;5]0M/?4$L#!!0    ( )R";U@"X703404  &$2   8    >&PO=V]R
M:W-H965T<R]S:&5E=#0N>&ULK5CA;]HZ$/]7+-[TU$EM$R<A0%^+Q"#;D#9:
ME6Y[TO0^&# 0S;$SVT#WW[^SDP8()MN'?B'$^=WY?G?V^<ZW.R%_J#6E&CUG
MC*N[UEKK_,;SU'Q-,Z*N14XY?%D*F1$-KW+EJ5Q2LK!"&?,"WX^]C*2\U;^U
M8P^R?RLVFJ6</DBD-EE&Y*]WE(G=70NW7@8>T]5:FP&O?YN3%9U2_25_D/#F
M55H6:4:Y2@5'DB[O6@-\D^".$;"(KRG=J8/_R%"9"?'#O(P7=RW?6$09G6NC
M@L!C2X>4,:,)[/A9*FU5<QK!P_\OVM];\D!F1A0="O8M7>CU7:O;0@NZ)!NF
M'\7N(RT)M8V^N6#*_J)=B?5;:+Y16F2E,%B0I;QXDN?2$0<".#PC$)0"05T@
M/B,0E@)A72 Z(Q"5 M&?"K1+ 4O=*[A;QXV()OU;*79(&C1H,W^L]ZTT^"OE
M9J%,M82O*<CI_E!P)5BZ()HNT%3# U:!5D@LT5!DL/;69E%L*?HDE$)7Z,MT
MA"[>O$5O4,K1TUIL%.$+=>MIL,5H].;EO,-BWN#,O#A GP77:X42OJ"+8P4>
MD*B8!"],AD&CQA&=7Z,07Z+ #T*'0:,_%P\<XLF?B^,&-F$5E]#J"\_H&_.Y
MR.@^(NC[8*:TA'WUG\O9A;+(K<PDFQN5DSF]:T%$%95;VNK__1>._7]<CGI-
M9<DK*3MR8E0Y,6K2WG^D6\HWU+D\"\G82IILNNUW(>S;0S^<0J+V,20YA>!H
MK^;(Z'9E=+LQ\LDS' **JAN7U>W7C/-K*DM>2=F1R^+*97%CG(=":9.Q9$.\
M"PWM@TA=Q?6 .S#8KT6\&7-D?J<RO_.;9:HHD?,U@E0*A]P63N_<[/E+Q*%2
MN)@(35%,WKI8=4ZM"4,<UW@Y4$'0P35F#A2.,'9SZU;<NHW<IH1198E!'?*#
MZI2O$"U7^!&_F9-?UV&Y[W=K_!PH'';JD7.@XKCMIM>KZ/4:Z7V@G$K"+$&R
M@/,Y-4G:U#X52Q>MGH-6]R3_.%"X%]7()PY4''3=M+"_+PO\1F)CGNH4B.6;
M&4OGL+F65![&SGGB-ZITYP#D2DREHB-./3^J$7>B.F>(']1#N)'X_4/R.'@:
M3SZ@3_?3J9,F/IVWB[OU3>>"Q5&['CX7+(CCWAD>P9Y'T,CC_7@RF P-C_%D
M>/\Y01?)OP_)9)I,W]I]YV06G-@2=NJKT@&Z"D]8G8+:9[8:WI=$N+%8Z$^2
M)QL4-)B,T-/]T^ 3 F8/C\E'X#7^FIR/6'AR3%]UNCBJ,W/ XJ@7U[DY8$%\
MH.V8WKY8P<W5R@22(3-5=DXE$G*1<NC<D%H3:5(E=$.P#R^@ZAX)QH@L8/:K
M,W.6DW4/K?2OZ]ECY(:UPSIG)RPXM]OVM0YNK OZWVPC!ZT'V4(>75'$-]G,
MT%_6/8"@RU4:\JS)0GMG3.U'EP?>_6;J[]A929=2ARL7QX&/@_H:'[F0<*QV
M@N D4YTB>QV_U^Z=*1RP*7R.1_:U!&XN)H 6&G,TR&7*;#-RB?2:VF:.\%\(
MNHJ<4>MQA&\PO'/PO&W[P>>$,?-(H0%,E=H8%!QLAYZOHC)XB4O*M3A=KI/Q
M%/G7/D8YD6A+V(9>HMTZA2)G1Z >R'.6@G9)M13%70'[A99"6EOGA,TWC.C2
M*#-4!-S61RG;&/.KG6)GO'95D=Y!6YQ1N;+W$0HH;[@NFHAJM+KS>&<[_=KX
MT-R%.,8'.+X90;!<7SKPQ5Z?>/NIB\N7ST2N4JX0HTLPP[_NP+J0Q7U&\:)%
M;AOVF=#0_MN_:TH65!H ?%\*J)C*%S-!=:O4_Q]02P,$%     @ G()O6 7]
MUQ=R P  B D  !@   !X;"]W;W)K<VAE971S+W-H965T-2YX;6RM5M^/VC@0
M_E=&N5/5D[;D%Y!="I%8H+J5KM6JJ[L^5/=@$D.L.G9J.]#][V_LA"S0P.U#
M7Y)X,M]G?^/QC*=[J;[I@E(#/THN],PKC*DFOJ^S@I9$#V1%!?[92%42@T.U
M]76E*,D=J.1^% 1COR1,>.G4V1Y5.I6UX4S01P6Z+DNBGN\IE_N9%WH'PV>V
M+8PU^.FT(EOZ1,W?U:/"D=^QY*RD0C,I0-'-S)N'DU5B_9W#/XSN]=$W6"5K
M*;_9P4,^\P*[(,II9BP#P=>.+BCGE@B7\;WE]+HI+?#X^\#^P6E'+6NBZ4+R
M+RPWQ<R[]2"G&U)S\UGN_Z2MGI'ERR37[@G[UC?P(*NUD64+QA643#1O\J.-
MPQ$@C"\ HA80G0/&%P!Q"XC/ <,+@&$+&+X6,&H!3KK?:'>!6Q)#TJF2>U#6
M&]GLAXN^0V.\F+!Y\F04_F6(,^E""BTYRXFA.3P9?&$2& UR PM98NH5-B=V
M%/Z26L/;1Z+P=T$-RPC7?\ [^!U\T 6:]=0WN"!+ZV?MY(MF\NC"Y&$$'R72
M:5B)G.:G!#XJZ>1$!SF+Z"KCDF8#B,,;B((H[EG0\O7PJ >^>CT\O*(F[C8G
M=GSQ!;X'D<F2OFP+?)VOM5%XN/[M"W9#-NPGLP5GHBN2T9F'VZJIVE$O??-;
M. [>]P7J5Y*M?A'921"'71"'U]C33UALN4W>BBJ0*F<"ZV&;LC>0,UZ;\]1K
MPMG0WCI:6VYWZ;M@,+R=^KOC./5ZC>)3KU6O5Y1T7B?*1IVRT55E7UP5Q'-+
M=E1A40=1EVLK<G.N$[!#:$,$&K=7)-]?G^]KV)MV#6ATI"T<1T$8Q>>AZG&,
MHB2)HN%9M'YVO$N"N]%=T!^OL7=F2+H )O\G"!X$S"O%N#NS-X"US14^(IX!
M#U_%J0LPA),0QP(#[3HDAIAP;E\,BR73NK9>(C\)=+<)\\,V,&'DSSGXZ>$)
M@D$00D44[ BOZ0WL"Y85L"<:2%5QANR*&B6;OLJ? 6\(;JU8AK.:$],NRIJP
M;[+,+:;=Z9?T=S,.^@Z5?]1"2JJVKG=KE%P+TYRUSMI=#^Y=5SRS+_#:$/;8
MY^/)<MQG3R9+=\WP7Z9M[B@?B=HRH8'3#2XA&"28$*KI^\W R,HUMK4TV";=
M9X%7):JL _[?2&D. SM!=_E*_P-02P,$%     @ G()O6-<+HZ5I"@  %EH
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M[A#BW9<JWS1'VC[D596OFX\K%BU942?@?W_,\^KU2VU@?Q3TU7\!4$L#!!0
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M6P3&.[C[0FO<&3Y _[JE?P%02P,$%     @ G()O6$GVU@-T"0  US,  !@
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M#=3O*\ZSPP?=P?%=GJO_ U!+ P04    " "<@F]8BO.[&F0/  !S*0  &
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M&YK1N3 CB9&/SXNZO%-(T?:8>KE*Z#=(3Y$'W*$9,S(J4-*%Z+=07?<TN'^
M&2";3V\Q=0FKVI*2A<<!M"ZF 25<:1+*8\O7<B*S,!$#8%K.Y3FA,2&? I@
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M>#">/&+I=PK2_;R5%&&,T.[AGB/>SQVN!L/-:+:"<E%7U&_$Q!O0H$66K;!
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MN9^_W+U7%\6)^@_;O5!W2U-HD&"STNT&95BZ-H 8*]V92LUMJ]O2ZEJ%#AZ
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MR .2+QEK4'2 B&N9+(-H"SVQXV" &&)%$3P^+L:/QTI%DJ;J76;S*'ODJ:=
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MK1.Y#&4GWP6ZBLX_'S,EJW!U,IK'U>\R<I*U/ :@L7T978X01R2Q+/#^@QV
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MR,19T,7N 5/+^2(5V5.U[\/ST^PO!C3&+^CO(M"7E&W'?SP@/4U_>N&*_^+
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M%I4-H.\K*<UN8Q-T,SO^ U!+ P04    " "<@F]8@PMB-/(#  #G"   &0
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M[$COX#J%9-QE#R^:V:+0QH4407H]@N&8/>@V9Y".QG#=9T_:<=G:<!SN8#2
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M%$>36$S'TZ-7[!VUD1ZQO:-_%*GXS^7<>0MR_'=?T,'D\7Z35# ?72D3=3Y
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M-PC%UMQX4_+WN;GQWN1\N5(2,D8#\'YAC&]N:('V@^W%_P%02P,$%     @
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M>)N^M[VJ7<4SL,!F]0-K(-7_N4'XI*+<%Y,H]L/A5<<8!]..;Z;A!NV$YOJ
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M^%_H^MCD+("L-595&S KJ$3=_^/SI@\[@//Q+P#)!I!XW7TBK_(S6IQ/M>I
MNVAF<P-?JD>S.%&[0UE:S;N"<7;^B,]D@-MS4V>JHFEDF=1M1=F&X*HG2'Y!
M$"=PJVI;&KBN<\I?$T2L9I"4;"5=)0<9/U,6PB0^@F2<3 [P3882)YYO\GLE
MPM^7J;&:K\,_^ZKMN8[W<[DG<F$:S&@6\!LPI)\HF'_X(SX=?SJ@]'A0>GR(
M??YX^=?U$N[OX.9N<7][O4_>88*[^\=KB,>CC_"&ZF*$(3R6! M5-5BO1\*
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M]P%\(ZG6%=WIFD2-B%-(6J@=OD-1$+4;\-JUG]H.KW,$[VMFG 0H*R0GNI"
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M#=(>,/N9$/IN8B^H6_GX+U!+ P04    " "<@F]8:CA RW "  #^!@  &0
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ML- 7% @3H/>WG*OCQ)R!W967_@502P,$%     @ G()O6$TPF5V6 P  :!
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M*_SK/%VQ[(D\Y.MD3FZY>!'P8QV+C1JI<K)Z[19^6,:S)5F7:Y8D3\T;S'*
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MWK8+K]?@=KY\_'_^9[LAMA90WKZP@-(NH.PL,%1>6&#8+C#<66 T>&&!4;O
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MP<ONC"A'I8K0/#E52$U%-0W5=%0S4,U$-0O5;%1S6JV7*O)NII C>JCFHUJ
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MS3$P$\\QD)9-OI#N\\6JV-RRUMP43_=&_SI?2FJY6.15_9OT7^F7@PF#SCF
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M-D^_V0SPK:S^>/@V/_X?4$L#!!0    ( )R";U@OMS2(;P(   H&   9
M>&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;*U484_;,!#]*U:0T) 829R4=I!&
M@K)IE8:&J+9]0'QPDTMCX<3!=EK8K]_9"5&!,C%I^9"<??=>WKO$EVRDNM,E
M@"$/E:CUU"N-:4Y\7V<E5$P?R09JS!125<S@4JU\W2A@N0-5PJ=!<.Q7C-=>
MFKB]*Y4FLC6"UW"EB&ZKBJG'<Q!R,_5"[VGCFJ]*8S?\-&G8"A9@?C17"E?^
MP)+S"FK-94T4%%/O+#R9Q;;>%?SDL-%;,;%.EE+>V<4\GWJ!%00",F,9&#[6
M, ,A+!'*N.\YO>&5%K@=/[%_<=[1RY)IF$GQB^>FG'H3C^10L%:8:[GY"KV?
MD>7+I-#N3C9];>"1K-5&5CT8%52\[I[LH>_#%B",WP#0'D#?"XAZ0.2,=LJ<
MK0MF6)HHN2'*5B.;#5QO'!K=\-I^Q851F.6(,^FB9 I**7)0>G]O0L/Q*?E\
MWW+S2#Y<0,$S;@YL9!@7^H!\) O\C_)6 )$%<6 R8PTW3&#NN\IYC?\"T3:A
MR<TE5$M0MYCJ=A+?H&;[9C_K]9UW^N@;^BX@.R)1>$AH0*,=\-G[X?0YW,=.
M#>VB0[NHXXO>:M>6>V>)9+W[FV]82N8&*GV[RV;'&^_FM6?U1#<L@ZF'AU&#
M6H.7[N^%Q\'I+M/_B>Q9"Z*A!='?V-,7'_F0G+6FE(K_AGR7[XYLY,CL2%FG
MHZ"[$G^][>D=A<_TQH/>^-_TSK5N(2>LS@F.-6TPX/5JE_;XE20:1)-Q3"<O
MM+\N#$=!_&E,7VKWMTZJG9*73*UXK8F  J'!T1@Y5#=YNH61C3N\2VEP%+BP
MQ&$-RA9@OI#2/"WL/!C&?_H'4$L#!!0    ( )R";UAMSJ>/7 (  #H&   9
M    >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;*U5;4_;,!#^*R<C(9!8G9=2
M$*211MDT)- JJFT?T#ZXR:6Q<.)@.RW\^]E.B(K4;DSB2WQGW_/XGK-]2392
M/>H2T<!S)6H]):4QS06E.BNQ8GHD&ZSM2B%5Q8QUU8KJ1B'+/:@2- J"":T8
MKTF:^+FY2A/9&L%KG"O0;54Q]7*%0FZF)"2O$_=\51HW0=.D82M<H/G1S)7U
MZ,"2\PIKS64-"HLI^1Q>S,8NW@?\Y+C16S8X)4LI'YUSDT])X!)"@9EQ#,P.
M:YRA$([(IO'4<Y)A2P?<ME_9OWKM5LN2:9Q)\8OGIIR2<P(Y%JP5YEYNOF&O
MY]3Q95)H_X5-'QL0R%IM9-6#;085K[N1/?=UV *$XSV J =$[P7$/2#V0KO,
MO*QK9EB:*+D!Y:(MFS-\;3S:JN&U.\6%47:56YQ)%R536$J1H]*'!^=1>'8)
M7YY:;E[@Z!H+GG%S["S#N-#'\ D6]A[EK4"0!7@PS%C##1-P-+=>;4HT/&-=
ML&6,)]$E4- N5"?4V)S=SC3K\[OJ\HOVY'>-V0CB\ 2B((IWP&?OAT=OX=16
M:BA7-)0K\GSC/7S?5<YK>]M[/?!PA]42U>]=PO[*Y%[GA6Y8AE-BGY]&M4:2
M'AZ$D^!RE\P/(GLC.AY$QYX]WG='MH[<ZX:L/_*'6QL*-P8KO;,$\4>6X(/(
MWI1@/)1@_#_G?@(-4[!FHL5=LCNN,\_EVN@Z#49!F-#UMIQ_!'5ITJV7[;KJ
M'5,K7FL06%A8,#H[):"Z3M4Y1C;^L2^EL:W#FZ5M[JA<@%TOI#2OCNL?P^\B
M_0-02P,$%     @ G()O6"=2\X8K!0  J1$  !D   !X;"]W;W)K<VAE971S
M+W-H965T-# N>&ULK5C?DYLV$/Y7-&XFD\S<&00VV!>?9^Y'VN8A32;7-@^9
M/LBP-DP $4G8\7_?E<#8QL+UW?0>SB!V5]_WK:1EF6VX^"X3 $5^YEDA;P>)
M4N6-X\@H@9S)(2^AP"=++G*F\%:L'%D*8+%QRC/'<]W R5E:#.8S,_99S&>\
M4EE:P&=!9)7G3&SO(>.;VP$=[ :^I*M$Z0%G/BO9"IY _55^%GCGM%'B-(="
MIKP@ I:W@SMZ\TA#[6 L_DYA(P^NB::RX/R[OOD0WPY<C0@RB)0.P?!G#0^0
M93H2XOC1!!VT<VK'P^M=]%\->22S8!(>>/8UC55R.Y@,2 Q+5F7J"]_\#@VA
ML8X7\4R:_V33V+H#$E52\;QQ1@1Y6M2_[&<CQ($##7H<O,;!ZSKX/0Y^X^!W
M'48]#J/&8624J:D8'1Z98O.9X!LBM#5&TQ=&3..-]--"Y_U)"7R:HI^:/R5,
M0,*S&(1\_<O$H^$[\OY'E:HM>?,(RS1*U5M]I5B:R;?DFCSARHNK# A?DD^E
MSITD=SIYVN6:O"(.D3JFG#D*\>E9G*C!<E]C\7JP4(]\Y(5*)'E?Q! ?!W"0
M6,O.V[&[]\Y&?(1H2'QZ13S7\RV 'B]W]\[ \5NQ?1//[Q/[G';?[A92"=P'
M_]B4JP./[('UX7 C2Q;![0!WOP2QAL'\]2\T<-_96/]/P8XT&+4:C,Y%GW^J
ME%2LB--BA<ME :NT*/#ZBMSEO"J4EH;7TMADJ&./36Q]I*WGT\G$"T8S9WU(
M\-1L$OB'9D?0QRWT\<N@?S6G"\2$K4'@:4G@)X@HE4!*D49@(U+/1-T#B.YP
M''C3P[\.*ZM/0'M8!2VKX"RKWP0K#/9+] ].A!V%=.RZQT@?SL_XC=J6^.-I
M;#K"T*Z=7MC2"R^BMWE^CL)3O>G0\[J+S6+F#NFD)RV3%O?D+.[W#;P+$W,V
MF'U+$UL2)B=)N!X%06#G,FVY3"_D\H(LG W]#&936YI<U[=3H^Z^@+K_0:Y,
M!3+B@N!KV!+2BS=3$_A([*,%7P.WF=&Q[_<L,'I0^NGSD;\@0\TTW8/IY%2V
MV_6GP-L3\9YQ,$,17UA-FK"=(V<4GB(_->S4G6/D^Q<">K;6VI"_H)@TDW2$
M#<.P2\-JUUMUCCGM"SP]7^&;W<X6^*+#U'/282G;DRGUQET:IW;AV/?\GE.*
M[NL[/5_@;<A?DHZ>0NUU>5CMPM[]H"OZ\<B^"-+S51!++OE01%EE5II*@*QT
M7=0)H9Y[A8?.+C%$<5)6(DJPF2)5J6]W%I\$>F-S2$S38"QC/$ BQ86\(DP2
M5I:"KU&KQ=;,\<#SDA7;IJ^0=6/0-!L$F[X_T#A?@""^6[^B7V'WHQ+"BH[*
M&N<K.O0]4J*U"3,D?^(,.]";-,O01Y]G.G-Z<F B2]$:7=^D;XF"@FQQ3)*E
MX+FQB)DRD1LI!-JAX=3%!ULTXQDVQ5HNALX">R]F.E5T@+S,^!:[7^.EBPYB
MK $M62K(FF65B0PL2AJ,6A\<V4MO9M_@Z"M\6_"NL%FM9T'Y*KG+TGW&HN_7
MV#?P# 5O(FE)M$'.8\A0K-B8*JZ8T0";<I"U8F-\PBNI38Q""]@9X*F/Z]DX
M-E'7()6.B@JG/&[ "H!:M:'MU=\YZ#MS$"O3OTL2Z;U>OU:WH^TW@CO3&7?&
M[_6W ]NX=_-@L[^C 3H$UB?A[C.$LX=4?\3XR 2^LDN2P1+AX4[#_2?J[P+U
MC>*EZ9077&'?;2X38+A:M0$^7W*N=C=Z@O;KS/Q?4$L#!!0    ( )R";UC[
M-M01I@(  (D&   9    >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;(U5VV[;
M, S]%<(%BA58XTMN19L82-H.ZT.!HL'6AV$/BDW'0F3+E92D^?M1LN.E@!/T
MQ99D\O <BJ0G.ZG6.D<T\%&(4D^]W)CJUO=UDF/!=$]66-*73*J"&=JJE:\K
MA2QU3H7PHR 8^07CI1=/W-F+BB=R8P0O\46!WA0%4_LY"KF;>J%W.'CEJ]S8
M S^>5&R%"S2_JA=%.[]%27F!I>:R!(79U)N%M_.QM7<&OSGN]-$:K)*EE&N[
M>4JG7F )H<#$6 1&KRW>HQ 6B&B\-YA>&](Z'J\/Z#^<=M*R9!KOI7CCJ<FG
MWHT'*69L(\RKW/W$1L_0XB52:/>$76,;>)!LM)%%XTP,"E[6;_;1Y.'((1R?
M<(@:A\CQK@,YE@_,L'BBY Z4M28TNW!2G3>1XZ6]E(51])63GXD7.5.82Y&B
MTI<7-U$XOH/']PTW>_CV@!E/N+FR*\.XT%=P#0LJBW0C$&0&;TXSIM>S+2JZ
M0IAINMS*IEM/?$/T;! _::C,:RK1"2IA!,^R-+F&QS+%]#. 3[I:<=%!W#PZ
MB_B 20_ZX7>(@JA_!J_?)JOO\/JGDM6A'3JTPY_94AM%%?>W*PUUD$%W$-N%
MM[IB"4X]:C.-:HM>?'D1CH*[,Q(&K83!.?3X\:.B?B#:*=_R%,L4]AQ%VD6S
M!@KK9-CFWL;!Q-]V!!^VP8=?"TYEG:RA4CQ!V$K!#!=4<5TDAATD>L-A-X]1
MRV-TEL<KUVO(%"+PTB EV8!B!KOBUT!A]"E^, B["8Q; N.O)4+PS%63/-TT
MYY%&L$>F-/2A<+W352+^T7@H4*W<$-20R$UIZDG1GK9S=E:/E__F]9!^9FK%
MJ< %9N0:],9T/ZH>?/7&R,H-FZ4T-+K<,J=_!2IK0-\S*<UA8P.T?Y_X'U!+
M P04    " "<@F]8-Z#&19P%  "C&0  &0   'AL+W=O<FMS:&5E=',O<VAE
M970T,BYX;6R]6=MNVS@0_17"6Q0-D%HB%5^2.@82IXLML-D6S5X>BCXPTM@F
M*HDJ2=D)L!^_0TJ6W-2F8R/>/,02R9DY,^3AD:C14JIO>@Y@R$.6YOJR,S>F
MN @"'<\AX[HK"\BQ9RI5Q@W>JEF@"P4\<499&K P[ <9%WEG/')MG]1X)$N3
MBAP^*:+++./J\1I2N;SLT,ZJX;.8S8UM",:C@L_@#LQ?Q2>%=T'C)1$9Y%K(
MG"B87G:NZ,4DBJR!&_&W@*5>NR8VE7LIO]F;#\EE)[2(((786!<<?Q8P@32U
MGA#']]IIIXEI#=>O5]Y_=<EC,O=<PT2F_XC$S"\[PPY)8,K+U'R6R]^@3JAG
M_<4RU>X_6=9CPPZ)2VUD5ALC@DSDU2]_J NQ9A"Q+0:L-F!/#&BTQ2"J#5SE
M@@J92^N&&SX>*;DDRHY&;_;"U<998S8BM]-X9Q3V"K0SX[LY5S"7:0)*O_YE
MR.C@'7G_O13FD;RY@:F(A3FQ5X:+5)^0M^0.%U)2ID#DE'PL[%1H8B29X"]6
MCN=&CP*#P*S[(*Y!7%<@V!80E)%;F9NY)N_S!)(?'02849,66Z5US;P>;R#N
MDHB>$A:RB+PB =$V45W_>")$3>$B%^%L2P06TA[Y<@O9/:BOFU+VFEMV7NB"
MQW#90?II4 OHC%__0OOA.P^XLP;<F?,>;9O5G9-$OOR.-N2#@4QOA']V!/B]
M!G[/6]L/.8EEGM=,7PHSWX30[^,SX%)2D! +3L3>.>\WN/I>GW_(KJVHK"LJ
MM"Z?KM8*6N6FY]S8C70QIC3L]WJC8+$A_* )/]@G/#R BH7F]RELPC#8"\.P
MP3#T8GA?!052*"PJ>2-R<B/3E"M-"E 5O4[(OVN4VX2MBD'#-7!A-PRCS=C.
M&VSGNR@Y\%+2:W[@FJ9AN].&QR9E'>&%,UC3"OH"O-SA9!]B4M9"8R]#S=K/
M.B^B_G"XA1:TE0/JUX/]R%D[>RZ*=M^GWGWYA>A9!WDN/VF[KU/_IHQJ3+T,
M]=L?NL#;_9WVCTY1KX0<FD$K$=2O$<^DJ-_)7A1ME8/ZI>/Y%!W^1([^>7@>
M;EE]K3Q0OS[L2='S?5"P5@:8=Y,>NR=2'P?\]@>N(-9N\HP>FP/,JP"'9M!J
M ?-KP?,XL,/)#@XX'Y,=/K[0K[Z$6FUA>VG+=N:PGV6%AO:O6;0U;G^\';A;
M-6)^-=J/<+6S'S1Q,!@,GV+WQ]R!O94JYI>JEU'2.L@3)>V=]9\FY0>S(ZE6
MWYC_!>96Y"(KLV;[0?P[)=GO\E RMX+&!D??CKQJ=V@&K>ZQ_^.5J0YB'R^>
M\TS&6E5D?E6\Y0_[KXECO$E%K81&1W^3BHXALE$KLI'_)>AEUD0=9+BV)%B7
M;7F)B*Q^_MBR=M:U4Q#(QYQ<(=J4L$%UK'9*S!RPZ%G!\\?Z[%"3:\E58B?F
M1BA48(D9\:)0<H%2:L?S)!%VQGA*9@JG:ET@< Z+4L5SCH4I"WN+ZG6*\D4^
MJD3D7#V2N^H8#[NX%?EZOD^=RA.>KS1F55AT_@KWVUY;U2[Y$U&L(BY%FJ)-
M@5@)-PX@<)4*'(VF;\0),9"31[ 3,U4R<R,2;ISG&K_"<3CP/,2.1QR&\RB7
M(I\A0@,J0]SN.00-5H\2%88I%XHL>%HZ9\#C>0V+<&U;;*@JA NXQ%;,A?5/
M20*58RQIJ6TD._0ZY?&WMT@-F6*!:D^V"G9 )A-(L3[5'!AIN$L;<@TNUBO6
MQQY9:CO$%>4>5@-P-A=8#].4C2Q &^L5BRID4H-5 %6ANIL8$JP=46>@9N[D
M7N,4EKFI#@:;UN;KP)4[$W_2?DTO)G13.[N8;!I_%6%'M+DG6GV "%I(U>>+
M6ZYF M='"E.$%W8'J,^J^B)0W1A9N$/U>VF,S-SE'#@^,=H!V#^5TJQN;(#F
MN\SX/U!+ P04    " "<@F]8\ 22P*D#  "2$0  &0   'AL+W=O<FMS:&5E
M=',O<VAE970T,RYX;6R]6&UOFSH4_BL6FZ95NBL8\MHED9K2O4BK5#7;W8=I
M'UPX"58!9[:3=/_^VH902"A*KZQ^26PXY_$YC_T8'T]VC#^(!$"BQRS-Q=1)
MI%Q?N*Z($LB(.&=KR-6;)>,9D:K+5ZY8<R"Q<<I2U_>\@9L1FCNSB7EVRV<3
MMI$IS>&6(['),L+_SB%ENZF#G?V#.[I*I'[@SB9KLH(%R!_K6ZYZ;H42TPQR
M05F.."RGSB6^"'&@'8S%OQ1VHM9&.I5[QAYTYVL\=3P=$:0020U!U-\6KB!-
M-9**XT\)ZE1C:L=Z>X_^R22ODKDG JY8^I/&,IDZ(P?%L"2;5-ZQW1<H$^IK
MO(BEPORB76GK.2C:",FRTEE%D-&\^">/)1$U!SQXQL$O'?Q#A]XS#D'I$)SJ
MT"L=>H:9(A7#0T@DF4TXVR&NK16:;A@RC;=*G^9ZWA>2J[=4^<G9(B$<$I;&
MP,6[-R,?#S^BZS\;*O^B]R$L:43EF6Y)0E-QACZ@A5IY\28%Q);(.'^8*]IC
M=,4RM18%,;-Y_:C;()3]CT6(WK\]0V\1S='WA&T$R6,Q<:4*7H?@1F6@\R)0
M_YE L8]N6"X3@:[S&.(F@*NRKE+W]ZG/_4[$$*)S%.!_D._Y04M 5Z>[^RWN
MX>GNN".;H)K(P. %STWDB^;EUS?ECKY*R,3OMKDHQNJUCZ7WH@NQ)A%,';79
M".!;<&;OWN"!][&-1YM@H26P!L>]BN->%WHA%K/-Q"BJ\PHEKVU4%I # ZEW
MX>W,[ZD)W]89.K89CKVF3=B",QY7-HU\^E4^_<Y\[A1#A$<)4I)$(6S55V"M
M]G2Y7R?HUPUD]\!;ET@G]$N7B$VPT!)8@])!1>G@%64XL,FQ3;#0$EB#XV'%
M\="^# O(?DT^H^! A<<F>'2HPA8;K]^NPE&5SJ@['77HH?G*B/"&\ >0NG>*
M!#MQ7[H\;(*%EL :?(XK/L>O*,&Q38YM@H66P!H<8^_IW.C9%V&)69?/X/!;
MV&+3\PZ,PA8CC'&[#G'M+(P[<_H,.7"2&B5>QNJT387D1!<F)\FQ&_VE:\4J
M6F@+K<FL_\2L_XJ:+ >S1;1-M- 66I/HIRH =QZ _Z<L@Z.SY7AX*,MC&]\;
M'\KRV*CVE2U2<FO%:@9\98I^H8+=Y+(HWJJGU<7"I2FG#Y[/]86#*8*?8(K;
M"O457=%<H!26"M(['ZI]@A<7 $5'LK4IB>^95 6V:29 5 VL#=3[)6-RW]$#
M5-<PL_\ 4$L#!!0    ( )R";UA%@I#DW04  ,89   9    >&PO=V]R:W-H
M965T<R]S:&5E=#0T+GAM;,5976_;-A1]SZ^X<(>B&3++I.*/I(Z!).VP .M:
M--OZ4/2!EFB;F"2J)&4W0'_\+BE9<A*9=MP6?;$H6O?PW$OR''V,5U+]IQ><
M&_B2)IF^Z"R,R<^#0$<+GC+=E3G/\)^95"DS>*KF@<X59[$+2I. ]GJ#(&4B
MZTS&KN^=FHQE81*1\7<*=)&F3-U=\42N+CJDL^YX+^8+8SN"R3AG<W[+S3_Y
M.X5G08T2BY1G6L@,%)]=="[)^75(;8"[XE_!5WJC#3:5J93_V9.;^*+3LXQX
MPB-C(1@>EOR:)XE%0AZ?*]!./:8-W&ROT7]WR6,R4Z;YM4P^B-@L+CJC#L1\
MQHK$O)>K/WB54-_B13+1[A=6U;6]#D2%-C*M@I%!*K+RR+Y4A=@(&)(M ;0*
MH \"2+@E(*P"0I=HR<RE]8H9-ADKN0)EKT8TVW"U<=&8C<CL--X:A?\*C#.3
MVP53?"&3F"O]_-F(DN%+>/VY$.8.7KSB,Q$)<VQ;AHE$'\-O<(L+*2X2#G(&
M-UH7+(M<NPKZP)1BF=%@)-QD2XX)* TLB^%2:QD)9O@X,$C<#A]$%<FKDB3=
M0I)0>",SL]#P.HMY?!\@P(SKM.DZ[2OJ17S%HRZ$Y 1HCX;P"P2@;2%T=?",
M$-:%#=T(I]L*RW/#TRE70$(W#(6/;US'I[8">,'L7C[7.8OX10<WJ^9JR3N3
MY\_(H/?20_6TIGKJT,-M5+]Y2N'CGX@)-YBQ;DWO] >DUZ_3ZWMGXJ_"30,F
MM*HR"61N-43#U];Y+BF7H'T':L5P.1F.!KW1@(R#90N;0<UFX&7S^@M7D= <
M<B6PS%\W%E\;BQ)LL,&"MH\_K,<?[C>^8EB#MB%WQ+-HL2XD" V\Q&-37#\B
MPR5"X*V*18:> $Y</#,XJCF/=G#.A:.;0;Q%0/P ?;CC#!?M3";H6R*;@UD@
MW?5:?PQZC^993?/,O]"D:9]$?]A[/A?:<,5CY*? *!9;AB]^/6[!NO9C?22?
M/(F07N,*O7W5J[^'>OG1#MS?9,/#R,\6L(K!=\Z0-AG2'Z%A%>JFB V&9# :
MMFL(:<R-^-WMB2I6H8TV>/2[]&P+B\:WB-<W]M"R70!/%;,3N.4<,MSH,'QQ
M=0QL*I<^Z2"-21&_2^VA<3L0R C2\B[I,)DCC841OX=M%;H=<6]7&8K<] XN
M<=DD5E8(EKG:D#YFC;D1OSL]5;>\:(?NZL;6R.BGZY;7& _-L'%$LL,2#]2M
MLT>Z14;#?J_7KABT\37J][4GZE:%=E^WPBUW@+3Q*^IUBSUT:Q? =[P)HXT)
M4;\)[2%1.Q"^[3Z,-O9$_?:T5:!VQ-4"5>!SIEHI@;=E/D*-4U&_T3Q1E_QH
M!^Y:VG@1[?]L7:)>+SLTP\;!Z X'.TR7*M1-7:+AX'2;+#6V1?=\*-M3EH:/
M9.FT2\,M+!H[HKL>LW;*T@Z [RE+C<=0O\?L(TM^!-+[)ET*&_L)_?:S59=V
MQ-6Z9&DE?,X28/%2:.E3I]#ZT?V>1NI#OU#C<^3?.-1Z<P#.U;W99.:(94A'
MI-B>H4I:9@(WE!)SG-^DJ9V5!6:@OKK(K6S8/&Q5L<'<4IF))2_W=SD37M N
M;)([6HDD@>D]@B=V3#M(N:OM1N=V<99O.D]P-<(*V_B_LNV<*6/+&_,$>2BW
M "042 -0!^\L<E08G *^WB+X""#*[$ZJ]([*8H!RC_/5@M0&DTPY;@=5/>4_
M6EQ(S9[?WQBZ=*#D;GUY/1.NWW7=(B=T*($77T;E?IO-N'LM?N2JOF0B<;/E
M7BL\&%,76(Y28DYLZCF[<SRQ&K,"ZXE'D:8\MFJ.%=@ 0P:ZALQJ(7V80%ZH
M:,$TCX^*W%;"CK<N7[=MV08;;[%3KN;NY;Z&2!:9*=_VU;WU!X1+]]K\0?\5
M.;\F;?WT_+KM^LO0?HEHB\!MLOY&$324RB\<;YC"5:EQ.\Z07J\[1%=0Y4>#
M\L3(W+UWGTIC9.J:"\YP]NP%^/],HAI4)W: ^M/-Y']02P,$%     @ G()O
M6#[GF&(2 P  5@P  !D   !X;"]W;W)K<VAE971S+W-H965T-#4N>&ULK9=K
M;YLP%(;_BL6JJ96V<,NU2Y"6L&J1%JEJU^Y#M0\.G"2H!C/;N?3?SS:$A8S0
M1.)+P,;O>WP>P]')<$O9*U\!"+2+2<)'QDJ(]-8T>;""&/,632&13Q:4Q5C(
M(5N:/&6 0RV*B>E85M>,<908WE#/W3-O2->"1 G<,\37<8S9VQ@(W8X,V]A/
M/$3+E5 3IC=,\1(>03RE]TR.S,(EC&)(>$03Q& Q,K[:M_Y K=<+GB/8\H-[
MI#*94_JJ!M-P9%AJ0T @$,H!R\L&)D"(,I+;^)-[&D5()3R\W[O?Z=QE+G/,
M84+)KR@4JY'1-U ("[PFXH%NOT.>3T?Y!91P_8NVV=J.9:!@S06-<['<01PE
MV17O<@X' KM[0N#D N=8T#XA<'.!>ZZ@G0O:FDR6BN;@8X&](:-;Q-1JZ:9N
M-$RMENE'B3KV1\'DTTCJA/<3[X C>0#3)* QH&L?!(X(OT&?T=.CCZZO;M 5
MBA(TBPB1!\6'II!AE=@,\A#C+(1S(H3MH!E-Q(JC;TD(8=G E/LM-NWL-SUV
M:AU]"%K(M3\AQW+<B@U-SI<[%7+_?+E=DXU;'(&K_=P3?CGY["1>?LBG:"H@
MYK^K4&=6[6HK52-N>8H#&!FR"'!@&S"\CQ_LKO6E"E.39GY#9B6$[0)AN\[=
MFV#&WF0-W&(6(H%WB%#.)<UK^>+ZE!#,^$T5S<S5[FE;52$WGNVV^D-S<XBI
M-O:EF!HR*V'J%)@ZM9B>,5GCK-P26>]Q$L"[B#K_(W);SA&AVK"7$FK(K$2H
M6Q#JUA*Z@Q 8)OH=8EA %9',P78/B%@M50E*2,Y:Y;^WJI1$KTBB5YO$E#,,
M)$(O,XCGP"KK2*W#I76D23._(;,2N7Y!KM]<*>XWB;!),[\ALQ+"08%P4%^*
M*4NI^G1JOZ%!Y7OO'GU#M9$NA=*060;%/.BX8F!+W;ER%-!U(K(^II@MFN.O
MNB<\FA_+ICGK<?_99!WW#+-EE'!$8"$MK59/UD66=;'90-!4]W5S*F27J&]7
MLO$'IA;(YPM*Q7Z@ A1_);R_4$L#!!0    ( )R";UA&QT-PI ,  .(1   9
M    >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;*V8;6^;.A3'OXK%IJF3MO"4
MYR5(30#=2NM=U&R[+Z:]<.$04 %S;:=II?OAKPV$AI:A1/*;!AN?W['/'_OT
M>'$@]('% !P]96G.EEK,>3'7=1;$D&$V( 7DXDU$:(:Y:-*=S@H*."R-LE2W
M#&.L9SC)-6=1]FVHLR![GB8Y;"AB^RS#]'D%*3DL-5,[=MPENYC+#MU9%'@'
M6^ _B@T5+;VAA$D&.4M(CBA$2^W:G/LS.;X<\#.! SMY1G(E]X0\R,9-N-0,
M.2%((>"2@,7/(ZPA325(3./?FJDU+J7AZ?.1[I=K%VNYQPS6)/TG"7F\U*8:
M"B'"^Y3?D<-?4*]G)'D!25GY%QVJL:.)AH(]XR2KC<4,LB2O?O%3'8<3 \OZ
M@X%5&UCG&MBU@7VNP; V&)YK,*H-1N<:C&N#<1G[*EAEI%W,L;.@Y("H'"UH
M\J&4J[06 4YR^6%M.15O$V''G3M(,8<0;3#E"3!TY0+'2<H^H@_OIO;8^H*2
M''V/R9[A/&2?T/M6>Z%S,0=)TH/:GUOYL_[@S[30+<EYS)"7AQ"V ;J8?+,"
MZ[B"E=5+O,5T@,SA)V09EH5^;%UT]?YCQ\36EV!NOF[151V!+IC;#W,A&"#;
M+&%VSYR\\S%]2_//QYC=F%;D[>;;L4NN?>:W\^NK&(!N.&3L=\<L5Q5MV$V3
M)^B<%3B I2:.2 ;T$33GPSMS;'SI4E,ES%4)\U3"?$6PEK[#1M]A']WY%D5)
M !1!5J3D&0!E<N>FSXCA5"0A="6.@K]%[MC&\ #RR/CO>&ATJ=_KZU+U*Y@Y
M+6DR>3XZ$V.A/YZ*JM*AIQ+F*X*U1!TUHHYZ1;UM:=@E5&4_/@FM.6N'=MWK
MXM+-IQ+FJ83YBF MG<:-3N->G:Y%3J?(Q3'.T:];R.Z!_A8;;$T^1V0O4B=E
M37>7B+WP2W>;2IBK$N:IA/F*8"VY)XW<$Z6Y=*)27Y4P5R7,4PGS%<%:^DX;
M?:>]VWD#-("<BUH-D0B10RXV<)P47=+V@BZ55B7,K6"F?9(:C($Q:B<'3Z5+
M7Q&LI=FLT6S6JYE7_M\CJFB.X$E4\@RZ"IY5+^12O53"W-F;3&[-[%=JO1UC
MVV9[C/]VC#E\4;V*K7Y2@V9 =^5M 4.!2%:\*BF:WN9"XKJLPU_UK\SYVNSH
M=\VY7]TWO."KVP]1NNV2G*$4(N'*&$Q$WJ;5C4+5X*0H*^![PD4]73[&@$4.
ME0/$^X@0?FQ(!\VUCO,_4$L#!!0    ( )R";U@;PLV8CP,  +\9   -
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MQ!', 7C $-?-WX-[[R.G?$\Y];]LIG\!4$L#!!0    ( )R";UB7BKL<P
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M(2I'02I'82I'@2I'H2I'P2I'X2I' 2M'(:M (:M (:M (:M (:M (:M (:M
M(:M (:M (:M (:M$(:M$(:M$(:M$(:M$(:M$(:M$(:M$(:M$(:M$(6N"0M8$
MA:P)"ED3%+(F*&1-4,B:_"=9W[5>_?7_IG:-:U4V1W_6_=2;?P)02P$"% ,4
M    " "<@F]8!T%-8H$   "Q    $               @ $     9&]C4')O
M<',O87!P+GAM;%!+ 0(4 Q0    ( )R";UAP7XZV[P   "L"   1
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M965T,BYX;6Q02P$"% ,4    " "<@F]8.!-F%: "  !.!P  &
M    @('/%0  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @
MG()O6 +A=!-1!0  81(  !@              ("!I1@  'AL+W=O<FMS:&5E
M=',O<VAE970T+GAM;%!+ 0(4 Q0    ( )R";U@%_=<7<@,  (@)   8
M          " @2P>  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4
M    " "<@F]8UPNCI6D*   66@  &               @('4(0  >&PO=V]R
M:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ G()O6",*26M7 @  Z00
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M:&5E=#$Q+GAM;%!+ 0(4 Q0    ( )R";UBTI=&GL@(  +\%   9
M      " @>YB  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%
M  @ G()O6(,+8C3R P  YP@  !D              ("!UV4  'AL+W=O<FMS
M:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    " "<@F]8O?O%-X$*   ^&@
M&0              @($ :@  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+
M 0(4 Q0    ( )R";UBB8+9%B0@  +P5   9              " @;AT  !X
M;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ G()O6.2@ F[U
M!@  51   !D              ("!>'T  'AL+W=O<FMS:&5E=',O<VAE970Q
M-BYX;6Q02P$"% ,4    " "<@F]8<(X9%)<0   (,   &0
M@(&DA   >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( )R"
M;UCD*SA#00,  /,&   9              " @7*5  !X;"]W;W)K<VAE971S
M+W-H965T,3@N>&UL4$L! A0#%     @ G()O6*EQ9"JQ P  Q0<  !D
M         ("!ZI@  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4
M    " "<@F]8GQK-5B49  #!30  &0              @('2G   >&PO=V]R
M:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( )R";UCK)_38A0(  ($%
M   9              " @2ZV  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL
M4$L! A0#%     @ G()O6%<.IV97 @  %@4  !D              ("!ZK@
M 'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    " "<@F]8"MGG
M1:$"  "N!0  &0              @(%XNP  >&PO=V]R:W-H965T<R]S:&5E
M=#(S+GAM;%!+ 0(4 Q0    ( )R";UBYZ',*@ ,  )$(   9
M  " @5"^  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @
MG()O6!WA3A@,"0  *1D  !D              ("!!\(  'AL+W=O<FMS:&5E
M=',O<VAE970R-2YX;6Q02P$"% ,4    " "<@F]8DK)XFZL.   (\@  &0
M            @(%*RP  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4
M Q0    ( )R";UA=6<T$C0(  #('   9              " @2S:  !X;"]W
M;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ G()O6"'_IW8( P
MU@L  !D              ("!\-P  'AL+W=O<FMS:&5E=',O<VAE970R."YX
M;6Q02P$"% ,4    " "<@F]8:CA RW "  #^!@  &0              @($O
MX   >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( )R";UA-
M,)E=E@,  &@0   9              " @=;B  !X;"]W;W)K<VAE971S+W-H
M965T,S N>&UL4$L! A0#%     @ G()O6(4CUB^A @  NP@  !D
M     ("!H^8  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( )R";U@9+^;@= 0  "49   9              "
M@1\# 0!X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @ G()O
M6!7X%705'0  PS4" !D              ("!R@<! 'AL+W=O<FMS:&5E=',O
M<VAE970S-RYX;6Q02P$"% ,4    " "<@F]8+[<TB&\"   *!@  &0
M        @($6)0$ >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0
M   ( )R";UAMSJ>/7 (  #H&   9              " @;PG 0!X;"]W;W)K
M<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ G()O6"=2\X8K!0  J1$
M !D              ("!3RH! 'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q0
M2P$"% ,4    " "<@F]8^S;4$:8"  ")!@  &0              @(&Q+P$
M>&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( )R";U@WH,9%
MG 4  *,9   9              " @8XR 0!X;"]W;W)K<VAE971S+W-H965T
M-#(N>&UL4$L! A0#%     @ G()O6/ $DL"I P  DA$  !D
M ("!83@! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4    " "<
M@F]818*0Y-T%  #&&0  &0              @(%!/ $ >&PO=V]R:W-H965T
M<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( )R";U@^YYAB$@,  %8,   9
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M 0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "<@F]8_2S5I:X!  #!&P
M&@              @ $24@$ >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-0
M2P$"% ,4    " "<@F]8)OJ'I[4!  #<&P  $P              @ 'X4P$
I6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     -@ V +$.  #>50$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>168</ContextCount>
  <ElementCount>346</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>52</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>001 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>002 - Statement - Consolidated Balance Sheets (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet_Parentheticals</Role>
      <ShortName>Consolidated Balance Sheets (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>003 - Statement - Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>004 - Statement - Consolidated Statements of Comprehensive Loss (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement_Parentheticals</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>005 - Statement - Consolidated Statements of Changes in Shareholders??? Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3</Role>
      <ShortName>Consolidated Statements of Changes in Shareholders??? Equity (Deficit)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>006 - Statement - Consolidated Statements of Changes in Shareholders??? Equity (Deficit) (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3_Parentheticals</Role>
      <ShortName>Consolidated Statements of Changes in Shareholders??? Equity (Deficit) (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>007 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ConsolidatedCashFlow</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>008 - Disclosure - General</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/General</Role>
      <ShortName>General</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>009 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>010 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/Inventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>011 - Disclosure - Property and Equipment, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/PropertyandEquipmentNet</Role>
      <ShortName>Property and Equipment, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>012 - Disclosure - Lease</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/Lease</Role>
      <ShortName>Lease</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>013 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>014 - Disclosure - Convertible Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ConvertibleSecurities</Role>
      <ShortName>Convertible Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>015 - Disclosure - Credit Facility</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/CreditFacility</Role>
      <ShortName>Credit Facility</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>016 - Disclosure - Shareholders??? Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ShareholdersEquityDeficit</Role>
      <ShortName>Shareholders??? Equity (Deficit)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>017 - Disclosure - Taxes on Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/TaxesonIncome</Role>
      <ShortName>Taxes on Income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>018 - Disclosure - Related Parties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/RelatedParties</Role>
      <ShortName>Related Parties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>996000 - Disclosure - Accounting Policies, by Policy (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy</Role>
      <ShortName>Accounting Policies, by Policy (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/SignificantAccountingPolicies</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>996001 - Disclosure - Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/SignificantAccountingPolicies</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>996002 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/InventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/Inventories</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>996003 - Disclosure - Property and Equipment, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/PropertyandEquipmentNetTables</Role>
      <ShortName>Property and Equipment, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/PropertyandEquipmentNet</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>996004 - Disclosure - Lease (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/LeaseTables</Role>
      <ShortName>Lease (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/Lease</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>996005 - Disclosure - Shareholders??? Equity (Deficit) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitTables</Role>
      <ShortName>Shareholders??? Equity (Deficit) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/ShareholdersEquityDeficit</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>996006 - Disclosure - General (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/GeneralDetails</Role>
      <ShortName>General (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/General</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>996007 - Disclosure - Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesDetails</Role>
      <ShortName>Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>996008 - Disclosure - Significant Accounting Policies (Details) - Schedule of Annual Rates of Depreciation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ScheduleofAnnualRatesofDepreciationTable</Role>
      <ShortName>Significant Accounting Policies (Details) - Schedule of Annual Rates of Depreciation</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>996009 - Disclosure - Inventories (Details) - Schedule of Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ScheduleofInventoriesTable</Role>
      <ShortName>Inventories (Details) - Schedule of Inventories</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/InventoriesTables</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>996010 - Disclosure - Property and Equipment, Net (Details) - Schedule of Property and Equipment Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable</Role>
      <ShortName>Property and Equipment, Net (Details) - Schedule of Property and Equipment Net</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/PropertyandEquipmentNetTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>996011 - Disclosure - Lease (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/LeaseDetails</Role>
      <ShortName>Lease (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/LeaseTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>996012 - Disclosure - Lease (Details) - Schedule of Classification of Operating Lease Right-of-Use Assets and Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable</Role>
      <ShortName>Lease (Details) - Schedule of Classification of Operating Lease Right-of-Use Assets and Liabilities</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/LeaseTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>996013 - Disclosure - Lease (Details) - Schedule of Future Minimum Lease Payments Under Our Operating Lease Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesTable</Role>
      <ShortName>Lease (Details) - Schedule of Future Minimum Lease Payments Under Our Operating Lease Liabilities</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/LeaseTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>996014 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/CommitmentsandContingencies</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>996015 - Disclosure - Convertible Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails</Role>
      <ShortName>Convertible Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/ConvertibleSecurities</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>996016 - Disclosure - Credit Facility (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/CreditFacilityDetails</Role>
      <ShortName>Credit Facility (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/CreditFacility</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>996017 - Disclosure - Shareholders??? Equity (Deficit) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails</Role>
      <ShortName>Shareholders??? Equity (Deficit) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>996018 - Disclosure - Shareholders??? Equity (Deficit) (Details) - Schedule of Share Capital</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable</Role>
      <ShortName>Shareholders??? Equity (Deficit) (Details) - Schedule of Share Capital</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>996019 - Disclosure - Shareholders??? Equity (Deficit) (Details) - Schedule of Share Capital (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable_Parentheticals</Role>
      <ShortName>Shareholders??? Equity (Deficit) (Details) - Schedule of Share Capital (Parentheticals)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>996020 - Disclosure - Shareholders??? Equity (Deficit) (Details) - Schedule of Options Activity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable</Role>
      <ShortName>Shareholders??? Equity (Deficit) (Details) - Schedule of Options Activity</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>996021 - Disclosure - Shareholders??? Equity (Deficit) (Details) - Schedule of Weighted-Average Assumptions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageAssumptionsTable</Role>
      <ShortName>Shareholders??? Equity (Deficit) (Details) - Schedule of Weighted-Average Assumptions</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>996022 - Disclosure - Shareholders??? Equity (Deficit) (Details) - Schedule of Options to Consultants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable</Role>
      <ShortName>Shareholders??? Equity (Deficit) (Details) - Schedule of Options to Consultants</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>996023 - Disclosure - Shareholders??? Equity (Deficit) (Details) - Schedule of Share-Based Compensation Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ScheduleofShareBasedCompensationExpensesTable</Role>
      <ShortName>Shareholders??? Equity (Deficit) (Details) - Schedule of Share-Based Compensation Expenses</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>996024 - Disclosure - Shareholders??? Equity (Deficit) (Details) - Schedule of Issuance of Equity Warrants to Investors and Associate</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable</Role>
      <ShortName>Shareholders??? Equity (Deficit) (Details) - Schedule of Issuance of Equity Warrants to Investors and Associate</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>996025 - Disclosure - Taxes on Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/TaxesonIncomeDetails</Role>
      <ShortName>Taxes on Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/TaxesonIncome</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="ea0200952-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>996026 - Disclosure - Related Parties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/RelatedPartiesDetails</Role>
      <ShortName>Related Parties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/RelatedParties</ParentRole>
      <Position>46</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="20-F" isDefinitelyFs="true" isUsgaap="true" original="ea0200952-20f_wearable.htm">ea0200952-20f_wearable.htm</File>
    <File>wlds-20231231.xsd</File>
    <File>wlds-20231231_cal.xml</File>
    <File>wlds-20231231_def.xml</File>
    <File>wlds-20231231_lab.xml</File>
    <File>wlds-20231231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image_001.jpg</File>
    <File>image_002.jpg</File>
    <File>image_003.jpg</File>
    <File>image_004.jpg</File>
    <File>image_005.jpg</File>
    <File>image_006.jpg</File>
    <File>image_007.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="453">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="48">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>77
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0200952-20f_wearable.htm": {
   "nsprefix": "wlds",
   "nsuri": "http://www.wearabledevices.co.il/20231231",
   "dts": {
    "inline": {
     "local": [
      "ea0200952-20f_wearable.htm"
     ]
    },
    "schema": {
     "local": [
      "wlds-20231231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "wlds-20231231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "wlds-20231231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "wlds-20231231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "wlds-20231231_pre.xml"
     ]
    }
   },
   "keyStandard": 210,
   "keyCustom": 136,
   "axisStandard": 23,
   "axisCustom": 0,
   "memberStandard": 23,
   "memberCustom": 25,
   "hidden": {
    "total": 102,
    "http://www.wearabledevices.co.il/20231231": 43,
    "http://fasb.org/us-gaap/2023": 56,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 168,
   "entityCount": 1,
   "segmentCount": 52,
   "elementCount": 517,
   "unitCount": 6,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 453,
    "http://xbrl.sec.gov/dei/2023": 48
   },
   "report": {
    "R1": {
     "role": "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation",
     "longName": "000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet",
     "longName": "001 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c4",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet_Parentheticals",
     "longName": "002 - Statement - Consolidated Balance Sheets (Parentheticals)",
     "shortName": "Consolidated Balance Sheets (Parentheticals)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "ilsPershares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c4",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement",
     "longName": "003 - Statement - Consolidated Statements of Comprehensive Loss",
     "shortName": "Consolidated Statements of Comprehensive Loss",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:CostDirectMaterial",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement_Parentheticals",
     "longName": "004 - Statement - Consolidated Statements of Comprehensive Loss (Parentheticals)",
     "shortName": "Consolidated Statements of Comprehensive Loss (Parentheticals)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R6": {
     "role": "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3",
     "longName": "005 - Statement - Consolidated Statements of Changes in Shareholders\u2019 Equity (Deficit)",
     "shortName": "Consolidated Statements of Changes in Shareholders\u2019 Equity (Deficit)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c9",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c9",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3_Parentheticals",
     "longName": "006 - Statement - Consolidated Statements of Changes in Shareholders\u2019 Equity (Deficit) (Parentheticals)",
     "shortName": "Consolidated Statements of Changes in Shareholders\u2019 Equity (Deficit) (Parentheticals)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c6",
      "name": "us-gaap:PaymentsOfStockIssuanceCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c6",
      "name": "us-gaap:PaymentsOfStockIssuanceCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow",
     "longName": "007 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:Depreciation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.wearabledevices.co.il/role/General",
     "longName": "008 - Disclosure - General",
     "shortName": "General",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.wearabledevices.co.il/role/SignificantAccountingPolicies",
     "longName": "009 - Disclosure - Significant Accounting Policies",
     "shortName": "Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.wearabledevices.co.il/role/Inventories",
     "longName": "010 - Disclosure - Inventories",
     "shortName": "Inventories",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.wearabledevices.co.il/role/PropertyandEquipmentNet",
     "longName": "011 - Disclosure - Property and Equipment, Net",
     "shortName": "Property and Equipment, Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.wearabledevices.co.il/role/Lease",
     "longName": "012 - Disclosure - Lease",
     "shortName": "Lease",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.wearabledevices.co.il/role/CommitmentsandContingencies",
     "longName": "013 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.wearabledevices.co.il/role/ConvertibleSecurities",
     "longName": "014 - Disclosure - Convertible Securities",
     "shortName": "Convertible Securities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.wearabledevices.co.il/role/CreditFacility",
     "longName": "015 - Disclosure - Credit Facility",
     "shortName": "Credit Facility",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "wlds:CreditFacilityDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "wlds:CreditFacilityDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficit",
     "longName": "016 - Disclosure - Shareholders\u2019 Equity (Deficit)",
     "shortName": "Shareholders\u2019 Equity (Deficit)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.wearabledevices.co.il/role/TaxesonIncome",
     "longName": "017 - Disclosure - Taxes on Income",
     "shortName": "Taxes on Income",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.wearabledevices.co.il/role/RelatedParties",
     "longName": "018 - Disclosure - Related Parties",
     "shortName": "Related Parties",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy",
     "longName": "996000 - Disclosure - Accounting Policies, by Policy (Policies)",
     "shortName": "Accounting Policies, by Policy (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesTables",
     "longName": "996001 - Disclosure - Significant Accounting Policies (Tables)",
     "shortName": "Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "wlds:ScheduleOfAnnualRatesOfDepreciationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ix:continuation",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "wlds:ScheduleOfAnnualRatesOfDepreciationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ix:continuation",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.wearabledevices.co.il/role/InventoriesTables",
     "longName": "996002 - Disclosure - Inventories (Tables)",
     "shortName": "Inventories (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.wearabledevices.co.il/role/PropertyandEquipmentNetTables",
     "longName": "996003 - Disclosure - Property and Equipment, Net (Tables)",
     "shortName": "Property and Equipment, Net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.wearabledevices.co.il/role/LeaseTables",
     "longName": "996004 - Disclosure - Lease (Tables)",
     "shortName": "Lease (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitTables",
     "longName": "996005 - Disclosure - Shareholders\u2019 Equity (Deficit) (Tables)",
     "shortName": "Shareholders\u2019 Equity (Deficit) (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.wearabledevices.co.il/role/GeneralDetails",
     "longName": "996006 - Disclosure - General (Details)",
     "shortName": "General (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "wlds:AnnualGrossRevenuesExceed",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "span",
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "wlds:AnnualGrossRevenuesExceed",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "span",
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesDetails",
     "longName": "996007 - Disclosure - Significant Accounting Policies (Details)",
     "shortName": "Significant Accounting Policies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "us-gaap:LesseeFinanceLeaseRenewalTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeLeasesPolicyTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c4",
      "name": "us-gaap:LesseeFinanceLeaseRenewalTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeLeasesPolicyTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.wearabledevices.co.il/role/ScheduleofAnnualRatesofDepreciationTable",
     "longName": "996008 - Disclosure - Significant Accounting Policies (Details) - Schedule of Annual Rates of Depreciation",
     "shortName": "Significant Accounting Policies (Details) - Schedule of Annual Rates of Depreciation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c53",
      "name": "wlds:AnnualRateOfDepreciation",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c53",
      "name": "wlds:AnnualRateOfDepreciation",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.wearabledevices.co.il/role/ScheduleofInventoriesTable",
     "longName": "996009 - Disclosure - Inventories (Details) - Schedule of Inventories",
     "shortName": "Inventories (Details) - Schedule of Inventories",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c4",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable",
     "longName": "996010 - Disclosure - Property and Equipment, Net (Details) - Schedule of Property and Equipment Net",
     "shortName": "Property and Equipment, Net (Details) - Schedule of Property and Equipment Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c4",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.wearabledevices.co.il/role/LeaseDetails",
     "longName": "996011 - Disclosure - Lease (Details)",
     "shortName": "Lease (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "us-gaap:LesseeOperatingLeaseRemainingLeaseTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c4",
      "name": "us-gaap:LesseeOperatingLeaseRemainingLeaseTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.wearabledevices.co.il/role/ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable",
     "longName": "996012 - Disclosure - Lease (Details) - Schedule of Classification of Operating Lease Right-of-Use Assets and Liabilities",
     "shortName": "Lease (Details) - Schedule of Classification of Operating Lease Right-of-Use Assets and Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R33": {
     "role": "http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesTable",
     "longName": "996013 - Disclosure - Lease (Details) - Schedule of Future Minimum Lease Payments Under Our Operating Lease Liabilities",
     "shortName": "Lease (Details) - Schedule of Future Minimum Lease Payments Under Our Operating Lease Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c4",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails",
     "longName": "996014 - Disclosure - Commitments and Contingencies (Details)",
     "shortName": "Commitments and Contingencies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "wlds:GrantsReceivedEqualPercentageRate",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "wlds:GrantsReceivedEqualPercentageRate",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails",
     "longName": "996015 - Disclosure - Convertible Securities (Details)",
     "shortName": "Convertible Securities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c86",
      "name": "us-gaap:ProceedsFromConvertibleDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c86",
      "name": "us-gaap:ProceedsFromConvertibleDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.wearabledevices.co.il/role/CreditFacilityDetails",
     "longName": "996016 - Disclosure - Credit Facility (Details)",
     "shortName": "Credit Facility (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c103",
      "name": "us-gaap:OtherBorrowings",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "wlds:CreditFacilityDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c103",
      "name": "us-gaap:OtherBorrowings",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "wlds:CreditFacilityDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails",
     "longName": "996017 - Disclosure - Shareholders\u2019 Equity (Deficit) (Details)",
     "shortName": "Shareholders\u2019 Equity (Deficit) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c122",
      "name": "wlds:OrdinarySharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable",
     "longName": "996018 - Disclosure - Shareholders\u2019 Equity (Deficit) (Details) - Schedule of Share Capital",
     "shortName": "Shareholders\u2019 Equity (Deficit) (Details) - Schedule of Share Capital",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c135",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c135",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable_Parentheticals",
     "longName": "996019 - Disclosure - Shareholders\u2019 Equity (Deficit) (Details) - Schedule of Share Capital (Parentheticals)",
     "shortName": "Shareholders\u2019 Equity (Deficit) (Details) - Schedule of Share Capital (Parentheticals)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c135",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "ilsPershares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R40": {
     "role": "http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable",
     "longName": "996020 - Disclosure - Shareholders\u2019 Equity (Deficit) (Details) - Schedule of Options Activity",
     "shortName": "Shareholders\u2019 Equity (Deficit) (Details) - Schedule of Options Activity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c24",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageAssumptionsTable",
     "longName": "996021 - Disclosure - Shareholders\u2019 Equity (Deficit) (Details) - Schedule of Weighted-Average Assumptions",
     "shortName": "Shareholders\u2019 Equity (Deficit) (Details) - Schedule of Weighted-Average Assumptions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable",
     "longName": "996022 - Disclosure - Shareholders\u2019 Equity (Deficit) (Details) - Schedule of Options to Consultants",
     "shortName": "Shareholders\u2019 Equity (Deficit) (Details) - Schedule of Options to Consultants",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c136",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c136",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.wearabledevices.co.il/role/ScheduleofShareBasedCompensationExpensesTable",
     "longName": "996023 - Disclosure - Shareholders\u2019 Equity (Deficit) (Details) - Schedule of Share-Based Compensation Expenses",
     "shortName": "Shareholders\u2019 Equity (Deficit) (Details) - Schedule of Share-Based Compensation Expenses",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ShareBasedCompensation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c146",
      "name": "us-gaap:ShareBasedCompensation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.wearabledevices.co.il/role/ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable",
     "longName": "996024 - Disclosure - Shareholders\u2019 Equity (Deficit) (Details) - Schedule of Issuance of Equity Warrants to Investors and Associate",
     "shortName": "Shareholders\u2019 Equity (Deficit) (Details) - Schedule of Issuance of Equity Warrants to Investors and Associate",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c155",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c155",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.wearabledevices.co.il/role/TaxesonIncomeDetails",
     "longName": "996025 - Disclosure - Taxes on Income (Details)",
     "shortName": "Taxes on Income (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "us-gaap:OperatingLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c4",
      "name": "us-gaap:OperatingLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.wearabledevices.co.il/role/RelatedPartiesDetails",
     "longName": "996026 - Disclosure - Related Parties (Details)",
     "shortName": "Related Parties (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c167",
      "name": "wlds:OfficerEmployeeMonthlySalary",
      "unitRef": "ils",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c167",
      "name": "wlds:OfficerEmployeeMonthlySalary",
      "unitRef": "ils",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0200952-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "wlds_AShareReclassifiedToOrdinaryShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "AShareReclassifiedToOrdinaryShares",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "A share reclassified to ordinary shares",
        "documentation": "Shares of a share reclassified to ordinary shares.",
        "label": "AShare Reclassified To Ordinary Shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r566"
     ]
    },
    "wlds_AccruedInterestOnConvertibleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "AccruedInterestOnConvertibleSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued interest on convertible securities",
        "documentation": "Amount of accrued interest on convertible securities.",
        "label": "Accrued Interest On Convertible Securities"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_AccruedInterestOnDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "AccruedInterestOnDeposits",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued interest on deposits",
        "documentation": "Represent the amount of accrued interest on deposit.",
        "label": "Accrued Interest On Deposits"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "label": "Accrued Liabilities, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less - accumulated depreciation",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r125",
      "r405"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated losses",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r26",
      "r75",
      "r130",
      "r401",
      "r415",
      "r416"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated losses",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r7",
      "r26",
      "r341",
      "r344",
      "r367",
      "r411",
      "r412",
      "r600",
      "r601",
      "r602",
      "r607",
      "r608",
      "r609"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r566",
      "r672"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r308",
      "r309",
      "r310",
      "r430",
      "r607",
      "r608",
      "r609",
      "r647",
      "r674"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments required to reconcile net loss to net cash used in operating activities",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_AdvanceFromCustomers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "AdvanceFromCustomers",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advance payments",
        "documentation": "It represent advances from customers.",
        "label": "Advance From Customers"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_AggregateAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "AggregateAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate amount",
        "documentation": "An aggregate amount or score is made up of several smaller amounts or scores added together.",
        "label": "Aggregate Amount"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_AggregateOrdinaryShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "AggregateOrdinaryShares",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate ordinary shares (in Shares)",
        "documentation": "Number of shares of aggregate ordinary shares.",
        "label": "Aggregate Ordinary Shares"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_AggrementTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "AggrementTerm",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggrement term",
        "documentation": "Aggrement term",
        "label": "Aggrement Term"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "wlds_AmountOfDevelopmentProgram": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "AmountOfDevelopmentProgram",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Approved development program",
        "documentation": "The amount of development program.",
        "label": "Amount Of Development Program"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_AmountsReceivedAggregateAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "AmountsReceivedAggregateAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amounts received aggregate amount",
        "documentation": "The amounts received aggregate amount.",
        "label": "Amounts Received Aggregate Amount"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_AnnualAlternativeInterestPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "AnnualAlternativeInterestPercentage",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Annual alternative interest percentage",
        "documentation": "The percentage as an alternative annual interest rate published by bank of israel.",
        "label": "Annual Alternative Interest Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_AnnualGrossRevenuesExceed": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "AnnualGrossRevenuesExceed",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Annual gross revenues exceed",
        "documentation": "Amount of annual gross revenues exceed.",
        "label": "Annual Gross Revenues Exceed"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_AnnualInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "AnnualInterestRate",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Annual interest rate",
        "documentation": "Annual interest rate",
        "label": "Annual Interest Rate"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_AnnualRateOfDepreciation": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "AnnualRateOfDepreciation",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofAnnualRatesofDepreciationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Annual rate of depreciation",
        "documentation": "The percentage of annual rate of depreciation.",
        "label": "Annual Rate Of Depreciation"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_AnnualRatesOfDepreciationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "AnnualRatesOfDepreciationLineItems",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofAnnualRatesofDepreciationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Annual Rates of Depreciation [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_AsherDahanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "AsherDahanMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asher Dahan [Member]",
        "label": "Asher Dahan Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL ASSETS",
        "label": "Assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r126",
      "r152",
      "r181",
      "r192",
      "r196",
      "r205",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r336",
      "r338",
      "r350",
      "r397",
      "r470",
      "r566",
      "r578",
      "r616",
      "r617",
      "r660"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet",
      "http://www.wearabledevices.co.il/role/ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL CURRENT ASSETS",
        "label": "Assets, Current",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r132",
      "r152",
      "r205",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r336",
      "r338",
      "r350",
      "r566",
      "r616",
      "r617",
      "r660"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CURRENT ASSETS:",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL NON-CURRENT ASSETS",
        "label": "Assets, Noncurrent",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r205",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r336",
      "r338",
      "r350",
      "r616",
      "r617",
      "r660"
     ]
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsNoncurrentAbstract",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NON-CURRENT ASSETS:",
        "label": "Assets, Noncurrent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Firm ID",
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r583",
      "r584",
      "r585"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorLocation",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Location",
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r583",
      "r584",
      "r585"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorName",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Name",
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r583",
      "r584",
      "r585"
     ]
    },
    "us-gaap_AwardDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardDateAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Date [Axis]",
        "documentation": "Information by date or year award under share-based payment arrangement is granted."
       }
      }
     },
     "auth_ref": [
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r279",
      "r280",
      "r281",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307"
     ]
    },
    "wlds_BaseMonthlyFeeImmediatelyIncreaseAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "BaseMonthlyFeeImmediatelyIncreaseAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Base monthly fee immediately increase amount",
        "documentation": "The amount of base monthly fee immediately increase amount.",
        "label": "Base Monthly Fee Immediately Increase Amount"
       }
      }
     },
     "auth_ref": []
    },
    "srt_BoardOfDirectorsChairmanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "BoardOfDirectorsChairmanMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Board of Directors [Member]",
        "label": "Board of Directors Chairman [Member]"
       }
      }
     },
     "auth_ref": [
      "r612"
     ]
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Acquiree [Domain]",
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r335",
      "r561",
      "r562"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r54",
      "r335",
      "r561",
      "r562"
     ]
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding voting securities percentage",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Contact",
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r584",
      "r585"
     ]
    },
    "us-gaap_Cash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Cash",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash (in Dollars)",
        "label": "Cash",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r399",
      "r442",
      "r465",
      "r566",
      "r578",
      "r594"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r123",
      "r541"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash and Cash Equivalents at the beginning of year",
        "periodEndLabel": "Cash and cash equivalents at the end of year",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r81",
      "r148"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net increase (decrease) in cash and cash equivalents",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r81"
     ]
    },
    "wlds_CashPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "CashPayment",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash payment (in Dollars)",
        "documentation": "Cash payment.",
        "label": "Cash Payment"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ChangesDuringTheYear2021Abstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ChangesDuringTheYear2021Abstract",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CHANGES DURING THE YEAR 2021:",
        "label": "Changes During The Year2021 Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ChangesDuringTheYear2022Abstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ChangesDuringTheYear2022Abstract",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CHANGES DURING THE YEAR 2022:",
        "label": "Changes During The Year2022 Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ChangesDuringTheYear2023Abstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ChangesDuringTheYear2023Abstract",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CHANGES DURING THE YEAR 2023:",
        "label": "Changes During The Year2023 Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation",
      "http://www.wearabledevices.co.il/role/GeneralDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r127",
      "r128",
      "r129",
      "r152",
      "r171",
      "r172",
      "r174",
      "r176",
      "r179",
      "r180",
      "r205",
      "r223",
      "r225",
      "r226",
      "r227",
      "r230",
      "r231",
      "r259",
      "r260",
      "r262",
      "r265",
      "r271",
      "r350",
      "r421",
      "r422",
      "r423",
      "r424",
      "r430",
      "r431",
      "r432",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r443",
      "r457",
      "r480",
      "r502",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r591",
      "r604",
      "r611"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Domain]",
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails",
      "http://www.wearabledevices.co.il/role/GeneralDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price (in Dollars per share)",
        "verboseLabel": "Exercise price",
        "netLabel": "Exercise price range (in Dollars per share)",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r272"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants to purchase",
        "label": "Class of Warrant or Right, Outstanding",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "wlds_CofoundersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "CofoundersMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/RelatedPartiesDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Co-founders [Member]",
        "label": "Cofounders Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "COMMITMENTS AND CONTINGENCIES (Note 6)",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r59",
      "r398",
      "r456"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "COMMITMENTS AND CONTINGENCIES",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r217",
      "r218",
      "r526",
      "r615"
     ]
    },
    "wlds_CommitmentsandContingenciesDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "CommitmentsandContingenciesDetailsLineItems",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_CommitmentsandContingenciesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "CommitmentsandContingenciesDetailsTable",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonClassAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonClassAMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "A",
        "verboseLabel": "Ordinary A Shares [Member]",
        "label": "Common Class A [Member]",
        "documentation": "Classification of common stock representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r674"
     ]
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares reserved for future issuance",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "documentation": "Aggregate number of common shares reserved for future issuance."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails",
      "http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable",
      "http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable_Parentheticals",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares",
        "verboseLabel": "Ordinary shares [Member]",
        "netLabel": "Ordinary Share [Member]",
        "label": "Ordinary Shares [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r568",
      "r569",
      "r570",
      "r572",
      "r573",
      "r574",
      "r575",
      "r607",
      "r608",
      "r647",
      "r670",
      "r674"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.wearabledevices.co.il/role/GeneralDetails",
      "http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, par value (in New Shekels per share)",
        "verboseLabel": "Ordinary shares, par value",
        "netLabel": "Ordinary share par value (in New Shekels per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, authorized",
        "verboseLabel": "Ordinary shares, Authorized",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r457"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.wearabledevices.co.il/role/GeneralDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, share issued",
        "verboseLabel": "Ordinary shares (in Shares)",
        "netLabel": "Ordinary shares",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, share outstanding",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r66",
      "r457",
      "r476",
      "r674",
      "r675"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, NIS 0.01 par value: Authorized 50,000,000 as of December 31, 2023 and December 31, 2022; Issued and outstanding 20,387,428 shares as of December 31, 2023 and 15,049,720 shares as of December 31, 2022",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r400",
      "r566"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Comprehensive loss",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r134",
      "r136",
      "r142",
      "r393",
      "r408"
     ]
    },
    "wlds_ComputersAndSoftwareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ComputersAndSoftwareMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofAnnualRatesofDepreciationTable",
      "http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Computers and software\t[Member]",
        "documentation": "Collection of computer and software.",
        "label": "Computers And Software Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration of Credit Risk",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r111"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principles of consolidation",
        "label": "Consolidation, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r546"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contact Personnel Name",
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ConversionOfOrdinaryASharesToOrdinaryShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ConversionOfOrdinaryASharesToOrdinaryShares",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of ordinary A shares to ordinary shares (in Shares)",
        "documentation": "It represent number of ordinary A shares converted to ordinary shares.",
        "label": "Conversion Of Ordinary AShares To Ordinary Shares"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ConversionOfOrdinaryASharesToOrdinarySharesValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ConversionOfOrdinaryASharesToOrdinarySharesValue",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of ordinary A shares to ordinary shares",
        "documentation": "Aggregate value of stock related to A share converted to ordinary shares during the period.",
        "label": "Conversion Of Ordinary AShares To Ordinary Shares Value"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ConversionOfSAFEToEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ConversionOfSAFEToEquity",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of SAFEs to equity",
        "documentation": "The amount of conversion of SAFE to equity.",
        "label": "Conversion Of SAFETo Equity"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of SAFEs into ordinary shares upon completion of initial public offering (in Shares)",
        "documentation": "Conversion of SAFEs into ordinary shares upon completion of initial public offering.",
        "label": "Conversion Of SAFEs Into Ordinary Shares Upon Completion Of Initial Public Offering"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ConvertedAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ConvertedAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Converted amount (in Dollars)",
        "documentation": "The amount of Converted.",
        "label": "Converted Amount"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ConvertedToOrdinaryShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ConvertedToOrdinaryShares",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Converted to ordinary shares",
        "documentation": "Number of converted to ordinary shares.",
        "label": "Converted To Ordinary Shares"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ConvertibleSecuritiesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ConvertibleSecuritiesDetailsTable",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Securities (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ConvertibleSecuritiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ConvertibleSecuritiesLineItems",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Securities [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ConvertibleSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ConvertibleSecuritiesMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Security Agreements [Member]",
        "label": "Convertible Securities Member"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ConvertibleSecurityDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ConvertibleSecurityDescription",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible security, description",
        "documentation": "Convertible security is a security usually a bond or a preferred stock that can be converted into a different security typically shares of the company's common stock.",
        "label": "Convertible Security Description"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_CorporateTaxRatePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "CorporateTaxRatePercentage",
     "presentation": [
      "http://www.wearabledevices.co.il/role/TaxesonIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corporate tax rate",
        "documentation": "Percentage of the corporate tax rate.",
        "label": "Corporate Tax Rate Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_CostAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "CostAbstract",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofInventoriesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost:",
        "label": "Cost Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_CostAbstract0": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "CostAbstract0",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost:",
        "label": "Cost Abstract0"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostDirectMaterial": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostDirectMaterial",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cost of revenues",
        "label": "Cost, Direct Material",
        "documentation": "Cost of material used for good produced and service rendered."
       }
      }
     },
     "auth_ref": [
      "r603"
     ]
    },
    "wlds_CostOfRevenuesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "CostOfRevenuesPolicyTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of revenues",
        "documentation": "Policy of cost of revenue.",
        "label": "Cost Of Revenues Policy Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_CreditFacilityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "CreditFacilityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit Facility [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_CreditFacilityDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "CreditFacilityDetailsTable",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit Facility (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_CreditFacilityDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "CreditFacilityDisclosureTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CreditFacility"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CREDIT FACILITY",
        "documentation": "The entire disclosure for credit facility.",
        "label": "Credit Facility Disclosure Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConvertibleSecurities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CONVERTIBLE SECURITIES",
        "label": "Debt Disclosure [Text Block]",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r150",
      "r232",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r248",
      "r255",
      "r256",
      "r257"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails",
      "http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r63",
      "r64",
      "r97",
      "r98",
      "r154",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r239",
      "r244",
      "r245",
      "r246",
      "r247",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r359",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r605"
     ]
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate principal amount (in Dollars)",
        "label": "Debt Instrument, Face Amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r58",
      "r233",
      "r359",
      "r555",
      "r556"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bearing interest rate",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r234"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails",
      "http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r154",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r239",
      "r244",
      "r245",
      "r246",
      "r247",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r359",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r605"
     ]
    },
    "us-gaap_DebtWeightedAverageInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtWeightedAverageInterestRate",
     "presentation": [
      "http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average interest rate",
        "label": "Debt, Weighted Average Interest Rate",
        "documentation": "Weighted average interest rate of debt outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "wlds_DecreaseincreaseInGovernmentalGrantsReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "DecreaseincreaseInGovernmentalGrantsReceivables",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Decrease (increase) in governmental grants receivables",
        "documentation": "Amount of decrease increase in governmental grants receivables.",
        "label": "Decreaseincrease In Governmental Grants Receivables"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredRevenueCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredRevenueCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenues",
        "label": "Deferred Revenue, Current",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r596"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/TaxesonIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation allowance (in Dollars)",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r324"
     ]
    },
    "us-gaap_DepositsAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepositsAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short term bank deposits",
        "label": "Deposits Assets, Current",
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter."
       }
      }
     },
     "auth_ref": [
      "r598"
     ]
    },
    "us-gaap_DepositsAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepositsAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long term bank deposits",
        "label": "Deposits Assets, Noncurrent",
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r595"
     ]
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation",
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r40"
     ]
    },
    "srt_DirectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "DirectorMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Director [Member]",
        "label": "Director [Member]"
       }
      }
     },
     "auth_ref": [
      "r612",
      "r671"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Accounting Standard",
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r584"
     ]
    },
    "wlds_DocumentAndEntityInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "DocumentAndEntityInformationAbstract",
     "auth_ref": []
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Annual Report",
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r583",
      "r584",
      "r585"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Financial Statement Error Correction [Flag]",
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r583",
      "r584",
      "r585",
      "r587"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Registration Statement",
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r579"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Shell Company Report",
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r584"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r586"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss per ordinary shares, basic (in Dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r169",
      "r171",
      "r174",
      "r175",
      "r176",
      "r177",
      "r348",
      "r349",
      "r394",
      "r409",
      "r549"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss per ordinary shares, diluted",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r171",
      "r174",
      "r175",
      "r176",
      "r177",
      "r348",
      "r349",
      "r394",
      "r409",
      "r549"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic and diluted loss per share",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r34"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "presentation": [
      "http://www.wearabledevices.co.il/role/TaxesonIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal tax rate",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r320",
      "r331"
     ]
    },
    "wlds_ElectronicEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ElectronicEquipmentMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Electronic equipment [Member]",
        "documentation": "Collection of Electronic equipment.",
        "label": "Electronic Equipment Member"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_EmployeeExercisedWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "EmployeeExercisedWarrants",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee exercised warrants",
        "documentation": "Employee exercised warrants.",
        "label": "Employee Exercised Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued payroll and other employment related accruals",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "wlds_EmploymentExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "EmploymentExpenses",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employment expenses",
        "documentation": "Represent the amount of expense on employment.",
        "label": "Employment Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Country",
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r581"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r581"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Ex Transition Period",
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r590"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r581"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r581"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r581"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Voluntary Filers",
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Well-known Seasoned Issuer",
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r589"
     ]
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r118",
      "r138",
      "r139",
      "r140",
      "r155",
      "r156",
      "r157",
      "r159",
      "r165",
      "r167",
      "r178",
      "r206",
      "r207",
      "r273",
      "r308",
      "r309",
      "r310",
      "r328",
      "r329",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r347",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r367",
      "r411",
      "r412",
      "r413",
      "r430",
      "r502"
     ]
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "EquityMethodInvesteeNameDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r202",
      "r203",
      "r204"
     ]
    },
    "wlds_ExceptTransferProductionRight": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ExceptTransferProductionRight",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Except transfer production right",
        "documentation": "Except transfer production right.",
        "label": "Except Transfer Production Right"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ExercisableWarrantsToShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ExercisableWarrantsToShares",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercised warrants to shares",
        "documentation": "Exercisable warrants to shares.",
        "label": "Exercisable Warrants To Shares"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ExercisePriceOfWarrant": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ExercisePriceOfWarrant",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price of warrants (in Dollars per share)",
        "documentation": "Exercise price of warrant.",
        "label": "Exercise Price Of Warrant"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ExercisePriceOfWarrants": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ExercisePriceOfWarrants",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of warrants (in Dollars per share)",
        "documentation": "Per share or per unit amount of exercise price.",
        "label": "Exercise Price Of Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ExercisePricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ExercisePricePerShare",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price per share (in Dollars per share)",
        "documentation": "Exercise price per share.",
        "label": "Exercise Price Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ExpenseOnServiceRendering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ExpenseOnServiceRendering",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total expense on service",
        "documentation": "Represent the amount of expense on service rendering.",
        "label": "Expense On Service Rendering"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FIFOInventoryAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FIFOInventoryAmount",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      },
      "http://www.wearabledevices.co.il/role/ScheduleofInventoriesTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet",
      "http://www.wearabledevices.co.il/role/ScheduleofInventoriesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Inventories",
        "terseLabel": "Inventories (Note 3)",
        "label": "FIFO Inventory Amount",
        "documentation": "The amount of FIFO (first in first out) inventory present at the reporting date when inventory is also valued using different valuation methods."
       }
      }
     },
     "auth_ref": [
      "r542"
     ]
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "FinanceIncomeAndExpensesPolicyPolicyTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance income and expenses",
        "documentation": "Disclosure of accounting policy for finance income and expenses.",
        "label": "Finance Income And Expenses Policy Policy Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r211",
      "r212",
      "r213",
      "r214",
      "r379",
      "r380"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r39"
     ]
    },
    "wlds_FixedAnnualInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "FixedAnnualInterestRate",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed annual interest rate",
        "documentation": "Fixed annual interest rate.",
        "label": "Fixed Annual Interest Rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCurrencyTransactionGainLossUnrealized",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Unrealized gain loss from foreign currency derivative activities",
        "label": "Unrealized Gain (Loss), Foreign Currency Transaction, before Tax",
        "documentation": "Amount, before tax, of unrealized gain (loss) from foreign currency transaction."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r478",
      "r576",
      "r650",
      "r651",
      "r673"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
       }
      }
     },
     "auth_ref": [
      "r351"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "General and administrative expenses",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r482"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofShareBasedCompensationExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and Administrative Expense [Member]",
        "label": "General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "wlds_GeneralDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "GeneralDetailsTable",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_GeneralLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "GeneralLineItems",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_GovernmentalGrantsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "GovernmentalGrantsPolicyTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Governmental grants",
        "documentation": "Disclosure of accounting policy for governmental grants.",
        "label": "Governmental Grants Policy Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GrantsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GrantsReceivable",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Governmental grant receivable",
        "label": "Grants Receivable",
        "documentation": "Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants."
       }
      }
     },
     "auth_ref": [
      "r597"
     ]
    },
    "us-gaap_GrantsReceivableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GrantsReceivableCurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum obligation amount",
        "label": "Grants Receivable, Current",
        "documentation": "Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r597"
     ]
    },
    "wlds_GrantsReceivedEqualPercentageRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "GrantsReceivedEqualPercentageRate",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grants received equal percentage rate",
        "label": "Grants Received Equal Percentage Rate"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_GrantsReceivedFromTheIMEI": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "GrantsReceivedFromTheIMEI",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grants received from the IMEI",
        "documentation": "Grants received from the IMEI.",
        "label": "Grants Received From The IMEI"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_GrossAfterOtherIPOExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "GrossAfterOtherIPOExpenses",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross after other IPO expenses",
        "documentation": "The amunt of gross after other IPO expenses.",
        "label": "Gross After Other IPOExpenses"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_GrossProceeds": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "GrossProceeds",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross proceeds",
        "documentation": "The amount of the IPO gross proceeds.",
        "label": "Gross Proceeds"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_IIAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "IIAMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "IIA [Member]",
        "label": "IIAMember"
       }
      }
     },
     "auth_ref": []
    },
    "country_IL": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "IL",
     "presentation": [
      "http://www.wearabledevices.co.il/role/TaxesonIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Israeli [Member]",
        "label": "ISRAEL"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_IMEIMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "IMEIMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "IMEI [Member]",
        "label": "IMEIMember"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IPOMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IPOMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CreditFacilityDetails",
      "http://www.wearabledevices.co.il/role/GeneralDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "IPO [Member]",
        "label": "IPO [Member]",
        "documentation": "First sale of stock by a private company to the public."
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ICFR Auditor Attestation Flag",
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r583",
      "r584",
      "r585"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofShareBasedCompensationExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement Location [Axis]",
        "documentation": "Information by location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r215",
      "r216",
      "r487"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofShareBasedCompensationExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement Location [Domain]",
        "documentation": "Location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r216",
      "r487"
     ]
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxContingencyLineItems",
     "presentation": [
      "http://www.wearabledevices.co.il/role/TaxesonIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes on Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/TaxesonIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "TAXES ON INCOME",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r317",
      "r321",
      "r322",
      "r326",
      "r330",
      "r332",
      "r333",
      "r334",
      "r426"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r318",
      "r319",
      "r322",
      "r323",
      "r325",
      "r327",
      "r420"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase in accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Decrease (increase) in accounts receivable",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase in accrued expenses",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "wlds_IncreaseDecreaseInAdvancePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "IncreaseDecreaseInAdvancePayments",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (decrease) in advance payments",
        "documentation": "Amount of advances from customers.",
        "label": "Increase Decrease In Advance Payments"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_IncreaseDecreaseInAdvancePaymentsOnGovernmentalGrant": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "IncreaseDecreaseInAdvancePaymentsOnGovernmentalGrant",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Decrease in advance payments on governmental grant",
        "documentation": "Amount of increase decrease in advance payments on governmental grant.",
        "label": "Increase Decrease In Advance Payments On Governmental Grant"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (decrease) in deferred revenues",
        "label": "Increase (Decrease) in Deferred Revenue",
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r538"
     ]
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase in accrued payroll and other employment related accruals",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Decrease (increase) in inventories",
        "label": "Increase (Decrease) in Inventories",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities items:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_IncreaseInOtherReceivablesAndPrepaidExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "IncreaseInOtherReceivablesAndPrepaidExpenses",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Increase in other receivables and prepaid expenses",
        "documentation": "Increase in other receivables and prepaid expenses.",
        "label": "Increase In Other Receivables And Prepaid Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_InitialExercisePricePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "InitialExercisePricePercentage",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial exercise price percentage",
        "documentation": "Initial exercise price percentage.",
        "label": "Initial Exercise Price Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_InitialExercisePricesPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "InitialExercisePricesPercentage",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial exercise price percentage",
        "documentation": "Initial exercise price percentage.",
        "label": "Initial Exercise Prices Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_InterestExpenseAndExchangeRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "InterestExpenseAndExchangeRate",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "FINANCING INCOME (EXPENSES), net",
        "documentation": "Represents the amount of financing income (expenses), net.",
        "label": "Interest Expense And Exchange Rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest on credit line",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r146",
      "r147"
     ]
    },
    "wlds_InterestPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "InterestPercentage",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest percentage",
        "documentation": "Interest percentage of return on investments.",
        "label": "Interest Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_InterestReceivedFromDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "InterestReceivedFromDeposits",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest received from deposits",
        "documentation": "The amount of interest received from deposits.",
        "label": "Interest Received From Deposits"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Inventories [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryDisclosureTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/Inventories"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INVENTORIES",
        "label": "Inventory Disclosure [Text Block]",
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory."
       }
      }
     },
     "auth_ref": [
      "r208"
     ]
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ScheduleofInventoriesTable": {
       "parentTag": "us-gaap_FIFOInventoryAmount",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofInventoriesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finished goods",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r543"
     ]
    },
    "us-gaap_InventoryNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryNetAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventories [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryPolicyTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories",
        "label": "Inventory, Policy [Policy Text Block]",
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r122",
      "r131",
      "r208",
      "r209",
      "r210",
      "r377",
      "r547"
     ]
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryRawMaterialsNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ScheduleofInventoriesTable": {
       "parentTag": "us-gaap_FIFOInventoryAmount",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofInventoriesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Raw materials",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r545"
     ]
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryWorkInProcessNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ScheduleofInventoriesTable": {
       "parentTag": "us-gaap_FIFOInventoryAmount",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofInventoriesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Work-in-progress",
        "label": "Inventory, Work in Process, Net of Reserves",
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r544"
     ]
    },
    "wlds_Investor": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "Investor",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of investor",
        "documentation": "Number of investors.",
        "label": "Investor"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_InvestorAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "InvestorAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investor amount (in Dollars)",
        "documentation": "The amount of Investor.",
        "label": "Investor Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestorMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investor [Member]",
        "label": "Investor [Member]",
        "documentation": "Business entity or individual that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value."
       }
      }
     },
     "auth_ref": [
      "r656",
      "r657"
     ]
    },
    "wlds_InvestorsExercisedWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "InvestorsExercisedWarrants",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investors exercised warrants",
        "documentation": "Shares of investors exercised warrants.",
        "label": "Investors Exercised Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_IssuanceExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "IssuanceExpenses",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance expenses (in Dollars)",
        "documentation": "Amount of issuance expenses.",
        "label": "Issuance Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of ordinary shares and warrants, net of issuance cost",
        "documentation": "It represent issuance of ordinary shares and warrants, net of issuance cost.",
        "label": "Issuance Of Ordinary Shares And Warrants Net Of Issuance Cost"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of ordinary shares as a result of exercise of warrants",
        "documentation": "Value of stock issued during the period upon the conversion of warrants.",
        "label": "Issuance Of Ordinary Shares As AResult Of Exercise Of Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrantsinShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrantsinShares",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of ordinary shares as a result of exercise of warrants (in Shares)",
        "documentation": "Issuance of ordinary shares as a result of exercise of warrants.",
        "label": "Issuance Of Ordinary Shares As AResult Of Exercise Of Warrantsin Shares"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_IssuanceOfSharesOptions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "IssuanceOfSharesOptions",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary Shares",
        "documentation": "Issuance of share options provides financial incentives for investors; or performance incentives for shareholders who are active in the operations of the company's business.",
        "label": "Issuance Of Shares Options"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of units of ordinary shares and warrants in connection with the initial public offering, net of issuance expenses of 1.6 million",
        "documentation": "Amount of issuance of units of ordinary shares and warrants in connection with the initial public offering.",
        "label": "Issuance Of Units Of Ordinary Shares And Warrants In Connection With The Initial Public Offering Net"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of units of ordinary shares and warrants in connection with the initial public offering, net of issuance expenses of 1.6 million (in Shares)",
        "documentation": "Issuance of units of ordinary shares and warrants in connection with the initial public offering shares.",
        "label": "Issuance Of Units Of Ordinary Shares And Warrants In Connection With The Initial Public Offering Net Shares"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_LeaseAgreements": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "LeaseAgreements",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease agreements vehicles",
        "documentation": "Lease agreements.",
        "label": "Lease Agreements"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseAgreementsMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease Agreements [Member]",
        "label": "Lease Agreements [Member]",
        "documentation": "Contractual agreement that stipulates the lessee pay the lessor for use of an asset."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "wlds_LeaseAgreementsPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "LeaseAgreementsPeriod",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease agreements period",
        "documentation": "Lease agreements period.",
        "label": "Lease Agreements Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Monthly lease payment",
        "label": "Lease, Cost",
        "documentation": "Amount of lease cost recognized by lessee for lease contract."
       }
      }
     },
     "auth_ref": [
      "r365",
      "r565"
     ]
    },
    "wlds_LeaseLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "LeaseLiabilityMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease Liability [Member]",
        "label": "Lease Liability Member"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_LeasePaymentIncreased": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "LeasePaymentIncreased",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease payment increased",
        "documentation": "Lease payment increased.",
        "label": "Lease Payment Increased"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeFinanceLeaseRenewalTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeFinanceLeaseRenewalTerm1",
     "presentation": [
      "http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease term",
        "label": "Lessee, Finance Lease, Renewal Term",
        "documentation": "Term of lessee's finance lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r654"
     ]
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r363"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/LeaseTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Future Minimum Lease Payments Under Our Operating Lease Liabilities",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r655"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total future minimum lease payments",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r366"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesTable": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r366"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesTable": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r366"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesTable": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r366"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less imputed interest",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r366"
     ]
    },
    "us-gaap_LesseeOperatingLeaseOptionToExtend": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseOptionToExtend",
     "presentation": [
      "http://www.wearabledevices.co.il/role/LeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases extend term",
        "label": "Lessee, Operating Lease, Option to Extend",
        "documentation": "Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability."
       }
      }
     },
     "auth_ref": [
      "r364"
     ]
    },
    "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseRemainingLeaseTerm",
     "presentation": [
      "http://www.wearabledevices.co.il/role/LeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases remaining terms",
        "label": "Lessee, Operating Lease, Remaining Lease Term",
        "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r653"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/Lease"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LEASES",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r360"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL LIABILITIES",
        "label": "Liabilities",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r152",
      "r205",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r337",
      "r338",
      "r339",
      "r350",
      "r455",
      "r550",
      "r578",
      "r616",
      "r660",
      "r661"
     ]
    },
    "us-gaap_LiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAbstract",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities",
        "label": "Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL LIABILITIES AND SHAREHOLDERS\u2019 EQUITY",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r99",
      "r403",
      "r566",
      "r606",
      "r613",
      "r649"
     ]
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL CURRENT LIABILITIES",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r121",
      "r152",
      "r205",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r337",
      "r338",
      "r339",
      "r350",
      "r566",
      "r616",
      "r660",
      "r661"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CURRENT LIABILITIES:",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityInterestRateAtPeriodEnd",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit facility bore interest",
        "label": "Line of Credit Facility, Interest Rate at Period End",
        "documentation": "The effective interest rate at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityLineItems",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit Facility [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r605"
     ]
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit facility",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "wlds_LowestResetPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "LowestResetPrice",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lowest reset price (in Dollars per share)",
        "documentation": "Lowest reset price.",
        "label": "Lowest Reset Price"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_MachinesAndMoldsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "MachinesAndMoldsMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Machines and molds [Member]",
        "label": "Machines And Molds Member"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_MarketingGrantReceived": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "MarketingGrantReceived",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketing grant received",
        "documentation": "Marketing grant received percentage.",
        "label": "Marketing Grant Received"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails",
      "http://www.wearabledevices.co.il/role/ScheduleofAnnualRatesofDepreciationTable",
      "http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum [Member]",
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r219",
      "r220",
      "r221",
      "r222",
      "r276",
      "r376",
      "r410",
      "r447",
      "r448",
      "r510",
      "r512",
      "r514",
      "r515",
      "r517",
      "r536",
      "r537",
      "r553",
      "r559",
      "r563",
      "r567",
      "r618",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667"
     ]
    },
    "wlds_MaximumObligatinAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "MaximumObligatinAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum obligatin amount",
        "documentation": "Maximum obligatin amount.",
        "label": "Maximum Obligatin Amount"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails",
      "http://www.wearabledevices.co.il/role/ScheduleofAnnualRatesofDepreciationTable",
      "http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum [Member]",
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r219",
      "r220",
      "r221",
      "r222",
      "r276",
      "r376",
      "r410",
      "r447",
      "r448",
      "r510",
      "r512",
      "r514",
      "r515",
      "r517",
      "r536",
      "r537",
      "r553",
      "r559",
      "r563",
      "r567",
      "r618",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667"
     ]
    },
    "wlds_MoldMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "MoldMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofAnnualRatesofDepreciationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mold [Member]",
        "label": "Mold Member"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_MudraInspireDevelopmentKitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "MudraInspireDevelopmentKitsMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mudra Inspire Development Kits Member",
        "label": "Mudra Inspire Development Kits Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES:",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES:",
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r82",
      "r83"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES:",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow",
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET LOSS AND TOTAL COMPREHENSIVE LOSS",
        "terseLabel": "Net loss",
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r83",
      "r101",
      "r119",
      "r133",
      "r135",
      "r140",
      "r152",
      "r158",
      "r160",
      "r161",
      "r162",
      "r163",
      "r166",
      "r167",
      "r173",
      "r181",
      "r191",
      "r195",
      "r197",
      "r205",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r349",
      "r350",
      "r407",
      "r479",
      "r500",
      "r501",
      "r551",
      "r576",
      "r616"
     ]
    },
    "wlds_NetProceedsFromIssuanceSecondaryPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "NetProceedsFromIssuanceSecondaryPublicOffering",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net proceeds from secondary",
        "documentation": "The cash inflow associated with the amount received from entity's secondary offering of stock to the public.",
        "label": "Net Proceeds From Issuance Secondary Public Offering"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_NonconvertibleDebtSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "NonconvertibleDebtSecurities",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-convertible debt securities",
        "documentation": "Amount of non-convertible debt securities.",
        "label": "Nonconvertible Debt Securities"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_NumberOfSharesIssuedAndOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "NumberOfSharesIssuedAndOutstanding",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, Issued and outstanding",
        "documentation": "Number of shares Issued and outstanding.",
        "label": "Number Of Shares Issued And Outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_OfferingOrFinancingTransactionAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "OfferingOrFinancingTransactionAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offering or financing transaction amount",
        "documentation": "The amount of offering or financing transaction amount.",
        "label": "Offering Or Financing Transaction Amount"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Office furniture and equipment and leasehold improvements [Member]",
        "label": "Office Furniture And Equipment And Leasehold Improvements Member"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofAnnualRatesofDepreciationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Office furniture and electronic equipment [Member]",
        "label": "Office Furniture Machines Leasehold Improvements And Electronic Equipment Member"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_OfficerEmployeeMonthlySalary": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "OfficerEmployeeMonthlySalary",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Officer employee monthly salary (in New Shekels)",
        "documentation": "The amount of officer employee monthly salary.",
        "label": "Officer Employee Monthly Salary"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingCostsAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingCostsAndExpensesAbstract",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expenses:",
        "label": "Operating Costs and Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "OPERATING LOSS",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r181",
      "r191",
      "r195",
      "r197",
      "r551"
     ]
    },
    "us-gaap_OperatingLeaseExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/LeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total operating leases",
        "label": "Operating Lease, Expense",
        "documentation": "Amount of operating lease expense. Excludes sublease income."
       }
      }
     },
     "auth_ref": [
      "r652"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable",
      "http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total lease liabilities",
        "terseLabel": "Total operating lease liabilities",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r362"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesTable": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet",
      "http://www.wearabledevices.co.il/role/ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable",
      "http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liabilities",
        "verboseLabel": "Short term",
        "negatedLabel": "Less operating lease liabilities, current",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r362"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.wearabledevices.co.il/role/ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesTable": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet",
      "http://www.wearabledevices.co.il/role/ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable",
      "http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liabilities",
        "verboseLabel": "Long term",
        "netLabel": "Operating lease liabilities, non-current",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r362"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet",
      "http://www.wearabledevices.co.il/role/ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets (Note 5)",
        "verboseLabel": "Right of use assets",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r361"
     ]
    },
    "us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeasesOfLesseeDisclosureTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/LeaseTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Classification of Operating Lease Right-of-Use Assets and Liabilities",
        "label": "Lessee, Operating Lease, Disclosure [Table Text Block]",
        "documentation": "Tabular disclosure for lessee's operating leases. Includes, but is not limited to, description of lessee's operating lease, existence and terms of renewal or purchase options and escalation clauses, restrictions imposed by lease, such as those concerning dividends, additional debt, and further leasing, rent holidays, rent concessions, or leasehold improvement incentives and unusual provisions or conditions."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r103",
      "r104",
      "r105",
      "r106"
     ]
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/TaxesonIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Carryforward tax losses (in Dollars)",
        "label": "Operating Loss Carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "wlds_OptionsAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "OptionsAvailableForGrant",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options available for grant",
        "documentation": "Total available options for grant,",
        "label": "Options Available For Grant"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_OptionsExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "OptionsExpenses",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Option expenses (in Dollars)",
        "documentation": "The amount options expenses.",
        "label": "Options Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_OrdinaryShareParValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "OrdinaryShareParValue",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary share par value (in New Shekels per share)",
        "documentation": "Ordinary share par value.",
        "label": "Ordinary Share Par Value"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_OrdinarySharePerValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "OrdinarySharePerValue",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary share per value (in Dollars per share)",
        "documentation": "The ordinary share per value.",
        "label": "Ordinary Share Per Value"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_OrdinarySharesAuthorizedIncreased": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "OrdinarySharesAuthorizedIncreased",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares authorized increased",
        "documentation": "Ordinary shares authorized increased.",
        "label": "Ordinary Shares Authorized Increased"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_OrdinarySharesInConsiderationPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "OrdinarySharesInConsiderationPercentage",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares in consideration percentage",
        "documentation": "Ordinary shares in consideration percentage.",
        "label": "Ordinary Shares In Consideration Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_OrdinarySharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "OrdinarySharesIssued",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares issued",
        "documentation": "Ordinary Shares Issued.",
        "label": "Ordinary Shares Issued"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_OrdinarySharesNIS001ParValuePerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "OrdinarySharesNIS001ParValuePerShareMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary Shares, NIS 0.01 par value per share",
        "label": "Ordinary Shares NIS001 Par Value Per Share Member"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_OrdinarySharesWarrantExercisable": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "OrdinarySharesWarrantExercisable",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares warrants exercisable",
        "documentation": "Ordinary shares warrants exercisable.",
        "label": "Ordinary Shares Warrant Exercisable"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_OrdinarySharesWarrantsHeldByNonaffiliates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "OrdinarySharesWarrantsHeldByNonaffiliates",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares warrants held by non-affiliates",
        "documentation": "Amount of ordinary shares warrants held by non-affiliates.",
        "label": "Ordinary Shares Warrants Held By Nonaffiliates"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "General [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/General"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "GENERAL",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r95",
      "r417",
      "r418"
     ]
    },
    "us-gaap_OtherBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherBorrowings",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial credit",
        "label": "Other Borrowings",
        "documentation": "The carrying amount as of the balance sheet date for the aggregate of other miscellaneous borrowings owed by the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "us-gaap_OtherCommitmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCommitmentsAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Commitments [Axis]",
        "documentation": "Information by type of other commitment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCommitmentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCommitmentsDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Commitments [Domain]",
        "documentation": "Other future obligation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OverAllotmentOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OverAllotmentOptionMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Over-Allotment Option [Member]",
        "label": "Over-Allotment Option [Member]",
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PartnerTypeOfPartnersCapitalAccountAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PartnerTypeOfPartnersCapitalAccountAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Partner Type [Axis]",
        "documentation": "Information by type or class of partner's capital account. Examples of classes of partners include, but not limited to, general partners, limited partners, preferred partners, and other ownership interests."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r433"
     ]
    },
    "us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PartnerTypeOfPartnersCapitalAccountNameDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Partner Type of Partners' Capital Account, Name [Domain]",
        "documentation": "Capital accounts of each type or class of partner. Examples of classes of partners include, but are not limited to, general partners, limited partners, preferred partners, and other ownership interests."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r433"
     ]
    },
    "wlds_PayIncreasedRoyaltiesDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "PayIncreasedRoyaltiesDescription",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay increased royalties, description",
        "documentation": "Pay increased royalties, description.",
        "label": "Pay Increased Royalties Description"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_PaymentOnBehalfOfIssuedShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "PaymentOnBehalfOfIssuedShares",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payment on behalf of issued shares",
        "documentation": "Amount of payment on behalf of issued shares.",
        "label": "Payment On Behalf Of Issued Shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForRent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForRent",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rent payment",
        "label": "Payments for Rent",
        "documentation": "Cash payments to lessor's for use of assets under operating leases."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net of issuance expenses",
        "label": "Payments of Stock Issuance Costs",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "us-gaap_PaymentsToAcquireRestrictedCertificatesOfDeposit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireRestrictedCertificatesOfDeposit",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Investment in deposits, net",
        "label": "Payments to Acquire Restricted Certificates of Deposit",
        "documentation": "The cash outflow from temporary investment with specific maturity and interest rate that are prohibited for current use."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "wlds_PercentageOfFinancing": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "PercentageOfFinancing",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing rate",
        "documentation": "The percentage of financing.",
        "label": "Percentage Of Financing"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_PercentageOfOwnership": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "PercentageOfOwnership",
     "presentation": [
      "http://www.wearabledevices.co.il/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of ownership",
        "documentation": "Percentage of ownership.",
        "label": "Percentage Of Ownership"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_PremoneyValuationAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "PremoneyValuationAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-money valuation amount (in Dollars)",
        "documentation": "The amount of pre money valuation amount.",
        "label": "Premoney Valuation Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other receivables and prepaid expenses",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r599"
     ]
    },
    "wlds_PrepaymentsOfLeasing": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "PrepaymentsOfLeasing",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepayments of leasing",
        "documentation": "The amount of prepayments of leasing.",
        "label": "Prepayments Of Leasing"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromConvertibleDebt",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate amount (in Dollars)",
        "label": "Proceeds from Convertible Debt",
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "wlds_ProceedsFromIssuanceFollowOnPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ProceedsFromIssuanceFollowOnPublicOffering",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross proceeds (in Dollars)",
        "documentation": "The cash inflow associated with the amount received from entity's additional offering of stock to the public.",
        "label": "Proceeds From Issuance Follow On Public Offering"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Raised net proceeds",
        "label": "Proceeds from Issuance Initial Public Offering",
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from ordinary shares",
        "label": "Proceeds from Issuance of Common Stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "wlds_ProceedsFromIssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ProceedsFromIssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of ordinary shares and warrants, net of issuance cost",
        "documentation": "Amount of proceeds from issuance of ordinary shares and warrants, net of issuance cost.",
        "label": "Proceeds From Issuance Of Ordinary Shares And Warrants Net Of Issuance Cost"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of ordinary shares as a result of exercise of warrants",
        "documentation": "Amount of proceeds from issuance of ordinary shares as a result of exercise of warrants.",
        "label": "Proceeds From Issuance Of Ordinary Shares As AResult Of Exercise Of Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ProceedsFromIssuanceOfSAFEs": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ProceedsFromIssuanceOfSAFEs",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of SAFEs",
        "documentation": "The cash inflow from the SAFE investor.",
        "label": "Proceeds From Issuance Of SAFEs"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of shares issued in the public offering, net of issuance cost",
        "documentation": "Represent the amount of proceeds from issuance of shares issued in the public offering, net of issuance cost",
        "label": "Proceeds From Issuance Of Shares Issued In The Public Offering Net Of Issuance Cost"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPubli": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPubli",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of units of ordinary shares and warrants in connection with the initial public offering, net of issuance expenses",
        "documentation": "Amount of proceeds from issuance of units of ordinary shares and warrants in connection with the initial public offering, net of issuance expenses.",
        "label": "Proceeds From Issuance Of Units Of Ordinary Shares And Warrants In Connection With The Initial Publi"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromLinesOfCredit",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from credit line",
        "label": "Proceeds from Lines of Credit",
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r605"
     ]
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of options",
        "label": "Proceeds from Stock Options Exercised",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r11"
     ]
    },
    "wlds_ProductionTransferred": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ProductionTransferred",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Production transferred",
        "documentation": "Production transferred.",
        "label": "Production Transferred"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and Equipment, Net [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails",
      "http://www.wearabledevices.co.il/role/ScheduleofAnnualRatesofDepreciationTable",
      "http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/PropertyandEquipmentNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PROPERTY AND EQUIPMENT, net",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r112",
      "r115",
      "r116"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost",
        "label": "Property, Plant and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r124",
      "r406"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet",
      "http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, net (Note 4)",
        "verboseLabel": "Total property and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r396",
      "r406",
      "r566"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r112",
      "r115",
      "r404"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/PropertyandEquipmentNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Property and Equipment Net",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails",
      "http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "wlds_ProspectiveInitialPublicOfferingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ProspectiveInitialPublicOfferingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Initial public offering expenses",
        "documentation": "Amount of initial public offering (IPO) refers to the process of offering shares of a private corporation to the public in a new stock issuance for the first time.",
        "label": "Prospective Initial Public Offering Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_PurchasePricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "PurchasePricePerShare",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase price per share",
        "documentation": "Purchase price per share.",
        "label": "Purchase Price Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails",
      "http://www.wearabledevices.co.il/role/ScheduleofAnnualRatesofDepreciationTable",
      "http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r219",
      "r220",
      "r221",
      "r222",
      "r274",
      "r276",
      "r304",
      "r305",
      "r306",
      "r375",
      "r376",
      "r410",
      "r447",
      "r448",
      "r510",
      "r512",
      "r514",
      "r515",
      "r517",
      "r536",
      "r537",
      "r553",
      "r559",
      "r563",
      "r567",
      "r570",
      "r614",
      "r618",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails",
      "http://www.wearabledevices.co.il/role/ScheduleofAnnualRatesofDepreciationTable",
      "http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r219",
      "r220",
      "r221",
      "r222",
      "r274",
      "r276",
      "r304",
      "r305",
      "r306",
      "r375",
      "r376",
      "r410",
      "r447",
      "r448",
      "r510",
      "r512",
      "r514",
      "r515",
      "r517",
      "r536",
      "r537",
      "r553",
      "r559",
      "r563",
      "r567",
      "r570",
      "r614",
      "r618",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667"
     ]
    },
    "wlds_RateOfMonthlySeverancePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "RateOfMonthlySeverancePercentage",
     "presentation": [
      "http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rate of monthly severance, percentage",
        "documentation": "The percentage of severance  monthly deposits rate can take their monthly salary.",
        "label": "Rate Of Monthly Severance Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_RefundToSAFEInvestors": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "RefundToSAFEInvestors",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Refund to SAFE investors",
        "documentation": "Amount of refund to SAFE investors.",
        "label": "Refund To SAFEInvestors"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_RelatedPartiesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "RelatedPartiesDetailsTable",
     "presentation": [
      "http://www.wearabledevices.co.il/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Parties (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/RelatedPartiesDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party, Type [Domain]",
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r275",
      "r371",
      "r372",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r475",
      "r477",
      "r509"
     ]
    },
    "wlds_RelatedPartyMonthlySalary": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "RelatedPartyMonthlySalary",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Monthly salary",
        "documentation": "The amount of related party monthly salary.",
        "label": "Related Party Monthly Salary"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Axis]",
        "documentation": "Information by type of related party transaction."
       }
      }
     },
     "auth_ref": [
      "r371",
      "r372",
      "r659"
     ]
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Domain]",
        "documentation": "Transaction between related party."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://www.wearabledevices.co.il/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Parties [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r483",
      "r484",
      "r487"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Parties [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/RelatedPartiesDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party, Type [Axis]",
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r275",
      "r371",
      "r372",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r475",
      "r477",
      "r509",
      "r659"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/RelatedParties"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RELATED PARTIES",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r368",
      "r369",
      "r370",
      "r372",
      "r373",
      "r427",
      "r428",
      "r429",
      "r485",
      "r486",
      "r487",
      "r506",
      "r508"
     ]
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfLinesOfCredit",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayment of credit line",
        "label": "Repayments of Lines of Credit",
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r605"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Research and development, net (Note 6a)",
        "label": "Research and Development Expense",
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r316",
      "r668"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofShareBasedCompensationExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development Expense [Member]",
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r315"
     ]
    },
    "wlds_ResearchAndDevelopmentGrantsDetection": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ResearchAndDevelopmentGrantsDetection",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development grants",
        "documentation": "The amount of grants detection from the value of research and development expenses.",
        "label": "Research And Development Grants Detection"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated losses",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r92",
      "r402",
      "r414",
      "r416",
      "r425",
      "r458",
      "r566"
     ]
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueRecognitionPolicyTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue recognition",
        "label": "Revenue [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources."
       }
      }
     },
     "auth_ref": [
      "r481",
      "r539",
      "r548"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement",
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenues",
        "label": "Revenues",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r152",
      "r182",
      "r183",
      "r190",
      "r193",
      "r194",
      "r198",
      "r199",
      "r201",
      "r205",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r350",
      "r395",
      "r616"
     ]
    },
    "us-gaap_RevenuesNetOfInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenuesNetOfInterestExpense",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenues",
        "label": "Revenues, Net of Interest Expense",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income after deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r183",
      "r190",
      "r193",
      "r194",
      "r198",
      "r199",
      "r201"
     ]
    },
    "wlds_RightofUseAssetRecognizedAgainstLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "RightofUseAssetRecognizedAgainstLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use asset recognized against lease liability",
        "documentation": "The amount is right-of use asset recognized against lease liability.",
        "label": "Rightof Use Asset Recognized Against Lease Liability"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_RoyaltiesRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "RoyaltiesRate",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalties rate",
        "documentation": "Percentage of royalties rate.",
        "label": "Royalties Rate"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_RoyaltiesRatePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "RoyaltiesRatePercentage",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalties rate percentage",
        "documentation": "Royalties rate percentage.",
        "label": "Royalties Rate Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_SAFEsAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "SAFEsAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SAFEs amount (in Dollars)",
        "documentation": "The amount of SAFEs.",
        "label": "SAFEs Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net proceeds",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "documentation": "Cash received on stock transaction after deduction of issuance costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CreditFacilityDetails",
      "http://www.wearabledevices.co.il/role/GeneralDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "wlds_SalesAndMarketingExpensesDeductions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "SalesAndMarketingExpensesDeductions",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sales and marketing deductions",
        "documentation": "Amount of sales and marketing expenses deductions.",
        "label": "Sales And Marketing Expenses Deductions"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScenarioForecastMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScenarioForecastMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forecast [Member]",
        "label": "Forecast [Member]"
       }
      }
     },
     "auth_ref": [
      "r277",
      "r610"
     ]
    },
    "srt_ScenarioUnspecifiedDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScenarioUnspecifiedDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]"
       }
      }
     },
     "auth_ref": [
      "r168",
      "r277",
      "r592",
      "r610"
     ]
    },
    "wlds_ScheduleOfAnnualRatesOfDepreciationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ScheduleOfAnnualRatesOfDepreciationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Annual Rates Of Depreciation Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ScheduleOfAnnualRatesOfDepreciationTableTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Annual Rates of Depreciation",
        "documentation": "Tabular disclosure of annual rates of depreciation.",
        "label": "Schedule Of Annual Rates Of Depreciation Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCapitalizationEquityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfCapitalizationEquityLineItems",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable",
      "http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of share capital [Line Items]",
        "terseLabel": "Schedule of share capital [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ScheduleOfClassificationOfOperatingLeaseRightOfUseAssetsAndLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ScheduleOfClassificationOfOperatingLeaseRightOfUseAssetsAndLiabilitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Classification of Operating Lease Right-of-Use Assets and Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofShareBasedCompensationExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-Based Compensation Expenses",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r202",
      "r203",
      "r204"
     ]
    },
    "wlds_ScheduleOfFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ScheduleOfFutureMinimumLeasePaymentsUnderOurOperatingLeaseLiabilitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Future Minimum Lease Payments Under Our Operating Lease Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/InventoriesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Inventories",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r72",
      "r73",
      "r74"
     ]
    },
    "wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Issuance of Equity Warrants to Investors and Associate",
        "documentation": "Tabular disclosure of the change in Issuance of equity warrants to investors and associat.",
        "label": "Schedule Of Issuance Of Equity Warrants To Investors And Associat Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Issuance Of Equity Warrants To Investors And Associate Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateLineItems",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Issuance of Equity Warrants to Investors and Associate [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ScheduleOfOptionsActivityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ScheduleOfOptionsActivityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Options Activity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ScheduleOfOptionsToConsultantsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ScheduleOfOptionsToConsultantsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Options To Consultants Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ScheduleOfOptionsToConsultantsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ScheduleOfOptionsToConsultantsLineItems",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Options to Consultants [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ScheduleOfOptionsToConsultantsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ScheduleOfOptionsToConsultantsTableTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Options to Consultants",
        "documentation": "Tabular disclosure of stock options issued to consultants.",
        "label": "Schedule Of Options To Consultants Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ScheduleOfPropertyAndEquipmentNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ScheduleOfPropertyAndEquipmentNetAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Property And Equipment Net Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "wlds_ScheduleOfShareBasedCompensationExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ScheduleOfShareBasedCompensationExpensesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Share Based Compensation Expenses Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ScheduleOfShareBasedCompensationExpensesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ScheduleOfShareBasedCompensationExpensesLineItems",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofShareBasedCompensationExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share-Based Compensation Expenses [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Options Activity",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r10",
      "r46"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of weighted-Average Assumptions",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "wlds_ScheduleOfShareCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ScheduleOfShareCapitalAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Share Capital Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfStockholdersEquityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfStockholdersEquityTableTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share Capital",
        "label": "Schedule of Stockholders Equity [Table Text Block]",
        "documentation": "Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SOFR Member",
        "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]",
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg."
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r580"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r582"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/TaxesonIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]"
       }
      }
     },
     "auth_ref": [
      "r199",
      "r200",
      "r444",
      "r445",
      "r446",
      "r511",
      "r513",
      "r516",
      "r518",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r540",
      "r560",
      "r570",
      "r619",
      "r669"
     ]
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Information",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r199",
      "r552"
     ]
    },
    "us-gaap_SellingAndMarketingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SellingAndMarketingExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Sales and marketing expenses, net (Note 6b)",
        "label": "Selling and Marketing Expense",
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SellingAndMarketingExpenseMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofShareBasedCompensationExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling and Marketing Expense [Member]",
        "label": "Selling and Marketing Expense [Member]",
        "documentation": "Primary financial statement caption encompassing selling and marketing expense."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "wlds_September132022Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "September132022Member",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "September 13, 2022 [Member]",
        "label": "September132022 Member"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_September152022OneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "September152022OneMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "September 15, 2022 [Member]",
        "label": "September152022 One Member"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_September152022ThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "September152022ThreeMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "September 15, 2022 [Member]",
        "label": "September152022 Three Member"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_September152022TwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "September152022TwoMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "September 15, 2022 [Member]",
        "label": "September152022 Two Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series of Individually Immaterial Business Acquisitions [Member]",
        "label": "Series of Individually Immaterial Business Acquisitions [Member]",
        "documentation": "Represents the aggregation and reporting of combined amounts of individually immaterial business combinations that were completed during the period."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "wlds_ServicesInExchangeForMonthlyBaseFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ServicesInExchangeForMonthlyBaseFee",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Services in exchange for monthly base fee",
        "documentation": "The amount of services in exchange for monthly base fee.",
        "label": "Services In Exchange For Monthly Base Fee"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_SeverancePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "SeverancePolicyTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Severance",
        "documentation": "Disclosure of accounting policy for severance.",
        "label": "Severance Policy Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow",
      "http://www.wearabledevices.co.il/role/ScheduleofShareBasedCompensationExpensesTable",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation",
        "verboseLabel": "Share based compensation expenses",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageAssumptionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected life of options",
        "documentation": "Expected life of options in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Expected Life Of Options"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Weighted Average Assumptions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageAssumptionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected dividend yield",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r305"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageAssumptionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk free interest rate",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r306"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageAssumptionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected stock price volatility",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate",
        "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r304"
     ]
    },
    "wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value option grant date (in Dollars per share)",
        "documentation": "The fair value option granted date during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Option Grant Date"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options to ordinary shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized",
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of warrants/options",
        "verboseLabel": "Options available for grant",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r564"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable at end, Amount of options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r285"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding - beginning, Weighted average exercise price",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r285"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Expired or forfeited amount of options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r289"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted amount of options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r287"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted weighted average exercise price (in Dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r297"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding - beginning, Amount of options",
        "periodEndLabel": "Outstanding - end, Amount of options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r283",
      "r284"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price (in Dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r283",
      "r284"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Outstanding - end, Weighted average exercise price",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r300"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable at end, Weighted average exercise price",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r299"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "In connection with",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Plan Modification, Description and Terms",
        "documentation": "Description of modification of award under share-based payment arrangement. Includes, but is not limited to, terms for expiration date, vesting rights and exercise price."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "No. of options issued",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period",
        "documentation": "Number of shares issued under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise ratio",
        "documentation": "Description of exercise ratio.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Exercise Ratio"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration date",
        "documentation": "Description of Expiration date\r    \r   \n.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Expiration Date"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ShareBasedCompensationArrangementNotes": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ShareBasedCompensationArrangementNotes",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes",
        "documentation": "Description of Notes.",
        "label": "Share Based Compensation Arrangement Notes"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r279",
      "r280",
      "r281",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercised weighted average exercise price",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r288"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expired or forfeited weighted average exercise price",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r289"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted weighted average exercise price",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r287"
     ]
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share based compensation",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r278",
      "r282",
      "r301",
      "r302",
      "r303",
      "r304",
      "r307",
      "r311",
      "r312",
      "r313",
      "r314"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit",
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range."
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "No. of options exercisable",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable",
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharePrice",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails",
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share price (in Dollars per share)",
        "verboseLabel": "Share price",
        "label": "Share Price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r300"
     ]
    },
    "wlds_ShareholdersEquityDeficitDetailsScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ShareholdersEquityDeficitDetailsScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders\u2019 Equity (Deficit) (Details) - Schedule of Issuance of Equity Warrants to Investors and Associate [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ShareholdersEquityDeficitDetailsScheduleofOptionstoConsultantsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ShareholdersEquityDeficitDetailsScheduleofOptionstoConsultantsTable",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders\u2019 Equity (Deficit) (Details) - Schedule of Options to Consultants [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ShareholdersEquityDeficitDetailsScheduleofShareCapitalParentheticalsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ShareholdersEquityDeficitDetailsScheduleofShareCapitalParentheticalsTable",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders\u2019 Equity (Deficit) (Details) - Schedule of Share Capital (Parentheticals) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ShareholdersEquityDeficitDetailsScheduleofShareCapitalTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ShareholdersEquityDeficitDetailsScheduleofShareCapitalTable",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders\u2019 Equity (Deficit) (Details) - Schedule of Share Capital [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ShareholdersEquityDeficitDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ShareholdersEquityDeficitDetailsTable",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders\u2019 Equity (Deficit) (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ShareholdersEquityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ShareholdersEquityLineItems",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholder's Equity [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharesIssued",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary A shares",
        "label": "Shares, Issued",
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharesIssuedPricePerShare",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary share price (in Dollars per share)",
        "label": "Shares Issued, Price Per Share",
        "documentation": "Per share or per unit amount of equity securities issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance (in Shares)",
        "periodEndLabel": "Balance (in Shares)",
        "label": "Shares, Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "wlds_SignificantAccountingPoliciesDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "SignificantAccountingPoliciesDetailsLineItems",
     "presentation": [
      "http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_SignificantAccountingPoliciesDetailsScheduleofAnnualRatesofDepreciationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "SignificantAccountingPoliciesDetailsScheduleofAnnualRatesofDepreciationTable",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofAnnualRatesofDepreciationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies (Details) - Schedule of Annual Rates of Depreciation [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_SignificantAccountingPoliciesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "SignificantAccountingPoliciesDetailsTable",
     "presentation": [
      "http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/SignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SIGNIFICANT ACCOUNTING POLICIES",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r149"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation",
      "http://www.wearabledevices.co.il/role/GeneralDetails",
      "http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable",
      "http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable_Parentheticals",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r127",
      "r128",
      "r129",
      "r152",
      "r171",
      "r172",
      "r174",
      "r176",
      "r179",
      "r180",
      "r205",
      "r223",
      "r225",
      "r226",
      "r227",
      "r230",
      "r231",
      "r259",
      "r260",
      "r262",
      "r265",
      "r271",
      "r350",
      "r421",
      "r422",
      "r423",
      "r424",
      "r430",
      "r431",
      "r432",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r443",
      "r457",
      "r480",
      "r502",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r591",
      "r604",
      "r611"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r24",
      "r118",
      "r138",
      "r139",
      "r140",
      "r155",
      "r156",
      "r157",
      "r159",
      "r165",
      "r167",
      "r178",
      "r206",
      "r207",
      "r273",
      "r308",
      "r309",
      "r310",
      "r328",
      "r329",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r347",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r367",
      "r411",
      "r412",
      "r413",
      "r430",
      "r502"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/TaxesonIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]"
       }
      }
     },
     "auth_ref": [
      "r199",
      "r200",
      "r444",
      "r445",
      "r446",
      "r511",
      "r513",
      "r516",
      "r518",
      "r525",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r540",
      "r560",
      "r570",
      "r619",
      "r669"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r155",
      "r156",
      "r157",
      "r178",
      "r378",
      "r419",
      "r443",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r457",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r466",
      "r467",
      "r468",
      "r469",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r477",
      "r481",
      "r482",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r502",
      "r571"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_StatementScenarioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "StatementScenarioAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "auth_ref": [
      "r168",
      "r277",
      "r592",
      "r593",
      "r610"
     ]
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r155",
      "r156",
      "r157",
      "r178",
      "r378",
      "r419",
      "r443",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r457",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r466",
      "r467",
      "r468",
      "r469",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r477",
      "r481",
      "r482",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r502",
      "r571"
     ]
    },
    "wlds_StockIssuedDuringPeriodShareOfExerciseOfOptionsinShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "StockIssuedDuringPeriodShareOfExerciseOfOptionsinShares",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of options (in Shares)",
        "documentation": "Shares of exercise of options.",
        "label": "Stock Issued During Period Share Of Exercise Of Optionsin Shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of convertible securities (including accrued interest) to ordinary shares (in Shares)",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r23",
      "r42",
      "r92",
      "r249"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesConversionOfUnits",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of ordinary shares and warrants, net of issuance cost (in Shares)",
        "label": "Stock Issued During Period, Shares, Conversion of Units",
        "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit)."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r42",
      "r65",
      "r66",
      "r92"
     ]
    },
    "wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "StockIssuedDuringPeriodSharesExerciseOfWarrants",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of warrants (in Shares)",
        "verboseLabel": "Exercised ordinary shares",
        "documentation": "Shares issued from the exercise of warrants",
        "label": "Stock Issued During Period Shares Exercise Of Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_StockIssuedDuringPeriodSharesInvestors": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "StockIssuedDuringPeriodSharesInvestors",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of shares to April 2021 investors (Note 7) (in Shares)",
        "documentation": "Shares issued to investors",
        "label": "Stock Issued During Period Shares Investors"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued in the public offering, net of issuance cost (in Shares)",
        "verboseLabel": "Secondary ordinary share (in Shares)",
        "label": "Stock Issued During Period, Shares, New Issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r65",
      "r66",
      "r92",
      "r421",
      "r502",
      "r520"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Exercised amount of options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r65",
      "r66",
      "r92",
      "r288"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of convertible securities (including accrued interest) to ordinary shares",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r24",
      "r92"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Securities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_StockIssuedDuringPeriodValueExerciseOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "StockIssuedDuringPeriodValueExerciseOfWarrants",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of warrants",
        "documentation": "Represent the value of stock issued during the period from the exercise of warrants.",
        "label": "Stock Issued During Period Value Exercise Of Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_StockIssuedDuringPeriodValueInvestors": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "StockIssuedDuringPeriodValueInvestors",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of shares to April 2021 investors (Note 7)",
        "documentation": "Represent the value of stock issued during the period to investors.",
        "label": "Stock Issued During Period Value Investors"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued in the public offering, net of issuance cost",
        "label": "Stock Issued During Period, Value, New Issues",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r65",
      "r66",
      "r92",
      "r430",
      "r502",
      "r520",
      "r577"
     ]
    },
    "wlds_StockIssuedDuringPeriodValueOfPaymentOnBehalfOfSharesIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "StockIssuedDuringPeriodValueOfPaymentOnBehalfOfSharesIssued",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payment on behalf of issued shares",
        "documentation": "Value of stock issued for payment on behalf of issued shares.",
        "label": "Stock Issued During Period Value Of Payment On Behalf Of Shares Issued"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueOther",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of SAFEs into ordinary shares upon completion of initial public offering",
        "label": "Stock Issued During Period, Value, Other",
        "documentation": "Value of shares of stock issued attributable to transactions classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of options",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r24",
      "r92"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL SHAREHOLDERS\u2019 EQUITY",
        "periodStartLabel": "Balance",
        "periodEndLabel": "Balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r69",
      "r70",
      "r85",
      "r459",
      "r476",
      "r503",
      "r504",
      "r566",
      "r578",
      "r606",
      "r613",
      "r649",
      "r674"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SHAREHOLDERS\u2019 EQUITY (Note 9):",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders' Equity (Deficit) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SHAREHOLDERS\u2019 EQUITY (DEFICIT)",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r151",
      "r258",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r273",
      "r346",
      "r505",
      "r507",
      "r524"
     ]
    },
    "wlds_SubscriptionReceivablesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "SubscriptionReceivablesMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subscription receivables (ordinary shares)",
        "label": "Subscription Receivables Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Member]",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r358",
      "r374"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r358",
      "r374"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r358",
      "r374"
     ]
    },
    "us-gaap_SubsequentEventsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events",
        "label": "Subsequent Events, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for reporting subsequent events."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CreditFacilityDetails",
      "http://www.wearabledevices.co.il/role/GeneralDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalCashFlowElementsAbstract",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental Disclosure:",
        "label": "Supplemental Cash Flow Elements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_TaxesonIncomeDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "TaxesonIncomeDetailsTable",
     "presentation": [
      "http://www.wearabledevices.co.il/role/TaxesonIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes on Income (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquityAggregateAmountOfRedemptionRequirement",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate amount (in Dollars)",
        "label": "Temporary Equity, Aggregate Amount of Redemption Requirement",
        "documentation": "Aggregate amount of redemption requirements for each class or type of redeemable stock classified as temporary equity for each of the five years following the latest balance sheet date. The redemption requirement does not constitute an unconditional obligation that will be settled in a variable number of shares constituting a monetary value predominantly indexed to (a) a fixed monetary amount known at inception, (b) an amount inversely correlated with the residual value of the entity, or (c) an amount determined by reference to something other than the fair value of issuer's stock. Does not include mandatorily redeemable stock. The exception is if redemption is required upon liquidation or termination of the reporting entity."
       }
      }
     },
     "auth_ref": []
    },
    "wlds_TerminationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "TerminationPeriod",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination period",
        "documentation": "Termination period.",
        "label": "Termination Period"
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r612",
      "r658"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_TotalCashReceivedFromTheIIA": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "TotalCashReceivedFromTheIIA",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total cash received from the IIA",
        "documentation": "Total cash received from the IIA.",
        "label": "Total Cash Received From The IIA"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_TotalConsiderationAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "TotalConsiderationAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total consideration amount (in Dollars)",
        "documentation": "The amount of Total consideration.",
        "label": "Total Consideration Amount"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_TotalValueOfTheShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "TotalValueOfTheShares",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total value of the shares (in Dollars)",
        "documentation": "Total value of the shares.",
        "label": "Total Value Of The Shares"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "wlds_TransactionFeeClosingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "TransactionFeeClosingValue",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transaction fee closing value",
        "documentation": "The amount of transaction fee closing value.",
        "label": "Transaction Fee Closing Value"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_TwoThousandFifteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "TwoThousandFifteenMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2015 [Member]",
        "label": "Two Thousand Fifteen Member"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_TwoThousandSeventeenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "TwoThousandSeventeenMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2017 [Member]",
        "label": "Two Thousand Seventeen Member"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_TwoThousandTwentyThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "TwoThousandTwentyThreeMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023 [Member]",
        "label": "Two Thousand Twenty Three Member"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_TwoThousandTwentyoneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "TwoThousandTwentyoneMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2021 [Member]",
        "label": "Two Thousand Twentyone Member"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_TwoZeroOneFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "TwoZeroOneFiveMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2015 Plan [Member]",
        "label": "Two Zero One Five Member"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_UnderwritingDiscountsAndCommissions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "UnderwritingDiscountsAndCommissions",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underwriting discounts and commissions",
        "documentation": "It represent underwriting discounts and commissions.",
        "label": "Underwriting Discounts And Commissions"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_UnderwritingNetProceed": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "UnderwritingNetProceed",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underwriting net proceed",
        "documentation": "Amount of net proceeds after deducting.",
        "label": "Underwriting Net Proceed"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r36",
      "r37",
      "r109",
      "r110",
      "r113",
      "r114"
     ]
    },
    "wlds_ValueOfOrdinaryAShare": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "ValueOfOrdinaryAShare",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Value of Ordinary A share (in Dollars)",
        "documentation": "Value of ordinary A shares.",
        "label": "Value Of Ordinary AShare"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableRateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableRateAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Rate [Axis]",
        "documentation": "Information by type of variable rate."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableRateDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableRateDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Rate [Domain]",
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VehiclesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VehiclesMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vehicles [Member]",
        "label": "Vehicles [Member]",
        "documentation": "Equipment used primarily for road transportation."
       }
      }
     },
     "auth_ref": []
    },
    "wlds_VestingPeriods": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "VestingPeriods",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting periods",
        "documentation": "Expensed over vesting periods.",
        "label": "Vesting Periods"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_WarrantBeReducedToAnExercisePricePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "WarrantBeReducedToAnExercisePricePercentage",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant be reduced to an exercise price percentage",
        "documentation": "Warrant be reduced to an exercise price percentage.",
        "label": "Warrant Be Reduced To An Exercise Price Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails",
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant [Member]",
        "label": "Warrant [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r568",
      "r569",
      "r572",
      "r573",
      "r574",
      "r575"
     ]
    },
    "wlds_WarrantPricePerSharePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "WarrantPricePerSharePercentage",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant price per share percentage",
        "documentation": "Percentage of warrant price per share.",
        "label": "Warrant Price Per Share Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_Warrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "Warrants",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants (in Shares)",
        "documentation": "Number of warrants.",
        "label": "Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantsAndRightsOutstandingTerm",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant period",
        "label": "Warrants and Rights Outstanding, Term",
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r648"
     ]
    },
    "wlds_WarrantsExerciseIntoOrdinaryShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "WarrantsExerciseIntoOrdinaryShares",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant exercised (in Shares)",
        "documentation": "It represent the warrants were exercised into ordinary shares.",
        "label": "Warrants Exercise Into Ordinary Shares"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_WarrantsExercisePricePerShare": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "WarrantsExercisePricePerShare",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant price",
        "documentation": "Warrants exercise price per share.",
        "label": "Warrants Exercise Price Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_WarrantsIssuedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "WarrantsIssuedPercentage",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants issued percentage",
        "documentation": "The warrants issued percentage.",
        "label": "Warrants Issued Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_WarrantsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "WarrantsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants",
        "documentation": "Disclosure of accounting policy for warrants.",
        "label": "Warrants Policy Policy Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_WarrantsToPurchaseOrdinarySharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "WarrantsToPurchaseOrdinarySharesMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants to Purchase Ordinary Shares",
        "label": "Warrants To Purchase Ordinary Shares Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average number of ordinary shares outstanding diluted",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r176"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average number of ordinary shares outstanding basic (in Shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r169",
      "r176"
     ]
    },
    "wlds_WeightedAveragePricePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20231231",
     "localname": "WeightedAveragePricePercentage",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average price percentage",
        "documentation": "Weighted average price percentage.",
        "label": "Weighted Average Price Percentage"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(g)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c),(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.21)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.25)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB TOPIC 4.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-5"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-31"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.17)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "985",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//205/tableOfContent"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//235/tableOfContent"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//360/tableOfContent"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//440/tableOfContent"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//470/tableOfContent"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//505/tableOfContent"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 4.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-5"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//810/tableOfContent"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.13,16)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481440/840-10-50-2"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "40",
   "Subparagraph": "(Note 3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481418/840-10-55-40"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481501/840-20-50-1"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481501/840-20-50-2"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "210",
   "Topic": "946",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-20"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "270",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-6"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//330/tableOfContent"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-4"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//718/tableOfContent"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483044/730-10-05-1"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//740/tableOfContent"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//830/tableOfContent"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//842-20/tableOfContent"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//850/tableOfContent"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "330",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482105/912-330-50-1"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-3"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-21"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-6"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3"
  },
  "r594": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r595": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r596": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r597": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r598": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r599": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r601": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r602": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r603": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r604": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r605": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r606": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r607": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r608": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r609": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r610": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r611": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55"
  },
  "r612": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13"
  },
  "r613": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r614": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10"
  },
  "r615": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//450/tableOfContent"
  },
  "r616": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r617": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r618": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r619": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r620": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r621": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r622": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r623": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r624": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r625": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r626": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r627": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r628": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r629": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r630": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r631": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r632": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r633": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r634": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r635": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r636": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r637": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r638": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r639": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r640": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r641": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r642": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r643": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r644": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r645": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r646": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480682/815-20-25-6A"
  },
  "r647": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r648": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r649": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r650": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-1"
  },
  "r651": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-1"
  },
  "r652": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4"
  },
  "r653": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r654": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r655": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r656": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r657": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r658": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2"
  },
  "r659": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r660": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r661": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r662": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r663": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r664": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r665": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r666": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r667": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r668": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1"
  },
  "r669": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B"
  },
  "r670": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r671": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r672": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r673": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r674": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r675": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>78
<FILENAME>0001213900-24-023073-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-24-023073-xbrl.zip
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M&%Z'XX.\ZZ8%&5:PY;QA.*R&EV?P_O)6N <R&$2D\XS$#WUMLL5HK-/TU0*
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M$+O?#O)BFMO^MU^U9QN)%X_SU?&L1!G]DKSZ*T_BR-\-ZMQ3S'7:J3$U<[3
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M+'LI #QW.B[D!4UH:Q"\)=I]D/\CO,K>C>BW/ )<#K\,2< @?O;",;HS0[@
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M!-=)>#ZE73+@K)$;<)UC-&8P,I/BYI&K>[-N]\2L>)73\("%.+JM@8&/6@9
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M_K6^X*;<0"?B:M R\AUWJJ*SV!-$$82W(,V -QF-S]X?D3@I1D]R86>@[S*
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M]XV4BRK4C51F3.;UJB+H<2<Q<J*))<*:3+E&5A80TB&-A50\4L93Z=!+5U$
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M%Z]H80(\;/;;V.QFH+%]-BE, XA<R@OY?#G$R9#.%]_RL?!";/_G:85?D0>
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MA.2WS]EZ:BS2A12Q8Y^]J3:24WF0A%]W4ZZ(H*[7I<\R"*D 0QWLQ M4O95
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M@]6L-9P+6C *FTW:RJFSEDM.#ZCYX2)/ZXN5QZ!%AI^$:N.^%= #JKE>Q%-
MRDOY;M27NY9*>MJD,9,YV20\WJ>!=]7I@8^E^G0_"$ZT?>X1W<!K=1)>IZUL
M,'(WV(P$% .$#B[.WE2C8HE),E[?*[6\:"M&7P-G?^.4,>-\GC,$^E&OX/1
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M"%/BI^/TWN/T MNJ(*L#/L<B_3]D!NYFZ9NR6M'^Z>%)/'N>WGGT\.3[/=U
M9M!J,X+7]>^H741E#L@QR<_'30FG8</;H,8WIU&\>U?2D9+/=_SU0\P+?07*
M$O/2=^?_Y\LGYU)W?=RQ;Y<E"H4NR#4IQ9O+7'S _859VN=OL?\NZ0S17D!+
M%)*A6*T#*BK3H0I SB%",2@F8%T+0Q;W$"6>P,Q)56 GW3B86A+"Z6-L6K+[
M@AL''6F^$IMO9FAV'S1)[018?TB;B,-3VD2,OL*M*0;$LPZOFQ>*K1.<6YNU
ME(!H.V]IPXKWC(ZK2@I]>5N5A6A8T-*11^Y97(G^.,L=!\&\;.D/\[(#61JN
MQ+@#SL &37$B?*%:EV 90MFL2_YPY_CT[GVY^(3B0HX/OIT$M]->(6F?FX!M
M ">\OF;%*B[@.*\*,:/SLI*D-KL/T79XO:DT07[G=')TZCV0A"L)P4H/J]VZ
M.^[MW!UQE5]>^LK+.BB12<BN=VWK/W-"D.%;%A7O+/@I.1V45<DF4@<L_<.#
MDQ-YB94,5]!/Q#/C*$YTBKBK$5HDP@=7*=2B4*6"AO6J>.Z4-3=+Z.6^G0ZG
MH+%)=2D':>9C8@AZ^#K]PYUH'C'D]!)T!Z;IP_Z<%1-:.BPL8[UYTT+)\MJB
M..+5(UUZ>V[1N3H/_3CRCRZY_0^CV88K5KL0!+MQ+3[##O=P)8J/ QNTD?Z[
M:^\&]+Z8VXZS)IS^&*!,U"PG.T75S'X]?RH@!#7A.[[R<][-\G_0B8^FB1?*
M]3-2-GZW%;"*DNI!?N*HNU(0PYQ\!'(YIOF:TP'ZQ?"^@CWG9X_."+/D8<NI
M%7$8IM:5BZ6+$)%A\$RCKM@C/:'FQ28NX31.< 2=0.&) =ND]C +.*J]-I.U
M  ]EY(*V"W?<\)!WR;SE='^O7->"ZEES;J:3"NF,+&;7E]. SC/HMO4+*UI!
M7R W\ EN\#&EI'LGAU+2N)1T[U!*^@@>PD$ZZ]ZG3V<].4Z?V('^\A)IY>)J
MKS-7'Y? 2?Z-!,ZGRMVDYW2*B3!=(-I^Q:=-S\)O'I/G^6&1C,N<+\7X,G3L
MXY9LXAG^_.3T"9\$3TZ?JC O*@ P\AK[<PEITRV/UAO K-$*52RVQ\D;.X"N
M;"CHHUH5W==+P#+XK(^(U69!KE3B&[H=SA^M6MD-@[?D/ 6>TA3N* :4EM8N
M!WD5+0#_DD(4AM'HEF64DE5O7K('3^A9+,^G[8<(,'@,3/=0;R>'?SY']E]Y
M;*=HFD7VU\WQ8XH/B^1-WG.YB^*(@DL&7;J@8W'3>LZ"?,HQ"G\?A08I;+GU
MX'R(5\@T9>3#R)&Z@<^LO[KX1>/<5_DLD_5(3E:9W[(W>_MIOB"^Y-*/@HY*
M:3!D?#1V8=-6L\2%AYAZR'2Z7RU%,!(Q'KS63<T]?&Y_RTQ(;MGV8Z4(6NTW
M%O?(+="(O<&)9/G/$7!U1=^;!VKL7R.#8O7$%T6?,SR0%_K3Y^?07KLGWJI?
MOO2BM8EL@B!O49>.#16&84[CL6F]CX\'HI%>Y/^$I:>5U2T=ENH7&FKZ[A/Z
MB6@'!;=!^,3H\.@F(+PWHEF:F*9"%,^WL.?U"IKT #GWRP*.K$\<[&]A:YH7
MO&P\,6.;N5=1=A@G=:I;^8EF#NR.%I&[&Z-.P*QJ%+0N_T)&B(*6.OVIF+3D
M%V^3.Z>9CNR5R!TQQ#1@^N>)_F_RI&%5Q%Q5+/XI7"II4167W"F8_K_7 3^O
M.M RAC_+X7$1+!=M-+9+ :K(V'R*RM?N=FZ]>IM<-<U;[;,PHK^RKIM+::V0
MVX6GPY+L?7"JN6&10P<_=^]V7N=K^OF"'N5\36L1Z:E[#T]_Q(MI>8NLS"L*
MMW#<H7C+$:1KP/4HV'RS4/X4VI B,0[[^%IF\[)L>TG_^L]^>0WM6?JDJ?>Y
M4/&F\)E).2G9<PB'+R!A2#@HC)T%038C5XB=K<U0]/M-R0L@[WA8C["7PM7(
M]JFDG<\BUU;G=@9RN:'WX481):7MWM)BY."86U.Z+"E6C<*9&7AI7HDL<P$#
M<494NDS4I\*11;^0Q>9<(V?M.G,'2GO$R(2*SW4TR47AV'Z4*'^K9.AH*4]*
M*!DV0L1@8RD/X>XI3V-L/<-159M2(RUDZH<B;L#VOZ.#I>!#)C@K$C'=JX+&
M2!R CE9 S^6A?5V_3YO51'8\MRY?<6O8FM98SQW,1=U9^N+Q&?DC"_1?+U==
M(F4F?B10GSK?6/PNL5IK-2S.;7+"VN8WC?:"5KS4=1XZS/P<?-*K T:K&(L"
MO+'KY;9CT0V>7X,#Y=+3!>#1>(4(.9GS#+G!C<Q5.04T"3-/QU0/Z$X6+@1R
MV%[3"<TM]1F9.3+P^:P#?6N"8J(VI63:U,. )MTV<B;F:PIGP[TT:^6R;4.>
M._VSZ*=[NMAD683 BO\JF;:;ID8TL^L<;4KRO;.Z6Y=MD7%\A$@AC#+>EKUW
MY<GW:B4I+?&81A;^C)6HZ:&9  D+UDTI<83+>PM1FB-Q<^JN'(7Q8Z"TL3WJ
MN.YD%8F;_3D71Z0<1VA<4N4+1#(<FNAK?*!/E'R@3[2?*^CE-7,@4!+:4PU.
M%K2605S7%$2B]20)4H2PZ[)J>CFTM7U,CI@./6NT<:,UA#[@*V;WE5ZVF939
M5#W9!ZB2?)8@U3+8R;\:I7)R&#?AAZ9_.=68>.;?G&[QAX>G?*YW'-/2___A
MWGWWARP-$2]9(BM[M6Z+9:#641>]8POZPX/CAZFK$>%RWQ_?MS_$E]O790;L
MXYV3DR#QS7D([<N4IMIX624#ZY2E=T]BY53N#Z^M2S!PZ0-EG8M8:D=*X>_6
M5<.%+RMGBY\2^)4X68^F]&!=HN%FZ=803I:\YHHN0SI=FSJ39+:E@2B,#K^S
M_A1?8=EU1 *UN8&@#AW#^/:N[R03NO,,1YK[FVS2NA!EVN@*9Q<._2H EF;>
M7V$ PI%U0Y/9$Y=ZQ.I?\<N-JJAHESMMW@2&PVF:NE)(--9E-\Q=%8$Q#^9K
M JS:%)L'@1*K%+"3NI"PSVPWN=VSJUP-CKU,,M93LC929\SY^SH2[$.;^*9K
MG6H+)WF0:P&T;XY0D \+H5Z.BYF+M+3$UB:)$XRYLW-. (43IOXU7?C,4 UZ
MB1><_+MS-PBVK;781=WZ^V(8?'L9@J[P2(L]M25!>4]=WQWNIHV>5=H3VO0Y
M=\=R"VEKU-KJLR*.:C@OPVFO-B_K(_,H@]23NN^9\>ZY'EA3OW-2&'+9,[,!
M]XY/V/6X V 0W>U*,[^ZLL_\SGM=7!H= U]JWM!**CI'[DNO6Q?"P[W-P.#4
M&(72"I2\%+M6M&!KYH:5O!3%A[Q<9WF?9^:U)^1D5SUY3YU0PT'%H>>1D]BU
MO2V-@Z^:]_3>G4-A<ER8O'\H3'Z52_N"<\RM@S6Y= $=Q'SFNF[<@CQT\Z$U
M\K<("%A%^O1M6_:*(56[Q9<\__GI,"?MJWCHPGG;&9 ;9Q8,HD+.H^("_P89
MM#KI-FQ:LQ"FYK(B((TLUTLY1<G!!F$ 8D[+5D@/S61KB0V7S@A*@@(5-@L^
MH3'K)!EG-2?8<C+*3N_ \AI&>9VAB:5AX(O+MXC#"-<&_ECZ 3D3<7K<@W-)
M4/.3>#=18)1@PGT)R4:0^>045[5"FH[T6CB2G"LEWWA6= QM"1Y:T4A65RV&
M.3U[)MP%NFXTM.;*)C8VW/X>>J[QZ&:CC%)F<)D%3L0U4[YWN!+Y<JI+% %T
MK!H[]+N%@FGD*>+B6(-R$-L L7OZ3PGRG3>^(D^@%S??.?/IE;AZK EEW[ %
M.UX\VA8?'IB(6! 3=Z.3<ZRB&9W^1K)THU>VRXY_K(EXC\7_A";I7S]URM4"
M?%=_^N:;M&NG?_H&:??B?T].3H]_72^^^>--D(K?UA#=T"0F#X_!^/-/Y0);
MY,X/#!:416]%)&G\W4=/S-X:.F67!=-/5/FV,WH1E"7JJ9%8_-JTB99J?>.G
M O4LSF.C>/KCS?E"9Q=WYDY3P6M&9AJ\%6W1NXY8$3=(EI8;&IM .[4*C1@'
M)Z*$G'((6F.MG4^P2V8+G2G;#8>A(PO\?$7B?CVRK!\6&Z4?'1O]<1P;)=[>
MWA0>^9,DM(XN+$F_1%CRU<$A3P]1QSCJ^/X0==RB+#/O"9BF\YYL[*)?=GL-
M=1SADCI[;3.#/WSI=^^E2%]4U1J6M5[\Z9N3;_B_NW4^M?_^%Y_HQ@W[(]GS
M6;_$]4[^@Q9&W]IMS*Z;%:"K7-,)G_S??F:_TJO)^Y*SM^.34V;_"*]4%7/>
M<X^^?_"(1J>?A;\;?Y%6[S-N%E!Y5#H(E^4ZP.PS_LV%40J[BDL*2512V)&Q
M=YE6[ TYR>,R*>-$BH+A2'5QE84P%-2(-  4@$2G>>]!*0()[@%&HXBK"5Q+
M=Y7UZXKI<<F=24\<]:V\F;'ULC-DOL:WBK5,I( ?5>2EY<L<MRR];%BGN0-9
M7%Y;Z?V[8YXN6L=]2Q:$U_&'>/>8R(_W[?\]N_+)[K_KR-^?'3P>IEO:T[_H
MXRK4="&-AB[1)<GWCLF>RRE89$3]A*D*B^,$^W1H[;6*LQ-Z2EM/?&T7$+P/
M/L6%[9<#9':7"D"+G/*N?)?09H%QD(27/G=;%"B?TX[JK%#@ZEV9K]QQC@)(
M-/F[RAM+S*0P*V#L9THAPU]-X9[W@@_G%D(?\L"V[*RJ>3NYDEZNO!+MCK=:
MH@-R5E--2)UTZ;JA;4_C(&^_^Z+%"E4/E '5\@4&,4N*O-L::!,YKB,/SI,B
M9!?58MPP#,;;JKS\3=]BQM$:<J/KOEQQL@B%.2ZF2382,J?II&R.'$\1P%"N
MV"QVGY-[_@NJ@=)[?$G/[7RNTTYCO MCHLT1"FW39;E8Q@\X!8U2?P4,'2<G
M>8V8&DHR7+#K1D0$&3F!4>I!9LRTO554"9>E=KT!_ISV[^:8ZF ,_VUC^)S#
M=H,:NFHW]&1<$E2[G2W^AK+SY,]G=1)F">)F%\5N>11#>5G. $:.T%^:L]V%
M8I!V4DLRJ+5A,)F@@&)HQ3#PC],";#X&>585Y3)LAT_NEO5E4UU:.MB,N>1Y
M@J0Q=^'Z(Z-))GP1$2#=D;/(7+O)G-ZQ9Q$K#!E[86OR%7W>.^^7Z.;N@N>F
M#Y<TI'G7?Z%M>"O.SOX'+5]LES].7Z&K[%785<:[EI;KJ#.-47H<C21_UR2A
MEOG<11RCAEU+FF3$!$B#M5%I1'BB= ?4/D"RBRGH!D#VQ(/*]3?>,M"N0H/8
M? -OSG0;'&QF5JR"SL (Q&?ZZLVEG.+Q8V+/L["M5\U+G,)%D!,%$FC4Y1=?
MRKC\Y<VX"MBIF*&:M<#J&JN)<_4@,<QQ&@T )X6Y5@B^K'^0AZ!O,2D@@=+(
M\+(^"\A83)8BKQJU8L)7,5V2-_8EPJG##O^,._P-4A%'4P3MK@L4O3[H1"E:
M:\@P5'-?Y"L]Q\$'YSBM3;9M5HI:&P4TC-OE-I48D>@=ZS"-X!U)LBSP4&E;
M@HR$)UCD9P2Z[?QYI1O-DB'T*"CA9ZQ ,"]5\JT'HEPH2/&:)<K.3+=I'OX1
M,LGD9[OW165[48N3'XQ)%C>>RK<2'AS1V^Z;A9*G-JFPJ ^])'0 94:T04^T
M-A/A&%R54$);>(6:564]*O9F& 4*8%6@,-MLNFJ;F JW%*K4J 41#>11^\UL
M:]/+Y \<>'(3&J#TG9,"#QJ?ELU5=$UN HGA'E8G.QB*/3,4YW"R@>LSJBY@
ME^/DAQ+AL0_PPV'^;WO^'WS\ J!Y/9(0^8.<P7$W&9L>Y>&)*\W^E A_-0J(
MAB@:=F\4=R570I@#-FE)48^:]0U '\9SSMT30D'<)#'MY?!.!L)Q #)M,Q1(
MC@)=+9VB\!P#[9A6$7,323,8[8\C4!#0<^2+NNG*@Q7\W%6<S[WF?Q[E"KVH
M3\P,,N(#X83ODZWE+7& ;VJ3K8E;<-,5@OPB[TKDW:["+F1RL9HKNFZ _@LS
MP'$[(GP/.&^_-MNXHB+8OJIDBA'L)J,&XX9/;NE8Y$'A1=VY;L51 9*F0D*:
MK]5;ZC9KSC#LR*7JYSL')8(8[H"[S/,5B.Y:3<7J:ZG_ QUFHW=4O%O*'&-5
M_@Z>(=(AM&\GS6R+).7'NB&'[?;EM]M?D5<_$CQ'88ZU%L8U=RZ-QX$W*QOM
M9>A?2Y^1-:XPFW7LMUJ7SO!2O"*ELJ@D&'71LT</7E(?C2-XMCY3=U'3F.TL
M@*&K0]]@3K$X:+4U#F**N2[S+(I,%"&Y 50N45X*_/<H[^"C\2NF3Y8( U_C
MW7)8[;^IU?Y8E]H0S6<^#F([9'3$E;J0=GHRH4V]E2H2!W^J5=%L9DK%0"]<
M3E1W3J%K$V8<7*\[QTDXV925%NJTDJXWPTH?(MJ]Q69>%'2K)9R1TH04="0H
MB%SG+901J\(O<T;@MP7W#;ITDP7<%$1\R15[V\BZNP=DW1A9]^" K#L8V8\T
MLD<?9%U_JHIWS#;L/4Q+\X5YK>FRX=9<F-B4PU7+::B/VPV!"W*.1VDZ(1<4
M0XJ^[D+"1O1:>MOY1A#6TE'CGPI!))?=K9@(YS9AS\1EZYO6,;HX:24SL9",
M4IXG9O=G!EL[0MA3*26O5_8>63%M6@:H&8X"^ !Z)7C8M<32\&&2?-:L0\H_
M";5=10/?&U/X9":1&&<&PSJ(L@,%U$!A]\P@C/^-GQ$H>6ONVY@[>8!4_^0E
M+S**#/O/)$7SS5#1[K/<X*+!C#T6X09>#_)^^]M"\IS1-/%:38^<;!I%#;7U
M'R(DS6!8IE*=RQ&=4*3.'.^.8("=).R\C8CEY.D5PN\CXXY6Z0W7;X'FPNN&
MG2]T\?A%MJ-RFH30LQXVBVNDFHD#6 WU$VEI8]@6\&%=P9QQUN>R"Q0J/211
M0F*)73[<SC"$V 7:89?S>]&;'M')#U!K)U0,,#69S[9D$45&S,B(81KE_JQ9
MW4C%K3V2P;=B":V];B?5ZTZ^*F?-]W--8TE1$( *F.(!:?E(4/[4NF[.;.A9
M(."O3\\RPPVW(@B3I37Y^8M@UFQN"CDRP[J2+&,6)D"&K E6N&];=.U F,BW
MQ7;2,'</QS8T<8SE>?44W$VA,GA\-<D*##CCY/35^$C@R1)G8VWWX>+&]N3M
MZEI:6U47#$#)R8+<6P[DFVH$@>;KHF):"-R/'X/<.+[C'\/4-EVDS>7J'E!]
MG/XR0#@[:E]Y54DXR,I6P+1L/W>*?GK#?_NK$\R7G)$/^G)1D9KJ)EW"G%17
M^;9+F$P97=NFJQ2#.&&(S!TR8<%Y8+_ZLNH#*7*TNP'[ MHH[_0X:\,T2BH<
MWT6H>,YYRGSH5$IN-B""SK"-(B3^#F)$YH@!KD-))MNBK"^%QC.' &A5C2D:
MA7]4O _K-\!N*;JBX,L;TV2 $AZ;=JVMS%GCJ=<$*[T/ TRZGE;X8.0,CD+W
M03G=JM;;T@XV''][;$(=V"$X?/WP(-N(^E8NT(@D)#66!5PPEI#L9IN#8,4P
MYW*.0=SEP8EH]1RG9[TCS-,OW'ET_T1[3=;DW2\IIF!CJ4!M=+.F(3?F<?K*
M?RUAQ4"@UME7466G_W[S_/7%_SC+ZTD(, #.V^^OFJ,9#5?=B07VIX \HFPF
M?<;O3Y0>P75SKB@,,%BY9)>*F2][Z,4*)Q_E:R"#TZ63)?:7-H=Z*OW][PCY
M_*DUI&1WC_20'\E998I1P%V^;M8;.@D%N<G/:,/#1QE>?,@"Z2_Y")?\B]KU
MD)S9;#R7.YG^@'W$42K0O(]$E1R'3\WT>1"(<L]N!YL51J,C+FC#T?<+8S U
M&(X.[\[)ON[1$*_O8?8.B%MYE"$-7J*N:."U9+[^C,'R/NJ>-^P%.2"7?F26
M['57_)#:OWV#?-G-&:)O-*5V36.>>R\$_M=]\50XE4+U4KS)$1<1MS^\[UWX
MNZAMRJL':!A6$8WNK?_R2;(!?S5/TI88PGY#>7MK6,)4@<'$Y9BF53EEX#<_
M#+F:RN9G[JA67ND)-YWZ>Y_JL<.D*%)O2,5\Q!SOFL[?WL2Q>54_2>>.DX8V
M=RZV6,,A:L,XXS 9GWHR_LOY(CX0""<E1 ,9N8=8>D6I\;/DU9I.7!1U*>0U
M_>'=WHWW9@Z3^:DG<Q#91A!_QR**:=6>0QS$9!I[[3&DT(L6 3\/_"GO< M!
MEO3#X"O@U>1)Y?D]S..GGD?S=,6E9<=?2"LC.[D8?4N]83G8_E8^R]LL?9W/
M<BE!!WU14HT("7>=J*NT4PHA^'5\;(<)_\03_L9K1@0Q;#3;EOF@26#T@?[
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M)U:)U-0,J;N@,.!ZFY.XK:@W(<@:+;$0[#CSG3-HD.<D@P%ZD0,XTL2(!?R
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M3T[N'O^Z7H!M]W/MQ^AI;Q2 _+3W^;QPPFMO^A/CO]/3'X2,D\.(5YXYT4N
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M<Z/CG1]W!#GI1P0Y>YH#>E/$^ U5KV2HV#!]TJ2NQ88E"2P@EXP"+5@XB!K
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M"XGL5-N.N>;(.3V1VD7>F?[B4,5;S5(BIU]/0S?6?I9;M06JK2 HFSI*.3G
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MO]IE-2'"FY3-.'6W9JK"N@OO*;:>FZI]) W+S)A*NIM-T+RLBY!=LO/K,"C
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M'G/>W7ZWR^[?M:;4[_HMZ0UQ:N]UT17,[RC!L.M/W=_LGC9<K7-6=.0FU,E
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MC^+6QK61AP\74?,$>;0;GCMRG,,' R#6?%A[-SQM5/)&)6;1-IMZ!GQ[T_Z
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M&&%Z F=E$:LT"5L \R+M#G71:X(Z:@U,ZS=XE[B<@9] %GWVX3W"]7&7#F[
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MGG0<=\2NJ<$,M]Q*R" B/[%< ?-IN TS_"M]_2?DK*Z#F<K!20<!5@>C>M3
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MTA4+QA@-F%?5&<LO2C<'+[6S$TG&9"["%3+IA2B721"KBV2T,S$IB3&H_+"
M:@KBYV)*Y'P%TAR8(OI5Q]97^2Z&<:H=F73@R/'_B6?SEW",VM-9AEO E0;;
MK#A04*UUI; [Z$Y,'68*_WL=9SMOL;WSJR3_ +K%+-:)JO\^?_/B]>EO;[>%
M=7,:3F"YA/Z,Y=5E,^GG]/(B3QVW8=@_.=B3 -R[Y#)#=01]9R66QX=;_^C]
MM&VR7,<@(^)R^CF_+#]?>RO&'*W7< 15(5E:C;7["5@?BGR"02GRI)ZK40&L
MM# <Z -Z/#]2 ,;W^E'N%E968I5?^(%S;87!48MY&VXR#LYZ5L_NOM06NN2T
M>]QC7IJ-))NG?W(L@DJOP(DB_@,3T%+\)1^^_7E+>VC9P1+HS%00KB-%;'4*
M2IUZG:,D+K=IM/X)EZGP%M-T^R<G?9DF3&XWXG.<QT4E-57D.H)-):^\_CU\
MAZIB\*,B'\TB QQ'AG2<4;NU1=IC,AEY'O44%SD&82M,0,(B'I@TR*T:F;<G
MT)J,68K!.6+IY@3:)6?NYM,^38'@X!9]<]*@[(7.\K]>%.! / 332WOB>2W]
M&!5,\Q<O]9-4E\L8R)S4%/9!)K4(4,!2A*,L5K&.Z&UXF.KU4M@$Y:9T6HD$
M*P2%,L7_G@/WJW;^.<?MR"ATMRA*6CQF#<)N:P;!FY7"_J >B?E5< 5D(I25
M@%IO&;ECC]6PPLQ<8LV<46M2:#'86=]UTLW:))-7S7%Z_M/I_WU!Q1QA[4@"
MB2.:(P%E\1K'#D=%0D7Q,,V4]A,$<B9=2HD)?"1V^A-*;B?C%QY$CI6B X"B
M:U,ZYM&B*("80%1C[BDKBPF7QUX"]R )\)X"11$.@;DNHQCQE9"SE)W%"599
M;Y))+_R)=Y 21C1_'NQ&SFIQ-ZDTG6V-UNH'O9P(4QC&<?B_L(X%G%$(9D<U
MR=,D=\LNQ"S#!50J@^?07+%#V$_;0WPKI"F1YD"G2K]! @9KK<3S$C7)I'8O
M0,$)MTP%S)N?SK=QLK^HJU155?@!K'0,$[ F\LN'_[LMC;:-):8+:/O>?F"J
M3:DN*477*EY.TO%<.M62N?<;SL1+#A)B^PM5K_QV_NGUME2"1CHJ6@'?B<2#
MXQ?@N&0(-P@U.BS/=B63SD2QX4Q)R3;YO;&FPK?.A;>1<*+<7]2P $;H6U-_
M5\4"0]ZSM80HEGE-_IK4 I#)VH)WW=-8U<4#DWU+&!3!1R5%Q& _EG;2S]@[
M_ GS&M *";,\9"0.8-;.+IB$!\SA8Z6R#$0JVG[M;@I_-O9%YL,1WZ,GN].B
MP!0RLF$"EG%2E>"U!J;[SEO/#>_U9G\3)+K:AAI"#H"08V=?0]A6PN\"BS(C
MDX$9+.>JE&#B*C08%*HW(S!*\QG]4V?.T/LYIO^ = 2M:($Z/X@9P0+(KL,E
MER' =]V[ %I1@7*246.>2YU$Q[G=*J \V 24FP'EPTU ^4^2-OU?'";COWT7
M_[_=P2&29?SC79K/KT0+=3$ZGZ_%#&S613.AI-$Y6 [$::4(+;X -?8"W7=Q
MFE*%M<$NO8*GXV2,#!1QM.K6-9M7[%1R50JJL@.N/S<UEVB/ABKC5$7)U]SK
M1U)VBK/DN8US6'"65V"-C5).S ;K:X;.F]*=3:&2V9",7F'IY,CBRD%.6!_E
M)2V1S#[""F/G+^[#0F2*<?V.V4PC@Y 18=:7)?2@]'"*1KYL9Z'0?.2]J?0)
MH ()U )_G*#0"Q@ IZRX0$+#[5Q'_%(.]DHV)BV'XH4_(6@PBN/5SOU49D*G
MBF;[V3GIMF3GIS'/#3Z,8P=C'EL;<>B;)]L8WMGK'9Z$?^,I?-_OH0-T&&,!
MO>2KQ6A- G.#%3/MQR3X]1#J"^: 7BBC.^,[-!<!+J*!^?N8*&PV;G@M::S9
M9QQ'',A"3)HB!5X(C<X')ZI;(4EW0D+7H*-7G7D=2;H+EK@5,M&B&1.PX)5*
M+J85OI..7X:R&"L346UHAT2&-: .][?O!M\M&;!-;;A903F/@4#@:OQU6/SE
M1W@^6V#9.1(1_X;,5:5_>J4R-4FJLKZ^UL4(GJ([R^^>W/Y\ +E",7*]'14(
M$DX8IE_@3KVGFC/^^3P!^S8NOMG]NCOL32K80<XJ6TG,D?_MZ4'2!T&CX3N6
MZEWL^<VPISS>[7JOZ[&$)QWN_^#O=ZHF58U+[IS@;/4B\($7X0GN$XK'U;6;
MB,+(2<EH%1->:K]OU)"8!&-#[M4W4S/3'Y:"N)NGFJO[[L?O.\8\J3U=X-%\
M]V,_.CP^BOI')YU3:?M(^_6Y_]GO[YY$!T='3W+N_<%>M+?;30(WS;T5G'9-
MNL3!L<_V'G5;BM:>"!TG>4_=)^X4\9ZLH?)%N)5LA_F<PQ\7F"RER!YR4.\H
M&K8H0*4%ZZ@_V(TPD/\>(30Q98+$0"D(^92^I6L)?U)L"U'$CI)R662\IZ^%
M'RBA$IG?C/3Y*!05GQ[%O[(=IR='F,OJRSR1;-8QJ#XEED%?F""(K0_9&WA
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M?SQXDE,_Z1\\R7D/3@;1X/C/1SF^YM[]WMV+\8:.XZON9\N";WZP;<#-9)[
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MT.'A4F*_%W:[M$^8-[UE(:""!Z8(&Y<^!X5>-%)4SZOX,_\^'K'PI 5K99:
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MF6YYB[E8_R%04KQL*U@XM=N=P1+_6[L'@[;],I'#Q)W !:2IUYL-7UW]MCQ
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M@^6HJ6 /#7:= 769IQ@>)FQ(^$[DY@J3I>EU7+!O&I^[&\1U,\$*K4HYT=M
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MA%4$#OR,ZZ9&XX=:.>(*I&'K-T/H2YUDGFSQB%PXU(T:@R1TO0 U8[L+(E#
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MO4KH0Y'0>N,[O-*A&@%K<?3V>?2T,9P]! *,V/*T0[-$ 4N^;(O8U_#"[6_
MDQWU./,;LC?H/[7DPKER,?<:M^A?O9HE5VV_II'@<+]^+%#H]: "6RNH0!LJ
M\&(%%7B01[M=:,3\?M08H/+B8UA<(O&GU'B!I[I8$C9K>C#9I#. ).V-J5+E
MRB&#V)#G4(&!<!P09,T<Q[ $RZ1+[;'KO4",[!3''F,'K[P1U\-35B%NED0H
MZQSIT(!\A\PQO0I\K0)?W6]!>E(^.'SJI?'7''2YJVCMJ.P=P?N/4W?Z+.5Y
M)_##:^K&#D)MS>GF!0@N:591]'AE2=]=>567\/#)GGN+O>-@;[50.3L33XR$
M:=]&$TKC.*@'=.9W6&^X2L<>==](ZE2N0=^&UC+)29E*C3<[/GUY5?O7!AU5
ME<XRHI)!6I$I)6G8M^;4)Q6:+\E_XME(3*ML_;!+PWIC=0FP9HB">?0;OW0]
M@OCT>+7Z2O2SF!.GM"4DX]-NJ7H\I)!*IRH-<V<P7?3^*97-D^W.3+OT\)V3
M:=U7"GA/B*Y_O/1O/Y*SD^3.""2!:<';H0HJO7!&)<>@K@*&BJ/C!;<O<D_W
M+.#FBPR]R'N<>V<35941_5!.D30,^R4EW!H<V#B9)DB>3GBI<=2L(&B&UKIF
M80)4WU.OL5(F!C>5#!78",;VEJO6>++%++\@3.JR-'#J3F9$'!^4.J8POI]B
M-F&*F?EXE,::HSE$*SCN34H'*?OS--R*GE5D*&]K6X*]6%0WM=@!A)*7$ 9]
MFAT38:._4LUA(%J27 ZJY6I9>1Y9",\3U0/3_G9RAC@",:X%\8J%%"^'&L+2
MWE.M-QF<V$S ([^//6.A7YD0!33W'? N'FXILG,Q"W\#2>V*UIC2WS2WA)U!
M)GG#ZBA>;C:1IF(#96W0*K<%(#]ND>=8_*@H:JO N$W6X+[8$>]:<[QSN_F#
M:8YV5,,V+/!E2* P#$F/7@#0C)GI*.3-N3^'5*.[B$ $?C@%&U1F672>UA?X
M4#<)K'LBQ@@QH)CZ-B3Q,Z6&DO V-#-,2Q&]0A/U5.L($NY4)%-FZD%7#8$*
M@.68OTC4V_%ZX-^ *(5;DI);DF-S<>>M]@!_S:+B?-2WS)PD0R;>-O\:4U7P
M<9FA7[VH):E$+'(YK0 8G5]PG>!?F)G&BDS0"2@IIRGU%;18]OQB[1=.='$!
M+DG>:595/J?7V-7?\JM(X<(YEMXK(*A.N$\XRVA!:7(2[3D_>T+4G)H5-IH5
MCN%7,^8G0+Q7.4DSY$0\R[Q<?VNE?B3:GU[ST3O-<=NITQ8R"JMKJ"]*C'8Q
MM3;Z-_;3O+6:W(6^#H-OC8<S4+>J2>=4-GF@?9\^9O]11G(?L-F'< :N:VH:
M-A::/8:PHW-(Z-=A,JTMZ434V+I+#!7#13?':6B[M([RC[231Z<<&#TIT.+E
MN+_TA:L64WA ]A\.:6@W*Y/0!:J$BAAMZ%&ZI"$1=Y_6WEZ)9@:DRPG>I3*=
MP&V[*!;^_M%@55TW_50F'<9$A;SV.F=1@T&HQ=*OY$O(R<ELA\\R1<8 #!&_
MP=9]F^O/WG#8A7NFC(H2_DXO02[#;&;@&-$TTCL,H3R0XU.F$F?29MW6;G-]
MKQ?<[7!1&O"1JFR<4<MPB< CU? I26@*205A/K:JLA!SZH5Q]1'DA?-#V$*4
M=)/K-<[-F%UW<;0(9<"/ON#A6GGVYZL\>SO/OKO*LS_P,W[\Z] CGOTDP8Z/
MQ*U^Y%/#DG%G-- )"N4>FKK<:T>9WSFS\0 ZR?SB-5;%3'A1_HS*N4[O5HTM
M&4:?LV,DU.$U_$PL9*T[1-Y'+</N.6FP\ZQ*F<R4>(F(VHC,G18>(YO<$4CB
M&[9HA9YXD.GRSOA2U1%>TKB1M+6P'*063,S5YN#Z3AM!_17VX?XV4VFQ>/_
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M?>&$<:3T(@9Q4=2OIO"?!D!OYFJW[JK^R"@>N&^V<:3(N3#0[4B^BBI3(IP
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M"J;RYU%L'QMZR5-9^$^53DS/H:((72EE!(&W8=YJD=<H14@0:7-'R7.A:Q2
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M7PYB8)H/)4Y'%#]I4N996GKFG?'?G7Z=XVEU]J5\'9Z&=WACG<D17%<# MS
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M5;7@;+\#'1A?]!8.%G%.5!)UM11*:6O,)06,#R=54<%A*9G2V7YG5,SH<N$
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M='P >N(;J@AO0T L&8:V:"7WA"BGX8*>EUE=IS/C-?3V6F5R+-OK7-%N;H!
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M'+O9F+4C1NMM^#R_,$L]U[9S&@UMATVKRVW1"[G23H>Z\ D1W?D/=O-ES\6
M@J7Q@2[P9+WV>T2'.T]K29CB)_L?#V)VK.NB!@TL42V8%OR#% H,(V*C5\4^
M:VE'W13B@B[?&\[W"J@1DW#M.M(NJP"Q]9NB05']87!+\R,Z;ID5K44D:V'.
MJ8F@(H[8Y&G.<X+KWS7-(&38%>,(@ACPCREJ0P9#^W$OX]S V[A.U[[!88[E
M^<8=Y5A>H2&&UJ=4H^Q]A:V4A/XK&'Z5YH\]$7V5(7P \_.AIN.>W^A1H;?O
M'^V]CW8'T9O]#\,/K_:'[Z+]#V\./KT?'NT??!C<=3SM&FNQ?4?79CB@"D T
MQR@_>5C#_W#P"&_. 66DWX I/T,,@-EWB9S5;?KIUT.0QUY<*]K HV87RZVE
MAK >RF&[O;>^(P#"Q[(8I2EZ=G>9WGX(Z(XW"$NKX5>DU>%_R9/GQ"3H<,*C
M%?D9QQ8)K6'F;K$T@)BYHHQ"77J'/CQ>5-DLK:I!]'I1>HVULV+L)P'QTXD>
M1IBLO=@2$89O*1CD/#64)<$THI=Y07,5+CL\&1X@T)+F8"FX?9J@H6B_FHP1
M/:<&*!JI:+"XL<P+#BT/(O"RDDJ2DM$HF9ECL+' 8IKQPR<+A A&F.@\D60.
M1E1QF%S+_BWO_'P*CR=C:PZ_K&FE7>)3+44#AD0V36R:&+=0D$R(EBK/& P9
MOL1;9+2,P7RCZ(8W?K+>&.:3)]FT&MQ]?=;]"(;7&;:DGHU_-(&@H(T9PAH0
M)PRV/Z:!X'0DV9BNV"BI3L&=D?4Q13],=5S0V0>G(1ME<SR[X(HPA5CS,2H_
M,/!0I2DG&^@Z#:*/XLMA.B?X$7AL$WQ6K#!FN8!TZ^!J,OX OE^!TZ/>7D\2
MGOD7D$X]Q7M #%QP\YZE7[.*$JT@ACAJBJ^=C?(%UXL&%\I^)S8%AUSA*PQ"
M@U]1+BH9U>AJH>%?9B-YWBB99S5]^N\%C(BN9&P%)THQ:KI>>?=QDO"X>Z:#
M]W\,CK,ITSP]@QWXD3"+?U <V44Q$';R+CFW@E&.-:TFG$CC3F$QRR_@4,6<
M9J3#DWIYK?[SHY!9PKM&Z&(7,ZXT+T!7E#.+AL'3"#M_O'#Z85ZFB"@R"RG=
M.D[ICN"O0:MAHC_,,C P2HXESL&_-,5Q+L);4P16EX\7<)EZUZ8Y-B.A 9C1
M9%'2F1.DDD8 3F":->-WX7JQBDZ3<D;:EJ 2\M^<4J1TLA8GU.<PLZ*J*>\
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M(?DZ"E]X924ML)=,7LT?EH\Q,Q0-:#"P,J$@F<VQ:C%Y,44L\'%=AAU)$3!
M6$%-+F-AM.+,X@)&_ %'@7V)%(V;2*[0^."8:A^"X )[516%-L5BJ!87W!-F
M)X,5/+E$63*BSMFQ T4Q_Y%A_&1KPBU2;#_G@U&67+]PS(#&EUD7K;!^0_NW
M,2@2,P-56<&,4,SQK1UH&<HX34!:PKQU)_R#AP[SL:NF$]Y*A.HTT[$1@[#)
MO=-X;HDZ'1L%KGQWXTHYA3]%/VBG"Z/CHWAAX1[,N<Z4'D'.2U[)3;B[Q<3=
M#1!N-&>B16V;/(K:TU+9;@>%VU0,)^AE=>'$_M88;OW/@[?QT&A@KH]4<P#)
M^G'PX7LV"74M:&=*&;&A&,-Q2, +%SNU784GP@OW=A<A=$3X]8+M.X;>-5?Y
M6@)A+/T371[L\D"9*/)BA]8"%M16"@S79]\H/I/<90R^U:.!:NN\%Y"[AE++
M.I*6%<UQP@,0FFS[\&OF[)J5WL2!P/>0@Z. <A5LE\XYAF\XCD1WWP8O$OD.
MWFM9U('_H#D$FP&$6X[Y& #G4E1^QM,7PCF.:#@P5BPJLBHRZX[2ECD1NUED
M8OCM>B:WW?@)_\H&%4YWZ.+T;CF=Q&4=?FMI9$Q>-KB -QY^;?"P^GUTGA_!
M]<I);]T;9AS\\'O@Y^K?G' 0Y!=-X/+SN5.9VX<G+6CN%'(7RJ6S2>'E$X"#
M&_FRI.PQ?8&%[/"WAP74N!VB=-%B;$U,T52U@$;LDBO8)2Q$,.C&6BOLG+
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M84WX:9LQAB\3P_<.]]8^@L[GBF9185@<DCZ\O#?NUK1\'3,I<7D:U42%3,%
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MQG; *"0*&(?D,Q(GN^.DG"A]IKS*0+ 0)N\5_G_5)_)5P8(+ CS89)=7L1
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M$E]B0_@I*Z7?5D_9XR^7UZ7V:YF5CN/TMX,&A[AO.5X8B'AE_;=C1B?MDV,
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MI!NU?.34JQ \G4ZB23 ?'<S)MCRJQ7TM#XGG]X7GI-L<I3UMCB/@^1P\;$!
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MB5L2=7P-R_Q"MP@O,[PDYN0K&CZ_ KF#Z!DHM56XVI@^9<&$"C%?1)H@NOW
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M89*>O$SD+5!>2%XL@1LL(IZ#'SW&JH$%1@_.L<KG.(&?D6C@34+J8 0(#R"
M(@=-S, >XA($ TP3('2<1>.\#P<Q:7J7M<;*-J^%5L6MC55QH>M(OB!+A=:@
M<K=&XU=][H06\G_F+F\M8\EBKJAJB'0R85'XX1#E>,1*3SA,7K&DG ->AR).
MLE3^U,H*M0P_*AJH#=Z'C'I]C=-/_8D+:PY\^;8RV]Y89G?6HFY_,ML,95:J
M7Z'T4%)= 2&"%\3%>%%P22BI5-.">RU YM A8K-)SF5\<%&MZU1^*K^C*=\!
ME>W.GR>P>Y[G@D?!]Y+L%N53XE)!D'(IT9GELK.Q1.^L#]S^)+JU2J+G3HI8
M@B]45>IZ%X64N,0I#NXK;<-XQ 8^$-B,1S<<"ON3Y258,-YRO&29>?8462*6
M$_:Y2"2?%(M$I+=T/TJA:TJ-P+_GYK.D4Q*U"M3XD59/;ZFK%>^MQH-0KXSS
M Z.A]*8V 5)&$!I6ASV3J8S+)WU0NQL?U)TUZ=N/YVKY6B@D43Y6-6I T-$O
M2-?U%7X(0TN*NW&88[0<:RHR5?S[X_B9%])-7Y>'"'2$%DGONY39S)'V362T
MT)+&M'@)%H'B548(K.LWV10%2(0$0M8(D$O0U5B['6!HWO,HI\FE1!^$X'1;
M]!**?X)0 PCA)@  .,M>4*62J:GKL #CY4M8(BAO'E)4\/KK<"0\FZQ,"=N]
MBTM!>8=#96["^"?W.@2FERCMH].MMTN0=AI(NU6"M$NZ]1*C76*T]Y1K*C':
M"<Z%O-#L7!CK?UV[1-K (S</EO_]FK@<\5]9$]TK'J&FMMNM,K5]R-2V=Y 6
M?LK6HR'+MU['O7_7^>TLQT9FM+,=L4.PHSS%8*.6@]AG/P1!H].EA8QV&#W6
M7^%<5K\[6&\JL<A([<K=(8.*=D7B$7]=VZ\WOG)JD16XD[UKY=B[G26]LNY=
M"./FN'G)4*-Q$D;'I9!C!#V'G?QV^RBB+U$IN#\?_ENPGBTP!2/E1TW_% >'
MZ<Q!,L%/;,00F::W&A6]66^VXG!D2AVCNZU-F/E,/7[]Q1=$%,#XIJ+*3681
MV%D.*;<(*)S.2OA BWK#25:8A2V 7W!B(4GZ'Z,XPBT%J>$'W??=D45_H=2.
M5!BRU9R$L*>63&@Y7YS\.-\@H99T?X)%]R#QG"1/,%SJ#'8!Q'ZDD\SY^G >
MA!R/)L,8.SY>,WSY >)1B+ T A./7?!(+'U1$Q %B7@\7ZYUA8_*L+'V/H3I
MJ!@/HN'&U $"0@6U$S\0&C:]KH3-'SQ3+*MX8W*#,;R/T0%:GY!5D%+&^.P]
MGYT"TN_\ZQKNJ8%CXG]N_C.'';%9_G8^H?&:Y6$Q,[93U@L>THSU#V'&8KB9
M^+3P'RR2@P\_'3]/[M-5X/ TSD%3=I-T[L1ZQ@(PVX+?FX)QAVO4$!WA,</$
MJQ-F2(>+IZ3@;D+Q &OG;8;GS>:)50[RLV ZAHWM5.>4<J4; RG3J.#,1[)6
MF_GOK+_!2L)41OGK!\F]NQ;YWNZ=:FW4Y4GJU6")7CUNZ$^(C7[K\.)15$N)
ML)Y>J$.R_6CVD$V-@0X-'7DKX52Y,X9.3(P5FXZ;SQ<]O>(9^X:-E>]B 2^5
M0".'I8=Y6!>SL&2ZTD=O?K#1G!R2N_'8&N%G&*>P%^ !>!1M+MKSV%<&^Y@A
MMR9B(<.$;X3"02B!['F-HA&:VRI]MK37T::G\>-08Z9S"C7W0DTL6=4P+Z(N
M79@QUD(3_UB<3DR9#O>QX6IP1_RK,$)W[E$U.9><E(SIH:R*5O>@B.3LK-WS
MH4]9Q.#FA64@!5Q][61Y6.S:N2Q QYS5M\X2!:$MN8K^=I5^?\0?8[/QED5W
M\X4+1'GO;E4:7@SAQNI\9Y,OU^@0+3U#!3]$N9FX<QZ:0X2G;BG0Z@@*"E5-
M$UFSR!!PJ$NZ:M8BU9R@JJ1>DB$Z4MXG)@8QI5BP%V'%<TCR5^I.V6A1C++-
M'T=LVZL&H-P-VBN+E0&(OBU4-EL[)F)FW^Z6@J?@[\T"ENF48)DTL$R[!,NL
M(RAH6,X!< QI&Y]W_&M$Y'1Q,RLG]K[1-(<%;&T>3KEU\'9SO;>H5#?5G.VT
M=H$IWP%\IZ55]=MO_X!-O'L04)VX65,D)WZ[2-=HPLRYS>[&X29=\[8,3V@X
MI&]3NY'7ZUCJ/B3<C*S+>89J?X7CP57 F;@<-H^XIT6X%$>!'L2Y3_"=MOFK
M+A8CNM!J.R6P05]!S G7$'_[_\ZZ9RL&E'9Y9+!/-AVO3+#3*%N-)0N7NDHB
MU*<.?Z<+1SY6*3>1W#0+)#>(Q2B4L)2[M7JWFH7:K?)H%_=*0* =C=#$2]_S
M]?\9>G_C8Z; MSOWD1OEQ.5IZ7IODP-V_>!#8EWVK61V?"X*_+A3FWU6F4P+
M\7K/P_-FO5UIMOJ59J=SL2BWP@[O=7]9C+5'.@Q_^J!?;J6_'HQ7Q!K #X:]
M[-1+K^"7_>C)Y%MVFEY8>3^(5UXF7NFAOMC&<UU%;=Q6J8VKK4S<Q@N^.^S:
M5[EIWUAP-WY@6/+,_)#@N*7P&\]],TYOW#J[ZC3:"^S&Z[;_X!M32MPN)*Y3
M (EKGUUU"R=OV^CP/WF:+BE2NU3-?[K>]ZKE5&>>^^PQ/ZF=]WDR#G4<3DOK
MXH;<.O>>BV1;&QR"#OIJF8_!OO?@9Y"?JL]&5>M'=6*9)H//\/_"JT=!];(I
M')>, ZD>99_V:V<NMRT3'MXN]=IGRT%^3Y,&\^RZ^;S-O5H$ZQSOPQD*^492
M?-TI-_TWW.\-=&?W[*K5:&;5G4ND^%";5PKN-H*[4FFW=J.TCR(@>[0WY3QV
MRBJP>LEV_:I,(@TOU4UW/K39D25ZV4 *JXD_WWZ^"[7Q@ BJLVG>WME5HU)O
M;:Q[%_!AA]2\I9 >7$BW"3=L+*3]'/&%(PBHU/Q+,,4+/Q<9F;0,8+PK@!+X
MUS.X%M_N;22J<4RL'9PAD'8-8*G;VT7M_/: )5P6OD :_*:M5_7[A[O[FX>G
M?Q(,[^9__[B]1TA:17=8\([13$OW,7WW^O42QU0FK4L<TZG+3<&0,26.Z91V
MJ\0Q%5E8BG0EE#BF30=6XIA*'-/[PS%A?><\P*:H<.QI&+X[#EZI;6X),=E[
MS*>W1=!GJ:/XF^?Z&=-#EV@^E(BFGT7<^L<5MV;][*K1+)ZX[2'!M%^M_7GN
MP1HC_R)UQ6"&S["W-3?CILC)*#O<_G30E=T=ELLC'Y;&V56K7Z*>3E!TNO4C
MBP[8SKUB2,ZQ<%B[T+(W-AL%GNM8(V*DI$THC\46QZ)QY&/10FNW&.>B%)U\
MHM,\LNBTSZXNBR$Y!S56]PAG_6J,)D@Y2(,A>BFP8$M(:Z$AK=W6D8]A!PR;
M$LWZ,\CL2C1K^R=%LRZWB$OCY#2+I':A%!'CW\H<52OMV@*)SC:@SUV(#H*4
MVP5QB?9@V*[)MZ^P=;>8VA?F<Z.VJB\^@_[]07=PF^U$YIS_\NS*&(WFTSGO
MQV.RF<>P]0]L2[A:I;E17!-YF\M@$&W\)V7?X=\VPW_ (1],L9O#7_3[I0H@
MV]GOYSK[I3%=2O=V]]5AI?NR\)[B?D/C987;SU0\M!<7Y!O+=M9:F-:_S.R
ME(5N/[>L[L7GR2RKC;.K;N:L^D]:\B:9X;'7QB[KHG95ZH8>%F-WLC_0%\2_
M1)W8U?*H?O>R$,5M>J>J?;D9/!:,AWM%TY,==2O)U@H;NV1%[9X(ST2MH32+
M^JQB$RO>\?J%3:R1S=(;W<HO3HP7;"&(S9>I>S+SIKQ;*_:W"B:P5*XC&BH'
MKF[,9I[[PT(R/_M-7R65[9BJP@#U!W/NX7.R".B#'!#]] 2#BBNFYME5,WFZ
M:9"PP+X[I4Y=KS#[B38UHJ;"[@SUEX\3@7$RWF!:64%]/L._K3ELZT=_1^]Y
M<F_H)?&18UJ=CS0Y?NJ-NY$LI8C,?@LV]S+&Z!"<K=-W\99<"=UV-^9[DE+*
MF[4O5_8GQO1G?YMUAC.JC5W;=E_I'/)6=_,I]L7^B_%6="/;\'T+#K@AVQ,E
M] "W1:KNN#J''[#]6\!5@6T90\NV HN%O:*3^N!::3&D?10-K!^Q@34\@E2"
MK)#D$B'[J=/SL:PJJO=(WL(;BO4!%'=JMZJ-Y*FL*UX20_[9B\C*NN+3D9N"
M5:J6=<6GM%ME77&1A:5(5\)"77%93;QR8 ,R9,N"VG+V!\P%<=ANO=9H4EAF
M597Q%JOU@ <$G"L:1>2TE06>Q4X#):)5.,R[\1\^(TV5+;;>/KOJ7&9.NI;5
MQ*<M;-OD<78@;)VSJT8_,WSEE&N)=VEW?(FB9B5N<S<O*D&T[WHS#EO!NL78
M'R>N%U"VJQ2F(IA04M7*9L39KK7NV57SLB#%VZ7H',D@VDQT>GF@+<55FML5
MJ6YC&[D"+5!BD(N,0=Z#AO[F.J,\)ZT/2KJW,8JLA,[_C&*[A]LAK]A>GEUM
M#M-]!YCX]5?(=G#@)S<P; %;L9<ZVLL6N(0BGQ1L?LF9S'02V_6SJTZO4V 8
M<BFF!1+3/5P=V<2T<7;5Z!:Y@U$:6EY%OYT OCH51;HUZ#HGWC0-\AO*RE<C
MF'OPWR=<X]S TPT>'1?"YMG5(%B"U*P0[G,\)R[,J>58T_E47, SXXTX,#4P
M$9B7B@]-0DU52*F!Y)H(H4;XJO_AY!&@V^WPB4%!EQM\*4B9]:B8?V*I  ,Q
M,D,QU$$"-X<%R9T[% 8,T3G\G0*>0ZS_NN7P7RI G4T1.LJ,]FS$"P'J]U-3
M>: 4VBNROFD+GR5#J$XO<]9U7Y;GRJ-\+]3>ISG[!F][>F7V"_L*KYYDHP1I
MM\ZN6O6TV$:.A.JNI"%C*)"VO1/&K%=L<M:=+>)VHA9Z>G6S[6(;UJ2?QEBX
M+@I\N(.<.<  F]O-&-1:L?6;!*72A6.SH%(AQ&?B,99-@#JP[FF6_X9!HH-K
M!!Z+66D9OG>%D6VCNV=7W<8[T12X,DB /T?J) NM(^8')Z\ZSH\C27\XIN6/
ML)<L,V]^C."C.3K+MGMG5^VT6/.&^N/BX*ICA7-XJHICJUA0?UG(\E3UQ(H-
MKN@BKU+JCGTB%MJ7R\ NA=,2&6.;=ZMD"J98S2A7[4VD:G60/(=0K0MR%SL[
MWZDOR\YO%*Y.4U\KPLU%#0KNG\^#;DWV8\8<Y)[@45?#7KA(??T5S#+]OU9*
MT38-5.)2=,,'E$UR&B YK46O)ZQDJVBKA]T]SK"QW<NBK16-FO@,5H]\FT9T
M6XR\!5;BBO4F!A.,W!.[2$H(5B0!L%15DC; +\'JGS%XU NSWXB"9 EKTJYH
MD_;'D;2#D2T\\_]4J_IGB]GF!_W>> 85_\C^,V?.B,'SN[_J_S#L.?Y3KU;%
M%^GNX=^%_Y$CXN^I!NX,/MQ$W2E^(_5I%W^7H>1T2^85&057QU-/&4X=K]3/
M577Z<N*_ZD]O,YCSP(,;9_2K_@W$FR_.-Q>7H=%1O_4W^35:(9(NN3;+UFKH
M,>-[=<A G.'!,UIU=;S=E/'BFJJKH^QK)#9+7ZZ.%R<2[>86HK7QLN_]>*2-
M+.^1V=<<X%+^\V;P,/CXY4;[=/./V^N;1_W+TZ>:/OCV2;]]>M0?__CX>/OI
M=O#PS\2UO2-=L')B:;NZQ62_W3W=/&I/=_K3[S?Z]=VWQ[LOMY\&3S>?],^W
MWP;?KF\'7_3')_C%UYMO,/5SO(1J%XMS?D]2FB<1?^U.IU9 $;R!8U[3WYY!
MV8 #L07Y4[ZG*E=TCSH?%8% KZM509Z^?KU]XI*#AP?DZ^GVVV\W(%8%(]9+
M8QC+E4'//N180GUIXGU=!AU.QM)4:[L_^W&(@MEF>XOWB*RT;_W%^+J1Z!BU
MF%@H[][M>Q[<-\,FW$C@DL%ZZWL&L_5;QW%?. IC, >K%D$6^CD"4)KU7V]O
M!_2OQJ\7'Y+#3+J:.W+@.KU:Y.9*FL]JO=;;K?[;G;_96^YP;D5+)YDG/7 F
MP$_P=8]V\ V,-,-#7_79,T!;ZF//G?(-O1U4R!TAOL@7\$/ RX#/CB;D>)@,
MG V7J&AU^/N_P?T0))7P$SQKZH>4C?+)KO=!>P73# :&Y).>!;Y71??G0]3H
MZ JYO"N[/@45#5K"<!AX13'F2_W5@)%C<TH/!@2B-S/>Q$P(PQ30T,$Y(_;(
MU:YK#&38S.0 OMJF_R$4_0=X3>CU59N*VS>#VR7N]\&ETEIP^WZIKAYAS+O.
MYJ)N/L(.C+"V&.[^18=A^?  H@^$O37GL-.:V'[8A%<KF A0FF/Z^(D7"[W6
MX5LD1IR3$X37H(0*=A<U;(6F,T-,),<&_4;R]L %'1F3#?N>>6@9@?#E69+N
MV17<,FE+,I9S6WXHA-2+\V96=-MROC-3$_J2XY+$&<'S9XQ&8,A$6;R:_@=8
M+;9^!^<"G?]F1T4 RD_1@8#)C$3[%#@!!I?_H>'#S["FC69UBG 8_<OMQ[L'
M/,XV7(2@8W$H?SSJG_A(3#9S?0L/\>_N*\S#J^"7T]^.$Y_-A[;E3_"=N@G'
MD<(/N($CYA$-[6AB@,U%Q$B>>EN +>!Q8EJ&T3/+H^M"$VM*@\2Y8S3-G\/"
MA@_'.,>SX=%JX0C$"H?Z*9(XD$++);+;OQO.W/#>=!XY:>O#><!)90GOZ,X#
M/X"-([;."2RH,89EK6B<*S/Y77RXX3@HNN'R6YE7__'N\P,LJ4<?@I-@PQ,<
M@Q:-OA&M)Y^']M%PON,PQ,TZL^=^CO/2RWY>!C2G032@6S&[Z-1D/3&]LRNX
MPAJ=1HJR^U6GT!Q>*<F=0R)43X^84[.LO#_!6.N0T1\GUC-L'Z[6N76AX6\:
M39W6W:>%C[Z&:UW)L)C=WH;:AZ^F7,(\Z@;[TRPN&\G,N65=@&B-K1\H98F5
MR'3=;:I,/^,K-Y_3Y=G58J#VE]K)F$XG9ND-?$TA^14!XT8?M/:K*Q2C,,XH
M)S$"J\IF =Y.H!1M?I;X'1W=7#(F/=6-YV?4P $WO=9D!OH;!-CY >+OE_?W
M0+XT <;HK@BS=[%!1ZW93,D1P#+:\(\:>"IX$UGX6U#XCHOZGY8HU$HSL$!Q
MB:88^R0E]=60.JG.<PQT^\I%Q$_\?6Z_R3@]_"\<"'\.N@[72UP[\$]"6XS7
M+>#EGA=P59ZBBUTCFHN)ZBA1 3/7I(34]$]S3]7;<4LA7% C6G)8 2&*N#1C
MRR&JZO'<HVU0[2AA%R1+&4#XY]@;E5ZLP;-&!'$8Z\B@_PHF&04?'#;WI*J$
M3Z/=).Y3[E9$>RT&8Y&](LQ4>%J<+']-2FF3))ZR8W?C3]&\[_F LNU6\^SJ
M,L50C7;K_-OMX^K[(3'XSDX'KYY5R_;C@T?\=6WQXI,G]:*BR48 H42]PI]"
MH<F>G<]Q[46FS]WX,[T(Q"SCI=<%9Z^;XC;\FN!@5_)YNT\.TRPH17UM^!.I
M"SZ#=P]R#VN83; 0%-M?1!;$U$!X492W^A[C-V%3#SP#PGZ."KUNG)$+FNZ9
M297Y(-S2BJX<2[JRGMAHXKBV^XS14#5>)WH*W#HF#!B-[\M^6\9:L(L(Q5:T
MF-Y50P+H"<]M@CU0# EDK(HA@4BY^FBMCPS/L_"N!$<L5,85F HU*S&$Y_;J
M64' '*&?^74I#[\%-LXP,"P'GG+.?HP8K#O%J?0 EL4?<S\@U@9DMR;Q#;WS
M2;SLGL\?GDZL?EEU!,46EH<69N%3.0C)YXZ3M"' 7(EZ2,@(+*T-^,S8/L:"
M[;X([^60OQYQ Q7U/HVL/$-9;34(2(^7"RO[LN E&Y<$G,"+J"0<>JZQ%VW0
M68 L%5@7[&.P8-\;*,3<B"*1X&>!MD!N'^Q8M#D\RF&988C^/.9J&W@&;,,3
MHH3'?(]')SHL\OAXS,QZ9'J9CPP<@R!ZOL8%\J*2K2L0'ZCQ=NN,/,3WF&$X
M]1/S1YY%C8'B(P//73U3K^[<-E'9)2/5EGQD%!&KB#,]!S_!!A-3F)[PA<8O
M9(H*@UF><HI7&9[R!/+_M=8OU5:M\PMW2V!;^*>YKQ&9LWAN)43S354<V&)I
MR)0!PM^&+'AE#$-8]5_HL:UZ_9?$%10YB: RM##@:[(9XV$UE]\J<67QXMJP
M!5S:8*]F8)R# /%;(2:J="DH\7T;1F>^P5I:-$)XUT5ML5(Y2DL7]B O9M!7
M]KG;*49J[:1R(:AZ)8(J#4'5+1%4ASM-RV# >VD6N2ODT-%A4ON9UJX 43\#
M5/4@&*%PB8=7'_8J2 >\+)-PLT7ZCXUQ93M:A_U$ J1;KRW)-H.W#2:P,,>6
MYZ;#H@5N&6:)Y_<:FP:AY)AA&Y18!$_2?V(!&W%[.DLX"K-)C46, ACVZH)B
MH]*J]:,ZL4R3P;+S_U;1_*Q>=LZN',L6LI2E3J!U_'GWZNGD!MG*!K1L90/Z
M8%EPDMOO/ZB@W!V"*/-C1L /\0CI2J1Y!2$,1!O)4X@^)CP!_F$%-GZ,5ZT3
MS*2"'L&:/6EO&JO^RJ=Q)V;AY,@I];!6II92NR'BU#RG'.$RR*M+NE5Y/"-M
MA6<4!T51-^%P8WP%)O'=<5^K$_<5-E&&_=XHH2RC=EBD%\1"/!Q=PA>4<F,\
M_L3Q$3!F%)^%Z)28+MCMB&<(=WV9 JJ@9_LZ<6U&8S$\^(WP3K_.3<^0+Z#O
MA;]%1$3X[@K)'T81I0LKSYO.57_ 6!@1B<6B"F52E##9H\!DA\>%R5KZ5\NQ
M*,H.8G\#RLV=OJ&PTRC""'R(F_UZ<WLXX&RK0[XV_K/7J[6*"93=AYG)@^4:
MS^ZGQ\CY!:=<:[ S"90LC/4[HS1(PLHBD-E:,VL3ZLL4U*-,],'XLID8F$)>
MM*Q""R,&[97(7I]4MS6R9AS"!TH]G#.B?7%J84X(UBA<FHINF*1I? I!.PB=
ML"V'J9\8V^+>P4;O$VMH\;LM!1]\4D)V8JG'1S3)R-N(Y#K5U^ 0X?@'-W$S
M-JDH)OFGD8*M_56^7M3E@JTM;)5L?'"]/"6Z2RIT&[LU..A_VY>U[GL1QS_"
MQ+7Q[#&>M YQY*13-6LL <+8Y,<#V]&9L[#QO<G&E/\-X+TL$"(7FMF(H%TC
M9MN4?S^(P7QCP=U8@B+S5('WL!J@D0)Y"64,,66&2!SA?!%.3 (7OY@6$DW:
M5B41O4TQK[&"@]RHX5XGM3A"9IKDKE;6EAJ X!RXU"!4-G3[RLLWZ[S7UA?@
MA$)UJG';(UE0($6$[MHI0]?.(J";R7Z$%N3U?6A U@YVRJ.,PT%>ER5^H66)
M7Z2%+\C.VU7\8AO*&-7,0WL_#_T0G.^51EY"HD!H=B4LB0(\R=A=NM&G[4:/
M#N1&$\^*KH3T=<(!-W[5(_XI^HQ_@+K2 M,5[<-AN7,T K5'I02* 4+)0EZT
M!I>NX "+;#H.RX,MLEQ3A BIXHMCY1_9+!"ZNLYCT]S+I+H=>&.,O%0C* OZ
MX#D0V=NP*I$\7;M^1M6*;($KW.<3V>R3<J4'6*RG+4I17$3]P'CC\H:_Y3*%
M86PN9M7 %?5Y8&);?DT?<'N984QBG%+0(!^+>%S+X;4P$\O7^(/)INC6==-X
M\T6I0OA)E$[$;8X$\(F[CE15@E%K::_\]**RGT#&+:BQI9N94&,./"2IRL#Q
M_*?[W6%B5XVI?FO;5E"14+4450>2YXFRH,]LZ(F*1HV_'LTMK@M]JAL28Q-2
MT!'.#LS5G4GX'ZP'BF4DQN)MZ/Z\NFIIC?IG6 )FP&AH@&H!CA:62,:R25&%
MC5##'I7X<RTL@A]@X8[!IB(0H>7G*Y+9I"Y,ZF3)]?S9]1XR&[V7V--GA=%K
M\LP;^966YP=B]2B\0R4.EFUK26QDKBEO4LFUS93[F"]>50ZD3-EG""=6YAR"
MQO&O0O@2\J1(H!"+9)Y3RX A[F_J=-/-+-8E!.EF]+G[C24@8E'(IP9=4I9&
MS;IB=',D ]3,&UD^4]>,'_#$B>6'D-<:TA-/1G\>1]VGZ25_/O0MTP)M61%Y
MX3]%N1]H.A^M?$%+ +H32R%@[=V1P0G2]6MX VR"8QE\,_FV6/YRDX K8I-5
MB5,?Z_U=!S/Q'#$/!D.H4.VWBB9.UJ(9$KMB$I<+R1#_W2J$.LCNPC$8A,^(
MBWE3,4<EI%A_87 OV3PY$UU6451PZ5N5DXG@F@\P2Y3>5<.YIX?'!]52XGSA
MH BR$I%6QMAE.<YKE_"T QV.(@.V^R5@.PVPW2L!VX5!=!8,TEPBM4\;J;VZ
MZFL5C^0G-@S6$$8V,8U3!#!XC\#@W_YQ\_!T"Y*J/]Y<__%P^U0TILC]4[;O
MA5BEIGV2IEVC)T.A442A<5G1!S//LNG?9/Q_<U]X7(K_=:DQ"/)(Z0),7X!Q
M17TI5=N0[,\1?,*P$&+S C:NZ\'(C-'(Y2C/D%QD:6&OI !12@%7^ZQ@0&[A
MLR(;!S-]!"%=1[/#PY3-?VV?7;57\5FL(TSH;P+:WMGH.TC_L,WHM\D/;CWZ
M)4GI[*/?IGGSUJ/O8>1CQ>BU]8C__C9-#;:>0'_M\JNH_8HNZ3M#X'D>P$=_
M \"'>C7>.C[<FCP.$W&#/0;H;>>&@?33N<+0327*LVE-?T0^0,E/%5$G$I H
M09\H":YH"YBID:J]0WV)"OMQ8GBHW4.:/@/YY#PFP!.D?4V>Y!>(HVC5E:#P
M>C7:WWR!:8SW.)YP >MQR8$EIE''??_+.I'P+9:+K#VYET<8;&/)8->,]7*#
MX.'68VWB6"\7L8'K%O:R<83!MI8,-D/-TV7S".-M(V5;-TUJ8PH/0<;2T$K@
M+$N@Y4[392&2:HW]JN2=,IFR,7L4=M)!_+B=V3*];&U0_)5^:7TV1GE8!;%V
ML)%"D2PKP"H:M\(Y*:"X>/2TBR?'O9/CLKG<@.QLZV/;Y4R+BXNR]W-Z4DGM
M?0SV:>+ZC(]8.7A:RL&KK."9KG!+"<L IT@M \ZE15E?$[[,LRJ.ZRD_2PM3
MY+D$5G7BVM3_##$9NJ&AQK;&2/1E$N$N\BX;@A(:OT*4[ZZM(Y0ZP.2;2=PZ
M0YZEB0F^+V#.F'<)K&".7BP-9\H'P!\AZR/3Z2(U\3Y*^G@4HZU0KS:!G$UJ
M+41.T[+,L(212A?P4'.LI=KDL):#4TCQ!Q[%'BUC%+KL\=S7D#D,V;Q"W>H3
M[1,S.+'3F*?V78=I?$T7M2\JHQ<,]Q,[]5_,<U<1YA19W$_L!OU8TR+]IX=Q
M&[V*S+-_GSML,4G(9QA''P_LV<30KXV9A4Q. S@"AAV$N&[ZJT1V2V&F7@J<
M32JL"Y"$>GB(&.>7FG%752F\N+_3S_$?XN'A(&%\]*WP153H)0XSSR6.#'\2
MH@'6WU2Q&$$]>^H?N2Q%YG_9/14_1^!.M^KU2CW-I0[1W6(E?,E!#PLA:;GP
M^!#;5 ROV.Q+I%E$I,87GZB %;4(CZKI]PH+, $+^)4_]V )$WE@I5-'S,A2
M@X"*,,4NV=CF*;]^O!_X<NLJ4KT*K3E&<\R"Y4,50Q3T(\R:,ZJ$%)_QB(=,
M_V39<_)_;WV<S4@^XYRT-Z_'&3)8C0LTV<<VFNQ$, <Z%!/J[(T4D2&79XV(
M=#<4D7N/T<O^(=^5L/!6B@OVY^U6VDLDAM/WZS!%Y)AT&!U>A[H41(%904PO
M3K%J'2>-0&)JB_[,K2M.ZFF_4?V<01+H(>1?B56L7K=-:WC^Y.\A&Q!L/6X0
MYHSA-.OULZO^2HX^-',QHD.SU80ID=0\G\(^[/K]_6,DN[;L&P$3&7*>S^2B
M6B"<(81G*J5=.0UCR>;+,7AXXJ*GK=Z#J.= A 4SX'U3>?Y#')!P9BPX&5:L
M1BD^LR1Z9,C@:G($.808<Y-7%-)@Y]01A-YD>+85=CR@7UW6447 )B$_(")0
MA3$6[[,A=R)J Z(3 <Y\YBO:3).[@M8;O*'&:N&=U;H(.Q($$]!<@G2$WU:Q
M,8.RB5ECI$H"%<$C5I0V3<=/)+93@V_@%?:"TPK\E TGA08Z##^%E(9(8R'.
M!8=9!1.#?^ '&HST*E1>%5&]PPN0WU F?=Z&@GY/Y(C&B&Y/;>'@4@</!FJ2
M!P034BW%U."R%_T^U/C\"^MUX ;10ZX#Q8MBASF78P<^/]&=I'B[Y[!]_Q8U
M4YRMUS#17 KQH5BLZ?E,$\6RK\A6":IQ]%WW0>8"7YX[L*._LPNX/Z)CG[AA
MHI./BI87VCO)B$,$QDH OU&T-&LZ92!J!-/D8B8NX=@ENDQ'<*1VI!]6:/.P
MT/#<N%BR[UK6?=\@$+NS?6\NVW=%DPGU%IJ99"'!,B)PFBS!V+9PW6>!%!!=
M@,"?D6*-+Z+<B04YT.A$G0\O,BM_;C83LP!I@6BWQ96#*7W!8+UT\]7N#?0!
M+;2G%HVZ!6NY$A.SE5+V:I#!#W^W/,FH@VM$_8^BT^5S GE2SJ;([TA%S1EV
M..'MXO?.+33TWBXXK:M075%5Q.+5D;!KXXN%1BWW519]LM)_W%W=E>)PI)6V
MA(A801KURE!RT"8!_8MX,*YTN=)!1R9^+X7&2D:MU*AOD7.YML%0NAL+(_/.
M(Z[T&S$"4E?A'WWQ5[^14W.U4'.E.GJ"L4&8<3YXYA([@2G4Z"*/#"95XCU#
M\G6%(?%&6Y"IG:<?'_76B1\E:7_0 98.IQP8O^C"'V4%46*G<"OYX49N_;@:
M OW!.P6L9=IHU+?(2AUB.]O+ME/U%.0[=7HIF--2YX7E[MKGV/HO_4(E7J?3
M5:O'I4DA[I=8!F-=CKU1;V[HR8:->^0U]RA6*649TQ80TQ7=RTHC[3)/WISB
M$HMN.:XMPVN3_XB")_H\9+@+TBFM]X*%+#PB=<FM%F(X<R&X+TL$=QJ"NU\B
MN'/+74&/2PG@/D$ ]_$*;/(#O'DV 7PE"U$ 5,FZ!N?=:O9W@//> _,]2H'6
M#QDQKA]N/MT^Z9\'U[=?;I_^J>\>9GTRCMD^Z3#::5P#B3IRGSD8'J-<+/QV
M1.(654XGN,^^U&YK XHKL##?]R4P:V&R3_V+-&^1\ MN;\]]%>DL:\HC7/A?
MB92,PL:+CKP(GT;H&UZYN\YWV 9@?8<1F8\T:!A+)E:^9KV+B865+0X5K^!6
M)+3X 0^CB *?$_\KS$R0J"DLS83 X;!/L"+\9!?*2IQC#+$3V(B,D9^8A_NI
MFX^2Q'+ KXIK+<%H'2XGR ?\)7C+@FAJUGMI+8=#1NOSP'UF%#Z+<L1\[30^
M""[]DF.,+Z<<F)HL#KTE7G2KI%?4#MQ27">&R0/+1"_@P![81EA2+<X4K?^;
MQH-[)AMB;N U2K.$+!WT,27Z^";ZMB*V0XECHU?S;/G\](YMUPA$!W/OF57"
M^ %'8Y PJ&>QHAG/AN4@]MJVEP!0,$_$L+FZ[)0ZQ\C#8/X\]SG+M1KK6=FC
M374\UYW230H)XJYG]IZQS7I_S1'5HGZ%"5D1A?7Q7Z)>4QK=Y\&U)V:>+[:1
M=LI4>/L@X+7--TY&TH%F?3VR'>>?<A90T:A'4*Z&)E%</"M(\7>2:9/R:"CK
M;Y3;$VHLD2ZD6+6@RVE'#<9)ZY&PS3@T($0<* F1*,&F15'M$$T@OS "N8;K
MTWOC?Z+,G<G&!D4.O#0H6+H,8*QK/.=0ED4<1N.2Z%0$;Y1*UF)B<T3FZ[)O
M93PK1!J;,K<\ZX@*1-$L*1*J4F9@@"T\YO0Q37XL;&09N\61GS\DJZ0$F/E"
M,< $*N=7KN$4M:0D:8W72C16/O:DNI/L Q3^IU&&"6L$[U%B8$AQ3]G#.WJ@
MD*?Y(C,K97$3\S%I!6-SBC7NU&(SDDS]20.&%&.\X>=(S9TL[MG,9N8SY8G&
MQHO+4W)<NU=)NPL;"__BZ1B/99Y&B6?>7( K8?R;;*H9X2(QK;6H^KGIQ!?4
MFC)%GN+R(?KN88PP5%AB20/>.*&BH1@,L:&>$&6<Q=RFG*&Z,C\]5G8URZ<*
MF$@]J:'@:@+]YB=- H^1CHK)]-B-DH2AQ>&#4O!>K)$ ZW!K@_Z(9RG N^@9
M',[P0XNX.$&BI!&![YAEN+7;FU 3<P9L,8Q;YT8,XK/K?>4#^ CO_\PRT1,W
M&_6SJ]8*,CO%/%[T)RI"A1@K@;$XR2RD(F2'X%X^@3:+#[*QC$Q$99T/9:&F
MWZZQ&=I; J?\6TH.Y(9,-9IG5[U4R)0'TN.%25Z9%*+^K5P24U#?%O,O9)K"
MHADZO-%0'.:)R7:953+3[C;2>%98*2&0;F0$HR1+;C"4:&K&KB2\M)"&>ZT?
MN;FLHSP+T0:QOHW>+@FA<ABNC5;J#BCRSOW&<%[\/L++&<T2,%X,49T4<C$O
MNMDF>3^W$0%;):Y_^#-1DS#-\%-=B$CA" DW."]=<I/YA<<QG"A%J<;;@D>+
M>(R*T&!HP;AC+=?F97-E:?/NQ.#NO,]R:$_1R+)7Y#0;[536S=!_%5V)7%#-
M:#V(MA5R3])PS#,RDL7:P=[_#2U"9=7VK,*590"QON9B1+F>;)+<65,]'+JR
M0D+!<$9:54UMVQ%=9QX94#&K,":S2@ +?8_=<[&*=NLTMCM'W&\/-"H8?+8E
MZ6([AU5+LKX><N.>%%L.':,S::55F=J^(94D<4W*AF_-1,.WO:=H3ZRAZV9T
M6LUZF8Q-2\9>ELG84\<LE$G8$TS"[EWIKLZU"OI&9@[@>OS7(P(0>66H?T,
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MGO6\RI1ZTJ?YH(G'EG'!_53:W3E:J+CP3ED 96117*E:*FM2IK%Q5H;?8/Y
M*H//KO<;JH+,@DWM==N5;B>E5"PIUB3-]AN&40NJA;(JH49S@TJCXVNA'E8I
M-SN]2KN3PH.R?+O"6"AM$ BKHH/DGS)K(8W2^$+!X5:+_0Q++%*4WCXTUWZ4
MP7%TUYVC#^;/\)..D9B%>(Q40-K^%- &[#Z[44#]LZM+,!<S12Y3)#J# M+V
MKH#T#110_Q05T"46OS3Z_4KG,J6T,%$3LB\%I&=60)JJ@'86&#I)Q7-V-2!A
M%N1@7,NTX]C3B;$VLKE!\C.E\.J:DV'P_7P06PF:XS-MI(SM9I7*7IV\UVZW
MTFVMD,JD<:YEO[MV5=,DMV+'!4PQ0M@]EC#1_[:Z%&;*5;?4+.N6TNJ6&F7=
MTDH9*XN5RF*E8E3[E.5(Q3_6NZX\:FU<>=3<5>51JQL&YRPP3/!!]5IS.Q,"
MMEKX;.0721](WWWW]"(:PZO"G1MV>$]UQDAHI&^,)$6[Z/R^X9O4CO!=9%C:
M>%L^,MM]U2PLC?#GTRD:U<M0OM(]%R,BK]ICML%9$[G;@*>4 +^"R@DCA4E'
M,2:C)@>NH&>'M)I(WV_"9Y8WI(_B3GOI.L\/Z6BZY^[S>Q.]L+ARE])<=KP/
M'[2WGI!;-[K>8C3_A)/'#QX?!37-5(_@45:D7/KC+7W9,;RX3>?+EL0GMENG
MV7OX9SG:1>I?S<M,Z1*@@6*2CVX$84,72I#*G5PQWC]Y2:L9[:4!QPSCJWQ#
MPUH-_B-AM\O=/97=+<_I>]E)>4X5ZSO]H!;UG![].C^4K.RRM>G>)W* =2GP
M<$NI**5B"U655N?H/0_/F_5VI=GJ5YJ=SL72NJ9.\Y?%#KZ)C$NUT:BU2#E+
MG8T? HW-?[T-\#BBPJ#Q5?4A>[8<1Z%:PC#WNL;$A^IQ?806U@?K4+U1?^JM
M\7@BI*[( 4?H948^-<ZN+OL@X]W%BL_U[:P/WJ']! 7UOXHJH_F8JK:54)6*
M0=C  V[XQHK[\]7S]JB>M]-=K#PH9?==*MEXZ=?I:%EDPN^V2BW[4VC9N)"^
M!S7;1C7;;11/>+<Q\?_D5"9)^3R0Y?X;1Z<<PEU+<5WWJ49V><[^>^5!J^>[
M#+A$_ZOUKS$\;-<'C_;3OW4X&]-OR&FSZG:X:O<:E30>[ R+NH_-.Q'!6Z;F
M#Z;;ZWM4[7XN$=NA>D<&\EJSF5F]E\)X6"V8G?#]T!9Q3JT7DSILFMA.[PU5
MREVAE6#W/2K!/MJXC7Y!E.!^8]<'LG%#3M;3/&=;Z?>JST95ZT=U8IFPS!]T
M_M\JFI[5RZY(TV8<2+74A_O0ARNWJ%=N45&.4IX7G>_15EI%O*O6-X1J+[,I
M=+F,@GK_4G5QF@+U4]M 4L#V8 ;UZV@&U>N9,RK%-8-6Q?=BN?HE0*J#&4DS
M[)7!<7T>RM&868N1P96HK[T&[->AX0Z7H,@WDOU>)3ECC[MUNS]S(9E[D0K(
M>M?T&V=7N9SN5:=C/U?03R+JRZZPPTIY8:.=*3*^PVN.@ /=[.G8_9^"E9KO
MG1^%D]'Z1PVV;J/U>=^T5JM  E^J_:*J_6/Z-OM5^^V<WLU1U/Z[B/V6T:I=
MOJ@,'9:;46Y&N1D_W68<)0#8/F#X;[&"A_&>[6MJ=U+&?'@;&5ZJF^Y\:+,C
MNX/+!K)7,_DTL>A]:D32[K0KO<W#'PL<>(<,?KPG4<_E#1Y?R@\+9O\'\]'M
M<\R;'TCNQ\PG%W^U%XQ[OXNN8:^W2/]='HE2^[^;>L]^+W>]9RGH/ZWN/V*]
MZ$%U?S]G&>D1CD09%"R][3+T46Y&N1GE9OSLF_'N@X**E<.Y' ,9%2PC@D6V
MEX\:$52$)J=/>'EVU>]?5AK-Q<;$Q3& ?PY!+[Y/6+QXH!(,V9U/>%GGG!?-
M\DB4NK_P\<"-=?]EX^RJUVE5FJW,Q4>EH/^TNK]X\<#]Z'Y"A_<VAPD>,![X
M-VJ5=+78Q767_<YV-_0#=4-_FC#]5<A#51)L4T,PW30"IH\-R]->L*$L.E4^
M%F]6ARAYNH$R%S8/XZ-_-7S]OXY6*+$-(0+]\1/,^#-,F!KHYCP)K674,)4U
M*](]0G/R+5>DE6E%VLMX(JAEW.I%Z;U7,>G@HK2:BPI3GS%/IV\HK??TE:WW
M*K%?\1.(76TT7-_DI^%_1>L_ZX79;S4=3[[L /AJV;;.J+X20RCX9GBQ;<'7
MX=2?6Q?ZJHZ-C59<;)$NX -,XA6N8Y\Y<H->;=/_\,2\J>70ELC"#'5YNF=7
M 7/XM).-!/6QYTYI;*298&!<3[D>C'##(9K&6ZK\#-?+SW!7^;@'-C4L)**^
MAA&C.,P-&Y>I$5\:S$?7%]8$)N!K8]>VW5<I,T&TQ+A(O*4CCI*ZJ[_SRVZ?
M34?5S59I#% /<"'Q_?F4_VYW#4@W?ZLB/_UZL[W%=H&N4(1LP5XPHA' 'T&'
MS'UJ/0HZG NC%,VIZP>@AK!]"%D6.ED6?FA:A II[LNOD!%?A85Q;>:3)<(E
M>^J:S/X02M!>>H[N6,"3O4:7]@/=B:"5O4'#!Y6===3Q%JY-8=DIIX@3V3.0
M1BB5?O^874&DB4:#,ZT7R\3LX9O%[&6L(J=,_5TXDOI8,*!Y&"\O=-R4.U2*
MP2<A 0_@7X1^7;6I.':SN<?B9CDBXH[+]OW+X5/^QSB>W$"D/F_ZBVO#?MM6
M\%9B3W9T_ X49$D[?@E_^!_AYN8YAY=G5YU.[1@,N;L[?QGAI\<XB@^6_YT&
M,_88 ]<.C%2&OASL4'D$=W0$V\<[@KB]GV%G;\7&9C]YK3JXR>U:X[1/7J%O
M/ML:4[@SO8?M>SUOJZ-U*;%<#!K'8LT;GQ"Y^E]@X>_&(O@2BZ8A$FSCI>C6
M$#^V)'!U#'CH/E.CQXJAJ5NNQM &F  !VV))W*R9-VZ6=UFJ@3NCI0E_(8,M
M]#LEUH8C6:K*X"E+PMS:HL-1!X%+9H"WE*;_SG"28Y'WL>L&CALPV5RF^2_Y
MFS/]Q]3^8!NXKLRI_O&XQ;!NG9$]-V7L6.2'QOK*.[C1:N1/P9*"08YCPQE)
MN?-#39$)4M2J-\ZN&LUZ*L=D& D/7!VNW-$$9%J?S_#'-9-I'FDRS163N?-@
M3PSO3>>/QEF8E@<ZUO5@[PQ?-V8SSWUAICY\HYW#TVLX;__W_^LW&[U??9X8
MG;BVR3Q?ASE_@P_S[&9=YD)?K6"B@]3(ON#"583=SX%(R!:$H/6*P6;NF4=3
MRY4-;M4)--!:1$Y&R>!=YFEWE*5MU=M[RM*>>(ZV5>\LS='J4?K,6)ZAQ57R
MF?<"$L4W/DJ2T0>-T43( AX:P7VBH'5RXF]R2/OVW@9?^A! D?.D$.E "L:X
M$N8807DLR1K*)4.%@!^@U"&!4"A=[@8&'2J8%$]%YEC!:K:P"2WA711LQ#<M
M0]/$YXV]?Q:+#6#@[MS'&9!&&#(Y?E,'Q>C1O,2D7T"N<=(S.L>^<AMNJ2/^
MP1_,]4-BM_J@("88*$A5$375^)56@'! R"8-#=+]X]]V9YPN6L\IOS&M%[1B
M_X;_C?^P)_0#SR>>\1'&7OA_JE7],V8Z/NCWH.%^A:?^9\[  /B@-UN_ZG1F
M81QZM2J^2+YA.'(Y7-6J;313S-HN_BY#.G.#!4A+G&:PLL^N/E?5Z<N)_ZH_
MO<U@S@//&%JC7_5O(.Q\<;ZYN S-IOJMO\FOT0J1 $2[FKY60X\9WZM#!B<,
M'CRC55?'VTT9+ZZINCK*ID="N/3EZGAQ(M%N'DKN=G>^=CKL'8_V?X97?]X,
M'@8?O]QHGV[^<7M]\ZA_>?I4TP??/NFW3X_ZXQ\?'V\_W0X>_OD_?QM>G<JT
MOMT]W3QJ3W?ZT^\W^O7=M\>[+[>?!D\WG_3/M]\&WZYO!U_TQR?XQ=>;;S#)
M<U1VM8N]S6Z[#9(2M<?EWVZ N-KZI49.3P/T\>^#AYO?[[Y\NGEX%(Z0?O._
M?]P^_5,__W3S^?;Z]@G,:9B.7/;AU8<"SR[#\B>#.PE('D9QA ]X\Y^Y%;Q]
M [OAD^6/;->?>RG!G/:9B _E_F9KLPMI43.VN@O5T#P:L]UB"EM2 T<:QNO/
M[0!!RWIB=8\;OENVYP6#>J(QJT00Q<H^N=?1NN8#<W)_*<<#U<ARH]W?$J>9
M#)VX4>&/&E12Q8;[D@OX<H[E-*3OZN\9;4G_V^O56BG\ :/IGN/(.Q*))M_+
M;63JQ'";RU-E*4C'/:(:9?B20[D6T]+% (06!@1ZZ]"80.8<QH,<&#\]?J.)
M-:C)'"M3,%,:[3NWIBEIW*'WMRO-HC:)2:OHX.M_XILMWE&\+9=) K[9E)$X
M^EXGE=$I;G@!MSKM=+,HH7#T;3\X,DV8'ZWF-ECI9KW16:*H#@K%;B5!NZ'(
MK*PZ[.X,M75O&\Y7U[3&L&'XE4_@>G@6"=O ,3$7%4.H-"ZWJ?=ZP(I3CYDR
M&>5GA*N4Z/@=8@-)>H[ E,)S]+Q_<\[V::WZY=E5HU&O=#N9&;*.MYLG*:;+
MN$^.(Z%'K-/?!Z%)JY&WJ_.AI'>I<)V@"!=0T_9V3<+!E>A@'DQ<S_J+F7_@
MA:K@$/$Z]V."^H!RSSFI[L8*$B4G#JO1**X&/@!">SM3LW<D;'4V8[)_+&.R
MV>P>T)A\KX#V/:FN_LD9B8WFV56K6^GW,VNHDK)ZI>UW0&F[?&\&7RNGP7<0
M*^]$Y+$H*O#R_5AO[6*IQL/&#+<C-6D4V7AKUX]FO'6V0124QML^-5>[?GK&
M6^?LJGM9J5\>H^"W--ZVDK;&>S/>NLN,M^KJ&HY&NWD$ZIF]+D4/[L!:]KX4
MI1E;O,N@]7[,V'ZQ+HFB!QZ;K60]=;&,U[;<W7^U_S6&C3RH+5L:KP755SF;
M. D)ZNQ6@O+:LE>->GJ1>FF]%MQZS=530PA;=[?"MFL+#IOIMC/WDREMMN+I
MP$X>FTT(92^'4![4A+MJ]2J]7K\0\GBXOBW'*CG9KE"D)"HZ$%%1:R]$17>.
M/IAYEJTW>Y+ )HWWYJ,+MPX59TFZG(@J!S^/VXXB8]@1V='&S$$;^)^[8 YJ
M-I<;96G,0892N[8Y[4^CU3X>\4^3LHXI")W]$/_07!<KW!98?JKXR;"V<2=<
M04W.%;3@<2U5AJL'=:4PBL0N@^V:P[1/G'@(\3D;$ ])MWA/7$.;'[$CLPTU
M>W@\FXN&^>'9AA)KN&^^H6;_["IEWOOC&UIV]G(R#C4O=\0XM#<K$XD =FQ0
M%JF*7C%B;XC.C+%'KEV6G&502CSD=S=^8"/WV4'OAF_MM>N#V9NUW'ZQ=]*.
M!Z FTTG0MBK/)W4C6BB.E/%$.@%;P'GAB+"-$AZO2(W;H'UT*V!37_X-[2&L
MBP-%A_8M_ <5(IT]?(7')O!DZX7IMNOCE[1$:[E#%/;O0?[7<,'N3P[?08G^
MKOF9ECM7LJCSN(7W8>5I8V%?EI:9IHYYIXLH*3=HF*TD@&G5:IY*IZ92]E*K
MGH\O>BNZ@!5'WLI=S;^KS7)7W^&N_BQWPU[:XL4>='S1:L2#\L<E OJC]ECC
MG$EHE'K"I^#>?K+5B'Q^L05LJWZ$W?9NJR ?F ]^UFA" 2"3O3#;G1'3MW3W
MWF&)>O'J>]O=#8)HJQ.SF<)IK?K95;]PM>2EF.U+S'I'$C.L^>X?N0UE*6>'
MD[/^D>2,,K4EKT"^ 3\:F!7"^W]J>-\994>6W/XE^"K7,;@\TC%HG5UU&\5
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M"P76$=%@VB"(6"I^]&B-B2/_*\[8P.[LE6:-'OT6WO">C31#=1P\P*R)J7,
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M]?1W0JZ"HZ@9*$7"] >P0%/#!F8F[EXSBGJNZGJN94\C7UXQDJ^5EMQMV:"
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MP?\_6OKT'-X;NB/C_/\!4$L#!!0    ( )V";UAX[UXI1 <  /TO   >
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M>CQEAERS$;E3*96!/Q&0>Z9Y7(.*4/7V6^LU2$KU@,M3@D4/&\2R1[M'!1_
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M,C Q97@R+3-?=V5A<F%B;&4N:'1M[3UI;]O&MM\%Z#_PY;6%#=".[<1-L]P
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MO$"?.TH_$>Y+=$810U#744 ^7YSH6DAVYY^\IG]2@:DSX1SDJWT2=^&/K_.
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M9(]>4Z)\8IN6/-F_XBPFRR?#G%@@P:!!LT\T*=&.Y[_;:Y#8BC3 \=_C^41
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M8/-H/L83!L%? 8G="!,ZE-6 2E_#NMJH>1C:+?C5LW9@[F;A(-9K,TY*!W@
M#90!D+FX"/($/=B[[,%^*J5JT>YK-_[_;6Z*$ZVB\+WX)*^!$JZ EA0@#>82
MFYLVX+5_=/J; X2'W\R3%![9Q<"#_:2?Y'DR>B_>XF=]V#AERL\.(O2S[&R]
M 9@RV*L00/A4'Y$ ]M>__Q)F;0"@#Z?DZV:?7)_O14I0^T"];8 ) 7WHE!YJ
M7B)N&!T__,Z34MU\+)8HB#$ILSPNT7%N@Q()S$P=%JS])$9*QIGU>[#W.8F
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M;JD:D$^^TR\/+HZ^H,K\\I?>Q[,/_P-02P,$%     @ G8)O6!8-<ZU%'
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M"K/^^]/_T?'W)/^G<ZP1OX8I;EQ3O_9/J34[86L5UT@IKA$S80@8;,WZ_SX
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MB&%?Y',IP_8$X:Z28C%,ABSA!/8V$FIVFW*:Q+%11C\.C5%V.K[^GP1=3CH
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M5&/&W@=6!DS$;[U SM*JE!A6>.:'&':=<->#PDJ-<Q7#$%;;]EGDEW)QFWS
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MMK*1G<5.6+MW9C=,_IBKWW.SXYS]_+MSQQ2%?I167<K$,">.LPWIURU/'D(
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ME^T"G@FYQJ-9$P5W+6UY6CYG 52JI5T!-,32W@_%\.0/77B&D/N,]5A((=D
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MA _?3&L.93]9HXHO=GUZWWQGHD3@K-_<SO7P#(RJ:/(<0IRR% V)L_D2'W^
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MD=R_,F^KUX@#A[++3>B&R9:/%JK$5:5!1H'-9^*H?(F+0 0!]G/[>_K'=1U
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M+93_CUVEQT%HM]JKC8\;S6"X%>=:ZUAJA3?=6:%MO;?0S;S<9=_6K/B2?DR
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M>]Y:[(M+>3;2ZG[P;X=9]=QYI)":5[L>Z4:<E=?1*LA1O=$D\H"&?2/9VO'
M*\/NZ],O6Z%;&D#]QCNHNF(!N5?'R[=V6NXGX3B5(71;JH!:K,E^WFV@?[K#
M!J5T,YKV![@OJQ,C[A_R,U]]$'?1:%371+MUE&5;UU2?O^ Z<._ZF_HX^W^$
MXG8Z41.8YNC1[27F!#+ %(5C#)^A+:$YDV*=\IUZZ8'NHCU"MQKCIJR=;,>T
M;1W6Y=J!HH+G/GZ4MT"_=IW$7FKFP</ZX(+/N_6SSIUFI!>Y/[MQ0$B@SE"N
MJK2LC@83UZONED*+<'%\<=>(*&<I9[//92@<[=AEEU[D>#DY7\:QR#%WTMR*
MGMGR6/&KID&0"[T)"""]R4S?DT9@R,&_ 2*C=5Q5NPM7YW\[;D0T8ZB02E1&
M:=I"2BS<R!K2W(7YHH[C;M @IPI_>.TZ(ZY%M1QKUH%7'%YK9L3@+X ]3RA&
MM]C&;I:@ZE3A0X'QP$SS^W0[T(14/A80\9N?3:HR^YAN:@N1[;8D*?1";.0B
M?4;4IP=O /1T$A1Q]_AO6D*!'/9F0A5O'S?:$0X;NX7[ RK42\"9<UKA],O"
MP/0V3K8>PFG=!K+B:Z.B+OYN53RW67^PZ,ODGSAU:/OBB];SUV1KPOW.,5,\
M3['CRFRR349MF\ NQXU'0=V> ^5E#9\H%G'FR;EW"Q+:G4FC)^-*#H7/ZKB_
MJ7CET-G@O-UR*O/HXV!55JB#4W&!TY&%[K<JB+&$+Q+;Q))=6%7)JL]5^4_G
M'6K3?!+O/E<)\/Q]XI3K7T,-?]Q\L_^O?ZJ/[V5]/UJQXX,+!UCQ>(V?V[K$
M IX=B(S3VH7Y+=#B")+AT['(8_A#6-G.!3"9&Q\K$%]HVP>F$3EYER8K>2[L
MHM%[HV0JXI ]P4_W>7A 1$20]+"H8C6V@\'=_V0G"&O6C3K>$@0P>K+A'Q!?
MFKO@QU?6@M3814L-R1[VBE")+6A'!CC&]EXMSSH$FB.UDZ?HU]Z#QO^Z&<16
M/9/NSAVRE.;/OJ:[P:UV84?S;DT5G74.5K]0M*3F?NEE$6/EH:68ZZ/BXB)I
MF>+ARO#!CR$'^^]</.YN,P^5KZG(IQ7=O_9N[4&&RJ&PC--SY=2+7P+U.JU3
MV [#*67G3%?6VQ4*>&)"SI*O2WVV/K>^),!G;*&%\IB(K-/[G^  3IU?J&-#
M>>)>%0NBNN&_+U'M8S/QBBRRED !NLS-2N+IE/C7^ L,LES_AEB=V5I$CH8V
M^/M\9'@:*3Q*=7C[P$%,D&);US\\*WZYB68/J,;1:Q\3B 68' 'TNHB*O"N
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M:K;2Z<V>KC$^A"W5+'2R.DW2RJYKK!JWUK/UHD*%ZZUV8M6[,/TR)6Z27F;
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MU72;J+/:Y'2+P[$MY\*K EG!83L:A^>4;<XPV>\S5<X3#3T]K9FD/T"_Q63
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M" X%=(1$ +/=C]KTLIQM47^ ]C'!,W&S5UL'WC+O+[ZM2SW)C-F/]>6-01+
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M\Q-@V(7Y9[A857.9_IS06H$^=@Q_)E ^8K&=BTB5V7:F':+=1R1.*^$-<<[
M=!<RA2!N(H:[.,2S)/M/*6'&$&R]Y)8@MJ:&=QNP&5L['5O7E%]3!#G.0!AZ
M]F;J2:K!^F)3:Z5,5JYL@C8"LJDT.<A3&S**P IC83J1,%-!^[U->0Q[>::^
M:Q>6JGP:R(K%Z3P&FEV;H3* V;$+4PHG:[0WS::V*:'Q9RV'=;PN_S%,I8E"
MH8[#X:0CYI65&_W[BH\5&D^Z-0>,U38^'DU%)FEIJKZA9@?.AJF_I7RJ?=0T
M8N*&-K[/M*\J_SR[8-DY+73=#F!6LL P,'LC@]L:Y<9<7!-+@=?J?2#&*VN!
M@T!/IV&K->O6,$^3C.V;J8\+CBU)7I]6AN\)= 7\M^_J+H!'=V%_R+A_CZ,:
M?M5D!1%V%'"_0264/E H=MH%R/?)G/W5,_ $P64HS,B!BSB$%>GVO@C$%L>&
MSJ3Z<.P[7!KJF:I"*Z0R8*0GVOW:F/K41B^N-L<VPHXFZ+W>\UW8V/9/IVNR
MVFGCAP6';C]F>_W>PU[I\M(3'-P"=IPA><V6"/ 0L_-AEP] W,@=,G(KA>09
M-\#H#C3SY]\!^;+U+4U)HG:K])JBV._-<YNL(2^OL#;Q.F@/*-:=K_N>WV84
M9)(>P$:,U6^$C"#]R(8]-*D6/X!+E^"='VF3G$#AKD'/9Q3Z93NG%(A=)*G@
MMM-%WTDIF.\-+".O0B4$76:T3G=T.UGA\V-FEOK+P)'W*1Z;'CF.,5X%>Y<T
M=%L75LTU6>KU0>IE_G-.-)T730Z;=X<>YMADN N67GHWH2ESF5D[DKS]-5"B
M;"=:3!2J63(@=%8P4C)-]@K!?+I+DJ<Z9(*8?S YX<6S9N+E6[E8@AWHU1<H
MGSI4>[$J0[DZ^G'E1,#%P-76[_<$0U,'^:06%*BR$3H@T)@7D@RJVUX&*NS!
M'Q6>QP 3WJ#>4UY$4!E\S[SR%:&R;&AQ^<=<DUP?'TX\"*D'V3LQ<?:8D#?3
M*/_LQ]1KHRJUH5L"RHZ),$RY)#KM$'Z4((F+JL0SZ@COU>@H24&O+*$6D<SS
M!0@V4%;YU/3\AM!Y&SWF3IKV;GZXC"8I:I./BAV:Z"K"%G-$@^ETV1XO9JU*
M1)F7-^O?7=A>G2@E=#>IQI<1AS^!<P613VMID#J2)Y5E!1&XNS YTC$HO:?)
M\G^U*U^8'$U:'*(6VV(9I$5^7 P%3S[#(:F9_W95!CS*UAX%IFS+:EFWH@[R
M@BM7#GB9N&84R9>IGAD/BM)9.L69 H.HH65W[M >E799D*]3$O7/Y"KF)%GU
M6.&7K8H>O267$QII^VAW$4_A-6DT#ER:=P8H;F1[170WX1X1Q,,-:=(0R8O$
M<:U66LO.Q>M"L6H).J)7>4Z@G#L'?95K..MU]^<+LX*M>,MJYOG%MA=FSY<U
M@ K!P>\AOV8IT11,9"$]4U K%=3K\M:&?N.F1NYP(]JG4^'B.*\WO+^8M9H1
M'<<\(<I&)20+*E'6[9_"Y=)*RFO\;7W)WA,,,@KB7I5ITLR5,=#,6GZ:*TY
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M?LK:@5_$JIB)$3BT;E?7'-P"<PYP#MG".!_GYXGFM&7,YFUA2O7G9D'S[X)
MD52IA9-M1[,?6E(+(0RF9,[^.42\Z8]6S<*74\DQLJ,M,G,MJ!*KJ=E-U4?#
MCP9\RHS@"G5-K,PUV@*6FV827P\%8%=B6PPM?Q+MN>)WIG<TGSNEQ8&]G3^,
MS9YNMQRUI!5\[?6AENV?S[WF'K227;<_NDY\@EFRI;%IT@%I#T^305L+R+,(
M6DZN.)'XW[__V8=?=HV@ _CQ>[,/OI]1^67[V#-MC]IK!*X]U[UA^:OT<^3_
M7P??F02C/?Q)!SS_F\9%YD!MD=PF9^#VTHL.F,K"1[/'K7>@N%U.^ZP#U_$I
M4;>G\NB 5KS9:(SV7=]?&L<'J_]J7F7[$6)DA/7M=<#GNPT(!EUE0V$V3^6G
MVFP]T#-8*"GT3^)F>SPF@ :-OWT)0@= ":1!U*DC[G%-4/+0\2O)9^_]3MWF
M X3/Y3)L_@+L@ <!-+A;"/&-5I\;YY_@A$M,'F=$I?.,SYAZ:OD/ 0+$?IQ+
MA=1+[7A/9M$N_S[1HXTT5[]CBM2Z'?*>@C))E>>.P6TR_YK:O7,[((1;-^HR
MW--*6)7KSX"/0*N_Q7@ ^X;OH-)R8V/T<=1I*GX^%LBDPZA;@L LAK0@*GK\
M?Z7E)'K)@)Z,W7J78GMMXL5)9[X PR4;/C^"W(<,C*?MD^SA59YGQ_QID7_L
MCK$2\[_41M+L)N+Z1@IOUE>/P+*+,5@A3(B9FL]_5)TKK/ -![ J[Y/#C;YI
M9\:QM.EL8WG[2>KK=2"#CN+F% S&*]<!C;6I3HVH<-= O:&"X4[6@<Z&,=CQ
M)+TG]YP3ZE@7&YEG)0\-FX-E3'O^&+7%GWKF%[CYN,*!PLB#0Y->R==%R)])
M$5?.?"F0>FX^CTU/0R5^H8IK /+H GZ2ULW9:1SS&@W+_V7D$W2TW!<@/1C$
M]1D0^H V@?\DUX&/!_M665,"P/'6UC9;5K,%<>/6T;^OK$_EBLAA4R3,DT]T
MP%Y*]BVWXU@T)H634,/R--9%TH3X>(?K#7FU=@>WA?(%UZB2V>HE SRV0O2P
M+D\YA%NV <HCJ%4 X994HV(X(SK4E:]Z2.K?*'2%+8J;E?*,Q,_VIU6^;Q?'
MYH#>LD43K[;ZDB'6]@R?!?F;"+_;_9N:%*?=LD6SKKH[Y:]9$7 \GM@V'6;$
M XA"Z[#]D>3P S<5>8?B"H3W//'+B+0-I>VTB"8T^5:8E!RF?'L!%!;$LA'F
M,-WEH-/6](E ?750*Y&TV]OQ<]U"]-&4RN@C.<X0B1,;J@SE;,4KV PMH  4
M2T.*V0*7AF@Q"=,));UQ;XY"EWS;]D=:+AAJ5GS7M!M;PV4O;+>"70Y)=H,I
MG[W&5S=6.X"]FA.M<MY:J;HPUAJMQ-OF3;;Q.0A>4P?(W.S I[I'WV]'S?4K
M6?.CY=,!(,W>9Z6=?TH?L&?Y.JX,B=CRN9F4WC1^.O-I0I7G9YF(4I4MN_1C
M@9%(ENU#A&2C1T>"CYJ=N20EL&A!2VM);7!=V[U[%FX:8:[>7<K3V&=U@(X'
M<H:"J-;8^I^XBA#5SOR+/R>S[E-@\Y:DWF@D9X'H/XG2>S)2IK/!OH<!1"@8
M]=%>Q0$\.Q%WE'1B-*:T]G14:?N!D9OE:^83J7BHO.+ADJ+^M8R+D-]",GSG
M+[GP^5:/'S@QG+XKZ7EZG9?/Q//63:98SRD>SO2K4E)2++U,PH1RN3!<<4T2
MBH52\21N:O>F6(B8%6BJV?/SRR_L YS$7*>GLE_C7[DD7EON,;Z V*_AE%>$
M^W!T/?TX;/RZ@K=*5TI/4C%2Y)*NC7RIX62'A,V-Q8RDS?MQ<78IB;.I\7'M
MQ]B5BHV5;]-M1+,OJG=DK;)>J*VI#PF]VI$?96@HL652]AJP&-T[2@U1.-CI
M>/K96L9+I $N@-B=U%/LLSL7'F6J8#S74*R2HLAV_5<M)4A?+=EZ^,'<+V[3
MM$X[6T7OFJ]7EZ?[<PP3=/D?"7GY[ZI+3S+$9*OK>>Z\@&?/K>C=??Y.H?C3
MO9>YN@KGBQ<LNGWGILI>YK<V)&0>K"94J<U6\36'B![(KE>O'RN=\OX\J@+Z
M!?FGD$57;WU"A WS_>KKG98N--2D[+Y2[8J3]GI[+A(B.65L_:VNGJL-9#SJ
M-_N"P;=XKCO@&AU@%2[AXX5J@GOT?HL\6OZ7S/^OB$P&-.-<H/S@'.1)T)LA
MCV2?I,EG>C##QZ.R>_$?,1Y>3@W-,7FU#SLU4;'VQLN9=U@%)3B7;KV=N)BW
M)!<K<KJ7I;!O(X&Q-<1B"G++=#>!\+,(@ ^ 9,V$F/'>3=&D;HYL2)73 6&&
M]<1I_ -M^87D.'24'S/YV*45T^&@6$OFZ'3U/0AF<;HQ?;W&T/Z1N*D35F[W
MB]^:SPFS"F$Z7O_==+\@^BRBH$507K-\-8*\E(^7M!QIPJKSX7L[4A,+5FID
M]"6/)6DZ@&% G)@);0O9-[)WD!VV-[/P7J74RFJ)=,L'@;8>!\QN95;TH0FZ
MN=2R(4+IT5(2]5F 6G5SSQ(C_Y)V4&A(F_&YS?Q<R[Q)2-BYXP Z0.V .@BK
MK$'GM[5!CO;7R$O_HK ;/<?H;G.AYJ/"$:63?^\JO'HDE$S@H?8)XJ;7#QE6
M&',YIL4VB1@\TSXFC*9*-4_6(VA=(*T9D"V3M32#JS9V83J@L79.BIDU.3H!
M*37/; 1\>L)?HLW=H:,BR(_NFA/VE"08C"IKLSYMP8[L(ZIZ+K^30&@N'N0M
M8.+QK$HGJ#@@D&HR_YM?+*95K/H+.6>!#HBA@A;:^+H5IM>S\L^W?R++5I$*
M/_.&9@54V$_#LIDG9]P;,%7N-B6);FZN-V*8J?5R2IVF74.L6Z=Y03>#,K3;
M;GXTQ_0YE:DUIR5*F!?R[B8LEO5_B =WN'G4/C;WD/9A;X:+OY!7*@N^LNM;
M'&WFV5R36GK9/%%RN."R65H%;X#Q2 EQ?1#]6L<D[4<0'9!RY!2*FYFP>_T^
M?S[9>/;X'/IY[HO6DIYYZKOY!(8-S2#VMPA0M,%.I9?"DZ0NP4+RP9FQ>X.R
M2<3!M>_&(,)R4'Z>;VKKG]^GX*&]ZFE(XQ *0NJ%#FE#[,XYV#[W^2/QM5<X
M];,GX#58#,!:"08 P+=<WLU#XD$LR, RF WH#>TV0K%'HR%J1G=10+534'@8
MUS++:B;QKVB%=^DL1"1%4>KAU8WW7Z\X-0PX<(G<5WB27L!CA+O4[Y-0LE@]
M>F>Y6*6P,EU(-+-ZP$S$H*A0XVVIZ9.B]/+!&VOBIJ99TO;@GNN1RA+!-7"1
M"V?OK[UZ?XQSA#%ITP&=?_:/=Q'=\'K?5^H[J*'=8_(&; !J-;*7J'-H,>9=
MI?1=S@B73P>8C'KOW,'6?*K%QI8VM[8VOTOE"[9%F*SF![X3BE.6W;IACHE&
M7:<!J8^'BPFA_(BU#@?MGU75<QUKYB14C-+0M0E;AQX&L)OVX#L?'W[N*Z4^
M<::8!NES3,EL'#<E=M5UC<']=U_'Y18*B(BP.HN=L851&Z/)QGH,3OSIJPQS
MXZ*R^R81&^5P 7&#@.6$#7$-G_3*&4?U'M.ZE83*[2V?!LB#,/F)O^K*1KY>
M#R2W 1I:&_XT_U;AS0;36C(=8+F^:9,"@E2CV*?)= "K.D:R2,:/IN_D[(=^
MZG;[+ZDL'U9]L/[E;UH$78Q<.OD':4QNZ/3DZQQ!7$7*AS\=(W8?3D75D/W_
M=-4[7/GI!V2D&)QT!Q4=^B),K91%6EN2?DI7KF0ZU82!KV:=HYGKJ,^CDM'8
MY#@DSP)TBNT)1=NS@"K02MI)@2\"(UYTFN8L%8_G!3MRSC61;3M_&(H_'%8R
M['G[$GT54P6)HX(7&+,<W+;AZQY8'JWRB;A7Y>LXDT'YU2P9"0-)7@<ODV:L
M>I9.5MVAHTG9QV K#SR'182\22;OC7*CX=)M'Z7U07B6JHCX2+;18%W$F%3?
MO5T\S(R-QS0#BC?Y%)(D_S_UWE[]3PFLUP[<9-7H5M>%6;[N?(YQ#ZT'"^AK
M$_?*7V;/O=.8L=I0X69N5G^?$GBUU,^W\T[1P4A1YB%[KY(W[QY9]?'ATIDY
M-^F 2&=3B8J>[\K?N;+=NBM^C8W8F^?86@DA^GI,?-)M$PJ%E\2Q,\X\>F #
MA?AX8QG17!LWA>._!J?AERS3EX.3<)FE3&?W+Y?0@\9Z$+E: \G!"PU;)Z2!
M)?TXVOED+BH/Y2?Y/DH0P=K;&: CGM9%8R#0^"C0#@WML=XX)>#UB7L+YWR6
M6MHLNRPR@\!C<,C6B:$A[$1803.0$ANL]N=C4_T2YZ7&4HGON]UBHA\PU;7^
M4,6QSS\1V>59N,B__W,-XG1-GY0:I-_8,.I)=[9 UKC_C+#+VZ/8TU83/_US
M^)56N$O#P2\Q"G:A=/;/*-(BZE]@ Z03= 'Q9S$Y#N0]%)/E#V4.O8$T(&_I
M $E4&I"P0 Z(:Q69;S.T)\TFQU2UFI/BP5'$#NC4U+,LZ,A>#D59QJ(C4&E"
M;NL?VX+C'-*?+NY0:1+3&RVSC_J,JC11DFLD]4$(9VUZ?=*A]4\/'#.V04^Z
M#]#8F-:GYR(A."H]\?U53U&Y^GT_=Y/49"US?:,F_9P4W-:*,&YX\/L.5CMH
MPNIY@7$5OQ<?G[&Y@ 2$[>IC3HVX[,H/M!J#G(SU*;L?S9#9K-:]WW^W6)3^
M;=)BR=XL>$H'#.'W*Y?5@<92:]Y3^$7N9!H?E=_(>R&II0@![<E>ZY8+ [(I
M_;Z^F<]=3ZY&O[=!/J8T++"=V[1IH-XA9">EN5;.6;\\WM^:"JF:*_3TDK.X
M[.+_J%]5VZ6 YZE;X\<&X09_>PXW^UF9\3:3R?"$BK%B/59)N-A-W>\XSN_!
M3<H\RC<*1;=Y-#UR:E&FA8Z_?"Q26H"=5-!0&S(3*7'BMI[U6B2YASAYV.W_
MZJLIQR(F7%",]'UEU&WW]]^FW/K=#9D'PU\[?67>(GX(E.6:;^,;+/]KMR=L
MZ?VX>M'- _1RK,D#[EFSX7"_AC^2\:.6*V>G23MVHP2]*U;:7SCR[4#"U,:6
M,SQ()@2[L%Y$*IO=]C;;V/.:[864T@&V5,GAW 0:RN;H#I0M=#H[HGR;##UP
M(E5*][7+,"Q NX <6H\>_;FJ@,CIYG)P>A,0^,+Y<B/+$>.;XA,E1.]B?DME
MZ$_!JY2:I1".1<$*4OS2,Y)<--7\ X4!0O$^^,U"1*J2N!.KJG @-C>;\19'
M$1H:M9AW_ZN[SVS/X?C;::T#\N.;@CSX0/U46#:U&BSBUU15-#UUJO5N?:1X
MX/)H8A GIXZ^^$CNBG"ILI%RT(WY;16,&[3<R(%H^7!B_A3T^0SH.OZFGL_8
M3P_*P_M$!96 /H[8&-OGS>6GP7>'MK=\3YA#)V;H@.]U2&?@D9-[[Y&O'7SI
MI F_8P1R %OGEYQ';:M9$MFCI_$-!:?(H<4L&@O+F=I>/"U$;8TKRYU:TP%L
M%:>7WOZ?E05=P]$!%V/X0V= 6#<ZH,)Z%+7OBM3AI$48!+'O8_@N\RU\H /P
MIK0L_1D?K>V\<>@^VYE0'S$[8V/V#W9KU"Z%2V_=_\ PFQ=CSK@G_"9W-![N
MKA<Z_>(2'5 Z;5R(/_Z]"Z/(T0'A,?CY]VA!JOF)':+W0)N4E=AJ. \,0UW8
M(S+;PG3X2?55P07HF'PYLES4WM^N"9NATBTCI6&;YB/83?L7!(.?6.L5#<^:
M^J;VU#G;B@@$*$=N6\:,%G;<2V/!R=$,*E='/&U=QN@ IH*->84KN$^CL-&N
MGIR*2V,)G&(J!2*()L-\J6R3.C?1C&'/ENG3V,S5T833V@'BJ0H!<THK2UTE
MW#QQS@+NG<!&:&?!B?*W+\-&>$E5)=M)O#N(FF&193*FP'107Y,,V?;4'Z&U
M5^0_3:_&>%483I.U#0*%(O%3:0VGZF=7.X >G,:DKDZ?C9>I#]F;=D ?GC10
MS"=6P_3,XU;']<56'NU4+?NK__J86B<_](P51O4O'(4;HQ8]*WT24%W3)DN8
M4VU+PX4A7@JAPZ8'O2AW!3'23>,A7WRG96GCU?2>@K8;AH?HK(I:)BT./*EM
MC]J8>CEKGOJHR.+J.::X?BM6)SH@$+;1]AU-8_3KE/.;PCGMG\5A3S_\'VVV
M V;!^;#+C(+OD]XG=04/8W]\/M>8/S<+35?EOC8=_>7+Y)J&-_^SC*^,CE6A
MUU%?;H+F"T#L=( ;B"(&[6*+!PFL-9)+N^0FX[P%7@J*D*6T+(XQ7?;,7QR8
M(;R_;#*K[O3<@EZW7Y_SBBV#QAS,V5EWEPWFAWR;_]MO%J>Z'4\^/.BG-"RB
M$J"\H;<1:?9CRFTVM*5[/X3&]IFAS BA>YD!M&^DH0BLN*P9Y.=>F\K7!Y[Q
M"-WNK9JV%>JAJJ^AXN[P9V.< 79%^0)XRK0N8WD_6=H+"[.8MC">JON0I?#:
M<IQUZ ^4X.IX"AUY,D).WI9133Z.F?0[6\@T_&"E:$&I(W#*QANXSUY+!RSM
MTW1,W#7R0<M2%:]NT %?+9^<^5]V>]9Q)H1J!/="[W&.ANB?:HTGWS'%GYAC
MZ #C$-#ZVK<-*[0+C6^CG6 ;Y.\/FK@$79\/4Q90/?,F%2@UM/0D]$QOW)/Y
M/\?XKQ>U]<T8:/>;&YB NYRC&CYT $397_N!F1J3^5C[#FI9ZB-\B98?LJG:
MJ47\P^-]DH6GK6C<?M<H-T^$'!UY@Y:#_4"$X\OSC8S3,[9V-U:ZV[JX+\C/
M=BFHF^Q\OM)8ZG]7 7*3 ?^>ED$S)M8U;(/)TP=FE+R%W_%X1IH0I;##09QT
M4. 6K'4-IA'1+!;K=^(V;(MAI93J92\:LOC>&[ME+2/G@7F6?JG$K6J*[^-"
M-N@W ^U*+!UPX3IY[0N:(A+]!N26'-;N&MXN%#J2+=:1I_KEN"!1N)6"\B0_
MZ!A8A)Z-C'@[<'TS2._=JO6O70,GV^#XXE;3/S:]:"&!MY:=EATFI1:<A8D?
M?XWDQ)?VF<!$U.9"-R)7B[EV/HRE5Z$@S-EF%<9MX(XG",2?08DR7[WQ5OO"
MBHQ"5YA*WG9PZ#)NK$BX5WD[04&B4U]YN])4KDXX3:I,X.X_0@+B)_#H4T:_
MW]2;9Q!'/J8#[FS#NFEWR<8U98CX+IH<&1K3>J_2?B"D8C.;&*N<![$8DW/U
M_#-+),[.#?C"?13SA@V5DK:"LJNSHXIS4>X;LXITP&U[?0*M'39,!Y@V938E
MYB=.7YEJS\)MEHRWF?JO_^CG-^K[\*4^DX!Q_8,3K<<-[<\9GIR7/RTH=4*-
MWA\H/0O991;'G_G/@&1]+IHFRA4"^GV*2E$*2BHY1P?$5E<1VBL^ B&VV=CF
MI-(W9Z!G;_N>#OBOI( .Z%/"C]J6X+%4_,QO.J#EXF9\KM]QY,XV[8\G?N<<
MK1GO^8D.>!^5=P:LS" :R++0V<]2#RSDL96J:NWX2CZO5N];@I[>/UX*4M38
MBX5ESU!=(^:_0*L2J+.A.4^ZSZ0P\+29IH#D/JW1X:(-:20G4!\LRKT!"2H'
M8RZXTYC&]S5GH8])0['5V(&3LYB!:.GXX?!=\V5#IVF=$<@BJK.O?DP:DVWX
M-=_VD1,_3S2C>><S\LUL-0HA4S!]4T.QL]GX53&W^L=1\W)9^*6^;@,)<&_6
M.Y5WA+#%#3CYQJO]5Z\+KXPY@I\F.INE^KK??1U>>G%Q>3''>/.=IK+O"?7_
MD3^6%&(,'[T.DJ0IH^;_X(^4(!-_:(/</:!C#&\[1/1,->9S4%^?A2<XVX?_
M)8L<_7]ED0-))O=(5DMB)Q9[H2DTSEV!D&C20]<O4F_ZQKQ1!VB*I0,K;1JR
MG+7&<?4![FPB@:&EY3<_:R5W-M !T%)4?]%3L0D4:%<CB&S!^$]N?LB99#VN
M.;M5FV4J3L]8<_>&0 0RQEZWY2BD-W\Z.*^A@QA)DZ9\6:IB6/@=YI%Y!D\[
MF3?S_>6MUL?+R57C566#YTY4\E[42@U)]+D@JA;9?+3$Z8"?0]3K60<,IQDT
M>2J,DC*/V)>@.B^BWW#EWT3WT&3(]KBL:7B;MYVB<><"\,V.ZA?'^4T^Q)(W
M!8*CX+3OKZZ&Z)SHUM6^X;4]DY6@R<VN9G08DO/D'TIRY[H/=\PMDG>4TDC9
M9)V^3RG%TG9\GT6QFUV)'"Z#*RD6Z8F&^;Q*R'_:\>TH7B(B69GB?7*/"J58
MDJ%&E%[2&=5FBJ$RD?7U&VOS.[N;+VQ:.P@'>1;GYWFZ!E]WF38?R>_H&!P^
M,1Z]U52'3[KK]2)E.NB4U<Q2IJ/<G*SFFE!=(V.<OE<,8>$UTGLZXI]A&9/N
M;O@.K&9V &U9@XMP%-I4BI:-'EB&/TFU#!UY9V\8,/ UVZ+.V.YW=K_4*;B5
M@>3Z&7BY5:,9\D9+\7E!A^>'I(VC:Y!*]SL"WX$'2662\?$1^JF648-"%]^]
M&.[/#HE,EUM.UB17! H^9\GE J3^T[N0<!*<?^:D_*CY'#0)ZOVW0*!G=20)
M=M"*8D/>HOQ4JQ]6@L3Z;V5[=R3':H1+=EX-BC>\G?Q94+0M!/_K\#6098-;
MVJ)_$Y*Q5(N:2(Z-'K!V4"@6T/J:Q^,@(93Q,,6(/\9&_4[&E3[^C]]2A9CT
MG)]!MEM9DCH7R3Z)ZO?O-F,YLZ2]8=92%9XPN6Y5LG4)5QO7F+F(:L"WZ=2L
MP_2Y5(?FJFS][SH2Y#N3TL5HP$6:-$>83_Y:_:N+H1EDU>[D>*X#KD- L_RY
M-U=G7-W$"N:#D@FX8.ZN[1<(QV9Q\!&4H'4]^*K/J)_6O[#=X"5"+.XVRWPB
M40UY#@V!OF="KX*!/Q&YL@\,92.1Y@Z!Y0'+$4'%P2I3>SJ0C8GL_2:E9:_!
M=<]@.(1,9<L%O4Q.XKVQN.Q@HZLYW2><.1+%/F/S]8$4V$TC(_.BD\C-GFG1
MA%8SJ4ZA'F(LB-LC]#SRT?C.\CA[.S>E?,/ZJ@[H!W8!OK"Y&>780./ 7'';
M2,;-A,O%:"G>L/0)%V[0,)HS=SQ67!IO^OA=>=4IY8U<*IB)DJ2Q1B24VA%6
MF1)WJIV;<WQUUOR?FC36<21(8D1B=P Z5,L_;#&!!Y9F:&9#F0Y"X65P]^)M
M"2-M2V6-3[F2)CE@V2!S(:7**J5TML:%;U$\(> 7=_=A/_)@&J/K8ZD%)NMN
M$-:CC_V&1VVY3@>O8>YT 'LH.V)MX;_:-@)V,^1!QU2/$^DPB:H:P-4VCV:_
M#YX6S5B4 BKTK7Z^ ^/+;!B5*;*,6YP45.&<I@C^FJ.\'J@ OQR>[.LQ.)(Y
M>>\ST_$U)' 537K08U,:YK7?Q@1M:QG3$:0,07(@9+%.ZQ5N#5",M]?55^L$
ML+/&=\_GBWQN[Z"0,8_,J0,>]MN9Y&<N]P@;(!;EY B:/ $)@GM+A_*VCUH(
MG%_<660(9B%.%K?:*QQ,BJ:^K+885'=4O'%WQLAE\VH28&BIKF,X7S ?Q,Q;
MP69:^<N\P,:@^+$(HG?JOBSV]J6Q0H<L[<=::[Q6^3;FC@Z)2[S[H1T5><4&
MA0[#5Y2%U$HY3;E7TI8]<>(JZ8NY!>4^:2T1+V=L'L"O9A[>%289%(M$O>Q*
M>53TK*+G<]G02/C7-48$)(YV8\:J:"HZ7%ZY210V=&6V!5<T_8!!-/L;'=#4
M9.XBW]/U_-_=929)(EB))>G]*=,1[:$@]2D+^TX;FSI_\%*[VOY2*4\U^$?"
M5F6:K5H+&"3FF?]=:?$@U559(S6JW/8W=WEH!=ZEDN [CU&_TG_U]70?8PES
MCNU;QQ9LNJ!C8T+Y L-Y]H[:E!YF9 ^'_&N?A.OW-G/7T+^OAO?J^R2E<'+N
M0[K8HC+S)1+WC>3Z1ZB&C ]U7UER':<;L$KO,S*P5NM8K0DA Y>WUG?+PH+Y
M<G*8-ZVEO2M77GIYE(I]>Y.UD_#IXB/^\Z2O(+_^F9IG3WV>)JSWZ<'@.]^E
M) )M;<$RA(IX'__D N,B=SWRK @\&$>#U1UI!]2X[W9+?DM54'A4V3ASR?G9
M@XL/\$$IC0J*&O7CUWOTI+:!%.&N!&+]6M2RBZL+*;FKP=7_[X>5=>FM[G?_
MI37%7^_:!6L1NN\=?/H*0K#>!?<V,#'D>DW?_"J9Y(.NHP/FTXP:#L9)/]=
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MXSEF0P>(;-.V]J[VHQ]&0L4I#9#X@4^DH4X9C?%I,THR5\;'+YHS>:]WI^B
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M\]%-AXLTU"T7-Z=&EL4OH:Z[UX],O*3=("5'8(T,[_'.SE5\G'W@R)*N85P
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M8(-&< MQUU&GLQ1:$Z[30C:Y];Y2%:/JIIT;&B:_-,7T:5ZC R+MJ*!XQ5-
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M?;T=RTI7/@9NC-O!A,TTQ5OJ:4X4O4Y]8 CC+HS??%S17OHO:FX47*O81KP
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MJ@YY1;3DKB-^4D9<G>4T*:^AE3 = 3$[-G5I"Z< >Q;/PW!=Z3D\E/WA5O^
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M3ZQ/2R-B?&4YJ6IMB=83:_>ZKXS.2 Q+EY>><NV@0<WO7"$M"%YQ4M&?]53
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M"PG?N-LII"HG>N/8P)#S)Q.@4M1@>?KI9N,J&F4ZAL%GF<1D)<UT+V<?U-2
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M-A(Z2ILN?JW'4Q=6W >L/(VF&%M&<;]9)%D(N.=K37P^[OFAXF%D\T&0'YF
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ME)2 O[$_0-$#[/YS]'_U^O.0_]MG*"GJ /7Y@$#IH++2*F".NI*RNI*""Q
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M/S0;&G18?2!,94=6;6)ZW1GZ$IL3.=!CA48A&I)<V?-'L&F#=%&87(O,C50
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M;+3_,WU;GK][4/HT9=13>5=K^G:LSSNQJS\3<Z<5P -@W*L5CZ'5U3SYZ;$
M#G7T'#B=2&")W=7I9O_2#8S23>F<+WT<ZH<<.P<ZB=,XY';VA-69,]"4^VHH
M\$P0I9JGD17,V#2R84U5(#N\;ZRWS.]\3U7YKY;1PLF$?(C0GU L8BZAB8\A
M=E#5$3@QM33*8@\,)H\3"7F$I4B%4UMZ=)KV"3Z&!UHX],J49>JD+%:8OGW!
MR ^($&-A)4#VLZL-A,]92WII&4XP"S6VCB"ER0JP:=H;FP?^/>C.E_2!WT]!
MK$2RZ XV47E$?'--HUQ3 7 9?5I=X/A]@@)(SL>(A@SKR>,]G2;:.<V9$B9>
M ;1U)LP*&)S,6X6GHC*7#84'D\I'./(#;(1%I$ !0O.Q^)I;F,8A [U#DDR&
M;75)637T,]4YH0#^*T L*B_):12][)HN@Y\0)K:ET95XFG0"0H9*)/1V!5!,
MFD_?#K$:9/K^8K?J4B@G_9)@;!%%9_G'U^#/OP%\G;?AK:E-B!NL$PH5O2+E
M[<6R=@=VB/7[G^<O6 _:.75\R\+&-$?0%_KQ*.MRPM#CK,G+Y_F<W1UN[*51
M1T]:<'_Y-16LM1[?Z_BX)R,R/RRJ*--[*KN?Q;U*6H'X4&HF=W PTMI37?YQ
MFXKR]?1Y&R_BSP<W,Z)7A-P(;XXJ[OPM+_L=",6A>Q /D46Y@$;%%%O<J<FT
M$S[VA%-FDP;>IER?F'GZ_?<?P=\8][[V-4;ZJ$!:KQ-^A//(1]X:1 #A6FAQ
M\]>S>F8M \2%-U_==3EOZ6C3].[Q#;\M'1F7J[X^DG1*!?4N5DW!^,4.2O<$
M4I_5J=Y^6W_83#PIJ+IXN;TGZ^-(R$-E +\S>8W^E2A?]C7R^=>'[#5S6MOE
M!WRRZ0<4P(T0,5.J;4616=9$K(_"6'7D!"YM*F4LLM%P1?MZ9[8DX:FPQ>5]
MF^><2^-C)BJ+/L0XM+XS7JB4<45/WSJ:M!:)%&E+TM+BMO_*+O3[6P$$N'L.
M+7_;T;AUWA:*WC.6&G)%.4:OH=;\VI-W1I^QD3=2 !4<S&4"/R-$8S^"ZG-^
MVVLAJZ5G: -BUT9J=WDCE[J<9"7_!"J1O2/9>+IE&>(*>TLNO8*\<J'.!E#3
MF$_8 []G?!HX ?&2T0.U^K!CE"IQX0]"?9/VS&-'MT<K.QB2=NI5KZT*("8;
MM6]#_6!;WG9"'0L?0'V%KV-VDQL)KUJ;+*YZBRR'6-I!:$C12(Y>6Z@"T*69
MU;4(,X2>H' \GF@O3IM+#A?!UJF?\R?*%TD9:Y!8Z6Y&MR$.YJ-:VI([43NU
M#\ONC).%QVFV^RIE#] SD= 'H0NK:)"AG&'?58J/#H1^U.JB5-B(%N0!+B-H
MT,JJ5XB;=Z*+N?%G'^"'#R>CI^ "5%-9K%WGBVX2!J41YE9K!,+*/+!DPW,X
M2/@&HG+3 HYVTB/A%'LD^P%->P_B]0BUA>XJ-[VB#=3)UPS.20OAMC]3V?>6
MB&'HW$VOX1_LE(+7$/-*K6$]Q)-X4-,(.D0',5:@[KS$ZD50C[B\ K;EDA=<
MLHC)6<&GQ-]QT(6UHZ>_8ZGY8NS\+G9,E^N)*XR/[=0X=PJJ9=OL'M9 [6YL
MDELC;D*R^HC@5<U 7?;(3\1;3-8=JEV 9 B9Z5F#[5NLVIA<BX0^#=@A$<,]
MM;6G39M(2Z@X6G6@^MA;WPK&9KF 7&I:;Q D9#92M%$MA"QL91+42PG)9.T-
M4U%'>* ZT1YJK:.JT;4*36+[[VNX\QD$^E:8FDS?"2<VO0*;R!;HJCYUDCI$
MC[YJH9N^2DD:;4\?D%JCU->(%+(4@LV13!PM15@SPZ7.]V.85$,.*>O?(YD-
M[BD:LI*'(][Z-F?F T8Q.B>3'\QNOK)@S</_V-;%WB\H.)3N A:<D\JU!N1$
M..%6/U-M6+ZJ:T"ZE97_-;NG(2)Z<//B\#K#.UH]Q"_*R@!!7ALAKWD^ 4K>
M(7=">R-ZZI:;CZ/[Z60:GV&TM2K,W] 4L]1+[?2UE'$-TJ-?%B[L]UXW-Y*X
M^L:I252DLZ7H9J9E1:-.J6#K;<_,9X/,UFH'T3_6"Z NG]3 M:]?-W]LO?LX
M<UUEH*>@]\!O-I>QI0OU%!N S9W4$]W#W3^^5!_RPZ0X-5\I^F'(N\'M&?<N
MANPAK8-=90LC^L#132_$G6A.+](4#(6A8/XY-_E/C_!^<B8FVT?JQJE=KP^D
MJ,;4O5B57'TRP+CVG\-.0;_R.=?EX:=*B%[!]ZHO;W5>=Z/Z44_8X>RP0$ZD
M8T#DMTD\1HAE_$9V"FG]9U09&A"%I1 ]GP\E'M6.P'P\:378@&=<,O#U=9^1
MF/[Q!0I Z!8@;F 8&>$:<BR4TG<8/U<:(FC*;79#ML+6JR03NCVLG7)I?"&-
M*MW8M\A(ZG,$MI(7% 5L7YR8.UAIDJ@ +'%7Z:XBNY ]$"^&OH'67)/1Q-CS
M08COQN\JASGUXU\XNV1/Z,H0IYD\'_0;Z1$HR]O[,!**,ZI3 ',8I@&5II+Q
MAFCI>OH1/BPZ17>#M=V[>.@J<;.7!104B[^*3T^"@FTS$V'VJ%#$,D1)2+N0
M&DTM&>"1$SA*U3[]XU]^M7)9\^3K?6LM.^D4<6MJI?:83[\!*&*G3MGAJ3 A
MI=H%%"Y#-L4C?-AI-?WTQ>-SH>NF [UTU\_N\K=IG<&4VQ9C6VI;^I(\ASA.
MQZ7QC6]V-S4I@,#5-VT>BS_>O/E&(^SBC1\SOVY&C7@\\V-_HR9R=,NH5ZG=
MR[8.8%:K^F2NVU!8GP7B(XZT0/;*36AX)SY8H0!><H0V;;PDX@DB&2-N'XGA
M&TS^.Y#3S3ZMY%<?9?Y>'  BNB^FQL840-?0QX )GR8J9AX;MW$PX9?<M[@6
MT8)7";!QTE  /N-ST-7((I@MG$%-(E@)I 4&:KN1Z0?(6%F++\(,:L1,-NTO
MFF G3(X!A6;O N] *^I.( [1#"U&+V=)M7U_.,,<"6ORTL=8VL^#$PO.X_@Z
M!5BHUV8Q5#!GL[R+00BH'.=6#QJNTI=_YGP!M4JN+;D?V7C&<R+_S;&320T]
M:BGOA&:]?BJR4$G@=/ELKUEIM@U!]8S-<Q%TPNW#F8<7G2*_@NH;F*'YA:NU
MUQ1(>V0U(O8Z@=RD4C#KNE/2XLU/)[?N9TDCFTE!UV5/"V6DKR^FT!JP@7/?
MEI- +BM(03VD%$1$B.O;@GC 1J+$T0_2<XA/,TD5\8&>-S/4(/,9KBQ,JB)O
M&=B-]#%6(56-A%(\EZSEXX&%74T1DG&(#6W+B-RT#J*M8#]@?"*_LF:6GD:4
M^L<3O.;#RQ*E6_S DIGT<YA-A:3],UP.<Y:-,5RL9]<E\MAXTJP@6DY _1!'
M41 >W6UH4 =1FN;(+;!TM6RNQ">YM,YG+OM)8HT]D;D+AA\%7:K5F?:C"BM[
M@P*[,OVEM6H-JV\[:3>]'[:\G4$YWM1BZI]=L]33*WG<7NH$VXJ;;T$^]96)
M3+D13>P!">*G/K18[)5Z%DA:DT)M94<\NQ*B<WTK#1/_&'>G:HH(KTXKX9X
M&\R%F^XM#F^A0#/B,XE-;!4,5*P;601_+R,(3!IM^L5\[MX[LCVHI[@0/!G
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M6S(9GB09<Z>\"W'$>C:7C_6L50%H.$K^K#M,N13]:\K)LY\'$$/6 !,BW-J
M>Z  R/+<W\<HQ@V!LJ?<WA?#^P5VE\=_!(.^[%E-J/6=&5HJJ+B?/C5,5@,'
M=[TAS&AV@;Q9_@/Z)I@?7VTF^A 9I;WG3?NEM,-M7WO5PU[XD\]_MJ:_7L2Y
MMT2UKM54F4C3TFI)%JXW,5-=OV%#Z.H-;C:3GYX:WW_T.6^M3=-8I,?ER&W4
MI:)7]/-'TNKSM71-?A\^YCA\Z\78^=-%$J>0J<A&E@;JP$9"]O')0B?T8+O'
MD1*I6T?USC"HT_G3U&0Z6,Y#UV>43JCJW_->D;I<8&@![R-/.!+!=^,OZ)8&
M$9>05#LXZSL)1_^S'>:YPU;K2>7G0W=*:EH]&U\/&%P9I8D+HY0_Y6SWUB6\
M50#W0(N!]:V+UA?H'IF;G)9U\V9X1DE)X!:^DWM?F"?^5]_RC]"]HQD_PFO5
MA_.T#G]LL=+,NE%9_G2\\RW4XQC_N#A89$NX8KBZG#^]*;O%O8UNL/UN?XR>
M&U;UU]3 *M2A/-C3 5TM7ZL 'N[$LA'5IV/$-7#=J\ >2XWC<L[C*/Q+UUH6
M_^TD!7&F'\*2%A3AY8M)6+9,\O(P1:L)MA.06$P9,Q/(*#S2,?A@D-CYOYP?
MYG;_*O3)-;@H;NPSF93T(Q?;?"N929O!) IJ[-WXMS3\SJ'8*^'LW0^O$#L;
MO3:VH6Z+?G<\?BUUN7OY7%F:V5]E\H^?ILSWI&=UI4U<<^P.Z2RR;,3O9F_I
M)']_07LN?\>[H@"F?HMGIRJ!8GO-@TK_H>%//<45_XJ*G!R>C]I%3F;$ZQ*5
M<@8,:UK=CWR)F)GB(5-L#:0,GM<H3(S%Y(FFU[IOE #_KO++L8# /S'$-VM_
MZL5_QA/L)OYQ?%OX\O4Y%TOMA29:GN\/I16&A9?>\*H 0Z+P!,LFX<5[^O"7
M\LP2%_<J8]&]6SW^W?DU'*/OA&X%(&+UG*U /')/!/O([KY F*.)/]ZM&,RR
M[EMQS0$U_OJW[CZH;[%^+*QIH  (0T>&E]<^+?)W[>XJV_C)*LIEU,N?OVY.
M2N\!^@.E5  '7)BW<>/<G3BL %RG'>9_![_HDC\O/]'IV#(Q;I(15EDU5CCK
MR^Q/MQ:=H&C"A@')35N&FEVV?/Z<IV62%^"8_Y!"L;N\9<4XH@#VM_T+P$G_
M@MC"^;9R<D=M<A\U$546GJ]BUX!W<_]\RU$$Y..?RD/_C?//_V5BST-)C]\<
MKO27N'M:@8GY[X]7;?D]=I;55)8%MG3PQ ZC:4**BB?J(<M%3Q8-4HOC><GF
M8 "Y)VAO.[KS.>V: FC$O(H_01>9V=6V)5!M]YBP8S[$8Z,K3[O^8Z@O>P[Z
MWU?#E!H(E4@N?ZY>_7A(KBN+9JC0G:&DSW1OZ1::92.X5+X&# SH4X9QL<3@
M0GD;IE9C:8E"01P&N_.Q,O-N[M-&#CJDHGIB3TRB-]"^T6P);73R0H;N;A$9
M.4!IM$@0-Y//R7O^_<]DY'G83139TU;4A5,!"O_(3Y9\J04;\?$X@D1" UYE
MG:.AK8DDH&MJ;-[X7UVE*90EB$9]Y>V[#X:SACY6%?IZ<PVQ3R6#7*\:W*E]
M[&N9B\0>X%\MUD%.=EH]PSG\R=]3TA_-;XC>'U+>'PM]^*HRV=G>WOK]P_ME
M8X\SQW_'BRU2,*ADK,5X<>Z\MNG6]"Z.&KH3.M)(-60L1?"2;=!T0:.=+5=N
MVXD;?2_?WE9K<C_(ZRPRPJ:E--4:=4TW]E^'GEC$@J(=\_7TF@]TD1;1=R+9
MXN,*H/\>65ENP.A6YD8X8"P3DV.'1,.F//D""*PCJR-W"/&$A:0Y 96$^A"L
M"@0I="OA! NZ%P!"V<J8UWF\ \];-'O?.A8U>$IC4N"TF=CJU4]I/"<,X]M1
MMS!AC=YA>&LL7[XCXB=9^,<VN'R3F>UV@# M:RT!D;VH@=!BD0+('\Z,E:N/
M+QKLPP8JZ7&5 E@I^ T0?F=AO/7MWN%P$[M3G.^!IGFUK]Q[?CDY>?$9[O?P
M*1<5P+/J=>\>W/I\Z\'HBT[7X*JH<[UE9?<?\K]CD]@](KY<(VZ-E1M])MG0
M*-P(7C,%<^[)R"9QZY?DS@8OM4[466I%TQ#N38)]!W.VR'L/<C1 X4HH%R)C
MBEL,:B O"?,0+@TQC:;$)B/;F%=&"*7L,=,\QC^5B4FDM?2_VAE6NV$%(%>]
M!9,E#970.%<01\!A20(1F/1%8FI<UA+H?-)#&M@8@+E35 ]V362L5<(D?44R
M_X]I4@$NFLU -->&ER/=B<D/(';"6/4AMENV@7?3[1R]=H[0A%]:R_E2^?,-
M+PG=.2Z_ #80^H<* T=]H+"XHL"Q2]@0KA\C"[%;2]83+7*V>)%_>BJ IQ[$
MX.D7AD[9@A,=% ^[WL^SOSW8Z*;VS.#+3M.9#,V82L;$#_=\V#3_GOO/]N<<
MR\G=>Y$!.):78R<K:<Z4'D!MD+4B!?!UALO1)"VD:\GNUJ[HINM!_!@K82Y=
M&Y+70 62:*2@"$D,X[8+!5I(R@G26ER#MWP)&]DU970O6KQNAO4E3+SA#1P@
M+$@IY>C3JIIKMR!LB"7:C%B*;O%3S$ES_'?O@O=6]-<H\\SS$#T> 7"B;T:B
M(;B:7*C1S]94 &]_ZEV VXXJ.7RJY#4* "3C2 6?[MB/!V@9W&5=WO8E,/XJ
MG= _KC[,^@I.J<A[8%S")#:\XP8UDUWE=&LA9P%"=HK=!87%8P<6^.Z^J JI
M:0-#K[W:^O% P7)"XJ2@8'AC0-6BV^*-7\KH'<X7>Q_W50S59$0&1$F.A35:
MMEX\=VSI<:+AT?GEG9S767XUO=FOJCHVNT9\N&M\NTGS$-4>^<W2*\CLUSJ5
MO":LMV"&/&&GTE'^[$,+8[G<(1 ::.JD.7&[EM\[HGP.;&.[L@<Z<PW _;*U
MG:%KK,SPY0TA<]MP?%@?SHFJB3*;B*FMD=V7KXPJ6HL:/3M :O=3 (9QTV;O
MC'*4<-='>@H9=B+RHA?'M*4^\S+\(KO];X1%>#QF=PR,>RT.+GD?$IKA[?GJ
MW,B^WB'=P=MC:Z1=+M^J\L96MH7U'^Z8,U_EDMW: !C?RF93N?+:8QT]'A07
M5GS,OS?E'30MF0(SB&RL=&\4B]A24Y** N@<YRZ8WC]18R'?STOFC-Y#-!0
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M!4"C+?EZ4B(T[&'$F8GOH P;M)\%<%Z2RV\)P]^//X:0/"I@IYN\/($5OC:
M!/U;XWQME!0??ZHGU8CHG_X&=60K$[\,-$Q@<.$^0$0HPQ[.V!X.8"NW[6\
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MHF;:@1\^1=Q2L4)TPV9D(<K/HC(!GY"GPTI[I#?9]J"]HR/VPY?:!G(* 9#
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M&CFI&XQ?\;[\SW N_YHWHC/$_,'LVJO4DS1S)K>@G@/T!K7@ \H32EQ@ -%
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M>[K]ZN4)S\=5L@9H&M;5K>1+X"QY*1?0L+_42N[@N#: O03M'70)*\!$?AB
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M@$70)WAD02N$T$%*#=,/#J5MC&9@>X!)L,+.*>FI,J"@8E]%=450@M!!*;A
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M .+K\(C[(S;C!>(1FA%683DQ;JDZ=;-]WI/?G2ID[TY6E9^Y7R1O?Z*I('W
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M#21Q.*NK4#FQF;D5TH=O$$ZI)1X#Z6E$VQI*ZJ0U7A0E!5R$S7NK#*4:T )
MC5/:NDRL"$A*9LAP]H 1QT<Y5NRMH"KTQ?&5+47KUXTC886[@;0>%4U:[W Q
MH-GIB<[JB3D("9,_%FDFDK647C]MU?DFF 74IN/\<8F>YN/D\Z :B][5.XRQ
M867%>1I"V#H_<+VW?1\-8\0LE)DM. KBDS$[:V3HAB@)H&T%+0D[6P2X= ;S
M$":-6,D*%HI-8?VXPK?BDD#T9C)D9[C*=$.[BU\^$39P:[V9.E4EHXV*6WJ/
M3<TTR!3P8>PQ]<?'/PI;7Y29F]('?R0(W=OXF=P0+;KIT.V&3VBH78SVMAOE
M,E@9_FRK8=G(WD&6VD,U\(>!ZMZQH_P4,XS-IA8'@!B]PY"CXS 6Y;_1WL9&
M)Z*EW%E.A9EDCY? /+/TR71M8O]T4,@TZJX!.(%;7$J*T8 $".T'L9I873#D
M-;S9_9V,.OSFZ\\)TH(0SQ4(PU',:$H2&0U&G'L+HCGZ]!2C+-% ^D;ODQ=
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M D8S]77CY&A?]^X"9/?9DGE/PZ%U&,\:I-+N7.M+&7%DDX2?]?!4]'K\$U&
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M1D?&&]KMMOGV+9Z-E_KM??:XS&\#IHKW6CG\)QB4ZK@?^%C!H[V1M20=N(T
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MAVP.4:0,V%$N<;)U"BK%&T R*=^ Y3AVO4R.9VV&<]3<B>8TLR@:3N"L%,T
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MB6#)J4'ASHKDHMV[.97[C0_/\SD&*(T@8XB01;E_F[)K+%;,FUQ*G#'^,#4
M_LHUX"7O!Y3+R*[MQR9YB[%1A(I7&["*29DQHV', E\0)Z%-9>JK.T\@CIJY
M(* QQ5:/E$L)T^C%A4R;#? E=8"=5']T1:^U8Q9KC6JVD 28>G0)[<#X] 9
MB0.C)\Q;6S&[\'*/%C.)[-S!]%*E#'T2@9S!J["_(INHX%==TF+P3 N5[5!F
MJ7P&W*OF)U&B&9R.Y:UE@*X6PX Y@!271@&OEU(RPFTA489@KDPLM[HD)5N
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M$J9?$[Z\60TNY:@#:!B@9CEX*R 6F2ZRX?'PQO7V86T8X@=3T7U17QAHAT[
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MP,+" MQC_@&,<>#:G];_U.?/)/^S<[ PO@ \!X&W^ZZPLIP&]O&PL/*P,-H
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MBM5//08K)GGD?WN0!#O9PPC(-=%I;@%X<F_+,%DY5J'1WLAU2_TU6EKE?<1
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MKW>:C$%O)4.V>QD !W^K(<5592_?B/M*A?C<5)2O>B!/>XC=SA #R%%&DKC
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M3/L52F P^@^>29G5M*X2L&W%/&-F?E+"];=B]IUO.*4%5]'!XVS(.0&MA=+
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MW#$,@(UJ,S,!6A#Y7\SPO/^%"U S?_/0#^2U6>(WE\Y_+=)^S,;*+@K1,78
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M%KJ)'<"XT?/!!WOH$K,=3Y)TD5O&$&VG((BPWBH@G%88<FY044:7;'?^3$;
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M8!WNZ_#3OX2*N%))Y;SZB7L+G$K>B=XI\?A\US]WP#\+""949F+W2X"B8*4
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M4]J4!#D0#5CX08^&8;=MRQV!+;E_%D3 _RB(J-Q9:,GV7:*T_*.KS:EUY$;
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MJ607,WV!+9#R/42=#TXV6=WVC4#"J^?!8O@'M:Q#[,?<#C^KXZL\P&5WPN7
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M4G0[ \.UUIXK\EFF(#A#=S_M-HM)OBW$E-NF]*!$>+[$1=0,?QNQT6^'UMP
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M[A?PL!N%:7 313H.N:--D@EDY?1S#J-R)SWW#7B11+UGO/MY QR+K-S5@9!
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MT6GBE++AD6F.4^JQ2?S-AX+.0A?H +:W/?$'@@WNS"&01.LN]+(R'Q5BT:A
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MD\6>G/H\/3,[M[3\;65UC;O.V]CA @%@T+_UCURP;2XA86&P,&2'"R04NI,
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M8-GZA !PEQ, 6>15I.)(5S 3BA\?UWWD1<B4-54V./4)Y&8CS>8]=V8<.2\
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MKU!%9UR>A.<6\347QL/&.T=687!6&"6;TGB17I03%[7V[V5ND -T9GO1I7;
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M&TUUESV1:T:P&NTIH,07$E1!M'/0%*@DF$C7Z\(1-D$:<*.&JIO/(,]ND_T
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ME(A]%KGR(\^,FKWPSCV,R;9)#\WQ=GP4D"G - 5?^>MYS/W],8.+3U3Z7;;
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M\7G^A::!RE?#;0Y^BO*.)0P1]/N)X9^5.OF&"Y0<_Y%L/%9!SOVR$J:E-&!
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M-WK_O:H9J/,M<\Y"XM+[B<'PO84!SK(R1L8\[WQVO2..8YE 9&Z+=5[--,(
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M1F2=IZBELFVI'7(+P_J>(JI?N(D1R+H3W695%0"1V,M%Q=X/:.'G5:FO96?
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M_I"PU)3#U/Q X: (3_!6M6$M?1E%?H9KIYM]@C1!GRRZ\48W.Y5CP>4XB1N
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MC-&=EU=ANO$"AZV(C+(U%XWW^[ -PSN^_"X8V40XZ[M/0^?/>2(]C"^QE7^
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MO[-3,RK&?SVUR* AO\S-W8/U7>6YPT?)_$K=X+M@Y65+I9KQ/_!VW7%Y)DT
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MEO#C1.%YOCPH^K6JU']]PV]6^G&HMF67-.CF>]+TR-*VXI-<^JD.H#4CFRC
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M4 \#I08$40I=(&;'%?]UIYR(PH]BS]!Q5(W>1IY#@[- K\]F/E\B8+B92CZ
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MCDU^P]5J2=L5]'UGH> %MM61I#CW%]67[$OV2; OYEZ48,M8?-0-U^B^E;I
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M+A+9BDW@=9IL=E2469CG3POD5[UV<@V1<2;<5ZLN$+7!GHZ9!M;B\$I<.*E
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M%@,Y2=S8V9<2C%1I(^-:^8MRZ&^Z)?LXTJ$_PCZ%A )\2_?R&J1$0;"'NC)
MMR 9Q:E9*3J_->[@];W0\]>WPJZ-)>A*DXTP7*:;,U1B.K@4N:S!YV-B9I[(
MMT=W51E[Z)8B?"V;HD1/8$4MN@@U@NH9#PU^9$#1<G["N.[*@&S,"19(DZ(4
M/LFZ<\_OT]\;MR2E?B?)[0G.4AX=.#FO!!73;E">-KQ0O(TUJR@Q;FMM1?Z"
MF "UHSPNN _]CNUGRO/$U(F_&HV"X[ Z)CO=3["]H'K'T\Y8*6*V)B6.1B?M
MTXVY%ICYQP[\N(K&H"ZO7<!U[!([LQ2=?+LY;A[=VNB!GH %720+%K'3L:8+
M[\#*ZVR-*Q)M!'HRQ=YE(%UJ1N+I",LA:B:Z"(CBF[+WW2"SY@N$&9O$,#-7
MDQ$"_S[_5F3;LJ.=$*O?9WQ-M#:N1/<9:ME6@""+XPC;%D'K.[F/9K/KT5@.
M.?K>"!*TQU"%QL)<:0P5N0$'2,4K'RO)$??9?DC@7;;W0/-(O<B\:@&7-%:O
MNS.?KSJ=<?P>DK'[(SV/#X4FA0-S$C.RS6U$K=OY%*[)EL0I#'?8--A%3K1&
MCU2CIK DZX,HZI)&8,+RT%P0U$Q\5KVK!4G$R=:PQJTJ2;9+L:)]>\)'SWEN
M >&XC7# 2#!<O@NU/(/]%:W$&;K^@ HKA&>WV<Y]Y.-PKC82.5*+/&8PKS2B
MWY=)BX<=+:J@"BWPHOQVXF;80[:=07%J@?;'?^PV+ZQ*6MIPN_' 7#(?<;&3
M%BV*QS:^1".4%Q72EXA2H/'OX)),)U!PA1P$^$5UQ5"A'ADUNU0A%SC&\ZVP
MC5R#X.6<I3#9L4C&M63ER=/\W@HSYI*".N:+&^^Y7"5Y!F_Z]V/@$]R\1'<1
MD=\Q]JIQQI7LE#Y/#$+P"5P'CBW+"4PJXGF=-J]CI>&=$$8PO+S7:]_12LO$
MR/63+OL'-Q0N^VW6+98%[HW=C33KXXVOBCENAC\YYJP H&;&3"/@<9=)XIBC
M"ETL<A:NG19O9$4%*HWNK/'#<,,-JHR^+'&X*JQIN(F>(5G"WGZ1N8!;_J'N
MTL\JEWP1%W2B6P1[-?-^3=&U&@10JM0MO%.%JC[-RM39XNU93!SBU&'V)TMZ
MI(_I&<]$[><[VI!?_S=!<>J]0W-&WJ8D$SP'3\0W/1OO3V[IGTM?MXSS#SE.
M2YOVU5/89Y] T>IL(Y'E[R^&BKJH7[$3GPV1/322Q:I)L:>2;-X@S!Z05G@.
M,LFDU(OUK%!9:<,(&AZW8>)B?>6US6? \',:8CY=Z"V7$!/H]MRD<O\@I22^
M_CP=^9FS C^BT,YVD.Q8\P.Z!$->LW. =&Q-*]Q0H ^.IZP83DIV(#U("1\4
M;V6'#I+]-;1<Z2'$3TNSB%<R 7AIVRTZAO(=(>Z<K5^><$M.1CMI[+ H@$G6
M*N-ZCHJ_I(EFAN[KBWU6(O4.?:ZAYU1L&>#E)">Y'-R#5?^L-?V]XV&?L<MG
MO=[81?KUWEQ[Z8]U-_VJ%'2(1C=!%#*NO<"364!T-MJA5$-5BEEYE.X*X@%-
MR0G6C4@Z3#TR*")5(R29X_5HAMAD&$W2!*EM65_."_ #_^(X(H).L_J("7CL
M]Z:A#V=FWWXFY4@:[2X;78X:>^:/#'75 >GK=4G(4TR^B!9S12M>1;[$'$8E
ML2#[-K#H4K'#X.W6@5EGT69"D>"8*BCA9VALM;6%,#<T"<=Q8[,-C>)MQ@$)
M]-R6:S$C.@*M#T1L]'$<F7BUH3GY]R?#R0:,"PD>AFIT,31PV'!MZZ>R"X]*
MPJ":K.0@0P#(+\02&>UB)=(M+15TNA&4(?'DJ(91Q5S8=<RLPAN'N/%EM*^B
MB%>$7/-/3-687D<>0%?7( /1SPSWDMC^IOF?F%FKV+$BZ'#:?H1AM+G*MYK+
M*["--O\QK>6&9O-6X_H8I/#HVW0<IX3--%2P76&EU&@+J;/=!<EF=#/T%V0[
M_*_9K!FFX4?5:J1'PY45F:&!T#]I9=$)J8_&CDZV\JXFE[L>^]]_:5=+?V!]
MW7;PT>7Q&+RAZ&?.&C1T6)0*J;5Q71(<8B6GK_HDR#6Z(XLJ&3%F(B2P ?T.
MW@@FBC<,_\E<A>"/(IE @;?<<32&,>8"U5P5I5:RXL*4I(99[<"#$R+)XV<X
M1*$[]V6^+Z=7;1VNVPB/R[@9_&6H#71=-_H,N0S@32-90:!W#CD4<_SEK($.
M(IZSGGV@$<;GDI@HJ9H5@MJ!- MT&^S65.K^NW!>F?7A;G\-GSX\^#HJX/D(
M5J?A;Z" ?/32'31TD!LWFR.V[Z7&$0NH3;;EM<;NF&TP-U>]NQ79W( 0=P]2
M[)&RP_"%S(3;K*(0N/IS4;+!M[/" YJ;I]Q(JHMOK;\KO-UAH[OIFWX<^'+F
M&K&CS11PF:Z#(H-3NU3**Y)3W6H"#;!/\0L-*M1W72"N$EMC(=*O(5[L^_1A
M[TS8OP/&U<P\QX^JF/B'[U4%+94U$W:!O_3O]@U^CM"-RWE0V?ZB3D=:(64C
M>A+;&\$BU 2ITI.0+R=DR&92,3B@2]6+.%L2"":]GVB+1URNLE<#;M^_^QC0
MCR4-9G"_**$V)@89CG+=ZUC<EGK>\=A!TQ?<%F8VEQ'$_Y5N(O*'2SK5B^=(
M]J^,KZD0[7DJ(+QL7(,,*!(2JAC>DJ:XJRO'<$@);'6TES VJ7+2]277J9V1
M4*GY\=I(.N/Z;LU?6Y/<+&KB% LX*)2$,=O2VT@15*4E\;Z,:EF&LB#)S&;H
MLX90H+TH2M*Z477,IC[*9A0_S(T/=@7M\KW,P_<5*7;TLP(Z*$2E9W1J9TN7
M69$UZ[[SHKDVYG?];/_4LY6&GR0/DUHJ-0NX%0@1^ZHFWHP53-\-V<D%OW)M
M4%-\T2<!+U7)<7AJ*.=\/<+^ 3I]U<O-#*C(X#;('TS9VD;2\\F[048!QO4O
M>'<G'HY.IJ4/>GO;I;+/ZW&H)[R *Q"[L?<_@X6R!9P9>S?"A[V!</F,51=G
MN;(I&D]'=FMG,_@K-R(!0!(7:'S-B@L=*-+59 B\TDGR4FJ!YZQMO(^Q_ '6
M-*H4^>TBS\5:/H\+'1+D2YS0*.@D0.J@\KB+V4=@/&B7^V4 .Z_"%=95P5;R
M;LC[P+ DMHYY1=7 U_9DS1<7 5%J*]9L!\</"WI=T:2#/ELS:$/)!8G]GZ5N
M@M;XTJP6/15K64TEMXF6,T,]3<V.H2 N4(:4OMRXRSA@7&O(]RK#NGL?') M
M7ON2'0D)L\5N"#4$*;_MU9/Y@+V!O](=C8!298ZQ19D-#9^H5@NXTS%'&0PP
M(2SL,4U(WJ5?-WJ4?0!9#1=U21PH6]E'L6VUVH.\K8RGK(?E/9>_IGS]&/F,
ME_XA"F8^F*A8#=EE-8WZNBWEV+\/!!A^*]0_,HY?NA]4%YWX<7_!L>(2;)FW
M];.70C3@3<P6^.V+(LA%)X3M9@H QNAS?__TT%"$!]*=T##XM>ZR(,B.=T+8
M"OT>B44R2W^F>7US10,6/G[PJ4R^F6TJQ1;6]PF3FH0?">\TKH6(,U$PM].*
MT\UO5N9JD&C])O9W7_ZO?\I(A68+N*?K/3K%OH,!&1P7MD?02[)O$A@=&M!8
M%MHV/#/7YB\K5H;[> W]>7']&_(BK("__N)*OW(?":3="[A\ZF)V$%RFX'_%
MCL.VCM[%5]$C8*&4:[)!O9P<58.8QB#,>Q-][W=PMK<B;R^"C%'!"N1*]#Y5
MI[,)=PDB[%)6$(>U3P;F@GKZ)2HKG?<3Y"W, .*ZU.;&7JX]UB4+N&S)"C8>
MQ@/#-P7L#1E NIX1LPHI;T 6RV*^Z??*H^5R+2CK(KZ/&S0ZL<Y>#^F;F7L>
M["8>2EHZU )O?AMJ7*Z%U-)(O-3>N(K] ](!A8/4SCIJ=DLDO4M@BI1\-RQ>
MSWJAUIKF52$Y<(P:%*(N,98P+9.S-A+1@^1MR.<(WF'H#?4XO(=Q#SDNHEA_
M_QUEIQA3XCKT>\PPHGJPBC41.Z/?0.,\D:G>BD72O4 RJXR]%628F-$@HC'
M44&NSU:UF=B6$>G"N]M2/"Y-6\!UUI_N"8.'ZZHGAZ]')U:L[E-WJ'X6N[8,
MUF__1!WE@46_<N/55N\K[)&H/Y&/"KYM"@G9-"O5G@1[<HB6XC7(/JS*51Z
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M&:5B%?PK&@,32O0[V>>QMJ;Q6JG3M?HH]JE>RG+VINL!,#4WA51@M!?![ZK
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MR8R(6L@V +!-0YH5VJ,.]CMR8*3<=G'M')&33+9_PGU"C<8:5DNN4O;\6EY
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MG)F">8-[Y8CV>;TLM-$#H.$EVBL+'WTI@>[%"UL#S<BM]LKA251F-#^+SMZ
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MR"2]?F.$+07;5-M,!<PJ=">NWD'71[E5!54H+K\9?2! [VAJCK\QGA@J9YA
MU)?%5D*W4'GO=7] FA)C>8#H&X<1ULD:^J>+?N\[T1S8+ K<OG^TZ2C&7KKM
MSGW>$X/?]"M2O#?>V]2^ZG&=_FH*L'31BR.+US]=XF#^%PZD*>)>3J7EQW*
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M_%&/6?^KU#L<VHF5?4R.F2DB[T6D_F]<,*_W>%\I476#\D[E)_QO6R1S"#5
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ME:$,\D:&&)IEEJF((+LFS8F.*+QJ!D*#USP<HB]$I]32P>L@[YZJE[MD\&/
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M_)N8'2*J1X_.<@@OT;KI]4*%\6K+G<TI(=2;TA'NP->Y9JG !;RJV]XU$^]
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M)@6"T!$29,=I8M*99A0/T.MP/5BDMH5!32!-M=\J:)@=NCOU1J7V?,V+VEI
MTU$_Z'63 @/ZV,:=(N/5D4F\Y"IX3.R-J-D%!O<*ZQ?M@0"9]BVZK@(SIT4&
M?%4,??^;4W'I95V];&X,T-15]/=,TV3J6:JTMG,3.:Z_[6XDQ;B(/!741YJB
M[%49PYKKWV< !>3]U'T?(>N6@.Q$HH*1H@:^ZFZ$J?8TFI6K20K^2>5.8=+:
MHO< SIK:BZNY50W&SU[M;?16F*Y6RPPS$3M 7!MLE6 O>5 A8!-!(R\PAZXE
M O%OJ#82ZGIRH%BP%OES]JC2FG(\ZSP/7)E*O%H3/KPEZ)KKJRZI;@$[,4W[
MX-I4?UY7Z2C82OFU3PO'*V ,O5B<'VEXC=A%8%$V5R\6<_+.0^6NR<Y$E"C;
M;2X-SN&DTD4'*4=Z_^\*QOT")FO@9V^!QU0:JAIWC[H'8HRX/HBD8%6=:R')
M['4@NT+!O(]T /KFZ.P9TIKQ^DJYZ0.=,R^P8_ND=.[\ZV[*"M2]&*+)UUXR
M&@?0,Q&XR^POELE!+H%FN9B*-K\^V<N3LUBL8[ZF9_[:=[,(AZ_C10E![)+A
M7'7%8)^]L**V<PTYI,W*HDC!W 31O$!L<NT)1;HO,)4:76%#\.I]FA;.2G-
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M:S_:1_$L'+M%W8DQ.MO#X79@?;LSGX66RMML,TDAK\T";3BI\@V-Y@!!;VB
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MN!?/+)I$:,KM7?CRWL?4+UK:$Y:/Y[&A>>&_9:Z3^L7_BEH:^']02P,$%
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MZTTX;+)J=QJYR/2;"9NT"0X\=H+[\&?DAPL^2AN3@QR3-<U*NC#'TL,:+)T
M-(;4\9&3?=W__>]/[=;1_SOQ:YT?V:'+=_UPIY0WX*UN/9OWTG/^S:-QWFRE
M[X1!J=W/ )WT GROU./+!C*5F>/R40TNLT$=/NK.5C9A6.PH"W(\2I]5;:0_
M,4YT?>H&F$8$.JG7+9!/_&[F"WK3'R.?J1J PH[KX@B%/AI?,:EVV2$XKRNU
M+2M.),=%)F5&<U;#.>EXNU5CP+L^FC.2,2ER*OM<NV^UFD6V9+KN6&# @JO8
M8;0 R.,[]XQO )<%AXRJC92R''M:1?:D0SEL+&<YV-\<-MQ.W9GPZQP*EUZ&
M._&3JKV_U2ZR0O3;&6,FQMATZH?",F)2RVPFKN@A*NTONG85-D#KH,B=S&!B
MK>2&V_E'3"SH.7>$LU]OH!L1/RRS2]9"O]V\+K-I.8BS&F6GRHQ81*#GASW@
M^@$[,>9YD_]);YNU#DM<$=V=M/].R:WC?D@.\!7NAK15Y?[SIF1 K^<VVK&N
MR+HA>( 4H]B=FV-7_I=J<^VHR",Q@(.1$P^Q6TC5W+B& 7>G7 %2VG$*/U5H
MM9);(.GN)/UWS*AF1OF<?[H0?^6W&TTSG3UP?/RFV2R=0"7.@+_Q]*EX0.?'
M]*%4N>WX9^[<&?).-5P\2?N*G4HPM71NK?#V.#_&@^_B''5\/A(&EG_5GYP$
MMTI'V\PH.\YLZ@J2<$G?4KNO"8:53KL:MY".@3L.2IQ#$GYEGU=N:*4SKNBM
M98-^2OX;.:$\*,DVK8JVE1PKG7_-XK([Q5@ON->%(? +\??"3]6JKW0,3D;@
MC!%C[.+CF]J%,CX9=:A<:*7S<:59J&/JCJ=YGKH3Z$4!Q*,.0A$(KMEAE^)1
M%[+)<'T!2FBL/%]-.YE8_:43MS%[>=L$"4^>B+$X @S_=Q;.;O^L)PS%$X&"
M_:5FE8NY%-'/G1H4G*T*+^_8J&"C[LB@8*FV2Y4SD[.XG!V@/6<H6"[OHXY8
M[T2@?":1;<FY'ZI/^>5<@N1<HMEB=ZQ0K,:S % J=C:.!(\&,W[-D^UM8DZO
M_?$DQ*-;"CN40A'-/O?!'8^E56CAS<<UV*<5J0S*!9P'Q9\L824]!;!]/-IG
MT)P8FUCM&72[;;N>A/6BD/'F@I$QC:9BEJ_ 0J0SW")V+!U$)"\;A@*V\;"5
M)[1R*H9>NF)$3@(I:9R"<@0JA\$JR5R5;.TDRS0)1[:Y&#2OE@1)MH<F*:?B
M!+_CJ$F&CIR7FH9&=F Y042:MK/SP:R?OB-EG+1%U<&LG"E22.?9F7Q;\$-+
MG615C0VL]+*+S,@7O?.3K6%CB:D] S,_!('.:"JW,V!DV1E6BY$%*TET=A(,
MN_UQ0SYK;P2:=S.0@O*UEZU)@='%P)U,*&1B,.,(:,<-_3F_]:E9_M*F!N?L
M=LE]MA'S$QA.BF-G8]7A]V?(?130ZS"[%8RY R6:QA.J8WU5KRI;K%U.A-I$
M!%(X^PD>)P/H/W]3$.7/_OGYXM?#?_WS-W<6/7Q!A\?>]Z/Y^,L"W7:C^X]'
MY/CHE_;7V^&"!D=S]WLS^!0VPAOXZ?O1P;>'EGL>-G_O]=HWOS3F#Z=G7YIS
M[X9\^7!, K_KDKO/DZ_4/?"/3L^"1G<>?/KUGOSUTW5ST$9?@+<XO(&M@X/3
M[N>SWD^#R\:G[_[HI]=G</+SKX?D>'[QC_LO#U?M&?VYBZY^IQ&*6F$;3YI_
M3KQ??NL$GQ;?+X\/!N2JC[K17_^<??T$VN''Q;S]V_W\YMOHJ_MY](_S[Y/9
MM/U[IXO@;U'O&W$OOYZWWO0NCB9OZ.#N-6K,;[Z^Z0RGW_K-6_":?#T]];S1
M&3CM08^VQH>3;\WF_9\_?PZ/;GH7[K^<LYOKM&[<HVC.$//;SU$0 G::-U"?
MDO8F.K3DJ]R*#@VQDT&SBT/4-Z=. 7LMKTL"$16(/CSP/_7>1Y.>)D)1<C%N
M;E7M"UA.%I>3 OO/5ZW;%9 ^VY5XA2D\BGGP&1#"UUF(>?B7_8]PIR+;NS"/
MZ4-M6'J=H:KM\G;)-;F1!*4H^=])IQ0H5S5+J,+IN02[\[[4NIDC\[A(&YAH
MD))'LW!39^<C6_?&CHQ-\A:5QG/)D5FXP;-CDCF3NMB->."E@[P/*&0:JH]X
M"6*!)N:5MH5>I2:W>)(!LG]V>,Z'&,W)#/=?X*EXV\B5T^4/XT>YPKOB,7OJ
M3V>8A Z2UD56U/)UXLK.YSB.RVNZ\'_MI_WV^:/]5GO_H/7J@7II;=*:*#C1
M<7'4>BC2?NN@4)5CEB&@:97E;*<Q #/1IP&#D"Z'$25CUYL+:4UF%9ZJGN+?
M= G$0#KD=:0-.9)VX*PX7+W5F O%TMYF;&"],BQ8CI'G@2GI%+JOQGC>H+YK
M J+8G/^1>W'RTJ3HN7CKN[W4T!MD4V0'N139SAT-"7#9W,?%B44][A/VS$?C
M?@BG7#/L.2!I]6XO)!$O*RQ:S2#QL3<4_;R() H9^4' -7G:ED:LLQ]&_->/
M!$>S]"4^&SZSU]8!FY]I%=%I^EXGGT5H(\E54*LYG$]U&LCRKP:K_*M.+O_*
MQAG9"CUF<K)!9I&-,[<-<K+Z5#5MV2"3C?,@Q==X;R 0B:]MF/7[V4BA%J>9
M[.O]6C82;8C8C/S4_3$H.&F&*R=-)^.DL7$^UB5!LQ)ND?@0!?3LH;<,2:VB
M2FV;%N)O:B6TU+QE(0FM>B2T+22A78^$ PM).-"2D)1L[D8<Z7 "OT! V+FA
M9<_*KD188Z&_?GYR))C6X$_;>OZT#?BCZ'I@/7$'ZPC?X?.3(\%42[^]L9"$
M-_5(.+*0A".]"L#4(I]$#HUF:6>:66!>Y>'4$IB?GA^]!%,M$HXM).&XIGUK
M@1#)0&7\ZGD*.MZ<G[IZ!$_/(G;*FD)"\R1,,8(A( L9$2,04"D5<:PC3'^Z
MBS]X]6[/%1<AUJ=-"E=S!+PBF,X@S]>$?1Z% L%5=!?X[F T@IPSZ7E["R2O
M&%>@V8-WFY!L3()F&OHHA(0=HI.VW#W[X J;@;NG'Y/X31E>@5RW.%<>A0'Q
M?,1($CX7[D9(G0N7,%QY'KCRM7HJUJ%'(Q3Q%3(:NZ63$3OQD$.<?\6O((BL
M%I/:M*@B$34&*FAZ\6S-V7@"LM6QEQ"[W[C,0"\^/UP)B*+78/3A 1+7IRLO
MK8^LH7Y=Y%J?JGQ,(32#41*!&*!3. '!*/'BTKB]Q7O()E0I38>5/KIE^Q+5
MJ*4^8H**^!Z&T6<_G+ 3JG0K$Y_ML%?)/ [!9EO8%M]HS?I]3.J44IM5F3>=
MW@<V=EA0E;<SC'A0)H!QS%;Z*@OF;VNDZ"Q'E=%!.]>0!^NRBC9EU\M8Q'4(
M4FV>:XUFT1:Z&7[E(M/M-\MPGLU28D: +@JOL4VH8@JL,Z)HCM3:G'Y9BJ$F
M)75E/Y[0JBFQ3P04I*O<2:[+7NVEI_8!4GS%R%I+V9  G=%6&J(+9YCZCRO]
MVR9[B5G#["YD:PY0Z*/X_WWT$;.Y0KP)"#X*8;F&+O3G2<EH>Q=_75*TOK9T
MB$$X@233BQFT5P3.@.\]A=MQ<\];#3K4$99TF'2&^RCQX:;9?!:OBFKLVL-;
M5>]!6<A>@D#4HD?KFV<RE/0<\13.TJG*+OJE>'4"<$6P"Z%'>;1B96AGG2M]
MQ$ZRI2/LT[FD-P]-;(- ??Q&\H8-W04O;D8WI;?V!-L1,'F4N:P9.ZFSL+D+
MYL7-1XQ:O7]?PU&$O"'F[5[$T5T.N"8O+7%V/<4*J/)[*35',6H0:WR9:\NN
M2='B5D<[DJ-1; =#C\_I"SC8:6'KT[GRSN4ACO/R+:95"5G)U$(];S9)>(S\
M[]#KC %/8<E=++*9])J$**/?^7JGRYO_0_@0G@;8_99.@1>2DS!]^-1ACTJ0
MFN /97KN&LXABB"-OV=I%VU:@!IM7'976$A=-4@EYWILRV(+):X-(K* 8L]#
M/("%M-8#K%J0Z49L+9EZ@+H ">05]+CWP#ZBE-B,KETJ[WV+VDAV$5H;]-H7
M3VTFW@"O$=WU[C#:/",;4:*,%1I\PL[\&VJYL-GCIUE[X<F$]21N= ?[A6G;
M)EVJR5MURZ_/K-QP>*S'$TN-$IDZ1%I1IEU;(-PBOF] AG)N+J/I'21Y+RI;
M:H,HY!GUWC8RCY;)^>MRW #CEGF?+[3]'R(),J*TN:G2D@$=KIG'HMWI8M4D
M<7-T[@$1MJ<;0N_<'ZUVN_S\I;/QU#O.=DG2U/LPYI"FNNY+%#@U.=N8K/4*
MC;[$>5R+4KT6K"GWJ7OVFK<UG43+UFZ>AFTK.Z84_)BJ;NE:TPN:HAP1ZXO0
M)0Y+.:963D(,5&7XYC]0;IT&D<%3W[84IC(;F-+4Q_?A@8=H; ZHJ4'KUF\^
MRI1JRY]AX)TN+C$"HY$?<$5I=2S1G BU/8^1NTHA[,*[\&GR(#<E78M;M58O
M82B+.;*>&'F,--T5"JOB*34)J7+?/O^1K1#1U<--=^GR?1)["-%@5*[%M,\5
M\=U5E+O@01&#//$6J0"FB_=P=9R*J,4+*8]37TN!&>'W7,&('+&DC\6D*0#K
M2NVL.O"P)?<4<C>J^"@KI>5#N;7DJM!7"6QG%$(BTHG[5X,74'M! [I*Y>>6
M]%6B5K9966-;"C0/4!?G,'!S6V>>FX/>)&IQ[B/Q8N/CUB-6U*P%5\/NV*%_
M@5$X"1:KB&@<8@!C^/R!ATJ$NKI/55_7MDZ232%KDE^J!K!(C.N U5D5UW@!
M GYFR1:Z>4:1S<'1 <_>.8*\FCH(5I)M!S'5$+77Y(1;H1.PS16!N+I1G*IH
MDXHQ :F[#BFZ+W,PK>":!)..33W_@0?W[*-#!4PK<U-AM:8BVQF/"1SS:M+B
M^2/6/=OT>J8>MWJ?BQOPN/P<!EA\CX&=4\8$3&TG5HI9>]MJN2('HSCY+N-B
M6E=,-[:VY:AT= QQ"((S0"?9E&U^HZ??L=E?J(.MT9#<DSP+AVPGH2-(&)^]
M2%QC$@G-SZ]D]/!TETJ2AFE7LG)E/!\U<EBJ@\\56*17/KVEW=*%U"7^+)MY
M](RAI4J(NO,-I! 0=])!7D;3Q#8-,S'CVW06E\(TPZ_>&B[  _^RRN N\,?\
M*RJV[X$*O,HUF+=.4VUT\:%OM;])A5GGEP'QG?P+0+[!,%,1M N3U6ZSB\T$
MO6X59P]4-IT<5,!T6_]R#H0<I&+P_+0H<*EU2_9S34L%_?QTR&&I]C_1NL,L
M;2BI4_$LVUT1D4Z6"FWCDCY6Y/S)D546JBV4X+'735<%MOK69;;WPBZ+JP*@
MEC9V.$@6G\5F51:ETC(FD&->\-I@<3+3MFRGQ[L)+D=LD V0BP_9M,-6X--=
M78^8W0P4L;FUTP V]Q5(82DOA*1.(.NJ4JN0&=XZME6QJU%6LLCVLY6Y0_$&
M$O%E\SY*Z_#W,$E"<#S'LP>W$>1^O"*/!O"U#F0^4?S?0TBF5EA3>41JQBUK
M!8G;.A;J\3(RY=&><RIA&F-8?SIE0L&$-U@Z@QY_/]Y4$$U)4#,T33X<D*5?
M67CU@/LT%LG&N;4F^)4BD&G*YN\LP+P:F_6?J="@UB0M"G_( "6ZZQKR1"R[
MTV?5F'5^K(J[.-99!&: U2M8A$R2;S ,)]#ZRDERO"KC)V?\70&26YS/F&LK
MQZ5<?@F]^:^K6,PD.5YE_7H+<RZ4*18*DTQ0> W= %#JCWSH6?BA'@.0FIT^
M7[ M"B>8\-I.)<_JV@1N?'2MAFA^5TCV-9UG89H45NT[3TF>K63S>G8^21":
M2J$H.4I]MO6)2;9)?Y@"5=N6(I4AV\MZ_YX2<N77FUY %GX)JC)5F]<RM9Y7
M693J?3F^4VZ!QW\)I0JK]1-? %KQB:@0>M935$1:'41[!.MHXTU)#4V;.+;<
MM%;%J:RQ]W3HM-^.2$I)I)=SO*W=(-V>(I" 4SLOIK, +R"TD1XU-IV-I[W7
M9<L5TMQU+N.RUST<!/A^@%[,+>T:1!C:M6SB[/13P"H_15+GIS,'OGA=#Q/)
M%T6>Y<RA0J8VP"&9^BBUUVW)6RFCJOXJ8*SRI16WGH,5*F"/4G6L!_Q8:..W
M")YWRU='GF-M;9^FJG7Y HY91:0:.^579@@LOQ-G1R6Y B3C+;S\(8?G2P!1
M 3/(TCF%USQ?EMO0'52T!:QQS=0!J_^TEOBZC;5T5N#3K*S/D-\L80<Z?IMY
M;!]E%?@TE)WC>_$="@KCE*WG7VXE1&H/1YF=U":N5 %4$38$#Y R52V*U-L:
M9E6#U+H[R P348CQP;:K 1IL*D9=PX U9*8(L3GW68-2F4J;N1\YN$>0T(D_
M>WX6R6&IB(@]"4GQ1MO-/ E8;4QK-&+*A*3.DK3:!@-#;/X@CA:VMF#$2H87
M3T;LYG<!5:"UD7,Z@:0+)@!=0%[0.[OL/#P%OM2&?[R:'R4\6OT^PA%/*J)V
M8"_AT6*?SJ(0BD\HW.!1R Z6T!8JE,CJWL^QA2 U-*4V#Z ;$HQ\ER=UB5NU
M=A"C!J:.\O8[=F!? =&>ZRX^]"W!NT*BG-S\1]7LP"W%I*3@ K@3'\7W;S'K
M;@<-"E2J]<K;6 )\A40]Y9%'0!_1F4]@YM[^+WYHR^Q7 M3FI#.KJQ<1=AZ-
MB/CL6:JIV-]"-GF^;'\Z(W@>7_^T@^CU@2O37_,CIC(M'8J_SM9-9VMT&.4)
MT\O^3;/92M-RTSBF)5-ACE29H01GH6C1.F@WVVT[Z)*#TGZ[+^UPR#L,D"4,
M4N+2QK?RG883 NTD)XO,G#G#>VPG-4M<6N:PP=/+Y7'="?YJ2S8-/3AMC:][
M/)S@B)>V[/FC$$)+3N!*7(;$\"*LR$IRBL@T"RC3:WC/'B\L4@E:;)J;1L5N
MV!:5K4&F9]'OD&"FX'O^W!Y*RIB4QX!55F!ZZS]O7=A!DR%*3?U)U6=E+2HU
M;("Q*E4X[U^RB+8*?#JG7J[<02?!:@%%<EQJ$4P^T&014TJ(E*>%-;_'"RTB
M=@LT5$]/FF+HAO[<*FFMAJBU?K5?J+:2R7J@2CVZ&D">FI>&*JVDV12RFOK2
M17*;Z-2 4VO=+G:CQ'OV ;'7+/IHA,DTSK.T9GD:H>3JYVV#44@9QZ= D/QO
M4$L#!!0    ( )V";U@ 38!700P  )^,   5    =VQD<RTR,#(S,3(S,5]C
M86PN>&UL[5U;4^.X$G[?7^&3\W).;65R 8:!@MT*"6'# &$3&(;9VMIR;'DB
M<*2,9.?"KS^2'8<DMGR5<3*'IV6\BKK]?:U6M]223WZ?C4QE @B%&)V6:A^J
M)04@#>L0?3\MW??+C7ZSTRG]_INB_'+RKW)9N0 ($-4"NC*8*TT\&O<UJ-P1
M%5$#DY'R'VOT7Z6L#"UK?%RI3*?3#QIK0S5( ,4VT0#E#Y1RF77H==DD@'=X
MK+0)5*Y5HM0.E%KUN%X_WMM3[N^:2KU:WW=_\LN)"='S0*5 87HC>EI:D30;
M$/,#)M\K]6IUK^(U++DMCV?\P5K[Z9[3NG9T=%1Q_N^R*85!#5FWM<K7ZZN^
M-@0CM0P1M52D<0$4'E/GX1765,M!,E(O1=B"_ZOL-2OS1^5:O;Q7^S"C>LG%
M35%."#9!#QB*H_FQ-1^#TQ*%H[')%7*>#0DP3DM34Z>LD_I>K>YV\6_^Y!_R
M3Q,CBDVH<^S/5)._2G\(@%52>-?WO<XZ!D EZL $.IA E\4/T*SPEA5A1Y5\
ME.TP^QR!OL7^'@&43=_-OER5Y>O<5.FP;>)I)F67G3 MI6C(+5FW38"-#IJP
MU\<$ GK'-4FL9TA7#J:2]6V:*J70@.YPPT9WS+T2<UI7@ V:'OP^M+!Q3T&#
M4F!1%>E74!U $UH27C"[;/G\M6W+)N :(CBR1XX>M^J<6S2]1SH@79NL:RD1
MCLRB7]V$IIJ:;3JP7K'77P,&S"S ^M,]:+@6F3W4PC*9:!-K:^),[LDQ\:29
MZ@"8IR6;EK^KZO@?E]JF38CC@%;)XAI1II+CTPV5#AS'OOAAA;-8 :9%O2<.
MKPZGP7V_.J3$2G)WT4".USC_8<.):G)2&E93)63.V/BBFC:0K'P\F957W%<H
M;Y#UMU.)YFG'_O3QO3YI+EI4J#T:.;V5(7/IWN\-@D<1[%DX,7*8,/MF05-)
MF0(^ZOF?[M!.S%4+C#&%3$:.AA4L8ZGP5C(AP&6!?'T#^;0CY8+%KQ;M 0TP
MK@>;[C<S\+[NMQMS/QH+N/<DP7U+P%B%^OEL#!";)I'>M8: Y&GZ<20NIZ%M
MY246; NJ]OU4I6&JW6EWO7ANWAAA6SHS01*XOEO,0R H"]P/?+BG#R]N,-)R
MC#!6NI<R:>6FKE#,-MB)_ZW%T]=J6XFQ0T#^T5WF'Y*Y")>U_81$8"6(*])-
M<IC)LN:W+-VPF+/F@>28IT4WTDD)%;4V3V\K+>%@20X_7(5R\:G;$-D%X1L<
M)&PZGVVP$['V =[3'_^GL8>5!8E\HL\  5G,5]-XR$%OU3F/SG-:A @64G#B
M+F9JS5P$ $F8<IUUMX8^X2M(;:9:TZ86'@&RX4T$"W:!/RPZ[0C'-.2%)<Z5
M+6  )EKO 195VSF9M$#(3IBT""#!S)B&@_/1V,1S 'K Y,NDN3O%:'F%STCQ
MN(D!G"@I3^G^B?T&_(CE;+?'BH&3,%>7D'YY\N;YL!(A;#>HB4)LP<]'.?RL
MZ)1?7%=LX!_PBJMXAXP!<0H@91#DMB84+6^;9H\$@R!6EI..H[Z%M><A-EFG
ME"?8UEPR*0$"LFQ?XM$((Z?/7'8J-[LO= 2+N5G;E_1!(GD8-W0=<DU5\U:%
M>@<UU3&T5%-V:"&04OB0C<>"$"31>$T9YMDCVXDHG6T>7FI'P! @"B? K5JZ
MPI3> *MKW*DS^<%?(ND%)U$Q>4L*J<3L:F4R:" ]=T\<*6Y[LMY0. 113)C?
M2SO50,NI6>)E'QCQ>1D@37[(&"9I!SD)!2XR?-F5MPQJ)?8-)Y6-,K;?WJRV
M;;.:->-^XJM/S"MZ7Y&0=J)<+(G)5G'9;>$6&T+'JI&^XB#TC>E<([5:D #-
MNF961:#T8#! P*Y 'H2-W^F5L\Q,/4#9T-=X-6*+$6QB9U=T40(DW>3#9!6[
MMQ][$(3"Y7?:Y6P9-3#9X^],VK5*G@'7+Q]J0@05FK;&I"4,)__:>#E]UN2>
M3C*9H(8^@@A2BZLW ?FP$B5M%ZB)1,R_6)Z"'V<;\99@.F;.TLFV6 3&\F=[
M8$*M:QC,>2Y-(MY>:NS.BEX2C^ A(3+^I?%RALF=I;JYQ7CK?1<^I0>^:N!Z
M[&HS*:&40W$'L0@!4.NU>O=\I@U5EBWU6.P0R^0CNBC:T(4(QWI_<35!@?G4
M\L!=ZOB-@<([80-\ IE"9_-[RM.TI;$U^*#/8V\J@>!W]Q'+N!/RN.I;-H"2
M>VZ(Y1_045]ZO<Q*UP6O366#?QTD2;MJ;F646V3@.;<N8MYC H@%F6_I \TF
M 4-;5!P6KZL='0F)T!+6^[KW!?SU</WEX.^_OFIC>_:(#H[TE\/)]\<YNF_9
MTXM#<G3XN?YT?S>GYN%$>ZF:EU;%ZH/+E\.]YUE-N[*JW]KM>O]S93([:SY6
M)WJ?/)X?$1.V-#)X&#Y1;0\>GC7-2FMB7GZ9DE\O>]5N'3VJ^OR@#VI[>V>M
MAV;[4_>F<OD"C4_[33#\X\L!.9I<_SE]G-W6Q_2/%KK]1FUDUZPZ'E9_#/7/
M7QOFY?SEYFBO2VX[J&7_^F/\=*G6K8OYI/YU.ND_&T_:@_'GU<MP/*I_:[00
M^&JWGXEV\W15^]B^/AQ^I-W!/JI,^D\?&W>CYT[U7MTG3V=GNFXTU;.;_6^Z
M]O#TY6$XQ.TS>X@/K\?FWTJSW_,N6LALV-Y)AG2VO/SU%@0ITJSW%1+QH:MT
MRPI#E8 SE6G&MZA8N)2'>Q<(V6E'+P).7/"5)I#7"*_8: 'WOQVT*(_U3KW'
MC.6C>MEE1Q\#(V&-5YH!XY>W43 K>>Q$R]M1]A( NB#P4$(0&V NZR7\N=.W
M*>^GH\\'Z(*^3[G0)RZ)SIW)$-'%[F#(9C0,XP6Y1S(*D0)M::.R^BW&YZ;(
M0A?7<QB>/DB]58*JI*BRC0GK!KD5P-K<N;--U?B+7J@0\96)>\34,>'+Z\*9
MK$/^243O\C!-AK''<$W29K'8[>=VM4DLD3_;4/5!ZA'IV_67P^+*C6JYT[<J
M:Y='8@2*'F-!I0")4T)/!D2>K L\ 03Q5$<U-Z_3B9<@)NUS)_/V=.AYW/E+
M!C*D\TQ77A.\(JB!]/4;=Y)E]K$ZW,41E@(VCS%?$8'\U9>NWWKD+,@$=;R[
M@RX=CAZ/ >4',G='N:>F1>R.!@E.O2CE(7F'&]H/&Q(@O.1$\LLE$+R=!AS"
M_]JE,0D ]F^YI@_0?')[3%L"-5XPP'>SG)MA >T:BPV"O.F-$K^MBUEI:8Z$
M6UB#FZ)DC<UD"X=H\(.:3-N8Y6D!/]S2S:\('D* $-732IP+VA"Q::F N2!(
M<+K2+]:S!H!.^?TI'4IM/LUV#6>OBO)_<VEW0[!>\N><0O-:\T+SN%61,D1M
MJ:&&V,)J*:44L"4=K W1Z1Y!/IBZ1&>O1>:NBFS6>E")D_-T>'D$ L[JT0.T
MADSKU>+0#/:05?)/9QZ9J9!94Q2LHE WF8XB@9"MS%S36T 2>,77$<J:&AKM
M\]A5\,+?;V=LG\&'NZC(O$MI5= 51#R(;!*@RP_9A7)VTY7&P$_*?<CQ!RQM
ML*S -ME8/9\!HD'*FGA#6)Y##)6RFU3*@EA\9U/FD>D<O^Z.^>M33[3L'<IH
M>=N:1:<8J@) )53TN-;D)HI== :&JFFXTR?073.*-QA#>]C=T",<&$%)3AJ?
MV0.&C?0[S.=,-[W',>\H#?[E-N[@QD%<@(._/B;#F=/>ZLI(CD&$6,YNSCPQ
M\ LH@<EV8)NKN?%5GY751/>K/^L/5EK> @*QOKES<C[33%MW#FF^GF<[-PR6
M+4HV@#=6OFBK*H:KC6-;L??7(DZ*O@,8M> <<:7[.X!1GE5\:NK-S]"&? PR
M0_UBP=\B2EK%M>BGITZ]VV'<Q21^1PF9Y%#*%2FPV, YA+_UPJUHX.3>_K:4
M^(#)<P<YF1)]&ZY")!8]_2:E*PP\R1?9+F6V^84ES-5<8*R_#6$A$G>-L##P
MPK^X4]ALDOW+N[)O>9=L9R(I\F_F_K^\GCZ"Q!1WU$N:@MZO3\^!JSA7J1?I
MS3)_.#OU!Z_8# V  #5/AY;T4[.QQ6;XUD-,$3>,P;LI,"?@&B-K*/W#$&G5
M*/8K$@G-8NURYM3 BQQIGO0_LN%Y-\4%L>Y)+_J^YS>@>PFTW _V)9'.R"W*
MD;W*+S;S?C.F7:PE?Z[S/?)^C[S?(^^=XBI#Y'U2X4(&K#?>YG]02P,$%
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MRSE9=H%(4DF&L*((E(BGNW1Q=2EOP2RQL@!W([KR'B_8IJ"A%Q6]4'CQ(OH
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ML"K%5NSFEPL4&>SINDP7UCYF&^4B]I"@E%U9/!#*R\1DW&PL,KQ01"#GX[0
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MD)R4C_-&$+UKL>%VD..%DV908\.=P(ME_A35RU^SH$3D-!BZ33WH7;(->6G
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M:+!8GC*%[;._2$]67DC77@RV WL8N+C*#<B4JG9M'VSPFK%B!2:8%L'#[VX
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MZ,HO_\;@7M+$)R1(S]E *[?Y>1)%R>,BOMS<1J%?]3S50MR W"0V@ D\E72
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M"!U.&N"^5HD\'/I:!TI#S[5J>J841^@L""A)F;%;_N.&?=6CO/I/EA[26-(
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M6XC%WJ+HS!RT6-YM,$K0P?I\UE@5.NZ*W">4OZ+(WSU ^,@DA*>PXM7(E+*
MZ1*R9_=S$FW8;8!NS\.(4 @)M"E.: -TP"A!5_8)M<,]YW#"3O6[I!TEMT*]
M26]*AVH+B>IN!'\=_85$T=_CY#&^)EZ:Q"3(>R -<P&H*4])#%)T*H% WE:K
MX17E$2%L?C'%2>@>"1@5[G"Y4G5F^]O%.?L)3'I&F^84#ETI'A7\0 ]RN[P*
M<4.C7Z<Z ?^8 I)* 'UO7BU.@K,UH7?,MGI/D\=LQ<L/>S'$(2RF.WY'CQ*5
M2@XPK3'W[*Y7[,2!P[Y!;@J:1X1"A350KX2:;)_R#,:J^VRG"X7=<N\2G9+%
M(\*D$H#JRFLJ@;F_I+--$++?SK*,I%D^N,$N'07929@]*E@J,:AJ^]N?OU4X
MAO/;91*!G,%BRM/8%#WH5")1W85M!3*+XXT7%2X/$#DT"$[(#&H"406RP'(&
M&T&=G>X#Q+U#=%I+OXM))0*,RV_]Z >4@8#L),X#%2R5&&#OPGO_4]$($L@-
M5Q*;!.A=""JH8>.\U?,2OZPR5YTM)T55OY,D@,@/4=.?P#F@!5,E(82+<9E"
M5/X/'Z:JNYEAWG*#ZF2$(82D$@%8IT 5OS<H(G@S91&\V8M 69%_D @N$W8G
MB?X9W@-I)R'9"9T28E@J.2B#Q,,$<<+^N: WR>.P['T9S>DXBP1X5/ K;LK#
ML"].'D#@2X)3TSX[("K$08/"94KN):%I$L<D&IPP*R0X <S%0%2YAZ W8;Z-
M9I1X@]5[@]#XO?W->5?0PB7:?TAX*&>5Q!#7J@ZQ21R870@JF&%OL-?$WU F
MSM=O;F_";.#S]0ZQ24#=A:""&O8&6_$Y>_)7O$/I8 TM)#@!#2T&H@(=X5(Z
MCS/".RR'#^34R[PR00[$72 D/!U[4(:,1B-[^]R%^#I;9V>4)O0D8?Q\D&"6
M!OEIN9)5.%7B45U=K4,I?MXHHT@<C0./#@OT*LA.XG10P=+?I]U&9Y4AS?.0
MKN?#L&]2FH)6:LU=HT.[);J##]\ZG4DLY,;$^_N<#UBYW';-:I4>AN"[HS4!
MNZ8S?:W^Y_*R73\><_*W7DKXW/\74$L#!!0    ( )V";U@T9C94(+4  -&]
M"  5    =VQD<RTR,#(S,3(S,5]L86(N>&UL['U[<^3&D>??MY^B3HYP:&*'
M&I*CAR5[?=%#-D=MDVPNV3.RUN%P@(UJ-C1HH 6@^="GOWK@C7H#J,+H+F*]
MXI#UR,K\H2HS*ROS+__G>1>"1YBD01S]UQ<G7QU_ 6"TCOT@>OBO+S[<'<WN
MSA:++_[/7P'XC[_\[Z,C\!Y&,/$RZ(/[%W 6[_9WZP"L$B]*-W&R U]FNU?@
M"&RS;/_#FS=/3T]?K5&;=!TD,(T/R1JF^!?@Z @-6 QYED \X _@(@G E9>
MDV_ R?$/IZ<_O'T+/JS.P.GQZ=>TRW_\)0RB3_=>"@&B.TK_ZXO:3,_W2?A5
MG#R\.3T^?ONF:/@%;?G#,_Y%H_W36]+ZY/OOOW]#_EHV30-60S3LR9M_7%W>
MK;=PYQT%49IYT1I/D 8_I.27E_':RP@GI70!;@O\KZ.BV1'^U=')Z=';DZ^>
M4_\+RC< _I+$(;R%&T H_R%[V</_^B(-=OL0$T1^MTW@ADU(F"1O</\W$7S
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M#N A)$B,ED;7U]1)!>($Y , /(*C&U5-@38A)6=)'X3-?!^),LW_<QE$\&0
M7+%&=8 F!AEB#.4M7Q<_ -P'+"/G>X] 3$VT\)8\+$9.1\'(Z30P<FJ"D=53
M/#V,G*IBY'0HC-S$:>:%_Q/L!SJ@F,,Z4519E"@"A?8!J%/[$'*)$Z:HF$#I
MKME8H\U'/$,_+I-5_!0-AY':F';=81PJ%,&!.V U!7=Q\F!-03A,5+16:N@-
M:PY)%9L!,9$/Z.Y<R2E0!0-M[5Q-9<N##8/: @UOTN(H\];8Z9[&403#WK8N
M<T"K$&!1P$^)@YN"LJUC6U<DC?+"C+<\0P!@-"70ZZTS- :R&4U3GY@G9_*A
MHS8M'<"V>!F\+L7:7H51/ T._ UOMG$TA).R,YAEW:\]/[=(%[[9(NTFX*3D
M2:"0,W-1!BI=GI+JY>3T?A5D8;]OMS.894FWY^?%V^*_X<=))Z=?WK\JDIB]
MN!0W3PR%N)DK,Q#W*O'PF\R[E]U]'/:2=7,DN]IZ8VZ>D&D;0!NY.XN9'"_$
MVEV(H0I>X*.H.-Y;_V(.:%7_8E' >W"8-P5%6\?ZET@:[2^ZL[P^'AR<V1,[
MF./U)_)NL)X<9 "+3#B\[2@%.4EB@XWV!*3K:T [@UIOYP:<BC";YIR4&28Q
M#73HGV 8_CV*GZ([Z"&# ?HD\^40M]>\D=W@B4.-&$JXT]$GW L4W0#MY]I/
M*!%;$SZBM9LCYV,<'I"IF9 ;]:1?[!Q[1">^Y!818H"4C0%M[3[\@2.5)B!8
M:S1V&^<1NC1Z!BL]F9?U#*44#NS"@<PF17(.Y7'792= >[G'B%ABK:.'O_)>
M7N5%A-B.7WP]PG,O\_)I!@F;8 [L C5L4F21$F4?')/M%3!RCQJQQ-IQ$=R5
M]T(-V:_.O P^Q(-<133'<Z.9-&B0!]HEH&CK*LI2((INJ%US9>;:QGP'DP>T
M_[Q/XJ=LFT=L#H  ]K@V_=,".L1H*+H VJ>(P76MF@HEU00(?]%&WNU\T.<J
M[)L^%AD")MU!W>P674(D('FNA^_3'HZOLOD":J&#O523/62QWB2S@Q^@O\ZR
M#"+;&0]Z$7K]O">"82W;+GQ*>/EMSBYN0=X#U+H W,?5R2(74X$0R7I[/0F+
M[K)=-D^2.#F+D=ZR'@0J"L.[>@[$)TG^:BSRHG7@A;4\26084(T#_HE'<E/A
M54^NW7=E0K[T>IF^7N/0#&I/1;Z7]#NC!,,Z>D?4I43Z6KWL 8HN4WB#R)=4
MY^TZ>\G&?I7ZTZ0!-)C&<"ZLX3H!8IVE\:3,N;N>)8>FHM)9F:&-FQ]H%T&R
M6_3;$)HCV95V8VY>[K1<\<"-P.+<H8R9/"_$VUU*/\GVOKVMCV-Y9Z]-+1%J
MZX[6D419=[/M-1CLS?D010;%(:19CF7U&KXUN42F13-G:AR'[RW)-E9C=N$^
M0V>Y3]2_OBI_<R3+FW!];IYLBS9-F\^^:%D<+P7;64C/U XT6P3U)PR=]*,^
MJI/T4!TR%/-^Y(E@.ID_G";^8,B(G?JCO=Y>D39HU,0+%Y$/G_\.AU"\VR,Z
MN=5N$2&YN:2- 6D-4'.W-PT<D;3N*1D+-,UJG*9PM*K$K<&M[1+L^7DG VGD
M/)\Q4PZ-A,;=Q?3)B$]&R^\J1Q5_>PY;UTU"*GAO(S[<WLZO5V!V=S=?W?W@
MLFBJ4$!=7+#69U[XY,Q+M[BJ.OH/+K_ZZ(40UW?.SKPD>0FB!U*U86"TJ,UI
M3[/4HHN')]0)>)$/UO@'6'5W6A%02[IUJ*FSPO T.H?[. W0D'5,#XPS]ARV
M=R4F%=Q*SW&2 33D#MQ[T2?@YWU=GUE":=5QPU^L^1;U'N>V26_A&B(<W@O?
M_)B@I#.\;8"T">!@XWW\"),(FP=(AWT@*8J2LH]K@/!D5,<&<YWFL+A)X-X+
M2+6P*(5HLUIF6YB,N9^HS&C1#-(@BU?V#C>LH2@E)]B>C@<@'3!UXT(Q$',=
M;*I,,2HN_R$B_X*^5C'Y;B][*@Z;  XL7!:"Y[*V+/S.7D5O ^D:$6;!1F),
MX\A8[E+"@</U\OJ(9RXYM*#Y NO:3)RU]@!-4]&IQA]5A:U-8QTT/$JXS].C
M!Z$BZUR+[<J,K\BVEML#-\L]Q&GUHH=+Z*7P%E>;7&X^I)#,,S!XQ'-91Y"0
M'%YE(-SJ*-X<'5((/"(+\.5UG$'PS2NG6%*28QU0\M6/$"B'+(;[N*=4CGEB
MP2D)*K&X]* -+XQC4[_&31*CL;.7&\2O#!<S_O40[+'1=CWXYRV<RF;4I0I!
MG.^[Z$(,#UBT?PTBF.7?^=>O'*FC.A)M6AX2+@RN]2M\Y3*B6!_Y*L:>ACU?
M0K\SP1P;."/8%LFQF3UX;/6KY="@8!.Z-PJ/Z_(5+437O"^P<AEX]T$8X&J$
M""DD1<$V#GW$2XR:;*RB[LK3.G SJ=+&,PBJ[F0K(1D?\@'^^(<_G9Y\]V=
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M3W@EM#088OKV\"S>[>*(/&:6GF-F@=3M\>U7C>G0(-NM'-;-E<JE&4'-6MC
M[R0$Y8N%=+!J%+<X#/Y)F__+<>9K<V8?CW!=E&FS^D1Z]'[^G#X9_-58J,OF
M4[F&P^#S9\7ETYX'R5GHI>ELQ).D,8&+!"A=,GB5"B?QJ;$$TD5!9SF#']+*
MITB;%.$Q,IO@9V?&\6/3F^J[PWVZ3@*2B*9V':YA#HA'L/M65T@+-_=#U:<1
M^/!E*V'6*X=1#TIB*A5_.1O,HPIGOA_@<;T0IPY81'DIP%'V;/%<#FJV"\CA
M%E\O^@ <7'*$,P33;JYC"94$V:R'+EM^CQB$V7I]V!U(Q2$2FH.VN7T"MS!*
MR;,#7'!]'(@ISVL[G8TR9?Q2QT5_$O#OO$"0MH@;X-/BAOGVMDP>O"CXC11N
M/XNC- X#G_R#!HBE..HF(YD1\G(*7GB'?D-3ZU29@U;P.7N'9OHT,%P')\]!
M8IVAU\![WC>_GM_.+IVJ=&.AJ?YEC,).XUQDP4-$(BFB+'_/$$0/-XBD=0#3
ML3X*Q4E=F'MJI/$TT\7[Z\7%XFQVO0*SL[/EAVM2<^EF>;DX6\SO'&_G>J)N
MO(-69XI9_,W=>@O]0PB7FUD4';SPM@SL0?I]0+Z&%=:(.8#D&3K:HUHV?G3I
MX\$N'P??V-.1 !D*_[L^F+/K$&/Q5@:2$:L,3>QJBN8,2J#C=K:++1X9/-V3
MPB9![3%J?!9J[!O1,D&4\!"NML^#//KTZF5\/5$XE9LZT7R">,&HUQ_GUZOE
MK?NC3D5PS5=WDL4:1YU5&U<Y!WW5G(D.M/X:ENJT#LP)5=H43KL%\Z6G"]U*
M4\P-[4J''X99'=.,G5B8F\FQUL%R$%)];D'NLQ]<A@^Q&%K+QMA:0*_D!#DB
M;KVG(FL:+2:$DUXECR.\"Y=.Z*!JO(PF7BRK]P1V10>G?@5U.3*/)?'"A\#7
M3W'R:1&1@@>I'8 )9G22/%I*%B\0#74X"J*C?1(_(-*<)F+4$"<39Y+%FSJ9
MRO$O<(8K=-J]CV/?#LH$,[I$&9\L#LJ*#N !]YB*>BV7)Q-FDM6;PHS[G'%\
M\TUK:NL'J YUO&=CM\N;^>WJ9S"[/@?S__ZPN+E"ME[SH:&+=X8&(F]5^-'C
M3+^R?.RYK(-RBE#4,?MNZD^SRQ' M>M'K\H"5H)@;^!UK)%C;>/OV*KOJ3N]
MJ@'HU (\KHN5LX;!S[3W29P.K35))G-3U5- D0 =CC4D-;$I;0/52DTQ5 O%
MJ#O'T<\AS.^=9[LXR?([:5O)1 8CR_X+DZ%(YP#X$K^T/,+9$\N (/<W,F.A
MB1,TU)^OAOE+,/,A7**!/7S-3<I8C!8)(9G,P8XKIH@'V/GLKG;IXP"5:E*K
M8TUAH:8;;FM0G+,"SV4AVDQ]8ON;ICIQ"B8 B:>G*6#RRDWE\(",#\IB/!_0
M/TB)&IH:KRA)X_S.2!\EC2@R/6Z:;H85LT:J3,F:P;I5RB""M],QT>,$/P+9
M-/8YSMIZ>#)86V=9Z>G*RPX)^N^H]]LF%-B.!S>@46'CNSB@CA!<!5&P.^SR
MO:Y(E04^1#Y,P/*0=+;#*0'7'#ZR UR%O^;Q0,(9"QF<'^ UFF_U!,-'>!5'
MV79H,]V8C$E] 0)".9\!8L37D\:N @24 2QCS_@H_AEZR>HI=@3>8G;[>JHF
MA7RP?C,U@TA!RB;XK#-B0*.;.Q5"XM 5.?3GMZ^CZI+(!^:W;@T?8V$;@[-D
M1P^E%[_C#C):D3WR<68Q-"V,\!.(\0U[S<EM'_1ZY/'<]LNKJ\4*7RO?D5OF
MLR5Y/C._;K^=<?767U_Z[3P FCPR/^//X;V%J ?>+"[BU3FT<+%V_7%^NUJ\
MNYR#N_G9A]O%:@(@DTBMCB;1<LW>8-$DF1?>FNR@4O#P+H^EH]B_4):1Q,/(
M[?Q\L0(7L[/%Y6+UL]OK9E7A5%?02JLV?C:*TPAMX]!'G*>UYG%UU_%W'/5Y
M;1^!RI3Q?#P_SF[G/RXOS^>W=W_\PY].3[[[,XFS6OT,OCR?7RS.%JM73J-;
MM$7>>..@Q1WS<Z]Z2]&=T=*#&^G$]BU:=>(4') TO]Q9.R>*TT<WJL)F/[M1
M8HI)XN#K TYP@28@Z8@6:7J /M+]EH<LS;S(5RTRH#",W<>E<H+4,FZ^!K0O
MN9>+J]Y.CUIUH95GK2(_!MG6\!3OD*WKXX0J,$K)_2=!\)*DCTIGM JLM>W.
ME"#K!W1ODA4VQ[P_* 9PG?)A,-QP=LX^G.SQ.3"GG>'DR0\D3<J[EZI)[@N:
M/7F)GQ-%RQ<NHAN8!+$_1B3E&!0Z28<R_#IXV7]P2WP4['!^$?PMQ70(QP][
MQX-:XY,:B<_F[]9E!*5:%/T$<30..A4?8>(]P/DS3-9!"F^28#VT*]\FY0Y4
M>7NKDWRH3WE7X-&^ .:=P1[W=GGWY0"\6A_SP#(RO'/K369!R6?YE>L1[R)-
MAM45<C[VHLWO^W,W O*@7[R^K(P]MWU)O8B3#0QP$-IG^=WKDO\9'O&:2^1^
M^OL@0=][G( -'5!C%YBHLCX2M@?="DRD9^*<_!"1?Z%1\ZC@/RDY(QG=K-_H
M=6G@8-BI(Y'/X-)QR%F(49*GSEC?F\GS^PG(\_O/0I[?R^7Y_;AGM9I6@5UO
MU$4],2]7ES[K3N&A5R#6HW$[X&4 1OYK,/M]>;JX8!O2S\7FMSM/\D>89N2N
M!VE+$%<F7\7X5[6;GRGIQN,NYG/[=OLM5^-#_TE5:?X,O_IA/H AMX@!Q#KL
M16V=QOK5&*X82]>6IH<=_9WU2]L>Q#FYCQIT"0H7NH7!>Y2#!=0&FTK*V2&A
M)KOG[<ELL]#4CEI]HI;)B-7/;J0,@P*9:>/<K#GIYC/B+<.!XG7A!;36=@UH
MQ4Y_'CP&/CIR<2+XJ>A6RO1.T-'8=TU\SR)I"OR\+7@)8.B[CKZW!LE!M!TM
M&8QU0ZA#7$OK^AB':#0<FS[UKU5,^&=C]6@O3?;UIOCXIR8,>"Q[?I[6C#%@
M1_N6Y:*9R.%[&Z2?+A((%Q'"+C*TIOXY,^G]S ]?UIIX.?%14[!!;4&0-R95
M?WY7AZ\(DJ-]L%P9F%S.&5-6[,Z7P0;9;;EQIF0L#3RE]4ND8>F7'7XA:LQV
MW=NOKC8*5JK2:\/SU>A^L_)&Y$.M8EP]\Q!F.%BN5WE A0%=50:4DZ;Q*B&+
M06T8IY>I)M)D5 -49(\#50GG)+V*_3)%X3DL*[S/(G\%D]UDWARHD/H9*4@*
MR^$5L(L PFV$=BW4%CP%V?:S58LTX#>(1J3*=-N>B/J3O"*<:BK?'9.VS^A#
M8]'/^;*NXZ]JVA((2)_/--Y!!*E!OB4N7P?]>.@LLT.VC9/@-^B3U)&U*QW\
M1:>-N]%;3'CQUK5VT<VT,D;ZK(:G>CK/Z@9?F]K'"*M^DXS?'0VH\H]U'(F,
M]RA/$AKQ>88E:<0?3>1#'GQMDM<YN1/^RR "YW$8>DD*]C"A219>?;8JK!EH
MAPPETHX9ZA<R--_MP_@%PCN8/*)A.=2'9#CT$ZZ:MXX?(KPQ424!%[X9K53%
M>'1:3Z4YVE)4T^<<D3E ?1* W651"EW7=AP=CNP(HS$$85HRK5:0&^G@'F(9
MHH_D!?K)2\C3W%6,:UFFJ#_.Y3A+TQA7JNGE@^PUE<7GJ0.2K5+@/1\>_TPG
M ,4,V)M9SD$R"!6S0#>&Y0C887@\>S/<M@>FF1RITJ6GHF5RZ?ML(CMX*^"9
M?Z0Y"6[-L?.F<XOU.>F),H -HA$*>3S\]HNTS/O8 5R.&7@I;H^\1R\(R<.&
M39R !XR<2;_ZGRQ>VD55W3GS+N,GF-"?@ETP=&FG44F=BI]\F.4H&?C3^]J&
MA=UH_C@6LVU%Y134W.*VHP7B-&>Q;@[TI5@&?USC(7;V0F(PL?>*J>DRS!Z$
M]T%";W4[L9V#8K@QC2WU>R!Z15E4J(/'=VR9#B;YGC#N<,WL49AT<IQA?*#0
M1SK4]$(:"5W<6[[,7:D_ PFIHZI:M6EBC46TCG=PY3V/7[% .)6+*RL101PH
MK6;_F-^!Y3587)\MK^9NXS949%?7)*7K-;ZYN86D4OF-EV0O*X3.U".!8Q;*
M0>G,[ )C&O3QGBG,+V>K^3FXF=VV*O,X@)R!H.L(U.6&,2"%-=&0K83FPREG
MH#]_7J.F- '-P- THV%(D'Y/01K!!\QU$4R-:.45AD8-0+#;'_#K@.)IS60+
M0,K H%QI3\@E\SMQ;-+3 +CS0X(FI7=\U/ROIQTH\Y,.[;K2)V! HUL=P?IT
M2A.]BA*P.ZL[9(2%3@$B?4:YRMS&2 (YE?LR 85N=O$15J*3$O5W5K! @+PA
M0ZMX3#?S!2PWFV -+PY)1(:\\M;;(((I.:IP8:?%;I_$CS3]*LX,%<)UEL11
ML,9WZ'O\ZRO8S8_(\18,-IF]*XQ!Z>;5=B+#@TTQ/@G)@.4@ !:C@'_2<?[E
M\M'DT(@IO1>#<MDT@@E_DP>,!C3#7;S)T(<'-1 NZ&[5*\NG@U>RL^A P)?F
M7?[7%  G%TE5NE.\;+,M\@IA3P,"M>:V;Y.JJ3E2Q@V8FXAUH7:96@JQM0K-
MNYHTR?Y]%43![K!C"8VM_:%.-<T/_:O2^KKC691J9W*>7&D;YZ+E,A\+E[T8
M@XV:#.0]#ROBQGBV15R?G"=BVF8:(F8QOQ1Q9S&F9W%+(<!G?G'2HY^9>H&Y
M,JHQNEOM4YU0+76SU#'QO\)B4.R7*T=UCKUA4,%3.#49:XKJ?B:4Q":R"$M=
M*V>N9-#81I.Z>2*U-_05R]S"06##.H_.YL7I:GEG8E/!/<!H8[+!['!S]](7
M2Z#22/GK--T%5D_Q:AL?4L2,BV"301AI2)_;V6ZN'1X9' "<'I]\,PD/AHSW
MI=R%"]3/C-,>\PX^HDW$6/3M[E8=#'PZ^-+_SOT'+^<^2_BL%9KY$FJ#KI[0
MF"]QI.->$G1W)?T6'5SIGYY,2OH<[K.DSUKA0-)?(6GWDG]] .M!=B)J^#AX
MRSH#G".!(0D^%MKK-+WKO(4I1!1OD5YQCK:8,-[G<9[X.;.Z:T,K_$D^HX.*
MK0ID\:*=\IY$JZSU+1Z%.]UT#.3<C'Y2XXKQ53L,T:\?L%;K)9\@#E$9$WO2
MZ1P\3)*0Q'MG3;L1S)4=^8BSK./JBK=Q.:W"$,-WT.]A!!,OQ&^L_5T0!;@>
M1A8\PC$QIS:G?> IT<4K(T_[TH?[C=Z3@Z"6R.LX5.>/T5,>1#89X>0M0LRI
MA@+&[FGWP0V+!.Y&E;<%)V]? ]S<.33D JB>,W!7:OCNI1SO&SS>4LOTXG:V
MG-^80X8< -_P >!._&Q!,!# 6*VA Z8U)E+NS5%0=7:*@I*,SQD%'4'P4-!<
M[4 HT#3$!=T='09M.GI!P3T8!.:X9,U#/TJ:/0=#)V@5S32X+AHRL*- "-?>
M)CT Z0)J?< _<2]7?GT-&2J\+RK7;YKQZ7"?!G[@)2]W'BD"B:/D1\ 1?Y[A
M?3@B&''IX&U"7I[1C]3!Z@+'B;4LDUG#3!8NV-0?<Q9Z:;K<Y'G)ELDM3IPY
M FSX\]B%#9<.7HPJ;H]QD_? KPE(GPZ$'.!'*KPZ?L0K-_;G(53"7P_81XCO
MJU:HRTB;#FN6$:X?9'L.@PS>CE.V!J0YP.W;L'&TZPA$UMYS> LVUGG.X7VV
MB-(L.9"HI^'1PIC ,E"Z%' P@AN"JN5$SB6^A.K@X"S2&!<?O23 ">MP*;81
M4-$9?F"C282']MP<-!3- &XW@9V")Y$Z"IA+,Z_@M,RV,#F+=[L@HX]NA@<"
M<PJ[6@B+!%[D+&X*:FVG8?2(Y%2'!W>EN@H'#O.^RQ#(\#!W:Q@AW,6JZ) $
MXK/'M71F< G@)ERF35PJH%)A%('Y_(49FKD7011D\#)XQ,5V,L27 .T]LS2%
M6?KNY<K[)4Z(GCO"MJ$SLV5U0X,T#JCH"$=D"%"- >@@X/X%D&$ -8>FH:48
M0*&^,^DR;?#$0^]>ZG^QY_)C33P%#R"#+A6'X&NF734E3Z! TBJ)ASAL,=Q
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MZB@>+CH.E%:3:",(6H$-YA K\SY=02\]T.J*"H=._P@$Y7EMPTZ9,E%.,C(
MJ(W@ZAPSEG,CKD"+)7V2T!,U*B&ZU6V0?CI+H!]D^*>!X2>:R?ZMG( :?MWI
MJ@?VF=,> '=QK7$K2+$5;R=<?(\*U$@QQ__!-\B/7@AE[LQ!2E3+YW2 +Q6Z
M1%6N\7&ZQC_ JGOM=N8O__OH"/SSIZN/W_SKG_]8[P_//T???.__]MWCP\\O
MT8?SP]/[[Y+OO_O[Z2\?5B]I^-WC^K?C\&_9F^P._NVW[]Y^>CY97V;'_W-Q
M<7KW]S>/S^_.?CY^].^2G^??)V%POD[N?]K^DJ[?!M^].PO?G#^&?_OXE/SG
MWVZ/EZ?1SY[_\LT=/'G[]MWY3V<7?UI>O_G;;\'F3U^?P>V/'[])OG^\^N^G
MGY]O3O?IC^?1S?^DA^APDIW&V^-?M_[?_S$+__;RV_7W;Y?)S2(Z/_SGK_M?
M_N:=9N]?'D__\?1X]VGSR_JGS7]?_K;=[T[_9W8>P7\<+CXEZ^M?+D^^O;CZ
M;OMMNKS_.GKS>/?+M[/5[M/B^(/W=?++NW>^OSGS9H?MAY,WI\_+_>7NS/MT
M\?WM?]Z=[?\%SNYNCXY<G0-:GT6[D+@:A@P_V#OX@,^56[B/$Y+@SH(6HC:G
M_0]6B2ZNZ43Z@D6TB9-=TP?CPO^B(]:&QT69!Z: .]RG:#_#MV>/4,W7TA]P
M2G,Z )P*73S E7T![>Q8U=62:P-QRDPP>5!Z=? 3;Q&E^R"!M9O;OP=9>@5Q
MC2\E=XY\%.MWJU*2> ^-<#^0=P2UG@!W!;2ONQ@097F57B U1IB&+"YNEBR<
M]+_M*L>U?[U53,V[S[I9@G_2%O]R>I_59GWC JNQB!XW5KG_>!0A-\=V$3?8
MH$"2_+(C<S<'"5,@C*2I;?$;90UZA G.W9'A'8->*XT"!/X\#F*ZN,3P'C"C
M]D=E!Y"G86>AQ4G*()D(&QF#A$LW/2-:&LPH"&+/8?WBFD6%HH(ZB3-%*"J!
M5MHY:_235^+ ^,O NP_"('O1T#V9'6U'8;&($#U= &5;IV*7<K[*7<E;H+%?
M97U(H(\WG @G0Z716LB@QNEQ[N)-4OYE$?GP^>[)V^._C+-W]*+%^A[3AUK>
M7K2\N'5IV@R*BJ:[IB^S#+>SQ6*FL8=5K>W&/Y3S\DR=Q8RER%A/IMIF9I4V
MM;$ 4UE=S1<ZPJJ:6\^R7D[-$QAJX%SUY#"U$EIS%9HG2)ID_[Y;P\A+@A@_
M+5][J89*B7K7C@3TK^HX$ QL[:ODTR#(&X ;.1>Z7"Q8_I+U&1NJ1#V9/220
MAC6,HB:PY[!]_#.I$*J:5>-)F!A"434?S/)6:A[+\1%N@W4(QP%(:W#KCLOF
M_-QZ8K31)+# %D<=!(PU&3@S\P>1$5+VLN ^A$0M#+* #03N0U9^?\MUN 6D
M\$-SBAX@[_(BW!D<J P* JJ];A5SP!PDF_B 3(%$#QFM3I8SXS=GYR+@J&@W
M!9V>Q^B:A!G+,E80<.*8%/UYG,NJYN!.<O]4\PLR_N!&D]CXV>)H9_IIK:G/
MNRN(,QTM-\C*#QX#_^"%X<MBA[.G)8$7OCND0033=+;^]1"D)(/".!J",1GV
MG4QFA'*C?_!P."*T/B"H1@3%D* ^IG.C9BCX-%U2/5AKZ.%8/<7_ Y-X&<&+
MX)'I1.6<;,R.MKT>+"(X0#L]/OD&X-=NSJ$CY7MYT'&79^ 8>1=[B;_<G ?(
MM$8MTK.M%R0[3^/65N(@D4Q@3P^6$\-[BH,[X:VH[.98'5*76^%!45BW_D:!
M!RY&' PNK0%M'6/=J3E@*!HQ(& 9 6S6%Q)G+$;W-GZ-M.DL>?GWXE(@UQ2N
MOWJ(']_DC:EH\W]4DJT-94W7K>;DZ;=IXL$P</PQ=[F,1=@BWB10<Y9N87+N
M;=E[.>?X[G2R:IBV9^<(CC0#I-T4#%,>H\OSFKDL8\/T+/12I W>9?'ZTWF\
M\X)H8)N#,<$(D78A P1\"G@N"MP0'\VD*?@G;>S44.6+I_$,A;U"8U#@MRS9
M"\[I$$<PRD;!!7N.@3<($2R8!/"*Q)"VH&P\"6P(I=1X+,U=J?E-!BXL17RW
M*^\^'+JN66OPH0]Y$2J:4_/\"44C\$_2S&W,'%,2#9._NZ8^OJQBM,L@@@OT
MX]!%&Q@36#XQNA3(@8"; M+6O;N(*R$F*IJ+-#XTN"FJ5ZCS*$>(RHS#.XM$
MP%&@B%MB/'HXN@P>H0]6Z/?DHHQ4L>P>-6Y I2%>I<3E+8[HFI/8*KU%C-((
MR93X"NJC6=IO6M,*-ID@S8*U%]:39[@&!D<"A<N@O2X3H_,N>(B"#5HX@LZ:
M&+'%D]< IN<P\X(PO5MOH7\(8;R91='!"W'\9!IOSN$^@6M:#9.AHO#R0@TY
MH05==G"B>1"LI@#5'*"8!'R93_,*'(%B*FQ(T<D F8WX/&OS=70G%Q[R,1!6
M)< :6C!F.=1K R\; W,4.)XS1SZ,#45=D18>D)7!R='GK+N#E(57.8C4F-/#
M]LN9N-SP3_<QK$+5:>WJ?*ID20K5O";WAAG)*E-V[.Z1+LP)37$WC P=YI@^
M\.,./9:%JC"A39^%G!Q9D20F]"9DT:I+6,GV8&V$!MHI3CRXC4,<(T9=;.<0
MG?9!UCG:2<LS;Q]D7JBAC/88W]I)W(-(4<[D?,0__N%/IR??_1GD_M<O\[%?
M<15.FG YGX6A85K7+_MCI%(G>[)ZB ,_'S3XC2@4E(K1_("*LUIU#ZO1I*!]
MDKRK8%T@E;G9.CWLE43-/NOEO+&[Y]Z@'Z-L"XD/)1U[!V;-9LFA-"S5XV_0
M7S9G?<7R"7P>6[8 8CTW<)Y@K(=Y:WS?QP-L?K_?W>_8-&O![,E+_'-DV(]R
MG=(>W:X9W9J=%ZR#6P'<S+7[6R*3.C182S,J+J6^@=#D.6D6GZ'_?P@S7()A
MC'.//\_@H;@#G'=<:L<XZ?+)0!:#VG33\'H/AR.#PTTL!6/-L-Q_\_%7]?'U
M7-VJ8]FSLM4(4C [>*AT?@2;"+$"GP9_S,U@6I6KBIO C=%DHQS&XKELFKQ"
M2L0UUZKPF*(7Z]1V\OY/09+=@FPB)O2)J"K1.]_MP_@%PCN8/ 9KR*ZOA3/D
MT>EQ?5U2=/DWZ-_ )(A]7'67== /Z(P9DD97-S4#KD&D.AR1,<&-]T(^@AE.
MC/E  /0:Y/4@?>)U+TT&Z+\&LQV^*G;KO+0"3;;Y-+1LS#3MDASV_$4U3U.]
M0G54!QJ&(FD*ND;]&ZB/56"?JW8XU#LTQ<W00'3XU\,ES_XLJATF??=2M<EW
M(&*(DO^'H^]FD8]OQJZ]W3C^A%%(M.KL'V$!0K\&[C$1#6E,?,E+B [ X_%O
M&!9I>L#E#>,-;5>4NLSB(GE$BL[V69K&./X&CN%^,2)A@G?#)NL8PV=3T(%_
MSCL5I&"+N22&*&TE.9_7K44?V!IX>XQ%:UH7MCR(BYF7K9E7U<RSVLRFJISQ
M--;B@WN3JJ#KF7XY3 70G?K7%S,,?; 7TXU?X]S"$ V&#LPD>UFA^5)O/9JO
M2CR738U-2 D'Q7D?0#J!6J^):&)*DJRK5'(F]/%5-1/OC_:VBS^/99\1CP[5
ML@H\G7X*5<#$3[?$2S>NQN$1(QD_5<<:^W(S]NZD,*%5HU)*#@]97NY5F4QR
M G51-F"EQH >>U2>#B$_:)?)+4ZP/V9R"^9,5B[ %0B1);LHZDO%"2"])@$M
M!1$R$F!PEV_R^/ ]C&#BA;E!HVZ]L_I9,[D9DW/DG[>LF<(.<QG(&%ZJU;SU
M&1J+^7!ZIE^GDRU#KCVQ1+(3N=/G\;@MTX$,GW-XGRVB-$L.V%,XFG.;.XU-
M78)'!"_;'&H.JO:O >XQE3@ZF=SJV[UPW<:.7X77NL.^))_>,_%AWH"[?+1H
M)DJM)]M]WV.KS*'IC-0:T8X!K4^8(>Z8Q]P4$2=P%FJSJ4?1H@]1NH=K-!WT
MU4]&Q;I%W;&M6$%"$KC.:]K>L9=/23+MTD7L-9H'$UP$48 ]SX_07T19GGZ(
M9!]*K[Q?XH285Z.I4KJS6S6L-8GCE<DBH^3YG:IQ:(:G]#4@0P%JDD])*3,$
M1EU7,V&@X?.89;:%R5F\VP6D@' Z"EHYDU@%)9L&7GUHW!C46D_D7D,LK499
M:/YR#9'R$>VB6(N['>LM%6,"RSD,NQ3P*G+E#4DBG,G<5/ EU"C/Q5ZDF5Y>
M0Y@7^6<QT<)@9&3^J8YES3&H2!"W>%.U>Y!XY7I_D>5G71'7%&*MW),Z?PR=
MC?(I]*P^G?%LOC_7H,L(;M.(&3&0I@;8NLY0 [@Q2M09;&2R4>Q"2T*->OE!
MV<8UD?J#DDU+A1W#H4=W?Q(.8=$-):9$#S-3V7U4Q",&2B^/$ATV@7Z077CK
M("01H+I["[^[+:<XGP0>*D@'4/28T/6I7!@5',2K-B^#C1"UW#1'Y^P9O2TL
M\5PV;^&$E"C"R/FNHB7"1IELZ>I[1/+40QE'#UUU8Z=W*5")4WW-B2MT')^J
M%I0Z1(D:1J%*\F,"QW'HR.>SC!LI0;SZ@XQ*IZ]!T97A_W$ *67AUA&FQA#S
M\A8(N1%,\&>WW.3_2/-WV_FEW6@W)'IS6RYYH4,;+P\M[4;WM'@#BF'^Z.WC
M],]EMKA\.%[<BHN\M":@:*2HU>:>2:&,59"1ERAER=^?@FQ+=F2<*V4;[%?Q
M/,H"G3-6<B&L.Z,-?<V +@Y>R2C-<M).X=A#QL75L@EC#,-?)$\'AWLG.[5$
M9 ,^6W7O:-<2H_*[T0'R@'5FT/-:B?J[A)+,HJSUH,=F6N#'N6VI*A<!2GI;
ME"1\!CY@G_M[&#\DWGZ+\ZD.%P'%'=M>!!2/!&Z<>-70K=ZO))PR"$JX3,.[
MN97WC"01T31?V@<1O[=%)S>7")X2@]N#. )YLK9I789(!5)N%N)U&P:(T-'0
MT-7EW&B>3/%<]E/]<2@1I_JC:)I /B<M"793_(D6;WCLT!/L"F;;V*=/_B'4
M<Q5(SA[)!-8.(#$=7/S@AJ+W*)8/(C5Q%:>1PIH-CZ2:Q]3DXE[0W=;E&I\$
M!1>W^'[>]G$D%T9Y'DE6/71&C[%.)>ET5B->9=0H FI*-:U4Y:F0VJ-S3 TI
M%C]>DV=VQ!/$^LQGQ%R[A6L<R4T>):SB9>('D9?0U&W\DA#DK]B1YN4E(9+:
M*#AO4)R/0_^<?N54)Y4OM+,9J/)FA,LCN=S6Z^1 HO(A&C];1LPH$9[L\BRU
M6'9T'!#D V&;8ET+GDG+L;YRYWY06VQ7?AH\&GQ#U)?@.=S':9!QA7:+JX&F
M."U-MH7 $XK0IV-]Y=#'R%V?7$Y-3@QM1,DEXS_BG%\7:"UGAS1#AD7"%<HB
M0]M>(1>/=DP!9@-8%WV=2H&QEJX N NVS_N'AP0^H'.2;E'<#2P"7M&R_!02
MD*YC= X%*=AY/@2'/2E7!!])1H5TYX4A3/+6:=D\16+SR8'U /%;%:?2:JZ^
M*R@6=]S)2$U1N#[@.O)EY2BJ,I3"FY:2P%X97PY<=<"^0$@Y7ICLN)],T0B@
M;7;G&N0%M6S6-M?B@*'D\\(%N!]A&).RLS<)=EESN;MJ',E^U0_L:<>OG)F_
M_,5TF2]9]_ ><451I$@+A_@9JN+Y4(DCQ68)Z=HY,;YRY.546!=',F(VV#\(
M2+'Z68@VE @U>H2%"G<#T52HXP,4"6A?M@(>?BL$O&HD]$\\=J74)EAN^\-]
M&*1;),O[%W#O19_PQQ:DB0=#I\>VG ]=@:KRSI%4WR=QBN#V"*,#3.?/:PA]
M!6N2"NT!]T7?'>T,(.GM^&3G+8HC&.[R'8FC0 =^+,M7BKN?C-,MKD,YA]G=
MQ3DX\@DEF )\_"&+#B=T1FT5-[ *_&2C(CI -8C#PY^S+(XD>.MWX>+"12.N
MXBC;AB\7$"YV.^CC'-OARR):)Q#]454%P-*X1^W!CHX&-A 9B=5XZ(NA TY!
M+U!<=4=^6MQR(<XS+]WF)4!X(L--P)ZV<7M<U(CM<+JS$ =:,?5DIJ2$5F&#
M4G=UJNJ_;WBNHM)&+^WQ66&NY^Y@N4_?S3M*)29TA:C+0/LGD@:)'[WPP%<+
M2K/G$3<CCAB2ACK)+]B06&=%56^!K(%_2'#RMHR>?$'L6*73Y4\?#-08[!8(
M=[.+^2JF@0MJ)]^Z[$T2D*/^6+:0C.#2:.*M2BBF[O*='&4MBE*DP+8 \V$?
M1[@H5@AIG<-%%&2!%]Y@ W:]W&P@_I2XYV!'9"G6ZKM?Y&%/KNN*:8@U3">B
MIO(:_89.Y?#V;BAN28'13PRV;][/BJU61XTM.TUAZRUIYTBFM3;KEG-)A:I*
M5-U4*.L\[EBOJ.)PE^]*'+7;]Y=SF*Z38"^RL\^ZP0@O^(;/J_YU2)'EBLPX
M#]S'D8\O]CR %%OT<2=(@%37R;9>!M9>!.[K2@[95#W@!W@GP'IP.2;B PY.
M#U]JEU98\<&;K1>]%*\TT#^144GG<+[%\EC+0X90$@[@D>SCA%21>\9N"+D/
M^:;A?J'2R<< F?=,/#&.#13>DA@B$:_>B8V99KA ,_6!DHS&+ROXG+T+$=BY
M,B'-Z!::DB,K=P.[<X$)U\$0A'353E3.9M:7(%V'<7I(H%0@6']  P?(N//+
M7F"#-LDU36.RR<=T*"#9VKI"4N.&?5/M'%)G6^%17$3O8[351J13^)[4#J1W
M>#BF6"$^S\\'K'R4000>:F."!UJG,:E&=2=)S>5WY&K$/MN*>U'C?OZ,]N@@
MA7Y1%)(GS:(#@$4/\)1W<7H\<1?2D8MDR=9U!4H/;E*49M<-FH2T'XZ5A.5@
M;C7[[J(X<NBNV_Y&AZ]$]QD)8T>J\TT2^P<2S4Z*=W$_!-()9'DO'!J3=P,)
M[N?2'25<4%<0\N6[T!+R[Q-OCE6E6K'-6^M2[DK8Z)V ?U^P&H9 )"NW?DKD
M6^5-$N#RP3E1$BE ]$D$M YS+HLI"*"U!A[OF4N=!MNYZ$=F5G[S@13B/?K'
M(4(J<?V8J,O%G6+%69:B*!R>$C5R$*_)!ZGX#>P+T3CTJS#I%S.]N4H'9GNN
M&2RC.Y@\(H)N8>0+;QL45*24#H6,C'PLQ]L29X4,R0AY85UOO0@B_-""OE:?
M17ZAQ5$W@Z*+I3)W\]<_156M/?6]8-M^0R?"5B-^X(_SL.?B=.R^UN) 1YX&
M_',@XV?HJP?MD>;,:%=WIPUG"0QQ")9J_[3I^@H&_*(8/A>W7Y)TM1UQ*?+'
M@>!JCAWHXV=HJRU<7,T7/(&]K_N\T.=#WMOATPMW<O?=<-?1%85XQ=8W+1+N
M/-N@;YC4:UK<+&6.%7HOG:L*-.#;P_U!3$I6H1$8)XY]@?"6Q9"(F ,.-#E"
MTDT2X^!SB1P*G8U\ XCU5"#[O*]C 11+8/.\N4#[FT\1'UOXGA=1_APVC_%4
M>40_O7>_TE5UA*'(APD*:-F])9#+K+Q/J=VP%((L8I!)AK7NP3]IN3*8H2]J
M+D=MNW,6Y440V95K=S](^[])X-X+?-E)M:C=G-'#J7971DRC/1UH @>6SGJY
M8E5GE@L?=1Z"UW::2&(]\EXMAUSM!8Y;95R\*(:DY#RPK@.RB$H'E<P4I))J
MBJ7# 0>*8&%<YQ\O<7RLMT@(4.19*/UZ:<NQ1YU#V+[-W4-?%AO?J]<@@F[O
M',1K98A,SAH'7Y+J,^BB9>LI80*S0Q)A[2,H,RRZO8M3>-$L>L#LAO]U^UJ6
M7:EI1U6.N(:+(4^KY-CS(UH>5RI\7KB0#P9UG,CCL(.\I6OP4RH8S*TOQ!TC
M=9X0%'W<6C%UNKEL=?UDM: C50[UJI(BEL@51GVY8GQW15PA\!;O0@]*TP,V
M4V467\W*SWM,Y/:KO8 NTYDK=,CJZF4DA392L H87,-LN2G:X;!II9?&I43J
M;XWS-Q;8%B^^$:*)-D2( \K='@,&/.%*6)^QUGTO/$K3V2U,#R$BLM@:Y($V
M'YM/C[%0T8;8>5%,7S32IQSU-Y 3V#E-N*$N?3E/'6@7)L0&D23M@.C[Q\^Z
M$C)T(_CJ\P5 P8UA@-#DK=-3@1*R) _&E&2=1]G1#OAFZC'P\8T)]460V =L
M-2(3)27W[:7^].<\- _]<E?$M-0;IK5Z0^!I&P,\#TZM_4@\OG@OB5%W6@N-
M\XSO/B\_Z3#4C,-: 7 8(G"Y1WR(D$4I.-46./UR!$F8-*Y/AR^\6:^QT>FG
MH=>AGW'(9BI3)S 4UN7\X D10( @?R[O$ D#LE2 H\$%9]_?-L9:U(^Q,0#8
MB;__7:!0>AB.)#\'1^4ER;GUD$ H#"*XI'G'RG8N-YX6R1TQ,9=D_6-O47%#
M[ 95]G82%SGF,:5>QNGZ&EU!.0\-*.Z8)1S/ RC** O7'&]3S^8X>XTN.!X_
M$9=]"C-R"<EE-FF'32:8N7ZBTJ:YRV+FHAQP]\I+/D$<WTL"6XJ+$1Z/R]8T
M^*>Z$>+$'MCF.WLU'>Z+%FW;LW3E/0>[PVZ)3NP'U"@27U_DK4%<-&>DZ;3/
M=-8*&$SG+]0VTZ_Q9T=#+?$=8*%SW4&T5A_I6FJIR?!=TAJGZ0RB31@_ 2]-
M8YPI%M]N%"IM?M?4O#J%I !Y87"GQ:R5PEOZ!K.8.@0)/6[]]7H\ZXC?A.4.
M]L-KQ(4J(] YO,]T*DA%<714KQCEH_[,LE'6A2=85E=44A[8]ZW0:_#"T;,@
M+G-D"RT/69HATU+PE79*KM#.Q""-J^Z./R[I\KI24N2(B\OBXC->)A=%?%6M
MRI_.#7VU)2:U6*VL&JQ[ -J6G<IB.])3YY"#31 1AW32I,ATDJ?2OO-"M$\K
MBPV/D.<3@56Z\90,XO9C$RV/)2@)+^QOAKF?>_;H!2&.:;Z($V&D_RK&\?I>
MT;R\>2!O^7#'URZ5=MYJNJ(0+MO)/D<I4GL?1K^-G/7,& Q'G.=&8#"79]W)
MU7" WGB),,'WLN%V!GLOH9F^79X/+/J[O.:OTL4)T* &BGF.X1VW^ X[?'?+
M=JC$=C@EMJ>S0[:-D^ W7 Y4XFE<MF];RJY3<#M*ER46"Y\1#H[>!F'D"B8-
M_/Q*71[CWI83O0BK1IB*(TUQF1*Y2=CCY,1N$DBL)JFP[NJ&XY3D0@B2":&V
M1K=G=YK?7-;RDZE^)^7-,:SZ.C8B)"N32(7'"MN>4"95Z8\P]-^]7,>1AZR?
M$+LT%9Q?[1O_4F9;-!HN4HB]8]6 $Q0?:]UJ<N1SS($6<>.5A:[\V_C%"['C
M3B&]/.I7:0L@*7J^!G[5UZW49"OK"$N-%;8_NOQN=1F]@ULOW-  9^B+HVRJ
M#ZVX4(YQ!G\\0!$%AC/\3Z L@W!Y+!')F.%"4:B4E>6F=-&)+*#FJ\725^E8
M%*Q5=$7 7ZN+[:M&S?(I@DFZ#?9J=0_BHKD[6X=)O9#CK36ZX'@"=W$$7[#Q
MZ^EZZ/<)\>["%V+P>VR?O OHLQ?5%85H\?8-3)*;(L\\LL&1.))MIR&(*E?+
M!H2TK\O( -9:6/SG+-BZM<*ZH+Z(PS!^6D960P(\WP\PD5ZH$1-@7[JJW&+(
M7(_1UA4T!GU#O/ZKZ7#Y#%3Z@ST$G (&>CT)'(;S3A1&%<I-G@L:@4;G]9B3
MDZ$GL\R H_:R< *P(24<50^9,N,G*6@:=',:3$.Z9$V*<JNM?QI[?]V7NHB0
M!#IO+-1. %Z"<?ZG7=P44/L^?\77>B'#/A>F]X'K<E$5+4;"F<BGWO.93Y]3
M8XS'6ETHLD(=I@''GJQ71.<@ G8!UKR.3U'9)^'?E%6-RX)&B>NZO,P%L$3&
M6Z831TR<[B%YK\U\RJ>1[(7SE/++Q<WR%2 %8=/2DL2P3=-&N&55Z177CPT>
M<1W1HJ(H$7/=""7I8M%W_U3+:$$^?1Q@AIMM@B1%)UZP<WNKK<I>%DHTY&+_
M6T4C;CW%TC)%XPF5EF'2WQ4"?Y4./E6<4G&Y*<)!X2-,2-)@:01(]ZH@+3J#
M,DJVR*U':E^04LV9]PGB3RE(1*&TM@4G8T)'AFI<LZWRW\+-(?)7,;8ZRE1?
M\CTV(=WP5M@PO%QFSF"NI"L%_GI=?$DPQ [2&R_)7@Q"S1/:'8=Z9B^3^CAX
MZV+(0\@!Z^<)?I>*5KE%2NHY^D;#>(^;TSH=YS"CJJJ:=/**O'[1JW)6/!99
ML))\-F)U^-5\$TA!KL0(ACB5V6=]I\,U.>/-AQ3.TA3BIZ_Q0X0#*V</7A"E
M&7GZ?1EX]Z28M(*(@Y26*SW"YB1.+X"'Q7<;^;C HP.3ZR@(PF)HM[:!'ANZ
M C;@HHN-M0AX$67&;EZ@ET$_K:I;#D14)[XK@>[2[%_5-HB0:WZW#=Y.)ET_
M9Q5BEKO/:TT\Q#IQ"J2#0]6L1G"'MYW%.-@MD,9!W%)E<H3"J#V'N8=$025.
MO:*.R*Y,%5$<X^AL+P9R=Z(KK+(K'57.6%?4[M9;1$*(3"I:>1!_FNER<XXO
M&7#8 79KX=AB:=4_U.J %$[@-ZO_T4J,>+LBKB"_-JY#$>HNNBM0,[:YN%6N
M2*T<RO-?#TBMJ$I[ER8<PN@L#SCI(W:2%)+4C<".O7IV-TAF;M1&KW)[XZ^^
MB'>9 CKZ,$P F?YR<+A-Y"\Z5S%^F',(,T)X#ZA0?V_QJ#6_HT2H6%?#NU0B
M=18N$+DJUYQL$+2:<[J(BF(O%W&2.Q'>(3/D @I=D95^E->U)O=],!^*./ +
ME\H]-N VT*6C6&&Q73&J,LC^9UGZ/X<KS5LZDQWNP)QE,20C6K^3CPE?*6!0
M^&?Q#NMX-" 8;_ /)/W@NY>J2?YP889.0U)*;IU!_S+85/L%3XY%8Q"BUN36
MK=@_(T C0&^BGZ.KZ'P5_8C^<T=_!TC2Y^PU$3-\]G;[$+XNVI_\_,W5R=OS
MO&525;M"/\8)GFOCK>DKK0B"%^@E:!R<%9I\W.EK<GAGVP UA1'PO1?'3TB&
M%407>2/(V8$);+J*"R^@#]WI HAG\ES@(\('Q0;U*7RVI!=U[>+"!=B;4:M>
M0"%']B5:Q\!+P=H+UP?JI[]_ =Y^'[X4S7.% OTE'Q??2^(_[F"VC?TXC!]>
M7!XY0S-Y.#"*Q>C"A6"PDB(0\Q:WY9Y\U8N]1C@K"49P>-+U7>\@6&!PT+XJ
M8T3W/J#1)**]IR7ZJA/9=_[XAV?_SWBAQ0__\?F=6TT^# 2)+FNGN!]<QX*7
MY2W)D[83ERZA45^"-38XT"*P"4]C9\_)(4XS;!.BZW'RN;(CJVE357VK/SK(
M-5R'6[79*KNR[,,M^]NR@-J4_03BA"_3W+U3WN"S7I5,4L",I6H)ELLJV]?W
M0B*ED4M-,=9]MVYW5:5%Z0F,%=4T!4D1=5W]Z5?SM<BC8MTXX0<ZN2V8PQ)5
M>0LYZD+G$9 I_4+-Y%W_DATK2"J+UY)L]T.>C#27FT[J$I6L8NSJC]BIIY/7
M94J2E3!"2]Y*3'7A&E[!9!=$11X[09F=6L-.A1WK8NM0W1$&9UVV/S22HOC,
M2[?UVNSX)=1B)LYJ3!["-G,IX*T1]7/WL0@6T^6_;.%N)%'/VZ@3994+I=[=
M:1 V;S4<.?"6[63'P13EFR)BLMCLIGPO-0;\"713@3EA?GL%;,ZSU^E ?ZME
MX;^ \"R,<3X::?KCZ@.HER;80 C6= 37V9#YR^K*0\(!!T+Y$*&/\@E7((D>
M\"TX9C:.LCF+=SND((DN6QL%UP^U<<C%T__M[LM[(\>1/;\*@0<LNH'LF:[J
MZ3FP?V7YJ#5>5:5ANWKP7F,PD#.9MG;2DD=2VN7WZ9?!2Y1X*IT.JA883+ML
M!L4(7L$X?L$[XL[/==]5SBV3P*DU8<G20;<_F2/K"P EU-'A)=QDVGJQ[6BC
M@D<'@%8Y)Z=G)S@?8ZZQ;W-YKJKD\V4P-50_330>P-(%*(DM=B</EM0#G&8X
ML7YCKU;]L@E&@E3<]?T$@/F"1KX:,C_EAPS8TG;PET-)DO:>#_0*S@>ZN:F7
ME;(&J43A2%Z&[(*]N=E-P3L!BTI1]>8SG2D]BX2-"2Q;TS997/B64SG$099W
M?!*':4S2V!E(<<\V;1Z^?#,5% /Z?1ZS5_>UUEPH8YDD;A]>#B-Q%C&JG7=1
M=?40'B9)FX5'G@[%?Z9-;_ 'G"AVAHU@?3)J3G&.O9,4$U+&6Z<='YU![4H1
M.>Z5^1Q/;I:BD^/%Y,@S+\)8G ;&T>-<"4N[ZYK/-1EC/KSSX&8XYQ2(F.XC
M1K8[<2NSS8R3/>_T!(2198XH)+#3S1+B[^^2]61)10I!-C>U.,B4/34),D#7
MKR ^;-]1GD%V76\[MN;I9PHZE6]23NK=3B)KL)VSEO3<HM7*#G*J8'Z&K F)
M\9[A$7\&HFWJJEQ#JA]'\9@R&STY3YSD]/GN%"\SUDQ$V#9V13T<-_MWT=7-
M2)0;6OYSN=FP&6IO6+/3^J$HM;CO&[H5S+6,.\Y92]=_N*N?_LCH&(?O?X$?
M?H(?_O"MW?R'N[<CF]4&,@RQ 1)Q63)%.P(-R>^BZ3\R:7=!\<.<^QD[^LO(
M)5>^Y$25W?-]4Y4=TP+8$:"7'ON9XZG<U[O-Q<-C4S_QF-DVO!-%AT3W2%@W
M1/?)_Z5[)6:W1/2;M<C;H<*P=O(KQ8JPJZ8X,%RAJ28IT;1\?@WJ;(?N&[IS
MWAU=/7'-S[[]Z:XH'H^0I+1D3Y0'$14]TKU^JW>L-X!*"@$5\>Y_XOT3<PS$
M& 0DEYGMY$ ('\F"P%B(<'(8HUD0K=G* 9%^1 2&E$NOQ1>^N1AS3?T;O(B\
M)T]*?3C7L0.E\C0AZ9&=#-+<)=B.7RCOZ/'NWFDYJ2NV/N"HDZ4 ;./?U\>Z
M@O6XHQUOYL3E]4U?WS]9260H I\@XY*O\!72?P9:RP\1\26B/I7UD74<:3F>
M9,><!MS% V>,#N#RKP%^ZO-V.36^T9 ]$S%B">/ZGX*@X<P<4J B%Q51Q(11
M$TE.@)ZP#G)*_PU117!FJ6VZ?UZO*=N59<V&0==%&S%4J%;D=]'N'SDT9/^P
M37''F#N^72BD!W^A'03K7K+W4KFAFP\O7UNH.;)ZY$&CU=T20.)+N#R7MVW7
M%&MOW"SKB4!71/4%RNL/7X7S[D>B>R1]E^1WU>D_\EPWATO!I5@>*DL4LP18
M14ZE@7"I'1+775%MF&KK=61("M*3$$638XN%N1A;@6+\8CXX.;)N=!.)5LY]
MD6%;#,?L6O(NKA#T(O5YO;6&",5?&&O[IJ%"LWCO,J?ITXA3+HBF79">.JOP
MH[RYYB-1(#AW##?$[C=E5S=?B@>O(40V(= FUR-S-%3+G#SF N/D@ ^?\3*J
M?Z>[W7]6]7-US6:UKMBE NYQKS(DB A0_?0O(".*C@C"C);[($-CL2=PCW9W
MBK&<ESLJ@L(BPH>&1+3,=4^.1^R6[I@CM%>8J!^@LL3._KUGKVSMKPX93@4A
M492$DQ(C8')DXL1^?D49LQY?B:+ <U\%L-%=K^+>7@CMC:G(5^CB]2#P[Q#E
M'2D:ZK38JG02H.E!C97Y+YODCU@K%<7$9FM.==N>%$WSLJT;L/I[8U<-'9*1
MD %-;@^+GYNPUNCF'<F#,7#0J!# E$A4:=P6% O":> 4$E;O'%LARHK7,>7G
M&^4X>A,GV579_NN\H1#R3-E NTQN41@&@7$0-9"1JO"]NT)=<GYS#ZA_<M%4
M26_&M>OB%)GE8GFPVQ)"I@5!]K3^PS/+W\W#:GQ>5NP*/Z;56/?X'5F- U*8
M8#6.RA+U.AB%.8@'HX*R6>V[%NRJ;+#LQ"C7T8!K%9;2IU?)&]SH:4%X7WEG
M>!+;KLD]0&YXKXY78#\Z?:,<_TGT1T2'1/0HIA=.6]4I_*R[M<[?F8!!88)I
MXD:_J;OZLB@W[/SQ9N<I-0G:+<#AO=O#:F4G]F/)KB)>$%$U6CA=?'GW[XA/
MUPYUB@)7U895 V&KM&E%"9[8I2E:+<BRZYKR=M]!Z1;(\;XLP,0_F_O1SYA3
M*8V( ?L1:@T'4(W[Q*YH#I@@(K]#0\);9@E*F,Q/VMP$A8$:\>BT(0V#NI;5
M1F6NL2W>E[PZJ5MO.)7?OC:.J8/8;)T+"_HL!-6I]O")C(7H7RF<1(O=5&DC
M;V45"'I*Q7\OJN5ZW>RAZHGPCY:!!'5)2WY0U#]"61O9 3%ZR/1\G,*D^_Y+
M%0[FKM;&! -$\)0^UFWI1_7NC3K*,\2WKB++MPM#S%@[+,XYJG(BK3_M3;U<
MLX._H5=L;$T)-8-.:-.5VW*MBTW"&+UX)K(?4%-D3Z3OBIA]P7M0]I97?YG*
MNVM['28_7&L.F!\@'X?]!R[WIV('(UYVW!,00PODQAM(S^4_&/0+4G1$=2'L
M;5DMK4E<NJ9P@GBPPD(^U>MB=WE?5Y%@!-Z.\(:9@Q'&(QX'([@YPGT3.RY"
MGJO&]C"\L*:K"")W3Y+G?@E'N$O6#6R1X)Y6VLH ^B0HFZIZ=>S5W)LG."4_
MM!3M;-[,4>Z"_MNP2'#FR?M..*]WN_IY5:6E-'G>7Z(3LJIFE*^4SFS2>RHD
M)\2 "(]?0A0P&/@E#O3MZ)[<YL(9>70</$_PY'@EAAM$"NG6=<4M.9;[(1+,
M*$@)IUTX?#4YHW;CS(U5C51QX#EBSAX>=[4J=,</;M^IV+?45U?6O%Q[Y-81
MYV,./>OEBMZ5<!V"[^6Z8Z^N!^JO J 37TPJHLFRO&2BS(Q7>@+GJ,:$LZ*I
MV/9J55S3:;G;=W[\;-6\#^5:$$F2TY+NX<)U(P09QE6;@^7%OM!G_J<#?+OJ
M/E@0UHEHD3WZ,8U7KZ,C44JX\P>IHN5==<+3>-8O1E&#CT590>#FUXH]TKA/
MUK>A^A8$B,@/0/;C@LB^B>J<&+TOR"W=LK^3F^);9NULB@A<DSM=A(CJ]B?:
MMI0.\[>N*$!7J7]!92.OH8=3FRYXF=>FNQ"_(-!)YFE,X]0U@5-DA/C85>:1
MLE)FDH^ ?U]Q++Z=F=P!-A/O&3ON!C &S([((/&%=Y4MRG\BRY92>)#($'8C
M).=_J(MFL]J>E@U=0Z6^D_NB;!Z**HQ P*FXZT+1$45H@Q*@[KLX3^;TI$I@
MZ U, DX4,5+K>[K9[Z@,@K.BD'WV+@&L"%UP[,1W['\</_&P3C%]F5,'Y\%@
M5-WP%!\>3^<(DM?V3-595AR2 Z>ZCZ<[1'*8/H-TB\\KXZ!=MK+9V*RG2^%U
MUK,,<= '5NR=&"8KDA+,&%G5V>QB8]^NRC'6PVI"40;7-.J(+SU=+L"U66"[
M'[U(!5H$EU7=)#03<Z@VX16H;?,\6&62P=>O49#&72#NN/!(DG4?26?K.9F5
M',_D^%0:%_N(1H=KNMXW=+."IQ<DJNBD(TCBNZZWC?[+1;6AWZZ?BT?X2_@E
M)#LEFM;(XN+X #]<K\ZO?C3^SCLGT+MHD!/$[2BB<9H67R]KS%-WN7GBSF@F
ME)-]V]4/M/&>P+*M<-7KUEGO/M?PK<WHYQ$M=54^85:5!&"\HH"6'8B+D 00
M 2%)B*;)5XO!QX7M#0SSB_EX@]?&**C/",X407_#7Q@MA1H[#I#2&5(*1!-V
M\-EV2_T//^AWX0B>-(-C>1,(5QK]<D@A'Q&.<#0S=4NCEO*35HPM[_,1=QY<
M1W..E8#R; 5CWN?B6_FP?PC?V;)1=OC4P6#'9DD')YBZ4GE7\7!M$T^2E\ J
M:1O-!C.H32Q-1>].$\OC/$WBTZGA3) 0'@*A"/>1!6'D?SZ5%7T7"7J231?J
M!P)$[-K-!>T<Y&4<^1%A&DF1#(WD_4'BOWFN9RC^]ZGB?Y])_.QVJIO'VH@
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M(09=5MM)F"5+(4R1 *J22'?LUW?L+/U<-/^B75_#/ 8(P.GXI:,I=0KM')!
M8YPY5;@D:6#,3]MT_SPM&[KNZB8\$ZI59LPV>\"F@'WLX+TE!718>T77E-U3
MFQ&DF._HD51$D5E8;-D2;,+\6.=."OMHEI1E5>V+G0"[/*6/;%F41>@"$.V)
MPOHT27*Z*'ULV,(/\HL=A>?T5P?]_J'(.B@6P>$]Q3F9]<1W<N8\YP,R0-L%
M/2K-+X!*DPK PQN/\\?R0>\88[=#(_P<(OM-7XE+\%&B90FSP0B:@/\1XCBT
MYP #D$*6-"PK;7VS4"EX$QYR0WH'3FX/+^Y,I&_^-UX,B&ZBFZ;8,,7U^N7A
MMMYY469%(R):970$#48[MB\X6,$U*+BM3:\TS05CS^=DE3O,%H=O@3-AN$<8
MW%>T[9H2(#@E1O?P%T;+$)3(P@%AWG=$1!.8Y-$O38K<J%ZOD8UK_H\@[%EH
MOL;!W[[FY#\:)%5[1!7@^P*F.I[\#[KWCSW]:"^)S\7Z'G#PP6Y5LU^$GQ*J
M-0>ZX^T=:!3H+PHW#]:3(L0J5I0]K ]9H^.<THN'![IA[WFZ>[FHU@TD;81M
M2D"NZY6P#HC1 U%=Y#8O)?)HS<\DV6#F7JOOGU+QWXMJN7GBU55D8LVJ^EBS
MK5S!/XH=W^O^^'@Y2:HS *26W:G3N@54'K-'<5SG#:F?+@([HN5@.2(J@H#3
MQ:0"*L@I?:*[^E%F78")*@R@H$BY.F<0*P/77&O7)+#LNA23)858\G6[95?H
M^;ZIRF[?4'7B\W0X@+RY>'ALV KCBPW>'3NZ[IJZ*M?Z!1(I7L?[)_H#1%^(
M^A/$_(8 A-5?,1YR,[@VCR4L:Y\?=Q:PKF:)7C]0QMIX%3%5.&"H+K?NZL#X
MQW:0)\<)G2 #1*?_ESVL YF WHH .;9B5ONN[=@A6U9WOFD1E.#R4>6;1=@A
M;$B#/%]5[2AGUN2D"@/17J@BX\2S)E+$2,<!R@! NX!1I@# P>C'=L0 BYC!
M%J=T2YN&;FZ*;\NVI5W;%UW<[>IGT**\<I>D4!*7".*%66Q2T>=401+8<ZD@
MR5)!##R7T5)2#XI7KE$-L]>740.Q;P4G2[ANN"&T0;O:"L2#"3&O7B2(0;BK
MW[R>85>D,^W:'%-%AGF<V4]!M95E 7,_A+1\-O^@2'\$*Z8^XR1Y7J](E#O7
M="6*!!OLVWJRK]=&.!!LEXE3I3H@?0_9P;[C3*;-F$\X<_-6^*S52L5<;C8\
M7[W8N>JRO%%\@E39ZRWI/Q^J<#-'-\3A@CUJN$'J/'XOZ])\\B@GRANNQ.&3
M43O)YHAV>J#PCKK:_+.#J5($(;"^LO=QR\]F"H6-6-/>F7 H;)C9)Q&=9G2]
MO$H,KN7P"GGB%5+N4_.JZ^ZA.VN:NCFIFT;4I3S?%7<)68D*@J9'IN']D+XC
M\CMTE;&D>9Q/G]TB)AE4-+^SHH%*M6!25$=)N?8FN<G&</J*(WE!.$%6%<#)
M@FO_!'C%=%[>U%VQ@Q :%;\/*5U0K/5BZ3--<!(1A*23%X!*%,J]6.8#(0@P
M8UDMHHPC.A7%62I.&LI/TBM:T>=()7!U"4DZ=05)TF$M[FPWC8\I_Y42%@,R
M#GC A7FHFS?K\13D:+(7%ST,4RD8 10)HTE>A=P8B'.QCUG!//4'A74NBSZ<
MW'7>#PL, :*]%>^/[IMVC=]V-/NY'*B@AZ([VJ5RWA[>,?!-Y)I("4-*@7@T
MJ?]7\5BW_YN(3EQ(CWEQ'N/S[0%ZC$BH/T"35J)(@-+HZWW^O>BZ+Z.EH8+9
MX;ULVQIR ZE[B4*??-V]8__C:^](7T&,!GCU8'W+5?:K2N!Q98O]+)>I691-
M=\\#"?0'B/I"1B#J8ZV7/@7O*.*>,WXUMU[I;"L1JJVSL-X"SII_T,BHDP'Y
M1KI=QCOWZ!*T5]3;S-%\@'2_T&?^EX,@T"28+NM#-,BLWB;QZ;X7DP6$:1\&
M\)JR4T&')W4%5DU:K0-/#8.$/_8&1%F?>0%F7%,2Y1T;/$["&M#'NO':X+6%
M5F$X\-89\TU=@_>976T&D7UMP7=].,HY9N!PP,7,S=+AQ^E)E@L:4/4 I?:$
M_;AJ;NKG*A68%RA(W1"@R>>@\# QWAY!7C'K%[Q:$V':[OY!)/?!XH%$U=/R
MJ=S0:G,5"((]@G?:4!^-02R(&@91XQA6@?R>7-:I4CZJ&WO:U*)E:+IB\@]-
M2W!E)<PA)V%B2H(K(P%E+LPBF#)5\;K8%<V+;QJ&54)5YJ:@R38#7BXLX4?X
MG4UXAU'A[ O]UMT\T]V3R"7UNQ$F%89;D/]B6@-959DC2P^5PN0 CZA$D=59
M WHTB)-DPJ[J)[5XC.9&T1AQX'NGV5QB.HX$4,'89?[Y[,)?BZ88H!SV@0*,
M*)\YU,N'=<9%.,;#=-O?:C#7/GXX LA@$AD!U0Y8!G1K8H@=VS(89QZ]6LIO
M]6[/E(SFY;S<T<9[D<CWF&Y-1/.\&-RCL;N?84X&L2Q!8@C\RR=,Q[BK&V]>
MO90P;TM4XVQ9@XZ!N\7KX TO#4VZ:#[0*[K9K^GFIEY6$Y\0L@OR@1+9"7C
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MXZH[.B4PQ51<1UW,0.S1CHLWBN)!G94"+!#9$MH/"RSLJ6U^TX1909]PN>O
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MZ,$/:G*?\[C/#]QG#>Z:,7,0E@;SLJ1KJ8!ED[CCT#(DNHU%NJ5"MYY8[ZB
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MFNQQ\PFD*Q&+"A%_R.E[C/FJG3UD(PD15+X16XA%4*JT8(TTB,ZFZ,3.9D'
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MF@!0KY_5PP, 84]K$IY<1P$5%%!! '[!PQ]>4"GNO!31O_U_4$L! A0#%
M  @ G8)O6$K06?/_3 , +0 : !H              ( !     &5A,#(P,#DU
M,BTR,&9?=V5A<F%B;&4N:'1M4$L! A0#%     @ G8)O6'CO7BE$!P  _2\
M !X              ( !-TT# &5A,#(P,#DU,C Q97@Q,BTQ7W=E87)A8FQE
M+FAT;5!+ 0(4 Q0    ( )V";UBB+.C670<  /DP   >              "
M ;=4 P!E83 R,# Y-3(P,65X,3(M,E]W96%R86)L92YH=&U02P$"% ,4
M" "=@F]8?Q*CGW@#   9#P  '@              @ %07 , 96$P,C P.34R
M,#%E>#$S+3%?=V5A<F%B;&4N:'1M4$L! A0#%     @ G8)O6%/+B:IL P
M! \  !X              ( !!& # &5A,#(P,#DU,C Q97@Q,RTR7W=E87)A
M8FQE+FAT;5!+ 0(4 Q0    ( )V";UAC)G1 I0,  "(.   >
M  "  :QC P!E83 R,# Y-3(P,65X,34M,5]W96%R86)L92YH=&U02P$"% ,4
M    " "=@F]8,3\R_TPH  #YU   '0              @ &-9P, 96$P,C P
M.34R,#%E>#(M,U]W96%R86)L92YH=&U02P$"% ,4    " "=@F]8?GQ?J>\6
M  #KG0  '@              @ $4D , 96$P,C P.34R,#%E>#DW+3%?=V5A
M<F%B;&4N:'1M4$L! A0#%     @ G8)O6!8-<ZU%'   2AT   T
M     ( !/Z<# &EM86=E7S P,2YJ<&=02P$"% ,4    " "=@F]8=] ^=CW/
M 0!UX@$ #0              @ &OPP, :6UA9V5?,# R+FIP9U!+ 0(4 Q0
M   ( )V";UA=(*"IU&L  '5R   -              "  1>3!0!I;6%G95\P
M,#,N:G!G4$L! A0#%     @ G8)O6"G"E9#K8@  O6L   T
M ( !%O\% &EM86=E7S P-"YJ<&=02P$"% ,4    " "=@F]8'9^;!ZUK  !)
M@   #0              @ $L8@8 :6UA9V5?,# U+FIP9U!+ 0(4 Q0    (
M )V";U@^WN('D D  %<*   -              "  03.!@!I;6%G95\P,#8N
M:G!G4$L! A0#%     @ G8)O6(+A&E7=,P$ K3H!  T              ( !
MO]<& &EM86=E7S P-RYJ<&=02P$"% ,4    " "=@F]82)"30L 7  "(' $
M$0              @ ''"P@ =VQD<RTR,#(S,3(S,2YX<V102P$"% ,4
M" "=@F]8 $V 5T$,  "?C   %0              @ &V(P@ =VQD<RTR,#(S
M,3(S,5]C86PN>&UL4$L! A0#%     @ G8)O6#OYL:QF1@  FD($ !4
M         ( !*C ( '=L9',M,C R,S$R,S%?9&5F+GAM;%!+ 0(4 Q0    (
M )V";U@T9C94(+4  -&]"  5              "  <-V" !W;&1S+3(P,C,Q
M,C,Q7VQA8BYX;6Q02P$"% ,4    " "=@F]8(E/]ZHU%  !_6P0 %0
M        @ $6+ D =VQD<RTR,#(S,3(S,5]P<F4N>&UL4$L%!@     4 !0
*0P4  -9Q"0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>ea0200952-20f_wearable_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2023"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:wlds="http://www.wearabledevices.co.il/20231231"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="wlds-20231231.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wlds:OrdinarySharesNIS001ParValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wlds:WarrantsToPurchaseOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">wlds:SubscriptionReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">wlds:SubscriptionReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">wlds:SubscriptionReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">wlds:MudraInspireDevelopmentKitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-11-30</endDate>
        </period>
    </context>
    <context id="c41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <instant>2022-09-16</instant>
        </period>
    </context>
    <context id="c46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-14</endDate>
        </period>
    </context>
    <context id="c47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-12</instant>
        </period>
    </context>
    <context id="c49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-25</instant>
        </period>
    </context>
    <context id="c50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-24</instant>
        </period>
    </context>
    <context id="c51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2023-11-13</endDate>
        </period>
    </context>
    <context id="c52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wlds:LeaseLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:ComputersAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:MoldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:ComputersAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:ComputersAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:ElectronicEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:ElectronicEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:MachinesAndMoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:MachinesAndMoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="c70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="c71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">wlds:IIAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">wlds:IIAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">wlds:IIAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">wlds:IMEIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">wlds:IMEIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">wlds:IMEIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">wlds:IMEIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LeaseAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="c83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="c84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-01-31</endDate>
        </period>
    </context>
    <context id="c85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2019-11-30</endDate>
        </period>
    </context>
    <context id="c87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wlds:ConvertibleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wlds:ConvertibleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="c89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wlds:ConvertibleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wlds:ConvertibleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-31</instant>
        </period>
    </context>
    <context id="c91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wlds:ConvertibleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-30</instant>
        </period>
    </context>
    <context id="c92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wlds:ConvertibleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-30</instant>
        </period>
    </context>
    <context id="c93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wlds:ConvertibleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wlds:ConvertibleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="c95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <instant>2021-04-22</instant>
        </period>
    </context>
    <context id="c99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="c100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <instant>2022-09-20</instant>
        </period>
    </context>
    <context id="c101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-20</instant>
        </period>
    </context>
    <context id="c102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wlds:ConvertibleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-16</endDate>
        </period>
    </context>
    <context id="c103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <instant>2022-07-04</instant>
        </period>
    </context>
    <context id="c104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">wlds:CofoundersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">wlds:CofoundersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-03-10</instant>
        </period>
    </context>
    <context id="c108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-03-10</startDate>
            <endDate>2016-03-10</endDate>
        </period>
    </context>
    <context id="c109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2023-11-30</endDate>
        </period>
    </context>
    <context id="c123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:TwoZeroOneFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-12-31</instant>
        </period>
    </context>
    <context id="c124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:TwoZeroOneFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-15</instant>
        </period>
    </context>
    <context id="c126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:TwoZeroOneFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-15</instant>
        </period>
    </context>
    <context id="c127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-23</instant>
        </period>
    </context>
    <context id="c128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:TwoZeroOneFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-23</instant>
        </period>
    </context>
    <context id="c129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:TwoZeroOneFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-30</endDate>
        </period>
    </context>
    <context id="c131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <instant>2023-04-27</instant>
        </period>
    </context>
    <context id="c134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-04-27</endDate>
        </period>
    </context>
    <context id="c135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandFifteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandFifteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandSeventeenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandSeventeenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandTwentyoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandTwentyoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandTwentyoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandTwentyoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandTwentyThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandTwentyThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:September132022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:September132022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:September152022OneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:September152022OneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:September152022TwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:September152022TwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:September152022ThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:September152022ThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wlds:CofoundersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">wlds:AsherDahanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wlds:CofoundersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">wlds:AsherDahanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wlds:CofoundersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">wlds:AsherDahanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-14</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="ilsPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:ILS</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="usdPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="ils">
        <measure>iso4217:ILS</measure>
    </unit>
    <dei:DocumentType contextRef="c0" id="ixv-18799">20-F</dei:DocumentType>
    <dei:DocumentRegistrationStatement contextRef="c0" id="ixv-18800">false</dei:DocumentRegistrationStatement>
    <dei:DocumentAnnualReport contextRef="c0" id="ixv-18801">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c0" id="ixv-18802">2023-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c0" id="ixv-18803">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="c0" id="ixv-18804">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="c0" id="ixv-18805">false</dei:DocumentTransitionReport>
    <dei:DocumentShellCompanyReport contextRef="c0" id="ixv-18806">false</dei:DocumentShellCompanyReport>
    <dei:EntityFileNumber contextRef="c0" id="ixv-18807">001-41502</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-62">Wearable Devices Ltd.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c0" id="ixv-78">L3</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1 contextRef="c0" id="ixv-18808">5 Ha-Tnufa Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c0" id="ixv-18809">Yokne&#x2019;am Illit</dei:EntityAddressAddressLine2>
    <dei:EntityAddressPostalZipCode contextRef="c0" id="ixv-18810">2066736</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry contextRef="c0" id="ixv-18811">IL</dei:EntityAddressCountry>
    <dei:EntityAddressCityOrTown contextRef="c0" id="ixv-18812">Israel</dei:EntityAddressCityOrTown>
    <dei:ContactPersonnelName contextRef="c1" id="ixv-103">Asher Dahan</dei:ContactPersonnelName>
    <dei:CityAreaCode contextRef="c1" id="ixv-18813">+972.</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c1" id="ixv-18814">4.6185670</dei:LocalPhoneNumber>
    <dei:EntityAddressAddressLine1 contextRef="c1" id="ixv-18815">5 Ha-Tnufa Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c1" id="ixv-18816">Yokne&#x2019;am Illit</dei:EntityAddressAddressLine2>
    <dei:EntityAddressPostalZipCode contextRef="c1" id="ixv-18817">2066736</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCityOrTown contextRef="c1" id="ixv-18818">Israel</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="c1" id="ixv-18819">IL</dei:EntityAddressCountry>
    <dei:Security12bTitle contextRef="c2" id="ixv-152">Ordinary Shares, NIS 0.01 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c2" id="ixv-156">WLDS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c2" id="ixv-18820">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c3" id="ixv-163">Warrants to Purchase Ordinary Shares</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c3" id="ixv-167">WLDSW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c3" id="ixv-18821">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="c4"
      decimals="INF"
      id="ixv-18822"
      unitRef="shares">20387428</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c0" id="ixv-18823">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c0" id="ixv-18824">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c0" id="ixv-18825">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c0" id="ixv-18826">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c0" id="ixv-242">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany contextRef="c0" id="ixv-252">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="c0" id="ixv-18827">true</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag contextRef="c0" id="ixv-18828">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="c0" id="ixv-18829">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:DocumentAccountingStandard contextRef="c0" id="ixv-18830">U.S. GAAP</dei:DocumentAccountingStandard>
    <dei:EntityShellCompany contextRef="c0" id="ixv-18831">false</dei:EntityShellCompany>
    <dei:AuditorFirmId contextRef="c0" id="ixv-18832">1185</dei:AuditorFirmId>
    <dei:AuditorName contextRef="c0" id="ixv-18833">Ziv Haft</dei:AuditorName>
    <dei:AuditorLocation contextRef="c0" id="ixv-18834">Tel Aviv, Israel</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c4" decimals="-3" id="ixv-18835" unitRef="usd">810000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c5" decimals="-3" id="ixv-18836" unitRef="usd">10373000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:DepositsAssetsCurrent contextRef="c4" decimals="-3" id="ixv-18837" unitRef="usd">4045000</us-gaap:DepositsAssetsCurrent>
    <us-gaap:GrantsReceivable contextRef="c4" decimals="-3" id="ixv-18838" unitRef="usd">108000</us-gaap:GrantsReceivable>
    <us-gaap:GrantsReceivable contextRef="c5" decimals="-3" id="ixv-18839" unitRef="usd">54000</us-gaap:GrantsReceivable>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c4" decimals="-3" id="ixv-18840" unitRef="usd">757000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c5" decimals="-3" id="ixv-18841" unitRef="usd">543000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:FIFOInventoryAmount contextRef="c4" decimals="-3" id="ixv-18842" unitRef="usd">1032000</us-gaap:FIFOInventoryAmount>
    <us-gaap:FIFOInventoryAmount contextRef="c5" decimals="-3" id="ixv-18843" unitRef="usd">6000</us-gaap:FIFOInventoryAmount>
    <us-gaap:AssetsCurrent contextRef="c4" decimals="-3" id="ixv-18844" unitRef="usd">6752000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c5" decimals="-3" id="ixv-18845" unitRef="usd">10976000</us-gaap:AssetsCurrent>
    <us-gaap:DepositsAssetsNoncurrent contextRef="c4" decimals="-3" id="ixv-18846" unitRef="usd">54000</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c4" decimals="-3" id="ixv-18847" unitRef="usd">592000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c5" decimals="-3" id="ixv-18848" unitRef="usd">180000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c4" decimals="-3" id="ixv-18849" unitRef="usd">194000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c5" decimals="-3" id="ixv-18850" unitRef="usd">68000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:AssetsNoncurrent contextRef="c4" decimals="-3" id="ixv-18851" unitRef="usd">840000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent contextRef="c5" decimals="-3" id="ixv-18852" unitRef="usd">248000</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets contextRef="c4" decimals="-3" id="ixv-18853" unitRef="usd">7592000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c5" decimals="-3" id="ixv-18854" unitRef="usd">11224000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c4" decimals="-3" id="ixv-18855" unitRef="usd">410000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c5" decimals="-3" id="ixv-18856" unitRef="usd">156000</us-gaap:AccountsPayableCurrent>
    <wlds:AdvanceFromCustomers contextRef="c4" decimals="-3" id="ixv-18857" unitRef="usd">312000</wlds:AdvanceFromCustomers>
    <wlds:AdvanceFromCustomers contextRef="c5" decimals="-3" id="ixv-18858" unitRef="usd">353000</wlds:AdvanceFromCustomers>
    <us-gaap:DeferredRevenueCurrent contextRef="c5" decimals="-3" id="ixv-18859" unitRef="usd">12000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c4" decimals="-3" id="ixv-18860" unitRef="usd">579000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c5" decimals="-3" id="ixv-18861" unitRef="usd">416000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c4" decimals="-3" id="ixv-18862" unitRef="usd">190000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c5" decimals="-3" id="ixv-18863" unitRef="usd">145000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c4" decimals="-3" id="ixv-18864" unitRef="usd">297000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c5" decimals="-3" id="ixv-18865" unitRef="usd">68000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c4" decimals="-3" id="ixv-18866" unitRef="usd">1788000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c5" decimals="-3" id="ixv-18867" unitRef="usd">1150000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c4" decimals="-3" id="ixv-18868" unitRef="usd">278000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c5" decimals="-3" id="ixv-18869" unitRef="usd">94000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities contextRef="c4" decimals="-3" id="ixv-18870" unitRef="usd">2066000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c5" decimals="-3" id="ixv-18871" unitRef="usd">1244000</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c4"
      decimals="2"
      id="ixv-18872"
      unitRef="ilsPershares">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c5"
      decimals="2"
      id="ixv-18873"
      unitRef="ilsPershares">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c4"
      decimals="INF"
      id="ixv-18874"
      unitRef="shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c5"
      decimals="INF"
      id="ixv-18875"
      unitRef="shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="c4"
      decimals="INF"
      id="ixv-18876"
      unitRef="shares">20387428</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c4"
      decimals="INF"
      id="ixv-18877"
      unitRef="shares">20387428</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="c5"
      decimals="INF"
      id="ixv-18878"
      unitRef="shares">15049720</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c5"
      decimals="INF"
      id="ixv-18879"
      unitRef="shares">15049720</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c4" decimals="-3" id="ixv-18880" unitRef="usd">57000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c5" decimals="-3" id="ixv-18881" unitRef="usd">43000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="c4" decimals="-3" id="ixv-18882" unitRef="usd">26692000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c5" decimals="-3" id="ixv-18883" unitRef="usd">23346000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c4" decimals="-3" id="ixv-18884" unitRef="usd">-21223000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c5" decimals="-3" id="ixv-18885" unitRef="usd">-13409000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity contextRef="c4" decimals="-3" id="ixv-18886" unitRef="usd">5526000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c5" decimals="-3" id="ixv-18887" unitRef="usd">9980000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c4" decimals="-3" id="ixv-18888" unitRef="usd">7592000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c5" decimals="-3" id="ixv-18889" unitRef="usd">11224000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues contextRef="c0" decimals="-3" id="ixv-18890" unitRef="usd">82000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c6" decimals="-3" id="ixv-18891" unitRef="usd">45000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c7" decimals="-3" id="ixv-18892" unitRef="usd">142000</us-gaap:Revenues>
    <us-gaap:CostDirectMaterial contextRef="c0" decimals="-3" id="ixv-18893" unitRef="usd">62000</us-gaap:CostDirectMaterial>
    <us-gaap:CostDirectMaterial contextRef="c6" decimals="-3" id="ixv-18894" unitRef="usd">10000</us-gaap:CostDirectMaterial>
    <us-gaap:CostDirectMaterial contextRef="c7" decimals="-3" id="ixv-18895" unitRef="usd">10000</us-gaap:CostDirectMaterial>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c0" decimals="-3" id="ixv-18896" unitRef="usd">3316000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c6" decimals="-3" id="ixv-18897" unitRef="usd">2271000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c7" decimals="-3" id="ixv-18898" unitRef="usd">1411000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c0" decimals="-3" id="ixv-18899" unitRef="usd">2008000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c6" decimals="-3" id="ixv-18900" unitRef="usd">1370000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c7" decimals="-3" id="ixv-18901" unitRef="usd">665000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c0" decimals="-3" id="ixv-18902" unitRef="usd">2882000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c6" decimals="-3" id="ixv-18903" unitRef="usd">1948000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c7" decimals="-3" id="ixv-18904" unitRef="usd">628000</us-gaap:GeneralAndAdministrativeExpense>
    <wlds:ProspectiveInitialPublicOfferingExpenses contextRef="c6" decimals="-3" id="ixv-18905" unitRef="usd">904000</wlds:ProspectiveInitialPublicOfferingExpenses>
    <wlds:ProspectiveInitialPublicOfferingExpenses contextRef="c7" decimals="-3" id="ixv-18906" unitRef="usd">97000</wlds:ProspectiveInitialPublicOfferingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c0" decimals="-3" id="ixv-18907" unitRef="usd">-8186000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c6" decimals="-3" id="ixv-18908" unitRef="usd">-6458000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c7" decimals="-3" id="ixv-18909" unitRef="usd">-2669000</us-gaap:OperatingIncomeLoss>
    <wlds:InterestExpenseAndExchangeRate contextRef="c0" decimals="-3" id="ixv-18910" unitRef="usd">372000</wlds:InterestExpenseAndExchangeRate>
    <wlds:InterestExpenseAndExchangeRate contextRef="c6" decimals="-3" id="ixv-18911" unitRef="usd">-38000</wlds:InterestExpenseAndExchangeRate>
    <wlds:InterestExpenseAndExchangeRate contextRef="c7" decimals="-3" id="ixv-18912" unitRef="usd">55000</wlds:InterestExpenseAndExchangeRate>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" id="ixv-18913" unitRef="usd">-7814000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c6" decimals="-3" id="ixv-18914" unitRef="usd">-6496000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c7" decimals="-3" id="ixv-18915" unitRef="usd">-2614000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c0"
      decimals="2"
      id="ixv-18916"
      unitRef="usdPershares">-0.48</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c6"
      decimals="2"
      id="ixv-18917"
      unitRef="usdPershares">-0.53</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c7"
      decimals="2"
      id="ixv-18918"
      unitRef="usdPershares">-0.27</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c0"
      decimals="0"
      id="ix_0_fact"
      unitRef="shares">16201238</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c6"
      decimals="0"
      id="ix_1_fact"
      unitRef="shares">12277224</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c7"
      decimals="0"
      id="ix_2_fact"
      unitRef="shares">9709590</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:SharesOutstanding
      contextRef="c8"
      decimals="INF"
      id="ixv-18922"
      unitRef="shares">4626572</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c8" decimals="-3" id="ixv-18923" unitRef="usd">12000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c9"
      decimals="INF"
      id="ixv-18924"
      unitRef="shares">1844268</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c9" decimals="-3" id="ixv-18925" unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c10" decimals="-3" id="ixv-18926" unitRef="usd">-12000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c11" decimals="-3" id="ixv-18927" unitRef="usd">1406000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c12" decimals="-3" id="ixv-18928" unitRef="usd">-4299000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c13" decimals="-3" id="ixv-18929" unitRef="usd">-2888000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits
      contextRef="c14"
      decimals="INF"
      id="ixv-18930"
      unitRef="shares">1343375</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <wlds:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost contextRef="c14" decimals="-3" id="ixv-18931" unitRef="usd">4000</wlds:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost>
    <wlds:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost contextRef="c17" decimals="-3" id="ixv-18932" unitRef="usd">2921000</wlds:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost>
    <wlds:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost contextRef="c7" decimals="-3" id="ixv-18933" unitRef="usd">2925000</wlds:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c14"
      decimals="INF"
      id="ixv-18934"
      unitRef="shares">3081102</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c14" decimals="-3" id="ixv-18935" unitRef="usd">9000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c17" decimals="-3" id="ixv-18936" unitRef="usd">3063000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c7" decimals="-3" id="ixv-18937" unitRef="usd">3072000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <wlds:ConversionOfOrdinaryASharesToOrdinaryShares
      contextRef="c14"
      decimals="INF"
      id="ixv-18938"
      unitRef="shares">1844268</wlds:ConversionOfOrdinaryASharesToOrdinaryShares>
    <wlds:ConversionOfOrdinaryASharesToOrdinarySharesValue contextRef="c14" decimals="-3" id="ixv-18939" unitRef="usd">5000</wlds:ConversionOfOrdinaryASharesToOrdinarySharesValue>
    <wlds:ConversionOfOrdinaryASharesToOrdinaryShares
      contextRef="c15"
      decimals="INF"
      id="ixv-18940"
      unitRef="shares">-1844268</wlds:ConversionOfOrdinaryASharesToOrdinaryShares>
    <wlds:ConversionOfOrdinaryASharesToOrdinarySharesValue contextRef="c15" decimals="-3" id="ixv-18941" unitRef="usd">-5000</wlds:ConversionOfOrdinaryASharesToOrdinarySharesValue>
    <us-gaap:ShareBasedCompensation contextRef="c17" decimals="-3" id="ixv-18942" unitRef="usd">299000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c7" decimals="-3" id="ixv-18943" unitRef="usd">299000</us-gaap:ShareBasedCompensation>
    <wlds:StockIssuedDuringPeriodShareOfExerciseOfOptionsinShares
      contextRef="c14"
      decimals="INF"
      id="ixv-18944"
      unitRef="shares">241533</wlds:StockIssuedDuringPeriodShareOfExerciseOfOptionsinShares>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c14" decimals="-3" id="ixv-18945" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c7" decimals="-3" id="ixv-18946" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <wlds:StockIssuedDuringPeriodValueOfPaymentOnBehalfOfSharesIssued contextRef="c16" decimals="-3" id="ixv-18947" unitRef="usd">12000</wlds:StockIssuedDuringPeriodValueOfPaymentOnBehalfOfSharesIssued>
    <wlds:StockIssuedDuringPeriodValueOfPaymentOnBehalfOfSharesIssued contextRef="c7" decimals="-3" id="ixv-18948" unitRef="usd">12000</wlds:StockIssuedDuringPeriodValueOfPaymentOnBehalfOfSharesIssued>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c18" decimals="-3" id="ixv-18949" unitRef="usd">-2614000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c7" decimals="-3" id="ixv-18950" unitRef="usd">-2614000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="c19"
      decimals="INF"
      id="ixv-18951"
      unitRef="shares">11136850</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c19" decimals="-3" id="ixv-18952" unitRef="usd">31000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c22" decimals="-3" id="ixv-18953" unitRef="usd">7689000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c23" decimals="-3" id="ixv-18954" unitRef="usd">-6913000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c24" decimals="-3" id="ixv-18955" unitRef="usd">807000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c19"
      decimals="INF"
      id="ixv-18956"
      unitRef="shares">11136850</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c19" decimals="-3" id="ixv-18957" unitRef="usd">31000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c22" decimals="-3" id="ixv-18958" unitRef="usd">7689000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c23" decimals="-3" id="ixv-18959" unitRef="usd">-6913000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c24" decimals="-3" id="ixv-18960" unitRef="usd">807000</us-gaap:StockholdersEquity>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c6" decimals="-2" id="ixv-18961" unitRef="usd">1600</us-gaap:PaymentsOfStockIssuanceCosts>
    <wlds:IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares
      contextRef="c25"
      decimals="INF"
      id="ixv-18962"
      unitRef="shares">3750000</wlds:IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares>
    <wlds:IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet contextRef="c25" decimals="-3" id="ixv-18963" unitRef="usd">11000</wlds:IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet>
    <wlds:IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet contextRef="c26" decimals="-3" id="ixv-18964" unitRef="usd">14308000</wlds:IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet>
    <wlds:IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet contextRef="c6" decimals="-3" id="ixv-18965" unitRef="usd">14319000</wlds:IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet>
    <wlds:ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering
      contextRef="c25"
      decimals="INF"
      id="ixv-18966"
      unitRef="shares">118204</wlds:ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="c25" decimals="-3" id="ixv-18967" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="c26" decimals="-3" id="ixv-18968" unitRef="usd">399000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="c6" decimals="-3" id="ixv-18969" unitRef="usd">400000</us-gaap:StockIssuedDuringPeriodValueOther>
    <wlds:IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrantsinShares
      contextRef="c25"
      decimals="INF"
      id="ixv-18970"
      unitRef="shares">40000</wlds:IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrantsinShares>
    <wlds:IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants contextRef="c26" decimals="-3" id="ixv-18971" unitRef="usd">160000</wlds:IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants>
    <wlds:IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants contextRef="c6" decimals="-3" id="ixv-18972" unitRef="usd">160000</wlds:IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants>
    <wlds:StockIssuedDuringPeriodShareOfExerciseOfOptionsinShares
      contextRef="c25"
      decimals="INF"
      id="ixv-18973"
      unitRef="shares">4666</wlds:StockIssuedDuringPeriodShareOfExerciseOfOptionsinShares>
    <us-gaap:ShareBasedCompensation contextRef="c26" decimals="-3" id="ixv-18974" unitRef="usd">790000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c6" decimals="-3" id="ixv-18975" unitRef="usd">790000</us-gaap:ShareBasedCompensation>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c27" decimals="-3" id="ixv-18976" unitRef="usd">-6496000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c6" decimals="-3" id="ixv-18977" unitRef="usd">-6496000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="c28"
      decimals="INF"
      id="ixv-18978"
      unitRef="shares">15049720</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c28" decimals="-3" id="ixv-18979" unitRef="usd">43000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c29" decimals="-3" id="ixv-18980" unitRef="usd">23346000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c30" decimals="-3" id="ixv-18981" unitRef="usd">-13409000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c5" decimals="-3" id="ixv-18982" unitRef="usd">9980000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c31"
      decimals="INF"
      id="ixv-18983"
      unitRef="shares">4444444</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c31" decimals="-3" id="ixv-18984" unitRef="usd">11000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c32" decimals="-3" id="ixv-18985" unitRef="usd">1659000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c0" decimals="-3" id="ixv-18986" unitRef="usd">1670000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <wlds:StockIssuedDuringPeriodSharesInvestors
      contextRef="c31"
      decimals="INF"
      id="ixv-18987"
      unitRef="shares">169125</wlds:StockIssuedDuringPeriodSharesInvestors>
    <wlds:StockIssuedDuringPeriodValueInvestors contextRef="c31" decimals="-3" id="ixv-18988" unitRef="usd">1000</wlds:StockIssuedDuringPeriodValueInvestors>
    <wlds:StockIssuedDuringPeriodValueInvestors contextRef="c32" decimals="-3" id="ixv-18989" unitRef="usd">-1000</wlds:StockIssuedDuringPeriodValueInvestors>
    <wlds:StockIssuedDuringPeriodSharesExerciseOfWarrants
      contextRef="c31"
      decimals="INF"
      id="ixv-18990"
      unitRef="shares">724139</wlds:StockIssuedDuringPeriodSharesExerciseOfWarrants>
    <wlds:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="c31" decimals="-3" id="ixv-18991" unitRef="usd">2000</wlds:StockIssuedDuringPeriodValueExerciseOfWarrants>
    <wlds:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="c32" decimals="-3" id="ixv-18992" unitRef="usd">1447000</wlds:StockIssuedDuringPeriodValueExerciseOfWarrants>
    <wlds:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="c0" decimals="-3" id="ixv-18993" unitRef="usd">1449000</wlds:StockIssuedDuringPeriodValueExerciseOfWarrants>
    <us-gaap:ShareBasedCompensation contextRef="c32" decimals="-3" id="ixv-18994" unitRef="usd">241000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c0" decimals="-3" id="ixv-18995" unitRef="usd">241000</us-gaap:ShareBasedCompensation>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c33" decimals="-3" id="ixv-18996" unitRef="usd">-7814000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c0" decimals="-3" id="ixv-18997" unitRef="usd">-7814000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="c34"
      decimals="INF"
      id="ixv-18998"
      unitRef="shares">20387428</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c34" decimals="-3" id="ixv-18999" unitRef="usd">57000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c35" decimals="-3" id="ixv-19000" unitRef="usd">26692000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c36" decimals="-3" id="ixv-19001" unitRef="usd">-21223000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c4" decimals="-3" id="ixv-19002" unitRef="usd">5526000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" id="ixv-19003" unitRef="usd">-7814000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c6" decimals="-3" id="ixv-19004" unitRef="usd">-6496000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c7" decimals="-3" id="ixv-19005" unitRef="usd">-2614000</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation contextRef="c0" decimals="-3" id="ixv-19006" unitRef="usd">68000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c6" decimals="-3" id="ixv-19007" unitRef="usd">23000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c7" decimals="-3" id="ixv-19008" unitRef="usd">11000</us-gaap:Depreciation>
    <wlds:AccruedInterestOnConvertibleSecurities contextRef="c7" decimals="-3" id="ixv-19009" unitRef="usd">20000</wlds:AccruedInterestOnConvertibleSecurities>
    <wlds:AccruedInterestOnDeposits contextRef="c0" decimals="-3" id="ixv-19010" unitRef="usd">-45000</wlds:AccruedInterestOnDeposits>
    <us-gaap:ShareBasedCompensation contextRef="c0" decimals="-3" id="ixv-19011" unitRef="usd">241000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c6" decimals="-3" id="ixv-19012" unitRef="usd">790000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c7" decimals="-3" id="ixv-19013" unitRef="usd">299000</us-gaap:ShareBasedCompensation>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized contextRef="c0" decimals="-3" id="ixv-19014" unitRef="usd">68000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c6" decimals="-3" id="ixv-19015" unitRef="usd">-8000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c7" decimals="-3" id="ixv-19016" unitRef="usd">8000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c0" decimals="-3" id="ixv-19017" unitRef="usd">1026000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c6" decimals="-3" id="ixv-19018" unitRef="usd">-5000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c7" decimals="-3" id="ixv-19019" unitRef="usd">-9000</us-gaap:IncreaseDecreaseInInventories>
    <wlds:DecreaseincreaseInGovernmentalGrantsReceivables contextRef="c0" decimals="-3" id="ixv-19020" unitRef="usd">54000</wlds:DecreaseincreaseInGovernmentalGrantsReceivables>
    <wlds:DecreaseincreaseInGovernmentalGrantsReceivables contextRef="c6" decimals="-3" id="ixv-19021" unitRef="usd">-8000</wlds:DecreaseincreaseInGovernmentalGrantsReceivables>
    <wlds:DecreaseincreaseInGovernmentalGrantsReceivables contextRef="c7" decimals="-3" id="ixv-19022" unitRef="usd">11000</wlds:DecreaseincreaseInGovernmentalGrantsReceivables>
    <wlds:IncreaseInOtherReceivablesAndPrepaidExpenses contextRef="c0" decimals="-3" id="ixv-19023" unitRef="usd">136000</wlds:IncreaseInOtherReceivablesAndPrepaidExpenses>
    <wlds:IncreaseInOtherReceivablesAndPrepaidExpenses contextRef="c6" decimals="-3" id="ixv-19024" unitRef="usd">496000</wlds:IncreaseInOtherReceivablesAndPrepaidExpenses>
    <wlds:IncreaseInOtherReceivablesAndPrepaidExpenses contextRef="c7" decimals="-3" id="ixv-19025" unitRef="usd">30000</wlds:IncreaseInOtherReceivablesAndPrepaidExpenses>
    <wlds:IncreaseDecreaseInAdvancePayments contextRef="c0" decimals="-3" id="ixv-19026" unitRef="usd">-41000</wlds:IncreaseDecreaseInAdvancePayments>
    <wlds:IncreaseDecreaseInAdvancePayments contextRef="c6" decimals="-3" id="ixv-19027" unitRef="usd">79000</wlds:IncreaseDecreaseInAdvancePayments>
    <wlds:IncreaseDecreaseInAdvancePayments contextRef="c7" decimals="-3" id="ixv-19028" unitRef="usd">63000</wlds:IncreaseDecreaseInAdvancePayments>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="c0" decimals="-3" id="ixv-19029" unitRef="usd">-12000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="c6" decimals="-3" id="ixv-19030" unitRef="usd">-12000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="c7" decimals="-3" id="ixv-19031" unitRef="usd">9000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c0" decimals="-3" id="ixv-19032" unitRef="usd">254000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c6" decimals="-3" id="ixv-19033" unitRef="usd">84000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c7" decimals="-3" id="ixv-19034" unitRef="usd">40000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c0" decimals="-3" id="ixv-19035" unitRef="usd">163000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c6" decimals="-3" id="ixv-19036" unitRef="usd">194000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c7" decimals="-3" id="ixv-19037" unitRef="usd">119000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <wlds:IncreaseDecreaseInAdvancePaymentsOnGovernmentalGrant contextRef="c7" decimals="-3" id="ixv-19038" unitRef="usd">42000</wlds:IncreaseDecreaseInAdvancePaymentsOnGovernmentalGrant>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c0" decimals="-3" id="ixv-19039" unitRef="usd">36000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c6" decimals="-3" id="ixv-19040" unitRef="usd">99000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c7" decimals="-3" id="ixv-19041" unitRef="usd">32000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c0" decimals="-3" id="ixv-19042" unitRef="usd">-8434000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c6" decimals="-3" id="ixv-19043" unitRef="usd">-5714000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c7" decimals="-3" id="ixv-19044" unitRef="usd">-2103000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c0" decimals="-3" id="ixv-19045" unitRef="usd">194000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c6" decimals="-3" id="ixv-19046" unitRef="usd">48000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c7" decimals="-3" id="ixv-19047" unitRef="usd">36000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireRestrictedCertificatesOfDeposit contextRef="c0" decimals="-3" id="ixv-19048" unitRef="usd">4054000</us-gaap:PaymentsToAcquireRestrictedCertificatesOfDeposit>
    <wlds:PrepaymentsOfLeasing contextRef="c6" decimals="-3" id="ixv-19049" unitRef="usd">18000</wlds:PrepaymentsOfLeasing>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c0" decimals="-3" id="ixv-19050" unitRef="usd">-4248000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c6" decimals="-3" id="ixv-19051" unitRef="usd">-66000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c7" decimals="-3" id="ixv-19052" unitRef="usd">-36000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <wlds:ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost contextRef="c0" decimals="-3" id="ixv-19053" unitRef="usd">1670000</wlds:ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost>
    <wlds:ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPubli contextRef="c6" decimals="-3" id="ixv-19054" unitRef="usd">14319000</wlds:ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPubli>
    <wlds:ProceedsFromIssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost contextRef="c7" decimals="-3" id="ixv-19055" unitRef="usd">2925000</wlds:ProceedsFromIssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost>
    <wlds:ProceedsFromIssuanceOfSAFEs contextRef="c6" decimals="-3" id="ixv-19056" unitRef="usd">500000</wlds:ProceedsFromIssuanceOfSAFEs>
    <wlds:RefundToSAFEInvestors contextRef="c6" decimals="-3" id="ixv-19057" unitRef="usd">100000</wlds:RefundToSAFEInvestors>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="c6" decimals="-3" id="ixv-19058" unitRef="usd">800000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="c6" decimals="-3" id="ixv-19059" unitRef="usd">800000</us-gaap:RepaymentsOfLinesOfCredit>
    <wlds:ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants contextRef="c6" decimals="-3" id="ixv-19060" unitRef="usd">160000</wlds:ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c7" decimals="-3" id="ixv-19061" unitRef="usd">1000</us-gaap:ProceedsFromStockOptionsExercised>
    <wlds:PaymentOnBehalfOfIssuedShares contextRef="c7" decimals="-3" id="ixv-19062" unitRef="usd">12000</wlds:PaymentOnBehalfOfIssuedShares>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c0" decimals="-3" id="ixv-19063" unitRef="usd">3119000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c6" decimals="-3" id="ixv-19064" unitRef="usd">14879000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c7" decimals="-3" id="ixv-19065" unitRef="usd">2938000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="c0" decimals="-3" id="ixv-19066" unitRef="usd">-9563000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="c6" decimals="-3" id="ixv-19067" unitRef="usd">9099000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="c7" decimals="-3" id="ixv-19068" unitRef="usd">799000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c5" decimals="-3" id="ixv-19069" unitRef="usd">10373000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c24" decimals="-3" id="ixv-19070" unitRef="usd">1274000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c13" decimals="-3" id="ixv-19071" unitRef="usd">475000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c4" decimals="-3" id="ixv-19072" unitRef="usd">810000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c5" decimals="-3" id="ixv-19073" unitRef="usd">10373000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c24" decimals="-3" id="ixv-19074" unitRef="usd">1274000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet contextRef="c6" decimals="-3" id="ixv-19075" unitRef="usd">40000</us-gaap:InterestPaidNet>
    <wlds:InterestReceivedFromDeposits contextRef="c0" decimals="-3" id="ixv-19076" unitRef="usd">-305000</wlds:InterestReceivedFromDeposits>
    <wlds:ConversionOfSAFEToEquity contextRef="c6" decimals="-3" id="ixv-19077" unitRef="usd">400000</wlds:ConversionOfSAFEToEquity>
    <wlds:RightofUseAssetRecognizedAgainstLeaseLiability contextRef="c0" decimals="-3" id="ixv-19078" unitRef="usd">644000</wlds:RightofUseAssetRecognizedAgainstLeaseLiability>
    <wlds:RightofUseAssetRecognizedAgainstLeaseLiability contextRef="c6" decimals="-3" id="ixv-19079" unitRef="usd">229000</wlds:RightofUseAssetRecognizedAgainstLeaseLiability>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c0" id="ixv-15617">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 1
- GENERAL:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 24px; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Wearable Devices Ltd. (the
    &#x201c;Company&#x201d;) was incorporated in Israel in March 2014. The Company develops&#160;and sells human-machine interface solutions
    for the smart wearables industry. In 2023, the Company started production of its B2C consumer product, the &#x201c;Mudra Band&#x201d;
    and started to generate revenues. The Company&#x2019;s products are designated directly to end users and also designated to businesses
    in integration of its technology in their smart wearable devices. The Company&#x2019;s Ordinary Shares and warrants began trading
    on the Nasdaq Capital Market (&#x201c;Nasdaq&#x201d;) on September 13, 2022, under the symbols &#x201c;WLDS&#x201d; and &#x201c;WLDSW,&#x201d;
    respectively (see Note 1e below). &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;We qualify as an &#x201c;emerging growth
company,&#x201d; as defined in Section 2(a) of the Securities Act of 1933, as amended, or the Securities Act, as modified by the U.S. Jumpstart
Our Business Startups Act of 2012 and we may take advantage of certain exemptions, including exemptions from various reporting requirements
that are otherwise applicable to public traded entities that do not qualify as emerging growth companies. These exemptions include:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.75in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.25in; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;not
                                            being required to comply with any requirement that may be adopted by the Public Company Accounting
                                            Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor&#x2019;s
                                            report providing additional information about the audit and the financial statements (i.e.,
                                            an auditor discussion and analysis).&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;We
will remain an emerging growth company until the earliest of: (i) the last day of the first fiscal year in which our annual gross revenues
exceed $1.235 billion; (ii) the last day of the fiscal year following the fifth anniversary of the date of our initial public offering
(i.e., December 31, 2027); (iii) the date that we become a &#x201c;large accelerated filer&#x201d; as defined in Rule&#160;12b-2&#160;under
the&#160;Exchange Act, which would occur if the aggregate worldwide market value of our ordinary shares, including ordinary shares represented
by warrants, held by non-affiliates is at least $700 million as of the last business day of our most recently completed second fiscal
quarter; or (iv) the date on which we have issued more than $1.0 billion in non-convertible debt securities during any three-year period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company&#x2019;s revenues were derived from:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 72px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
        sales of B2C consumer product, the &#x201c;Mudra Band&#x201d;.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The sales of B2B Mudra
    development kits composed of multiple performance obligations including tangible parts (&#x201c;Hardware&#x201d;) and a limited period
    (generally one year) application programming interface (&#x201c;API&#x201d;) with no commercial rights, to enable the customer to evaluate
    the Company&#x2019;s solution with its own products.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 72px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The sales of pilot transactions
    to evaluate the integration of the Company&#x2019;s solution with the customer&#x2019;s products composed of multiple performance obligations
    including Hardware, tailor-made software applications and technical support during the pilot period.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
2023, most of the Company&#x2019;s revenues were derived from the sales of Mudra Band to B2C customers. In 2022, all of the Company&#x2019;s
revenues were derived from the sales of Mudra development kits. In 2021, most of the Company&#x2019;s revenues were derived from a pilot
transaction in the amount of $84 thousand, which was fully completed in 2021 and from the sales of Mudra development kits to multinational
technology companies.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
    2018, the Company established a wholly owned subsidiary in the United States of America for the purpose of marketing and distribution
    of its solutions &#x2013; Mudra Wearable, Inc. (the &#x201c;Subsidiary&#x201d;) &#x2013; which commenced its operations in 2020. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 48px; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 24px; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;c.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3pt; text-align: justify; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company&#x2019;s headquarters is located in Israel. On October 7, 2023, Hamas terrorists infiltrated Israel&#x2019;s southern border from the Gaza Strip and conducted a series of attacks on civilian and military targets. Following the attack, Israel declared war against Hamas and the Israeli military began to call-up reservists for active duty. At the same time, and because of the declaration of war against Hamas, the clash between Israel and Hezbollah in Lebanon has escalated and there is a possibility that it will turn into a greater regional conflict in the future. Further, many Israeli citizens are obligated to perform several days, and in some cases, more, of annual military reserve duty each year until they reach the age of 40 (or older for certain reservists) and, in the event of a military conflict, may be called to active duty. As of today, these events have had no material impact on the Company&#x2019;s operations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 36pt"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal"&gt;d.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Going
                                            Concern:&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The accompanying consolidated financial
statements have been prepared assuming that the Company will continue as a going concern. To date, the Company is still in a transition
phase from its development stage to an early stage of generating revenues. Therefore, the Company has suffered recurring losses from operations
and negative cash flows from operations since inception. As detailed in Note 1e below, in September 2022, the Company completed an initial
public offering (&#x201c;IPO&#x201d;) and listed its ordinary shares, NIS 0.01 par value, (the &#x201c;Ordinary Shares&#x201d;) and warrants
for trading on Nasdaq and raised net proceeds of $13.3 million. In November 2023, the Company completed a secondary offering and raised
net proceeds of $1.7 million.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
of December 31, 2023, the Company had incurred accumulated losses of $21.2 million and expects to continue to fund its operations through
fundings such as issuance of convertible securities, Ordinary Shares and warrants and through Israeli governmental grants. There is no
assurance that such financing will be obtained. Considering the above, the Company&#x2019;s dependency on external funding for its operations
raises a substantial doubt about its ability to continue as a going concern. The consolidated financial statements do not include any
adjustments that might result from the outcome of these uncertainties.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 36pt"&gt;&lt;/td&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;e.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In September 2022, &lt;span style="background-color: white"&gt;the Company completed its IPO whereby the Company issued and sold in connection with the closing of the IPO 3,750,000 units, each consisting of one Ordinary Share and two warrants to purchase one Ordinary Share each. In addition, the underwriter exercised its over-allotment option with respect to 1,125,000 warrants to purchase 1,125,000 Ordinary Shares.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;The
warrants were exercisable immediately upon issuance, at an exercise price of $4.00 per Ordinary Share and are exercisable until September
12, 2027. On September 16, 2022, 40,000 warrants were exercised into 40,000 Ordinary Shares. On December 14, 2022, the exercise price
of the warrants was adjusted to $2.00 per Ordinary Share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="background-color: white"&gt;In connection with the IPO, the
Company received gross proceeds of approximately $16.0 million, before deducting underwriting discounts and commissions and before offering
expenses ($14.9 million net proceeds after deducting approximately $1.1 million of underwriting discounts and commissions and approximately
$13.3 million after other IPO expenses).&#160;The Ordinary Shares and warrants were approved for listing on the Nasdaq and commenced trading
under the symbol &#x201c;WLDS&#x201d; and &#x201c;WLDSW,&#x201d; respectively, on September 13, 2022. The Company&#x2019;s Ordinary Share and
warrant prices on Nasdaq were $0.4450 and $0.0682, respectively, as of March 12, 2024.&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 36pt"&gt;&lt;/td&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;f.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On November&#160;25, 2022, the Company received a written notification from the Listing Qualifications Department of the Nasdaq Stock Market LLC regarding its noncompliance with Nasdaq&#x2019;s minimum bid price requirement because the closing bid price of the Ordinary Shares was below $1.00 per Ordinary Share for the previous 30 consecutive business days. On May 23, 2023, the Company received a notification letter from Nasdaq that the Company had been granted an additional 180-day compliance period, or until November 20, 2023, to regain compliance with Nasdaq&#x2019;s minimum bid price rule. On June 9, 2023, the Company received a written notice from Nasdaq Stock Market LLC, indicating that it has regained compliance with the minimum bid price requirement. On October 24, 2023, the Company received a written notification from the Listing Qualifications Department of the Nasdaq Stock Market LLC regarding its noncompliance with Nasdaq&#x2019;s minimum bid price requirement because the closing bid price of the Ordinary Shares was below $1.00 per Ordinary Share for the previous 30 consecutive business days. The Company was granted 180 calendar days, or until April&#160;22, 2024, to regain compliance with the minimum bid price requirement. In the event the Company does not regain compliance with the minimum bid price requirement by April 22, 2024, it may be eligible for an additional 180-calendar day grace period.&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 36pt"&gt;&lt;/td&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;g.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On November 13, 2023, &lt;span style="background-color: white"&gt;the Company completed a public offering of its securities whereby the Company issued and sold 4,444,444 Ordinary Shares. The Company received gross proceeds of approximately $2 million, before deducting underwriting discounts and commissions and before offering expenses ($1.7 million net proceeds after deducting underwriting discounts and commissions and other expenses).&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <wlds:AnnualGrossRevenuesExceed contextRef="c0" decimals="-6" id="ixv-19080" unitRef="usd">1235000000</wlds:AnnualGrossRevenuesExceed>
    <wlds:OrdinarySharesWarrantsHeldByNonaffiliates contextRef="c0" decimals="-6" id="ixv-19081" unitRef="usd">700000000</wlds:OrdinarySharesWarrantsHeldByNonaffiliates>
    <wlds:NonconvertibleDebtSecurities contextRef="c0" decimals="-8" id="ixv-19082" unitRef="usd">1000000000</wlds:NonconvertibleDebtSecurities>
    <us-gaap:Revenues contextRef="c37" decimals="-3" id="ixv-19083" unitRef="usd">84000</us-gaap:Revenues>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c38"
      decimals="2"
      id="ixv-19084"
      unitRef="ilsPershares">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="c39" decimals="-5" id="ixv-19085" unitRef="usd">13300000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <wlds:NetProceedsFromIssuanceSecondaryPublicOffering contextRef="c40" decimals="-5" id="ixv-19086" unitRef="usd">1700000</wlds:NetProceedsFromIssuanceSecondaryPublicOffering>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c4" decimals="-5" id="ixv-19087" unitRef="usd">21200000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:CommonStockSharesIssued
      contextRef="c41"
      decimals="0"
      id="ixv-19088"
      unitRef="shares">3750000</us-gaap:CommonStockSharesIssued>
    <wlds:Warrants
      contextRef="c42"
      decimals="0"
      id="ixv-19089"
      unitRef="shares">1125000</wlds:Warrants>
    <us-gaap:CommonStockSharesIssued
      contextRef="c43"
      decimals="0"
      id="ixv-19090"
      unitRef="shares">1125000</us-gaap:CommonStockSharesIssued>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c44"
      decimals="2"
      id="ixv-19091"
      unitRef="usdPershares">4</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <wlds:WarrantsExerciseIntoOrdinaryShares
      contextRef="c45"
      decimals="0"
      id="ixv-19092"
      unitRef="shares">40000</wlds:WarrantsExerciseIntoOrdinaryShares>
    <us-gaap:CommonStockSharesIssued
      contextRef="c45"
      decimals="0"
      id="ixv-19093"
      unitRef="shares">40000</us-gaap:CommonStockSharesIssued>
    <wlds:ExercisePriceOfWarrant
      contextRef="c46"
      decimals="2"
      id="ixv-19094"
      unitRef="usdPershares">2</wlds:ExercisePriceOfWarrant>
    <wlds:GrossProceeds contextRef="c0" decimals="-5" id="ixv-19095" unitRef="usd">16000000</wlds:GrossProceeds>
    <wlds:UnderwritingNetProceed contextRef="c0" decimals="-5" id="ixv-19096" unitRef="usd">14900000</wlds:UnderwritingNetProceed>
    <wlds:UnderwritingDiscountsAndCommissions contextRef="c0" decimals="-5" id="ixv-19097" unitRef="usd">1100000</wlds:UnderwritingDiscountsAndCommissions>
    <wlds:GrossAfterOtherIPOExpenses contextRef="c47" decimals="-5" id="ixv-19098" unitRef="usd">13300000</wlds:GrossAfterOtherIPOExpenses>
    <us-gaap:SharePrice
      contextRef="c48"
      decimals="4"
      id="ixv-19099"
      unitRef="usdPershares">0.445</us-gaap:SharePrice>
    <wlds:WarrantsExercisePricePerShare contextRef="c48" decimals="4" id="ixv-19100" unitRef="usd">0.0682</wlds:WarrantsExercisePricePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c49"
      decimals="2"
      id="ixv-19101"
      unitRef="usdPershares">1</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c50"
      decimals="2"
      id="ixv-19102"
      unitRef="usdPershares">1</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c51"
      decimals="0"
      id="ixv-19103"
      unitRef="shares">4444444</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c51" decimals="-6" id="ixv-19104" unitRef="usd">2000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c51" decimals="-5" id="ixv-19105" unitRef="usd">1700000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c0" id="ixv-15832">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 2
- SIGNIFICANT ACCOUNTING POLICIES:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the
United States of America (&#x201c;U.S. GAAP&#x201d;). The significant accounting policies followed in the preparation of the financial
statements are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;a.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-right: 3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Principles of consolidation&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
accompanying consolidated financial statements include the accounts of the Company and the Subsidiary. All intercompany transactions
have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;b.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-right: 3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Use of estimates&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities, as well as to disclose contingent liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the reporting years. On an ongoing basis, management evaluates its
estimates, judgments and assumptions. Management bases its estimates, judgments and assumptions on historical experience and on various
other factors that are believed to be reasonable under the circumstances. Actual results could differ from those estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;c.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-right: 3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Foreign currency&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
currency of the primary economic environment in which the operations of the Company are conducted is the U.S. dollar (&#x201c;USD&#x201d;).
The Company&#x2019;s funding and revenues are mostly in USD. Thus, the functional currency of the Company is the USD.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt 0pt 80.3pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Transactions
and balances originally denominated in USD are presented at their original amounts. Balances in non-USD currencies are translated into
USD using historical and current exchange rates for non-monetary and monetary balances, respectively. For non-USD transactions and other
items (stated below) reflected in the statements of operations, the following exchange rates are used: (i) for transactions &#x2013; exchange
rates at transaction dates or average rates; and (ii) for other items (derived from non-monetary balance sheet items such as depreciation
etc.) &#x2013; historical exchange rates. Currency transaction gains or losses are recorded to finance income or expenses, as appropriate.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;d.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-right: 3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Inventories:&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Inventories
are composed of parts of the Company&#x2019;s products as well as completed products and are stated at the lower of cost or net realizable
value. Inventory cost is determined on FIFO basis. Net realizable value is the estimated selling prices in the ordinary course of business,
less reasonably predictable costs of completion, disposal, and transportation. The cost of inventories comprises all costs of purchase,
and other costs incurred in bringing the inventories to their present location and condition.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;e.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-right: 3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Property and equipment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Property
and equipment are stated at cost. Depreciation is computed based on the straight-line method, over the estimated useful life of the assets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Annual
rates of depreciation are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;%
    &lt;/b&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Office furniture, machines, leasehold improvements,
    and electronic equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7-15&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Computers and software&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;33&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Mold&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;f.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Leases&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On January 1, 2022, the Company began to implement ASU 2016-02, Leases (Topic 842) (&#x201c;ASU 2016-02&#x201d;) using the modified retrospective approach for all lease arrangements as of such date. The Company leases office space and vehicles under operating leases.&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Arrangements meeting the definition of a lease are classified as operating or financing leases and are recorded on the balance sheet as both a right-of-use asset and lease liability, calculated by discounting fixed lease payments over the lease term at the rate implicit in the lease or the Company&#x2019;s incremental borrowing rate. Lease liabilities are increased by interest and reduced by payments each period, and the right-of-use asset is amortized over the lease term.&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The lease liability was measured at the present value of the remaining lease payments, discounted using the Company&#x2019;s incremental borrowing rate. The weighted-average&#160;rate applied was 8%. Right-of-use&#160;assets were measured at an amount equal to the lease liability.&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For operating leases, interest on the lease liability and the amortization of the right-of-use asset result in straight-line&#160;rent expense over the lease term. Variable lease expenses are recorded when incurred.&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Leases with a lease term of 12 months or less at inception are not recorded within the Consolidated Balance Sheets and are expensed on a straight-line basis over the lease term in the Consolidated Statements of Operations and Comprehensive Loss.&lt;span style="font-size: 10pt; background-color: white"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;g.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Revenue recognition &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Revenue
is recognized when (or as) control of the promised goods or services is transferred to the customer, and in an amount that reflects the
consideration the Company is contractually due in exchange for those services or goods. The Company follows five steps to record revenue:
(i) identify the contract with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction
price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the
Company satisfies its performance obligations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The Company generate revenues from
the sales of B2C &#x201c;Mudra Band&#x201d;, sales of B2B &#x201c;Mudra development kits&#x201d; and sales of pilot transactions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The &#x201c;Mudra Band&#x201d; is an
aftermarket accessory band for the Apple Watch which allows touchless operation and control of the watch and iPhone by using an app which
is considered combined with the band as one performance obligation. Revenue derived from the sale of &#x201c;Mudra Band&#x201d; is recognized
at a point of time when control transfers to the customer. The Company believes that the delivery date is the most appropriate point in
time indicating control has transferred to the customer.&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The Company allows return and refund
of Mudra Band within 30 days of having the Mudra Band delivered. The Company records an appropriate provision for such refunds.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Revenue derived from freight charges
is considered as a separate performance obligation recognized when the related product revenue is recognized.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;A
pilot transaction has multiple performance obligations, and it generally takes a few months but less than one year. Each Mudra development
kit sale also has multiple performance obligations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
payment terms of the Mudra development kit sales are upon delivery of the Hardware, while the payment terms of the pilot transactions
are within the pilot period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
those transactions, each obligation- Hardware and API (for Mudra development kit) and tailor-made software application and technical
support (for a pilot transaction) - is distinct and separately identifiable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
amount allocated to the delivered items is recognized upon delivery, the amount allocated to API is recognized over the API period and
the amount allocated to the technical support is recognized over the service period (a pilot period).&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;h.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Cost of revenues&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Costs
are expensed as incurred. The primary components of cost of revenues include the cost of the product and outbound freight charges.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 80.3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;i.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Research and development&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Research
and development expenses consist primarily of payroll, payroll related expenses, subcontractors, and materials. Costs are expensed as
incurred.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;j.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Governmental grants&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company receives royalty-bearing grants from the Israeli government for approved research and development projects and marketing efforts.
These grants are recognized at the time the Company is entitled to such grants based on the costs incurred or milestones achieved as
provided by the relevant agreement and included as a deduction from research and development or sales and marketing expenses, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;k.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Finance income and expenses&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 80.55pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Finance
income is composed of interest on deposits and unrealized gain from foreign currency derivative activities, while finance expenses are
composed of interest on senior secured credit facility, bank charges and net currency exchange rates differences.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;l.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Income taxes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 80.3pt; text-indent: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company accounts for income taxes in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) 740, &#x201c;Income Taxes&#x201d;
(&#x201c;ASC 740&#x201d;). Deferred taxes are determined utilizing the assets and liabilities method, which is based on the estimated future
tax effects of the differences between the financial accounting and tax bases of assets and liabilities under the applicable tax laws.
Deferred tax balances are computed using the tax rates expected to be in effect when those differences reverse. A valuation allowance
in respect of deferred tax assets is provided if, based upon the weight of available evidence, it is more likely than not that some or
all the deferred tax assets will not be realized. The measurement of deferred tax assets is reduced, if necessary, by the amount of any
tax benefits that, based on available evidence, are not expected to be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 80.3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company applies ASC 740, which clarifies the accounting and reporting for uncertainties with respect to income taxes. ASC 740 prescribes
a comprehensive model for the financial statement recognition, measurement, presentation, and disclosure of uncertain tax positions taken
or expected to be taken in income tax returns.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;m.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Share based compensation&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Share-based
compensation expenses related to employees&#x2019; and consultants&#x2019; options are measured at the grant date based on the fair value
of the award and are generally expensed over the requisite service period (generally the vesting period). The Company recognizes compensation
expense on a straight-line basis from the beginning of the service period. For awards with graded-vesting features, each vesting tranche
is separately expensed over the related vesting period. The Company estimates the fair value of each stock option grant using the Black-Scholes
option pricing model, which requires management to make certain assumptions of future expectations based on historical and current data
include the expected term of the stock option, expected volatility, dividend yield, and risk-free interest rate.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;m.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Warrants&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
warrants&#x2019; mechanism does not create any obligation to transfer cash to the investors. Warrants are exercised for a fixed amount
of Ordinary Shares upon exercise. Therefore, the Company accounts for the warrants as equity-classified instruments (as part of additional
paid in capital), based on an assessment of the applicable U.S. GAAP authoritative guidance. The assessment considers whether the warrants
are freestanding financial instruments, meet the definition of a liability or whether the warrants meet all of the requirements for equity
classification, including whether the warrants are indexed to the Company&#x2019;s own shares, among other conditions for equity classification.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;o.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Severance&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 15pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Israeli
labor law generally requires payment of severance pay upon dismissal of an employee or upon termination of employment in certain other
circumstances. The Company&#x2019;s pension and severance pay liabilities are covered mainly by insurance policies. Pursuant to section
14 of the Israeli Severance Compensation Act, 1963 (&#x201c;section 14&#x201d;), the Company&#x2019;s employees are entitled to monthly
deposits, at a rate of 8.33% of their monthly salary, made in their name with insurance companies. Payments in accordance with section
14 relieve the Company from any future severance payments in respect of those employees and, as such, the Company may only utilize the
insurance policies for the purpose of paying severance pay.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 15pt 0pt 80.3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;p.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Basic and diluted loss per share&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 80.55pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic
and diluted loss per share is calculated by dividing the loss attributable to equity holders of the Company by the weighted average number
of Ordinary Shares outstanding during the financial year, adjusted for Ordinary Shares issued during the year, if applicable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;q.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fair Value Measurements&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company measures and discloses fair value in accordance with the Financial Accounting Standards Board (&#x201c;FASB&#x201d;), ASC 820,
Fair Value Measurements and Disclosures (&#x201c;ASC 820&#x201d;). ASC 820 defines fair value, establishes a framework and gives guidance
regarding the methods used for measuring fair value, and expands disclosures about fair value measurements. Fair value is an exit price,
representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market
participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions
that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, there exists a three-tier
fair-value hierarchy, which prioritizes the inputs used in measuring fair value as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 79.1pt; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
1 &#x2013; unadjusted quoted prices are available in active markets for identical assets or liabilities that the Company has the ability
to access as of the measurement date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 79.1pt; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
2 &#x2013; pricing inputs are other than quoted prices in active markets that are directly observable for the asset or liability or indirectly
observable through corroboration with observable market data.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 79.1pt; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
3 &#x2013; pricing inputs are unobservable for the non-financial asset or liability and only used when there is little, if any, market
activity for the non-financial asset or liability at the measurement date. The inputs into the determination of fair value require significant
management judgment or estimation. Level 3 inputs are considered as the lowest priority within the fair value hierarchy.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 79.1pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;This
hierarchy requires the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining
fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 79.1pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
fair value of cash is based on its demand value, which is equal to its carrying value. Additionally, the carrying value of all other
short-term monetary assets and liabilities are estimated to be equal to their fair value due to the short-term nature of these instruments.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;r.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Concentration of Credit Risk&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The Company maintains certain cash
balances in a well-known Israeli banks and a U.S.-based bank.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The Company&#x2019;s labor expenses
are denominated mainly in NIS, and therefore, subject to foreign currency risk. During the year ended December 31, 2023, the Company partially
hedged its foreign currency exchange risk.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The Company&#x2019;s derivative instruments
primarily include foreign currency forward agreements related to the NIS and associated with certain payroll payments. The Company&#x2019;s
foreign currency forward agreements related to foreign currency&#160;balance sheet exposure provide economic hedges but are not designated
as hedges for accounting purposes. Changes in the value of the derivative,&#160;along with the transaction gain or loss on the hedged
item, are recorded within the Company&#x2019;s consolidated statements of loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;s.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Cash and cash equivalents:&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cash
equivalents are highly liquid investments that are readily convertible into cash, typically with an original maturity of three months
or less.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 49px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;t.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Segment Information &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company has a single operating and reportable segment. The Company&#x2019;s chief operating decision maker, who is the Chief Executive Officer, evaluates the performance of its business based on financial data consistent with the presentation in the accompanying consolidated financial statements for the purposes of making operating decisions, assessing financial performance, and allocating resources. &#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 49px"&gt;&lt;/td&gt;&lt;td style="width: 24px; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;u.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Subsequent Events&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;In connection with the preparation of these consolidated financial
statements, the Company and management evaluated subsequent events through March 13, 2024, the date these consolidated financial statements
were available to be issued.&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c0" id="ixv-15842">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;a.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-right: 3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Principles of consolidation&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
accompanying consolidated financial statements include the accounts of the Company and the Subsidiary. All intercompany transactions
have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c0" id="ixv-15860">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;b.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-right: 3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Use of estimates&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities, as well as to disclose contingent liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the reporting years. On an ongoing basis, management evaluates its
estimates, judgments and assumptions. Management bases its estimates, judgments and assumptions on historical experience and on various
other factors that are believed to be reasonable under the circumstances. Actual results could differ from those estimates.&lt;/span&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="c0" id="ixv-15879">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;c.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-right: 3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Foreign currency&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
currency of the primary economic environment in which the operations of the Company are conducted is the U.S. dollar (&#x201c;USD&#x201d;).
The Company&#x2019;s funding and revenues are mostly in USD. Thus, the functional currency of the Company is the USD.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Transactions
and balances originally denominated in USD are presented at their original amounts. Balances in non-USD currencies are translated into
USD using historical and current exchange rates for non-monetary and monetary balances, respectively. For non-USD transactions and other
items (stated below) reflected in the statements of operations, the following exchange rates are used: (i) for transactions &#x2013; exchange
rates at transaction dates or average rates; and (ii) for other items (derived from non-monetary balance sheet items such as depreciation
etc.) &#x2013; historical exchange rates. Currency transaction gains or losses are recorded to finance income or expenses, as appropriate.&lt;/span&gt;&lt;/p&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:InventoryPolicyTextBlock contextRef="c0" id="ixv-15903">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;d.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-right: 3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Inventories:&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Inventories
are composed of parts of the Company&#x2019;s products as well as completed products and are stated at the lower of cost or net realizable
value. Inventory cost is determined on FIFO basis. Net realizable value is the estimated selling prices in the ordinary course of business,
less reasonably predictable costs of completion, disposal, and transportation. The cost of inventories comprises all costs of purchase,
and other costs incurred in bringing the inventories to their present location and condition.&lt;/span&gt;&lt;/p&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="c0" id="ixv-15922">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;e.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-right: 3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Property and equipment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Property
and equipment are stated at cost. Depreciation is computed based on the straight-line method, over the estimated useful life of the assets.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Annual
rates of depreciation are as follows:&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;%
    &lt;/b&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Office furniture, machines, leasehold improvements,
    and electronic equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7-15&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Computers and software&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;33&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Mold&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <wlds:ScheduleOfAnnualRatesOfDepreciationTableTextBlock contextRef="c0" id="ixv-15943">&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Annual
rates of depreciation are as follows:&lt;/span&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;%
    &lt;/b&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Office furniture, machines, leasehold improvements,
    and electronic equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7-15&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Computers and software&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;33&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Mold&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;</wlds:ScheduleOfAnnualRatesOfDepreciationTableTextBlock>
    <wlds:AnnualRateOfDepreciation contextRef="c53" decimals="2" id="ixv-19106" unitRef="pure">0.07</wlds:AnnualRateOfDepreciation>
    <wlds:AnnualRateOfDepreciation contextRef="c54" decimals="2" id="ixv-19107" unitRef="pure">0.15</wlds:AnnualRateOfDepreciation>
    <wlds:AnnualRateOfDepreciation contextRef="c55" decimals="2" id="ixv-19108" unitRef="pure">0.33</wlds:AnnualRateOfDepreciation>
    <wlds:AnnualRateOfDepreciation contextRef="c56" decimals="2" id="ixv-19109" unitRef="pure">0.50</wlds:AnnualRateOfDepreciation>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="c0" id="ixv-16032">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;f.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Leases&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On January 1, 2022, the Company began to implement ASU 2016-02, Leases (Topic 842) (&#x201c;ASU 2016-02&#x201d;) using the modified retrospective approach for all lease arrangements as of such date. The Company leases office space and vehicles under operating leases.&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Arrangements meeting the definition of a lease are classified as operating or financing leases and are recorded on the balance sheet as both a right-of-use asset and lease liability, calculated by discounting fixed lease payments over the lease term at the rate implicit in the lease or the Company&#x2019;s incremental borrowing rate. Lease liabilities are increased by interest and reduced by payments each period, and the right-of-use asset is amortized over the lease term.&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The lease liability was measured at the present value of the remaining lease payments, discounted using the Company&#x2019;s incremental borrowing rate. The weighted-average&#160;rate applied was 8%. Right-of-use&#160;assets were measured at an amount equal to the lease liability.&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For operating leases, interest on the lease liability and the amortization of the right-of-use asset result in straight-line&#160;rent expense over the lease term. Variable lease expenses are recorded when incurred.&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Leases with a lease term of 12 months or less at inception are not recorded within the Consolidated Balance Sheets and are expensed on a straight-line basis over the lease term in the Consolidated Statements of Operations and Comprehensive Loss.&lt;span style="font-size: 10pt; background-color: white"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:DebtWeightedAverageInterestRate contextRef="c52" decimals="2" id="ixv-19110" unitRef="pure">0.08</us-gaap:DebtWeightedAverageInterestRate>
    <us-gaap:LesseeFinanceLeaseRenewalTerm1 contextRef="c4" id="ixv-19111">P12M</us-gaap:LesseeFinanceLeaseRenewalTerm1>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="c0" id="ixv-16068">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;g.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Revenue recognition &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Revenue
is recognized when (or as) control of the promised goods or services is transferred to the customer, and in an amount that reflects the
consideration the Company is contractually due in exchange for those services or goods. The Company follows five steps to record revenue:
(i) identify the contract with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction
price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the
Company satisfies its performance obligations.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The Company generate revenues from
the sales of B2C &#x201c;Mudra Band&#x201d;, sales of B2B &#x201c;Mudra development kits&#x201d; and sales of pilot transactions.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The &#x201c;Mudra Band&#x201d; is an
aftermarket accessory band for the Apple Watch which allows touchless operation and control of the watch and iPhone by using an app which
is considered combined with the band as one performance obligation. Revenue derived from the sale of &#x201c;Mudra Band&#x201d; is recognized
at a point of time when control transfers to the customer. The Company believes that the delivery date is the most appropriate point in
time indicating control has transferred to the customer.&#160;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The Company allows return and refund
of Mudra Band within 30 days of having the Mudra Band delivered. The Company records an appropriate provision for such refunds.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Revenue derived from freight charges
is considered as a separate performance obligation recognized when the related product revenue is recognized.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;A
pilot transaction has multiple performance obligations, and it generally takes a few months but less than one year. Each Mudra development
kit sale also has multiple performance obligations.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
payment terms of the Mudra development kit sales are upon delivery of the Hardware, while the payment terms of the pilot transactions
are within the pilot period.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
those transactions, each obligation- Hardware and API (for Mudra development kit) and tailor-made software application and technical
support (for a pilot transaction) - is distinct and separately identifiable.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
amount allocated to the delivered items is recognized upon delivery, the amount allocated to API is recognized over the API period and
the amount allocated to the technical support is recognized over the service period (a pilot period).&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <wlds:CostOfRevenuesPolicyTextBlock contextRef="c0" id="ixv-16119">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;h.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Cost of revenues&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Costs
are expensed as incurred. The primary components of cost of revenues include the cost of the product and outbound freight charges.&lt;/span&gt;&lt;/p&gt;</wlds:CostOfRevenuesPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="c0" id="ixv-16137">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;i.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Research and development&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Research
and development expenses consist primarily of payroll, payroll related expenses, subcontractors, and materials. Costs are expensed as
incurred.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <wlds:GovernmentalGrantsPolicyTextBlock contextRef="c0" id="ixv-16189">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;j.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Governmental grants&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company receives royalty-bearing grants from the Israeli government for approved research and development projects and marketing efforts.
These grants are recognized at the time the Company is entitled to such grants based on the costs incurred or milestones achieved as
provided by the relevant agreement and included as a deduction from research and development or sales and marketing expenses, respectively.&lt;/span&gt;&lt;/p&gt;</wlds:GovernmentalGrantsPolicyTextBlock>
    <wlds:FinanceIncomeAndExpensesPolicyPolicyTextBlock contextRef="c0" id="ixv-16207">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;k.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Finance income and expenses&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Finance
income is composed of interest on deposits and unrealized gain from foreign currency derivative activities, while finance expenses are
composed of interest on senior secured credit facility, bank charges and net currency exchange rates differences.&lt;/span&gt;&lt;/p&gt;</wlds:FinanceIncomeAndExpensesPolicyPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c0" id="ixv-16225">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;l.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Income taxes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company accounts for income taxes in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) 740, &#x201c;Income Taxes&#x201d;
(&#x201c;ASC 740&#x201d;). Deferred taxes are determined utilizing the assets and liabilities method, which is based on the estimated future
tax effects of the differences between the financial accounting and tax bases of assets and liabilities under the applicable tax laws.
Deferred tax balances are computed using the tax rates expected to be in effect when those differences reverse. A valuation allowance
in respect of deferred tax assets is provided if, based upon the weight of available evidence, it is more likely than not that some or
all the deferred tax assets will not be realized. The measurement of deferred tax assets is reduced, if necessary, by the amount of any
tax benefits that, based on available evidence, are not expected to be realized.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company applies ASC 740, which clarifies the accounting and reporting for uncertainties with respect to income taxes. ASC 740 prescribes
a comprehensive model for the financial statement recognition, measurement, presentation, and disclosure of uncertain tax positions taken
or expected to be taken in income tax returns.&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c0" id="ixv-16248">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;m.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Share based compensation&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Share-based
compensation expenses related to employees&#x2019; and consultants&#x2019; options are measured at the grant date based on the fair value
of the award and are generally expensed over the requisite service period (generally the vesting period). The Company recognizes compensation
expense on a straight-line basis from the beginning of the service period. For awards with graded-vesting features, each vesting tranche
is separately expensed over the related vesting period. The Company estimates the fair value of each stock option grant using the Black-Scholes
option pricing model, which requires management to make certain assumptions of future expectations based on historical and current data
include the expected term of the stock option, expected volatility, dividend yield, and risk-free interest rate.&lt;/span&gt;&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <wlds:WarrantsPolicyPolicyTextBlock contextRef="c0" id="ixv-16267">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;m.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Warrants&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
warrants&#x2019; mechanism does not create any obligation to transfer cash to the investors. Warrants are exercised for a fixed amount
of Ordinary Shares upon exercise. Therefore, the Company accounts for the warrants as equity-classified instruments (as part of additional
paid in capital), based on an assessment of the applicable U.S. GAAP authoritative guidance. The assessment considers whether the warrants
are freestanding financial instruments, meet the definition of a liability or whether the warrants meet all of the requirements for equity
classification, including whether the warrants are indexed to the Company&#x2019;s own shares, among other conditions for equity classification.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</wlds:WarrantsPolicyPolicyTextBlock>
    <wlds:SeverancePolicyTextBlock contextRef="c0" id="ixv-16319">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;o.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Severance&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Israeli
labor law generally requires payment of severance pay upon dismissal of an employee or upon termination of employment in certain other
circumstances. The Company&#x2019;s pension and severance pay liabilities are covered mainly by insurance policies. Pursuant to section
14 of the Israeli Severance Compensation Act, 1963 (&#x201c;section 14&#x201d;), the Company&#x2019;s employees are entitled to monthly
deposits, at a rate of 8.33% of their monthly salary, made in their name with insurance companies. Payments in accordance with section
14 relieve the Company from any future severance payments in respect of those employees and, as such, the Company may only utilize the
insurance policies for the purpose of paying severance pay.&lt;/span&gt;&lt;/p&gt;</wlds:SeverancePolicyTextBlock>
    <wlds:RateOfMonthlySeverancePercentage contextRef="c0" decimals="4" id="ixv-19112" unitRef="pure">0.0833</wlds:RateOfMonthlySeverancePercentage>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c0" id="ixv-16337">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;p.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Basic and diluted loss per share&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic
and diluted loss per share is calculated by dividing the loss attributable to equity holders of the Company by the weighted average number
of Ordinary Shares outstanding during the financial year, adjusted for Ordinary Shares issued during the year, if applicable.&lt;/span&gt;&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="c0" id="ixv-16356">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;q.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fair Value Measurements&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company measures and discloses fair value in accordance with the Financial Accounting Standards Board (&#x201c;FASB&#x201d;), ASC 820,
Fair Value Measurements and Disclosures (&#x201c;ASC 820&#x201d;). ASC 820 defines fair value, establishes a framework and gives guidance
regarding the methods used for measuring fair value, and expands disclosures about fair value measurements. Fair value is an exit price,
representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market
participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions
that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, there exists a three-tier
fair-value hierarchy, which prioritizes the inputs used in measuring fair value as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
1 &#x2013; unadjusted quoted prices are available in active markets for identical assets or liabilities that the Company has the ability
to access as of the measurement date.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
2 &#x2013; pricing inputs are other than quoted prices in active markets that are directly observable for the asset or liability or indirectly
observable through corroboration with observable market data.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
3 &#x2013; pricing inputs are unobservable for the non-financial asset or liability and only used when there is little, if any, market
activity for the non-financial asset or liability at the measurement date. The inputs into the determination of fair value require significant
management judgment or estimation. Level 3 inputs are considered as the lowest priority within the fair value hierarchy.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;This
hierarchy requires the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining
fair value.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
fair value of cash is based on its demand value, which is equal to its carrying value. Additionally, the carrying value of all other
short-term monetary assets and liabilities are estimated to be equal to their fair value due to the short-term nature of these instruments.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="c0" id="ixv-16436">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;r.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Concentration of Credit Risk&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The Company maintains certain cash
balances in a well-known Israeli banks and a U.S.-based bank.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The Company&#x2019;s labor expenses
are denominated mainly in NIS, and therefore, subject to foreign currency risk. During the year ended December 31, 2023, the Company partially
hedged its foreign currency exchange risk.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The Company&#x2019;s derivative instruments
primarily include foreign currency forward agreements related to the NIS and associated with certain payroll payments. The Company&#x2019;s
foreign currency forward agreements related to foreign currency&#160;balance sheet exposure provide economic hedges but are not designated
as hedges for accounting purposes. Changes in the value of the derivative,&#160;along with the transaction gain or loss on the hedged
item, are recorded within the Company&#x2019;s consolidated statements of loss.&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c0" id="ixv-16459">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;s.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Cash and cash equivalents:&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cash
equivalents are highly liquid investments that are readily convertible into cash, typically with an original maturity of three months
or less.&lt;/span&gt;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="c0" id="ixv-16477">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 49px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;t.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Segment Information &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The Company has a single operating and reportable segment. The Company&#x2019;s chief operating decision maker, who is the Chief Executive Officer, evaluates the performance of its business based on financial data consistent with the presentation in the accompanying consolidated financial statements for the purposes of making operating decisions, assessing financial performance, and allocating resources. &#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:SubsequentEventsPolicyPolicyTextBlock contextRef="c0" id="ixv-16495">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 49px"&gt;&lt;/td&gt;&lt;td style="width: 24px; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;u.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Subsequent Events&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;In connection with the preparation of these consolidated financial
statements, the Company and management evaluated subsequent events through March 13, 2024, the date these consolidated financial statements
were available to be issued.&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:SubsequentEventsPolicyPolicyTextBlock>
    <us-gaap:InventoryDisclosureTextBlock contextRef="c0" id="ixv-16535">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 3
- INVENTORIES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;U.S.
    dollars &lt;br/&gt;
    in thousands&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cost:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;514&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Work-in-progress&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;206&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-92; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Finished
    goods&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;312&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-93; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,032&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="c0" id="ixv-16541">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;U.S.
    dollars &lt;br/&gt;
    in thousands&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cost:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;514&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Work-in-progress&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;206&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-92; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Finished
    goods&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;312&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-93; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,032&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="c4" decimals="-3" id="ixv-19113" unitRef="usd">514000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="c5" decimals="-3" id="ixv-19114" unitRef="usd">6000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves contextRef="c4" decimals="-3" id="ixv-19115" unitRef="usd">206000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="c4" decimals="-3" id="ixv-19116" unitRef="usd">312000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:FIFOInventoryAmount contextRef="c4" decimals="-3" id="ixv-19117" unitRef="usd">1032000</us-gaap:FIFOInventoryAmount>
    <us-gaap:FIFOInventoryAmount contextRef="c5" decimals="-3" id="ixv-19118" unitRef="usd">6000</us-gaap:FIFOInventoryAmount>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="c0" id="ixv-16673">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE&lt;/b&gt;&#160;
&lt;b&gt;4 - PROPERTY AND EQUIPMENT, net&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;U.S.
    dollars &lt;br/&gt;
    in thousands&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cost:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Computers and
    software&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;204&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;124&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Furniture and leasehold
    improvements&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;38&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Electronic equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Machines
    and molds&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;72&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-94; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;334&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;140&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less
    - &lt;span style="font-style: normal; font-weight: normal"&gt;accumulated depreciation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;140&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;72&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;194&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;68&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c0" id="ixv-16680">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;U.S.
    dollars &lt;br/&gt;
    in thousands&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cost:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Computers and
    software&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;204&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;124&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Furniture and leasehold
    improvements&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;38&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Electronic equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Machines
    and molds&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;72&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-94; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;334&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;140&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less
    - &lt;span style="font-style: normal; font-weight: normal"&gt;accumulated depreciation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;140&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;72&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;194&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;68&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c57" decimals="-3" id="ixv-19119" unitRef="usd">204000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c58" decimals="-3" id="ixv-19120" unitRef="usd">124000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c59" decimals="-3" id="ixv-19121" unitRef="usd">38000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c60" decimals="-3" id="ixv-19122" unitRef="usd">7000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c61" decimals="-3" id="ixv-19123" unitRef="usd">20000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c62" decimals="-3" id="ixv-19124" unitRef="usd">9000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c63" decimals="-3" id="ixv-19125" unitRef="usd">72000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c4" decimals="-3" id="ixv-19126" unitRef="usd">334000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c5" decimals="-3" id="ixv-19127" unitRef="usd">140000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c4" decimals="-3" id="ixv-19128" unitRef="usd">140000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c5" decimals="-3" id="ixv-19129" unitRef="usd">72000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c4" decimals="-3" id="ixv-19130" unitRef="usd">194000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c5" decimals="-3" id="ixv-19131" unitRef="usd">68000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c0" id="ixv-16869">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 5-
LEASES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company has operating leases for
its offices and vehicles. The Company&#x2019;s leases have remaining terms of less than one year to approximately 2 years, some of which
may include options to extend the leases for up to 2 years.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
following table summarizes the classification of operating lease right-of-use assets and liabilities in the Company&#x2019;s Consolidated
Balance Sheets as of December&#160;31, 2023 and 2022:&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;U.S.
    dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; width: 76%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Right of
    use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;592&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;180&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Short term&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;297&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;68&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Long term&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;278&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;94&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;575&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;162&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;At December&#160;31, 2023, the future minimum lease payments
under the Company&#x2019;s operating lease liabilities are as follows:&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;U.S.&#160;dollars&lt;br/&gt; in&#160;thousands&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;2024&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;308&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;289&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;2026&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;22&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total future minimum lease payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;619&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;Less imputed interest&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(44&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total operating lease liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;575&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;Less operating lease liabilities, current&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(297&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;Operating lease liabilities, non-current&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;278&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Total expenses under all operating leases were $232 thousand,
$74 thousand, and $42 thousand for the years ended December 31, 2023, 2022 and 2021, respectively.&lt;/p&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm contextRef="c4" id="ixv-19132">P2Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseOptionToExtend contextRef="c0" id="ixv-19133">2 years</us-gaap:LesseeOperatingLeaseOptionToExtend>
    <us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock contextRef="c0" id="ixv-16880">&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
following table summarizes the classification of operating lease right-of-use assets and liabilities in the Company&#x2019;s Consolidated
Balance Sheets as of December&#160;31, 2023 and 2022:&lt;/span&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;U.S.
    dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; width: 76%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Right of
    use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;592&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;180&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Short term&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;297&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;68&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Long term&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;278&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;94&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;575&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;162&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c4" decimals="-3" id="ixv-19134" unitRef="usd">592000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c5" decimals="-3" id="ixv-19135" unitRef="usd">180000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c4" decimals="-3" id="ixv-19136" unitRef="usd">297000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c5" decimals="-3" id="ixv-19137" unitRef="usd">68000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c4" decimals="-3" id="ixv-19138" unitRef="usd">278000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c5" decimals="-3" id="ixv-19139" unitRef="usd">94000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability contextRef="c4" decimals="-3" id="ixv-19140" unitRef="usd">575000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability contextRef="c5" decimals="-3" id="ixv-19141" unitRef="usd">162000</us-gaap:OperatingLeaseLiability>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c0" id="ixv-19142">At December&#160;31, 2023, the future minimum lease payments
under the Company&#x2019;s operating lease liabilities are as follows:&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;U.S.&#160;dollars&lt;br/&gt; in&#160;thousands&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;2024&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;308&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;289&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;2026&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;22&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total future minimum lease payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;619&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;Less imputed interest&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(44&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total operating lease liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;575&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;Less operating lease liabilities, current&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(297&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;Operating lease liabilities, non-current&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;278&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c4" decimals="-3" id="ixv-19143" unitRef="usd">308000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c4" decimals="-3" id="ixv-19144" unitRef="usd">289000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c4" decimals="-3" id="ixv-19145" unitRef="usd">22000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c4" decimals="-3" id="ixv-19146" unitRef="usd">619000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c4" decimals="-3" id="ixv-19147" unitRef="usd">44000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c4" decimals="-3" id="ixv-19148" unitRef="usd">575000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c4" decimals="-3" id="ixv-19149" unitRef="usd">297000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c4" decimals="-3" id="ixv-19150" unitRef="usd">278000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseExpense contextRef="c0" decimals="-3" id="ixv-19151" unitRef="usd">232000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense contextRef="c6" decimals="-3" id="ixv-19152" unitRef="usd">74000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense contextRef="c7" decimals="-3" id="ixv-19153" unitRef="usd">42000</us-gaap:OperatingLeaseExpense>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c0" id="ixv-17124">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 6
- COMMITMENTS AND CONTINGENCIES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;a.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Royalties to the Israel Innovation Authority (&#x201c;IIA&#x201d;):&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.4pt; text-indent: -0.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company receives royalty-bearing grants from the IIA, for approved research and development projects. The programs include grants for:
wages, materials, subcontractors and miscellaneous. The Company was required to pay royalties at the rate of 3%-3.5% on sales of products
developed with the funds provided by the IIA, up to an amount equal to 100% of the IIA research and development grants received, linked
to the dollar including accrued interest. Until October 25, 2023, the interest was calculated at a rate based on 12-month LIBOR applicable
to US Dollar deposits. However, on October 25, 2023, the IIA published a directive concerning changes in royalties to address the expiration
of the LIBOR. Under such directive, regarding IIA grants approved by the IIA prior to January 1, 2024 but which are outstanding thereafter,
as of January 1, 2024 the annual interest is calculated at a rate based on 12-month SOFR, or at an alternative rate published by the
Bank of Israel plus 0.71513%; and, for grants approved on or following January 1, 2024 the annual interest shall be the higher of (i)
the 12 months SOFR interest rate, plus 1%, or (ii) a fixed annual interest rate of 4%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
of December 31, 2018, two IIA programs were completed, while the amounts received for them aggregated to $1.224 million. In addition,
another IIA approved plan commenced on May 1, 2020, and was completed on July 31, 2021, pursuant to which a total of $627 thousand was
received. During January 2023, the IIA approved an additional program to finance further development of the Company&#x2019;s manufacturing
process of its wearable neural interface in Israel. The approved program is in amount of approximately $900 thousand (NIS 3.1 million),
of which the IIA will finance 60%; as of December 31, 2023, $288 thousand was received.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
terms of the grants under the Encouragement of Research, Development and Technological Innovation in the Industry 1984 require that the
manufacturing of products resulting from IIA-funded programs be carried out in Israel, unless a prior written approval of the IIA is
obtained (except for a transfer of up to 10% of the production rights, for which a notification to the IIA is sufficient). During December
2022, the Company received an approval from the IIA to transfer some of its manufacturing activities abroad.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
a condition for obtaining approval to manufacture outside Israel (or following a declaration that up to 10% of the production is transferred
abroad), the Company would be required to pay increased royalties, which usually amount to 1% in addition to the standard royalties rate
3%-3.5%, and also the total amount of its liability to the IIA may be increased to between 120% and 300% of the grants received from
the IIA, depending on the manufacturing volume that is performed outside Israel (less royalties already paid to IIA).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Research
and development grants deducted from research and development expenses amounted to $415, &lt;span style="-sec-ix-hidden: hidden-fact-95"&gt;nil&lt;/span&gt; and $289 thousand for the years ended December
31, 2023, 2022 and 2021, respectively. As of December 31, 2023, the maximum obligation with respect to the grants received from the IIA,
contingent upon entitled future sales, is $2.2 million plus interest which may be increased, depending on the manufacturing volume that
is performed outside Israel. The Company has obligations regarding know-how, technology, or products, not to transfer the information,
rights thereon and production rights which derive from the research and development, in whole or part, of its Mudra product and its Mudra
Band product, without the IIA Research Committee approval.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;b.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Royalties to the Israeli Ministry of Economy and
    Industry (&#x201c;IMEI&#x201d;):&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 35.5pt 0pt 77.3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;During
2020, the Company received a grant from the IMEI, for approved marketing expenses amounting to $95 thousand. The program includes participation
in expenses for: consulting for marketing, advertising and online marketing, flights to exhibitions and miscellaneous. &#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Sales
and marketing grants deducted from sales and marketing expenses amounted to $42 thousand for the year ended December 31, 2021.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.6pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Under the agreement with the IMEI,
if the export revenues in the defined target market increase by $311 thousand compared to the base year, the Company would be required
to pay royalties at the rate of 3% of the increase, with the funds provided by the IMEI up to an amount equal to 100% of the IMEI marketing
grant received, linked to the consumer price index (&#x201c;CPI&#x201d;).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;As of December 31, 2023, the maximum
obligation with respect to the grant received from the IMEI, contingent upon entitled future sales, is $95 thousand linked to the CPI.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;c.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Lease Commitments &#x2013; Operating Leases:&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On
July 1, 2018, the Company entered into a lease agreement for a period which expired on September 30, 2022. The monthly lease payment
totaled approximately $5 thousand.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;After
September 30, 2022, the Company stayed on the lease on a month-to-month basis. At the end of January 2023, the Company terminated this
lease with 60 days&#x2019; termination notice that ended on March 31, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
January 2023, the Company entered into a new lease agreement in Yokne&#x2019;am Illit, Israel for a period which started on February 1,
2023, and expires on January 31, 2025, with an option to extend the lease period by two additional lease periods, each for an additional
12 months. The Company&#x2019;s monthly rent payment for this facility is approximately $16 thousand during the first lease year and will
be increased to approximately $20 thousand during the second lease year. During the option lease periods, the lease payment may be increased
up to 10% as compared to the second lease year. The Company expects to exercise the option and extend the lease for another year.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The Company&#x2019;s subsidiary, Mudra
Wearable, established an office located in California. The lease is on a month-to-month basis with de-minimis consideration. Additionally,
during 2022, the Company entered into lease agreements to lease 5 vehicles for a period of 3 years.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <wlds:RoyaltiesRate contextRef="c65" decimals="2" id="ixv-19154" unitRef="pure">0.03</wlds:RoyaltiesRate>
    <wlds:RoyaltiesRate contextRef="c66" decimals="3" id="ixv-19155" unitRef="pure">0.035</wlds:RoyaltiesRate>
    <wlds:GrantsReceivedEqualPercentageRate contextRef="c0" decimals="2" id="ixv-19156" unitRef="pure">1</wlds:GrantsReceivedEqualPercentageRate>
    <wlds:AnnualAlternativeInterestPercentage contextRef="c0" decimals="7" id="ixv-19157" unitRef="pure">0.0071513</wlds:AnnualAlternativeInterestPercentage>
    <wlds:AnnualInterestRate contextRef="c67" decimals="2" id="ixv-19158" unitRef="pure">0.01</wlds:AnnualInterestRate>
    <wlds:FixedAnnualInterestRate contextRef="c0" decimals="2" id="ixv-19159" unitRef="pure">0.04</wlds:FixedAnnualInterestRate>
    <wlds:AmountsReceivedAggregateAmount contextRef="c68" decimals="-3" id="ixv-19160" unitRef="usd">1224000</wlds:AmountsReceivedAggregateAmount>
    <wlds:AmountsReceivedAggregateAmount contextRef="c69" decimals="-3" id="ixv-19161" unitRef="usd">627000</wlds:AmountsReceivedAggregateAmount>
    <wlds:AmountOfDevelopmentProgram contextRef="c70" decimals="-3" id="ixv-19162" unitRef="usd">900000</wlds:AmountOfDevelopmentProgram>
    <wlds:AmountOfDevelopmentProgram contextRef="c70" decimals="-5" id="ixv-19163" unitRef="ils">3100000</wlds:AmountOfDevelopmentProgram>
    <wlds:PercentageOfFinancing contextRef="c4" decimals="2" id="ixv-19164" unitRef="pure">0.60</wlds:PercentageOfFinancing>
    <wlds:TotalCashReceivedFromTheIIA contextRef="c0" decimals="-3" id="ixv-19165" unitRef="usd">288000</wlds:TotalCashReceivedFromTheIIA>
    <wlds:ExceptTransferProductionRight contextRef="c0" decimals="2" id="ixv-19166" unitRef="pure">0.10</wlds:ExceptTransferProductionRight>
    <wlds:ProductionTransferred contextRef="c0" decimals="2" id="ixv-19167" unitRef="pure">0.10</wlds:ProductionTransferred>
    <wlds:PayIncreasedRoyaltiesDescription contextRef="c0" id="ixv-19168">the Company would be required to pay increased royalties, which usually amount to 1% in addition to the standard royalties rate
3%-3.5%, and also the total amount of its liability to the IIA may be increased to between 120% and 300% of the grants received from
the IIA, depending on the manufacturing volume that is performed outside Israel (less royalties already paid to IIA).</wlds:PayIncreasedRoyaltiesDescription>
    <wlds:ResearchAndDevelopmentGrantsDetection contextRef="c71" decimals="-3" id="ixv-19169" unitRef="usd">415000</wlds:ResearchAndDevelopmentGrantsDetection>
    <wlds:ResearchAndDevelopmentGrantsDetection contextRef="c73" decimals="-3" id="ixv-19170" unitRef="usd">289000</wlds:ResearchAndDevelopmentGrantsDetection>
    <wlds:MaximumObligatinAmount contextRef="c74" decimals="-5" id="ixv-19171" unitRef="usd">2200000</wlds:MaximumObligatinAmount>
    <wlds:GrantsReceivedFromTheIMEI contextRef="c75" decimals="-3" id="ixv-19172" unitRef="usd">95000</wlds:GrantsReceivedFromTheIMEI>
    <wlds:SalesAndMarketingExpensesDeductions contextRef="c76" decimals="-3" id="ixv-19173" unitRef="usd">42000</wlds:SalesAndMarketingExpensesDeductions>
    <us-gaap:RevenuesNetOfInterestExpense contextRef="c77" decimals="-3" id="ixv-19174" unitRef="usd">311000</us-gaap:RevenuesNetOfInterestExpense>
    <wlds:RoyaltiesRatePercentage contextRef="c77" decimals="2" id="ixv-19175" unitRef="pure">0.03</wlds:RoyaltiesRatePercentage>
    <wlds:MarketingGrantReceived contextRef="c0" decimals="2" id="ixv-19176" unitRef="pure">1</wlds:MarketingGrantReceived>
    <us-gaap:GrantsReceivableCurrent contextRef="c4" decimals="-3" id="ixv-19177" unitRef="usd">95000</us-gaap:GrantsReceivableCurrent>
    <us-gaap:LeaseCost contextRef="c0" decimals="-3" id="ixv-19178" unitRef="usd">5000</us-gaap:LeaseCost>
    <us-gaap:PaymentsForRent contextRef="c78" decimals="-3" id="ixv-19179" unitRef="usd">16000</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent contextRef="c79" decimals="-3" id="ixv-19180" unitRef="usd">20000</us-gaap:PaymentsForRent>
    <wlds:LeasePaymentIncreased contextRef="c80" decimals="2" id="ixv-19181" unitRef="pure">0.10</wlds:LeasePaymentIncreased>
    <wlds:LeaseAgreements contextRef="c81" id="ixv-19182">5</wlds:LeaseAgreements>
    <wlds:LeaseAgreementsPeriod contextRef="c81" id="ixv-19183">P3Y</wlds:LeaseAgreementsPeriod>
    <us-gaap:DebtDisclosureTextBlock contextRef="c0" id="ixv-17276">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 7
- CONVERTIBLE SECURITIES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;A.
During 2017, 2018, January 2019, April 2019 and November 2019, the Company entered into convertible security agreements with certain
investors, according to which the Company received an aggregate amount of $400 thousand, $600 thousand, $100 thousand, $200 thousand
and $100 thousand, respectively, bearing interest at the rate of 4% per annum. Such amounts including the accrued interest were converted
into Ordinary Shares, based on a share price agreed upon in the respective agreement of $0.79, $0.79 $0.92, $0.92 and $1.69, respectively,
in April 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.6pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
December 2019, the Company entered into additional convertible security agreements with an aggregate principal amount of $1.5 million,
which was converted into Ordinary Shares based on a share price agreed upon in the agreement of $1.22 in April 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Those&#160;convertible
security agreements, including accrued interest, were not mandatorily redeemable, nor redeemable at the option of the holder after a
specified date, but a change of control event as described in the agreements would constitute a redemption event outside of the Company&#x2019;s
control. Therefore, all the convertible securities were presented as current liabilities. The beneficial conversion feature of each one
of convertible security was valued at zero.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;B.
April 2021 investors - In June 2022, the Company&#160;received from Alpha Capital Anstalt (&#x201c;Alpha&#x201d;) the contractually required
written consent to proceed with the IPO (the &#x201c;June 2022 Consent&#x201d;) in exchange for a cash payment of $300,000 from the proceeds
of the IPO, which was paid on September 28, 2022, following the completion of the IPO. Pursuant to the share purchase agreements the
Company entered into with certain investors in April 2021 (the &#x201c;April 2021 SPAs&#x201d;), in the event of an initial public offering
event or in a Dilutive Issuance event (as defined below), reflecting a pre-money valuation of $26,400,000, or a lower one, then such
investors shall receive additional Ordinary Shares and additional shares underlying each warrant, based on 80% of the price per share
at the IPO (the &#x201c;Discounted PPS&#x201d;), less the number of Ordinary Shares issued to them in the April 2021 financing, and the
number of shares underlying each warrant shall be increased assuming the exercise amount is divided by the Discounted PPS. Additionally,
beginning on April 22, 2021 and until the earlier of (i) the 90th calendar day after the expiration of the applicable lock-ups, following
the IPO date (i.e. June 2023) or (ii) three years from April 22, 2021, if the Company or its subsidiary shall issue any Ordinary Shares
or equivalents of Ordinary Shares, in an equity transaction other than an exempt issuance, entitling any person or entity to acquire
Ordinary Shares at an effective price per share less than the per share purchase price of $2.25 (subject to prior adjustment for reverse
and forward stock splits and the like) (a &#x201c;Dilutive Issuance&#x201d;), then, for no additional consideration, the Company shall
immediately issue to the investors in the April 2021 financing that number of additional Ordinary Shares equal to (a) the per share purchase
price of $2.25 divided by amount actually paid in new cash consideration by third parties for each Ordinary Share in the Dilutive Issuance
less (b) the number of Ordinary Shares issued to Alpha and other investors at the closing of the April 2021 financing pursuant to April
2021 SPAs. Pursuant to the June 2022 Consent, the investor in the April 2021 financing waived their rights for such adjustments as of
the date of the IPO and deferred such adjustments (if any) to be effected on the 90th calendar day following the closing of the IPO.&#160;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On
September 20, 2022, the Company&#x2019;s volume weighted average stock price was less than the exercise price of $2.00 for the warrants.
Accordingly, effective after the closing of trading on December 14, 2022 (the 90th calendar day immediately following the issuance date
of the warrants), the warrants&#x2019; exercise price was adjusted pursuant to their terms to $2.00 (the &#x201c;Exercise Price Adjustment&#x201d;).
Following the Exercise Price Adjustment, on February 16, 2023, the Company issued an aggregate of 169,125 Ordinary Shares to the April
2021&#160;investors&#160;as a result of the IPO.&#160;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c82" decimals="-3" id="ixv-19184" unitRef="usd">400000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c83" decimals="-3" id="ixv-19185" unitRef="usd">600000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c84" decimals="-3" id="ixv-19186" unitRef="usd">100000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c85" decimals="-3" id="ixv-19187" unitRef="usd">200000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c86" decimals="-3" id="ixv-19188" unitRef="usd">100000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c87" decimals="2" id="ixv-19189" unitRef="pure">0.04</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SharePrice
      contextRef="c88"
      decimals="2"
      id="ixv-19190"
      unitRef="usdPershares">0.79</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="c89"
      decimals="2"
      id="ixv-19191"
      unitRef="usdPershares">0.79</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="c90"
      decimals="2"
      id="ixv-19192"
      unitRef="usdPershares">0.92</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="c91"
      decimals="2"
      id="ixv-19193"
      unitRef="usdPershares">0.92</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="c92"
      decimals="2"
      id="ixv-19194"
      unitRef="usdPershares">1.69</us-gaap:SharePrice>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c93" decimals="-5" id="ixv-19195" unitRef="usd">1500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:SharePrice
      contextRef="c94"
      decimals="2"
      id="ixv-19196"
      unitRef="usdPershares">1.22</us-gaap:SharePrice>
    <wlds:ConvertibleSecurityDescription contextRef="c0" id="ixv-19197">The beneficial conversion feature of each one
of convertible security was valued at zero.</wlds:ConvertibleSecurityDescription>
    <wlds:CashPayment contextRef="c95" decimals="0" id="ixv-19198" unitRef="usd">300000</wlds:CashPayment>
    <wlds:PremoneyValuationAmount contextRef="c96" decimals="0" id="ixv-19199" unitRef="usd">26400000</wlds:PremoneyValuationAmount>
    <wlds:WarrantPricePerSharePercentage contextRef="c97" decimals="2" id="ixv-19200" unitRef="pure">0.80</wlds:WarrantPricePerSharePercentage>
    <wlds:PurchasePricePerShare
      contextRef="c98"
      decimals="2"
      id="ixv-19201"
      unitRef="usdPershares">2.25</wlds:PurchasePricePerShare>
    <wlds:PurchasePricePerShare
      contextRef="c99"
      decimals="2"
      id="ixv-19202"
      unitRef="usdPershares">2.25</wlds:PurchasePricePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c100"
      decimals="2"
      id="ixv-19203"
      unitRef="usdPershares">2</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c101"
      decimals="2"
      id="ixv-19204"
      unitRef="usdPershares">2</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <wlds:AggregateOrdinaryShares
      contextRef="c102"
      decimals="0"
      id="ixv-19205"
      unitRef="shares">169125</wlds:AggregateOrdinaryShares>
    <wlds:CreditFacilityDisclosureTextBlock contextRef="c0" id="ixv-17328">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE
8 &#x2013; CREDIT FACILITY &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On
July 4, 2022, the Company entered into a senior secured credit facility agreement with L.I.A. Pure Capital Ltd. (&#x201c;Pure Capital&#x201d;)
to borrow from time to time amounts until the closing of the IPO in an amount of up to $800 thousand (the &#x201c;Initial Credit&#x201d;),
which Initial Credit could be increased, upon the request of the Company, to an amount not exceeding $1 million (together with the Initial
Credit, the &#x201c;Credit Facility&#x201d;) in aggregate. The underlying outstanding amounts had priority in relation and senior to any
other debts owed by the Company to any third party, and were subject to a registered floating charge, for the benefit of Pure Capital,
against all of the Company&#x2019;s assets. During July, August and September 2022, the Company received an aggregate of $800 thousand
under the Credit Facility. The Credit Facility bore interest at the rate of 4% per annum. The outstanding amounts, together with interest
accrued and unpaid were due and payable on the earlier of (i) June 30, 2024, or (ii) upon receipt of a certain financing transaction
or in the event of certain customary events of default or a change of control. The Credit Facility was fully repaid on September 19,
2022. The agreement indicates that the Company shall not assume any debt senior to the Credit Facility during the term of the Credit
Facility, unless Pure Capital has provided its advance written consent; and subject to applicable law, any debt assumed by the Company
during such term shall be deemed subordinated to any debt accrued under the agreement, if Pure Capital had not provided its prior written
consent; and without Pure Capital&#x2019;s prior written consent, the Company shall not pledge in favor of a third-party creditor or lender
any of its assets or rights, including by a floating charge, until such time that the Credit Facility, and any interest accrued thereon,
has been repaid in full to Pure Capital.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Additionally, the Credit Facility agreement
requires the Company to retain Pure Capital for investor relations services and other related strategic services in exchange for a monthly
base fee of $35 thousand, upon the closing of the IPO, under a 3 year consulting agreement. If 70% or more of the warrants (or other convertible
securities) issued in connection with the IPO are exercised during the term of such instrument, then the base monthly fee will immediately
increase to $70 thousand, which increase shall apply retroactively to the closing of the IPO date. In addition, Pure Capital shall serve
as the Company&#x2019;s strategic consultant in connection with any offering or financing transaction of the Company, each, in excess of
$5 million (which does not include the IPO) in exchange for a per offering and/or transaction fee of $100 thousand for the closing. Total
expenses for services rendered under the Pure Capital agreement were $420 thousand and $122 thousand for the years ended December 31,
2023 and 2022, respectively.&lt;/p&gt;</wlds:CreditFacilityDisclosureTextBlock>
    <us-gaap:OtherBorrowings
      contextRef="c103"
      decimals="-3"
      id="ixv-19206"
      unitRef="usd">800000</us-gaap:OtherBorrowings>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c4" decimals="-6" id="ixv-19207" unitRef="usd">1000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <wlds:AggregateAmount
      contextRef="c104"
      decimals="-3"
      id="ixv-19208"
      unitRef="usd">800000</wlds:AggregateAmount>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="c104"
      decimals="2"
      id="ixv-19209"
      unitRef="pure">0.04</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <wlds:ServicesInExchangeForMonthlyBaseFee contextRef="c47" decimals="-3" id="ixv-19210" unitRef="usd">35000</wlds:ServicesInExchangeForMonthlyBaseFee>
    <wlds:AggrementTerm contextRef="c47" id="ixv-19211">P3Y</wlds:AggrementTerm>
    <wlds:WarrantsIssuedPercentage contextRef="c47" decimals="2" id="ixv-19212" unitRef="pure">0.70</wlds:WarrantsIssuedPercentage>
    <wlds:BaseMonthlyFeeImmediatelyIncreaseAmount contextRef="c47" decimals="-3" id="ixv-19213" unitRef="usd">70000</wlds:BaseMonthlyFeeImmediatelyIncreaseAmount>
    <wlds:OfferingOrFinancingTransactionAmount contextRef="c47" decimals="-6" id="ixv-19214" unitRef="usd">5000000</wlds:OfferingOrFinancingTransactionAmount>
    <wlds:TransactionFeeClosingValue contextRef="c47" decimals="-3" id="ixv-19215" unitRef="usd">100000</wlds:TransactionFeeClosingValue>
    <wlds:ExpenseOnServiceRendering contextRef="c0" decimals="-3" id="ixv-19216" unitRef="usd">420000</wlds:ExpenseOnServiceRendering>
    <wlds:ExpenseOnServiceRendering contextRef="c6" decimals="-3" id="ixv-19217" unitRef="usd">122000</wlds:ExpenseOnServiceRendering>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c0" id="ixv-17368">&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE
9 &#x2013; SHAREHOLDERS&#x2019; EQUITY (DEFICIT):&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;a.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Share capital&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
share capital as of December 31, 2023 and 2022, is composed of as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number
    of shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Authorized&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issued
    and outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31,&lt;br/&gt; 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, &lt;br/&gt; 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31,&lt;br/&gt; 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, &lt;br/&gt; 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Ordinary shares, NIS 0.01 par value&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;50,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;50,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,387,428&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15,049,720&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Ordinary Shares entitle their holders: to receive notices of, and to attend, general meetings where each Ordinary Share shall have one
vote for all purposes; to share distributions as may be declared by the Board of Directors of the Company and approved by the shareholders,
if required; and, upon liquidation or dissolution - to participate in the distribution of the assets of the Company after payment of
all debts and other liabilities of the Company, in accordance with the terms of the Company&#x2019;s Articles of Association.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On
inception, the Company issued 4,500,000 Ordinary Shares to its three co-founders for a total consideration equal to their par value (approximately
$12 thousand). In October 2021, the total consideration was paid off by the co-founders.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On
March 10, 2016, the Company issued to certain investors 1,844,268 ordinary A shares, NIS 0.01 par value of the Company (&#x201c;Ordinary
A Shares&#x201d;) for a total consideration of $500 thousand.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Ordinary A Shares conferred on the holders all rights to holders of Ordinary Shares in the Company and, in addition, bore preferred rights
primarily advanced in return of their investments plus 2% per year, in a liquidation event as described in the Company&#x2019;s Articles
of Association.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
2021, those Ordinary A Shares were converted into Ordinary Shares, and the Company reclassified the Company&#x2019;s authorized share
capital of 2,000,000 Ordinary A Shares into 2,000,000 Ordinary Shares and increased the Company&#x2019;s authorized share capital by 10,000,000
Ordinary Shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;During
2018, 2020, 2021 and 2022, the Company issued 111,142, 15,430, 241,533 and 4,666 Ordinary Shares, respectively, upon exercise of employees&#x2019;
options.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
April 2021, the Company issued to new investors 1,343,374 Ordinary Shares, and 671,687 warrants exercisable into Ordinary Shares in consideration
of 125% of the per share purchase price in an initial public offering of the Company, if and when it shall occur, for total consideration
of $3.025 million, before $100 thousand of issuance expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;During
September 2022, the Company completed the IPO, in which were issued 3,750,000 Ordinary Shares and warrants to purchase 8,625,000 Ordinary
Shares.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;During
2022, the Company entered into SAFEs for $500 thousand with 5 investors, $100 thousand each, of which $400 thousand were converted to
118,204&#160;Ordinary Shares and $100 thousand of one investor were paid back in cash upon the closing of the IPO. Those&#160;SAFEs were
not mandatorily redeemable, nor redeemable at the option of the holder after a specified date, but in an Equity Financing (as defined
in the SAFEs) which under current liquidity circumstances constitutes a redemption event outside of the Company&#x2019;s control. The
Company issued to each SAFE investor a warrant to purchase Ordinary Shares of the Company with an exercise price of $6.345 per share
in such offering for an aggregate amount of up to $25 thousand (exercisable for a total of 15,760 Ordinary Shares, until the earlier
of: (i) eighteen (18) months from January 2022; or (ii) in a change of control event, which generally covers (a) a transaction in which
any person or group becomes the beneficial owner, directly or indirectly, of more than 50% of the Company&#x2019;s outstanding voting
securities with the right to vote for the election of members of the Company&#x2019;s Board of Directors, or (b) any reorganization, merger
or consolidation of the Company, or (c) a sale, lease or other disposition of all or substantially all of the Company&#x2019;s assets).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;During
September 2022, investors exercised 40,000 warrants into Ordinary Shares. During October 2022, a former employee of the Company exercised
4,666 options into Ordinary Shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
June 2023, 724,139 warrants were exercised into 724,139 Ordinary Shares at an exercise price of $2.00 per Ordinary Share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; background-color: white"&gt;During November 2023, the Company
completed a follow-on public offering for gross proceeds of $2 million, in which the Company issued 4,444,444 Ordinary Shares priced to
the public at $0.45 per share.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;b.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Share-based compensation&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 77.3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
2015, the Company&#x2019;s Board of Directors adopted the 2015 Share Option Plan (the &#x201c;2015 Plan&#x201d;), with&#160;1,032,805 options
available for grant, and through December 31, 2021, the Company&#x2019;s Board of Directors approved, in the aggregate, an increase of&#160;800,000
options available for grant, for allocation to existing and future employees, consultants and directors of the Company and/or its Subsidiary,
such that, there are 1,832,805 Ordinary Shares reserved under the 2015 Plan (including those that were exercised into Ordinary Shares).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On
December 15, 2022, the Company&#x2019;s Board of Directors approved an increase of&#160;a total of 424,653 Ordinary Shares underlying
options available for grant, for allocation to existing and future employees, consultants and directors of the Company and/or its Subsidiary,
such that there are 2,257,458 Ordinary Shares underlying options granted (including options that were exercised into Ordinary Shares)
or reserved for future issuance under the 2015 Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;On August 23, 2023, the Company&#x2019;s
Board of Directors approved an increase of&#160;a total of 931,139 Ordinary Shares underlying options available for grant, for allocation
to existing and future employees, consultants and directors of the Company and/or its Subsidiary, such that there are 3,188,597 Ordinary
Shares underlying options granted (including options that were exercised into Ordinary Shares) or reserved for future issuance under the
2015 Plan.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;As of March 13, 2024, the Company had 1,066,637 Ordinary Shares reserved
for future issuance under the 2015 Plan.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Options
to employees &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Below
is a summary of the Company&#x2019;s options activity and related information with respect to options granted to employees during the
years ended December 31, 2023 and 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3cm"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Year ended
    &lt;br/&gt; December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Year ended
    &lt;br/&gt; December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amount&lt;br/&gt;
    of &lt;br/&gt; options&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted&lt;br/&gt;
    average &lt;br/&gt; exercise &lt;br/&gt; price&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amount&lt;br/&gt;
    of &lt;br/&gt; options&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted
    &lt;br/&gt; average &lt;br/&gt; exercise&lt;br/&gt; price&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; text-indent: -11.35pt; padding-left: 11.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding
    - beginning of the year&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;988,264&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.563&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;863,264&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.614&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -11.35pt; padding-left: 11.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;*471,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.224&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;145,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.184&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -11.35pt; padding-left: 11.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-96; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-97; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,666&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.003&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -11.35pt; padding-left: 11.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired
    or forfeited&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(5,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.664&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(15,334&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.003&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -11.35pt; padding-left: 11.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -11.35pt; padding-left: 11.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding
    - end of the year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,454,764&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.777&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;988,264&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.563&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -11.35pt; padding-left: 11.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -11.35pt; padding-left: 11.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercisable
    at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;889,125&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.612&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;753,236&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.703&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The weighted-average grant date fair
value of stock-based awards granted&#160;was $1.224, $0.184 and $0.323 per share during the years ended December 31, 2023, December 31,&#160;2022
and December 31, 2021, respectively. The options will expire at the earlier of (i) ten years from the date of grant or (ii) 90 days
following the termination of employment.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
following weighted-average assumptions were used in determining the most recent fair values of stock options using the Black-Scholes
valuation model:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left; text-indent: -11.35pt; padding-left: 11.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected
    dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -11.35pt; padding-left: 11.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected
    stock price volatility&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;55.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -11.35pt; padding-left: 11.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Risk
    free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -11.35pt; padding-left: 11.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected
    life of options&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6.25&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Including the grant of 120,000 options to purchase up to 120,000 Ordinary Shares to directors, as approved by the Company&#x2019;s shareholders on November 30, 2023, with an exercise price of $1.32 per share. The options will expire at the earlier of (i) ten years from the date of grant or (ii) 90 days following a termination of employment or service. The fair value of each option as of the grant date was $0.12, determined using the Black-Scholes option pricing model and the total expenses of $15 thousand will be expensed over the option vesting periods of three years.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Options
to consultants &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company&#x2019;s outstanding options to consultants as of December 31, 2023 were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 77.3pt; text-indent: -1cm"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance
    date&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
    connection with&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;No.
of options&lt;br/&gt;
issued&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&#160;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Exercise&lt;br/&gt;
price&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;No.
of options&lt;br/&gt;
exercisable&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; width: 32%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2015&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 31%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Rendered services&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;110,655&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.003&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;110,655&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Rendered services&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;36,885&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.003&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;36,885&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Rendered services&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;69,090&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.003-$2.25&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;69,090&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023*&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Rendered services&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;100,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.546&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;37,778&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 77.3pt; text-indent: -1cm"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On April 27, 2023, the Company&#x2019;s Board of Directors approved the additional grant of options to purchase up to 100,000 Ordinary Shares to a consultant, with an exercise price of $0.55 per share. The options will expire at the earlier of (i) ten years from the date of grant or (ii) 90 days following a termination of services. The fair value of each option as of the grant date was $0.26, determined using the Black-Scholes option pricing model and the total expenses of $26 thousand will be expensed over the option vesting periods of three years.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
share-based compensation expenses are recognized in the following line items in the consolidated statements of comprehensive loss in
the years ended:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;U.S.
    dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;83&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;180&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;105&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Sales and marketing expenses&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;61&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;401&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;111&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;General and administrative
    expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;97&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;209&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;83&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;241&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;790&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;299&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Equity
Warrants to investors and associated with the IPO, as of December 31, 2023:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Number&#160;of
    warrants/ options&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Issuance
    date&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Exercise
    price&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Exercise
    ratio&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Expiration
    date&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,860,861&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 14%; text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
    13, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2.00&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 25%; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Each warrant is exercisable into 1 Ordinary Share&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 16%; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5 years following the issuance date&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 18%; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Registered for trading (*)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;671,687&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September 15, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5.29&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Each warrant is exercisable into 1 Ordinary Share, See note 7(B) above&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18 months following the issuance date&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Owned by April 2021 investors&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;187,500&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September 15, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5.31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Each warrant is exercisable into 1 Ordinary Share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5 years following the issuance date&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Owned by underwriter&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;23,640&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September 15, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.23&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Each warrant is exercisable into 1 Ordinary Share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10 years following the issuance date&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Owned by the legal advisor&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;(*) The warrants are exercisable at
any time after their original issuance and at any time up to the date that is five&#160;years after their original issuance. The warrants
will be exercisable, at the option of each holder, in whole or in part by delivering to us a duly executed exercise notice and, at any
time a registration statement registering the issuance of the Ordinary Shares underlying the warrants under the Securities Act is effective
and available for the issuance of such shares, by payment in full in immediately available funds for the number of Ordinary Shares purchased
upon such exercise.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The exercise price per whole Ordinary
Share purchasable upon exercise of the warrants $4.00 per share (the &#x201c;Initial Exercise Price&#x201d;). The exercise price is subject
to appropriate adjustment in the event of certain stock dividends and distributions, stock splits, stock combinations, reclassifications
or similar events affecting the Company&#x2019;s Ordinary Shares and also upon any distributions of assets, including cash, stock or other
property to the Company&#x2019;s shareholders. Subject to certain exemptions outlined in the warrant, for a period until &lt;span style="-sec-ix-hidden: hidden-fact-98"&gt;two&lt;/span&gt; years from
the date of issuance of the warrant, if the Company shall sell, enter into an agreement to sell and subsequently sells, or grant any option
to purchase, or sell, enter into an agreement to sell and subsequently sells, or grant any right to reprice, or otherwise dispose of or
issue (or announce any offer, sale, grant or any option to purchase or other disposition the subsequently closes) any Ordinary Shares
or convertible security, at an effective price per share less than the exercise price of the warrant then in effect, the exercise price
of the warrant shall be reduced to equal the effective price per share in such Dilutive Issuance;&#160;provided, however, that in no event
shall the exercise price of the warrant be reduced to an exercise price lower than 50% of the Initial Exercise Price. On the date that
is 90 calendar days immediately following the initial issuance date of the warrants, the exercise price of the warrants will adjust (the
&#x201c;Reset Price&#x201d;), provided that such value is less than the exercise price in effect on that date. The Reset Price is equal
to the greater of (a) 50% of the Initial Exercise Price of the warrants on the issuance date or (b) 100% of the lowest volume weighted
average price per Ordinary Share occurring on any day between the initial exercise date of the warrants and 90 calendar days following
the issuance date of the warrants. The lowest Reset Price is $2.00, which is 50% of the Initial Exercise Price.&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityTableTextBlock contextRef="c0" id="ixv-17389">&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
share capital as of December 31, 2023 and 2022, is composed of as follows:&lt;/span&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number
    of shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Authorized&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issued
    and outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31,&lt;br/&gt; 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, &lt;br/&gt; 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31,&lt;br/&gt; 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31, &lt;br/&gt; 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Ordinary shares, NIS 0.01 par value&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;50,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;50,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,387,428&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15,049,720&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityTableTextBlock>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c135"
      decimals="2"
      id="ixv-19218"
      unitRef="ilsPershares">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c115"
      decimals="2"
      id="ixv-19219"
      unitRef="ilsPershares">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c135"
      decimals="0"
      id="ixv-19220"
      unitRef="shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c115"
      decimals="0"
      id="ixv-19221"
      unitRef="shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <wlds:NumberOfSharesIssuedAndOutstanding
      contextRef="c135"
      decimals="INF"
      id="ixv-19222"
      unitRef="shares">20387428</wlds:NumberOfSharesIssuedAndOutstanding>
    <wlds:NumberOfSharesIssuedAndOutstanding
      contextRef="c115"
      decimals="INF"
      id="ixv-19223"
      unitRef="shares">15049720</wlds:NumberOfSharesIssuedAndOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="c105"
      decimals="0"
      id="ixv-19224"
      unitRef="shares">4500000</us-gaap:CommonStockSharesIssued>
    <wlds:TotalValueOfTheShares
      contextRef="c106"
      decimals="-3"
      id="ixv-19225"
      unitRef="usd">12000</wlds:TotalValueOfTheShares>
    <us-gaap:CommonStockSharesIssued
      contextRef="c107"
      decimals="0"
      id="ixv-19226"
      unitRef="shares">1844268</us-gaap:CommonStockSharesIssued>
    <wlds:OrdinaryShareParValue
      contextRef="c108"
      decimals="2"
      id="ixv-19227"
      unitRef="ilsPershares">0.01</wlds:OrdinaryShareParValue>
    <wlds:ValueOfOrdinaryAShare
      contextRef="c108"
      decimals="-3"
      id="ixv-19228"
      unitRef="usd">500000</wlds:ValueOfOrdinaryAShare>
    <wlds:InterestPercentage
      contextRef="c109"
      decimals="2"
      id="ixv-19229"
      unitRef="pure">0.02</wlds:InterestPercentage>
    <us-gaap:SharesIssued
      contextRef="c110"
      decimals="0"
      id="ixv-19230"
      unitRef="shares">2000000</us-gaap:SharesIssued>
    <wlds:AShareReclassifiedToOrdinaryShares
      contextRef="c111"
      decimals="0"
      id="ixv-19231"
      unitRef="shares">2000000</wlds:AShareReclassifiedToOrdinaryShares>
    <wlds:OrdinarySharesAuthorizedIncreased
      contextRef="c110"
      decimals="0"
      id="ixv-19232"
      unitRef="shares">10000000</wlds:OrdinarySharesAuthorizedIncreased>
    <us-gaap:CommonStockSharesIssued
      contextRef="c112"
      decimals="0"
      id="ixv-19233"
      unitRef="shares">111142</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="c113"
      decimals="0"
      id="ixv-19234"
      unitRef="shares">15430</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="c114"
      decimals="0"
      id="ixv-19235"
      unitRef="shares">241533</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="c115"
      decimals="0"
      id="ixv-19236"
      unitRef="shares">4666</us-gaap:CommonStockSharesIssued>
    <wlds:OrdinarySharesIssued
      contextRef="c116"
      decimals="0"
      id="ixv-19237"
      unitRef="shares">1343374</wlds:OrdinarySharesIssued>
    <wlds:OrdinarySharesWarrantExercisable
      contextRef="c99"
      decimals="0"
      id="ixv-19238"
      unitRef="shares">671687</wlds:OrdinarySharesWarrantExercisable>
    <wlds:OrdinarySharesInConsiderationPercentage
      contextRef="c117"
      decimals="2"
      id="ixv-19239"
      unitRef="pure">1.25</wlds:OrdinarySharesInConsiderationPercentage>
    <wlds:TotalConsiderationAmount
      contextRef="c117"
      decimals="-3"
      id="ixv-19240"
      unitRef="usd">3025000.000</wlds:TotalConsiderationAmount>
    <wlds:IssuanceExpenses
      contextRef="c117"
      decimals="-3"
      id="ixv-19241"
      unitRef="usd">100000</wlds:IssuanceExpenses>
    <us-gaap:CommonStockSharesIssued
      contextRef="c41"
      decimals="0"
      id="ixv-19242"
      unitRef="shares">3750000</us-gaap:CommonStockSharesIssued>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c41"
      decimals="0"
      id="ixv-19243"
      unitRef="shares">8625000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <wlds:SAFEsAmount contextRef="c6" decimals="-3" id="ixv-19244" unitRef="usd">500000</wlds:SAFEsAmount>
    <wlds:Investor contextRef="c6" id="ixv-19245">5</wlds:Investor>
    <wlds:InvestorAmount contextRef="c6" decimals="-3" id="ixv-19246" unitRef="usd">100000</wlds:InvestorAmount>
    <wlds:ConvertedAmount contextRef="c6" decimals="-3" id="ixv-19247" unitRef="usd">400000</wlds:ConvertedAmount>
    <wlds:ConvertedToOrdinaryShares
      contextRef="c5"
      decimals="0"
      id="ixv-19248"
      unitRef="shares">118204</wlds:ConvertedToOrdinaryShares>
    <us-gaap:Cash contextRef="c5" decimals="-3" id="ixv-19249" unitRef="usd">100000</us-gaap:Cash>
    <wlds:Investor contextRef="c118" id="ixv-19250">one</wlds:Investor>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c28"
      decimals="3"
      id="ixv-19251"
      unitRef="usdPershares">6.345</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement contextRef="c5" decimals="-3" id="ixv-19252" unitRef="usd">25000</us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement>
    <wlds:ExercisableWarrantsToShares
      contextRef="c25"
      decimals="0"
      id="ixv-19253"
      unitRef="shares">15760</wlds:ExercisableWarrantsToShares>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c119"
      decimals="2"
      id="ixv-19254"
      unitRef="pure">0.50</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <wlds:InvestorsExercisedWarrants
      contextRef="c39"
      decimals="0"
      id="ixv-19255"
      unitRef="shares">40000</wlds:InvestorsExercisedWarrants>
    <wlds:EmployeeExercisedWarrants
      contextRef="c120"
      decimals="0"
      id="ixv-19256"
      unitRef="shares">4666</wlds:EmployeeExercisedWarrants>
    <wlds:ExercisableWarrantsToShares
      contextRef="c121"
      decimals="0"
      id="ixv-19257"
      unitRef="shares">724139</wlds:ExercisableWarrantsToShares>
    <wlds:StockIssuedDuringPeriodSharesExerciseOfWarrants
      contextRef="c121"
      decimals="0"
      id="ixv-19258"
      unitRef="shares">724139</wlds:StockIssuedDuringPeriodSharesExerciseOfWarrants>
    <wlds:ExercisePricePerShare
      contextRef="c121"
      decimals="2"
      id="ixv-19259"
      unitRef="usdPershares">2</wlds:ExercisePricePerShare>
    <wlds:ProceedsFromIssuanceFollowOnPublicOffering
      contextRef="c122"
      decimals="-6"
      id="ixv-19260"
      unitRef="usd">2000000</wlds:ProceedsFromIssuanceFollowOnPublicOffering>
    <wlds:OrdinarySharesIssued
      contextRef="c122"
      decimals="0"
      id="ixv-19261"
      unitRef="shares">4444444</wlds:OrdinarySharesIssued>
    <wlds:OrdinarySharePerValue
      contextRef="c122"
      decimals="2"
      id="ixv-19262"
      unitRef="usdPershares">0.45</wlds:OrdinarySharePerValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c123"
      decimals="0"
      id="ixv-19263"
      unitRef="shares">1032805</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="c124"
      decimals="0"
      id="ixv-19264"
      unitRef="shares">800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c24"
      decimals="0"
      id="ixv-19265"
      unitRef="shares">1832805</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <wlds:OptionsAvailableForGrant
      contextRef="c125"
      decimals="0"
      id="ixv-19266"
      unitRef="shares">424653</wlds:OptionsAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c126"
      decimals="0"
      id="ixv-19267"
      unitRef="shares">2257458</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <wlds:OptionsAvailableForGrant
      contextRef="c127"
      decimals="0"
      id="ixv-19268"
      unitRef="shares">931139</wlds:OptionsAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c128"
      decimals="0"
      id="ixv-19269"
      unitRef="shares">3188597</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c129"
      decimals="0"
      id="ixv-19270"
      unitRef="shares">1066637</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c0" id="ixv-17636">&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Below
is a summary of the Company&#x2019;s options activity and related information with respect to options granted to employees during the
years ended December 31, 2023 and 2022.&lt;/span&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Year ended
    &lt;br/&gt; December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Year ended
    &lt;br/&gt; December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amount&lt;br/&gt;
    of &lt;br/&gt; options&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted&lt;br/&gt;
    average &lt;br/&gt; exercise &lt;br/&gt; price&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amount&lt;br/&gt;
    of &lt;br/&gt; options&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted
    &lt;br/&gt; average &lt;br/&gt; exercise&lt;br/&gt; price&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; text-indent: -11.35pt; padding-left: 11.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding
    - beginning of the year&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;988,264&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.563&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;863,264&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.614&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -11.35pt; padding-left: 11.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;*471,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.224&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;145,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.184&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -11.35pt; padding-left: 11.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-96; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-97; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,666&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.003&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -11.35pt; padding-left: 11.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired
    or forfeited&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(5,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.664&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(15,334&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.003&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -11.35pt; padding-left: 11.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -11.35pt; padding-left: 11.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding
    - end of the year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,454,764&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.777&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;988,264&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.563&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -11.35pt; padding-left: 11.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -11.35pt; padding-left: 11.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercisable
    at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;889,125&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.612&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;753,236&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.703&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Including the grant of 120,000 options to purchase up to 120,000 Ordinary Shares to directors, as approved by the Company&#x2019;s shareholders on November 30, 2023, with an exercise price of $1.32 per share. The options will expire at the earlier of (i) ten years from the date of grant or (ii) 90 days following a termination of employment or service. The fair value of each option as of the grant date was $0.12, determined using the Black-Scholes option pricing model and the total expenses of $15 thousand will be expensed over the option vesting periods of three years.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c5"
      decimals="INF"
      id="ixv-19271"
      unitRef="shares">988264</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c5"
      decimals="3"
      id="ixv-19272"
      unitRef="usdPershares">0.563</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c24"
      decimals="INF"
      id="ixv-19273"
      unitRef="shares">863264</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c24"
      decimals="3"
      id="ixv-19274"
      unitRef="usdPershares">0.614</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c0"
      decimals="INF"
      id="ix_3_fact"
      unitRef="shares">471500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c0"
      decimals="3"
      id="ixv-19276"
      unitRef="usdPershares">1.224</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c6"
      decimals="INF"
      id="ixv-19277"
      unitRef="shares">145000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c6"
      decimals="3"
      id="ixv-19278"
      unitRef="usdPershares">0.184</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c6"
      decimals="INF"
      id="ixv-19279"
      unitRef="shares">4666</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c6"
      decimals="3"
      id="ixv-19280"
      unitRef="usdPershares">0.003</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c0"
      decimals="INF"
      id="ixv-19281"
      unitRef="shares">5000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c0"
      decimals="3"
      id="ixv-19282"
      unitRef="usdPershares">0.664</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c6"
      decimals="INF"
      id="ixv-19283"
      unitRef="shares">15334</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c6"
      decimals="3"
      id="ixv-19284"
      unitRef="usdPershares">0.003</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c4"
      decimals="INF"
      id="ixv-19285"
      unitRef="shares">1454764</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="c4"
      decimals="3"
      id="ixv-19286"
      unitRef="usdPershares">0.777</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c5"
      decimals="INF"
      id="ixv-19287"
      unitRef="shares">988264</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="c5"
      decimals="3"
      id="ixv-19288"
      unitRef="usdPershares">0.563</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="c4"
      decimals="INF"
      id="ixv-19289"
      unitRef="shares">889125</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="c4"
      decimals="3"
      id="ixv-19290"
      unitRef="usdPershares">0.612</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="c5"
      decimals="INF"
      id="ixv-19291"
      unitRef="shares">753236</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="c5"
      decimals="3"
      id="ixv-19292"
      unitRef="usdPershares">0.703</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c0"
      decimals="3"
      id="ixv-19293"
      unitRef="usdPershares">1.224</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c6"
      decimals="0"
      id="ixv-19294"
      unitRef="usdPershares">184</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c7"
      decimals="3"
      id="ixv-19295"
      unitRef="usdPershares">0.323</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <wlds:TerminationPeriod contextRef="c130" id="ixv-19296">P10Y</wlds:TerminationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="c130" id="ixv-19297">P90D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c0" id="ixv-18024">&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
following weighted-average assumptions were used in determining the most recent fair values of stock options using the Black-Scholes
valuation model:&lt;/span&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left; text-indent: -11.35pt; padding-left: 11.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected
    dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -11.35pt; padding-left: 11.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected
    stock price volatility&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;55.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -11.35pt; padding-left: 11.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Risk
    free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -11.35pt; padding-left: 11.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected
    life of options&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6.25&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c0" decimals="2" id="ixv-19298" unitRef="pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate contextRef="c0" decimals="3" id="ixv-19299" unitRef="pure">0.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c0" decimals="4" id="ixv-19300" unitRef="pure">0.041</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <wlds:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions contextRef="c0" id="ixv-18089">P6Y3M</wlds:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions>
    <wlds:IssuanceOfSharesOptions
      contextRef="c131"
      decimals="0"
      id="ixv-19301"
      unitRef="shares">120000</wlds:IssuanceOfSharesOptions>
    <wlds:IssuanceOfSharesOptions
      contextRef="c132"
      decimals="0"
      id="ixv-19302"
      unitRef="shares">120000</wlds:IssuanceOfSharesOptions>
    <wlds:ExercisePricePerShare
      contextRef="c0"
      decimals="2"
      id="ixv-19303"
      unitRef="usdPershares">1.32</wlds:ExercisePricePerShare>
    <wlds:TerminationPeriod contextRef="c0" id="ixv-19304">P10Y</wlds:TerminationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="c0" id="ixv-19305">P90D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <wlds:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate
      contextRef="c0"
      decimals="2"
      id="ixv-19306"
      unitRef="usdPershares">0.12</wlds:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate>
    <wlds:OptionsExpenses contextRef="c0" decimals="-3" id="ixv-19307" unitRef="usd">15000</wlds:OptionsExpenses>
    <wlds:VestingPeriods contextRef="c0" id="ixv-19308">P3Y</wlds:VestingPeriods>
    <wlds:ScheduleOfOptionsToConsultantsTableTextBlock contextRef="c0" id="ixv-18148">&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company&#x2019;s outstanding options to consultants as of December 31, 2023 were as follows:&lt;/span&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issuance
    date&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
    connection with&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;No.
of options&lt;br/&gt;
issued&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&#160;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Exercise&lt;br/&gt;
price&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;No.
of options&lt;br/&gt;
exercisable&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; width: 32%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2015&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 31%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Rendered services&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;110,655&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.003&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;110,655&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Rendered services&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;36,885&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.003&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;36,885&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Rendered services&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;69,090&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.003-$2.25&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;69,090&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023*&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Rendered services&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;100,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.546&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;37,778&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On April 27, 2023, the Company&#x2019;s Board of Directors approved the additional grant of options to purchase up to 100,000 Ordinary Shares to a consultant, with an exercise price of $0.55 per share. The options will expire at the earlier of (i) ten years from the date of grant or (ii) 90 days following a termination of services. The fair value of each option as of the grant date was $0.26, determined using the Black-Scholes option pricing model and the total expenses of $26 thousand will be expensed over the option vesting periods of three years.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</wlds:ScheduleOfOptionsToConsultantsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms contextRef="c136" id="ixv-18194">Rendered services</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="c136"
      decimals="INF"
      id="ixv-19309"
      unitRef="shares">110655</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c137"
      decimals="3"
      id="ixv-19310"
      unitRef="usdPershares">0.003</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="c137"
      decimals="0"
      id="ixv-19311"
      unitRef="shares">110655</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms contextRef="c138" id="ixv-18226">Rendered services</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="c138"
      decimals="INF"
      id="ixv-19312"
      unitRef="shares">36885</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c139"
      decimals="3"
      id="ixv-19313"
      unitRef="usdPershares">0.003</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="c139"
      decimals="0"
      id="ixv-19314"
      unitRef="shares">36885</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms contextRef="c140" id="ixv-18258">Rendered services</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="c140"
      decimals="INF"
      id="ixv-19315"
      unitRef="shares">69090</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c141"
      decimals="3"
      id="ixv-19316"
      unitRef="usdPershares">0.003</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c142"
      decimals="2"
      id="ixv-19317"
      unitRef="usdPershares">2.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="c143"
      decimals="0"
      id="ixv-19318"
      unitRef="shares">69090</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms contextRef="c144" id="ix_4_fact">Rendered services</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="c144"
      decimals="INF"
      id="ix_5_fact"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c145"
      decimals="3"
      id="ix_6_fact"
      unitRef="usdPershares">0.546</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="c145"
      decimals="0"
      id="ix_7_fact"
      unitRef="shares">37778</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <wlds:IssuanceOfSharesOptions
      contextRef="c133"
      decimals="0"
      id="ixv-19322"
      unitRef="shares">100000</wlds:IssuanceOfSharesOptions>
    <wlds:ExercisePricePerShare
      contextRef="c134"
      decimals="2"
      id="ixv-19323"
      unitRef="usdPershares">0.55</wlds:ExercisePricePerShare>
    <wlds:TerminationPeriod contextRef="c134" id="ixv-19324">P10Y</wlds:TerminationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="c134" id="ixv-19326">P90D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <wlds:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate
      contextRef="c134"
      decimals="2"
      id="ixv-19327"
      unitRef="usdPershares">0.26</wlds:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate>
    <wlds:OptionsExpenses
      contextRef="c134"
      decimals="-3"
      id="ixv-19328"
      unitRef="usd">26000</wlds:OptionsExpenses>
    <wlds:VestingPeriods contextRef="c134" id="ixv-19329">P3Y</wlds:VestingPeriods>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="c0" id="ixv-18329">&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
share-based compensation expenses are recognized in the following line items in the consolidated statements of comprehensive loss in
the years ended:&lt;/span&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;U.S.
    dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;83&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;180&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;105&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Sales and marketing expenses&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;61&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;401&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;111&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;General and administrative
    expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;97&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;209&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;83&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;241&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;790&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;299&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:ShareBasedCompensation
      contextRef="c146"
      decimals="-3"
      id="ixv-19330"
      unitRef="usd">83000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c147"
      decimals="-3"
      id="ixv-19331"
      unitRef="usd">180000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c148"
      decimals="-3"
      id="ixv-19332"
      unitRef="usd">105000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c149"
      decimals="-3"
      id="ixv-19333"
      unitRef="usd">61000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c150"
      decimals="-3"
      id="ixv-19334"
      unitRef="usd">401000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c151"
      decimals="-3"
      id="ixv-19335"
      unitRef="usd">111000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c152"
      decimals="-3"
      id="ixv-19336"
      unitRef="usd">97000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c153"
      decimals="-3"
      id="ixv-19337"
      unitRef="usd">209000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c154"
      decimals="-3"
      id="ixv-19338"
      unitRef="usd">83000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c0" decimals="-3" id="ixv-19339" unitRef="usd">241000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c6" decimals="-3" id="ixv-19340" unitRef="usd">790000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c7" decimals="-3" id="ixv-19341" unitRef="usd">299000</us-gaap:ShareBasedCompensation>
    <wlds:ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock contextRef="c0" id="ixv-18485">&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Equity
Warrants to investors and associated with the IPO, as of December 31, 2023:&lt;/b&gt;&lt;/span&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Number&#160;of
    warrants/ options&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Issuance
    date&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Exercise
    price&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Exercise
    ratio&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Expiration
    date&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,860,861&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 14%; text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
    13, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2.00&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 25%; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Each warrant is exercisable into 1 Ordinary Share&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 16%; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5 years following the issuance date&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 18%; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Registered for trading (*)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;671,687&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September 15, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5.29&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Each warrant is exercisable into 1 Ordinary Share, See note 7(B) above&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18 months following the issuance date&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Owned by April 2021 investors&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;187,500&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September 15, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5.31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Each warrant is exercisable into 1 Ordinary Share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5 years following the issuance date&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Owned by underwriter&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;23,640&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September 15, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.23&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Each warrant is exercisable into 1 Ordinary Share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10 years following the issuance date&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Owned by the legal advisor&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;(*) The warrants are exercisable at
any time after their original issuance and at any time up to the date that is five&#160;years after their original issuance. The warrants
will be exercisable, at the option of each holder, in whole or in part by delivering to us a duly executed exercise notice and, at any
time a registration statement registering the issuance of the Ordinary Shares underlying the warrants under the Securities Act is effective
and available for the issuance of such shares, by payment in full in immediately available funds for the number of Ordinary Shares purchased
upon such exercise.&lt;/p&gt;</wlds:ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c155"
      decimals="INF"
      id="ixv-19342"
      unitRef="shares">7860861</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="c156"
      decimals="2"
      id="ixv-19343"
      unitRef="usdPershares">2</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <wlds:ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio contextRef="c156" id="ixv-18554">Each warrant is exercisable into 1 Ordinary Share</wlds:ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio>
    <wlds:ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate contextRef="c156" id="ixv-18559">5 years following the issuance date</wlds:ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate>
    <wlds:ShareBasedCompensationArrangementNotes contextRef="c156" id="ix_8_fact">Registered for trading (*)</wlds:ShareBasedCompensationArrangementNotes>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c157"
      decimals="INF"
      id="ixv-19344"
      unitRef="shares">671687</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="c158"
      decimals="2"
      id="ixv-19345"
      unitRef="usdPershares">5.29</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <wlds:ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio contextRef="c158" id="ixv-18588">Each warrant is exercisable into 1 Ordinary Share, See note 7(B) above</wlds:ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio>
    <wlds:ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate contextRef="c158" id="ixv-18593">18 months following the issuance date</wlds:ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate>
    <wlds:ShareBasedCompensationArrangementNotes contextRef="c158" id="ixv-18598">Owned by April 2021 investors</wlds:ShareBasedCompensationArrangementNotes>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c159"
      decimals="INF"
      id="ixv-19346"
      unitRef="shares">187500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="c160"
      decimals="2"
      id="ixv-19347"
      unitRef="usdPershares">5.31</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <wlds:ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio contextRef="c160" id="ixv-18622">Each warrant is exercisable into 1 Ordinary Share</wlds:ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio>
    <wlds:ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate contextRef="c160" id="ixv-18627">5 years following the issuance date</wlds:ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate>
    <wlds:ShareBasedCompensationArrangementNotes contextRef="c160" id="ixv-18632">Owned by underwriter</wlds:ShareBasedCompensationArrangementNotes>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c161"
      decimals="INF"
      id="ixv-19348"
      unitRef="shares">23640</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="c162"
      decimals="2"
      id="ixv-19349"
      unitRef="usdPershares">4.23</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <wlds:ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio contextRef="c162" id="ixv-18656">Each warrant is exercisable into 1 Ordinary Share</wlds:ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio>
    <wlds:ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate contextRef="c162" id="ixv-18661">10 years following the issuance date</wlds:ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate>
    <wlds:ShareBasedCompensationArrangementNotes contextRef="c162" id="ixv-18666">Owned by the legal advisor</wlds:ShareBasedCompensationArrangementNotes>
    <wlds:ExercisePriceOfWarrants
      contextRef="c4"
      decimals="2"
      id="ixv-19351"
      unitRef="usdPershares">4</wlds:ExercisePriceOfWarrants>
    <wlds:WarrantBeReducedToAnExercisePricePercentage contextRef="c0" decimals="2" id="ixv-19352" unitRef="pure">0.50</wlds:WarrantBeReducedToAnExercisePricePercentage>
    <wlds:InitialExercisePricePercentage contextRef="c0" decimals="2" id="ixv-19353" unitRef="pure">0.50</wlds:InitialExercisePricePercentage>
    <wlds:WeightedAveragePricePercentage contextRef="c0" decimals="2" id="ixv-19354" unitRef="pure">1</wlds:WeightedAveragePricePercentage>
    <wlds:LowestResetPrice
      contextRef="c4"
      decimals="2"
      id="ixv-19355"
      unitRef="usdPershares">2</wlds:LowestResetPrice>
    <wlds:InitialExercisePricesPercentage contextRef="c0" decimals="2" id="ixv-19356" unitRef="pure">0.50</wlds:InitialExercisePricesPercentage>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c0" id="ixv-18713">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 10
- TAXES ON INCOME:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 54pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-indent: 0in; padding-left: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company
    is taxed under the Israeli law.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 54pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b.&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Income of an Israeli company is subject to corporate tax. The corporate tax rate in Israel is&#160;23%.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 54pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;c.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Tax assessments - In accordance
    with the Israeli Income Tax Ordinance, tax assessments of the Company through tax year 2016 are considered final.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 54pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;d.&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Carryforward tax losses of the Company as of December 31, 2023, amounted to approximately $13.8 million; however, a full valuation allowance of $3.2 million was recorded against the potential future tax benefits.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 54pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;e.&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Subsidiary is taxed under the U.S. tax law. The federal tax rate is 21%.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <wlds:CorporateTaxRatePercentage
      contextRef="c163"
      decimals="2"
      id="ixv-19357"
      unitRef="pure">0.23</wlds:CorporateTaxRatePercentage>
    <us-gaap:OperatingLossCarryforwards contextRef="c4" decimals="-5" id="ixv-19358" unitRef="usd">13800000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c4" decimals="-5" id="ixv-19359" unitRef="usd">3200000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c7" decimals="2" id="ixv-19360" unitRef="pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c6" decimals="2" id="ixv-19361" unitRef="pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c0" decimals="2" id="ixv-19362" unitRef="pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="c0" id="ixv-18771">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE
11 &#x2013; RELATED PARTIES&lt;/b&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
employment expenses of the co-founders who each owns more than 5% of the Company&#x2019;s Ordinary Shares: Asher Dahan (the Chairman of
the Board of Directors and the Chief Executive Officer), Guy Wanger (President and Director) and Leeor Langer (the Chief Technology Officer),
for the years ended December 31, 2023, 2022 and 2021 amounted to approximately $293 thousand, $331 thousand, and $145 thousand, respectively.
On March 14, 2022, the Company&#x2019;s shareholders meeting approved the increase of the monthly salary of each of the Company&#x2019;s
co-founders to NIS&#160;70&#160;thousand (approximately $19&#160;thousand), plus social benefits and leased car, and approved a one-time
bonus equal to 6 monthly salaries, upon the closing of the IPO which was accomplished in September 2022 (see note 1e).&lt;/span&gt;&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <wlds:PercentageOfOwnership
      contextRef="c164"
      decimals="2"
      id="ixv-19363"
      unitRef="pure">0.05</wlds:PercentageOfOwnership>
    <wlds:EmploymentExpenses
      contextRef="c164"
      decimals="-3"
      id="ixv-19364"
      unitRef="usd">293000</wlds:EmploymentExpenses>
    <wlds:EmploymentExpenses
      contextRef="c165"
      decimals="-3"
      id="ixv-19365"
      unitRef="usd">331000</wlds:EmploymentExpenses>
    <wlds:EmploymentExpenses
      contextRef="c166"
      decimals="-3"
      id="ixv-19366"
      unitRef="usd">145000</wlds:EmploymentExpenses>
    <wlds:OfficerEmployeeMonthlySalary
      contextRef="c167"
      decimals="-3"
      id="ixv-19367"
      unitRef="ils">70000</wlds:OfficerEmployeeMonthlySalary>
    <wlds:RelatedPartyMonthlySalary
      contextRef="c167"
      decimals="-3"
      id="ixv-19368"
      unitRef="usd">19000</wlds:RelatedPartyMonthlySalary>
    <us-gaap:DepositsAssetsCurrent
      contextRef="c5"
      id="hidden-fact-0"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DepositsAssetsNoncurrent
      contextRef="c5"
      id="hidden-fact-1"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DeferredRevenueCurrent
      contextRef="c4"
      id="hidden-fact-2"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c4"
      id="hidden-fact-3"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c5"
      id="hidden-fact-4"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:ProspectiveInitialPublicOfferingExpenses
      contextRef="c0"
      id="hidden-fact-5"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c7"
      decimals="2"
      id="hidden-fact-6"
      unitRef="usdPershares">-0.27</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c0"
      decimals="2"
      id="hidden-fact-7"
      unitRef="usdPershares">-0.48</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c6"
      decimals="2"
      id="hidden-fact-8"
      unitRef="usdPershares">-0.53</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c6"
      decimals="0"
      id="hidden-fact-9"
      unitRef="shares">12277224</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c0"
      decimals="0"
      id="hidden-fact-10"
      unitRef="shares">16201238</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c7"
      decimals="0"
      id="hidden-fact-11"
      unitRef="shares">9709590</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <wlds:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost
      contextRef="c15"
      id="hidden-fact-12"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost
      contextRef="c16"
      id="hidden-fact-13"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost
      contextRef="c18"
      id="hidden-fact-14"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="c15"
      id="hidden-fact-15"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="c16"
      id="hidden-fact-16"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="c18"
      id="hidden-fact-17"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:ConversionOfOrdinaryASharesToOrdinarySharesValue
      contextRef="c16"
      id="hidden-fact-18"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:ConversionOfOrdinaryASharesToOrdinarySharesValue
      contextRef="c17"
      id="hidden-fact-19"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:ConversionOfOrdinaryASharesToOrdinarySharesValue
      contextRef="c18"
      id="hidden-fact-20"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:ConversionOfOrdinaryASharesToOrdinarySharesValue
      contextRef="c7"
      id="hidden-fact-21"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensation
      contextRef="c14"
      id="hidden-fact-22"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensation
      contextRef="c15"
      id="hidden-fact-23"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensation
      contextRef="c16"
      id="hidden-fact-24"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensation
      contextRef="c18"
      id="hidden-fact-25"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c15"
      id="hidden-fact-26"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c16"
      id="hidden-fact-27"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c17"
      id="hidden-fact-28"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c18"
      id="hidden-fact-29"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:StockIssuedDuringPeriodValueOfPaymentOnBehalfOfSharesIssued
      contextRef="c14"
      id="hidden-fact-30"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:StockIssuedDuringPeriodValueOfPaymentOnBehalfOfSharesIssued
      contextRef="c15"
      id="hidden-fact-31"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:StockIssuedDuringPeriodValueOfPaymentOnBehalfOfSharesIssued
      contextRef="c17"
      id="hidden-fact-32"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:StockIssuedDuringPeriodValueOfPaymentOnBehalfOfSharesIssued
      contextRef="c18"
      id="hidden-fact-33"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="c14"
      id="hidden-fact-34"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="c15"
      id="hidden-fact-35"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="c16"
      id="hidden-fact-36"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="c17"
      id="hidden-fact-37"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c20"
      id="hidden-fact-38"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c21"
      id="hidden-fact-39"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet
      contextRef="c27"
      id="hidden-fact-40"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="c27"
      id="hidden-fact-41"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants
      contextRef="c25"
      id="hidden-fact-42"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants
      contextRef="c27"
      id="hidden-fact-43"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c25"
      id="hidden-fact-44"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c26"
      id="hidden-fact-45"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c27"
      id="hidden-fact-46"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c6"
      id="hidden-fact-47"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensation
      contextRef="c25"
      id="hidden-fact-48"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensation
      contextRef="c27"
      id="hidden-fact-49"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="c25"
      id="hidden-fact-50"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="c26"
      id="hidden-fact-51"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:AccruedInterestOnConvertibleSecurities
      contextRef="c0"
      id="hidden-fact-52"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:AccruedInterestOnConvertibleSecurities
      contextRef="c6"
      id="hidden-fact-53"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:AccruedInterestOnDeposits
      contextRef="c6"
      id="hidden-fact-54"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:AccruedInterestOnDeposits
      contextRef="c7"
      id="hidden-fact-55"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="c6"
      id="hidden-fact-56"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="c7"
      id="hidden-fact-57"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="c0"
      id="hidden-fact-58"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:IncreaseDecreaseInAdvancePaymentsOnGovernmentalGrant
      contextRef="c0"
      id="hidden-fact-59"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:IncreaseDecreaseInAdvancePaymentsOnGovernmentalGrant
      contextRef="c6"
      id="hidden-fact-60"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquireRestrictedCertificatesOfDeposit
      contextRef="c6"
      id="hidden-fact-61"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquireRestrictedCertificatesOfDeposit
      contextRef="c7"
      id="hidden-fact-62"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:PrepaymentsOfLeasing
      contextRef="c0"
      id="hidden-fact-63"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:PrepaymentsOfLeasing
      contextRef="c7"
      id="hidden-fact-64"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost
      contextRef="c6"
      id="hidden-fact-65"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost
      contextRef="c7"
      id="hidden-fact-66"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPubli
      contextRef="c0"
      id="hidden-fact-67"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPubli
      contextRef="c7"
      id="hidden-fact-68"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:ProceedsFromIssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost
      contextRef="c0"
      id="hidden-fact-69"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:ProceedsFromIssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCost
      contextRef="c6"
      id="hidden-fact-70"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:ProceedsFromIssuanceOfSAFEs
      contextRef="c0"
      id="hidden-fact-71"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:ProceedsFromIssuanceOfSAFEs
      contextRef="c7"
      id="hidden-fact-72"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:RefundToSAFEInvestors
      contextRef="c0"
      id="hidden-fact-73"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:RefundToSAFEInvestors
      contextRef="c7"
      id="hidden-fact-74"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="c0"
      id="hidden-fact-75"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="c7"
      id="hidden-fact-76"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="c0"
      id="hidden-fact-77"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="c7"
      id="hidden-fact-78"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants
      contextRef="c0"
      decimals="-3"
      id="hidden-fact-79"
      unitRef="usd">1449000</wlds:ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants>
    <wlds:ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants
      contextRef="c7"
      id="hidden-fact-80"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="c0"
      id="hidden-fact-81"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="c6"
      id="hidden-fact-82"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:PaymentOnBehalfOfIssuedShares
      contextRef="c0"
      id="hidden-fact-83"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:PaymentOnBehalfOfIssuedShares
      contextRef="c6"
      id="hidden-fact-84"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InterestPaidNet
      contextRef="c0"
      id="hidden-fact-85"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InterestPaidNet
      contextRef="c7"
      id="hidden-fact-86"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:InterestReceivedFromDeposits
      contextRef="c6"
      id="hidden-fact-87"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:InterestReceivedFromDeposits
      contextRef="c7"
      id="hidden-fact-88"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:ConversionOfSAFEToEquity
      contextRef="c0"
      id="hidden-fact-89"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:ConversionOfSAFEToEquity
      contextRef="c7"
      id="hidden-fact-90"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:RightofUseAssetRecognizedAgainstLeaseLiability
      contextRef="c7"
      id="hidden-fact-91"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="c5"
      id="hidden-fact-92"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="c5"
      id="hidden-fact-93"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c64"
      id="hidden-fact-94"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:ResearchAndDevelopmentGrantsDetection
      contextRef="c72"
      id="hidden-fact-95"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c0"
      id="hidden-fact-96"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c0"
      id="hidden-fact-97"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c4" id="hidden-fact-98">P2Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <dei:AmendmentFlag contextRef="c0" id="ixv-19470">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="c0" id="ixv-19471">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-19472">0001887673</dei:EntityCentralIndexKey>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#ix_0_fact"
          xlink:label="ix_0_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-9"
          xlink:label="hidden-fact-9"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_1_fact"
          xlink:label="ix_1_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-11"
          xlink:label="hidden-fact-11"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-10"
          xlink:label="hidden-fact-10"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_2_fact"
          xlink:label="ix_2_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_0_footnote" xlink:label="ix_0_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In April 2021, the Company completed a 1:1 conversion of all of its issued and outstanding ordinary A shares into ordinary shares, NIS 0.01 par value, which was applied retroactively for the calculation of the basic and diluted loss per share.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_0_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-9"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_1_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-11"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-10"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_2_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#hidden-fact-44"
          xlink:label="hidden-fact-44"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-42"
          xlink:label="hidden-fact-42"
          xlink:type="locator"/>
        <link:footnote id="ix_1_footnote" xlink:label="ix_1_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represent an amount less than $500</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-44"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-42"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_3_fact"
          xlink:label="ix_3_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_2_footnote" xlink:label="ix_2_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif">Including the grant of 120,000 options to purchase up to 120,000 Ordinary Shares to directors, as approved by the Company&#x2019;s shareholders on November 30, 2023, with an exercise price of $1.32 per share. The options will expire at the earlier of (i) ten years from the date of grant or (ii) 90 days following a termination of employment or service. The fair value of each option as of the grant date was $0.12, determined using the Black-Scholes option pricing model and the total expenses of $15 thousand will be expensed over the option vesting periods of three years.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_3_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_5_fact"
          xlink:label="ix_5_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_4_fact"
          xlink:label="ix_4_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_7_fact"
          xlink:label="ix_7_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_6_fact"
          xlink:label="ix_6_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_3_footnote" xlink:label="ix_3_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif">On April 27, 2023, the Company&#x2019;s Board of Directors approved the additional grant of options to purchase up to 100,000 Ordinary Shares to a consultant, with an exercise price of $0.55 per share. The options will expire at the earlier of (i) ten years from the date of grant or (ii) 90 days following a termination of services. The fair value of each option as of the grant date was $0.26, determined using the Black-Scholes option pricing model and the total expenses of $26 thousand will be expensed over the option vesting periods of three years.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_5_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_4_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_7_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_6_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_8_fact"
          xlink:label="ix_8_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_4_footnote" xlink:label="ix_4_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The warrants are exercisable at
any time after their original issuance and at any time up to the date that is five&#160;years after their original issuance. The warrants
will be exercisable, at the option of each holder, in whole or in part by delivering to us a duly executed exercise notice and, at any
time a registration statement registering the issuance of the Ordinary Shares underlying the warrants under the Securities Act is effective
and available for the issuance of such shares, by payment in full in immediately available funds for the number of Ordinary Shares purchased
upon such exercise.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_8_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
